PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kind, J; Vaquerizas, JM; Gebhardt, P; Gentzel, M; Luscombe, NM; Bertone, P; Akhtar, A				Kind, Jop; Vaquerizas, Juan M.; Gebhardt, Philipp; Gentzel, Marc; Luscombe, Nicholas M.; Bertone, Paul; Akhtar, Asifa			Genome-wide analysis reveals MOF as a key regulator of dosage compensation and gene expression in Drosophila	CELL			English	Article							GLOBAL HISTONE ACETYLATION; MSL COMPLEX; HIGH-RESOLUTION; H4 ACETYLATION; X-CHROMOSOME; ACETYLTRANSFERASE; PROTEIN; TRANSCRIPTION; RECRUITMENT; METHYLATION	Dosage compensation, mediated by the MSL complex, regulates X-chromosomal gene expression in Drosophila. Here we report that the histone H4 lysine 16 (H4K16) specific histone acetyltransferase MOF displays differential binding behavior depending on whether the target gene is located on the X chromosome versus the autosomes. More specifically, on the male X chromosome, where MSL1 and MSL3 are preferentially associated with the 30 end of dosage compensated genes, MOF displays a bimodal distribution binding to promoters and the 30 ends of genes. In contrast, on MSL1/MSL3 independent X-linked genes and autosomal genes in males and females, MOF binds primarily to promoters. Binding of MOF to autosomes is functional, as H4K16 acetylation and the transcription levels of a number of genes are affected upon MOF depletion. Therefore, MOF is not only involved in the onset of dosage compensation, but also acts as a regulator of gene expression in the Drosophila genome.	[Kind, Jop; Gebhardt, Philipp; Gentzel, Marc; Luscombe, Nicholas M.; Bertone, Paul; Akhtar, Asifa] European Mol Biol Lab, Gene Express Unit, D-69117 Heidelberg, Germany; [Vaquerizas, Juan M.; Luscombe, Nicholas M.; Bertone, Paul] EMBL European Bioinformat Inst, Cambridge CB10 1SD, England	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Akhtar, A (corresponding author), European Mol Biol Lab, Gene Express Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	akhtar@embl.de	Vaquerizas, Juan M/F-2676-2011; Vaquerizas, Juan M/AAY-2339-2020; Bertone, Paul/A-6600-2013; Bertone, Paul/Z-3734-2019	Vaquerizas, Juan M/0000-0002-6583-6541; Vaquerizas, Juan M/0000-0002-6583-6541; Bertone, Paul/0000-0001-5059-4829; Bertone, Paul/0000-0001-5059-4829; Gentzel, Marc/0000-0002-4482-6010; Gebhardt, Philipp/0000-0001-5879-2512				Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Alekseyenko AA, 2006, GENE DEV, V20, P848, DOI 10.1101/gad.1400206; Anguita E, 2001, P NATL ACAD SCI USA, V98, P12114, DOI 10.1073/pnas.201413098; BASHAW GJ, 1995, DEVELOPMENT, V121, P3245; Bell O, 2008, MOL CELL BIOL, V28, P3401, DOI 10.1128/MCB.00006-08; Bhadra U, 1999, GENETICS, V152, P249; BONE JR, 1994, GENE DEV, V8, P96, DOI 10.1101/gad.8.1.96; Calestagne-Morelli A, 2006, BIOCHEM CELL BIOL, V84, P518, DOI 10.1139/O06-067; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Corona DFV, 2002, EMBO REP, V3, P242, DOI 10.1093/embo-reports/kvf056; Dahlsveen IK, 2006, PLOS GENET, V2, P104, DOI 10.1371/journal.pgen.0020005; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Duncan K, 2006, GENE DEV, V20, P368, DOI 10.1101/gad.371406; Gilfillan GD, 2006, GENE DEV, V20, P858, DOI 10.1101/gad.1399406; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Horak CE, 2002, METHOD ENZYMOL, V350, P469, DOI 10.1016/S0076-6879(02)50979-4; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; Kelley RL, 1999, CELL, V98, P513, DOI 10.1016/S0092-8674(00)81979-0; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; Kind J, 2007, GENE DEV, V21, P2030, DOI 10.1101/gad.430807; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Larschan E, 2007, MOL CELL, V28, P121, DOI 10.1016/j.molcel.2007.08.011; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Legube G, 2006, GENE DEV, V20, P871, DOI 10.1101/gad.377506; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; Marin I, 2003, J MOL EVOL, V56, P527, DOI 10.1007/s00239-002-2422-1; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Mendjan S, 2007, CHROMOSOMA, V116, P95, DOI 10.1007/s00412-006-0089-x; Morales V, 2004, EMBO J, V23, P2258, DOI 10.1038/sj.emboj.7600235; Park Y, 2002, SCIENCE, V298, P1620, DOI 10.1126/science.1076686; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Schubeler D, 2006, GENE DEV, V20, P749, DOI 10.1101/gad.1423006; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Smith ER, 2001, J BIOL CHEM, V276, P31483, DOI 10.1074/jbc.C100351200; Straub T, 2007, NAT REV GENET, V8, P47, DOI 10.1038/nrg2013; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; WORBY C, 2001, SCI STKE, V1, P95; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; ZHOU SB, 1995, EMBO J, V14, P2884, DOI 10.1002/j.1460-2075.1995.tb07288.x	46	121	122	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 30	2008	133	5					813	828		10.1016/j.cell.2008.04.036	http://dx.doi.org/10.1016/j.cell.2008.04.036			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	306UY	18510926	Bronze			2022-12-24	WOS:000256274500014
J	Simon, DJ; Madison, JM; Conery, AL; Thompson-Peer, KL; Soskis, M; Ruvkun, GB; Kaplan, JM; Kim, JK				Simon, David J.; Madison, Jon M.; Conery, Annie L.; Thompson-Peer, Katherine L.; Soskis, Michael; Ruvkun, Gary B.; Kaplan, Joshua M.; Kim, John K.			The MicroRNA miR-1 regulates a MEF-2-dependent retrograde signal at neuromuscular junctions	CELL			English	Article							SYNAPTIC-TRANSMISSION; ACETYLCHOLINE-RECEPTORS; NICOTINIC RECEPTOR; DIFFERENTIATION; ABUNDANCE; TARGETS; IDENTIFICATION; EXPRESSION; MATURATION; PROTEINS	We show that miR-1, a conserved muscle-specific microRNA, regulates aspects of both pre- and post-synaptic function at C. elegans neuromuscular junctions. miR-1 regulates the expression level of two nicotinic acetylcholine receptor (nAChR) subunits (UNC-29 and UNC-63), thereby altering muscle sensitivity to acetylcholine (ACh). miR-1 also regulates the muscle transcription factor MEF-2, which results in altered presynaptic ACh secretion, suggesting that MEF-2 activity in muscles controls a retrograde signal. The effect of the MEF-2-dependent retrograde signal on secretion is mediated by the synaptic vesicle protein RAB-3. Finally, acute activation of levamisole-sensitive nAChRs stimulates MEF-2-dependent transcriptional responses and induces the MEF-2-dependent retrograde signal. We propose that miR-1 refines synaptic function by coupling changes in muscle activity to changes in presynaptic function.	[Simon, David J.; Madison, Jon M.; Conery, Annie L.; Thompson-Peer, Katherine L.; Ruvkun, Gary B.; Kaplan, Joshua M.; Kim, John K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Simon, David J.; Soskis, Michael] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kaplan, JM (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	kaplan@molbio.mgh.harvard.edu	Thompson-Peer, Katherine/AAC-1051-2020	Thompson-Peer, Katherine/0000-0002-4200-3870; Simon, David/0000-0002-2683-5757	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032196, F32NS010310] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS032196-15, R01 NS032196-13, R01 NS032196, F32 NS010310, R01 NS032196-14, R01 NS032196-11, R01 NS032196-12, 1F32NS10310] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Black BL, 1997, MOL CELL BIOL, V17, P2756, DOI 10.1128/MCB.17.5.2756; Brown LA, 2006, INT J PARASITOL, V36, P617, DOI 10.1016/j.ijpara.2006.01.016; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; CHEN L, 1992, SCIENCE, V256, P240, DOI 10.1126/science.1314423; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; Dichoso D, 2000, DEV BIOL, V223, P431, DOI 10.1006/dbio.2000.9758; Dittman JS, 2006, P NATL ACAD SCI USA, V103, P11399, DOI 10.1073/pnas.0600784103; Doi M, 2002, NEURON, V33, P249, DOI 10.1016/S0896-6273(01)00587-6; Dreier L, 2005, NEURON, V46, P51, DOI 10.1016/j.neuron.2004.12.058; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Francis MM, 2005, NEURON, V46, P581, DOI 10.1016/j.neuron.2005.04.010; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gottschalk A, 2005, EMBO J, V24, P2566, DOI 10.1038/sj.emboj.7600741; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; GU Y, 1988, NEURON, V1, P117, DOI 10.1016/0896-6273(88)90195-X; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Kalinovsky A, 2004, CURR OPIN NEUROBIOL, V14, P272, DOI 10.1016/j.conb.2004.05.011; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; Millar NS, 2003, BIOCHEM SOC T, V31, P869, DOI 10.1042/BST0310869; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Missias AC, 1996, DEV BIOL, V179, P223, DOI 10.1006/dbio.1996.0253; Nguyen HT, 2006, CURR OPIN GENET DEV, V16, P533, DOI 10.1016/j.gde.2006.08.010; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shalizi AK, 2005, CURR TOP DEV BIOL, V69, P239, DOI 10.1016/S0070-2153(05)69009-6; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Thiagarajan R, 2004, J PHYSIOL-LONDON, V555, P439, DOI 10.1113/jphysiol.2003.056333; Touroutine D, 2005, J BIOL CHEM, V280, P27013, DOI 10.1074/jbc.M502818200; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; van der Linden AM, 2007, EMBO J, V26, P358, DOI 10.1038/sj.emboj.7601479; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	48	145	160	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 30	2008	133	5					903	915		10.1016/j.cell.2008.04.035	http://dx.doi.org/10.1016/j.cell.2008.04.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	306UY	18510933	Green Accepted, Bronze			2022-12-24	WOS:000256274500021
J	Tosca, NJ; Knoll, AH; McLennan, SM				Tosca, Nicholas J.; Knoll, Andrew H.; McLennan, Scott M.			Water activity and the challenge for life on early Mars	SCIENCE			English	Article							MERIDIANI-PLANUM; BURNS FORMATION; ASSEMBLAGES; RECORD	In situ and orbital exploration of the martian surface has shown that acidic, saline liquid water was intermittently available on ancient Mars. The habitability of these waters depends critically on water activity (aH(2)O), a thermodynamic measure of salinity, which, for terrestrial organisms, has sharply defined limits. Using constraints on fluid chemistry and saline mineralogy based on martian data, we calculated the maximum aH(2)O for Meridiani Planum and other environments where salts precipitated from martian brines. Our calculations indicate that the salinity of well-documented surface waters often exceeded levels tolerated by known terrestrial organisms.	[Tosca, Nicholas J.; Knoll, Andrew H.] Harvard Univ, Dept Organism & Evolut Biol, Cambridge, MA 02138 USA; [McLennan, Scott M.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA	Harvard University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Tosca, NJ (corresponding author), Harvard Univ, Dept Organism & Evolut Biol, Cambridge, MA 02138 USA.	ntosca@fas.harvard.edu		McLennan, Scott/0000-0003-4259-7178; Tosca, Nicholas/0000-0003-4415-4231				Andrews-Hanna JC, 2007, NATURE, V446, P163, DOI 10.1038/nature05594; Bridges JC, 2000, EARTH PLANET SC LETT, V176, P267, DOI 10.1016/S0012-821X(00)00019-4; Carr M. H, 2007, SURFACE MARS; Clark BC, 2005, EARTH PLANET SC LETT, V240, P73, DOI 10.1016/j.epsl.2005.09.040; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Grant WD, 2004, PHILOS T R SOC B, V359, P1249, DOI 10.1098/rstb.2004.1502; Grotzinger JP, 2005, EARTH PLANET SC LETT, V240, P11, DOI 10.1016/j.epsl.2005.09.039; Hardie L. A, 1970, MINERALOG SOC AM SPE, P273; Hurowitz JA, 2007, EARTH PLANET SC LETT, V260, P432, DOI 10.1016/j.epsl.2007.05.043; Johnson JR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029894; Keller JM, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002679; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; Knoll AH, 2005, EARTH PLANET SC LETT, V240, P179, DOI 10.1016/j.epsl.2005.09.045; Knoll AH, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002949; Madden MEE, 2004, NATURE, V431, P821, DOI 10.1038/nature02971; MARION GM, 2008, COLD AQUEOUS GEOCHEM; McLennan SM, 2005, EARTH PLANET SC LETT, V240, P95, DOI 10.1016/j.epsl.2005.09.041; Ming DW, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002560; Oren A, 2002, J IND MICROBIOL BIOT, V28, P56, DOI 10.1038/sj.jim.7000176; Osterloo MM, 2008, SCIENCE, V319, P1651, DOI 10.1126/science.1150690; Peterson RC, 2006, GEOLOGY, V34, P957, DOI 10.1130/G22678A.1; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; Tosca NJ, 2006, EARTH PLANET SC LETT, V241, P21, DOI 10.1016/j.epsl.2005.10.021; Tosca NJ, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002218; Tosca NJ, 2005, EARTH PLANET SC LETT, V240, P122, DOI 10.1016/j.epsl.2005.09.042	25	190	190	1	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2008	320	5880					1204	1207		10.1126/science.1155432	http://dx.doi.org/10.1126/science.1155432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306FF	18511686				2022-12-24	WOS:000256233000035
J	Zhou, LB; Bar, I; Achouri, Y; Campbell, K; De Backer, O; Hebert, JM; Jones, K; Kessaris, N; de Rouvroit, CL; O'Leary, D; Richardson, WD; Goffinet, AM; Tissir, F				Zhou, Libing; Bar, Isabelle; Achouri, Younes; Campbell, Kenneth; De Backer, Olivier; Hebert, Jean M.; Jones, Kevin; Kessaris, Nicoletta; de Rouvroit, Catherine Lambert; O'Leary, Dennis; Richardson, William D.; Goffinet, Andre M.; Tissir, Fadel			Early forebrain wiring: Genetic dissection using conditional Celsr3 mutant mice	SCIENCE			English	Article							PLANAR CELL POLARITY; EXPRESSION; AXONS; CONNECTIONS; FLAMINGO; DEFECTS; NEURONS; LINEAGE; CORTEX; MOUSE	Development of axonal tracts requires interactions between growth cones and the environment. Tracts such as the anterior commissure and internal capsule are defective in mice with null mutation of Celsr3. We generated a conditional Celsr3 allele, allowing regional inactivation. Inactivation in telencephalon, ventral forebrain, or cortex demonstrated essential roles for Celsr3 in neurons that project axons to the anterior commissure and subcerebral targets, as well as in cells that guide axons through the internal capsule. When Celsr3 was inactivated in cortex, subcerebral projections failed to grow, yet corticothalamic axons developed normally, indicating that besides guidepost cells, additional Celsr3-independent cues can assist their progression. These observations provide in vivo evidence that Celsr3-mediated interactions between axons and guidepost cells govern axonal tract formation in mammals.	[Zhou, Libing; Achouri, Younes; Goffinet, Andre M.; Tissir, Fadel] Univ Catholique Louvain, B-1200 Brussels, Belgium; [Bar, Isabelle; De Backer, Olivier; de Rouvroit, Catherine Lambert] Fac Univ Notre Dame Paix, B-5000 Namur, Belgium; [Campbell, Kenneth] Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA; [Hebert, Jean M.] Albert Einstein Coll Med, Bronx, NY 10461 USA; [Jones, Kevin] Univ Colorado, Boulder, CO 80309 USA; [Kessaris, Nicoletta; Richardson, William D.] UCL, London WC1E 6AE, England; [O'Leary, Dennis] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Universite Catholique Louvain; University of Namur; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Yeshiva University; Albert Einstein College of Medicine; University of Colorado System; University of Colorado Boulder; University of London; University College London; Salk Institute	Tissir, F (corresponding author), Univ Catholique Louvain, B-1200 Brussels, Belgium.	fadel.tissir@uclouvain.be	Campbell, Kenneth/ABC-3570-2021; Kessaris, Nicoletta/C-7249-2008; Kessaris, Nicoletta/AAD-6774-2019; bar, isabelle/AAQ-7795-2020; Richardson, William/C-1762-2008	Kessaris, Nicoletta/0000-0003-1191-6009; Kessaris, Nicoletta/0000-0003-1191-6009; Richardson, William/0000-0001-7261-2485; JONES, KEVIN/0000-0002-3802-7562; ACHOURI, Younes/0000-0001-7409-1441; Tissir, Fadel/0000-0002-9292-6622; Zhou, Libing/0000-0002-8975-5228	MRC [G9708005, G0501173] Funding Source: UKRI; Medical Research Council [G0501173, G0800575, G9708005] Funding Source: Medline; NIMH NIH HHS [R01 MH086147, R01 MH086147-05] Funding Source: Medline; NINDS NIH HHS [R37 NS031558-15, R37 NS031558] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031558] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BENTLEY D, 1983, NATURE, V304, P62, DOI 10.1038/304062a0; Braisted JE, 1999, DEV BIOL, V208, P430, DOI 10.1006/dbio.1999.9216; Chae J, 1999, DEVELOPMENT, V126, P5421; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; GHOSH A, 1990, NATURE, V347, P179, DOI 10.1038/347179a0; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Hevner RF, 2002, J COMP NEUROL, V447, P8, DOI 10.1002/cne.10219; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Lopez-Bendito G, 2006, CELL, V125, P127, DOI 10.1016/j.cell.2006.01.042; MITROFANIS J, 1993, TRENDS NEUROSCI, V16, P240, DOI 10.1016/0166-2236(93)90163-G; MOLNAR Z, 1991, NATURE, V351, P475, DOI 10.1038/351475a0; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stenman J, 2003, J NEUROSCI, V23, P167; Tessier-Lavigne Marc, 2002, Harvey Lect, V98, P103; Tissir F, 2006, EUR J NEUROSCI, V23, P597, DOI 10.1111/j.1460-9568.2006.04596.x; Tissir F, 2005, NAT NEUROSCI, V8, P451, DOI 10.1038/nn1428; Tissir F, 2002, MECH DEVELOP, V112, P157, DOI 10.1016/S0925-4773(01)00623-2; Tuttle R, 1999, DEVELOPMENT, V126, P1903; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Wang YS, 2002, J NEUROSCI, V22, P8563	23	138	140	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2008	320	5878					946	949		10.1126/science.1155244	http://dx.doi.org/10.1126/science.1155244			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18487195	Green Submitted, Green Accepted			2022-12-24	WOS:000255868300046
J	Kuipers, EJ; Surawicz, CM				Kuipers, Ernst J.; Surawicz, Christina M.			Clostridium difficile infection	LANCET			English	Editorial Material							DISEASE; METRONIDAZOLE; VANCOMYCIN; DIARRHEA; EPIDEMIOLOGY; STRAIN		[Kuipers, Ernst J.] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, NL-3000 CA Rotterdam, Netherlands; [Kuipers, Ernst J.] Erasmus MC Univ Med Ctr, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands; [Surawicz, Christina M.] Univ Washington, Harborview Med Ctr, Sch Med, Div Gastroenterol,Dept Med, Seattle, WA 98104 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harborview Medical Center; University of Washington; University of Washington Seattle	Kuipers, EJ (corresponding author), Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, NL-3000 CA Rotterdam, Netherlands.	e.j.kuipers@erasmusmc.nl	Kuipers, Ernst J/H-3293-2019; Smits, Wiep Klaas/A-8366-2008; Steer, Andrew C/C-2840-2013	Kuipers, Ernst J/0000-0002-0633-3098; Smits, Wiep Klaas/0000-0002-7409-2847; 				COHEN SH, IN PRESS INFECT CONT, P5231; Fernandez A, 2004, J CLIN GASTROENTEROL, V38, P414, DOI 10.1097/00004836-200405000-00005; Gerding DN, 2005, CLIN INFECT DIS, V40, P1598, DOI 10.1086/430317; Hubert B, 2007, CLIN INFECT DIS, V44, P238, DOI 10.1086/510391; Kuijper EJ, 2007, CURR OPIN INFECT DIS, V20, P376; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Matamouros S, 2007, MOL MICROBIOL, V64, P1274, DOI 10.1111/j.1365-2958.2007.05739.x; McFarland LV, 2002, AM J GASTROENTEROL, V97, P1769, DOI 10.1111/j.1572-0241.2002.05839.x; McFarland LV, 2000, J PEDIATR GASTR NUTR, V31, P220, DOI 10.1097/00005176-200009000-00004; Miller MA, 2007, CLIN INFECT DIS, V45, pS122, DOI 10.1086/519257; Musher DM, 2005, CLIN INFECT DIS, V40, P1586, DOI 10.1086/430311; Nelson R, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004610.pub3; Numan SC, 2007, GUT, V56, P888, DOI 10.1136/gut.2006.119016; Pepin J, 2007, AM J GASTROENTEROL, V102, P2781, DOI 10.1111/j.1572-0241.2007.01539.x; Surawicz CM, 2000, CLIN INFECT DIS, V31, P1012, DOI 10.1086/318130; Wanahita A, 2003, AM J MED, V115, P543, DOI 10.1016/S0002-9343(03)00420-0; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Zar FA, 2007, CLIN INFECT DIS, V45, P302, DOI 10.1086/519265	19	48	51	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2008	371	9623					1486	1488		10.1016/S0140-6736(08)60635-2	http://dx.doi.org/10.1016/S0140-6736(08)60635-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298ED	18456087				2022-12-24	WOS:000255668300008
J	Belloc, E; Mendez, R				Belloc, Eulalia; Mendez, Raul			A deadenylation negative feedback mechanism governs meiotic metaphase arrest	NATURE			English	Article							CYTOSTATIC FACTOR ARREST; ANAPHASE-PROMOTING COMPLEX; ZINC-FINGER PROTEINS; CYTOPLASMIC POLYADENYLATION; MESSENGER-RNA; XENOPUS-LAEVIS; POSITIVE FEEDBACK; BINDING PROTEIN; II TRANSITION; MEIOSIS-I	In vertebrate oocytes, meiotic progression is driven by the sequential translational activation of maternal messenger RNAs stored in the cytoplasm. This activation is mainly induced by the cytoplasmic elongation of their poly( A) tails, which is mediated by the cytoplasmic polyadenylation element ( CPE) present in their 39 untranslated regions(1,2). In Xenopus oocytes, sequential phase-specific translation of CPE- regulated mRNAs is required to activate the maturation- promoting factor, which in turn mediates entry into the two consecutive meiotic metaphases ( MI and MII)(3-6). Here we report a genome- wide functional screening to identify previously unknown mRNAs cytoplasmically polyadenylated at meiotic phase transitions. A significant fraction of transcripts containing, in addition to CPEs, ( A+U)- rich element ( ARE) sequences ( characteristic of mRNAs regulated by deadenylation(7)) were identified. Among these is the mRNA encoding C3H-4, an ARE- binding protein that we find to accumulate in MI and the ablation of which induces meiotic arrest. Our results suggest that C3H- 4 recruits the CCR4 deadenylase complex to ARE-containing mRNAs and this, in turn, causes shortening of poly( A) tails. We also show that the opposing activities of the CPEs and the AREs define the precise activation times of the mRNAs encoding the anaphase- promoting complex inhibitors Emi1 and Emi2 during distinct phases of the meiotic cycle. Taken together, our results show that an 'early' wave of cytoplasmic polyadenylation activates a negative feedback loop by activating the synthesis of C3H- 4, which in turn would recruit the deadenylase complex to mRNAs containing both CPEs and AREs. This negative feedback loop is required to exit from metaphase into interkinesis and for meiotic progression.	[Belloc, Eulalia; Mendez, Raul] Pompeu Fabra Univ, Ctr Genom Regulat, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Mendez, R (corresponding author), Pompeu Fabra Univ, Ctr Genom Regulat, C Dr Aiguader 88, Barcelona 08003, Spain.	raul.mendez@crg.es		Mendez, Raul/0000-0002-1952-6905				Aoki K, 2003, J BIOL CHEM, V278, P48491, DOI 10.1074/jbc.M308328200; Ballantyne S, 1997, MOL BIOL CELL, V8, P1633, DOI 10.1091/mbc.8.8.1633; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Castro A, 2003, J BIOL CHEM, V278, P2236, DOI 10.1074/jbc.M207894200; Charlesworth A, 2004, J BIOL CHEM, V279, P17650, DOI 10.1074/jbc.M313837200; Charlesworth A, 2000, DEV BIOL, V227, P706, DOI 10.1006/dbio.2000.9922; Collart MA, 2003, GENE, V313, P1, DOI 10.1016/S0378-1119(03)00672-3; De J, 1999, GENE, V228, P133, DOI 10.1016/S0378-1119(98)00617-9; deMoor CH, 1997, MOL CELL BIOL, V17, P6419, DOI 10.1128/MCB.17.11.6419; Ferrell JE, 1999, BIOESSAYS, V21, P866, DOI 10.1002/(SICI)1521-1878(199910)21:10<866::AID-BIES9>3.0.CO;2-1; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Inoue D, 2007, NATURE, V446, P1100, DOI 10.1038/nature05688; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Liu J, 2007, ONCOGENE, V26, P1286, DOI 10.1038/sj.onc.1210203; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Mendez R, 2002, EMBO J, V21, P1833, DOI 10.1093/emboj/21.7.1833; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Morita M, 2007, MOL CELL BIOL, V27, P4980, DOI 10.1128/MCB.02304-06; Nishiyama T, 2007, NATURE, V446, P1096, DOI 10.1038/nature05696; Ohe M, 2007, DEV BIOL, V303, P157, DOI 10.1016/j.ydbio.2006.10.044; Parry DH, 2003, CURR BIOL, V13, P647, DOI 10.1016/S0960-9822(03)00242-2; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; REMPEL RE, 1995, J BIOL CHEM, V270, P6843, DOI 10.1074/jbc.270.12.6843; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; SIMON R, 1994, MOL CELL BIOL, V14, P7867, DOI 10.1128/MCB.14.12.7867; Tung JJ, 2007, CELL CYCLE, V6, P725, DOI 10.4161/cc.6.6.3936; Tung JJ, 2005, P NATL ACAD SCI USA, V102, P4318, DOI 10.1073/pnas.0501108102; Voeltz GK, 1998, MOL CELL BIOL, V18, P7537, DOI 10.1128/MCB.18.12.7537; Wu L, 1997, MOL CELL BIOL, V17, P6402, DOI 10.1128/MCB.17.11.6402; Yang ZY, 2005, MOL CELL BIOL, V25, P4062, DOI 10.1128/MCB.25.10.4062-4074.2005	34	78	79	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2008	452	7190					1017	U11		10.1038/nature06809	http://dx.doi.org/10.1038/nature06809			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291PF	18385675				2022-12-24	WOS:000255208600044
J	Theoharides, TC				Theoharides, Theoharis C.			Mast cells and pancreatic cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Theoharides, Theoharis C.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Theoharides, Theoharis C.] Tufts Med Ctr, Boston, MA USA	Tufts University; Tufts Medical Center	Theoharides, TC (corresponding author), Tufts Univ, Sch Med, Boston, MA 02111 USA.							Cao J, 2005, J IMMUNOL, V174, P7665, DOI 10.4049/jimmunol.174.12.7665; Esposito I, 2004, J CLIN PATHOL, V57, P630, DOI 10.1136/jcp.2003.014498; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Theoharides TC, 2007, IMMUNOL REV, V217, P65, DOI 10.1111/j.1600-065X.2007.00519.x	5	53	54	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 24	2008	358	17					1860	1861		10.1056/NEJMcibr0801519	http://dx.doi.org/10.1056/NEJMcibr0801519			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PL	18434656				2022-12-24	WOS:000255209200018
J	Galkin, VE; Yu, X; Bielnicki, J; Heuser, J; Ewing, CP; Guerry, P; Egelman, EH				Galkin, Vitold E.; Yu, Xiong; Bielnicki, Jakub; Heuser, John; Ewing, Cheryl P.; Guerry, Patricia; Egelman, Edward H.			Divergence of quaternary structures among bacterial flagellar filaments	SCIENCE			English	Article							SALMONELLA-TYPHIMURIUM; MOTILITY; TRANSFORMATIONS; MUTATIONS; SEQUENCE	It has been widely assumed that the atomic structure of the flagellar filament from Salmonella typhimurium serves as a model for all bacterial flagellar filaments given the sequence conservation in the coiled- coil regions responsible for polymerization. On the basis of electron microscopic images, we show that the flagellar filaments from Campylobacter jejuni have seven protofilaments rather than the 11 in S. typhimurium. The vertebrate Toll- like receptor 5 ( TLR5) recognizes a region of bacterial flagellin that is involved in subunit- subunit assembly in Salmonella and many other pathogenic bacteria, and this short region has diverged in Campylobacter and related bacteria, such as Helicobacter pylori, which are not recognized by TLR5. The driving force in the change of quaternary structure between Salmonella and Campylobacter may have been the evasion of TLR5.	[Galkin, Vitold E.; Yu, Xiong; Bielnicki, Jakub; Egelman, Edward H.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Heuser, John] Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA; [Ewing, Cheryl P.; Guerry, Patricia] USN, Enter Dis Dept, Med Res Ctr, Silver Spring, MD 20910 USA	University of Virginia; Washington University (WUSTL); United States Department of Defense; United States Navy	Egelman, EH (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Box 800733, Charlottesville, VA 22908 USA.	egelman@virginia.edu	Egelman, Edward H/A-2488-2009; Guerry, Patricia/A-8024-2011; Galkin, Vitold/AAD-2844-2019	Egelman, Edward/0000-0003-4844-5212	NIAID NIH HHS [AI043559] Funding Source: Medline; NIBIB NIH HHS [EB001567] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001567] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Asakura S, 1970, Adv Biophys, V1, P99; Beatson SA, 2006, TRENDS MICROBIOL, V14, P151, DOI 10.1016/j.tim.2006.02.008; CALLADINE CR, 1975, NATURE, V255, P121, DOI 10.1038/255121a0; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Frank MK, 2002, NAT STRUCT BIOL, V9, P877, DOI 10.1038/nsb854; GUERRY P, 1991, J BACTERIOL, V173, P4757, DOI 10.1128/jb.173.15.4757-4764.1991; Guerry P, 2007, TRENDS MICROBIOL, V15, P456, DOI 10.1016/j.tim.2007.09.006; Heuser J, 1981, Methods Cell Biol, V22, P97; HOTANI H, 1982, J MOL BIOL, V156, P791, DOI 10.1016/0022-2836(82)90142-5; HYMAN HC, 1991, J MOL BIOL, V220, P79, DOI 10.1016/0022-2836(91)90382-G; KAMIYA R, 1976, J MOL BIOL, V106, P167, DOI 10.1016/0022-2836(76)90306-5; KAMIYA R, 1976, J MOL BIOL, V108, P513, DOI 10.1016/S0022-2836(76)80133-7; KANTO S, 1991, J MOL BIOL, V219, P471, DOI 10.1016/0022-2836(91)90187-B; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Orlova A, 2007, NAT STRUCT MOL BIOL, V14, P921, DOI 10.1038/nsmb1300; Ramos HC, 2004, TRENDS MICROBIOL, V12, P509, DOI 10.1016/j.tim.2004.09.002; Shibata S, 2005, J MOL BIOL, V352, P510, DOI 10.1016/j.jmb.2005.07.023; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Woodward JD, 2008, J STRUCT BIOL, V161, P111, DOI 10.1016/j.jsb.2007.09.019; Yamashita I, 1998, NAT STRUCT BIOL, V5, P125; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830	25	86	89	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2008	320	5874					382	385		10.1126/science.1155307	http://dx.doi.org/10.1126/science.1155307			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZZ	18420936				2022-12-24	WOS:000255026100046
J	Kestenbaum, B; Rudser, KD; de Boer, IH; Peralta, CA; Fried, LF; Shlipak, MG; Palmas, W; Stehman-Breen, C; Siscovick, DS				Kestenbaum, Bryan; Rudser, Kyle D.; de Boer, Ian H.; Peralta, Carmen A.; Fried, Linda F.; Shlipak, Michael G.; Palmas, Walter; Stehman-Breen, Catherine; Siscovick, David S.			Differences in kidney function and incident hypertension: The multi-ethnic study of atherosclerosis	ANNALS OF INTERNAL MEDICINE			English	Article							SERUM CYSTATIN-C; GLOMERULAR-FILTRATION-RATE; RENAL-DISEASE; BLOOD-PRESSURE; BIRTH-WEIGHT; CREATININE; RISK; PROTEINURIA; POPULATION; PREVALENCE	Background: Kidney disease and hypertension commonly coexist, yet the direction of their association is still debated. Objective: To evaluate whether early kidney dysfunction, measured by serum cystatin C levels and urinary albumin excretion, predates hypertension in adults without clinically recognized kidney or cardiovascular disease. Design: Observational cohort study using data from 2000 to 2005. Setting: The MESA (Multi-Ethnic Study of Atherosclerosis), a community-based study of subclinical cardiovascular disease in adults age 45 to 84 years. Participants: 2767 MESA participants without prevalent hypertension, cardiovascular disease, or clinically recognized kidney disease (an estimated glomerular filtration rate <60 mL/min per 1.73 m(2) or microalbuminuria). Measurements: Cystatin C was measured by using a nephelometer, and urinary albumin and creatinine were measured from a spot morning collection. The primary outcome was incident hypertension, defined as systolic blood pressure of at least 140 mm Hg, diastolic blood pressure of at least 90 mm Hg, or use of an anti hypertensive medication. Results: During a median follow-up of 3.1 years, 19.7% of the cohort (545 participants) developed hypertension. After adjustment for established hypertension risk factors, each 15-nmol/L increase in cystatin C was associated with a statistically significant 15% greater incidence of hypertension (P = 0.017). The highest sex-specific quartile of urinary albumin-creatinine ratio was associated with a statistically insignificant 16% greater incidence of hypertension (P = 0.192) compared with the lowest quartile. No statistical evidence suggested a multiplicative interaction. Limitations: Unmeasured characteristics may have confounded observed associations of kidney markers with hypertension. Follow-up was relatively short. Hypertension that may have occurred between study visits or hypertension that was not captured by standard cuff measurements may have been missed. Conclusion: Differences in kidney function, indicated by cystatin C levels, are associated with incident hypertension among individuals without clinical kidney or cardiovascular disease. These population-based findings complement experimental work implicating early kidney damage in the pathogenesis of essential hypertension.	[Kestenbaum, Bryan] Univ Washington, Harborview Med Ctr, Div Nephrol, Seattle, WA 98104 USA; San Francisco VA Med Ctr, San Francisco, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Pittsburgh, Sch Med, Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA USA; Columbia Univ, New York, NY USA; Amgen Inc, Thousand Oaks, CA USA; Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Pittsburgh, PA USA	Harborview Medical Center; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Columbia University; Amgen; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kestenbaum, B (corresponding author), Univ Washington, Harborview Med Ctr, Div Nephrol, Room 10EH11,325 9Th Ave, Seattle, WA 98104 USA.	brk@u.washington.edu	de Boer, Ian/GYJ-3282-2022		DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095165, N01HC095162, N01HC095169, N01HC095160, N01HC095163, N01HC095161, N01HC095159, N01HC095164] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000422, UL1TR000423] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025015] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL095169, R44HL095169, R21HL095165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK063274] Funding Source: NIH RePORTER	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON S, 1986, J CLIN INVEST, V77, P1993, DOI 10.1172/JCI112528; Andoh TF, 2001, AM J TRANSPLANT, V1, P222, DOI 10.1046/j.1600-6135.ajt10305.x; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; BORST JGG, 1963, LANCET, V1, P677; Brantsma AH, 2006, J AM SOC NEPHROL, V17, P331, DOI 10.1681/ASN.2005111153; Buckalew VM, 1996, AM J KIDNEY DIS, V28, P811, DOI 10.1016/S0272-6386(96)90380-7; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Coll E, 2000, AM J KIDNEY DIS, V36, P29, DOI 10.1053/ajkd.2000.8237; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Curhan GC, 1996, CIRCULATION, V94, P1310, DOI 10.1161/01.CIR.94.6.1310; DAHL LK, 1975, CIRC RES, V36, P692, DOI 10.1161/01.RES.36.6.692; Erlandsen EJ, 1999, SCAND J CLIN LAB INV, V59, P1, DOI 10.1080/00365519950185940; Foley RN, 2005, MAYO CLIN PROC, V80, P1270, DOI 10.4065/80.10.1270; Genuth S, 2003, DIABETES CARE, V26, P3160; GUYTON AC, 1972, AM J MED, V52, P584, DOI 10.1016/0002-9343(72)90050-2; HARVEY JM, 1992, LANCET, V340, P1435, DOI 10.1016/0140-6736(92)92624-O; Howie AJ, 1996, J HUM HYPERTENS, V10, P691; Hsu CY, 2005, ARCH INTERN MED, V165, P923, DOI 10.1001/archinte.165.8.923; Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3; Johnson RJ, 2002, NEW ENGL J MED, V346, P913, DOI 10.1056/NEJMra011078; Julius S, 1996, CLIN EXP HYPERTENS, V18, P305, DOI 10.3109/10641969609088965; Keller G, 2003, NEW ENGL J MED, V348, P101, DOI 10.1056/NEJMoa020549; Knight EL, 2004, KIDNEY INT, V65, P1416, DOI 10.1111/j.1523-1755.2004.00517.x; LAW CM, 1993, BRIT MED J, V306, P24, DOI 10.1136/bmj.306.6869.24; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Luyckx VA, 2005, KIDNEY INT, V68, pS68, DOI 10.1111/j.1523-1755.2005.09712.x; Mattix HJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341034; NEWMAN DJ, 1995, KIDNEY INT, V47, P312, DOI 10.1038/ki.1995.40; *NIH N I DIAB DIG, 2006, US REN DAT SYST ANN; NORRELUND H, 1994, HYPERTENSION, V24, P301, DOI 10.1161/01.HYP.24.3.301; PSATY BM, 1992, J CLIN EPIDEMIOL, V45, P683, DOI 10.1016/0895-4356(92)90143-B; SCHWAB SJ, 1987, ARCH INTERN MED, V147, P943, DOI 10.1001/archinte.147.5.943; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; STAESSEN JA, 1992, NEW ENGL J MED, V327, P151, DOI 10.1056/NEJM199207163270303; Wang TJ, 2005, CIRCULATION, V111, P1370, DOI 10.1161/01.CIR.0000158434.69180.2D; WILEY V, 1993, BIOSTATISTICS METHOD; Zelmanovitz T, 1998, DIABETES CARE, V21, P1076, DOI 10.2337/diacare.21.7.1076	39	93	100	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 1	2008	148	7					501	508		10.7326/0003-4819-148-7-200804010-00006	http://dx.doi.org/10.7326/0003-4819-148-7-200804010-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284IV	18378946	Green Accepted			2022-12-24	WOS:000254701000002
J	Trainor, L				Trainor, Laurel			Science & music: The neural roots of music	NATURE			English	Editorial Material									McMaster Univ, McMaster Inst Mus & Mind, Hamilton, ON L8S 4L8, Canada; McMaster Univ, Auditory Dev Lab, Hamilton, ON L8S 4L8, Canada	McMaster University; McMaster University	Trainor, L (corresponding author), McMaster Univ, McMaster Inst Mus & Mind, 1280 Main St W, Hamilton, ON L8S 4L8, Canada.			Trainor, Laurel/0000-0003-3397-2079				Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; Phillips-Silver J, 2005, SCIENCE, V308, P1430, DOI 10.1126/science.1110922; Trainor LJ, 2005, DEV PSYCHOBIOL, V46, P262, DOI 10.1002/dev.20059; TRAINOR LJ, IN PRESS CORTEX	4	51	55	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 29	2008	453	7195					598	599		10.1038/453598a	http://dx.doi.org/10.1038/453598a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305NN	18509429	Bronze			2022-12-24	WOS:000256185200028
J	Salmena, L; Carracedo, A; Pandolfi, PP				Salmena, Leonardo; Carracedo, Arkaitz; Pandolfi, Pier Paolo			Tenets of PTEN tumor suppression	CELL			English	Review							HEMATOPOIETIC STEM-CELLS; TENSIN-HOMOLOG; NUCLEAR PTEN; CELLULAR-TRANSFORMATION; PROMOTER METHYLATION; NEGATIVE REGULATION; MUTATIONAL SPECTRA; PROTEIN EXPRESSION; PROSTATE-CANCER; CYCLE ARREST	Since its discovery as the elusive tumor suppressor gene at the frequently mutated 10q23 locus, PTEN has been identified as lost or mutated in several sporadic and heritable tumor types. A decade of work has established that PTEN is a nonredundant phosphatase that is essential for regulating the highly oncogenic prosurvival PI3K/AKT signaling pathway. This review discusses emerging modes of PTEN function and regulation, and speculates about how manipulation of PTEN function could be used for cancer therapy.	[Salmena, Leonardo; Carracedo, Arkaitz; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Canc Genet Program, Boston, MA 02115 USA; [Salmena, Leonardo; Carracedo, Arkaitz; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol,Canc Genet Program, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Pandolfi, PP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Canc Genet Program, New Res Bldg,330 Brookline Ave, Boston, MA 02115 USA.	ppandolf@bidmc.harvard.edu	Carracedo, Arkaitz/F-7029-2011	Carracedo, Arkaitz/0000-0001-5957-1260; Salmena, Leonardo/0000-0003-4023-658X				Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Bose S, 1998, ONCOGENE, V17, P123, DOI 10.1038/sj.onc.1201940; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chappell WH, 2005, CELL CYCLE, V4, P1389, DOI 10.4161/cc.4.10.2028; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chow JYC, 2007, CARCINOGENESIS, V28, P2321, DOI 10.1093/carcin/bgm159; Chung JH, 2005, CANCER RES, V65, P4108, DOI 10.1158/0008-5472.CAN-05-0124; Chung JH, 2006, HUM MOL GENET, V15, P2553, DOI 10.1093/hmg/ddl177; Dahia PLM, 2000, ENDOCR-RELAT CANCER, V7, P115, DOI 10.1677/erc.0.0070115; Davidson B, 2008, HUM PATHOL, V39, P87, DOI 10.1016/j.humpath.2007.05.014; Deleris P, 2003, J BIOL CHEM, V278, P38884, DOI 10.1074/jbc.M300816200; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Feilotter HE, 1999, BRIT J CANCER, V79, P718, DOI 10.1038/sj.bjc.6690115; Franca-Koh J, 2007, NAT CELL BIOL, V9, P15, DOI 10.1038/ncb0107-15; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Fridberg M, 2007, LEUKEMIA LYMPHOMA, V48, P2221, DOI 10.1080/10428190701636443; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Garcia JM, 2004, GENE CHROMOSOME CANC, V41, P117, DOI 10.1002/gcc.20062; Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182; Gil A, 2006, MOL BIOL CELL, V17, P4002, DOI 10.1091/mbc.E06-05-0380; Gimm O, 2000, AM J PATHOL, V156, P1693, DOI 10.1016/S0002-9440(10)65040-7; Ginn-Pease ME, 2003, CANCER RES, V63, P282; Goel A, 2004, CANCER RES, V64, P3014, DOI 10.1158/0008-5472.CAN-2401-2; Gray IC, 1998, BRIT J CANCER, V78, P1296, DOI 10.1038/bjc.1998.674; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Han SY, 2000, CANCER RES, V60, P3147; Hettinger K, 2007, CELL DEATH DIFFER, V14, P218, DOI 10.1038/sj.cdd.4401946; Kang YH, 2002, LAB INVEST, V82, P285, DOI 10.1038/labinvest.3780422; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lachyankar MB, 2000, J NEUROSCI, V20, P1404; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Leupin N, 2003, BRIT J HAEMATOL, V121, P97, DOI 10.1046/j.1365-2141.2003.04227.x; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Li DM, 1997, CANCER RES, V57, P2124; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Lian ZL, 2005, ONCOGENE, V24, P7394, DOI 10.1038/sj.onc.1209089; Lindsay Y, 2006, J CELL SCI, V119, P5160, DOI 10.1242/jcs.000133; Liu FH, 2005, J CELL BIOCHEM, V96, P221, DOI 10.1002/jcb.20525; Liu JL, 2005, MOL CELL BIOL, V25, P6211, DOI 10.1128/MCB.25.14.6211-6224.2005; Liu JL, 2007, CANCER RES, V67, P11054, DOI 10.1158/0008-5472.CAN-07-1263; Maccario H, 2007, BIOCHEM J, V405, P439, DOI 10.1042/BJ20061837; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maier D, 1999, CANCER RES, V59, P5479; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; Marsh DJ, 1998, GENE CHROMOSOME CANC, V21, P61, DOI 10.1002/(SICI)1098-2264(199801)21:1<61::AID-GCC8>3.0.CO;2-6; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Miller SJ, 2002, FEBS LETT, V528, P145, DOI 10.1016/S0014-5793(02)03274-X; Minaguchi T, 2006, CANCER RES, V66, P11677, DOI 10.1158/0008-5472.CAN-06-2240; Mirmohammadsadegh A, 2006, CANCER RES, V66, P6546, DOI 10.1158/0008-5472.CAN-06-0384; Moorehead RA, 2003, J BIOL CHEM, V278, P50422, DOI 10.1074/jbc.M306894200; Mutter GL, 2000, JNCI-J NATL CANCER I, V92, P924, DOI 10.1093/jnci/92.11.924; NAHI H, 2008, BR J HAEMATOL   0312, DOI DOI 10.1111/J.1365-2141.2008.07074; Okahara F, 2004, J BIOL CHEM, V279, P45300, DOI 10.1074/jbc.C400377200; Okumura K, 2005, P NATL ACAD SCI USA, V102, P2703, DOI 10.1073/pnas.0409370102; Okumura K, 2006, J BIOL CHEM, V281, P26562, DOI 10.1074/jbc.M605391200; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Patel L, 2001, CURR BIOL, V11, P764, DOI 10.1016/S0960-9822(01)00225-1; Perren A, 2000, AM J PATHOL, V157, P1097, DOI 10.1016/S0002-9440(10)64624-X; Perren A, 1999, AM J PATHOL, V155, P1253, DOI 10.1016/S0002-9440(10)65227-3; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Puc J, 2005, CELL CYCLE, V4, P927, DOI 10.4161/cc.4.7.1795; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Saal LH, 2008, NAT GENET, V40, P102, DOI 10.1038/ng.2007.39; Sano T, 1999, CANCER RES, V59, P1820; Seo JH, 2005, MOL BIOL CELL, V16, P348, DOI 10.1091/mbc.E04-05-0369; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Shi W, 2003, INT J CANCER, V104, P195, DOI 10.1002/ijc.10909; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Tachibana M, 2002, CANCER-AM CANCER SOC, V94, P1955, DOI 10.1002/cncr.0678; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tang YF, 2006, CANCER RES, V66, P6139, DOI 10.1158/0008-5472.CAN-06-0772; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vasudevan KM, 2007, CANCER RES, V67, P10343, DOI 10.1158/0008-5472.CAN-07-1827; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Vivanco I, 2007, CANCER CELL, V11, P555, DOI 10.1016/j.ccr.2007.04.021; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Waite KA, 2002, AM J HUM GENET, V70, P829, DOI 10.1086/340026; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Whelan JT, 2007, CELL CYCLE, V6, P80, DOI 10.4161/cc.6.1.3648; Whiteman DC, 2002, INT J CANCER, V99, P63, DOI 10.1002/ijc.10294; Wu WD, 2003, J BIOL CHEM, V278, P28258, DOI 10.1074/jbc.M303318200; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Xia DR, 2007, J BIOL CHEM, V282, P3507, DOI 10.1074/jbc.M610141200; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhou XP, 2000, AM J PATHOL, V157, P1123, DOI 10.1016/S0002-9440(10)64627-5; Zhou XP, 2002, AM J PATHOL, V161, P439, DOI 10.1016/S0002-9440(10)64200-9; Zysman MA, 2002, AM J PATHOL, V160, P795, DOI 10.1016/S0002-9440(10)64902-4	121	833	905	1	85	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2008	133	3					403	414		10.1016/j.cell.2008.04.013	http://dx.doi.org/10.1016/j.cell.2008.04.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455982	Bronze			2022-12-24	WOS:000255503900012
J	Csete, J; Wolfe, D				Csete, Joanne; Wolfe, Daniel			Progress or backsliding on HIV and illicit drugs in 20008?	LANCET			English	Editorial Material									[Csete, Joanne] Canadian HIV AIDS Legal Network, Toronto, ON M5R 2A7, Canada; [Wolfe, Daniel] Open Soc Inst, New York, NY USA		Csete, J (corresponding author), Canadian HIV AIDS Legal Network, Toronto, ON M5R 2A7, Canada.	Jcsete2@hotmail.com						*AMN INT, 2004, THAIL ANT DRUG POL S; [Anonymous], 1961, SINGL CONV NARC DRUG; BEZLOV T, 2005, HEROIN USERS BULGARI; Csete J, 2007, DEPENDENT RIGHTS ASS; *INT NARC CONTR BO, 2005, ANN REP 2004; *INT NARC CONTR BO, 2006, ANN REP 2005; Lines R, 2005, INT J PRISON HEALTH, V1, P49, DOI 10.1080/17449200500157085; Mazlan M, 2006, DRUG ALCOHOL REV, V25, P473, DOI 10.1080/09595230600883354; *UN GEN ASS, 1998, AS24 UN GEN ASS; *UN GEN ASS, 2001, ARESS262 UN GEN ASS; *WHO, SUMM CONTR PROF HIV; WHO Model List of Essential Medicines, 2007, WHO MOD LIST ESS MED; Wolfe D, 2007, INT J DRUG POLICY, V18, P246, DOI 10.1016/j.drugpo.2007.01.012	13	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY-JUN	2008	371	9627					1820	1821		10.1016/S0140-6736(08)60777-1	http://dx.doi.org/10.1016/S0140-6736(08)60777-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	307NL	18514715				2022-12-24	WOS:000256325500008
J	Hanna, J; Markoulaki, S; Schorderet, P; Carey, BW; Beard, C; Wernig, M; Creyghton, MP; Steine, EJ; Cassady, JP; Foreman, R; Lengner, CJ; Dausman, JA; Jaenisch, R				Hanna, Jacob; Markoulaki, Styliani; Schorderet, Patrick; Carey, Bryce W.; Beard, Caroline; Wernig, Marius; Creyghton, Menno P.; Steine, Eveline J.; Cassady, John P.; Foreman, Ruth; Lengner, Christopher J.; Dausman, Jessica A.; Jaenisch, Rudolf			Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency	CELL			English	Article							NUCLEAR TRANSFER; STEM-CELLS; GENE REARRANGEMENT; MOUSE; FIBROBLASTS; MICE; GENERATION; LIVER; PAX5; HOMEOSTASIS	Pluripotent cells can be derived from fibroblasts by ectopic expression of defined transcription factors. A fundamental unresolved question is whether terminally differentiated cells can be reprogrammed to pluripotency. We utilized transgenic and inducible expression of four transcription factors (Oct4, Sox2, Klf4, and c-Myc) to reprogram mouse B lymphocytes. These factors were sufficient to convert nonterminally differentiated B cells to a pluripotent state. However, reprogramming of mature B cells required additional interruption with the transcriptional state maintaining B cell identity by either ectopic expression of the myeloid transcription factor CCAAT/enhancer-binding-protein-alpha (C/EBP alpha) or specific knockdown of the B cell transcription factor Pax5. Multiple iPS lines were clonally derived from both nonfully and fully differentiated B lymphocytes, which gave rise to adult chimeras with germline contribution, and to late-term embryos when injected into tetraploid blastocysts. Our study provides definite proof for the direct nuclear reprogramming of terminally differentiated adult cells to pluripotency.	[Hanna, Jacob; Markoulaki, Styliani; Schorderet, Patrick; Carey, Bryce W.; Beard, Caroline; Wernig, Marius; Creyghton, Menno P.; Steine, Eveline J.; Cassady, John P.; Foreman, Ruth; Lengner, Christopher J.; Dausman, Jessica A.; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Carey, Bryce W.; Cassady, John P.; Foreman, Ruth; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	Hanna, Jacob/K-1339-2012	Hanna, Jacob/0000-0003-2042-9974; Lengner, Christopher/0000-0002-0574-5189	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R37 CA084198-08, 5-R37-CA084198, 5-R01-CA087869, R37 CA084198, R01 CA087869] Funding Source: Medline; NICHD NIH HHS [R01 HD045022, R01 HD045022-05] Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline; PHS HHS [5-R01-HDO45022] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198, R01CA087869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; BYME JA, 2007, NATURE, V450, P497; CHANG Y, 1992, EMBO J, V11, P1891, DOI 10.1002/j.1460-2075.1992.tb05241.x; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Grompe M, 2005, GASTROENTEROLOGY, V128, P2158, DOI 10.1053/j.gastro.2005.04.022; Gurdon JB, 2006, ANNU REV CELL DEV BI, V22, P1, DOI 10.1146/annurev.cellbio.22.090805.140144; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hayashi EA, 2005, J IMMUNOL, V174, P6639, DOI 10.4049/jimmunol.174.11.6639; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Inoue K, 2005, CURR BIOL, V15, P1114, DOI 10.1016/j.cub.2005.05.021; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; LEWIS S, 1982, CELL, V30, P807, DOI 10.1016/0092-8674(82)90285-9; Li JS, 2007, P NATL ACAD SCI USA, V104, P2738, DOI 10.1073/pnas.0611358104; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Matthews VB, 2004, HEPATOLOGY, V40, P759, DOI 10.1002/hep.20396; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Milne CD, 2004, EUR J IMMUNOL, V34, P2647, DOI 10.1002/eji.200425400; NADEL B, 1990, EMBO J, V9, P435, DOI 10.1002/j.1460-2075.1990.tb08128.x; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Oberdoerffer P, 2003, J EXP MED, V197, P1165, DOI 10.1084/jem.20030402; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rountree CB, 2007, STEM CELLS, V25, P2419, DOI 10.1634/stemcells.2007-0176; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Teng G, 2007, ANNU REV GENET, V41, P107, DOI 10.1146/annurev.genet.41.110306.130340; Wakayama T, 2001, MOL REPROD DEV, V58, P376, DOI 10.1002/1098-2795(20010401)58:4<376::AID-MRD4>3.0.CO;2-L; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	50	619	773	1	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2008	133	2					250	264		10.1016/j.cell.2008.03.028	http://dx.doi.org/10.1016/j.cell.2008.03.028			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	289JY	18423197	Bronze, Green Accepted			2022-12-24	WOS:000255052000015
J	Liu, L; Botos, I; Wang, Y; Leonard, JN; Shiloach, J; Segal, DM; Davies, DR				Liu, Lin; Botos, Istvan; Wang, Yan; Leonard, Joshua N.; Shiloach, Joseph; Segal, David M.; Davies, David R.			Structural basis of toll-like receptor 3 signaling with double-stranded RNA	SCIENCE			English	Article							CRYSTAL-STRUCTURE; BINDING; RECOGNITION	Toll- like receptor 3 ( TLR3) recognizes double- stranded RNA ( dsRNA), a molecular signature of most viruses, and triggers inflammatory responses that prevent viral spread. TLR3 ectodomains ( ECDs) dimerize on oligonucleotides of at least 40 to 50 base pairs in length, the minimal length required for signal transduction. To establish the molecular basis for ligand binding and signaling, we determined the crystal structure of a complex between two mouse TLR3- ECDs and dsRNA at 3.4 angstrom resolution. Each TLR3- ECD binds dsRNA at two sites located at opposite ends of the TLR3 horseshoe, and an intermolecular contact between the two TLR3- ECD C- terminal domains coordinates and stabilizes the dimer. This juxtaposition could mediate downstream signaling by dimerizing the cytoplasmic Toll interleukin- 1 receptor ( TIR) domains. The overall shape of the TLR3- ECD does not change upon binding to dsRNA.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Wang, Yan; Leonard, Joshua N.; Segal, David M.] NCI, Expt Immunol Branch, Bethesda, MD 20892 USA; [Shiloach, Joseph] NIDDKD, Biotechnol Unit, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Davies, DR (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	david.davies@nih.gov	Leonard, Joshua/B-7649-2009	Leonard, Joshua/0000-0003-4359-6126; Botos, Istvan/0000-0002-7702-6749	NATIONAL CANCER INSTITUTE [ZIABC009254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK015500, Z01DK034002] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 BC009254-33] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; de Bouteiller O, 2005, J BIOL CHEM, V280, P38133, DOI 10.1074/jbc.M507163200; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Sun JC, 2006, J BIOL CHEM, V281, P11144, DOI 10.1074/jbc.M510442200; Takada E, 2007, MOL IMMUNOL, V44, P3633, DOI 10.1016/j.molimm.2007.04.021; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	15	533	553	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2008	320	5874					379	381		10.1126/science.1155406	http://dx.doi.org/10.1126/science.1155406			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZZ	18420935	Green Accepted			2022-12-24	WOS:000255026100045
J	Wu, XM; Tu, XL; Joeng, KS; Hilton, MJ; Williams, DA; Long, FX				Wu, Ximei; Tu, Xiaolin; Joeng, Kyu Sang; Hilton, Matthew J.; Williams, David A.; Long, Fanxin			Rac1 activation controls nuclear localization of beta-catenin during canonical Wnt signaling	CELL			English	Article							CONVERGENT EXTENSION MOVEMENTS; SUBCELLULAR-LOCALIZATION; AXIS FORMATION; PIK3CA GENE; VERTEBRATE GASTRULATION; PLANAR POLARITY; DROSOPHILA EYE; RHO GTPASES; PATHWAY; PROTEIN	Canonical Wnt signaling critically regulates cell fate and proliferation in development and disease. Nuclear localization of beta-catenin is indispensable for canonical Wnt signaling; however, the mechanisms governing beta-catenin nuclear localization are not well understood. Here we demonstrate that nuclear accumulation of beta-catenin in response to Wnt requires Rac1 activation. The role of Rac1 depends on phosphorylation of beta-catenin at Ser191 and Ser605, which is mediated by JNK2 kinase. Mutations of these residues significantly affect Wnt-induced beta-catenin nuclear accumulation. Genetic ablation of Rac1 in the mouse embryonic limb bud ectoderm disrupts canonical Wnt signaling and phenocopies deletion of beta-catenin in causing severe truncations of the limb. Finally, Rac1 interacts genetically with beta-catenin and Dkk1 in controlling limb outgrowth. Together these results uncover Rac1 activation and subsequent beta-catenin phosphorylation as a hitherto uncharacterized mechanism controlling canonical Wnt signaling and may provide additional targets for therapeutic intervention of this important pathway.	[Wu, Ximei; Tu, Xiaolin; Joeng, Kyu Sang; Hilton, Matthew J.; Long, Fanxin] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Joeng, Kyu Sang; Long, Fanxin] Washington Univ, Sch Med, Div Biol & Biomed Sci, St Louis, MO 63110 USA; [Long, Fanxin] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Williams, David A.] Cincinnati Childrens Hosp, Med Ctr, Div Expt Hematol, Cincinnati, OH 45229 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Long, FX (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	flong@wustl.edu		Hilton, Matthew/0000-0003-3165-267X; Wu, Ximei/0000-0002-3316-893X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062757, R01DK065789] Funding Source: NIH RePORTER; NIAMS NIH HHS [5T32AR07033, T32 AR007033] Funding Source: Medline; NICHD NIH HHS [P01 HD070394] Funding Source: Medline; NIDDK NIH HHS [R01 DK065789-04, R01 DK 065789, R01 DK065789, R01 DK 62757, R01 DK062757, R01 DK065789-03] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Barrow JR, 2003, GENE DEV, V17, P394, DOI 10.1101/gad.1044903; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Bruinsma SP, 2007, P NATL ACAD SCI USA, V104, P7098, DOI 10.1073/pnas.0701686104; Choi SC, 2002, DEV BIOL, V244, P342, DOI 10.1006/dbio.2002.0602; Cong F, 2004, P NATL ACAD SCI USA, V101, P2882, DOI 10.1073/pnas.0307344101; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Eaton S, 1996, J CELL BIOL, V135, P1277, DOI 10.1083/jcb.135.5.1277; Esufali S, 2004, ONCOGENE, V23, P8260, DOI 10.1038/sj.onc.1208007; Fanto M, 2000, CURR BIOL, V10, P979, DOI 10.1016/S0960-9822(00)00645-X; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Jones WM, 2005, GENETICS, V169, P2075, DOI 10.1534/genetics.104.039735; Kawashima T, 2006, J CELL BIOL, V175, P937, DOI 10.1083/jcb.200604073; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; Lee JW, 2005, ONCOGENE, V24, P1477, DOI 10.1038/sj.onc.1208304; Levine DA, 2005, CLIN CANCER RES, V11, P2875, DOI 10.1158/1078-0432.CCR-04-2142; Liao GH, 2006, P NATL ACAD SCI USA, V103, P16313, DOI 10.1073/pnas.0602557103; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Long FX, 2001, DEVELOPMENT, V128, P5099; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; McEwen DG, 2000, DEVELOPMENT, V127, P3607; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Neufeld KL, 2000, EMBO REP, V1, P519; Penzo-Mendez A, 2003, DEV BIOL, V257, P302, DOI 10.1016/S0012-1606(03)00067-8; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Townsley FM, 2004, NAT CELL BIOL, V6, P626, DOI 10.1038/ncb1141; Tu XL, 2007, DEV CELL, V12, P113, DOI 10.1016/j.devcel.2006.11.003; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100	52	365	375	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 18	2008	133	2					340	353		10.1016/j.cell.2008.01.052	http://dx.doi.org/10.1016/j.cell.2008.01.052			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	289JY	18423204	Green Accepted, Bronze			2022-12-24	WOS:000255052000022
J	Gosse, NJ; Nevin, LM; Baier, H				Gosse, Nathan J.; Nevin, Linda M.; Baier, Herwig			Retinotopic order in the absence of axon competition	NATURE			English	Article							RETINOTECTAL PROJECTION; RETINAL AXONS; NEURAL MAP; IN-VIVO; ZEBRAFISH RETINA; EPHRIN-AS; GRADIENTS; GROWTH; MODEL; CONNECTIONS	The retinotectal projection has long been studied experimentally and theoretically, as a model for the formation of topographic brain maps(1-3). Neighbouring retinal ganglion cells ( RGCs) project their axons to neighbouring positions in the optic tectum, thus reestablishing a continuous neural representation of visual space. Mapping along this axis requires chemorepellent signalling from tectal cells, expressing ephrin- A ligands, to retinal growth cones, expressing EphA receptors(4). High concentrations of ephrin A, increasing from anterior to posterior, prevent temporal axons from invading the posterior tectum. However, the force that drives nasal axons to extend past the anterior tectum and terminate in posterior regions remains to be identified. We tested whether axon - axon interactions, such as competition, are required for posterior tectum innervation. By transplanting blastomeres from a wild- type ( WT) zebrafish into a lakritz ( lak) mutant, which lacks all RGCs(5), we created chimaeras with eyes that contained single RGCs. These solitary RGCs often extended axons into the tectum, where they branched to form a terminal arbor. Here we show that the distal tips of these arbors were positioned at retinotopically appropriate positions, ruling out an essential role for competition in innervation of the ephrin- A- rich posterior tectum. However, solitary arbors were larger and more complex than under normal, crowded conditions, owing to a lack of pruning of proximal branches during refinement of the retinotectal projection. We conclude that dense innervation is not required for targeting of retinal axons within the zebrafish tectum but serves to restrict arbor size and shape.	[Gosse, Nathan J.; Baier, Herwig] Univ Calif San Francisco, Program Dev Biol, San Francisco, CA 94158 USA; [Nevin, Linda M.; Baier, Herwig] Univ Calif San Francisco, Neurosci Program, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Baier, H (corresponding author), Univ Calif San Francisco, Program Dev Biol, 1550 4th St, San Francisco, CA 94158 USA.	herwig.baier@ucsf.edu	Nevin, Linda/AAL-6321-2021	Nevin, Linda/0000-0003-4095-8574	NATIONAL EYE INSTITUTE [R01EY012406, R01EY013855] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY012406-08, R01 EY013855-02, R01 EY012406-06A2, R01 EY013855-08, R01 EY012406, R01 EY013855, R01 EY012406-09, R01 EY013855-07, R01 EY012406-07, R01 EY013855-01A1, R01 EY013855-05, R01 EY013855-04, R01 EY013855-03, R01 EY013855-06] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Baier H, 1996, DEVELOPMENT, V123, P415; Brennan C, 1997, DEVELOPMENT, V124, P655; Carvalho RF, 2006, NAT NEUROSCI, V9, P322, DOI 10.1038/nn1655; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; FRASER SE, 1990, J NEUROBIOL, V21, P51, DOI 10.1002/neu.480210105; GIERER A, 1983, PROC R SOC SER B-BIO, V218, P77, DOI 10.1098/rspb.1983.0027; Goodhill GJ, 2007, NEURON, V56, P301, DOI 10.1016/j.neuron.2007.09.027; Goodhill GJ, 2005, NETWORK-COMP NEURAL, V16, P5, DOI 10.1080/09548980500254654; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; Honda H, 2003, J NEUROSCI, V23, P10368; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Hua JY, 2005, NATURE, V434, P1022, DOI 10.1038/nature03409; Ichijo H, 1998, J NEUROSCI, V18, P5008; Kay JN, 2005, DEVELOPMENT, V132, P2573, DOI 10.1242/dev.01831; Kay JN, 2001, NEURON, V30, P725, DOI 10.1016/S0896-6273(01)00312-9; Lemke G, 2005, ANNU REV CELL DEV BI, V21, P551, DOI 10.1146/annurev.cellbio.20.022403.093702; Monschau B, 1997, EMBO J, V16, P1258, DOI 10.1093/emboj/16.6.1258; Picker A, 1999, DEVELOPMENT, V126, P2967; Poggi L, 2005, J CELL BIOL, V171, P991, DOI 10.1083/jcb.200509098; Rashid T, 2005, NEURON, V47, P57, DOI 10.1016/j.neuron.2005.05.030; Reber M, 2004, NATURE, V431, P847, DOI 10.1038/nature02957; Ruthazer ES, 2004, J NEUROBIOL, V59, P134, DOI 10.1002/neu.10344; Smear MC, 2007, NEURON, V53, P65, DOI 10.1016/j.neuron.2006.12.013; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; Tsigankov DN, 2006, J COMPUT NEUROSCI, V21, P101, DOI 10.1007/s10827-006-9575-7; VONBOXBERG Y, 1993, NEURON, V10, P345; Willshaw D, 2006, DEVELOPMENT, V133, P2705, DOI 10.1242/dev.02430; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Yates PA, 2004, J NEUROBIOL, V59, P95, DOI 10.1002/neu.10341	31	65	66	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 17	2008	452	7189					892	U9		10.1038/nature06816	http://dx.doi.org/10.1038/nature06816			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZY	18368050	Green Accepted			2022-12-24	WOS:000255026000052
J	Pagel, M				Pagel, Mark			Rise of the digital machine	NATURE			English	Editorial Material									Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England; Santa Fe Inst, Santa Fe, NM 87501 USA	University of Reading; The Santa Fe Institute	Pagel, M (corresponding author), Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England.							Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Gell-Mann M., 1994, QUARK JAGUAR ADVENTU; Mattick JS, 2003, BIOESSAYS, V25, P930, DOI 10.1002/bies.10332; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131	4	5	5	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2008	452	7188					699	699		10.1038/452699a	http://dx.doi.org/10.1038/452699a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	285QY	18401394	Bronze			2022-12-24	WOS:000254792500029
J	Dantas, G; Sommer, MOA; Oluwasegun, RD; Church, GM				Dantas, Gautam; Sommer, Morten O. A.; Oluwasegun, Rantimi D.; Church, George M.			Bacteria subsisting on antibiotics	SCIENCE			English	Article							RESISTANCE GENES; MOLECULAR-MECHANISMS; DATABASE; SOIL; BENZYLPENICILLIN; DIVERSITY; RESISTOME; NITROGEN; CARBON; ARB	Antibiotics are a crucial line of defense against bacterial infections. Nevertheless, several antibiotics are natural products of microorganisms that have as yet poorly appreciated ecological roles in the wider environment. We isolated hundreds of soil bacteria with the capacity to grow on antibiotics as a sole carbon source. Of 18 antibiotics tested, representing eight major classes of natural and synthetic origin, 13 to 17 supported the growth of clonal bacteria from each of 11 diverse soils. Bacteria subsisting on antibiotics are surprisingly phylogenetically diverse, and many are closely related to human pathogens. Furthermore, each antibiotic- consuming isolate was resistant to multiple antibiotics at clinically relevant concentrations. This phenomenon suggests that this unappreciated reservoir of antibiotic- resistance determinants can contribute to the increasing levels of multiple antibiotic resistance in pathogenic bacteria.	[Dantas, Gautam; Sommer, Morten O. A.; Oluwasegun, Rantimi D.; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Sommer, Morten O. A.] Harvard Univ, Program Biophys, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Church, GM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.			church, george/0000-0001-6232-9969; Sommer, Morten Otto Alexander/0000-0003-4005-5674; Dantas, Gautam/0000-0003-0455-8370				ABDELM.Y, 1961, NATURE, V189, P775, DOI 10.1038/189775a0; Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; D'Costa VM, 2007, CURR OPIN MICROBIOL, V10, P481, DOI 10.1016/j.mib.2007.08.009; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Fredrickson JK, 2000, APPL ENVIRON MICROB, V66, P2006, DOI 10.1128/AEM.66.5.2006-2011.2000; JOHNSEN J, 1977, ARCH MICROBIOL, V115, P271, DOI 10.1007/BF00446452; KAMEDA Y, 1961, NATURE, V191, P1122, DOI 10.1038/1911122a0; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Marshall CG, 1998, ANTIMICROB AGENTS CH, V42, P2215, DOI 10.1128/AAC.42.9.2215; McAllister KA, 1996, BIODEGRADATION, V7, P1, DOI 10.1007/BF00056556; Parke JL, 2001, ANNU REV PHYTOPATHOL, V39, P225, DOI 10.1146/annurev.phyto.39.1.225; Projan SJ, 2007, ANTIMICROB AGENTS CH, V51, P1133, DOI 10.1128/AAC.01370-06; Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Wheeler DL, 2000, NUCLEIC ACIDS RES, V28, P10, DOI 10.1093/nar/28.1.10	18	387	426	19	318	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 4	2008	320	5872					100	103		10.1126/science.1155157	http://dx.doi.org/10.1126/science.1155157			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283JR	18388292	Green Published			2022-12-24	WOS:000254633000040
J	Amrani, N; Ghosh, S; Mangus, DA; Jacobson, A				Amrani, Nadia; Ghosh, Shubhendu; Mangus, David A.; Jacobson, Allan			Translation factors promote the formation of two states of the closed-loop mRNP	NATURE			English	Article							YEAST POLY(A)-BINDING PROTEIN; MESSENGER-RNA; POLY(A) TAIL; INITIATION; BINDING; CAP; RECOGNITION; TERMINATION; EIF4G; DOMAIN	Efficient translation initiation and optimal stability of most eukaryotic messenger RNAs depends on the formation of a closed- loop structure and the resulting synergistic interplay between the 59 m (7)G cap and the 3 ' poly( A) tail(1,2). Evidence of eIF4G and Pab1 interaction supports the notion of a closed- loop mRNP(3), but the mechanistic events that lead to its formation and maintenance are still unknown. Here we use toeprinting and polysome profiling assays to delineate ribosome positioning at initiator AUG codons and ribosome - mRNA association, respectively, and find that two distinct stable ( resistant to cap analogue) closed- loop structures are formed during initiation in yeast cell- free extracts. The integrity of both forms requires the mRNA cap and poly( A) tail, as well as eIF4E, eIF4G, Pab1 and eIF3, and is dependent on the length of both the mRNA and the poly( A) tail. Formation of the first structure requires the 48S ribosomal complex, whereas the second requires an 80S ribosome and the termination factors eRF3/ Sup35 and eRF1/ Sup45. The involvement of the termination factors is independent of a termination event.	[Amrani, Nadia; Ghosh, Shubhendu; Mangus, David A.; Jacobson, Allan] Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Jacobson, A (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA.	allan.jacobson@umassmed.edu	Amrani, Nadia/AAG-7474-2021	Amrani, Nadia/0000-0001-6871-7962	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027757, R01GM027757] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM027757-29, R37 GM027757, R01 GM027757, R37 GM027757-28, R37 GM027757-27, R37 GM027757-26] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; BAER BW, 1983, J CELL BIOL, V96, P717, DOI 10.1083/jcb.96.3.717; BARNES CA, 1993, EMBO J, V12, P3323, DOI 10.1002/j.1460-2075.1993.tb06002.x; CHRISTENSEN AK, 1987, AM J ANAT, V178, P1, DOI 10.1002/aja.1001780102; Cosson B, 2002, MOL CELL BIOL, V22, P3301, DOI 10.1128/MCB.22.10.3301-3315.2002; De Gregorio E, 1998, RNA, V4, P828, DOI 10.1017/S1355838298980372; Dmitriev SE, 2003, FEBS LETT, V533, P99, DOI 10.1016/S0014-5793(02)03776-6; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; Gebauer F, 1999, EMBO J, V18, P6146, DOI 10.1093/emboj/18.21.6146; GOYER C, 1993, MOL CELL BIOL, V13, P4860, DOI 10.1128/MCB.13.8.4860; Iizuka N, 1997, METHODS, V11, P353, DOI 10.1006/meth.1996.0433; Jacobson A., 1996, TRANSLATIONAL CONTRO, P451; Karim MM, 2006, P NATL ACAD SCI USA, V103, P9494, DOI 10.1073/pnas.0603701103; Kessler SH, 1998, MOL CELL BIOL, V18, P51, DOI 10.1128/MCB.18.1.51; Mangus DA, 1999, METHODS, V17, P28, DOI 10.1006/meth.1998.0704; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Mangus DA, 1998, MOL CELL BIOL, V18, P7383, DOI 10.1128/MCB.18.12.7383; MUNROE D, 1990, MOL CELL BIOL, V10, P3441, DOI 10.1128/MCB.10.7.3441; Nielsen KH, 2004, EMBO J, V23, P1166, DOI 10.1038/sj.emboj.7600116; Otero LJ, 1999, EMBO J, V18, P3153, DOI 10.1093/emboj/18.11.3153; Sachs A, 2000, COLD SPRING HARBOR M, V39, P447; SACHS AB, 1986, CELL, V45, P827, DOI 10.1016/0092-8674(86)90557-X; SACHS AB, 1987, MOL CELL BIOL, V7, P3268, DOI 10.1128/MCB.7.9.3268; Salas-Marco J, 2004, MOL CELL BIOL, V24, P7769, DOI 10.1128/MCB.24.17.7769-7778.2004; Stansfield I, 1997, EUR J BIOCHEM, V245, P557, DOI 10.1111/j.1432-1033.1997.00557.x; Tarun SZ, 1997, P NATL ACAD SCI USA, V94, P9046, DOI 10.1073/pnas.94.17.9046; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Uchida N, 2002, J BIOL CHEM, V277, P50286, DOI 10.1074/jbc.M203029200; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wu C, 2007, METHOD ENZYMOL, V429, P203, DOI 10.1016/S0076-6879(07)29010-X	30	141	143	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2008	453	7199					1276	U85		10.1038/nature06974	http://dx.doi.org/10.1038/nature06974			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18496529	Green Accepted			2022-12-24	WOS:000257075800051
J	Fan, L; Fuss, JO; Cheng, QJ; Arvai, AS; Hammel, M; Roberts, VA; Cooper, PK; Tainer, JA				Fan, Li; Fuss, Jill O.; Cheng, Quen J.; Arvai, Andrew S.; Hammel, Michal; Roberts, Victoria A.; Cooper, Priscilla K.; Tainer, John A.			XPD helicase structures and activities: Insights into the cancer and aging phenotypes from XPD mutations	CELL			English	Article							NUCLEOTIDE EXCISION-REPAIR; DNA-REPAIR; XERODERMA-PIGMENTOSUM; COCKAYNE-SYNDROME; TRANSCRIPTION FACTOR; BASAL TRANSCRIPTION; FACTOR TFIIH; GENE; TRICHOTHIODYSTROPHY; PROTEIN	Mutations in XPD helicase, required for nucleotide excision repair (NER) as part of the transcription/repair complex TFIIH, cause three distinct phenotypes: cancer-prone xeroderma pigmentosum (XP), or aging disorders Cockayne syndrome (CS), and trichothiodystrophy (TTD). To clarify molecular differences underlying these diseases, we determined crystal structures of the XPD catalytic core from Sulfolobus acidocaldarius and measured mutant enzyme activities. Substrate-binding grooves separate adjacent Rad51/RecA-like helicase domains (HD1, HD2) and an arch formed by 4FeS and Arch domains. XP mutations map along the HD1 ATP-binding edge and HD2 DNA-binding channel and impair helicase activity essential for NER. XP/CS mutations both impair helicase activity and likely affect HD2 functional movement. TTD mutants lose or retain helicase activity but map to sites in all four domains expected to cause framework defects impacting TFIIH integrity. These results provide a foundation for understanding disease consequences of mutations in XPD and related 4Fe-4S helicases including FancJ.	[Fan, Li; Arvai, Andrew S.; Tainer, John A.] Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Fuss, Jill O.; Cheng, Quen J.; Cooper, Priscilla K.; Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genom Stabil, Div Life Sci, Berkeley, CA 94720 USA; [Hammel, Michal] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biophys Div, Berkeley, CA 94720 USA; [Roberts, Victoria A.] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92037 USA	Scripps Research Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Diego	Tainer, JA (corresponding author), Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jat@scripps.edu	Classen, Scott/AAY-8176-2020; Tainer, John/GWQ-4878-2022	Tainer, John/0000-0003-1659-2429; Hammel, Michal/0000-0002-5610-9289; Cheng, Quen/0000-0002-0161-1917	NCI NIH HHS [P01 CA092584, F32 CA108393, 1F32CA108393, F32 CA108393-03, P01 CA92584, R01 CA112093, R01 CA112093-02, P01 CA092584-07] Funding Source: Medline; NIGMS NIH HHS [R01 GM070996, R01 GM070996-01, GM070996] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA112093, F32CA108393, P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070996] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bienstock RJ, 2003, J BIOL CHEM, V278, P5309, DOI 10.1074/jbc.M210159200; Boal AK, 2005, BIOCHEMISTRY-US, V44, P8397, DOI 10.1021/bi047494n; BOOTSMA D, 1993, NATURE, V363, P114, DOI 10.1038/363114a0; Botta E, 2002, HUM MOL GENET, V11, P2919, DOI 10.1093/hmg/11.23.2919; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Clarkson SG, 2005, DNA REPAIR, V4, P1068, DOI 10.1016/j.dnarep.2005.07.001; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; Dubaele S, 2003, MOL CELL, V11, P1635, DOI 10.1016/S1097-2765(03)00182-5; Fan L, 2006, MOL CELL, V22, P27, DOI 10.1016/j.molcel.2006.02.017; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Ito S, 2007, MOL CELL, V26, P231, DOI 10.1016/j.molcel.2007.03.013; Laine JP, 2006, METHOD ENZYMOL, V408, P246, DOI 10.1016/S0076-6879(06)08015-3; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Ludovic C, 2006, CHEM REV, V106, P253; Outten FW, 2007, NAT CHEM BIOL, V3, P206, DOI 10.1038/nchembio0407-206; Pugh RA, 2008, J BIOL CHEM, V283, P1732, DOI 10.1074/jbc.M707064200; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; Schumacher B, 2008, TRENDS GENET, V24, P77, DOI 10.1016/j.tig.2007.11.004; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; SUNG P, 1993, NATURE, V365, P852, DOI 10.1038/365852a0; Taylor EM, 1997, P NATL ACAD SCI USA, V94, P8658, DOI 10.1073/pnas.94.16.8658; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; Theron T, 2005, MOL CELL BIOL, V25, P8368, DOI 10.1128/MCB.25.18.8368-8378.2005; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; Vermeulen W, 2001, NAT GENET, V27, P299, DOI 10.1038/85864; Winkler GS, 2000, J BIOL CHEM, V275, P4258, DOI 10.1074/jbc.275.6.4258; Yamagata A, 2007, EMBO J, V26, P878, DOI 10.1038/sj.emboj.7601544; Yavin E, 2006, P NATL ACAD SCI USA, V103, P3610, DOI 10.1073/pnas.0600239103	38	290	298	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 30	2008	133	5					789	800		10.1016/j.cell.2008.04.030	http://dx.doi.org/10.1016/j.cell.2008.04.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	306UY	18510924	Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000256274500012
J	Du, X; She, E; Gelbart, T; Truksa, J; Lee, P; Xia, Y; Khovananth, K; Mudd, S; Mann, N; Moresco, EMY; Beutler, E; Beutler, B				Du, Xin; She, Ellen; Gelbart, Terri; Truksa, Jaroslav; Lee, Pauline; Xia, Yu; Khovananth, Kevin; Mudd, Suzanne; Mann, Navjiwan; Moresco, Eva Marie Y.; Beutler, Ernest; Beutler, Bruce			The serine protease TMPRSS6 is required to sense iron deficiency	SCIENCE			English	Article							HEPCIDIN EXPRESSION; LIVER HEPCIDIN; ANEMIA; HYPOXIA; INFLAMMATION; MOUSE; MICE; HEMOCHROMATOSIS; INTERLEUKIN-6; TRANSCRIPTION	Hepcidin, a liver- derived protein that restricts enteric iron absorption, is the key regulator of body iron content. Several proteins induce expression of the hepcidin- encoding gene Hamp in response to infection or high levels of iron. However, mechanism( s) of Hamp suppression during iron depletion are poorly understood. We describe mask: a recessive, chemically induced mutant mouse phenotype, characterized by progressive loss of body ( but not facial) hair and microcytic anemia. The mask phenotype results from reduced absorption of dietary iron caused by high levels of hepcidin and is due to a splicing defect in the transmembrane serine protease 6 gene Tmprss6. Overexpression of normal TMPRSS6 protein suppresses activation of the Hamp promoter, and the TMPRSS6 cytoplasmic domain mediates Hamp suppression via proximal promoter element( s). TMPRSS6 is an essential component of a pathway that detects iron deficiency and blocks Hamp transcription, permitting enhanced dietary iron absorption.	[Du, Xin; She, Ellen; Xia, Yu; Khovananth, Kevin; Mudd, Suzanne; Mann, Navjiwan; Moresco, Eva Marie Y.; Beutler, Bruce] Scripps Res Inst, Dept Genet, La Jolla, CA 92037 USA; [Gelbart, Terri; Truksa, Jaroslav; Lee, Pauline; Beutler, Ernest] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Beutler, B (corresponding author), Scripps Res Inst, Dept Genet, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bruce@scripps.edu	Truksa, Jaroslav/AAB-5089-2020; Truksa, Jaroslav/G-9454-2014	Truksa, Jaroslav/0000-0002-8967-7354; Truksa, Jaroslav/0000-0002-8967-7354; Gelbart, Terri/0000-0002-7863-1262; Moresco, Eva Marie/0000-0002-2049-7291	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI054523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053505] Funding Source: NIH RePORTER; NIAID NIH HHS [U54 AI054523-019005, U54 AI054523, AI054523] Funding Source: Medline; NIDDK NIH HHS [DK53505-09, R01 DK053505-09] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahmad KA, 2002, BLOOD CELL MOL DIS, V29, P361, DOI 10.1006/bcmd.2002.0575; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607; Beutler E, 2004, SCIENCE, V306, P2051, DOI 10.1126/science.1107224; Deloche C, 2007, EUR J DERMATOL, V17, P507; GITLIN D, 1962, J CLIN INVEST, V41, P344, DOI 10.1172/JCI104488; Kawabata H, 2005, BLOOD, V105, P376, DOI 10.1182/blood-2004-04-1416; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; McNeill LA, 2005, MOL BIOSYST, V1, P321, DOI 10.1039/b511249b; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2006, ANNU REV NUTR, V26, P323, DOI 10.1146/annurev.nutr.26.061505.111303; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Roy CN, 2005, CURR OPIN HEMATOL, V12, P107, DOI 10.1097/00062752-200503000-00001; RUSSELL ES, 1970, TRANSPLANT P, V2, P144; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Truksa J, 2007, BLOOD, V110, P3436, DOI 10.1182/blood-2007-05-091108; Truksa J, 2007, BRIT J HAEMATOL, V139, P138, DOI 10.1111/j.1365-2141.2007.06728.x; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; WATOWICH SS, 1994, MOL CELL BIOL, V14, P3535, DOI 10.1128/MCB.14.6.3535; Yoon D, 2006, J BIOL CHEM, V281, P25703, DOI 10.1074/jbc.M602329200	26	442	464	3	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 23	2008	320	5879					1088	1092		10.1126/science.1157121	http://dx.doi.org/10.1126/science.1157121			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303RY	18451267	Green Accepted			2022-12-24	WOS:000256059800049
J	Singh, SK; Kagalwala, MN; Parker-Thornburg, J; Adams, H; Majumder, S				Singh, Sanjay K.; Kagalwala, Mohamedi N.; Parker-Thornburg, Jan; Adams, Henry; Majumder, Sadhan			REST maintains self-renewal and pluripotency of embryonic stem cells	NATURE			English	Article							TRANSCRIPTIONAL REGULATION; NEURONAL DIFFERENTIATION; REST/NRSF; CHROMATIN; NETWORK; GENES; TUMORS; NANOG	The neuronal repressor REST ( RE1- silencing transcription factor; also called NRSF) is expressed at high levels in mouse embryonic stem ( ES) cells(1), but its role in these cells is unclear. Here we show that REST maintains self- renewal and pluripotency in mouse ES cells through suppression of the microRNA miR- 21. We found that, as with known self- renewal markers, the level of REST expression is much higher in self- renewing mouse ES cells than in differentiating mouse ES ( embryoid body, EB) cells. Heterozygous deletion of Rest ( Rest(+/-)) and its short- interfering-RNA- mediated knockdown in mouse ES cells cause a loss of self- renewal - even when these cells are grown under self- renewal conditions - and lead to the expression of markers specific for multiple lineages. Conversely, exogenously added REST maintains self- renewal in mouse EB cells. Furthermore, Rest(+/-) mouse ES cells cultured under self- renewal conditions express substantially reduced levels of several self- renewal regulators, including Oct4 ( also called Pou5f1), Nanog, Sox2 and c- Myc, and exogenously added REST in mouse EB cells maintains the self- renewal phenotypes and expression of these self- renewal regulators. We also show that in mouse ES cells, REST is bound to the gene chromatin of a set of miRNAs that potentially target self- renewal genes. Whereas mouse ES cells and mouse EB cells containing exogenously added REST express lower levels of these miRNAs, EB cells, Rest(+/-) ES cells and ES cells treated with short interfering RNA targeting Rest express higher levels of these miRNAs. At least one of these REST- regulated miRNAs, miR- 21, specifically suppresses the self- renewal of mouse ES cells, corresponding to the decreased expression of Oct4, Nanog, Sox2 and c- Myc. Thus, REST is a newly discovered element of the interconnected regulatory network that maintains the self- renewal and pluripotency of mouse ES cells.	[Singh, Sanjay K.; Kagalwala, Mohamedi N.; Adams, Henry; Majumder, Sadhan] Univ Texas MD Anderson Canc Ctr, Dept Canc Genet, Houston, TX 77030 USA; [Parker-Thornburg, Jan] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Majumder, Sadhan] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Majumder, Sadhan] Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA; [Singh, Sanjay K.; Kagalwala, Mohamedi N.; Majumder, Sadhan] Univ Texas MD Anderson Canc Ctr, Ctr Stem Cell & Dev Biol, Houston, TX 77030 USA; [Majumder, Sadhan] Univ Texas Houston, Grad Sch Biomed Sci, Program Genes & Dev, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Majumder, S (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Genet, Houston, TX 77030 USA.	smajumder@mdanderson.org			NATIONAL CANCER INSTITUTE [R01CA097124, R01CA081255] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA081255, CA81255, R01 CA097124-07, CA97124, R01 CA081255-10, R01 CA097124] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cai JL, 2006, STEM CELLS, V24, P516, DOI 10.1634/stemcells.2005-0143; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Coulson JM, 2005, CURR BIOL, V15, pR665, DOI 10.1016/j.cub.2005.08.032; Cui RT, 2005, J BIOL CHEM, V280, P39152, DOI 10.1074/jbc.M504655200; Fuller GN, 2005, MOL CANCER THER, V4, P343; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Lawinger P, 2000, NAT MED, V6, P826, DOI 10.1038/77565; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Majumder S, 2006, CELL CYCLE, V5, P1929, DOI 10.4161/cc.5.17.2982; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Pritsker M, 2006, P NATL ACAD SCI USA, V103, P6946, DOI 10.1073/pnas.0509861103; Su XH, 2004, MOL CELL BIOL, V24, P8018, DOI 10.1128/MCB.24.18.8018-8025.2004; Su XH, 2006, MOL CELL BIOL, V26, P1666, DOI 10.1128/MCB.26.5.1666-1678.2006; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Watanabe Y, 2004, GENE DEV, V18, P889, DOI 10.1101/gad.1179004; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	24	253	274	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 8	2008	453	7192					223	U11		10.1038/nature06863	http://dx.doi.org/10.1038/nature06863			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297BP	18362916	Bronze, Green Accepted			2022-12-24	WOS:000255592400040
J	Richards, JB; Rivadeneira, F; Inouye, M; Pastinen, TM; Soranzo, N; Wilson, SG; Andrew, T; Falchi, M; Gwilliam, R; Ahmadi, KR; Valdes, AM; Arp, P; Whittaker, P; Verlaan, DJ; Jhamai, M; Kumanduri, V; Moorhouse, M; van Meurs, JB; Hofman, A; Pols, HAP; Hart, D; Zhai, G; Kato, BS; Mullin, BH; Zhang, F; Deloukas, P; Uitterlinden, AG; Spector, TD				Richards, J. B.; Rivadeneira, F.; Inouye, M.; Pastinen, T. M.; Soranzo, N.; Wilson, S. G.; Andrew, T.; Falchi, M.; Gwilliam, R.; Ahmadi, K. R.; Valdes, A. M.; Arp, P.; Whittaker, P.; Verlaan, D. J.; Jhamai, M.; Kumanduri, V.; Moorhouse, M.; van Meurs, J. B.; Hofman, A.; Pols, H. A. P.; Hart, D.; Zhai, G.; Kato, B. S.; Mullin, B. H.; Zhang, F.; Deloukas, P.; Uitterlinden, A. G.; Spector, T. D.			Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study	LANCET			English	Article							BODY-MASS INDEX; ORAL CORTICOSTEROIDS; GENE POLYMORPHISMS; COMMON VARIANT; RISK; RECEPTOR; WOMEN; OSTEOPROTEGERIN; PROBABILITY; CHILDHOOD	Background Osteoporosis is diagnosed by the measurement of bone mineral density which is a highly heritable and multifactorial trait. We aimed to identify genetic loci that are associated with bone mineral density. Methods In this genome-wide association study, we identified the most promising of 314075 single nucleotide polymorphisms (SNPs) in 2094 women in a UK study. We then tested these SNPs for replication in 6463 people from three other cohorts in western Europe. We also investigated allelic expression in lymphoblast cell lines. We tested the association between the replicated SNPs and osteoporotic fractures with data from two studies. Findings We identified genome-wide evidence for an association between bone mineral density and two SNPs (p<5x10(-8)). The SNPs were rs4355801, on chromosome 8, near to the TNFRSF11B (osteoprotegerin) gene, and rs3736228, on chromosome 11 in the LRP5 (lipoprotein-receptor-related protein) gene. A non-synonymous SNP in the LRP5 gene was associated with decreased bone mineral density (rs3736228, p=6.3x10(-12) for lumbar spine and p=1.9x10(-4) for femoral neck) and an increased risk of both osteoporotic fractures (odds ratio [OR] 1.3, 95% Cl 1.09-1.52, p=0.002) and osteoporosis (OR 1.3, 1.08-1.63, p=0.008). Three SNPs near the TNFRSF11B gene were associated with decreased bone mineral density (top SNP, rs4355801: p=7.6x10(-10) for lumbar spine and p=3.3x10(-8) for femoral neck) and increased risk of osteoporosis (OR 1.2, 95% Cl 1 .01-1.42, p=0.038). For carriers of the risk allele at rs4355801, expression of TNFRSF11B in lymphoblast cell lines was halved (p=3.0x10(-6)). 1883 (22%) of 8557 people were at least heterozygous for these risk alleles, and these alleles had a cumulative association with bone mineral density (trend p=2.3x10(-17)). The presence of both risk alleles increased the risk of osteoporotic fractures (OR 1 .3, 1.08-1.63, p=0.006) and this effect was independent of bone mineral density. Interpretation Two gene variants of key biological proteins increase the risk of osteoporosis and osteoporotic fracture. The combined effect of these risk alleles on fractures is similar to that of most well-replicated environmental risk factors, and they are present in more than one in five white people, suggesting a potential role in screening. Funding Wellcome Trust, European Commission, NWO Investments, Arthritis Research Campaign, Chronic Disease Research Foundation, Canadian Institutes of Health Research, European Society for Clinical and Economic Aspects of Osteoporosis, Genome Canada, Genome Quebec, Canada Research Chairs, National Health and Medical Research Council of Australia, and European Union.	[Richards, J. B.; Andrew, T.; Falchi, M.; Ahmadi, K. R.; Valdes, A. M.; Hart, D.; Zhai, G.; Kato, B. S.; Zhang, F.; Spector, T. D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Rivadeneira, F.; Arp, P.; Jhamai, M.; Moorhouse, M.; van Meurs, J. B.; Pols, H. A. P.; Uitterlinden, A. G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Rivadeneira, F.; Hofman, A.; Pols, H. A. P.; Uitterlinden, A. G.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Inouye, M.; Soranzo, N.; Gwilliam, R.; Whittaker, P.; Kumanduri, V.; Deloukas, P.] Wellcome Trust Sanger Inst, Hinxton, England; [Pastinen, T. M.; Verlaan, D. J.] McGill Univ, Genome Quebec Innovat Ctr, Dept Human Genet, Montreal, PQ, Canada; [Wilson, S. G.] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia; [Wilson, S. G.; Mullin, B. H.] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA, Australia; [Verlaan, D. J.] Univ Montreal, Hop St Justine, Montreal, PQ H3T 1C5, Canada	University of London; King's College London; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Wellcome Trust Sanger Institute; McGill University; University of Western Australia; University of Western Australia; Universite de Montreal	Spector, TD (corresponding author), St Thomas Hosp, Twin Res & Genet Epidemiol Unit, London SE1 7EH, England.	tim.spector@kcl.ac.uk	Deloukas, Panos/B-2922-2013; Mullin, Benjamin/H-5493-2014; Falchi, Mario/F-5956-2013; Rivadeneira, Fernando/O-5385-2015; Richards, J Brent/AAF-4225-2019; Spector, Tim D/F-6533-2012; Ahmadi, Kourosh R/B-6379-2012; Andrew, Toby/O-8868-2017	Deloukas, Panos/0000-0001-9251-070X; Rivadeneira, Fernando/0000-0001-9435-9441; Richards, J Brent/0000-0002-3746-9086; Inouye, Michael/0000-0001-9413-6520; Andrew, Toby/0000-0001-8838-4384; Wilson, Scott/0000-0002-0357-1373; Falchi, Mario/0000-0002-5646-1004; Valdes, Ana M./0000-0003-1141-4471; Mullin, Benjamin/0000-0003-0743-770X; Soranzo, Nicole/0000-0003-1095-3852	Arthritis Research UK [17489] Funding Source: Medline; Versus Arthritis [17489] Funding Source: Medline; Wellcome Trust [077011] Funding Source: Medline	Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission)		Arden NK, 1996, J BONE MINER RES, V11, P530; Arden NK, 1996, BRIT J RHEUMATOL, V35, P1299; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Coleman T, 2004, BRIT MED J, V328, P575, DOI 10.1136/bmj.328.7439.575; *CONS IH, 2007, NATURE, V449, P10; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Fang Y, 2005, AM J HUM GENET, V77, P807, DOI 10.1086/497438; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gong YQ, 1996, AM J HUM GENET, V59, P146; Hofbauer LC, 2000, J CLIN ENDOCR METAB, V85, P2355, DOI 10.1210/jc.85.7.2355; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P466, DOI 10.1007/BF00143123; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Hsu YH, 2006, HUM GENET, V118, P568, DOI 10.1007/s00439-005-0062-4; Ioannidis JPA, 2004, JAMA-J AM MED ASSOC, V292, P2105, DOI 10.1001/jama.292.17.2105; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI [10.1007/s00198-004-1734-y, 10.1007/s00198-004-1640-3]; Kanis JA, 2004, BONE, V35, P1029, DOI 10.1016/j.bone.2004.06.017; Kanis JA, 2004, J BONE MINER RES, V19, P893, DOI 10.1359/JBMR.040134; Kiel DP, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S14; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Langdahl BL, 2002, J BONE MINER RES, V17, P1245, DOI 10.1359/jbmr.2002.17.7.1245; Li Y, 2007, BLOOD, V109, P3839, DOI 10.1182/blood-2006-07-037994; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; Pastinen T, 2005, HUM MOL GENET, V14, P3963, DOI 10.1093/hmg/ddi420; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ralston SH, 2006, PLOS MED, V3, P515, DOI 10.1371/journal.pmed.0030090; Ray NF, 1997, J BONE MINER RES, V12, P24, DOI 10.1359/jbmr.1997.12.1.24; Richards JB, 2007, J BONE MINER RES, V22, P228, DOI 10.1359/JBMR.061109; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001; Sims AM, 2008, J BONE MINER RES, V23, P499, DOI 10.1359/JBMR.071113; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stolk L, 2007, J CLIN ENDOCR METAB, V92, P3206, DOI 10.1210/jc.2006-2136; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Ueland T, 2007, BONE, V40, P175, DOI 10.1016/j.bone.2006.06.022; Uitterlinden AG, 2006, ANN INTERN MED, V145, P255, DOI 10.7326/0003-4819-145-4-200608150-00005; van Meurs JBJ, 2006, J BONE MINER RES, V21, P141, DOI 10.1359/JBMR.050904; van Meurs JBJ, 2008, JAMA-J AM MED ASSOC, V299, P1277, DOI 10.1001/jama.299.11.1277; van Staa TP, 2000, QJM-MON J ASSOC PHYS, V93, P105, DOI 10.1093/qjmed/93.2.105; Van Staa TP, 2000, J BONE MINER RES, V15, P993, DOI 10.1359/jbmr.2000.15.6.993; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; WILLIAMS FM, 2007, AETA RHEUM PORT, V32, P103	57	501	531	1	41	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2008	371	9623					1505	1512		10.1016/S0140-6736(08)60599-1	http://dx.doi.org/10.1016/S0140-6736(08)60599-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298ED	18455228	Green Published, Green Accepted			2022-12-24	WOS:000255668300026
J	Guest, J				Guest, James			Ecology - How reefs respond to mass coral spawning	SCIENCE			English	Editorial Material							GREAT-BARRIER-REEF; AUSTRALIA; FISH/		Univ Newcastle Upon Tyne, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Guest, J (corresponding author), Univ Newcastle Upon Tyne, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	james.guest@ncl.ac.uk	Guest, James/D-5179-2011	Guest, James/0000-0002-9714-9009				BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Baird AH, 2001, MAR FRESHWATER RES, V52, P865, DOI 10.1071/MF00144; Eyre BD, 2008, LIMNOL OCEANOGR, V53, P997, DOI 10.4319/lo.2008.53.3.0997; Glud RN, 2008, LIMNOL OCEANOGR, V53, P1014, DOI 10.4319/lo.2008.53.3.1014; Guest JR, 2005, INVERTEBR REPROD DEV, V48, P207, DOI 10.1080/07924259.2005.9652186; Hagman Derek K., 1998, Gulf of Mexico Science, V16, P170; HAMNER WM, 1988, B MAR SCI, V42, P459; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Pratchett MS, 2001, CORAL REEFS, V20, P13, DOI 10.1007/s003380000113; SIMPSON CJ, 1993, CORAL REEFS, V12, P185, DOI 10.1007/BF00334478; Wild C, 2008, CORAL REEFS, V27, P123, DOI 10.1007/s00338-007-0298-7; Wild C, 2004, MAR ECOL PROG SER, V271, P159, DOI 10.3354/meps271159; Wild C, 2004, NATURE, V428, P66, DOI 10.1038/nature02344; [No title captured]	14	14	14	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2008	320	5876					621	623		10.1126/science.1155285	http://dx.doi.org/10.1126/science.1155285			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451290				2022-12-24	WOS:000255454300031
J	Stacey, D; Hawker, G; Dervin, G; Tomek, I; Cochran, N; Tugwell, P; O'Connor, AM				Stacey, Dawn; Hawker, Gillian; Dervin, Geoff; Tomek, Ivan; Cochran, Nan; Tugwell, Peter; O'Connor, Annette M.			Making a difference - Management of chronic pain - Improving shared decision making in osteoarthritis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AIDS		[Stacey, Dawn; O'Connor, Annette M.] Univ Ottawa, Sch Nursing, Ottawa, ON, Canada; [Hawker, Gillian] Univ Toronto, Div Rheumatol, Toronto, ON, Canada; [Dervin, Geoff] Univ Ottawa, Dept Surg, Div Orthopaed Surg, Ottawa, ON K1N 6N5, Canada; [Tomek, Ivan] Dartmouth Hitchcock Med Ctr, Dept Orthopaed Surg, Lebanon, NH 03766 USA; [Tomek, Ivan] Dartmouth Med Sch, Lebanon, NH USA; [Cochran, Nan] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Med & Community & Family Med, Hanover, NH 03756 USA; [Tugwell, Peter] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [O'Connor, Annette M.] Ottawa Hlth Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada	University of Ottawa; University of Toronto; University of Ottawa; Dartmouth College; Dartmouth College; Dartmouth College; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Stacey, D (corresponding author), Univ Ottawa, Sch Nursing, Ottawa, ON, Canada.	dawn.stacey@uottawa.ca	Tugwell, Peter/AFD-8076-2022	Tugwell, Peter/0000-0001-5062-0556				Coulter A, 2007, BMJ-BRIT MED J, V335, P24, DOI 10.1136/bmj.39246.581169.80; *DARTM HITCHC MED, 2008, QUAL REP KNEE REPL; Elwyn G, 2006, BMJ-BRIT MED J, V333, P417, DOI 10.1136/bmj.38926.629329.AE; Gravel K, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-16; LLEWELLYNTHOMAS HA, 2003, MED DECIS MAKING, V23, P551; *NAT STEER GROUP D, 2005, IMPL PAT DEC AIDS UR; O'Connor AM, 2007, HEALTH AFFAIR, V26, P716, DOI 10.1377/hlthaff.26.3.716; Silvia KA, 2006, HEALTH EXPECT, V9, P255, DOI 10.1111/j.1369-7625.2006.00393.x; Weinstein JN, 2007, HEALTH AFFAIR, V26, P726, DOI 10.1377/hlthaff.26.3.726; Weng HLH, 2007, ARTHRIT RHEUM-ARTHR, V57, P568, DOI 10.1002/art.22670	10	26	26	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2008	336	7650					954	+						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296KC	18397937	Bronze, Green Submitted, Green Published			2022-12-24	WOS:000255540900042
J	Darland-Ransom, M; Wang, XC; Sun, CL; Mapes, J; Gengyo-Ando, K; Mitani, S; Xue, D				Darland-Ransom, Monica; Wang, Xiaochen; Sun, Chun-Ling; Mapes, James; Gengyo-Ando, Keiko; Mitani, Shohei; Xue, Ding			Role of C-elegans TAT-1 protein in maintaining plasma membrane phosphatidylserine asymmetry	SCIENCE			English	Article							CELL CORPSE ENGULFMENT; C-ELEGANS; APOPTOTIC CELLS; AMINOPHOSPHOLIPID TRANSLOCASE; GENETIC INTERFERENCE; ATPASE-II; DEATH; RECEPTOR; PHAGOCYTOSIS; EXPRESSION	The asymmetrical distribution of phospholipids on the plasma membrane is critical for maintaining cell integrity and physiology and for regulating intracellular signaling and important cellular events such as clearance of apoptotic cells. How phospholipid asymmetry is established and maintained is not fully understood. We report that the Caenorhabditis elegans P- type adenosine triphosphatase homolog, TAT-1, is critical for maintaining cell surface asymmetry of phosphatidylserine ( PS). In animals deficient in tat-1, PS is abnormally exposed on the cell surface, and normally living cells are randomly lost through a mechanism dependent on PSR- 1, a PS- recognizing phagocyte receptor, and CED- 1, which contributes to recognition and engulfment of apoptotic cells. Thus, tat- 1 appears to function in preventing appearance of PS in the outer leaflet of plasma membrane, and ectopic exposure of PS on the cell surface may result in removal of living cells by neighboring phagocytes.	[Darland-Ransom, Monica; Wang, Xiaochen; Sun, Chun-Ling; Mapes, James; Xue, Ding] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Gengyo-Ando, Keiko; Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan; [Gengyo-Ando, Keiko; Mitani, Shohei] Japan Sci & Technol Agcy, CREST, Tokyo 1628666, Japan	University of Colorado System; University of Colorado Boulder; Tokyo Women's Medical University; Japan Science & Technology Agency (JST)	Xue, D (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	ding.xue@colorado.edu	Gengyo-Ando, Keiko/B-2753-2012; Gengyo-Ando, Keiko/AAC-4504-2019	XUE, DING/0000-0002-8429-8136; Ransom, Monica/0000-0002-7527-7122	NIGMS NIH HHS [R01 GM059083, R01 GM088241, R01 GM079097, R01 GM59083] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059083, R01GM088241, R01GM079097] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AULAND ME, 1994, P NATL ACAD SCI USA, V91, P10938, DOI 10.1073/pnas.91.23.10938; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Bayir H, 2006, BBA-BIOENERGETICS, V1757, P648, DOI 10.1016/j.bbabio.2006.03.002; Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; Ding JT, 2000, J BIOL CHEM, V275, P23378, DOI 10.1074/jbc.M910319199; FADOK VA, 1992, J IMMUNOL, V149, P4029; Fadok VA, 2001, CELL DEATH DIFFER, V8, P582, DOI 10.1038/sj.cdd.4400856; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; HARRISON RAP, 1990, J REPROD FERTIL, V88, P343, DOI 10.1530/jrf.0.0880343; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Kelly WG, 1997, GENETICS, V146, P227; Paterson JK, 2006, BIOCHEMISTRY-US, V45, P5367, DOI 10.1021/bi052359b; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Royal DC, 2005, J BIOL CHEM, V280, P41976, DOI 10.1074/jbc.M510732200; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Wang XC, 2003, SCIENCE, V302, P1563, DOI 10.1126/science.1087641; Wang XC, 2007, NAT CELL BIOL, V9, P541, DOI 10.1038/ncb1574; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zahn TR, 2001, J COMP NEUROL, V429, P127, DOI 10.1002/1096-9861(20000101)429:1&lt;127::AID-CNE10&gt;3.0.CO;2-H; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8; Zullig S, 2007, CURR BIOL, V17, P994, DOI 10.1016/j.cub.2007.05.024	24	101	119	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					528	531		10.1126/science.1155847	http://dx.doi.org/10.1126/science.1155847			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436785				2022-12-24	WOS:000255249300050
J	Weisel, JW				Weisel, John W.			Biophysics - Enigmas of blood clot elasticity	SCIENCE			English	Editorial Material							FIBRIN; FIBERS		[Weisel, John W.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Weisel, JW (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	weisel@mail.med.upenn.edu						Brown AEX, 2007, BIOPHYS J, V92, pL39, DOI 10.1529/biophysj.106.101261; Collet JP, 2006, ARTERIOSCL THROM VAS, V26, P2567, DOI 10.1161/01.ATV.0000241589.52950.4c; Collet JP, 2005, P NATL ACAD SCI USA, V102, P9133, DOI 10.1073/pnas.0504120102; Ferry J. D., 1988, BIOL SYNTHETIC POLYM, P41; Lim BBC, 2008, STRUCTURE, V16, P449, DOI 10.1016/j.str.2007.12.019; Liu W, 2006, SCIENCE, V313, P634, DOI 10.1126/science.1127317; Lord ST, 2007, CURR OPIN HEMATOL, V14, P236, DOI 10.1097/MOH.0b013e3280dce58c; Mizuno D, 2007, SCIENCE, V315, P370, DOI 10.1126/science.1134404; MULLER MF, 1984, J MOL BIOL, V174, P369, DOI 10.1016/0022-2836(84)90343-7; Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Surrey T, 2001, SCIENCE, V292, P1167, DOI 10.1126/science.1059758; Weisel JW, 2004, BIOPHYS CHEM, V112, P267, DOI 10.1016/j.bpc.2004.07.029; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X	14	62	62	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					456	457		10.1126/science.1154210	http://dx.doi.org/10.1126/science.1154210			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436761				2022-12-24	WOS:000255249300022
J	Yang, CG; Yi, CQ; Duguid, EM; Sullivan, CT; Jian, X; Rice, PA; He, C				Yang, Cai-Guang; Yi, Chengqi; Duguid, Erica M.; Sullivan, Christopher T.; Jian, Xing; Rice, Phoebe A.; He, Chuan			Crystal structures of DNA/RNA repair enzymes AlkB and ABH2 bound to dsDNA	NATURE			English	Article							OXIDATIVE DEMETHYLATION; ALKYLATION DAMAGE; DNA; BACTERIAL; LESIONS; 3-METHYLTHYMINE; PROTEIN; IRON; 1-METHYLGUANINE; 8-OXOGUANINE	Escherichia coli AlkB and its human homologues ABH2 and ABH3 repair DNA/ RNA base lesions by using a direct oxidative dealkylation mechanism. ABH2 has the primary role of guarding mammalian genomes against 1- meA damage by repairing this lesion in double- stranded DNA ( dsDNA), whereas AlkB and ABH3 preferentially repair single- stranded DNA ( ssDNA) lesions and can repair damaged bases in RNA. Here we show the first crystal structures of AlkB - dsDNA and ABH2 - dsDNA complexes, stabilized by a chemical cross- linking strategy. This study reveals that AlkB uses an unprecedented base- flipping mechanism to access the damaged base: it squeezes together the two bases flanking the flipped- out one to maintain the base stack, explaining the preference of AlkB for repairing ssDNA lesions over dsDNA ones. In addition, the first crystal structure of ABH2, presented here, provides a structural basis for designing inhibitors of this human DNA repair protein.	[Yang, Cai-Guang; Yi, Chengqi; Duguid, Erica M.; Sullivan, Christopher T.; Jian, Xing; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Rice, Phoebe A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	He, C (corresponding author), Univ Chicago, Dept Chem, 929 E 57th St, Chicago, IL 60637 USA.	chuanhe@uchicago.edu	Jian, Xing/N-3753-2018	Jian, Xing/0000-0002-0043-8729; Duguid, Erica/0000-0003-4319-1030; Yi, Chengqi/0000-0003-2540-9729	NIGMS NIH HHS [GM071440, R01 GM071440, R01 GM071440-03] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071440] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; ARAVIND L, 2001, GENOME BIOL, V2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banerjee A, 2006, SCIENCE, V311, P1153, DOI 10.1126/science.1120288; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Delaney JC, 2005, NAT STRUCT MOL BIOL, V12, P855, DOI 10.1038/nsmb996; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dinglay S, 2000, GENE DEV, V14, P2097; Duguid EM, 2003, CHEM BIOL, V10, P827, DOI 10.1016/j.chembiol.2003.08.007; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Elkins JM, 2002, BIOCHEMISTRY-US, V41, P5185, DOI 10.1021/bi016014e; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P6260, DOI 10.1093/nar/gkh964; Friedberg EC, 1995, DNA REPAIR MUTAGENES; Fromme JC, 2004, NATURE, V427, P652, DOI 10.1038/nature02306; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Koivisto P, 2004, J BIOL CHEM, V279, P40470, DOI 10.1074/jbc.M407960200; Lange SJ, 1998, CURR OPIN CHEM BIOL, V2, P159, DOI 10.1016/S1367-5931(98)80057-4; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; Lee DH, 2005, J BIOL CHEM, V280, P39448, DOI 10.1074/jbc.M509881200; LINDAHL T, 1988, ANNU REV BIOCHEM, V57, P133, DOI 10.1146/annurev.bi.57.070188.001025; Mishina Y, 2003, J AM CHEM SOC, V125, P8730, DOI 10.1021/ja034636c; Mishina Y, 2005, J AM CHEM SOC, V127, P14594, DOI 10.1021/ja055957m; Mishina Y, 2004, J AM CHEM SOC, V126, P16930, DOI 10.1021/ja045066z; Mishina Y, 2004, NUCLEIC ACIDS RES, V32, P1548, DOI 10.1093/nar/gkh319; Mishina Y, 2006, J INORG BIOCHEM, V100, P670, DOI 10.1016/j.jinorgbio.2005.12.018; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker JB, 2007, NATURE, V449, P433, DOI 10.1038/nature06131; Read RJ, 2003, ACTA CRYSTALLOGR D, V59, P404, DOI 10.1107/S0907444903000490; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Schofield CJ, 1999, CURR OPIN STRUC BIOL, V9, P722, DOI 10.1016/S0959-440X(99)00036-6; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Verdine GL, 2003, ANNU REV BIOCHEM, V72, P337, DOI 10.1146/annurev.biochem.72.121801.161447; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561	44	193	199	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2008	452	7190					961	U4		10.1038/nature06889	http://dx.doi.org/10.1038/nature06889			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291PF	18432238	Green Accepted			2022-12-24	WOS:000255208600032
J	Gallarda, BW; Bonanomi, D; Muller, D; Brown, A; Alaynick, WA; Andrews, SE; Lemke, G; Pfaff, SL; Marquardt, T				Gallarda, Benjamin W.; Bonanomi, Dario; Mueller, Daniel; Brown, Arthur; Alaynick, William A.; Andrews, Shane E.; Lemke, Greg; Pfaff, Samuel L.; Marquardt, Till			Segregation of axial motor and sensory pathways via heterotypic trans-axonal signaling	SCIENCE			English	Article							CHICK HINDLIMB; LOCOMOTOR CIRCUITS; EMBRYONIC CHICK; PROJECTIONS; LIMB	Execution of motor behaviors relies on circuitries effectively integrating immediate sensory feedback to efferent pathways controlling muscle activity. It remains unclear how, during neuromuscular circuit assembly, sensory and motor projections become incorporated into tightly coordinated, yet functionally separate pathways. We report that, within axial nerves, establishment of discrete afferent and efferent pathways depends on coordinate signaling between coextending sensory and motor projections. These heterotypic axon-axon interactions require motor axonal EphA3/EphA4 receptor tyrosine kinases activated by cognate sensory axonal ephrin-A ligands. Genetic elimination of trans-axonal ephrin-A -> EphA signaling in mice triggers drastic motor-sensory miswiring, culminating in functional efferents within proximal afferent pathways. Effective assembly of a key circuit underlying motor behaviors thus critically depends on trans-axonal signaling interactions resolving motor and sensory projections into discrete pathways.	[Gallarda, Benjamin W.; Bonanomi, Dario; Alaynick, William A.; Andrews, Shane E.; Pfaff, Samuel L.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Mueller, Daniel; Marquardt, Till] Univ Gottingen, Sch Med, Dev Neurobiol Lab, European Neurosci Inst Gottingen,Max Planck Soc, D-37077 Gottingen, Germany; [Mueller, Daniel; Marquardt, Till] European Neurosci Inst Gottingen, Deutsche Forschungsgemeinschaft Emmy Noether Grp, D-37077 Gottingen, Germany; [Brown, Arthur] Univ Western Ontario, Biotherapeut Res Grp, Robarts Res Inst, Dept Anat & Cell Biol, London, ON N6A 5K8, Canada; [Lemke, Greg] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute; Max Planck Society; University of Gottingen; Western University (University of Western Ontario); Salk Institute	Pfaff, SL (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pfaff@salk.edu; till.marquardt@mpi-mail.mpg.de	Bonanomi, Dario/K-3450-2016; Brown, Arthur/K-8328-2013	Bonanomi, Dario/0000-0003-4517-1244; Brown, Arthur/0000-0002-8725-3195; Gallarda, Benjamin/0000-0002-2968-2549	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054172, P01NS031249] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS054172-04, P01 NS031249, R01 NS054172, R01 NS054172-02, R01 NS054172-05, R01 NS054172-03, NS054172-01A2, NS031249-14A1, R01 NS054172-01A2] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Chen HH, 2003, CURR OPIN NEUROBIOL, V13, P96, DOI 10.1016/S0959-4388(03)00006-0; Dong ZP, 1999, J NEUROSCI RES, V56, P334, DOI 10.1002/(SICI)1097-4547(19990515)56:4<334::AID-JNR2>3.0.CO;2-#; ECCLES JC, 1981, APPL NEUROPHYSIOL, V44, P5; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Goulding M, 2005, CURR OPIN NEUROBIOL, V15, P14, DOI 10.1016/j.conb.2005.01.017; Gramsbergen A, 1999, DEV BRAIN RES, V112, P217, DOI 10.1016/S0165-3806(98)00184-9; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Honig MG, 1998, DEVELOPMENT, V125, P995; Honig MG, 1996, DEV BIOL, V175, P325, DOI 10.1006/dbio.1996.0118; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; LANDMESSER L, 1986, DEV BIOL, V118, P511, DOI 10.1016/0012-1606(86)90023-0; Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3; Lee SK, 2004, DEVELOPMENT, V131, P3295, DOI 10.1242/dev.01179; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; MCLACHLAN EM, 1993, NATURE, V363, P543, DOI 10.1038/363543a0; Myers CP, 2005, NEURON, V46, P37, DOI 10.1016/j.neuron.2005.02.022; Quina LA, 2005, J NEUROSCI, V25, P11595, DOI 10.1523/JNEUROSCI.2837-05.2005; Shirasaki R, 2006, NEURON, V50, P841, DOI 10.1016/j.neuron.2006.04.030; TANG JC, 1994, NEURON, V13, P405, DOI 10.1016/0896-6273(94)90356-5; TOSNEY KW, 1989, J EXP ZOOL, V251, P232, DOI 10.1002/jez.1402510211; Vaidya A, 2003, MOL CELL BIOL, V23, P8092, DOI 10.1128/MCB.23.22.8092-8098.2003; Wang G, 1999, DEV BIOL, V208, P324, DOI 10.1006/dbio.1999.9212	26	72	74	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 11	2008	320	5873					233	236		10.1126/science.1153758	http://dx.doi.org/10.1126/science.1153758			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286HJ	18403711	Green Accepted			2022-12-24	WOS:000254836700044
J	Thorgeirsson, TE; Geller, F; Sulem, P; Rafnar, T; Wiste, A; Magnusson, KP; Manolescu, A; Thorleifsson, G; Stefansson, H; Ingason, A; Stacey, SN; Bergthorsson, JT; Thorlacius, S; Gudmundsson, J; Jonsson, T; Jakobsdottir, M; Saemundsdottir, J; Olafsdottir, O; Gudmundsson, LJ; Bjornsdottir, G; Kristjansson, K; Skuladottir, H; Isaksson, HJ; Gudbjartsson, T; Jones, GT; Mueller, T; Gottsater, A; Flex, A; Aben, KKH; de Vegt, F; Mulders, PFA; Isla, D; Vidal, MJ; Asin, L; Saez, B; Murillo, L; Blondal, T; Kolbeinsson, H; Stefansson, JG; Hansdottir, I; Runarsdottir, V; Pola, R; Lindblad, B; van Rij, AM; Dieplinger, B; Haltmayer, M; Mayordomo, JI; Kiemeney, LA; Matthiasson, SE; Oskarsson, H; Tyrfingsson, T; Gudbjartsson, DF; Gulcher, JR; Jonsson, S; Thorsteinsdottir, U; Kong, A; Stefansson, K				Thorgeirsson, Thorgeir E.; Geller, Frank; Sulem, Patrick; Rafnar, Thorunn; Wiste, Anna; Magnusson, Kristinn P.; Manolescu, Andrei; Thorleifsson, Gudmar; Stefansson, Hreinn; Ingason, Andres; Stacey, Simon N.; Bergthorsson, Jon T.; Thorlacius, Steinunn; Gudmundsson, Julius; Jonsson, Thorlakur; Jakobsdottir, Margret; Saemundsdottir, Jona; Olafsdottir, Olof; Gudmundsson, Larus J.; Bjornsdottir, Gyda; Kristjansson, Kristleifur; Skuladottir, Halla; Isaksson, Helgi J.; Gudbjartsson, Tomas; Jones, Gregory T.; Mueller, Thomas; Gottsater, Anders; Flex, Andrea; Aben, Katja K. H.; de Vegt, Femmie; Mulders, Peter F. A.; Isla, Dolores; Vidal, Maria J.; Asin, Laura; Saez, Berta; Murillo, Laura; Blondal, Thorsteinn; Kolbeinsson, Halldor; Stefansson, Jon G.; Hansdottir, Ingunn; Runarsdottir, Valgerdur; Pola, Roberto; Lindblad, Bengt; van Rij, Andre M.; Dieplinger, Benjamin; Haltmayer, Meinhard; Mayordomo, Jose I.; Kiemeney, Lambertus A.; Matthiasson, Stefan E.; Oskarsson, Hogni; Tyrfingsson, Thorarinn; Gudbjartsson, Daniel F.; Gulcher, Jeffrey R.; Jonsson, Steinn; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari			A variant associated with nicotine dependence, lung cancer and peripheral arterial disease	NATURE			English	Article							GENETIC INFLUENCE; LOWER-EXTREMITY; FAGERSTROM TEST; RISK-FACTORS; SMOKING; CARCINOMA; SMOKERS; STATISTICS; ADDICTION; ISCHEMIA	Smoking is a leading cause of preventable death, causing about 5 million premature deaths worldwide each year(1,2). Evidence for genetic influence on smoking behaviour and nicotine dependence (ND)(3-8) has prompted a search for susceptibility genes. Furthermore, assessing the impact of sequence variants on smoking-related diseases is important to public health(9,10). Smoking is the major risk factor for lung cancer (LC)(11-14) and is one of the main risk factors for peripheral arterial disease (PAD)(15-17). Here we identify a common variant in the nicotinic acetylcholine receptor gene cluster on chromosome 15q24 with an effect on smoking quantity, ND and the risk of two smoking- related diseases in populations of European descent. The variant has an effect on the number of cigarettes smoked per day in our sample of smokers. The same variant was associated with ND in a previous genomewide association study that used low- quantity smokers as controls(18,19), and with a similar approach we observe a highly significant association with ND. A comparison of cases of LC and PAD with population controls each showed that the variant confers risk of LC and PAD. The findings provide a case study of a gene - environment interaction(20), highlighting the role of nicotine addiction in the pathology of other serious diseases.	[Thorgeirsson, Thorgeir E.; Geller, Frank; Sulem, Patrick; Rafnar, Thorunn; Wiste, Anna; Magnusson, Kristinn P.; Manolescu, Andrei; Thorleifsson, Gudmar; Stefansson, Hreinn; Ingason, Andres; Stacey, Simon N.; Bergthorsson, Jon T.; Thorlacius, Steinunn; Gudmundsson, Julius; Jonsson, Thorlakur; Jakobsdottir, Margret; Saemundsdottir, Jona; Olafsdottir, Olof; Gudmundsson, Larus J.; Bjornsdottir, Gyda; Kristjansson, Kristleifur; Gudbjartsson, Daniel F.; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Wiste, Anna] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Skuladottir, Halla] Landspital Univ Hosp, Dept Med Oncol, IS-101 Reykjavik, Iceland; [Isaksson, Helgi J.] Landspital Univ Hosp, Dept Pathol, IS-101 Reykjavik, Iceland; [Gudbjartsson, Tomas] Landspital Univ Hosp, Dept Cardiothorac Surg, IS-101 Reykjavik, Iceland; [Kolbeinsson, Halldor; Stefansson, Jon G.] Landspital Univ Hosp, Dept Gen Adult Psychiat, IS-101 Reykjavik, Iceland; [Jonsson, Steinn] Landspital Univ Hosp, Dept Med, IS-101 Reykjavik, Iceland; [Jones, Gregory T.; van Rij, Andre M.] Univ Otago, Dept Surg, Dunedin Sch Med, Dunedin 9054, New Zealand; [Mueller, Thomas; Dieplinger, Benjamin; Haltmayer, Meinhard] Konventhosp Barmherzige Brueder, Dept Lab Med, A-4020 Linz, Austria; [Gottsater, Anders; Lindblad, Bengt] Malmo Univ Hosp, MAS, Ctr Vasc Dis, S-20502 Malmo, Sweden; [Flex, Andrea; Pola, Roberto] Univ Cattolica Sacro Cuore, Sch Med, Lab Vasc Biol & Genet, A Gemelli Univ Hosp, I-00168 Rome, Italy; [Aben, Katja K. H.; de Vegt, Femmie; Kiemeney, Lambertus A.] Radboud Univ Nijmegen Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; [Aben, Katja K. H.; Kiemeney, Lambertus A.] Comprehens Canc Ctr E, NL-6501 BG Nijmegen, Netherlands; [Mulders, Peter F. A.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen Med Ctr, Dept Urol, NL-6525 GA Nijmegen, Netherlands; [Isla, Dolores; Vidal, Maria J.; Mayordomo, Jose I.] Univ Hosp, Div Med Oncol, Zaragoza 5009, Spain; [Asin, Laura; Mayordomo, Jose I.] Nanotechnol Inst Aragon, Zaragoza 5009, Spain; [Saez, Berta; Mayordomo, Jose I.] Hlth Sci Inst, Zaragoza 5009, Spain; [Murillo, Laura] Hosp Reina Sofia, Div Med Oncol, Tudela 31500, Spain; [Blondal, Thorsteinn] Primary Hlth Care Ctr, Dept Lung Dis, IS-101 Reykjavik, Iceland; [Hansdottir, Ingunn; Runarsdottir, Valgerdur; Tyrfingsson, Thorarinn] Vogur SAA Addict Treatment Ctr, IS-112 Reykjavik, Iceland; [Pola, Roberto] IRCCS, OASI Inst Res & Care, I-94018 Troina, EN, Italy; [Matthiasson, Stefan E.; Stefansson, Kari] Univ Iceland, Sch Med, IS-101 Reykjavik, Iceland; [Oskarsson, Hogni] Therapeia, IS-101 Reykjavik, Iceland	Emory University; Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; University of Otago; Konventhospital Der Barmherzigen Bruder; Lund University; Skane University Hospital; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Radboud University Nijmegen; Radboud University Nijmegen; Miguel Servet University Hospital; Servicio Navarro de Salud - Osasunbidea; IRCCS Oasi Maria SS; University of Iceland	Thorgeirsson, TE (corresponding author), deCODE Genet, IS-101 Reykjavik, Iceland.	thorgeir@decode.is; kari.stefansson@decode.is	Stefansson, Kari/AAE-7187-2019; Hansdottir, Ingunn/A-6735-2012; Aben, Katja KH/G-9686-2016; Manolescu, Andrei/G-4565-2014; Ingason, Andres/G-6817-2012; Flex, Andrea/K-7305-2016; Magnusson, Kristinn P Pétur/X-4907-2019; Losada, Maria Vidal/AAJ-8633-2021; Mulders, Peter F.A./H-8076-2014; Magnusson, Kristinn/A-6479-2011; Mayordomo, Jose/K-3453-2013; ASIN, LAURA/H-7276-2017; Kiemeney, Lambertus A./D-3357-2009; de Vegt, F./L-4704-2015	Aben, Katja KH/0000-0002-0214-2147; Manolescu, Andrei/0000-0002-0713-4664; Flex, Andrea/0000-0003-2664-4165; Magnusson, Kristinn P Pétur/0000-0003-4528-6826; Losada, Maria Vidal/0000-0003-1992-5727; Magnusson, Kristinn/0000-0003-4528-6826; ASIN, LAURA/0000-0003-0641-3407; Kiemeney, Lambertus A./0000-0002-2368-1326; de Vegt, F./0000-0001-8728-3397; Geller, Frank/0000-0002-9238-3269; Stefansson, Hreinn/0000-0002-9331-6666; Thorgeirsson, Thorgeir/0000-0002-5149-7040; Saez, Berta/0000-0003-0753-1165; Skuladottir, Halla/0000-0001-8703-9407; Pola, Roberto/0000-0001-5224-2931; Isla, Dolores/0000-0002-2483-198X; Bergthorsson, Jon Thor/0000-0002-0560-2639; Jones, Gregory T/0000-0002-6950-4210; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Bjornsdottir, Gyda/0000-0002-8100-0306; Kong, Augustine/0000-0001-8193-5438; Gudbjartsson, Daniel/0000-0002-5222-9857	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017932] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA017932] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Barani J, 2005, J VASC SURG, V42, P75, DOI 10.1016/j.jvs.2005.03.025; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; BERRETTINI W, IN PRESS MOL PSYCHIA; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Bierut LJ, 2007, JAMA-J AM MED ASSOC, V297, P809, DOI 10.1001/jama.297.8.809; Carlsten C, 2006, JAMA-J AM MED ASSOC, V296, P2480, DOI 10.1001/jama.296.20.2480; CARMELLI D, 1992, NEW ENGL J MED, V327, P829, DOI 10.1056/NEJM199209173271201; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; DOLL R, 1952, BMJ-BRIT MED J, V2, P1271, DOI 10.1136/bmj.2.4797.1271; DOLL R, 1978, J EPIDEMIOL COMMUN H, V32, P303, DOI 10.1136/jech.32.4.303; Flex A, 2002, EUR J VASC ENDOVASC, V24, P264, DOI 10.1053/ejvs.2002.1711; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Haiman CA, 2006, NEW ENGL J MED, V354, P333, DOI 10.1056/NEJMoa033250; HEATH AC, 1993, ADDICT BEHAV, V18, P19, DOI 10.1016/0306-4603(93)90005-T; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Kendler KS, 1999, PSYCHOL MED, V29, P299, DOI 10.1017/S0033291798008022; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x; Madden PAF, 1999, BEHAV GENET, V29, P423, DOI 10.1023/A:1021674804714; Mueller T, 2005, J VASC SURG, V41, P808, DOI 10.1016/j.jvs.2005.01.039; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; PLOMIN R, 1977, PSYCHOL BULL, V84, P309, DOI 10.1037/0033-2909.84.2.309; Powell JT, 1997, ATHEROSCLEROSIS, V129, P41, DOI 10.1016/S0021-9150(96)06012-1; Price JF, 1999, EUR HEART J, V20, P344, DOI 10.1053/euhj.1998.1194; Rose JE, 1996, ANNU REV MED, V47, P493; RUSSELL MAH, 1990, BRIT J ADDICT, V85, P293; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; RUTHERFORD RB, 1986, J VASC SURG, V4, P80; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Stellman SD, 2003, ANN EPIDEMIOL, V13, P294, DOI 10.1016/S1047-2797(02)00420-9; STOLERMAN IP, 1995, PSYCHOPHARMACOLOGY, V117, P2, DOI 10.1007/BF02245088; TASC Working Group, 2000, EUR J VASC ENDOVASC, V19, pS1; Thorgeirsson TE, 2003, AM J HUM GENET, V72, P1221, DOI 10.1086/375141; Vink JM, 2005, ADDICT BEHAV, V30, P575, DOI 10.1016/j.addbeh.2004.05.023; *WHO, EC TOB CONTR; WYNDER EL, 1950, JAMA-J AM MED ASSOC, V143, P329, DOI 10.1001/jama.1950.02910390001001; 2005, MMWR MORB MORTAL WKL, V54, P625	39	1136	1173	1	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2008	452	7187					638	U9		10.1038/nature06846	http://dx.doi.org/10.1038/nature06846			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282KR	18385739	Green Accepted			2022-12-24	WOS:000254567200047
J	Phillips, AN; Pillay, D; Miners, AH; Bennett, DE; Gilks, CF; Lundgren, JD				Phillips, Andrew N.; Pillay, Deenan; Miners, Alec H.; Bennett, Diane E.; Gilks, Charles F.; Lundgren, Jens D.			Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model	LANCET			English	Article							ZIDOVUDINE COMBINATION THERAPY; THYMIDINE ANALOG MUTATIONS; SUB-SAHARAN AFRICA; HIV-1-INFECTED PATIENTS; COST-EFFECTIVENESS; NAIVE PATIENTS; POOR SETTINGS; HIV TREATMENT; LAMIVUDINE; ADHERENCE	Background In lower-income countries, WHO recommends a population-based approach to antiretroviral treatment with standardised regimens and clinical decision making based on clinical status and, where available CD4 cell count, rather than viral load. Our aim was to study the potential consequences of such monitoring strategies, especially in terms of survival and resistance development. Methods A validated computer simulation model of HIV infection and the effect of antiretroviral therapy was used to compare survival, use of second-line regimens, and development of resistance that result from different strategies-based on viral load, CD4 cell count, or clinical observation alone-for determining when to switch people starting antiretroviral treatment with the WHO-recommended first-line regimen of stavudine, lamivudine, and nevirapine to second-line antiretroviral treatment. Findings Over 5 years, the predicted proportion of potential life-years survived was 83% with viral load monitoring (switch when viral load >500 copies per mL), 82% with CD4 cell count monitoring (switch at 50% drop from peak), and 82% with clinical monitoring (switch when two new WHO stage 3 events or a WHO stage 4 event occur). Corresponding values over 20 years were 67%, 64%, and 64%. Findings were robust to variations in model specification in extensive univariable and multivariable sensitivity analyses. Although survival was slightly longer with viral load monitoring, this strategy was not the most cost effective. Interpretation For patients on the first-line regimen of stavudine, lamivudine, and nevirapine the benefits of viral load or CD4 cell count monitoring over clinical monitoring alone are modest. Development of cheap and robust versions of these assays is important, but widening access to antiretrovirals-with or without laboratory monitoring-is currently the highest priority.	[Phillips, Andrew N.] UCL, Dept Primary Care & Populat Sci, Royal Free & Univ Coll Med Sch, HIV Epidemiol & Biostat Grp, London, England; [Phillips, Andrew N.] UCL, Royal Free Ctr HIV Med, Royal Free & Univ Coll Med Sch, London, England; [Pillay, Deenan] UCL, Ctr Virol, Dept Infect, Royal Free & Univ Coll Med Sch, London, England; [Pillay, Deenan] Hlth Protect Agcy, Ctr Infect, London, England; [Miners, Alec H.] London Sch Hyg & Trop Med, London WC1, England; [Bennett, Diane E.; Gilks, Charles F.] WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland; [Lundgren, Jens D.] Rigshosp, Ctr Viral Dis, KMA, DK-2100 Copenhagen, Denmark; [Lundgren, Jens D.] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of London; University College London; University of London; University College London; University of London; University College London; Health Protection Agency; University of London; London School of Hygiene & Tropical Medicine; World Health Organization; Rigshospitalet; University of Copenhagen; University of Copenhagen	Phillips, AN (corresponding author), UCL, Dept Primary Care & Populat Sci, Royal Free & Univ Coll Med Sch, HIV Epidemiol & Biostat Grp, London, England.	a.phillips@pcps.ucl.ac.uk	Lundgren, Jens/AAE-6876-2019; Gilks, Charles/B-4184-2012; Phillips, Andrew N/B-4427-2008	Gilks, Charles/0000-0002-8953-3123; Phillips, Andrew N/0000-0003-2384-4807; Lundgren, Jens/0000-0001-8901-7850				Abbas UL, 2006, JAIDS-J ACQ IMM DEF, V41, P632, DOI 10.1097/01.qai.0000194234.31078.bf; Ait-Khaled M, 2002, AIDS, V16, P1686, DOI 10.1097/00002030-200208160-00017; Badri M, 2004, AIDS, V18, P1159, DOI 10.1097/00002030-200405210-00009; Bagchi S, 2007, CLIN INFECT DIS, V44, P135, DOI 10.1086/510072; Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; Bangsberg DR, 2007, AIDS READ, V17, pS11; BASENERO A, 2007, 4 INT AIDS SOC C HIV; Benzie AA, 2007, AIDS, V21, P1423, DOI 10.1097/QAD.0b013e3281532ca7; Beral V, 2004, AIDS, V18, P51, DOI [10.1097/00002030-200401020-00006, 10.1097/01.aids.0000096908.73209.5d]; Bishai D, 2007, AIDS, V21, P1333, DOI 10.1097/QAD.0b013e328137709e; Blower S, 2005, AIDS, V19, P1, DOI 10.1097/00002030-200501030-00001; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Braithwaite RS, 2006, J ANTIMICROB CHEMOTH, V58, P1036, DOI 10.1093/jac/dkl386; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Calmy A, 2007, CLIN INFECT DIS, V44, P128, DOI 10.1086/510073; Campbell TB, 2005, CLIN INFECT DIS, V41, P236, DOI 10.1086/430709; Castagna A, 2006, AIDS, V20, P795, DOI 10.1097/01.aids.0000218542.08845.b2; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Colebunders R, 2005, CLIN INFECT DIS, V41, P386, DOI 10.1086/431490; Cooper DA, 1997, LANCET, V349, P1413, DOI 10.1016/S0140-6736(97)04441-3; Cozzi-Lepri A, 2005, ANTIVIR THER, V10, P791; Deeks SG, 2005, J INFECT DIS, V192, P1537, DOI 10.1086/496892; Department of Health and Human Services (DHHS), 2008, GUID US ANT AG HIV 1; Eron JJ, 2004, JAIDS-J ACQ IMM DEF, V37, P1581, DOI 10.1097/00126334-200412150-00009; ERON JJ, 1995, NEW ENGL J MED, V333, P1662, DOI 10.1056/NEJM199512213332502; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Godin G, 2005, AIDS CARE, V17, P493, DOI 10.1080/09540120412331291715; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Hill A, 2007, AIDS, V21, P361, DOI 10.1097/QAD.0b013e328012c560; Holguin A, 2006, AIDS REV, V8, P98; HOSSEINIPOUR M, 2007, 4 INT AIDS SOC C HIV; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Kantor R, 2004, AIDS, V18, P1503, DOI 10.1097/01.aids.0000131358.29586.6b; Katlama C, 1996, JAMA-J AM MED ASSOC, V276, P118, DOI 10.1001/jama.276.2.118; Kuritzkes DR, 1999, AIDS, V13, P685, DOI 10.1097/00002030-199904160-00009; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; Maldarelli F, 2003, ANTIVIR THER, V8, pS149; *MED SANS FRONT, UNT WEB PRIC RED PRI; Miller LG, 2002, J GEN INTERN MED, V17, P1, DOI 10.1046/j.1525-1497.2002.09004.x; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Mocroft A, 2001, AIDS, V15, P201, DOI 10.1097/00002030-200101260-00009; Mouroux M, 2001, ANTIVIR THER, V6, P179; Phillips AN, 2007, HIV MED, V8, P536, DOI 10.1111/j.1468-1293.2007.00507.x; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Sow PS, 2007, JAIDS-J ACQ IMM DEF, V44, P262, DOI 10.1097/QAI.0b013e31802bf109; Staszewski S, 1996, JAMA-J AM MED ASSOC, V276, P111, DOI 10.1001/jama.276.2.111; Sungkanuparph S, 2007, CLIN INFECT DIS, V44, P447, DOI 10.1086/510745; Vijayaraghavan A, 2007, JAIDS-J ACQ IMM DEF, V46, P91; World Health Organisation, 2007, WHO CAS DEF HIV SURV; World Health Organization, 2007, US LIQ MED CULT DRUG, P1; World Health Organization, 2006, ANT THER HIV INF AD	51	141	145	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2008	371	9622					1443	1451		10.1016/S0140-6736(08)60624-8	http://dx.doi.org/10.1016/S0140-6736(08)60624-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294XW	18440426				2022-12-24	WOS:000255440600025
J	Assie, G; LaFramboise, T; Platzer, P; Eng, C				Assie, Guillaume; LaFramboise, Thomas; Platzer, Petra; Eng, Charis			Frequency of germline genomic homozygosity associated with cancer cases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BREAST-CANCER; WIDE ASSOCIATION; COLORECTAL-CANCER; HUMAN-POPULATIONS; RISK; HETEROZYGOSITY; STROMA; SCAN; EPITHELIUM; CARCINOMA	Context Cancer is a multigenic disease resulting from both germline susceptibility and somatic events. While studying loss of heterozygosity ( LOH) in cancer tissues, we anecdotally observed a low frequency of heterozygosity in cancer patients compared with controls, raising the question whether homozygosity could play a role in cancer predisposition. Objectives To determine the frequency of germline homozygosity in a large series of patients with 3 different types of solid tumors compared with population- based controls. Design, Setting, and Patients Germline and corresponding tumor DNA isolated from 385 patients with carcinomas ( 147 breast, 116 prostate, and 122 head and neck carcinomas) were subjected to whole genome ( 345- microsatellite marker) LOH analysis. Main Outcome Measures Frequency of homozygosity at microsatellite markers in cancer cases vs controls and frequency of somatic LOH in cancers at loci with the highest homozygosity. Results We identified 16 loci in common among the 3 cancer types, with significantly increased germline homozygosity frequencies in the cancer patients compared with controls ( P <. 001). In the cases who happened to be germline heterozygous at these 16 loci, we found a mean ( SD) LOH frequency of 58% ( 4.2%) compared with 50% ( 7.5%) at 197 markers without increased germline homozygosity ( P <. 001). Across the genome, this relationship holds as well ( r= 0.46; 95% confidence interval, 0.37-0.53; P <. 001). We validated the association of specific loci with high germline homozygosity frequencies in an independent, single- nucleotide polymorphism - based, public data set of 205 lung carcinomas from white individuals ( P <. 05 to P <. 001) as well as the correlation between genome- wide germline homozygosity and LOH frequencies ( r= 0.21; 95% confidence interval, 0.18- 0.24; P <. 001). Conclusions In our study of 4 different types of solid tumors ( our data for 3 types validated in a fourth type), increased germline homozygosity occurred at specific loci. When the germline was heterozygous at these loci, high frequencies of LOH/ allelic imbalance occurred at these loci in the corresponding carcinomas.	[Assie, Guillaume; LaFramboise, Thomas; Platzer, Petra; Eng, Charis] Cleveland Clin Fdn, Genom Med Inst, Cleveland, OH 44195 USA; [Assie, Guillaume; Platzer, Petra; Eng, Charis] Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA; [Eng, Charis] Cleveland Clin Fdn, Tausig Canc Inst, Cleveland, OH 44195 USA; [LaFramboise, Thomas; Eng, Charis] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Eng, Charis] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University	Assie, G (corresponding author), Cleveland Clin Fdn, Genom Med Inst, 9500 Euclid Ave,NE-50, Cleveland, OH 44195 USA.	engc@ccf.org		Eng, Charis/0000-0002-3693-5145; Assie, Guillaume/0000-0001-9590-0906	NATIONAL CANCER INSTITUTE [P01CA097189] Funding Source: NIH RePORTER; NCI NIH HHS [1P50/U54CA113001-01, 1P01CA97189-01A2] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Bhattacharya P, 2002, CANCER LETT, V188, P207, DOI 10.1016/S0304-3835(02)00430-5; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Clark AG, 1999, AM J HUM GENET, V65, P1489, DOI 10.1086/302668; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Deligezer U, 2005, IN VIVO, V19, P889; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fukino K, 2004, CANCER RES, V64, P7231, DOI 10.1158/0008-5472.CAN-04-2866; Fukino K, 2007, JAMA-J AM MED ASSOC, V297, P2103, DOI 10.1001/jama.297.19.2103; Gibson J, 2006, HUM MOL GENET, V15, P789, DOI 10.1093/hmg/ddi493; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; Huebner K, 2001, NAT REV CANCER, V1, P214, DOI 10.1038/35106058; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kurose K, 2001, HUM MOL GENET, V10, P1907, DOI 10.1093/hmg/10.18.1907; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Patocs A, 2007, NEW ENGL J MED, V357, P2543, DOI 10.1056/NEJMoa071825; *R DEV COR TEAM, 2007, R LANG ENV STAT COMP, P5149; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rudan I, 2003, J MED GENET, V40, P925, DOI 10.1136/jmg.40.12.925; Rudan I, 1999, HUM BIOL, V71, P173; Sarquis MS, 2006, J CLIN ENDOCR METAB, V91, P262, DOI 10.1210/jc.2005-1880; SHAMI SA, 1991, LANCET, V338, P954, DOI 10.1016/0140-6736(91)91828-I; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; SIMPSON JL, 1981, AM J OBSTET GYNECOL, V141, P629, DOI 10.1016/S0002-9378(15)33302-0; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Weber F, 2007, JAMA-J AM MED ASSOC, V297, P187, DOI 10.1001/jama.297.2.187; WEBER JL, 1989, AM J HUM GENET, V44, P388; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	34	41	43	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 26	2008	299	12					1437	1445		10.1001/jama.299.12.1437	http://dx.doi.org/10.1001/jama.299.12.1437			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	278MY	18364486				2022-12-24	WOS:000254292200018
J	Kruijshaar, ME; Watson, JM; Drobniewski, F; Anderson, C; Brown, TJ; Magee, JG; Smith, EG; Story, A; Abubakar, I				Kruijshaar, Michelle E.; Watson, John M.; Drobniewski, Francis; Anderson, Charlotte; Brown, Timothy J.; Magee, John G.; Smith, E. Grace; Story, Alistair; Abubakar, Ibrahim			Increasing antituberculosis drug resistance in the United Kingdom: analysis of national surveillance data	BRITISH MEDICAL JOURNAL			English	Article							MULTIDRUG-RESISTANCE; NORTH LONDON; RISK-FACTORS; TUBERCULOSIS; EPIDEMIOLOGY; OUTBREAK; TB	Objective To identify recent trends in, and factors associated with, resistance to antituberculosis drugs in England, Wales, and Northern Ireland. Design Cohort of tuberculosis cases reported to the enhanced tuberculosis surveillance system matched to data on drug susceptibility and national strain typing data. Setting England, Wales, and Northern Ireland 1998-2005. Main outcome measures Unadjusted and adjusted odds ratios for drug resistance and associated factors. Proportion of multidrug resistant tuberculosis cases clustered. Results 28 620 culture confirmed cases were available for analysis. The proportion of cases resistant to isoniazid increased from 5% to 7%. Rifampicin resistance increased from 1.0% to 1.2% and multidrug resistance from 0.8% to 0.9%. Ethambutol and pyrazinamide resistance remained stable at around 0.4% and 0.6%, respectively. Regression analyses showed a significant increase in isoniazid resistance outside London (odds ratio 1.04, 95% confidence interval 1.01 to 1.07, a year, associated with changes in age (0.98, 0.98 to 0.99, a year), place of birth (1.49, 1.16 to 1.92), and ethnicity (P<0.05). In London, the rise (1.05, 1.02 to 1.08, a year) was related mainly to an ongoing outbreak. Increases in rifampicin resistance (1.06, 1.01 to 1.11, a year) and multidrug resistance (1.06, 1.00 to 1.12, a year) were small. A fifth of patients with multidrug resistant tuberculosis in 2004-5 had indistinguishable strain types, and one case was identified as extensively drug resistant. Conclusions The rise in isoniazid resistance reflects increasing numbers of patients from sub-Saharan Africa and the Indian subcontinent, who might have acquired resistance abroad, and inadequate control of transmission in London. The observed increases highlight the need for early case detection, rapid testing of susceptibility to drugs, and improved treatment completion.	[Kruijshaar, Michelle E.; Watson, John M.; Anderson, Charlotte; Story, Alistair; Abubakar, Ibrahim] Hlth Protect Agcy, Dept Resp Dis, Ctr Infect, London NW9 5EQ, England; [Drobniewski, Francis; Brown, Timothy J.] Univ London St Bartholomews Hosp Med Coll, Queen Marys Sch Med & Dent, Mycobacterium Reference Unit, London E1 2AT, England; [Magee, John G.] Newcastle Gen Hosp, Reg Ctr Mycobacteriol, Hlth Protect Agcy N E, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; [Smith, E. Grace] Heart England NHS Fdn Trust, Reg Ctr Mycobacteriol, Hlth Protect Agcy, Birmingham B9 5SS, W Midlands, England; [Abubakar, Ibrahim] Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England	Health Protection Agency; University of London; Queen Mary University London; Newcastle General Hospital; Health Protection Agency; Heart of England NHS Foundation Trust; University of East Anglia	Kruijshaar, ME (corresponding author), Hlth Protect Agcy, Dept Resp Dis, Ctr Infect, London NW9 5EQ, England.	michelle.kruijshaar@hpa.org.uk		Abubakar, Ibrahim/0000-0002-0370-1430				[Anonymous], 2007, GLOB TUB CONTR SURV; *APPL MATHS BVBA, 2004, BIONUMERICS MAN; Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Djuretic T, 2002, THORAX, V57, P477, DOI 10.1136/thorax.57.6.477; Drobniewski FA, 2003, LANCET INFECT DIS, V3, P141, DOI 10.1016/S1473-3099(03)00544-9; Espinal MA, 2001, INT J TUBERC LUNG D, V5, P887; *EUROTB, 2007, SURV TUB EUR REP TUB; Falzon D, 2006, INT J TUBERC LUNG D, V10, P954; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Glynn JR, 1999, AM J EPIDEMIOL, V149, P366, DOI 10.1093/oxfordjournals.aje.a009822; *HLTH PROT AG, 2003, ANN REP TUB CAS REP; Irish C, 1999, BMJ-BRIT MED J, V318, P497, DOI 10.1136/bmj.318.7182.497; KRUIJSHAAR ME, 2007, TUBERCULOSIS UK ANN; Maguire H, 2006, THORAX, V61, P547, DOI 10.1136/thx.2005.052423; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Moniruzzaman A, 2006, INT J TUBERC LUNG D, V10, P631; *NAT COLL CTR CHRO, 2006, TUB CLIN DIAGN MAN T; *NAT COORD TUB SUR, 2007, SURV TUB EUR REP TUB; Rose AMC, 2001, THORAX, V56, P173, DOI 10.1136/thorax.56.3.173; Ruddy MC, 2004, THORAX, V59, P279, DOI 10.1136/thx.2003.010405; Story A, 2007, THORAX, V62, P667, DOI 10.1136/thx.2006.065409; *WHO, 2006, XDR TB EXT DRUG RES	23	32	32	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 31	2008	336	7655					1231	+		10.1136/bmj.39546.573067.25	http://dx.doi.org/10.1136/bmj.39546.573067.25			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	311PS	18456593	Green Accepted, Bronze, Green Published, Green Submitted			2022-12-24	WOS:000256612700031
J	Johnson, RP				Johnson, R. Paul			How HIV guts the immune system	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							T-CELL DEPLETION; GASTROINTESTINAL-TRACT; SIV INFECTION; REPLICATION		Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Southborough, MA 01772 USA; Massachusetts Gen Hosp, Partners AIDS Res Ctr, Infect Dis Unit, Boston, MA 02114 USA	Harvard University; Harvard University; Massachusetts General Hospital	Johnson, RP (corresponding author), Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Southborough, MA 01772 USA.							Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427	5	7	7	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 22	2008	358	21					2287	2289		10.1056/NEJMcibr0802134	http://dx.doi.org/10.1056/NEJMcibr0802134			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	303EK	18499575				2022-12-24	WOS:000256023600017
J	Cavanaugh, K; Huizinga, MM; Wallston, KA; Gebretsadik, T; Shintani, A; Davis, D; Gregory, RP; Fuchs, L; Malone, R; Cherrington, A; Pignone, M; DeWalt, DA; Elasy, TA; Rothman, RL				Cavanaugh, Kerri; Huizinga, Mary Margaret; Wallston, Kenneth A.; Gebretsadik, Tebeb; Shintani, Ayumi; Davis, Dianne; Gregory, Rebecca Pratt; Fuchs, Lynn; Malone, Robb; Cherrington, Andrea; Pignone, Michael; DeWalt, Darren A.; Elasy, Tom A.; Rothman, Russell L.			Association of numeracy and diabetes control	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH LITERACY; KNOWLEDGE; SCALE	Background: The influence of a patient's quantitative skills (numeracy) on the management of diabetes is only partially understood. Objective: To examine the association between diabetes-related numeracy and glycemic control and other diabetes measurements. Design: Cross-sectional survey. Setting: 2 primary care and 2 diabetes clinics at 3 medical centers. Participants: 398 adult patients with type 1 or type 2 diabetes mellitus enrolled between March 2004 and November 2005. Measurements: Health literacy, general numeracy, and diabetes-related numeracy assessed by using the Rapid Estimate of Adult Literacy in Medicine; the Wide Range Achievement Test, 3rd edition; and the Diabetes Numeracy Test (DNT), respectively. The primary outcome was most recent level of hemoglobin A(1c). Additional measurements were diabetes knowledge, perceived self-efficacy of diabetes self-management, and self-management behaviors. Results: The median DNT score was 65% (interquartile range, 42% to 81%). Common errors included misinterpreting glucose meter readings and miscalculating carbohydrate intake and medication dosages. Lower DNT scores were associated with older age, nonwhite race, fewer years of education, lower reported income, lower literacy and general numeracy skills, lower perceived self-efficacy, and selected self-management behaviors. Patients scoring in the lowest DNT quartile (score < 42%) had a median hemoglobin A(1c) level of 7.6% (interquartile range, 6.5% to 9.0%) compared with 7.1% (interquartile range, 6.3% to 8.1%) in those scoring in the highest quartile (P = 0.119 for trend). A regression analysis adjusted for age, sex, race, income, and other factors found a modest association between DNT score and hemoglobin A1c level. Limitation: Causality cannot be determined in this cross-sectional study, especially with its risk for unmeasured confounding variables. Conclusion: Poor numeracy skills were common in patients with diabetes. Low diabetes-related numeracy skills were associated with worse perceived self-efficacy, fewer self-management behaviors, and possibly poorer glycemic control.	[Rothman, Russell L.] Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Hlth Serv Res, Sch Med, Nashville, TN 37232 USA; Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA; Univ N Carolina, Chapel Hill, NC USA; Univ Alabama Birmingham, Birmingham, AL USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; University of North Carolina; University of North Carolina Chapel Hill; University of Alabama System; University of Alabama Birmingham	Rothman, RL (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Hlth Serv Res, Sch Med, 6100 Med Ctr E,N Tower, Nashville, TN 37232 USA.	russell.rothman@vanderbilt.edu	Albertin, Paloma C/X-1093-2018; Fuchs, Lynn/AAV-3828-2021	Fuchs, Lynn/0000-0003-2099-5247; DeWalt, Darren/0000-0003-2270-751X; Rothman, Russsell/0000-0002-1506-3990; Pignone, Michael/0000-0002-6657-7342	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, K23DK065294] Funding Source: NIH RePORTER; NIDDK NIH HHS [5K23DK065294, 5P60DK020593] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Apter AJ, 2006, J ASTHMA, V43, P705, DOI 10.1080/02770900600925585; Ashcraft MH, 2001, J EXP PSYCHOL GEN, V130, P224, DOI 10.1037/0096-3445.130.2.224; Baker DW, 1999, PATIENT EDUC COUNS, V38, P33, DOI 10.1016/S0738-3991(98)00116-5; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Davis T C, 1993, Fam Med, V25, P391; Davis T C, 1991, Fam Med, V23, P433; DeVellis RF, 2016, SCALE DEV THEORY APP; DeWalt DA, 2005, ARCH INTERN MED, V165, P1943, DOI 10.1001/archinte.165.17.1943; DeWalt DA, 2007, AM J HEALTH BEHAV, V31, pS27; Estrada CA, 2004, AM J MED SCI, V328, P88, DOI 10.1097/00000441-200408000-00004; Fitzgerald JT, 1998, DIABETES CARE, V21, P706, DOI 10.2337/diacare.21.5.706; Gazmararian JA, 2003, PATIENT EDUC COUNS, V51, P267, DOI 10.1016/S0738-3991(02)00239-2; Gazmararian JA, 1999, JAMA-J AM MED ASSOC, V281, P545, DOI 10.1001/jama.281.6.545; Harrell FE, 2001, REGRESSION MODELING; Hodge M B, 1999, Nurse Educ, V24, P41, DOI 10.1097/00006223-199907000-00010; HUIZINGA MM, 2008, BMC HLTH SE IN PRESS; *I MED, 2004, HLTH LIT PRESCR END; KIRSCH IS, NCES PUBLICATION; Kutner M., 2005, NCES PUBLICATION; Lipkus IM, 2001, MED DECIS MAKING, V21, P37, DOI 10.1177/0272989X0102100105; Montori VM, 2005, J GEN INTERN MED, V20, P1071, DOI 10.1111/j.1525-1497.2005.051498.x; Morris Nancy S, 2006, BMC Fam Pract, V7, P49, DOI 10.1186/1471-2296-7-49; Parker RM, 1999, JAMA-J AM MED ASSOC, V281, P552; Rothman RL, 2005, DIABETES EDUCATOR, V31, P215, DOI 10.1177/0145721705275002; Rothman RL, 2006, AM J PREV MED, V31, P391, DOI 10.1016/j.amepre.2006.07.025; Schapira MM, 2006, J HEALTH COMMUN, V11, P569, DOI 10.1080/10810730600829916; Schapira MM, 2004, RISK ANAL, V24, P665, DOI 10.1111/j.0272-4332.2004.00466.x; Schillinger D, 2002, JAMA-J AM MED ASSOC, V288, P475, DOI 10.1001/jama.288.4.475; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; Sheridan SL, 2003, J GEN INTERN MED, V18, P884, DOI 10.1046/j.1525-1497.2003.21102.x; Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943; Wallston KA, 2007, J BEHAV MED, V30, P395, DOI 10.1007/s10865-007-9110-y; Wilkinson G, 1993, WRAT 3 WIDE RANGE AC; Williams MV, 1998, ARCH INTERN MED, V158, P166, DOI 10.1001/archinte.158.2.166	34	236	238	0	32	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 20	2008	148	10					737	U40		10.7326/0003-4819-148-10-200805200-00006	http://dx.doi.org/10.7326/0003-4819-148-10-200805200-00006			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	308EX	18490687				2022-12-24	WOS:000256372200003
J	Max, X; Yoon, SO; Richardson, CJ; Julich, K; Blenis, J				Max, Xiaoju; Yoon, Sang-Oh; Richardson, Celeste J.; Julich, Kristina; Blenis, John			SKAR links pre-mRNA splicing to mTOR/S6K1-mediated enhanced translation efficiency of spliced mRNAs	CELL			English	Article							EXON JUNCTION COMPLEX; NONSENSE-MEDIATED DECAY; MAMMALIAN-CELLS; GENE-EXPRESSION; BINDING PROTEIN; INITIATION; CYTOPLASM; INTRONS; NUCLEUS; GROWTH	Different protein complexes form on newly spliced mRNA to ensure the accuracy and efficiency of eukaryotic gene expression. For example, the exon junction complex (EJC) plays an important role in mRNA surveillance. The EJC also influences the first, or pioneer round of protein synthesis through a mechanism that is poorly understood. We show that the nutrient-, stress-, and energy-sensing checkpoint kinase, mTOR, contributes to the observed enhanced translation efficiency of spliced over nonspliced mRNAs. We demonstrate that, when activated, S6K1 is recruited to the newly synthesized mRNA by SKAR, which is deposited at the EJC during splicing, and that SKAR and S6K1 increase the translation efficiency of spliced mRNA. Thus, SKAR-mediated recruitment of activated S6K1 to newly processed mRNPs serves as a conduit between mTOR checkpoint signaling and the pioneer round of translation when cells exist in conditions supportive of protein synthesis.	[Max, Xiaoju; Yoon, Sang-Oh; Richardson, Celeste J.; Julich, Kristina; Blenis, John] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Blenis, J (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	jblenis@hms.harvard.edu			NIGMS NIH HHS [GM051405] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRADDOCK M, 1994, NUCLEIC ACIDS RES, V22, P5255, DOI 10.1093/nar/22.24.5255; CALLIS J, 1987, GENE DEV, V1, P1183, DOI 10.1101/gad.1.10.1183; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Chin SY, 2004, GENE DEV, V18, P745, DOI 10.1101/gad.1170204; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gudikote JP, 2005, NAT STRUCT MOL BIOL, V12, P801, DOI 10.1038/nsmb980; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Kataoka N, 2004, J BIOL CHEM, V279, P7009, DOI 10.1074/jbc.M307692200; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Lejeune F, 2004, NAT STRUCT MOL BIOL, V11, P992, DOI 10.1038/nsmb824; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Lejeune Fabrice, 2004, Methods Mol Biol, V257, P115, DOI 10.1385/1-59259-750-5:115; Lu SH, 2003, RNA, V9, P618, DOI 10.1261/rna.5260303; Ma XJ, 2003, EMBO J, V22, P1889, DOI 10.1093/emboj/cdg191; Matsumoto K, 1998, EMBO J, V17, P2107, DOI 10.1093/emboj/17.7.2107; Methot N, 1996, RNA, V2, P38; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; PALMITER RD, 1991, P NATL ACAD SCI USA, V88, P478, DOI 10.1073/pnas.88.2.478; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Reed R, 2005, CURR OPIN CELL BIOL, V17, P269, DOI 10.1016/j.ceb.2005.04.011; Richardson CJ, 2004, CURR BIOL, V14, P1540, DOI 10.1016/j.cub.2004.08.061; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; Sonenberg N, 1996, TRANSLATIONAL CONTRO, P245; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880; Wiegand HL, 2003, P NATL ACAD SCI USA, V100, P11327, DOI 10.1073/pnas.1934877100; Wilkinson MF, 2005, TRENDS GENET, V21, P143, DOI 10.1016/j.tig.2005.01.007; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	42	232	239	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2008	133	2					303	313		10.1016/j.cell.2008.02.031	http://dx.doi.org/10.1016/j.cell.2008.02.031			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	289JY	18423201	Bronze			2022-12-24	WOS:000255052000019
J	Datta, SD; Koutsky, LA; Ratelle, S; Unger, ER; Shlay, J; McClain, T; Weaver, B; Kerndt, P; Zenilman, J; Hagensee, M; Suhr, CJ; Weinstock, H				Datta, S. Deblina; Koutsky, Laura A.; Ratelle, Sylvie; Unger, Elizabeth R.; Shlay, Judith; McClain, Tracie; Weaver, Beth; Kerndt, Peter; Zenilman, Jonathan; Hagensee, Michael; Suhr, Cristen J.; Weinstock, Hillard			Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005	ANNALS OF INTERNAL MEDICINE			English	Article							PREVALENCE; AGE; PERSISTENCE	Background: Millions of women in the United States receive cervical screening in sexually transmitted disease (STD), family planning, and primary care clinical settings. Objective: To inform current cervical screening programs. Design: Measurement of abnormal Papanicolaou (Pap) tests and high-risk human papillomavirus (HPV) infection among demographically diverse women who received routine cervical screening from January 2003 to December 2005 in the United States. Setting: 26 STD, family planning, and primary care clinics in 6 U.S. cities. Patients: 9657 women age 14 to 65 years receiving routine cervical screening. Measurements: Pap test results and high-risk HPV prevalence by Hybrid Capture 2 assay (Digene, Gaithersburg, Maryland). Results: Among 9657 patients, overall high-risk HPV prevalence by Hybrid Capture 2 testing was 23% (95% Cl, 22% to 24%). Prevalence was highest among women age 14 to 19 years (35% [Cl, 32% to 38%]) and lowest among women age 50 to 65 years (6% [Cl, 4% to 8%]). Prevalence by clinic type (adjusted for age and city) ranged from 26% (Cl, 24% to 29%) in STD clinics to 17% (Cl, 16% to 20%) in primary care clinics. Women younger than 30 years of age whose Pap test showed atypical squamous cells of undetermined significance had a high-risk HPV prevalence of 53%; women 30 years of age or older with normal Pap tests had a 9% prevalence. Values did not vary substantially by clinic type. Limitation: Hybrid Capture 2 and Pap testing were noncentralized, and consent was required for enrollment. Conclusion: High-risk HPV was widespread among women receiving cervical screening in the United States. Many women 30 years of age or older with normal Pap tests would need follow-up if Hybrid Capture 2 testing is added to cytology screening.	[Datta, S. Deblina] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Univ Washington, Seattle, WA 98195 USA; Massachusetts Dept Publ Hlth, Boston, MA USA; Denver Publ Hlth, Denver, CO USA; Cty Los Angeles Dept Hlth Serv, Los Angeles, CA USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA	Centers for Disease Control & Prevention - USA; University of Washington; University of Washington Seattle; Massachusetts Department of Public Health; Johns Hopkins University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Datta, SD (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,MS E-02, Atlanta, GA 30333 USA.	ddatta@cdc.gov		Unger, Elizabeth/0000-0002-2925-5635				ACOG Comm Obstet Practice, 2003, OBSTET GYNECOL, V102, P415; Armitage P., 2002, STAT METHODS MED RES; Bosch FX, 2002, VIRUS RES, V89, P183, DOI 10.1016/S0168-1702(02)00187-9; Castle PE, 2005, J INFECT DIS, V191, P1808, DOI 10.1086/428779; Datta SD, 2007, ANN INTERN MED, V147, P89, DOI 10.7326/0003-4819-147-2-200707170-00007; Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813; Fleming DT, 1997, NEW ENGL J MED, V337, P1105, DOI 10.1056/NEJM199710163371601; Franceschi S, 2006, INT J CANCER, V119, P2677, DOI 10.1002/ijc.22241; GOTTLIEB SL, 2008, IN PRESS SEX TRANSM; Kulasingam SL, 2006, JNCI-J NATL CANCER I, V98, P92, DOI 10.1093/jnci/djj009; Kulasingam SL, 2002, JAMA-J AM MED ASSOC, V288, P1749, DOI 10.1001/jama.288.14.1749; Manhart LE, 2006, SEX TRANSM DIS, V33, P502, DOI 10.1097/01.olq.0000204545.89516.0a; Moscicki AB, 2004, J INFECT DIS, V190, P37, DOI 10.1086/421467; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Saraiya M, 2007, OBSTET GYNECOL, V109, P360, DOI 10.1097/01.AOG.0000254165.92653.e8; Saslow D, 2002, CA-CANCER J CLIN, V52, P342, DOI 10.3322/canjclin.52.6.342; US Cancer Statistics Working Group, 2007, US CANC STAT 2004 IN; *US PREV ERV TASK, 2003, SCREEN CERV CANC; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P346, DOI 10.1016/j.ajog.2007.07.047; Xi LF, 2006, J NATL CANCER I, V98, P1045, DOI 10.1093/jnci/djj297; Yabroff KR, 2005, J RURAL HEALTH, V21, P149, DOI 10.1111/j.1748-0361.2005.tb00075.x	22	112	119	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 1	2008	148	7					493	500		10.7326/0003-4819-148-7-200804010-00004	http://dx.doi.org/10.7326/0003-4819-148-7-200804010-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284IV	18378945				2022-12-24	WOS:000254701000001
J	Miserez, A; Schneberk, T; Sun, CJ; Zok, FW; Waite, JH				Miserez, Ali; Schneberk, Todd; Sun, Chengjun; Zok, Frank W.; Waite, J. Herbert			The transition from stiff to compliant materials in squid beaks	SCIENCE			English	Article							INSECT-CUTICLE; CROSS-LINKING; GRADIENTS; PROTEINS; MASS	The beak of the Humboldt squid Dosidicus gigas represents one of the hardest and stiffest wholly organic materials known. As it is deeply embedded within the soft buccal envelope, the manner in which impact forces are transmitted between beak and envelope is a matter of considerable scientific interest. Here, we show that the hydrated beak exhibits a large stiffness gradient, spanning two orders of magnitude from the tip to the base. This gradient is correlated with a chemical gradient involving mixtures of chitin, water, and His- rich proteins that contain 3,4- dihydroxyphenyl- L- alanine ( dopa) and undergo extensive stabilization by histidyl- dopa cross- link formation. These findings may serve as a foundation for identifying design principles for attaching mechanically mismatched materials in engineering and biological applications.	[Miserez, Ali; Zok, Frank W.] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA; [Miserez, Ali; Schneberk, Todd; Sun, Chengjun; Waite, J. Herbert] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Miserez, Ali; Schneberk, Todd; Sun, Chengjun; Waite, J. Herbert] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Zok, FW (corresponding author), Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA.	zok@engineering.ucsb.edu; waite@lifesci.ucsb.edu	Miserez, Ali/D-1074-2010; Schneberk, Todd/AAA-5800-2020; Miserez, Ali/CAF-2662-2022	Miserez, Ali/0000-0003-0864-8170; Schneberk, Todd/0000-0003-1642-2075; Miserez, Ali/0000-0003-0864-8170	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015415, R01DE014672] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01 DE015415-01, DE015415, R01 DE015415-04, R01 DE014672, R01 DE015415, R01 DE015415-03] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ANDERSEN SO, 1979, ANNU REV ENTOMOL, V24, P29, DOI 10.1146/annurev.en.24.010179.000333; BARNES RD, 1966, INVERTEBRATE ZOOLOGY; Benjamin M, 2006, J ANAT, V208, P471, DOI 10.1111/j.1469-7580.2006.00540.x; BRUNET PCJ, 1980, INSECT BIOCHEM, V10, P467, DOI 10.1016/0020-1790(80)90082-7; Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501; HOPKINS TL, 1992, ANNU REV ENTOMOL, V37, P273, DOI 10.1146/annurev.en.37.010192.001421; Iconomidou VA, 2005, INSECT BIOCHEM MOLEC, V35, P553, DOI 10.1016/j.ibmb.2005.01.017; Imbeni V, 2005, NAT MATER, V4, P229, DOI 10.1038/nmat1323; Kerwin JL, 1999, ANAL BIOCHEM, V268, P229, DOI 10.1006/abio.1998.3069; KINLOCH AJ, 1987, ADHES ADHES, P206; Lee H, 2007, NATURE, V448, P338, DOI 10.1038/nature05968; Liu B, 2006, J AM CHEM SOC, V128, P15228, DOI 10.1021/ja065794h; Miessner M, 2001, BIOMACROMOLECULES, V2, P369, DOI 10.1021/bm005652u; Miserez A, 2007, ACTA BIOMATER, V3, P139, DOI 10.1016/j.actbio.2006.09.004; Moses DN, 2006, J BIOL CHEM, V281, P34826, DOI 10.1074/jbc.M603429200; MURRAY NJ, 1994, EUR J BIOCHEM, V219, P923, DOI 10.1111/j.1432-1033.1994.tb18574.x; Neville A. C., 1993, BIOL FIBROUS COMPOSI; Nishino T, 1999, J POLYM SCI POL PHYS, V37, P1191, DOI 10.1002/(SICI)1099-0488(19990601)37:11<1191::AID-POLB13>3.0.CO;2-H; Raabe D, 2005, ACTA MATER, V53, P4281, DOI 10.1016/j.actamat.2005.05.027; SCHAEFER J, 1987, SCIENCE, V235, P1200, DOI 10.1126/science.3823880; Sun CJ, 2005, J BIOL CHEM, V280, P39332, DOI 10.1074/jbc.M508674200; Suresh S, 2001, SCIENCE, V292, P2447, DOI 10.1126/science.1059716; Sweeney AM, 2007, J R SOC INTERFACE, V4, P685, DOI 10.1098/rsif.2006.0210; Uyeno TA, 2005, J MORPHOL, V264, P211, DOI 10.1002/jmor.10330; Vincent JFV, 2002, COMPOS PART A-APPL S, V33, P1311, DOI 10.1016/S1359-835X(02)00167-7; VINCENT JFV, 1987, J INSECT PHYSIOL, V33, P973, DOI 10.1016/0022-1910(87)90010-2; Waite JH, 2004, BIOCHEMISTRY-US, V43, P7653, DOI 10.1021/bi049380h	27	294	310	5	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2008	319	5871					1816	1819		10.1126/science.1154117	http://dx.doi.org/10.1126/science.1154117			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279ZF	18369144	Green Accepted			2022-12-24	WOS:000254394000044
J	Eisenbarth, SC; Colegio, OR; O'Connor, W; Sutterwala, FS; Flavell, RA				Eisenbarth, Stephanie C.; Colegio, Oscar R.; O'Connor, William, Jr.; Sutterwala, Fayyaz S.; Flavell, Richard A.			Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants	NATURE			English	Article							IMMUNE-RESPONSE; DYING CELLS; T-CELLS; INDUCTION; ANTIGEN; ACTIVATION; RECOGNITION; CASPASE-1; HYDROXIDE; RECEPTOR	Aluminium adjuvants, typically referred to as 'alum', are the most commonly used adjuvants in human and animal vaccines worldwide, yet the mechanism underlying the stimulation of the immune system by alum remains unknown. Toll-like receptors are critical in sensing infections and are therefore common targets of various adjuvants used in immunological studies. Although alum is known to induce the production of proinflammatory cytokines in vitro, it has been repeatedly demonstrated that alum does not require intact Toll-like receptor signalling to activate the immune system(1,2). Here we show that aluminium adjuvants activate an intracellular innate immune response system called the Nalp3 (also known as cryopyrin, CIAS1 or NLRP3) inflammasome. Production of the pro-inflammatory cytokines interleukin-1 beta and interleukin-18 by macrophages in response to alum in vitro required intact inflammasome signalling. Furthermore, in vivo, mice deficient in Nalp3, ASC (apoptosis-associated speck-like protein containing a caspase recruitment domain) or caspase-1 failed to mount a significant antibody response to an antigen administered with aluminium adjuvants, whereas the response to complete Freund's adjuvant remained intact. We identify the Nalp3 inflammasome as a crucial element in the adjuvant effect of aluminium adjuvants; in addition, we show that the innate inflammasome pathway can direct a humoral adaptive immune response. This is likely to affect how we design effective, but safe, adjuvants in the future.	[Eisenbarth, Stephanie C.; Colegio, Oscar R.; O'Connor, William, Jr.; Sutterwala, Fayyaz S.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Eisenbarth, Stephanie C.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Colegio, Oscar R.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Sutterwala, Fayyaz S.] Univ Iowa, Dept Med, Inflammat Program, Iowa City, IA 52241 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; University of Iowa	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Ibrahim, Essam Hassan/G-1960-2018; Eckhardt, Erik/G-1567-2010; Sutterwala, Fayyaz/AAH-5859-2021; Cassel, Suzanne/AAI-3947-2021	Ibrahim, Essam Hassan/0000-0003-0130-2257; Cassel, Suzanne/0000-0003-2492-1923; Eisenbarth, Stephanie/0000-0002-1244-208X; Colegio, Oscar/0000-0002-6519-3718; Colegio, Oscar/0000-0002-9524-6235	Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [T32 HL007974] Funding Source: Medline; NIAID NIH HHS [K08 AI065517] Funding Source: Medline; NIAMS NIH HHS [T32 AR007016] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI065517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007016] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Chang MF, 2001, VACCINE, V19, P2884, DOI 10.1016/S0264-410X(00)00559-4; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Davis CN, 2006, P NATL ACAD SCI USA, V103, P2953, DOI 10.1073/pnas.0510802103; DUNNE A, 2003, SCI STKE, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Jordan MB, 2004, SCIENCE, V304, P1808, DOI 10.1126/science.1089926; KAYE J, 1984, J IMMUNOL, V133, P1339; Li HF, 2007, J IMMUNOL, V178, P5271, DOI 10.4049/jimmunol.178.8.5271; Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.0818-9641.2004.01286.x; MANNHALTER JW, 1985, CLIN EXP IMMUNOL, V61, P143; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Nakae S, 2001, J IMMUNOL, V167, P90, DOI 10.4049/jimmunol.167.1.90; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Piggott DA, 2005, J CLIN INVEST, V115, P459, DOI 10.1172/JCI200522462; Rimaniol AC, 2004, VACCINE, V22, P3127, DOI 10.1016/j.vaccine.2004.01.061; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Sokolovska A, 2007, VACCINE, V25, P4575, DOI 10.1016/j.vaccine.2007.03.045; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Sutterwala FS, 2007, J LEUKOCYTE BIOL, V82, P259, DOI 10.1189/jlb.1206755; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Toda Y, 2002, J IMMUNOL, V168, P1984, DOI 10.4049/jimmunol.168.4.1984; Yoshimoto T, 2000, NAT IMMUNOL, V1, P132, DOI 10.1038/77811	30	1101	1156	4	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2008	453	7198					1122	U13		10.1038/nature06939	http://dx.doi.org/10.1038/nature06939			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18496530	Green Accepted			2022-12-24	WOS:000256839900061
J	Patel, AD				Patel, Aniruddh D.			Science & music: Talk of the tone	NATURE			English	Editorial Material																			0	27	29	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2008	453	7196					726	727		10.1038/453726a	http://dx.doi.org/10.1038/453726a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308UK	18528382	Bronze			2022-12-24	WOS:000256415300028
J	Kruse, JP; Gu, W				Kruse, Jan-Philipp; Gu, Wei			SnapShot: p53 posttranslational modifications	CELL			English	Editorial Material							UBIQUITINATION; ACETYLATION; ACTIVATION; PATHWAY		[Kruse, Jan-Philipp] Columbia Univ, Inst Canc Genet, New York, NY 10027 USA; Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA	Columbia University; Columbia University	Kruse, JP (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10027 USA.				NATIONAL CANCER INSTITUTE [R01CA131439, R01CA104843, P01CA097403, R01CA129627, R01CA098821, R01CA085533, R01CA118561, P01CA080058] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA104843, R01 CA085533, R01 CA098821, P01 CA097403, P01 CA080058, R01 CA129627, R01 CA131439, R01 CA118561] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; HUPP TR, 1994, CURR BIOL, V4, P865, DOI 10.1016/S0960-9822(00)00195-0; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Prives C, 1999, J PATHOL, V187, P112; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675	10	119	123	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 30	2008	133	5							930.e1	10.1016/j.cell.2008.05.020	http://dx.doi.org/10.1016/j.cell.2008.05.020			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	306UY	18510935	Green Accepted, Bronze			2022-12-24	WOS:000256274500025
J	Tucker, TJ; Makgoba, MW				Tucker, T. J.; Makgoba, M. W.			Public health - Public-private partnerships and scientific imperialism	SCIENCE			English	Editorial Material									[Tucker, T. J.] Sci Med Res Proprietary Ltd, Cape Town, South Africa; [Tucker, T. J.] Univ Cape Town, Div Med Virol, Dept Clin Lab Sci, ZA-7925 Cape Town, South Africa; [Makgoba, M. W.] Univ Kwazulu Natal, Durban, South Africa	University of Cape Town; University of Kwazulu Natal	Tucker, TJ (corresponding author), Sci Med Res Proprietary Ltd, Mandela Rhodes Bldg,St Georges Mall, Cape Town, South Africa.	tim@smr.co.za; makgoba@ukzn.ac.za						Chataway J., 2007, EUR J DEV RES, V19, P100, DOI DOI 10.1080/09578810601144350; Eaton L, 2005, BRIT MED J, V331, P718, DOI 10.1136/bmj.331.7519.718; Trouiller P, 2001, TROP MED INT HEALTH, V6, P945, DOI 10.1046/j.1365-3156.2001.00803.x	3	24	24	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2008	320	5879					1016	1017		10.1126/science.1156720	http://dx.doi.org/10.1126/science.1156720			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303RY	18497279				2022-12-24	WOS:000256059800023
J	Blum, A				Blum, Alan			Alchemy, the safer cigarette, and Philip Morris	LANCET			English	Editorial Material							TOBACCO		Univ Alabama, Ctr Study Tobacco & Soc, Tuscaloosa, AL 35401 USA	University of Alabama System; University of Alabama Tuscaloosa	Blum, A (corresponding author), Univ Alabama, Ctr Study Tobacco & Soc, Tuscaloosa, AL 35401 USA.	ABlum@cchs.ua.edu						*ALTR GROUP INC, 2007, 2006 ANN REP; BOWE C, 2007, FINANCIAL TIMES 0829; CAMILLERI LC, 2007, 2007 ALTR ANN M SHAR; FINORA J, 2007, TOBACCO INT      DEC, P14; MILLER GH, 1985, NEW YORK STATE J MED, V85, P313; MILLIGAN J, 2007, VIRGINIA BUSINES APR, P9; OCONNELL V, 2008, WALL STREET J   0129; *P MORR COMP INC, 1989, 1988 ANN REP; RICKERT WS, 1983, NEW YORK STATE J MED, V83, P1269; Siegel M, 2006, LANCET, V368, P266, DOI 10.1016/S0140-6736(06)69052-1; Smith EA, 2003, AM J PUBLIC HEALTH, V93, P553, DOI 10.2105/AJPH.93.4.553; *TOB IND RES COMM, 1954, CHICAGO AM      0104, P7; 2008, TOBACCO REPORTER MAR, P45	13	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 17	2008	371	9625					1644	1646		10.1016/S0140-6736(08)60705-9	http://dx.doi.org/10.1016/S0140-6736(08)60705-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302XB	18486727				2022-12-24	WOS:000256002200007
J	Cescon, DW; Etchells, E				Cescon, David W.; Etchells, Edward			Barcoded medication administration - A last line of defense	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ADVERSE DRUG EVENTS; BAR-CODE TECHNOLOGY; ERRORS		[Etchells, Edward] Sunnybrook Hlth Sci Ctr, Ctr Hlth Serv Sci, Toronto, ON M4N 3M5, Canada; [Etchells, Edward] Sunnybrook Hlth Sci Ctr, Dept Med, Patient Safety Serv, Toronto, ON M4N 3M5, Canada; [Cescon, David W.; Etchells, Edward] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Etchells, E (corresponding author), Sunnybrook Hlth Sci Ctr, Ctr Hlth Serv Sci, Room C410,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	edward.etchells@sunnybrook.ca						BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Cochran GL, 2007, JT COMM J QUAL PATIE, V33, P293, DOI 10.1016/S1553-7250(07)33034-1; Cummings J, 2005, AM J HEALTH-SYST PH, V62, P2626, DOI 10.2146/ajhp050222; Englebright JD, 2005, J NURS ADMIN, V35, P410; *FOOD DRUG ADM, 2003, FED REGISTER, V68, P12500; *FOOD DRUG ADM, 2003, FDA RUL REQ BAR COD; Hurley AC, 2007, J NURS ADMIN, V37, P343, DOI 10.1097/01.NNA.0000285114.60689.02; *I MED, 2000, TO ERR IS HUM BUILD; Jacobson PD, 2008, JAMA-J AM MED ASSOC, V299, P208, DOI 10.1001/jama.2007.12; Johnson Connie L, 2002, J Healthc Inf Manag, V16, P46; Maviglia SM, 2007, ARCH INTERN MED, V167, P788, DOI 10.1001/archinte.167.8.788; Paoletti RD, 2007, AM J HEALTH-SYST PH, V64, P536, DOI 10.2146/ajhp060140; Pedersen CA, 2006, AM J HEALTH-SYST PH, V63, P327, DOI 10.2146/ajhp050538; Poon EG, 2006, ANN INTERN MED, V145, P426, DOI 10.7326/0003-4819-145-6-200609190-00006; Sakowski J, 2005, AM J HEALTH-SYST PH, V62, P2619, DOI 10.2146/ajhp050138	15	18	18	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2008	299	18					2200	2202		10.1001/jama.299.18.2200	http://dx.doi.org/10.1001/jama.299.18.2200			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299XX	18477788				2022-12-24	WOS:000255790000029
J	Moreno, JC; Klootwijk, W; van Toor, H; Pinto, G; D'Alessandro, M; Leger, A; Goudie, D; Polak, M; Gruters, A; Visser, TJ				Moreno, Jose C.; Klootwijk, Willem; van Toor, Hans; Pinto, Graziella; D'Alessandro, Mariella; Leger, Aubene; Goudie, David; Polak, Michel; Gruters, Annette; Visser, Theo J.			Mutations in the iodotyrosine deiodinase gene and hypothyroidism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGENITAL HYPOTHYROIDISM; DI-IODOTYROSINE; SERIAL ANALYSIS; METABOLISM; CLONING	DEHAL1 has been identified as the gene encoding iodotyrosine deiodinase in the thyroid, where it controls the reuse of iodide for thyroid hormone synthesis. We screened patients with hypothyroidism who had features suggestive of an iodotyrosine deiodinase defect for mutations in DEHAL1. Two missense mutations and a deletion of three base pairs were identified in four patients from three unrelated families; all the patients had a dramatic reduction of in vitro activity of iodotyrosine deiodinase. Patients had severe goitrous hypothyroidism, which was evident in infancy and childhood. Two patients had cognitive deficits due to late diagnosis and treatment. Thus, mutations in DEHAL1 led to a deficiency in iodotyrosine deiodinase in these patients. Because infants with DEHAL1 defects may have normal thyroid function at birth, they may be missed by neonatal screening programs for congenital hypothyroidism.	[Moreno, Jose C.; Klootwijk, Willem; van Toor, Hans; Visser, Theo J.] Erasmus Univ, Erasmus Med Ctr, Dept Internal Med, NL-3015 GE Rotterdam, Netherlands; [Pinto, Graziella; Polak, Michel] Hop Necker Enfants Malad, INSERM, Unite 845, Paris, France; [Leger, Aubene] Grp Hosp Pitie Salpetriere, F-75634 Paris, France; [D'Alessandro, Mariella] Univ Dundee, Canc Res UK Cell Struct Res Grp, Dundee, Scotland; [Goudie, David] Univ Dundee, Ninewells Hosp & Med Sch, Tayside Univ Hosp Natl Hlth Serv Trust, Dundee DD1 9SY, Scotland; [Gruters, Annette] Humboldt Univ, Charite Hosp, Berlin, Germany	Erasmus University Rotterdam; Erasmus MC; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Dundee; University of Dundee; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Moreno, JC (corresponding author), Erasmus Univ, Erasmus Med Ctr, Dept Internal Med, Room Ee 593,Dr Molewaterpl 50, NL-3015 GE Rotterdam, Netherlands.	j.morenonavarro@erasmusmc.nl	Visser, Theo J/C-8059-2013	Visser, Theo J/0000-0002-6997-284X				Andersson M, 2005, B WORLD HEALTH ORGAN, V83, P518; CHOUFOER JC, 1960, J CLIN ENDOCR METAB, V20, P983, DOI 10.1210/jcem-20-7-983; Dai G, 1996, NATURE, V379, P458, DOI 10.1038/379458a0; de Vijlder JJM, 2003, EUR J ENDOCRINOL, V149, P247, DOI 10.1530/eje.0.1490247; Gnidehou S, 2004, FASEB J, V18, P1574, DOI 10.1096/fj.04-2023fje; GRUTERS A, 1994, HORM RES, V41, P3, DOI 10.1159/000183869; Haynes CA, 2002, J BIOL CHEM, V277, P11513, DOI 10.1074/jbc.M111334200; HECHT HJ, 1995, NAT STRUCT BIOL, V2, P1109, DOI 10.1038/nsb1295-1109; HUTCHISON JH, 1956, LANCET, V270, P1035; HUTCHISON JH, 1954, J CLIN ENDOCR METAB, V14, P869, DOI 10.1210/jcem-14-8-869; Lavado-Autric R, 2003, J CLIN INVEST, V111, P1073, DOI 10.1172/JCI200316262; MCDOUGALL TR, 2000, WERNER INGBARS THYRO, P355; MEINHOLD H, 1991, J CLIN ENDOCR METAB, V72, P945, DOI 10.1210/jcem-72-4-945; Moreno JC, 2003, HORM RES, V60, P96, DOI 10.1159/000074509; Moreno JC, 2002, NEW ENGL J MED, V347, P95, DOI 10.1056/NEJMoa012752; Moreno JC, 2001, GENOMICS, V75, P70, DOI 10.1006/geno.2001.6586; MURRAY P, 1965, LANCET, V1, P183; *NEW ENGL CONG HYP, 1981, LANCET, V14, P1095; Park SM, 2005, J MED GENET, V42, P379, DOI 10.1136/jmg.2004.024158; Pedraza PE, 2006, ENDOCRINOLOGY, V147, P2098, DOI 10.1210/en.2005-1325; QUERIDO A, 1956, J CLIN ENDOCR METAB, V16, P1096, DOI 10.1210/jcem-16-8-1096; ROCHE J, 1952, BIOCHIM BIOPHYS ACTA, V9, P161, DOI 10.1016/0006-3002(52)90143-1; ROSENBERG IN, 1979, J BIOL CHEM, V254, P2318; STANBURY JB, 1956, J CLIN ENDOCR METAB, V16, P735, DOI 10.1210/jcem-16-6-735	24	125	136	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 24	2008	358	17					1811	1818		10.1056/NEJMoa0706819	http://dx.doi.org/10.1056/NEJMoa0706819			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PL	18434651				2022-12-24	WOS:000255209200007
J	Psaty, BM; Kronmal, RA				Psaty, Bruce M.; Kronmal, Richard A.			Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment - A case study based on documents from rofecoxib litigation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICAL-JOURNAL-EDITORS; CLINICAL-TRIALS; INTERNATIONAL-COMMITTEE; EVENTS; STATEMENT; PUBLICATION	Sponsors have a marketing interest to represent their products in the best light. This approach conflicts with scientific standards that require the symmetric and comparable reporting of safety and efficacy data. Selective reporting of the results of clinical trials can misrepresent the risk- benefit profile of drugs. We summarize how the sponsor represented mortality findings associated with rofecoxib in clinical trials of patients with Alzheimer disease or cognitive impairment. We reviewed documents that became available during litigation related to rofecoxib involving Merck & Co, including internal company analyses and information provided by the sponsor to the FDA. We also evaluated information in 2 published articles that reported results of these trials. In one article ( reporting results of protocol 091) published in 2004,11 "non- drug related deaths" were reported ( 9 deaths among 346 rofecoxib patients and 2 deaths among 346 placebo patients). In another article ( reporting results of protocol 078) published in 2005,39 deaths were reported among patients taking study treatment or within 14 days of the last dose ( 24 among 725 rofecoxib patients and 15 among 732 placebo patients) and an additional 22 deaths in the off- drug period ( 17 in rofecoxib patients and 5 in placebo patients). However, these articles did not include analyses or statistical tests of the mortality data, and the 2 articles concluded that regarding safety, rofecoxib is "well tolerated." In contrast, in April 2001, the company's internal intention- to- treat analyses of pooled data from these 2 trials identified a significant increase in total mortality ( hazard ratio [ HR], 4.43; 95% CI, 1.26- 15.53 for protocol 091, and HR, 2.55; 95% CI, 1.17- 5.56 for protocol 078), with overall mortality of 34 deaths among 1069 rofecoxib patients and 12 deaths among 1078 placebo patients ( HR, 2.99; 95% CI, 1.55- 5.77). These mortality analyses were neither provided to the FDA nor made public in a timely fashion. The data submitted by the sponsor to the FDA in a Safety Update Report in July 2001 used on- treatment analysis methods and reported 29 deaths ( 2.7%) among 1067 rofecoxib patients and 17 deaths ( 1.6%) among 1075 placebo patients. This on- treatment approach to reporting minimized the appearance of any mortality risk. In December 2001, when the FDA raised safety questions about the submitted safety data, the sponsor did not bring these issues to an institutional review board for review and revealed that there was no data and safety monitoring board for the protocol 078 study. The findings from this case study suggest that additional protections for human research participants, including new approaches for the conduct, oversight, and reporting of industry sponsored trials, are necessary.	[Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; [Kronmal, Richard A.] Univ Washington, Collaborat Hlth Studies Coordinating Ctr, Dept Biostat, Seattle, WA 98101 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Washington; University of Washington Seattle	Psaty, BM (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, 1730 Minor Ave,Ste 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu						Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; De Angelis CD, 2005, JAMA-J AM MED ASSOC, V293, P2927, DOI 10.1001/jama.293.23.jed50037; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Fontanarosa PB, 2008, JAMA-J AM MED ASSOC, V299, P95, DOI 10.1001/jama.2007.28; GRASSLEY CE, 2006, COMMUNICATION   1213; Kerr DJ, 2007, NEW ENGL J MED, V357, P360, DOI 10.1056/NEJMoa071841; Konstam MA, 2001, CIRCULATION, V104, P2280, DOI 10.1161/hc4401.100078; Korn D, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010001; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; *OFF INSP GEN, 2007, FOOD DRUG ADM OV CLI; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Reines SA, 2004, NEUROLOGY, V62, P66, DOI 10.1212/WNL.62.1.66; Shuchman M, 2007, NEW ENGL J MED, V357, P1365, DOI 10.1056/NEJMp078176; Thal LJ, 2005, NEUROPSYCHOPHARMACOL, V30, P1204, DOI 10.1038/sj.npp.1300690; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779	15	126	128	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2008	299	15					1813	1817		10.1001/jama.299.15.1813	http://dx.doi.org/10.1001/jama.299.15.1813			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	287ZA	18413875				2022-12-24	WOS:000254954800025
J	Ferner, R; Beard, K				Ferner, Robin; Beard, Keith			Over the counter medicines: proceed with caution	BRITISH MEDICAL JOURNAL			English	Editorial Material							PARACETAMOL		[Ferner, Robin] City Hosp, W Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England; [Beard, Keith] Victoria Infirm, Mansionhouse Unit, Glasgow G41 3DX, Lanark, Scotland	University of Birmingham	Ferner, R (corresponding author), City Hosp, W Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England.	r.e.ferner@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346				Bateman DN, 2003, QJM-INT J MED, V96, P125, DOI 10.1093/qjmed/hcg015; CAMPBELL D, 2008, OBSERVER        0217, P1; Choudhry NK, 2005, ANN INTERN MED, V142, P910, DOI 10.7326/0003-4819-142-11-200506070-00009; Cohen JP, 2005, BRIT MED J, V330, P39, DOI 10.1136/bmj.330.7481.39; Glasgow JFT, 2006, DRUG SAFETY, V29, P1111, DOI 10.2165/00002018-200629120-00003; Glasier A, 1998, NEW ENGL J MED, V339, P1, DOI 10.1056/NEJM199807023390101; Hawton K, 2001, BMJ-BRIT MED J, V322, P1203, DOI 10.1136/bmj.322.7296.1203; JENKINS R, 2007, TIMES           1215; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Mansfield PR, 2005, BMJ-BRIT MED J, V330, P5, DOI 10.1136/bmj.330.7481.5; *MED HEALTHC PROD, 2006, LIST A CONS LIST SUB; *MED HEALTHC PROD, 2007, LIST B CONS LIST SUB; *MED HEALTHC PROD, AV MED; *MHRA, 2008, YELL CARD HELP MAK M; Pichichero ME, 2007, JAMA-J AM MED ASSOC, V298, P1772, DOI 10.1001/jama.298.15.1772; Rajkumar SV, 2004, MAYO CLIN PROC, V79, P899, DOI 10.4065/79.7.899; Reeves D, 2007, J ANTIMICROB CHEMOTH, V59, P333, DOI 10.1093/jac/dkl502; *ROYAL PHARM SOC G, 2007, RPS E PIC REF PRESCR; SAUL S, 2007, NY TIMES        1024; WISE J, 1997, BRIT MED J, V314, P1297; 2008, GET BRACKNELL   0111; 2006, CURR PROB PHARMACOVI, V31, P11; 2002, MAIL MHRA UPDATING S, V130, P3	23	19	21	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 29	2008	336	7646					694	696		10.1136/bmj.39504.389676.AD	http://dx.doi.org/10.1136/bmj.39504.389676.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZS	18369225	Green Published			2022-12-24	WOS:000254675600022
J	Amaral, PP; Dinger, ME; Mercer, TR; Mattick, JS				Amaral, Paulo P.; Dinger, Marcel E.; Mercer, Tim R.; Mattick, John S.			The eukaryotic genome as an RNA machine	SCIENCE			English	Editorial Material							LONG NONCODING RNAS; REGULATORY RNAS; MESSENGER-RNA; HUMAN-CELLS; GENE-EXPRESSION; POLYMERASE-II; TRANSCRIPTION; CHROMATIN; ACTIVATION; DROSOPHILA		[Amaral, Paulo P.; Dinger, Marcel E.; Mercer, Tim R.; Mattick, John S.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia	University of Queensland	Mattick, JS (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	j.mattick@imb.uq.edu.au	Mercer, Tim/AAK-5060-2020; Mattick, John/ABH-6130-2020; Mattick, John S/I-7789-2012; Dinger, Marcel/N-1398-2019	Mercer, Tim/0000-0001-8780-894X; Mattick, John/0000-0002-7680-7527; Mattick, John S/0000-0002-7680-7527; Dinger, Marcel/0000-0003-4423-934X; de Paiva Amaral, Paulo/0000-0002-6696-5142				Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chekanova JA, 2007, CELL, V131, P1340, DOI 10.1016/j.cell.2007.10.056; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; Espinoza CA, 2007, RNA, V13, P583, DOI 10.1261/rna.310307; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hale CJ, 2007, PLOS BIOL, V5, P2156, DOI 10.1371/journal.pbio.0050275; Han J, 2007, P NATL ACAD SCI USA, V104, P12422, DOI 10.1073/pnas.0701635104; Ishii N, 2006, J HUM GENET, V51, P1087, DOI 10.1007/s10038-006-0070-9; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Leung AKL, 2007, CELL, V130, P581, DOI 10.1016/j.cell.2007.08.010; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Lin R, 2007, ONCOGENE, V26, P851, DOI 10.1038/sj.onc.1209846; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; Lunyak VV, 2007, SCIENCE, V317, P248, DOI 10.1126/science.1140871; Maeda N, 2006, PLOS GENET, V2, P498, DOI 10.1371/journal.pgen.0020062; Makeyev EV, 2008, SCIENCE, V319, P1789, DOI 10.1126/science.1152326; Mariner PD, 2008, MOL CELL, V29, P499, DOI 10.1016/j.molcel.2007.12.013; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Mattick JS, 2007, J EXP BIOL, V210, P1526, DOI 10.1242/jeb.005017; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Murakami H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000317; NICKERSON JA, 1989, P NATL ACAD SCI USA, V86, P177, DOI 10.1073/pnas.86.1.177; Noma KI, 2006, CELL, V125, P859, DOI 10.1016/j.cell.2006.04.028; Nowacki M, 2008, NATURE, V451, P153, DOI 10.1038/nature06452; Ohno M, 2002, CHROMOSOMA, V111, P201, DOI 10.1007/s00412-002-0198-0; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Pagano A, 2007, PLOS GENET, V3, P174, DOI 10.1371/journal.pgen.0030001; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Perez DS, 2008, HUM MOL GENET, V17, P642, DOI 10.1093/hmg/ddm336; Pheasant M, 2007, GENOME RES, V17, P1245, DOI 10.1101/gr.6406307; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rodriguez-Campos A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001182; Royo H, 2007, MOL BIOL CELL, V18, P2817, DOI 10.1091/mbc.E06-10-0920; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Sone M, 2007, J CELL SCI, V120, P2498, DOI 10.1242/jcs.009357; Stark A, 2007, GENOME RES, V17, P1865, DOI 10.1101/gr.6593807; Stephen S, 2008, MOL BIOL EVOL, V25, P402, DOI 10.1093/molbev/msm268; Torarinsson E, 2008, GENOME RES, V18, P242, DOI 10.1101/gr.6887408; Tyler DM, 2008, GENE DEV, V22, P26, DOI 10.1101/gad.1615208; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Willoughby DA, 2000, J BIOL CHEM, V275, P759, DOI 10.1074/jbc.275.2.759; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5; Yang PK, 2007, CELL, V128, P777, DOI 10.1016/j.cell.2007.01.032; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036	71	463	497	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2008	319	5871					1787	1789		10.1126/science.1155472	http://dx.doi.org/10.1126/science.1155472			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279ZF	18369136				2022-12-24	WOS:000254394000033
J	Montel-Hagen, A; Kinet, S; Manel, N; Mongellaz, C; Prohaska, R; Battini, JL; Delaunay, J; Sitbon, M; Taylor, N				Montel-Hagen, Amelie; Kinet, Sandrina; Manel, Nicolas; Mongellaz, Cedric; Prohaska, Rainer; Battini, Jean-Luc; Delaunay, Jean; Sitbon, Marc; Taylor, Naomi			Erythrocyte glut1 triggers dehydroascorbic acid uptake in mammals unable to synthesize vitamin C	CELL			English	Article							L-ASCORBIC-ACID; GAMMA-LACTONE OXIDASE; RED-BLOOD-CELLS; GLUCOSE-TRANSPORTER; LIPID RAFTS; STOMATIN; BIOSYNTHESIS; RECEPTOR; DOMAINS; BINDING	Of all cells, human erythrocytes express the highest level of the Glut1 glucose transporter. However, the regulation and function of Glut1 during erythropoiesis are not known. Here, we report that glucose transport actually decreases during human erythropoiesis despite a >3-log increase in Glut1 transcripts. In contrast, Glut1-mediated transport of L-dehydroascorbic acid (DHA), an oxidized form of ascorbic acid ( AA), is dramatically enhanced. We identified stomatin, an integral erythrocyte membrane protein, as regulating the switch from glucose to DHA transport. Notably though, we found that erythrocyte Glut1 and associated DHA uptake are unique traits of humans and the few other mammals that have lost the ability to synthesize AA from glucose. Accordingly, we show that mice, a species capable of synthesizing AA, express Glut4 but not Glut1 in mature erythrocytes. Thus, erythrocyte-specific coexpression of Glut1 with stomatin constitutes a compensatory mechanism in mammals that are unable to synthesize vitamin C.	[Montel-Hagen, Amelie; Kinet, Sandrina; Manel, Nicolas; Mongellaz, Cedric; Battini, Jean-Luc; Sitbon, Marc; Taylor, Naomi] Univ Montpellier I, CNRS, Inst Genet Mol Montpellier, Montpellier, France; [Montel-Hagen, Amelie; Kinet, Sandrina; Manel, Nicolas; Mongellaz, Cedric; Battini, Jean-Luc; Sitbon, Marc; Taylor, Naomi] Univ Montpellier 2, Montpellier, France; [Prohaska, Rainer] Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, Vienna Bioctr, A-1030 Vienna, Austria; [Delaunay, Jean] Hop Bicetre, INSERM, Fac Med Paris Sud, APHP,U Hematol 779, Le Kremlin Bicetre, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Taylor, N (corresponding author), Univ Montpellier I, CNRS, Inst Genet Mol Montpellier, Montpellier, France.	taylor@igmm.cnrs.fr	Taylor, Naomi/H-4016-2014; Sitbon, Marc/A-6771-2010; Manel, Nicolas/E-2128-2011	Sitbon, Marc/0000-0003-3616-2338; Manel, Nicolas/0000-0002-1481-4430; Battini, Jean-Luc/0000-0002-5884-9934; kinet, sandrina/0000-0003-0699-108X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059349] Funding Source: NIH RePORTER; Austrian Science Fund FWF [P 22038] Funding Source: Medline; NIAID NIH HHS [R01 AI059349] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Austrian Science Fund FWF(Austrian Science Fund (FWF)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; BIANCHI J, 1986, P SOC EXP BIOL MED, V181, P333; BURNS JJ, 1957, NATURE, V180, P552, DOI 10.1038/180553a0; CHATTERJEE I, 1961, NATURE, V192, P163, DOI 10.1038/192163a0; CHATTERJEE IB, 1973, SCIENCE, V182, P1271, DOI 10.1126/science.182.4118.1271; Cloherty EK, 1996, BIOCHEMISTRY-US, V35, P10411, DOI 10.1021/bi953077m; Delaunay J, 2004, SEMIN HEMATOL, V41, P165, DOI 10.1053/j.seminhematol.2004.02.005; DHARIWAL KR, 1991, AM J CLIN NUTR, V54, P712, DOI 10.1093/ajcn/54.4.712; EVANS RM, 1982, BRIT J NUTR, V47, P473, DOI 10.1079/BJN19820059; Fecchi K, 2006, FASEB J, V20, P705, DOI 10.1096/fj.05-4661fje; Fricke B, 2005, BRIT J HAEMATOL, V131, P265, DOI 10.1111/j.1365-2141.2005.05742.x; HEBERT DN, 1992, J BIOL CHEM, V267, P23829; HELGERSON AL, 1987, J BIOL CHEM, V262, P5464; HORIO F, 1985, J NUTR, V115, P1630, DOI 10.1093/jn/115.12.1630; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Kim Felix J, 2004, Retrovirology, V1, P41, DOI 10.1186/1742-4690-1-41; Kimura A, 2001, P NATL ACAD SCI USA, V98, P9098, DOI 10.1073/pnas.151252898; Kinet S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-31; Kumar A, 2004, AM J PHYSIOL-ENDOC M, V286, pE568, DOI 10.1152/ajpendo.00372.2003; Leitch JM, 2007, AM J PHYSIOL-CELL PH, V292, pC974, DOI 10.1152/ajpcell.00335.2006; LOWE AG, 1986, BIOCHIM BIOPHYS ACTA, V857, P146, DOI 10.1016/0005-2736(86)90342-1; Maeda N, 2000, P NATL ACAD SCI USA, V97, P841, DOI 10.1073/pnas.97.2.841; Manel N, 2003, CELL, V115, P449, DOI 10.1016/S0092-8674(03)00881-X; Manel N, 2005, J BIOL CHEM, V280, P29025, DOI 10.1074/jbc.M504549200; Manel N, 2003, BLOOD, V101, P1913, DOI 10.1182/blood-2002-09-2681; May James M., 1998, Frontiers in Bioscience, V3, pD1; May JM, 2001, BBA-GEN SUBJECTS, V1528, P159, DOI 10.1016/S0304-4165(01)00188-X; MIZUSHIMA Y, 1984, EXPERIENTIA, V40, P359, DOI 10.1007/BF01952551; MORGAN PG, 2007, WORMBOOK, V1, P1; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; NAKAJIMA Y, 1969, HISTOCHEMISTRY, V18, P293; NISHIKIMI M, 1994, J BIOL CHEM, V269, P13685; NISHIKIMI M, 1992, J BIOL CHEM, V267, P21967; PAULING L, 1970, P NATL ACAD SCI USA, V67, P1643, DOI 10.1073/pnas.67.4.1643; POLLOCK JI, 1987, AM J PHYS ANTHROPOL, V73, P65, DOI 10.1002/ajpa.1330730106; Rubin D, 2003, AM J PHYSIOL-CELL PH, V285, pC377, DOI 10.1152/ajpcell.00060.2003; Rumsey SC, 1997, J BIOL CHEM, V272, P18982, DOI 10.1074/jbc.272.30.18982; Rumsey SC, 2000, J BIOL CHEM, V275, P28246; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; Salzer U., 2007, DYN CELL BIOL, V1, P20; Santalucia T, 1999, J BIOL CHEM, V274, P17626, DOI 10.1074/jbc.274.25.17626; Sedensky MM, 2006, ANESTHESIOLOGY, V105, P498, DOI 10.1097/00000542-200609000-00013; Seidner G, 1998, NAT GENET, V18, P188, DOI 10.1038/ng0298-188; STEWART GW, 1992, BLOOD, V79, P1593, DOI 10.1182/blood.V79.6.1593.bloodjournal7961593; STONE I, 1966, PERSPECT BIOL MED, V10, P133; Swainson L, 2005, P NATL ACAD SCI USA, V102, P12867, DOI 10.1073/pnas.0503603102; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; VERA JC, 1995, J BIOL CHEM, V270, P23706, DOI 10.1074/jbc.270.40.23706; VERA JC, 1993, NATURE, V364, P79, DOI 10.1038/364079a0; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394; Zhang JZ, 1999, ARCH BIOCHEM BIOPHYS, V372, P173, DOI 10.1006/abbi.1999.1489; Zhang JZ, 2001, AM J PHYSIOL-CELL PH, V280, pC1277, DOI 10.1152/ajpcell.2001.280.5.C1277; Zhu YW, 1999, BLOOD, V93, P2404, DOI 10.1182/blood.V93.7.2404.407k13_2404_2410	57	176	181	5	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 21	2008	132	6					1039	1048		10.1016/j.cell.2008.01.042	http://dx.doi.org/10.1016/j.cell.2008.01.042			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	278GR	18358815	Bronze			2022-12-24	WOS:000254273600021
J	Lin, HS; Lee, E; Hestir, K; Leo, C; Huang, MM; Bosch, E; Halenbeck, R; Wu, G; Zhou, A; Behrens, D; Hollenbaugh, D; Linnemann, T; Qin, MM; Wong, J; Chu, KT; Doberstein, SK; Williams, LT				Lin, Haishan; Lee, Ernestine; Hestir, Kevin; Leo, Cindy; Huang, Minmei; Bosch, Elizabeth; Halenbeck, Robert; Wu, Ge; Zhou, Aileen; Behrens, Dirk; Hollenbaugh, Diane; Linnemann, Thomas; Qin, Minmin; Wong, Justin; Chu, Keting; Doberstein, Stephen K.; Williams, Lewis T.			Discovery of a cytokine and its receptor by functional screening of the extracellular proteome	SCIENCE			English	Article							GROWTH-FACTOR	To understand the system of secreted proteins and receptors involved in cell- cell signaling, we produced a comprehensive set of recombinant secreted proteins and the extracellular domains of transmembrane proteins, which constitute most of the protein components of the extracellular space. Each protein was tested in a suite of assays that measured metabolic, growth, or transcriptional responses in diverse cell types. The pattern of responses across assays was analyzed for the degree of functional selectivity of each protein. One of the highly selective proteins was a previously undescribed ligand, designated interleukin- 34 ( IL- 34), which stimulates monocyte viability but does not affect responses in a wide spectrum of other assays. In a separate functional screen, we used a collection of extracellular domains of transmembrane proteins to discover the receptor for IL- 34, which was a known cytokine receptor, colony-stimulating factor 1 ( also called macrophage colony- stimulating factor) receptor. This systematic approach is thus useful for discovering new ligands and receptors and assessing the functional selectivity of extracellular regulatory proteins.	[Lin, Haishan; Lee, Ernestine; Hestir, Kevin; Leo, Cindy; Huang, Minmei; Bosch, Elizabeth; Halenbeck, Robert; Wu, Ge; Zhou, Aileen; Behrens, Dirk; Hollenbaugh, Diane; Linnemann, Thomas; Qin, Minmin; Wong, Justin; Chu, Keting; Doberstein, Stephen K.; Williams, Lewis T.] Five Prime Therapeut Inc, San Francisco, CA 94158 USA; [Williams, Lewis T.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Williams, LT (corresponding author), Five Prime Therapeut Inc, 1650 Owens St,Suite 200, San Francisco, CA 94158 USA.	rusty.williams@fiveprime.com						Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Conway JG, 2005, P NATL ACAD SCI USA, V102, P16078, DOI 10.1073/pnas.0502000102; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; LEE EA, IN PRESS PROTEIN PEP; Nissen-Druey C, 2005, ACTA HAEMATOL-BASEL, V113, P5, DOI 10.1159/000081987; PEREIRA C, 2004, BIOPROCESS INT, V2, P70; TESTA NG, 1993, HAEMOPOIESIS PRACTIC; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Xie MH, 1999, CYTOKINE, V11, P729, DOI 10.1006/cyto.1999.0485	14	523	611	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2008	320	5877					807	811		10.1126/science.1154370	http://dx.doi.org/10.1126/science.1154370			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18467591				2022-12-24	WOS:000255644400045
J	Wardle, DA; Nilsson, MC; Zackrisson, O				Wardle, David A.; Nilsson, Marie-Charlotte; Zackrisson, Olle			Fire-derived charcoal causes loss of forest humus	SCIENCE			English	Article							BLACK CARBON		[Wardle, David A.; Nilsson, Marie-Charlotte; Zackrisson, Olle] Swedish Univ Agr Sci, Dept Forest Ecol & Management, SE-90183 Umea, Sweden	Swedish University of Agricultural Sciences	Wardle, DA (corresponding author), Swedish Univ Agr Sci, Dept Forest Ecol & Management, SE-90183 Umea, Sweden.	david.wardle@svek.slu.se	Wardle, David A./F-6031-2011; Hegethorn, Marie-Charlotte Nilsson/B-1802-2017	Wardle, David A./0000-0002-0476-7335; Hegethorn, Marie-Charlotte Nilsson/0000-0002-9254-2223				Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Hamer U, 2004, ORG GEOCHEM, V35, P823, DOI 10.1016/j.orggeochem.2004.03.003; Hammes K, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002914; Harden JW, 2000, GLOBAL CHANGE BIOL, V6, P174, DOI 10.1046/j.1365-2486.2000.06019.x; Lehmann J, 2007, NATURE, V447, P143, DOI 10.1038/447143a; Neff JC, 2002, GLOBAL CHANGE BIOL, V8, P872, DOI 10.1046/j.1365-2486.2002.00517.x; Pietikainen J, 2000, OIKOS, V89, P231, DOI 10.1034/j.1600-0706.2000.890203.x; Preston CM, 2006, BIOGEOSCIENCES, V3, P397, DOI 10.5194/bg-3-397-2006; Schmidt MWI, 2000, GLOBAL BIOGEOCHEM CY, V14, P777, DOI 10.1029/1999GB001208; ZACLROSSPM P, POLPS, V88, P20	10	452	531	8	309	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2008	320	5876					629	629		10.1126/science.1154960	http://dx.doi.org/10.1126/science.1154960			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451294				2022-12-24	WOS:000255454300035
J	Isken, O; Kim, YK; Hosoda, N; Mayeur, GL; Hershey, JWB; Maquat, LE				Isken, Olaf; Kim, Yoon Ki; Hosoda, Nao; Mayeur, Greg L.; Hershey, John W. B.; Maquat, Lynne E.			Upf1 phosphorylation triggers translational repression during nonsense-mediated mRNA decay	CELL			English	Article							EXON JUNCTION COMPLEX; MAMMALIAN-CELLS; SURVEILLANCE COMPLEX; GENOTOXIC STRESS; P-BODIES; PROTEIN; INITIATION; DEGRADATION; BINDING; YEAST	In mammalian cells, nonsense-mediated mRNA decay (NMD) generally requires that translation terminates sufficiently upstream of a post-splicing exon junction complex (EJC) during a pioneer round of translation. The subsequent binding of Upf1 to the EJC triggers Upf1 phosphorylation. We provide evidence that phospho-Upf1 functions after nonsense codon recognition during steps that involve the translation initiation factor eIF3 and mRNA decay factors. Phospho-Upf1 interacts directly with eIF3 and inhibits the eIF3-dependent conversion of 40S/Met-tRNAi(Met)/mRNA to translationally competent 80S/Met-tRNAi(Met)/mRNA initiation complexes to repress continued translation initiation. Consistent with phospho-Upf1 impairing eIF3 function, NMD fails to detectably target nonsense-containing transcripts that initiate translation independently of eIF3 from the CrPV IRES. There is growing evidence that translational repression is a key transition that precedes mRNA delivery to the degradation machinery. Our results uncover a critical step during NMD that converts a pioneer translation initiation complex to a translationally compromised mRNP.	[Isken, Olaf; Kim, Yoon Ki; Hosoda, Nao; Maquat, Lynne E.] Univ Rochester, Dept Biochem & Biophys, Sch Med & Dent, Rochester, NY 14642 USA; [Mayeur, Greg L.; Hershey, John W. B.] Univ Calif Davis, Dept Biochem & Mol Med, Sch Med, Davis, CA 95616 USA	University of Rochester; University of California System; University of California Davis	Maquat, LE (corresponding author), Univ Rochester, Dept Biochem & Biophys, Sch Med & Dent, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	lynne_maquat@urmc.rochester.edu		Maquat, Lynne/0000-0002-2789-2075; Kim, Yoon Ki/0000-0003-1303-072X	NIGMS NIH HHS [R01 GM074593, GM073732, GM074593, P01 GM073732, R37 GM074593] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM073732, R01GM074593, R37GM074593] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BROWNLUEDI ML, 1982, BIOCHEMISTRY-US, V21, P4202, DOI 10.1021/bi00261a002; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; BU X, 1993, J BIOL CHEM, V268, P4975; Chin SY, 2004, GENE DEV, V18, P745, DOI 10.1101/gad.1170204; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; DARNBROUGH C, 1972, BIOCHEM BIOPH RES CO, V48, P1556, DOI 10.1016/0006-291X(72)90891-1; DOUDNA JA, 2007, TRANSLATIONAL CONTRO, P129; Durand S, 2007, J CELL BIOL, V178, P1145, DOI 10.1083/jcb.200611086; ERNST H, 1987, J BIOL CHEM, V262, P1206; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Ferraiuolo MA, 2005, J CELL BIOL, V170, P913, DOI 10.1083/jcb.200504039; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Holbrook JA, 2006, EMBO REP, V7, P722, DOI 10.1038/sj.embor.7400721; Hosoda N, 2006, MOL CELL BIOL, V26, P3085, DOI 10.1128/MCB.26.8.3085-3097.2006; Hosoda N, 2005, NAT STRUCT MOL BIOL, V12, P893, DOI 10.1038/nsmb995; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Jackson RJ, 2005, BIOCHEM SOC T, V33, P1231, DOI 10.1042/BST0331231; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; Kim VN, 2001, SCIENCE, V293, P1832, DOI 10.1126/science.1062829; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Lal A, 2006, MOL CELL, V22, P117, DOI 10.1016/j.molcel.2006.03.016; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lehner B, 2004, GENOME RES, V14, P1315, DOI 10.1101/gr.2122004; Lejeune F, 2004, NAT STRUCT MOL BIOL, V11, P992, DOI 10.1038/nsmb824; Lejeune F, 2003, MOL CELL, V12, P675, DOI 10.1016/S1097-2765(03)00349-6; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; Matsuda D, 2007, NAT STRUCT MOL BIOL, V14, P974, DOI 10.1038/nsmb1297; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Morris C, 2007, EMBO REP, V8, P596, DOI 10.1038/sj.embor.7400955; Muhlrad D, 1999, MOL BIOL CELL, V10, P3971, DOI 10.1091/mbc.10.11.3971; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Page MF, 1999, MOL CELL BIOL, V19, P5943; Pal M, 2001, RNA, V7, P5, DOI 10.1017/S1355838201000127; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pestova TV, 2001, RNA, V7, P1496, DOI 10.1017/S135583820101038X; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Robertson MEM, 1999, RNA, V5, P1167, DOI 10.1017/S1355838299990301; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; Stanley W M Jr, 1974, Methods Enzymol, V29, P530; Sun XL, 1998, P NATL ACAD SCI USA, V95, P10009, DOI 10.1073/pnas.95.17.10009; Unterholzner L, 2004, MOL CELL, V16, P587, DOI 10.1016/j.molcel.2004.10.013; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Wittmann J, 2006, MOL CELL BIOL, V26, P1272, DOI 10.1128/MCB.26.4.1272-1287.2006; Woeller CF, 2008, EMBO REP, V9, P446, DOI 10.1038/embor.2008.36; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001	57	219	221	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2008	133	2					314	327		10.1016/j.cell.2008.02.030	http://dx.doi.org/10.1016/j.cell.2008.02.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	289JY	18423202	Green Accepted, Bronze			2022-12-24	WOS:000255052000020
J	Witze, ES; Litman, ES; Argast, GM; Moon, RT; Ahn, NG				Witze, Eric S.; Litman, Elizabeth S.; Argast, Gretchen M.; Moon, Randall T.; Ahn, Natalie G.			Wnt5a control of cell polarity and directional movement by polarized redistribution of adhesion receptors	SCIENCE			English	Article							C-ELEGANS; MELANOMA; DROSOPHILA; INVASION; SIGNALS; KINASE	Mechanisms by which Wnt pathways integrate the organization of receptors, organelles, and cytoskeletal proteins to confer cell polarity and directional cell movement are incompletely understood. We show that acute responses to Wnt5a involve recruitment of actin, myosin IIB, Frizzled 3, and melanoma cell adhesion molecule into an intracellular structure in a melanoma cell line. In the presence of a chemokine gradient, this Wnt- mediated receptor- actin- myosin polarity ( W- RAMP) structure accumulates asymmetrically at the cell periphery, where it triggers membrane contractility and nuclear movement in the direction of membrane retraction. The process requires endosome trafficking, is associated with multivesicular bodies, and is regulated by Wnt5a through the small guanosine triphosphatases Rab4 and RhoB. Thus, cell- autonomous mechanisms allow Wnt5a to control cell orientation, polarity, and directional movement in response to positional cues from chemokine gradients.	[Witze, Eric S.; Litman, Elizabeth S.; Argast, Gretchen M.; Ahn, Natalie G.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Litman, Elizabeth S.; Moon, Randall T.; Ahn, Natalie G.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Moon, Randall T.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Moon, Randall T.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Ahn, NG (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	natalie.ahn@colorado.edu	Moon, Randall/M-5605-2019; Moon, Randall T/B-1743-2014	Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408	NCI NIH HHS [R01 CA118972, R01 CA118972-01A2, F32-CA105796, R01-CA118972, R01 CA118972-02, F32 CA105796, F32-CA112847, F32 CA112847] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA112847, R01CA118972, F32CA105796] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Bartolome RA, 2004, CANCER RES, V64, P2534, DOI 10.1158/0008-5472.CAN-03-3398; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Ellis S, 2000, TRENDS CELL BIOL, V10, P85, DOI 10.1016/S0962-8924(99)01710-9; Goldstein B, 2006, DEV CELL, V10, P391, DOI 10.1016/j.devcel.2005.12.016; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Kolega J, 2003, MOL BIOL CELL, V14, P4745, DOI 10.1091/mbc.E03-04-0205; Murakami T, 2002, CANCER RES, V62, P7328; Park FD, 2004, CURR BIOL, V14, P2252, DOI 10.1016/j.cub.2004.12.019; Satyamoorthy K, 2001, ONCOGENE, V20, P4676, DOI 10.1038/sj.onc.1204616; Shimada Y, 2006, DEV CELL, V10, P209, DOI 10.1016/j.devcel.2005.11.016; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Whangbo J, 1999, MOL CELL, V4, P851, DOI 10.1016/S1097-2765(00)80394-9; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7	18	191	201	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2008	320	5874					365	369		10.1126/science.1151250	http://dx.doi.org/10.1126/science.1151250			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZZ	18420933	Green Accepted			2022-12-24	WOS:000255026100041
J	Deborde, S; Perret, E; Gravotta, D; Deora, A; Salvarezza, S; Schreiner, R; Rodriguez-Boulan, E				Deborde, Sylvie; Perret, Emilie; Gravotta, Diego; Deora, Ami; Salvarezza, Susana; Schreiner, Ryan; Rodriguez-Boulan, Enrique			Clathrin is a key regulator of basolateral polarity	NATURE			English	Article							DARBY CANINE KIDNEY; EPITHELIAL-CELLS; MDCK CELLS; PLASMA-MEMBRANE; PROTEINS; ENDOSOMES; RECEPTOR; TRAFFICKING; ENDOCYTOSIS; TRANSPORT	Clathrin-coated vesicles are vehicles for intracellular trafficking in all nucleated cells, from yeasts to humans. Many studies have demonstrated their essential roles in endocytosis and cellular signalling processes at the plasma membrane. By contrast, very few of their non-endocytic trafficking roles are known, the best characterized being the transport of hydrolases from the Golgi complex to the lysosome. Here we show that clathrin is required for polarity of the basolateral plasma membrane proteins in the epithelial cell line MDCK. Clathrin knockdown depolarized most basolateral proteins, by interfering with their biosynthetic delivery and recycling, but did not affect the polarity of apical proteins. Quantitative live imaging showed that chronic and acute clathrin knockdown selectively slowed down the exit of basolateral proteins from the Golgi complex, and promoted their mis-sorting into apical carrier vesicles. Our results demonstrate a broad requirement for clathrin in basolateral protein trafficking in epithelial cells.	[Deborde, Sylvie; Perret, Emilie; Gravotta, Diego; Deora, Ami; Salvarezza, Susana; Schreiner, Ryan; Rodriguez-Boulan, Enrique] Cornell Univ, Dept Ophthalmol, Dyson Vis Res Inst, New York, NY 10065 USA; [Rodriguez-Boulan, Enrique] Cornell Univ, Dept Cell & Dev Biol, Weill Med Coll, New York, NY 10065 USA	Cornell University; Dyson; Cornell University	Rodriguez-Boulan, E (corresponding author), Cornell Univ, Dept Ophthalmol, Dyson Vis Res Inst, LC-300,1300 York Ave, New York, NY 10065 USA.	boulan@med.cornell.edu		Schreiner, Ryan/0000-0002-7457-6606; Deborde, Sylvie/0000-0002-6630-4029	NATIONAL EYE INSTITUTE [R01EY008538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034107] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY008538] Funding Source: Medline; NIGMS NIH HHS [R01 GM034107] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BREWER CB, 1991, J CELL BIOL, V114, P413, DOI 10.1083/jcb.114.3.413; Cancino J, 2007, MOL BIOL CELL, V18, P4872, DOI 10.1091/mbc.E07-06-0563; CEREIJIDO M, 1978, J CELL BIOL, V77, P853, DOI 10.1083/jcb.77.3.853; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Deora AA, 2004, MOL BIOL CELL, V15, P4148, DOI 10.1091/mbc.E04-01-0058; Deora AA, 2007, TRAFFIC, V8, P1304, DOI 10.1111/j.1600-0854.2007.00617.x; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; Gan YB, 2002, NAT CELL BIOL, V4, P605, DOI 10.1038/ncb827; Gravotta D, 2007, P NATL ACAD SCI USA, V104, P1564, DOI 10.1073/pnas.0610700104; HERZLINGER DA, 1984, J CELL BIOL, V98, P1777, DOI 10.1083/jcb.98.5.1777; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; HUNZIKER W, 1994, EMBO J, V13, P2963, DOI 10.1002/j.1460-2075.1994.tb06594.x; Iversen TG, 2003, P NATL ACAD SCI USA, V100, P5175, DOI 10.1073/pnas.0534231100; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; Kreitzer G, 2003, NAT CELL BIOL, V5, P126, DOI 10.1038/ncb917; LEBIVIC A, 1991, J CELL BIOL, V115, P607, DOI 10.1083/jcb.115.3.607; LEMMON SK, 1987, SCIENCE, V238, P504, DOI 10.1126/science.3116672; Li J, 2007, J CELL BIOL, V178, P453, DOI 10.1083/jcb.200608033; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; Miranda KC, 2001, J BIOL CHEM, V276, P22565, DOI 10.1074/jbc.M101907200; Moskowitz HS, 2003, MOL BIOL CELL, V14, P4437, DOI 10.1091/mbc.e03-04-0230; Mostov K, 2003, NAT CELL BIOL, V5, P287, DOI 10.1038/ncb0403-287; Musch A, 2001, EMBO J, V20, P2171, DOI 10.1093/emboj/20.9.2171; NELSON WJ, 1987, NATURE, V328, P533, DOI 10.1038/328533a0; Odorizzi G, 1997, J CELL BIOL, V137, P1255, DOI 10.1083/jcb.137.6.1255; Ohno H, 1999, FEBS LETT, V449, P215, DOI 10.1016/S0014-5793(99)00432-9; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Pagano A, 2004, MOL BIOL CELL, V15, P4990, DOI 10.1091/mbc.E04-04-0355; Pearse BMF, 2000, CURR OPIN STRUC BIOL, V10, P220, DOI 10.1016/S0959-440X(00)00071-3; Raiborg C, 2006, J CELL SCI, V119, P2414, DOI 10.1242/jcs.02978; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; ROTHMAN JE, 1980, P NATL ACAD SCI-BIOL, V77, P780, DOI 10.1073/pnas.77.2.780; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; Simmen T, 2002, NAT CELL BIOL, V4, P154, DOI 10.1038/ncb745; THOMAS DC, 1993, J BIOL CHEM, V268, P3313; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73	39	148	150	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2008	452	7188					719	U3		10.1038/nature06828	http://dx.doi.org/10.1038/nature06828			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	285QY	18401403	Green Accepted			2022-12-24	WOS:000254792500038
J	Shi, HF; Bencze, KZ; Stemmler, TL; Philpott, CC				Shi, Haifeng; Bencze, Krisztina Z.; Stemmler, Timothy L.; Philpott, Caroline C.			A cytosolic iron chaperone that delivers iron to ferritin	SCIENCE			English	Article							COPPER CHAPERONE; PROTEIN; BINDING; MECHANISMS; FRATAXIN; DISEASE	Ferritins are the main iron storage proteins found in animals, plants, and bacteria. The capacity to store iron in ferritin is essential for life in mammals, but the mechanism by which cytosolic iron is delivered to ferritin is unknown. Human ferritins expressed in yeast contain little iron. Human poly (rC)- binding protein 1 ( PCBP1) increased the amount of iron loaded into ferritin when expressed in yeast. PCBP1 bound to ferritin in vivo and bound iron and facilitated iron loading into ferritin in vitro. Depletion of PCBP1 in human cells inhibited ferritin iron loading and increased cytosolic iron pools. Thus, PCBP1 can function as a cytosolic iron chaperone in the delivery of iron to ferritin.	[Shi, Haifeng; Philpott, Caroline C.] NIDDKD, Liver Dis Branch, NIH, Bethesda, MD 20892 USA; [Bencze, Krisztina Z.; Stemmler, Timothy L.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Wayne State University	Philpott, CC (corresponding author), NIDDKD, Liver Dis Branch, NIH, Bethesda, MD 20892 USA.	carolinep@intra.niddk.nih.gov	Shi, Haifeng/AAT-4640-2020	Shi, Haifeng/0000-0001-9050-2140; Stemmler, Timothy/0000-0002-6298-088X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK054510, R01DK068139] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DK054510-03] Funding Source: Medline; NIDDK NIH HHS [R01 DK068139, R01 DK068139-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; Bou-Abdallah F, 2002, BIOCHEMISTRY-US, V41, P11184, DOI 10.1021/bi020215g; Bourdon E, 2003, BLOOD CELL MOL DIS, V31, P247, DOI 10.1016/S1079-9796(03)00161-X; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; Epsztejn S, 1997, ANAL BIOCHEM, V248, P31, DOI 10.1006/abio.1997.2126; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Kuchar J, 2004, CHEM REV, V104, P509, DOI 10.1021/cr020613p; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Missirlis F, 2007, GENETICS, V177, P89, DOI 10.1534/genetics.107.075150; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Pandolfo M, 2006, J NEURAL TRANSM-SUPP, P143; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Theil EC, 2006, J BIOL INORG CHEM, V11, P803, DOI 10.1007/s00775-006-0125-6; Wernimont AK, 2004, J BIOL CHEM, V279, P12269, DOI 10.1074/jbc.M311213200	19	343	358	3	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 30	2008	320	5880					1207	1210		10.1126/science.1157643	http://dx.doi.org/10.1126/science.1157643			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306FF	18511687	Green Accepted, Green Submitted			2022-12-24	WOS:000256233000036
J	Guo, W; Lasky, JL; Chang, CJ; Mosessian, S; Lewis, X; Xiao, Y; Yeh, JE; Chen, JY; Iruela-Arispe, ML; Varella-Garcia, M; Wu, H				Guo, Wei; Lasky, Joseph L.; Chang, Chun-Ju; Mosessian, Sherly; Lewis, Xiaoman; Xiao, Yun; Yeh, Jennifer E.; Chen, James Y.; Iruela-Arispe, M. Luisa; Varella-Garcia, Marileila; Wu, Hong			Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation	NATURE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; C-MYC; NOTCH1; EXPRESSION; CANCER; MOUSE; LEUKEMIA/LYMPHOMA; TRANSLOCATIONS; INACTIVATION; DELETION	Cancer stem cells, which share many common properties and regulatory machineries with normal stem cells, have recently been proposed to be responsible for tumorigenesis and to contribute to cancer resistance(1). The main challenges in cancer biology are to identify cancer stem cells and to define the molecular events required for transforming normal cells to cancer stem cells. Here we show that Pten deletion in mouse haematopoietic stem cells leads to a myeloproliferative disorder, followed by acute T-lymphoblastic leukaemia (T-ALL). Self- renewable leukaemia stem cells (LSCs) are enriched in the c-Kit(mid)CD3(+)Lin(-) compartment, where unphosphorylated beta-catenin is significantly increased. Conditional ablation of one allele of the beta-catenin gene substantially decreases the incidence and delays the occurrence of T-ALL caused by Pten loss, indicating that activation of the beta-catenin pathway may contribute to the formation or expansion of the LSC population. Moreover, a recurring chromosomal translocation, T(14;15), results in aberrant overexpression of the c-myc oncogene in c-Kit mid CD3(+)Lin(-) LSCs and CD3(+) leukaemic blasts, recapitulating a subset of human T-ALL. No alterations in Notch1 signalling are detected in this model, suggesting that Pten inactivation and c-myc overexpression may substitute functionally for Notch1 abnormalities(2,3), leading to T-ALL development. Our study indicates that multiple genetic or molecular alterations contribute cooperatively to LSC transformation.	[Guo, Wei; Chang, Chun-Ju; Mosessian, Sherly; Lewis, Xiaoman; Chen, James Y.; Wu, Hong] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Lasky, Joseph L.] Univ Calif Los Angeles, Dept Pediat Hematol Oncol, Los Angeles, CA 90095 USA; [Iruela-Arispe, M. Luisa] Univ Calif Los Angeles, Dept Mol Cellular & Dev Biol, Los Angeles, CA 90095 USA; [Wu, Hong] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Xiao, Yun; Varella-Garcia, Marileila] Univ Colorado, Hlth Sci Ctr, Dept Med, Div Med Oncol,Univ Colorado Canc Ctr, Denver, CO 80262 USA; [Yeh, Jennifer E.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Massachusetts Institute of Technology (MIT)	Wu, H (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	hwu@mednet.ucla.edu	Iruela-Arispe, M. Luisa/AAJ-1297-2020	Iruela-Arispe, M. Luisa/0000-0002-3050-4168; Yeh, Jennifer/0000-0003-3144-6702; Chang, Chunju/0000-0003-2887-9603; Mosessian, Sherly/0000-0002-8665-5053	NATIONAL CANCER INSTITUTE [P30CA016042, R01CA121110] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA121110, CA16042, R01 CA121110-01A1, P30 CA016042] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Boomer T, 2001, LEUKEMIA, V15, P95, DOI 10.1038/sj.leu.2401988; BOROWITZ MJ, 1993, AM J CLIN PATHOL, V100, P534, DOI 10.1093/ajcp/100.5.534; Boxer LM, 2001, ONCOGENE, V20, P5595, DOI 10.1038/sj.onc.1204595; Brault V, 2001, DEVELOPMENT, V128, P1253; Castor A, 2005, NAT MED, V11, P630, DOI 10.1038/nm1253; ERIKSON J, 1986, SCIENCE, V232, P884, DOI 10.1126/science.3486470; Fukuda R, 2005, P NATL ACAD SCI USA, V102, P15213, DOI 10.1073/pnas.0507184102; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Putti MC, 1998, BLOOD, V92, P795; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sharma VM, 2006, MOL CELL BIOL, V26, P8022, DOI 10.1128/MCB.01091-06; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Weissman I, 2005, JAMA-J AM MED ASSOC, V294, P1359, DOI 10.1001/jama.294.11.1359; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747	27	174	188	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2008	453	7194					529	U7		10.1038/nature06933	http://dx.doi.org/10.1038/nature06933			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303EL	18463637	Green Accepted			2022-12-24	WOS:000256023700044
J	Vrijens, B; Vincze, G; Kristanto, P; Urquhart, J; Burnier, M				Vrijens, Bernard; Vincze, Gabor; Kristanto, Paulus; Urquhart, John; Burnier, Michel			Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BLOOD-PRESSURE; MEDICATION; HYPERTENSION; PERSISTENCE; THERAPY; DISEASE; PLASMA; TIME; CARE	Objective To describe characteristics of dosing history in patients prescribed a once a day antihypertensive medication. Design Longitudinal database study. Setting Clinical studies archived in database for 1989-2006. Participants Patients who participated in the studies whose dosing histories were available through electronic monitoring. Main outcome measures Persistence with prescribed anti hypertensive treatment and execution of their once a day drug dosing regimens. Results The database contained dosing histories of 4783 patients with hypertension. The data came from 21 phase IV clinical studies, with lengths ranging from 30 to 330 days and involving 43 different antihypertensive drugs, including angiotensin 11 receptor blockers (n=2088), calcium channel blockers (n=937), angiotensin converting enzyme inhibitors (n=665), P blockers (n=195), and diuretics (n=155). About half of the patients who were prescribed an antihypertensive drug had stopped taking it within one year. On any day, patients who were still engaged with the drug dosing regimen omitted about 10% of the scheduled doses: 42% of these omissions were of a single day's dose, whereas 43% were part of a sequence of several days (three or more days that is, drug "holidays"). Almost half of the patients had at least one drug holiday a year. The likelihood that a patient would discontinue treatment early was inversely related to the quality of his or her daily execution of the dosing regimen. Conclusions Early discontinuation of treatment and suboptimal daily adherence to execution of the prescribed regimens are the most common facets of poor adherence with once a day antihypertensive drug treatments. The shortfalls in drug exposure that these dosing errors create might be a common cause of low rates of blood pressure control and high variability in responses to prescribed antihypertensive drugs.	[Vrijens, Bernard; Kristanto, Paulus] Pharmion Res Ctr, B-4600 Vise, Belgium; [Vrijens, Bernard] Univ Liege, Dept Biostat & Med Informat, Liege, Belgium; [Vincze, Gabor] Novartis Pharmaceut, Basel, Switzerland; [Urquhart, John] Univ Calif San Francisco, Ctr Drug Dev Sci, San Francisco, CA 94143 USA; [Burnier, Michel] Univ Lausanne Hosp, Div Nephrol & Hypertens Consultat, Lausanne, Switzerland	University of Liege; Novartis; University of California System; University of California San Francisco; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Vrijens, B (corresponding author), Pharmion Res Ctr, Rue Cyclistes Frontiere 24, B-4600 Vise, Belgium.	bernard.vrijens@pharmionic.com	Jain, Rakesh K/I-1384-2017; Yuan, Fan/A-1287-2011	Jain, Rakesh K/0000-0001-7571-3548; Vrijens, Bernard/0000-0002-9090-1253				Black HR, 1997, ARCH INTERN MED, V157, P2413; Bloom BS, 2001, BMJ-BRIT MED J, V323, P647, DOI 10.1136/bmj.323.7314.647; Burnier M, 2001, J HYPERTENS, V19, P335, DOI 10.1097/00004872-200102000-00022; Burnier M, 2006, AM J HYPERTENS, V19, P1190, DOI 10.1016/j.amjhyper.2006.04.006; Canto JG, 2003, JAMA-J AM MED ASSOC, V290, P947, DOI 10.1001/jama.290.7.947; Caro JJ, 1999, CAN MED ASSOC J, V160, P41; CRAMER JA, 1990, ARCH INTERN MED, V150, P1509, DOI 10.1001/archinte.150.7.1509; Cramer JA, 1999, J NERV MENT DIS, V187, P53, DOI 10.1097/00005053-199901000-00009; DUESING R, 2001, CURR HYPERTENS REP, V3, P488; Ebrahim S, 1998, HEALTH TECHNOL ASSES, V2, pi; FEINSTEIN AR, 1990, ARCH INTERN MED, V150, P1377, DOI 10.1001/archinte.150.7.1377; Feldman SR, 2007, J AM ACAD DERMATOL, V57, P81, DOI 10.1016/j.jaad.2007.04.005; Girard P, 1996, J PHARMACOKINET BIOP, V24, P265, DOI 10.1007/BF02353671; Halpern MT, 2006, HYPERTENSION, V47, P1039, DOI 10.1161/01.HYP.0000222373.59104.3d; Hyman DJ, 2001, NEW ENGL J MED, V345, P479, DOI 10.1056/NEJMoa010273; Hyre Amanda D, 2007, J Clin Hypertens (Greenwich), V9, P179, DOI 10.1111/j.1524-6175.2007.06372.x; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Morgan Steven G, 2004, Can J Clin Pharmacol, V11, pe267; PULLAR T, 1989, ANN RHEUM DIS, V48, P871, DOI 10.1136/ard.48.10.871; Rosen MI, 2004, BEHAV RES THER, V42, P409, DOI 10.1016/S0005-7967(03)00149-9; RUBIO A, 1992, CLIN PHARMACOKINET, V22, P238, DOI 10.2165/00003088-199222030-00006; RUDD P, 1990, CLIN PHARMACOL THER, V48, P676, DOI 10.1038/clpt.1990.211; SCHNEIDER MP, 2003, J INFORM TECHNOLOGY, V1, P419; Schroeder K, 2004, ARCH INTERN MED, V164, P722, DOI 10.1001/archinte.164.7.722; Urquhart J, 1996, EUR HEART J, V17, P8, DOI 10.1093/eurheartj/17.suppl_A.8; Urquhart J, 1998, ADV DRUG DELIVER REV, V33, P207, DOI 10.1016/S0169-409X(98)00029-5; Urquhart J., 2005, EUR J HOSP PHARM SCI, V103, P103; Vrijens B, 2006, PHARMACOEPIDEM DR S, V15, P115, DOI 10.1002/pds.1198; Vrijens B, 2005, J CLIN PHARMACOL, V45, P461, DOI 10.1177/0091270004274433; Vrijens B, 1997, CONTROL CLIN TRIALS, V18, P187, DOI 10.1016/S0197-2456(96)00235-8; Vrijens B, 1999, STAT METHODS MED RES, V8, P247, DOI 10.1191/096228099669221405; Waeber B, 1999, CLIN EXP HYPERTENS, V21, P973, DOI 10.3109/10641969909061025	32	555	570	1	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 17	2008	336	7653					1114	1117		10.1136/bmj.39553.670231.25	http://dx.doi.org/10.1136/bmj.39553.670231.25			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302NM	18480115	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000255975100039
J	Fu, Y; Zhu, Y; Zhang, K; Yeung, M; Durocher, D; Xiao, W				Fu, Yu; Zhu, Yu; Zhang, Ke; Yeung, ManTek; Durocher, Daniel; Xiao, Wei			Rad6-Rad18 mediates a eukaryotic SOS response by ubiquitinating the 9-1-1 checkpoint clamp	CELL			English	Article							DNA-DAMAGE CHECKPOINT; SINGLE-STRANDED-DNA; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CELL-CYCLE; POSTREPLICATION REPAIR; CONJUGATING-ENZYME; ESCHERICHIA-COLI; S-PHASE; COMPLEX-FORMATION	Bacteria employ a coordinated SOS response to DNA damage by enhancing transcription, translesion synthesis, and recombination; a similar phenomenon has not been reported in eukaryotes. Here, we demonstrate that the ubiquitination complex Rad6-Rad18 is required for the increased transcription of a large number of yeast genes in response to DNA damage. Rad6-Rad18 promotes DNA-damage-dependent transcriptional induction as well as checkpoint functions by catalyzing monoubiquitination at the K197 residue of the Rad17 subunit of the 9-1-1 complex. Rad17 ubiquitination invokes both DNA damage responsive pathways by promoting efficient Rad53 phosphorylation, possibly through the recruitment or maintenance of the 9-1-1 clamp at sites of lesions. Taken together, the Rad6-Rad18 complex is involved in the control of global gene regulation in a way reminiscent of the bacterial SOS response and plays key roles in coordinating several DNA damage response pathways through ubiquitination of two DNA clamps, PCNA and 9-1-1.	[Fu, Yu; Zhu, Yu; Zhang, Ke; Xiao, Wei] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada; [Yeung, ManTek; Durocher, Daniel] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Yeung, ManTek; Durocher, Daniel] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Saskatchewan; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Xiao, W (corresponding author), Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada.	wei.xiao@usask.ca	FU, YU Vincent/AAX-4936-2021; Durocher, Daniel/A-7733-2010	FU, YU Vincent/0000-0001-8251-2306; Durocher, Daniel/0000-0003-3863-8635; Xiao, Wei/0000-0001-7568-0782; Yeung, ManTek/0000-0002-9800-942X				Aboussekhra A, 1996, EMBO J, V15, P3912, DOI 10.1002/j.1460-2075.1996.tb00765.x; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; BAILLY V, 1994, GENE DEV, V8, P811, DOI 10.1101/gad.8.7.811; Bailly V, 1997, J BIOL CHEM, V272, P23360, DOI 10.1074/jbc.272.37.23360; BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Broomfield S, 1998, P NATL ACAD SCI USA, V95, P5678, DOI 10.1073/pnas.95.10.5678; Broomfield S, 2001, MUTAT RES-DNA REPAIR, V486, P167, DOI 10.1016/S0921-8777(01)00091-X; CHEN J, 1989, P NATL ACAD SCI USA, V86, P7961, DOI 10.1073/pnas.86.20.7961; CHEN J, 1990, EMBO J, V9, P4569, DOI 10.1002/j.1460-2075.1990.tb07910.x; Chow KH, 2004, J BIOL CHEM, V279, P3492, DOI 10.1074/jbc.M311012200; de la Torre-Ruiz MA, 1998, EMBO J, V17, P2687, DOI 10.1093/emboj/17.9.2687; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; Frei C, 2000, GENE DEV, V14, P81; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Fu Y, 2006, NUCLEIC ACIDS RES, V34, P1876, DOI 10.1093/nar/gkl100; Fu Y, 2003, DNA REPAIR, V2, P1435, DOI 10.1016/j.dnarep.2003.08.013; Fu Yu, 2006, Methods Mol Biol, V313, P257; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Green CM, 2000, CURR BIOL, V10, P39, DOI 10.1016/S0960-9822(99)00263-8; GRIFFITHS DJF, 1995, EMBO J, V14, P5812, DOI 10.1002/j.1460-2075.1995.tb00269.x; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang HH, 1997, MOL CELL BIOL, V17, P6693, DOI 10.1128/MCB.17.11.6693; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Jang YK, 1999, MOL CELL BIOL, V19, P7630; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; Jia XD, 2004, GENETICS, V166, P753, DOI 10.1534/genetics.166.2.753; Johnson RE, 1998, GENE DEV, V12, P3137, DOI 10.1101/gad.12.19.3137; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Ke SH, 1997, NUCLEIC ACIDS RES, V25, P3371, DOI 10.1093/nar/25.16.3371; Kiser GL, 1996, MOL BIOL CELL, V7, P703, DOI 10.1091/mbc.7.5.703; Kondo T, 2001, SCIENCE, V294, P867, DOI 10.1126/science.1063827; Kondo T, 1999, MOL CELL BIOL, V19, P1136; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Liu YL, 1997, MOL MICROBIOL, V23, P777, DOI 10.1046/j.1365-2958.1997.2701631.x; Longhese MP, 1997, EMBO J, V16, P5216, DOI 10.1093/emboj/16.17.5216; Lustgarten V, 1999, MOL CELL BIOL, V19, P4480; LYDALL D, 1995, SCIENCE, V270, P1488, DOI 10.1126/science.270.5241.1488; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Melo JA, 2001, GENE DEV, V15, P2809; MORRISON A, 1988, MOL CELL BIOL, V8, P1179, DOI 10.1128/MCB.8.3.1179; Myung K, 2002, P NATL ACAD SCI USA, V99, P4500, DOI 10.1073/pnas.062702199; Navas TA, 1996, GENE DEV, V10, P2632, DOI 10.1101/gad.10.20.2632; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; PRAKASH S, 1993, ANNU REV GENET, V27, P33, DOI 10.1146/annurev.ge.27.120193.000341; Sabbioneda S, 2005, J BIOL CHEM, V280, P38657, DOI 10.1074/jbc.M507638200; Sherman F., 1983, METHODS YEAST GENETI; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Sweeney FD, 2005, CURR BIOL, V15, P1364, DOI 10.1016/j.cub.2005.06.063; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Xiao W, 2000, GENETICS, V155, P1633; XIAO W, 1993, MOL CELL BIOL, V13, P7213, DOI 10.1128/MCB.13.12.7213; Xiao W, 1996, CURR GENET, V30, P461, DOI 10.1007/s002940050157; Xiao W, 2001, MUTAT RES-DNA REPAIR, V487, P137, DOI 10.1016/S0921-8777(01)00113-6; ZHOU Z, 1993, CELL, V75, P1119, DOI 10.1016/0092-8674(93)90321-G; Zhu Y, 2004, NUCLEIC ACIDS RES, V32, P5066, DOI 10.1093/nar/gkh838; Zhu Y, 1998, NUCLEIC ACIDS RES, V26, P5402, DOI 10.1093/nar/26.23.5402; Zhu Y, 2001, MOL GENET GENOMICS, V266, P436; Zubko MK, 2006, METHOD ENZYMOL, V409, P285, DOI 10.1016/S0076-6879(05)09016-6	62	62	64	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 16	2008	133	4					601	611		10.1016/j.cell.2008.02.050	http://dx.doi.org/10.1016/j.cell.2008.02.050			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485869	Bronze			2022-12-24	WOS:000255903300016
J	Stevenson, DG				Stevenson, David G.			Planning for the future - Long-term care and the 2008 election	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Stevenson, DG (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							[Anonymous], 2007, LONG TERM CARE FINAN; Grabowski DC, 2007, MILBANK Q, V85, P579, DOI 10.1111/j.1468-0009.2007.00502.x; National Commission for Quality Long-Term Care, 2007, IS INT REC IMPR QUAL; VLADECK BC, 1980, 20 CENTURY FUND UNLO; Wiener JM, 2001, MILBANK Q, V79, P207, DOI 10.1111/1468-0009.00204	5	9	9	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2008	358	19					1985	1987		10.1056/NEJMp0802347	http://dx.doi.org/10.1056/NEJMp0802347			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296WY	18463373				2022-12-24	WOS:000255577700001
J	Gaut, BS; Ross-Ibarra, J				Gaut, Brandon S.; Ross-Ibarra, Jeffrey			Perspective - Selection on major components of angiosperm genomes	SCIENCE			English	Editorial Material							ARABIDOPSIS-THALIANA; TRANSPOSABLE ELEMENT; PLANT GENOMES; DNA CONTENT; GENE; EVOLUTION; RICE; HETEROCHROMATIN; AMPLIFICATION; CHROMOSOMES	Angiosperms are a relatively recent evolutionary innovation, but their genome sizes have diversified remarkably since their origin, at a rate beyond that of most other taxa. Genome size is often correlated with plant growth and ecology, and extremely large genomes may be limited both ecologically and evolutionarily. Yet the relationship between genome size and natural selection remains poorly understood. The manifold cellular and physiological effects of large genomes may be a function of selection on the major components that contribute to genome size, such as transposable elements and gene duplication. To understand the nature of selection on these genomic components, both population- genetic and comparative approaches are needed.	[Gaut, Brandon S.; Ross-Ibarra, Jeffrey] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Gaut, BS (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, 321 Steinhaus Hall, Irvine, CA 92697 USA.	bgaut@uci.edu	Ross-Ibarra, Jeffrey/D-7782-2011	Ross-Ibarra, Jeffrey/0000-0003-1656-4954				Aminetzach YT, 2005, SCIENCE, V309, P764, DOI 10.1126/science.1112699; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Borevitz JO, 2007, P NATL ACAD SCI USA, V104, P12057, DOI 10.1073/pnas.0705323104; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; GASNEUF T, 2006, GENOME BIOL, V7, pR13; Gaut BS, 2007, NAT REV GENET, V8, P77, DOI 10.1038/nrg1970; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Greilhuber J, 2006, PLANT BIOLOGY, V8, P770, DOI 10.1055/s-2006-924101; Hollister JD, 2007, MOL BIOL EVOL, V24, P2515, DOI 10.1093/molbev/msm197; Hudson ME, 2003, PLANT J, V34, P453, DOI 10.1046/j.1365-313X.2003.01741.x; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kliebenstein DJ, 2001, PLANT CELL, V13, P681, DOI 10.1105/tpc.13.3.681; Knight CA, 2005, ANN BOT-LONDON, V95, P177, DOI 10.1093/aob/mci011; LACOUR LF, 1978, PHILOS T ROY SOC B, V285, P61; Lockton S, 2005, TRENDS GENET, V21, P60, DOI 10.1016/j.tig.2004.11.013; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Ma JX, 2004, GENOME RES, V14, P860, DOI 10.1101/gr.1466204; Meagher TR, 2005, NEW PHYTOL, V168, P71, DOI 10.1111/j.1469-8137.2005.01527.x; Naito K, 2006, P NATL ACAD SCI USA, V103, P17620, DOI 10.1073/pnas.0605421103; Neafsey DE, 2004, MOL BIOL EVOL, V21, P2310, DOI 10.1093/molbev/msh243; RAYBURN AL, 1994, PLANT BREEDING, V112, P318, DOI 10.1111/j.1439-0523.1994.tb00690.x; RAYBURN AL, 1985, AM J BOT, V72, P1610, DOI 10.2307/2443312; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rizzon C, 2006, PLOS COMPUT BIOL, V2, P989, DOI 10.1371/journal.pcbi.0020115; Shoja V, 2006, MOL BIOL EVOL, V23, P2134, DOI 10.1093/molbev/msl085; Sutton T, 2007, SCIENCE, V318, P1446, DOI 10.1126/science.1146853; TORKAMANZEHI A, 1992, GENETICS, V131, P73; Wang W, 2006, PLANT CELL, V18, P1791, DOI 10.1105/tpc.106.041905; Wright SI, 2001, GENETICS, V158, P1279; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920	30	40	46	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					484	486		10.1126/science.1153586	http://dx.doi.org/10.1126/science.1153586			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436777				2022-12-24	WOS:000255249300036
J	Turner, BJ; Hollenbeak, CS; Weiner, M; Ten Have, T; Tang, SSK				Turner, Barbara J.; Hollenbeak, Christopher S.; Weiner, Mark; Ten Have, Thomas; Tang, Simon S. K.			Effect of unrelated comorbid conditions on hypertension management	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE; MULTIMORBIDITY; ADHERENCE; INERTIA	Background: Quality-of-care assessment at a single visit can be affected by whether a patient's comorbid conditions are related or unrelated to a specific measure. Objective: To examine the association of unrelated comorbid conditions with treatment of uncontrolled hypertension in primary care visits. Design: Examination of a database derived from electronic medical records collected during routine care of a cohort of primary care patients. Setting: 6 primary care practices in Philadelphia, Pennsylvania. Patients: 15459 patients with uncontrolled hypertension who made 70557 visits to 200 clinicians from January 2004 through December 2006. Measurements: Intensification of any anti hypertensive treatment before the next visit was assessed. Patient and clinician information were obtained from electronic medical records and administrative data. Unrelated comorbid conditions included 28 conditions, such as arthritis and emphysema, whereas related comorbid conditions included vascular diseases. Generalized estimating equation logistic regression models were used to adjust for patient, health care, and provider characteristics and for clustering. Variation in the effect of unrelated comorbid conditions was examined at the visit, patient, and provider level. Results: At study visits, patients had a mean of 2.2 (SD, 1.8) unrelated comorbid conditions. The adjusted odds of treatment intensification decreased with the number of unrelated comorbid conditions, from 0.85 (95% CI, 0.80 to 0.90) for 1 to 0.59 (CI, 0.51 to 0.69) for 7 or more versus none. The relationship between treatment intensification and unrelated comorbid conditions persisted at the visit, patient, and provider levels (P < 0.001). Limitations: The reasons for not intensifying treatments are unknown. The recorded blood pressure may be inaccurate. Physicians may vary in their recording of comorbid conditions. Conclusion: Patients with more unrelated comorbid conditions were less likely to have uncontrolled hypertension addressed at a visit. The effect of different types of comorbid conditions on meeting quality-of-care measures merits further investigation.	[Turner, Barbara J.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Pfizer, New York, NY USA; Penn State Coll Med, Hershey, PA USA	University of Pennsylvania; Pfizer; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Turner, BJ (corresponding author), Univ Penn, Sch Med, 1123 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	bturner@mail.med.upenn.edu	Hollenbeak, Christopher S./A-5309-2019	Hollenbeak, Christopher S./0000-0002-3362-814X; Ten Have, Thomas/0000-0003-0026-3073				Baldwin LM, 2006, MED CARE, V44, P745, DOI 10.1097/01.mlr.0000223475.70440.07; Berlowitz DR, 1998, MED CARE, V36, P928, DOI 10.1097/00005650-199806000-00015; Bokhour BG, 2006, J GEN INTERN MED, V21, P577, DOI 10.1111/j.1525-1497.2006.00397.x; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; *CTR MED MED SERV, PFS FED REG NOT; Durso SC, 2006, JAMA-J AM MED ASSOC, V295, P1935, DOI 10.1001/jama.295.16.1935; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Grant RW, 2004, DIABETIC MED, V21, P150, DOI 10.1111/j.1464-5491.2004.01095.x; Hayward RA, 2007, AM J MANAG CARE, V13, P126; Higashi T, 2007, NEW ENGL J MED, V356, P2496, DOI 10.1056/NEJMsa066253; Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836; Hyman DJ, 2001, NEW ENGL J MED, V345, P479, DOI 10.1056/NEJMoa010273; Kaboli PJ, 2004, AM J MANAG CARE, V10, P872; Kerr EA, 2001, AM J MANAG CARE, V7, P1033; LIANG KY, 1993, ANNU REV PUBL HEALTH, V14, P43, DOI 10.1146/annurev.pu.14.050193.000355; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; Min LC, 2007, MED CARE, V45, P480, DOI 10.1097/MLR.0b013e318030fff9; Okonofua EC, 2006, HYPERTENSION, V47, P345, DOI 10.1161/01.HYP.0000200702.76436.4b; Oliveria SA, 2002, ARCH INTERN MED, V162, P413, DOI 10.1001/archinte.162.4.413; Piette JD, 2006, DIABETES CARE, V29, P725, DOI 10.2337/diacare.29.03.06.dc05-2078; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Ritchie C, 2007, MED CARE, V45, P477, DOI 10.1097/MLR.0b013e318074d3c1; Rodondi N, 2006, ANN INTERN MED, V144, P475, DOI 10.7326/0003-4819-144-7-200604040-00006; Turner BJ, 2004, ANN INTERN MED, V140, P528, DOI 10.7326/0003-4819-140-7-200404060-00013; Vasan RS, 2005, ANN INTERN MED, V142, P393, DOI 10.7326/0003-4819-142-6-200503150-00005; Wang PS, 2005, HYPERTENSION, V46, P273, DOI 10.1161/01.HYP.0000172753.96583.e1; Werner RM, 2007, J GEN INTERN MED, V22, P1206, DOI 10.1007/s11606-007-0230-4; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635; Yelin E., 2007, Morbidity and Mortality Weekly Report, V56, P4	29	98	98	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 15	2008	148	8					578	586		10.7326/0003-4819-148-8-200804150-00002	http://dx.doi.org/10.7326/0003-4819-148-8-200804150-00002			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290LF	18413619				2022-12-24	WOS:000255123600002
J	Chokshi, DA; Kesselheim, AS				Chokshi, Dave A.; Kesselheim, Aaron S.			Rethinking global access to vaccines	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DEVELOPING-COUNTRIES; HUMAN-PAPILLOMAVIRUS; PUBLIC-HEALTH; ROTAVIRUS; EFFICACY; OPPORTUNITIES; IMMUNIZATION; TECHNOLOGY; CHALLENGES; SAFETY		[Chokshi, Dave A.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Kesselheim, Aaron S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA USA	University of Pennsylvania; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Chokshi, DA (corresponding author), Univ Penn, Sch Med, 3434 Sansom St, Philadelphia, PA 19104 USA.	daveash@med.upenn.edu	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Chokshi, Dave/0000-0001-7467-4591				AABY P, 1994, B WORLD HEALTH ORGAN, V72, P761; Agosti JM, 2007, NEW ENGL J MED, V356, P1908, DOI 10.1056/NEJMp078053; Alliance for Health Policy and Systems Research, 2004, STRENGTH HLTH SYST D; Basu S, 2006, NATURE, V440, P605, DOI 10.1038/440605d; Behforouz HL, 2004, CLIN INFECT DIS, V38, pS429, DOI 10.1086/421408; Birn AE, 2005, LANCET, V366, P514, DOI 10.1016/S0140-6736(05)66479-3; BLOOM DE, 2005, WORLD ECON, V6, P25; BROOKE S, 2006, HPV VACCINES REGULAT; Buekens P, 2004, JAMA-J AM MED ASSOC, V291, P2639, DOI 10.1001/jama.291.21.2639; Chokshi DA, 2007, JAMA-J AM MED ASSOC, V298, P1934, DOI 10.1001/jama.298.16.1934; Clemens J, 2005, NAT MED, V11, pS12, DOI 10.1038/nm1225; Cohen J, 2001, SCIENCE, V293, P1576, DOI 10.1126/science.293.5535.1576; Farmer P, 1998, BRIT MED J, V317, P671, DOI 10.1136/bmj.317.7159.671; *GAVI, 2005, GLOB VACC SUPPL CHAN; *GAVI ALL, 2007, ACC DEV INTR PRIOR N; *HIB IN, 2007, SER I IND OBT 1 EV I; Kim S-Y, 2007, B WORLD HEALTH ORGAN, V85, P821; KNOBLER S, 2002, CONSIDERATIONS VIRAL, P33; Madon T, 2007, SCIENCE, V318, P1728, DOI 10.1126/science.1150009; Mahmoud A, 2004, SCIENCE, V305, P147, DOI 10.1126/science.305.5681.147; *MED SANS FRONT, GIL TEN ACC PROGR DE; *MEN VACC PROJ, 2007, IMPR MEN VACC AFR CO; Milstlen JB, 2006, HEALTH AFFAIR, V25, P1061, DOI 10.1377/hlthaff.25.4.1061; Morel CM, 2005, SCIENCE, V309, P401, DOI 10.1126/science.1115538; Outterson K, 2008, HEALTH AFFAIR, V27, P130, DOI 10.1377/hlthaff.27.1.130; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; *PATH, 2006, CERV CANC VACC PROJ; Peny JM, 2005, VACCINE, V23, P4610, DOI 10.1016/j.vaccine.2005.04.044; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Salicrup LA, 2006, BIOTECHNOL ADV, V24, P69, DOI 10.1016/j.biotechadv.2005.06.004; Sanders D, 2006, PLOS MED, V3, P719, DOI 10.1371/journal.pmed.0030186; SEKHRI, 2006, FORECASTING GLOBAL H; SEN AK, 2003, VACCINE S2, V21, pS114; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization, 2004, REV GLOB BURD DIS 20; 2007, WHO WEEKLY EPIDEMIOL, V82, P285; 2007, ROTAVIRUS VACCINE PR	41	18	19	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 5	2008	336	7647					750	753		10.1136/bmj.39497.598044.BE	http://dx.doi.org/10.1136/bmj.39497.598044.BE			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284JW	18390526	Green Published			2022-12-24	WOS:000254703700030
J	Wagner, GP; Kenney-Hunt, JP; Pavlicev, M; Peck, JR; Waxman, D; Cheverud, JM				Wagner, Gunter P.; Kenney-Hunt, Jane P.; Pavlicev, Mihaela; Peck, Joel R.; Waxman, David; Cheverud, James M.			Pleiotropic scaling of gene effects and the 'cost of complexity'	NATURE			English	Article							QUANTITATIVE TRAIT LOCI; MUTATION-SELECTION BALANCE; MURINE GROWTH; MODULARITY; MICE; EVOLVABILITY; ARCHITECTURE; EVOLUTION	As perceived by Darwin, evolutionary adaptation by the processes of mutation and selection is difficult to understand for complex features that are the product of numerous traits acting in concert, for example the eye or the apparatus of flight. Typically, mutations simultaneously affect multiple phenotypic characters. This phenomenon is known as pleiotropy. The impact of pleiotropy on evolution has for decades been the subject of formal analysis(1-6). Some authors have suggested that pleiotropy can impede evolutionary progress ( a so- called 'cost of complexity'(5)). The plausibility of various phenomena attributed to pleiotropy depends on how many traits are affected by each mutation and on our understanding of the correlation between the number of traits affected by each gene substitution and the size of mutational effects on individual traits. Here we show, by studying pleiotropy in mice with the use of quantitative trait loci ( QTLs) affecting skeletal characters, that most QTLs affect a relatively small subset of traits and that a substitution at a QTL has an effect on each trait that increases with the total number of traits affected. This suggests that evolution of higher organisms does not suffer a 'cost of complexity' because most mutations affect few traits and the size of the effects does not decrease with pleiotropy.	[Wagner, Gunter P.] Yale Univ, Dept Ecol & Evolut Biol, New Haven, CT 06520 USA; [Kenney-Hunt, Jane P.; Pavlicev, Mihaela; Cheverud, James M.] Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Peck, Joel R.; Waxman, David] Univ Sussex, Sch Life Sci, Ctr Study Evolut, Brighton BN1 9QG, E Sussex, England	Yale University; Washington University (WUSTL); University of Sussex	Wagner, GP (corresponding author), Yale Univ, Dept Ecol & Evolut Biol, New Haven, CT 06520 USA.	gunter.wagner@yale.edu; cheverud@pcg.wustl.edu	; Pavlicev, Mihaela/O-4460-2015	Kenney-Hunt, Jane/0000-0002-4143-5022; Peck, Joel/0000-0003-0421-8739; Pavlicev, Mihaela/0000-0001-8439-9351; Wagner, Gunter/0000-0002-3097-002X				CHAI CK, 1956, GENETICS, V41, P165; Cheverud JM, 2001, MAMM GENOME, V12, P3, DOI 10.1007/s003350010218; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; Cheverud JM, 1996, GENETICS, V142, P1305; Ehrich TH, 2003, J EXP ZOOL PART B, V296B, P58, DOI 10.1002/jez.b.00009; Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113; Fisher R.A., 1930, GENETICAL THEORY NAT; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; Hansen TF, 2003, BIOSYSTEMS, V69, P83, DOI 10.1016/S0303-2647(02)00132-6; Hermisson J, 2004, GENETICS, V168, P2271, DOI 10.1534/genetics.104.029173; KENNEYHUNT JP, IN PRESS GENETICS; Knott SA, 2000, GENETICS, V156, P899; Martin G, 2006, EVOLUTION, V60, P893; Orr HA, 2000, EVOLUTION, V54, P13, DOI 10.1111/j.0014-3820.2000.tb00002.x; Rechenberg I., 1973, EVOLUTIONSSTRATEGIE; TURELLI M, 1985, GENETICS, V111, P165; Vaughn TT, 1999, GENET RES, V74, P313, DOI 10.1017/S0016672399004103; Waddington C., 1957, STRATEGY GENES; WAGNER GP, 1989, GENETICS, V122, P223; WAGNER GP, 1988, J EVOLUTION BIOL, V1, P45, DOI 10.1046/j.1420-9101.1988.1010045.x; Wagner GP, 1996, EVOLUTION, V50, P967, DOI 10.1111/j.1558-5646.1996.tb02339.x; Wagner GP, 2007, NAT REV GENET, V8, P921, DOI 10.1038/nrg2267; Waxman D, 1998, SCIENCE, V279, P1210, DOI 10.1126/science.279.5354.1210; Welch JJ, 2003, EVOLUTION, V57, P1723, DOI 10.1554/02-673; Wingreen NS, 2003, GENETICS, V164, P1221; Xu SZ, 2003, GENETICS, V165, P2259	26	160	162	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2008	452	7186					470	U9		10.1038/nature06756	http://dx.doi.org/10.1038/nature06756			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279FU	18368117				2022-12-24	WOS:000254341300031
J	Doll, D; Bowley, DM				Doll, Dietrich; Bowley, Douglas M.			Veterans' health-surviving acute injuries is not enough	LANCET			English	Editorial Material							TRAUMATIC BRAIN-INJURY; HOMELESS VETERANS; RECEIPT; IRAQ		[Doll, Dietrich; Bowley, Douglas M.] Charite Univ Med Berlin, Teaching Hosp, Mil Hosp Berlin, D-10115 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Doll, D (corresponding author), Charite Univ Med Berlin, Teaching Hosp, Mil Hosp Berlin, D-10115 Berlin, Germany.	ddoll@gmx.de	Doll, med. Dr. phil. Dietrich/H-6633-2019	Doll, med. Dr. phil. Dietrich/0000-0001-9832-4545				Adams J, 2007, J HEALTH CARE POOR U, V18, P173, DOI 10.1353/hpu.2007.0000; Chen JH, 2007, PSYCHIAT QUART, V78, P63, DOI 10.1007/s11126-006-9027-6; Cunningham M., 2007, VITAL MISSION ENDING; Dandeker C, 2006, ARMED FORCES SOC, V32, P161, DOI 10.1177/0095327X05279177; *DEP VET AFF, 2006, FACT SHEET VA SERV R; Greenberg G, 2007, MIL MED, V172, P461, DOI 10.7205/MILMED.172.5.461; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kaplan MS, 2007, J EPIDEMIOL COMMUN H, V61, P619, DOI 10.1136/jech.2006.054346; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; *NAT ALL END HOM, 2006, FACT CHECK VET HOM; PERL L, 2007, CRS REPORT C VET HOM; Sherer M, 2008, ARCH PHYS MED REHAB, V89, P42, DOI 10.1016/j.apmr.2007.08.128; Thoresen S, 2006, ARCH SUICIDE RES, V10, P353, DOI 10.1080/13811110600791106; ZOROYA G, 2008, 20 000 VETS BRAIN IN; 2007, LANCET, V370, P1879	15	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2008	371	9618					1053	1055		10.1016/S0140-6736(08)60465-1	http://dx.doi.org/10.1016/S0140-6736(08)60465-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280RA	18374826				2022-12-24	WOS:000254442700008
J	BRUNGER, AT				BRUNGER, AT			FREE R-VALUE - A NOVEL STATISTICAL QUANTITY FOR ASSESSING THE ACCURACY OF CRYSTAL-STRUCTURES	NATURE			English	Article							MOLECULAR-DYNAMICS; FACTOR REFINEMENT; PENICILLOPEPSIN; MINIMIZATION; RESOLUTION; ENERGY; 2.8-A	THE determination of macromolecular structure by crystallography involves fitting atomic models to the observed diffraction data 1. The traditional measure of the quality of this fit, and presumably the accuracy of the model, is the R value. Despite stereochemical restraints 2, it is possible to overfit or 'misfit' the diffraction data: an incorrect model can be refined to fairly good R values as several recent examples have shown 3. Here I propose a reliable and unbiased indicator of the accuracy of such models. By analogy with the cross-validation method 4,5 of testing statistical models I define a statistical quantity (R(T)free) that measures the agreement between observed and computed structure factor amplitudes for a 'test' set of reflections that is omitted in the modelling and refinement process. As examples show, there is a high correlation between R(T)free and the accuracy of the atomic model phases. This is useful because experimental phase information is usually inaccurate, incomplete or unavailable. I expect that R(T)free will provide a measure of the information content of recently proposed models of thermal motion and disorder 6-8, time-averaging 9 and bulk solvent 10.	YALE UNIV,DEPT MOLEC BIOPHYS & BIOCHEM,NEW HAVEN,CT 06511	Yale University	BRUNGER, AT (corresponding author), YALE UNIV,HOWARD HUGHES MED INST,NEW HAVEN,CT 06511, USA.			Brunger, Axel/0000-0001-5121-2036				BADGER J, 1991, P NATL ACAD SCI USA, V88, P622, DOI 10.1073/pnas.88.2.622; BRANDEN CI, 1990, NATURE, V343, P687, DOI 10.1038/343687a0; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUNGER AT, 1991, ANNU REV PHYS CHEM, V42, P197, DOI 10.1146/annurev.pc.42.100191.001213; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P585, DOI 10.1107/S0108767390002355; BRUNGER AT, 1988, J MOL BIOL, V203, P803, DOI 10.1016/0022-2836(88)90211-2; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; BRUNGER AT, 1990, X PLOR VERSION 21; CHAPMAN MS, 1988, SCIENCE, V241, P71, DOI 10.1126/science.3133767; CHEN GM, 1991, SCIENCE, V252, P1390; CURMI PA, IN PRESS J BIOL CHEM; DIAMOND R, 1990, ACTA CRYSTALLOGR A, V46, P425, DOI 10.1107/S0108767390002082; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; Ernst R. R., 1987, PRINCIPLES NUCL MAGN; GROS P, 1990, SCIENCE, V249, P1149, DOI 10.1126/science.2396108; HAMILTON WC, 1965, ACTA CRYSTALLOGR, V18, P502, DOI 10.1107/S0365110X65001081; HENDRICKSON WA, 1985, METHOD ENZYMOL, V115, P252; HSU IN, 1977, NATURE, V266, P140, DOI 10.1038/266140a0; JACK A, 1978, ACTA CRYSTALLOGR A, V34, P931, DOI 10.1107/S0567739478001904; JAMES MNG, 1983, J MOL BIOL, V163, P299, DOI 10.1016/0022-2836(83)90008-6; JENSEN LH, 1985, METHOD ENZYMOL, V115, P227; KONNERT JH, 1980, ACTA CRYSTALLOGR A, V36, P344, DOI 10.1107/S0567739480000794; KURIYAN J, 1991, PROTEINS, V10, P340, DOI 10.1002/prot.340100407; KURIYAN J, 1991, P NATL ACAD SCI USA, V88, P2773, DOI 10.1073/pnas.88.7.2773; Mosteller F., 1968, HDB SOC PSYCHOL, V2, P80; PRESS WH, 1986, NUMERICAL RECIPES, P498; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; STOUT GH, 1989, XRAY STRUCTURE DETER, P343; Wuthrich K., 1986, NMR PROTEINS NUCL AC	29	3858	3914	3	100	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JAN 30	1992	355	6359					472	475		10.1038/355472a0	http://dx.doi.org/10.1038/355472a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB530	18481394				2022-12-24	WOS:A1992HB53000078
J	Neumuller, RA; Betschinger, J; Fischer, A; Bushati, N; Poernbacher, I; Mechtler, K; Cohen, SM; Knoblich, JA				Neumueller, Ralph A.; Betschinger, Joerg; Fischer, Anja; Bushati, Natascha; Poernbacher, Ingrid; Mechtler, Karl; Cohen, Stephen M.; Knoblich, Juergen A.			Mei-P26 regulates microRNAs and cell growth in the Drosophila ovarian stem cell lineage	NATURE			English	Article							NEUROBLAST SELF-RENEWAL; RIBOSOMAL-RNA SYNTHESIS; ASYMMETRIC DIVISION; TUMOR-SUPPRESSOR; PROLIFERATION; MELANOGASTER; PROTEIN; CANCER; POLARITY; BRAIN	Drosophila neuroblasts(1) and ovarian stem cells(2,3) are well characterized models for stem cell biology. In both cell types, one daughter cell self- renews continuously while the other undergoes a limited number of divisions, stops to proliferate mitotically and differentiates. Whereas neuroblasts segregate the Trim - NHL( tripartite motif and Ncl- 1, HT2A and Lin- 41 domain)- containing protein Brain tumour ( Brat) into one of the two daughter cells(4-6), ovarian stem cells are regulated by an extracellular signal from the surrounding stem cell niche. After division, one daughter cell looses niche contact. It undergoes 4 transit- amplifying divisions to form a cyst of 16 interconnected cells that reduce their rate of growth and stop to proliferate mitotically. Here we show that the Trim - NHL protein Mei- P26 ( refs 7, 8) restricts growth and proliferation in the ovarian stem cell lineage. Mei- P26 expression is low in stem cells but is strongly induced in 16- cell cysts. In mei- P26 mutants, transit-amplifying cells are larger and proliferate indefinitely leading to the formation of an ovarian tumour. Like brat, mei- P26 regulates nucleolar size and can induce differentiation in Drosophila neuroblasts, suggesting that these genes act through the same pathway. We identify Argonaute- 1, a component of the RISC complex, as a common binding partner of Brat and Mei- P26, and show that Mei- P26 acts by inhibiting the microRNA pathway. Mei- P26 and Brat have a similar domain composition that is also found in other tumour suppressors and might be a defining property of a new family of microRNA regulators that act specifically in stem cell lineages.	[Neumueller, Ralph A.; Betschinger, Joerg; Fischer, Anja; Poernbacher, Ingrid; Mechtler, Karl; Knoblich, Juergen A.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Bushati, Natascha; Cohen, Stephen M.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Mechtler, Karl] Res Inst Mol Pathol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); European Molecular Biology Laboratory (EMBL); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Knoblich, JA (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Knoblich, Juergen A/C-2974-2015; Cohen, Stephen M/G-9930-2011; Mechtler, Karl/AAF-2717-2019	Knoblich, Juergen A/0000-0002-6751-3404; Cohen, Stephen M/0000-0003-2858-9163; Mechtler, Karl/0000-0002-3392-9946; Poernbacher, Ingrid/0000-0003-2766-9700; Betschinger, Joerg/0000-0002-2627-8479	Austrian Science Fund FWF [P 16629] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Chen DH, 2003, DEVELOPMENT, V130, P1159, DOI 10.1242/dev.00325; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Frank DJ, 2002, DEVELOPMENT, V129, P399; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Gilboa L, 2004, DEVELOPMENT, V131, P4895, DOI 10.1242/dev.01373; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Jin ZG, 2007, CURR BIOL, V17, P539, DOI 10.1016/j.cub.2007.01.050; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; LANTZ V, 1994, GENE DEV, V8, P598, DOI 10.1101/gad.8.5.598; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; LIN HF, 1994, DEVELOPMENT, V120, P947; Ohlmeyer JT, 2003, DEVELOPMENT, V130, P6339, DOI 10.1242/dev.00855; Page SL, 2000, GENETICS, V155, P1757; Park JK, 2007, CURR BIOL, V17, P533, DOI 10.1016/j.cub.2007.01.060; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Rudra D, 2004, GENE DEV, V18, P2431, DOI 10.1101/gad.1256704; Sekelsky JJ, 1999, GENETICS, V152, P529; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; Zaccai M, 1996, ZYGOTE, V4, P159, DOI 10.1017/S096719940000304X	28	169	173	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 10	2008	454	7201					241	U72		10.1038/nature07014	http://dx.doi.org/10.1038/nature07014			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18528333	Green Accepted			2022-12-24	WOS:000257466900049
J	Orlando, DA; Lin, CY; Bernard, A; Wang, JY; Socolar, JES; Iversen, ES; Hartemink, AJ; Haase, SB				Orlando, David A.; Lin, Charles Y.; Bernard, Allister; Wang, Jean Y.; Socolar, Joshua E. S.; Iversen, Edwin S.; Hartemink, Alexander J.; Haase, Steven B.			Global control of cell-cycle transcription by coupled CDK and network oscillators	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; DEPENDENT KINASE; NUCLEAR-LOCALIZATION; REGULATED GENES; YEAST; PHOSPHORYLATION; EXPRESSION; INHIBITOR; GENOME; PHASE	A significant fraction of the Saccharomyces cerevisiae genome is transcribed periodically during the cell division cycle(1,2), indicating that properly timed gene expression is important for regulating cell- cycle events. Genomic analyses of the localization and expression dynamics of transcription factors suggest that a network of sequentially expressed transcription factors could control the temporal programme of transcription during the cell cycle(3). However, directed studies interrogating small numbers of genes indicate that their periodic transcription is governed by the activity of cyclin- dependent kinases (CDKs)(4). To determine the extent to which the global cell- cycle transcription programme is controlled by cyclin - CDK complexes, we examined genome- wide transcription dynamics in budding yeast mutant cells that do not express S- phase and mitotic cyclins. Here we show that a significant fraction of periodic genes are aberrantly expressed in the cyclin mutant. Although cells lacking cyclins are blocked at the G1/S border, nearly 70% of periodic genes continued to be expressed periodically and on schedule. Our findings reveal that although CDKs have a function in the regulation of cell- cycle transcription, they are not solely responsible for establishing the global periodic transcription programme. We propose that periodic transcription is an emergent property of a transcription factor network that can function as a cell- cycle oscillator independently of, and in tandem with, the CDK oscillator.	[Orlando, David A.; Lin, Charles Y.; Wang, Jean Y.; Haase, Steven B.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Orlando, David A.] Duke Univ, Program Computat Biol & Bioinformat, Durham, NC 27708 USA; [Bernard, Allister; Hartemink, Alexander J.] Duke Univ, Dept Comp Sci, Durham, NC 27708 USA; [Socolar, Joshua E. S.] Duke Univ, Dept Phys, Durham, NC 27708 USA; [Iversen, Edwin S.] Duke Univ, Dept Stat Sci, Durham, NC 27708 USA	Duke University; Duke University; Duke University; Duke University; Duke University	Haase, SB (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	shaase@duke.edu	Socolar, Joshua/AAV-6822-2021	Socolar, Joshua/0000-0003-0532-7099; Haase, Steve/0000-0001-8127-8992	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081883] Funding Source: NIH RePORTER; NIGMS NIH HHS [P50 GM081883-030001, P50 GM081883, P50 GM081883-020001] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; de Bruin RAM, 2006, MOL CELL, V23, P483, DOI 10.1016/j.molcel.2006.06.025; de Lichtenberg U, 2005, BIOINFORMATICS, V21, P1164, DOI 10.1093/bioinformatics/bti093; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Haase SB, 1999, NATURE, V401, P394, DOI 10.1038/43930; Haase SB, 2001, NAT CELL BIOL, V3, P38, DOI 10.1038/35050543; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Ho W, 1999, MOL CELL BIOL, V19, P5267; Knapp D, 1996, MOL CELL BIOL, V16, P5701; Koch C, 1996, GENE DEV, V10, P129, DOI 10.1101/gad.10.2.129; Kumar R, 2000, CURR BIOL, V10, P896, DOI 10.1016/S0960-9822(00)00618-7; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; LEW DJ, 1993, J CELL BIOL, V120, P1305, DOI 10.1083/jcb.120.6.1305; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; O'Conallain C, 1999, MOL GEN GENET, V262, P275, DOI 10.1007/s004380051084; Orlando DA, 2007, CELL CYCLE, V6, P478, DOI 10.4161/cc.6.4.3859; Pic-Taylor A, 2004, MOL CELL BIOL, V24, P10036, DOI 10.1128/MCB.24.22.10036-10046.2004; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; SIDOROVA JM, 1995, MOL BIOL CELL, V6, P1641, DOI 10.1091/mbc.6.12.1641; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Toyn JH, 1997, GENETICS, V145, P85; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Wittenberg C, 2005, ONCOGENE, V24, P2746, DOI 10.1038/sj.onc.1208606; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581; Zwicker J, 1995, Prog Cell Cycle Res, V1, P91	32	215	216	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2008	453	7197					944	U78		10.1038/nature06955	http://dx.doi.org/10.1038/nature06955			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311WV	18463633	Green Accepted			2022-12-24	WOS:000256632000049
J	Okie, S				Okie, Susan			A new attack on malaria	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		DELACOLLETTE C, 2006, WHO PUBLICATION; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Kiszewski A, 2007, B WORLD HEALTH ORGAN, V85, P623, DOI 10.2471/BLT.06.039529; MCNEIL DG, 2008, GATES FDN INFLUENCE	4	13	14	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 5	2008	358	23					2425	2428		10.1056/NEJMp0803483	http://dx.doi.org/10.1056/NEJMp0803483			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	308HY	18525039				2022-12-24	WOS:000256380700001
J	Lee, JH; Lin, HW; Joo, S; Goodenough, U				Lee, Jae-Hyeok; Lin, Huawen; Joo, Sunjoo; Goodenough, Ursula			Early sexual origins of homeoprotein heterodimerization and evolution of the plant KNOX/BELL family	CELL			English	Article							MATING-TYPE LOCUS; KNOX GENE-FUNCTION; CHLAMYDOMONAS-REINHARDTII; HOMEODOMAIN PROTEIN; LAND PLANTS; NUCLEAR-LOCALIZATION; COMPARATIVE GENOMICS; MOLECULAR-GENETICS; DNA RECOGNITION; USTILAGO-MAYDIS	Developmental mechanisms that yield multicellular diversity are proving to be well conserved within lineages, generating interest in their origins in unicellular ancestors. We report that molecular regulation of the haploid-diploid transition in Chlamydomonas, a unicellular green soil alga, shares common ancestry with differentiation pathways in land plants. Two homeoproteins, Gsp1 and Gsm1, contributed by gametes of plus and minus mating types respectively, physically interact and translocate from the cytosol to the nucleus upon gametic fusion, initiating zygote development. Their ectopic expression activates zygote development in vegetative cells and, in a diploid background, the resulting zygotes undergo a normal meiosis. Gsm1/Gsp1 dyads share sequence homology with and are functionally related to KNOX/BELL dyads regulating stem-cell (meristem) specification in land plants. We propose that combinatorial homeoprotein-based transcriptional control, a core feature of the fungal/animal radiation, may have originated in a sexual context and enabled the evolution of land-plant body plans.	[Lee, Jae-Hyeok; Lin, Huawen; Joo, Sunjoo; Goodenough, Ursula] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Goodenough, U (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	ursula@biology.wustl.edu	Lin, Huawen/B-7768-2012; Lee, Jae-Hyeok/AAE-6736-2022	Lee, Jae-Hyeok/0000-0001-8993-1853				ARMBRUST EV, 1993, CELL, V74, P801, DOI 10.1016/0092-8674(93)90460-8; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; BALDAUF SL, 2003, PLANT CELL, V13, P2455; Bezanilla M, 2003, PLANT PHYSIOL, V133, P470, DOI 10.1104/pp.103.024901; Bhatt AA, 2004, GENE, V328, P103, DOI 10.1016/j.gene.2003.12.033; Bowman JL, 2007, CELL, V129, P229, DOI 10.1016/j.cell.2007.04.004; CAMPBELL AM, 1995, MOL BIOL CELL, V6, P87, DOI 10.1091/mbc.6.1.87; Chan RL, 1998, BBA-GENE STRUCT EXPR, V1442, P1, DOI 10.1016/S0167-4781(98)00119-5; Cole M, 2006, NUCLEIC ACIDS RES, V34, P1281, DOI 10.1093/nar/gkl016; Dacks J, 1999, J MOL EVOL, V48, P779, DOI 10.1007/PL00013156; Damante G, 1996, EMBO J, V15, P4992, DOI 10.1002/j.1460-2075.1996.tb00879.x; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; DePristo MA, 2006, GENE, V378, P19, DOI 10.1016/j.gene.2006.03.023; Derelle R, 2007, EVOL DEV, V9, P212, DOI 10.1111/j.1525-142X.2007.00153.x; DUTCHER SK, 1988, P NATL ACAD SCI USA, V85, P3946, DOI 10.1073/pnas.85.11.3946; EBERSOLD WT, 1967, SCIENCE, V157, P447, DOI 10.1126/science.157.3787.447; FERNANDEZ E, 1984, CURR GENET, V8, P635, DOI 10.1007/BF00395710; Ferris PJ, 1997, GENETICS, V146, P859; FERRIS PJ, 1994, CELL, V76, P1135, DOI 10.1016/0092-8674(94)90389-1; Ferris PJ, 2002, GENETICS, V160, P181; FERRIS PJ, 1987, MOL CELL BIOL, V7, P2360, DOI 10.1128/MCB.7.7.2360; Floyd SK, 2007, INT J PLANT SCI, V168, P1, DOI 10.1086/509079; GALLOWAY RE, 1985, GENETICS, V111, P447; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; GILLISSEN B, 1992, CELL, V68, P647, DOI 10.1016/0092-8674(92)90141-X; Goodenough U, 2007, SEMIN CELL DEV BIOL, V18, P350, DOI 10.1016/j.semcdb.2007.02.006; GOODENOUGH UW, 1995, ANNU REV PLANT PHYS, V46, P21; GOUTTE C, 1988, CELL, V52, P875, DOI 10.1016/0092-8674(88)90429-1; Graham LE, 2000, ALGAE; Hake S, 2004, ANNU REV CELL DEV BI, V20, P125, DOI 10.1146/annurev.cellbio.20.031803.093824; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hull CM, 2005, EUKARYOT CELL, V4, P526, DOI 10.1128/EC.4.3.526-535.2005; Karol KG, 2001, SCIENCE, V294, P2351, DOI 10.1126/science.1065156; Kenrick P., 1997, ORIGIN EARLY DIVERSI; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Knoepfler PS, 1997, P NATL ACAD SCI USA, V94, P14553, DOI 10.1073/pnas.94.26.14553; Krusell L, 1997, FEBS LETT, V408, P25, DOI 10.1016/S0014-5793(97)00382-7; KUES U, 1992, GENE DEV, V6, P568, DOI 10.1101/gad.6.4.568; Kurvari V, 1998, J CELL BIOL, V143, P1971, DOI 10.1083/jcb.143.7.1971; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Lin H, 2007, GENETICS, V176, P913, DOI 10.1534/genetics.106.066167; Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243; Meisel L, 1996, PLANT MOL BIOL, V30, P1, DOI 10.1007/BF00017799; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Meyerowitz EM, 2002, SCIENCE, V295, P1482, DOI 10.1126/science.1066609; MINAMI SA, 1978, J CELL BIOL, V77, P165, DOI 10.1083/jcb.77.1.165; Muller J, 2001, PLANT J, V27, P13, DOI 10.1046/j.1365-313x.2001.01064.x; Nam J, 2005, MOL BIOL EVOL, V22, P2386, DOI 10.1093/molbev/msi229; PASQUALE SM, 1987, J CELL BIOL, V105, P2279, DOI 10.1083/jcb.105.5.2279; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; SAKAKIBARA K, 2008, EVOL DEV IN PRESS, V10; Sano R, 2005, EVOL DEV, V7, P69, DOI 10.1111/j.1525-142X.2005.05008.x; Saupe SJ, 2000, MICROBIOL MOL BIOL R, V64, P489, DOI 10.1128/MMBR.64.3.489-502.2000; Scofield S, 2006, PLANT MOL BIOL, V60, P929, DOI 10.1007/s11103-005-4478-y; Shiu SH, 2005, PLANT PHYSIOL, V139, P18, DOI 10.1104/pp.105.065110; SINGER SD, 2007, PLANT CELL REP, V28, P28; Smith HMS, 2002, P NATL ACAD SCI USA, V99, P9579, DOI 10.1073/pnas.092271599; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stevens KE, 2007, GENETICS, V175, P1625, DOI 10.1534/genetics.106.066449; Uchida H, 1999, CURR GENET, V36, P232, DOI 10.1007/s002940050495; UCHIDA H, 1993, CURR GENET, V24, P296, DOI 10.1007/BF00336779; Urban M, 1996, MOL GEN GENET, V251, P31; VANWINKLESWIFT KP, 1977, J PHYCOL, V13, P225; Viola IL, 2006, BIOL CHEM, V387, P31, DOI 10.1515/BC.2006.006; WEGENER D, 1991, PLANT MOL BIOL, V16, P937, DOI 10.1007/BF00016066; WILLER M, 1995, MOL CELL BIOL, V15, P4964; Zhao H, 2001, GENE DEV, V15, P2767, DOI 10.1101/gad.919501	73	133	137	0	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 30	2008	133	5					829	840		10.1016/j.cell.2008.04.028	http://dx.doi.org/10.1016/j.cell.2008.04.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	306UY	18510927	Bronze			2022-12-24	WOS:000256274500015
J	Djulbegovic, B; Kumar, A				Djulbegovic, Benjamin; Kumar, Ambuj			Multiple myeloma: detecting the effects of new treatments	LANCET			English	Editorial Material							LENALIDOMIDE PLUS DEXAMETHASONE; ELDERLY-PATIENTS; PHASE-III; THALIDOMIDE; BORTEZOMIB; PREDNISONE; MELPHALAN; TRIAL; TRANSPLANTATION; CHEMOTHERAPY		[Djulbegovic, Benjamin] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Div Hematol Malignancies, Tampa, FL 33612 USA; [Kumar, Ambuj] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Hlth Outcomes & Behav, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Djulbegovic, B (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Div Hematol Malignancies, Tampa, FL 33612 USA.	benjamin.djulbegovic@moffitt.org	Kumar, Ambuj/I-4940-2012; Djulbegovic, Benjamin/I-3661-2012; Kumar, Ambuj/U-5268-2019; KUMAR, ASHOK/AAF-4055-2021	Djulbegovic, Benjamin/0000-0003-0671-1447; KUMAR, ASHOK/0000-0002-9244-0622				[Anonymous], 1998, J Clin Oncol, V16, P3832; Attal M, 1996, NEW ENGL J MED, V335, P91, DOI 10.1056/NEJM199607113350204; Dimopoulos M, 2007, NEW ENGL J MED, V357, P2123, DOI 10.1056/NEJMoa070594; Djulbegovic B, 2001, ANN ONCOL, V12, P1611, DOI 10.1023/A:1013181331874; Facon T, 2007, LANCET, V370, P1209, DOI 10.1016/S0140-6736(07)61537-2; Hulin C, 2007, J CLIN ONCOL, V25; Kristinsson SY, 2007, J CLIN ONCOL, V25, P1993, DOI 10.1200/JCO.2006.09.0100; Kumar A, 2007, HAEMATOL-HEMATOL J, V92, P208; Kumar A, 2003, LANCET ONCOL, V4, P293, DOI 10.1016/S1470-2045(03)01077-5; Kumar A, 2006, CLIN EVID, V15, P1; Orlowski RZ, 2007, J CLIN ONCOL, V25, P3892, DOI 10.1200/JCO.2006.10.5460; Orlowski RZ, 2002, J CLIN ONCOL, V20, P4420, DOI 10.1200/JCO.2002.01.133; Palumbo A, 2006, LANCET, V367, P825, DOI 10.1016/S0140-6736(06)68338-4; Rajkumar SV, 2007, J CLIN ONCOL, V25; Rajkumar SV, 2006, J CLIN ONCOL, V24, P431, DOI 10.1200/JCO.2005.03.0221; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Weber DM, 2007, NEW ENGL J MED, V357, P2133, DOI 10.1056/NEJMoa070596	18	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 17	2008	371	9625					1642	1644		10.1016/S0140-6736(08)60704-7	http://dx.doi.org/10.1016/S0140-6736(08)60704-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302XB	18486726				2022-12-24	WOS:000256002200006
J	Cardinale, CJ; Washburn, RS; Tadigotla, VR; Brown, LM; Gottesman, ME; Nudler, E				Cardinale, Christopher J.; Washburn, Robert S.; Tadigotla, Vasisht R.; Brown, Lewis M.; Gottesman, Max E.; Nudler, Evgeny			Termination factor Rho and its cofactors NusA and NusG silence foreign DNA in E-coli	SCIENCE			English	Article							DEPENDENT TRANSCRIPTION TERMINATION; COMPLETE GENOME SEQUENCE; LAMBDA N PROTEIN; BACTERIOPHAGE-LAMBDA; RNA-POLYMERASE; REQUIREMENT; BINDING; BICYCLOMYCIN; SALMONELLA; EXPRESSION	Transcription of the bacterial genome by the RNA polymerase must terminate at specific points. Transcription can be terminated by Rho factor, an essential protein in enterobacteria. We used the antibiotic bicyclomycin, which inhibits Rho, to assess its role on a genome-wide scale. Rho is revealed as a global regulator of gene expression that matches Escherichia coli transcription to translational needs. We also found that genes in E. coli that are most repressed by Rho are prophages and other horizontally acquired portions of the genome. Elimination of these foreign DNA elements increases resistance to bicyclomycin. Although rho remains essential, such reduced-genome bacteria no longer require Rho cofactors NusA and NusG. Deletion of the cryptic rac prophage in wild-type E. coli increases bicyclomycin resistance and permits deletion of nusG. Thus, Rho termination, supported by NusA and NusG, is required to suppress the toxic activity of foreign genes.	[Washburn, Robert S.; Gottesman, Max E.] Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA; [Cardinale, Christopher J.; Nudler, Evgeny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Tadigotla, Vasisht R.] Rutgers State Univ, BioMaPS Inst Quantitat Biol, Piscataway, NJ 08854 USA; [Brown, Lewis M.] Columbia Univ, Comparat Proteom Ctr, Dept Biol Sci, New York, NY 10027 USA; [Gottesman, Max E.] Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; New York University; Rutgers State University New Brunswick; Columbia University; Columbia University	Gottesman, ME (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA.	meg8@columbia.edu; evgeny.nudler@med.nyu.edu	Cardinale, Christopher J./G-3351-2013	Cardinale, Christopher J./0000-0001-7513-8977; Nudler, Evgeny/0000-0002-8811-3071	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058750, R01GM037219, R01GM072814] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM72814, R01 GM037219, R01 GM058750, R01 GM37219, R01 GM072814, R01 GM58750] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADHYA S, 1978, ANNU REV BIOCHEM, V47, P967, DOI 10.1146/annurev.bi.47.070178.004535; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Browne RJ, 2005, J BIOL CHEM, V280, P13292, DOI 10.1074/jbc.M500221200; Ciampi MS, 2006, MICROBIOL-SGM, V152, P2515, DOI 10.1099/mic.0.28982-0; COURT D, 1980, J MOL BIOL, V138, P231, DOI 10.1016/0022-2836(80)90285-5; DAS A, 1976, P NATL ACAD SCI USA, V73, P1959, DOI 10.1073/pnas.73.6.1959; GEISELMANN J, 1993, P NATL ACAD SCI USA, V90, P7754, DOI 10.1073/pnas.90.16.7754; Glasner JD, 2008, NUCLEIC ACIDS RES, V36, pD519, DOI 10.1093/nar/gkm973; HART CM, 1991, J BIOL CHEM, V266, P24140; Kolisnychenko V, 2002, GENOME RES, V12, P640, DOI 10.1101/gr.217202; Lesnik EA, 2001, NUCLEIC ACIDS RES, V29, P3583, DOI 10.1093/nar/29.17.3583; Mah TF, 1999, MOL MICROBIOL, V34, P523, DOI 10.1046/j.1365-2958.1999.01618.x; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Nudler E, 2002, GENES CELLS, V7, P755, DOI 10.1046/j.1365-2443.2002.00563.x; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; PLATT T, 1994, MOL MICROBIOL, V11, P983, DOI 10.1111/j.1365-2958.1994.tb00376.x; PLATT T, 1986, ANNU REV BIOCHEM, V55, P339, DOI 10.1146/annurev.bi.55.070186.002011; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Richardson JP, 2003, CELL, V114, P157, DOI 10.1016/S0092-8674(03)00554-3; Richardson LV, 1996, J BIOL CHEM, V271, P21597, DOI 10.1074/jbc.271.35.21597; Rivard CJ, 2007, J BIOL CHEM, V282, P6644, DOI 10.1074/jbc.M609432200; ROBERTS JW, 1969, NATURE, V224, P1168, DOI 10.1038/2241168a0; SCHMIDT MC, 1984, J BIOL CHEM, V259, P5000; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; STEWART V, 1986, J BACTERIOL, V166, P217, DOI 10.1128/jb.166.1.217-223.1986; SULLIVAN SL, 1992, CELL, V68, P989, DOI 10.1016/0092-8674(92)90041-A; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vincent F, 2000, BIOCHEMISTRY-US, V39, P9077, DOI 10.1021/bi000504+; Washburn RS, 2003, J MOL BIOL, V329, P655, DOI 10.1016/S0022-2836(03)00465-0; Zhou Y, 2002, J BACTERIOL, V184, P3416, DOI 10.1128/JB.184.12.3416-3418.2002; ZWIEFKA A, 1993, BIOCHEMISTRY-US, V32, P3564, DOI 10.1021/bi00065a007	33	211	216	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2008	320	5878					935	938		10.1126/science.1152763	http://dx.doi.org/10.1126/science.1152763			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18487194	Green Accepted			2022-12-24	WOS:000255868300043
J	O'Manique, C; Labonte, R				O'Manique, Colleen; Labonte, Ronald			Rethinking (Product) RED	LANCET			English	Editorial Material									[Labonte, Ronald] Univ Ottawa, Inst Populat Hlth, Dept Epidemiol & Community Med, Ottawa, ON K1N 6N5, Canada; [O'Manique, Colleen] Trent Univ, Peterborough, ON K9J 7B8, Canada	University of Ottawa; Trent University	Labonte, R (corresponding author), Univ Ottawa, Inst Populat Hlth, Dept Epidemiol & Community Med, Ottawa, ON K1N 6N5, Canada.	rlabonte@uottawa.ca	Labonte, Ronald/G-4229-2011					Bond P, 2007, INT J HEALTH SERV, V37, P171, DOI 10.2190/UK65-4235-N866-3R34; DIAMOND J, 2008, NY TIMES        0102; LABONTE R, 2004, FATAL INDIFFERENCE G; OManique C, 2004, INT POLIT ECON SER, P1, DOI 10.1057/9780230504080; 2006, LANCET, V368, P423; 2007, VANITY FAIR      JUL, P32	6	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 10	2008	371	9624					1561	1563		10.1016/S0140-6736(08)60671-6	http://dx.doi.org/10.1016/S0140-6736(08)60671-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298VO	18468531				2022-12-24	WOS:000255715400009
J	Lam, FH; Steger, DJ; O'Shea, EK				Lam, Felix H.; Steger, David J.; O'Shea, Erin K.			Chromatin decouples promoter threshold from dynamic range	NATURE			English	Article							TRANSCRIPTION FACTOR PHO4; CYCLIN-CDK COMPLEX; SACCHAROMYCES-CEREVISIAE; IN-VIVO; TARGET SITE; NUCLEOSOME; YEAST; BINDING; ACTIVATION; ELEMENTS	Chromatin influences gene expression by restricting access of DNA binding proteins to their cognate sites in the genome(1-3). Large- scale characterization of nucleosome positioning in Saccharomyces cerevisiae has revealed a stereotyped promoter organization in which a nucleosome- free region ( NFR) is present within several hundred base pairs upstream of the translation start site(4,5). Many transcription factors bind within NFRs and nucleate chromatin remodelling events which then expose other cis- regulatory elements(6-9). However, it is not clear how transcription- factor binding and chromatin influence quantitative attributes of gene expression. Here we show that nucleosomes function largely to decouple the threshold of induction from dynamic range. With a series of variants of one promoter, we establish that the affinity of exposed binding sites is a primary determinant of the level of physiological stimulus necessary for substantial gene activation, and sites located within nucleosomal regions serve to scale expression once chromatin is remodelled. Furthermore, we find that the S. cerevisiae phosphate response ( PHO) pathway exploits these promoter designs to tailor gene expression to different environmental phosphate levels. Our results suggest that the interplay of chromatin and binding- site affinity provides a mechanism for fine-tuning responses to the same cellular state. Moreover, these findings may be a starting point for more detailed models of eukaryotic transcriptional control.	[Lam, Felix H.; Steger, David J.; O'Shea, Erin K.] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Dept Mol & Cellular Biol,Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Lam, Felix H.; Steger, David J.; O'Shea, Erin K.] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Dept Chem & Chem Biol,Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Lam, Felix H.] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94158 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Howard Hughes Medical Institute; University of California System; University of California San Francisco	O'Shea, EK (corresponding author), Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Dept Mol & Cellular Biol,Howard Hughes Med Inst, 7 Divin Ave,Bauer 307, Cambridge, MA 02138 USA.	erin_oshea@harvard.edu		Lam, Felix/0000-0001-6585-3360	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM051377, R01 GM051377-15] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051377] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adkins MW, 2006, MOL CELL, V21, P405, DOI 10.1016/j.molcel.2005.12.010; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; BARBARIC S, 1992, NUCLEIC ACIDS RES, V20, P1031, DOI 10.1093/nar/20.5.1031; Barbaric S, 1998, MOL CELL BIOL, V18, P2629, DOI 10.1128/MCB.18.5.2629; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Buck MJ, 2006, NAT GENET, V38, P1446, DOI 10.1038/ng1917; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; Dhasarathy A, 2005, MOL CELL BIOL, V25, P2698, DOI 10.1128/MCB.25.7.2698-2707.2005; FISHER F, 1992, EMBO J, V11, P4103, DOI 10.1002/j.1460-2075.1992.tb05503.x; KAFFMAN A, 1994, SCIENCE, V263, P1153, DOI 10.1126/science.8108735; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Komeili A, 1999, SCIENCE, V284, P977, DOI 10.1126/science.284.5416.977; Korber P, 2004, MOL CELL BIOL, V24, P10965, DOI 10.1128/MCB.24.24.10965-10974.2004; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Liu X, 2006, GENOME RES, V16, P1517, DOI 10.1101/gr.5655606; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Magbanua JPV, 1997, YEAST, V13, P1299, DOI 10.1002/(SICI)1097-0061(199711)13:14<1299::AID-YEA178>3.0.CO;2-A; Miller JA, 2003, MOL CELL BIOL, V23, P1623, DOI 10.1128/MCB.23.5.1623-1632.2003; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; OGAWA N, 1994, PHOSPHATE IN MICROORGANISMS, P56; Ogawa N, 1995, MOL GEN GENET, V249, P406, DOI 10.1007/BF00287102; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Shimizu T, 1997, EMBO J, V16, P4689, DOI 10.1093/emboj/16.15.4689; Springer M, 2003, PLOS BIOL, V1, P261, DOI 10.1371/journal.pbio.0000028; SVAREN J, 1994, EMBO J, V13, P4856, DOI 10.1002/j.1460-2075.1994.tb06812.x; Thomas MR, 2005, P NATL ACAD SCI USA, V102, P9565, DOI 10.1073/pnas.0501122102; VENTER U, 1994, EMBO J, V13, P4848, DOI 10.1002/j.1460-2075.1994.tb06811.x; VOGEL K, 1989, MOL CELL BIOL, V9, P2050, DOI 10.1128/MCB.9.5.2050; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	34	192	194	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2008	453	7192					246	U16		10.1038/nature06867	http://dx.doi.org/10.1038/nature06867			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297BP	18418379	Green Accepted, Bronze			2022-12-24	WOS:000255592400045
J	Lakkaraju, AKK; Mary, C; Scherrer, A; Johnson, AE; Strub, K				Lakkaraju, Asvin K. K.; Mary, Camille; Scherrer, Anne; Johnson, Arthur E.; Strub, Katharina			SRP keeps polypeptides translocation-competent by slowing translation to match limiting ER-targeting sites	CELL			English	Article							SIGNAL-RECOGNITION-PARTICLE; ENDOPLASMIC-RETICULUM MEMBRANE; SECRETORY PROTEIN TRANSLOCATION; ELONGATION ARREST; ALU-DOMAIN; MICROSOMAL-MEMBRANES; BINDING-PROTEIN; SRP9/14 SUBUNIT; IN-VIVO; RIBOSOME	SRP is essential for targeting nascent chains to the endoplasmic reticulum, and it delays nascent chain elongation in cell-free translation systems. However, the significance of this function has remained unclear. We show that efficient protein translocation into the ER is incompatible with normal cellular translation rates due to rate-limiting concentrations of SRP receptor (SR). We complemented mammalian cells depleted of SRP14 by expressing mutant versions of the protein lacking the elongation arrest function. The absence of a delay caused inefficient targeting of preproteins leading to defects in secretion, depletion of proteins in the endogenous membranes, and reduced cell growth. The detrimental effects were reversed by either reducing the cellular protein synthesis rate or increasing SR expression. SRP therefore ensures that nascent chains remain translocation competent during the targeting time window dictated by SR. Since SRP-signal sequence affinities vary, the delay may also regulate which proteins are preferentially targeted.	[Lakkaraju, Asvin K. K.; Mary, Camille; Scherrer, Anne; Strub, Katharina] Univ Geneva, Dept Biol Cellulaire, CH-1211 Geneva, Switzerland; [Johnson, Arthur E.] Texas A&M Univ Syst Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77840 USA	University of Geneva; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Strub, K (corresponding author), Univ Geneva, Dept Biol Cellulaire, CH-1211 Geneva, Switzerland.	strub@cellbio.unige.ch	Johnson, Arthur E/G-3457-2012	Lakkaraju, Asvin/0000-0001-8752-148X	NIGMS NIH HHS [R01GM26494, R01 GM026494-28, R01 GM026494] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026494] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alder NN, 2004, J BIOL CHEM, V279, P22787, DOI 10.1074/jbc.R400002200; Blau M, 2005, NAT STRUCT MOL BIOL, V12, P1015, DOI 10.1038/nsmb998; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Bovia F, 1997, NUCLEIC ACIDS RES, V25, P318, DOI 10.1093/nar/25.2.318; BOVIA F, 1995, MOL BIOL CELL, V6, P471, DOI 10.1091/mbc.6.4.471; CONNOLLY T, 1991, SCIENCE, V252, P1171, DOI 10.1126/science.252.5009.1171; CONNOLLY T, 1986, J CELL BIOL, V103, P2253, DOI 10.1083/jcb.103.6.2253; Dudek J, 2005, NAT STRUCT MOL BIOL, V12, P1008, DOI 10.1038/nsmb1007; Flanagan JJ, 2003, J BIOL CHEM, V278, P18628, DOI 10.1074/jbc.M300173200; GILMORE R, 1982, J CELL BIOL, V95, P463, DOI 10.1083/jcb.95.2.463; Goder V, 2000, EMBO J, V19, P6704, DOI 10.1093/emboj/19.24.6704; Guth S, 2004, EUR J BIOCHEM, V271, P3200, DOI 10.1111/j.1432-1033.2004.04252.x; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; HARE JF, 1990, BIOCHIM BIOPHYS ACTA, V1031, P71, DOI 10.1016/0304-4157(90)90003-U; HAUSER S, 1995, EMBO J, V14, P5485, DOI 10.1002/j.1460-2075.1995.tb00235.x; Huck L, 2004, NUCLEIC ACIDS RES, V32, P4915, DOI 10.1093/nar/gkh837; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Lakkaraju AKK, 2007, EXP CELL RES, V313, P834, DOI 10.1016/j.yexcr.2006.12.003; LIPP J, 1987, J BIOL CHEM, V262, P1680; Liu L, 2003, J BIOL CHEM, V278, P18271, DOI 10.1074/jbc.M209215200; Lustig Y, 2005, J CELL SCI, V118, P4551, DOI 10.1242/jcs.02578; Mason N, 2000, EMBO J, V19, P4164, DOI 10.1093/emboj/19.15.4164; MEYER DI, 1982, NATURE, V297, P647, DOI 10.1038/297647a0; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; OGG SC, 1995, CELL, V81, P1075, DOI 10.1016/S0092-8674(05)80012-1; OKUN MM, 1992, J BIOL CHEM, V267, P11476; Pool MR, 2005, MOL MEMBR BIOL, V22, P3, DOI 10.1080/09687860400026348; Powers T, 1996, CURR BIOL, V6, P331, DOI 10.1016/S0960-9822(02)00484-0; RAPOPORT TA, 1987, J MOL BIOL, V195, P621, DOI 10.1016/0022-2836(87)90186-0; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Raue U, 2007, J BIOL CHEM, V282, P7809, DOI 10.1074/jbc.M611436200; RUTLEDGE EA, 1991, J BIOL CHEM, V266, P21125; Schaletzky J, 2006, MOL BIOL CELL, V17, P3860, DOI 10.1091/mbc.e06-05-0439; Shan SO, 2004, PLOS BIOL, V2, P1572, DOI 10.1371/journal.pbio.0020320; SIEGEL V, 1986, NATURE, V320, P81, DOI 10.1038/320081a0; SIEGEL V, 1985, J CELL BIOL, V100, P1913, DOI 10.1083/jcb.100.6.1913; Terzi L, 2004, BIOCHEMISTRY-US, V43, P107, DOI 10.1021/bi0353777; Thomas Y, 1997, NUCLEIC ACIDS RES, V25, P1920, DOI 10.1093/nar/25.10.1920; WALTER P, 1981, J CELL BIOL, V91, P557, DOI 10.1083/jcb.91.2.557; Weichenrieder O, 2000, NATURE, V408, P167, DOI 10.1038/35041507; WIEDMANN M, 1987, J CELL BIOL, V104, P201, DOI 10.1083/jcb.104.2.201; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; WOLIN SL, 1989, J CELL BIOL, V109, P2617, DOI 10.1083/jcb.109.6.2617; WOLIN SL, 1993, J CELL BIOL, V121, P1211, DOI 10.1083/jcb.121.6.1211	45	92	94	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2008	133	3					440	451		10.1016/j.cell.2008.02.049	http://dx.doi.org/10.1016/j.cell.2008.02.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455985	Green Accepted, Bronze			2022-12-24	WOS:000255503900015
J	Taylor, IW; Wrana, JL				Taylor, Ian W.; Wrana, Jeffrey L.			SnapShot: The TGF beta pathway interactome	CELL			English	Editorial Material							CELL-MEMBRANE; NUCLEUS		[Taylor, Ian W.; Wrana, Jeffrey L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Taylor, IW (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.		Wrana, Jeffrey/F-8857-2013					Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Huse M, 2001, MOL CELL, V8, P671, DOI 10.1016/S1097-2765(01)00332-X; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; LAIHO M, 1992, Critical Reviews in Oncogenesis, V3, P1; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; ROBERTS AB, 1981, P NATL ACAD SCI-BIOL, V78, P5339, DOI 10.1073/pnas.78.9.5339; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X	9	37	38	1	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 18	2008	133	2							378.e1	10.1016/j.cell.2008.04.007	http://dx.doi.org/10.1016/j.cell.2008.04.007			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	289JY	18423207	Bronze			2022-12-24	WOS:000255052000027
J	Malanchi, I; Peinado, H; Kassen, D; Hussenet, T; Metzger, D; Chambon, P; Huber, M; Hohl, D; Cano, A; Birchmeier, W; Huelsken, J				Malanchi, Ilaria; Peinado, Hector; Kassen, Deepika; Hussenet, Thomas; Metzger, Daniel; Chambon, Pierre; Huber, Marcel; Hohl, Daniel; Cano, Amparo; Birchmeier, Walter; Huelsken, Joerg			Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling	NATURE			English	Article							HAIR FOLLICLE BULGE; SKIN TUMORS; EXPRESSION; GENE; DIFFERENTIATION; EPIDERMIS; MUTATION; RAS; TUMORIGENESIS; POPULATIONS	Continuous turnover of epithelia is ensured by the extensive self-renewal capacity of tissue- specific stem cells(1). Similarly, epithelial tumour maintenance relies on cancer stem cells ( CSCs), which co-opt stem cell properties(2). For most tumours, the cellular origin of these CSCs and regulatory pathways essential for sustaining stemness have not been identified. In murine skin, follicular morphogenesis is driven by bulge stem cells that specifically express CD34. Here we identify a population of cells in early epidermal tumours characterized by phenotypic and functional similarities to normal bulge skin stem cells. This population contains CSCs, which are the only cells with tumour initiation properties. Transplants derived from these CSCs preserve the hierarchical organization of the primary tumour. We describe beta-catenin signalling(3) as being essential in sustaining the CSC phenotype. Ablation of the beta-catenin gene results in the loss of CSCs and complete tumour regression. In addition, we provide evidence for the involvement of increased beta-catenin signalling in malignant human squamous cell carcinomas. Because Wnt/beta-catenin signalling is not essential for normal epidermal homeostasis, such a mechanistic difference may thus be targeted to eliminate CSCs(4) and consequently eradicate squamous cell carcinomas.	[Malanchi, Ilaria; Kassen, Deepika; Hussenet, Thomas; Huelsken, Joerg] EPFL, ISREC Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland; [Malanchi, Ilaria; Kassen, Deepika; Hussenet, Thomas; Huelsken, Joerg] NCCR Mol Oncol, CH-1066 Epalinges, Switzerland; [Peinado, Hector; Cano, Amparo] UAM, CSIC, Dept Bioquim, Inst Invest Biomed Alberto Sols, Madrid 28029, Spain; [Metzger, Daniel; Chambon, Pierre] CU Strasbourg, IGBMC, F-67404 Illkirch Graffenstaden, France; [Huber, Marcel; Hohl, Daniel] CHU Vaudois, Lab Cutaneous Biol Dermatol, CH-1011 Lausanne, Switzerland; [Huber, Marcel; Hohl, Daniel] FBM UNIL, CH-1011 Lausanne, Switzerland; [Birchmeier, Walter] Max Delbruck Ctr Mol Med, D-13122 Berlin, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Huelsken, J (corresponding author), EPFL, ISREC Swiss Inst Expt Canc Res, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	joerg.huelsken@epfl.ch	Huber, Marcel/M-8822-2016; Hohl, Daniel M/N-7554-2016; Peinado, Hector/A-6417-2013; Huelsken, Joerg/AAC-9581-2021	Huber, Marcel/0000-0003-3821-2378; Peinado, Hector/0000-0002-4256-3413; Huelsken, Joerg/0000-0003-3105-9606; Metzger, Daniel/0000-0002-5555-046X				Al-Hajj M, 2004, CURR OPIN GENET DEV, V14, P43, DOI 10.1016/j.gde.2003.11.007; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Brasanac D, 2005, BRIT J DERMATOL, V153, P1166, DOI 10.1111/j.1365-2133.2005.06898.x; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; Doglioni C, 2003, AM J PATHOL, V163, P2277, DOI 10.1016/S0002-9440(10)63585-7; GASPAR C, UNPUB NATURE; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; LEDER A, 1990, P NATL ACAD SCI USA, V87, P9178, DOI 10.1073/pnas.87.23.9178; Li M, 2000, NATURE, V407, P633, DOI 10.1038/35036595; Lichti U, 1993, J INVEST DERMATOL, V101, P124; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mackenzie IC, 1997, J INVEST DERMATOL, V109, P377, DOI 10.1111/1523-1747.ep12336255; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Morris RJ, 2000, J CLIN INVEST, V106, P3, DOI 10.1172/JCI10508; Niemann C, 2002, DEVELOPMENT, V129, P95; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Papadavid E, 2002, J PATHOL, V196, P154, DOI 10.1002/path.1019; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Oskarsson T, 2006, GENE DEV, V20, P2024, DOI 10.1101/gad.381206; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Trempus CS, 2007, CANCER RES, V67, P4173, DOI 10.1158/0008-5472.CAN-06-3128; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865	32	467	504	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 3	2008	452	7187					650	U12		10.1038/nature06835	http://dx.doi.org/10.1038/nature06835			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282KR	18385740				2022-12-24	WOS:000254567200050
J	Richards, T				Richards, Tessa			Purely medicinal?	BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com						Brown H, 2007, BRIT MED J, V334, P664, DOI 10.1136/bmj.39153.511701.BE; 2008, BMJ, V336, P694	2	9	9	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 29	2008	336	7646					693	693		10.1136/bmj.39527.454560.59	http://dx.doi.org/10.1136/bmj.39527.454560.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZS	18369224	Green Published			2022-12-24	WOS:000254675600021
J	Detrano, R; Guerci, AD; Carr, JJ; Bild, DE; Burke, G; Folsom, AR; Liu, K; Shea, S; Szklo, M; Bluemke, DA; O'Leary, DH; Tracy, R; Watson, K; Wong, ND; Kronmal, RA				Detrano, Robert; Guerci, Alan D.; Carr, J. Jeffrey; Bild, Diane E.; Burke, Gregory; Folsom, Aaron R.; Liu, Kiang; Shea, Steven; Szklo, Moyses; Bluemke, David A.; O'Leary, Daniel H.; Tracy, Russell; Watson, Karol; Wong, Nathan D.; Kronmal, Richard A.			Coronary calcium as a predictor of coronary events in four racial or ethnic groups	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BEAM COMPUTED-TOMOGRAPHY; HEART-DISEASE EVENTS; ARTERY CALCIUM; RISK-FACTORS; CALCIFICATION; ATHEROSCLEROSIS; PREVALENCE; SCORE; CT	Background: In white populations, computed tomographic measurements of coronary-artery calcium predict coronary heart disease independently of traditional coronary risk factors. However, it is not known whether coronary-artery calcium predicts coronary heart disease in other racial or ethnic groups. Methods: We collected data on risk factors and performed scanning for coronary calcium in a population-based sample of 6722 men and women, of whom 38.6% were white, 27.6% were black, 21.9% were Hispanic, and 11.9% were Chinese. The study subjects had no clinical cardiovascular disease at entry and were followed for a median of 3.8 years. Results: There were 162 coronary events, of which 89 were major events (myocardial infarction or death from coronary heart disease). In comparison with participants with no coronary calcium, the adjusted risk of a coronary event was increased by a factor of 7.73 among participants with coronary calcium scores between 101 and 300 and by a factor of 9.67 among participants with scores above 300 (P<0.001 for both comparisons). Among the four racial and ethnic groups, a doubling of the calcium score increased the risk of a major coronary event by 15 to 35% and the risk of any coronary event by 18 to 39%. The areas under the receiver-operating-characteristic curves for the prediction of both major coronary events and any coronary event were higher when the calcium score was added to the standard risk factors. Conclusions: The coronary calcium score is a strong predictor of incident coronary heart disease and provides predictive information beyond that provided by standard risk factors in four major racial and ethnic groups in the United States. No major differences among racial and ethnic groups in the predictive value of calcium scores were detected.	[Detrano, Robert; Wong, Nathan D.] Univ Calif Irvine, Dept Radiol Sci, Irvine, CA 92697 USA; [Guerci, Alan D.] St Francis Hosp, Roslyn, NY USA; [Carr, J. Jeffrey; Burke, Gregory] Wake Forest Baptist Med Ctr, Winston Salem, NC USA; [Bild, Diane E.] NHLBI, Div Prevent & Populat Sci, Bethesda, MD 20892 USA; [Folsom, Aaron R.] Univ Minnesota, Minneapolis, MN USA; [Liu, Kiang] Northwestern Univ, Chicago, IL 60611 USA; [Shea, Steven] Columbia Univ, New York, NY USA; [Szklo, Moyses; Bluemke, David A.] Johns Hopkins Univ, Baltimore, MD USA; [O'Leary, Daniel H.] Caritas Carney Hosp, Dorchester, MA USA; [Tracy, Russell] Univ Vermont, Burlington, VT USA; [Watson, Karol] Univ Calif Los Angeles, Los Angeles, CA USA; [Kronmal, Richard A.] Univ Washington, Seattle, WA 98195 USA	University of California System; University of California Irvine; Wake Forest University; Wake Forest Baptist Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Minnesota System; University of Minnesota Twin Cities; Northwestern University; Columbia University; Johns Hopkins University; University of Vermont; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle	Detrano, R (corresponding author), Univ Calif Irvine, Dept Radiol Sci, Med Sci Bldg, Irvine, CA 92697 USA.	robert@chinacal.org	Carr, John/AAN-7531-2021; Carr, John Jeffrey/A-1938-2012; Watson, Karol/ABD-7425-2021; Bluemke, David/GYU-8169-2022	Carr, John/0000-0002-4398-8237; Carr, John Jeffrey/0000-0002-4398-8237; Bluemke, David/0000-0002-8323-8086; Szklo, Moyses/0000-0001-9433-6266	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095164, N01HC095163, N01HC095162, N01HC095169, N01HC095161, N01HC095160, N01HC095166, N01HC095165, N01HC095159] Funding Source: NIH RePORTER	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Arad Y, 2005, J AM COLL CARDIOL, V46, P158, DOI 10.1016/j.jacc.2005.02.088; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bild DE, 2005, CIRCULATION, V111, P1313, DOI 10.1161/01.CIR.0000157730.94423.4B; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Greenland P, 2001, CIRCULATION, V104, P1863, DOI 10.1161/hc4201.097189; Hawthorne V, 2002, HEART, V88, P222; Jain T, 2004, J AM COLL CARDIOL, V44, P1011, DOI 10.1016/j.jacc.2004.05.069; Kondos GT, 2003, CIRCULATION, V107, P2571, DOI 10.1161/01.CIR.0000068341.61180.55; LaMonte MJ, 2005, AM J EPIDEMIOL, V162, P421, DOI 10.1093/aje/kwi228; Lee TC, 2003, J AM COLL CARDIOL, V41, P39, DOI 10.1016/S0735-1097(02)02618-9; Nelson JC, 2005, RADIOLOGY, V235, P403, DOI 10.1148/radiol.2352040515; Newman AB, 2002, ARTERIOSCL THROM VAS, V22, P424, DOI 10.1161/hq0302.105357; O'Malley PG, 2000, AM J CARDIOL, V85, P945, DOI 10.1016/S0002-9149(99)00906-6; Raggi P, 2004, ARTERIOSCL THROM VAS, V24, P1272, DOI 10.1161/01.ATV.0000127024.40516.ef; Raggi P, 2001, AM HEART J, V141, P375, DOI 10.1067/mhj.2001.113220; Shaw LJ, 2003, RADIOLOGY, V228, P826, DOI 10.1148/radiol.2283021006; Smith S C Jr, 2000, Circulation, V101, P111; TANG WY, 1995, AM J CARDIOL, V75, P1088, DOI 10.1016/S0002-9149(99)80735-8; Taylor AJ, 2005, J AM COLL CARDIOL, V46, P807, DOI 10.1016/j.jacc.2005.05.049; Vliegenthart R, 2005, CIRCULATION, V112, P572, DOI 10.1161/CIRCULATIONAHA.104.488916; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wong ND, 2000, AM J CARDIOL, V86, P495, DOI 10.1016/S0002-9149(00)01000-6; Yaghoubi S, 1995, Am J Card Imaging, V9, P231	28	1994	2050	1	59	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 27	2008	358	13					1336	1345		10.1056/NEJMoa072100	http://dx.doi.org/10.1056/NEJMoa072100			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	278TE	18367736				2022-12-24	WOS:000254308400004
J	Ha, TS; Smith, DP				Ha, Tal Soo; Smith, Dean P.			Insect odorant receptors: Channeling scent	CELL			English	Editorial Material							OLFACTORY RECEPTORS; DROSOPHILA-ANTENNA; EXPRESSION	Odorant detection in insects involves heterodimers between an odorant receptor (OR) and a conserved seven-transmembrane protein called Or83b, but the exact mechanism of OR signal transduction is unclear. Two recent studies in Nature (Sato et al., 2008; Wicher et al., 2008) now reveal that these OR-Or83b heterodimers form odorant-gated ion channels, revealing a surprising new mode of olfactory transduction.	[Ha, Tal Soo; Smith, Dean P.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Ha, Tal Soo; Smith, Dean P.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Smith, DP (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	dean.smith@utsouthwestern.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002539] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC002539] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Elmore T, 2003, J NEUROSCI, V23, P9906; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861	11	13	16	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 30	2008	133	5					761	763		10.1016/j.cell.2008.05.007	http://dx.doi.org/10.1016/j.cell.2008.05.007			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	306UY	18510917	Bronze			2022-12-24	WOS:000256274500005
J	Maurange, C; Cheng, L; Gould, AP				Maurange, Cedric; Cheng, Louise; Gould, Alex P.			Temporal transcription factors and their targets schedule the end of neural proliferation in Drosophila	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; PROGENITOR-CELL PROLIFERATION; POSTEMBRYONIC NEUROBLASTS; ASYMMETRIC SEGREGATION; SELF-RENEWAL; STEM-CELLS; SOX-DOMAIN; PROSPERO; IDENTITY; PROTEIN	The timing mechanisms responsible for terminating cell proliferation toward the end of development remain unclear. In the Drosophila CNS, individual progenitors called neuroblasts are known to express a series of transcription factors endowing daughter neurons with different temporal identities. Here we show that Castor and Seven-Up, members of this temporal series, regulate key events in many different neuroblast lineages during late neurogenesis. First, they schedule a switch in the cell size and identity of neurons involving the targets Chinmo and Broad Complex. Second, they regulate the time at which neuroblasts undergo Prospero-dependent cell-cycle exit or Reaper/Hid/Grim-dependent apoptosis. Both types of progenitor termination require the combined action of a late phase of the temporal series and indirect feedforward via Castor targets such as Grainyhead and Dichaete. These studies identify the timing mechanism ending CNS proliferation and reveal how aging progenitors transduce bursts of transcription factors into long-lasting changes in cell proliferation and cell identity.	[Maurange, Cedric; Cheng, Louise; Gould, Alex P.] Natl Inst Med Res, MRC, London NW7 1AA, England	MRC National Institute for Medical Research	Gould, AP (corresponding author), Natl Inst Med Res, MRC, Ridgeway, London NW7 1AA, England.	agould@nimr.mrc.ac.uk	Cheng, Louise/B-5112-2012; Gould, Alex/M-5353-2019; Gould, Alex/A-7479-2010	Gould, Alex/0000-0002-6875-6985; Gould, Alex/0000-0002-6875-6985; Maurange, Cedric/0000-0001-8931-1419; Cheng, Louise/0000-0001-9712-4082	MRC [MC_U117584237] Funding Source: UKRI; Medical Research Council [MC_U117584237] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Almeida MS, 2005, MECH DEVELOP, V122, P1282, DOI 10.1016/j.mod.2005.08.004; Bello BC, 2003, NEURON, V37, P209, DOI 10.1016/S0896-6273(02)01181-9; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; BRAY SJ, 1989, GENE DEV, V3, P1130, DOI 10.1101/gad.3.8.1130; Brody T, 2000, DEV BIOL, V226, P34, DOI 10.1006/dbio.2000.9829; Brown HLD, 2006, DEVELOPMENT, V133, P275, DOI 10.1242/dev.02191; Caviness VS, 2003, CEREB CORTEX, V13, P592, DOI 10.1093/cercor/13.6.592; Cenci C, 2005, DEVELOPMENT, V132, P3835, DOI 10.1242/dev.01932; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Cleary MD, 2006, GENE DEV, V20, P429, DOI 10.1101/gad.1382206; Donovan SL, 2005, SEMIN CELL DEV BIOL, V16, P407, DOI 10.1016/j.semcdb.2005.02.012; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; EMERY IF, 1994, DEVELOPMENT, V120, P3275; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Grosskortenhaus R, 2006, GENE DEV, V20, P2618, DOI 10.1101/gad.1445306; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Higashijima S, 1996, DEVELOPMENT, V122, P527; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Kambadur R, 1998, GENE DEV, V12, P246, DOI 10.1101/gad.12.2.246; Kanai MI, 2005, DEV CELL, V8, P203, DOI 10.1016/j.devcel.2004.12.014; Kessaris N, 2001, NEURON, V31, P677, DOI 10.1016/S0896-6273(01)00430-5; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; Lee T, 1999, DEVELOPMENT, V126, P4065; Li L, 2000, GENE DEV, V14, P147; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Maurange C, 2005, TRENDS NEUROSCI, V28, P30, DOI 10.1016/j.tins.2004.10.009; MCCONNELL SK, 1988, BRAIN RES REV, V13, P1, DOI 10.1016/0165-0173(88)90002-1; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Mettler U, 2006, DEVELOPMENT, V133, P429, DOI 10.1242/dev.02229; Nambu PA, 1996, DEVELOPMENT, V122, P3467; Novotny T, 2002, DEVELOPMENT, V129, P1027; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Pearson BJ, 2003, NATURE, V425, P624, DOI 10.1038/nature01910; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Peterson C, 2002, DEVELOPMENT, V129, P1467; PROKOP A, 1991, DEVELOPMENT, V111, P79; Prokop A, 1998, MECH DEVELOP, V74, P99, DOI 10.1016/S0925-4773(98)00068-9; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Roy K, 2004, J NEUROSCI, V24, P8333, DOI 10.1523/JNEUROSCI.1148-04.2004; Schmid A, 1999, DEVELOPMENT, V126, P4653; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Soriano NS, 1998, DEVELOPMENT, V125, P3989; SPANA EP, 1995, DEVELOPMENT, V121, P3187; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; Wang HY, 2005, BIOL CELL, V97, P63; Yu FW, 2006, NEURON, V51, P13, DOI 10.1016/j.neuron.2006.06.016; Zhao GY, 2002, DEVELOPMENT, V129, P1165; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045	58	228	232	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 30	2008	133	5					891	902		10.1016/j.cell.2008.03.034	http://dx.doi.org/10.1016/j.cell.2008.03.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	306UY	18510932	Bronze			2022-12-24	WOS:000256274500020
J	Horner-Devine, MC; Martiny, AC				Horner-Devine, M. Claire; Martiny, Adam C.			Biogeochemistry - News about nitrogen	SCIENCE			English	Editorial Material							ANAEROBIC AMMONIUM OXIDATION; OXIDIZING BACTERIA; NITRIFICATION; PLANKTON; ARCHAEA; OCEAN; CRENARCHAEOTA; DIVERSITY; COMMUNITY; FIXATION		[Horner-Devine, M. Claire] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Martiny, Adam C.] Univ Calif Irvine, Irvine, CA 92697 USA	University of Washington; University of Washington Seattle; University of California System; University of California Irvine	Horner-Devine, MC (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	mchd@u.washington.edu	Martiny, Adam/AAC-4459-2019	Martiny, Adam/0000-0003-2829-4314				Beman JM, 2008, ISME J, V2, P429, DOI 10.1038/ismej.2007.118; Caffrey JM, 2007, ISME J, V1, P660, DOI 10.1038/ismej.2007.79; Carney KM, 2004, ECOL LETT, V7, P684, DOI 10.1111/j.1461-0248.2004.00628.x; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; Graham DW, 2007, ISME J, V1, P385, DOI 10.1038/ismej.2007.45; Hawkes CV, 2005, ECOL LETT, V8, P976, DOI 10.1111/j.1461-0248.2005.00802.x; Horz HP, 2004, P NATL ACAD SCI USA, V101, P15136, DOI 10.1073/pnas.0406616101; Karl DM, 2001, DEEP-SEA RES PT II, V48, P1449, DOI 10.1016/S0967-0645(00)00149-1; Knapp CW, 2007, FEMS MICROBIOL ECOL, V62, P195, DOI 10.1111/j.1574-6941.2007.00380.x; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kuypers MMM, 2005, P NATL ACAD SCI USA, V102, P6478, DOI 10.1073/pnas.0502088102; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Mehta MP, 2006, SCIENCE, V314, P1783, DOI 10.1126/science.1134772; MULDER A, 1995, FEMS MICROBIOL ECOL, V16, P177, DOI 10.1016/0168-6496(94)00081-7; Sohm JA, 2006, MAR ECOL PROG SER, V317, P21, DOI 10.3354/meps317021; Steunou AS, 2006, P NATL ACAD SCI USA, V103, P2398, DOI 10.1073/pnas.0507513103; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Webster G, 2005, ENVIRON MICROBIOL, V7, P676, DOI 10.1111/j.1462-2920.2005.00740.x; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103	24	21	26	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2008	320	5877					757	758		10.1126/science.1147012	http://dx.doi.org/10.1126/science.1147012			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18467581				2022-12-24	WOS:000255644400029
J	Rainer, TH; Graham, CA				Rainer, Timothy H.; Graham, Colin A.			A significant step forward for gout	LANCET			English	Editorial Material							DOUBLE-BLIND; ARTHRITIS; THERAPY		[Rainer, Timothy H.; Graham, Colin A.] Chinese Univ Hong Kong, Prince Wales Hosp, Accident & Emergency Med Acad Unit, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Rainer, TH (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Accident & Emergency Med Acad Unit, Shatin, Hong Kong, Peoples R China.	thrainer@cuhk.edu.hk	Rainer, Timothy/I-2591-2013; Graham, Colin A/B-4535-2013	Rainer, Timothy/0000-0003-3355-3237; Graham, Colin A/0000-0002-4381-7470				Annemans L, 2008, ANN RHEUM DIS, V67, P960, DOI 10.1136/ard.2007.076232; James David S, 1999, J Am Osteopath Assoc, V99, pS1, DOI 10.7556/jaoa.1999.99.11.S1; Janssens HJEM, 2008, LANCET, V371, P1854, DOI 10.1016/S0140-6736(08)60799-0; Janssens HJ, 2008, COCHRANE DB SYST REV, V16; Man CY, 2007, ANN EMERG MED, V49, P670, DOI 10.1016/j.annemergmed.2006.11.014; Odio CM, 2003, PEDIATR INFECT DIS J, V22, P883, DOI 10.1097/01.inf.0000091293.32187.7b; Roddy E, 2007, RHEUMATOLOGY, V46, P1441, DOI 10.1093/rheumatology/kem150; Roddy E, 2007, NAT CLIN PRACT RHEUM, V3, P443, DOI 10.1038/ncprheum0556; RODRIGUEZ LAG, 1994, LANCET, V343, P769, DOI 10.1016/S0140-6736(94)91843-0; Rodriguez LAG, 2001, ARTHRITIS RES, V3, P98, DOI 10.1186/ar146; Schumacher HR, 2005, J RHEUMATOL, V32, P2452; Todd KH, 1996, ANN EMERG MED, V27, P485, DOI 10.1016/S0196-0644(96)70238-X	12	5	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY-JUN	2008	371	9627					1816	1818		10.1016/S0140-6736(08)60775-8	http://dx.doi.org/10.1016/S0140-6736(08)60775-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	307NL	18514713				2022-12-24	WOS:000256325500006
J	Weber, MA; Klein, NJ; Hartley, JC; Lock, PE; Malone, M; Sebire, NJ				Weber, M. A.; Klein, N. J.; Hartley, J. C.; Lock, P. E.; Malone, M.; Sebire, N. J.			Infection and sudden unexpected death in infancy: a systematic retrospective case review	LANCET			English	Review								Background The cause and mechanism of most cases of sudden unexpected death in infancy (SUDI) remain unknown, despite specialist autopsy examination. We reviewed autopsy results to determine whether infection was a cause of SUDI. Methods We did a systematic retrospective case review of autopsies, done at one specialist Centre between 1996 and 2005, of 546 infants (aged 7-365 days) who died suddenly and unexpectedly. Cases of SUDI were categorised as unexplained, explained with histological evidence of bacterial infection, or explained by non-infective causes. Microbial isolates gathered at autopsy were classified as non-pathogens, group 1 pathogens (organisms usually associated with an identifiable focus of infection), or group 2 pathogens (organisms known to cause septicaemia without an obvious focus of infection). Findings Of 546 SUDI cases, 39 autopsies were excluded because of viral or pneumocystis infection or secondary bacterial infection after initial collapse and resuscitation. Bacteriological sampling was done in 470 (93%) of the remaining 507 autopsies. 2079 bacteriological samples were taken, of which 571 (27%) were sterile. Positive cultures yielded 2871 separate isolates, 484 (32%) of which showed pure growth and 1024 (68%) mixed growth. Significantly more isolates from infants whose deaths were explained by bacterial infection (78/322, 24%) and from those whose death was unexplained (440/2306, 19%) contained group 2 pathogens than did those from infants whose death was explained by a non-infective cause (27/243, 11%; difference 13.1%, 95% CI 6.9-19.2, p<0 . 0001 vs bacterial infection; and 8.0%, 3.2-11.8, p=0.001 vs unexplained). Significantly more cultures from infants whose deaths were unexplained contained Staphylococcus aureus (262/1628, 16%) or Escherichia coli (93/1628;6%) than did those from infants whose deaths were of non-infective cause (S aureus: 19/211, 9%; difference 7.1%, 95% Cl 2.2-10.8, p=0 . 005; E coli: 3/211, 1%, difference 4.3%, 1.5-5 . 9, p=0 . 003). Interpretation Although many post-mortem bacteriological cultures in SUDI yield organisms, most seem to be unrelated to the cause of death. The high rate of detection of group 2 pathogens, particularly S aureus and E coli, in otherwise unexplained cases of SUDI suggests that these bacteria could be associated with this condition. Funding Foundation for the Study of Infant Deaths.	[Weber, M. A.; Malone, M.; Sebire, N. J.] Great Ormond St Hosp Sick Children, Dept Paediat Pathol, London WC1N 3JH, England; [Klein, N. J.; Hartley, J. C.; Lock, P. E.] Great Ormond St Hosp Sick Children, Dept Infect Dis & Microbiol, London WC1N 3JH, England; UCL, Inst Child Hlth, London, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London	Sebire, NJ (corresponding author), Great Ormond St Hosp Sick Children, Dept Paediat Pathol, Great Ormond St, London WC1N 3JH, England.	SebirN@gosh.nhs.uk	sebire, neil J/C-4960-2008; Weber, Martin/GPW-6095-2022	Sebire, Neil/0000-0001-5348-9063; Klein, Nigel/0000-0003-3925-9258				Arnestad M, 2002, FORENSIC SCI INT, V125, P262, DOI 10.1016/S0379-0738(02)00009-9; Byard R W, 2004, SUDDEN DEATH INFANCY; BYARD RW, 1994, PEDIATR PATHOL, V14, P817, DOI 10.3109/15513819409037679; Carmichael EM, 1996, J PAEDIATR CHILD H, V32, P412, DOI 10.1111/j.1440-1754.1996.tb00940.x; Chuang Yu-Yu, 2005, Paediatr Drugs, V7, P11, DOI 10.2165/00148581-200507010-00002; Dyer Clare, 2003, BMJ, V327, P10, DOI 10.1136/bmj.327.7405.10-a; Fleming P, 2000, SUDDEN UNEXPECTED DE, P97; Harrison LM, 1999, FEMS IMMUNOL MED MIC, V25, P19, DOI 10.1111/j.1574-695X.1999.tb01323.x; Highet AR, 2008, J APPL MICROBIOL, V105, P625, DOI 10.1111/j.1365-2672.2008.03747.x; Howatson A.G., 2006, CURRENT DIAGNOSTIC P, V12, P173, DOI [10.1016/j.cdip.2006.03.008, DOI 10.1016/J.CDIP.2006.03.008]; Krous HF, 2003, AM J FOREN MED PATH, V24, P1, DOI 10.1097/00000433-200303000-00001; Krous HF, 2004, PEDIATRICS, V114, P234, DOI 10.1542/peds.114.1.234; Mitchell E, 2000, AM J FOREN MED PATH, V21, P395, DOI 10.1097/00000433-200012000-00020; Moon RY, 2007, LANCET, V370, P1578, DOI 10.1016/S0140-6736(07)61662-6; Morris JA, 2006, J CLIN PATHOL, V59, P1, DOI 10.1136/jcp.2005.028183; Morris JA, 2007, CURR DIAGN PATHOL, V13, P65, DOI DOI 10.1016/J.CDIP.2006.07.005; *OFF NAT STAT, 2006, HLTH STAT Q, V31, P82; Royal College of Pathologists Royal College of Paediatrics and Child Health, 2004, SUDD UN DEATH INF MU; Sadler DW, 1998, J CLIN PATHOL, V51, P689, DOI 10.1136/jcp.51.9.689; Weinstein MP, 2003, J CLIN MICROBIOL, V41, P2275, DOI 10.1128/JCM.41.6.2275-2278.2003; 2006, ATTORNEY GEN ANNOUNC	21	110	112	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY-JUN	2008	371	9627					1848	1853		10.1016/S0140-6736(08)60798-9	http://dx.doi.org/10.1016/S0140-6736(08)60798-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	307NL	18514728				2022-12-24	WOS:000256325500028
J	Ayi, K; Min-Oo, G; Serghides, L; Crockett, M; Kirby-Allen, M; Quirt, I; Gros, P; Kain, KC				Ayi, Kodjo; Min-Oo, Gundula; Serghides, Lena; Crockett, Maryanne; Kirby-Allen, Melanie; Quirt, Ian; Gros, Philippe; Kain, Kevin C.			Pyruvate kinase deficiency and malaria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; PHAGOCYTOSIS; PROTECTION; PARASITES	Malaria that is caused by Plasmodium falciparum is a significant global health problem. Genetic characteristics of the host influence the severity of disease and the ultimate outcome of infection, and there is evidence of coevolution of the plasmodium parasite with its host. In humans, pyruvate kinase deficiency is the second most common erythrocyte enzyme disorder. Here, we show that pyruvate kinase deficiency provides protection against infection and replication of P. falciparum in human erythrocytes, raising the possibility that mutant pyruvate kinase alleles may confer a protective advantage against malaria in human populations in areas where the disease is endemic.	[Min-Oo, Gundula; Gros, Philippe] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Min-Oo, Gundula; Gros, Philippe] McGill Univ, Ctr Study Host Resistance, Montreal, PQ H3G 1Y6, Canada; [Ayi, Kodjo; Serghides, Lena; Crockett, Maryanne; Kain, Kevin C.] Toronto Gen Hosp, McLaughlin Rotman Ctr Global Hlth, Univ Hlth Network, Toronto, ON, Canada; [Quirt, Ian; Kain, Kevin C.] Toronto Gen Hosp, Dept Med, Univ Hlth Network, Toronto, ON M5G 1L7, Canada; [Kirby-Allen, Melanie] Hosp Sick Children, Hematol Unit, Toronto, ON M5G 1X8, Canada; [Kain, Kevin C.] Univ Toronto, McLaughlin Ctr Mol Med, Toronto, ON, Canada	McGill University; McGill University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Gros, P (corresponding author), McGill Univ, Dept Biochem, 3655 Promenade Sir William Osler,Rm 907, Montreal, PQ H3G 1Y6, Canada.	philippe.gros@mcgill.ca	Serghides, Lena/C-7968-2018	Serghides, Lena/0000-0002-2817-6134; Crockett, Maryanne/0000-0001-5879-143X; Kain, Kevin/0000-0001-6068-1272				Ayi K, 2004, BLOOD, V104, P3364, DOI 10.1182/blood-2003-11-3820; Ayi K, 2005, INFECT IMMUN, V73, P2559, DOI 10.1128/IAI.73.4.2559-2563.2005; DRONAMRAJU KR, 2006, MALARIA GENETIC EVOL; Haldane J.B.S., 1949, HEREDITAS, V35, P267; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Min-Oo G, 2005, CELL MICROBIOL, V7, P753, DOI 10.1111/j.1462-5822.2005.00524.x; Min-Oo G, 2004, GENES IMMUN, V5, P168, DOI 10.1038/sj.gene.6364069; Min-Oo G, 2003, NAT GENET, V35, P357, DOI 10.1038/ng1260; Mordmuller B, 2006, CURR MOL MED, V6, P247, DOI 10.2174/156652406776055122; Patel SN, 2004, J INFECT DIS, V189, P204, DOI 10.1086/380764; PONGPONRATN E, 1991, AM J TROP MED HYG, V44, P168, DOI 10.4269/ajtmh.1991.44.168; SCHWARZER E, 1992, J EXP MED, V176, P1033, DOI 10.1084/jem.176.4.1033; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Targett GA, 2005, TRENDS PARASITOL, V21, P499, DOI 10.1016/j.pt.2005.08.018; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009; Zanella A, 2005, BRIT J HAEMATOL, V130, P11, DOI 10.1111/j.1365-2141.2005.05527.x; Zanella A, 1997, BLOOD, V89, P3847, DOI 10.1182/blood.V89.10.3847.3847_3847_3852; Zanella A, 2000, BEST PRACT RES CL HA, V13, P57, DOI 10.1053/beha.1999.0057	19	69	71	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 24	2008	358	17					1805	1810		10.1056/NEJMoa072464	http://dx.doi.org/10.1056/NEJMoa072464			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PL	18420493				2022-12-24	WOS:000255209200006
J	Groll, M; Schellenberg, B; Bachmann, AS; Archer, CR; Huber, R; Powell, TK; Lindow, S; Kaiser, M; Dudler, R				Groll, Michael; Schellenberg, Barbara; Bachmann, Andre S.; Archer, Crystal R.; Huber, Robert; Powell, Tracy K.; Lindow, Steven; Kaiser, Markus; Dudler, Robert			A plant pathogen virulence factor inhibits the eukaryotic proteasome by a novel mechanism	NATURE			English	Article							SYRINGAE PV.-SYRINGAE; CERULENIN-MEDIATED APOPTOSIS; HYPERSENSITIVE CELL-DEATH; III EFFECTOR PROTEINS; PSEUDOMONAS-SYRINGAE; 20S PROTEASOME; BACTERIAL VIRULENCE; INNATE IMMUNITY; POWDERY MILDEW; KEY ROLE	Pathogenic bacteria often use effector molecules to increase virulence. In most cases, the mode of action of effectors remains unknown. Strains of Pseudomonas syringae pv. syringae (Pss) secrete syringolin A (SylA), a product of a mixed non-ribosomal peptide/polyketide synthetase, in planta(1). Here we identify SylA as a virulence factor because a SylA-negative mutant in Pss strain B728a obtained by gene disruption was markedly less virulent on its host, Phaseolus vulgaris (bean). We show that SylA irreversibly inhibits all three catalytic activities of eukaryotic proteasomes, thus adding proteasome inhibition to the repertoire of modes of action of virulence factors. The crystal structure of the yeast proteasome in complex with SylA revealed a novel mechanism of covalent binding to the catalytic subunits. Thus, SylA defines a new class of proteasome inhibitors that includes glidobactin A (GlbA), a structurally related compound from an unknown species of the order Burkholderiales(2), for which we demonstrate a similar proteasome inhibition mechanism. As proteasome inhibitors are a promising class of anti-tumour agents, the discovery of a novel family of inhibitory natural products, which we refer to as syrbactins, may also have implications for the development of anti-cancer drugs(3). Homologues of SylA and GlbA synthetase genes are found in some other pathogenic bacteria, including the human pathogen Burkholderia pseudomallei, the causative agent of melioidosis(4). It is thus possible that these bacteria are capable of producing proteasome inhibitors of the syrbactin class.	[Schellenberg, Barbara; Dudler, Robert] Univ Zurich, Inst Plant Biol, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland; [Groll, Michael] Tech Univ Munich, Ctr Integrated Prot Sci, Dept Chem, Lehrstuhl Biochem, D-85747 Garching, Germany; [Bachmann, Andre S.; Archer, Crystal R.] Univ Hawaii Manoa, Canc Res Ctr Hawaii, Honolulu, HI 96813 USA; [Bachmann, Andre S.; Archer, Crystal R.] Univ Hawaii Manoa, Cell & Mol Biol Grad Program, John A Burns Sch Med, Honolulu, HI 96813 USA; [Huber, Robert] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Huber, Robert] Cardiff Univ, Sch Biosci, Cardiff CF10 3US, Wales; [Huber, Robert] Univ Duisburg Essen, Zentrum Med Biotechnol, D-45117 Essen, Germany; [Powell, Tracy K.; Lindow, Steven] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Kaiser, Markus] Max Planck Soc, Chem Genom Ctr, D-44227 Dortmund, Germany	University of Zurich; Technical University of Munich; Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; Max Planck Society; Cardiff University; University of Duisburg Essen; University of California System; University of California Berkeley; Max Planck Society	Dudler, R (corresponding author), Univ Zurich, Inst Plant Biol, Zurich Basel Plant Sci Ctr, Zollikerstr 107, CH-8008 Zurich, Switzerland.	abachmann@crch.hawaii.edu; markus.kaiser@cgc.mpg.de; rdudler@botinst.uzh.ch	Groll, Michael/F-5572-2015; Groll, Michael/C-1174-2010	Schellenberg, Barbara/0000-0002-4382-8065				Adams J, 2002, CURR OPIN ONCOL, V14, P628, DOI 10.1097/00001622-200211000-00007; Amrein H, 2004, MOL PLANT MICROBE IN, V17, P90, DOI 10.1094/MPMI.2004.17.1.90; Borissenko L, 2007, CHEM REV, V107, P687, DOI 10.1021/cr0502504; Brukhin V, 2005, PLANT CELL, V17, P2723, DOI 10.1105/tpc.105.034975; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Coleman CS, 2006, CELL PROLIFERAT, V39, P599, DOI 10.1111/j.1365-2184.2006.00402.x; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; Desveaux D, 2006, CURR OPIN PLANT BIOL, V9, P376, DOI 10.1016/j.pbi.2006.05.005; Doerner P, 1996, NATURE, V380, P520, DOI 10.1038/380520a0; Dong WB, 2006, PLANT CELL, V18, P3321, DOI 10.1105/tpc.106.046326; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Geerts D, 2007, CLIN CANCER RES, V13, P6312, DOI 10.1158/1078-0432.CCR-07-0829; Goritschnig S, 2007, PLANT J, V49, P540, DOI 10.1111/j.1365-313X.2006.02978.x; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Groll M, 2005, METHOD ENZYMOL, V398, P329, DOI 10.1016/S0076-6879(05)98027-0; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Heiligtag SJ, 2002, CELL DEATH DIFFER, V9, P1017, DOI 10.1038/sj.cdd.4401055; Hirano SS, 2000, MICROBIOL MOL BIOL R, V64, P624, DOI 10.1128/MMBR.64.3.624-653.2000; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Michel K, 2006, PLANT MOL BIOL, V62, P561, DOI 10.1007/s11103-006-9045-7; Nomura K, 2006, SCIENCE, V313, P220, DOI 10.1126/science.1129523; OKA M, 1988, J ANTIBIOT, V41, P1331, DOI 10.7164/antibiotics.41.1331; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Quinones B, 2005, MOL PLANT MICROBE IN, V18, P682, DOI 10.1094/MPMI-18-0682; RODRIGUESPOUSADA RA, 1993, PLANT CELL, V5, P897, DOI 10.1105/tpc.5.8.897; Rosebrock TR, 2007, NATURE, V448, P370, DOI 10.1038/nature05966; Schellenberg B, 2007, ENVIRON MICROBIOL, V9, P1640, DOI 10.1111/j.1462-2920.2007.01278.x; TURK D, 1992, THESIS TU MUNCHEN; Wallick CJ, 2005, ONCOGENE, V24, P5606, DOI 10.1038/sj.onc.1208808; Waspi U, 1998, MOL PLANT MICROBE IN, V11, P727, DOI 10.1094/MPMI.1998.11.8.727; Waspi U, 2001, PLANT CELL, V13, P153, DOI 10.1105/tpc.13.1.153	36	244	252	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2008	452	7188					755	U7		10.1038/nature06782	http://dx.doi.org/10.1038/nature06782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	285QY	18401409				2022-12-24	WOS:000254792500046
J	Chang, M; Lingner, J				Chang, Michael; Lingner, Joachim			Cell signaling - Tel2 finally tells one story	SCIENCE			English	Editorial Material							TELOMERE LENGTH REGULATION; SACCHAROMYCES-CEREVISIAE; ELEGANS; PROTEIN; GENE; CHECKPOINT; STABILITY		[Chang, Michael; Lingner, Joachim] Swiss Inst Expt Canc Res, Ecole Polytech Fed Lausanne, CH-1066 Epalinges, Switzerland; [Chang, Michael; Lingner, Joachim] Frontiers Genet Natl Ctr Competence Res, CH-1211 Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; University of Geneva	Chang, M (corresponding author), Swiss Inst Expt Canc Res, Ecole Polytech Fed Lausanne, CH-1066 Epalinges, Switzerland.	michael.chang@epfl.ch; joachim.lingner@epfl.ch	Chang, Michael/B-9279-2012	Chang, Michael/0000-0002-1706-3337; Lingner, Joachim/0000-0002-2853-5803				Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; ANDERSON CM, 2008, GENES DEV       0311; Benard C, 2001, DEVELOPMENT, V128, P4045; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; Garcia-Muse T, 2005, EMBO J, V24, P4345, DOI 10.1038/sj.emboj.7600896; GREENWELL PW, 1995, CELL, V82, P823, DOI 10.1016/0092-8674(95)90479-4; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Jiang N, 2003, J BIOL CHEM, V278, P21678, DOI 10.1074/jbc.M300286200; LUSTIG AJ, 1986, P NATL ACAD SCI USA, V83, P1398, DOI 10.1073/pnas.83.5.1398; Runge KW, 1996, MOL CELL BIOL, V16, P3094; Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052	11	7	8	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 4	2008	320	5872					60	61		10.1126/science.1155132	http://dx.doi.org/10.1126/science.1155132			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283JR	18388281				2022-12-24	WOS:000254633000026
J	Williams-Guillen, K; Perfecto, I; Vandermeer, J				Williams-Guillen, Kimberly; Perfecto, Ivette; Vandermeer, John			Bats limit insects in a neotropical agroforestry system	SCIENCE			English	Article							BIRDS		[Williams-Guillen, Kimberly; Perfecto, Ivette; Vandermeer, John] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Vandermeer, John] Univ Michigan, Dept Ecol & Evolut Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Williams-Guillen, K (corresponding author), Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA.	kimwg@umich.edu						Ceballos G., 2010, ISSUES ECOL, V8, P1821; Cleveland CJ, 2006, FRONT ECOL ENVIRON, V4, P238, DOI 10.1890/1540-9295(2006)004[0238:EVOTPC]2.0.CO;2; GRAHAM GL, 1990, J BIOGEOGR, V17, P657, DOI 10.2307/2845147; GREENBERG R, 1995, J AVIAN BIOL, V26, P260, DOI 10.2307/3677328; Hutson A, 2001, MICROCHIROPTERAN BAT; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300	7	167	182	2	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2008	320	5872					70	70		10.1126/science.1152944	http://dx.doi.org/10.1126/science.1152944			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283JR	18388285				2022-12-24	WOS:000254633000030
J	von Gottberg, A; Klugman, KP; Cohen, C; Wolter, N; de Gouveia, L; du Plessis, M; Mpembe, R; Quan, V; Whitelaw, A; Hoffmann, R; Govender, N; Meiring, S; Smith, AM; Schrag, S				von Gottberg, Anne; Klugman, Keith P.; Cohen, Cheryl; Wolter, Nicole; de Gouveia, Linda; du Plessis, Mignon; Mpembe, Ruth; Quan, Vanessa; Whitelaw, Andrew; Hoffmann, Rena; Govender, Nelesh; Meiring, Susan; Smith, Anthony M.; Schrag, Stephanie		GERMS SA	Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study	LANCET			English	Article							TERM-CARE FACILITY; FLUOROQUINOLONE-RESISTANT; ANTIMICROBIAL RESISTANCE; NASOPHARYNGEAL CARRIAGE; ANTIBIOTIC-RESISTANCE; UNITED-STATES; PNEUMOCOCCI; RISK; OPPORTUNITIES; FAILURE	Background Use of fluoroquinolones to treat paediatric cases of multidrug-resistant tuberculosis could affect the emergence of resistance to this class of drugs. Our aim was to estimate the incidence of, and risk factors for, invasive pneumococcal disease caused by fluoroquinolone-resistant Streptococcus pneumoniae in children in South Africa. Methods 21521 cases of invasive pneumococcal disease were identified by active national surveillance between 2000 and 2006, with enhanced surveillance at 15 sentinel hospitals in seven provinces introduced in 2003. We screened 19 404 isolates (90% of cases) for ofloxacin resistance and measured levofloxacin minimum inhibitory concentrations (MICs) for all isolates that were ofloxacin resistant. Non-susceptibility to levofloxacin was defined as an MIC of 4 mg/L or more. Nasopharyngeal pneumococcal carriage was assessed in 65 children in two tuberculosis hospitals where invasive pneumococcal disease caused by levofloxacin-non-susceptible S pneumoniae had been detected. Findings 12 cases of invasive pneumococcal disease were identified as being non-susceptible to levofloxacin, an in children aged under 15 years. All isolates were rifampicin resistant. Outcome was known for 11 of these patients; five (45%) died. Invasive disease caused by levofloxacin-non-susceptible S pneumoniae was associated with a history of tuberculosis treatment (eight [89%] of nine children with non-susceptible isolates had a history of treatment vs 396 [18%] of 2202 children with susceptible isolates; relative risk [RR] 35 . 78, 95% Cl 4.49-285.30) and nosocomial invasive pneumococcal disease (eight [80%] of ten children with non-susceptible isolates had acquired infection nosocomially vs 109 [4%] of 2709 with susceptible isolates; RR 88.96, 19.10-414.29). 31 (89%) of 35 pneumococcal carriers had bacteria that were non-susceptible to levofloxacin. Interpretation Our data suggest that the use of fluoroquinolones to treat multidrug-resistant tuberculosis in children has led to the emergence of invasive pneumococcal disease caused by levofloxacin-non-susceptible S pneumoniae and its nosocomial spread. Funding National Institute for Communicable Diseases of the National Health Laboratory Service (South Africa), US Agency for International Development Antimicrobial Resistance Initiative, US Centers for Disease Control and Prevention.	[von Gottberg, Anne; Klugman, Keith P.; Cohen, Cheryl; Wolter, Nicole; de Gouveia, Linda; du Plessis, Mignon; Mpembe, Ruth; Quan, Vanessa; Govender, Nelesh; Meiring, Susan; Smith, Anthony M.] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Johannesburg, South Africa; [von Gottberg, Anne; Klugman, Keith P.; Wolter, Nicole; du Plessis, Mignon; Govender, Nelesh; Smith, Anthony M.] Univ Witwatersrand, Sch Pathol, Fac Hlth Sci, Johannesburg, South Africa; [Cohen, Cheryl] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [von Gottberg, Anne; Klugman, Keith P.; Wolter, Nicole; de Gouveia, Linda; du Plessis, Mignon; Mpembe, Ruth] MRC, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Klugman, Keith P.] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Klugman, Keith P.] Emory Univ, Div Infect Dis, Sch Med, Atlanta, GA 30322 USA; [Whitelaw, Andrew; Hoffmann, Rena] Natl Hlth Lab Serv, Cape Town, South Africa; [Whitelaw, Andrew] Univ Cape Town, Dept Clin & Lab Sci, ZA-7925 Cape Town, South Africa; [Hoffmann, Rena] Univ Stellenbosch, Dept Med Microbiol, ZA-7600 Stellenbosch, South Africa; [Schrag, Stephanie] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Witwatersrand; Emory University; Rollins School Public Health; Emory University; University of Cape Town; Stellenbosch University; Centers for Disease Control & Prevention - USA	von Gottberg, A (corresponding author), Natl Inst Communicable Dis, Resp & Meningeal Pathogens Res Unit, Private Bag X4, ZA-2131 Johannesburg, Gauteng, South Africa.	annev@nicd.ac.za	Meiring, Susan/M-1463-2019; Govender, Nelesh/ABI-6429-2020	Meiring, Susan/0000-0003-4508-5469; de Gouveia, Linda/0000-0002-1418-8468; Cohen, Cheryl/0000-0003-0376-2302; du Plessis, Mignon/0000-0001-9186-0679; von Gottberg, Anne/0000-0002-0243-7455; Govender, Nelesh/0000-0001-7869-9462; McCarthy, Kerrigan/0000-0001-8958-9795; Whitelaw, Andrew/0000-0001-9070-5247	PHS HHS [U60/CCU022088, U62/CCU022901] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adam HJ, 2007, ANTIMICROB AGENTS CH, V51, P198, DOI 10.1128/AAC.00609-06; APPELBAUM PC, 1977, LANCET, V2, P995; Borer A, 2001, CLIN INFECT DIS, V33, P436, DOI 10.1086/321888; Buie KA, 2004, J INFECT DIS, V189, P1996, DOI 10.1086/386548; Carter RJ, 2005, INFECT CONT HOSP EP, V26, P248, DOI 10.1086/502534; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P800; Chen DK, 1999, NEW ENGL J MED, V341, P233, DOI 10.1056/NEJM199907223410403; Clinical and Laboratory Standards Institute (CLSI) C, 2005, M100S15 CLSI NCCLS; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Davidson R, 2002, NEW ENGL J MED, V346, P747, DOI 10.1056/NEJMoa012122; Fry AM, 2005, INFECT CONT HOSP EP, V26, P239, DOI 10.1086/502533; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gendrel D, 2003, LANCET INFECT DIS, V3, P537, DOI 10.1016/S1473-3099(03)00736-9; Gosling R, 2004, ANTIMICROB AGENTS CH, V48, P3642, DOI 10.1128/AAC.48.9.3642-3643.2004; Ho PL, 2004, EMERG INFECT DIS, V10, P1250, DOI 10.3201/eid1007.030612; Ho PL, 2001, CLIN INFECT DIS, V32, P701, DOI 10.1086/319222; Huang TD, 2006, PEDIATR INFECT DIS J, V25, P1195, DOI 10.1097/01.inf.0000243766.85379.d6; Huebner RE, 1999, S AFR MED J, V89, P924; JACOBS MR, 1978, NEW ENGL J MED, V299, P735, DOI 10.1056/NEJM197810052991402; Karstaedt AS, 2001, CLIN INFECT DIS, V33, P610, DOI 10.1086/322589; Klugman K P, 2001, Lancet Infect Dis, V1, P85, DOI 10.1016/S1473-3099(01)00063-9; Klugman KP, 2003, CLIN INFECT DIS, V36, P783, DOI 10.1086/367935; KOORNHOF HJ, 1992, CLIN INFECT DIS, V15, P84, DOI 10.1093/clinids/15.1.84; LEFEVRE JC, 1993, J CLIN MICROBIOL, V31, P2724, DOI 10.1128/JCM.31.10.2724-2728.1993; Linares J, 1999, NEW ENGL J MED, V341, P1546; Low DE, 2005, CLIN INFECT DIS, V40, P236, DOI 10.1086/426822; Mandell LA, 2002, CLIN INFECT DIS, V35, P721, DOI 10.1086/341900; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; McEllistrem MC, 2000, J CLIN MICROBIOL, V38, P351; McGee L, 2002, J ANTIMICROB CHEMOTH, V49, P173, DOI 10.1093/jac/49.1.173; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; Pletz MWR, 2004, ANTIMICROB AGENTS CH, V48, P3491, DOI 10.1128/AAC.48.9.3491-3497.2004; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; Ruoff KL, 2003, MANUAL CLIN MICROBIO, P405; *STAT S AFR, 2005, P03093 MORT CAUS DEA; von Gottberg A, 2003, PEDIATR INFECT DIS J, V22, P1020, DOI 10.1097/01.inf.0000095430.29265.7f; Woolfson A, 1997, B WORLD HEALTH ORGAN, V75, P453; Yew WW, 2002, INT J TUBERC LUNG D, V6, P174	39	45	45	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2008	371	9618					1108	1113		10.1016/S0140-6736(08)60350-5	http://dx.doi.org/10.1016/S0140-6736(08)60350-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280RA	18359074				2022-12-24	WOS:000254442700029
J	Yang, L; Anderson, DE; Baecher-Allan, C; Hastings, WD; Bettelli, E; Oukka, M; Kuchroo, VK; Hafler, DA				Yang, Li; Anderson, David E.; Baecher-Allan, Clare; Hastings, William D.; Bettelli, Estelle; Oukka, Mohamed; Kuchroo, Vijay K.; Hafler, David A.			IL-21 and TGF-beta are required for differentiation of human T(H)17 cells	NATURE			English	Article							GROWTH-FACTOR-BETA; T-CELLS; GENERATION; PATHWAYS; LINEAGE; CONTEXT; IL-17	The recent discovery of CD4(+) T cells characterized by secretion of interleukin ( IL)- 17 (T(H)17 cells) and the naturally occurring regulatory FOXP3(+) CD4 T cell ( nT(reg)) has had a major impact on our understanding of immune processes not readily explained by the T(H)1/T(H)2 paradigm. T(H)17 and nT(reg) cells have been implicated in the pathogenesis of human autoimmune diseases, including multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease and psoriasis(1,2). Our recent data and the work of others demonstrated that transforming growth factor-beta ( TGF-beta) and IL- 6 are responsible for the differentiation of naive mouse T cells into T(H)17 cells, and it has been proposed that IL-23 may have a critical role in stabilization of the T(H)17 phenotype(3-5). A second pathway has been discovered in which a combination of TGF-beta and IL- 21 is capable of inducing differentiation of mouse T(H)17 cells in the absence of IL- 6 ( refs 6 - 8). However, TGF-beta and IL- 6 are not capable of differentiating human T(H)17 cells(2,9) and it has been suggested that TGF-beta may in fact suppress the generation of human T(H)17 cells(10). Instead, it has been recently shown that the cytokines IL-1 beta, IL- 6 and IL- 23 are capable of driving IL- 17 secretion in short- term CD4(+) T cell lines isolated from human peripheral blood(11), although the factors required for differentiation of naive human CD4 to T(H)17 cells are still unknown. Here we confirm that whereas IL-1 beta and IL- 6 induce IL- 17A secretion from human central memory CD4(+) T cells, TGF-beta and IL- 21 uniquely promote the differentiation of human naive CD4(+) T cells into T(H)17 cells accompanied by expression of the transcription factor RORC2. These data will allow the investigation of this new population of T(H)17 cells in human inflammatory disease.	[Yang, Li; Anderson, David E.; Baecher-Allan, Clare; Hastings, William D.; Bettelli, Estelle; Oukka, Mohamed; Kuchroo, Vijay K.; Hafler, David A.] Harvard Univ, Sch Med, Div Mol Immunol, Ctr Neurol Dis,Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Anderson, DE (corresponding author), Harvard Univ, Sch Med, Div Mol Immunol, Ctr Neurol Dis,Brigham & Womens Hosp, Boston, MA 02115 USA.	danderson@rics.bwh.harvard.edu			NIAID NIH HHS [P01 AI039671-14, U19 AI070352, R01 AI073542, R01 AI073542-02, R01 AI073542-03, P01 AI039671, R01 AI073542-01, U19 AI070352-03] Funding Source: Medline; NINDS NIH HHS [R37 NS024247, P01 NS038037-080006, P01 NS038037, R37 NS024247-20] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070352, P01AI039671, R01AI073542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS024247, P01NS038037] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Evans HG, 2007, P NATL ACAD SCI USA, V104, P17034, DOI 10.1073/pnas.0708426104; Kikly K, 2006, CURR OPIN IMMUNOL, V18, P670, DOI 10.1016/j.coi.2006.09.008; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Laurence A, 2007, NAT IMMUNOL, V8, P903, DOI 10.1038/ni0907-903; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	14	752	818	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2008	454	7202					350	U55		10.1038/nature07021	http://dx.doi.org/10.1038/nature07021			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326ND	18469800	Green Accepted			2022-12-24	WOS:000257665300042
J	Cai, CL; Martin, JC; Sun, YF; Cui, L; Wang, LC; Ouyang, K; Yang, L; Bu, L; Liang, XQ; Zhang, XX; Stallcup, WB; Denton, CP; McCulloch, A; Chen, J; Evans, SM				Cai, Chen-Leng; Martin, Jody C.; Sun, Yunfu; Cui, Li; Wang, Lianchun; Ouyang, Kunfu; Yang, Lei; Bu, Lei; Liang, Xingqun; Zhang, Xiaoxue; Stallcup, William B.; Denton, Christopher P.; McCulloch, Andrew; Chen, Ju; Evans, Sylvia M.			A myocardial lineage derives from Tbx18 epicardial cells	NATURE			English	Article							SMOOTH-MUSCLE-CELLS; PERICARDIAL MESODERM; HEART; POPULATION; EXPRESSION; MOUSE; DIFFERENTIATION; MORPHOGENESIS; MESOTHELIUM; SEPTUM	Understanding the origins and roles of cardiac progenitor cells is important for elucidating the pathogenesis of congenital and acquired heart diseases(1,2). Moreover, manipulation of cardiac myocyte progenitors has potential for cell- based repair strategies for various myocardial disorders(3). Here we report the identification in mouse of a previously unknown cardiac myocyte lineage that derives from the proepicardial organ. These progenitor cells, which express the T- box transcription factor Tbx18, migrate onto the outer cardiac surface to form the epicardium, and then make a substantial contribution to myocytes in the ventricular septum and the atrial and ventricular walls. Tbx18- expressing cardiac progenitors also give rise to cardiac fibroblasts and coronary smooth muscle cells. The pluripotency of Tbx18 proepicardial cells provides a theoretical framework for applying these progenitors to effect cardiac repair and regeneration.	[Cai, Chen-Leng; Sun, Yunfu; Cui, Li; Yang, Lei; Bu, Lei; Zhang, Xiaoxue; Evans, Sylvia M.] Univ Calif San Diego, Skaggs Sch Pharm, La Jolla, CA 92093 USA; [Martin, Jody C.; McCulloch, Andrew] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Ouyang, Kunfu; Liang, Xingqun; Chen, Ju; Evans, Sylvia M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Cai, Chen-Leng] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Cai, Chen-Leng] Mt Sinai Sch Med, Ctr Mol Cardiol, New York, NY 10029 USA; [Cai, Chen-Leng] Mt Sinai Sch Med, Black Family Stem Cell Inst, New York, NY 10029 USA; [Wang, Lianchun] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Stallcup, William B.] Burnham Inst, Dev Neurobiol Programme, La Jolla, CA 92037 USA; [Denton, Christopher P.] UCL Royal Free & Univ Coll Med Sch, Ctr Rheumatol, London NW3 2PF, England	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University System of Georgia; University of Georgia; Sanford Burnham Prebys Medical Discovery Institute; University of London; University College London; UCL Medical School	Evans, SM (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm, La Jolla, CA 92093 USA.	syevans@ucsd.edu	Evans, Sylvia/G-1980-2015; Yang, Lei/D-7462-2015; Chen, Ju/E-5579-2011; ouyang, kunfu/B-3073-2011	ouyang, kunfu/0000-0003-0292-375X; BU, LEI/0000-0003-4476-2157	NCRR NIH HHS [P41 RR005351] Funding Source: Medline; NHLBI NIH HHS [DP1 HL117649, R01 HL070867, T32 HL007444] Funding Source: Medline; NIH HHS [DP1 OD006428] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007444, DP1HL117649, R01HL070867] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006428] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Cai CL, 2005, DEVELOPMENT, V132, P2475, DOI 10.1242/dev.01832; Christoffels VM, 2006, CIRC RES, V98, P1555, DOI 10.1161/01.RES.0000227571.84189.65; Franco D, 2006, DEV BIOL, V294, P366, DOI 10.1016/j.ydbio.2006.02.045; Gittenberger-de Groot AC, 1998, CIRC RES, V82, P1043, DOI 10.1161/01.RES.82.10.1043; Hadjantonakis AK, 2003, NAT REV GENET, V4, P613, DOI 10.1038/nrg1126; KELLY R, IN PRESS HEART DEV R; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Kruithof BPT, 2006, DEV BIOL, V295, P507, DOI 10.1016/j.ydbio.2006.03.033; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; MIKAWA T, 1992, P NATL ACAD SCI USA, V89, P9504, DOI 10.1073/pnas.89.20.9504; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Murry CE, 2005, CIRCULATION, V112, P3174, DOI 10.1161/CIRCULATIONAHA.105.546218; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Ouyang KF, 2005, P NATL ACAD SCI USA, V102, P12259, DOI 10.1073/pnas.0408494102; Perez-Pomares JM, 2002, INT J DEV BIOL, V46, P1005; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Subramanian SV, 2002, CARDIOVASC RES, V54, P539, DOI 10.1016/S0008-6363(02)00270-5; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Zheng B, 2002, AM J PATHOL, V160, P1609, DOI 10.1016/S0002-9440(10)61108-X; Zhou YY, 2000, AM J PHYSIOL-HEART C, V279, pH429	29	569	603	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2008	454	7200					104	U4		10.1038/nature06969	http://dx.doi.org/10.1038/nature06969			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18480752	Green Accepted			2022-12-24	WOS:000257308300046
J	Liu, H; Rudolf, J; Johnson, KA; McMahon, SA; Oke, M; Carter, L; McRobbie, AM; Brown, SE; Naismith, JH; White, MF				Liu, Huanting; Rudolf, Jana; Johnson, Kenneth A.; McMahon, Stephen A.; Oke, Muse; Carter, Lester; McRobbie, Anne-Marie; Brown, Sara E.; Naismith, James H.; White, Malcolm F.			Structure of the DNA repair helicase XPD	CELL			English	Article							XERODERMA-PIGMENTOSUM; CRYSTAL-STRUCTURE; COCKAYNE-SYNDROME; BASAL TRANSCRIPTION; DIFFRACTION DATA; TRICHOTHIODYSTROPHY; DEFICIENT; MUTATIONS; SEQUENCE; FEATURES	The XPD helicase (Rad3 in Saccharomyces cerevisiae) is a component of transcription factor IIH (TFIIH), which functions in transcription initiation and Nucleotide Excision Repair in eukaryotes, catalyzing DNA duplex opening localized to the transcription start site or site of DNA damage, respectively. XPD has a 50 to 30 polarity and the helicase activity is dependent on an iron-sulfur cluster binding domain, a feature that is conserved in related helicases such as FancJ. The xpd gene is the target of mutation in patients with xeroderma pigmentosum, trichothiodystrophy, and Cockayne's syndrome, characterized by a wide spectrum of symptoms ranging from cancer susceptibility to neurological and developmental defects. The 2.25 angstrom crystal structure of XPD from the crenarchaeon Sulfolobus tokodaii, presented here together with detailed biochemical analyses, allows a molecular understanding of the structural basis for helicase activity and explains the phenotypes of xpd mutations in humans.	[Liu, Huanting; Rudolf, Jana; Johnson, Kenneth A.; McMahon, Stephen A.; Oke, Muse; Carter, Lester; McRobbie, Anne-Marie; Brown, Sara E.; Naismith, James H.; White, Malcolm F.] Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland	University of St Andrews	Naismith, JH (corresponding author), Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland.	jhn@st-and.ac.uk; mfw2@st-and.ac.uk	White, Malcolm F/A-6055-2010; Naismith, James Henderson/AAB-8614-2020; Carter, Lester/G-6561-2014; Naismith, James Henderson/H-3408-2012	White, Malcolm F/0000-0003-1543-9342; Naismith, James Henderson/0000-0001-6744-5061; Naismith, James Henderson/0000-0001-6744-5061; Rudolf, Jana/0000-0003-1134-2340; Liu, Huanting/0000-0001-5953-9367; Oke, Muse/0000-0002-0169-752X	MRC [G0500367] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/14426] Funding Source: Medline; Medical Research Council [G0500367] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Andressoo JO, 2006, CANCER CELL, V10, P121, DOI 10.1016/j.ccr.2006.05.027; Berneburg M, 2000, CANCER RES, V60, P431; Boal AK, 2005, BIOCHEMISTRY-US, V44, P8397, DOI 10.1021/bi047494n; Botta E, 2002, HUM MOL GENET, V11, P2919, DOI 10.1093/hmg/11.23.2919; Botta E, 1998, AM J HUM GENET, V63, P1036, DOI 10.1086/302063; Broughton BC, 2001, HUM MOL GENET, V10, P2539, DOI 10.1093/hmg/10.22.2539; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bruns CM, 1999, J MOL BIOL, V288, P427, DOI 10.1006/jmbi.1999.2697; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Chen J, 2003, NATURE, V424, P228, DOI 10.1038/nature01746; Chen J, 2003, CELL CYCLE, V2, P503, DOI 10.4161/cc.2.6.558; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; Dubaele S, 2003, MOL CELL, V11, P1635, DOI 10.1016/S1097-2765(03)00182-5; DUPUY JM, 1978, PEDIATRICS, V61, P675; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujimoto M, 2005, J INVEST DERMATOL, V125, P86, DOI 10.1111/j.0022-202X.2005.23745.x; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; Hinks JA, 2002, J BIOL CHEM, V277, P16936, DOI 10.1074/jbc.M200668200; Hirata A, 2008, NATURE, V451, P851, DOI 10.1038/nature06530; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kawarabayasi Y, 2001, DNA RES, V8, P123, DOI 10.1093/dnares/8.4.123; Kelman Z, 2005, CURR OPIN MICROBIOL, V8, P669, DOI 10.1016/j.mib.2005.10.001; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; KUO CF, 1992, SCIENCE, V258, P434, DOI 10.1126/science.1411536; Lee BS, 2000, MOL CELL BIOL, V20, P2436, DOI 10.1128/MCB.20.7.2436-2445.2000; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Nishiwaki Y, 2004, J INVEST DERMATOL, V122, P526, DOI 10.1046/j.0022-202X.2004.22226.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pugh RA, 2008, J BIOL CHEM, V283, P1732, DOI 10.1074/jbc.M707064200; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Seetharamappa J, 2007, ACTA CRYSTALLOGR F, V63, P488, DOI 10.1107/S1744309107020362; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; Soultanas P, 2000, EMBO J, V19, P3799, DOI 10.1093/emboj/19.14.3799; Taylor EM, 1997, P NATL ACAD SCI USA, V94, P8658, DOI 10.1073/pnas.94.16.8658; Theis K, 1999, EMBO J, V18, P6899, DOI 10.1093/emboj/18.24.6899; Theron T, 2005, MOL CELL BIOL, V25, P8368, DOI 10.1128/MCB.25.18.8368-8378.2005; van Hoffen A, 1999, NUCLEIC ACIDS RES, V27, P2898, DOI 10.1093/nar/27.14.2898; Vermeulen W, 2001, NAT GENET, V27, P299, DOI 10.1038/85864; Voloshin ON, 2007, J BIOL CHEM, V282, P18437, DOI 10.1074/jbc.M700376200; Winkler GS, 2000, J BIOL CHEM, V275, P4258, DOI 10.1074/jbc.275.6.4258	50	199	222	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 30	2008	133	5					801	812		10.1016/j.cell.2008.04.029	http://dx.doi.org/10.1016/j.cell.2008.04.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	306UY	18510925	Green Accepted, Bronze			2022-12-24	WOS:000256274500013
J	Uren, AG; Kool, J; Matentzoglu, K; de Ridder, J; Mattison, J; van Uitert, M; Lagcher, W; Sie, D; Tanger, E; Cox, T; Reinders, M; Hubbard, TJ; Rogers, J; Jonkers, J; Wessels, L; Adams, DJ; van Lohuizen, M; Berns, A				Uren, Anthony G.; Kool, Jaap; Matentzoglu, Konstantin; de Ridder, Jeroen; Mattison, Jenny; van Uitert, Miranda; Lagcher, Wendy; Sie, Daoud; Tanger, Ellen; Cox, Tony; Reinders, Marcel; Hubbard, Tim J.; Rogers, Jane; Jonkers, Jos; Wessels, Lodewyk; Adams, David J.; van Lohuizen, Maarten; Berns, Anton			Large-scale mutagenesis in p19(ARF)- and p53- Deficient mice identifies cancer genes and their collaborative networks	CELL			English	Article							RETROVIRAL INSERTIONAL MUTAGENESIS; TUMOR-SUPPRESSOR GENE; T-CELL LYMPHOMAGENESIS; TRANSCRIPTION FACTOR; HUMAN BREAST; LEUKEMIA; PATHWAY; P53; MUTATIONS; DEFICIENT	p53 and p19 ARF are tumor suppressors frequently mutated in human tumors. In a high- throughput screen in mice for mutations collaborating with either p53 or p19(ARF) deficiency, we identified 10,806 retroviral insertion sites, implicating over 300 loci in tumorigenesis. This dataset reveals 20 genes that are specifically mutated in either p19(ARF)-deficient, p53-deficient or wildtype mice ( including Flt3, mmu-mir-106a-363, Smg6, and Ccnd3), as well as networks of significant collaborative and mutually exclusive interactions between cancergenes. Furthermore, we found candidate tumor suppressor genes, as well as distinct clusters of insertions within genes like Flt3 and Notch1 that induce mutants with different spectra of genetic interactions. Cross species comparative analysis with aCGH data of human cancer cell lines revealed known and candidate oncogenes ( Mmp13, Slamf6, and Rreb1) and tumor suppressors ( Wwox and Arfrp2). This dataset should prove to be a rich resource for the study of genetic interactions that underlie tumorigenesis.	[de Ridder, Jeroen; van Uitert, Miranda; Jonkers, Jos; Wessels, Lodewyk] Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands; [Uren, Anthony G.; Kool, Jaap; Matentzoglu, Konstantin; Lagcher, Wendy; Tanger, Ellen; van Lohuizen, Maarten; Berns, Anton] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Uren, Anthony G.; Kool, Jaap; Matentzoglu, Konstantin; Lagcher, Wendy; Tanger, Ellen; van Lohuizen, Maarten; Berns, Anton] Netherlands Canc Inst, Canc Genom Ctr, NL-1066 CX Amsterdam, Netherlands; [de Ridder, Jeroen; Reinders, Marcel; Wessels, Lodewyk] Delft Univ Technol, Fac Elect Engn Math & Comp Sci, NL-2628 CD Delft, Netherlands; [Mattison, Jenny; Cox, Tony; Rogers, Jane; Adams, David J.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Sie, Daoud] Netherlands Canc Inst, Cent Microarray Facil, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Delft University of Technology; Wellcome Trust Sanger Institute; Netherlands Cancer Institute	Wessels, L (corresponding author), Netherlands Canc Inst, Div Mol Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	l.wessels@nki.nl; da1@sanger.ac.uk; m.v.lohuizen@nki.nl; a.berns@nki.nl	Hubbard, Tim J.P./AAT-4571-2020; Hubbard, Tim J/C-2567-2008; Uren, Anthony G/A-5784-2009; Jonkers, Jos/AAG-3246-2019	Hubbard, Tim J.P./0000-0002-1767-9318; Hubbard, Tim J/0000-0002-1767-9318; Uren, Anthony G/0000-0002-6019-7111; Jonkers, Jos/0000-0002-9264-9792; de Ridder, Jeroen/0000-0002-0828-3477; Adams, David/0000-0001-9490-0306; Sie, Daoud/0000-0001-6762-2582	Cancer Research UK Funding Source: Medline; Wellcome Trust [76943, 077198] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Beverly LJ, 2005, CANCER RES, V65, P7159, DOI 10.1158/0008-5472.CAN-05-1664; Beverly LJ, 2003, CANCER CELL, V3, P551, DOI 10.1016/S1535-6108(03)00137-5; Brock C, 2003, J CELL BIOL, V160, P89, DOI 10.1083/jcb.200210115; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; CUYPERS HT, 1984, CELL, V37, P141; Dave UP, 2004, SCIENCE, V303, P333, DOI 10.1126/science.1091667; DAVID YB, 1988, ONCOGENE, V3, P179; de Ridder J, 2007, BIOINFORMATICS, V23, pI133, DOI 10.1093/bioinformatics/btm202; de Ridder J, 2006, PLOS COMPUT BIOL, V2, P1530, DOI 10.1371/journal.pcbi.0020166; DEVON RS, 1995, NUCLEIC ACIDS RES, V23, P1644, DOI 10.1093/nar/23.9.1644; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Ebinu JO, 2000, BLOOD, V95, P3199; Efeyan A, 2006, NATURE, V443, P159, DOI 10.1038/443159a; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Eischen CM, 2001, MOL CELL BIOL, V21, P5063, DOI 10.1128/MCB.21.15.5063-5070.2001; Frank B, 2005, NEW ENGL J MED, V353, P313; Fukuhara N, 2005, MOL CELL, V17, P537, DOI 10.1016/j.molcel.2005.01.010; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Glud SZ, 2005, BLOOD, V106, P3546, DOI 10.1182/blood-2005-02-0493; Gupta M, 2005, ONCOGENE, V24, P7170, DOI 10.1038/sj.onc.1208847; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hoemann CD, 2000, MOL CELL BIOL, V20, P3831, DOI 10.1128/MCB.20.11.3831-3842.2000; Hwang HC, 2002, P NATL ACAD SCI USA, V99, P11293, DOI 10.1073/pnas.162356099; Johansson FK, 2004, P NATL ACAD SCI USA, V101, P11334, DOI 10.1073/pnas.0402716101; Jonkers J, 1996, BBA-REV CANCER, V1287, P29, DOI 10.1016/0304-419X(95)00020-G; Kamijo T, 1999, CANCER RES, V59, P2217; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kelly-Spratt KS, 2004, PLOS BIOL, V2, P1138, DOI 10.1371/journal.pbio.0020242; Kim AC, 1997, GENOMICS, V46, P291, DOI 10.1006/geno.1997.5029; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lee H, 2005, MOL CARCINOGEN, V44, P219, DOI 10.1002/mc.20136; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Li GC, 1998, MOL CELL, V2, P1, DOI 10.1016/S1097-2765(00)80108-2; Li JY, 1999, NAT GENET, V23, P348, DOI 10.1038/15531; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Moore L, 2003, ONCOGENE, V22, P7831, DOI 10.1038/sj.onc.1206985; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Opavsky R, 2007, P NATL ACAD SCI USA, V104, P15400, DOI 10.1073/pnas.0706307104; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Petrocca F, 2006, CANCER RES, V66, P10287, DOI 10.1158/0008-5472.CAN-06-2289; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Sharma VM, 2007, CELL CYCLE, V6, P927, DOI 10.4161/cc.6.8.4134; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Slape C, 2007, CANCER RES, V67, P5148, DOI 10.1158/0008-5472.CAN-07-0075; Stewart M, 2007, CANCER RES, V67, P5126, DOI 10.1158/0008-5472.CAN-07-0433; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Stirewalt DL, 2001, BLOOD, V97, P3589, DOI 10.1182/blood.V97.11.3589; Sun L, 1999, P NATL ACAD SCI USA, V96, P680, DOI 10.1073/pnas.96.2.680; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Suzuki T, 2006, EMBO J, V25, P3422, DOI 10.1038/sj.emboj.7601215; SYCH F, 1978, CANC RES CLIN ONCOL, V92, P105; Theodorou V, 2007, NAT GENET, V39, P759, DOI 10.1038/ng2034; Uren AG, 2005, ONCOGENE, V24, P7656, DOI 10.1038/sj.onc.1209043; Wandstrat AE, 2004, IMMUNITY, V21, P769, DOI 10.1016/j.immuni.2004.10.009; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zhang SL, 2003, ONCOGENE, V22, P2285, DOI 10.1038/sj.onc.1206257	66	151	154	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 16	2008	133	4					727	741		10.1016/j.cell.2008.03.021	http://dx.doi.org/10.1016/j.cell.2008.03.021			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485879	hybrid, Green Published			2022-12-24	WOS:000255903300026
J	Mavrich, TN; Jiang, CZ; Ioshikhes, IP; Li, XY; Venters, BJ; Zanton, SJ; Tomsho, LP; Qi, J; Glaser, RL; Schuster, SC; Gilmour, DS; Albert, I; Pugh, BF				Mavrich, Travis N.; Jiang, Cizhong; Ioshikhes, Ilya P.; Li, Xiaoyong; Venters, Bryan J.; Zanton, Sara J.; Tomsho, Lynn P.; Qi, Ji; Glaser, Robert L.; Schuster, Stephan C.; Gilmour, David S.; Albert, Istvan; Pugh, B. Franklin			Nucleosome organization in the Drosophila genome	NATURE			English	Article							RNA-POLYMERASE-II; HIGH-RESOLUTION MAP; PROMOTER ELEMENT; HISTONE H2A.Z; TRANSCRIPTION; CHROMATIN; REPLACEMENT; VARIANT; GENES; ACETYLATION	Comparative genomics of nucleosome positions provides a powerful means for understanding how the organization of chromatin and the transcription machinery co-evolve. Here we produce a high-resolution reference map of H2A.Z and bulk nucleosome locations across the genome of the fly Drosophila melanogaster and compare it to that from the yeast Saccharomyces cerevisiae. Like Saccharomyces, Drosophila nucleosomes are organized around active transcription start sites in a canonical -1, nucleosome-free region, +1 arrangement. However, Drosophila does not incorporate H2A.Z into the -1 nucleosome and does not bury its transcriptional start site in the +1 nucleosome. At thousands of genes, RNA polymerase II engages the +1 nucleosome and pauses. How the transcription initiation machinery contends with the +1 nucleosome seems to be fundamentally different across major eukaryotic lines.	[Mavrich, Travis N.; Jiang, Cizhong; Venters, Bryan J.; Zanton, Sara J.; Gilmour, David S.; Pugh, B. Franklin] Penn State Univ, Ctr Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Mavrich, Travis N.; Jiang, Cizhong; Venters, Bryan J.; Zanton, Sara J.; Tomsho, Lynn P.; Qi, Ji; Schuster, Stephan C.; Albert, Istvan; Pugh, B. Franklin] Penn State Univ, Ctr Comparat Genom & Bioinformat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Ioshikhes, Ilya P.] Ohio State Univ, Dept Biomed Informat, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Ioshikhes, Ilya P.] Ohio State Univ, Dept Mol & Cellular Biochem, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Li, Xiaoyong] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley Drosophila Transcript Network Project, Genom Div, Berkeley, CA 94720 USA; [Glaser, Robert L.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Glaser, Robert L.] SUNY Albany, Dept Biomed Sci, Albany, NY 12201 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Pugh, BF (corresponding author), Penn State Univ, Ctr Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	bfp2@psu.edu	QI, JI/E-2797-2016; Albert, Istvan/J-3734-2015	Mavrich, Travis/0000-0001-9252-5020; Albert, Istvan/0000-0001-8366-984X	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047477] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG004160-01A1, HG004160, R01 HG004160] Funding Source: Medline; NIGMS NIH HHS [GM47477, R01 GM047477] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BIGGIN MD, 1988, CELL, V53, P699, DOI 10.1016/0092-8674(88)90088-8; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Brown SA, 1997, GENE DEV, V11, P3116, DOI 10.1101/gad.11.23.3116; Brown SA, 1996, GENE DEV, V10, P1479, DOI 10.1101/gad.10.12.1479; Bruce K, 2005, NUCLEIC ACIDS RES, V33, P5633, DOI 10.1093/nar/gki874; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FYRBERG E, 1994, METHOD CELL BIOL, V44, P1; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hild M, 2004, GENOME BIOL, V5; Ioshikhes I, 1996, J MOL BIOL, V262, P129, DOI 10.1006/jmbi.1996.0503; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Johnson SM, 2006, GENOME RES, V16, P1505, DOI 10.1101/gr.5560806; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kogan SB, 2006, J BIOMOL STRUCT DYN, V24, P43, DOI 10.1080/07391102.2006.10507097; KORNBERG R, 1981, NATURE, V292, P579, DOI 10.1038/292579a0; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; Law A, 1998, NUCLEIC ACIDS RES, V26, P919, DOI 10.1093/nar/26.4.919; Leach TJ, 2000, J BIOL CHEM, V275, P23267, DOI 10.1074/jbc.M910206199; LEE C, IN PRESS MOL CELL BI; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Lehmann M, 2004, TRENDS GENET, V20, P15, DOI 10.1016/j.tig.2003.11.005; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Lieb JD, 2005, CELL, V123, P1187, DOI 10.1016/j.cell.2005.12.010; Lim CY, 2004, GENE DEV, V18, P1606, DOI 10.1101/gad.1193404; Lis JT, 2007, NATURE, V450, P198, DOI 10.1038/nature06324; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Orlando V, 1998, EMBO J, V17, P5141, DOI 10.1093/emboj/17.17.5141; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; PURNELL BA, 1994, GENE DEV, V8, P830, DOI 10.1101/gad.8.7.830; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; SOELLER WC, 1993, MOL CELL BIOL, V13, P7961, DOI 10.1128/MCB.13.12.7961; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Swaminathan J, 2005, GENE DEV, V19, P65, DOI 10.1101/gad.1259105; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Updike DL, 2006, PLOS GENET, V2, P1500, DOI 10.1371/journal.pgen.0020161; van Steensel B, 2003, P NATL ACAD SCI USA, V100, P2580, DOI 10.1073/pnas.0438000100; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583	54	535	552	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2008	453	7193					358	U27		10.1038/nature06929	http://dx.doi.org/10.1038/nature06929			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18408708	Green Accepted			2022-12-24	WOS:000255868400044
J	Krueger, AB; Stone, AA				Krueger, Alan B.; Stone, Arthur A.			Assessment of pain: a community-based diary survey in the USA	LANCET			English	Article							CHRONIC MUSCULOSKELETAL PAIN; GENERAL-POPULATION; PREVALENCE; HEALTH	Background Pain is costly and a major reason for seeking medical care. Our aim was to assess the proportion of people experiencing pain, and the severity of pain, at randomly selected times in a representative sample of individuals in the USA. Methods A community-based telephone survey was designed that attempted to contact about 10 700 individuals by random-digit dialling. After collecting diary information for one 24-h period, ratings of pain on a 0-6 anchored scale for three randomly selected 15-min intervals of the day were obtained. Outcome measures were the proportion of intervals with non-zero pain, the proportion of intervals with pain above 3 (the scale midpoint), and the average pain rating. Activities of those individuals who reported substantial pain were also examined. To make the results representative of the US population, sample data were adjusted with sample weights developed by the Gallup Organisation. Findings 3982 individuals were interviewed (response rate 37%). After adjustment for weighting, 28.8% of men and 26.6% of women reported feeling some pain at sampled times. Those with lower income or less education spent a higher proportion of time in pain and reported higher average pain than did those with higher income or more education. The average pain rating increased with age, although it reached a plateau between the ages of about 45 years and 75 years, with little difference between men and women. Satisfaction with life or health and the pain indicators tended to move in opposite directions. Interpretation The diary-survey methods described here could be used to study pain at the population level, and will enable the combination of pain assessments with information about activities of daily living. Funding US National Institute of Aging, Hewlett Foundation.	[Krueger, Alan B.] Princeton Univ, Dept Econ, Princeton, NJ 08540 USA; [Krueger, Alan B.] Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08540 USA; [Stone, Arthur A.] SUNY Stony Brook, Dept Psychiat & Behav Sci, Stony Brook, NY 11794 USA	Princeton University; Princeton University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Krueger, AB (corresponding author), Princeton Univ, Dept Econ, Robertson Hall,Prospect Ave, Princeton, NJ 08540 USA.	akrueger@princeton.edu	Stone, Arthur A./AAC-3610-2019		NIA NIH HHS [P30 AG024928] Funding Source: Medline; NICHD NIH HHS [R24 HD047879] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024928] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		American Association for Public Opinion Research, 2006, STAND DEF FIN DISP C, V4th; Ashenfelter O. C., 1999, HDB LABOR EC C, V3, P3417, DOI DOI 10.1016/S1573-4463(99)30042-0; ATLAS S, 2007, ED DISABILITY PREVAL; *BEH RISK SURV SYS, SUMM DAT QUAL REP 20; BRADBURN NM, 1987, SCIENCE, V236, P157, DOI 10.1126/science.3563494; Buskila D, 2000, J RHEUMATOL, V27, P1521; Catala E, 2002, EUR J PAIN-LONDON, V6, P133, DOI 10.1053/eujp.2001.0310; *CDCP, 2006, HLTH US 2006 CHARTB, P68; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3; Gerdle B, 2004, J RHEUMATOL, V31, P1399; Gorin AA, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P405; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; Kahneman D, 2004, SCIENCE, V306, P1776, DOI 10.1126/science.1103572; KAPTEYN A, 2006, DYNAMICS WORK DISABI; Litcher-Kelly L, 2007, J PAIN, V8, P906, DOI 10.1016/j.jpain.2007.06.009; MAGNI G, 1990, PAIN, V43, P299, DOI 10.1016/0304-3959(90)90027-B; Mantyselka PT, 2003, JAMA-J AM MED ASSOC, V290, P2435, DOI 10.1001/jama.290.18.2435; SMITH JP, 1993, J ECON PERSPECT, V13, P145; STAGNITTI M, 2004, TOP 5 THERAPEUTIC CL; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; TURUNEN J, THESIS U KUOPIO FINL; Verhaak PFM, 1998, PAIN, V77, P231, DOI 10.1016/S0304-3959(98)00117-1; VONKORFF M, 1990, PAIN, V40, P279, DOI 10.1016/0304-3959(90)91125-3; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; 2007, CHAIN DRUG REV, V29, P62	27	92	92	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2008	371	9623					1519	1525		10.1016/S0140-6736(08)60656-X	http://dx.doi.org/10.1016/S0140-6736(08)60656-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298ED	18456101	Green Submitted			2022-12-24	WOS:000255668300028
J	Varjosalo, M; Bjorklund, M; Cheng, F; Syvanen, H; Kivioja, T; Kilpinen, S; Sun, Z; Kallioniemi, O; Stunnenberg, HG; He, WW; Ojala, P; Taipale, J				Varjosalo, Markku; Bjorklund, Mikael; Cheng, Fang; Syvanen, Heidi; Kivioja, Teemu; Kilpinen, Sami; Sun, Zairen; Kallioniemi, Olli; Stunnenberg, Hendrik G.; He, Wei-Wu; Ojala, Paivi; Taipale, Jussi			Application of active and kinase-deficient kinome collection for identification of kinases regulating hedgehog signaling	CELL			English	Article							PROTEIN-KINASE; KAPOSIS-SARCOMA; TRANSCRIPTIONAL ACTIVITY; CUBITUS INTERRUPTUS; DNA-SEQUENCES; HUMAN GENOME; MEK KINASE; 1 GENE; ACTIVATION; PATHWAY	To allow genome-scale identification of genes that regulate cellular signaling, we cloned > 90% of all human full-length protein kinase cDNAs and constructed the corresponding kinase activity-deficient mutants. To establish the utility of this resource, we tested the effect of expression of the kinases on three different cellular signaling models. In all screens, many kinases had a modest but significant effect, apparently due to crosstalk between signaling pathways. However, the strongest effects were found with known regulators and novel components, such as MAP3K10 and DYRK2, which we identified in a mammalian Hedgehog (Hh) signaling screen. DYRK2 directly phosphorylated and induced the proteasome-dependent degradation of the key Hh pathway-regulated transcription factor, GLI2. MAP3K10, in turn, affected GLI2 indirectly by modulating the activity of DYRK2 and the known Hh pathway component, GSK3b. Our results establish kinome expression screening as a highly effective way to identify physiological signaling pathway components and genes involved in pathological signaling crosstalk.	[Varjosalo, Markku; Bjorklund, Mikael; Cheng, Fang; Syvanen, Heidi; Kivioja, Teemu; Kilpinen, Sami; Kallioniemi, Olli; Ojala, Paivi; Taipale, Jussi] Univ Helsinki, Inst Biomed, Biomedicum Helsinki, Genome Scale Biol Program, FI-00014 Helsinki, Finland; [Varjosalo, Markku; Bjorklund, Mikael; Syvanen, Heidi; Kivioja, Teemu; Taipale, Jussi] Natl Publ Hlth Inst, Dept Mol Med, FI-00290 Helsinki, Finland; [Varjosalo, Markku; Bjorklund, Mikael; Syvanen, Heidi; Taipale, Jussi] Univ Helsinki, High Throughput Ctr, FI-00014 Helsinki, Finland; [Kivioja, Teemu] Univ Helsinki, Dept Comp Sci, FI-00014 Helsinki, Finland; [Kilpinen, Sami; Kallioniemi, Olli] VTT Tech Res Ctr Finland, Ctr Med Biotechnol, FI-20520 Turku, Finland; [Kilpinen, Sami; Kallioniemi, Olli] Univ Turku, FI-20520 Turku, Finland; [He, Wei-Wu] OriGene Technol Inc, Rockville, MD 20850 USA; [Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Dept Mol Biol, NL-6500 HB Nijmegen, Netherlands	University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; VTT Technical Research Center Finland; University of Turku; Radboud University Nijmegen	Ojala, P (corresponding author), Univ Helsinki, Inst Biomed, Biomedicum Helsinki, Genome Scale Biol Program, POB 63, FI-00014 Helsinki, Finland.	paivi.ojala@helsinki.fi; jussi.taipale@helsinki.fi	Kallioniemi, Olli P/H-5111-2011; Varjosalo, Markku/K-6424-2015; Björklund, Mikael/D-3362-2009; Ojala, Paivi M/J-3266-2014; Stunnenberg, Hendrik G./D-6875-2012; Bjorklund, Mikael/AAA-2894-2020	Kallioniemi, Olli P/0000-0002-3231-0332; Varjosalo, Markku/0000-0002-1340-9732; Björklund, Mikael/0000-0002-2176-681X; Stunnenberg, Hendrik G./0000-0002-0066-1576; Kilpinen, Sami/0000-0003-3444-2539; Ojala, Paivi/0000-0001-9065-1832				Akbarzadeh S, 2002, J BIOL CHEM, V277, P36280, DOI 10.1074/jbc.M204626200; Bajaj BG, 2006, VIROLOGY, V351, P18, DOI 10.1016/j.virol.2006.03.037; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen MH, 2005, MOL CELL BIOL, V25, P7042, DOI 10.1128/MCB.25.16.7042-7053.2005; Cooper AF, 2005, DEVELOPMENT, V132, P4407, DOI 10.1242/dev.02021; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Grundhoff A, 2004, J CLIN INVEST, V113, P124, DOI 10.1172/JCI200417803; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hall DA, 2007, MECH AGEING DEV, V128, P161, DOI 10.1016/j.mad.2006.11.021; Hayward S Diane, 2006, Sci STKE, V2006, pre4; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jacob J, 2003, EMBO REP, V4, P761, DOI 10.1038/sj.embor.embor896; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Kalderon D, 2005, BIOCHEM SOC T, V33, P1509, DOI 10.1042/BST0331509; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mao JH, 2002, J BIOL CHEM, V277, P35156, DOI 10.1074/jbc.M206743200; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; MENDENHALL MD, 1988, P NATL ACAD SCI USA, V85, P4426, DOI 10.1073/pnas.85.12.4426; Merchant M, 2005, MOL CELL BIOL, V25, P7054, DOI 10.1128/MCB.25.16.7054-7068.2005; Murone M, 2000, NAT CELL BIOL, V2, P310, DOI 10.1038/35010610; Nagata K, 1998, EMBO J, V17, P149, DOI 10.1093/emboj/17.1.149; Nishi Y, 2005, DEV BIOL, V288, P139, DOI 10.1016/j.ydbio.2005.09.053; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Rainio EM, 2005, VIROLOGY, V333, P201, DOI 10.1016/j.virol.2005.01.001; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Varjosalo M, 2007, J CELL SCI, V120, P3, DOI 10.1242/jcs.03309; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vieira J, 2004, VIROLOGY, V325, P225, DOI 10.1016/j.virol.2004.03.049; YAN MH, 1994, NATURE, V372, P798; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697; Zhou QH, 2006, GENETICS, V173, P2049, DOI 10.1534/genetics.106.061036	53	140	150	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 2	2008	133	3					537	548		10.1016/j.cell.2008.02.047	http://dx.doi.org/10.1016/j.cell.2008.02.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455992	Bronze			2022-12-24	WOS:000255503900023
J	Butte, AJ				Butte, Atul J.			Medicine - The ultimate model organism	SCIENCE			English	Editorial Material							NETWORK; CANCER; PROJECT; MAP		[Butte, Atul J.] Stanford Univ, Sch Med, Stanford Ctr Biomed Informat Res, Stanford, CA 94305 USA; [Butte, Atul J.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Butte, Atul J.] Lucile Packard Childrens Hosp, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Lucile Packard Children's Hospital (LPCH)	Butte, AJ (corresponding author), Stanford Univ, Sch Med, Stanford Ctr Biomed Informat Res, Stanford, CA 94305 USA.	abutte@stanford.edu			NIGMS NIH HHS [R01 GM079719-02, R01 GM079719] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079719] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Butte AJ, 2006, NAT BIOTECHNOL, V24, P55, DOI 10.1038/nbt1150; Chen David P, 2008, Pac Symp Biocomput, P243; FLISS A, 2008, SUMM TRANSL BIOINF P, P11; Freimer N, 2003, NAT GENET, V34, P15, DOI 10.1038/ng0503-15; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hunter PJ, 2003, NAT REV MOL CELL BIO, V4, P237, DOI 10.1038/nrm1054; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Payne PRO, 2005, J INVEST MED, V53, P192, DOI 10.2310/6650.2005.00402; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Segal E, 2007, NAT BIOTECHNOL, V25, P675, DOI 10.1038/nbt1306; Stoll M, 2001, SCIENCE, V294, P1723, DOI 10.1126/science.1062117; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278	14	30	30	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2008	320	5874					325	327		10.1126/science.1158343	http://dx.doi.org/10.1126/science.1158343			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZZ	18420921	Green Accepted			2022-12-24	WOS:000255026100028
J	Chappell, LC; Germain, SJ				Chappell, Lucy C.; Germain, Sarah J.			Commentary: Controversies in management of diabetes from preconception to the postnatal period	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Chappell, Lucy C.] Kings Coll London, Div Reprod & Endocrinol, London SE1 7EH, England; [Germain, Sarah J.] Guys & St Thomas NHS Fdn Trust, Dept Diabet & Endocrinol, London SE1 7EH, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Chappell, LC (corresponding author), Kings Coll London, Div Reprod & Endocrinol, London SE1 7EH, England.	lucy.chappell@kcl.ac.uk						[Anonymous], 2007, DIAB PREGN AR WE PRO; *CONF ENQ MAT CHIL, 2007, SAV MOTH LIV REV MAT; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Poyhonen-Alho MK, 2005, EUR J OBSTET GYN R B, V121, P34, DOI 10.1016/j.ejogrb.2004.10.008; 1990, DIABET MED, V7, P360	5	2	2	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 29	2008	336	7646					717	718		10.1136/bmj.39518.615058.AE	http://dx.doi.org/10.1136/bmj.39518.615058.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZS	18369228	Green Published			2022-12-24	WOS:000254675600032
J	Core, LJ; Lis, JT				Core, Leighton J.; Lis, John T.			Transcription regulation through promoter-proximal pausing of RNA polymerase II	SCIENCE			English	Editorial Material							DROSOPHILA-MELANOGASTER; IN-VIVO; ELONGATION; ACTIVATION; RECRUITMENT; GENOME; GENE; ARCHITECTURE; INITIATION; COMPLEXES		[Core, Leighton J.; Lis, John T.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Lis, JT (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	jtl10@cornell.edu			NIGMS NIH HHS [R01 GM025232-32, R01 GM025232] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025232] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENTLEY DL, 1995, CURR OPIN GENET DEV, V5, P210, DOI 10.1016/0959-437X(95)80010-7; Blau J, 1996, MOL CELL BIOL, V16, P2044; Fivaz J, 2000, GENE, V255, P185, DOI 10.1016/S0378-1119(00)00340-1; GARIGLIO P, 1981, NUCLEIC ACIDS RES, V9, P2589, DOI 10.1093/nar/9.11.2589; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Keaveney M, 1998, MOL CELL, V1, P917, DOI 10.1016/S1097-2765(00)80091-X; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Pal M, 2001, MOL CELL BIOL, V21, P5815, DOI 10.1128/MCB.21.17.5815-5825.2001; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Roberts JW, 1998, COLD SPRING HARB SYM, V63, P319, DOI 10.1101/sqb.1998.63.319; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Sawado T, 2003, GENE DEV, V17, P1009, DOI 10.1101/gad.1072303; SHOPLAND LS, 1995, GENE DEV, V9, P2756, DOI 10.1101/gad.9.22.2756; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Ujvari A, 2002, J BIOL CHEM, V277, P32527, DOI 10.1074/jbc.M201145200; Wang XL, 2007, GENE DEV, V21, P1031, DOI 10.1101/gad.1521207; Wang YV, 2005, MOL CELL BIOL, V25, P3543, DOI 10.1128/MCB.25.9.3543-3552.2005; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	25	291	299	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2008	319	5871					1791	1792		10.1126/science.1150843	http://dx.doi.org/10.1126/science.1150843			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279ZF	18369138	Green Accepted			2022-12-24	WOS:000254394000035
J	Mansy, SS; Schrum, JP; Krishnamurthy, M; Tobe, S; Treco, DA; Szostak, JW				Mansy, Sheref S.; Schrum, Jason P.; Krishnamurthy, Mathangi; Tobe, Sylvia; Treco, Douglas A.; Szostak, Jack W.			Template-directed synthesis of a genetic polymer in a model protocell	NATURE			English	Article							MONOCARBOXYLIC ACIDS; MEMBRANE; GROWTH; OLIGOMERIZATION; ENCAPSULATION; STABILITY; BILAYERS; WATER; RNA	Contemporary phospholipid- based cell membranes are formidable barriers to the uptake of polar and charged molecules ranging from metal ions to complex nutrients. Modern cells therefore require sophisticated protein channels and pumps to mediate the exchange of molecules with their environment. The strong barrier function of membranes has made it difficult to understand the origin of cellular life and has been thought to preclude a heterotrophic lifestyle for primitive cells. Although nucleotides can cross dimyristoyl phosphatidylcholine membranes through defects formed at the gel- to- liquid transition temperature(1,2), phospholipid membranes lack the dynamic properties required for membrane growth. Fatty acids and their corresponding alcohols and glycerol monoesters are attractive candidates for the components of protocell membranes because they are simple amphiphiles that form bilayer membrane vesicles(3-5) that retain encapsulated oligonucleotides(3,6) and are capable of growth and division(7-9). Here we show that such membranes allow the passage of charged molecules such as nucleotides, so that activated nucleotides added to the outside of a model protocell spontaneously cross the membrane and take part in efficient template copying in the protocell interior. The permeability properties of prebiotically plausible membranes suggest that primitive protocells could have acquired complex nutrients from their environment in the absence of any macromolecular transport machinery; that is, they could have been obligate heterotrophs.	[Mansy, Sheref S.; Schrum, Jason P.; Krishnamurthy, Mathangi; Tobe, Sylvia; Treco, Douglas A.; Szostak, Jack W.] Massachusetts Gen Hosp, Dept Mol Biol, Howard Hughes Med Inst, Boston, MA 02114 USA; [Mansy, Sheref S.; Schrum, Jason P.; Krishnamurthy, Mathangi; Tobe, Sylvia; Treco, Douglas A.; Szostak, Jack W.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital	Szostak, JW (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Howard Hughes Med Inst, Boston, MA 02114 USA.	szostak@molbio.mgh.harvard.edu	Mansy, Sheref/E-6266-2010	Mansy, Sheref/0000-0003-2382-198X	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [F32 GM074506-01, F32 GM07450601] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074506] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1992, INTERMOLECULAR SURFA; Apel CL, 2002, BBA-BIOMEMBRANES, V1559, P1, DOI 10.1016/S0005-2736(01)00400-X; Blochliger E, 1998, J PHYS CHEM B, V102, P10383, DOI 10.1021/jp981234w; CHAKRABARTI AC, 1994, J MOL EVOL, V39, P555, DOI 10.1007/BF00160400; Chen IA, 2005, J AM CHEM SOC, V127, P13213, DOI 10.1021/ja051784p; Chen IA, 2004, BIOPHYS J, V87, P988, DOI 10.1529/biophysj.104.039875; Chen IA, 2004, SCIENCE, V305, P1474, DOI 10.1126/science.1100757; Chen IA, 2004, P NATL ACAD SCI USA, V101, P7965, DOI 10.1073/pnas.0308045101; Chen IA, 2006, COLD SPRING HARB MON, V43, P57; CHEN PY, 1988, BIOCHEMISTRY-US, V27, P5713, DOI 10.1021/bi00415a048; DANILOV LL, 1981, FEBS LETT, V131, P310, DOI 10.1016/0014-5793(81)80392-4; DEAMER DW, 1985, NATURE, V317, P792, DOI 10.1038/317792a0; Eschenmoser A, 2007, TETRAHEDRON, V63, P12821, DOI 10.1016/j.tet.2007.10.012; Ferris JP, 1996, NATURE, V381, P59, DOI 10.1038/381059a0; Guernelli S, 2003, EUR J ORG CHEM, V2003, P4765, DOI 10.1002/ejoc.200300456; Hagenbuch P, 2005, ANGEW CHEM INT EDIT, V44, P6588, DOI 10.1002/anie.200501794; Hanczyc MM, 2003, SCIENCE, V302, P618, DOI 10.1126/science.1089904; HARGREAVES WR, 1978, BIOCHEMISTRY-US, V17, P3759, DOI 10.1021/bi00611a014; Huang YS, 2005, GEOCHIM COSMOCHIM AC, V69, P1073, DOI 10.1016/j.gca.2004.07.030; KAWANA M, 1992, J CHEM SOC P1, V4, P469; Khalil MM, 2000, J CHEM ENG DATA, V45, P70, DOI 10.1021/je9901886; Kozlov IA, 1998, P NATL ACAD SCI USA, V95, P13448, DOI 10.1073/pnas.95.23.13448; LANDE MB, 1995, J GEN PHYSIOL, V106, P67, DOI 10.1085/jgp.106.1.67; McCollom TM, 1999, ORIGINS LIFE EVOL B, V29, P153, DOI 10.1023/A:1006592502746; Monnard PA, 2007, PHILOS T R SOC B, V362, P1741, DOI 10.1098/rstb.2007.2066; Morowitz H. J., 2004, BEGINNINGS CELLULAR; NELSON AK, 1963, INORG CHEM, V2, P775, DOI 10.1021/ic50008a026; Paula S, 1996, BIOPHYS J, V70, P339, DOI 10.1016/S0006-3495(96)79575-9; Rowat AC, 2005, BBA-BIOMEMBRANES, V1713, P29, DOI 10.1016/j.bbamem.2005.04.014; Sacerdote MG, 2005, P NATL ACAD SCI USA, V102, P6004, DOI 10.1073/pnas.0408440102; TOHIDI M, 1987, J MOL EVOL, V25, P97, DOI 10.1007/BF02101750; WACHTERSHAUSER G, 1990, P NATL ACAD SCI USA, V87, P200, DOI 10.1073/pnas.87.1.200; WESTHEIMER FH, 1987, SCIENCE, V235, P1173, DOI 10.1126/science.2434996; Wilson MA, 1996, J AM CHEM SOC, V118, P6580, DOI 10.1021/ja9540381	34	465	479	8	254	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2008	454	7200					122	U10		10.1038/nature07018	http://dx.doi.org/10.1038/nature07018			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18528332	Green Accepted			2022-12-24	WOS:000257308300050
J	McMurray, HR; Sampson, ER; Compitello, G; Kinsey, C; Newman, L; Smith, B; Chen, SR; Klebanov, L; Salzman, P; Yakovlev, A; Land, H				McMurray, Helene R.; Sampson, Erik R.; Compitello, George; Kinsey, Conan; Newman, Laurel; Smith, Bradley; Chen, Shaw-Ree; Klebanov, Lev; Salzman, Peter; Yakovlev, Andrei; Land, Hartmut			Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype	NATURE			English	Article							CELL-CYCLE ARREST; TUMOR-SUPPRESSOR; EPITHELIAL-CELLS; C-MYC; P53; TRANSFORMATION; METASTASIS; PATHWAY; MICE; REVEALS	Understanding the molecular underpinnings of cancer is of critical importance to the development of targeted intervention strategies. Identification of such targets, however, is notoriously difficult and unpredictable. Malignant cell transformation requires the cooperation of a few oncogenic mutations that cause substantial reorganization of many cell features(1) and induce complex changes in gene expression patterns(2-6). Genes critical to this multifaceted cellular phenotype have therefore only been identified after signalling pathway analysis(7-10) or on an ad hoc basis(4,11-14). Our observations that cell transformation by cooperating oncogenic lesions depends on synergistic modulation of downstream signalling circuitry(15-17) suggest that malignant transformation is a highly cooperative process, involving synergy at multiple levels of regulation, including gene expression. Here we show that a large proportion of genes controlled synergistically by loss-of-function p53 and Ras activation are critical to the malignant state of murine and human colon cells. Notably, 14 out of 24 'cooperation response genes' were found to contribute to tumour formation in gene perturbation experiments. In contrast, only 1 in 14 perturbations of the genes responding in a non-synergistic manner had a similar effect. Synergistic control of gene expression by oncogenic mutations thus emerges as an underlying key to malignancy, and provides an attractive rationale for identifying intervention targets in gene networks downstream of oncogenic gain- and loss-of-function mutations.	[McMurray, Helene R.; Sampson, Erik R.; Compitello, George; Kinsey, Conan; Newman, Laurel; Smith, Bradley; Chen, Shaw-Ree; Land, Hartmut] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA; [Klebanov, Lev; Salzman, Peter; Yakovlev, Andrei] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Yakovlev, Andrei; Land, Hartmut] Univ Rochester, Med Ctr, James Wilmot Canc Ctr, Rochester, NY 14642 USA; [Klebanov, Lev] Charles Univ Prague, Dept Probabil & Stat, CZ-18675 Prague 8, Czech Republic	University of Rochester; University of Rochester; University of Rochester; Charles University Prague	Land, H (corresponding author), Univ Rochester, Med Ctr, Dept Biomed Genet, 601 Elmwood Ave, Rochester, NY 14642 USA.	land@urmc.rochester.edu	Klebanov, Lev/C-2408-2009; Klebanov, Lev/F-3373-2014	Klebanov, Lev/0000-0001-8496-6432; McMurray, Helene/0000-0003-1738-8622; salzman, peter/0000-0001-8114-4863	NCI NIH HHS [R01 CA090663-04, R01 CA120317-01A1, R01 CA120317-02, CA120317, T32 CA009363, R01 CA090663-05, T32 CA009363-25, R01 CA090663, R01 CA120317, CA90663, R01 CA090663-03, T32 CA09363] Funding Source: Medline; NIGMS NIH HHS [R01 GM075299, R01 GM075299-01, R01 GM075299-03, GM075299, R01 GM075299-03S1, R01 GM075299-02] Funding Source: Medline; NLM NIH HHS [K99 LM009477, K99 LM009477-01A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090663, R01CA120317, T32CA009363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075299] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K99LM009477] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; Boiko AD, 2006, GENE DEV, V20, P236, DOI 10.1101/gad.1372606; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; FANIDI A, 1992, NATURE, V359, P554, DOI 10.1038/359554a0; Fattman CL, 2003, FREE RADICAL BIO MED, V35, P236, DOI 10.1016/S0891-5849(03)00275-2; Godwin AR, 1998, GENE DEV, V12, P11, DOI 10.1101/gad.12.1.11; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HIRAKAWA T, 1988, P NATL ACAD SCI USA, V85, P1519, DOI 10.1073/pnas.85.5.1519; Houde C, 2004, BLOOD, V104, P3697, DOI 10.1182/blood-2003-12-4114; Huang E, 2003, NAT GENET, V34, P226, DOI 10.1038/ng1167; Klebanov L, 2006, COMPUT STAT DATA AN, V50, P3619, DOI 10.1016/j.csda.2005.08.005; Ledford JG, 2007, J IMMUNOL, V178, P5132, DOI 10.4049/jimmunol.178.8.5132; Lloyd AC, 1997, GENE DEV, V11, P663, DOI 10.1101/gad.11.5.663; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Okada F, 1998, P NATL ACAD SCI USA, V95, P3609, DOI 10.1073/pnas.95.7.3609; Panagopoulos L, 2003, GENE CHROMOSOME CANC, V36, P107, DOI 10.1002/gcc.10139; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; RIDLEY AJ, 1988, EMBO J, V7, P1635, DOI 10.1002/j.1460-2075.1988.tb02990.x; Rodriguez-Viciana P, 2005, COLD SH Q B, V70, P461, DOI 10.1101/sqb.2005.70.044; Rogulski K, 2005, ONCOGENE, V24, P7524, DOI 10.1038/sj.onc.1208897; Saaf AM, 2007, MOL BIOL CELL, V18, P4245, DOI 10.1091/mbc.E07-04-0309; Schulze A, 2001, GENE DEV, V15, P981, DOI 10.1101/gad.191101; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Xia MX, 2007, NAT STRUCT MOL BIOL, V14, P215, DOI 10.1038/nsmb1208; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517; Zhao RB, 2000, GENE DEV, V14, P981	37	113	123	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2008	453	7198					1112	U10		10.1038/nature06973	http://dx.doi.org/10.1038/nature06973			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18500333	Green Accepted			2022-12-24	WOS:000256839900059
J	Carmeliet, P; Baes, M				Carmeliet, Peter; Baes, Myriam			Metabolism and therapeutic angiogenesis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HYPOXIA TOLERANCE; COACTIVATORS		[Carmeliet, Peter] Katholieke Univ Leuven VIB, Vesalius Res Ctr, Louvain, Belgium; [Baes, Myriam] Katholieke Univ Leuven, Lab Cell Metab, Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven	Carmeliet, P (corresponding author), Katholieke Univ Leuven VIB, Vesalius Res Ctr, Louvain, Belgium.		Carmeliet, Peter/AAQ-5140-2020	Carmeliet, Peter/0000-0001-7961-1821; Baes, Myriam/0000-0002-2525-2269				Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Ramirez JM, 2007, ANNU REV PHYSIOL, V69, P113, DOI 10.1146/annurev.physiol.69.031905.163111	5	33	35	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 5	2008	358	23					2511	2512		10.1056/NEJMcibr0802500	http://dx.doi.org/10.1056/NEJMcibr0802500			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	308HY	18525050				2022-12-24	WOS:000256380700014
J	Harjutsalo, V; Sjoberg, L; Tuomilehto, J				Harjutsalo, Valma; Sjoberg, Lena; Tuomilehto, Jaakko			Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study	LANCET			English	Article							POPULATION-BASED COHORT; YOUNG-ADULTS; MELLITUS; AGE; ONSET; RISK; FINLAND; DISEASE; EPIDEMIOLOGY; NATIONWIDE	Background Finland has the highest incidence of type 1 diabetes worldwide, reaching 40 per 100000 people per year in the 1990s. Our aim was to assess the temporal trend in type 1 diabetes incidence since 2000 in Finnish children aged younger than 15 years and to predict the number of cases of type 1 diabetes in the future. Methods Children with newly diagnosed type 1 diabetes in Finland who were listed on the National Public Health Institute diabetes register, Central Drug Register, and Hospital Discharge Register in 1980-2005 were included in a cohort study. We excluded patients with type 2 diabetes and diabetes occurring secondary to other conditions, such as steroid use, Down's syndrome, and congenital malformations of pancreas. Findings 10737 children-5816 boys and 4921 girls-were diagnosed with type 1 diabetes before 15 years of age during 1980-2005. The average age-standardised incidence was 42.9 per 100000 per year (95% Cl 42.6-44.3) during this period, increasing from 31.4 per 100 000 per year in 1980 to 64.2 per 100 000 per year in 2005. The age-specific rates per 100 000 per year were 31.0, 50.5, and 50 . 6 at ages 0-4 years, 5-9 years, and 10-14-years, respectively. We noted a significant non-linear component to the time trend (p<0 - 0003). In children aged 0-4 years, the increase was largest, at 4.7% more affected every year. The overall boy-to-girl ratio of incidence was 1 . 1; at the age of 13 years, it was 1 . 7 (1-4-2-0). The predicted cumulative number of new cases with type 1 diabetes before 15 years of age between 2006 and 2020 was about 10 800. Interpretation The incidence of type 1 diabetes in Finnish children is increasing even faster than before. The number of new cases diagnosed at or before 14 years of age will double in the next 15 years and the age of onset will be younger (0-4 years). Funding Academy of Finland, Sigrid Juselius Foundation, Juvenile Diabetes Research Foundation.	[Harjutsalo, Valma; Tuomilehto, Jaakko] Natl Publ Hlth Inst, Diabet Unit, Dept Hlth Promot & Chron Dis Prevent, FIN-00300 Helsinki, Finland; [Sjoberg, Lena; Tuomilehto, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Tuomilehto, Jaakko] S Ostrobotnia Cent Hosp, Seinajoki, Finland	Finland National Institute for Health & Welfare; University of Helsinki	Harjutsalo, V (corresponding author), Natl Publ Hlth Inst, Diabet Unit, Dept Hlth Promot & Chron Dis Prevent, Mannerheimintie 166, FIN-00300 Helsinki, Finland.	valma.harjutsalo@ktl.fi	Harjutsalo, Valma/AAL-6588-2021	Harjutsalo, Valma/0000-0003-3568-9779; Sjoberg, Lena/0000-0002-5420-5189				Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; BLOM L, 1992, DIABETOLOGIA, V35, P528, DOI 10.1007/BF00400480; Bruno G, 2001, DIABETOLOGIA, V44, P22, DOI 10.1007/s001250051575; Feltbower RG, 2003, DIABETIC MED, V20, P437, DOI 10.1046/j.1464-5491.2003.00960.x; Gale EAM, 2005, DIABETOLOGIA, V48, P2445, DOI 10.1007/s00125-005-0028-z; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; Green A, 2000, LANCET, V355, P873; Harjutsalo V, 2006, DIABETES, V55, P1517, DOI 10.2337/db05-1296; Harjutsalo V, 2005, DIABETES, V54, P563, DOI 10.2337/diabetes.54.2.563; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hyttinen V, 2003, DIABETES, V52, P1052, DOI 10.2337/diabetes.52.4.1052; IAMMI N, 2008, DIABETOLOGIA, V51, P897; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Kautiainen S, 2002, INT J OBESITY, V26, P544, DOI 10.1038/sj.ijo.0801928; Lammi N, 2007, DIABETOLOGIA, V50, P1393, DOI 10.1007/s00125-007-0690-4; LAPORTE RE, 1991, DIABETES CARE, V14, P49; Lindblad K, 1999, SEMIN NEUROL, V19, P289, DOI 10.1055/s-2008-1040845; Morel BA, 1857, TRAITE DEGENERESCENC; *NAT RES DEV CTR W, 2003, NORD MED BIRTH REG; Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309; Podar T, 1999, DIABETES CARE, V22, P2092, DOI 10.2337/diacare.22.12.2092a; Pundziute-Lycka A, 2004, ACTA PAEDIATR, V93, P1519, DOI 10.1080/08035250410026680; Pundziute-Lycka A, 2002, DIABETOLOGIA, V45, P783, DOI 10.1007/s00125-002-0845-2; ROSS CA, 1993, TRENDS NEUROSCI, V16, P254, DOI 10.1016/0166-2236(93)90175-L; Salo Matti, 2006, Duodecim, V122, P1211; SCHOBER E, 2007, EUR J PEDIAT; Schoenle EJ, 2001, DIABETOLOGIA, V44, P286, DOI 10.1007/s001250051615; Speiser PW, 2005, J CLIN ENDOCR METAB, V90, P1871, DOI 10.1210/jc.2004-1389; STEINBERG AG, 1950, P STAFF M MAYO CLIN, V25, P625; Stene LC, 2001, BMJ-BRIT MED J, V322, P889, DOI 10.1136/bmj.322.7291.889; Svensson J, 2002, DIABETES CARE, V25, P2197, DOI 10.2337/diacare.25.12.2197; THOMSON G, 1988, AM J HUM GENET, V43, P799; Todd JA, 1999, BIOESSAYS, V21, P164, DOI 10.1002/(SICI)1521-1878(199902)21:2<164::AID-BIES10>3.3.CO;2-W; TUOMILEHTO J, 1992, DIABETOLOGIA, V35, P70, DOI 10.1007/BF00400854; Tuomilehto J, 1999, DIABETOLOGIA, V42, P655, DOI 10.1007/s001250051212; Weets I, 2007, DIABETES-METAB RES, V23, P637, DOI 10.1002/dmrr.758; Weets I, 2002, DIABETES CARE, V25, P840, DOI 10.2337/diacare.25.5.840; Wilkin TJ, 2001, DIABETOLOGIA, V44, P914, DOI 10.1007/s001250100548	38	435	447	2	40	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 24	2008	371	9626					1777	1782		10.1016/S0140-6736(08)60765-5	http://dx.doi.org/10.1016/S0140-6736(08)60765-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	304IO	18502302				2022-12-24	WOS:000256103400032
J	Martinvalet, D; Dykxhoorn, DM; Ferrini, R; Lieberman, J				Martinvalet, Denis; Dykxhoorn, Derek M.; Ferrini, Roger; Lieberman, Judy			Granzyme A cleaves a mitochondrial complex I protein to initiate caspase-independent cell death	CELL			English	Article							BOVINE HEART-MITOCHONDRIA; CYTOCHROME-C RELEASE; B-INDUCED APOPTOSIS; MEDIATED APOPTOSIS; OXIDATIVE STRESS; DNA-DAMAGE; ACTIVATION; IMPORT; SUPEROXIDE; SUBUNITS	The killer lymphocyte protease granzyme A (GzmA) triggers caspase-independent target cell death with morphological features of apoptosis. We previously showed that GzmA acts directly on mitochondria to generate reactive oxygen species (ROS) and disrupt the transmembrane potential (Delta Psi m) but does not permeabilize the mitochondrial outer membrane. Mitochondrial damage is critical to GzmA-induced cell death since cells treated with superoxide scavengers are resistant to GzmA. Here we find that GzmA accesses the mitochondrial matrix to cleave the complex I protein NDUFS3, an iron-sulfur subunit of the NADH: ubiquinone oxidoreductase complex I, after Lys56 to interfere with NADH oxidation and generate superoxide anions. Target cells expressing a cleavage site mutant of NDUFS3 are resistant to GzmA-mediated cell death but remain sensitive to GzmB.	[Martinvalet, Denis; Dykxhoorn, Derek M.; Ferrini, Roger; Lieberman, Judy] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Martinvalet, Denis; Dykxhoorn, Derek M.; Ferrini, Roger; Lieberman, Judy] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Lieberman, J (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA.	lieberman@cbr.med.harvard.edu	Dykxhoorn, Derek M/D-1357-2015; Lieberman, Judy/A-2717-2015		NHLBI NIH HHS [T32 HL66987, T32 HL066987] Funding Source: Medline; NIAID NIH HHS [R01 AI045587-10, R56 AI045587, R01 AI045587, AI45587] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI045587, R01AI045587] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aronis A, 2003, CELL DEATH DIFFER, V10, P335, DOI 10.1038/sj.cdd.4401150; Bell JK, 2003, NAT STRUCT BIOL, V10, P527, DOI 10.1038/nsb944; Beresford PJ, 1999, IMMUNITY, V10, P585, DOI 10.1016/S1074-7613(00)80058-8; Beresford PJ, 1998, J IMMUNOL, V161, P161; Bredemeyer AJ, 2004, P NATL ACAD SCI USA, V101, P11785, DOI 10.1073/pnas.0402353101; Bredemeyer AJ, 2006, J BIOL CHEM, V281, P37130, DOI 10.1074/jbc.M607969200; Camello-Almaraz C, 2006, AM J PHYSIOL-CELL PH, V291, pC1082, DOI 10.1152/ajpcell.00217.2006; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; DAUM G, 1982, J BIOL CHEM, V257, P3075; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Geissler A, 2001, MOL CELL BIOL, V21, P7097, DOI 10.1128/MCB.21.20.7097-7104.2001; Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Heibein JA, 1999, J IMMUNOL, V163, P4683; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; Hink-Schauer C, 2003, NAT STRUCT BIOL, V10, P535, DOI 10.1038/nsb945; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Hostetter DR, 2007, J BIOL CHEM, V282, P27865, DOI 10.1074/jbc.M704312200; Huang G, 2007, CELL DEATH DIFFER, V14, P327, DOI 10.1038/sj.cdd.4402004; Johnson H, 2003, BLOOD, V101, P3093, DOI 10.1182/blood-2002-08-2485; Kaminski M, 2007, MOL CELL BIOL, V27, P3625, DOI 10.1128/MCB.02295-06; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Ladha JS, 2005, CELL DEATH DIFFER, V12, P1417, DOI 10.1038/sj.cdd.4401668; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Loeb CRK, 2006, J BIOL CHEM, V281, P28326, DOI 10.1074/jbc.M604544200; MacDonald G, 1999, J EXP MED, V189, P131, DOI 10.1084/jem.189.1.131; Malassagne B, 2001, GASTROENTEROLOGY, V121, P1451, DOI 10.1053/gast.2001.29590; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Papa S, 2000, J BIOENERG BIOMEMBR, V32, P401, DOI 10.1023/A:1005584221456; Pardo J, 2004, J CELL BIOL, V167, P457, DOI 10.1083/jcb.200406115; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Prokisch H, 2006, NUCLEIC ACIDS RES, V34, pD705, DOI 10.1093/nar/gkj127; Reeves MB, 2007, SCIENCE, V316, P1345, DOI 10.1126/science.1142984; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; SANDSTROM PA, 1994, J LEUKOCYTE BIOL, V55, P221, DOI 10.1002/jlb.55.2.221; Sazanov LA, 2000, BIOCHEMISTRY-US, V39, P7229, DOI 10.1021/bi000335t; Shresta S, 1999, IMMUNITY, V10, P595, DOI 10.1016/S1074-7613(00)80059-X; Susin SA, 2000, METHOD ENZYMOL, V322, P205; Thomas DA, 2001, P NATL ACAD SCI USA, V98, P14985, DOI 10.1073/pnas.261581498; Wang GQ, 2001, J EXP MED, V194, P1325, DOI 10.1084/jem.194.9.1325; Yamaguchi M, 1998, J BIOL CHEM, V273, P8094, DOI 10.1074/jbc.273.14.8094; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhu PC, 2006, EMBO REP, V7, P431, DOI 10.1038/sj.embor.7400622	51	155	160	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 16	2008	133	4					681	692		10.1016/j.cell.2008.03.032	http://dx.doi.org/10.1016/j.cell.2008.03.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485875	Green Accepted, Bronze			2022-12-24	WOS:000255903300022
J	Chaitman, BR; Fromer, M				Chaitman, Bernard R.; Fromer, Martin			Should ECG be required in young athletes?	LANCET			English	Editorial Material							OF-CARDIOLOGY; SUDDEN-DEATH; PREPARTICIPATION; ELECTROCARDIOGRAM; ABNORMALITIES; STATEMENT; HEART		[Chaitman, Bernard R.] St Louis Univ, Sch Med, Dept Med, Div Cardiol, St Louis, MO 63117 USA; [Fromer, Martin] Univ Hosp CHUV, Dept Med, Serv Cardiol, Arrhythmia Unit, Lausanne, Switzerland	Saint Louis University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Chaitman, BR (corresponding author), St Louis Univ, Sch Med, Dept Med, Div Cardiol, St Louis, MO 63117 USA.	chaitman@slu.edu						Atchley AE, 2007, CARDIOL CLIN, V25, P371, DOI 10.1016/j.ccl.2007.06.009; Basavarajaiah S, 2008, J AM COLL CARDIOL, V51, P1033, DOI 10.1016/j.jacc.2007.10.055; Chaitman BR, 2007, CIRCULATION, V116, P2610, DOI 10.1161/CIRCULATIONAHA.107.711465; Corrado D, 2005, EUR HEART J, V26, P516, DOI 10.1093/eurheartj/ehi108; FERST JA, 1984, SPORTS MED, V1, P390, DOI 10.2165/00007256-198401050-00004; *IOC MED COMM, 2004, SUDD CARD DEATH SPOR; Maron BJ, 2007, CIRCULATION, V115, P1643, DOI 10.1161/CIRCULATIONAHA.107.181423; Maron BJ, 2006, CIRCULATION, V114, P1633, DOI 10.1161/CIRCULATIONAHA.106.613562; Myerburg RJ, 2007, CIRCULATION, V116, P2616, DOI 10.1161/CIRCULATIONAHA.107.733519; Pelliccia A, 2000, CIRCULATION, V102, P278; Pelliccia A, 2008, NEW ENGL J MED, V358, P152, DOI 10.1056/NEJMoa060781; Pelliccia A, 2007, EUR HEART J, V28, P2703, DOI 10.1093/eurheartj/ehm455	12	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 3	2008	371	9623					1489	1490		10.1016/S0140-6736(08)60636-4	http://dx.doi.org/10.1016/S0140-6736(08)60636-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298ED	18456088	Green Published			2022-12-24	WOS:000255668300009
J	DellaPenna, D; Last, RL				DellaPenna, Dean; Last, Robert L.			Perspective - Genome-enabled approaches shed new light on plant metabolism	SCIENCE			English	Editorial Material							ARABIDOPSIS MUTANT; BIOSYNTHESIS; GENE; EXPRESSION; TOCOPHEROL; DEFICIENT; PATHWAYS; SYNTHASE; FAMILY; OIL	Plant metabolism research has experienced a second golden age resulting from synergies between genome- enabled technologies and classical biochemistry. The rapid rate at which genomics data are being accumulated creates increased needs for robust metabolomic technologies and fast and accurate methods for identifying the activities of enzymes.	[DellaPenna, Dean; Last, Robert L.] Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA; [Last, Robert L.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	DellaPenna, D (corresponding author), Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA.	dellapen@msu.edu	Last, Robert L/D-9197-2011	Last, Robert/0000-0001-6974-9587				Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Cheng ZG, 2003, PLANT CELL, V15, P2343, DOI 10.1105/tpc.013656; Cocuron JC, 2007, P NATL ACAD SCI USA, V104, P8550, DOI 10.1073/pnas.0703133104; Conklin PL, 1996, P NATL ACAD SCI USA, V93, P9970, DOI 10.1073/pnas.93.18.9970; Croteau RB, 2005, NATURWISSENSCHAFTEN, V92, P562, DOI 10.1007/s00114-005-0055-0; de Crecy-Lagard V, 2007, TRENDS MICROBIOL, V15, P563, DOI 10.1016/j.tim.2007.10.008; DellaPenna D, 2006, ANNU REV PLANT BIOL, V57, P711, DOI 10.1146/annurev.arplant.56.032604.144301; Dhugga KS, 2004, SCIENCE, V303, P363, DOI 10.1126/science.1090908; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Lange BM, 2000, P NATL ACAD SCI USA, V97, P2934, DOI 10.1073/pnas.97.6.2934; Last RL, 2007, NAT REV MOL CELL BIO, V8, P167, DOI 10.1038/nrm2098; Maeda H, 2007, CURR OPIN PLANT BIOL, V10, P260, DOI 10.1016/j.pbi.2007.04.006; Naoumkina M, 2007, P NATL ACAD SCI USA, V104, P17909, DOI 10.1073/pnas.0708697104; Nelson T, 2006, ANNU REV PLANT BIOL, V57, P181, DOI 10.1146/annurev.arplant.56.032604.144138; Osterman A, 2003, CURR OPIN CHEM BIOL, V7, P238, DOI 10.1016/S1367-5931(03)00027-9; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; SCHILMILLER AL, IN PRESS PLANT J; SOMERVILLE CR, 1980, P NATL ACAD SCI-BIOL, V77, P2684, DOI 10.1073/pnas.77.5.2684; Sweetlove LJ, 2008, BIOCHEM J, V409, P27, DOI 10.1042/BJ20071115; Tholl D, 2006, CURR OPIN PLANT BIOL, V9, P297, DOI 10.1016/j.pbi.2006.03.014; Trethewey RN, 2004, CURR OPIN PLANT BIOL, V7, P196, DOI 10.1016/j.pbi.2003.12.003; Van Eenennaam AL, 2003, PLANT CELL, V15, P3007, DOI 10.1105/tpc.015875; Webb ME, 2007, NAT PROD REP, V24, P988, DOI 10.1039/b703105j	25	21	23	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					479	481		10.1126/science.1153715	http://dx.doi.org/10.1126/science.1153715			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436775				2022-12-24	WOS:000255249300034
J	Kanasaki, K; Palmsten, K; Sugimoto, H; Ahmad, S; Hamano, Y; Xie, L; Parry, S; Augustin, HG; Gattone, VH; Folkman, J; Strauss, JF; Kalluri, R				Kanasaki, Keizo; Palmsten, Kristin; Sugimoto, Hikaru; Ahmad, Shakil; Hamano, Yuki; Xie, Liang; Parry, Samuel; Augustin, Hellmut G.; Gattone, Vincent H., Jr.; Folkman, Judah; Strauss, Jerome F.; Kalluri, Raghu			Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia	NATURE			English	Article							GROWTH-FACTOR RECEPTOR-1; INHIBITS ANGIOGENESIS; TUMOR-GROWTH; IN-VITRO; PREGNANCY; PLACENTA; 2-HYDROXYESTRADIOL; 2-METHOXYESTRADIOL; DIFFERENTIATION; PROTEINURIA	Despite intense investigation, mechanisms that facilitate the emergence of the pre-eclampsia phenotype in women are still unknown. Placental hypoxia, hypertension, proteinuria and oedema are the principal clinical features of this disease. It is speculated that hypoxia-driven disruption of the angiogenic balance involving vascular endothelial growth factor (VEGF)/ placenta-derived growth factor (PLGF) and soluble Fms-like tyrosine kinase-1 (sFLT-1, the soluble form of VEGF receptor 1) might contribute to some of the maternal symptoms of pre-eclampsia(1-5). However, pre-eclampsia does not develop in all women with high sFLT-1 or low PLGF levels, and it also occurs in some women with low sFLT-1 and high PLGF levels(5,6). Moreover, recent experiments strongly suggest that several soluble factors affecting the vasculature are probably elevated because of placental hypoxia in the pre-eclamptic women, indicating that upstream molecular defect(s) may contribute to pre-eclampsia. Here we show that pregnant mice deficient in catechol-O-methyltransferase (COMT) show a pre-eclampsia-like phenotype resulting from an absence of 2-methoxyoestradiol (2-ME), a natural metabolite of oestradiol that is elevated during the third trimester of normal human pregnancy. 2-ME ameliorates all pre-eclampsia-like features without toxicity in the Comt(-/-) pregnant mice and suppresses placental hypoxia, hypoxia-inducible factor-1 alpha expression and sFLT-1 elevation. The levels of COMT and 2-ME are significantly lower in women with severe pre-eclampsia. Our studies identify a genetic mouse model for pre-eclampsia and suggest that 2-ME may have utility as a plasma and urine diagnostic marker for this disease, and may also serve as a therapeutic supplement to prevent or treat this disorder.	[Kanasaki, Keizo; Palmsten, Kristin; Sugimoto, Hikaru; Hamano, Yuki; Xie, Liang; Kalluri, Raghu] Beth Israel Deaconess Med Ctr, Div Matrix Biol, Dept Med, Boston, MA 02215 USA; [Kanasaki, Keizo; Palmsten, Kristin; Sugimoto, Hikaru; Hamano, Yuki; Xie, Liang; Kalluri, Raghu] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Ahmad, Shakil] Univ Birmingham, Sch Med, Dept Reprod Biol, Biomed Res Inst, Birmingham B15 2TT, W Midlands, England; [Ahmad, Shakil] Univ Birmingham, Sch Med, Dept Vasc Biol, Biomed Res Inst, Birmingham B15 2TT, W Midlands, England; [Ahmad, Shakil] Birmingham Womens Hosp, Birmingham B15 2TG, W Midlands, England; [Parry, Samuel] Univ Penn, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Augustin, Hellmut G.] Univ Heidelberg, Joint Res Div Vasc Biol, Med Fac Mannheim, D-69120 Heidelberg, Germany; [Augustin, Hellmut G.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Gattone, Vincent H., Jr.] Indiana Univ, Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Folkman, Judah] Childrens Hosp, Program Vasc Biol, Dept Surg Res, Boston, MA 02215 USA; [Strauss, Jerome F.] Virginia Commonwealth Univ, Sch Med, Richmond, VA 23298 USA; [Kalluri, Raghu] Harvard Mit Div Hlth Sci & Technol, Boston, MA 02215 USA; [Kalluri, Raghu] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Birmingham; University of Birmingham; Birmingham Women's Hospital; University of Pennsylvania; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Indiana University System; Indiana University-Purdue University Indianapolis; Harvard University; Boston Children's Hospital; Virginia Commonwealth University; Harvard University; Harvard University; Harvard Medical School	Kalluri, R (corresponding author), Beth Israel Deaconess Med Ctr, Div Matrix Biol, Dept Med, Boston, MA 02215 USA.	rkalluri@bidmc.harvard.edu	Augustin, Hellmut/AAA-5246-2020; Ahmad, Shakil/A-9421-2008; Kalluri, Raghu/E-2677-2015	Augustin, Hellmut/0000-0002-7173-4242; Ahmad, Shakil/0000-0002-9294-0475; Kalluri, Raghu/0000-0002-2190-547X	MRC [G0700288] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061688, R01DK055001, R01DK062987] Funding Source: NIH RePORTER; British Heart Foundation Funding Source: Medline; Medical Research Council [G0700288] Funding Source: Medline; NIDDK NIH HHS [DK 62987, DK 61688, R01 DK055001, DK 55001, R01 DK061688, DK 13193] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahmad S, 2004, CIRC RES, V95, P884, DOI 10.1161/01.RES.0000147365.86159.f5; BARNEA ER, 1988, AM J PERINAT, V5, P121, DOI 10.1055/s-2007-999669; BERG D, 1983, ACTA ENDOCRINOL-COP, V103, P282, DOI 10.1530/acta.0.1030282; Caniggia I, 2000, J CLIN INVEST, V105, P577, DOI 10.1172/JCI8316; CASEY ML, 1983, AM J OBSTET GYNECOL, V145, P453, DOI 10.1016/0002-9378(83)90316-2; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P3964, DOI 10.1073/pnas.91.9.3964; FOTSIS T, 1994, NATURE, V368, P237, DOI 10.1038/368237a0; Genbacev O, 1996, J CLIN INVEST, V97, P540, DOI 10.1172/JCI118447; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Hata T, 1997, LANCET, V350, P1600, DOI 10.1016/S0140-6736(05)64016-0; Ireson CR, 2004, BRIT J CANCER, V90, P932, DOI 10.1038/sj.bjc.6601591; Krauss T, 2004, HYPERTENS PREGNANCY, V23, P101, DOI 10.1081/PRG-120028286; LABARRERE CA, 1988, PLACENTA, V9, P95, DOI 10.1016/0143-4004(88)90076-8; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; MACGILLIVRAY I, 1969, CLIN SCI, V37, P395; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Myatt L, 1997, HUM REPROD, V12, P167, DOI 10.1093/humrep/12.1.167; Nagamatsu T, 2004, ENDOCRINOLOGY, V145, P4838, DOI 10.1210/en.2004-0533; Rajakumar A, 2004, PLACENTA, V25, P763, DOI 10.1016/j.placenta.2004.02.011; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; ROSING U, 1984, GYNECOL OBSTET INVES, V18, P199, DOI 10.1159/000299081; Sata F, 2006, PHARMACOGENET GENOM, V16, P775, DOI 10.1097/01.fpc.0000230116.49452.c0; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Senthilkumaran B, 2001, J ENDOCRINOL, V168, P239, DOI 10.1677/joe.0.1680239; Solomon CG, 2004, NEW ENGL J MED, V350, P641, DOI 10.1056/NEJMp038241; Sugimoto H, 2003, J BIOL CHEM, V278, P12605, DOI 10.1074/jbc.C300012200; Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P7321, DOI 10.1073/pnas.0601436103; Takanashi K, 2000, CLIN CHEM, V46, P373; Tanaka TS, 2000, P NATL ACAD SCI USA, V97, P9127, DOI 10.1073/pnas.97.16.9127; Vuorela P, 2000, OBSTET GYNECOL, V95, P353, DOI 10.1016/S0029-7844(99)00565-7; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Zacharia LC, 2004, J PHARMACOL EXP THER, V309, P1093, DOI 10.1124/jpet.103.062505	33	300	317	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2008	453	7198					1117	U12		10.1038/nature06951	http://dx.doi.org/10.1038/nature06951			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18469803				2022-12-24	WOS:000256839900060
J	Fabry, VJ				Fabry, Victoria J.			Ocean science - Marine calcifiers in a high-CO2 ocean	SCIENCE			English	Editorial Material							EMILIANIA-HUXLEYI; CALCIFICATION; ACIDIFICATION		[Fabry, Victoria J.] Calif State Univ San Marcos, Dept Biol Sci, San Marcos, CA 92096 USA	California State University System; California State University San Marcos	Fabry, VJ (corresponding author), Calif State Univ San Marcos, Dept Biol Sci, San Marcos, CA 92096 USA.	fabry@csusm.edu						Cubillos JC, 2007, MAR ECOL PROG SER, V348, P47, DOI 10.3354/meps07058; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; FEELY RA, 2008, EOS T AGU; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Iglesias-Rodriguez MD, 2006, J PHYCOL, V42, P526; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Langer G, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001227; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; RIES JB, 2008, EOS T AGU; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; The Royal Society, 2005, 1205 ROYAL SOC; TYRRELL T, 2007, BIOGEOSCIENCES DISCU, V4, P3581; Zondervan I, 2007, DEEP-SEA RES PT II, V54, P521, DOI 10.1016/j.dsr2.2006.12.004	15	125	129	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2008	320	5879					1020	1022		10.1126/science.1157130	http://dx.doi.org/10.1126/science.1157130			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303RY	18420898				2022-12-24	WOS:000256059800026
J	Pocivavsek, L; Dellsy, R; Kern, A; Johnson, S; Lin, BH; Lee, KYC; Cerda, E				Pocivavsek, Luka; Dellsy, Robert; Kern, Andrew; Johnson, Sebastian; Lin, Binhua; Lee, Ka Yee C.; Cerda, Enrique			Stress and fold localization in thin elastic membranes	SCIENCE			English	Article							MONOLAYER SPREAD; TRANSITIONS; COLLAPSE	Thin elastic membranes supported on a much softer elastic solid or a fluid deviate from their flat geometries upon compression. We demonstrate that periodic wrinkling is only one possible solution for such strained membranes. Folds, which involve highly localized curvature, appear whenever the membrane is compressed beyond a third of its initial wrinkle wavelength. Eventually the surface transforms into a symmetry-broken state with flat regions of membrane coexisting with locally folded points, reminiscent of a crumpled, unsupported membrane. We provide general scaling laws for the wrinkled and folded states and proved the transition with numerical and experimental supported membranes. Our work provides insight into the interfacial stability of such diverse systems as biological membranes such as lung surfactant and nanoparticle thin films.	[Johnson, Sebastian; Cerda, Enrique] Univ Santiago, Dept Fis, Santiago, Chile; [Johnson, Sebastian; Cerda, Enrique] Univ Santiago, Ctr Invest Interdisciplinaria Avanzada Ciencias M, Santiago, Chile; [Pocivavsek, Luka; Kern, Andrew; Lee, Ka Yee C.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Pocivavsek, Luka; Kern, Andrew; Lee, Ka Yee C.] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; [Dellsy, Robert; Lin, Binhua] Univ Chicago, Ctr Adv Radiat Sources, Chicago, IL 60637 USA	Universidad de Santiago de Chile; Universidad de Santiago de Chile; University of Chicago; University of Chicago; University of Chicago	Cerda, E (corresponding author), Univ Santiago, Dept Fis, Av Ecuador 3493, Santiago, Chile.	ecerda@lauca.usach.cl		Kern-Goldberger, Andrew/0000-0003-0610-4292				BOURDIEU L, 1994, PHYS REV LETT, V72, P1502, DOI 10.1103/PhysRevLett.72.1502; Bowden N, 1998, NATURE, V393, P146, DOI 10.1038/30193; Cerda E, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.074302; Collier CP, 1998, ANNU REV PHYS CHEM, V49, P371, DOI 10.1146/annurev.physchem.49.1.371; Diamant H, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.061602; Efimenko K, 2005, NAT MATER, V4, P293, DOI 10.1038/nmat1342; Gopal A, 2006, J PHYS CHEM B, V110, P10220, DOI 10.1021/jp0618983; Gopal A, 2001, J PHYS CHEM B, V105, P10348, DOI 10.1021/jp012532n; HERTZ H, 1884, WIEDEMANNS ANN PHYS, V22, P449; Huang J, 2007, SCIENCE, V317, P650, DOI 10.1126/science.1144616; Huang R, 2002, J APPL PHYS, V91, P1135, DOI 10.1063/1.1427407; Kim DH, 2008, SCIENCE, V320, P507, DOI 10.1126/science.1154367; LOBKOVSKY A, 1995, SCIENCE, V270, P1482, DOI 10.1126/science.270.5241.1482; Lu WX, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.146107; MILNER ST, 1989, EUROPHYS LETT, V9, P495, DOI 10.1209/0295-5075/9/5/015; Mueggenburg KE, 2007, NAT MATER, V6, P656, DOI 10.1038/nmat1965; NIKOMAROV ES, 1990, LANGMUIR, V6, P410, DOI 10.1021/la00092a021; RIES HE, 1955, J PHYS CHEM-US, V59, P94, DOI 10.1021/j150523a028; Saint-Jalmes A, 1998, J PHYS CHEM B, V102, P5810, DOI 10.1021/jp980541z; SAINTJALMES A, 1994, EUROPHYS LETT, V28, P565, DOI 10.1209/0295-5075/28/8/005; Schultz DG, 2006, J PHYS CHEM B, V110, P24522, DOI 10.1021/jp063820s; Vaia R, 2008, SCIENCE, V319, P420, DOI 10.1126/science.1152931; Vella D, 2004, EUROPHYS LETT, V68, P212, DOI 10.1209/epl/i2004-10202-x; Witten TA, 2007, REV MOD PHYS, V79, P643, DOI 10.1103/RevModPhys.79.643; Ybert C, 2002, J PHYS-CONDENS MAT, V14, P4753, DOI 10.1088/0953-8984/14/19/301; Zasadzinski JA, 2001, CURR OPIN COLLOID IN, V6, P506, DOI 10.1016/S1359-0294(01)00124-8	26	393	400	6	247	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2008	320	5878					912	916		10.1126/science.1154069	http://dx.doi.org/10.1126/science.1154069			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18487188				2022-12-24	WOS:000255868300037
J	Schenck, A; Goto-Silva, L; Collinet, C; Rhinn, M; Giner, A; Habermann, B; Brand, M; Zerial, M				Schenck, Annette; Goto-Silva, Livia; Collinet, Claudio; Rhinn, Muriel; Giner, Angelika; Habermann, Bianca; Brand, Michael; Zerial, Marino			The endosomal protein Appl1 mediates akt substrate specificity and cell survival in vertebrate development	CELL			English	Article							SIGNAL-TRANSDUCTION; ENDOCYTIC PATHWAY; RAB5 EFFECTORS; COMPLEX; GIPC; INTERACTS; TURNOVER; DOMAINS; CANCER; DEATH	During development of multicellular organisms, cells respond to extracellular cues through nonlinear signal transduction cascades whose principal components have been identified. Nevertheless, the molecular mechanisms underlying specificity of cellular responses remain poorly understood. Spatial distribution of signaling proteins may contribute to signaling specificity. Here, we tested this hypothesis by investigating the role of the Rab5 effector Appl1, an endosomal protein that interacts with transmembrane receptors and Akt. We show that in zebrafish, Appl1 regulates Akt activity and substrate specificity, controlling GSK-3 beta but not TSC2. Consistent with this pattern, Appl1 is selectively required for cell survival, most critically in highly expressing tissues. Remarkably, Appl1 function requires its endosomal localization. Indeed, Akt and GSK-3 beta, but not TSC2, dynamically associate with Appl1 endosomes upon growth factor stimulation. We propose that partitioning of Akt and selected effectors onto endosomal compartments represents a key mechanism contributing to the specificity of signal transduction in vertebrate development.	[Schenck, Annette; Goto-Silva, Livia; Collinet, Claudio; Giner, Angelika; Habermann, Bianca; Zerial, Marino] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Rhinn, Muriel; Brand, Michael] Univ Technol Dresden, Ctr Biotechnol, D-01307 Dresden, Germany; [Rhinn, Muriel; Brand, Michael] Univ Technol Dresden, Ctr Regenerat Therapies, D-01307 Dresden, Germany; [Habermann, Bianca] Scion Comp Innovat GmbH, D-01307 Dresden, Germany	Max Planck Society; Technische Universitat Dresden; Technische Universitat Dresden	Zerial, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	zerial@mpi-cbg.de	Brand, Michael/A-5509-2010; Habermann, Bianca/N-4886-2016; Schenck, Annette/E-4514-2012; Goto, Livia/I-3072-2012	Brand, Michael/0000-0001-5711-6512; Habermann, Bianca/0000-0002-2457-7504; Schenck, Annette/0000-0002-6918-3314; Collinet, Claudio/0000-0002-8532-2601; Rhinn, Muriel/0000-0002-1918-0246				ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Caruso-Neves C, 2006, P NATL ACAD SCI USA, V103, P18810, DOI 10.1073/pnas.0605029103; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; Cooper MS, 2005, DEV DYNAM, V232, P359, DOI 10.1002/dvdy.20252; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dumont JE, 2001, CELL SIGNAL, V13, P457, DOI 10.1016/S0898-6568(01)00168-1; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Hoeller D, 2005, CURR OPIN CELL BIOL, V17, P107, DOI 10.1016/j.ceb.2005.01.001; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Hunker CM, 2006, ARCH BIOCHEM BIOPHYS, V449, P130, DOI 10.1016/j.abb.2006.01.020; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Katoh M, 2002, INT J MOL MED, V9, P585; Kholodenko BN, 2003, J EXP BIOL, V206, P2073, DOI 10.1242/jeb.00298; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lin DC, 2006, MOL CELL BIOL, V26, P8928, DOI 10.1128/MCB.00228-06; Liu J, 2002, J BIOL CHEM, V277, P26281, DOI 10.1074/jbc.M204679200; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455, DOI 10.1038/74542; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Muders MH, 2006, CANCER RES, V66, P10264, DOI 10.1158/0008-5472.CAN-06-2321; Nechamen CA, 2004, BIOL REPROD, V71, P629, DOI 10.1095/biolreprod.103.025833; Nechamen CA, 2007, MOL CELL ENDOCRINOL, V260, P93, DOI 10.1016/j.mce.2006.08.014; Nowak M, 2005, CELL DEATH DIFFER, V12, P52, DOI 10.1038/sj.cdd.4401519; Pal A, 2006, J CELL BIOL, V172, P605, DOI 10.1083/jcb.200509091; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Polak P, 2006, DEV CELL, V11, P433, DOI 10.1016/j.devcel.2006.09.005; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Su X, 2006, J BIOL CHEM, V281, P27982, DOI 10.1074/jbc.M602873200; Teis D, 2003, CELL MOL LIFE SCI, V60, P2020, DOI 10.1007/s00018-003-3010-2; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Varsano T, 2006, MOL CELL BIOL, V26, P8942, DOI 10.1128/MCB.00305-06; Weston CR, 2001, SCIENCE, V292, P2439, DOI 10.1126/science.1063279; Yang L, 2003, J BIOL CHEM, V278, P16820, DOI 10.1074/jbc.M213163200	48	249	260	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 2	2008	133	3					486	497		10.1016/j.cell.2008.02.044	http://dx.doi.org/10.1016/j.cell.2008.02.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455989	Bronze			2022-12-24	WOS:000255503900019
J	Cristol, DA; Brasso, RL; Condon, AM; Fovargue, RE; Friedman, SL; Hallinger, KK; Monroe, AP; White, AE				Cristol, Daniel A.; Brasso, Rebecka L.; Condon, Anne M.; Fovargue, Rachel E.; Friedman, Scott L.; Hallinger, Kelly K.; Monroe, Adrian P.; White, Ariel E.			The movement of aquatic Mercury through terrestrial food webs	SCIENCE			English	Article							METHYLMERCURY; HEALTH		[Cristol, Daniel A.; Brasso, Rebecka L.; Condon, Anne M.; Fovargue, Rachel E.; Friedman, Scott L.; Hallinger, Kelly K.; Monroe, Adrian P.; White, Ariel E.] Coll William & Mary, Dept Biol, Inst Integrat Bird Behav Studies, Williamsburg, VA 23185 USA	William & Mary	Cristol, DA (corresponding author), Coll William & Mary, Dept Biol, Inst Integrat Bird Behav Studies, Williamsburg, VA 23185 USA.	dacris@wm.edu	Monroe, Adrian/I-4018-2019; Brasso, Rebecka/I-7014-2013	Monroe, Adrian/0000-0003-0934-8225; 				CARTER LJ, 1977, SCIENCE, V198, P1015, DOI 10.1126/science.198.4321.1015; Evers DC, 2008, ECOTOXICOLOGY, V17, P69, DOI 10.1007/s10646-007-0168-7; Haines TA, 2003, ENVIRON MONIT ASSESS, V86, P211, DOI 10.1023/A:1024017329382; Mergler D, 2007, AMBIO, V36, P3, DOI 10.1579/0044-7447(2007)36[3:MEAHEI]2.0.CO;2; Scheulhammer AM, 2007, AMBIO, V36, P12, DOI 10.1579/0044-7447(2007)36[12:EOEMOT]2.0.CO;2	5	308	316	9	232	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2008	320	5874					335	335		10.1126/science.1154082	http://dx.doi.org/10.1126/science.1154082			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZZ	18420925				2022-12-24	WOS:000255026100032
J	Jhunjhunwala, S; van Zelm, MC; Peak, MM; Cutchin, S; Riblet, R; van Dongen, JJM; Grosveld, FG; Knoch, TA; Murre, C				Jhunjhunwala, Suchit; van Zelm, Menno C.; Peak, Mandy M.; Cutchin, Steve; Riblet, Roy; van Dongen, Jacques J. M.; Grosveld, Frank G.; Knoch, Tobias A.; Murre, Cornelis			The 3D structure of the immunoglobulin heavy-chain locus: Implications for long-range genomic interactions	CELL			English	Article							IN-SITU HYBRIDIZATION; CHROMATIN; ENHANCER; REGION; GENES; REARRANGEMENT; ARCHITECTURE; EXPRESSION; CELLS	The immunoglobulin heavy-chain (Igh) locus is organized into distinct regions that contain multiple variable (V-H), diversity (D-H), joining (J(H)) and constant (C-H) coding elements. How the Igh locus is structured in 3D space is unknown. To probe the topography of the Igh locus, spatial distance distributions were determined between 12 genomic markers that span the entire Igh locus. Comparison of the distance distributions to computer simulations of alternative chromatin arrangements predicted that the Igh locus is organized into compartments containing clusters of loops separated by linkers. Trilateration and triple-point angle measurements indicated the mean relative 3D positions of the V-H, D-H, J(H), and C-H elements, showed compartmentalization and striking conformational changes involving V-H and D-H-J(H) elements during early B cell development. In pro-B cells, the entire repertoire of V-H regions (2 Mbp) appeared to have merged and juxtaposed to the D-H elements, mechanistically permitting long-range genomic interactions to occur with relatively high frequency.	[Grosveld, Frank G.; Knoch, Tobias A.] Erasmus MC, Dept Biophys Genom, NL-3015 GE Rotterdam, Netherlands; [Grosveld, Frank G.; Knoch, Tobias A.] Erasmus MC, Dept Cell Biol & Genet, NL-3015 GE Rotterdam, Netherlands; [Knoch, Tobias A.] Heidelberg Univ, Kirchhoff Inst Phys, Dept Biophys Genom, D-69120 Heidelberg, Germany; [Jhunjhunwala, Suchit; van Zelm, Menno C.; Peak, Mandy M.; Murre, Cornelis] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Cutchin, Steve] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92037 USA; [Riblet, Roy] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA; [van Dongen, Jacques J. M.] Erasmus MC, Dept Immunol, NL-3015 GE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Ruprecht Karls University Heidelberg; University of California System; University of California San Diego; University of California System; University of California San Diego; Torrey Pines Institute for Molecular Studies, California; Erasmus University Rotterdam; Erasmus MC	Knoch, TA (corresponding author), Erasmus MC, Dept Biophys Genom, Dr Molewaterplein 50, NL-3015 GE Rotterdam, Netherlands.	ta.knoch@taknoch.org; murre@biomail.ucsd.edu	Jhunjhunwala, Suchit/GNH-2256-2022; van Dongen, Jacques J.M./F-8537-2015; van Zelm, Menno C/O-4404-2015	Jhunjhunwala, Suchit/0000-0003-3484-0588; van Dongen, Jacques J.M./0000-0001-7686-0021; van Zelm, Menno C/0000-0003-4161-1919; Cutchin, Steven/0000-0002-6515-1905; van Dongen, Jacques J.M./0000-0002-3650-7087	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023548] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI023548-13, R01 AI023548-18, R01 AI023548-20A2, R01 AI023548-21, R01 AI023548-16, R01 AI023548-19, R01 AI023548-22, R01 AI023548-15, R01 AI023548-17A1] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Boveri T., 1909, ARCH ZELLFORSCH, V3, P181; BRODEUR PH, 1984, EUR J IMMUNOL, V14, P922, DOI 10.1002/eji.1830141012; Bystricky K, 2004, P NATL ACAD SCI USA, V101, P16495, DOI 10.1073/pnas.0402766101; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chen YW, 2007, J PHYS CHEM B, V111, P7432, DOI 10.1021/jp068963t; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; De Gennes P.-G., 1979, SCALING CONCEPTS POL; Eivazova ER, 2004, P NATL ACAD SCI USA, V101, P251, DOI 10.1073/pnas.0303919101; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; GROSBERG AY, 1997, GIANT MOL, P78; GU H, 1991, J EXP MED, V173, P1357, DOI 10.1084/jem.173.6.1357; HERENDEEN DR, 1992, SCIENCE, V256, P1298, DOI 10.1126/science.1598572; Ikawa T, 2004, IMMUNITY, V20, P349, DOI 10.1016/S1074-7613(04)00049-4; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Knoch TA, 2003, HIGH PERFORMANCE COMPUTING IN SCIENCE AND ENGINEERING'03, P421; Knoch TA, 2000, HIGH PERFORMANCE COMPUTING IN SCIENCE AND ENGINEERING '99, P229; KNOCH TA, 2002, VIVO QUANTIFICATION; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; KRATKY O, 1949, RECL TRAV CHIM PAY B, V68, P1106; Love VA, 2000, MOL IMMUNOL, V37, P29, DOI 10.1016/S0161-5890(00)00023-7; MALYNN BA, 1990, J EXP MED, V171, P843, DOI 10.1084/jem.171.3.843; Munkel C, 1998, PHYS REV E, V57, P5888, DOI 10.1103/PhysRevE.57.5888; OKADA TA, 1979, CHROMOSOMA, V72, P1, DOI 10.1007/BF00286426; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; Paulson JR, 1988, CHROMOSOMES CHROMATI, VIII, P3; PIENTA KJ, 1984, J CELL SCI, P123; Rabl C, 1885, MORPHOL JB, V10, P214; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Rombel I, 1998, COLD SPRING HARB SYM, V63, P157, DOI 10.1101/sqb.1998.63.157; SACHS RK, 1995, P NATL ACAD SCI USA, V92, P2710, DOI 10.1073/pnas.92.7.2710; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; Schatz DG, 2005, CURR TOP MICROBIOL, V290, P49; Solovei I, 2002, EXP CELL RES, V276, P10, DOI 10.1006/excr.2002.5513; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; TRASK BJ, 1991, AM J HUM GENET, V48, P1; WARRINGTON JA, 1994, GENOMICS, V24, P395, DOI 10.1006/geno.1994.1636; YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0; YOKOTA H, 1995, J CELL BIOL, V130, P1239, DOI 10.1083/jcb.130.6.1239	41	212	217	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2008	133	2					265	279		10.1016/j.cell.2008.03.024	http://dx.doi.org/10.1016/j.cell.2008.03.024			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	289JY	18423198	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000255052000016
J	Nishiyama, M; Ishikawa, T; Rechsteiner, H; Glockshuber, R				Nishiyama, Mireille; Ishikawa, Takashi; Rechsteiner, Helene; Glockshuber, Rudi			Reconstitution of pilus assembly reveals a bacterial outer membrane catalyst	SCIENCE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; FIMH ADHESIN; STRUCTURAL BASIS; TYPE-1 FIMBRIAE; PLATFORM FIMD; BIOGENESIS; COMPLEX; RECOGNITION; MECHANISM; RECEPTOR	Type 1 pili from uropathogenic Escherichia coli are a prototype of adhesive surface organelles assembled and secreted by the conserved chaperone/ usher pathway. We reconstituted type 1 pilus biogenesis from purified pilus proteins. The usher FimD acted as a catalyst to accelerate the ordered assembly of protein subunits independently of cellular energy. Its activity was highly dependent on the adhesin subunit FimH, which triggered the conversion of FimD into a high-efficiency assembly catalyst. Furthermore, a simple kinetic model adequately rationalized usher- catalyzed pilus assembly in vivo. Our results contribute to a mechanistic understanding of protein- catalyzed biogenesis of supramolecular protein complexes at the bacterial outer cell membrane.	[Nishiyama, Mireille; Ishikawa, Takashi; Rechsteiner, Helene; Glockshuber, Rudi] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Glockshuber, R (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	rudi@mol.biol.ethz.ch	Ishikawa, Takashi/E-5023-2017	Ishikawa, Takashi/0000-0002-1976-7477				Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Connell I, 1996, P NATL ACAD SCI USA, V93, P9827, DOI DOI 10.1073/PNAS.93.18.9827; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; JACOBDUBUISSON F, 1994, J BIOL CHEM, V269, P12447; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; KLEMM P, 1987, MOL GEN GENET, V208, P439, DOI 10.1007/BF00328136; Knight SD, 2007, ADV EXP MED BIOL, V603, P74; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; Munera D, 2007, MOL MICROBIOL, V64, P333, DOI 10.1111/j.1365-2958.2007.05657.x; Nishiyama M, 2005, EMBO J, V24, P2075, DOI 10.1038/sj.emboj.7600693; Nishlyama M, 2003, J MOL BIOL, V330, P513, DOI 10.1016/S0022-2836(03)00591-6; Pinkner JS, 2006, P NATL ACAD SCI USA, V103, P17897, DOI 10.1073/pnas.0606795103; Remaut H, 2006, MOL CELL, V22, P831, DOI 10.1016/j.molcel.2006.05.033; RUSSELL PW, 1992, J BACTERIOL, V174, P5923, DOI 10.1128/jb.174.18.5923-5935.1992; Sauer FG, 2002, CELL, V111, P543, DOI 10.1016/S0092-8674(02)01050-4; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Saulino ET, 1998, EMBO J, V17, P2177, DOI 10.1093/emboj/17.8.2177; Schembri MA, 1996, FEMS MICROBIOL LETT, V137, P257, DOI 10.1016/0378-1097(96)00067-5; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Vetsch M, 2004, NATURE, V431, P329, DOI 10.1038/nature02891; Vetsch M, 2006, EMBO REP, V7, P734, DOI 10.1038/sj.embor.7400722; Zhou G, 2001, J CELL SCI, V114, P4095	22	88	89	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2008	320	5874					376	379		10.1126/science.1154994	http://dx.doi.org/10.1126/science.1154994			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZZ	18369105				2022-12-24	WOS:000255026100044
J	Swamy, GK; Ostbye, T; Skjaerven, R				Swamy, Geeta K.; Ostbye, Truls; Skjaerven, Rolv			Association of preterm birth with long-term survival, reproduction, and next-generation preterm birth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUBSEQUENT MARITAL-STATUS; GESTATIONAL-AGE; WEIGHT INFANTS; PRENATAL GROWTH; YOUNG ADULTHOOD; SEX-DIFFERENCES; DEFECTS; RISK; MORTALITY; NORWAY	Context Preterm birth is a major cause of infant morbidity and mortality. Less is known about long- term health among persons born preterm. Objective To determine the long- term effects of preterm birth on survival, reproduction, and next- generation preterm birth. Design, Setting, and Participants Population- based, observational, longitudinal study using registry data from 1 167 506 singleton births in the Medical Birth Registry of Norway in 1967- 1988. The cohort was followed up through 2002 for survival. The cohort was truncated to births from 1967- 1976 for assessment of educational achievement and reproductive outcomes through 2004. Main OutcomeMeasures In relation to sex and gestational age at birth, absolute mortality, risk of fetal, infant, child, and adolescent mortality, and incidence and risk of reproduction and next- generation preterm birth. Singleton term ( 37- 42 weeks) fetal deaths and live births, stratified by sex, served as the reference group for all analyses. Results The percentage who were born preterm was higher among boys ( 5.6%) than among girls ( 4.7%). Preterm participants had an increased risk of mortality throughout childhood. For boys born at 22 to 27 weeks, mortality rates were 1.33% and 1.01% for early and late childhood death, with relative risks ( RRs) of 5.3 ( 95% confidence interval [ CI], 2.0- 14.2) and 7.0 ( 95% CI, 2.3- 22.0), respectively. The mortality rate for girls born at 22 to 27 weeks was 1.71% for early childhood death, with an RR of 9.7 ( 95% CI, 4.0- 23.7); there were no late childhood deaths. For 28 to 32 weeks, the early and late childhood mortality rates among boys were 0.73% and 0.37%, with RRs of 2.5 ( 95% CI, 1.6- 3.7) and 2.3 ( 95% CI, 1.3- 4.1), respectively. Girls born at 28 to 32 weeks did not have a significantly increased risk of childhood mortality. Reproduction was diminished for index participants born preterm. For men and women born at 22 to 27 weeks, absolute reproduction was 13.9% and 25%, with RRs of 0.24 ( 95% CI, 0.17- 0.32) and 0.33 ( 95% CI, 0.26- 0.42), respectively. For 28 to 32 weeks, absolute reproduction was 38.6% and 59.2% for men and women, with RRs of 0.7 ( 95% CI, 0.66- 0.74) and 0.81 ( 95% CI, 0.78- 0.85), respectively. Preterm women but not men were at increased risk of having preterm offspring. Conclusion In persons born in Norway in 1967- 1988, preterm birth was associated with diminished long- term survival and reproduction.	[Swamy, Geeta K.] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27710 USA; [Ostbye, Truls] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA; [Ostbye, Truls] Duke NUS Grad Med Sch, Singapore, Singapore; [Skjaerven, Rolv] Univ Bergen, Sect Epidemiol & Med Stat, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Skjaerven, Rolv] Norwegian Inst Publ Hlth, Med Birth Registry Norway, Bergen, Norway	Duke University; Duke University; National University of Singapore; University of Bergen; Norwegian Institute of Public Health (NIPH)	Swamy, GK (corresponding author), Duke Univ, Med Ctr, Dept Obstet & Gynecol, Box 3967, Durham, NC 27710 USA.	swamy002@mc.duke.edu						ALEXANDER GR, 1995, PUBLIC HEALTH REP, V110, P395; ALLEN MC, 1986, OBSTET GYNECOL, V67, P427; Cui W, 2005, BIRTH DEFECTS RES A, V73, P876, DOI 10.1002/bdra.20196; Dolan SM, 2007, OBSTET GYNECOL, V110, P318, DOI 10.1097/01.AOG.0000275264.78506.63; Ekholm K, 2005, AM J EPIDEMIOL, V161, P725, DOI 10.1093/aje/kwi096; Friedlander Y, 2003, PAEDIATR PERINAT EP, V17, P398, DOI 10.1046/j.1365-3016.2003.00522.x; GEIRSSON RT, 1991, BRIT J OBSTET GYNAEC, V98, P108, DOI 10.1111/j.1471-0528.1991.tb10323.x; Grunau RE, 2004, PEDIATRICS, V114, pE725, DOI 10.1542/peds.2004-0932; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; *HELP AM YOUTH, INCR RISK FACT BOYS; Hoyert Donna L, 2006, Natl Vital Stat Rep, V54, P1; Kalish RB, 2004, AM J OBSTET GYNECOL, V191, P975, DOI 10.1016/j.ajog.2004.06.053; Koppe JGV-VP, 1998, TXB PERINATAL MED, P1362; Kunitz SJ, 2007, INT J EPIDEMIOL, V36, P3, DOI 10.1093/ije/dyl296; Lary JM, 2001, TERATOLOGY, V64, P237, DOI 10.1002/tera.1070; Lefebvre F, 2005, ACTA PAEDIATR, V94, P733, DOI 10.1080/08035250510025987; Li CI, 2003, PAEDIATR PERINAT EP, V17, P164, DOI 10.1046/j.1365-3016.2003.00487.x; Lie RT, 2001, JAMA-J AM MED ASSOC, V285, P755, DOI 10.1001/jama.285.6.755; MacDorman Marian F, 2005, Natl Vital Stat Rep, V53, P1; Majnemer A, 2000, DEV MED CHILD NEUROL, V42, P53; Philip AGS, 2005, PEDIATR RES, V58, P799, DOI 10.1203/01.PDR.0000151693.46655.66; Phillips DIW, 2001, BRIT MED J, V322, P771, DOI 10.1136/bmj.322.7289.771; Phillips Susan P, 2005, Int J Equity Health, V4, P11, DOI 10.1186/1475-9276-4-11; Rasmussen SA, 2001, J PEDIATR-US, V138, P668, DOI 10.1067/mpd.2001.112249; Saigal S, 2006, JAMA-J AM MED ASSOC, V295, P667, DOI 10.1001/jama.295.6.667; Samuelsen SO, 1998, AM J EPIDEMIOL, V148, P983, DOI 10.1093/oxfordjournals.aje.a009575; SELMER ES, 1967, J R STAT SOC SER A-G, V130, P225, DOI 10.2307/2343402; Skjaerven R, 1999, NEW ENGL J MED, V340, P1057, DOI 10.1056/NEJM199904083401401; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; *STAT NORW, 2005, IMM EM 1951 2005; Stoelhorst GMSJ, 2005, PEDIATRICS, V115, P396, DOI 10.1542/peds.2004-1497; Vagero D, 2002, BRIT MED J, V324, P398, DOI 10.1136/bmj.324.7334.398; Vatten LJ, 2004, EARLY HUM DEV, V76, P47, DOI 10.1016/j.earlhumdev.2003.10.006; Wilson-Costello D, 2005, PEDIATRICS, V115, P997, DOI 10.1542/peds.2004-0221; Wood NS, 2005, ARCH DIS CHILD-FETAL, V90, P134, DOI 10.1136/adc.2004.052407	35	221	229	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 26	2008	299	12					1429	1436		10.1001/jama.299.12.1429	http://dx.doi.org/10.1001/jama.299.12.1429			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	278MY	18364485	Bronze			2022-12-24	WOS:000254292200017
J	Quintana, FJ; Basso, AS; Iglesias, AH; Korn, T; Farez, MF; Bettelli, E; Caccamo, M; Oukka, M; Weiner, HL				Quintana, Francisco J.; Basso, Alexandre S.; Iglesias, Antonio H.; Korn, Thomas; Farez, Mauricio F.; Bettelli, Estelle; Caccamo, Mario; Oukka, Mohamed; Weiner, Howard L.			Control of T-reg and TH17 cell differentiation by the aryl hydrocarbon receptor	NATURE			English	Article							TGF-BETA; INDEPENDENT REGULATION; MICROARRAY ANALYSIS; AH RECEPTOR; ACTIVATION; EXPRESSION; INDUCTION; DIOXIN; T(H)17; LIGAND	Regulatory T cells (T-reg) expressing the transcription factor Foxp3 control the autoreactive components of the immune system. The development of T-reg cells is reciprocally related to that of pro- inflammatory T cells producing interleukin- 17 ( T(H)17). Although T-reg cell dysfunction and/ or T(H)17 cell dysregulation are thought to contribute to the development of autoimmune disorders, little is known about the physiological pathways that control the generation of these cell lineages. Here we report the identification of the ligand- activated transcription factor aryl hydrocarbon receptor ( AHR) as a regulator of T-reg and T(H)17 cell differentiation in mice. AHR activation by its ligand 2,3,7,8- tetrachlorodibenzo- p- dioxin induced functional Treg cells that suppressed experimental autoimmune encephalomyelitis. On the other hand, AHR activation by 6- formylindolo[ 3,2- b] carbazole interfered with T-reg cell development, boosted T(H)17 cell differentiation and increased the severity of experimental autoimmune encephalomyelitis in mice. Thus, AHR regulates both T-reg and T(H)17 cell differentiation in a ligand- specific fashion, constituting a unique target for therapeutic immunomodulation.	[Quintana, Francisco J.; Basso, Alexandre S.; Iglesias, Antonio H.; Korn, Thomas; Farez, Mauricio F.; Bettelli, Estelle; Weiner, Howard L.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Caccamo, Mario] European Bioinformat Inst, EMBL Outstn Hinxton, Cambridge CB10 1SD, England; [Oukka, Mohamed] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; European Molecular Biology Laboratory (EMBL); Harvard University; Brigham & Women's Hospital	Weiner, HL (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	hweiner@rics.bwh.harvard.edu	Korn, Thomas/AAE-6960-2019; Basso, Alexandre S/K-2281-2012; Quintana, Francisco Javier/AAB-6915-2020	Korn, Thomas/0000-0002-3633-0955; Basso, Alexandre S/0000-0002-3302-4792; 	NIAID NIH HHS [R01AI073542-01, R01 AI073542-02, R01 AI073542, AI435801, R01 AI073542-01] Funding Source: Medline; NINDS NIH HHS [NS38037, R01 NS059996, P01 NS038037] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038037, R01NS059996] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baccarelli A, 2002, ENVIRON HEALTH PERSP, V110, P1169, DOI 10.1289/ehp.021101169; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chang XQ, 2007, MOL CELL BIOL, V27, P6127, DOI 10.1128/MCB.00323-07; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Frericks M, 2007, TOXICOL APPL PHARM, V220, P320, DOI 10.1016/j.taap.2007.01.014; Fritsche E, 2007, P NATL ACAD SCI USA, V104, P8851, DOI 10.1073/pnas.0701764104; Funatake CJ, 2005, J IMMUNOL, V175, P4184, DOI 10.4049/jimmunol.175.7.4184; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Hestermann EV, 2003, MOL CELL BIOL, V23, P7920, DOI 10.1128/MCB.23.21.7920-7925.2003; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Loser K, 2006, NAT MED, V12, P1372, DOI 10.1038/nm1518; Mantel PY, 2006, J IMMUNOL, V176, P3593, DOI 10.4049/jimmunol.176.6.3593; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Murphy KA, 2004, J BIOL CHEM, V279, P25284, DOI 10.1074/jbc.M402168200; Oesch-Bartlomowicz B, 2005, P NATL ACAD SCI USA, V102, P9218, DOI 10.1073/pnas.0503488102; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; OKEY AB, 1989, MOL PHARMACOL, V35, P823; Okino ST, 2007, MOL PHARMACOL, V72, P1457, DOI 10.1124/mol.107.039826; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Ovcharenko I, 2005, GENOME RES, V15, P184, DOI 10.1101/gr.3007205; Quintana FJ, 2004, P NATL ACAD SCI USA, V101, P14615, DOI 10.1073/pnas.0404848101; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Song JS, 2002, P NATL ACAD SCI USA, V99, P14694, DOI 10.1073/pnas.232562899; Stekel D, 2003, MICROARRAY BIOINFORM; Tai P, 2008, J CELL PHYSIOL, V214, P456, DOI 10.1002/jcp.21221; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wolff S, 2001, MOL PHARMACOL, V59, P716, DOI 10.1124/mol.59.4.716; Zhang S, 2008, TOXICOL APPL PHARM, V227, P196, DOI 10.1016/j.taap.2007.10.019	41	1239	1311	4	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2008	453	7191					65	+		10.1038/nature06880	http://dx.doi.org/10.1038/nature06880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294ID	18362915				2022-12-24	WOS:000255398800039
J	Stoltenberg, J				Stoltenberg, Jens			Delivering for women and children	LANCET			English	Editorial Material									Norwegian Govt, NO-0030 Oslo, Norway		Stoltenberg, J (corresponding author), Norwegian Govt, NO-0030 Oslo, Norway.	Tore.Godal@smk.dep.no						*UN UNICEF, 2002, UN SPEC SESS CHILDR; United Nations Children's Fund (UNICEF), 2014, STATE WORLDS CHILDRE	2	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 12	2008	371	9620					1230	1232		10.1016/S0140-6736(08)60540-1	http://dx.doi.org/10.1016/S0140-6736(08)60540-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	286XH	18406848				2022-12-24	WOS:000254878900011
J	Kleinman, ME; Yamada, K; Takeda, A; Chandrasekaran, V; Nozaki, M; Baffi, JZ; Albuquerque, RJC; Yamasaki, S; Itaya, M; Pan, YZ; Appukuttan, B; Gibbs, D; Yang, ZL; Kariko, K; Ambati, BK; Wilgus, TA; DiPietro, LA; Sakurai, E; Zhang, K; Smith, JR; Taylor, EW; Ambati, J				Kleinman, Mark E.; Yamada, Kiyoshi; Takeda, Atsunobu; Chandrasekaran, Vasu; Nozaki, Miho; Baffi, Judit Z.; Albuquerque, Romulo J. C.; Yamasaki, Satoshi; Itaya, Masahiro; Pan, Yuzhen; Appukuttan, Binoy; Gibbs, Daniel; Yang, Zhenglin; Kariko, Katalin; Ambati, Balamurali K.; Wilgus, Traci A.; DiPietro, Luisa A.; Sakurai, Eiji; Zhang, Kang; Smith, Justine R.; Taylor, Ethan W.; Ambati, Jayakrishna			Sequence- and target-independent angiogenesis suppression by siRNA via TLR3	NATURE			English	Article							TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; SMALL INTERFERING RNAS; IN-VIVO DELIVERY; NF-KAPPA-B; CHOROIDAL NEOVASCULARIZATION; OCULAR NEOVASCULARIZATION; NEGATIVE REGULATOR; ENDOTHELIAL-CELLS; SIGNALING PATHWAY	Clinical trials of small interfering RNA ( siRNA) targeting vascular endothelial growth factor-A ( VEGFA) or its receptor VEGFR1 ( also called FLT1), in patients with blinding choroidal neovascularization ( CNV) from age- related macular degeneration, are premised on gene silencing by means of intracellular RNA interference ( RNAi). Weshow instead that CNV inhibition is a siRNA- class effect: 21- nucleotide or longer siRNAs targeting non- mammalian genes, non- expressed genes, non- genomic sequences, pro- and anti- angiogenic genes, and RNAi- incompetent siRNAs all suppressed CNV in mice comparably to siRNAs targeting Vegfa or Vegfr1 without off- target RNAi or interferon-alpha/beta activation. Non- targeted ( against non- mammalian genes) and targeted ( against Vegfa or Vegfr1) siRNA suppressed CNV via cell- surface toll- like receptor 3 ( TLR3), its adaptor TRIF, and induction of interferon-gamma and interleukin- 12. Non- targeted siRNA suppressed dermal neovascularization in mice as effectively as Vegfa siRNA. siRNA- induced inhibition of neovascularization required a minimum length of 21 nucleotides, a bridging necessity in a modelled 2: 1 TLR3 - RNA complex. Choroidal endothelial cells from people expressing the TLR3 coding variant 412FF were refractory to extracellular siRNA- induced cytotoxicity, facilitating individualized pharmacogenetic therapy. Multiple human endothelial cell types expressed surface TLR3, indicating that generic siRNAs might treat angiogenic disorders that affect 8% of the world's population, and that siRNAs might induce unanticipated vascular or immune effects.	[Kleinman, Mark E.; Yamada, Kiyoshi; Takeda, Atsunobu; Nozaki, Miho; Baffi, Judit Z.; Albuquerque, Romulo J. C.; Ambati, Jayakrishna] Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA; [Albuquerque, Romulo J. C.; Ambati, Jayakrishna] Univ Kentucky, Dept Physiol, Lexington, KY 40506 USA; [Chandrasekaran, Vasu] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Yamasaki, Satoshi; Itaya, Masahiro; Sakurai, Eiji] Nagoya City Univ, Sch Med, Dept Ophthalmol, Nagoya, Aichi 4678601, Japan; [Pan, Yuzhen; Appukuttan, Binoy; Smith, Justine R.] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97239 USA; [Gibbs, Daniel; Yang, Zhenglin; Ambati, Balamurali K.; Zhang, Kang] Univ Utah, Sch Med, Dept Ophthalmol & Visual Sci, Moran Eye Ctr, Salt Lake City, UT 84132 USA; [Gibbs, Daniel; Yang, Zhenglin; Zhang, Kang] Univ Utah, Sch Med, Program Human Mol Biol & Genet, Eccles Inst Human Genet, Salt Lake City, UT 84132 USA; [Kariko, Katalin] Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Ambati, Balamurali K.] Vet Affairs Salt Lake City Healthcare Syst, Salt Lake City, UT 84148 USA; [Wilgus, Traci A.; DiPietro, Luisa A.] Univ Illinois, Coll Dent, Ctr Wound Healing & Tissue Regenerat, Chicago, IL 60612 USA; [Taylor, Ethan W.] Univ N Carolina, Mol Med Lab, Greensboro, NC 27402 USA	University of Kentucky; University of Kentucky; University of North Carolina; University of North Carolina Chapel Hill; Nagoya City University; Oregon Health & Science University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Pennsylvania; US Department of Veterans Affairs; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of North Carolina; University of North Carolina Greensboro	Ambati, J (corresponding author), Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA.	jamba2@email.uky.edu	Zhang, Kang/Y-2740-2019; Peng, Chunwei/F-6788-2010; Smith, Justine/Y-9044-2019	Zhang, Kang/0000-0002-4549-1697; Smith, Justine/0000-0002-4756-5493; Kleinman, Mark/0000-0001-8557-7949	NATIONAL EYE INSTITUTE [R01EY015422, R01EY018350, R01EY018836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050875] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY018350, R01 EY015422, R01 EY015422-04, R01 EY018836-01, R01 EY018350-02, R01 EY018836] Funding Source: Medline; NIGMS NIH HHS [R01 GM050875] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Battle TE, 2006, CANCER RES, V66, P3649, DOI 10.1158/0008-5472.CAN-05-3612; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Cameron JS, 2007, J NEUROSCI, V27, P13033, DOI 10.1523/JNEUROSCI.4290-06.2007; Chiu YL, 2004, CHEM BIOL, V11, P1165, DOI 10.1016/j.chembiol.2004.06.006; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Corey DR, 2007, NAT CHEM BIOL, V3, P8, DOI 10.1038/nchembio0107-8; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Gay NJ, 2006, NAT REV IMMUNOL, V6, P693, DOI 10.1038/nri1916; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Gowen BB, 2007, J IMMUNOL, V178, P5200, DOI 10.4049/jimmunol.178.8.5200; Heidel JD, 2004, NAT BIOTECHNOL, V22, P1579, DOI 10.1038/nbt1038; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Judge AD, 2006, MOL THER, V13, P494, DOI 10.1016/j.ymthe.2005.11.002; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338; Lang KS, 2006, J CLIN INVEST, V116, P2456, DOI 10.1172/JCI28349; Lee HK, 2006, IMMUNITY, V24, P153, DOI 10.1016/j.immuni.2005.12.012; Lin Y, 2006, J IMMUNOL, V176, P4147, DOI 10.4049/jimmunol.176.7.4147; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Nozaki M, 2006, J CLIN INVEST, V116, P422, DOI 10.1172/JCI26316; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P17696, DOI 10.1074/jbc.M700209200; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P7668, DOI 10.1074/jbc.M610946200; Reich S, 2003, MOL VIS, V9, P210; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Shen J, 2006, GENE THER, V13, P225, DOI 10.1038/sj.gt.3302641; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Smith JR, 2007, INVEST OPHTH VIS SCI, V48, P2676, DOI 10.1167/iovs.06-0598; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Takada E, 2007, MOL IMMUNOL, V44, P3633, DOI 10.1016/j.molimm.2007.04.021; VOEST EE, 1995, J NATL CANCER I, V87, P581, DOI 10.1093/jnci/87.8.581; Wolfrum C, 2007, NAT BIOTECHNOL, V25, P1149, DOI 10.1038/nbt1339; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang L, 2002, BIOCHEM BIOPH RES CO, V292, P860, DOI 10.1006/bbrc.2002.6710	55	722	789	4	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2008	452	7187					591	U1		10.1038/nature06765	http://dx.doi.org/10.1038/nature06765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282KR	18368052	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000254567200037
J	Levine, S; Nguyen, T; Taylor, N; Friscia, ME; Budak, MT; Rothenberg, P; Zhu, JL; Sachdeva, R; Sonnad, S; Kaiser, LR; Rubinstein, NA; Powers, SK; Shrager, JB				Levine, Sanford; Nguyen, Taitan; Taylor, Nyali; Friscia, Michael E.; Budak, Murat T.; Rothenberg, Pamela; Zhu, Jianliang; Sachdeva, Rajeev; Sonnad, Seema; Kaiser, Larry R.; Rubinstein, Neal A.; Powers, Scott K.; Shrager, Joseph B.			Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; UBIQUITIN-PROTEASOME PATHWAY; SKELETAL-MUSCLE; OXIDATIVE STRESS; INJURY; MECHANISMS; EXPRESSION; CYTOKINES; FAILURE; MYOSIN	Background: The combination of complete diaphragm inactivity and mechanical ventilation (for more than 18 hours) elicits disuse atrophy of myofibers in animals. We hypothesized that the same may also occur in the human diaphragm. Methods: We obtained biopsy specimens from the costal diaphragms of 14 brain-dead organ donors before organ harvest (case subjects) and compared them with intraoperative biopsy specimens from the diaphragms of 8 patients who were undergoing surgery for either benign lesions or localized lung cancer (control subjects). Case subjects had diaphragmatic inactivity and underwent mechanical ventilation for 18 to 69 hours; among control subjects diaphragmatic inactivity and mechanical ventilation were limited to 2 to 3 hours. We carried out histologic, biochemical, and gene-expression studies on these specimens. Results: As compared with diaphragm-biopsy specimens from controls, specimens from case subjects showed decreased cross-sectional areas of slow-twitch and fast-twitch fibers of 57% (P=0.001) and 53% (P=0.01), respectively, decreased glutathione concentration of 23% (P=0.01), increased active caspase-3 expression of 100% (P=0.05), a 200% higher ratio of atrogin-1 messenger RNA (mRNA) transcripts to MBD4 (a housekeeping gene) (P=0.002), and a 590% higher ratio of MuRF-1 mRNA transcripts to MBD4 (P=0.001). Conclusions: The combination of 18 to 69 hours of complete diaphragmatic inactivity and mechanical ventilation results in marked atrophy of human diaphragm myofibers. These findings are consistent with increased diaphragmatic proteolysis during inactivity.	[Levine, Sanford; Nguyen, Taitan; Taylor, Nyali; Friscia, Michael E.; Budak, Murat T.; Rothenberg, Pamela; Zhu, Jianliang; Sonnad, Seema; Kaiser, Larry R.; Shrager, Joseph B.] Univ Penn, Dept Surg, Philadelphia, PA 19104 USA; [Rubinstein, Neal A.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Levine, Sanford; Budak, Murat T.; Rubinstein, Neal A.; Shrager, Joseph B.] Univ Penn, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Levine, Sanford] Gift Life Donor Program, Philadelphia, PA USA; [Levine, Sanford; Nguyen, Taitan; Sachdeva, Rajeev; Shrager, Joseph B.] Dept Vet Affairs Med Ctr, Med Res Surg & Lab Med Serv, Philadelphia, PA 19104 USA; [Powers, Scott K.] Univ Florida, Ctr Exercise Sci, Gainesville, FL 32611 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; State University System of Florida; University of Florida	Levine, S (corresponding author), 1495 Wesleys Run, Gladwyne, PA 19035 USA.	sdlevine@mail.med.upenn.edu	Kaiser, Larry/L-7940-2019; Budak, Murat/I-8358-2013	Budak, Murat/0000-0002-5059-9651	NHLBI NIH HHS [R01-HL-078834] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078834] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams GR, 2003, J APPL PHYSIOL, V95, P2185, DOI 10.1152/japplphysiol.00346.2003; AMADO JA, 1995, METABOLISM, V44, P812, DOI 10.1016/0026-0495(95)90198-1; Belperio JA, 2006, SEMIN RESP CRIT CARE, V27, P350, DOI 10.1055/s-2006-948289; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Castro MJ, 1999, J APPL PHYSIOL, V86, P350, DOI 10.1152/jappl.1999.86.1.350; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Du J, 2004, J CLIN INVEST, V113, P115, DOI 10.1172/JCI200418330; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; Falk DJ, 2006, J APPL PHYSIOL, V101, P1017, DOI 10.1152/japplphysiol.00104.2006; Gayan-Ramirez G, 2005, CRIT CARE MED, V33, P2804, DOI 10.1097/01.CCM.0000191250.32988.A3; Hudson NJ, 2002, J EXP BIOL, V205, P2297; Laghi F, 2003, AM J RESP CRIT CARE, V167, P120, DOI 10.1164/rccm.200210-1246OC; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lawler JM, 1998, CAN J APPL PHYSIOL, V23, P23, DOI 10.1139/h98-002; Levine S, 2003, AM J RESP CRIT CARE, V168, P706, DOI 10.1164/rccm.200209-1070OC; Levine S, 2006, J APPL PHYSIOL, V101, P1297, DOI 10.1152/japplphysiol.01607.2005; MacIntyre NR, 2005, CHEST, V128, P3937, DOI 10.1378/chest.128.6.3937; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Moore AJ, 2006, J APPL PHYSIOL, V101, P1400, DOI 10.1152/japplphysiol.01614.2005; NARUSAWA M, 1987, J CELL BIOL, V104, P447, DOI 10.1083/jcb.104.3.447; NAUMANN K, 1994, DIFFERENTIATION, V55, P203, DOI 10.1046/j.1432-0436.1994.5530203.x; Ohira Y, 2000, JPN J PHYSIOL, V50, P41, DOI 10.2170/jjphysiol.50.41; Powers SK, 2005, AM J PHYSIOL-REG I, V288, pR337, DOI 10.1152/ajpregu.00469.2004; Reid MB, 2005, AM J PHYSIOL-REG I, V288, pR1423, DOI 10.1152/ajpregu.00545.2004; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Shanely RA, 2002, AM J RESP CRIT CARE, V166, P1369, DOI 10.1164/rccm.200202-088OC; Trapp R.G., 2004, BASIC CLIN BIOSTATIS, V4th; Vassilakopoulos T, 2004, AM J RESP CRIT CARE, V169, P336, DOI 10.1164/rccm.200304-489CP; VATER R, 1994, HISTOCHEM J, V26, P916	29	884	969	4	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 27	2008	358	13					1327	1335		10.1056/NEJMoa070447	http://dx.doi.org/10.1056/NEJMoa070447			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	278TE	18367735				2022-12-24	WOS:000254308400003
J	Gillies, CL; Lambert, PC; Abrams, KR; Sutton, AJ; Cooper, NJ; Hsu, RT; Davies, MJ; Khunti, K				Gillies, Clare L.; Lambert, Paul C.; Abrams, Keith R.; Sutton, Alex J.; Cooper, Nicola J.; Hsu, Ron T.; Davies, Melanie J.; Khunti, Kamlesh			Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTIONS; ECONOMIC-EVALUATION; PROGRESSION; RISK; POPULATION; METFORMIN; MELLITUS; PEOPLE; MODEL	Objective To compare four potential screening strategies, and subsequent interventions, for the prevention and treatment of type 2 diabetes: (a) screening for type 2 diabetes to enable early detection and treatment, (b) screening for type 2 diabetes and impaired glucose tolerance, intervening with lifestyle interventions in those with a diagnosis of impaired glucose tolerance to delay or prevent diabetes, (c) as for (b) but with pharmacological interventions, and (d) no screening. Design Cost effectiveness analysis based on development and evaluation of probabilistic, comprehensive economic decision analytic model, from screening to death. Setting A hypothetical population, aged 45 at time of screening, with above average risk of diabetes. Data sources Published clinical trials and epidemiological studies retrieved from electronic bibliographic databases; supplementary data obtained from the Department of Health statistics for England and Wales, the screening those at risk (STAR) study, and the Leicester division of the ADDITION study. Methods A hybrid decision tree/Markov model was developed to simulate the long term effects of each screening strategy, in terms of both clinical and cost effectiveness outcomes. The base case model assumed a 50 year time horizon with discounting of both costs and benefits at 3.5%. Sensitivity analyses were carried out to investigate assumptions of the model and to identify which model inputs had most impact on the results. Results Estimated costs for each quality adjusted life year (QALY) gained (discounted at 3.5% a year for both costs and benefits) were 14 pound 150 ((euro)17 560; $27 860) for screening for type 2 diabetes, 6242 pound for screening for diabetes and impaired glucose tolerance followed by lifestyle interventions, and 7023 pound for screening for diabetes and impaired glucose tolerance followed by pharmacological interventions, all compared with no screening. At a willingness-to-pay threshold of 20 pound 000 the probability of the intervention being cost effective was 49%, 93%, and 85% for each of the active screening strategies respectively. Conclusions Screening for type 2 diabetes and impaired glucose tolerance, with appropriate intervention for those with impaired glucose tolerance, in an above average risk population aged 45, seems to be cost effective. The cost effectiveness of a policy of screening for diabetes alone, which offered no intervention to those with impaired glucose tolerance, is still uncertain, and further research on the impact of early detection of diabetes is needed.	[Gillies, Clare L.; Lambert, Paul C.; Abrams, Keith R.; Sutton, Alex J.; Cooper, Nicola J.; Hsu, Ron T.] Univ Leicester, Ctr Biostat & Genet Epidemiol, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Davies, Melanie J.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE1 7RH, Leics, England; [Khunti, Kamlesh] Univ Leicester, Div Gen Practice & Primary Hlth Care, Dept Hlth Sci, Leicester LE1 7RH, Leics, England	University of Leicester; University of Leicester; University of Leicester	Gillies, CL (corresponding author), Univ Leicester, Ctr Biostat & Genet Epidemiol, Dept Hlth Sci, Leicester LE1 7RH, Leics, England.	clg13@le.ac.uk	/ABC-9527-2021; Abrams, Keith/AAA-2557-2020	Gillies, Clare/0000-0002-8417-9700; Davies, Melanie/0000-0002-9987-9371; Abrams, Keith/0000-0002-7557-1567; Lambert, Paul/0000-0002-5337-663X; Khunti, Kamlesh/0000-0003-2343-7099; Sutton, Alexander/0000-0002-8934-9940	MRC [G106/1170] Funding Source: UKRI; Medical Research Council [G106/1170] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Avenell A, 2004, HEALTH TECHNOL ASSES, V8, P1; Bonora E, 2004, DIABETES, V53, P1782, DOI 10.2337/diabetes.53.7.1782; Borch-Johnsen K, 1999, LANCET, V354, P617; Caro JJ, 2004, DIABETIC MED, V21, P1229, DOI 10.1111/j.1464-5491.2004.01330.x; Chen THH, 2001, DIABETES RES CLIN PR, V54, pS37; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Clarke P, 2002, MED DECIS MAKING, V22, P340, DOI 10.1177/027298902400448902; Clarke PM, 2005, DIABETOLOGIA, V48, P868, DOI 10.1007/s00125-005-1717-3; Clarke PM, 2004, DIABETOLOGIA, V47, P1747, DOI 10.1007/s00125-004-1527-z; Cooper NJ, 2004, HEALTH ECON, V13, P203, DOI 10.1002/hec.804; Curtis L, 2006, UNIT COSTS HLTH SOCI; Davies M.J., 2005, DIABETIC MED, V22, P99; Davies MJ, 2004, DIABETIC MED, V21, P403, DOI 10.1111/j.1464-5491.2004.01176.x; de Vegt F, 2001, JAMA-J AM MED ASSOC, V285, P2109, DOI 10.1001/jama.285.16.2109; Donnelly R, 2000, BRIT MED J, V320, P1062, DOI 10.1136/bmj.320.7241.1062; Eddy DM, 2005, ANN INTERN MED, V143, P251, DOI 10.7326/0003-4819-143-4-200508160-00006; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; Engelgau MM, 1998, JAMA-J AM MED ASSOC, V280, P1757; Eriksson J, 1999, DIABETOLOGIA, V42, P793, DOI 10.1007/s001250051229; Eriksson JG, 2006, J INTERN MED, V259, P553, DOI 10.1111/j.1365-2796.2006.01633.x; Gilks W. R., 2003, BUGS BAYESIAN INFERE; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Glumer C, 2006, DIABETOLOGIA, V49, P1536, DOI 10.1007/s00125-006-0248-x; Gulliford MC, 2005, DIABETES CARE, V28, P47, DOI 10.2337/diacare.28.1.47; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Herman WH, 2005, ANN INTERN MED, V142, P323, DOI 10.7326/0003-4819-142-5-200503010-00007; Hoerger TJ, 2004, ANN INTERN MED, V140, P689, DOI 10.7326/0003-4819-140-9-200405040-00008; Icks A, 2007, DIABETIC MED, V24, P473, DOI 10.1111/j.1464-5491.2007.02108.x; Jacobs-van der Bruggen MAM, 2007, DIABETES CARE, V30, P128, DOI 10.2337/dc06-0690; JARRETT RJ, 1979, DIABETOLOGIA, V16, P25, DOI 10.1007/BF00423146; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Meigs JB, 2003, DIABETES, V52, P1475, DOI 10.2337/diabetes.52.6.1475; National Institute for Clinical Excellence, 2004, GUID METH TECHN APPR; Palmer AJ, 2004, CLIN THER, V26, P304, DOI 10.1016/S0149-2918(04)90029-X; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Rasmussen SS, 2007, DIABETOLOGIA, V50, P293, DOI 10.1007/s00125-006-0530-y; Rossing P, 1996, BRIT MED J, V313, P779; Segal L, 1998, HEALTH PROMOT INT, V13, P197, DOI 10.1093/heapro/13.3.197; Srinivasan BT, 2007, DIABETIC MED, V24, P51; TURNER RC, 1991, DIABETOLOGIA, V34, P877; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *UK NAT SCREEN COM, 2008, HDB VASC RISK ASS RI; Wareham NJ, 1999, DIABETES CARE, V22, P262, DOI 10.2337/diacare.22.2.262; Waugh N, 2007, HEALTH TECHNOL ASSES, V11, P1; Wein P, 1999, AUST NZ J OBSTET GYN, V39, P162, DOI 10.1111/j.1479-828X.1999.tb03363.x; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	47	189	194	0	36	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2008	336	7654					1180	+		10.1136/bmj.39545.585289.25	http://dx.doi.org/10.1136/bmj.39545.585289.25			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	308WJ	18426840	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000256420900042
J	Tang, Y; Zhao, WH; Chen, Y; Zhao, YM; Gu, W				Tang, Yi; Zhao, Wenhui; Chen, Yue; Zhao, Yingming; Gu, Wei			Acetylation is indispensable for p53 activation	CELL			English	Article							DNA-BINDING; TRANSCRIPTIONAL ACTIVATION; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; NEGATIVE REGULATOR; TUMOR-SUPPRESSOR; CELL-SURVIVAL; IN-VIVO; MDM2; PHOSPHORYLATION	The activation of the tumor suppressor p53 facilitates the cellular response to genotoxic stress; however, the p53 response can only be executed if its interaction with its inhibitor Mdm2 is abolished. There have been conflicting reports on the question of whether p53 posttranslational modifications, such as phosphorylation or acetylation, are essential or only play a subtle, fine-tuning role in the p53 response. Thus, it remains unclear whether p53 modification is absolutely required for its activation. We have now identified all major acetylation sites of p53. Although unacetylated p53 retains its ability to induce the p53-Mdm2 feedback loop, loss of acetylation completely abolishes p53-dependent growth arrest and apoptosis. Notably, acetylation of p53 abrogates Mdm2-mediated repression by blocking the recruitment of Mdm2 to p53-responsive promoters, which leads to p53 activation independent of its phosphorylation status. Our study identifies p53 acetylation as an indispensable event that destabilizes the p53-Mdm2 and enables the p53-mediated stress response.	[Tang, Yi; Zhao, Wenhui; Gu, Wei] Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; [Gu, Wei] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Chen, Yue; Zhao, Yingming] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	Columbia University; Columbia University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Gu, W (corresponding author), Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA.	wg8@columbia.edu		ZHAO, WENHUI/0000-0002-7703-7106; Tang, Yi/0000-0002-3561-8447	NCI NIH HHS [R01 CA126832-01A1, R01 CA126832] Funding Source: Medline; NIDDK NIH HHS [R01 DK082664-01, R01 DK082664] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA126832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082664] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Aparicio O, 2004, CURR PROTOC CELL BIO, V17; Arva NC, 2005, J BIOL CHEM, V280, P26776, DOI 10.1074/jbc.M505203200; Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Blattner C, 1999, ONCOGENE, V18, P1723, DOI 10.1038/sj.onc.1202480; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Das S, 2007, CELL, V130, P624, DOI 10.1016/j.cell.2007.06.013; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; EL DW, 1993, CELL, V75, P817; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Joo WS, 2002, GENE DEV, V16, P583, DOI 10.1101/gad.959202; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Krummel KA, 2005, P NATL ACAD SCI USA, V102, P10188, DOI 10.1073/pnas.0503068102; Kulikov R, 2006, J BIOL CHEM, V281, P28575, DOI 10.1074/jbc.M513311200; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li AG, 2007, MOL CELL, V28, P408, DOI 10.1016/j.molcel.2007.09.006; LUNA RMD, 1995, NATURE, V378, P203; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Minsky N, 2004, MOL CELL, V16, P631, DOI 10.1016/j.molcel.2004.10.016; Ohkubo S, 2006, J BIOL CHEM, V281, P16943, DOI 10.1074/jbc.M601388200; Prives C, 1999, J PATHOL, V187, P112; Ringshausen I, 2006, CANCER CELL, V10, P501, DOI 10.1016/j.ccr.2006.10.010; Sullivan A, 2007, BRIT J CANCER, V96, P196, DOI 10.1038/sj.bjc.6603525; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wu ZQ, 2002, MOL CELL BIOL, V22, P2441, DOI 10.1128/MCB.22.8.2441-2449.2002; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zupnick A, 2006, J BIOL CHEM, V281, P20464, DOI 10.1074/jbc.M603387200	53	635	658	1	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 16	2008	133	4					612	626		10.1016/j.cell.2008.03.025	http://dx.doi.org/10.1016/j.cell.2008.03.025			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485870	Bronze, Green Accepted			2022-12-24	WOS:000255903300017
J	Bhutta, ZA				Bhutta, Zulfiqar A.			Making a difference - Drug resistant infections in poor countries - A major burden on children	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan	Aga Khan University	Bhutta, ZA (corresponding author), Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan.	zulfiqar.bhutta@aku.edu						BHUTTA ZA, REDUCING ANTIBIOTICS; Bhutta ZA, 2007, ARCH DIS CHILD, V92, P286, DOI 10.1136/adc.2006.111849; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Brooks WA, 2007, AM J TROP MED HYG, V77, P795, DOI 10.4269/ajtmh.2007.77.795; Capoor MR, 2007, J MED MICROBIOL, V56, P1490, DOI 10.1099/jmm.0.47353-0; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Molstad S, 2008, LANCET INFECT DIS, V8, P125, DOI 10.1016/S1473-3099(08)70017-3; Sneag DB, 2007, PEDIATR INFECT DIS J, V26, P1142, DOI 10.1097/INF.0b013e31814523e4; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X; Zucker JR, 2003, AM J TROP MED HYG, V68, P386, DOI 10.4269/ajtmh.2003.68.386	10	8	8	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2008	336	7650					948	+		10.1136/bmj.39520.680718.94	http://dx.doi.org/10.1136/bmj.39520.680718.94			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296KC	18397947	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000255540900035
J	Harrison, JL; Hoen, B; Prendergast, BD				Harrison, James L.; Hoen, Bruno; Prendergast, Bernard D.			Antibiotic prophylaxis for infective endocarditis	LANCET			English	Editorial Material							BACTEREMIA; PREVENTION; GUIDELINES; ADULTS; RISK		[Prendergast, Bernard D.] John Radcliffe Hosp, Dept Cardiol, Oxford OX3 9DU, England; [Harrison, James L.] St Marys Hosp, Dept Cardiol, London W2 1NY, England; [Hoen, Bruno] Univ Franche Comte, Hop St Jacques, Serv Malad Infect & Trop, F-25030 Besancon, France	University of Oxford; Imperial College London; Universite de Franche-Comte; CHU Besancon	Prendergast, BD (corresponding author), John Radcliffe Hosp, Dept Cardiol, Oxford OX3 9DU, England.	bernard.prendergast@orh.nhs.uk						AHLSTEDT S, 1984, ALLERGY, V39, P151, DOI 10.1111/j.1398-9995.1984.tb02619.x; Danchin N, 2005, HEART, V91, P715, DOI 10.1136/hrt.2003.033183; Duval X, 2006, CLIN INFECT DIS, V42, pE102, DOI 10.1086/504385; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Gould FK, 2006, J ANTIMICROB CHEMOTH, V57, P1035, DOI 10.1093/jac/dkl121; Hoen B, 2006, HEART, V92, P1694, DOI 10.1136/hrt.2005.072595; Lacassin F, 1995, EUR HEART J, V16, P1968, DOI 10.1093/oxfordjournals.eurheartj.a060855; Martin MV, 2007, BRIT DENT J, V203, DOI 10.1038/bdj.2007.123; Martin M, 2006, BRIT DENT J, V200, P471, DOI 10.1038/sj.bdj.4813621; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; NICE-Short_Clinical_Guidelines_Technical_Team, 2008, PROPH INF END ANT PR; OLIVER R, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003813.PUB2; Prendergast BD, 2006, HEART, V92, P879, DOI 10.1136/hrt.2005.067256; Roberts GJ, 2006, HEART, V92, P1274, DOI 10.1136/hrt.2004.046581; Roberts GJ, 1999, PEDIATR CARDIOL, V20, P317, DOI 10.1007/s002469900477; Strom BL, 1998, ANN INTERN MED, V129, P761, DOI 10.7326/0003-4819-129-10-199811150-00002; VANDERMEER JTM, 1992, LANCET, V339, P135, DOI 10.1016/0140-6736(92)90207-J; Wang A, 2007, JAMA-J AM MED ASSOC, V297, P1354, DOI 10.1001/jama.297.12.1354; Wilson W, 2007, J AM DENT ASSOC, V138, P739, DOI 10.1161/CIRCULATIONAHA.106.183095	19	9	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 19	2008	371	9621					1317	1319		10.1016/S0140-6736(08)60574-7	http://dx.doi.org/10.1016/S0140-6736(08)60574-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PE	18424310	Green Accepted			2022-12-24	WOS:000255208500007
J	Crawford, JM; Thomas, PM; Scheerer, JR; Vagstad, AL; Kelleher, NL; Townsend, CA				Crawford, Jason M.; Thomas, Paul M.; Scheerer, Jonathan R.; Vagstad, Anna L.; Kelleher, Neil L.; Townsend, Craig A.			Deconstruction of iterative multidomain polyketide synthase function	SCIENCE			English	Article							IDENTIFICATION; BIOSYNTHESIS; DOMAIN; ACYL	PksA, which initiates biosynthesis of the environmental carcinogen aflatoxin B1, is one of the multidomain iterative polyketide synthases (IPKSs), a large, poorly understood family of biosynthetic enzymes. We found that dissection of PksA and its reconstitution from selected sets of domains allows the accumulation and characterization of advanced octaketide intermediates bound to the enzyme, permitting the reactions controlled by individual catalytic domains to be identified. A product template (PT) domain unites with the ketosynthase and thioesterase in this IPKS system to assemble precisely seven malonyl-derived building blocks to a hexanoyl starter unit and mediate a specific cyclization cascade. Because the PT domain is common among nonreducing IPKSs, these mechanistic features should prove to be general for IPKS-catalyzed production of aromatic polyketides.	[Thomas, Paul M.; Kelleher, Neil L.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Crawford, Jason M.; Scheerer, Jonathan R.; Vagstad, Anna L.; Townsend, Craig A.] Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA	University of Illinois System; University of Illinois Urbana-Champaign; Johns Hopkins University	Kelleher, NL (corresponding author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.	kelleher@scs.uiuc.edu; ctownsend@jhu.edu	Thomas, Paul/C-2777-2008; Thomas, Paul M/A-6233-2011	Thomas, Paul M/0000-0003-2887-4765; Vagstad, Anna Lisa/0000-0001-8074-0137	NIAID NIH HHS [R37 AI014937, R37 AI014937-30] Funding Source: Medline; NIEHS NIH HHS [R01 ES001670, ES001670] Funding Source: Medline; NIGMS NIH HHS [F32 GM079408-02, GM070421, T32 GM080189, R01 GM067725, GM067725, F32 GM079408-01, GM079408, R01 GM067725-05] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI014937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES001670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080189, F32GM079408, T32GM070421, R01GM067725] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHEN ZG, 1995, PHYTOCHEMISTRY, V38, P299, DOI 10.1016/0031-9422(94)00543-3; Crawford JM, 2008, BIOORG CHEM, V36, P16, DOI 10.1016/j.bioorg.2007.11.002; Crawford JM, 2006, P NATL ACAD SCI USA, V103, P16728, DOI 10.1073/pnas.0604112103; Dorrestein PC, 2006, BIOCHEMISTRY-US, V45, P12756, DOI 10.1021/bi061169d; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Fujii I, 2001, CHEM BIOL, V8, P189, DOI 10.1016/S1074-5521(00)90068-1; Keatinge-Clay A, 2004, NAT STRUCT MOL BIOL, V11, P888, DOI 10.1038/nsmb808; Ma SM, 2008, J AM CHEM SOC, V130, P38, DOI 10.1021/ja078091o; Ma Y, 2006, CHEMBIOCHEM, V7, P1951, DOI 10.1002/cbic.200600341; MCDANIEL R, 1993, SCIENCE, V262, P1546, DOI 10.1126/science.8248802; Sanchez C, 2001, CHEM BIOL, V8, P725, DOI 10.1016/S1074-5521(01)00047-3; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Tang Y, 2003, J AM CHEM SOC, V125, P12708, DOI 10.1021/ja0378759; Udwary DW, 2002, J MOL BIOL, V323, P585, DOI 10.1016/S0022-2836(02)00972-5	14	162	183	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 11	2008	320	5873					243	246		10.1126/science.1154711	http://dx.doi.org/10.1126/science.1154711			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286HJ	18403714	Green Accepted			2022-12-24	WOS:000254836700047
J	Tuch, BB; Li, H; Johnson, AD				Tuch, Brian B.; Li, Hao; Johnson, Alexander D.			Evolution of eukaryotic transcription circuits	SCIENCE			English	Editorial Material							CIS-REGULATORY MUTATIONS; FACTOR-BINDING-SITES; HOX PROTEIN; EVOLVABILITY; NETWORKS; YEAST		[Tuch, Brian B.; Li, Hao; Johnson, Alexander D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Tuch, Brian B.; Johnson, Alexander D.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Johnson, AD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	ajohnson@cgl.ucsf.edu						Bilu Y, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r103; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; CARROLL SB, 2005, DNA DIVERSITY MOL GE; Davidson E. H., 2001, DEV EVOLUTION; Galant R, 2002, NATURE, V415, P910, DOI 10.1038/nature717; Gasch AP, 2004, PLOS BIOL, V2, P2202, DOI 10.1371/journal.pbio.0020398; Haag ES, 2005, EVOLUTION, V59, P1620, DOI 10.1111/j.0014-3820.2005.tb01813.x; Jeong S, 2008, CELL, V132, P783, DOI 10.1016/j.cell.2008.01.014; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Martchenko M, 2007, CURR BIOL, V17, P1007, DOI 10.1016/j.cub.2007.05.017; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Zuckerkandl E, 1997, J MOL EVOL, V44, pS2, DOI 10.1007/PL00000048	24	123	126	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2008	319	5871					1797	1799		10.1126/science.1152398	http://dx.doi.org/10.1126/science.1152398			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279ZF	18369141				2022-12-24	WOS:000254394000038
J	Kovacs, JJ; Whalen, EJ; Liu, RS; Xiao, KH; Kim, J; Chen, MY; Wang, JB; Chen, W; Lefkowitz, RJ				Kovacs, Jeffrey J.; Whalen, Erin J.; Liu, Renshui; Xiao, Kunhong; Kim, Jihee; Chen, Minyong; Wang, Jiangbo; Chen, Wei; Lefkowitz, Robert J.			beta-arrestin-mediated localization of smoothened to the primary cilium	SCIENCE			English	Article							HEDGEHOG SIGNALING PATHWAY; NEURONAL CILIA; RECEPTORS; TRANSPORT; PROTEIN; MOUSE; KINESIN-2; SMO	beta-arrestins have important roles in the regulation of seven- transmembrane receptors ( 7TMRs). Smoothened ( Smo) is a 7TMR that mediates effects of Hedgehog on developmental processes and whose dysregulation may cause tumorigenesis. beta-Arrestins are required for endocytosis of Smo and signaling to Gli transcription factors. In mammalian cells, Smo- dependent signaling requires translocation to primary cilia. We demonstrated that beta- arrestins mediate the activity- dependent interaction of Smo and the kinesin motor protein Kif3A. This multimeric complex localized to primary cilia and was disrupted in cells transfected with beta- arrestin small interfering RNA. beta- Arrestin 1 or beta- arrestin 2 depletion prevented the localization of Smo to primary cilia and the Smo- dependent activation of Gli. These results suggest roles for beta- arrestins in mediating the intracellular transport of a 7TMR to its obligate subcellular location for signaling.	[Kovacs, Jeffrey J.; Whalen, Erin J.; Liu, Renshui; Kim, Jihee; Chen, Minyong; Wang, Jiangbo; Chen, Wei; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Kovacs, Jeffrey J.; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Xiao, Kunhong; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Howard Hughes Medical Institute	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	lefko001@receptor-biol.duke.edu	Xiao, Kunhong/AAG-4275-2020; Lefkowitz, Robert/AAW-2649-2021; Wang, Jiangbo/F-9246-2011	Xiao, Kunhong/0000-0002-1069-1226; Chen, Wei/0000-0002-9934-4000	NATIONAL CANCER INSTITUTE [R01CA113656] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, R01HL070631, R37HL016037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007217] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA113656-02, R01 CA113656-03, 5R01 CA113656-02, R01 CA113656] Funding Source: Medline; NHLBI NIH HHS [R01 HL016037, R01 HL070631, HL70631, R01 HL070631-04, R01 HL016037-35, HL16037] Funding Source: Medline; NIAID NIH HHS [T32 AI007217-26, T32 AI007217-25, T32 AI007217, 5T32 AI007217-25] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brailov I, 2000, BRAIN RES, V872, P271, DOI 10.1016/S0006-8993(00)02519-1; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Hirokawa N, 2000, TRAFFIC, V1, P29, DOI 10.1034/j.1600-0854.2000.010105.x; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Kolpakova-Hart E, 2007, DEV BIOL, V309, P273, DOI 10.1016/j.ydbio.2007.07.018; Koyama E, 2007, DEVELOPMENT, V134, P2159, DOI 10.1242/dev.001586; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Mans DA, 2008, EXP CELL RES, V314, P1229, DOI 10.1016/j.yexcr.2007.12.020; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Meloni AR, 2006, MOL CELL BIOL, V26, P7550, DOI 10.1128/MCB.00546-06; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Wang Y, 2007, CURR OPIN CELL BIOL, V19, P159, DOI 10.1016/j.ceb.2007.02.005; Wilbanks AM, 2004, SCIENCE, V306, P2264, DOI 10.1126/science.1104193; Woost PG, 2006, IN VITRO CELL DEV-AN, V42, P189; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104	24	203	209	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2008	320	5884					1777	1781		10.1126/science.1157983	http://dx.doi.org/10.1126/science.1157983			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18497258	Green Accepted			2022-12-24	WOS:000257121200039
J	Joh, NH; Min, A; Faham, S; Whitelegge, JP; Yang, D; Woods, VL; Bowie, JU				Joh, Nathan HyunJoong; Min, Andrew; Faham, Salem; Whitelegge, Julian P.; Yang, Duan; Woods, Virgil L., Jr.; Bowie, James U.			Modest stabilization by most hydrogen-bonded side-chain interactions in membrane proteins	NATURE			English	Article							EXCHANGE MASS-SPECTROMETRY; TRANSMEMBRANE HELICES; CRYSTAL-STRUCTURE; POLAR RESIDUES; STABILITY; MUTATIONS; NMR; BACTERIORHODOPSIN; ASSOCIATION; RESOLUTION	Understanding the energetics of molecular interactions is fundamental to all of the central quests of structural biology including structure prediction and design, mapping evolutionary pathways, learning how mutations cause disease, drug design, and relating structure to function. Hydrogen- bonding is widely regarded as an important force in a membrane environment because of the low dielectric constant of membranes and a lack of competition from water(1-6). Indeed, polar residue substitutions are the most common disease- causing mutations in membrane proteins(6,7). Because of limited structural information and technical challenges, however, there have been few quantitative tests of hydrogen- bond strength in the context of large membrane proteins. Here we show, by using a double- mutant cycle analysis, that the average contribution of eight interhelical side- chain hydrogen- bonding interactions throughout bacteriorhodopsin is only 0.6 kcal mol(-1). In agreement with these experiments, we find that 4% of polar atoms in the non- polar core regions of membrane proteins have no hydrogen- bond partner and the lengths of buried hydrogen bonds in soluble proteins and membrane protein transmembrane regions are statistically identical. Our results indicate that most hydrogen- bond interactions in membrane proteins are only modestly stabilizing. Weak hydrogen-bonding should be reflected in considerations of membrane protein folding, dynamics, design, evolution and function.	[Joh, Nathan HyunJoong; Min, Andrew; Yang, Duan; Bowie, James U.] Univ Calif Los Angeles, Inst Mol Biol, Dept Chem & Biochem, UCLA DOE Ctr Genom & Proteom, Los Angeles, CA 90095 USA; [Faham, Salem] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Whitelegge, Julian P.] Univ Calif Los Angeles, NPI Semel Inst, Pasarow Mass Spec Lab, Los Angeles, CA 90095 USA; [Woods, Virgil L., Jr.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Woods, Virgil L., Jr.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Diego; University of California System; University of California San Diego	Bowie, JU (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Dept Chem & Biochem, UCLA DOE Ctr Genom & Proteom, Los Angeles, CA 90095 USA.	bowie@mbi.ucla.edu		Joh, Nathan/0000-0003-3221-9325	NCI NIH HHS [R01 CA081000, R01 CA081000-08, R01 CA081000-09, R01 CA081000-07] Funding Source: Medline; NIGMS NIH HHS [R01 GM063919-07, R01 GM063919-06, R01 GM063919, R01 GM063919-08] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA081000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063919] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adamian L, 2005, PROTEINS, V59, P496, DOI 10.1002/prot.20456; Adamian L, 2002, PROTEINS, V47, P209, DOI 10.1002/prot.10071; Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Busenlehner LS, 2005, ARCH BIOCHEM BIOPHYS, V433, P34, DOI 10.1016/j.abb.2004.09.002; Busenlehner LS, 2004, BIOCHEMISTRY-US, V43, P11145, DOI 10.1021/bi048716k; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; Chamberlain AK, 2004, J MOL BIOL, V339, P471, DOI 10.1016/j.jmb.2004.03.072; Duong MT, 2007, J MOL BIOL, V371, P422, DOI 10.1016/j.jmb.2007.05.026; Faham S, 2004, J MOL BIOL, V335, P297, DOI 10.1016/j.jmb.2003.10.041; Faham S, 2002, J MOL BIOL, V316, P1, DOI 10.1006/jmbi.2001.5295; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Fleming KG, 2001, P NATL ACAD SCI USA, V98, P14340, DOI 10.1073/pnas.251367498; Fleming PJ, 2005, PROTEIN SCI, V14, P1911, DOI 10.1110/ps.051454805; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Hamuro Y, 2003, J MOL BIOL, V327, P1065, DOI 10.1016/S0022-2836(03)00234-1; Hong H, 2006, NAT CHEM BIOL, V2, P627, DOI 10.1038/nchembio827; Jormakka M, 2002, SCIENCE, V295, P1863, DOI 10.1126/science.1068186; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Lear JD, 2003, BIOCHEMISTRY-US, V42, P6400, DOI 10.1021/bi020573j; Lees AM, 2005, ATHEROSCLEROSIS, V182, P219, DOI 10.1016/j.atherosclerosis.2005.01.041; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MOLDAY RS, 1972, BIOCHEMISTRY-US, V11, P150, DOI 10.1021/bi00752a003; Myers JK, 1996, BIOPHYS J, V71, P2033, DOI 10.1016/S0006-3495(96)79401-8; ONEIL JDJ, 1989, BIOCHEMISTRY-US, V28, P699, DOI 10.1021/bi00428a043; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Partridge AW, 2004, PROTEINS, V54, P648, DOI 10.1002/prot.10611; Partridge AW, 2002, BIOPOLYMERS, V66, P350, DOI 10.1002/bip.10313; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; REES DC, 1989, SCIENCE, V245, P510, DOI 10.1126/science.2667138; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Shan SO, 1999, METHOD ENZYMOL, V308, P246; Stanley AM, 2007, J MOL BIOL, V370, P912, DOI 10.1016/j.jmb.2007.05.009; White SH, 2005, ADV PROTEIN CHEM, V72, P157, DOI 10.1016/S0065-3233(05)72006-4; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5; Zhang ZQ, 1997, PROTEIN SCI, V6, P2203; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698	40	200	203	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2008	453	7199					1266	U73		10.1038/nature06977	http://dx.doi.org/10.1038/nature06977			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18500332	Green Accepted			2022-12-24	WOS:000257075800049
J	Chan, JA; Meyerhardt, JA; Niedzwiecki, D; Hollis, D; Saltz, LB; Mayer, RJ; Thomas, J; Schaefer, P; Whittom, R; Hantel, A; Goldberg, RM; Warren, RS; Bertagnolli, M; Fuchs, CS				Chan, Jennifer A.; Meyerhardt, Jeffrey A.; Niedzwiecki, Donna; Hollis, Donna; Saltz, Leonard B.; Mayer, Robert J.; Thomas, James; Schaefer, Paul; Whittom, Renaud; Hantel, Alexander; Goldberg, Richard M.; Warren, Robert S.; Bertagnolli, Monica; Fuchs, Charles S.			Association of family history with cancer recurrence and survival among patients with stage III colon cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MICROSATELLITE INSTABILITY; ADENOMATOUS POLYPS; IMPACT; PROGNOSIS; RISK	Context A family history of colorectal cancer in a first- degree relative increases the risk of developing colorectal cancer. However, the influence of family history on cancer recurrence and survival among patients with established disease remains uncertain. Objective To examine the association of family history of colorectal cancer with cancer recurrence and survival of patients with colon cancer. Design, Setting, and Participants Prospective observational study of 1087 patients with stage III colon cancer enrolled in a randomized adjuvant chemotherapy trial ( CALGB 89803) between April 1999 and May 2001. Patients provided data on family history at baseline and were followed up until March 2007 for disease recurrence and death ( median follow- up, 5.6 years). In a subset of patients, we assessed microsatellite instability ( MSI) and expression of the mismatch repair ( MMR) proteins MLH1 and MSH2 in tumor specimens. Main Outcome Measures Disease- free survival, recurrence- free survival, and overall survival according to the presence or absence of a family history of colorectal cancer. Results Among 1087 eligible patients, 195 ( 17.9%) reported a family history of colorectal cancer in a first- degree relative. Cancer recurrence or death occurred in 57 of 195 patients ( 29%; 95% confidence interval [ CI], 23%- 36%) with a family history of colorectal cancer and 343 of 892 patients ( 38%; 95% CI, 35%- 42%) without a family history. Compared with patients without a family history, the adjusted hazard ratios ( HRs) among those with 1 or more affected first- degree relatives were 0.72 ( 95% CI, 0.54- 0.96) for disease- free survival, 0.74 ( 95% CI, 0.55- 0.99) for recurrence- free survival, and 0.75 ( 95% CI, 0.54- 1.05) for overall survival. This reduction in risk of cancer recurrence or death associated with a family history became stronger with an increasing number of affected first- degree relatives. Compared with participants without a family history of colorectal cancer, those with 1 affected relative had a multivariate HR of 0.77 ( 95% CI, 0.57- 1.04) for disease- free survival. For participants with 2 or more affected relatives, we observed a greater reduction in risk ( multivariate HR for disease- free survival, 0.49; 95% CI, 0.23- 1.04; P for trend with increasing number of affected relatives=. 01). The improved disease- free survival associated with a family history was independent of tumoral MSI or MMR status. Conclusion Among patients with stage III colon cancer receiving adjuvant chemotherapy, a family history of colorectal cancer is associated with a significant reduction in cancer recurrence and death.	[Chan, Jennifer A.; Meyerhardt, Jeffrey A.; Mayer, Robert J.; Fuchs, Charles S.] Dana Farber Canc Inst, Div Med Oncol, Boston, MA 02115 USA; [Niedzwiecki, Donna; Hollis, Donna] Duke Univ, Med Ctr, CALGB Stat Ctr, Durham, NC USA; [Saltz, Leonard B.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Thomas, James] Ohio State Univ, Columbus, OH 43210 USA; [Schaefer, Paul] Toledo Community Hosp Oncol Program, Community Clin Oncol Program, Toledo, OH USA; [Whittom, Renaud] Hop Sacre Coeur, Montreal, PQ H4J 1C5, Canada; [Hantel, Alexander] Loyola Univ, Stritch Sch Med, Maywood, IL 60153 USA; [Goldberg, Richard M.] Univ N Carolina, Dept Hematol Oncol, Chapel Hill, NC USA; [Warren, Robert S.] Univ Calif San Francisco, Div Surg Oncol, San Francisco, CA 94143 USA; [Bertagnolli, Monica] Brigham & Womens Hosp, Div Surg Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Duke University; Memorial Sloan Kettering Cancer Center; University System of Ohio; Ohio State University; Universite de Montreal; Loyola University Chicago; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital	Chan, JA (corresponding author), Dana Farber Canc Inst, Div Med Oncol, 44 Binney St, Boston, MA 02115 USA.	jang@partners.org	Goldberg, Richard M/M-1311-2013; Goldberg, Richard/O-1871-2017	Goldberg, Richard/0000-0003-3713-6895; Niedzwiecki, Donna/0000-0002-3566-0450; Saltz, Leonard/0000-0001-8353-4670	NATIONAL CANCER INSTITUTE [U10CA045564, U10CA077406, U10CA077440, U10CA046282, U10CA047559, U10CA007968, U10CA045418, U10CA021076, U10CA021115, U10CA045389, U10CA011789, U10CA023318, T32CA009172, U10CA016450, U10CA047555, U10CA037135, U10CA004326, U10CA002599, U10CA032102, U10CA077651, R01CA118553, U10CA060138, U10CA031983, U10CA071323, U10CA077597, U10CA066636, U10CA035415, U10CA035279, U10CA012046, U10CA047577, U10CA035421, U10CA041287, T32CA009001, U10CA003927, U10CA077298, U10CA077658, U10CA045808, U10CA011028, U10CA008025, U10CA031946, U10CA047642, U10CA033601, U10CA004457, U10CA012449, U10CA026806, U10CA074811, U10CA038926, U10CA032291] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Benatti P, 2005, CLIN CANCER RES, V11, P8332, DOI 10.1158/1078-0432.CCR-05-1030; BERTAGNOLLI MM, 2006, J CLIN ONCOL, P24; CANNONALBRIGHT LA, 1989, CANCER, V64, P1971, DOI 10.1002/1097-0142(19891101)64:9<1971::AID-CNCR2820640935>3.0.CO;2-L; CANNONALBRIGHT LA, 1988, NEW ENGL J MED, V319, P533, DOI 10.1056/NEJM198809013190902; Clark TG, 2002, LANCET, V359, P1309, DOI 10.1016/S0140-6736(02)08272-7; FUCHS CS, 1994, NEW ENGL J MED, V331, P1669, DOI 10.1056/NEJM199412223312501; Gryfe R, 2000, NEW ENGL J MED, V342, P69, DOI 10.1056/NEJM200001133420201; Johns LE, 2001, AM J GASTROENTEROL, V96, P2992, DOI 10.1111/j.1572-0241.2001.04677.x; JONES MP, 1989, BIOMETRICS, V45, P157, DOI 10.2307/2532042; Kerber RA, 1997, AM J EPIDEMIOL, V146, P244; KOYAMA Y, 1993, JPN J CLIN ONCOL, V23, P342; Lin H, 2002, MODELING SURVIVAL DA, V44, P85; Lindor NM, 2002, J CLIN ONCOL, V20, P1043, DOI 10.1200/JCO.20.4.1043; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Meyerhardt JA, 2007, JAMA-J AM MED ASSOC, V298, P754, DOI 10.1001/jama.298.7.754; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3535, DOI 10.1200/JCO.2006.06.0863; OGINO S, 2005, MOD PATHOL, V18, pA114; Parc Y, 2004, GUT, V53, P371, DOI 10.1136/gut.2003.019190; POTTER JD, 1993, EPIDEMIOL REV, V15, P499, DOI 10.1093/oxfordjournals.epirev.a036132; Ricciardiello L, 2003, CANCER RES, V63, P787; Rustgi AK, 2007, GENE DEV, V21, P2525, DOI 10.1101/gad.1593107; Saltz LB, 2007, J CLIN ONCOL, V25, P3456, DOI 10.1200/JCO.2007.11.2144; Samowitz WS, 2001, CANCER EPIDEM BIOMAR, V10, P917; Sinicrope FA, 2006, AM J GASTROENTEROL, V101, P2818, DOI 10.1111/j.1572-0241.2006.00845.x; Sinicrope FA, 2006, GASTROENTEROLOGY, V131, P729, DOI 10.1053/j.gastro.2006.06.005; SLATTERY ML, 1995, INT J EPIDEMIOL, V24, P888, DOI 10.1093/ije/24.5.888; SLATTERY ML, 1994, J NATL CANCER I, V86, P1618, DOI 10.1093/jnci/86.21.1618; Wu YX, 2008, ANN THORAC SURG, V85, P1155, DOI 10.1016/j.athoracsur.2007.12.012	28	61	64	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2008	299	21					2515	2523		10.1001/jama.299.21.2515	http://dx.doi.org/10.1001/jama.299.21.2515			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	308AR	18523220	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000256361200023
J	Edes, TE				Edes, Thomas E.			Waging peace in the war on cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												thomas.edes@va.gov							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2008	299	21					2483	2483		10.1001/jama.299.21.2483	http://dx.doi.org/10.1001/jama.299.21.2483			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	308AR	18523208				2022-12-24	WOS:000256361200001
J	Hamzah, J; Jugold, M; Kiessling, F; Rigby, P; Manzur, M; Marti, HH; Rabie, T; Kaden, S; Grone, HJ; Hammerling, GJ; Arnold, B; Ganss, R				Hamzah, Juliana; Jugold, Manfred; Kiessling, Fabian; Rigby, Paul; Manzur, Mitali; Marti, Hugo H.; Rabie, Tamer; Kaden, Sylvia; Groene, Hermann-Josef; Haemmerling, Guenter J.; Arnold, Bernd; Ganss, Ruth			Vascular normalization in Rgs5-deficient tumours promotes immune destruction	NATURE			English	Article							HEPATOCELLULAR-CARCINOMA; ANTIANGIOGENIC THERAPY; BLOOD-VESSELS; PERICYTES; PROTEIN; CELLS; MODEL; RGS5; EDEMA; TUMORIGENESIS	The vasculature of solid tumours is morphologically aberrant and characterized by dilated and fragile vessels, intensive vessel sprouting and loss of hierarchical architecture(1). Constant vessel remodelling leads to spontaneous haemorrhages(2) and increased interstitial fluid pressure in the tumour environment(3,4). Tumour-related angiogenesis supports tumour growth and is also a major obstacle for successful immune therapy as it prevents migration of immune effector cells into established tumour parenchyma(2,5,6). The molecular mechanisms for these angiogenic alterations are largely unknown. Here we identify regulator of G-protein signalling 5 (Rgs5) as a master gene responsible for the abnormal tumour vascular morphology in mice. Loss of Rgs5 results in pericyte maturation, vascular normalization and consequent marked reductions in tumour hypoxia and vessel leakiness. These vascular and intratumoral changes enhance influx of immune effector cells into tumour parenchyma and markedly prolong survival of tumour-bearing mice. This is the first demonstration, to our knowledge, of reduced tumour angiogenesis and improved immune therapeutic outcome on loss of a vascular gene function and establishes a previously unrecognized role of G-protein signalling in tumour angiogenesis.	[Hamzah, Juliana; Manzur, Mitali; Ganss, Ruth] Univ Western Australia, Med Res Ctr, Western Australian Inst Med Res, Perth, WA 6000, Australia; [Jugold, Manfred; Kiessling, Fabian] German Canc Res Ctr, Juniorgrp Mol Imaging, Dept Med Phys Radiol, D-69120 Heidelberg, Germany; [Kaden, Sylvia; Groene, Hermann-Josef] German Canc Res Ctr, Dept Cellular & Mol Pathol, D-69120 Heidelberg, Germany; [Haemmerling, Guenter J.; Arnold, Bernd] German Canc Res Ctr, Dept Mol Immunol, D-69120 Heidelberg, Germany; [Rigby, Paul] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Perth, WA 6000, Australia; [Marti, Hugo H.; Rabie, Tamer] Univ Heidelberg, Inst Physiol & Pathophysiol, D-69120 Heidelberg, Germany	University of Western Australia; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Western Australia; Ruprecht Karls University Heidelberg	Ganss, R (corresponding author), Univ Western Australia, Med Res Ctr, Western Australian Inst Med Res, Perth, WA 6000, Australia.	ganss@waimr.uwa.edu.au	Rabie, Tamer/C-7886-2013; Rigby, Paul/G-5248-2012; hamzah, juliana/G-3114-2013; Kiessling, Fabian/Y-2417-2019	Kiessling, Fabian/0000-0002-7341-0399; Ganss, Ruth/0000-0002-5551-045X; Marti, Hugo/0000-0002-8456-334X; Rabie, Tamer/0000-0001-9060-8797				Allt G, 2001, CELLS TISSUES ORGANS, V169, P1, DOI 10.1159/000047855; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Berger M, 2005, BLOOD, V105, P1094, DOI 10.1182/blood-2004-06-2315; Bondjers C, 2003, AM J PATHOL, V162, P721, DOI 10.1016/S0002-9440(10)63868-0; Boss CN, 2007, CLIN CANCER RES, V13, P3347, DOI 10.1158/1078-0432.CCR-06-2156; BRIX G, 1991, J COMPUT ASSIST TOMO, V15, P621, DOI 10.1097/00004728-199107000-00018; Buckanovich RJ, 2008, NAT MED, V14, P28, DOI 10.1038/nm1699; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Chen CH, 1997, J BIOL CHEM, V272, P8679, DOI 10.1074/jbc.272.13.8679; Chen X, 2004, MODERN PATHOL, V17, P1198, DOI 10.1038/modpathol.3800167; Furuya M, 2004, J PATHOL, V203, P551, DOI 10.1002/path.1543; Ganss R, 1998, CANCER RES, V58, P4673; Ganss R, 2002, CANCER RES, V62, P1462; Ganss R, 2004, EUR J IMMUNOL, V34, P2635, DOI 10.1002/eji.200425474; Garbi N, 2004, J IMMUNOL, V172, P5861, DOI 10.4049/jimmunol.172.10.5861; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hata R, 1998, J CEREBR BLOOD F MET, V18, P367, DOI 10.1097/00004647-199804000-00004; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Manome Y, 2003, CELLS TISSUES ORGANS, V174, P155, DOI 10.1159/000072718; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Ryschich E, 2006, CANCER RES, V66, P198, DOI 10.1158/0008-5472.CAN-05-1636; Ryschich E, 2002, INT J CANCER, V97, P719, DOI 10.1002/ijc.10074; Seaman S, 2007, CANCER CELL, V11, P539, DOI 10.1016/j.ccr.2007.04.017; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8	30	412	432	11	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 15	2008	453	7193					410	U67		10.1038/nature06868	http://dx.doi.org/10.1038/nature06868			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18418378	Bronze			2022-12-24	WOS:000255868400056
J	Lynn, J				Lynn, Joanne			Making a difference - Palliative care beyond cancer - Reliable comfort and meaningfulness	BRITISH MEDICAL JOURNAL			English	Editorial Material							QUALITY IMPROVEMENT		Ctr Medicare & Medicaid Serv, Off Clin Stand & Qual, Baltimore, MD 21244 USA	Centers for Medicare & Medicaid Services	Lynn, J (corresponding author), Ctr Medicare & Medicaid Serv, Off Clin Stand & Qual, 7500 Secur Blvd, Baltimore, MD 21244 USA.	Joanne.Lynn@cms.hhs.gov						Arnold R, 2005, J PALLIAT MED, V8, P1086, DOI 10.1089/jpm.2005.8.1086; DAVIS K, 2007, MED HOMES COULD IMPR; Fox E, 1999, JAMA-J AM MED ASSOC, V282, P1638, DOI 10.1001/jama.282.17.1638; Lynn J, 2002, ANN INTERN MED, V137, P117, DOI 10.7326/0003-4819-137-2-200207160-00010; LYNN J, 2007, COMMON SENSE GUIDE I; LYNN J, 2007, IMPROVING CARE END L; LYNN J, 2004, SICK DEATH NOT GOING; Lynn J, 2007, J AM GERIATR SOC, V55, P1663, DOI 10.1111/j.1532-5415.2007.01380.x; Lynn J, 2007, MILBANK Q, V85, P185, DOI 10.1111/j.1468-0009.2007.00483.x	9	11	12	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 26	2008	336	7650					958	+		10.1136/bmj.39535.656319.94	http://dx.doi.org/10.1136/bmj.39535.656319.94			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296KC	18397941	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000255540900046
J	Chu, SY; Bachman, DJ; Callaghan, WM; Whitlock, EP; Dietz, PM; Berg, CJ; O'Keeffe-Rosetti, M; Bruce, FC; Hornbrook, MC				Chu, Susan Y.; Bachman, Donald J.; Callaghan, William M.; Whitlock, Evelyn P.; Dietz, Patricia M.; Berg, Cynthia J.; O'Keeffe-Rosetti, Maureen; Bruce, F. Carol; Hornbrook, Mark C.			Association between obesity during pregnancy and increased use of health care	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MATERNAL OBESITY; WEIGHT; TRENDS; RISK; IMPACT	Background: In the United States, obesity during pregnancy is common and increases obstetrical risks. An estimate of the increase in use of health care services associated with obesity during pregnancy is needed. Methods: We used electronic data systems of a large U.S. group-practice health maintenance organization to identify 13,442 pregnancies among women 18 years of age or older at the time of conception that resulted in live births or stillbirths. The study period was between January 1, 2000, and December 31, 2004. We assessed associations between measures of use of health care services and body-mass index (BMI, defined as the weight in kilograms divided by the square of the height in meters) before pregnancy or in early pregnancy. The women were categorized as underweight (BMI <18.5), normal (BMI 18.5 to 24.9), overweight (BMI 25.0 to 29.9), obese (BMI 30.0 to 34.9), very obese (BMI 35.0 to 39.9), or extremely obese (BMI greater/equal 40.0). The primary outcome was the mean length of hospital stay for delivery. Results: After adjustment for age, race or ethnic group, level of education, and parity, the mean (+/-SE) length of hospital stay for delivery was significantly (P<0.05) greater among women who were overweight (3.7+/-0.1 days), obese (4.0+/-0.1 days), very obese (4.1+/-0.1 days), and extremely obese (4.4+/-0.1 days) than among women with normal BMI (3.6+/-0.1 days). A higher-than-normal BMI was associated with significantly more prenatal fetal tests, obstetrical ultrasonographic examinations, medications dispensed from the outpatient pharmacy, telephone calls to the department of obstetrics and gynecology, and prenatal visits with physicians. A higher-than-normal BMI was also associated with significantly fewer prenatal visits with nurse practitioners and physician assistants. Most of the increase in length of stay associated with higher BMI was related to increased rates of cesarean delivery and obesity-related high-risk conditions. Conclusions: Obesity during pregnancy is associated with increased use of health care services.	[Chu, Susan Y.; Callaghan, William M.; Dietz, Patricia M.; Berg, Cynthia J.; Bruce, F. Carol] Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; [Bachman, Donald J.; Whitlock, Evelyn P.; O'Keeffe-Rosetti, Maureen; Hornbrook, Mark C.] Kaiser Permanente NW, Ctr Hlth Res NW Hawaii SE, Portland, OR USA	Centers for Disease Control & Prevention - USA; Kaiser Permanente	Chu, SY (corresponding author), Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy NE,Mailstop K-23, Atlanta, GA 30341 USA.	syc1@cdc.gov						American College of Obstetricians and Gynecologists (ACOG), 2005, OBSTET GYNECOL, V106, P671, DOI [10.1097/00006250-200509000-00054, DOI 10.1097/00006250-200509000-00054]; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Cogswell M E., 2001, Prim Care Update Ob Gyns, V8, P89, DOI 10.1016/S1068-607X(00)00087-1; Ehrenberg HM, 2004, AM J OBSTET GYNECOL, V191, P969, DOI 10.1016/j.ajog.2004.06.057; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Galtier-Dereure F, 2000, AM J CLIN NUTR, V71, p1242S, DOI 10.1093/ajcn/71.5.1242s; GALTIERDEREURE F, 1995, INT J OBESITY, V19, P443; GARBACIAK JA, 1985, AM J OBSTET GYNECOL, V152, P238, DOI 10.1016/S0002-9378(85)80029-6; Hendler I, 2004, INT J OBESITY, V28, P1607, DOI 10.1038/sj.ijo.0802759; Heslehurst N, 2007, BJOG-INT J OBSTET GY, V114, P334, DOI 10.1111/j.1471-0528.2006.01230.x; Hornbrook MC, 2007, HEALTH SERV RES, V42, P908, DOI 10.1111/j.1475-6773.2006.00635.x; Kim SY, 2007, OBESITY, V15, P986, DOI 10.1038/oby.2007.621; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7; Yeh J, 2005, AM J OBSTET GYNECOL, V193, P1994, DOI 10.1016/j.ajog.2005.05.001	15	168	172	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 3	2008	358	14					1444	1453		10.1056/NEJMoa0706786	http://dx.doi.org/10.1056/NEJMoa0706786			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	282CY	18385496				2022-12-24	WOS:000254546400005
J	Thakur, JK; Arthanari, H; Yang, FJ; Pan, SJ; Fan, XC; Breger, J; Frueh, DP; Gulshan, K; Li, DK; Mylonakis, E; Struhl, K; Moye-Rowley, WS; Cormack, BP; Wagner, G; Naar, AM				Thakur, Jitendra K.; Arthanari, Haribabu; Yang, Fajun; Pan, Shih-Jung; Fan, Xiaochun; Breger, Julia; Frueh, Dominique P.; Gulshan, Kailash; Li, Darrick K.; Mylonakis, Eleftherios; Struhl, Kevin; Moye-Rowley, W. Scott; Cormack, Brendan P.; Wagner, Gerhard; Naar, Anders M.			A nuclear receptor-like pathway regulating multidrug resistance in fungi	NATURE			English	Article							TRANSCRIPTION-FACTOR-BINDING; DRUG-RESISTANCE; SACCHAROMYCES-CEREVISIAE; TRANSACTIVATION DOMAIN; CASSETTE TRANSPORTER; SECONDARY STRUCTURE; CANDIDA-GLABRATA; NMR-SPECTROSCOPY; AZOLE RESISTANCE; KIX DOMAIN	Multidrug resistance ( MDR) is a serious complication during treatment of opportunistic fungal infections that frequently afflict immunocompromised individuals, such as transplant recipients and cancer patients undergoing cytotoxic chemotherapy. Improved knowledge of the molecular pathways controlling MDR in pathogenic fungi should facilitate the development of novel therapies to combat these intransigent infections. MDR is often caused by upregulation of drug efflux pumps by members of the fungal zinc- cluster transcription- factor family ( for example Pdr1p orthologues). However, the molecular mechanisms are poorly understood. Here we show that Pdr1p family members in Saccharomyces cerevisiae and the human pathogen Candida glabrata directly bind to structurally diverse drugs and xenobiotics, resulting in stimulated expression of drug efflux pumps and induction of MDR. Notably, this is mechanistically similar to regulation of MDR in vertebrates by the PXR nuclear receptor, revealing an unexpected functional analogy of fungal and metazoan regulators of MDR. We have also uncovered a critical and specific role of the Gal11p/ MED15 subunit of the Mediator co- activator and its activator- targeted KIX domain in antifungal/ xenobiotic- dependent regulation of MDR. This detailed mechanistic understanding of a fungal nuclear receptor- like gene regulatory pathway provides novel therapeutic targets for the treatment of multidrug- resistant fungal infections.	[Thakur, Jitendra K.; Yang, Fajun; Li, Darrick K.; Naar, Anders M.] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Thakur, Jitendra K.; Yang, Fajun; Naar, Anders M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Arthanari, Haribabu; Fan, Xiaochun; Frueh, Dominique P.; Struhl, Kevin; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Pan, Shih-Jung; Cormack, Brendan P.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Breger, Julia; Mylonakis, Eleftherios] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Gulshan, Kailash; Moye-Rowley, W. Scott] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Johns Hopkins University; Harvard University; Massachusetts General Hospital; University of Iowa	Naar, AM (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.	naar@helix.mgh.harvard.edu	Moye-Rowley, Scott/AFL-7135-2022; Thakur, Jitendra/AAN-8674-2021; Frueh, Dominique P/A-6462-2008	Moye-Rowley, Scott/0000-0002-7163-1120; Frueh, Dominique P/0000-0003-4605-3776; Arthanari, Haribabu/0000-0002-7281-1289; Thakur, Jitendra Kumar/0000-0001-7874-1923	NCI NIH HHS [CA127990, R01 CA127990] Funding Source: Medline; NIBIB NIH HHS [EB2026] Funding Source: Medline; NIGMS NIH HHS [GM071449, GM30186, GM49825, GM47467] Funding Source: Medline; PHS HHS [A1046223] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA127990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049825, R37GM030186, R01GM071449, P01GM047467, R01GM030186] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alenquer M, 2006, FEMS YEAST RES, V6, P1130, DOI 10.1111/j.1567-1364.2006.00095.x; Aparicio JG, 2004, MOL CELL BIOL, V24, P4769, DOI 10.1128/MCB.24.11.4769-4780.2004; Aperis G, 2006, EXPERT OPIN INV DRUG, V15, P1319, DOI 10.1517/13543784.15.11.1319; BALZI E, 1987, J BIOL CHEM, V262, P16871; BALZI E, 1994, J BIOL CHEM, V269, P2206; Bertrand W, 2004, MOL BIOL EVOL, V21, P1923, DOI 10.1093/molbev/msh200; Breger J, 2007, PLOS PATHOG, V3, P168, DOI 10.1371/journal.ppat.0030018; Cormack BP, 1999, GENETICS, V151, P979; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dai P, 1996, GENE DEV, V10, P528, DOI 10.1101/gad.10.5.528; De Guzman RN, 2006, J MOL BIOL, V355, P1005, DOI 10.1016/j.jmb.2005.09.059; DECOTTIGNIES A, 1995, J BIOL CHEM, V270, P18150, DOI 10.1074/jbc.270.30.18150; DELAVEAU T, 1994, MOL GEN GENET, V244, P501, DOI 10.1007/BF00583901; Fardeau V, 2007, J BIOL CHEM, V282, P5063, DOI 10.1074/jbc.M610197200; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Frueh DP, 2005, J BIOMOL NMR, V33, P187, DOI 10.1007/s10858-005-3204-z; Gao C, 2004, J BIOL CHEM, V279, P42677, DOI 10.1074/jbc.M406363200; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Goodman RH, 2000, GENE DEV, V14, P1553; Goto NK, 2002, J BIOL CHEM, V277, P43168, DOI 10.1074/jbc.M207660200; Gulshan K, 2005, J BIOL CHEM, V280, P40524, DOI 10.1074/jbc.M504716200; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Kasper LH, 2006, MOL CELL BIOL, V26, P789, DOI 10.1128/MCB.26.3.789-809.2006; Kasper LH, 2002, NATURE, V419, P738, DOI 10.1038/nature01062; KATZMANN DJ, 1995, MOL CELL BIOL, V15, P6875; KATZMANN DJ, 1994, MOL CELL BIOL, V14, P4653, DOI 10.1128/MCB.14.7.4653; Kean LS, 1997, J CELL BIOL, V138, P255, DOI 10.1083/jcb.138.2.255; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Klepser ME, 2006, PHARMACOTHERAPY, V26, p68S, DOI 10.1592/phco.26.6part2.68S; Kliewer SA, 2002, ENDOCR REV, V23, P687, DOI 10.1210/er.2001-0038; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Lucau-Danila A, 2005, MOL CELL BIOL, V25, P1860, DOI 10.1128/MCB.25.5.1860-1868.2005; Mamnun YM, 2004, FEBS LETT, V559, P111, DOI 10.1016/S0014-5793(04)00046-8; MEYERS S, 1992, CURR GENET, V21, P431, DOI 10.1007/BF00351651; Moye-Rowley WS, 2003, PROG NUCLEIC ACID RE, V73, P251, DOI 10.1016/S0079-6603(03)01008-0; Mylonakis E, 2005, INFECT IMMUN, V73, P3833, DOI 10.1128/IAI.73.7.3833-3841.2005; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Naar AM, 1998, GENE DEV, V12, P3020, DOI 10.1101/gad.12.19.3020; Novatchkova M, 2004, CURR BIOL, V14, pR54, DOI 10.1016/j.cub.2003.12.042; Parker D, 1999, MOL CELL BIOL, V19, P5601; Parker D, 1998, MOL CELL, V2, P353, DOI 10.1016/S1097-2765(00)80279-8; Pfaller MA, 2007, J CLIN MICROBIOL, V45, P1735, DOI 10.1128/JCM.00409-07; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Phelps C, 2006, P NATL ACAD SCI USA, V103, P7077, DOI 10.1073/pnas.0510080103; Prasad R., 2006, Infectious Disorders - Drug Targets, V6, P69, DOI 10.2174/187152606784112164; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Radhakrishnan I, 1999, J MOL BIOL, V287, P859, DOI 10.1006/jmbi.1999.2658; Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218; Sherman F., 1986, METHODS YEAST GENETI; Sipos G, 2006, CURR DRUG TARGETS, V7, P471, DOI 10.2174/138945006776359403; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; Tsai HF, 2006, ANTIMICROB AGENTS CH, V50, P1384, DOI 10.1128/AAC.50.4.1384-1392.2006; van den Hazel HB, 1999, J BIOL CHEM, V274, P1934, DOI 10.1074/jbc.274.4.1934; Vermitsky JP, 2006, MOL MICROBIOL, V61, P704, DOI 10.1111/j.1365-2958.2006.05235.x; Vermitsky JP, 2004, ANTIMICROB AGENTS CH, V48, P3773, DOI 10.1128/AAC.48.10.3773-3781.2004; Willson TM, 2002, NAT REV DRUG DISCOV, V1, P259, DOI 10.1038/nrd753; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Zor T, 2004, J MOL BIOL, V337, P521, DOI 10.1016/j.jmb.2004.01.038	60	237	256	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2008	452	7187					604	U4		10.1038/nature06836	http://dx.doi.org/10.1038/nature06836			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282KR	18385733				2022-12-24	WOS:000254567200039
J	Swanson, CM; Malim, MH				Swanson, Chad M.; Malim, Michael H.			SnapShot: HIV-1 proteins	CELL			English	Editorial Material								Human immunodeficiency virus type-1 (HIV-1) is the etiologic agent of acquired immunodeficiency syndrome ( AIDS) and the prototypic member of the lentivirus genus of retroviruses. Lentivirus infections are considered as chronic or "slow" and, when pathogenic ( most notably, HIV-1 infection of humans), are associated with severe immunological and neurological dysfunction. HIV-1 has nine genes, with only the gag, pol, and env genes common to all replication-competent retroviruses. The pol gene encodes two enzymes that define the replicative strategy of the retrovirus: reverse transcriptase (RT) copies the viral RNA genome into DNA, and integrase ( IN) mediates the insertion of that DNA into the genomic DNA of an infected cell to establish the provirus ( and persistent infection). A third enzyme protease ( PR), also derived from pol, is necessary for maturation of virions into an infectious form. Of the remaining six regulatory/accessory genes of HIV-1, tat and rev are essential for virus replication, whereas vif, vpr, vpu, and nef are thought to modulate immune functions in vivo ( often in a species-specific fashion). Current frontline highly active antiretroviral therapy ( HAART) for treating AIDS includes combinations of small-molecule inhibitors of PR and RT ( nucleoside RT inhibitors, NRTIs; non-nucleoside RT inhibitors, NNRTIs). A peptide inhibitor of TM that inhibits viral entry is used in salvage therapy, and a small-molecule IN inhibitor, Raltegravir, was recently approved by the FDA. Three crucial viral enzymes are inhibited pharmacologically, but blocking remaining viral proteins and virus-host interactions is an important objective ( a CCR5 coreceptor antagonist, Maraviroc, received FDA approval in 2007).	[Swanson, Chad M.; Malim, Michael H.] Kings Coll London, Sch Med, Dept Infect Dis, London SE1 9RT, England	University of London; King's College London	Swanson, CM (corresponding author), Kings Coll London, Sch Med, Dept Infect Dis, London SE1 9RT, England.			Swanson, Chad/0000-0002-6650-3634; Malim, Michael/0000-0002-7699-2064	Medical Research Council [G0401570] Funding Source: Medline; MRC [G0401570] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; Coffin J, 1997, RETROVIRUSES; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; *HIV 1, HIV 1 HUM PROT INT D; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033	8	32	36	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 16	2008	133	4							742.e1	10.1016/j.cell.2008.05.005	http://dx.doi.org/10.1016/j.cell.2008.05.005			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485880	Bronze			2022-12-24	WOS:000255903300027
J	Akala, OO; Park, IK; Qian, DL; Pihalja, M; Becker, MW; Clarke, MF				Akala, Omobolaji O.; Park, In-Kyung; Qian, Dalong; Pihalja, Michael; Becker, Michael W.; Clarke, Michael F.			Long-term haematopoietic reconstitution by Trp53(-/-)p16(Ink4a-/-)p19(Arf-/-) multipotent progenitors	NATURE			English	Article							SLAM FAMILY RECEPTORS; LEUKEMIC STEM-CELLS; EX-VIVO EXPANSION; SELF-RENEWAL; BMI-1; P53; P16(INK4A); PROLIFERATION; SENESCENCE; EXPRESSION	Haematopoiesis is maintained by a hierarchical system where haematopoietic stem cells ( HSCs) give rise to multipotent progenitors, which in turn differentiate into all types of mature blood cells1. HSCs maintain themselves for the lifetime of the organism because of their ability to self- renew. However, multipotent progenitors lack the ability to self- renew, therefore their mitotic capacity and expansion potential are limited and they are destined to eventually stop proliferating after a finite number of cell divisions(1,2). The molecular mechanisms that limit the proliferation capacity of multipotent progenitors and other more mature progenitors are not fully understood(2,3). Here we show that bone marrow cells from mice deficient in three genes genetically downstream of Bmi1-p16(Ink4a), p19(Arf) and Trp53 ( triple mutant mice; p16(Ink4a) and p19(Arf) are alternative reading frames of the same gene ( also called Cdkn2a) that encode different proteins) - have an approximately 10-fold increase in cells able to reconstitute the blood long term. This increase is associated with the acquisition of long- term reconstitution capacity by cells of the phenotype c-kit(+)Sca-1(+)Flt3(+)CD150(-)CD48(-)Lin(-), which defines multipotent progenitors in wild- type mice(4-6). The pattern of triple mutant multipotent progenitor response to growth factors resembles that of wild- type multipotent progenitors but not wild- type HSCs. These results demonstrate that p16(Ink4a)/p19(Arf) and Trp53 have a central role in limiting the expansion potential of multipotent progenitors. These pathways are commonly repressed in cancer, suggesting a mechanism by which early progenitor cells could gain the ability to self- renew and become malignant with further oncogenic mutations.	[Akala, Omobolaji O.; Qian, Dalong; Clarke, Michael F.] Stanford Univ, Stanford Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA 94304 USA; [Akala, Omobolaji O.] Univ Michigan, Cellular & Mol Biol Grad Program, Taubman Med Lib 2966, Ann Arbor, MI 48109 USA; [Akala, Omobolaji O.; Qian, Dalong; Clarke, Michael F.] Stanford Univ, Div Hematol Oncol, Palo Alto, CA 94304 USA; [Park, In-Kyung; Pihalja, Michael] Univ Michigan, Dept Hematol Oncol, Ann Arbor, MI 48109 USA; [Becker, Michael W.] Univ Rochester, Div Hematol Oncol, Rochester, NY 14642 USA	Stanford University; University of Michigan System; University of Michigan; Stanford University; University of Michigan System; University of Michigan; University of Rochester	Clarke, MF (corresponding author), Stanford Univ, Stanford Inst Stem Cell Biol & Regenerat Med, 1050 Arastradero Rd, Palo Alto, CA 94304 USA.	mfclarke@stanford.edu		Becker, Michael/0000-0001-9890-8815				Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Berggren P, 2003, CLIN CANCER RES, V9, P235; Burke L, 2005, CLIN CANCER RES, V11, P232; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Dumble M, 2007, BLOOD, V109, P1736, DOI 10.1182/blood-2006-03-010413; Esteller M, 2000, CANCER RES, V60, P129; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim I, 2006, BLOOD, V108, P737, DOI 10.1182/blood-2005-10-4135; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 2002, J IMMUNOL, V168, P635, DOI 10.4049/jimmunol.168.2.635; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Stepanova L, 2005, BLOOD, V106, P827, DOI 10.1182/blood-2004-06-2242; Weber A, 2002, VIRCHOWS ARCH, V441, P133, DOI 10.1007/s00428-002-0637-6; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang CC, 2005, BLOOD, V105, P4314, DOI 10.1182/blood-2004-11-4418; Zhang CC, 2004, BLOOD, V103, P2513, DOI 10.1182/blood-2003-08-2955; Zolota V, 2007, PATHOL RES PRACT, V203, P199, DOI 10.1016/j.prp.2007.01.010	27	127	134	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 8	2008	453	7192					228	U12		10.1038/nature06869	http://dx.doi.org/10.1038/nature06869			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297BP	18418377	Bronze, Green Published			2022-12-24	WOS:000255592400041
J	Randau, L; Schroder, I; Soll, D				Randau, Lennart; Schroder, Imke; Soll, Dieter			Life without RNase P	NATURE			English	Article							NANOARCHAEUM-EQUITANS; RIBONUCLEASE-P; GENES; EVOLUTION; PROTEIN; GENOME; ENZYME; SEQUENCES; PROMOTER; SUBUNIT	The universality of ribonuclease P ( RNase P), the ribonucleoprotein essential for transfer RNA ( tRNA) 5' maturation(1,2), is challenged in the archaeon Nanoarchaeum equitans. Neither extensive computational analysis of the genome nor biochemical tests in cell extracts revealed the existence of this enzyme. Here we show that the conserved placement of its tRNA gene promoters allows the synthesis of leaderless tRNAs, whose presence was verified by the observation of 5' triphosphorylated mature tRNA species. Initiation of tRNA gene transcription requires a purine, which coincides with the finding that tRNAs with a cytosine in position 1 display unusually extended 5' termini with an extra purine residue. These tRNAs were shown to be substrates for their cognate aminoacyl- tRNA synthetases. These findings demonstrate how nature can cope with the loss of the universal and supposedly ancient RNase P through genomic rearrangement at tRNA genes under the pressure of genome condensation.	[Randau, Lennart; Soll, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Soll, Dieter] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Schroder, Imke] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA	Yale University; Yale University; University of California System; University of California Los Angeles	Soll, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	dieter.soll@yale.edu		Randau, Lennart/0000-0002-2780-2076	NIGMS NIH HHS [R01 GM022854] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTMAN S, 1993, FASEB J, V7, P7, DOI 10.1096/fasebj.7.1.7916700; ALTMAN S, 1989, GENE, V82, P63, DOI 10.1016/0378-1119(89)90030-9; Connolly SA, 2004, BIOCHEMISTRY-US, V43, P962, DOI 10.1021/bi035708f; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Das S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-186; Evans D, 2006, TRENDS BIOCHEM SCI, V31, P333, DOI 10.1016/j.tibs.2006.04.007; Farruggio D, 1996, MOL CELL BIOL, V16, P4248; Fechter P, 1998, FEBS LETT, V436, P99, DOI 10.1016/S0014-5793(98)01096-5; Fitz-Gibbon ST, 2002, P NATL ACAD SCI USA, V99, P984, DOI 10.1073/pnas.241636498; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; GUPTA R, 1984, J BIOL CHEM, V259, P9461; Hartmann E, 2003, TRENDS GENET, V19, P561, DOI 10.1016/j.tig.2003.08.007; HAUSNER W, 2007, ARCHAEA EVOLUTION PH, P185; Kikovska E, 2007, P NATL ACAD SCI USA, V104, P2062, DOI 10.1073/pnas.0607326104; Klein RJ, 2002, P NATL ACAD SCI USA, V99, P7542, DOI 10.1073/pnas.112063799; Kobayashi T, 2003, NAT STRUCT BIOL, V10, P425, DOI 10.1038/nsb934; Li Y, 2004, RNA, V10, P1533, DOI 10.1261/rna.7970404; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; NOREN CJ, 1990, NUCLEIC ACIDS RES, V18, P83, DOI 10.1093/nar/18.1.83; PALMER JR, 1995, J BACTERIOL, V177, P1844, DOI 10.1128/jb.177.7.1844-1849.1995; Pannucci JA, 1999, P NATL ACAD SCI USA, V96, P7803, DOI 10.1073/pnas.96.14.7803; Randau L, 2005, P NATL ACAD SCI USA, V102, P17934, DOI 10.1073/pnas.0509197102; Randau L, 2005, NATURE, V433, P537, DOI 10.1038/nature03233; She Q, 2004, BIOCHEM SOC T, V32, P222, DOI 10.1042/BST0320222; SHUMAN S, 1980, J BIOL CHEM, V255, P1588; Sprinzl M, 2005, NUCLEIC ACIDS RES, V33, pD139, DOI 10.1093/nar/gki012; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tsai HY, 2006, P NATL ACAD SCI USA, V103, P16147, DOI 10.1073/pnas.0608000103; VOGELI G, 1975, P NATL ACAD SCI USA, V72, P4790, DOI 10.1073/pnas.72.12.4790; Walker SC, 2006, CRIT REV BIOCHEM MOL, V41, P77, DOI 10.1080/10409230600602634; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; Willkomm DK, 2002, BIOCHIMIE, V84, P713, DOI 10.1016/S0300-9084(02)01447-5	32	81	82	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2008	453	7191					120	+		10.1038/nature06833	http://dx.doi.org/10.1038/nature06833			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294ID	18451863				2022-12-24	WOS:000255398800051
J	McQuay, H				McQuay, Henry			Making a difference - Management of chronic pain - Help and hope at the bottom of the pile	BRITISH MEDICAL JOURNAL			English	Editorial Material							LIFE; IMPACT		[McQuay, Henry] The Churchill, Pain Relief Unit, Oxford OX3 7LJ, England; [McQuay, Henry] Univ Oxford, Nuffield Dept Anaesthet, Oxford OX1 2JD, England	University of Oxford; University of Oxford	McQuay, H (corresponding author), The Churchill, Pain Relief Unit, Oxford OX3 7LJ, England.	henry.mcquay@pru.ox.ac.uk						Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Katz WA, 2002, CLIN RHEUMATOL, V21, pS2, DOI 10.1007/s100670200028; Kemler MA, 2002, J PAIN SYMPTOM MANAG, V23, P433, DOI 10.1016/S0885-3924(02)00386-X; Lachaine J, 2007, PAIN RES MANAG, V12, P31, DOI 10.1155/2007/713835; Maniadakis N, 2000, PAIN, V84, P95, DOI 10.1016/S0304-3959(99)00187-6; McQuay HJ, 2007, HLTH CARE NEEDS ASSE, P519; Sprangers MAG, 2000, J CLIN EPIDEMIOL, V53, P895, DOI 10.1016/S0895-4356(00)00204-3	7	9	9	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 26	2008	336	7650					954	+		10.1136/bmj.39520.699190.94	http://dx.doi.org/10.1136/bmj.39520.699190.94			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296KC	18397945	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000255540900041
J	Durham, WJ; Aracena-Parks, P; Long, C; Rossi, AE; Goonasekera, SA; Boncompagni, S; Galvan, DL; Gilman, CP; Baker, MR; Shirokova, N; Protasi, F; Dirksen, R; Hamilton, SL				Durham, William J.; Aracena-Parks, Paula; Long, Cheng; Rossi, Ann E.; Goonasekera, Sanjeewa A.; Boncompagni, Simona; Galvan, Daniel L.; Gilman, Charles P.; Baker, Mariah R.; Shirokova, Natalia; Protasi, Feliciano; Dirksen, Robert; Hamilton, Susan L.			RyR1 S-nitrosylation underlies environmental heat stroke and sudden death in Y522S RyR1 knockin mice	CELL			English	Article							CA2+ RELEASE CHANNEL; SKELETAL-MUSCLE; MALIGNANT HYPERTHERMIA; NITRIC-OXIDE; CALCIUM-RELEASE; RYANODINE BINDING; FUNCTIONAL-STATE; RECEPTOR; EXERCISE; OXIDATION	Mice with a malignant hyperthermia mutation (Y522S) in the ryanodine receptor (RyR1) display muscle contractures, rhabdomyolysis, and death in response to elevated environmental temperatures. We demonstrate that this mutation in RyR1 causes Ca2+ leak, which drives increased generation of reactive nitrogen species (RNS). Subsequent S-nitrosylation of the mutant RyR1 increases its temperature sensitivity for activation, producing muscle contractures upon exposure to elevated temperatures. The Y522S mutation in humans is associated with central core disease. Many mitochondria in the muscle of heterozygous Y522S mice are swollen and misshapen. The mutant muscle displays decreased force production and increased mitochondrial lipid peroxidation with aging. Chronic treatment with N-acetylcysteine protects against mitochondrial oxidative damage and the decline in force generation. We propose a feed-forward cyclic mechanism that increases the temperature sensitivity of RyR1 activation and underlies heat stroke and sudden death. The cycle eventually produces a myopathy with damaged mitochondria.	[Durham, William J.; Aracena-Parks, Paula; Long, Cheng; Galvan, Daniel L.; Gilman, Charles P.; Baker, Mariah R.; Hamilton, Susan L.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Rossi, Ann E.; Goonasekera, Sanjeewa A.; Dirksen, Robert] Univ Rochester, Med Ctr, Dept Pharmacol & Physiol, Rochester, NY 14642 USA; [Boncompagni, Simona; Protasi, Feliciano] Univ G Dannunzio, Ctr Sci Invecchiamento, Lab Cellular Physiol, I-66013 Chieti, Italy; [Shirokova, Natalia] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Pharmacol & Physiol, Newark, NJ 07103 USA	Baylor College of Medicine; University of Rochester; G d'Annunzio University of Chieti-Pescara; Rutgers State University New Brunswick; Rutgers State University Medical Center	Hamilton, SL (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, 1 Baylor Plaza,410B, Houston, TX 77030 USA.	susanh@bcm.edu	Galvan, Daniel L./L-2768-2019; Tuluc, Petronel/C-2527-2011; Aracena, Paula/A-5607-2012	Galvan, Daniel L./0000-0001-7541-6252; Aracena, Paula/0000-0002-2144-6875; Shirokova, Natalia/0000-0003-4648-4592; Hamilton, Susan/0000-0003-0241-9369; Baker, Mariah/0000-0002-1613-9387	NIAMS NIH HHS [R01 AR053349, R01 AR053349-02, P01 AR052354-01A10003, R01 AR044657-12, R01 AR050503-01, R01 AR044657, R01 AR050503, R01 AR050503-05, R01 AR053349-03, AR053349, R29 AR044657, R01 AR053349-01A1, R01 AR050503-03, P01 AR052354-020003, R01 AR041802, R01 AR050503-02, P01 AR052354, AR 050503, R01 AR053349-01A1S1, R01 AR050503-04, 5P01AR052354, AR44657] Funding Source: Medline; NIDCR NIH HHS [T32-DE07202, T32 DE007202] Funding Source: Medline; Telethon [GGP030289] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041802, P01AR052354, R01AR053349, R01AR044657, R29AR044657, R01AR050503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007202] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Aghdasi B, 1997, J BIOL CHEM, V272, P25462, DOI 10.1074/jbc.272.41.25462; Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; Bellinger AM, 2008, P NATL ACAD SCI USA, V105, P2198, DOI 10.1073/pnas.0711074105; Bendahan D, 2001, ANESTH ANALG, V93, P683, DOI 10.1097/00000539-200109000-00030; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; CARROLL S, 1991, ARCH BIOCHEM BIOPHYS, V290, P239, DOI 10.1016/0003-9861(91)90615-P; Chelu MG, 2006, FASEB J, V20, P329, DOI 10.1096/fj.05-4497fje; CHU A, 1990, MOL PHARMACOL, V37, P735; Clark CB, 2004, RESUSCITATION, V60, P349, DOI 10.1016/j.resuscitation.2004.02.002; Davis M, 2002, BRIT J ANAESTH, V88, P508, DOI 10.1093/bja/88.4.508; Donoso P, 2000, BIOPHYS J, V79, P279, DOI 10.1016/S0006-3495(00)76290-4; Ducreux S, 2004, J BIOL CHEM, V279, P43838, DOI 10.1074/jbc.M403612200; ELLIS FR, 1988, BRIT J ANAESTH, V60, P28, DOI 10.1093/bja/60.1.28; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; HACKL W, 1991, BRIT J ANAESTH, V66, P138, DOI 10.1093/bja/66.1.138; Hare JM, 2003, J MOL CELL CARDIOL, V35, P719, DOI 10.1016/S0022-2828(03)00143-3; HAWKES MJ, 1992, J BIOL CHEM, V267, P6702; Hopkins PM, 2000, BRIT J ANAESTH, V85, P118, DOI 10.1093/bja/85.1.118; Jurkat-Rott K, 2000, MUSCLE NERVE, V23, P4, DOI 10.1002/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D; Letelier ME, 2005, CHEM-BIOL INTERACT, V151, P71, DOI 10.1016/j.cbi.2004.12.004; Lichtman AD, 2006, ANESTH ANALG, V102, P372, DOI 10.1213/01.ane.0000189596.70694.36; Long C, 2007, HYPERTENSION, V49, P569, DOI 10.1161/01.HYP.0000257914.80918.72; Marengo JJ, 1998, BIOPHYS J, V74, P1263, DOI 10.1016/S0006-3495(98)77840-3; Oba T, 2002, AM J PHYSIOL-CELL PH, V282, pC684, DOI 10.1152/ajpcell.01273.2000; PAMUKCOGLU T, 1988, AM J FOREN MED PATH, V9, P161, DOI 10.1097/00000433-198806000-00015; Paolini C, 2007, J PHYSIOL-LONDON, V583, P767, DOI 10.1113/jphysiol.2007.138024; PESSAH IN, 1987, MOL PHARMACOL, V31, P232; Pollard JW, 1997, BASIC CELL CULTURE P; Pou S, 1999, J BIOL CHEM, V274, P9573, DOI 10.1074/jbc.274.14.9573; QUANE KA, 1994, GENOMICS, V23, P236, DOI 10.1006/geno.1994.1483; ROBERTSON S, 1992, VET CLIN N AM-SMALL, V22, P277, DOI 10.1016/S0195-5616(92)50609-X; Rodney GG, 2000, BIOCHEMISTRY-US, V39, P7807, DOI 10.1021/bi0005660; ROSSI AE, 2006, BIOPHYS J, V90, pA269; Ryan JF, 1997, J CLIN ANESTH, V9, P66, DOI 10.1016/S0952-8180(96)00207-3; Sun JH, 2003, J BIOL CHEM, V278, P8184, DOI 10.1074/jbc.M211940200; Sun JH, 2001, J BIOL CHEM, V276, P15625, DOI 10.1074/jbc.M100083200; Sun JH, 2001, P NATL ACAD SCI USA, V98, P11158, DOI 10.1073/pnas.201289098; Thompson PD, 2007, CIRCULATION, V115, P2358, DOI 10.1161/CIRCULATIONAHA.107.181485; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Treves S, 2005, NEUROMUSCULAR DISORD, V15, P577, DOI 10.1016/j.nmd.2005.06.008; Wappler F, 2001, ANESTHESIOLOGY, V94, P95, DOI 10.1097/00000542-200101000-00019; Wells KE, 2003, NEUROMUSCULAR DISORD, V13, P21, DOI 10.1016/S0960-8966(02)00191-8; Zhang HW, 2003, J BIOL CHEM, V278, P8348, DOI 10.1074/jbc.M209565200	45	248	255	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 4	2008	133	1					53	65		10.1016/j.cell.2008.02.042	http://dx.doi.org/10.1016/j.cell.2008.02.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	283MW	18394989	Green Accepted, Bronze			2022-12-24	WOS:000254641300008
J	Katsanis, SH; Javitt, G; Hudson, K				Katsanis, S. H.; Javitt, G.; Hudson, K.			Public health - A case study of personalized medicine	SCIENCE			English	Editorial Material									[Katsanis, S. H.; Javitt, G.; Hudson, K.] Johns Hopkins Univ, Genet & Publ Policy Ctr, Washington, DC 20036 USA	Johns Hopkins University	Hudson, K (corresponding author), Johns Hopkins Univ, Genet & Publ Policy Ctr, Washington, DC 20036 USA.	khudson5@jhu.edu		Katsanis, Sara/0000-0002-5044-8765				Berg AO, 2007, GENET MED, V9, P819, DOI 10.1097/GIM.0b013e31815bf9a3; *DNA DIR INC, 2007, DRUGS TEST FOR; EUGSTER HP, 1993, DRUG METAB DISPOS, V21, P43; EYER JD, 2007, PUBLIC COMMENT BEHAL; *FTC, 2006, FTC FACTS CONS HOM G; *GEN CORP, 2007, PHARM PAX PAR; Hudson K, 2007, AM J HUM GENET, V81, P635, DOI 10.1086/521634; Hudson KL, 2006, SCIENCE, V313, P1853, DOI 10.1126/science.1134996; Hunter DJ, 2008, NEW ENGL J MED, V358, P105, DOI 10.1056/NEJMp0708162; Javitt GH, 2007, FOOD DRUG LAW J, V62, P617; Javitt Gail H, 2004, Oklahoma Law Rev, V57, P251; *LAB CORP AM INC, 2006, LABCORP CAPS CYT P45; MATCHAR DB, 2007, 146 EV REP TECHN ASS, V146, P1; McCabe LL, 2004, GENET MED, V6, P58, DOI 10.1097/01.GIM.0000105753.01536.BE; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; *ROCH MOL SYST INC, 2006, AMPLICHIP CYP450 TES; *SACGHS, 2007, US SYST OV GEN TEST; *SACGT, 2000, ENH OV GEN TESTS; *SERYX INC, 2007, DRUG GEN REP; Shurin SB, 2008, NEW ENGL J MED, V358, P1061, DOI 10.1056/NEJMe0800801; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112	21	85	88	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2008	320	5872					53	54		10.1126/science.1156604	http://dx.doi.org/10.1126/science.1156604			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	283JR	18388277				2022-12-24	WOS:000254633000022
J	Carpenter, D; Zucker, EJ; Avorn, J				Carpenter, Daniel; Zucker, Evan James; Avorn, Jerry			Drug-review deadlines and safety problems	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							FDA; REFORM	Background: The Prescription Drug User Fee Act (PDUFA) imposes deadlines for the completion of drug reviews by the Food and Drug Administration (FDA). Critics have suggested that these deadlines may result in rushed approvals and the emergence of unanticipated safety problems once a product is in clinical use. Methods: We assessed the association between the PDUFA deadlines and the timing of FDA drug approval by constructing dynamic Cox proportional-hazards models of review times for all new molecular entities approved between 1950 and 2005. To determine whether the deadlines were associated with postmarketing safety problems, we focused on drugs submitted since January 1993, when the deadlines were first imposed. We used exact logistic regression to determine whether drugs approved immediately before the deadlines were associated with a higher rate of postmarketing safety problems (e.g., withdrawals and black-box warnings) than drugs approved at other times. Results: Initiation of the PDUFA requirements concentrated the number of approval decisions made in the weeks immediately preceding the deadlines. As compared with drugs approved at other times, drugs approved in the 2 months before their PDUFA deadlines were more likely to be withdrawn for safety reasons (odds ratio, 5.5; 95% confidence interval [CI], 1.3 to 27.8), more likely to carry a subsequent black-box warning (odds ratio, 4.4; 95% CI, 1.2 to 20.5), and more likely to have one or more dosage forms voluntarily discontinued by the manufacturer (odds ratio, 3.3; 95% CI, 1.5 to 7.5). Conclusions: PDUFA deadlines have appreciably changed the approval decisions of the FDA. Once medications are in clinical use, the discovery of safety problems is more likely for drugs approved immediately before a deadline than for those approved at other times.	[Carpenter, Daniel] Harvard Univ, Dept Govt, Fac Arts & Sci, Cambridge, MA 02138 USA; [Zucker, Evan James; Avorn, Jerry] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Avorn, Jerry] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Carpenter, D (corresponding author), Harvard Univ, Dept Govt, Fac Arts & Sci, N405,1737 Cambridge St, Cambridge, MA 02138 USA.	dcarpenter@gov.harvard.edu						Avorn J, 2004, POWERFUL MED BENEFIT; BACIU A, 2006, FUTURE DRUG SAFETY P; CARPENTER D, 2003, APPROVAL TIMES NEW D; *FDA OFF COMM, PERF FY99 FDAMA GOAL; *FDA OFF PLANN, REP PDUFA GOALS OR N; Fontanarosa PB, 2004, JAMA-J AM MED ASSOC, V292, P2647, DOI 10.1001/jama.292.21.2647; *FOOD DRUG ADM, 2005, PRESCR DRUG US FEE A; *FOOD DRUG ADM, FDA APPR DRUG PROD D; Fung M, 2001, DRUG INF J, V35, P293, DOI 10.1177/009286150103500134; *GOV ACC OFF, 2006, DRUG SAF IMPR NEED F; *HARV U FAC ARTS S, FDA NEW MOL ENT APPR; Horton R, 2001, LANCET, V357, P1544, DOI 10.1016/S0140-6736(00)04776-0; *INF, 2007, PHARM PHARM R D PIP; *KANS U MED CTR, WARN INF PAG; King EN, 2002, AM STAT, V56, P163, DOI 10.1198/00031300283; Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215; LEWIS C, 2003, FDA CONSUMER     MAY; McClellan M, 2007, NEW ENGL J MED, V356, P1700, DOI 10.1056/NEJMp078057; MEHTA C, 2007, LOGXACT8 STAT SOFTWA; MOFFITT S, 2005, THESIS U MICHIGAN AN; Nissen SE, 2007, NEW ENGL J MED, V357, P100; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Okie S, 2005, NEW ENGL J MED, V352, P2563; Olson MK, 2004, J HEALTH POLIT POLIC, V29, P397, DOI 10.1215/03616878-29-3-397; Ray WA, 2006, NEW ENGL J MED, V354, P194, DOI 10.1056/NEJMsb053432; Ross DB, 2007, NEW ENGL J MED, V356, P1601, DOI 10.1056/NEJMp078032; Therneau TM, 2000, MODELING SURVIVAL DA; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286; *UNION CONC SCI, 2006, VOIC SCI FDA PROT PU; WOODCOCK J, 2005, DRUG SAFETY DRUG APP; 2006, PDUFA 3 IND EV FDAS	31	134	138	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 27	2008	358	13					1354	1361		10.1056/NEJMsa0706341	http://dx.doi.org/10.1056/NEJMsa0706341			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	278TE	18367738				2022-12-24	WOS:000254308400006
J	Smith, C; Richardus, JH				Smith, Cairns; Richardus, Jan Hendrik			Leprosy strategy is about control, not eradication	LANCET			English	Editorial Material							CHEMOPROPHYLAXIS; TRANSMISSION; PREVENTION		[Smith, Cairns] Univ Aberdeen, Dept Publ Hlth, Sch Med, Aberdeen AB25 2ZD, Scotland; [Richardus, Jan Hendrik] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	University of Aberdeen; Erasmus University Rotterdam; Erasmus MC	Smith, C (corresponding author), Univ Aberdeen, Dept Publ Hlth, Sch Med, Aberdeen AB25 2ZD, Scotland.	w.c.s.smith@abdn.ac.uk	Richardus, Jan Hendrik/AAE-1278-2021	Richardus, Jan Hendrik/0000-0003-0564-6313				Childs James E., 1993, Morbidity and Mortality Weekly Report, V42, P1; Fine PEM, 2007, B WORLD HEALTH ORGAN, V85, P2, DOI 10.2471/BLT.06.039206; Geluk A, 2006, HUM IMMUNOL, V67, P439, DOI 10.1016/j.humimm.2006.03.009; LEISINGER KM, 2008, 17 INT LEPR C HYD IN; Meima A, 2004, B WORLD HEALTH ORGAN, V82, P373; Moet FJ, 2004, LEPROSY REV, V75, P376; Richardus JH, 2007, LEPROSY REV, V78, P330; Setia MS, 2006, LANCET INFECT DIS, V6, P162, DOI 10.1016/S1473-3099(06)70412-1; Smith CM, 2000, J INFECTION, V41, P137, DOI 10.1053/jinf.2000.0698; *WHO, 2005, GLOB STRAT RED LEPR; *WHO, 2007, WKLY EPIDEMIOL REC, V82, P225; *WHO, 2002, WKLY EPIDEMIOL REC, V77, P1	12	14	14	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 22	2008	371	9617					969	970		10.1016/S0140-6736(08)60433-X	http://dx.doi.org/10.1016/S0140-6736(08)60433-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277IN	18358914				2022-12-24	WOS:000254206000009
J	Sekido, R; Lovell-Badge, R				Sekido, Ryohei; Lovell-Badge, Robin			Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer	NATURE			English	Article							CAMPOMELIC DYSPLASIA; TESTIS DEVELOPMENT; DISTINCT FUNCTIONS; DETERMINING REGION; MOUSE; GENE; MICE; DIFFERENTIATION; ACTIVATION; EXPRESSION	The mammalian Y chromosome acts as a dominant male determinant as a result of the action of a single gene, Sry, whose role in sex determination is to initiate testis rather than ovary development from early bipotential gonads(1-3). It does so by triggering the differentiation of Sertoli cells from supporting cell precursors, which would otherwise give follicle cells. The related autosomal gene Sox9 is also known from loss- of- function mutations in mice and humans to be essential for Sertoli cell differentiation(4,5); moreover, its abnormal expression in an XX gonad can lead to male development in the absence of Sry(6,7). These genetic data, together with the finding that Sox9 is upregulated in Sertoli cell precursors just after SRY expression begins(8,9), has led to the proposal that Sox9 could be directly regulated by SRY. However, the mechanism by which SRY action might affect Sox9 expression was not understood. Here we show that SRY binds to multiple elements within a Sox9 gonad- specific enhancer in mice, and that it does so along with steroidogenic factor 1 ( SF1, encoded by the gene Nr5a1 ( Sf1)), an orphan nuclear receptor. Mutation, co- transfection and sex-reversal studies all point to a feedforward, self- reinforcing pathway in which SF1 and SRY cooperatively upregulate Sox9 and then, together with SF1, SOX9 also binds to the enhancer to help maintain its own expression after that of SRY has ceased. Our results open up the field, permitting further characterization of the molecular mechanisms regulating sex determination and how they have evolved, as well as how they fail in cases of sex reversal.	[Sekido, Ryohei; Lovell-Badge, Robin] Natl Inst Med Res, MRC, Div Dev Genet, London NW7 1AA, England	MRC National Institute for Medical Research	Sekido, R (corresponding author), Natl Inst Med Res, MRC, Div Dev Genet, Ridgeway,Mill Hill, London NW7 1AA, England.	rsekido@nimr.mrc.ac.uk; rlovell@nimr.mrc.ac.uk		Sekido, Ryohei/0000-0003-2364-1882; Lovell-Badge, Robin/0000-0001-9364-4179	MRC [MC_U117562207] Funding Source: UKRI; Medical Research Council [MC_U117562207] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; Bagheri-Fam S, 2006, DEV BIOL, V291, P382, DOI 10.1016/j.ydbio.2005.11.013; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; DUBIN RA, 1994, MOL ENDOCRINOL, V8, P1182, DOI 10.1210/me.8.9.1182; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Hammes A, 2001, CELL, V106, P319, DOI 10.1016/S0092-8674(01)00453-6; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; Ikeda Y, 2001, DEV DYNAM, V220, P363, DOI 10.1002/dvdy.1116; Kidokoro T, 2005, DEV BIOL, V278, P511, DOI 10.1016/j.ydbio.2004.11.006; Kim Y, 2007, P NATL ACAD SCI USA, V104, P16558, DOI 10.1073/pnas.0702581104; Kim Y, 2006, PLOS BIOL, V4, P1000, DOI 10.1371/journal.pbio.0040187; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Lin L, 2007, J CLIN ENDOCR METAB, V92, P991, DOI 10.1210/jc.2006-1672; LUO X, 1994, CELL, V77, P663; MCELREAVEY K, 1993, P NATL ACAD SCI USA, V90, P3368, DOI 10.1073/pnas.90.8.3368; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Ohe K, 2002, P NATL ACAD SCI USA, V99, P1146, DOI 10.1073/pnas.022645899; Park SY, 2005, DEVELOPMENT, V132, P2415, DOI 10.1242/dev.01826; PONTIGGIA A, 1994, EMBO J, V13, P6115, DOI 10.1002/j.1460-2075.1994.tb06958.x; Qin YJ, 2004, HUM MOL GENET, V13, P1213, DOI 10.1093/hmg/ddh141; Sekido R, 2004, DEV BIOL, V274, P271, DOI 10.1016/j.ydbio.2004.07.011; Shen JHC, 2002, MOL ENDOCRINOL, V16, P529, DOI 10.1210/me.16.3.529; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Thevenet L, 2005, J BIOL CHEM, V280, P38625, DOI 10.1074/jbc.M504127200; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; Wilhelm D, 2002, GENE DEV, V16, P1839, DOI 10.1101/gad.220102; Wunderle VM, 1998, P NATL ACAD SCI USA, V95, P10649, DOI 10.1073/pnas.95.18.10649	30	647	676	5	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2008	453	7197					930	934		10.1038/nature06944	http://dx.doi.org/10.1038/nature06944			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311WV	18454134				2022-12-24	WOS:000256632000046
J	Klass, P				Klass, Perri			The moral of the story	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NYU, New York, NY USA	New York University	Klass, P (corresponding author), NYU, New York, NY USA.								0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 29	2008	358	22					2313	2316		10.1056/NEJMp0802542	http://dx.doi.org/10.1056/NEJMp0802542			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	307GF	18509118				2022-12-24	WOS:000256306700001
J	Osmond, R				Osmond, Ros			First catch your sloth	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Osmond, R (corresponding author), The Lancet, London NW1 7BY, England.							RATTENBORG NC, 2008, BIOL LETT       0515	1	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 24	2008	371	9626					1736	1736		10.1016/S0140-6736(08)60743-6	http://dx.doi.org/10.1016/S0140-6736(08)60743-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	304IO	18502285				2022-12-24	WOS:000256103400011
J	DasGupta, S				DasGupta, Sayantani			The question	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												sd2030@columbia.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2008	299	17					2003	2004		10.1001/jama.299.17.2003	http://dx.doi.org/10.1001/jama.299.17.2003			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296NI	18460654				2022-12-24	WOS:000255552700001
J	Fiore, MC; Jaen, CR				Fiore, Michael C.; Jaen, Carlos Roberto			A clinical blueprint to accelerate the elimination of tobacco use	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SMOKING-CESSATION; HEALTH-CARE		[Fiore, Michael C.] Univ Wisconsin, Ctr Tobacco Res & Intervent, Madison, WI 53706 USA; [Jaen, Carlos Roberto] Univ Texas Hlth Sci Ctr San Antonio, Dept Family & Community Med, San Antonio, TX 78229 USA	University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Health San Antonio	Fiore, MC (corresponding author), Univ Wisconsin, Ctr Tobacco Res & Intervent, 1300 Univ Ave, Madison, WI 53706 USA.	mcf@ctri.medicine.wisc.edu		Jaen, Carlos Roberto/0000-0001-5904-4719				Armour B. S., 2005, Morbidity and Mortality Weekly Report, V54, P625; Bellows NM, 2007, MED CARE, V45, P350, DOI 10.1097/01.mlr.0000254610.90363.dc; Curry SJ, 2006, AM J PREV MED, V31, P269, DOI 10.1016/j.amepre.2006.05.003; Fiore MC, 1996, SMOKING CESSATION CL; Fiore MC, 2008, TREATING TOBACCO USE; FIORE MC, 2000, TREATING TOBACCO USE; Fiore MC, 2007, AM J PREV MED, V33, pS349, DOI 10.1016/j.amepre.2007.09.001; Keller PA, 2005, NICOTINE TOB RES, V7, pS5, DOI 10.1080/14622200500077966; McPhillips-Tangum Carol, 2006, Prev Chronic Dis, V3, pA87; Orleans CT, 2007, AM J PREV MED, V33, pS340, DOI 10.1016/j.amepre.2007.09.003; Rock V. J., 2007, Morbidity and Mortality Weekly Report, V56, P1157; Steinberg MB, 2006, AM J HEALTH BEHAV, V30, P375, DOI 10.5993/AJHB.30.4.4	12	100	101	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2008	299	17					2083	2085		10.1001/jama.299.17.2083	http://dx.doi.org/10.1001/jama.299.17.2083			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296NI	18460668				2022-12-24	WOS:000255552700026
J	Murray, SA; Sheikh, A				Murray, Scott A.; Sheikh, Aziz			Making a difference - Palliative care beyond cancer - Care for all at the end of life	BRITISH MEDICAL JOURNAL			English	Editorial Material							ILLNESS		[Murray, Scott A.; Sheikh, Aziz] Univ Edinburgh, Div Community Hlth Sci, Gen Practice Sect, Primary Palliat Care Res Grp, Edinburgh EH8 9DX, Midlothian, Scotland	University of Edinburgh	Murray, SA (corresponding author), Univ Edinburgh, Div Community Hlth Sci, Gen Practice Sect, Primary Palliat Care Res Grp, Edinburgh EH8 9DX, Midlothian, Scotland.	Scott.Murray@ed.ac.uk	Sheikh, Aziz/D-2818-2009; Ram, Prem/K-4511-2012	Sheikh, Aziz/0000-0001-7022-3056; Harris, Fiona/0000-0003-3258-5624; Grant, Liz/0000-0001-7248-7792				[Anonymous], 2005, PREV CHRON DIS VIT I; Coventry PA, 2005, AGE AGEING, V34, P218, DOI 10.1093/ageing/afi054; Glare PA, 2008, J PALLIAT MED, V11, P84, DOI 10.1089/jpm.2008.9992; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; MATHERS CD, 2006, UPDATED PROJECTIONS; Murray SA, 2005, BRIT MED J, V330, P611, DOI 10.1136/bmj.330.7492.611; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Reisfeld GM, 2007, J PALLIAT MED, V10, P247, DOI 10.1089/jpm.2007.10.247; World Health Organization, 2004, PALL CAR OLD PEOPL; World Health Organization, 2004, PALL CAR SOL FACTS	10	122	125	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 26	2008	336	7650					958	+		10.1136/bmj.39535.491238.94	http://dx.doi.org/10.1136/bmj.39535.491238.94			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296KC	18397942	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000255540900045
J	Stayrook, S; Jaru-Ampornpan, P; Ni, J; Hochschild, A; Lewis, M				Stayrook, Steven; Jaru-Ampornpan, Peera; Ni, Jenny; Hochschild, Ann; Lewis, Mitchell			Crystal structure of the lambda repressor and a model for pairwise cooperative operator binding	NATURE			English	Article							BACTERIOPHAGE-LAMBDA; LEXA; CLEAVAGE; DOMAIN; CRYSTALLOGRAPHY; RECOGNITION; PROTEIN; DIMERS	Bacteriophage lambda has for many years been a model system for understanding mechanisms of gene regulation(1). A 'genetic switch' enables the phage to transition from lysogenic growth to lytic development when triggered by specific environmental conditions. The key component of the switch is the cI repressor, which binds to two sets of three operator sites on the lambda chromosome that are separated by about 2,400 base pairs (bp)(2,3). A hallmark of the lambda system is the pairwise cooperativity of repressor binding(4). In the absence of detailed structural information, it has been difficult to understand fully how repressor molecules establish the cooperativity complex. Here we present the X- ray crystal structure of the intact lambda cI repressor dimer bound to a DNA operator site. The structure of the repressor, determined by multiple isomorphous replacement methods, reveals an unusual overall architecture that allows it to adopt a conformation that appears to facilitate pairwise cooperative binding to adjacent operator sites.	[Stayrook, Steven; Jaru-Ampornpan, Peera; Ni, Jenny; Lewis, Mitchell] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19102 USA; [Hochschild, Ann] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	University of Pennsylvania; Harvard University; Harvard Medical School	Lewis, M (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, 37th & Hamilton Walk, Philadelphia, PA 19102 USA.	lewis@mail.med.upenn.edu		Stayrook, Steven/0000-0002-1677-8293	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044025] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM044025] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bell CE, 2000, CELL, V101, P801, DOI 10.1016/S0092-8674(00)80891-0; Bell CE, 2001, J MOL BIOL, V314, P1127, DOI 10.1006/jmbi.2000.5196; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang G, 1997, ACTA CRYSTALLOGR D, V53, P279, DOI 10.1107/S0907444996014990; Dodd IB, 2001, GENE DEV, V15, P3013, DOI 10.1101/gad.937301; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; JOHNSON AD, 1979, P NATL ACAD SCI USA, V76, P5061, DOI 10.1073/pnas.76.10.5061; JORDAN SR, 1988, SCIENCE, V242, P893, DOI 10.1126/science.3187530; LITTLE JW, 1984, P NATL ACAD SCI-BIOL, V81, P1375, DOI 10.1073/pnas.81.5.1375; Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2; MANIATIS T, 1975, CELL, V5, P109, DOI 10.1016/0092-8674(75)90018-5; MANIATIS T, 1973, P NATL ACAD SCI USA, V70, P1531, DOI 10.1073/pnas.70.5.1531; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PABO CO, 1979, P NATL ACAD SCI USA, V76, P1608, DOI 10.1073/pnas.76.4.1608; PABO CO, 1982, NATURE, V298, P443, DOI 10.1038/298443a0; PTASHNE M, 2004, GENETIC SWITCH; Revet B, 1999, CURR BIOL, V9, P151, DOI 10.1016/S0960-9822(99)80069-4; ROLAND KL, 1992, J MOL BIOL, V228, P395, DOI 10.1016/0022-2836(92)90829-9; SAUER RT, 1982, J BIOL CHEM, V257, P4458; SLILATY SN, 1987, P NATL ACAD SCI USA, V84, P3987, DOI 10.1073/pnas.84.12.3987; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; WHIPPLE FW, 1994, GENE DEV, V8, P1212, DOI 10.1101/gad.8.10.1212; Winn MD, 2003, J SYNCHROTRON RADIAT, V10, P23, DOI 10.1107/S0909049502017235	23	71	73	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2008	452	7190					1022	U12		10.1038/nature06831	http://dx.doi.org/10.1038/nature06831			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291PF	18432246				2022-12-24	WOS:000255208600045
J	Ross, JS; Hill, KP; Egilman, DS; Krumholz, HM				Ross, Joseph S.; Hill, Kevin P.; Egilman, David S.; Krumholz, Harlan M.			Guest authorship and ghostwriting in publications related to rofecoxib - A case study of industry documents from rofecoxib litigation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; UPPER GASTROINTESTINAL TOXICITY; LARGE OUTCOMES TRIALS; DOUBLE-BLIND; COX-2 INHIBITORS; PAIN MANAGEMENT; RHEUMATOID-ARTHRITIS; SAFETY PROFILE; CYCLOOXYGENASE-2 INHIBITORS; SELECTIVE INHIBITORS	Context Authorship in biomedical publication provides recognition and establishes accountability and responsibility. Recent litigation related to rofecoxib provided a unique opportunity to examine guest authorship and ghostwriting, practices that have been suspected in biomedical publication but for which there is little documentation. Objective To characterize different types and the extent of guest authorship and ghostwriting in 1 case study. Data Sources Court documents originally obtained during litigation related to rofecoxib against Merck & Co Inc. Documents were created predominantly between 1996 and 2004. In addition, publicly available articles related to rofecoxib identified via MEDLINE. Data Extraction All documents were reviewed by one author, with selected review by coauthors, using an iterative process of review, discussion, and rereview of documents to identify information related to guest authorship or ghostwriting. Data Synthesis Approximately 250 documents were relevant to our review. For the publication of clinical trials, documents were found describing Merck employees working either independently or in collaboration with medical publishing companies to prepare manuscripts and subsequently recruiting external, academically affiliated investigators to be authors. Recruited authors were frequently placed in the first and second positions of the authorship list. For the publication of scientific review papers, documents were found describing Merck marketing employees developing plans for manuscripts, contracting with medical publishing companies to ghostwrite manuscripts, and recruiting external, academically affiliated investigators to be authors. Recruited authors were commonly the sole author on the manuscript and offered honoraria for their participation. Among 96 relevant published articles, we found that 92% ( 22 of 24) of clinical trial articles published a disclosure of Merck's financial support, but only 50% ( 36 of 72) of review articles published either a disclosure of Merck sponsorship or a disclosure of whether the author had received any financial compensation from the company. Conclusions This case- study review of industry documents demonstrates that clinical trial manuscripts related to rofecoxib were authored by sponsor employees but often attributed first authorship to academically affiliated investigators who did not always disclose industry financial support. Review manuscripts were often prepared by unacknowledged authors and subsequently attributed authorship to academically affiliated investigators who often did not disclose industry financial support.	[Ross, Joseph S.] Mt Sinai Sch Med, Dept Geriatr & Adult Dev, New York, NY 10029 USA; [Hill, Kevin P.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Hill, Kevin P.] McLean Hosp, Belmont, MA 02178 USA; [Egilman, David S.] Brown Univ, Sch Med, Dept Community Hlth, Providence, RI 02912 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Robert Wood Johnson lin Scholars Program, New Haven, CT USA; [Krumholz, Harlan M.] Yale Univ, Sch Publ Hlth, Sect Cardiovasc Med, Dept Med,Sect Hlth Policy & Adm, New Haven, CT USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	Icahn School of Medicine at Mount Sinai; Harvard University; Harvard Medical School; Harvard University; McLean Hospital; Brown University; Yale University; Yale University; Yale University	Ross, JS (corresponding author), Mt Sinai Sch Med, Dept Geriatr & Adult Dev, 1 Gustave L Levy Pl,Box 1070, New York, NY 10029 USA.	joseph.ross@mssm.edu	, Harlan/AAI-2875-2020; Hill, Kevin/GLQ-8874-2022	Ross, Joseph/0000-0002-9218-3320				Aisen PS, 2002, J PAIN SYMPTOM MANAG, V23, pS35, DOI 10.1016/S0885-3924(02)00374-3; Aisen PS, 2002, LANCET NEUROL, V1, P279, DOI 10.1016/S1474-4422(02)00133-3; Anderson SJ, 2006, TOB CONTROL, V15, P254, DOI 10.1136/tc.2005.013854; ARMSTRONG D, ODD GHOSTWRITING OFF; Bell GM, 2001, CLIN GERIATR MED, V17, P489, DOI 10.1016/S0749-0690(05)70082-3; Berenson Alex, 2005, N Y Times Web, pC13; Bingham CO, 2007, RHEUMATOLOGY, V46, P496, DOI 10.1093/rheumatology/kel296; Bingham Clifton O 3rd, 2002, Cleve Clin J Med, V69 Suppl 1, pSI5; Bombardier C, 2006, NEW ENGL J MED, V354, P1196; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bombardier C, 2002, AM J CARDIOL, V89, p3D; Brater DC, 2002, SEMIN ARTHRITIS RHEU, V32, P33, DOI 10.1053/sarh.2002.37216; Brater DC, 2002, J PAIN SYMPTOM MANAG, V23, pS15, DOI 10.1016/S0885-3924(02)00370-6; Brater DC, 2001, AM J NEPHROL, V21, P1, DOI 10.1159/000046212; Breyer MD, 2001, CURR OPIN NEPHROL HY, V10, P89, DOI 10.1097/00041552-200101000-00014; Buttgereit Frank, 2001, American Journal of Medicine, V110, p13S; Campion EW, 2000, NEW ENGL J MED, V343, P1485, DOI 10.1056/NEJM200011163432009; Cannon Grant W., 2001, American Journal of Medicine, V110, p6S; Cannon GW, 2000, ARTHRITIS RHEUM-US, V43, P978, DOI 10.1002/1529-0131(200005)43:5<978::AID-ANR4>3.0.CO;2-0; Cannon GW, 1999, DRUG TODAY, V35, P487, DOI 10.1358/dot.1999.35.7.548261; Cannon GW, 2000, DRUG TODAY, V36, P255, DOI 10.1358/dot.2000.36.4.570204; Catella-Lawson Francesca, 2001, American Journal of Medicine, V110, p28S; Chen HF, 2003, CURR HYPERTENS REP, V5, P87, DOI 10.1007/s11906-003-0016-y; Crofford LJ, 2000, CURR PHARM DESIGN, V6, P1725, DOI 10.2174/1381612003398753; Cronstein BN, 2002, CLEV CLIN J MED, V69, P13, DOI 10.3949/ccjm.69.Suppl_1.SI13; Curfman GD, 2005, NEW ENGL J MED, V353, P2813, DOI 10.1056/NEJMe058314; Day R, 2000, ARCH INTERN MED, V160, P1781, DOI 10.1001/archinte.160.12.1781; Day RO, 2001, CLIN EXP RHEUMATOL, V19, pS59; DeMaria AN, 2003, J PAIN SYMPTOM MANAG, V25, pS41; Ehrich EW, 1999, J RHEUMATOL, V26, P2438; Ehrich EW, 2001, AM J MANAG CARE, V7, P609; Fendrick AM, 2002, CLEV CLIN J MED, V69, P59, DOI 10.3949/ccjm.69.Suppl_1.SI59; Fendrick AM, 2002, AM J MANAG CARE, V8, pS529; Fine PG, 2002, J PAIN, V3, P272, DOI 10.1054/jpai.2002.125957; FitzGerald GA, 2001, NEW ENGL J MED, V345, P433, DOI 10.1056/NEJM200108093450607; Flanagin A, 1998, JAMA-J AM MED ASSOC, V280, P222, DOI 10.1001/jama.280.3.222; Gajraj NM, 2003, ANESTH ANALG, V96, P1720, DOI 10.1213/01.ANE.0000061461.55712.C5; Gajraj NM, 2003, REGION ANESTH PAIN M, V28, P456, DOI 10.1016/j.rapm.2003.09.001; Gajraj Noor M, 2005, Anesthesiol Clin North Am, V23, P49, DOI 10.1016/j.atc.2004.11.011; Garnett WR, 2001, PHARMACOTHERAPY, V21, P1223, DOI 10.1592/phco.21.15.1223.33891; Geba GP, 2002, JAMA-J AM MED ASSOC, V287, P64, DOI 10.1001/jama.287.1.64; Geusens PP, 2002, SCAND J RHEUMATOL, V31, P230, DOI 10.1080/030097402320318431; Gloth FM, 2001, J AM GERIATR SOC, V49, P188, DOI 10.1046/j.1532-5415.2001.49041.x; Gloth FM, 2001, CLIN GERIATR MED, V17, P553, DOI 10.1016/S0749-0690(05)70086-0; Harris CJ, 2001, CURR OPIN NEPHROL HY, V10, P603, DOI 10.1097/00041552-200109000-00009; Harris RC, 2002, AM J CARDIOL, V89, p10D; Harris RC, 2001, AM J PHYSIOL-RENAL, V281, pF1, DOI 10.1152/ajprenal.2001.281.1.F1; Harris RC, 2000, J AM SOC NEPHROL, V11, P2387, DOI 10.1681/ASN.V11122387; Hawkey C, 2000, ARTHRITIS RHEUM-US, V43, P370, DOI 10.1002/1529-0131(200002)43:2<370::AID-ANR17>3.0.CO;2-D; Hawkey CJ, 2003, GUT, V52, P820, DOI 10.1136/gut.52.6.820; Hawkey CJ, 1999, LANCET, V353, P307, DOI 10.1016/S0140-6736(98)12154-2; Hawkey CJ, 2002, GUT, V50, P25; Hawkey CJ, 2001, GASTROENTEROL CLIN N, V30, P921, DOI 10.1016/S0889-8553(05)70220-X; Hawkey CJ, 2001, BEST PRACT RES CL GA, V15, P801, DOI 10.1053/bega.2001.0236; Hawkey CJ, 2001, ALIMENT PHARM THER, V15, P1, DOI 10.1046/j.1365-2036.2001.00894.x; Hawkey CJ, 2001, ALIMENT PHARM THER, V15, P1593, DOI 10.1046/j.1365-2036.2001.01007.x; Hawkey CJ, 2001, CLIN EXP RHEUMATOL, V19, pS23; Healy D, 2003, BRIT J PSYCHIAT, V183, P22, DOI 10.1192/bjp.183.1.22; Hernandez-Diaz Sonia, 2001, American Journal of Medicine, V110, p20S; Hirsch LJ, 2002, SCI ENG ETHICS, V8, P429, DOI 10.1007/s11948-002-0065-7; Hochberg MC, 2002, SEMIN ARTHRITIS RHEU, V32, P4, DOI 10.1053/sarh.2002.37215; Hochberg MC, 2002, AM J MANAG CARE, V8, pS502; Hochberg MC, 2001, CLIN EXP RHEUMATOL, V19, pS15; Hunt RH, 2000, AM J MED, V109, P201, DOI 10.1016/S0002-9343(00)00470-8; Jackson LM, 2000, DRUGS, V59, P1207, DOI 10.2165/00003495-200059060-00001; JOHNSON GE, VIOXX C1 MANUSCRIPT; Katz N, 2003, SPINE, V28, P851, DOI 10.1097/00007632-200305010-00002; Katz N, 2002, SEMIN ARTHRITIS RHEU, V32, P15, DOI 10.1053/sarh.2002.37218; Katz N, 2002, J PAIN SYMPTOM MANAG, V24, pS38, DOI 10.1016/S0885-3924(02)00411-6; Katz WA, 2002, CLEV CLIN J MED, V69, P65; Katz WA, 2002, CURR OPIN RHEUMATOL, V14, P63, DOI 10.1097/00002281-200201000-00012; Kesselheim AS, 2007, JAMA-J AM MED ASSOC, V297, P308, DOI 10.1001/jama.297.3.308; KISTNER U, UPDATE VIOXX MANUSCR; Kivitz AJ, 2004, J AM GERIATR SOC, V52, P666, DOI 10.1111/j.1532-5415.2004.52201.x; Konstam MA, 2002, CLEV CLIN J MED, V69, P47; Krumholz H, 2007, BMJ-BRIT MED J, V334, P120, DOI 10.1136/bmj.39024.487720.68; Kuritzky L, 2003, J PAIN SYMPTOM MANAG, V25, pS6; Laine L, 2003, J PAIN SYMPTOM MANAG, V25, pS32; Laine L, 2002, SEMIN ARTHRITIS RHEU, V32, P25, DOI 10.1053/sarh.2002.37217; Laine L, 2002, J PAIN SYMPTOM MANAG, V23, pS5, DOI 10.1016/S0885-3924(02)00368-8; Lema MJ, 2002, CLEV CLIN J MED, V69, P76; LINES CR, VIOXX PROT 078 PAP; Lipsky Peter E., 2001, American Journal of Medicine, V110, p3S; Lisse JR, 2003, ANN INTERN MED, V139, P539, DOI 10.7326/0003-4819-139-7-200310070-00005; MOAN A, PUBLICATION 901 STUD; Mowatt G, 2002, JAMA-J AM MED ASSOC, V287, P2769, DOI 10.1001/jama.287.21.2769; Myllykangas-Luosujarvi R, 2002, SCAND J RHEUMATOL, V31, P337, DOI 10.1080/030097402320817059; Patrono C, 2001, CLIN EXP RHEUMATOL, V19, pS45; Peloso Paul M., 2001, American Journal of Medicine, V110, p50S; Peura DA, 2002, CLEV CLIN J MED, V69, P31, DOI 10.3949/ccjm.69.Suppl_1.SI31; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Raisz Lawrence G., 2001, American Journal of Medicine, V110, p43S; Reicin A, 2001, Am J Orthop (Belle Mead NJ), V30, P40; Relman AS, 2007, JAMA-J AM MED ASSOC, V298, P2668, DOI 10.1001/jama.298.22.2668; RENNIE D, 1994, JAMA-J AM MED ASSOC, V271, P469, DOI 10.1001/jama.271.6.469; Rennie D, 1997, JAMA-J AM MED ASSOC, V278, P579, DOI 10.1001/jama.278.7.579; Rex DK, 2002, J PAIN SYMPTOM MANAG, V23, pS41, DOI 10.1016/S0885-3924(02)00375-5; Ruoff G, 2003, J PAIN SYMPTOM MANAG, V25, pS21; Ruoff GE, 2002, SEMIN ARTHRITIS RHEU, V32, P43, DOI 10.1053/sarh.2002.37214; Saag K, 2000, ARCH FAM MED, V9, P1124, DOI 10.1001/archfami.9.10.1124; Scheiman JM, 2003, CURR PHARM DESIGN, V9, P2197, DOI 10.2174/1381612033454018; Scheiman JM, 2002, CLEV CLIN J MED, V69, P40; Scheiman JM, 2002, AM J MANAG CARE, V8, pS518; Schnitzer Thomas J., 2001, American Journal of Medicine, V110, p46S, DOI 10.1016/S0002-9343(00)00650-1; Schnitzer TJ, 1999, CLIN THER, V21, P1688, DOI 10.1016/S0149-2918(99)80048-4; Schnitzer TJ, 2005, J RHEUMATOL, V32, P1093; Schnitzer TJ, 2002, CLEV CLIN J MED, V69, P20; Schnitzer TJ, 2002, J PAIN SYMPTOM MANAG, V23, pS24, DOI 10.1016/S0885-3924(02)00372-X; Schnitzer TJ, 2001, CLIN THER, V23, P313, DOI 10.1016/S0149-2918(01)80041-2; Shamoon Mohammed, 2001, American Journal of Medicine, V110, p46S; SHAPIRO DW, 1994, JAMA-J AM MED ASSOC, V271, P438, DOI 10.1001/jama.271.6.438; Sigthorsson G, 2000, GUT, V47, P527, DOI 10.1136/gut.47.4.527; Steinman MA, 2006, ANN INTERN MED, V145, P284, DOI 10.7326/0003-4819-145-4-200608150-00008; Swan SK, 2000, ANN INTERN MED, V133, P1, DOI 10.7326/0003-4819-133-1-200007040-00002; Thal LJ, 2005, NEUROPSYCHOPHARMACOL, V30, P1204, DOI 10.1038/sj.npp.1300690; Truitt KE, 2001, AGING-CLIN EXP RES, V13, P112, DOI 10.1007/BF03351533; Wayne GF, 2002, TOB CONTROL, V11, pI32, DOI 10.1136/tc.11.suppl_1.i32; Weaver AL, 2006, JCR-J CLIN RHEUMATOL, V12, P17, DOI 10.1097/01.rhu.0000200384.79405.33; Weaver AL, 2001, CLIN THER, V23, P1323, DOI 10.1016/S0149-2918(01)80112-0; Weir MR, 2002, CLEV CLIN J MED, V69, P53; Whelton Andrew, 2001, American Journal of Medicine, V110, p33S; Wight NJ, 2001, GASTROENTEROLOGY, V120, P867, DOI 10.1053/gast.2001.22432; World Assoc Med Editors, 2005, J GEN INTERN MED, V20, P549, DOI 10.1111/j.1525-1497.2005.41015x	123	302	303	0	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2008	299	15					1800	1812		10.1001/jama.299.15.1800	http://dx.doi.org/10.1001/jama.299.15.1800			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	287ZA	18413874				2022-12-24	WOS:000254954800024
J	Anvari, M				Anvari, Mehran			Endoscopic treatments for gastro-oesophageal reflux disease	LANCET			English	Editorial Material							ENDOCINCH ENDOLUMINAL GASTROPLICATION; MULTICENTER TRIAL; FOLLOW-UP; GERD; ENTERYX; INJECTION; IMPLANTATION; FAILURE		[Anvari, Mehran] St Josephs Healthcare, Hamilton, ON L8N 4A6, Canada		Anvari, M (corresponding author), St Josephs Healthcare, Hamilton, ON L8N 4A6, Canada.	anvari@mcmaster.ca	Anvari, Mehran/AAQ-1738-2021	Anvari, Mehran/0000-0001-7256-5789				Cohen LB, 2005, GASTROINTEST ENDOSC, V61, P650, DOI 10.1016/S0016-5107(04)02835-4; Fry LC, 2007, EUR J GASTROEN HEPAT, V19, P1125, DOI 10.1097/MEG.0b013e3282f16a21; Houston H, 2003, SURG ENDOSC, V17, P401, DOI 10.1007/s00464-002-8923-6; Johnson DA, 2003, AM J GASTROENTEROL, V98, P250, DOI 10.1016/S0002-9270(02)06013-6; Kahrilas PJ, 2003, GASTROINTEST ENDOSC, V57, P723, DOI 10.1067/mge.2003.203; Noh KW, 2005, AM J GASTROENTEROL, V100, P723, DOI 10.1111/j.1572-0241.2005.41293.x; Pleskow D, 2004, GASTROINTEST ENDOSC, V59, P163, DOI 10.1016/S0016-5107(03)02542-2; Schiefke I, 2005, GUT, V54, P752, DOI 10.1136/gut.2004.058354; Schiefke I, 2005, ENDOSCOPY, V37, P700, DOI 10.1055/s-2005-870128; Tintillier M, 2004, AM J GASTROENTEROL, V99, P1856, DOI 10.1111/j.1572-0241.2004.40554.x; Tuebergen D, 2004, ENDOSCOPY, V36, P663, DOI 10.1055/s-2004-814526; Wong RF, 2005, GASTROINTEST ENDOSC, V61, P753, DOI 10.1016/S0016-5107(04)02645-8	12	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 22	2008	371	9617					965	966		10.1016/S0140-6736(08)60430-4	http://dx.doi.org/10.1016/S0140-6736(08)60430-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277IN	18358911				2022-12-24	WOS:000254206000006
J	Fuller, BG; Lampson, MA; Foley, EA; Rosasco-Nitcher, S; Le, KV; Tobelmann, P; Brautigan, DL; Stukenberg, PT; Kapoor, TM				Fuller, Brian G.; Lampson, Michael A.; Foley, Emily A.; Rosasco-Nitcher, Sara; Le, Kim V.; Tobelmann, Page; Brautigan, David L.; Stukenberg, P. Todd; Kapoor, Tarun M.			Midzone activation of aurora B in anaphase produces an intracellular phosphorylation gradient	NATURE			English	Article							IN-SITU; SPINDLE; MICROTUBULES; CYTOKINESIS; CLEAVAGE; REVEALS	Proper partitioning of the contents of a cell between two daughters requires integration of spatial and temporal cues. The anaphase array of microtubules that self-organize at the spindle midzone contributes to positioning the cell-division plane midway between the segregating chromosomes(1). How this signalling occurs over length scales of micrometres, from the midzone to the cell cortex, is not known. Here we examine the anaphase dynamics of protein phosphorylation by aurora B kinase, a key mitotic regulator, using fluorescence resonance energy transfer (FRET)-based sensors in living HeLa cells and immunofluorescence of native aurora B substrates. Quantitative analysis of phosphorylation dynamics, using chromosome- and centromere-targeted sensors, reveals that changes are due primarily to position along the division axis rather than time. These dynamics result in the formation of a spatial phosphorylation gradient early in anaphase that is centred at the spindle midzone. This gradient depends on aurora B targeting to a subpopulation of microtubules that activate it. Aurora kinase activity organizes the targeted microtubules to generate a structure-based feedback loop. We propose that feedback between aurora B kinase activation and midzone microtubules generates a gradient of post-translational marks that provides spatial information for events in anaphase and cytokinesis.	[Fuller, Brian G.; Rosasco-Nitcher, Sara; Tobelmann, Page; Stukenberg, P. Todd] Univ Virginia, Sch Med, Dept Biochem, Charlottesville, VA 22908 USA; [Fuller, Brian G.; Rosasco-Nitcher, Sara; Tobelmann, Page; Stukenberg, P. Todd] Univ Virginia, Sch Med, Dept Mol Genet, Charlottesville, VA 22908 USA; [Lampson, Michael A.; Le, Kim V.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Foley, Emily A.; Kapoor, Tarun M.] Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10021 USA; [Brautigan, David L.] Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Pennsylvania; Rockefeller University; University of Virginia	Stukenberg, PT (corresponding author), Univ Virginia, Sch Med, Dept Biochem, Charlottesville, VA 22908 USA.	lampson@sas.upenn.edu; pts7h@virginia.edu		Stukenberg, Todd/0000-0002-6788-2111	NIGMS NIH HHS [R01 GM065933, R01 GM065933-06, R01 GM083988-01, R01 GM063045-08, R01 GM063045, R01 GM083988] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063045, R01GM065933, R01GM083988] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alsop GB, 2004, J CELL SCI, V117, P1591, DOI 10.1242/jcs.01007; Bement WM, 2005, J CELL BIOL, V170, P91, DOI 10.1083/jcb.200501131; Bishop JD, 2002, J BIOL CHEM, V277, P27577, DOI 10.1074/jbc.C200307200; Canman JC, 2003, NATURE, V424, P1074, DOI 10.1038/nature01860; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.0.CO;2-Z; Murata-Hori M, 2002, MOL BIOL CELL, V13, P1099, DOI 10.1091/mbc.01-09-0467; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Peters U, 2006, NAT CHEM BIOL, V2, P618, DOI 10.1038/nchembio826; Rappaport R., 1996, CYTOKINESIS ANIMAL C; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Shelby RD, 1996, J CELL BIOL, V135, P545, DOI 10.1083/jcb.135.3.545; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; SU TT, 1998, GENE DEV, V21, P495; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Wheatley SP, 1996, J CELL BIOL, V135, P981, DOI 10.1083/jcb.135.4.981; Wheatley SP, 1997, J CELL BIOL, V138, P385, DOI 10.1083/jcb.138.2.385; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200; Zeitlin SG, 2001, J CELL SCI, V114, P653	27	271	273	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2008	453	7198					1132	U14		10.1038/nature06923	http://dx.doi.org/10.1038/nature06923			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18463638	Green Accepted			2022-12-24	WOS:000256839900063
J	Ayoub, N; Jeyasekharan, AD; Bernal, JA; Venkitaraman, AR				Ayoub, Nabieh; Jeyasekharan, Anand D.; Bernal, Juan A.; Venkitaraman, Ashok R.			HP1-beta mobilization promotes chromatin changes that initiate the DNA damage response	NATURE			English	Article							PROTEIN-KINASE CK2; DOUBLE-STRAND BREAKS; HETEROCHROMATIN PROTEIN-1; MAMMALIAN-CELLS; HISTONE H2AX; PHOSPHORYLATION; HP1; DYNAMICS; ATM; MOBILITY	Minutes after DNA damage, the variant histone H2AX is phosphorylated by protein kinases of the phosphoinositide kinase family, including ATM, ATR or DNA- PK1. Phosphorylated (gamma)-H2AX - which recruits molecules that sense or signal the presence of DNA breaks, activating the response that leads to repair(2,3) - is the earliest known marker of chromosomal DNA breakage. Here we identify a dynamic change in chromatin that promotes H2AX phosphorylation in mammalian cells. DNA breaks swiftly mobilize heterochromatin protein 1 (HP1)-beta ( also called CBX1), a chromatin factor bound to histone H3 methylated on lysine 9 ( H3K9me). Local changes in histone- tail modifications are not apparent. Instead, phosphorylation of HP1-beta on amino acid Thr 51 accompanies mobilization, releasing HP1-beta from chromatin by disrupting hydrogen bonds that fold its chromodomain around H3K9me. Inhibition of casein kinase 2 ( CK2), an enzyme implicated in DNA damage sensing and repair(4-6), suppresses Thr 51 phosphorylation and HP1-beta mobilization in living cells. CK2 inhibition, or a constitutively chromatin- bound HP1-beta mutant, diminishes H2AX phosphorylation. Our findings reveal an unrecognized signalling cascade that helps to initiate the DNA damage response, altering chromatin by modifying a histone- code mediator protein, HP1, but not the code itself.	[Ayoub, Nabieh; Jeyasekharan, Anand D.; Bernal, Juan A.; Venkitaraman, Ashok R.] Hutchison MRC Res Ctr, Med Res Council Canc Cell Unit, Cambridge CB2 0XZ, England		Venkitaraman, AR (corresponding author), Hutchison MRC Res Ctr, Med Res Council Canc Cell Unit, Hills Rd, Cambridge CB2 0XZ, England.	arv22@cam.ac.uk	Jeyasekharan, Anand/O-3398-2019; Bernal, Juan A/N-4544-2014; Ayoub, Nabieh/AFK-5616-2022; Ayoub, Nabieh/AAG-4076-2022	Bernal, Juan A/0000-0002-9933-5550; Ayoub, Nabieh/0000-0002-9549-9929; Jeyasekharan, Anand/0000-0001-9816-6137	MRC [G0700651, G0600332, MC_U105359877, G9900064] Funding Source: UKRI; Medical Research Council [G0600332, G9900064, MC_U105359877, G0700651] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allende-Vega N, 2005, MOL CELL BIOCHEM, V274, P85, DOI 10.1007/s11010-005-3074-4; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Canton DA, 2001, BIOCHEM J, V358, P87, DOI 10.1042/0264-6021:3580087; Cheung WL, 2005, CURR BIOL, V15, P656, DOI 10.1016/j.cub.2005.02.049; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; Daniels MJ, 2004, NAT STRUCT MOL BIOL, V11, P1114, DOI 10.1038/nsmb837; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Festenstein R, 2003, SCIENCE, V299, P719, DOI 10.1126/science.1078694; Formby B, 1998, MOL CELL BIOCHEM, V187, P23, DOI 10.1023/A:1006865721693; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Lowndes NF, 2005, CURR BIOL, V15, pR99, DOI 10.1016/j.cub.2005.01.029; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Ruzzene M, 2002, BIOCHEM J, V364, P41, DOI 10.1042/bj3640041; Schmiedeberg L, 2004, MOL BIOL CELL, V15, P2819, DOI 10.1091/mbc.E03-11-0827; Zhao T, 1999, J BIOL CHEM, V274, P15095, DOI 10.1074/jbc.274.21.15095; Zhao T, 2001, J BIOL CHEM, V276, P9512, DOI 10.1074/jbc.M010098200; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	26	327	337	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2008	453	7195					682	U14		10.1038/nature06875	http://dx.doi.org/10.1038/nature06875			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305NN	18438399				2022-12-24	WOS:000256185200050
J	Metcalfe, S; Burgess, C; Laking, G; Evans, J; Wells, S; Crausaz, S				Metcalfe, Scott; Burgess, Carl; Laking, George; Evans, Jackie; Wells, Susan; Crausaz, Steffan			Trastuzumab: possible publication bias	LANCET			English	Editorial Material							BREAST-CANCER; ADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIALS; DOXORUBICIN; PACLITAXEL; THERAPY		[Metcalfe, Scott; Evans, Jackie; Crausaz, Steffan] Pharmaceut Management Agcy PHARMAC, Wellington 6143, New Zealand; [Burgess, Carl] Univ Otago, Wellington Sch Med & Hlth Sci, Wellington, New Zealand; [Laking, George] Auckland Dist Hlth Board, Dept Med Oncol, Reg Canc & Blood Serv, Auckland, New Zealand; [Wells, Susan] Univ Auckland, Epidemiol & Biostat Sect, Sch Populat Hlth, Auckland 1, New Zealand	University of Otago; Auckland District Health Board; University of Auckland	Metcalfe, S (corresponding author), Pharmaceut Management Agcy PHARMAC, Wellington 6143, New Zealand.	scott.metcalfe@pharmac.govt.nz		Laking, George/0000-0002-7749-8922				[Anonymous], 2005, LANCET, V366, P1673; *FOOD DRUG ADM, 103792 FDA BLA; Geddes John, 2004, Evid Based Ment Health, V7, P98; Hind D, 2007, LANCET, V369, P3, DOI 10.1016/S0140-6736(07)60004-X; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Krzyzanowska MK, 2003, JAMA-J AM MED ASSOC, V290, P495, DOI 10.1001/jama.290.4.495; Metcalfe Scott, 2007, N Z Med J, V120, pU2593; Perez EA, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2006.09.3849; PEREZ EA, 2005, 45 ANN M AM SOC CLIN; Perez EA, 2008, J CLIN ONCOL, V26, P1231, DOI 10.1200/JCO.2007.13.5467; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Schulz KF, 2005, LANCET, V365, P1348, DOI 10.1016/S0140-6736(05)61034-3; SLEDGE GW, 2005, 45 ANN M AM SOC CLIN; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Spielmann M, 2007, SAN ANT BREAST CANC; Tan-Chiu E, 2005, J CLIN ONCOL, V23, P7811, DOI 10.1200/JCO.2005.02.4091	17	8	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 17	2008	371	9625					1646	1648		10.1016/S0140-6736(08)60706-0	http://dx.doi.org/10.1016/S0140-6736(08)60706-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302XB	18486728				2022-12-24	WOS:000256002200008
J	Ho, DD; Bieniasz, PD				Ho, David D.; Bieniasz, Paul D.			HIV-1 at 25	CELL			English	Article							INFECTION; RECEPTOR; PROTEIN; VIRUS; GENE; LYMPHOCYTES; RETROVIRUS; TURNOVER; PLASMA; AIDS		[Ho, David D.; Bieniasz, Paul D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA	Rockefeller University	Ho, DD (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA.	dho@adarc.org						BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mohri H, 2001, J EXP MED, V194, P1277, DOI 10.1084/jem.194.9.1277; MUESING MA, 2008, NATURE, V451, P425; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; POPOVIC M, 1984, SCIENCE, V224, P500; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0	20	22	25	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 16	2008	133	4					561	565		10.1016/j.cell.2008.05.003	http://dx.doi.org/10.1016/j.cell.2008.05.003			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485860	Bronze			2022-12-24	WOS:000255903300007
J	Kim, AY; Tang, ZX; Liu, Q; Patel, KN; Maag, D; Geng, YX; Dong, XZ				Kim, Andrew Y.; Tang, Zongxiang; Liu, Qin; Patel, Kush N.; Maag, David; Geng, Yixun; Dong, Xinzhong			Pirt, a phosphoinositide-binding protein, functions as a regulatory subunit of TRPV1	CELL			English	Article							CAPSAICIN RECEPTOR; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; ION-CHANNEL; TRPA1; DESENSITIZATION; SENSITIVITY; NOCICEPTION; MODULATION; ACTIVATION; DOMAIN	Transient receptor potential vanilloid 1 (TRPV1) is a molecular sensor of noxious heat and capsaicin. Its channel activity can be modulated by several mechanisms. Here we identify a membrane protein, Pirt, as a regulator of TRPV1. Pirt is expressed in most nociceptive neurons in the dorsal root ganglia (DRG) including TRPV1-positive cells. Pirt null mice show impaired responsiveness to noxious heat and capsaicin. Noxious heat- and capsaicin-sensitive currents in Pirt-deficient DRG neurons are significantly attenuated. Heterologous expression of Pirt strongly enhances TRPV1-mediated currents. Furthermore, the C terminus of Pirt binds to TRPV1 and several phosphoinositides, including phosphatidylinositol-4,5-bisphosphate (PIP(2)), and can potentiate TRPV1. The PIP(2) binding is dependent on the cluster of basic residues in the Pirt C terminus and is crucial for Pirt regulation of TRPV1. Importantly, the enhancement of TRPV1 by PIP(2) requires Pirt. Therefore, Pirt is a key component of the TRPV1 complex and positively regulates TRPV1 activity.	[Kim, Andrew Y.; Tang, Zongxiang; Liu, Qin; Patel, Kush N.; Maag, David; Geng, Yixun; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Dong, XZ (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	xdong2@jhmi.edu			NEI NIH HHS [T32 EY017203] Funding Source: Medline; NINDS NIH HHS [R01 NS054791-01A1, R01 NS054791-02, R01 NS054791, NS054791, R01 NS054791-03, R01 NS054791-04] Funding Source: Medline; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054791] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, CURR OPIN NEUROBIOL, V9, P525, DOI 10.1016/S0959-4388(99)00009-4; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; DHAKA A, 2007, CELL, V106, P619; Guler AD, 2002, J NEUROSCI, V22, P6408; Hardie RC, 2007, J PHYSIOL-LONDON, V578, P9, DOI 10.1113/jphysiol.2006.118372; Hill K, 2007, J BIOL CHEM, V282, P7145, DOI 10.1074/jbc.M609600200; Huang JJ, 2006, SEMIN CELL DEV BIOL, V17, P638, DOI 10.1016/j.semcdb.2006.11.002; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Lo LC, 2002, DEVELOPMENT, V129, P1553; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; MONTELL C, 2005, SCI STKE, P272; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Scott SA, 1992, SENSORY NEURONS DIVE; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tsai RYL, 1997, BIOTECHNIQUES, V23, P794, DOI 10.2144/97235bm06; Voets T, 2007, J PHYSIOL-LONDON, V582, P939, DOI 10.1113/jphysiol.2007.132522; Wang JY, 2001, J BIOL CHEM, V276, P5012, DOI 10.1074/jbc.M008355200	27	134	137	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 2	2008	133	3					475	485		10.1016/j.cell.2008.02.053	http://dx.doi.org/10.1016/j.cell.2008.02.053			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455988	Green Accepted, Bronze			2022-12-24	WOS:000255503900018
J	Paul, R; Jaeger, T; Abel, S; Wiederkehr, I; Folcher, M; Biondi, EG; Laub, MT; Jenal, U				Paul, Ralf; Jaeger, Tina; Abel, Soeren; Wiederkehr, Irene; Folcher, Marc; Biondi, Emanuele G.; Laub, Michael T.; Jenal, Urs			Allosteric regulation of histidine kinases by their cognate response regulator determines cell fate	CELL			English	Article							2-COMPONENT SIGNAL-TRANSDUCTION; CAULOBACTER-CRESCENTUS; DYNAMIC LOCALIZATION; CYCLE PROGRESSION; TYROSINE KINASE; PROTEIN-KINASE; DIFFERENTIATION; DIVISION; PHOSPHORYLATION; MORPHOGENESIS	The two-component phosphorylation network is of critical importance for bacterial growth and physiology. Here, we address plasticity and interconnection of distinct signal transduction pathways within this network. In Caulobacter crescentus antagonistic activities of the PleC phosphatase and DivJ kinase localized at opposite cell poles control the phosphorylation state and subcellular localization of the cell fate determinator protein DivK. We show that DivK functions as an allosteric regulator that switches PleC from a phosphatase into an autokinase state and thereby mediates a cyclic di-GMP-dependent morphogenetic program. Through allosteric activation of the DivJ autokinase, DivK also stimulates its own phosphorylation and polar localization. These data suggest that DivK is the central effector of an integrated circuit that operates via spatially organized feedback loops to control asymmetry and cell fate determination in C. crescentus. Thus, single domain response regulators can facilitate crosstalk, feedback control, and long-range communication among members of the two-component network.	[Paul, Ralf; Jaeger, Tina; Abel, Soeren; Wiederkehr, Irene; Folcher, Marc; Jenal, Urs] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Biondi, Emanuele G.; Laub, Michael T.] MIT, Dept Biol, Cambridge, MA 02139 USA	University of Basel; Massachusetts Institute of Technology (MIT)	Jenal, U (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.	urs.jenal@unibas.ch		Abel, Soren/0000-0002-4041-6989; Laub, Michael/0000-0002-8288-7607	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082899] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM082899, R01 GM082899-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aldridge P, 1999, MOL MICROBIOL, V32, P379, DOI 10.1046/j.1365-2958.1999.01358.x; Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x; BETSCHINGER J, 2004, NATURE, V444, P899; Crymes WB, 1999, J BACTERIOL, V181, P3967, DOI 10.1128/JB.181.13.3967-3973.1999; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; ELY B, 1991, METHOD ENZYMOL, V204, P372; HECHT GB, 1995, EMBO J, V14, P3915, DOI 10.1002/j.1460-2075.1995.tb00063.x; Hung DY, 2002, P NATL ACAD SCI USA, V99, P13160, DOI 10.1073/pnas.202495099; Jacobs C, 2001, P NATL ACAD SCI USA, V98, P4095, DOI 10.1073/pnas.051609998; Jenal U, 1996, EMBO J, V15, P2393, DOI 10.1002/j.1460-2075.1996.tb00597.x; Lam H, 2003, DEV CELL, V5, P149, DOI 10.1016/S1534-5807(03)00191-6; Levi A, 2006, J BACTERIOL, V188, P5315, DOI 10.1128/JB.01725-05; Matroule JY, 2004, CELL, V118, P579, DOI 10.1016/j.cell.2004.08.019; McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694; Ohta N, 2003, J BACTERIOL, V185, P4424, DOI 10.1128/JB.185.15.4424-4431.2003; OHTA N, 1992, P NATL ACAD SCI USA, V89, P10297, DOI 10.1073/pnas.89.21.10297; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Paul R, 2007, J BIOL CHEM, V282, P29170, DOI 10.1074/jbc.M704702200; Quon KC, 1998, P NATL ACAD SCI USA, V95, P120, DOI 10.1073/pnas.95.1.120; Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2; Radhakrishnan SK, 2008, GENE DEV, V22, P212, DOI 10.1101/gad.1601808; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; Sciochetti SA, 2005, MOL MICROBIOL, V56, P1467, DOI 10.1111/j.1365-2958.2005.04652.x; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; SOMMER JM, 1991, GENETICS, V129, P623; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Viollier PH, 2002, P NATL ACAD SCI USA, V99, P13831, DOI 10.1073/pnas.182411999; WANG SP, 1993, P NATL ACAD SCI USA, V90, P630, DOI 10.1073/pnas.90.2.630; Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2; Wu JG, 1999, P NATL ACAD SCI USA, V96, P13068, DOI 10.1073/pnas.96.23.13068; Wu JG, 1998, P NATL ACAD SCI USA, V95, P1443, DOI 10.1073/pnas.95.4.1443; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Zapf J, 2000, STRUCTURE, V8, P851, DOI 10.1016/S0969-2126(00)00174-X	35	117	121	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2008	133	3					452	461		10.1016/j.cell.2008.02.045	http://dx.doi.org/10.1016/j.cell.2008.02.045			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455986	Green Accepted, Bronze			2022-12-24	WOS:000255503900016
J	Marcucci, G; Radmacher, MD; Maharry, K; Mrozek, K; Ruppert, AS; Paschka, P; Vukosavljevic, T; Whitman, SP; Baldus, CD; Langer, C; Liu, CG; Carroll, AJ; Powell, BL; Garzon, R; Croce, CM; Kolitz, JE; Caligiuri, MA; Larson, RA; Bloomfield, CD				Marcucci, Guido; Radmacher, Michael D.; Maharry, Kati; Mrozek, Krzysztof; Ruppert, Amy S.; Paschka, Peter; Vukosavljevic, Tamara; Whitman, Susan P.; Baldus, Claudia D.; Langer, Christian; Liu, Chang-Gong; Carroll, Andrew J.; Powell, Bayard L.; Garzon, Ramiro; Croce, Carlo M.; Kolitz, Jonathan E.; Caligiuri, Michael A.; Larson, Richard A.; Bloomfield, Clara D.			MicroRNA expression in cytogenetically normal acute myeloid leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYELOGENOUS LEUKEMIA; BLOCKS INTERLEUKIN-1-BETA-INDUCED ACTIVATION; ETS-RELATED GENE; NF-KAPPA-B; INHIBITS PROLIFERATION; NORMAL KARYOTYPE; CANCER; ADULT; CELLS; PROGNOSIS	Background: A role of microRNAs in cancer has recently been recognized. However, little is known about the role of microRNAs in acute myeloid leukemia (AML). Methods: Using microRNA expression profiling, we studied samples of leukemia cells from adults under the age of 60 years who had cytogenetically normal AML and high-risk molecular features - that is, an internal tandem duplication in the fms-related tyrosine kinase 3 gene (FLT3-ITD), a wild-type nucleophosmin (NPM1), or both. A microRNA signature that was associated with event-free survival was derived from a training group of 64 patients and tested in a validation group of 55 patients. For the latter, a microRNA compound covariate predictor (called a microRNA summary value) was computed on the basis of weighted levels of the microRNAs forming the outcome signature. Results: Of 305 microRNA probes, 12 (including 5 representing microRNA-181 family members) were associated with event-free survival in the training group (P<0.005). In the validation group, the microRNA summary value was inversely associated with event-free survival (P=0.03). In multivariable analysis, the microRNA summary value remained associated with event-free survival (P=0.04) after adjustment for the allelic ratio of FLT3-ITD to wild-type FLT3 and for the white-cell count. Using results of gene-expression microarray analysis, we found that expression levels of the microRNA-181 family were inversely correlated with expression levels of predicted target genes encoding proteins involved in pathways of innate immunity mediated by toll-like receptors and interleukin-1 beta. Conclusions: A microRNA signature in molecularly defined, high-risk, cytogenetically normal AML is associated with the clinical outcome and with target genes encoding proteins involved in specific innate-immunity pathways.	[Marcucci, Guido; Radmacher, Michael D.; Maharry, Kati; Mrozek, Krzysztof; Ruppert, Amy S.; Paschka, Peter; Vukosavljevic, Tamara; Whitman, Susan P.; Langer, Christian; Liu, Chang-Gong; Garzon, Ramiro; Croce, Carlo M.; Caligiuri, Michael A.; Bloomfield, Clara D.] Ohio State Univ, Ctr Comprehens Canc, Div Hematol & Oncol, Columbus, OH 43210 USA; [Radmacher, Michael D.; Maharry, Kati; Ruppert, Amy S.] Duke Univ, Med Ctr, Ctr Stat, Canc & Leukemia Grp B, Durham, NC USA; [Baldus, Claudia D.] Charite Univ Med Berlin, Berlin, Germany; [Carroll, Andrew J.] Univ Alabama, Birmingham, AL USA; [Powell, Bayard L.] Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USA; [Kolitz, Jonathan E.] N Shore Univ Hosp, Manhasset, NY USA; [Larson, Richard A.] Univ Chicago, Chicago, IL 60637 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Duke University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Alabama System; University of Alabama Birmingham; Wake Forest University; Northwell Health; North Shore University Hospital; University of Chicago	Marcucci, G (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Div Hematol & Oncol, Suite A434,Starling Loving Hall,320 W 10th Ave, Columbus, OH 43210 USA.	guido.marcucci@osumc.edu	Young, Richard A/F-6495-2012; Mrózek, Krzysztof/A-3142-2008; Garzon, Ramiro/E-3104-2011; Larson, Richard A./AAE-7223-2019	Young, Richard A/0000-0001-8855-8647; Larson, Richard A./0000-0001-9168-3203	NCI NIH HHS [U10 CA035279, U10 CA101140, CA31946, CA35279, CA03927, CA114725, CA16058, CA33601, CA102031, CA101140, UG1 CA189850, P30 CA016058, CA41287, CA77658, U10 CA003927, U10 CA077658] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U24CA114725, UG1CA189850, U10CA033601, U10CA031946, U10CA077658, U10CA035279, U10CA101140, U10CA003927, U10CA041287, P30CA016058, R01CA102031] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Awomoyi AA, 2007, FEMS IMMUNOL MED MIC, V49, P324, DOI 10.1111/j.1574-695X.2007.00231.x; Baldus CD, 2003, BLOOD, V102, P1613, DOI 10.1182/blood-2003-02-0359; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Calin GA, 2006, NEW ENGL J MED, V355, P533; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Debernardi S, 2007, LEUKEMIA, V21, P912, DOI 10.1038/sj.leu.2404605; Dohner K, 2005, BLOOD, V106, P3740, DOI 10.1182/blood-2005-05-2164; Estrov Z, 1999, BLOOD, V94, P2844, DOI 10.1182/blood.V94.8.2844.420k43_2844_2853; Estrov Z, 2003, BLOOD, V102, P987, DOI 10.1182/blood-2002-11-3550; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Kobayashi R, 2007, CLIN IMMUNOL, V125, P149, DOI 10.1016/j.clim.2007.07.008; Kobayashi Y, 2000, J PATHOL, V192, P263; Kolitz JE, 2004, J CLIN ONCOL, V22, P4290, DOI 10.1200/JCO.2004.11.106; Kolitz JE, 2005, BLOOD, V106, p122A; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Marcucci G, 2005, J CLIN ONCOL, V23, P9234, DOI 10.1200/JCO.2005.03.6137; Marcucci G, 2007, J CLIN ONCOL, V25, P3337, DOI 10.1200/JCO.2007.10.8720; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Mrozek K, 2004, BLOOD REV, V18, P115, DOI 10.1016/S0268-960X(03)00040-7; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; Radmacher MD, 2002, J COMPUT BIOL, V9, P505, DOI 10.1089/106652702760138592; Radmacher MD, 2006, BLOOD, V108, P1677, DOI 10.1182/blood-2006-02-005538; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Turzanski J, 2004, LEUKEMIA, V18, P1662, DOI 10.1038/sj.leu.2403457; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	34	361	407	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2008	358	18					1919	1928		10.1056/NEJMoa074256	http://dx.doi.org/10.1056/NEJMoa074256			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294ER	18450603				2022-12-24	WOS:000255387900006
J	Marvier, M; Carriere, Y; Ellstrand, N; Gepts, P; Kareiva, P; Rosi-Marshall, E; Tabashnik, BE; Wolfenbarger, LL				Marvier, Michelle; Carriere, Yves; Ellstrand, Norman; Gepts, Paul; Kareiva, Peter; Rosi-Marshall, Emma; Tabashnik, Bruce E.; Wolfenbarger, L. LaReesa			Ecology - Harvesting data from genetically engineered crops	SCIENCE			English	Editorial Material							TRANSGENIC CROPS; COTTON		[Marvier, Michelle; Kareiva, Peter] Santa Clara Univ, Inst Environm Studies, Santa Clara, CA 95053 USA; [Carriere, Yves; Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Ellstrand, Norman] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Gepts, Paul] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Kareiva, Peter] Nature Conservancy, Seattle, WA 98105 USA; [Rosi-Marshall, Emma] Loyola Univ, Dept Biol, Chicago, IL 60626 USA; [Wolfenbarger, L. LaReesa] Univ Nebraska, Dept Biol, Omaha, NE 68182 USA	Santa Clara University; University of Arizona; University of California System; University of California Riverside; University of California System; University of California Davis; Nature Conservancy; Loyola University Chicago; University of Nebraska System	Marvier, M (corresponding author), Santa Clara Univ, Inst Environm Studies, Santa Clara, CA 95053 USA.	mmarvier@scu.edu	Gepts, Paul/O-8229-2019; Ellstrand, Norman/F-7665-2011; Rosi-Marshall, Emma J/F-1777-2011	Gepts, Paul/0000-0002-1056-4665; Rosi-Marshall, Emma J/0000-0002-3476-6368; Marvier, Michelle/0000-0001-8360-9265				Bradford KJ, 2005, NAT BIOTECHNOL, V23, P439, DOI 10.1038/nbt1084; *CAL DEP PEST REG, 2000, OV CAL UN FULL REP S; Carriere Y, 2005, PEST MANAG SCI, V61, P327, DOI 10.1002/ps.1039; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Cattaneo MG, 2006, P NATL ACAD SCI USA, V103, P7571, DOI 10.1073/pnas.0508312103; *EPA, 1998, EPA PUBL; *EPA, 2007, EPAS REP ENV ROE SCI; Ervin DE, 2003, AGR ECOSYST ENVIRON, V99, P1, DOI 10.1016/S0167-8809(03)00145-2; FOURNIER A, 2007, COTTON COLL AGR REP, V151, P155; *NASS, 2007, ACR DAT; Siegfried Blair D., 2007, American Entomologist, V53, P208; *USDA ERS, 2002, AER810 USDA ERS	12	15	17	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					452	453		10.1126/science.1154521	http://dx.doi.org/10.1126/science.1154521			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436759				2022-12-24	WOS:000255249300020
J	Brearley, S; Johnson, JN				Brearley, Stephen; Johnson, James N.			Should we screen for abdominal aortic aneurysm?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Brearley, Stephen] Whipps Cross Univ Hosp, London E11 1NR, England; [Johnson, James N.] Halton Gen Hosp, Runcorn WA7 2DA, Cheshire, England	University of London; Queen Mary University London	Brearley, S (corresponding author), Whipps Cross Univ Hosp, London E11 1NR, England.	vascusurg@btconnect.com; jnjohnson33@hotmail.com							0	8	9	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2008	336	7649					862	863		10.1136/bmj.39517.443796.AD	http://dx.doi.org/10.1136/bmj.39517.443796.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290QH	18420691	Green Published			2022-12-24	WOS:000255136800030
J	Chereau, D; Boczkowska, M; Skwarek-Maruszewska, A; Fujiwara, I; Hayes, DB; Rebowski, G; Lappalainen, P; Pollard, TD; Dominguez, R				Chereau, David; Boczkowska, Malgorzata; Skwarek-Maruszewska, Aneta; Fujiwara, Ikuko; Hayes, David B.; Rebowski, Grzegorz; Lappalainen, Pekka; Pollard, Thomas D.; Dominguez, Roberto			Leiomodin is an actin filament nucleator in muscle cells	SCIENCE			English	Article							ARP2/3 COMPLEX; TROPOMODULIN; END	Initiation of actin polymerization in cells requires nucleation factors. Here we describe an actin-binding protein, leiomodin, that acted as a strong filament nucleator in muscle cells. Leiomodin shared two actin-binding sites with the filament pointed end-capping protein tropomodulin: a flexible N-terminal region and a leucine-rich repeat domain. Leiomodin also contained a C-terminal extension of 150 residues. The smallest fragment with strong nucleation activity included the leucine-rich repeat and C-terminal extension. The N-terminal region enhanced the nucleation activity threefold and recruited tropomyosin, which weakly stimulated nucleation and mediated localization of leiomodin to the middle of muscle sarcomeres. Knocking down leiomodin severely compromised sarcomere assembly in cultured muscle cells, which suggests a role for leiomodin in the nucleation of tropomyosin-decorated filaments in muscles.	[Boczkowska, Malgorzata; Rebowski, Grzegorz; Dominguez, Roberto] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Chereau, David; Hayes, David B.] Boston Biomed Res Inst, Watertown, MA 02472 USA; [Skwarek-Maruszewska, Aneta; Lappalainen, Pekka] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Fujiwara, Ikuko; Pollard, Thomas D.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	University of Pennsylvania; Boston Biomedical Research Institute; University of Helsinki; Yale University	Dominguez, R (corresponding author), Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA.	droberto@mail.med.upenn.edu	Fujiwara, Ikuko/H-5717-2016; Hayes, David B/CAH-1880-2022	Fujiwara, Ikuko/0000-0002-9361-636X; Hayes, David B/0000-0002-1133-3471; Lappalainen, Pekka/0000-0001-6227-0354	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL086655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073791, R01GM026338] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL086655, HL086655, P01 HL086655-01A10004] Funding Source: Medline; NIGMS NIH HHS [R01 GM073791-04, R01 GM073791, GM073791, GM026338] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Clarkson E, 2004, J PATHOL, V204, P407, DOI 10.1002/path.1648; Conley CA, 2001, GENOMICS, V73, P127, DOI 10.1006/geno.2000.6501; Fischer RS, 2003, TRENDS CELL BIOL, V13, P593, DOI 10.1016/j.tcb.2003.09.007; Fowler VM, 2003, J BIOL CHEM, V278, P40000, DOI 10.1074/jbc.M306895200; HITCHCOCKDEGREGORI SE, 1988, BIOCHEMISTRY-US, V27, P9182, DOI 10.1021/bi00426a016; Kostyukova AS, 2007, J MOL BIOL, V372, P608, DOI 10.1016/j.jmb.2007.05.084; Krieger I, 2002, BIOPHYS J, V83, P2716, DOI 10.1016/S0006-3495(02)75281-8; Mahaffy RE, 2006, BIOPHYS J, V91, P3519, DOI 10.1529/biophysj.106.080937; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241	10	165	170	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 11	2008	320	5873					239	243		10.1126/science.1155313	http://dx.doi.org/10.1126/science.1155313			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286HJ	18403713	Green Accepted			2022-12-24	WOS:000254836700046
J	Bell, JJ; Bhandoola, A				Bell, J. Jeremiah; Bhandoola, Avinash			The earliest thymic progenitors for T cells possess myeloid lineage potential	NATURE			English	Article							COMMON LYMPHOID PROGENITORS; HEMATOPOIETIC STEM-CELLS; BONE-MARROW; DENDRITIC CELLS; IDENTIFICATION; PRECURSOR; DIFFERENTIATION; TRANSCRIPTION; MACROPHAGES; COMMITMENT	There exists controversy over the nature of haematopoietic progenitors of T cells. Most T cells develop in the thymus, but the lineage potential of thymus-colonizing progenitors is unknown. One approach to resolving this question is to determine the lineage potentials of the earliest thymic progenitors (ETPs). Previous work has shown that ETPs possess T and natural killer lymphoid potentials, and rare subsets of ETPs also possess B lymphoid potential(1), suggesting an origin from lymphoid-restricted progenitor cells. However, whether ETPs also possess myeloid potential is unknown. Here we show that nearly all ETPs in adult mice possess both T and myeloid potential in clonal assays. The existence of progenitors possessing T and myeloid potential within the thymus is incompatible with the current dominant model of haematopoiesis, in which T cells are proposed to arise from lymphoid-restricted progenitors(2). Our results indicate that alternative models for lineage commitment during haematopoiesis must be considered.	[Bell, J. Jeremiah; Bhandoola, Avinash] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Bhandoola, A (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	bhandooa@mail.med.upenn.edu						Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; Balciunaite G, 2005, BLOOD, V105, P1930, DOI 10.1182/blood-2004-08-3087; Benz C, 2005, J EXP MED, V202, P21, DOI 10.1084/jem.20050146; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Borghesi L, 2004, J EXP MED, V199, P491, DOI 10.1084/jem.20031800; Ceredig R, 2007, EUR J IMMUNOL, V37, P830, DOI 10.1002/eji.200636728; Faust N, 2000, BLOOD, V96, P719; Franco CB, 2006, P NATL ACAD SCI USA, V103, P11993, DOI 10.1073/pnas.0601188103; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kondo M, 2001, CURR OPIN GENET DEV, V11, P520, DOI 10.1016/S0959-437X(00)00227-6; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Lu M, 2005, J IMMUNOL, V175, P5848, DOI 10.4049/jimmunol.175.9.5848; MATSUZAKI Y, 1993, J EXP MED, V178, P1283, DOI 10.1084/jem.178.4.1283; Min H, 2004, J IMMUNOL, V173, P245, DOI 10.4049/jimmunol.173.1.245; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Schmitt TM, 2006, IMMUNOL REV, V209, P95, DOI 10.1111/j.0105-2896.2006.00353.x; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Taghon TN, 2005, GENE DEV, V19, P965, DOI 10.1101/gad.1298305; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314	29	314	330	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2008	452	7188					764	U9		10.1038/nature06840	http://dx.doi.org/10.1038/nature06840			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	285QY	18401411				2022-12-24	WOS:000254792500048
J	Gabut, M; Chaudhry, S; Blencowe, BJ				Gabut, Mathieu; Chaudhry, Sidharth; Blencowe, Benjamin J.			SnapShot: The splicing regulatory machinery	CELL			English	Editorial Material							RNA-BINDING PROTEINS		[Gabut, Mathieu; Chaudhry, Sidharth; Blencowe, Benjamin J.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada	University of Toronto	Gabut, M (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada.		GABUT, Mathieu/M-7624-2017	GABUT, Mathieu/0000-0001-7343-5361				Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; LIN S, 2007, ALTERNATIVE SPLICING, P108; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Moroy T, 2007, RNA, V13, P1155, DOI 10.1261/rna.554607; Musunuru K, 2003, TRENDS CARDIOVAS MED, V13, P188, DOI 10.1016/S1050-1738(03)00075-6; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Pascual M, 2006, DIFFERENTIATION, V74, P65, DOI 10.1111/j.1432-0436.2006.00060.x; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Singh R, 2005, NAT STRUCT MOL BIOL, V12, P645, DOI 10.1038/nsmb961; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003	13	45	45	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 4	2008	133	1					192	U1		10.1016/j.cell.2008.03.010	http://dx.doi.org/10.1016/j.cell.2008.03.010			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	283MW	18394998	Bronze			2022-12-24	WOS:000254641300019
J	Makeyev, EV; Maniatis, T				Makeyev, Eugene V.; Maniatis, Tom			Multilevel regulation of gene expression by microRNAs	SCIENCE			English	Editorial Material							MIR-124; NPTB		[Makeyev, Eugene V.; Maniatis, Tom] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Makeyev, EV (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	makeyev@mcb.harvard.edu; maniatis@mcb.harvard.edu		Makeyev, Eugene/0000-0001-6034-6896	NINDS NIH HHS [2R01NS043915-27, R01 NS043915, R01 NS043915-27] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043915] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Davidson EH, 2006, REG GEN GEN REG; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Niwa R, 2007, CURR OPIN GENET DEV, V17, P145, DOI 10.1016/j.gde.2007.02.004; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	19	228	242	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2008	319	5871					1789	1790		10.1126/science.1152326	http://dx.doi.org/10.1126/science.1152326			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279ZF	18369137	Green Accepted			2022-12-24	WOS:000254394000034
J	Cheung, AM; Detsky, AS				Cheung, Angela M.; Detsky, Allan S.			Osteoporosis and fractures - Missing the bridge?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HIP FRACTURE; POSTMENOPAUSAL OSTEOPOROSIS; ELDERLY-WOMEN; FALLS; RISK; MORTALITY; BMD; QUALITY; HEALTH; MEN		[Cheung, Angela M.; Detsky, Allan S.] Univ Hlth Network, Toronto, ON M5G 2C4, Canada; [Cheung, Angela M.; Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 2C4, Canada; [Cheung, Angela M.; Detsky, Allan S.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Cheung, Angela M.; Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto	Cheung, AM (corresponding author), Univ Hlth Network, 200 Elizabeth St,7 Eaton N 221, Toronto, ON M5G 2C4, Canada.	angela.cheung@uhn.on.ca		Cheung, Angela M./0000-0001-8332-0744	CIHR [44917] Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR))		Adachi JD, 2001, OSTEOPOROSIS INT, V12, P903, DOI 10.1007/s001980170017; Cauley JA, 2007, JAMA-J AM MED ASSOC, V298, P2761, DOI 10.1001/jama.298.23.2761; Cranney A, 2002, ENDOCR REV, V23, P570, DOI 10.1210/er.2001-9002; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Ensrud KE, 2000, J AM GERIATR SOC, V48, P241, DOI 10.1111/j.1532-5415.2000.tb02641.x; GREENDALE GA, 1995, J AM GERIATR SOC, V43, P955, DOI 10.1111/j.1532-5415.1995.tb05557.x; Jarvinen TLN, 2008, BRIT MED J, V336, P124, DOI 10.1136/bmj.39428.470752.AD; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; Kanis JA, 2001, OSTEOPOROSIS INT, V12, P989, DOI 10.1007/s001980170006; Kaptoge S, 2005, BONE, V36, P387, DOI 10.1016/j.bone.2004.11.012; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; McCloskey EV, 2007, J BONE MINER RES, V22, P135, DOI 10.1359/JBMR.061008; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; *NAT OST FDN, NOFS NEW CLIN GUID P; Nyberg L, 1996, J AM GERIATR SOC, V44, P156, DOI 10.1111/j.1532-5415.1996.tb02432.x; Pasco JA, 2006, OSTEOPOROSIS INT, V17, P1404, DOI 10.1007/s00198-006-0135-9; Robbins JA, 2006, J AM GERIATR SOC, V54, P1885, DOI 10.1111/j.1532-5415.2006.00985.x; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Siminoski K, 2005, CAN ASSOC RADIOL J, V56, P178; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; 2000, NIH CONSENS STATEMEN, V17, P1	23	63	68	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 26	2008	299	12					1468	1470		10.1001/jama.299.12.1468	http://dx.doi.org/10.1001/jama.299.12.1468			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	278MY	18364489				2022-12-24	WOS:000254292200021
J	Klein, DE; Stayrook, SE; Shi, FM; Narayan, K; Lemmon, MA				Klein, Daryl E.; Stayrook, Steven E.; Shi, Fumin; Narayan, Kartik; Lemmon, Mark A.			Structural basis for EGFR ligand sequestration by Argos	NATURE			English	Article							EPIDERMAL-GROWTH-FACTOR; CRYSTAL-STRUCTURE; PLASMINOGEN-ACTIVATOR; ERBB RECEPTORS; COMPLEX; DOMAIN; SUPERFAMILY; INHIBITION; EXPRESSION; ALIGNMENT	Members of the epidermal growth factor receptor ( EGFR) or ErbB/ HER family and their activating ligands are essential regulators of diverse developmental processes(1,2). Inappropriate activation of these receptors is a key feature of many human cancers(3), and its reversal is an important clinical goal. A natural secreted antagonist of EGFR signalling, called Argos, was identified in Drosophila(4). We showed previously that Argos functions by directly binding ( and sequestering) growth factor ligands that activate EGFR(5). Here we describe the 1.6-angstrom resolution crystal structure of Argos bound to an EGFR ligand. Contrary to expectations(4,6), Argos contains no EGF- like domain. Instead, a trio of closely related domains ( resembling a three- finger toxin fold(7)) form a clamp- like structure around the bound EGF ligand. Although structurally unrelated to the receptor, Argos mimics EGFR by using a bipartite binding surface to entrap EGF. The individual Argos domains share unexpected structural similarities with the extracellular ligand- binding regions of transforming growth factor-beta family receptors(8). The three- domain clamp of Argos also resembles the urokinase- type plasminogen activator ( uPA) receptor, which uses a similar mechanism to engulf the EGF- like module of uPA(9). Our results indicate that undiscovered mammalian counterparts of Argos may exist among other poorly characterized structural homologues. In addition, the structures presented here define requirements for the design of artificial EGF- sequestering proteins that would be valuable anti- cancer therapeutics.	[Klein, Daryl E.; Stayrook, Steven E.; Shi, Fumin; Narayan, Kartik; Lemmon, Mark A.] Univ Penn, Sch Med, Dept Biochem & Biophys, Stellar Chance Labs 809C, Philadelphia, PA 19104 USA	University of Pennsylvania	Lemmon, MA (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Stellar Chance Labs 809C, 422 Curie Blvd, Philadelphia, PA 19104 USA.	mlemmon@mail.med.upenn.edu	Shi, Fumin/H-3472-2013	Lemmon, Mark/0000-0002-3379-5319; Klein, Daryl/0000-0002-7188-0450; Stayrook, Steven/0000-0002-1677-8293	NCI NIH HHS [R01 CA079992-10, R01 CA125432-01A1, R01 CA125432, R01 CA079992] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA079992, R01CA125432] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Alvarado D, 2006, J BIOL CHEM, V281, P28993, DOI 10.1074/jbc.M603782200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barinka C, 2006, J MOL BIOL, V363, P482, DOI 10.1016/j.jmb.2006.08.063; Borrell-Pages M, 2003, EMBO J, V22, P1114, DOI 10.1093/emboj/cdg111; Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FREEMAN M, 1992, CELL, V69, P963, DOI 10.1016/0092-8674(92)90615-J; Fujimoto N, 2005, CANCER RES, V65, P11478, DOI 10.1158/0008-5472.CAN-05-1977; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Greenwald J, 1999, NAT STRUCT BIOL, V6, P18; Hansen LV, 2008, INT J CANCER, V122, P734, DOI 10.1002/ijc.23082; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huai Q, 2006, SCIENCE, V311, P656, DOI 10.1126/science.1121143; Hynes NE, 2006, CANCER CELL, V10, P7, DOI 10.1016/j.ccr.2006.06.012; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Iwaki T, 2003, BIOTECHNIQUES, V35, P482, DOI 10.2144/03353bm08; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Klein DE, 2004, NATURE, V430, P1040, DOI 10.1038/nature02840; KRETZSCHMAR D, 1992, EMBO J, V11, P2531, DOI 10.1002/j.1460-2075.1992.tb05318.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lu HS, 2001, J BIOL CHEM, V276, P34913, DOI 10.1074/jbc.M102874200; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miura GI, 2006, DEV CELL, V10, P167, DOI 10.1016/j.devcel.2005.11.017; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Rosel M, 1998, ONCOGENE, V17, P1989, DOI 10.1038/sj.onc.1202079; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; Temerinac S, 2000, BLOOD, V95, P2569; Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x; Zhang C, 2000, J MOL BIOL, V299, P1075, DOI 10.1006/jmbi.2000.3678; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024	38	41	47	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2008	453	7199					1271	U79		10.1038/nature06978	http://dx.doi.org/10.1038/nature06978			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18500331	Green Accepted			2022-12-24	WOS:000257075800050
J	Chen, ST; Lin, YL; Huang, MT; Wu, MF; Cheng, SC; Lei, HY; Lee, CK; Chiou, TW; Wong, CH; Hsieh, SL				Chen, Szu-Ting; Lin, Yi-Ling; Huang, Ming-Ting; Wu, Ming-Fang; Cheng, Shih-Chin; Lei, Huan-Yao; Lee, Chien-Kuo; Chiou, Tzyy-Wen; Wong, Chi-Huey; Hsieh, Shie-Liang			CLEC5A is critical for dengue-virus-induced lethal disease	NATURE			English	Article							C-TYPE LECTINS; DC-SIGN; DENDRITIC CELLS; CARBOHYDRATE-RECOGNITION; DECOY RECEPTOR-3; INNATE IMMUNITY; INFECTION; ENHANCEMENT; ACTIVATION; ANTIBODY	Dengue haemorrhagic fever and dengue shock syndrome, the most severe responses to dengue virus ( DV) infection, are characterized by plasma leakage ( due to increased vascular permeability) and low platelet counts(1,2). CLEC5A ( C- type lectin domain family 5, member A; also known as myeloid DAP12- associating lectin ( MDL-1))(3) contains a C- type lectin- like fold similar to the natural- killer T- cell C- type lectin domains and associates with a 12- kDa DNAX- activating protein ( DAP12)(4) on myeloid cells. Here we show that CLEC5A interacts with the dengue virion directly and thereby brings about DAP12 phosphorylation. The CLEC5A DV interaction does not result in viral entry but stimulates the release of proinflammatory cytokines. Blockade of CLEC5A - DV interaction suppresses the secretion of proinflammatory cytokines without affecting the release of interferon-alpha, supporting the notion that CLEC5A acts as a signalling receptor for proinflammatory cytokine release. Moreover, anti- CLEC5A monoclonal antibodies inhibit DV- induced plasma leakage, as well as subcutaneous and vital- organ haemorrhaging, and reduce the mortality of DV infection by about 50% in STAT1- deficient mice. Our observation that blockade of CLEC5A- mediated signalling attenuates the production of proinflammatory cytokines by macrophages infected with DV ( either alone or complexed with an enhancing antibody) offers a promising strategy for alleviating tissue damage and increasing the survival of patients suffering from dengue haemorrhagic fever and dengue shock syndrome, and possibly even other virus- induced inflammatory diseases.	[Chen, Szu-Ting; Huang, Ming-Ting; Wu, Ming-Fang; Cheng, Shih-Chin; Hsieh, Shie-Liang] Natl Yang Ming Univ, Dept Microbiol & Immunol, Taipei 112, Taiwan; [Chen, Szu-Ting; Huang, Ming-Ting; Wu, Ming-Fang; Cheng, Shih-Chin; Hsieh, Shie-Liang] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Lin, Yi-Ling] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Lin, Yi-Ling; Wong, Chi-Huey; Hsieh, Shie-Liang] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lei, Huan-Yao] Natl Cheng Kung Univ, Dept Microbiol & Immunol, Tainan 70101, Taiwan; [Lee, Chien-Kuo] Natl Taiwan Univ, Inst Immunol, Taipei 100, Taiwan; [Chiou, Tzyy-Wen] Natl Dong Hwa Univ, Dept Life Sci, Hualien 974, Taiwan; [Chiou, Tzyy-Wen] Natl Dong Hwa Univ, Inst Biotechnol, Hualien 974, Taiwan; [Hsieh, Shie-Liang] Natl Yang Ming Univ, Immunol Res Ctr, Taipei 112, Taiwan; [Hsieh, Shie-Liang] Taipei Vet Gen Hosp, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Cheng Kung University; National Taiwan University; National Dong Hwa University; National Dong Hwa University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Hsieh, SL (corresponding author), Natl Yang Ming Univ, Dept Microbiol & Immunol, Taipei 112, Taiwan.	slhsieh@ym.edu.tw	Lee, Chien-Kuo/AAZ-1039-2020; 陳, 斯婷/GVU-2169-2022; Lin, Yi-Ling/N-7128-2018; Hsieh, Shie-Liang Edmond/ABA-9184-2021; CHENG, SHIH-CHIN/M-3773-2019	Lee, Chien-Kuo/0000-0001-8189-6045; Lin, Yi-Ling/0000-0002-1838-6410; CHENG, SHIH-CHIN/0000-0003-1251-8774; Hsieh, Shie-Liang/0000-0001-9415-346X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62116] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arrighi JF, 2004, J VIROL, V78, P10848, DOI 10.1128/JVI.78.20.10848-10855.2004; Bakker ABH, 1999, P NATL ACAD SCI USA, V96, P9792, DOI 10.1073/pnas.96.17.9792; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Chang YC, 2004, J LEUKOCYTE BIOL, V75, P486, DOI 10.1189/jlb.0903448; Chen YC, 2002, J VIROL, V76, P9877, DOI 10.1128/JVI.76.19.9877-9887.2002; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104; HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201; Hsu TL, 2002, J IMMUNOL, V168, P4846, DOI 10.4049/jimmunol.168.10.4846; Huang KJ, 2006, J IMMUNOL, V176, P2825, DOI 10.4049/jimmunol.176.5.2825; JOHNSON AJ, 1994, VIROLOGY, V203, P241, DOI 10.1006/viro.1994.1481; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Lin YL, 1998, J VIROL, V72, P9729, DOI 10.1128/JVI.72.12.9729-9737.1998; Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Palmer DR, 2005, J VIROL, V79, P2432, DOI 10.1128/JVI.79.4.2432-2439.2005; Palucka AK, 2000, NAT MED, V6, P748, DOI 10.1038/77470; Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008; Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Shresta S, 2005, J IMMUNOL, V175, P3946, DOI 10.4049/jimmunol.175.6.3946; Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Wilder-Smith A, 2005, NEW ENGL J MED, V353, P924, DOI 10.1056/NEJMra041927; Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553	30	285	293	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 29	2008	453	7195					672	U12		10.1038/nature07013	http://dx.doi.org/10.1038/nature07013			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305NN	18496526	Green Published			2022-12-24	WOS:000256185200048
J	Hato, N; Murakami, S; Gyo, K				Hato, Naohito; Murakami, Shingo; Gyo, Kiyofumi			Steroid and antiviral treatment for Bell's palsy	LANCET			English	Editorial Material							HERPES-SIMPLEX-VIRUS; RAMSAY-HUNT-SYNDROME; ACYCLOVIR; PREDNISOLONE; DNA		[Hato, Naohito; Gyo, Kiyofumi] Ehime Univ, Sch Med, Dept Otolaryngol, Matsuyama, Ehime 7910295, Japan; [Murakami, Shingo] Nagoya City Univ Hosp, Dept Otolaryngol, Nagoya, Aichi, Japan	Ehime University; Nagoya City University	Hato, N (corresponding author), Ehime Univ, Sch Med, Dept Otolaryngol, Matsuyama, Ehime 7910295, Japan.	nhato@m.ehime-u.ac.jp						Abiko Y, 2002, OTOL NEUROTOL, V23, P779, DOI 10.1097/00129492-200209000-00028; Adour KK, 1996, ANN OTO RHINOL LARYN, V105, P371, DOI 10.1177/000348949610500508; ADOUR KK, 1994, ANN NEUROL, V35, P62; Allen D, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001869.PUB2; Furuta Y, 2001, J CLIN MICROBIOL, V39, P2856, DOI 10.1128/JCM.39.8.2856-2859.2001; Furuta Y, 1998, J MED VIROL, V54, P162, DOI 10.1002/(SICI)1096-9071(199803)54:3&lt;162::AID-JMV3&gt;3.0.CO;2-3; Gilden DH, 2007, NEW ENGL J MED, V357, P1653, DOI 10.1056/NEJMe078188; Grogan PM, 2001, NEUROLOGY, V56, P830, DOI 10.1212/WNL.56.7.830; Hato N, 2003, OTOL NEUROTOL, V24, P948, DOI 10.1097/00129492-200311000-00022; Hato N, 2007, OTOL NEUROTOL, V28, P408, DOI 10.1097/01.mao.0000265190.29969.12; Murakami S, 1997, ANN NEUROL, V41, P353, DOI 10.1002/ana.410410310; Murakami S, 1996, ANN INTERN MED, V124, P27, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00005; Sullivan FM, 2007, NEW ENGL J MED, V357, P1598, DOI 10.1056/NEJMoa072006	13	56	57	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY-JUN	2008	371	9627					1818	1820		10.1016/S0140-6736(08)60776-X	http://dx.doi.org/10.1016/S0140-6736(08)60776-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	307NL	18514714				2022-12-24	WOS:000256325500007
J	Burdelya, LG; Krivokrysenko, VI; Tallant, TC; Strom, E; Gleiberman, AS; Gupta, D; Kurnasov, OV; Fort, FL; Osterman, AL; DiDonato, JA; Feinstein, E; Gudkov, AV				Burdelya, Lyudmila G.; Krivokrysenko, Vadim I.; Tallant, Thomas C.; Strom, Evguenia; Gleiberman, Anatoly S.; Gupta, Damodar; Kurnasov, Oleg V.; Fort, Farrel L.; Osterman, Andrei L.; DiDonato, Joseph A.; Feinstein, Elena; Gudkov, Andrei V.			An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models	SCIENCE			English	Article							TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTOR-5; FACTOR-KAPPA-B; INDUCED APOPTOSIS; IN-VIVO; IONIZING-RADIATION; ADAPTIVE IMMUNITY; MICE; FLAGELLIN; CANCER	The toxicity of ionizing radiation is associated with massive apoptosis in radiosensitive organs. Here, we investigate whether a drug that activates a signaling mechanism used by tumor cells to suppress apoptosis can protect healthy cells from the harmful effects of radiation. We studied CBLB502, a polypeptide drug derived from Salmonella flagellin that binds to Toll-like receptor 5 (TLR5) and activates nuclear factor-kappa B signaling. A single injection of CBLB502 before lethal total-body irradiation protected mice from both gastrointestinal and hematopoietic acute radiation syndromes and resulted in improved survival. CBLB502 injected after irradiation also enhanced survival, but at lower radiation doses. It is noteworthy that the drug did not decrease tumor radiosensitivity in mouse models. CBLB502 also showed radioprotective activity in lethally irradiated rhesus monkeys. Thus, TLR5 agonists could potentially improve the therapeutic index of cancer radiotherapy and serve as biological protectants in radiation emergencies.	[Krivokrysenko, Vadim I.; Strom, Evguenia; Gleiberman, Anatoly S.; Fort, Farrel L.; Feinstein, Elena; Gudkov, Andrei V.] Cleveland Biolabs Inc CBLI, Buffalo, NY 14203 USA; [Burdelya, Lyudmila G.; Gupta, Damodar; Gudkov, Andrei V.] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA; [Tallant, Thomas C.; DiDonato, Joseph A.] Cleveland Clin, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44195 USA; [Kurnasov, Oleg V.; Osterman, Andrei L.] Burnham Inst, La Jolla, CA 92037 USA	Roswell Park Cancer Institute; Cleveland Clinic Foundation; Sanford Burnham Prebys Medical Discovery Institute	Feinstein, E (corresponding author), Cleveland Biolabs Inc CBLI, Buffalo, NY 14203 USA.	efeinstein@cbiolabs.com; andrei.gudkov@roswellpark.org	Hazen, Stanley L/ABD-5845-2021	Gudkov, Andrei/0000-0003-2548-0154; Strom, Evguenia/0000-0003-1237-2138; gleiberman, anatoli/0000-0001-8491-0826	NATIONAL CANCER INSTITUTE [R01CA084406, R01CA075179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066497] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA084406, CA75179, CA84406, R01 CA075179, R01 CA084406-01A1] Funding Source: Medline; NIAID NIH HHS [R01 AI066497, AI066497] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Apetoh Lionel, 2007, Cancer Genomics & Proteomics, V4, P65; ATKINSON K, 1995, CYTOKINES MOL THER, V1, P47; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; Dale DC, 2002, DRUGS, V62, P1, DOI 10.2165/00003495-200262001-00001; Dodd Mi., 2001, MANAGING SIDE EFFECT; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; Epperly MW, 2002, RADIAT RES, V157, P568, DOI 10.1667/0033-7587(2002)157[0568:MSDSIR]2.0.CO;2; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; Honko AN, 2005, IMMUNOL RES, V33, P83, DOI 10.1385/IR:33:1:083; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Karkanitsa LV, 1997, STEM CELLS, V15, P95; KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66; Kolesnick R, 2003, ONCOGENE, V22, P5897, DOI 10.1038/sj.onc.1206702; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Komarova EA, 2004, ONCOGENE, V23, P3265, DOI 10.1038/sj.onc.1207494; Lu T, 2004, CELL CYCLE, V3, P1114; Maaser C, 2004, J IMMUNOL, V172, P5056, DOI 10.4049/jimmunol.172.8.5056; Murthy KGK, 2004, J BIOL CHEM, V279, P5667, DOI 10.1074/jbc.M307759200; NETA R, 1991, J EXP MED, V173, P1177, DOI 10.1084/jem.173.5.1177; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; POTTEN CS, 1992, CANCER METAST REV, V11, P179, DOI 10.1007/BF00048063; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Sebastiani G, 2000, GENOMICS, V64, P230, DOI 10.1006/geno.2000.6115; Stickney DR, 2007, INT IMMUNOPHARMACOL, V7, P500, DOI 10.1016/j.intimp.2006.12.005; Tallant T, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-33; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Vidrich A, 2005, AM J PATHOL, V166, P1055, DOI 10.1016/S0002-9440(10)62326-7; Wang Y, 2004, CANCER RES, V64, P6240, DOI 10.1158/0008-5472.CAN-04-0591; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Weiss JF, 2003, TOXICOLOGY, V189, P1, DOI 10.1016/S0300-483X(03)00149-5; Weiss JF, 1997, ENVIRON HEALTH PERSP, V105, P1473, DOI 10.2307/3433654; Whitnall MH, 2000, INT J IMMUNOPHARMACO, V22, P1, DOI 10.1016/S0192-0561(99)00059-4; Yu YM, 2006, J IMMUNOL, V176, P6194, DOI 10.4049/jimmunol.176.10.6194	35	517	630	3	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 11	2008	320	5873					226	230		10.1126/science.1154986	http://dx.doi.org/10.1126/science.1154986			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286HJ	18403709	Green Accepted			2022-12-24	WOS:000254836700042
J	Zhu, WD; Shiojima, I; Ito, Y; Li, Z; Ikeda, H; Yoshida, M; Naito, AT; Nishi, JI; Ueno, H; Umezawa, A; Minamino, T; Nagai, T; Kikuchi, A; Asashima, M; Komuro, I				Zhu, Weidong; Shiojima, Ichiro; Ito, Yuzuru; Li, Zhi; Ikeda, Hiroyuki; Yoshida, Masashi; Naito, Atsuhiko T.; Nishi, Jun-ichiro; Ueno, Hiroo; Umezawa, Akihiro; Minamino, Tohru; Nagai, Toshio; Kikuchi, Akira; Asashima, Makoto; Komuro, Issei			IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis	NATURE			English	Article							CATENIN; PROTEIN; GROWTH; DIFFERENTIATION; PATHWAY; IDENTIFICATION; SPECIFICATION; INDUCTION; MESODERM; RECEPTOR	Insulin- like growth- factor- binding proteins ( IGFBPs) bind to and modulate the actions of insulin- like growth factors ( IGFs)(1). Although some of the actions of IGFBPs have been reported to be independent of IGFs, the precise mechanisms of IGF- independent actions of IGFBPs are largely unknown(1,2). Here we report a previously unknown function for IGFBP- 4 as a cardiogenic growth factor. IGFBP- 4 enhanced cardiomyocyte differentiation in vitro, and knockdown of Igfbp4 attenuated cardiomyogenesis both in vitro and in vivo. The cardiogenic effect of IGFBP- 4 was independent of its IGF- binding activity but was mediated by the inhibitory effect on canonical Wnt signalling. IGFBP- 4 physically interacted with a Wnt receptor, Frizzled 8 ( Frz8), and a Wnt co- receptor, low-density lipoprotein receptor- related protein 6 ( LRP6), and inhibited the binding of Wnt3A to Frz8 and LRP6. Although IGF- independent, the cardiogenic effect of IGFBP- 4 was attenuated by IGFs through IGFBP- 4 sequestration. IGFBP- 4 is therefore an inhibitor of the canonical Wnt signalling required for cardiogenesis and provides a molecular link between IGF signalling and Wnt signalling.	[Zhu, Weidong; Shiojima, Ichiro; Li, Zhi; Ikeda, Hiroyuki; Yoshida, Masashi; Naito, Atsuhiko T.; Nishi, Jun-ichiro; Minamino, Tohru; Nagai, Toshio; Komuro, Issei] Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chiba 2608670, Japan; [Ito, Yuzuru; Asashima, Makoto] Japan Sci & Technol Agcy, ICORP Organ Regenerat Project, Tokyo 1538902, Japan; [Ueno, Hiroo] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Umezawa, Akihiro] Natl Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo 1578535, Japan; [Kikuchi, Akira] Hiroshima Univ, Dept Biochem, Grad Sch Biomed Sci, Hiroshima 7348551, Japan; [Asashima, Makoto] Univ Tokyo, Dept Life Sci Biol, Grad Sch Arts & Sci, Tokyo 1538902, Japan; [Asashima, Makoto] Natl Inst Adv Ind Sci & Technol, Tsukuba 3058562, Japan	Chiba University; Japan Science & Technology Agency (JST); Stanford University; National Center for Child Health & Development - Japan; Hiroshima University; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Komuro, I (corresponding author), Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chiba 2608670, Japan.	komuro-tky@umin.ac.jp	Minamino, Tohru/P-8145-2018; Asashima, Makoto/O-8389-2018	Minamino, Tohru/0000-0003-1627-6151; Asashima, Makoto/0000-0002-0012-026X				CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cohen ED, 2008, DEVELOPMENT, V135, P789, DOI 10.1242/dev.016865; Durai R, 2006, INT J ONCOL, V28, P1317; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Foley A, 2004, TRENDS CARDIOVAS MED, V14, P121, DOI 10.1016/j.tcm.2004.01.003; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Hosoda T, 2001, J BIOL CHEM, V276, P35978, DOI 10.1074/jbc.M100485200; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kishida M, 2001, J BIOL CHEM, V276, P33147, DOI 10.1074/jbc.M103555200; Kobayashi H, 2005, MECH DEVELOP, V122, P1138, DOI 10.1016/j.mod.2005.05.003; Kolossov E, 2005, FASEB J, V19, P577, DOI 10.1096/fj.03-1451fje; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Leri A, 2005, PHYSIOL REV, V85, P1373, DOI 10.1152/physrev.00013.2005; Liu Y, 2007, P NATL ACAD SCI USA, V104, P3859, DOI 10.1073/pnas.0609100104; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mohan S, 2002, J ENDOCRINOL, V175, P19, DOI 10.1677/joe.0.1750019; Monzen K, 1999, MOL CELL BIOL, V19, P7096; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Ning Y, 2006, MOL ENDOCRINOL, V20, P2173, DOI 10.1210/me.2005-0196; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Qin XZ, 1998, J BIOL CHEM, V273, P23509, DOI 10.1074/jbc.273.36.23509; Sasagawa S, 2002, GENESIS, V33, P81, DOI 10.1002/gene.10094; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Ueno H, 2003, NAT IMMUNOL, V4, P457, DOI 10.1038/ni916; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	30	170	186	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2008	454	7202					345	U51		10.1038/nature07027	http://dx.doi.org/10.1038/nature07027			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326ND	18528331	Bronze			2022-12-24	WOS:000257665300041
J	Home, P; Mant, J; Diaz, J; Turner, C				Home, Philip; Mant, Jonathan; Diaz, Jose; Turner, Claire		Guideline Dev Grp	Guidelines - Management of type 2 diabetes: updated NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Home, Philip] Univ Newcastle, Sch Med, Newcastle Upon Tyne, Tyne & Wear, England; [Mant, Jonathan] Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham, W Midlands, England; [Diaz, Jose; Turner, Claire] Royal Coll Physicians, Natl Collaborating Ctr Chron Condit, London NW1 4LE, England	Newcastle University - UK; University of Birmingham; Royal College of Physicians	Home, P (corresponding author), Med Sch Newcastle Upon Tyne, SCMS Diabet, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	philip.home@ncl.ac.uk		Mant, Jonathan/0000-0002-9531-0268				*INT DIAB FED, 2006, DIAB ATL; Marshall SM, 2006, BMJ-BRIT MED J, V333, P475, DOI 10.1136/bmj.38922.650521.80; *NAT I HLTH CLIN E, 2007, EZ TREATM PRIM HET F; *NAT I HLTH CLIN E, 2008, MAN TYP 2 DIAB UPD; National Institute of Clinical Excellence, 2004, TYP 2 DIAB PREV MAN; *UK NAT SCREEN COM, 2007, ESS EL DEV DIAB RET, V4, P1; [WHO] World Health Organization, 2006, DIAB FACT SHEET	7	68	80	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 7	2008	336	7656					1306	1308		10.1136/bmj.39560.442095.AD	http://dx.doi.org/10.1136/bmj.39560.442095.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	312XO	18535074	Green Published			2022-12-24	WOS:000256705900037
J	Allen, LA; Yager, JE; Funk, MJ; Levy, WC; Tulsky, JA; Bowers, MT; Dodson, GC; O'Connor, CM; Felker, GM				Allen, Larry A.; Yager, Jonathan E.; Funk, Michele Jonsson; Levy, Wayne C.; Tulsky, James A.; Bowers, Margaret T.; Dodson, Gwen C.; O'Connor, Christopher M.; Felker, G. Michael			Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-LIFE; CANCER; END; DEPRESSION; SURVIVAL; PREFERENCES; VALIDATION; PROGNOSIS; MORTALITY; DEATH	Context Patients with chronic heart failure have impaired long- term survival, but their own expectations regarding prognosis have not been well studied. Objectives To quantify expectations for survival in patients with heart failure, to compare patient expectations to model predictions, and to identify factors associated with discrepancies between patient- predicted and model- predicted prognosis. Design, Setting, and Participants Prospective face- to- face survey of patients from the single- center Duke Heart Failure Disease Management Program between July and December 2004, with follow- up through February 2008. Patient- predicted life expectancy was obtained using a visual analog scale. Model- predicted life expectancy was calculated using the Seattle Heart Failure Model. Actuarial- predicted life expectancy, based on age and sex alone, was calculated using life tables. Observed survival was determined from review of medical records and search of the Social Security Death Index. Main Outcome Measure Life expectancy ratio ( LER), defined as the ratio of patient-predicted to model- predicted life expectancy. Results The cohort consisted of 122 patients ( mean age, 62 years; 47% African American, 42% New York Heart Association [ NYHA] class III or IV). On average, patients overestimated their life expectancy relative to model- predicted life expectancy ( median patient-predicted life expectancy, 13.0 years; model- predicted expectancy, 10.0 years). Median LER was 1.4 ( interquartile range, 0.8- 2.5). Younger age, increased NYHA class, lower ejection fraction, and less depression were the most significant predictors of higher LER. During a median follow- up of 3.1 years, 29% of the original cohort died. There was no association between higher LER and improved survival ( adjusted hazard ratio for overestimated compared with concordant LER, 1.05; 95% confidence interval, 0.46- 2.42). Conclusions Ambulatory patients with heart failure tended to substantially overestimate their life expectancy compared with model- based predictions for survival. Because differences in perceived survival could affect decision making regarding advanced therapies and end- of- life planning, the causes of these discordant predictions warrant further study.	[Allen, Larry A.; Bowers, Margaret T.; Dodson, Gwen C.; O'Connor, Christopher M.; Felker, G. Michael] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27705 USA; [Tulsky, James A.] Duke Univ, Med Ctr, Ctr Palliat Care, Durham, NC 27705 USA; [Tulsky, James A.] Duke Univ, Med Ctr, Div Gen Internal Med, Durham, NC 27705 USA; [Yager, Jonathan E.] Cardiac Care Assoc, Fairfax, VA USA; [Funk, Michele Jonsson] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Levy, Wayne C.] Univ Washington, Div Cardiol, Seattle, WA 98195 USA	Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle	Allen, LA (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, 2400 Pratt St,Room 0311,Terrace Level, Durham, NC 27705 USA.	larry_allen@post.harvard.edu	Allen, Larry/AAI-1323-2020; Felker, Michael/AAX-2288-2021; Levy, Wayne/AAI-8177-2021; Funk, Michele Jonsson/F-6885-2011	Levy, Wayne/0000-0003-1530-2194; Funk, Michele Jonsson/0000-0002-3756-7540; Felker, Gary/0000-0002-5931-1239	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL072357, T32HL069749] Funding Source: NIH RePORTER; NHLBI NIH HHS [2 T32HL069749-04, K23 HL72357-01A, T32 HL069749] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aaronson KD, 1997, CIRCULATION, V95, P2660, DOI 10.1161/01.CIR.95.12.2660; *AM HEART ASS AFF, 1994, NOM CRIT DIAGN DIS H; CHAPPELL NL, 1975, OMEGA-J DEATH DYING, V6, P325, DOI 10.2190/5WKA-QB1M-VTGA-RRGF; DARDAS T, 2007, AM HEART ASS SCI SES; Davidson PM, 2007, J CARDIOVASC NURS, V22, P159, DOI 10.1097/01.JCN.0000267821.74084.72; EIDINGER RN, 1984, CANCER, V53, P2736, DOI 10.1002/1097-0142(19840615)53:12<2736::AID-CNCR2820531233>3.0.CO;2-W; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; Formiga F, 2004, QJM-INT J MED, V97, P803, DOI 10.1093/qjmed/hch135; Gigerenzer G, 2003, BMJ-BRIT MED J, V327, P741, DOI 10.1136/bmj.327.7417.741; Hauptman PJ, 2008, AM J MED, V121, P127, DOI 10.1016/j.amjmed.2007.08.035; Hauptman PJ, 2007, ARCH INTERN MED, V167, P1990, DOI 10.1001/archinte.167.18.1990; Hauptman PJ, 2005, ARCH INTERN MED, V165, P374, DOI 10.1001/archinte.165.4.374; Heart Failure Society Of America, 2006, J Card Fail, V12, pe1; Hershberger RE, 2003, J CARD FAIL, V9, P180, DOI 10.1054/jcaf.2003.24; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; Jiang W, 2007, AM HEART J, V154, P102, DOI 10.1016/j.ahj.2007.03.043; Joynt KE, 2004, J CARD FAIL, V10, P258, DOI 10.1016/j.cardfail.2003.09.008; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Koenig H, 1997, AM J PSYCHIAT, V154, P885; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Krumholz HM, 1998, CIRCULATION, V98, P648, DOI 10.1161/01.CIR.98.7.648; Lamont EB, 2001, ANN INTERN MED, V134, P1096, DOI 10.7326/0003-4819-134-12-200106190-00009; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Lee SJ, 2001, JAMA-J AM MED ASSOC, V285, P1034, DOI 10.1001/jama.285.8.1034; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; LEVY WC, 2006, SEATTLE HEART FAILUR; Lewis EF, 2001, J HEART LUNG TRANSPL, V20, P1016, DOI 10.1016/S1053-2498(01)00298-4; Li CY, 2007, J AM GERIATR SOC, V55, P596, DOI 10.1111/j.1532-5415.2007.01103.x; Lowe B, 2005, J PSYCHOSOM RES, V58, P163, DOI 10.1016/j.jpsychores.2004.09.006; Mack JW, 2007, J CLIN ONCOL, V25, P1357, DOI 10.1200/JCO.2006.08.3170; Maggioni AP, 2005, J CARD FAIL, V11, P91, DOI 10.1016/j.cardfail.2004.05.004; May HT, 2007, AM J CARDIOL, V100, P697, DOI 10.1016/j.amjcard.2007.03.083; McDowell I., 1996, MEASURING HLTH GUIDE; Mozaffarian D, 2007, CIRCULATION, V116, P392, DOI 10.1161/CIRCULATIONAHA.106.687103; Murray SA, 2002, BRIT MED J, V325, P929, DOI 10.1136/bmj.325.7370.929; Nieminen MS, 2005, EUR HEART J, V26, P384; Robinson TM, 2008, SUPPORT CARE CANCER, V16, P1049, DOI 10.1007/s00520-007-0372-2; ROSAMOND W, 2007, CIRCULATION, V155, pE172; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Steinhauser KE, 2006, PALLIATIVE MED, V20, P745, DOI 10.1177/0269216306073112; Stewart S, 2001, EUR J HEART FAIL, V3, P315, DOI 10.1016/S1388-9842(00)00141-0; Sulmasy DP, 1998, ANN INTERN MED, V128, P621, DOI 10.7326/0003-4819-128-8-199804150-00002; WACHTER RM, 1989, ANN INTERN MED, V111, P525, DOI 10.7326/0003-4819-111-6-525; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; Weinfurt KP, 2003, CANCER-AM CANCER SOC, V98, P166, DOI 10.1002/cncr.11483; Whelan T, 2004, JAMA-J AM MED ASSOC, V292, P435, DOI 10.1001/jama.292.4.435; Yamokoski LM, 2007, J CARD FAIL, V13, P8, DOI 10.1016/j.cardfail.2006.10.002	50	182	185	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2008	299	21					2533	2542		10.1001/jama.299.21.2533	http://dx.doi.org/10.1001/jama.299.21.2533			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	308AR	18523222	Bronze, Green Submitted, Green Accepted			2022-12-24	WOS:000256361200025
J	Graupera, M; Guillermet-Guibert, J; Foukas, LC; Phng, LK; Cain, RJ; Salpekar, A; Pearce, W; Meek, S; Millan, J; Cutillas, PR; Smith, AJH; Ridley, AJ; Ruhrberg, C; Gerhardt, H; Vanhaesebroeck, B				Graupera, Mariona; Guillermet-Guibert, Julie; Foukas, Lazaros C.; Phng, Li-Kun; Cain, Robert J.; Salpekar, Ashreena; Pearce, Wayne; Meek, Stephen; Millan, Jaime; Cutillas, Pedro R.; Smith, Andrew J. H.; Ridley, Anne J.; Ruhrberg, Christiana; Gerhardt, Holger; Vanhaesebroeck, Bart			Angiogenesis selectively requires the p110 alpha isoform of PI3K to control endothelial cell migration	NATURE			English	Article							GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; EMBRYONIC LETHALITY; CATALYTIC SUBUNIT; P110 DELTA; B-CELL; EXPRESSION; MICE; TRAFFICKING	Phosphoinositide 3- kinases ( PI3Ks) signal downstream of multiple cell- surface receptor types. Class IA PI3K isoforms(1) couple to tyrosine kinases and consist of a p110 catalytic subunit ( p110 alpha, p110 beta or p110 delta), constitutively bound to one of five distinct p85 regulatory subunits. PI3Ks have been implicated in angiogenesis(2-5), but little is known about potential selectivity among the PI3K isoforms and their mechanism of action in endothelial cells during angiogenesis in vivo. Here we show that only p110 alpha activity is essential for vascular development. Ubiquitous or endothelial cell- specific inactivation of p110 alpha led to embryonic lethality at mid- gestation because of severe defects in angiogenic sprouting and vascular remodelling. p110 alpha exerts this critical endothelial cell- autonomous function by regulating endothelial cell migration through the small GTPase RhoA. p110 alpha activity is particularly high in endothelial cells and preferentially induced by tyrosine kinase ligands ( such as vascular endothelial growth factor ( VEGF)- A). In contrast, p110 delta in endothelial cells signals downstream of G- protein- coupled receptor ( GPCR) ligands such as SDF-1 alpha, whereas p110 delta is expressed at low level and contributes only minimally to PI3K activity in endothelial cells. These results provide the first in vivo evidence for p110- isoform	[Phng, Li-Kun; Gerhardt, Holger] Canc Res UK London Res Inst, Vasc Biol Lab, London WC2A 3PX, England; [Graupera, Mariona; Guillermet-Guibert, Julie; Foukas, Lazaros C.; Salpekar, Ashreena; Pearce, Wayne; Cutillas, Pedro R.; Vanhaesebroeck, Bart] Queen Mary Univ London, Ctr Cell Signalling, Inst Canc, London EC1M 6BQ, England; [Cain, Robert J.; Millan, Jaime; Ridley, Anne J.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Meek, Stephen; Smith, Andrew J. H.] Univ Edinburgh, Gene Targeting Lab, Inst Stem Cell Res, Edinburgh EH9 3JQ, Midlothian, Scotland; [Ruhrberg, Christiana] UCL, Dept Cell Biol, Inst Ophthalmol, London EC1V 9EL, England	Cancer Research UK; University of London; Queen Mary University London; University of London; King's College London; University of Edinburgh; University of London; University College London	Gerhardt, H (corresponding author), Canc Res UK London Res Inst, Vasc Biol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	Holger.gerhardt@cancer.org.uk; bart.vanh@qmul.ac.uk	Graupera, Mariona/J-1122-2017; Ruhrberg, Christiana/C-6404-2009; Phng, Li-Kun/L-7346-2013; Guillermet-Guibert, Julie/D-2317-2014; Gerhardt, Holger/G-4610-2011; Gerhardt, Holger/G-4610-2011	Graupera, Mariona/0000-0003-4608-4185; Ruhrberg, Christiana/0000-0002-3212-9381; Guillermet-Guibert, Julie/0000-0003-3173-4907; Gerhardt, Holger/0000-0002-3030-0384; Rodriguez Cutillas, Pedro/0000-0002-3426-2274; Pearce, Wayne/0000-0001-5407-4767; Gerhardt, Holger/0000-0001-9228-7472; Ridley, Anne/0000-0001-8186-5708; Millan, Jaime/0000-0003-3107-147X	Biotechnology and Biological Sciences Research Council [BB/C505659/1, BB/C505659/2] Funding Source: Medline; Cancer Research UK Funding Source: Medline; Medical Research Council [G0700711, G0601093, G0601093(79633)] Funding Source: Medline; MRC [G0601093, G0700711] Funding Source: UKRI; Medical Research Council [G0700711B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Adini I, 2003, GENE DEV, V17, P2721, DOI 10.1101/gad.1134603; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bi L, 2002, MAMM GENOME, V13, P169, DOI 10.1007/s00335-001-2123-x; Bilancio A, 2006, BLOOD, V107, P642, DOI 10.1182/blood-2005-07-3041; Chantry D, 1997, J BIOL CHEM, V272, P19236, DOI 10.1074/jbc.272.31.19236; Cutillas PR, 2006, P NATL ACAD SCI USA, V103, P8959, DOI 10.1073/pnas.0602101103; Dayanir V, 2001, J BIOL CHEM, V276, P17686, DOI 10.1074/jbc.M009128200; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Geng L, 2004, CANCER RES, V64, P4893, DOI 10.1158/0008-5472.CAN-03-3955; Gerber HP, 1998, J BIOL CHEM, V273, P13313, DOI 10.1074/jbc.273.21.13313; Gerhardt H, 2005, EXP SUPPL, V94, P3; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gille H, 2000, EMBO J, V19, P4064, DOI 10.1093/emboj/19.15.4064; GUILLERMETGUIBE.J, IN PRESS P NATL ACAD; Hughes S, 2000, MICROCIRCULATION, V7, P317, DOI 10.1038/sj.mn.7300119; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Lelievre E, 2005, BLOOD, V105, P3935, DOI 10.1182/blood-2004-10-3955; Lidington EA, 2002, AM J PHYSIOL-CELL PH, V282, pC67, DOI 10.1152/ajpcell.2002.282.1.C67; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; Okkenhaug K, 2002, SCIENCE, V297, P1031; Puri KD, 2004, BLOOD, V103, P3448, DOI 10.1182/blood-2003-05-1667; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Sawyer C, 2003, CANCER RES, V63, P1667; Ueki K, 2000, MOL CELL BIOL, V20, P8035, DOI 10.1128/MCB.20.21.8035-8046.2000; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Wells Claire M., 2004, V294, P31; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048	31	390	447	3	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2008	453	7195					662	666		10.1038/nature06892	http://dx.doi.org/10.1038/nature06892			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305NN	18449193				2022-12-24	WOS:000256185200046
J	Milstein, JM				Milstein, Jay M.			Introducing spirituality in medical care - Transition from hopelessness to wholeness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DEATH; HEALTH		Univ Calif Davis, Div Neonatol, Dept Pediat, Sacramento, CA 95817 USA	University of California System; University of California Davis	Milstein, JM (corresponding author), Univ Calif Davis, Div Neonatol, Dept Pediat, 2516 Stockton Blvd, Sacramento, CA 95817 USA.	jmmilstein@ucdavis.edu						Croog SH, 2001, ALZ DIS ASSOC DIS, V15, P201, DOI 10.1097/00002093-200110000-00006; Enyert G, 1999, Am J Hosp Palliat Care, V16, P455, DOI 10.1177/104990919901600207; Frank Arthur W, 1995, WOUNDED STORYTELLER, P53; Handzo G, 2004, SOUTH MED J, V97, P1242, DOI 10.1097/01.SMJ.0000146490.49723.AE; Lang A, 2004, INT J NURS STUD, V41, P869, DOI 10.1016/j.ijnurstu.2004.03.013; Lang A, 2003, DEATH STUD, V27, P851, DOI 10.1080/716100345; Milstein Jay, 2005, J Perinatol, V25, P563, DOI 10.1038/sj.jp.7211358; Milstein Jay M, 2007, Am J Hosp Palliat Care, V24, P343, DOI 10.1177/1049909107305645; Milstein Jay M, 2003, J Perinatol, V23, P333, DOI 10.1038/sj.jp.7210903; Park CL, 2007, J BEHAV MED, V30, P319, DOI 10.1007/s10865-007-9111-x; Puchalski CM, 2004, CLIN GERIATR MED, V20, P689, DOI 10.1016/j.cger.2004.07.004; Raingruber B, 2007, J HOLIST NURS, V25, P39, DOI 10.1177/0898010106289859; Rajajee S, 2007, INDIAN J PEDIATR, V74, P837, DOI 10.1007/s12098-007-0149-0; RAO N, 1986, ARCH PHYS MED REHAB, V67, P759, DOI 10.1016/0003-9993(86)90011-0; Schaap AHP, 1997, EUR J OBSTET GYN R B, V75, P161, DOI 10.1016/S0301-2115(97)00127-9	15	26	26	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 28	2008	299	20					2440	2441		10.1001/jama.299.20.2440	http://dx.doi.org/10.1001/jama.299.20.2440			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	305BD	18505954				2022-12-24	WOS:000256151900029
J	Benhar, M; Forrester, MT; Hess, DT; Stamler, JS				Benhar, Moran; Forrester, Michael T.; Hess, Douglas T.; Stamler, Jonathan S.			Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins	SCIENCE			English	Article							NITRIC-OXIDE SYNTHASE; S-NITROSYLATION; ENDOTHELIAL-CELLS; REDUCTASE; DENITROSATION; NITROSOTHIOLS; NITROSATION; INHIBITION; APOPTOSIS; ENZYME	Nitric oxide acts substantially in cellular signal transduction through stimulus- coupled S- nitrosylation of cysteine residues. The mechanisms that might subserve protein denitrosylation in cellular signaling remain uncharacterized. Our search for denitrosylase activities focused on caspase- 3, an exemplar of stimulus- dependent denitrosylation, and identified thioredoxin and thioredoxin reductase in a biochemical screen. In resting human lymphocytes, thioredoxin- 1 actively denitrosylated cytosolic caspase- 3 and thereby maintained a low steady- state amount of S- nitrosylation. Upon stimulation of Fas, thioredoxin- 2 mediated denitrosylation of mitochondria- associated caspase- 3, a process required for caspase- 3 activation, and promoted apoptosis. Inhibition of thioredoxin- thioredoxin reductases enabled identification of additional substrates subject to endogenous S- nitrosylation. Thus, specific enzymatic mechanisms may regulate basal and stimulus- induced denitrosylation in mammalian cells.	[Benhar, Moran; Hess, Douglas T.; Stamler, Jonathan S.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Forrester, Michael T.; Stamler, Jonathan S.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Duke University	Stamler, JS (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	staml001@mc.duke.edu	Benhar, Moran/AAV-5764-2020	Benhar, Moran/0000-0002-7094-3456; Stamler, Jonathan/0000-0002-6866-1572	NHLBI NIH HHS [P01 HL075443-050003, R01 HL059130, R01 HL059130-11, P01 HL075443] Funding Source: Medline; NIEHS NIH HHS [U19 ES012496, U19 ES012496-05] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075443, R01HL059130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U19ES012496] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ARNELLE DR, 1995, ARCH BIOCHEM BIOPHYS, V318, P279, DOI 10.1006/abbi.1995.1231; ARNER ESJ, 1995, J BIOL CHEM, V270, P3479, DOI 10.1074/jbc.270.8.3479; Erwin PA, 2005, J BIOL CHEM, V280, P19888, DOI 10.1074/jbc.M413058200; Forrester MT, 2007, J BIOL CHEM, V282, P13977, DOI 10.1074/jbc.M609684200; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; Haendeler J, 2002, NAT CELL BIOL, V4, P743, DOI 10.1038/ncb851; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hoffmann J, 2001, J BIOL CHEM, V276, P41383, DOI 10.1074/jbc.M107566200; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jeong W, 2004, J BIOL CHEM, V279, P3142, DOI 10.1074/jbc.M307932200; Kim JE, 2004, J BIOL CHEM, V279, P9758, DOI 10.1074/jbc.M312722200; Lee SR, 1999, J BIOL CHEM, V274, P4722, DOI 10.1074/jbc.274.8.4722; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Mannick JB, 2001, J CELL BIOL, V154, P1111, DOI 10.1083/jcb.200104008; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Mitchell DA, 2007, P NATL ACAD SCI USA, V104, P11609, DOI 10.1073/pnas.0704898104; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; Ravi K, 2004, P NATL ACAD SCI USA, V101, P2619, DOI 10.1073/pnas.0300464101; Rigobello MP, 2004, J INORG BIOCHEM, V98, P1634, DOI 10.1016/j.jinorgbio.2004.04.020; Sengupta R, 2007, BIOCHEMISTRY-US, V46, P8472, DOI 10.1021/bi700449x; Sliskovic I, 2005, J BIOL CHEM, V280, P8733, DOI 10.1074/jbc.M408080200; Stoyanovsky DA, 2005, J AM CHEM SOC, V127, P15815, DOI 10.1021/ja0529135; Verdoucq L, 1999, J BIOL CHEM, V274, P19714, DOI 10.1074/jbc.274.28.19714	26	430	437	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 23	2008	320	5879					1050	1054		10.1126/science.1158265	http://dx.doi.org/10.1126/science.1158265			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303RY	18497292	Green Accepted			2022-12-24	WOS:000256059800038
J	Christakis, NA				Christakis, Nicholas A.			Medicine may change our genes	BRITISH MEDICAL JOURNAL			English	Editorial Material									Harvard Univ, Sch Med, Cambridge, MA 02138 USA; Mt Auburn Hosp, Cambridge, MA 02138 USA	Harvard University; Harvard University; Mount Auburn Hospital	Christakis, NA (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02138 USA.	christak@hcp.med.harvard.edu	Christakis, Nicholas A/C-3205-2009; Christakis, Nicholas A/B-6690-2008						0	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 17	2008	336	7653					1101	1101		10.1136/bmj.39580.445856.59	http://dx.doi.org/10.1136/bmj.39580.445856.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302NM	18483052	Green Published			2022-12-24	WOS:000255975100034
J	Pace, N; Seal, A; Costello, A				Pace, Noemi; Seal, Andrew; Costello, Anthony			Food commodity derivatives: a new cause of malnutrition?	LANCET			English	Editorial Material									[Pace, Noemi; Seal, Andrew; Costello, Anthony] Inst Child Hlth, UCL Ctr Int Hlth & Dev, London WC1N 1EH, England	University of London; University College London	Pace, N (corresponding author), Inst Child Hlth, UCL Ctr Int Hlth & Dev, London WC1N 1EH, England.	n.pace@ich.ucl.ac.uk	Seal, Andrew/C-8550-2014	Seal, Andrew/0000-0003-3656-4054; Pace, Noemi/0000-0001-6413-4890				BLAS J, 2008, FT COM          0507; *CHIC BOARD TRAD, ROUGH RIC COMM TRAD; *CME GROUP, 2008, MONTHL AGR GRAINS UP; Dodd R., 2003, CONSEQUENCES LIBERAL; JEEHOON L, 2008, JOONGANG DAILY  0407; Sahi G. S., 2006, COMMODITY FUTURES MA; Sahi Gurpreet S, 2006, INFLUENCE COMMODITY; SHENK M, 2008, BLOOMBERG COM   0418; STEWART H, 2008, GUARDIAN        0420; *USDA, 2003, DAT SETS INT FOOD CO; Yang J, 2005, J BUS FINAN ACCOUNT, V32, P297, DOI 10.1111/j.0306-686X.2005.00595.x; 2007, ECONOMIST       1206; 2008, ECONOMIST       0427	13	17	17	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 17	2008	371	9625					1648	1650		10.1016/S0140-6736(08)60707-2	http://dx.doi.org/10.1016/S0140-6736(08)60707-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302XB	18486729	Green Submitted			2022-12-24	WOS:000256002200009
J	Spinewine, A				Spinewine, Anne			Making a difference - Adverse drug reactions in elderly people - The challenge of safer prescribing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OLDER; HOMES		Clin Univ Mt Godinne, Yvoir, Belgium	Universite Catholique Louvain; Universite Catholique Louvain Hospital	Spinewine, A (corresponding author), Clin Univ Mt Godinne, Yvoir, Belgium.	anne.spinewine@uclouvain.be						Carnes D, 2008, BRIT MED J, V336, P142, DOI 10.1136/bmj.39401.699063.BE; Elliott RA, 2007, J GEN INTERN MED, V22, P805, DOI 10.1007/s11606-007-0193-5; Glintborg B, 2008, BRIT J CLIN PHARMACO, V65, P265, DOI 10.1111/j.1365-2125.2007.03017.x; Hanlon JT, 2001, J AM GERIATR SOC, V49, P200, DOI 10.1046/j.1532-5415.2001.49042.x; Hughes CM, 2007, DRUG AGING, V24, P81, DOI 10.2165/00002512-200724020-00001; Patterson SM, 2007, PHARM WORLD SCI, V29, P517, DOI 10.1007/s11096-006-9044-4; Spinewine A, 2007, LANCET, V370, P173, DOI 10.1016/S0140-6736(07)61091-5; Witherington EMA, 2008, QUAL SAF HEALTH CARE, V17, P71, DOI 10.1136/qshc.2006.020842	8	15	16	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2008	336	7650					956	+		10.1136/bmj.39520.686458.94	http://dx.doi.org/10.1136/bmj.39520.686458.94			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296KC	18397946	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000255540900044
J	DeLuca, TH; Zackrisson, O; Gundale, MJ; Nilsson, MC				DeLuca, Thomas H.; Zackrisson, Olle; Gundale, Michael J.; Nilsson, Marie-Charlotte			Ecosystem feedbacks and nitrogen fixation in boreal forests	SCIENCE			English	Article									[DeLuca, Thomas H.] Wilderness Soc, Ecol & Econ Res Dept, Bozeman, MT 59715 USA; [DeLuca, Thomas H.; Zackrisson, Olle; Gundale, Michael J.; Nilsson, Marie-Charlotte] Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90183 Umea, Sweden	Swedish University of Agricultural Sciences	DeLuca, TH (corresponding author), Wilderness Soc, Ecol & Econ Res Dept, 503 W Mendenhall, Bozeman, MT 59715 USA.	tom_deluca@tws.org	DeLuca, Thomas Henry/B-4547-2012; Gundale, Michael J/O-1265-2013; Hegethorn, Marie-Charlotte Nilsson/B-1802-2017; DeLuca, Thomas/GYU-3468-2022	DeLuca, Thomas Henry/0000-0003-1561-9597; Gundale, Michael J/0000-0003-2447-609X; Hegethorn, Marie-Charlotte Nilsson/0000-0002-9254-2223; 				Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; DeLuca TH, 2002, NATURE, V419, P917, DOI 10.1038/nature01051; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Vitousek PM, 2002, BIOGEOCHEMISTRY, V57, P1, DOI 10.1023/A:1015798428743; Wardle DA, 2003, SCIENCE, V300, P972, DOI 10.1126/science.1082709; Zackrisson O, 2004, ECOLOGY, V85, P3327, DOI 10.1890/04-0461	6	129	135	6	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 30	2008	320	5880					1181	1181		10.1126/science.1154836	http://dx.doi.org/10.1126/science.1154836			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306FF	18511682				2022-12-24	WOS:000256233000028
J	Feachem, R; Sabot, O				Feachem, Richard; Sabot, Oliver			A new global malaria eradication strategy	LANCET			English	Editorial Material							MOZAMBIQUE		[Sabot, Oliver] Clinton Fdn HIV AID Initiat, New York, NY USA; [Feachem, Richard] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Sabot, O (corresponding author), Clinton Fdn HIV AID Initiat, Quincy, MA 02169 USA.	osabot@clintonfoundation.org						*ALLAFRICA COM, 2006, NAM CROSS BORD IN LA; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; CHOUDHURY D S, 1985, Indian Journal of Pediatrics, V52, P243, DOI 10.1007/BF02754849; FEACHEM R, 2002, FINAL REPORT EXTERNA; Feachem RGA, 2007, JAMA-J AM MED ASSOC, V297, P2281, DOI 10.1001/jama.297.20.2281; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; Harrison G, 1978, MOSQUITOES MALARIA M; Humphreys M., 2001, MALARIA POVERTY RACE; *MAL NO MOR, 2008, WE CANT AFF WAIT BUS; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; *PAC MAL IN, 2007, UNPUB 2 M MAL REF GR; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; *SO AFR DEV COMM, 2007, SADC MAL STRAT PLAN; *UNICEF, 2007, ROLL BACK MAL PARTN; *WHO, 1956, INT ORGAN, V10, P642; World Health Organization, 2007, MAL EL FIELD MAN LOW	17	147	147	0	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2008	371	9624					1633	1635		10.1016/S0140-6736(08)60424-9	http://dx.doi.org/10.1016/S0140-6736(08)60424-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	298VO	18374409	Green Submitted			2022-12-24	WOS:000255715400031
J	Dostert, C; Petrilli, V; Van Bruggen, R; Steele, C; Mossman, BT; Tschopp, J				Dostert, Catherine; Petrilli, Virginie; Van Bruggen, Robin; Steele, Chad; Mossman, Brooke T.; Tschopp, Jurg			Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica	SCIENCE			English	Article							CASPASE-1 ACTIVATION; PATHOGENESIS; MACROPHAGES; ANTAGONIST; MECHANISMS; RECEPTOR; GOUT; MICE; ATP	The inhalation of airborne pollutants, such as asbestos or silica, is linked to inflammation of the lung, fibrosis, and lung cancer. How the presence of pathogenic dust is recognized and how chronic inflammatory diseases are triggered are poorly understood. Here, we show that asbestos and silica are sensed by the Nalp3 inflammasome, whose subsequent activation leads to interleukin-1 beta secretion. Inflammasome activation is triggered by reactive oxygen species, which are generated by a NADPH oxidase upon particle phagocytosis. ( NADPH is the reduced form of nicotinamide adenine dinucleotide phosphate.) In a model of asbestos inhalation, Nalp3(-/-) mice showed diminished recruitment of inflammatory cells to the lungs, paralleled by lower cytokine production. Our findings implicate the Nalp3 inflammasome in particulate matter- related pulmonary diseases and support its role as a major proinflammatory "danger" receptor.	[Dostert, Catherine; Petrilli, Virginie; Tschopp, Jurg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Van Bruggen, Robin] Sanquin Res, Dept Blood Cell Res, Amsterdam, Netherlands; [Van Bruggen, Robin] Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Steele, Chad] Univ Alabama, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Mossman, Brooke T.] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA	University of Lausanne; University of Amsterdam; Academic Medical Center Amsterdam; University of Alabama System; University of Alabama Birmingham; University of Vermont	Tschopp, J (corresponding author), Univ Lausanne, Dept Biochem, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	jurg.tschopp@unil.ch	Dostert, Catherine/AAJ-5473-2020; Petrilli, Virginie/ABI-8199-2020	Petrilli, Virginie/0000-0001-8502-6979	NCI NIH HHS [P01 CA114047-01A10002, P01 CA114047] Funding Source: Medline; NHLBI NIH HHS [P01HL67004] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA114047] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL067004] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Haegens A, 2007, J IMMUNOL, V178, P1800, DOI 10.4049/jimmunol.178.3.1800; HANSEN K, 1987, CANCER RES, V47, P1681; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; Kamp DW, 1999, THORAX, V54, P638, DOI 10.1136/thx.54.7.638; Krelin Y, 2007, CANCER RES, V67, P1062, DOI 10.1158/0008-5472.CAN-06-2956; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mossman BT, 1998, AM J RESP CRIT CARE, V157, P1666, DOI 10.1164/ajrccm.157.5.9707141; MOSSMAN BT, 1990, SCIENCE, V247, P294, DOI 10.1126/science.2153315; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; PIGUET PF, 1993, CYTOKINE, V5, P57, DOI 10.1016/1043-4666(93)90024-Y; Ramos-Nino ME, 2006, J CELL BIOCHEM, V98, P723, DOI 10.1002/jcb.20828; Rimal B, 2005, CURR OPIN PULM MED, V11, P169, DOI 10.1097/01.mcp.0000152998.11335.24; Robledo RF, 2000, AM J PATHOL, V156, P1307, DOI 10.1016/S0002-9440(10)65001-8; Sabo-Attwood T, 2005, AM J PATHOL, V167, P1243, DOI 10.1016/S0002-9440(10)61212-6; Shukla A, 2003, FREE RADICAL BIO MED, V34, P1117, DOI 10.1016/S0891-5849(03)00060-1; So A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2143; Wang YH, 2004, INT J ONCOL, V25, P173	24	1915	1989	9	235	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2008	320	5876					674	677		10.1126/science.1156995	http://dx.doi.org/10.1126/science.1156995			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18403674	Green Submitted, Green Accepted			2022-12-24	WOS:000255454300049
J	Wender, PA; Kee, JM; Warrington, JM				Wender, Paul A.; Kee, Jung-Min; Warrington, Jeffrey M.			Practical synthesis of prostratin, DPP, and their analogs, adjuvant leads against latent HIV	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PHORBOL ESTER; TUMOR PROMOTERS; SEED OIL; ACTIVATION; EXPRESSION; REACTIVATION; CHEMISTRY; RESERVOIR	Although antiretroviral therapies have been effective in decreasing active viral loads in AIDS patients, the persistence of latent viral reservoirs prevents eradication of the virus. Prostratin and DPP ( 12- deoxyphorbol- 13- phenylacetate) activate the latent virus and thus represent promising adjuvants for antiviral therapy. Their limited supply and the challenges of accessing related structures have, however, impeded therapeutic development and the search for clinically superior analogs. Here we report a practical synthesis of prostratin and DPP starting from phorbol or crotophorbolone, agents readily available from renewable sources, including a biodiesel candidate. This synthesis reliably supplies gram quantities of the therapeutically promising natural products, hitherto available only in low and variable amounts from natural sources, and opens access to a variety of new analogs.	[Wender, Paul A.; Kee, Jung-Min; Warrington, Jeffrey M.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Wender, Paul A.; Kee, Jung-Min; Warrington, Jeffrey M.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Wender, PA (corresponding author), Stanford Univ, Dept Chem, 337 Campus Dr, Stanford, CA 94305 USA.	wenderp@stanford.edu	Kee, Jung-Min/H-4798-2016; Chen, Yao/AAJ-2409-2020	Warrington, Jeff/0000-0002-2851-3110	NCI NIH HHS [R37 CA031845-28, CA31841, R37 CA031845, R01 CA031841-28, R01 CA031841, CA31845] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA031841, R37CA031845, R01CA031841, R01CA031845] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARTSCH H, 1969, Z NATURFORSCH PT B, VB 24, P91, DOI 10.1515/znb-1969-0120; Biancotto A, 2004, J VIROL, V78, P10507, DOI 10.1128/JVI.78.19.10507-10515.2004; Black H, 2004, SCIENTIST, V18, P59; Bocklandt S, 2003, ANTIVIR RES, V59, P89, DOI 10.1016/S0166-3542(03)00034-2; BOWRY VW, 1992, J AM CHEM SOC, V114, P4992, DOI 10.1021/ja00039a006; BROWN SJ, 2004, 15 INT AIDS C BANGK; BUSTON JEH, 1995, J CHEM SOC PERK T 2, P639, DOI 10.1039/p29950000639; CAIRNES DA, 1981, CANCER LETT, V14, P85, DOI 10.1016/0304-3835(81)90013-6; CASHMORE AR, 1976, TETRAHEDRON LETT, P1737, DOI 10.1016/S0040-4039(00)92940-X; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Cox PA, 2001, PHARM BIOL, V39, P33, DOI [10.1076/phbi.39.7.33.5875, 10.1076/phbi.39.s1.33.0001]; ENGEL PS, 1974, CAN J CHEM, V52, P4040, DOI 10.1139/v74-602; EVANS FJ, 1979, ACTA PHARMACOL TOX, V45, P181; Fairless D, 2007, NATURE, V449, P652, DOI 10.1038/449652a; FREEMAN JP, 1964, J ORG CHEM, V29, P1379, DOI 10.1021/jo01029a027; GSCHWEND.M, 1970, TETRAHEDRON LETT, P567; Gulakowski RJ, 1997, ANTIVIR RES, V33, P87, DOI 10.1016/S0166-3542(96)01004-2; GUSTAFSON KR, 1992, J MED CHEM, V35, P1978, DOI 10.1021/jm00089a006; Haas W, 2002, J NAT PROD, V65, P1434, DOI 10.1021/np020060d; Hezareh Marjan, 2004, Antiviral Chemistry & Chemotherapy, V15, P207; HIROTA M, 1988, CANCER RES, V48, P5800; Hongpaisan J, 2007, P NATL ACAD SCI USA, V104, P19571, DOI 10.1073/pnas.0709311104; Hook BDA, 2005, J ORG CHEM, V70, P7558, DOI 10.1021/jo050705p; Korin YD, 2002, J VIROL, V76, P8118, DOI 10.1128/JVI.76.16.8118-8123.2002; Kulkosky J, 2004, AIDS RES HUM RETROV, V20, P497, DOI 10.1089/088922204323087741; Kulkosky J, 2001, BLOOD, V98, P3006, DOI 10.1182/blood.V98.10.3006; LAURENCE J, 1990, BIOCHEM BIOPH RES CO, V166, P349, DOI 10.1016/0006-291X(90)91952-O; MIANA GA, 1985, PLANTA MED, V51, P353, DOI 10.1055/s-2007-969515; Polley H. Wayne, 2007, Ecological Society of America Annual Meeting Abstracts; Roebuck KA, 1996, AIDS, V10, P819, DOI 10.1097/00002030-199607000-00004; Rullas J, 2004, ANTIVIR THER, V9, P545; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; SZALLASI Z, 1993, CANCER RES, V53, P2507; THIELMANN HW, 1969, LIEBIGS ANN CHEM, V728, P158; Trushin SA, 2005, J VIROL, V79, P9821, DOI 10.1128/JVI.79.15.9821-9830.2005; TSENG SS, 1977, J ORG CHEM, V42, P3645, DOI 10.1021/jo00443a002; *UNAIDS WHO, AIDS EP UPD DEC 2007; Wender PA, 1997, J AM CHEM SOC, V119, P7897, DOI 10.1021/ja9706256; WENDER PA, 1990, J AM CHEM SOC, V112, P4956, DOI 10.1021/ja00168a050; WENDER PA, 1989, J AM CHEM SOC, V111, P8957, DOI 10.1021/ja00206a050; Wender Paul A, 2004, Curr Drug Discov Technol, V1, P1, DOI 10.2174/1570163043484888; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Witvrouw Myriam, 2003, Antiviral Chemistry & Chemotherapy, V14, P321; Yang QE, 2004, MED SCI MONITOR, V10, pRA155	44	151	169	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2008	320	5876					649	652		10.1126/science.1154690	http://dx.doi.org/10.1126/science.1154690			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	295DD	18451298	Green Accepted			2022-12-24	WOS:000255454300041
J	Oertel, YC; Odegbile, A				Oertel, Yolanda C.; Odegbile, Adedotun			Fine-needle aspiration in rural areas	LANCET			English	Editorial Material							FNA CYTOLOGY; DIAGNOSIS; COST		[Oertel, Yolanda C.; Odegbile, Adedotun] Washington Hosp Ctr, Washington, DC 20010 USA	MedStar Washington Hospital Center	Oertel, YC (corresponding author), Washington Hosp Ctr, Washington, DC 20010 USA.	Yolanda.C.Oertel@medstar.net						FOX CH, 1979, LANCET, V1, P1387; HAAS S, 1993, AM J MED, V94, P357, DOI 10.1016/0002-9343(93)90145-F; Lahiri S K, 2001, Indian J Public Health, V45, P43; Malami S, 2006, CANCER CYTOPATHOL, V108, P433; Malami S, 2006, CANCER CYTOPATHOL, V108, P424; Mayall F, 1998, J CLIN PATHOL, V51, P541, DOI 10.1136/jcp.51.7.541; MELKERT PWJ, 1990, ACTA CYTOL, V34, P677; OERTEL YC, 1993, SOUTHERN MED J, V86, P282, DOI 10.1097/00007611-199303000-00004; Reyes CV, 2005, AM J CLIN PATHOL, V124, P631; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Spillane AJ, 1999, AUST NZ J SURG, V69, P178, DOI 10.1046/j.1440-1622.1999.01518.x; Thomas JO, 1999, CYTOPATHOLOGY, V10, P206, DOI 10.1046/j.1365-2303.1999.00187.x; Zardawi IM, 1998, ACTA CYTOL, V42, P899, DOI 10.1159/000331965	13	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 5	2008	371	9619					1147	1148		10.1016/S0140-6736(08)60503-6	http://dx.doi.org/10.1016/S0140-6736(08)60503-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	287ZM	18395564				2022-12-24	WOS:000254956000009
J	Martinez-Gonzalez, MA; de la Fuente-Arrillaga, C; Nunez-Cordoba, JM; Basterra-Gortari, FJ; Beunza, JJ; Vazquez, Z; Benito, S; Tortosa, A; Bes-Rastrollo, M				Martinez-Gonzalez, M. A.; de la Fuente-Arrillaga, C.; Nunez-Cordoba, J. M.; Basterra-Gortari, F. J.; Beunza, J. J.; Vazquez, Z.; Benito, S.; Tortosa, A.; Bes-Rastrollo, M.			Adherence to Mediterranean diet and risk of developing diabetes: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; VIRGIN OLIVE OIL; LIFE-STYLE; MYOCARDIAL-INFARCTION; ENDOTHELIAL DYSFUNCTION; PLASMA-CONCENTRATIONS; MONOUNSATURATED-FAT; METABOLIC SYNDROME; SURVIVAL; INFLAMMATION	Objective To assess the relation between adherence to a Mediterranean diet and the incidence of diabetes among initially healthy participants. Design Prospective cohort study with estimates of relative risk adjusted for sex, age, years of university education, total energy intake, body mass index, physical activity, sedentary habits, smoking, family history of diabetes, and personal history of hypertension. Setting Spanish university department. Participants 13 380 Spanish university graduates without diabetes at baseline followed up fora median of 4.4 years. Main outcome measures Dietary habits assessed at baseline with a validated 136 item food frequency questionnaire and scored on a nine point index. New cases of diabetes confirmed through medical reports and an additional detailed questionnaire posted to those who self reported a new diagnosis of diabetes by a doctor during follow-up. Confirmed cases of type 2 diabetes. Results Participants who adhered closely to a Mediterranean diet had a lower risk of diabetes. The incidence rate ratios adjusted for sex and age were 0.41 (95% confidence interval 0.19 to 0.87) for those with moderate adherence (score 3-6) and 0.17 (0.04 to 0.75) for those with the highest adherence (score 7-9) compared with those with low adherence (score <3). In the fully adjusted analyses the results were similar. A two point increase in the score was associated with a 35% relative reduction in the risk of diabetes (incidence rate ratio 0.65, 0.44 to 0.95), with a significant inverse linear trend (P=0.04) in the multivariate analysis. Conclusion Adherence to a Mediterranean diet is associated with a reduced risk of diabetes.	[Martinez-Gonzalez, M. A.; de la Fuente-Arrillaga, C.; Nunez-Cordoba, J. M.; Basterra-Gortari, F. J.; Beunza, J. J.; Vazquez, Z.; Benito, S.; Tortosa, A.; Bes-Rastrollo, M.] Univ Navarra, Sch Med, Clin Univ, Dept Prevent Med & Publ Hlth, E-31080 Pamplona, Spain; [Nunez-Cordoba, J. M.] Hosp Virgen Camino, Dept Prevent Med & Qual Management, Pamplona, Spain; [Basterra-Gortari, F. J.] Hosp Navarra, Dept Endocrinol, Pamplona, Spain	University of Navarra; Hospital Virgen del Camino; Servicio Navarro de Salud - Osasunbidea; Servicio Navarro de Salud - Osasunbidea	Martinez-Gonzalez, MA (corresponding author), Univ Navarra, Sch Med, Clin Univ, Dept Prevent Med & Publ Hlth, E-31080 Pamplona, Spain.	mamartinez@unav.es	Beunza, Juan-Jose/ABF-4650-2020; Bes-Rastrollo, Maira/A-1329-2009; Vázquez-Ruiz, Zenaida/AAB-7202-2020; Martinez-Gonzalez, Miguel A./AAE-7669-2019	Bes-Rastrollo, Maira/0000-0002-9139-4206; Vázquez-Ruiz, Zenaida/0000-0002-6828-9627; Beunza, Juan-Jose/0000-0001-8192-2952; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808				Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Alberti KGMM, 2007, DIABETIC MED, V24, P451, DOI 10.1111/j.1464-5491.2007.02157.x; Bach A, 2006, PUBLIC HEALTH NUTR, V9, P132, DOI 10.1079/PHN2005936; Bes-Rastrollo M., 2005, REV ESP OBES, V3, P352; Biesalski H. K., 2004, European Journal of Nutrition, V43, DOI 10.1007/s00394-004-0493-z; Biesalski HK, 2004, EUR J NUTR, V43, P26, DOI 10.1007/s00394-004-1106-6; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; Esposito K, 2004, JAMA-J AM MED ASSOC, V292, P1440, DOI 10.1001/jama.292.12.1440; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; Fito M, 2008, EUR J CLIN NUTR, V62, P570, DOI 10.1038/sj.ejcn.1602724; Fung TT, 2005, AM J CLIN NUTR, V82, P163; Garg A, 1998, AM J CLIN NUTR, V67, p577S, DOI 10.1093/ajcn/67.3.577S; Gonzalez-Clemente JM, 2007, REV ESP CARDIOL, V60, P1167, DOI 10.1157/13111789; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Iestra J, 2006, EUR J CARDIOV PREV R, V13, P894, DOI 10.1097/01.hjr.0000201517.36214.ba; *INT DIAB FED, 2006, DIAB ATL; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Lopez-Garcia E, 2004, AM J CLIN NUTR, V80, P1029, DOI 10.1093/ajcn/80.4.1029; Mantzoros CS, 2006, AM J CLIN NUTR, V84, P328; Martinez-Gonzalez MA, 2005, PUBLIC HEALTH NUTR, V8, P920, DOI 10.1079/PHN2005745; Martinez-Gonzalez MA, 2004, EUR J EPIDEMIOL, V19, P9, DOI 10.1023/B:EJEP.0000013351.60227.7b; Martinez-Gonzalez MA, 2002, EUR J NUTR, V41, P153, DOI 10.1007/s00394-002-0370-6; Martinez-Gonzalez MA, 2002, NUTR NEUROSCI, V5, P65, DOI 10.1080/10284150290007047; MARTINMORENO JM, 1993, INT J EPIDEMIOL, V22, P512, DOI 10.1093/ije/22.3.512; Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978; Mitrou PN, 2007, ARCH INTERN MED, V167, P2461, DOI 10.1001/archinte.167.22.2461; Mozaffarian D, 2007, LANCET, V370, P667, DOI 10.1016/S0140-6736(07)61343-9; Paniagua JA, 2007, J AM COLL NUTR, V26, P434, DOI 10.1080/07315724.2007.10719633; Perez-Jimenez F, 2005, EUR J CLIN INVEST, V35, P421, DOI 10.1111/j.1365-2362.2005.01516.x; Perez-Jimenez F, 2002, ATHEROSCLEROSIS, V163, P385, DOI 10.1016/S0021-9150(02)00033-3; Perez-Martinez P, 2007, ATHEROSCLEROSIS, V194, pE141, DOI 10.1016/j.atherosclerosis.2006.11.033; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Rocca AS, 2001, ENDOCRINOLOGY, V142, P1148, DOI 10.1210/en.142.3.1148; Ros E, 2003, AM J CLIN NUTR, V78, p617S, DOI 10.1093/ajcn/78.3.617S; SALASSALVADO J, 2007, EUR J CLIN NUTR 0418; Salmeron J, 2001, AM J CLIN NUTR, V73, P1019; Schroder H, 2007, J NUTR BIOCHEM, V18, P149, DOI 10.1016/j.jnutbio.2006.05.006; Schulze MB, 2007, ARCH INTERN MED, V167, P956, DOI 10.1001/archinte.167.9.956; Segui-Gomez M, 2006, INT J EPIDEMIOL, V35, P1417, DOI 10.1093/ije/dyl223; Tortosa A, 2007, DIABETES CARE, V30, P2957, DOI 10.2337/dc07-1231; Trichopoulou A, 2007, EUR J EPIDEMIOL, V22, P871, DOI 10.1007/s10654-007-9190-6; Trichopoulou A, 2005, ARCH INTERN MED, V165, P929, DOI 10.1001/archinte.165.8.929; TRICHOPOULOU A, 1995, BMJ-BRIT MED J, V311, P1457, DOI 10.1136/bmj.311.7018.1457; Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Willett WC, 2006, PUBLIC HEALTH NUTR, V9, P105, DOI 10.1079/PHN2005931	48	343	345	0	45	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2008	336	7657					1348	1351		10.1136/bmj.39561.501007.BE	http://dx.doi.org/10.1136/bmj.39561.501007.BE			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	316YB	18511765	Bronze, Green Published, Green Submitted			2022-12-24	WOS:000256984700039
J	Soutoglou, E; Misteli, T				Soutoglou, Evi; Misteli, Tom			Activation of the cellular DNA damage response in the absence of DNA lesions	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX; MDC1; CHECKPOINT; ATM; PHOSPHORYLATION; 53BP1; RECOGNITION; MACHINERY; RETENTION	The cellular DNA damage response (DDR) is initiated by the rapid recruitment of repair factors to the site of DNA damage to form a multiprotein repair complex. How the repair complex senses damaged DNA and then activates the DDR is not well understood. We show that prolonged binding of DNA repair factors to chromatin can elicit the DDR in an ATM (ataxia telangiectasia mutated)- and DNAPK (DNA-dependent protein kinase)-dependent manner in the absence of DNA damage. Targeting of single repair factors to chromatin revealed a hierarchy of protein interactions within the repair complex and suggests amplification of the damage signal. We conclude that activation of the DDR does not require DNA damage and stable association of repair factors with chromatin is likely a critical step in triggering, amplifying, and maintaining the DDR signal.	[Soutoglou, Evi; Misteli, Tom] NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Soutoglou, E (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	soutogle@mail.nih.gov; mistelit@mail.nih.gov		Soutoglou, Evi/0000-0002-3724-5613	NATIONAL CANCER INSTITUTE [ZIABC010309] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 BC010309-09] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Lukas J, 2004, CELL, V118, P666, DOI 10.1016/j.cell.2004.09.006; Monier K, 2007, J CELL SCI, V120, P101, DOI 10.1242/jcs.03326; Peng AM, 2003, J BIOL CHEM, V278, P8873, DOI 10.1074/jbc.C300001200; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Shiloh Y, 2003, CELL CYCLE, V2, P116, DOI 10.4161/cc.2.2.342; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038	21	234	236	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 13	2008	320	5882					1507	1510		10.1126/science.1159051	http://dx.doi.org/10.1126/science.1159051			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	312MV	18483401	Green Accepted			2022-12-24	WOS:000256676400048
J	Murayama, A; Ohmori, K; Fujimura, A; Minami, H; Yasuzawa-Tanaka, K; Kuroda, T; Oie, S; Daitoku, H; Okuwaki, M; Nagata, K; Fukamizu, A; Kimura, K; Shimizu, T; Yanagisawa, J				Murayama, Akiko; Ohmori, Kazuji; Fujimura, Akiko; Minami, Hiroshi; Yasuzawa-Tanaka, Kayoko; Kuroda, Takao; Oie, Shohei; Daitoku, Hiroaki; Okuwaki, Mitsuru; Nagata, Kyosuke; Fukamizu, Akiyoshi; Kimura, Keiji; Shimizu, Toshiyuki; Yanagisawa, Junn			Epigenetic control of rDNA loci in response to intracellular energy status	CELL			English	Article							RNA-POLYMERASE-I; HISTONE METHYLTRANSFERASE; HETEROCHROMATIN FORMATION; NUCLEOLAR DOMINANCE; CALORIE RESTRICTION; GENE-TRANSCRIPTION; LYSINE METHYLATION; CATALYTIC DOMAIN; CELL-SURVIVAL; YEAST	Intracellular energy balance is important for cell survival. In eukaryotic cells, the most energy-consuming process is ribosome biosynthesis, which adapts to changes in intracellular energy status. However, the mechanism that links energy status and ribosome biosynthesis is largely unknown. Here, we describe eNoSC, a protein complex that senses energy status and controls rRNA transcription. eNoSC contains Nucleomethylin, which binds histone H3 dimethylated Lys9 in the rDNA locus, in a complex with SIRT1 and SUV39H1. Both SIRT1 and SUV39H1 are required for energy-dependent transcriptional repression, suggesting that a change in the NAD(+)/NADH ratio induced by reduction of energy status could activate SIRT1, leading to deacetylation of histone H3 and dimethylation at Lys9 by SUV39H1, thus establishing silent chromatin in the rDNA locus. Furthermore, eNoSC promotes restoration of energy balance by limiting rRNA transcription, thus protecting cells from energy deprivation-dependent apoptosis. These findings provide key insight into the mechanisms of energy homeostasis in cells.	[Murayama, Akiko; Ohmori, Kazuji; Fujimura, Akiko; Yasuzawa-Tanaka, Kayoko; Kuroda, Takao; Oie, Shohei; Kimura, Keiji; Yanagisawa, Junn] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Murayama, Akiko; Daitoku, Hiroaki; Fukamizu, Akiyoshi] Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058572, Japan; [Okuwaki, Mitsuru; Nagata, Kyosuke] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058572, Japan; [Okuwaki, Mitsuru; Nagata, Kyosuke] Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058572, Japan; [Minami, Hiroshi; Shimizu, Toshiyuki] Yokohama City Univ, Int Grad Sch Arts & Sci, Kanagawa 2300045, Japan; [Murayama, Akiko; Ohmori, Kazuji] JST, PRESTO, Saitama, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tsukuba; Yokohama City University; Japan Science & Technology Agency (JST)	Yanagisawa, J (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	junny@agbi.tsukuba.ac.jp	Okuwaki, Mitsuru/R-3038-2019; fukamizu, akiyoshi/J-5350-2012	Okuwaki, Mitsuru/0000-0003-2118-442X; fukamizu, akiyoshi/0000-0002-8786-6020				Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bousquet-Antonelli C, 2000, RNA, V6, P826, DOI 10.1017/S1355838200992288; Buck SW, 2002, CELL, V111, P1003, DOI 10.1016/S0092-8674(02)01193-5; Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fingerman IM, 2007, GENE DEV, V21, P2018, DOI 10.1101/gad.1560607; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Guarente L, 2000, GENE DEV, V14, P1021; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; McStay B, 2006, GENE DEV, V20, P1207, DOI 10.1101/gad.1436906; Mekhail K, 2006, CELL CYCLE, V5, P2401, DOI 10.4161/cc.5.20.3387; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; MURAMATSU M, 1964, CANCER RES, V24, P1028; Muth V, 2001, EMBO J, V20, P1353, DOI 10.1093/emboj/20.6.1353; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Oakes ML, 2006, MOL CELL BIOL, V26, P3889, DOI 10.1128/MCB.26.10.3889-3901.2006; Preuss S, 2007, BBA-GENE STRUCT EXPR, V1769, P383, DOI 10.1016/j.bbaexp.2007.02.005; ROUSSEL P, 1993, J CELL SCI, V104, P327; Sandmeier JJ, 2002, EMBO J, V21, P4959, DOI 10.1093/emboj/cdf498; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Santoro R, 2005, MOL CELL BIOL, V25, P2539, DOI 10.1128/MCB.25.7.2539-2546.2005; Sawada K, 2004, J BIOL CHEM, V279, P43296, DOI 10.1074/jbc.M405902200; SCHLUCKEBIER G, 1995, J MOL BIOL, V247, P16, DOI 10.1006/jmbi.1994.0117; Shankaranarayana GD, 2003, CURR BIOL, V13, P1240, DOI 10.1016/S0960-9822(03)00489-5; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Strohner R, 2001, EMBO J, V20, P4892, DOI 10.1093/emboj/20.17.4892; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Yang TL, 2006, TRENDS ENDOCRIN MET, V17, P186, DOI 10.1016/j.tem.2006.04.002; Yuan XJ, 2007, MOL CELL, V27, P585, DOI 10.1016/j.molcel.2007.06.021	42	288	292	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 16	2008	133	4					627	639		10.1016/j.cell.2008.03.030	http://dx.doi.org/10.1016/j.cell.2008.03.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485871	Bronze			2022-12-24	WOS:000255903300018
J	Schweitzer, SO				Schweitzer, Stuart O.			Trying times at the FDA - The challenge of ensuring the safety of imported pharmaceuticals	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif Los Angeles, Sch Publ Hlth, Dept Hlth Serv, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Schweitzer, SO (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth, Dept Hlth Serv, Los Angeles, CA 90024 USA.							BARNES K, 2006, US EU PHARMA TRADE B; BOGDANICH W, 2008, NY TIMES        0320; BOGDANICH W, 2008, NY TIMES        0229; *COMM EN COMM, 2007, GAO08224T; *FOOD DRUG ADM, 2004, RISK BAS METH PRIOR	5	9	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 24	2008	358	17					1773	+		10.1056/NEJMp0802041	http://dx.doi.org/10.1056/NEJMp0802041			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PL	18434648				2022-12-24	WOS:000255209200001
J	Bernheim, JL; Deschepper, R; Distelmans, W; Mullie, A; Bilsen, J; Deliens, L				Bernheim, Jan L.; Deschepper, Reginald; Distelmans, Wim; Mullie, Arsene; Bilsen, Johan; Deliens, Luc			Development of palliative care and legalisation of euthanasia: antagonism or synergy?	BRITISH MEDICAL JOURNAL			English	Editorial Material							EUROPEAN COUNTRIES; TASK-FORCE; BELGIUM; NETHERLANDS; ETHICS		[Bernheim, Jan L.; Deschepper, Reginald; Distelmans, Wim; Mullie, Arsene; Bilsen, Johan; Deliens, Luc] Vrije Univ Brussels, Dept Med Sociol & Hlth Sci, End Life Care Res Grp, B-1090 Brussels, Belgium	Vrije Universiteit Brussel	Bernheim, JL (corresponding author), Vrije Univ Brussels, Dept Med Sociol & Hlth Sci, End Life Care Res Grp, Laarbeeklaan 103, B-1090 Brussels, Belgium.	jan.bernheim@vub.ac.be	Deschepper, Reginald/B-8103-2013	Deschepper, Reginald/0000-0002-4222-3945; Bernheim, Jan/0000-0003-1610-5790; Deliens, Luc/0000-0002-8158-2422				*BELG MED DISC BOA, 2003, REC REG PALL CAR EUT; Bernheim J. L., 1996, WAARDIG STERVEN, P67; Bernheim JL, 1990, BIOETHIEK, P103; BILSEN J, 2007, SOC SCI MED     0507; Broeckaert B, 2001, EUR J HEALTH LAW, V8, P95; Broeckaert Bert, 2002, Ethical Perspect, V9, P156, DOI 10.2143/EP.9.2.503854; Broekaert B., 2005, EUTHANASIA PALLIATIV, P35; *CATH U LEUV AC CT, 2003, POS MED END OF LIF D; Centeno C, 2007, PALLIATIVE MED, V21, P463, DOI 10.1177/0269216307081942; CHILDRESS JF, 1998, REGULATING WE DIE ET, P120; Clark D, 2000, PALLIATIVE MED, V14, P479, DOI 10.1191/026921600701536408; DEKEYSER E, 2003, NIEUW JURIDISCH WEEK, V2, P1067; Deliens L, 2003, LANCET, V362, P1239, DOI 10.1016/S0140-6736(03)14520-5; Deliens L, 2000, LANCET, V356, P1806, DOI 10.1016/S0140-6736(00)03233-5; DESCHEPPER R, 2003, CAREFULLY DYING HOME; DISTELMANS W, 2008, BELG J MED ONCOL, V2, P16; DISTELMANS W, 2004, TIJDSCHR VR GK, V60, P232; DISTELMANS W, 2005, EUR J PALLIAT CARE, V12, P170; *EUR ASS PALL CAR, EAPC TASKF PALL CAR; *FLEM PALL CAR FED, 2003, DEAL EUTH OTH KINDS; Gastmans C, 2004, J MED ETHICS, V30, P212, DOI 10.1136/jme.2003.005082; Gastmans Chris, 2002, Ethical Perspect, V9, P134, DOI 10.2143/EP.9.2.503852; Hamel R, 1998, Health Prog, V79, P54; HOTTOIS G, 1988, BIOETHIQUE LIBRE EXA; Hurst SA, 2006, PALLIATIVE MED, V20, P107, DOI 10.1191/0269216306pm1109oa; LEONTINE S, 1996, WHY EUTHANASIA YET; Loop J, 2003, PALLIATIVE MED, V17, P174, DOI 10.1191/0269216303pm727op; Materstvedt LJ, 2003, PALLIATIVE MED, V17, P97, DOI 10.1191/0269216303pm673oa; Schotsmans P, 2005, EUTHANASIA PALLIATIV; SUZANNE C, 1990, EUTHANASIE; van der Heide A, 2003, LANCET, V362, P345, DOI 10.1016/S0140-6736(03)14019-6; van der Heide A, 2007, NEW ENGL J MED, V356, P1957, DOI 10.1056/NEJMsa071143	32	68	70	5	19	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 19	2008	336	7649					864	867		10.1136/bmj.39497.397257.AD	http://dx.doi.org/10.1136/bmj.39497.397257.AD			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	290QH	18420693	Green Published			2022-12-24	WOS:000255136800031
J	Iglesias-Rodriguez, MD; Halloran, PR; Rickaby, REM; Hall, IR; Colmenero-Hidalgo, E; Gittins, JR; Green, DRH; Tyrrell, T; Gibbs, SJ; von Dassow, P; Rehm, E; Armbrust, EV; Boessenkool, KP				Iglesias-Rodriguez, M. Debora; Halloran, Paul R.; Rickaby, Rosalind E. M.; Hall, Ian R.; Colmenero-Hidalgo, Elena; Gittins, John R.; Green, Darryl R. H.; Tyrrell, Toby; Gibbs, Samantha J.; von Dassow, Peter; Rehm, Eric; Armbrust, E. Virginia; Boessenkool, Karin P.			Phytoplankton calcification in a high-CO2 world	SCIENCE			English	Article							EMILIANIA-HUXLEYI; CARBONATE; CO2; SEDIMENTS; OCEAN; FEEDBACK; LIGHT	Ocean acidification in response to rising atmospheric CO2 partial pressures is widely expected to reduce calcification by marine organisms. From the mid- Mesozoic, coccolithophores have been major calcium carbonate producers in the world's oceans, today accounting for about a third of the total marine CaCO3 production. Here, we present laboratory evidence that calcification and net primary production in the coccolithophore species Emiliania huxleyi are significantly increased by high CO2 partial pressures. Field evidence from the deep ocean is consistent with these laboratory conclusions, indicating that over the past 220 years there has been a 40% increase in average coccolith mass. Our findings show that coccolithophores are already responding and will probably continue to respond to rising atmospheric CO2 partial pressures, which has important implications for biogeochemical modeling of future oceans and climate.	[Iglesias-Rodriguez, M. Debora; Green, Darryl R. H.; Tyrrell, Toby; Gibbs, Samantha J.] Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; [Halloran, Paul R.; Rickaby, Rosalind E. M.] Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; [Hall, Ian R.; Colmenero-Hidalgo, Elena; Boessenkool, Karin P.] Cardiff Univ, Sch Earth Ocean & Planetary Sci, Cardiff CF10 3YE, S Glam, Wales; [von Dassow, Peter] Stn Biol Roscoff, F-29682 Roscoff, France; [Armbrust, E. Virginia] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	NERC National Oceanography Centre; University of Southampton; University of Oxford; Cardiff University; UDICE-French Research Universities; Sorbonne Universite; University of Washington; University of Washington Seattle	Iglesias-Rodriguez, MD (corresponding author), Univ Southampton, Natl Oceanog Ctr, Waterfront Campus,European Way, Southampton SO14 3ZH, Hants, England.		Hall, Ian R/C-2755-2009; Halloran, Paul R/G-3965-2012; von Dassow, Peter/A-5399-2012; Colmenero-Hidalgo, Elena/I-1634-2015	Hall, Ian R/0000-0001-6960-1419; Halloran, Paul R/0000-0002-9227-0678; Colmenero-Hidalgo, Elena/0000-0002-5449-2739; Rehm, Eric/0000-0002-8417-538X; Boessenkool, Karin/0000-0003-0887-4864; Rickaby, Rosalind/0000-0002-6095-8419; von Dassow, Peter/0000-0002-1858-1953	Natural Environment Research Council [soc010007, NER/T/S/2002/00436, soc010008, NE/C002407/1] Funding Source: researchfish; NERC [soc010007, soc010008] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Anderson TR, 2003, DEEP-SEA RES PT I, V50, P573, DOI 10.1016/S0967-0637(03)00034-7; ARCHER D, 1994, NATURE, V367, P260, DOI 10.1038/367260a0; Barker S, 2003, PHILOS T R SOC A, V361, P1977, DOI 10.1098/rsta.2003.1238; Baumann Karl-Heinz, 2005, Palaeontologische Zeitschrift, V79, P93; BEAUFORT L, GEOCHEM GEOPHY GEOSY, V8, DOI DOI 10.1029/2006GC00149; Bijma J., 1999, USE PROXIES PALEOCEA, DOI DOI 10.1007/978-3-642-58646-0_20; Boessenkool KP, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030285; Bollmann J, 2007, EARTH PLANET SC LETT, V255, P273, DOI 10.1016/j.epsl.2006.12.029; Burkhardt S, 1999, LIMNOL OCEANOGR, V44, P683, DOI 10.4319/lo.1999.44.3.0683; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Delille B, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002318; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Flores JA, 1997, MICROPALEONTOLOGY, V43, P321, DOI 10.2307/1485832; FRANKIGNOULLE M, 1994, LIMNOL OCEANOGR, V39, P458, DOI 10.4319/lo.1994.39.2.0458; Frenz M, 2005, J SEDIMENT RES, V75, P464, DOI 10.2110/jsr.2005.036; Frenz M, 2007, SEDIMENTOLOGY, V54, P391, DOI 10.1111/j.1365-3091.2006.00841.x; Gibbs SJ, 2006, SCIENCE, V314, P1770, DOI 10.1126/science.1133902; Hill M.E. III., 1975, Micropalaeontology, V21, P227, DOI 10.2307/1485025; Keeling C.D., 2005, TRENDS COMPENDIUM DA; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Langer G, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001227; McCave IN, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001284; MCINTYRE A, 1967, DEEP-SEA RES, V14, P561, DOI 10.1016/0011-7471(67)90065-4; NIMER NA, 1993, NEW PHYTOL, V123, P673, DOI 10.1111/j.1469-8137.1993.tb03776.x; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Poulton AJ, 2007, DEEP-SEA RES PT II, V54, P538, DOI 10.1016/j.dsr2.2006.12.003; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; ROYER DL, GSA TODAY, V14, DOI DOI 10.1130/1052-5173(2004)0142.0.CO;2; Sciandra A, 2003, MAR ECOL PROG SER, V261, P111, DOI 10.3354/meps261111; Trimborn S, 2007, LIMNOL OCEANOGR, V52, P2285, DOI 10.4319/lo.2007.52.5.2285; Tyrrell T, 2004, GEOCHIM COSMOCHIM AC, V68, P3521, DOI 10.1016/j.gca.2004.02.018; VANBLEIJSWIJK JDL, 1994, J PHYCOL, V30, P230; WANG HZ, 1990, J GEOL SOC LONDON, V147, P373, DOI 10.1144/gsjgs.147.2.0373; Young JR, 2000, DEEP-SEA RES PT II, V47, P1679, DOI 10.1016/S0967-0645(00)00003-5; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004; Ziveri P, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P403; Zondervan I, 2001, GLOBAL BIOGEOCHEM CY, V15, P507, DOI 10.1029/2000GB001321	38	562	588	8	479	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2008	320	5874					336	340		10.1126/science.1154122	http://dx.doi.org/10.1126/science.1154122			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZZ	18420926				2022-12-24	WOS:000255026100033
J	Christakis, NA				Christakis, Nicholas A.			Don't just blame the system	BRITISH MEDICAL JOURNAL			English	Editorial Material									Harvard Univ, Sch Med, Cambridge, MA 02138 USA; Mt Auburn Hosp, Cambridge, MA USA	Harvard University; Harvard University; Mount Auburn Hospital	Christakis, NA (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02138 USA.	christak@hcp.med.harvard.edu	Christakis, Nicholas A/B-6690-2008; Christakis, Nicholas A/C-3205-2009						0	3	5	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 5	2008	336	7647					747	747		10.1136/bmj.39534.461134.59	http://dx.doi.org/10.1136/bmj.39534.461134.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	284JW	18390523	Green Published			2022-12-24	WOS:000254703700028
J	Duffy, HS				Duffy, Heather S.			Cardiac connections - The antiarrhythmic solution?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							STEM-CELLS		[Duffy, Heather S.] Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA	Columbia University	Duffy, HS (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pharmacol, 630 W 168th St, New York, NY 10032 USA.							Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Mills WR, 2007, J MOL CELL CARDIOL, V42, P304, DOI 10.1016/j.yjmcc.2006.09.011; Murry CE, 2006, J AM COLL CARDIOL, V47, P1777, DOI 10.1016/j.jacc.2006.02.002; Roell W, 2007, NATURE, V450, P819, DOI 10.1038/nature06321; Rosen MR, 2006, CIRCULATION, V114, P1992, DOI 10.1161/CIRCULATIONAHA.106.641670	5	10	10	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 27	2008	358	13					1397	1398		10.1056/NEJMcibr0708922	http://dx.doi.org/10.1056/NEJMcibr0708922			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	278TE	18367745				2022-12-24	WOS:000254308400014
J	Ziegenfuss, JS; Biswas, R; Avery, MA; Hong, K; Sheehan, AE; Yeung, YG; Stanley, ER; Freeman, MR				Ziegenfuss, Jennifer S.; Biswas, Romi; Avery, Michelle A.; Hong, Kyoungja; Sheehan, Amy E.; Yeung, Yee-Guide; Stanley, E. Richard; Freeman, Marc R.			Draper-dependent glial phagocytic activity is mediated by Src and Syk family kinase signalling	NATURE			English	Article							EMBRYONIC DORSAL CLOSURE; CELL CORPSE ENGULFMENT; APOPTOTIC CELLS; C-ELEGANS; DROSOPHILA METAMORPHOSIS; TYROSINE KINASE; RECEPTOR; PROTEIN; REMOVAL; CED-1	The cellular machinery promoting phagocytosis of corpses of apoptotic cells is well conserved from worms to mammals. An important component is the Caenorhabditis elegans engulfment receptor CED- 1 ( ref. 1) and its Drosophila orthologue, Draper(2). The CED- 1/ Draper signalling pathway is also essential for the phagocytosis of other types of 'modified self' including necrotic cells(3), developmentally pruned axons(4,5) and dendrites(6), and axons undergoing Wallerian degeneration(7). Here we show that Drosophila Shark, a non- receptor tyrosine kinase similar to mammalian Syk and Zap- 70, binds Draper through an immunoreceptor tyrosine- based activation motif ( ITAM) in the Draper intracellular domain. We show that Shark activity is essential for Draper-mediated signalling events in vivo, including the recruitment of glial membranes to severed axons and the phagocytosis of axonal debris and neuronal cell corpses by glia. We also show that the Src family kinase ( SFK) Src42A can markedly increase Draper phosphorylation and is essential for glial phagocytic activity. We propose that ligand- dependent Draper receptor activation initiates the Src42A- dependent tyrosine phosphorylation of Draper, the association of Shark and the activation of the Draper pathway. These Draper - Src42A - Shark interactions are strikingly similar to mammalian immunoreceptor - SFK - Syk signalling events in mammalian myeloid and lymphoid cells(8,9). Thus, Draper seems to be an ancient immunoreceptor with an extracellular domain tuned to modified self, and an intracellular domain promoting phagocytosis through an ITAM- domain - SFK - Syk- mediated signalling cascade.	[Ziegenfuss, Jennifer S.; Avery, Michelle A.; Sheehan, Amy E.; Freeman, Marc R.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Biswas, Romi; Hong, Kyoungja; Yeung, Yee-Guide; Stanley, E. Richard] Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	University of Massachusetts System; University of Massachusetts Worcester; Yeshiva University; Albert Einstein College of Medicine	Freeman, MR (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	rstanley@aecom.yu.edu; marc.freeman@umassmed.edu	Stanley, Evan R/J-9154-2013	Stanley, Evan R/0000-0002-2910-2065; Freeman, Marc/0000-0003-3481-3715	NCI NIH HHS [R37 CA026504-30, 1R01CA26504, R01 CA026504, R37 CA026504] Funding Source: Medline; NIGMS NIH HHS [1R01GM55293] Funding Source: Medline; NINDS NIH HHS [R01 NS053538, 1R01NS053538] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA026504, R01CA026504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053538] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aldskogius H, 1998, PROG NEUROBIOL, V55, P1, DOI 10.1016/S0301-0082(97)00093-2; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Berton G, 2005, TRENDS IMMUNOL, V26, P208, DOI 10.1016/j.it.2005.02.002; Biswas R, 2006, DEVELOPMENT, V133, P217, DOI 10.1242/dev.02198; Chung SB, 2000, NAT CELL BIOL, V2, P931, DOI 10.1038/35046585; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Cox D, 2001, SEMIN IMMUNOL, V13, P339, DOI 10.1006/smim.2001.0330; ELLIS RE, 1991, GENETICS, V129, P79; Fadok VA, 2001, J CLIN INVEST, V108, P957, DOI 10.1172/JCI14122; Fernandez R, 2000, GENE DEV, V14, P604; FERRANTE AW, 1995, P NATL ACAD SCI USA, V92, P1911, DOI 10.1073/pnas.92.6.1911; Fodor S, 2006, IMMUNOL LETT, V104, P29, DOI 10.1016/j.imlet.2005.11.001; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Hengartner MO, 1999, RECENT PROG HORM RES, V54, P213; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; Keegan K, 1996, ONCOGENE, V12, P1537; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; LI W, 1991, J BIOL CHEM, V266, P6808; Lioubin MN, 1996, GENE DEV, V10, P1084, DOI 10.1101/gad.10.9.1084; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Pitcher LA, 2003, TRENDS IMMUNOL, V24, P554, DOI 10.1016/j.it.2003.08.003; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Su HP, 2002, J BIOL CHEM, V277, P11772, DOI 10.1074/jbc.M109336200; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035; Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	32	143	147	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 12	2008	453	7197					935	U68		10.1038/nature06901	http://dx.doi.org/10.1038/nature06901			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311WV	18432193	Green Accepted			2022-12-24	WOS:000256632000047
J	Lamb, MP; Dietrich, WE; Aciego, SM; DePaolo, DJ; Manga, M				Lamb, Michael P.; Dietrich, William E.; Aciego, Sarah M.; DePaolo, Donald J.; Manga, Michael			Formation of Box Canyon, Idaho, by megaflood: Implications for seepage erosion on Earth and Mars	SCIENCE			English	Article							SNAKE-RIVER-PLAIN; BIG-LOST-RIVER; MARTIAN VALLEYS; AGE; PLATEAU; HAWAII; HE-3	Amphitheater- headed canyons have been used as diagnostic indicators of erosion by groundwater seepage, which has important implications for landscape evolution on Earth and astrobiology on Mars. Of perhaps any canyon studied, Box Canyon, Idaho, most strongly meets the proposed morphologic criteria for groundwater sapping because it is incised into a basaltic plain with no drainage network upstream, and approximately 10 cubic meters per second of seepage emanates from its vertical headwall. However, sediment transport constraints, He-4 and C-14 dates, plunge pools, and scoured rock indicate that a megaflood ( greater than 220 cubic meters per second) carved the canyon about 45,000 years ago. These results add to a growing recognition of Quaternary catastrophic flooding in the American northwest, and may imply that similar features on Mars also formed by floods rather than seepage erosion.	[Lamb, Michael P.; Dietrich, William E.; Aciego, Sarah M.; DePaolo, Donald J.; Manga, Michael] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Lamb, MP (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	mpl@berkeley.edu	Manga, Michael/D-3847-2013	Manga, Michael/0000-0003-3286-4682				Aciego SM, 2007, EARTH PLANET SC LETT, V254, P288, DOI 10.1016/j.epsl.2006.11.039; Bathurst JC, 2002, J HYDROL, V269, P11, DOI 10.1016/S0022-1694(02)00191-9; Bretz JH, 1923, J GEOL, V31, P617, DOI 10.1086/623053; CERLING TE, 1994, GEOLOGY, V22, P227, DOI 10.1130/0091-7613(1994)022<0227:CHANAO>2.3.CO;2; Christensen PR, 2004, SPACE SCI REV, V110, P85, DOI 10.1023/B:SPAC.0000021008.16305.94; Dunne T., 1980, PROG PHYS GEOG, V4, P211, DOI [10.1177/030913338000400204, DOI 10.1177/030913338000400204, DOI 10.1016/S1546-5098(08)60146-6]; FORMAN SL, 1993, QUATERNARY RES, V40, P30, DOI 10.1006/qres.1993.1053; HARRISON KP, 2005, J GEOPHYS RES; HOWARD AD, 1988, WATER RESOUR RES, V24, P1659, DOI 10.1029/WR024i010p01659; HOWARD AD, 1994, J GEOPHYS RES-SOL EA, V99, P13971, DOI 10.1029/94JB00744; Kauffman JD, 2005, GEOLOGIC MAP TWIN FA; KOCHEL RC, 1986, J GEOPHYS RES-SOLID, V91, pE175, DOI 10.1029/JB091iB13p0E175; LAITY JE, 1985, GEOL SOC AM BULL, V96, P203, DOI 10.1130/0016-7606(1985)96<203:SPATDO>2.0.CO;2; Lamb M. P., 2006, J GEOPHYS RES, V111; Lamb MP, 2007, GEOL SOC AM BULL, V119, P805, DOI 10.1130/B25986.1; LAMB MP, 2008, J GEOPHYS RES; Luque R. F., 1976, J HYDRAUL RES, V14, P127, DOI DOI 10.1080/00221687609499677; Madsen DB, 2001, PALAEOGEOGR PALAEOCL, V167, P243, DOI 10.1016/S0031-0182(00)00240-6; MALDE HE, 1991, QUATERNARY NONGLACI, V2; MALDE HE, 1971, US GEOL SURV PROF PA, V20, P20; Malin MC, 1999, NATURE, V397, P589, DOI 10.1038/17551; OCONNOR JE, 1993, 274 GSA, P90; RATHBURN SL, 1993, GEOMORPHOLOGY, V8, P305, DOI 10.1016/0169-555X(93)90026-X; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; RUSSEL IC, 2002, US GEOL SURV B, V199, P192; SCHUMM SA, 1995, GEOMORPHOLOGY, V12, P281; Stearns HT, 1936, J GEOL, V44, P429, DOI 10.1086/624441; Tauxe L., 2004, GEOCHEM GEOPHYS GEOS, V5; TOMASKO MG, 2005, NATURE, V438; TOMASSON H, 1973, NATTURUFRAEDINGURINN, V43, P12	30	92	93	3	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2008	320	5879					1067	1070		10.1126/science.1156630	http://dx.doi.org/10.1126/science.1156630			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303RY	18497296				2022-12-24	WOS:000256059800043
J	Squyres, SW; Arvidson, RE; Ruff, S; Gellert, R; Morris, RV; Ming, DW; Crumpler, L; Farmer, JD; Des Marais, DJ; Yen, A; McLennan, SM; Calvin, W; Bell, JF; Clark, BC; Wang, A; Mccoy, TJ; Schmidt, ME; de Souza, PA				Squyres, S. W.; Arvidson, R. E.; Ruff, S.; Gellert, R.; Morris, R. V.; Ming, D. W.; Crumpler, L.; Farmer, J. D.; Des Marais, D. J.; Yen, A.; McLennan, S. M.; Calvin, W.; Bell, J. F., III; Clark, B. C.; Wang, A.; McCoy, T. J.; Schmidt, M. E.; de Souza, P. A., Jr.			Detection of silica-rich deposits on Mars	SCIENCE			English	Article							GEOTHERMAL FIELDS; GUSEV CRATER; HOT-SPRINGS; NEW-ZEALAND; PRECIPITATION; SPECTROSCOPY; MINERALOGY; POWDERS; TES	Mineral deposits on the martian surface can elucidate ancient environmental conditions on the planet. Opaline silica deposits ( as much as 91 weight percent SiO2) have been found in association with volcanic materials by the Mars rover Spirit. The deposits are present both as light- toned soils and as bedrock. We interpret these materials to have formed under hydrothermal conditions and therefore to be strong indicators of a former aqueous environment. This discovery is important for understanding the past habitability of Mars because hydrothermal environments on Earth support thriving microbial ecosystems.	[Squyres, S. W.; Bell, J. F., III] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Arvidson, R. E.; Wang, A.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Ruff, S.; Farmer, J. D.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Gellert, R.] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada; [Morris, R. V.; Ming, D. W.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Crumpler, L.] New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA; [Des Marais, D. J.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Yen, A.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [McLennan, S. M.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; [Calvin, W.] Univ Nevada, Dept Geol Sci, Reno, NV 89557 USA; [Clark, B. C.] Lockheed Martin Corp, Littleton, CO 80127 USA; [McCoy, T. J.; Schmidt, M. E.] Smithsonian Inst, Natl Museum Nat Hist, Dept Mineral Sci, Washington, DC 20560 USA; [de Souza, P. A., Jr.] CSIRO, Tasmanian Informat & Commun Technol Ctr, Hobart, Tas 7000, Australia	Cornell University; Washington University (WUSTL); Arizona State University; Arizona State University-Tempe; University of Guelph; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Nevada System of Higher Education (NSHE); University of Nevada Reno; Lockheed Martin; Smithsonian Institution; Smithsonian National Museum of Natural History; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Squyres, SW (corresponding author), Cornell Univ, Dept Astron, Space Sci Bldg, Ithaca, NY 14853 USA.	squyres@astro.cornell.edu	de Souza, Paulo/P-7294-2019; de Souza, Paulo A/B-8961-2008; Farmer, Jack D/B-9343-2019; de Souza, Paulo/W-2993-2019	de Souza, Paulo A/0000-0002-0091-8925; de Souza, Paulo/0000-0002-0091-8925; McCoy, Timothy/0000-0002-4573-3553; McLennan, Scott/0000-0003-4259-7178				ALMEIDA RM, 1992, PHYS REV B, V45, P161, DOI 10.1103/PhysRevB.45.161; Arvidson RE, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002499; Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Bell JF, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002070; Cady SL, 1996, CIBA F SYMP, V202, P150; Christensen PR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002117; DOEMEL WN, 1977, APPL ENVIRON MICROB, V34, P433, DOI 10.1128/AEM.34.4.433-452.1977; DOVE PM, 1994, REV MINERAL, V29, P259; Glotch TD, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002671; Herkenhoff KE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002076; INSKEEP WP, 2003, GEOTHERMAL BIOL GEOC; Johnson JR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029894; Kim SJ, 1999, J AM CERAM SOC, V82, P927, DOI 10.1111/j.1151-2916.1999.tb01855.x; Klingelhofer G, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002138; Kraft MD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018848; Marion GM, 2008, GEOCHIM COSMOCHIM AC, V72, P242, DOI 10.1016/j.gca.2007.10.012; Michalski JR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018354; Michalski JR, 2005, ICARUS, V174, P161, DOI 10.1016/j.icarus.2004.10.022; MILLIKEN RE, 2007, AM GEOPH UN FALL M S; Morris R.V., 2000, LUNAR PLANET SCI C, VXXXI; Murchie S, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002682; Nam HD, 1998, JPN J APPL PHYS 1, V37, P4603, DOI 10.1143/JJAP.37.4603; RICE MS, 2008, 39 ANN LUN PLAN SCI; Rieder R., 2003, Journal of Geophysical Research, V108, pROV7, DOI 10.1029/2003JE002150; Rodgers KA, 2004, EARTH-SCI REV, V66, P1, DOI 10.1016/j.earscirev.2003.10.001; Rodgers KA, 2002, CLAY MINER, V37, P299, DOI 10.1180/0009855023720035; Salisbury J.W., 1991, INFRARED 2 1 25 MUM; SALISBURY JW, 1987, J GEOPHYS RES-SOLID, V92, P702, DOI 10.1029/JB092iB01p00702; Siering PL, 2006, GEOMICROBIOL J, V23, P129, DOI 10.1080/01490450500533916; Squyres SW, 2007, SCIENCE, V316, P738, DOI 10.1126/science.1139045; Tosca NJ, 2007, GEOCHIM COSMOCHIM AC, V71, P2680, DOI 10.1016/j.gca.2007.03.020; Tosca NJ, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003019; WALTER MR, 1993, ICARUS, V101, P129, DOI 10.1006/icar.1993.1011; Yen AS, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002978	34	324	327	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2008	320	5879					1063	1067		10.1126/science.1155429	http://dx.doi.org/10.1126/science.1155429			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303RY	18497295				2022-12-24	WOS:000256059800042
J	Remaut, H; Tang, C; Henderson, NS; Pinkner, JS; Wang, T; Hultgren, SJ; Thanassi, DG; Waksman, G; Li, HL				Remaut, Han; Tang, Chunyan; Henderson, Nadine S.; Pinkner, Jerome S.; Wang, Tao; Hultgren, Scott J.; Thanassi, David G.; Waksman, Gabriel; Li, Huilin			Fiber formation across the bacterial outer membrane by the chaperone/usher pathway	CELL			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; ASSEMBLY PLATFORM FIMD; PILUS BIOGENESIS; STRUCTURAL BASIS; TYPE-1 PILI; SUBUNIT COMPLEXES; CRYSTAL-STRUCTURE; ADHESIN COMPLEX; USHER PATHWAY; DIFFRACTION	Gram-negative pathogens commonly exhibit adhesive pili on their surfaces that mediate specific attachment to the host. A major class of pili is assembled via the chaperone/usher pathway. Here, the structural basis for pilus fiber assembly and secretion performed by the outer membrane assembly platform the usher-is revealed by the crystal structure of the translocation domain of the P pilus usher PapC and single particle cryo-electron microscopy imaging of the FimD usher bound to a translocating type 1 pilus assembly intermediate. These structures provide molecular snapshots of a twinned-pore translocation machinery in action. Unexpectedly, only one pore is used for secretion, while both usher protomers are used for chaperone-subunit complex recruitment. The translocating pore itself comprises 24 beta strands and is occluded by a folded plug domain, likely gated by a conformationally constrained beta-hairpin. These structures capture the secretion of a virulence factor across the outer membrane of Gram-negative bacteria.	[Pinkner, Jerome S.; Hultgren, Scott J.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Remaut, Han; Waksman, Gabriel] UCL, Inst Struct Mol Sci, London WC1E 7HX, England; [Remaut, Han; Waksman, Gabriel] Birkbeck Coll, Inst Struct Mol Biol, London WC1E 7HX, England; [Tang, Chunyan; Wang, Tao; Li, Huilin] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Henderson, Nadine S.; Thanassi, David G.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Ctr Infect Dis, Stony Brook, NY 11794 USA; [Li, Huilin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Washington University (WUSTL); University of London; University College London; University of London; Birkbeck University London; United States Department of Energy (DOE); Brookhaven National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Hultgren, SJ (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	hultgren@borcim.wustl.edu; david.thanassi@stonybrook.edu; g.waksman@mail.cryst.bbk.ac.uk; hli@bnl.gov	Tang, Chunyan/E-8352-2010	Pinkner, Jerome/0000-0002-7389-7440; Remaut, Han/0000-0002-9775-4102; Li, Huilin/0000-0001-8085-8928	Medical Research Council [58149, G0800002] Funding Source: Medline; NIAID NIH HHS [R37 AI048689, AI049950, R37 AI029549, R01 AI029549, R01 AI049950, R01 AI048689-08, AI48689, AI029549, R01 AI048689] Funding Source: Medline; NIGMS NIH HHS [GM062987, R01 GM062987, GM074985, R01 GM074985] Funding Source: Medline; MRC [G0800002] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048689, R37AI029549, R01AI049950, R01AI029549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074985, R01GM062987] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bann JG, 2004, P NATL ACAD SCI USA, V101, P17389, DOI 10.1073/pnas.0408072101; Barnhart MM, 2000, P NATL ACAD SCI USA, V97, P7709, DOI 10.1073/pnas.130183897; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Capitani G, 2006, PROTEINS, V65, P816, DOI 10.1002/prot.21147; *CCP4 SUIT, 1994, COMPUTATIONAL PROJ D, V50, P760; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dodson KW, 2001, CELL, V105, P733, DOI 10.1016/S0092-8674(01)00388-9; DODSON KW, 1993, P NATL ACAD SCI USA, V90, P3670, DOI 10.1073/pnas.90.8.3670; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frank J, 2006, 3 DIMENSIONAL ELECT; Gumbart J, 2007, BIOPHYS J, V93, P496, DOI 10.1529/biophysj.107.104158; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; JACOBDUBUISSON F, 1994, J BIOL CHEM, V269, P12447; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; Justice SS, 2006, P NATL ACAD SCI USA, V103, P19884, DOI 10.1073/pnas.0606329104; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Knight S, 1997, ACTA CRYSTALLOGR D, V53, P207, DOI 10.1107/S0907444996011511; KUEHN MJ, 1992, NATURE, V356, P252, DOI 10.1038/356252a0; Li HL, 2004, J MOL BIOL, V344, P1397, DOI 10.1016/j.jmb.2004.10.008; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Munera D, 2007, MOL MICROBIOL, V64, P333, DOI 10.1111/j.1365-2958.2007.05657.x; Ng TW, 2004, J BACTERIOL, V186, P5321, DOI 10.1128/JB.186.16.5321-5331.2004; Nishiyama M, 2005, EMBO J, V24, P2075, DOI 10.1038/sj.emboj.7600693; Nishlyama M, 2003, J MOL BIOL, V330, P513, DOI 10.1016/S0022-2836(03)00591-6; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Remaut H, 2006, MOL CELL, V22, P831, DOI 10.1016/j.molcel.2006.05.033; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; ROBERTS JA, 1994, P NATL ACAD SCI USA, V91, P11889, DOI 10.1073/pnas.91.25.11889; Sauer FG, 2004, BBA-MOL CELL RES, V1694, P259, DOI 10.1016/j.bbamcr.2004.02.010; Sauer FG, 2002, CELL, V111, P543, DOI 10.1016/S0092-8674(02)01050-4; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Saulino ET, 2000, P NATL ACAD SCI USA, V97, P9240, DOI 10.1073/pnas.160070497; Saulino ET, 1998, EMBO J, V17, P2177, DOI 10.1093/emboj/17.8.2177; So SSK, 2006, MOL MICROBIOL, V60, P364, DOI 10.1111/j.1365-2958.2006.052111.x; Thanassi DG, 2002, J BACTERIOL, V184, P6260, DOI 10.1128/JB.184.22.6260-6269.2002; Topf M, 2005, J STRUCT BIOL, V149, P191, DOI 10.1016/j.jsb.2004.11.004; Verger D, 2007, PLOS PATHOG, V3, P674, DOI 10.1371/journal.ppat.0030073; Vetsch M, 2004, NATURE, V431, P329, DOI 10.1038/nature02891; Vetsch M, 2006, EMBO REP, V7, P734, DOI 10.1038/sj.embor.7400722; Wright KJ, 2007, CELL MICROBIOL, V9, P2230, DOI 10.1111/j.1462-5822.2007.00952.x; Zavialov AV, 2003, CELL, V113, P587, DOI 10.1016/S0092-8674(03)00351-9	45	173	176	2	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 16	2008	133	4					640	652		10.1016/j.cell.2008.03.033	http://dx.doi.org/10.1016/j.cell.2008.03.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485872	Bronze, Green Accepted			2022-12-24	WOS:000255903300019
J	Maeda, K; Henbest, KB; Cintolesi, F; Kuprov, I; Rodgers, CT; Liddell, PA; Gust, D; Timmel, CR; Hore, PJ				Maeda, Kiminori; Henbest, Kevin B.; Cintolesi, Filippo; Kuprov, Ilya; Rodgers, Christopher T.; Liddell, Paul A.; Gust, Devens; Timmel, Christiane R.; Hore, P. J.			Chemical compass model of avian magnetoreception	NATURE			English	Article							RADICAL-PAIR MECHANISM; WEAK MAGNETIC-FIELDS; ARABIDOPSIS-THALIANA; CHARGE SEPARATION; EPR SPECTROSCOPY; MIGRATORY BIRDS; EUROPEAN ROBINS; RECOMBINATION; CRYPTOCHROME; ORIENTATION	Approximately 50 species, including birds, mammals, reptiles, amphibians, fish, crustaceans and insects, are known to use the Earth's magnetic field for orientation and navigation(1). Birds in particular have been intensively studied, but the biophysical mechanisms that underlie the avian magnetic compass are still poorly understood. One proposal, based on magnetically sensitive free radical reactions(2,3), is gaining support(4-11) despite the fact that no chemical reaction in vitro has been shown to respond to magnetic fields as weak as the Earth's (similar to 50 mu T) or to be sensitive to the direction of such a field. Here we use spectroscopic observation of a carotenoid-porphyrin-fullerene model system to demonstrate that the lifetime of a photochemically formed radical pair is changed by application of <= 50 mu T magnetic fields, and to measure the anisotropic chemical response that is essential for its operation as a chemical compass sensor. These experiments establish the feasibility of chemical magnetoreception and give insight into the structural and dynamic design features required for optimal detection of the direction of the Earth's magnetic field.	[Cintolesi, Filippo; Kuprov, Ilya; Rodgers, Christopher T.; Hore, P. J.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England; [Maeda, Kiminori; Henbest, Kevin B.; Timmel, Christiane R.] Univ Oxford, Inorgan Chem Lab, Dept Chem, Oxford OX1 3QR, England; [Liddell, Paul A.; Gust, Devens] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	University of Oxford; University of Oxford; Arizona State University; Arizona State University-Tempe	Hore, PJ (corresponding author), Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, S Parks Rd, Oxford OX1 3QZ, England.	christiane.timmel@chem.ox.ac.uk; peter.hore@chem.ox.ac.uk	Timmel, Christiane/GLU-4087-2022; Rodgers, Christopher T./AAD-3344-2019; Hore, Peter/R-1923-2017; Maeda, Kiminori/A-3500-2012	Rodgers, Christopher T./0000-0003-1275-1197; Hore, Peter/0000-0002-8863-570X; Timmel, Christiane/0000-0003-1828-7700	EPSRC [EP/D048559/1, EP/F065205/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D048559/1, GR/T05424/01, EP/F065205/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Ahmad M, 2007, PLANTA, V225, P615, DOI 10.1007/s00425-006-0383-0; Brocklehurst B, 2002, CHEM SOC REV, V31, P301, DOI 10.1039/b107250c; Buchachenko AL, 2005, P NATL ACAD SCI USA, V102, P10793, DOI 10.1073/pnas.0504876102; Cintolesi F, 2003, CHEM PHYS, V294, P385, DOI 10.1016/S0301-0104(03)00320-3; Efimova O, 2008, BIOPHYS J, V94, P1565, DOI 10.1529/biophysj.107.119362; Henbest KB, 2004, J AM CHEM SOC, V126, P8102, DOI 10.1021/ja048220q; Johnsen S, 2005, NAT REV NEUROSCI, V6, P703, DOI 10.1038/nrn1745; Kodis G, 2004, J PHYS ORG CHEM, V17, P724, DOI 10.1002/poc.787; Kuciauskas D, 1998, J AM CHEM SOC, V120, P10880, DOI 10.1021/ja981848e; Liddell PA, 1997, J AM CHEM SOC, V119, P1400, DOI 10.1021/ja9631054; Moller A, 2004, NATURWISSENSCHAFTEN, V91, P585, DOI 10.1007/s00114-004-0578-9; Mouritsen H, 2004, P NATL ACAD SCI USA, V101, P14294, DOI 10.1073/pnas.0405968101; Poluektov OG, 2005, J AM CHEM SOC, V127, P11910, DOI 10.1021/ja053315t; Prabhakar R, 2002, J PHYS CHEM B, V106, P3742, DOI 10.1021/jp014013q; Ritz T, 2004, NATURE, V429, P177, DOI 10.1038/nature02534; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Rodgers CT, 2007, J AM CHEM SOC, V129, P6746, DOI 10.1021/ja068209l; Rodgers CT, 2005, J PHYS CHEM A, V109, P5035, DOI 10.1021/jp050765z; SCHULTEN K, 1978, Z PHYS CHEM NEUE FOL, V111, P1, DOI 10.1524/zpch.1978.111.1.001; Solov'yov IA, 2007, BIOPHYS J, V92, P2711, DOI 10.1529/biophysj.106.097139; Thalau P, 2005, NATURWISSENSCHAFTEN, V92, P86, DOI 10.1007/s00114-004-0595-8; Timmel CR, 1998, MOL PHYS, V95, P71, DOI 10.1080/00268979809483134; Timmel CR, 2004, PHILOS T ROY SOC A, V362, P2573, DOI 10.1098/rsta.2004.1459; van Dijk B, 1998, J PHYS CHEM B, V102, P464, DOI 10.1021/jp9721816; Wang K, 2006, PHYS BIOL, V3, P220, DOI 10.1088/1478-3975/3/3/007; Weaver JC, 2000, NATURE, V405, P707, DOI 10.1038/35015128; Weber S, 2005, BBA-BIOENERGETICS, V1707, P1, DOI 10.1016/j.bbabio.2004.02.010; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; Wiltschko W, 2001, J EXP BIOL, V204, P3295	29	356	361	10	335	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 15	2008	453	7193					387	U38		10.1038/nature06834	http://dx.doi.org/10.1038/nature06834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18449197				2022-12-24	WOS:000255868400051
J	Pronovost, PJ; Goeschel, CA; Wachter, RM				Pronovost, Peter J.; Goeschel, Christine A.; Wachter, Robert M.			The wisdom and justice of not paying for "preventable complications"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICAL-CARE; PERFORMANCE; INFECTIONS; TRAUMA; RATES		[Pronovost, Peter J.; Goeschel, Christine A.] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA; [Pronovost, Peter J.] Johns Hopkins Univ, Dept Surg, Baltimore, MD USA; [Pronovost, Peter J.] Johns Hopkins Univ, Dept Hlth Policy & Management, Baltimore, MD 21218 USA; [Goeschel, Christine A.] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21218 USA; [Wachter, Robert M.] Univ Calif San Francisco, Div Hosp Med, San Francisco, CA 94143 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of California System; University of California San Francisco	Pronovost, PJ (corresponding author), Johns Hopkins Med Inst, Dept Anesthesiol & Crit Care Med, 1909T Hames St,2nd Floor, Baltimore, MD 21231 USA.	ppronov1@jhmi.edu	Goeschel, Christine/AAA-6783-2020					Berwick DM, 2008, JAMA-J AM MED ASSOC, V299, P1182, DOI 10.1001/jama.299.10.1182; Epstein AM, 2006, NEW ENGL J MED, V355, P406, DOI 10.1056/NEJMe068131; Haut ER, 2007, J TRAUMA, V63, P1132, DOI 10.1097/TA.0b013e31814856ad; Hayward RA, 2007, HEALTH SERV RES, V42, P1718, DOI 10.1111/j.1475-6773.2006.00661.x; Klompas M, 2007, ANN INTERN MED, V147, P803, DOI 10.7326/0003-4819-147-11-200712040-00013; Larson DM, 2007, JAMA-J AM MED ASSOC, V298, P2754, DOI 10.1001/jama.298.23.2754; Lawthers AG, 2000, MED CARE, V38, P785, DOI 10.1097/00005650-200008000-00003; Lilford R, 2004, LANCET, V363, P1147, DOI 10.1016/S0140-6736(04)15901-1; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Smith GCS, 2003, BRIT MED J, V327, P1459, DOI 10.1136/bmj.327.7429.1459; Swoboda Sandra M, 2006, Surg Infect (Larchmt), V7, P331, DOI 10.1089/sur.2006.7.331; Wachter RM, 2008, JT COMM J QUAL PATIE, V34, P116, DOI 10.1016/S1553-7250(08)34014-8; Wald HL, 2007, JAMA-J AM MED ASSOC, V298, P2782, DOI 10.1001/jama.298.23.2782; Zhan CL, 2007, JT COMM J QUAL PATIE, V33, P326, DOI 10.1016/S1553-7250(07)33037-7	14	106	106	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2008	299	18					2197	2199		10.1001/jama.299.18.2197	http://dx.doi.org/10.1001/jama.299.18.2197			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299XX	18477787				2022-12-24	WOS:000255790000028
J	England, R				England, Roger			The writing is on the wall for UNAIDS	BRITISH MEDICAL JOURNAL			English	Editorial Material												roger.england@healthsystemsworkshop.org							0	54	54	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 10	2008	336	7652					1072	1072		10.1136/bmj.39569.497708.94	http://dx.doi.org/10.1136/bmj.39569.497708.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	304IN	18467417	Green Published			2022-12-24	WOS:000256103300034
J	Jahn, A; Floyd, S; Crampin, AC; Mwaungulu, F; Mvula, H; Munthali, F; McGrath, N; Mwafilaso, J; Mwinuka, V; Mangongo, B; Fine, PEM; Zaba, B; Glynn, JR				Jahn, Andreas; Floyd, Sian; Crampin, Amelia C.; Mwaungulu, Frank; Mvula, Hazzie; Munthali, Fipson; McGrath, Nuala; Mwafilaso, Johnbosco; Mwinuka, Venance; Mangongo, Bernard; Fine, Paul E. M.; Zaba, Basia; Glynn, Judith R.			Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi	LANCET			English	Article							KARONGA DISTRICT; SOUTH-AFRICA; PREVALENCE; LEPROSY; EPIDEMIC; IMPACT	Background Malawi, which has about 80000 deaths from AIDS every year, made free antiretroviral therapy available to more than 80000 patients between 2004 and 2006. We aimed to investigate mortality in a population before and after the introduction of free antiretroviral therapy, and therefore to assess the effects of such programmes on survival at the population level. Methods We used a demographic surveillance system to measure mortality in a population of 32 000 in northern Malawi, from August, 2002, when free antiretroviral therapy was not available in the study district, until February, 2006, 8 months after a clinic opened. Causes of death were established through verbal autopsies (retrospective interviews). Patients who registered for antiretroviral therapy at the clinic were identified and linked to the population under surveillance. Trends in mortality were analysed by age, sex, cause of death, and zone of residence. Findings Before antiretroviral therapy became available in June, 2005, mortality in adults (aged 15-59 years) was 9.8 deaths for 1000 person-years of observation (95% CI 8.9-10.9). The probability of dying between the ages of 15 and 60 years was 43% (39-49) for men and 43% (38-47) for women; 229 of 352 deaths (65 . 1%) were attributed to AIDS. 8 months after the clinic that provided antiretroviral therapy opened, 107 adults from the study population had accessed treatment, out of an estimated 334 in need of treatment. Overall mortality in adults had decreased by 10% from 10 . 2 to 8.7 deaths for 1000 person-years of observation (adjusted rate ratio 0 . 90, 95% Cl 0 . 70-1.14). Mortality was reduced by 35% (adjusted rate ratio 0 . 65, 0.46.0 . 92) in adults near the main road, where mortality before antiretroviral therapy was highest (from 13.2 to 8.5 deaths per 1000 person-years of observation before and after antiretroviral therapy). Mortality in adults aged 60 years or older did not change. Interpretation Our findings of a reduction in mortality in adults aged between 15 and 59 years, with no change in those older than 60 years, suggests that deaths from AIDS were averted by the rapid scale-up of free antiretroviral therapy in rural Malawi, which led to a decline in adult mortality that was detectable at the population level. Funding Wellcome Trust and British Leprosy Relief Association.	[Jahn, Andreas; Floyd, Sian; Crampin, Amelia C.; McGrath, Nuala; Fine, Paul E. M.; Zaba, Basia; Glynn, Judith R.] Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1E 7HT, England; [Mwaungulu, Frank; Mvula, Hazzie; Munthali, Fipson; Mwafilaso, Johnbosco; Mwinuka, Venance; Mangongo, Bernard] Karonga Prevent Study, Karonga, Malawi	University of London; London School of Hygiene & Tropical Medicine; Malawi Epidemiology and Intervention Research Unit	Jahn, A (corresponding author), Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, Keppel St, London WC1E 7HT, England.	andreas.jahn@lshtm.ac.uk	Jahn, Andreas/ABB-7796-2020	Jahn, Andreas/0000-0003-4645-1600; Crampin, Amelia/0000-0002-1513-4330; McGrath, Nuala/0000-0002-1039-0159	Wellcome Trust [075886, 079828] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adjuik M, 2006, B WORLD HEALTH ORGAN, V84, P181, DOI 10.2471/BLT.05.026492; Blacker J, 2004, AIDS, V18, pS19, DOI 10.1097/00002030-200406002-00003; BLACKER J, 1997, HLTH T REV S2, V7, P45; BOERMA JT, 1998, AIDS S1, V12, P3; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Chan KCW, 2006, HIV MED, V7, P186, DOI 10.1111/j.1468-1293.2006.00352.x; CHIMZIZI R, 2003, REPORT COUNTRY WIDE; CHIPETA J, 2005, MALAWI DEMOGRAPHIC H, P225; Crampin AC, 2003, AIDS, V17, P1817, DOI 10.1097/00002030-200308150-00011; FINE PEM, 1988, T ROY SOC TROP MED H, V82, P810, DOI 10.1016/0035-9203(88)90003-X; FINE PEM, 1986, LANCET, V2, P499, DOI 10.1016/S0140-6736(86)90367-3; Glynn JR, 2001, AIDS, V15, P2025, DOI 10.1097/00002030-200110190-00016; Glynn JR, 1998, B WORLD HEALTH ORGAN, V76, P295; Harries AD, 2006, LANCET, V367, P1870, DOI 10.1016/S0140-6736(06)68809-0; Hosegood V, 2004, AIDS, V18, P663, DOI 10.1097/00002030-200403050-00011; *INDEPTH NETW, 2003, INDEPTH STAND VERB A; Jahn A, 2007, DEMOGR RES, V16, P219, DOI 10.4054/DemRes.2007.16.8; Kahn K, 2000, TROP MED INT HEALTH, V5, P824, DOI 10.1046/j.1365-3156.2000.00638.x; Kamali A, 1996, INT J EPIDEMIOL, V25, P679, DOI 10.1093/ije/25.3.679; Libamba E, 2006, B WORLD HEALTH ORGAN, V84, P320; Lopman BA, 2006, PLOS MED, V3, P1273, DOI 10.1371/journal.pmed.0030312; *MAL NAT AIDS COMM, 2003, NAT EST HIV AIDS MAL; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; McGrath N, 2007, AIDS, V21, pS105, DOI 10.1097/01.aids.0000299417.69432.65; *MIN HLTH POP, 2007, ART PUBL SECT MAL RE; *MIN HTH POP, 2007, ART PUBL SECT MAL RE; *NAT STAT OFF, 2005, INT HOUS SURV 2004 2, V1, P73; NGOM P, 2003, WORKSH HIV AIDS AD M; PONNIGHAUS JM, 1988, LEPROSY REV, V59, P97; Porter K, 2004, AIDS, V18, pS9, DOI 10.1097/00002030-200406002-00002; SANKOH O, 2002, POPULATION HLTH DEV, P356; Todd J, 1997, AIDS, V11, P801, DOI 10.1097/00002030-199706000-00013; UNAIDS/WHO, 2006, 2006 REP GLOB AIDS E; *UNAIDS WHO, 2006, ANN 1 COUNTR PROF 20, P412; Urassa M, 2001, AIDS, V15, P2017, DOI 10.1097/00002030-200110190-00015; van Oosterhout JJG, 2005, JAIDS-J ACQ IMM DEF, V39, P626; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; White RG, 2007, EPIDEMIOL INFECT, V135, P922, DOI 10.1017/S0950268806007680; Whiting DR, 2006, B WORLD HEALTH ORGAN, V84, P940, DOI 10.2471/BLT.05.028910; Zaba B, 2004, AIDS, V18, pS1, DOI 10.1097/00002030-200406002-00001	40	187	188	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2008	371	9624					1603	1611		10.1016/S0140-6736(08)60693-5	http://dx.doi.org/10.1016/S0140-6736(08)60693-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298VO	18468544	Green Published, Green Accepted			2022-12-24	WOS:000255715400028
J	Drin, G; Morello, V; Casella, JF; Gounon, P; Antonny, B				Drin, Guillaume; Morello, Vincent; Casella, Jean-Francois; Gounon, Pierre; Antonny, Bruno			Asymmetric tethering of flat and curved lipid membranes by a golgin	SCIENCE			English	Article							CIS-GOLGI; RETROGRADE TRANSPORT; ARF-GAP; CURVATURE; APPARATUS; VESICLES; DOMAINS; PROTEINS; MOTIF; ER	Golgins, long stringlike proteins, tether cisternae and transport vesicles at the Golgi apparatus. We examined the attachment of golgin GMAP-210 to lipid membranes. GMAP- 210 connected highly curved liposomes to flatter ones. This asymmetric tethering relied on motifs that sensed membrane curvature both in the N terminus of GMAP- 210 and in ArfGAP1, which controlled the interaction of the C terminus of GMAP- 210 with the small guanine nucleotide-binding protein Arf1. Because membrane curvature constantly changes during vesicular trafficking, this mode of tethering suggests a way to maintain the Golgi architecture without compromising membrane flow.	[Drin, Guillaume; Morello, Vincent; Casella, Jean-Francois; Antonny, Bruno] Univ Nice, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Drin, Guillaume; Morello, Vincent; Casella, Jean-Francois; Antonny, Bruno] CNRS, F-06560 Valbonne, France; [Gounon, Pierre] Ctr Commun Microscopie Appl, F-06108 Nice, France	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS)	Antonny, B (corresponding author), Univ Nice, Inst Pharmacol Mol & Cellulaire, 660 Route Lucioles, F-06560 Valbonne, France.	antonny@ipmc.cnrs.fr	Antonny, Bruno/ABH-7434-2020	Antonny, Bruno/0000-0002-9166-8668; DRIN, Guillaume/0000-0002-3484-4581				Altan-Bonnet N, 2004, CURR OPIN CELL BIOL, V16, P364, DOI 10.1016/j.ceb.2004.06.011; Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Chan YHM, 2007, P NATL ACAD SCI USA, V104, P18913, DOI 10.1073/pnas.0706114104; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905; Gillingham AK, 2004, J CELL BIOL, V167, P281, DOI 10.1083/jcb.200407088; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Liu YW, 2005, MOL BIOL CELL, V16, P4024, DOI 10.1091/mbc.E05-01-0023; Lu L, 2006, TRAFFIC, V7, P1399, DOI 10.1111/j.1600-0854.2006.00473.x; Malsam J, 2005, SCIENCE, V307, P1095, DOI 10.1126/science.1108061; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Orci L, 1998, P NATL ACAD SCI USA, V95, P2279, DOI 10.1073/pnas.95.5.2279; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Pernet-Gallay K, 2002, TRAFFIC, V3, P822, DOI 10.1034/j.1600-0854.2002.31107.x; Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555; Rios RM, 2004, CELL, V118, P323; RIOS RM, 1994, J CELL BIOL, V125, P997, DOI 10.1083/jcb.125.5.997; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001	22	139	140	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2008	320	5876					670	673		10.1126/science.1155821	http://dx.doi.org/10.1126/science.1155821			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451304				2022-12-24	WOS:000255454300048
J	Zarivach, R; Deng, WY; Vuckovic, M; Felise, HB; Nguyen, HV; Miller, SI; Finlay, BB; Strynadka, NCJ				Zarivach, Raz; Deng, Wanyin; Vuckovic, Marija; Felise, Heather B.; Nguyen, Hai V.; Miller, Samuel I.; Finlay, B. Brett; Strynadka, Natalie C. J.			Structural analysis of the essential self-cleaving type III secretion proteins EscU and SpaS	NATURE			English	Article							SUCCINIMIDE FORMATION; ESCHERICHIA-COLI; ASPARAGINYL; SALMONELLA; ASPARTYL; EXPORT; FLHB; DEGRADATION; COMPONENTS; MECHANISM	During infection by Gram- negative pathogenic bacteria, the type III secretion system ( T3SS) is assembled to allow for the direct transmission of bacterial virulence effectors into the host cell(1). The T3SS system is characterized by a series of prominent multicomponent rings in the inner and outer bacterial membranes, as well as a translocation pore in the host cell membrane. These are all connected by a series of polymerized tubes that act as the direct conduit for the T3SS proteins to pass through to the host cell. During assembly of the T3SS, as well as the evolutionarily related flagellar apparatus(2), a post- translational cleavage event within the inner membrane proteins EscU/FlhB is required to promote a secretion- competent state. These proteins have long been proposed to act as a part of a molecular switch, which would regulate the appropriate chronological secretion of the various T3SS apparatus components during assembly and subsequently the transported virulence effectors. Here we show that a surface type II beta- turn in the Escherichia coli protein EscU undergoes auto-cleavage by a mechanism involving cyclization of a strictly conserved asparagine residue(3). Structural and in vivo analysis of point and deletion mutations illustrates the subtle conformational effects of auto- cleavage in modulating the molecular features of a highly conserved surface region of EscU, a potential point of interaction with other T3SS components at the inner membrane. In addition, this work provides new structural insight into the distinct conformational requirements for a large class of self-cleaving reactions involving asparagine cyclization.	[Zarivach, Raz; Vuckovic, Marija; Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Zarivach, Raz; Vuckovic, Marija; Strynadka, Natalie C. J.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Deng, Wanyin; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Felise, Heather B.; Nguyen, Hai V.; Miller, Samuel I.] Dept Microbiol & Med, Seattle, WA 98195 USA	University of British Columbia; University of British Columbia; University of British Columbia	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	natalie@byron.biochem.ubc.ca	ZARIVACH, RAZ/F-1671-2012	ZARIVACH, RAZ/0000-0001-6543-0296	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057141, R01AI030479] Funding Source: NIH RePORTER; NIAID NIH HHS [5R01 AI030479, U54 AI057141, U19 AI107775, R01 AI030479] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; CLARKE S, 1987, INT J PEPT PROT RES, V30, P808, DOI 10.1111/j.1399-3011.1987.tb03390.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; *DELANO SCI, 2002, PYMOL V 1; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferris HU, 2006, TRENDS MICROBIOL, V14, P519, DOI 10.1016/j.tim.2006.10.006; Ferris HU, 2005, J BIOL CHEM, V280, P41236, DOI 10.1074/jbc.M509438200; Fraser GM, 2003, MOL MICROBIOL, V48, P1043, DOI 10.1046/j.1365-2958.2003.03487.x; GEIGER T, 1987, J BIOL CHEM, V262, P785; Hodges JA, 2006, ORG LETT, V8, P4695, DOI 10.1021/ol061569t; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497; Lavander M, 2002, J BACTERIOL, V184, P4500, DOI 10.1128/JB.184.16.4500-4509.2002; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; MALOY SR, 1981, J BACTERIOL, V145, P1110, DOI 10.1128/JB.145.2.1110-1111.1981; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; PEGUES DA, 1995, MOL MICROBIOL, V17, P169, DOI 10.1111/j.1365-2958.1995.mmi_17010169.x; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shemella P, 2007, BIOPHYS J, V92, P847, DOI 10.1529/biophysj.106.092049; Sorg I, 2007, EMBO J, V26, P3015, DOI 10.1038/sj.emboj.7601731; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; Zarivach R, 2007, NAT STRUCT MOL BIOL, V14, P131, DOI 10.1038/nsmb1196	28	112	112	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2008	453	7191					124	+		10.1038/nature06832	http://dx.doi.org/10.1038/nature06832			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294ID	18451864				2022-12-24	WOS:000255398800052
J	He, J; Ma, LM; Kim, S; Nakai, J; Yu, CR				He, Jie; Ma, Limei; Kim, SangSeong; Nakai, Junichi; Yu, C. Ron			Encoding gender and individual information in the mouse vomeronasal organ	SCIENCE			English	Article							PUTATIVE PHEROMONE RECEPTORS; MAJOR URINARY PROTEINS; MULTIGENE FAMILY; SENSORY NEURONS; GENE REPERTOIRE; MUTANT MICE; MAMMALS; RECOGNITION; SYSTEM; PEPTIDES	The mammalian vomeronasal organ detects complex chemical signals that convey information about gender, strain, and the social and reproductive status of an individual. How these signals are encoded is poorly understood. We developed transgenic mice expressing the calcium indicator G- CaMP2 and analyzed population responses of vomeronasal neurons to urine from individual animals. A substantial portion of cells was activated by either male or female urine, but only a small population of cells responded exclusively to gender- specific cues shared across strains and individuals. Female cues activated more cells and were subject to more complex hormonal regulations than male cues. In contrast to gender, strain and individual information was encoded by the combinatorial activation of neurons such that urine from different individuals activated distinctive cell populations.	[He, Jie; Ma, Limei; Kim, SangSeong; Yu, C. Ron] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Nakai, Junichi] RIKEN Brain Sci Inst, Lab Memory & Learning, Wako, Saitama 3510198, Japan	Stowers Institute for Medical Research; RIKEN	Yu, CR (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	cry@stowers-institute.org	Nakai, Junichi/GQZ-6415-2022		NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008003] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC008003, R01 DC008003-03] Funding Source: Medline; PHS HHS [NIDCD 008003] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], 2014, PHEROMONES ANIMAL BE; Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Beynon RJ, 2003, BIOCHEM SOC T, V31, P142, DOI 10.1042/bst0310142; Birch M.C., 1974, PHEROMONES; Brennan PA, 2006, PHILOS T R SOC B, V361, P2061, DOI 10.1098/rstb.2006.1931; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grus WE, 2005, P NATL ACAD SCI USA, V102, P5767, DOI 10.1073/pnas.0501589102; Halpern M, 2003, PROG NEUROBIOL, V70, P245, DOI 10.1016/S0301-0082(03)00103-5; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; JEMIOLO B, 1986, P NATL ACAD SCI USA, V83, P4576, DOI 10.1073/pnas.83.12.4576; Ji GJ, 2004, J BIOL CHEM, V279, P21461, DOI 10.1074/jbc.M401084200; Keverne EB, 1999, SCIENCE, V286, P716, DOI 10.1126/science.286.5440.716; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; Luo MM, 2004, CURR OPIN NEUROBIOL, V14, P428, DOI 10.1016/j.conb.2004.07.001; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; NOVOTNY M, 1984, EXPERIENTIA, V40, P217, DOI 10.1007/BF01963608; NOVOTNY M, 1985, P NATL ACAD SCI USA, V82, P2059, DOI 10.1073/pnas.82.7.2059; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; SINGH PB, 1987, NATURE, V327, P161, DOI 10.1038/327161a0; VANDENBERGH JG, 1976, BIOL REPROD, V15, P260, DOI 10.1095/biolreprod15.2.260; Yang H, 2005, GENOMICS, V86, P306, DOI 10.1016/j.ygeno.2005.05.012; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7	31	118	120	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2008	320	5875					535	538		10.1126/science.1154476	http://dx.doi.org/10.1126/science.1154476			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436787	Green Accepted			2022-12-24	WOS:000255249300052
J	Wada, H; Masuda, K; Satoh, R; Kakugawa, K; Ikawa, T; Katsura, Y; Kawamoto, H				Wada, Haruka; Masuda, Kyoko; Satoh, Rumi; Kakugawa, Kiyokazu; Ikawa, Tomokatsu; Katsura, Yoshimoto; Kawamoto, Hiroshi			Adult T-cell progenitors retain myeloid potential	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; NATURAL-KILLER-CELL; MURINE FETAL LIVER; LYMPHOID PROGENITORS; B-LINEAGE; THYMUS; PRECURSOR; MOUSE; IDENTIFICATION; SUBPOPULATION	During haematopoiesis, pluripotent haematopoietic stem cells are sequentially restricted to give rise to a variety of lineage-committed progenitors. The classical model of haematopoiesis postulates that, in the first step of differentiation, the stem cell generates common myelo-erythroid progenitors and common lymphoid progenitors (CLPs). However, our previous studies in fetal mice showed that myeloid potential persists even as the lineage branches segregate towards T and B cells(1-6). We therefore proposed the 'myeloid-based' model of haematopoiesis(7,8), in which the stem cell initially generates common myelo-erythroid progenitors and common myelo-lymphoid progenitors. T-cell and B-cell progenitors subsequently arise from common myelo-lymphoid progenitors through myeloid-T and myeloid-B stages, respectively. However, it has been unclear whether this myeloid-based model is also valid for adult haematopoiesis. Here we provide clonal evidence that the early cell populations in the adult thymus contain progenitors that have lost the potential to generate B cells but retain substantial macrophage potential as well as T-cell, natural killer (NK)-cell and dendritic-cell potential. We also show that such T-cell progenitors can give rise to macrophages in the thymic environment in vivo. Our findings argue against the classical dichotomy model in which T cells are derived from CLPs; instead, they support the validity of the 'myeloid-based' model for both adult and fetal haematopoiesis.	[Wada, Haruka; Masuda, Kyoko; Satoh, Rumi; Kakugawa, Kiyokazu; Ikawa, Tomokatsu; Katsura, Yoshimoto; Kawamoto, Hiroshi] RIKEN Res Ctr Allergy & Immunol, Lab Lymphocyte Dev, Yokohama, Kanagawa 2300045, Japan; [Katsura, Yoshimoto] Nihon Univ, Sch Med, Div Cell Regenerat & Transplantat, Adv Med Res Ctr, Tokyo 1738610, Japan	RIKEN; Nihon University	Kawamoto, H (corresponding author), RIKEN Res Ctr Allergy & Immunol, Lab Lymphocyte Dev, Yokohama, Kanagawa 2300045, Japan.	kawamoto@rcai.riken.jp	Wada, Haruka/F-8828-2012	Kakugawa, Kiyokazu/0000-0002-2560-5562				Anderson MK, 2002, IMMUNITY, V16, P285, DOI 10.1016/S1074-7613(02)00277-7; ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; Balciunaite G, 2005, BLOOD, V105, P1930, DOI 10.1182/blood-2004-08-3087; Benz C, 2005, J EXP MED, V202, P21, DOI 10.1084/jem.20050146; Buza-Vidas N, 2007, CURR OPIN HEMATOL, V14, P315, DOI 10.1097/MOH.0b013e3281de72bb; HOLLANDER GA, 1995, NATURE, V373, P350, DOI 10.1038/373350a0; Ikawa M, 1998, FEBS LETT, V430, P83, DOI 10.1016/S0014-5793(98)00593-6; Ikawa T, 2004, BLOOD, V103, P530, DOI 10.1182/blood-2003-06-1797; Katsura Y, 2002, NAT REV IMMUNOL, V2, P127, DOI 10.1038/nri721; Kawamoto H, 2006, TRENDS IMMUNOL, V27, P169, DOI 10.1016/j.it.2006.02.004; Kawamoto H, 2000, IMMUNITY, V12, P441, DOI 10.1016/S1074-7613(00)80196-X; Kawamoto H, 1997, INT IMMUNOL, V9, P1011, DOI 10.1093/intimm/9.7.1011; Kawamoto H, 1998, J IMMUNOL, V161, P3799; Kincade PW, 2002, IMMUNOL REV, V187, P116, DOI 10.1034/j.1600-065X.2002.18710.x; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Lee CK, 2001, J IMMUNOL, V166, P5964, DOI 10.4049/jimmunol.166.10.5964; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; Lu M, 2005, J IMMUNOL, V175, P5848, DOI 10.4049/jimmunol.175.9.5848; Lu M, 2002, J IMMUNOL, V169, P3519, DOI 10.4049/jimmunol.169.7.3519; Masuda K, 2005, EMBO J, V24, P4052, DOI 10.1038/sj.emboj.7600878; NISHIKAWA SI, 1988, EUR J IMMUNOL, V18, P1767, DOI 10.1002/eji.1830181117; Ohmura K, 1999, J IMMUNOL, V163, P4788; Spangrude GJ, 2002, IMMUNOL REV, V187, P40, DOI 10.1034/j.1600-065X.2002.18704.x; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; WANG BP, 1994, P NATL ACAD SCI USA, V91, P9402, DOI 10.1073/pnas.91.20.9402	26	262	276	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2008	452	7188					768	U10		10.1038/nature06839	http://dx.doi.org/10.1038/nature06839			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	285QY	18401412				2022-12-24	WOS:000254792500049
J	Hiyama, E; Iehara, T; Sugimoto, T; Fukuzawa, M; Hayashi, Y; Sasaki, F; Sugiyama, M; Kondo, S; Yoneda, A; Yamaoka, H; Tajiri, T; Akazawa, K; Ohtaki, M				Hiyama, Eiso; Iehara, Tomoko; Sugimoto, Tohru; Fukuzawa, Masahiro; Hayashi, Yutaka; Sasaki, Fumiaki; Sugiyama, Masahiko; Kondo, Satoshi; Yoneda, Akihiro; Yamaoka, Hiroaki; Tajiri, Tatsuro; Akazawa, Kohei; Ohtaki, Mequ			Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study	LANCET			English	Article							TEXAS OUTREACH PROGRAM; NEURO-BLASTOMA; UNITED-STATES; JAPAN; MORTALITY; SURVIVAL; DECREASE; CHILDREN; INFANTS; CANCER	Background In Japan, a nationwide programme between 1984 and 2003 screened all infants for urinary catecholamine metabolites as a marker for neuroblastoma. Before 1989, this was done by qualitative spot tests for vanillylmandelic acid in urine, and subsequently by quantitative assay with high-performance liquid chromatography (HPLC). However, the Japanese government stopped the mass-screening programme in 2003, after reports that it did not reduce mortality due to neuroblastoma. We aimed to assess the effectiveness of the programme, by comparing the rates of incidence and mortality from neuroblastomas diagnosed before 6 years of age in three cohorts. Methods We did a retrospective population-based cohort study on all children born between 1980 and 1998, except for a 2-year period from 1984. We divided these 22 289 695 children into three cohorts: children born before screening in 1980-83 (n=6 130 423); those born during qualitative screening in 1986-89 (n=5 290 412); and those born during quantitative screening 1990-98 (n=10 868 860). We used databases from hospitals, screening centres, and national cancer registries. Cases of neuroblastoma were followed up for a mean of 78.7 months. Findings 21.56 cases of neuroblastorna per 100 000 births over 72 months were identified in the qualitatively screened group (relative risk [RR] 1 . 87, 95% Cl 1 . 66-2. 10), and 29.80 cases per 100 000 births over 72 months in the quantitatively screened group (RR 2.58, 2.33-2.86). The cumulative incidence of neuroblastorna in the prescreening cohort (11 . 56 cases per 100 000 births over 72 months) was lower than that in other cohorts (p<0 . 0001 for all comparisons), but more neuroblastomas were diagnosed after 24 months of age in this cohort (p=0 . 0002 for qualitative screening vs prescreening, p<0 . 0001 for quantitative screening vs prescreening). Cumulative mortality was lower in the qualititative screening (3.90 cases per 100 000 livebirths over 72 months) and quantitative screening cohorts (2.83 cases) than in the prescreening cohort (5.38 cases). Compared with the prescreening cohort, the relative risk of mortality was 0 . 73 (95% Cl 0 . 58-0.90) for qualitative screening, and 0 . 53 (0.42-0.63) for quantitative screening. Mortality rates for both the qualitative and quantitative screening groups were lower than were those for the prescreening cohort (p=0 . 0041 for prescreening vs qualitative screening, p<0. 0001 for prescreening vs quantitative screening). Interpretation More infantile neuroblastomas were recorded in children who were screened for neuroblastoma at 6 months of age than in those who were not. The mortality rate from neuroblastoma in children who were screened at 6 months was lower than that in the prescreening cohort, especially in children screened by quantitative HPLC. Any new screening programme should aim to decrease mortality but also to minimise overdiagnosis of turnours with favourable prognoses (eg, by screening children at 18 months).	[Hiyama, Eiso] Hiroshima Univ, Nat Sci Ctr Basic Res & Dev, Minami Ku, Hiroshima 7348551, Japan; [Hiyama, Eiso; Yamaoka, Hiroaki] Hiroshima Univ Hosp, Dept Paediat Surg, Hiroshima, Japan; [Ohtaki, Mequ] Hiroshima Univ, Dept Environmetr & Biometr, Res Inst Radiat Biol & Med, Hiroshima 7348551, Japan; [Iehara, Tomoko; Sugimoto, Tohru] Kyoto Prefectural Univ Med, Dept Paediat, Kyoto, Japan; [Fukuzawa, Masahiro; Yoneda, Akihiro] Osaka Univ, Grad Sch Med, Dept Paediat Surg, Osaka, Japan; [Hayashi, Yutaka] Tohoku Univ, Sch Med, Dept Paediat Surg, Sendai, Miyagi 980, Japan; [Sasaki, Fumiaki] Hokkaido Univ, Grad Sch Med, Dept Paediat Surg, Sapporo, Hokkaido, Japan; [Sugiyama, Masahiko] Univ Tokyo, Grad Sch Med, Dept Paediat Surg, Tokyo, Japan; [Kondo, Satoshi] Nagoya City Univ, Grad Sch Med Sci, Dept Oncol Immunol & Surg, Nagoya, Aichi, Japan; [Tajiri, Tatsuro] Kyushu Univ, Dept Pediat Surg, Grad Sch Med Sci, Fukuoka 812, Japan; [Akazawa, Kohei] Niigata Univ, Med & Dent Hosp, Dept Med Informat, Niigata, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Kyoto Prefectural University of Medicine; Osaka University; Tohoku University; Hokkaido University; University of Tokyo; Nagoya City University; Kyushu University; Niigata University	Hiyama, E (corresponding author), Hiroshima Univ, Nat Sci Ctr Basic Res & Dev, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	eiso@hiroshima-u.ac.jp	Hiyama, Eiso/A-2013-2019; Ohtaki, Megu/S-9927-2018	Hiyama, Eiso/0000-0001-9179-5037; 				Ajiki W, 1998, CANCER CAUSE CONTROL, V9, P631, DOI 10.1023/A:1008897123707; Ater JL, 1998, CANCER, V82, P1593, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1593::AID-CNCR23>3.0.CO;2-Z; BERNSTEIN ML, 1992, J CLIN ONCOL, V10, P323, DOI 10.1200/JCO.1992.10.2.323; Berthold F, 1999, J CLIN ONCOL, V17, P1200, DOI 10.1200/JCO.1999.17.4.1200; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Dobrovoljski G, 2003, J PEDIAT HEMATOL ONC, V25, P14, DOI 10.1097/00043426-200301000-00005; EVANS AE, 1971, CANCER, V27, P374, DOI 10.1002/1097-0142(197102)27:2<374::AID-CNCR2820270221>3.0.CO;2-G; HAYASHI K, 2004, ADV NEUR RES C GEN I, P95; HISASHIGE A, 2000, EVALUATION MASS SCRE; Honjo S, 2003, INT J CANCER, V103, P538, DOI 10.1002/ijc.10859; *JAP SOC MASS SCRE, 1999, J JPN SOC MASS SCREE, V9, P81; Kerbl R, 1998, CANCER, V83, P2047, DOI 10.1002/(SICI)1097-0142(19981101)83:9<2047::AID-CNCR27>3.0.CO;2-N; Mathieu P, 1996, EARLY HUM DEV, V46, P177, DOI 10.1016/0378-3782(96)01763-X; Nishi M, 1998, ONCOL REP, V5, P1399; Nishi M, 2002, J EXP CLIN CANC RES, V21, P73; Nishi M, 1998, CANCER, V82, P1973, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1973::AID-CNCR22>3.0.CO;2-P; Oue T, 2005, J PEDIATR SURG, V40, P359, DOI 10.1016/j.jpedsurg.2004.10.062; PARKIN DM, 1988, INT J CANCER, V42, P511, DOI 10.1002/ijc.2910420408; Powell JE, 1998, LANCET, V352, P682, DOI 10.1016/S0140-6736(97)11239-9; SAWADA T, 1984, LANCET, V2, P271; SAWADA T, 1982, AM J DIS CHILD, V136, P710, DOI 10.1001/archpedi.1982.03970440054015; SAWADA T, 1988, LANCET, V2, P1134; SAWADA T, 1984, MED PEDIATR ONCOL, V12, P101, DOI 10.1002/mpo.2950120208; SAWAGUCHI S, 1990, CANCER, V66, P1879, DOI 10.1002/1097-0142(19901101)66:9<1879::AID-CNCR2820660905>3.0.CO;2-L; Schilling FH, 2002, NEW ENGL J MED, V346, P1047, DOI 10.1056/NEJMoa012277; SCHILLING FH, 1994, LANCET, V344, P1157, DOI 10.1016/S0140-6736(94)90665-3; TREUNER J, 1995, EUR J CANCER, V31A, P565, DOI 10.1016/0959-8049(95)00034-G; Woods WG, 1996, LANCET, V348, P1682, DOI 10.1016/S0140-6736(96)06020-5; Woods WG, 2002, NEW ENGL J MED, V346, P1041, DOI 10.1056/NEJMoa012387; Yamamoto K, 1998, J CLIN ONCOL, V16, P1265, DOI 10.1200/JCO.1998.16.4.1265; Yamamoto K, 2002, J CLIN ONCOL, V20, P1209, DOI 10.1200/JCO.2002.20.5.1209; Yoneda A, 2001, MED PEDIATR ONCOL, V36, P160, DOI 10.1002/1096-911X(20010101)36:1<160::AID-MPO1039>3.0.CO;2-G; YOUNG JL, 1987, CANCER, V56, P598; 1999, MED PEDIAT ONCOL, V33, P357	34	57	60	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 5	2008	371	9619					1173	1180		10.1016/S0140-6736(08)60523-1	http://dx.doi.org/10.1016/S0140-6736(08)60523-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	287ZM	18395578				2022-12-24	WOS:000254956000026
J	Vento, S; Nobili, V				Vento, Sandro; Nobili, Valerio			Aminotransferases as predictors of mortality	LANCET			English	Editorial Material							FATTY LIVER-DISEASE; RISK		[Vento, Sandro] Annunziata Hosp, Infect Dis Unit, I-87100 Cosenza, Italy; [Nobili, Valerio] Bambino Gesu Pediat Hosp, Liver Unit, Rome, Italy	IRCCS Bambino Gesu	Vento, S (corresponding author), Annunziata Hosp, Infect Dis Unit, I-87100 Cosenza, Italy.	ventosandro@yahoo.it	Nobili, Valerio/K-8670-2018; Vento, Sandro/I-1662-2017	Vento, Sandro/0000-0003-0084-4062; nobili, valerio/0000-0002-4570-3979				Adams LA, 2007, ANN EPIDEMIOL, V17, P863, DOI 10.1016/j.annepidem.2007.05.013; Arndt V, 1998, INT ARCH OCC ENV HEA, V71, P405, DOI 10.1007/s004200050299; DE RITIS F, 1955, Boll Soc Ital Biol Sper, V31, P394; Elinav E, 2006, J AM GERIATR SOC, V54, P1719, DOI 10.1111/j.1532-5415.2006.00921.x; FRIEDMAN LS, 1987, ANN INTERN MED, V107, P137, DOI 10.7326/0003-4819-107-2-137; Kagansky N, 2004, LIVER INT, V24, P588, DOI 10.1111/j.1478-3231.2004.0969.x; Kim HC, 2005, STROKE, V36, P1642, DOI 10.1161/01.STR.0000173404.37692.9b; Kim HC, 2004, BMJ-BRIT MED J, V328, P983, DOI 10.1136/bmj.38050.593634.63; Lee TH, 2008, HEPATOLOGY, V47, P880, DOI 10.1002/hep.22090; Targher G, 2007, ATHEROSCLEROSIS, V191, P235, DOI 10.1016/j.atherosclerosis.2006.08.021	10	11	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY-JUN	2008	371	9627					1822	1823		10.1016/S0140-6736(08)60778-3	http://dx.doi.org/10.1016/S0140-6736(08)60778-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	307NL	18514716				2022-12-24	WOS:000256325500009
J	Johnson, DL; Johnson, SAS				Johnson, Deborah L.; Johnson, Sandra A. S.			Cell biology - RNA metabolism and oncogenesis	SCIENCE			English	Editorial Material							POLYMERASE-III TRANSCRIPTION; TATA-BINDING PROTEIN; RETINOBLASTOMA PROTEIN; TRANSFORMATION; EXPRESSION; TFIIIB		[Johnson, Deborah L.; Johnson, Sandra A. S.] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA	University of Southern California	Johnson, DL (corresponding author), Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA.	johnsond@hsc.usc.edu			NCI NIH HHS [R01 CA074138] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA074138] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Crighton D, 2003, EMBO J, V22, P2810, DOI 10.1093/emboj/cdg265; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; Felton-Edkins ZA, 2003, EMBO J, V22, P2422, DOI 10.1093/emboj/cdg240; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Johnson SS, 2007, MOL CELL, V26, P367, DOI 10.1016/j.molcel.2007.03.021; Johnson SAS, 2003, MOL CELL BIOL, V23, P3043, DOI 10.1128/MCB.23.9.3043-3051.2003; Larminie CGC, 1997, EMBO J, V16, P2061, DOI 10.1093/emboj/16.8.2061; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Marshall L, 2008, CELL, V133, P78, DOI 10.1016/j.cell.2008.02.035; Thumma SC, 2007, CANCER LETT, V258, P1, DOI 10.1016/j.canlet.2007.08.022; Wang HD, 1997, MOL CELL BIOL, V17, P6838, DOI 10.1128/MCB.17.12.6838; White RJ, 1996, NATURE, V382, P88, DOI 10.1038/382088a0; WOIWODE A, 2008, MOL CELL BIOL; Zhong SP, 2004, MOL CELL BIOL, V24, P5119, DOI 10.1128/MCB.24.12.5119-5129.2004	15	39	39	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					461	462		10.1126/science.1158680	http://dx.doi.org/10.1126/science.1158680			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436765				2022-12-24	WOS:000255249300026
J	Ehrenfeld, E; Glass, RI; Agol, VI; Chumakov, K; Dowdle, W; John, TJ; Katz, SL; Miller, M; Breman, JG; Modlin, J; Wright, P				Ehrenfeld, Ellie; Glass, Roger I.; Agol, Vadim I.; Chumakov, Konstantin; Dowdle, Walter; John, T. Jacob; Katz, Samuel L.; Miller, Mark; Breman, Joel G.; Modlin, John; Wright, Peter			Immunisation against poliomyelitis: moving forward	LANCET			English	Editorial Material							POLIOVIRUS VACCINES		[Glass, Roger I.; Miller, Mark; Breman, Joel G.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Ehrenfeld, Ellie] NIAID, NIH, Bethesda, MD 20892 USA; [Agol, Vadim I.] Inst Poliomyelitis & Viral Encephalitides, Moscow, Russia; [Chumakov, Konstantin] US FDA, PHHS, Rockville, MD 20857 USA; [Dowdle, Walter] Task Force Child Survival & Dev, Atlanta, GA USA; [John, T. Jacob] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Katz, Samuel L.] Duke Univ, Sch Med, Durham, NC USA; [Modlin, John; Wright, Peter] Dartmouth Med Sch, Hanover, NH USA; [Wright, Peter] Vanderbilt Univ Sch Med, Nashville, TN USA	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Chumakov Federal Scientific Center for Research & Development of Immune & Biological Products of Russian Academy of Sciences; US Food & Drug Administration (FDA); Christian Medical College & Hospital (CMCH) Vellore; Duke University; Dartmouth College; Vanderbilt University	Glass, RI (corresponding author), NIH, Fogarty Int Ctr, 31 Ctr Dr,MSC 2220, Bethesda, MD 20892 USA.	glassr@mail.nih.gov	Agol, Vadim I./E-1941-2013					Agol VI, 2006, BIOLOGICALS, V34, P103, DOI 10.1016/j.biologicals.2006.02.007; Arita I, 2006, SCIENCE, V312, P852, DOI 10.1126/science.1124959; Asturias EJ, 2007, J INFECT DIS, V196, P692, DOI 10.1086/520546; Aylward RB, 2005, SCIENCE, V310, P625, DOI 10.1126/science.1115547; *CDC, 2007, MMWR-MORBID MORTAL W, V56, P996; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Chumakov K, 2007, NAT REV MICROBIOL, V5, P952, DOI 10.1038/nrmicro1769; *COMM DEV POL ANT, EXPL ROL ANT DRUGS E; Dragunsky EM, 2004, J INFECT DIS, V190, P1404, DOI 10.1086/424524; Fine P E, 2001, Dev Biol (Basel), V105, P129; Fine PEM, 1999, AM J EPIDEMIOL, V150, P1001, DOI 10.1093/oxfordjournals.aje.a009924; Galindo M, 2007, NEW ENGL J MED, V356, P1536, DOI 10.1056/NEJMoa054960; Geller R, 2007, GENE DEV, V21, P195, DOI 10.1101/gad.1505307; Grassly NC, 2007, LANCET, V369, P1356, DOI 10.1016/S0140-6736(07)60531-5; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Macadam AJ, 2006, J VIROL, V80, P8653, DOI 10.1128/JVI.00370-06; Shulman LM, 2006, ISR MED ASSOC J, V8, P312; Simizu B, 2006, BIOLOGICALS, V34, P151, DOI 10.1016/j.biologicals.2006.02.010; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388	20	18	21	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 19	2008	371	9621					1385	1387		10.1016/S0140-6736(08)60597-8	http://dx.doi.org/10.1016/S0140-6736(08)60597-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PE	18424327				2022-12-24	WOS:000255208500029
J	Boutin, AT; Weidemann, A; Fu, ZX; Mesropian, L; Gradin, K; Jamora, C; Wiesener, M; Eckardt, KU; Koch, CJ; Ellies, LG; Haddad, G; Haase, VH; Simon, MC; Poellinger, L; Powell, FL; Johnson, RS				Boutin, Adam T.; Weidemann, Alexander; Fu, Zhenxing; Mesropian, Lernik; Gradin, Katarina; Jamora, Colin; Wiesener, Michael; Eckardt, Kai-Uwe; Koch, Cameron J.; Ellies, Lesley G.; Haddad, Gabriel; Haase, Volker H.; Simon, M. Celeste; Poellinger, Lorenz; Powell, Frank L.; Johnson, Randall S.			Epidermal sensing of oxygen is essential for systemic hypoxic response	CELL			English	Article							NITRIC-OXIDE; TUMOR-SUPPRESSOR; ERYTHROPOIETIN PRODUCTION; GENE-EXPRESSION; BLOOD-FLOW; HUMAN SKIN; MICE; VHL; HIF; VASOCONSTRICTION	Skin plays an essential role, mediated in part by its remarkable vascular plasticity, in adaptation to environmental stimuli. Certain vertebrates, such as amphibians, respond to hypoxia in part through the skin; but it is unknown whether this tissue can influence mammalian systemic adaptation to low oxygen levels. We have found that epidermal deletion of the hypoxia-responsive transcription factor HIF-1 alpha inhibits renal erythropoietin (EPO) synthesis in response to hypoxia. Conversely, mice with an epidermal deletion of the vonHippel-Lindau (VHL) factor, a negative regulator of HIF, have increased EPO synthesis and polycythemia. We show that nitric oxide release induced by the HIF pathway acts on cutaneous vascular flow to increase systemic erythropoietin expression. These results demonstrate that in mice the skin is a critical mediator of systemic responses to environmental oxygen.	[Boutin, Adam T.; Weidemann, Alexander; Mesropian, Lernik; Jamora, Colin; Johnson, Randall S.] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Gradin, Katarina; Poellinger, Lorenz] Karolinska Inst, S-17177 Stockholm, Sweden; [Wiesener, Michael; Eckardt, Kai-Uwe] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany; [Koch, Cameron J.; Haase, Volker H.; Simon, M. Celeste] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Fu, Zhenxing; Ellies, Lesley G.; Haddad, Gabriel; Powell, Frank L.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Fu, Zhenxing; Ellies, Lesley G.; Haddad, Gabriel; Powell, Frank L.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Fu, Zhenxing; Ellies, Lesley G.; Haddad, Gabriel; Powell, Frank L.] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Karolinska Institutet; University of Erlangen Nuremberg; University of Pennsylvania; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Johnson, RS (corresponding author), Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA.	rsjohnson@ucsd.edu	Simon, Celeste/AAG-3941-2021; Haase, Volker Hans/AAJ-5061-2021; Johnson, Randall/AAM-1189-2021; Haase, Volker Hans/A-6758-2013	Johnson, Randall/0000-0002-4084-6639; Haase, Volker Hans/0000-0002-7051-8994	NCI NIH HHS [R01 CA082515, R01CA082515, K22CA118182, R01 CA082515-09, R01 CA100787] Funding Source: Medline; NHLBI NIH HHS [R01 HL081823] Funding Source: Medline; NIAID NIH HHS [R01AI060840] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K22CA118182, R01CA100787, R01CA082515] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060840] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABBRECHT PH, 1972, J APPL PHYSIOL, V32, P54, DOI 10.1152/jappl.1972.32.1.54; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; Bozzini CE, 2005, HIGH ALT MED BIOL, V6, P238, DOI 10.1089/ham.2005.6.238; Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519; DURAND J, 1969, FED PROC, V28, P1124; Elson DA, 2001, GENE DEV, V15, P2520, DOI 10.1101/gad.914801; Evans SM, 2006, J INVEST DERMATOL, V126, P2596, DOI 10.1038/sj.jid.5700451; Fandrey J, 2004, AM J PHYSIOL-REG I, V286, pR977, DOI 10.1152/ajpregu.00577.2003; Fikree FF, 2005, SOC SCI MED, V60, P911, DOI 10.1016/j.socscimed.2004.06.034; Gassmann M, 2003, ADV EXP MED BIOL, V543, P323; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Haase VH, 2005, SEMIN CELL DEV BIOL, V16, P564, DOI 10.1016/j.semcdb.2005.03.006; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Harbrecht BG, 2006, CURR PHARM DESIGN, V12, P3543, DOI 10.2174/138161206778343000; Houghton BL, 2006, J PHYSIOL-LONDON, V572, P811, DOI 10.1113/jphysiol.2005.104067; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; KUWAHIRA I, 1993, J APPL PHYSIOL, V74, P211, DOI 10.1152/jappl.1993.74.1.211; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Lewis LD, 2004, SEMIN HEMATOL, V41, P17, DOI 10.1053/j.seminhematol.2004.09.004; Lezon C, 1995, HAEMATOLOGICA, V80, P491; Malvin GM, 2001, AM J PHYSIOL-REG I, V280, pR1308, DOI 10.1152/ajpregu.2001.280.5.R1308; Mateo J, 2003, BIOCHEM J, V376, P537, DOI 10.1042/BJ20031155; Maxwell PH, 2001, ADV EXP MED BIOL, V502, P365; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Metzen E, 2003, MOL BIOL CELL, V14, P3470, DOI 10.1091/mbc.e02-12-0791; Minson CT, 2003, ADV EXP MED BIOL, V543, P249; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Moudgil R, 2005, J APPL PHYSIOL, V98, P390, DOI 10.1152/japplphysiol.00733.2004; Moudgil R, 2006, MICROCIRCULATION, V13, P615, DOI 10.1080/10739680600930222; Mullany LC, 2005, J TROP PEDIATRICS, V51, P82, DOI 10.1093/tropej/fmh083; Powell FL, 1998, RESP PHYSIOL, V112, P123, DOI 10.1016/S0034-5687(98)00026-7; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Rubner M., 1883, Z BIOL, V19, P535; Russell RC, 2007, CELL CYCLE, V6, P56, DOI 10.4161/cc.6.1.3668; Scortegagna M, 2005, BLOOD, V105, P3133, DOI 10.1182/blood-2004-05-1695; Semenza GL, 2004, J APPL PHYSIOL, V96, P1173, DOI 10.1152/japplphysiol.00770.2003; Soliz J, 2007, J PHYSIOL-LONDON, V583, P329, DOI 10.1113/jphysiol.2007.133454; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stucker M, 2002, J PHYSIOL-LONDON, V538, P985, DOI 10.1013/jphysiol.2001.013067; Tam BYY, 2006, NAT MED, V12, P793, DOI 10.1038/nm1428; Tobin DJ, 2006, CHEM SOC REV, V35, P52, DOI 10.1039/b505793k; Todorov V, 2000, PFLUG ARCH EUR J PHY, V439, P445, DOI 10.1007/s004240050961; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; WEIL JV, 1969, FED PROC, V28, P1160; Weir EK, 2005, NEW ENGL J MED, V353, P2042, DOI 10.1056/NEJMra050002; Whitman EM, 2008, AM J PHYSIOL-LUNG C, V294, pL309, DOI 10.1152/ajplung.00091.2007	52	135	139	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2008	133	2					223	234		10.1016/j.cell.2008.02.038	http://dx.doi.org/10.1016/j.cell.2008.02.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	289JY	18423195	Green Accepted, Bronze			2022-12-24	WOS:000255052000013
J	Chambers, RG; Gupta, RK; Ghebreyesus, TA				Chambers, Raymond G.; Gupta, Rajat K.; Ghebreyesus, Tedros Adhanom			Responding to the challenge to end malaria deaths in Africa	LANCET			English	Editorial Material									[Gupta, Rajat K.] Global Fund Fight AIDS TB & Malaria, New York, NY 10022 USA; [Chambers, Raymond G.] UN, New York, NY 10017 USA; [Ghebreyesus, Tedros Adhanom] Fed Democrat Republ Ethiopia, Addis Ababa, Ethiopia; [Ghebreyesus, Tedros Adhanom] Roll Back Malaria Partnership, Addis Ababa, Ethiopia		Gupta, RK (corresponding author), Global Fund Fight AIDS TB & Malaria, New York, NY 10022 USA.	rajat_gupta@mckinsey.com						Roll Back Malaria Partnership, 2000, AB DECL PLAN ACT; *WHO, 2008, IMP LONG LAST INS NE; *WORLD BANK, 2006, ETH PROT BAS SERV PR	3	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2008	371	9622					1399	1401		10.1016/S0140-6736(08)60609-1	http://dx.doi.org/10.1016/S0140-6736(08)60609-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	294XW	18440416				2022-12-24	WOS:000255440600009
J	Richard, DJ; Bolderson, E; Cubeddu, L; Wadsworth, RIM; Savage, K; Sharma, GG; Nicolette, ML; Tsvetanov, S; McIlwraith, MJ; Pandita, RK; Takeda, S; Hay, RT; Gautier, J; West, SC; Paull, TT; Pandita, TK; White, MF; Khanna, KK				Richard, Derek J.; Bolderson, Emma; Cubeddu, Liza; Wadsworth, Ross I. M.; Savage, Kienan; Sharma, Girdhar G.; Nicolette, Matthew L.; Tsvetanov, Sergie; McIlwraith, Michael J.; Pandita, Raj K.; Takeda, Shunichi; Hay, Ronald T.; Gautier, Jean; West, Stephen C.; Paull, Tanya T.; Pandita, Tej K.; White, Malcolm F.; Khanna, Kum Kum			Single-stranded DNA-binding protein hSSB1 is critical for genomic stability	NATURE			English	Article							MAMMALIAN-CELLS; RAD52 PROTEIN; BREAK REPAIR; S-PHASE; DAMAGE; ATM; PHOSPHORYLATION; RECOMBINATION; ACTIVATION; CHECKPOINT	Single- strand DNA ( ssDNA)- binding proteins ( SSBs) are ubiquitous and essential for a wide variety of DNA metabolic processes, including DNA replication, recombination, DNA damage detection and repair(1). SSBs have multiple roles in binding and sequestering ssDNA, detecting DNA damage, stimulating nucleases, helicases and strand- exchange proteins, activating transcription and mediating protein - protein interactions. In eukaryotes, the major SSB, replication protein A ( RPA), is a heterotrimer(1). Here we describe a second human SSB ( hSSB1), with a domain organization closer to the archaeal SSB than to RPA. Ataxia telangiectasia mutated ( ATM) kinase phosphorylates hSSB1 in response to DNA double- strand breaks ( DSBs). This phosphorylation event is required for DNA damage- induced stabilization of hSSB1. Upon induction of DNA damage, hSSB1 accumulates in the nucleus and forms distinct foci independent of cell- cycle phase. These foci co-localize with other known repair proteins. In contrast to RPA, hSSB1 does not localize to replication foci in S- phase cells and hSSB1 deficiency does not influence S- phase progression. Depletion of hSSB1 abrogates the cellular response to DSBs, including activation of ATM and phosphorylation of ATM targets after ionizing radiation. Cells deficient in hSSB1 exhibit increased radiosensitivity, defective checkpoint activation and enhanced genomic instability coupled with a diminished capacity for DNA repair. These findings establish that hSSB1 influences diverse end-points in the cellular DNA damage response.	[Richard, Derek J.; Bolderson, Emma; Savage, Kienan; Tsvetanov, Sergie; Khanna, Kum Kum] Queensland Inst Med Res, Signal Transduct Lab, Brisbane, Qld 4029, Australia; [Cubeddu, Liza; Wadsworth, Ross I. M.; White, Malcolm F.] Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland; [Cubeddu, Liza] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; [Savage, Kienan] Univ Queensland, Cent Clin Div, Sch Med, Brisbane, Qld 4072, Australia; [Sharma, Girdhar G.; Pandita, Raj K.; Pandita, Tej K.] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63108 USA; [Nicolette, Matthew L.; Paull, Tanya T.] Univ Texas Austin, Dept Mol Genet & Microbiol, Austin, TX 78712 USA; [McIlwraith, Michael J.; West, Stephen C.] Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; [Takeda, Shunichi] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Kyoto 6068501, Japan; [Hay, Ronald T.] Univ Dundee, Div Gene Regulat & Express, Wellcome Bioctr, Dundee DD1 5EH, Scotland; [Gautier, Jean] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA	QIMR Berghofer Medical Research Institute; University of St Andrews; University of Sydney; University of Queensland; Washington University (WUSTL); University of Texas System; University of Texas Austin; Cancer Research UK; Kyoto University; University of Dundee; Columbia University	Khanna, KK (corresponding author), Queensland Inst Med Res, Signal Transduct Lab, Brisbane, Qld 4029, Australia.	mfw2@st-and.ac.uk; kumkumK@qimr.edu.au	Hay, Ronald/S-3233-2019; Pandita, Tej K/AAM-9188-2020; Richard, Derek/J-1338-2012; Hay, Ronald T/F-9338-2011; Khanna, Kum Kum/I-1747-2013; White, Malcolm F/A-6055-2010; Bolderson, Emma/B-8743-2013	Hay, Ronald/0000-0001-7113-9024; Richard, Derek/0000-0002-4839-8471; Hay, Ronald T/0000-0001-7113-9024; White, Malcolm F/0000-0003-1543-9342; Mcilwraith, Michael/0000-0003-1559-4369; Savage, Kienan/0000-0002-4898-899X; Paull, Tanya/0000-0002-2991-651X; Khanna, Kum Kum/0000-0001-8650-5381; Bolderson, Emma/0000-0002-2849-1177; West, Stephen/0000-0001-8848-9418	Biotechnology and Biological Sciences Research Council [BB/C000110/1] Funding Source: Medline; NCI NIH HHS [CA92245, CA10445, CA123232] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA092245, R01CA123232] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aparicio O. M., 2005, CURRENT PROTOCOLS MO; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Dodson GE, 2004, J BIOL CHEM, V279, P34010, DOI 10.1074/jbc.C400242200; Fabbro M, 2004, J BIOL CHEM, V279, P31251, DOI 10.1074/jbc.M405372200; Gatei M, 2000, CANCER RES, V60, P3299; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lisby M, 2004, CURR OPIN CELL BIOL, V16, P328, DOI 10.1016/j.ceb.2004.03.011; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; McIlwraith MJ, 2000, J MOL BIOL, V304, P151, DOI 10.1006/jmbi.2000.4180; New JH, 2002, J BIOL CHEM, V277, P26171, DOI 10.1074/jbc.M203670200; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; SLAVOTINEK A, 1994, EUR J CANCER, V30A, P1376, DOI 10.1016/0959-8049(94)90189-9; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Wadsworth RIM, 2001, NUCLEIC ACIDS RES, V29, P914, DOI 10.1093/nar/29.4.914; Wang YX, 2005, NAT GENET, V37, P750, DOI 10.1038/ng1587; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; WOLD MS, 1997, ANNU REV BIOCHEM, V66, P3050; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Zhang JR, 2005, NAT STRUCT MOL BIOL, V12, P902, DOI 10.1038/nsmb991	27	183	193	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2008	453	7195					677	U13		10.1038/nature06883	http://dx.doi.org/10.1038/nature06883			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305NN	18449195				2022-12-24	WOS:000256185200049
J	Ogden, CL; Carroll, MD; Flegal, KM				Ogden, Cynthia L.; Carroll, Margaret D.; Flegal, Katherine M.			High body mass index for age among US children and adolescents, 2003-2006	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OVERWEIGHT; OBESITY; RECOMMENDATIONS; PREVALENCE	Context The prevalence of overweight among US children and adolescents increased between 1980 and 2004. Objectives To estimate the prevalence of 3 measures of high body mass index ( BMI) for age ( calculated as weight in kilograms divided by height in meters squared) and to examine recent trends for US children and adolescents using national data with measured heights and weights. Design, Setting, and Participants Height and weight measurements were obtained from 8165 children and adolescents as part of the 2003- 2004 and 2005- 2006 National Health and Nutrition Examination Survey ( NHANES), nationally representative surveys of the US civilian, noninstitutionalized population. Main Outcome Measures Prevalence of BMI for age at or above the 97th percentile, at or above the 95th percentile, and at or above the 85th percentile of the 2000 sex- specific Centers for Disease Control and Prevention ( CDC) BMI- for- age growth charts among US children by age, sex, and racial/ ethnic group. Results Because no statistically significant differences in the prevalence of high BMI for age were found between estimates for 2003- 2004 and 2005- 2006, data for the 4 years were combined to provide more stable estimates for the most recent time period. Overall, in 2003- 2006, 11.3% ( 95% confidence interval [ CI], 9.7%- 12.9%) of children and adolescents aged 2 through 19 years were at or above the 97th percentile of the 2000 BMI- for- age growth charts, 16.3% ( 95% CI, 14.5%- 18.1%) were at or above the 95th percentile, and 31.9% ( 95% CI, 29.4%- 34.4%) were at or above the 85th percentile. Prevalence estimates varied by age and by racial/ ethnic group. Analyses of the trends in high BMI for age showed no statistically significant trend over the 4 time periods ( 1999- 2000, 2001- 2002, 2003- 2004, and 2005- 2006) for either boys or girls ( P values between .07 and .41). Conclusion The prevalence of high BMI for age among children and adolescents showed no significant changes between 2003- 2004 and 2005- 2006 and no significant trends between 1999 and 2006.	[Ogden, Cynthia L.; Carroll, Margaret D.; Flegal, Katherine M.] Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Ogden, CL (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd,Room 4414, Hyattsville, MD 20782 USA.	cogden@cdc.gov	Flegal, Katherine M/A-4608-2013	Flegal, Katherine/0000-0002-0838-469X				Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Barlow SE, 2002, PEDIATRICS, V110, P236; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Flegal KM, 2006, HEALTH EDUC RES, V21, P755, DOI 10.1093/her/cyl128; Freedman DS, 2008, OBESITY, V16, P1105, DOI 10.1038/oby.2008.30; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; HIMES JH, 1994, AM J CLIN NUTR, V59, P307, DOI 10.1093/ajcn/59.2.307; Kuczmarski RJ, 2002, SERIES-J SPAN ECON, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; ROCHE AF, 1981, AM J CLIN NUTR, V34, P2831, DOI 10.1093/ajcn/34.12.2831	12	1292	1312	1	46	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 28	2008	299	20					2401	2405		10.1001/jama.299.20.2401	http://dx.doi.org/10.1001/jama.299.20.2401			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	305BD	18505949				2022-12-24	WOS:000256151900024
J	Burn, J				Burn, John			Can a cell have a soul?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Burn, John] Univ Newcastle, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK	Burn, J (corresponding author), Univ Newcastle, Newcastle Upon Tyne, Tyne & Wear, England.	john.burn@newcastle.ac.uk		Burn, John/0000-0002-9823-2322					0	1	1	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 17	2008	336	7653					1132	1132		10.1136/bmj.39581.436875.94	http://dx.doi.org/10.1136/bmj.39581.436875.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302NM	18483057	Green Published			2022-12-24	WOS:000255975100044
J	Hanna, JB; Schmitt, D; Griffin, TM				Hanna, Jandy B.; Schmitt, Daniel; Griffin, Timothy M.			The energetic cost of climbing in primates	SCIENCE			English	Article							ORIGINS		[Hanna, Jandy B.; Schmitt, Daniel; Griffin, Timothy M.] Duke Univ, Med Ctr, Dept Surg, Orthopaed Bioengn Lab, Durham, NC 27710 USA	Duke University	Hanna, JB (corresponding author), W Virginia Sch Osteopath Med, Lewisburg, WV 24901 USA.	jhanna@wvsom.edu	Griffin, Timothy M./V-8838-2019	Griffin, Timothy M./0000-0001-8840-9940; Hanna, Jandy/0000-0003-1543-973X	NCRR NIH HHS [P40-RR001254] Funding Source: Medline; NIAMS NIH HHS [AR051672] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR001254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR051672] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Booth J, 1999, BRIT J SPORT MED, V33, P14, DOI 10.1136/bjsm.33.1.14; CARTMILL M, 1974, SCIENCE, V184, P436, DOI 10.1126/science.184.4135.436; FULL RJ, 1990, J EXP BIOL, V149, P307; KRAM R, 1990, NATURE, V346, P265, DOI 10.1038/346265a0; Rubenson J, 2007, J EXP BIOL, V210, P3513, DOI 10.1242/jeb.000992; Soligo C, 2006, J HUM EVOL, V50, P414, DOI 10.1016/j.jhevol.2005.11.001; TAYLOR CR, 1972, SCIENCE, V178, P1096, DOI 10.1126/science.178.4065.1096	7	50	50	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2008	320	5878					898	898		10.1126/science.1155504	http://dx.doi.org/10.1126/science.1155504			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18487185				2022-12-24	WOS:000255868300033
J	Carracedo, A; Salmena, L; Pandolfi, PP				Carracedo, Arkaitz; Salmena, Leonardo; Pandolfi, Pier Paolo			SnapShot: PTEN signaling pathways	CELL			English	Editorial Material							TUMOR-SUPPRESSOR; GENE		[Carracedo, Arkaitz; Salmena, Leonardo; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Carracedo, A (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.		Carracedo, Arkaitz/F-7029-2011	Carracedo, Arkaitz/0000-0001-5957-1260; Salmena, Leonardo/0000-0003-4023-658X				Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039	8	11	11	1	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 2	2008	133	3					550	U15		10.1016/j.cell.2008.04.023	http://dx.doi.org/10.1016/j.cell.2008.04.023			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455993	Bronze			2022-12-24	WOS:000255503900025
J	Anderson, CNK; Hsieh, CH; Sandin, SA; Hewitt, R; Hollowed, A; Beddington, J; May, RM; Sugihara, G				Anderson, Christian N. K.; Hsieh, Chih-Hao; Sandin, Stuart A.; Hewitt, Roger; Hollowed, Anne; Beddington, John; May, Robert M.; Sugihara, George			Why fishing magnifies fluctuations in fish abundance	NATURE			English	Article							COD GADUS-MORHUA; NATURAL-POPULATIONS; AGE STRUCTURE; LIFE-HISTORY; FISHERIES; SIZE; SUSTAINABILITY; VARIABILITY; ECOLOGY; BIOMASS	It is now clear that fished populations can fluctuate more than unharvested stocks. However, it is not clear why. Here we distinguish among three major competing mechanisms for this phenomenon, by using the 50- year California Cooperative Oceanic Fisheries Investigations ( CalCOFI) larval fish record. First, variable fishing pressure directly increases variability in exploited populations. Second, commercial fishing can decrease the average body size and age of a stock, causing the truncated population to track environmental fluctuations directly. Third, age- truncated or juvenescent populations have increasingly unstable population dynamics because of changing demographic parameters such as intrinsic growth rates. We find no evidence for the first hypothesis, limited evidence for the second and strong evidence for the third. Therefore, in California Current fisheries, increased temporal variability in the population does not arise from variable exploitation, nor does it reflect direct environmental tracking. More fundamentally, it arises from increased instability in dynamics. This finding has implications for resource management as an empirical example of how selective harvesting can alter the basic dynamics of exploited populations, and lead to unstable booms and busts that can precede systematic declines in stock levels.	[Anderson, Christian N. K.; Hsieh, Chih-Hao; Sandin, Stuart A.; Sugihara, George] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Hsieh, Chih-Hao] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan; [Hsieh, Chih-Hao] Natl Taiwan Univ, Inst Oceanog, Taipei 10617, Taiwan; [Hsieh, Chih-Hao] Natl Taiwan Ocean Univ, Inst Marine Environm Chem & Ecol, Chilung 20224, Taiwan; [Hewitt, Roger] Natl Marine Fisheries Serv, SW Fisheries Sci Ctr, La Jolla, CA 92037 USA; [Hollowed, Anne] NOAA, Natl Marine Fisheries Serv, Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA; [Beddington, John] Univ London Imperial Coll Sci Technol & Med, Div Biol, Fac Nat Sci, London SW7 2AZ, England; [May, Robert M.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of California System; University of California San Diego; Scripps Institution of Oceanography; Kyoto University; National Taiwan University; National Taiwan Ocean University; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Imperial College London; University of Oxford	Sugihara, G (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	gsugihara@ucsd.edu	Hsieh, Chih-hao/B-3797-2008	Hsieh, Chih-hao/0000-0001-5935-7272				ARMSTRONG M, 2006, 200607 FISH SCI PART; BEDDINGTON JR, 1977, SCIENCE, V197, P463, DOI 10.1126/science.197.4302.463; Berkeley SA, 2004, FISHERIES, V29, P23, DOI 10.1577/1548-8446(2004)29[23:FSVPOA]2.0.CO;2; Bobko SJ, 2004, FISH B-NOAA, V102, P418; Clark FN, 1955, CAL COOP OCEAN FISH, V4, P11; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; Dixon PA, 1999, SCIENCE, V283, P1528, DOI 10.1126/science.283.5407.1528; Gunderson DR., 1993, SURVEYS FISHERIES RE; Halley JM, 1996, TRENDS ECOL EVOL, V11, P33, DOI 10.1016/0169-5347(96)81067-6; Harvey CJ, 2006, ECOL APPL, V16, P1502, DOI 10.1890/1051-0761(2006)016[1502:CIBSAA]2.0.CO;2; HASTINGS A, 1991, ECOLOGY, V72, P896, DOI 10.2307/1940591; HILBORN R, 1992; Hsieh CH, 2005, PROG OCEANOGR, V67, P160, DOI 10.1016/j.pocean.2005.05.002; Hsieh CH, 2005, NATURE, V435, P336, DOI 10.1038/nature03553; HSIEH CH, IN PRESS CAN J FISH; Hsieh CH, 2008, AM NAT, V171, P71, DOI 10.1086/524202; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; HUNTER JR, 1993, B MAR SCI, V53, P723; Hutchings JA, 2005, PHILOS T R SOC B, V360, P315, DOI 10.1098/rstb.2004.1586; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; HUTCHINGS JA, 1993, CAN J FISH AQUAT SCI, V50, P2468, DOI 10.1139/f93-271; *ICCAT, 2006, STOCK STAT REP SWORD; Jonzen N, 2002, AM NAT, V159, P427, DOI 10.1086/339456; Jonzen N, 2001, MAR ECOL PROG SER, V210, P291, DOI 10.3354/meps210291; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; Kuparinen A, 2007, TRENDS ECOL EVOL, V22, P652, DOI 10.1016/j.tree.2007.08.011; LAMBERT TC, 1987, MAR ECOL PROG SER, V39, P209, DOI 10.3354/meps039209; Lande R., 2003, OXFORD SERIES ECOLOG; Longhurst A, 2006, FISH RES, V81, P107, DOI 10.1016/j.fishres.2006.06.022; Marr JC, 1960, P WORLD SCI M BIOL S, P667; Marteinsdottir G, 1998, J FISH BIOL, V52, P1241, DOI 10.1111/j.1095-8649.1998.tb00969.x; MAY RM, 1978, MATH BIOSCI, V42, P219, DOI 10.1016/0025-5564(78)90097-4; MAY RM, 1974, SCIENCE, V186, P645, DOI 10.1126/science.186.4164.645; Murawski SA, 2001, ICES J MAR SCI, V58, P1002, DOI 10.1006/jmsc.2001.1097; MURPHY GARTH L, 1966, PROC CALIF ACAD SCI, V34, P1; MURPHY GI, 1968, AM NAT, V102, P391, DOI 10.1086/282553; MURPHY GI, 1967, ECOLOGY, V48, P731, DOI 10.2307/1933730; Poulsen RT, 2007, FISH RES, V87, P196, DOI 10.1016/j.fishres.2007.07.002; RICKER WE, 1981, CAN J FISH AQUAT SCI, V38, P1636, DOI 10.1139/f81-213; Rykaczewski RR, 2008, P NATL ACAD SCI USA, V105, P1965, DOI 10.1073/pnas.0711777105; Sibert J, 2006, SCIENCE, V314, P1773, DOI 10.1126/science.1135347; Spencer P, 2007, LOW WAKE FI, V23, P513; STEELE JH, 1985, NATURE, V313, P355, DOI 10.1038/313355a0; STEELE JH, 1984, SCIENCE, V224, P985, DOI 10.1126/science.224.4652.985; Stefansson G, 2005, PHILOS T R SOC B, V360, P133, DOI 10.1098/rstb.2004.1579; Sugihara G, 1999, P NATL ACAD SCI USA, V96, P14210, DOI 10.1073/pnas.96.25.14210; SUGIHARA G, 1990, PHILOS T R SOC B, V330, P235, DOI 10.1098/rstb.1990.0195; SUGIHARA G, 1994, PHILOS T R SOC A, V348, P477, DOI 10.1098/rsta.1994.0106; Vasseur DA, 2004, ECOLOGY, V85, P1146, DOI 10.1890/02-3122; 2004, ALASKA GROUNDFISH FI	50	500	517	4	269	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2008	452	7189					835	839		10.1038/nature06851	http://dx.doi.org/10.1038/nature06851			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZY	18421346	Green Published			2022-12-24	WOS:000255026000040
J	Dayan, GH; Quinlisk, MP; Parker, AA; Barskey, AE; Harris, ML; Schwartz, JMH; Hunt, K; Finley, CG; Leschinsky, DP; O'Keefe, AL; Clayton, J; Kightlinger, LK; Dietle, EG; Berg, J; Kenyon, CL; Goldstein, ST; Stokley, SK; Redd, SB; Rota, PA; Rota, J; Bi, DL; Roush, SW; Bridges, CB; Santibanez, TA; Parashar, U; Bellini, WJ; Seward, JF				Dayan, Gustavo H.; Quinlisk, M. Patricia; Parker, Amy A.; Barskey, Albert E.; Harris, Meghan L.; Schwartz, Jennifer M. Hill; Hunt, Kae; Finley, Carol G.; Leschinsky, Dennis P.; O'Keefe, Anne L.; Clayton, Joshua; Kightlinger, Lon K.; Dietle, Eden G.; Berg, Jeffrey; Kenyon, Cynthia L.; Goldstein, Susan T.; Stokley, Shannon K.; Redd, Susan B.; Rota, Paul A.; Rota, Jennifer; Bi, Daoling; Roush, Sandra W.; Bridges, Carolyn B.; Santibanez, Tammy A.; Parashar, Umesh; Bellini, William J.; Seward, Jane F.			Recent resurgence of mumps in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VACCINATION; VIRUS; OUTBREAK; DIAGNOSIS; POPULATION; ANTIBODIES; SPECIMENS	Background: The widespread use of a second dose of mumps vaccine among U.S. schoolchildren beginning in 1990 was followed by historically low reports of mumps cases. A 2010 elimination goal was established, but in 2006 the largest mumps outbreak in two decades occurred in the United States. Methods: We examined national data on mumps cases reported during 2006, detailed case data from the most highly affected states, and vaccination-coverage data from three nationwide surveys. Results: A total of 6584 cases of mumps were reported in 2006, with 76% occurring between March and May. There were 85 hospitalizations, but no deaths were reported; 85% of patients lived in eight contiguous midwestern states. The national incidence of mumps was 2.2 per 100,000, with the highest incidence among persons 18 to 24 years of age (an incidence 3.7 times that of all other age groups combined). In a subgroup analysis, 83% of these patients reported current college attendance. Among patients in eight highly affected states with known vaccination status, 63% overall and 84% between the ages of 18 and 24 years had received two doses of mumps vaccine. For the 12 years preceding the outbreak, national coverage of one-dose mumps vaccination among preschoolers was 89% or more nationwide and 86% or more in highly affected states. In 2006, the national two-dose coverage among adolescents was 87%, the highest in U.S. history. Conclusions: Despite a high coverage rate with two doses of mumps-containing vaccine, a large mumps outbreak occurred, characterized by two-dose vaccine failure, particularly among midwestern college-age adults who probably received the second dose as schoolchildren. A more effective mumps vaccine or changes in vaccine policy may be needed to avert future outbreaks and achieve the elimination of mumps.	[Dayan, Gustavo H.; Parker, Amy A.; Barskey, Albert E.; Goldstein, Susan T.; Redd, Susan B.; Rota, Paul A.; Rota, Jennifer; Bi, Daoling; Parashar, Umesh; Bellini, William J.; Seward, Jane F.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, MS A-47, Atlanta, GA 30333 USA; [Stokley, Shannon K.; Santibanez, Tammy A.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Immunizat Serv Div, Atlanta, GA 30333 USA; [Roush, Sandra W.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Bacterial Dis, Atlanta, GA 30333 USA; [Bridges, Carolyn B.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA 30333 USA; [Quinlisk, M. Patricia; Harris, Meghan L.] Iowa Dept Publ Hlth, Des Moines, IA 50319 USA; [Schwartz, Jennifer M. Hill] Kansas Dept Hlth & Environm, Topeka, KS USA; [Hunt, Kae; Finley, Carol G.] Illinois Dept Publ Hlth, Springfield, IL 62761 USA; [Leschinsky, Dennis P.; O'Keefe, Anne L.] Nebraska Dept Hlth & Human Serv, Lincoln, NE USA; [Clayton, Joshua; Kightlinger, Lon K.] S Dakota Dept Hlth, Pierre, SD USA; [Dietle, Eden G.] Missouri Dept Hlth & Sr Serv, Jefferson City, MO USA; [Berg, Jeffrey] Wisconsin Dept Hlth & Family Serv, Madison, WI USA; [Kenyon, Cynthia L.] Minnesota Dept Hlth, St Paul, MN USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Minnesota Department of Health (MHD)	Parker, AA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, MS A-47, Atlanta, GA 30333 USA.			Santibanez, Tammy A./0000-0002-5784-7427				*ACIP, 1989, MMWR-MORBID MORTAL W, V38, P1; ANDERSON R M, 1991; ANDERSON RM, 1985, NATURE, V318, P323, DOI 10.1038/318323a0; [Anonymous], 2005, Wkly Epidemiol Rec, V80, P418; [Anonymous], STAT SURV IMM COV US; BRISS PA, 1994, J INFECT DIS, V169, P77, DOI 10.1093/infdis/169.1.77; *CENS BUR, POP EST; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P629; CHEEK JE, 1995, ARCH PEDIAT ADOL MED, V149, P774, DOI 10.1001/archpedi.1995.02170200064010; Cohen C, 2007, EMERG INFECT DIS, V13, P12; CORTESE MM, IN PRESS CLIN INFECT; DATE A, 2006, IN PRESS J INFECT DI; DAVIDKIN I, 1995, VACCINE, V13, P1617, DOI 10.1016/0264-410X(95)00064-8; *DEP ED NAT CTR ED, 2005, 2004 2005 INT POSTS; *DEP ED NAT CTR ED, 2006, 2004 2005 INT POSTS; Galazka AM, 1999, B WORLD HEALTH ORGAN, V77, P3; Gershman K., 2006, Morbidity and Mortality Weekly Report, V55, P559; GUT JP, 1985, J CLIN MICROBIOL, V21, P346, DOI 10.1128/JCM.21.3.346-352.1985; Harling R, 2005, VACCINE, V23, P4070, DOI 10.1016/j.vaccine.2004.10.020; HERSH BS, 1991, J PEDIATR-US, V119, P187, DOI 10.1016/S0022-3476(05)80726-7; Jin L, 2004, J INFECT DIS, V189, P1001, DOI 10.1086/382134; Kolasa MS, 2004, J INFECT DIS, V189, pS98, DOI 10.1086/374720; Krause CH, 2006, J CLIN VIROL, V37, P184, DOI 10.1016/j.jcv.2006.07.009; Nojd J, 2001, VACCINE, V19, P1727, DOI 10.1016/S0264-410X(00)00392-3; Novek J, 2000, J NURS CARE QUAL, V14, P1, DOI 10.1097/00001786-200001000-00003; PLOTKIN S A, 2004, VACCINES, P441; RUBIN SA, IN PRESS J INFECT DI; Sanz JC, 2006, APMIS, V114, P788, DOI 10.1111/j.1600-0463.2006.apm_463.x; Schaffzin JK, 2007, PEDIATRICS, V120, pE862, DOI 10.1542/peds.2006-3451; Simpson DM, 2001, AM J PREV MED, V20, P6, DOI 10.1016/S0749-3797(01)00286-0; STOKLEY S, 2006, 40 NAT IMM C ATL MAR; Van Loon Frederik P. L., 1995, Morbidity and Mortality Weekly Report, V44, P1; WERNER CA, 1950, ANN INTERN MED, V32, P1066, DOI 10.7326/0003-4819-32-6-1066; WHARTON M, 1988, J INFECT DIS, V158, P1253, DOI 10.1093/infdis/158.6.1253; [No title captured]; 2006, MMWR MORB MORTAL WKL, V55, P173; 2006, MMWR MORB MORTAL WKL, V55, P401; 1977, MMWR MORB MORTAL WKL, V26, P393; 2006, MMWR MORB MORTAL WKL, V55, P366; 2006, MMWR MORB MORTAL WKL, V55, P434; 2007, WKLY EPIDEMIOL REC, V82, P51	41	272	282	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 10	2008	358	15					1580	1589		10.1056/NEJMoa0706589	http://dx.doi.org/10.1056/NEJMoa0706589			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	285NK	18403766				2022-12-24	WOS:000254783300007
J	Gandhi, GY; Murad, MH; Fujiyoshi, A; Mullan, RJ; Flynn, DN; Elamin, MB; Swiglo, BA; Isley, WL; Guyatt, GH; Montori, VM				Gandhi, Gunjan Y.; Murad, M. Hassan; Fujiyoshi, Akira; Mullan, Rebecca J.; Flynn, David N.; Elamin, Mohamed B.; Swiglo, Brian A.; Isley, William L.; Guyatt, Gordon H.; Montori, Victor M.			Patient-important outcomes in registered diabetes trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIALS; CARDIOVASCULAR EVENTS; ROSIGLITAZONE; REGISTRATION; RISK; TESTOSTERONE; METAANALYSIS; STATEMENT; DEATH; MEN	Context Concerns about the safety and efficacy of diabetes interventions persist, in part because randomized clinical trials ( RCTs) have not measured their effect on patient-important outcomes, ie, death and quality of life ( morbidity, pain, function). Objective To systematically determine the extent to which ongoing and future RCTs in diabetes will ascertain patient- important outcomes. Data Sources On November 10, 2007, we searched primary RCT registries ClinicalTrials. gov ( http:// www. clinicaltrials. gov), International Standard Randomized Controlled Trial Number Register ( http:// isrctn. org), and Australian New Zealand Clinical Trials Registry ( http:// www. anzctr. org. au). Study Selection We identified phase 2 through 4 RCTs enrolling patients with diabetes. Of 2019 RCTs, 1054 proved eligible. We randomly sampled 50% of the eligible RCTs ( 527 of 1054) and selected 436 registered since registration became mandatory ( 2004). Data Extraction Pairs of reviewers working independently collected study characteristics and determined the outcomes measured and their type ( physiological outcomes, surrogate outcomes thought to reflect an increased risk for patient- important outcomes, and patient- important outcomes). Results Of the 436 registered RCTs included in this analysis, 24 ( 6%) had not started enrollment, 109 ( 25%) were actively enrolling, and 303 ( 69%) had completed enrollment. Primary outcomes were patient- important outcomes in only 78 of 436 RCTs ( 18%; 95% confidence interval [ CI], 14%- 22%), physiological and laboratory outcomes in 69 of 436 ( 16%; 95% CI, 13%- 20%), and surrogate outcomes in 268 of 436 ( 61%; 95% CI, 57%- 66%). Patient- important outcomes were reported as primary or secondary outcomes in 201 of 436 ( 46%; 95% CI, 41%- 51%). In multivariate analysis, large trials ( odds ratio [ OR], 1.10; 95% CI, 1.02- 1.19 for every additional 100 patients) and trials of longer duration ( OR, 1.03; 95% CI, 1.01- 1.06 for every additional 30 days) were more likely while parallel design RCTs ( OR, 0.15; 95% CI, 0.05- 0.44) and type 2 diabetes trials ( OR, 0.23; 95% CI, 0.09- 0.61) were less likely to assess patient- important outcomes as a primary outcome. Conclusion In this sample of registered ongoing RCTs in diabetes, only 18% included patient- important outcomes as primary outcomes.	[Gandhi, Gunjan Y.; Murad, M. Hassan; Fujiyoshi, Akira; Mullan, Rebecca J.; Flynn, David N.; Elamin, Mohamed B.; Swiglo, Brian A.; Isley, William L.; Montori, Victor M.] Mayo Clin, Coll Med, Knowledge & Encounter Res Unit, Rochester, MN 55905 USA; [Gandhi, Gunjan Y.; Swiglo, Brian A.; Isley, William L.; Montori, Victor M.] Mayo Clin, Coll Med, Div Endocrinol Diabet Metab & Nutr, Rochester, MN 55905 USA; [Murad, M. Hassan] Mayo Clin, Coll Med, Div Prevent Occupat & Aerosp Med, Rochester, MN 55905 USA; [Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	Mayo Clinic; Mayo Clinic; Mayo Clinic; McMaster University	Montori, VM (corresponding author), Mayo Clin, Coll Med, Knowledge & Encounter Res Unit, 200 1st St SW, Rochester, MN 55905 USA.	montori.victor@mayo.edu	Murad, M. Hassan/AAW-4367-2020	Fujiyoshi, Akira/0000-0002-5790-7119; Montori, Victor/0000-0003-0595-2898; Murad, Mohammad Hassan/0000-0001-5502-5975				Boers M, 2005, CLIN EXP RHEUMATOL, V23, pS10; Bucher HC, 1999, JAMA-J AM MED ASSOC, V282, P771, DOI 10.1001/jama.282.8.771; Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Cleland JGF, 2007, LANCET, V370, P1103, DOI 10.1016/S0140-6736(07)61488-3; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Ferreira-Gonzalez I, 2007, BRIT MED J, V334, P786, DOI 10.1136/bmj.39136.682083.AE; Guyatt Gordon, 2004, ACP J Club, V140, pA11; Guyatt GH, 2008, PLOS MED, V5, P3, DOI 10.1371/journal.pmed.0050004; Haddad RM, 2007, MAYO CLIN PROC, V82, P29; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Laine C, 2007, JAMA-J AM MED ASSOC, V298, P93, DOI 10.1001/jama.298.1.jed70037; McIver B, 1996, DIABETOLOGIA, V39, P731; Montori VM, 2006, DIABETES CARE, V29, P1833, DOI 10.2337/dc06-0077; Mulrow CD, 2007, ANN INTERN MED, V147, P585, DOI 10.7326/0003-4819-147-8-200710160-00013; Nathan DM, 2007, NEW ENGL J MED, V357, P64, DOI 10.1056/NEJMe078117; Nathan DM, 2006, DIABETES CARE, V29, P1963, DOI 10.2337/dc06-9912; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Richter B, 2000, DIABETOLOGIA, V43, P254, DOI 10.1007/s001250050039; Riis P, 2000, DIABETOLOGIA, V43, P526; Rosen CJ, 2007, NEW ENGL J MED, V357, P844, DOI 10.1056/NEJMp078167; Sim I, 2006, LANCET, V367, P1631, DOI 10.1016/S0140-6736(06)68708-4; Singh S, 2007, JAMA-J AM MED ASSOC, V298, P1189, DOI 10.1001/jama.298.10.1189; Tracz MJ, 2006, J CLIN ENDOCR METAB, V91, P2011, DOI 10.1210/jc.2006-0036; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vijan S, 2000, DIABETOLOGIA, V43, P125, DOI 10.1007/s001250050017; WHO, INT CLIN TRIALS REG; Zarin DA, 2007, JAMA-J AM MED ASSOC, V297, P2112, DOI 10.1001/jama.297.19.2112	30	173	180	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2008	299	21					2543	2549		10.1001/jama.299.21.2543	http://dx.doi.org/10.1001/jama.299.21.2543			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	308AR	18523223				2022-12-24	WOS:000256361200026
J	Tanaka, H; Imai, Y; Hiramatsu, N; Ito, Y; Imanaka, K; Oshita, M; Hijioka, T; Katayama, K; Yabuuchi, I; Yoshihara, H; Inoue, A; Kato, M; Takehara, T; Tamura, S; Kasahara, A; Hayashi, N; Tsukuma, H				Tanaka, Hideo; Imai, Yasuharu; Hiramatsu, Naoki; Ito, Yuri; Imanaka, Kazuho; Oshita, Masahide; Hijioka, Taizo; Katayama, Kazuhiro; Yabuuchi, Iwao; Yoshihara, Harumasa; Inoue, Atsuo; Kato, Michio; Takehara, Tetsuo; Tamura, Shinji; Kasahara, Akinori; Hayashi, Norio; Tsukuma, Hideaki			Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY LIVER-CANCER; HEPATITIS-C VIRUS; INTERFERON THERAPY; UNITED-STATES; MORTALITY; TRENDS; INFECTION; PATTERNS; INCREASE; RATES	Background: Japan has the highest incidence rate of primary liver cancer attributed to chronic hepatitis C virus (HCV) infection among developed countries. Molecular clock analysis of HCV sequences revealed that the spread of HCV took place earlier in Japan than in other countries. This might influence recent temporal trends in hepatocellular carcinoma (HCC) incidence. Objective: To characterize the contribution of HCV-related hepatocellular carcinoma (HCC) to recent changes in HCC incidence in Osaka, Japan. Design: Population-based survey. Setting: Osaka Cancer Registry and 10 hospitals in Osaka. Participants: 63 862 patients with HCC that was diagnosed between 1981 and 2003 in Osaka Prefecture, including 5253 HCV-seropositive patients with HCC that was diagnosed between 1990 and 2003 at 10 hospitals. Measurements: Incidence of HCC and estimated incidence rate of HCV-related HCC, measured by multiplying the prevalence of anti-HCV by the corresponding HCC incidence rate. Results: Between 1981 and 2003, peak incidence of HCC among men age 50 to 59 years, 60 to 69 years, and 70 to 79 years occurred in 1986, 1995, and 2000, respectively, with marked downward trends thereafter (average annual change, -7.9, -22.3, and -12.4 per 100 000 persons, respectively). Similar trends were observed in women. Estimated sex- and age-specific incidence of HCV-related HCC (per 100 000 persons) decreased from 255 to 92 cases at the maximum in men age 60 to 69 years and from 61 to 34 cases in women age 60 to 69 years, whereas estimated incidence of non-HCV-related HCC did not change between 1990 and 2003. Limitation: Infection was determined only by HCV seropositivity. Conclusion: The incidence of HCC in Osaka started to decrease by 2000, mainly because of decreased HCV-related HCC.	Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan; Ikeda Municipal Hosp, Osaka, Japan; Osaka Univ, Grad Sch Med, Osaka, Japan; Osaka Police Hosp, Osaka, Japan; Natl Hosp Org Osaka Minami Med Ctr, Osaka, Japan; Osaka Koseinenkin Hosp, Osaka, Japan; Otemae Hosp, Osaka, Japan; Ossaka Rousai Hosp, Osaka, Japan; Osaka Gen Med Ctr, Osaka, Japan; Natl Hosp Org Osaka Natl Hosp, Osaka, Japan	Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka University; Osaka Police Hospital; Osaka National Hospital	Tanaka, H (corresponding author), 1-1 Kanokoden,Chikusa Ku, Nagoya, Aichi 4648681, Japan.	hitanaka@aichi-cc.jp	Ito, Yuri/AAA-2742-2021; Tanaka, Hideo/A-8145-2016					Ajiki W, 2000, JPN J CLIN ONCOL, V30, P318; Davila JA, 2004, GASTROENTEROLOGY, V127, P1372, DOI 10.1053/j.gastro.2004.07.020; El-Serag H, 2003, ANN INTERN MED, V139, P817, DOI 10.7326/0003-4819-139-10-200311180-00009; El-Serag HB, 2000, ARCH INTERN MED, V160, P3227, DOI 10.1001/archinte.160.21.3227; Ferlay J, 2001, GLOBOCAN 2000 CANC I; Fritz A, 2000, INT CLASSIFICATION D; Iida F, 1999, B WORLD HEALTH ORGAN, V77, P573; Imai Y, 1998, ANN INTERN MED, V129, P94, DOI 10.7326/0003-4819-129-2-199807150-00005; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; La Vecchia C, 2000, EUR J CANCER, V36, P909, DOI 10.1016/S0959-8049(00)00052-6; McGlynn KA, 2001, INT J CANCER, V94, P290, DOI 10.1002/ijc.1456; Parkin D M, 1992, IARC Sci Publ, P45; PARKIN DM, 2002, IARC SCI PUBL, V143, P719; PARKIN DM, 1997, IARC SCI PUBL, V143, P1146; PARKIN DM, 2002, IARC SCI PUBL, V155, P264; Sasaki F, 1996, J Epidemiol, V6, P198; TANAKA H, 1994, CANCER CAUSE CONTROL, V5, P409, DOI 10.1007/BF01694754; Tanaka H, 2000, INT J CANCER, V87, P741, DOI 10.1002/1097-0215(20000901)87:5&lt;741::AID-IJC18&gt;3.0.CO;2-B; Tanaka H, 2002, HEPATOL RES, V24, pS11; Tanaka H, 1999, CANCER SURV, V33, P213; Tanaka H, 1998, J Epidemiol, V8, P292; Tanaka H, 2007, JPN J CLIN ONCOL, V37, P193, DOI 10.1093/jjco/hyl148; Tanaka Y, 2006, GASTROENTEROLOGY, V130, P703, DOI 10.1053/j.gastro.2006.01.032; TaylorRobinson SD, 1997, LANCET, V350, P1142, DOI 10.1016/S0140-6736(05)63789-0; Tsukuma Hideaki, 2005, Asian Pac J Cancer Prev, V6, P244; Yoshizawa H, 2002, HEPATOL RES, V24, pS28; Yoshizawa H, 2002, ONCOLOGY-BASEL, V62, P8, DOI 10.1159/000048270	27	97	98	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 3	2008	148	11					820	U29		10.7326/0003-4819-148-11-200806030-00004	http://dx.doi.org/10.7326/0003-4819-148-11-200806030-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	308CG	18519928				2022-12-24	WOS:000256365300003
J	Moore, JP; Klasse, PJ; Dolan, MJ; Ahuja, SK				Moore, John P.; Klasse, P. J.; Dolan, Matthew J.; Ahuja, Sunil K.			AIDS/HIV - A STEP into darkness or light?	SCIENCE			English	Editorial Material							PREVENTIVE VACCINE; HIV-1; MEASLES; SUSCEPTIBILITY; TRANSMISSION; RESPONSES; ALLELES; IMPACT; MUMPS; CCR5		[Moore, John P.; Klasse, P. J.] Cornell Univ, Weill Med Coll, New York, NY 10065 USA; [Dolan, Matthew J.] San Antonio Mil Med Ctr, Infect Dis Clin Res Program, Ft Sam Houston, TX 78234 USA; [Dolan, Matthew J.] San Antonio Mil Med Ctr, Infect Dis Clin Res Program, Lackland AFB, TX USA; [Ahuja, Sunil K.] S Texas Vet Hlth Care Syst, Vet Adm Res Ctr AIDS & HIV 1 Infect, San Antonio, TX 78229 USA; [Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	Cornell University; San Antonio Military Medical Center; San Antonio Military Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio	Moore, JP (corresponding author), Cornell Univ, Weill Med Coll, New York, NY 10065 USA.	jpm2003@med.cornell.edu; ahujas@uthscsa.edu	Klasse, P.J./AEX-0142-2022	Klasse, P.J./0000-0001-8222-278X				Ahuja SK, 2004, LANCET, V363, P2103, DOI 10.1016/S0140-6736(04)16536-7; Anderson R, 2005, J INFECT DIS, V191, pS85, DOI 10.1086/425267; Blower S., 2003, AIDS Reviews, V5, P113; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Cohen J, 2005, SCIENCE, V307, P23, DOI 10.1126/science.307.5706.23; Cohen J, 2007, SCIENCE, V318, P1048, DOI 10.1126/science.318.5853.1048; Desrosiers RC, 2004, NAT MED, V10, P221, DOI 10.1038/nm0304-221; Dhiman N, 2007, J INFECT DIS, V195, P21, DOI 10.1086/510596; Dolan MJ, 2007, NAT IMMUNOL, V8, P1324, DOI 10.1038/ni1521; Gallo RC, 2005, LANCET, V366, P1894, DOI 10.1016/S0140-6736(05)67395-3; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Killian MS, 2004, AIDS, V18, P161, DOI 10.1097/00002030-200401230-00004; Koning FA, 2005, J IMMUNOL, V175, P6117, DOI 10.4049/jimmunol.175.9.6117; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; O'Brien SJ, 2004, NAT GENET, V36, P565, DOI 10.1038/ng1369; Ovsyannikova IG, 2007, VACCINE, V25, P3090, DOI 10.1016/j.vaccine.2007.01.020; Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; SHAN M, 2001, PLOS PATHOG, V3, pE169; Shin HD, 2000, P NATL ACAD SCI USA, V97, P14467, DOI 10.1073/pnas.97.26.14467; St Sauver JL, 2001, VACCINE, V19, P1363, DOI 10.1016/S0264-410X(00)00376-5; van Asten L, 2004, AIDS, V18, P1885, DOI 10.1097/00002030-200409240-00004	26	42	44	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2008	320	5877					753	755		10.1126/science.1154258	http://dx.doi.org/10.1126/science.1154258			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18467578				2022-12-24	WOS:000255644400026
J	Thornton, TM; Pedraza-Alva, G; Deng, B; Wood, CD; Aronshtam, A; Clements, JL; Sabio, G; Davis, RJ; Matthews, DE; Doble, B; Rincon, M				Thornton, Tina M.; Pedraza-Alva, Gustavo; Deng, Bin; Wood, C. David; Aronshtam, Alexander; Clements, James L.; Sabio, Guadalupe; Davis, Roger J.; Matthews, Dwight E.; Doble, Bradley; Rincon, Mercedes			Phosphorylation by p38 MAPK as an alternative pathway for GSK3 beta inactivation	SCIENCE			English	Article							BETA-CATENIN; KINASE PATHWAY; IN-VIVO; C-MYC; ACTIVATION; CHECKPOINT; PROTEIN; CELLS; PROGRESSION; GSK-3-BETA	Glycogen synthase kinase 3 beta (GSK3 beta) is involved in metabolism, neurodegeneration, and cancer. Inhibition of GSK3 beta activity is the primary mechanism that regulates this widely expressed active kinase. Although the protein kinase Akt inhibits GSK3 beta by phosphorylation at the N terminus, preventing Akt- mediated phosphorylation does not affect the cell- survival pathway activated through the GSK3 beta substrate beta- catenin. Here, we show that p38 mitogen- activated protein kinase ( MAPK) also inactivates GSK3 beta by direct phosphorylation at its C terminus, and this inactivation can lead to an accumulation of beta- catenin. p38 MAPK- mediated phosphorylation of GSK3 beta occurs primarily in the brain and thymocytes. Activation of beta- catenin- mediated signaling through GSK3 beta inhibition provides a potential mechanism for p38 MAPK- mediated survival in specific tissues.	[Thornton, Tina M.; Pedraza-Alva, Gustavo; Wood, C. David; Aronshtam, Alexander; Matthews, Dwight E.; Rincon, Mercedes] Univ Vermont, Dept Med, Immunobiol Program, Burlington, VT 05405 USA; [Deng, Bin] Univ Vermont, Dept Biol, Burlington, VT 05405 USA; [Deng, Bin; Matthews, Dwight E.] Univ Vermont, Dept Chem, Burlington, VT 05405 USA; [Clements, James L.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Sabio, Guadalupe; Davis, Roger J.] Univ Massachusetts, Program Mol Med, Worcester, MA 01605 USA; [Doble, Bradley] McMaster Univ, McMaster Stem Cell & Canc Res Inst, Hamilton, ON L8N 3Z5, Canada	University of Vermont; University of Vermont; University of Vermont; Roswell Park Cancer Institute; University of Massachusetts System; University of Massachusetts Worcester; McMaster University	Rincon, M (corresponding author), Univ Vermont, Dept Med, Immunobiol Program, Burlington, VT 05405 USA.	mrincon@uvm.edu	Doble, Bradley/V-7848-2019; Sabio, Guadalupe/H-9733-2015	Doble, Bradley/0000-0002-0260-2983; Sabio, Guadalupe/0000-0002-2822-0625; Wood, David/0000-0002-0758-0592; Davis, Roger/0000-0002-0130-1652	NCRR NIH HHS [P20 RR016462, P20 RR021905, P20 RR16462, P20 RR15557, P20 RR015557] Funding Source: Medline; NIAID NIH HHS [R01 AI051454, R01 AI051454-03, R01 AI051454-02, R01 AI051454-04, R01 AI051454-01A1, R01 AI051454-05] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015557, P20RR021905, P20RR016462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051454] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Diehl NL, 2000, J EXP MED, V191, P321, DOI 10.1084/jem.191.2.321; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Dmitrieva NI, 2002, P NATL ACAD SCI USA, V99, P184, DOI 10.1073/pnas.231623498; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hoffman B, 2002, ONCOGENE, V21, P3414, DOI 10.1038/sj.onc.1205400; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Kurosu T, 2005, APOPTOSIS, V10, P1111, DOI 10.1007/s10495-005-3372-z; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Mikhailov A, 2005, CELL CYCLE, V4, P57, DOI 10.4161/cc.4.1.1357; Pedraza-Alva G, 2006, EMBO J, V25, P763, DOI 10.1038/sj.emboj.7600972; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Salahshor S, 2005, J CLIN PATHOL, V58, P225, DOI 10.1136/jcp.2003.009506; She QB, 2000, J BIOL CHEM, V275, P20444, DOI 10.1074/jbc.M001020200; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257	23	349	370	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2008	320	5876					667	670		10.1126/science.1156037	http://dx.doi.org/10.1126/science.1156037			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451303	Green Accepted			2022-12-24	WOS:000255454300047
J	Morita, H; Rehm, HL; Menesses, A; McDonough, B; Roberts, AE; Kucherlapati, R; Towbin, JA; Seidman, JG; Seidman, CE				Morita, Hiroyuki; Rehm, Heidi L.; Menesses, Andres; McDonough, Barbara; Roberts, Amy E.; Kucherlapati, Raju; Towbin, Jeffrey A.; Seidman, J. G.; Seidman, Christine E.			Shared genetic causes of cardiac hypertrophy in children and adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYOSIN HEAVY-CHAIN; BINDING PROTEIN-C; PEDIATRIC CARDIOMYOPATHY; ALPHA-TROPOMYOSIN; TROPONIN-T; MUTATIONS; EPIDEMIOLOGY; EXPRESSION; COMPOUND; DISTINCT	Background: The childhood onset of idiopathic cardiac hypertrophy that occurs without a family history of cardiomyopathy can portend a poor prognosis. Despite morphologic similarities to genetic cardiomyopathies of adulthood, the contribution of genetics to childhood-onset hypertrophy is unknown. Methods: We assessed the family and medical histories of 84 children (63 boys and 21 girls) with idiopathic cardiac hypertrophy diagnosed before 15 years of age (mean [+/-SD] age, 6.99+/-6.12 years). We sequenced eight genes: MYH7, MYBPC3, TNNT2, TNNI3, TPM1, MYL3, MYL2, and ACTC. These genes encode sarcomere proteins that, when mutated, cause adult-onset cardiomyopathies. We also sequenced PRKAG2 and LAMP2, which encode metabolic proteins; mutations in these genes can cause early-onset ventricular hypertrophy. Results: We identified mutations in 25 of 51 affected children without family histories of cardiomyopathy and in 21 of 33 affected children with familial cardiomyopathy. Among 11 of the 25 children with presumed sporadic disease, 4 carried new mutations and 7 inherited the mutations. Mutations occurred predominantly (in >75% of the children) in MYH7 and MYBPC3; significantly more MYBPC3 missense mutations were detected than occur in adult-onset cardiomyopathy (P<0.005). Neither hypertrophic severity nor contractile function correlated with familial or genetic status. Cardiac transplantation and sudden death were more prevalent among mutation-positive than among mutation-negative children; implantable cardioverter-defibrillators were more frequent (P=0.007) in children with family histories that were positive for the mutation. Conclusions: Genetic causes account for about half of presumed sporadic cases and nearly two thirds of familial cases of childhood-onset hypertrophy. Childhood-onset hypertrophy should prompt genetic analyses and family evaluations.	[Morita, Hiroyuki; McDonough, Barbara; Kucherlapati, Raju; Seidman, J. G.; Seidman, Christine E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Rehm, Heidi L.; Roberts, Amy E.; Kucherlapati, Raju; Seidman, J. G.] Harvard Univ, Sch Med, Partners HealthCare Ctr Genet & Genom, Boston, MA USA; [McDonough, Barbara; Seidman, Christine E.] Howard Hughes Med Inst, Boston, MA 02115 USA; [McDonough, Barbara; Seidman, Christine E.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Roberts, Amy E.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Menesses, Andres; Towbin, Jeffrey A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Partners Healthcare System; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Baylor College of Medicine	Seidman, CE (corresponding author), Harvard Univ, Sch Med, Dept Genet, Rm 256 NRB,77 Ave Louis Pasteur, Boston, MA 02115 USA.	cseidman@genetics.med.harvard.edu	Kucherlapati, Raju/ABC-8807-2021; Towbin, Jeffrey A./J-5595-2019	Towbin, Jeffrey A./0000-0002-6585-714X; Rehm, Heidi L./0000-0002-6025-0015	Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL087000-02, R01 HL087000] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087000] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alders M, 2003, EUR HEART J, V24, P1848, DOI 10.1016/S0195-668X(03)00466-4; Anan R, 2007, AM J CARDIOL, V99, P1750, DOI 10.1016/j.amjcard.2007.01.066; Arad M, 2005, NEW ENGL J MED, V352, P362, DOI 10.1056/NEJMoa033349; Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI200214571; Burwinkel B, 2005, AM J HUM GENET, V76, P1034, DOI 10.1086/430840; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; Colan SD, 2007, CIRCULATION, V115, P773, DOI 10.1161/CIRCULATIONAHA.106.621185; CONSEVAGE MW, 1994, HUM MOL GENET, V3, P1025, DOI 10.1093/hmg/3.6.1025; EPSTEIN ND, 1992, CIRCULATION, V86, P345, DOI 10.1161/01.CIR.86.2.345; FANANAPAZIR L, 1994, CIRCULATION, V89, P22, DOI 10.1161/01.CIR.89.1.22; Flavigny J, 1999, J MOL BIOL, V294, P443, DOI 10.1006/jmbi.1999.3276; Gruver EJ, 1999, AM J CARDIOL, V83, p13H; Ingles J, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.033886; Lind Joanne M, 2006, Expert Rev Cardiovasc Ther, V4, P927, DOI 10.1586/14779072.4.6.927; Lipshultz SE, 2003, NEW ENGL J MED, V348, P1647, DOI 10.1056/NEJMoa021715; Maron BJ, 2004, PEDIATR CLIN N AM, V51, P1305, DOI 10.1016/j.pcl.2004.04.017; Maron BJ, 2003, J AM COLL CARDIOL, V42, P882, DOI 10.1016/S0735-1097(03)00855-6; Morita H, 2002, COLD SPRING HARB SYM, V67, P383, DOI 10.1101/sqb.2002.67.383; Morita H, 2006, CIRCULATION, V113, P2697, DOI 10.1161/CIRCULATIONAHA.105.593558; Niimura H, 2002, CIRCULATION, V105, P446, DOI 10.1161/hc0402.102990; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Nugent AW, 2003, NEW ENGL J MED, V348, P1639, DOI 10.1056/NEJMoa021737; Nugent AW, 2005, CIRCULATION, V112, P1332, DOI 10.1161/CIRCULATIONAHA.104.530303; Osio A, 2007, CIRC RES, V100, P766, DOI 10.1161/01.RES.0000263008.66799.aa; Probst V, 2003, J AM COLL CARDIOL, V41, P643, DOI 10.1016/S0735-1097(02)02864-4; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Roberts AE, 2005, AM J MED GENET A, V132A, P333, DOI 10.1002/ajmg.a.30405; SAS Institute, 2000, SAS STAT US GUID REL; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P1903, DOI 10.1016/j.jacc.2004.07.045; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P602, DOI 10.1016/j.jacc.2004.04.039; Van Driest SL, 2002, CIRCULATION, V106, P3085, DOI 10.1161/01.CIR.0000042675.59901.14; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; WATKINS H, 1995, NAT GENET, V11, P434, DOI 10.1038/ng1295-434; WATKINS H, 1992, NEW ENGL J MED, V326, P1108, DOI 10.1056/NEJM199204233261703; Yetman AT, 2005, CURR OPIN CARDIOL, V20, P80, DOI 10.1097/01.hco.0000153452.45341.36	37	266	286	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2008	358	18					1899	1908		10.1056/NEJMoa075463	http://dx.doi.org/10.1056/NEJMoa075463			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294ER	18403758	Green Accepted, Bronze			2022-12-24	WOS:000255387900004
J	Avorn, J; Shrank, WH				Avorn, Jerry; Shrank, William H.			Making a difference - Adverse drug reactions in elderly people - A substantial cause of preventable illness	BRITISH MEDICAL JOURNAL			English	Editorial Material							PHARMACOLOGICAL CARE; QUALITY		[Avorn, Jerry; Shrank, William H.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Avorn, J (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA.	javorn@medsoc.harvard.edu						AVORN J, 1995, AM J MED, V99, P48, DOI 10.1016/S0002-9343(99)80104-1; AVORN J, 2003, GERIATRIC MED EVIDEN; Avorn J, 2004, POWERFUL MED BENEFIT; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Higashi T, 2004, ANN INTERN MED, V140, P714, DOI 10.7326/0003-4819-140-9-200405040-00011; Peterson JF, 2005, ARCH INTERN MED, V165, P802, DOI 10.1001/archinte.165.7.802; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Shrank WH, 2006, MED CARE, V44, P936, DOI 10.1097/01.mlr.0000223460.60033.79	9	23	24	1	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 26	2008	336	7650					956	+		10.1136/bmj.39520.671053.94	http://dx.doi.org/10.1136/bmj.39520.671053.94			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296KC	18397948	Bronze, Green Submitted, Green Published			2022-12-24	WOS:000255540900043
J	Heine, M; Groc, L; Frischknecht, R; Beique, JC; Lounis, B; Rumbaugh, G; Huganir, RL; Cognet, L; Choquet, D				Heine, Martin; Groc, Laurent; Frischknecht, Renato; Beique, Jean-Claude; Lounis, Brahim; Rumbaugh, Gavin; Huganir, Richard L.; Cognet, Laurent; Choquet, Daniel			Surface mobility of postsynaptic AMPARs tunes synaptic transmission	SCIENCE			English	Article							CENTRAL GLUTAMATERGIC SYNAPSES; CA1 PYRAMIDAL NEURONS; RECEPTOR DESENSITIZATION; MOSSY FIBER; RELEASE; TRAFFICKING; MECHANISM; CYCLOTHIAZIDE; TRANSPORTERS; VARIABILITY	AMPA glutamate receptors (AMPARs) mediate fast excitatory synaptic transmission. Upon fast consecutive synaptic stimulation, transmission can be depressed. Recuperation from fast synaptic depression has been attributed solely to recovery of transmitter release and/or AMPAR desensitization. We show that AMPAR lateral diffusion, observed in both intact hippocampi and cultured neurons, allows fast exchange of desensitized receptors with naive functional ones within or near the postsynaptic density. Recovery from depression in the tens of millisecond time range can be explained in part by this fast receptor exchange. Preventing AMPAR surface movements through cross-linking, endogenous clustering, or calcium rise all slow recovery from depression. Physiological regulation of postsynaptic receptor mobility affects the fidelity of synaptic transmission by shaping the frequency dependence of synaptic responses.	[Heine, Martin; Groc, Laurent; Choquet, Daniel] Univ Bordeaux 1, CNRS, UMR 5091, Bordeaux, France; [Lounis, Brahim; Cognet, Laurent] Univ Bordeaux 1, Ctr Phys Mol Opt & Hertzienne, CNRS, F-33405 Talence, France; [Beique, Jean-Claude; Rumbaugh, Gavin; Huganir, Richard L.] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD USA; [Frischknecht, Renato] Leibniz Inst Neurobiol, Magdeburg, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Johns Hopkins University; Leibniz Institut fur Neurobiologie (LIN)	Choquet, D (corresponding author), Univ Bordeaux 1, CNRS, UMR 5091, Bordeaux, France.	dchoquet@u-bordeaux2.fr	Choquet, Daniel/E-4203-2013; Choquet, Daniel/GOJ-8825-2022; Choquet, Daniel/K-7893-2018; Cognet, Laurent/F-4163-2011; Lounis, Brahim/I-7862-2016; Cognet, Laurent/M-4505-2019	Choquet, Daniel/0000-0003-4726-9763; Choquet, Daniel/0000-0003-4726-9763; Cognet, Laurent/0000-0002-3573-5387; Lounis, Brahim/0000-0001-7501-0236; 	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; Andrasfalvy BK, 2001, J NEUROSCI, V21, P9151, DOI 10.1523/JNEUROSCI.21-23-09151.2001; Arai A, 1998, BRAIN RES, V799, P230, DOI 10.1016/S0006-8993(98)00446-6; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Diamond JS, 1997, J NEUROSCI, V17, P4672; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Fortune ES, 2001, TRENDS NEUROSCI, V24, P381, DOI 10.1016/S0166-2236(00)01835-X; Franks KM, 2003, J NEUROSCI, V23, P3186; Franks KM, 2002, BIOPHYS J, V83, P2333, DOI 10.1016/S0006-3495(02)75248-X; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Groc L, 2007, J NEUROSCI, V27, P12433, DOI 10.1523/JNEUROSCI.3349-07.2007; Grosskreutz J, 2003, EUR J NEUROSCI, V17, P1173, DOI 10.1046/j.1460-9568.2003.02531.x; Hjelmstad GO, 1999, J NEUROPHYSIOL, V81, P3096, DOI 10.1152/jn.1999.81.6.3096; Ishikawa T, 2001, J PHYSIOL-LONDON, V533, P423, DOI 10.1111/j.1469-7793.2001.0423a.x; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Lisman JE, 2007, NAT REV NEUROSCI, V8, P597, DOI 10.1038/nrn2191; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; RAMAN IM, 1995, BIOPHYS J, V68, P137, DOI 10.1016/S0006-3495(95)80168-2; Scheuss V, 2002, J NEUROSCI, V22, P728, DOI 10.1523/JNEUROSCI.22-03-00728.2002; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Smith MA, 2003, J PHYSIOL-LONDON, V548, P245, DOI 10.1113/jphysiol.2002.036376; Sugiyama Y, 2005, NAT METHODS, V2, P677, DOI 10.1038/NMETH783; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; Xie XP, 1997, P NATL ACAD SCI USA, V94, P6983, DOI 10.1073/pnas.94.13.6983; Xu-Friedman MA, 2003, J NEUROSCI, V23, P2182; YAMADA KA, 1993, J NEUROSCI, V13, P3904; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	37	342	346	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2008	320	5873					201	205		10.1126/science.1152089	http://dx.doi.org/10.1126/science.1152089			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286HJ	18403705	Green Accepted			2022-12-24	WOS:000254836700035
J	Gilbert, RE; Marsden, PA				Gilbert, Richard E.; Marsden, Philip A.			Activated protein C and diabetic nephropathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SEPSIS		[Gilbert, Richard E.; Marsden, Philip A.] Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada; [Gilbert, Richard E.; Marsden, Philip A.] St Michaels Hosp, Div Endocrinol, Toronto, ON M5B 1W8, Canada; [Gilbert, Richard E.; Marsden, Philip A.] St Michaels Hosp, Div Nephrol, Toronto, ON M5B 1W8, Canada; [Gilbert, Richard E.; Marsden, Philip A.] Univ Toronto, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Gilbert, RE (corresponding author), Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada.		Marsden, Philip A/B-1441-2012					Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884	4	10	12	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 10	2008	358	15					1628	1630		10.1056/NEJMcibr0801042	http://dx.doi.org/10.1056/NEJMcibr0801042			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	285NK	18403772				2022-12-24	WOS:000254783300015
J	Lelieveld, J; Butler, TM; Crowley, JN; Dillon, TJ; Fischer, H; Ganzeveld, L; Harder, H; Lawrence, MG; Martinez, M; Taraborrelli, D; Williams, J				Lelieveld, J.; Butler, T. M.; Crowley, J. N.; Dillon, T. J.; Fischer, H.; Ganzeveld, L.; Harder, H.; Lawrence, M. G.; Martinez, M.; Taraborrelli, D.; Williams, J.			Atmospheric oxidation capacity sustained by a tropical forest	NATURE			English	Article							ISOPRENE; CHEMISTRY; EMISSION; MODEL; THERMOTOLERANCE; HYDROCARBONS; TERRESTRIAL; SIMULATION; OZONE	Terrestrial vegetation, especially tropical rain forest, releases vast quantities of volatile organic compounds (VOCs) to the atmosphere(1-3), which are removed by oxidation reactions and deposition of reaction products(4-6). The oxidation is mainly initiated by hydroxyl radicals (OH), primarily formed through the photodissociation of ozone(4). Previously it was thought that, in unpolluted air, biogenic VOCs deplete OH and reduce the atmospheric oxidation capacity(5-10). Conversely, in polluted air VOC oxidation leads to noxious oxidant build-up by the catalytic action of nitrogen oxides(5-10) (NOx = NO + NO2). Here we report aircraft measurements of atmospheric trace gases performed over the pristine Amazon forest. Our data reveal unexpectedly high OH concentrations. We propose that natural VOC oxidation, notably of isoprene, recycles OH efficiently in low-NOx air through reactions of organic peroxy radicals. Computations with an atmospheric chemistry model and the results of laboratory experiments suggest that an OH recycling efficiency of 40-80 per cent in isoprene oxidation may be able to explain the high OH levels we observed in the field. Although further laboratory studies are necessary to explore the chemical mechanism responsible for OH recycling in more detail, our results demonstrate that the biosphere maintains a remarkable balance with the atmospheric environment.	[Lelieveld, J.; Butler, T. M.; Crowley, J. N.; Dillon, T. J.; Fischer, H.; Ganzeveld, L.; Harder, H.; Lawrence, M. G.; Martinez, M.; Taraborrelli, D.; Williams, J.] Max Planck Inst Chem, D-55128 Mainz, Germany	Max Planck Society	Lelieveld, J (corresponding author), Max Planck Inst Chem, 27 Becherweg, D-55128 Mainz, Germany.	lelieveld@mpch-mainz.mpg.de	Lelieveld, Jos/A-1986-2013; Taraborrelli, Domenico/O-8668-2015; Butler, Tim/G-1139-2011; Dillon, Terry J/A-3921-2011; Harder, Hartwig D/L-2511-2014; Harder, Hartwig/AAE-8557-2019; Williams, Jonathan/K-7686-2017	Lelieveld, Jos/0000-0001-6307-3846; Taraborrelli, Domenico/0000-0003-2213-6307; Dillon, Terry J/0000-0001-8974-9410; Harder, Hartwig D/0000-0002-6868-714X; Harder, Hartwig/0000-0002-6868-714X; Williams, Jonathan/0000-0001-9421-1703; Butler, Timothy/0000-0002-2219-4657; Lawrence, Mark/0000-0002-2178-4903				Ciccioli P, 1999, J GEOPHYS RES-ATMOS, V104, P8077, DOI 10.1029/1998JD100026; Di Carlo P, 2004, SCIENCE, V304, P722, DOI 10.1126/science.1094392; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Ganzeveld LN, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001289; Goldstein AH, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021259; Goldstein AH, 2007, ENVIRON SCI TECHNOL, V41, P1514, DOI 10.1021/es072476p; Granier C, 2000, ATMOS ENVIRON, V34, P5255, DOI 10.1016/S1352-2310(00)00299-5; Guenther A, 2006, ATMOS CHEM PHYS, V6, P3181, DOI 10.5194/acp-6-3181-2006; Hasson AS, 2004, J PHYS CHEM A, V108, P5979, DOI 10.1021/jp048873t; Jenkin ME, 2007, PHYS CHEM CHEM PHYS, V9, P3149, DOI 10.1039/b702757e; Jockel P, 2006, ATMOS CHEM PHYS, V6, P5067; Karl T, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008539; Kesselmeier J, 1999, J ATMOS CHEM, V33, P23, DOI 10.1023/A:1006127516791; Kuhn U, 2007, ATMOS CHEM PHYS, V7, P2855, DOI 10.5194/acp-7-2855-2007; Lawrence MG, 1999, J GEOPHYS RES-ATMOS, V104, P26245, DOI 10.1029/1999JD900425; Lelieveld J, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002272; LEVY H, 1971, SCIENCE, V173, P141, DOI 10.1126/science.173.3992.141; Penuelas J, 2005, PLANT CELL ENVIRON, V28, P278, DOI 10.1111/j.1365-3040.2004.01250.x; Poschl U, 2000, J ATMOS CHEM, V37, P29, DOI 10.1023/A:1006391009798; Sander R, 2005, ATMOS CHEM PHYS, V5, P445, DOI 10.5194/acp-5-445-2005; Saunders SM, 2003, ATMOS CHEM PHYS, V3, P161, DOI 10.5194/acp-3-161-2003; Singsaas EL, 1997, PLANT PHYSIOL, V115, P1413, DOI 10.1104/pp.115.4.1413; Tan D, 2001, J GEOPHYS RES-ATMOS, V106, P24407, DOI 10.1029/2001JD900016; TERRY GM, 1995, J EXP BOT, V46, P1629, DOI 10.1093/jxb/46.10.1629; Thornton JA, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000932; von Kuhlmann R, 2004, ATMOS CHEM PHYS, V4, P1, DOI 10.5194/acp-4-1-2004; Wang YH, 1998, J GEOPHYS RES-ATMOS, V103, P10757, DOI 10.1029/98JD00156; Wildermuth MC, 1996, PLANT PHYSIOL, V112, P171, DOI 10.1104/pp.112.1.171; Williams J, 2007, ATMOS CHEM PHYS, V7, P973, DOI 10.5194/acp-7-973-2007	29	591	599	11	435	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2008	452	7188					737	740		10.1038/nature06870	http://dx.doi.org/10.1038/nature06870			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	285QY	18401407				2022-12-24	WOS:000254792500042
J	Connaughton, M				Connaughton, Mark			Commentary: Controversies in NICE guidance on infective endocarditis	BRITISH MEDICAL JOURNAL			English	Editorial Material									St Marys Hosp, Newport PO30 5TG, Wight, England		Connaughton, M (corresponding author), St Marys Hosp, Newport PO30 5TG, Wight, England.	mconnaughton@doctors.org.uk						*BRIT CARD SOC, 2006, END GUID; Gould FK, 2006, J ANTIMICROB CHEMOTH, V57, P1035, DOI 10.1093/jac/dkl121	2	9	9	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 5	2008	336	7647					771	771		10.1136/bmj.39512.666412.AD	http://dx.doi.org/10.1136/bmj.39512.666412.AD			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284JW	18390529	Green Published			2022-12-24	WOS:000254703700036
J	Toor, N; Keating, KS; Taylor, SD; Pyle, AM				Toor, Navtej; Keating, Kevin S.; Taylor, Sean D.; Pyle, Anna Marie			Crystal structure of a self-spliced group II intron	SCIENCE			English	Article							METAL-ION COORDINATION; ACTIVE-SITE; IN-VIVO; CONSERVED DINUCLEOTIDE; 2-METAL-ION MECHANISM; TERTIARY INTERACTION; EXON-BINDING; RNA; DOMAIN-5; CATALYSIS	Group II introns are self- splicing ribozymes that catalyze their own excision from precursor transcripts and insertion into new genetic locations. Here we report the crystal structure of an intact, self- spliced group II intron from Oceanobacillus iheyensis at 3.1 angstrom resolution. An extensive network of tertiary interactions facilitates the ordered packing of intron subdomains around a ribozyme core that includes catalytic domain V. The bulge of domain V adopts an unusual helical structure that is located adjacent to a major groove triple helix ( catalytic triplex). The bulge and catalytic triplex jointly coordinate two divalent metal ions in a configuration that is consistent with a two- metal ion mechanism for catalysis. Structural and functional analogies support the hypothesis that group II introns and the spliceosome share a common ancestor.	[Toor, Navtej; Pyle, Anna Marie] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06511 USA; [Keating, Kevin S.] Yale Univ, Interdept Program Computat Biol & Bioinformat, New Haven, CT 06511 USA; [Taylor, Sean D.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; [Pyle, Anna Marie] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute	Toor, N (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave,Bass Bldg, New Haven, CT 06511 USA.	navtej.toor@yale.edu; anna.pyle@yale.edu		Toor, Navtej/0000-0002-6134-163X; Keating, Kevin/0000-0001-5855-6739	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050313] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007056] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM50313, R01 GM050313] Funding Source: Medline; NLM NIH HHS [T15 LM07056] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; Baeyens KJ, 1996, P NATL ACAD SCI USA, V93, P12851, DOI 10.1073/pnas.93.23.12851; Boudvillain M, 2000, NATURE, V406, P315, DOI 10.1038/35018589; Boudvillain M, 1998, EMBO J, V17, P7091, DOI 10.1093/emboj/17.23.7091; BOULANGER SC, 1995, MOL CELL BIOL, V15, P4479; CECH TR, 1986, CELL, V44, P207, DOI 10.1016/0092-8674(86)90751-8; CHANFREAU G, 1994, SCIENCE, V266, P1383, DOI 10.1126/science.7973729; COSTA M, 1995, EMBO J, V14, P1276, DOI 10.1002/j.1460-2075.1995.tb07111.x; Costa M, 2000, EMBO J, V19, P5007, DOI 10.1093/emboj/19.18.5007; Costa M, 1997, J MOL BIOL, V267, P520, DOI 10.1006/jmbi.1996.0882; de Lencastre A, 2005, NAT STRUCT MOL BIOL, V12, P626, DOI 10.1038/nsmb957; Fedorova O, 2005, EMBO J, V24, P3906, DOI 10.1038/sj.emboj.7600852; Fedorova O, 2003, J MOL BIOL, V330, P197, DOI 10.1016/S0022-2836(03)00594-1; FERAT JL, 1993, NATURE, V364, P358, DOI 10.1038/364358a0; Gordon PM, 2007, CHEM BIOL, V14, P607, DOI 10.1016/j.chembiol.2007.05.008; Gordon PM, 2001, NAT STRUCT BIOL, V8, P893, DOI 10.1038/nsb1001-893; Granlund M, 2001, J BACTERIOL, V183, P2560, DOI 10.1128/JB.183.8.2560-2569.2001; HARRISKERR CL, 1993, P NATL ACAD SCI USA, V90, P10658, DOI 10.1073/pnas.90.22.10658; HENDRICKSON WA, 1985, METHOD ENZYMOL, V115, P41; JACQUIER A, 1990, J MOL BIOL, V213, P437, DOI 10.1016/S0022-2836(05)80206-2; JACQUIER A, 1987, CELL, V50, P17, DOI 10.1016/0092-8674(87)90658-1; Keel AY, 2007, STRUCTURE, V15, P761, DOI 10.1016/j.str.2007.06.003; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; MADHANI HD, 1994, GENE DEV, V8, P1071, DOI 10.1101/gad.8.9.1071; Martin W, 2006, NATURE, V440, P41, DOI 10.1038/nature04531; Mikheeva S, 2000, RNA, V6, P1509, DOI 10.1017/S1355838200000972; Podar M, 1998, RNA, V4, P151; Podar M, 1998, NATURE, V391, P915, DOI 10.1038/36142; PODAR M, 1995, RNA, V1, P828; Podar M, 1999, RNA, V5, P318, DOI 10.1017/S1355838299981724; Pyle A. M., 2006, RNA WORLD; Pyle AM, 2007, TRENDS BIOCHEM SCI, V32, P138, DOI 10.1016/j.tibs.2007.01.005; Rest JS, 2003, MOL BIOL EVOL, V20, P1134, DOI 10.1093/molbev/msg135; Robart AR, 2007, P NATL ACAD SCI USA, V104, P6620, DOI 10.1073/pnas.0700561104; Schmidt U, 1996, RNA, V2, P1161; SHARP PA, 1991, SCIENCE, V254, P663, DOI 10.1126/science.1948046; Shukla GC, 2002, MOL CELL, V9, P1145, DOI 10.1016/S1097-2765(02)00505-1; Sigel RKO, 2004, NAT STRUCT MOL BIOL, V11, P187, DOI 10.1038/nsmb717; Stahley MR, 2005, SCIENCE, V309, P1587, DOI 10.1126/science.1114994; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Tamura M, 2002, J MOL BIOL, V320, P455, DOI 10.1016/S0022-2836(02)00515-6; Toor N, 2001, RNA, V7, P1142, DOI 10.1017/S1355838201010251; Toor N, 2006, NUCLEIC ACIDS RES, V34, P6461, DOI 10.1093/nar/gkl820; Valles Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001488; Wank H, 1999, MOL CELL, V4, P239, DOI 10.1016/S1097-2765(00)80371-8; Yean SL, 2000, NATURE, V408, P881, DOI 10.1038/35048617; Zhang L, 2002, SCIENCE, V295, P2084, DOI 10.1126/science.1069268; ZIMMERLY S, 1995, CELL, V82, P545, DOI 10.1016/0092-8674(95)90027-6	48	361	367	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 4	2008	320	5872					77	82		10.1126/science.1153803	http://dx.doi.org/10.1126/science.1153803			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283JR	18388288	Green Accepted			2022-12-24	WOS:000254633000033
J	Neuser, K; Triphan, T; Mronz, M; Poeck, B; Strauss, R				Neuser, Kirsa; Triphan, Tilman; Mronz, Markus; Poeck, Burkhard; Strauss, Roland			Analysis of a spatial orientation memory in Drosophila	NATURE			English	Article							WORKING-MEMORY; EXPRESSION; GENE; MELANOGASTER; MUTANTS; OPERANT; DUNCE; FLY; RSK	Flexible goal- driven orientation requires that the position of a target be stored, especially in case the target moves out of sight. The capability to retain, recall and integrate such positional information into guiding behaviour has been summarized under the term spatial working memory(1). This kind of memory contains specific details of the presence that are not necessarily part of a long- term memory. Neurophysiological studies in primates(2) indicate that sustained activity of neurons encodes the sensory information even though the object is no longer present. Furthermore they suggest that dopamine transmits the respective input to the prefrontal cortex, and simultaneous suppression by GABA spatially restricts this neuronal activity(3). Here we show that Drosophila melanogaster possesses a similar spatial memory during locomotion. Using a new detour setup, we show that flies can remember the position of an object for several seconds after it has been removed from their environment. In this setup, flies are temporarily lured away from the direction towards their hidden target, yet they are thereafter able to aim for their former target. Furthermore, we find that the GABAergic ( stainable with antibodies against GABA) ring neurons(4) of the ellipsoid body in the central brain are necessary and their plasticity is sufficient for a functional spatial orientation memory in flies. We also find that the protein kinase S6KII ( ignorant)(5) is required in a distinct subset of ring neurons to display this memory. Conditional expression of S6KII in these neurons only in adults can restore the loss of the orientation memory of the ignorant mutant. The S6KII signalling pathway therefore seems to be acutely required in the ring neurons for spatial orientation memory in flies.	[Neuser, Kirsa; Triphan, Tilman; Mronz, Markus; Poeck, Burkhard; Strauss, Roland] Univ Wurzburg, Lehrstuhl Genet & Neurobiol, Biozentrum, D-97074 Wurzburg, Germany	University of Wurzburg	Strauss, R (corresponding author), Johannes Gutenberg Univ Mainz, Inst Zool Neurobiol 3, Col Kleinmann Weg 2, D-55099 Mainz, Germany.	rstrauss@uni-mainz.de						Botella JA, 2003, MOL BIOL CELL, V14, P241, DOI 10.1091/mbc.E02-05-0297; BRAND AH, 1993, DEVELOPMENT, V118, P401; BULTHOFF H, 1982, J COMP PHYSIOL, V148, P471; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Collett TS, 2002, NAT REV NEUROSCI, V3, P542, DOI 10.1038/nrn872; DAVIS RL, 1981, J CELL BIOL, V90, P101, DOI 10.1083/jcb.90.1.101; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; Funahashi S, 2006, NEUROSCIENCE, V139, P251, DOI 10.1016/j.neuroscience.2005.07.003; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; HEISENBERG M, 1979, Z NATURFORSCH C, V34, P143; Kim MJ, 2006, EMBO J, V25, P3056, DOI 10.1038/sj.emboj.7601180; Kim YC, 2003, GENE EXPR PATTERNS, V3, P237, DOI 10.1016/S1567-133X(02)00098-4; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2005, PROG NEUROBIOL, V76, P328, DOI 10.1016/j.pneurobio.2005.09.003; MRONZ M, 2004, THESIS U WURZBURG; Myers AP, 2004, MOL CELL BIOL, V24, P4255, DOI 10.1128/MCB.24.10.4255-4266.2004; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Putz G, 2004, J NEUROSCI, V24, P9745, DOI 10.1523/JNEUROSCI.3211-04.2004; Renn SCP, 1999, J NEUROBIOL, V41, P189; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Strauss R, 1997, J EXP BIOL, V200, P1281; Strauss R, 1998, J COMP PHYSIOL A, V182, P411, DOI 10.1007/s003590050190; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Torroja L, 1999, CURR BIOL, V9, P489, DOI 10.1016/S0960-9822(99)80215-2; Wustmann G, 1996, J COMP PHYSIOL A, V179, P429, DOI 10.1007/BF00194996	30	256	259	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2008	453	7199					1244	U44		10.1038/nature07003	http://dx.doi.org/10.1038/nature07003			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18509336				2022-12-24	WOS:000257075800044
J	Bonetta, L				Bonetta, Laura			Getting up close and personal with your genome	CELL			English	Editorial Material								A new type of company is offering to scan a person's genome and reveal the information it holds for as little as $1000. Are these services fun novelty items or do they provide valuable information that will help people take better care of their health?											0	16	16	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 30	2008	133	5					753	756		10.1016/j.cell.2008.05.008	http://dx.doi.org/10.1016/j.cell.2008.05.008			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	306UY	18510915	Bronze			2022-12-24	WOS:000256274500003
J	Sasai, N; Yakura, R; Kamiya, D; Nakazawa, Y; Sasai, Y				Sasai, Noriaki; Yakura, Rieko; Kamiya, Daisuke; Nakazawa, Yoko; Sasai, Yoshiki			Ectodermal factor restricts mesoderm differentiation by inhibiting p53	CELL			English	Article							GERM-LAYER SPECIFICATION; ZINC-FINGER PROTEINS; EMBRYONIC STEM-CELLS; EARLY XENOPUS EMBRYO; TGF-BETA; TRANSCRIPTIONAL REGULATION; MOLECULAR MECHANISMS; UBIQUITIN LIGASE; DNA-BINDING; COMPETENCE	During gastrulation of the amphibian embryo, specification of the three germ layers, endo-, ecto-, and mesoderm, is regulated by maternal and zygotic mechanisms. Although it is known that mesoderm specification requires the cooperation between TGF-beta signaling and p53 activity and requires maternal factors, essential zygotic factors have been elusive. Here, we report that the Zn-finger protein XFDL156 is an ectodermal, zygotic factor that suppresses mesodermal differentiation. XFDL156 overexpression suppresses mesodermal markers, and its depletion induces aberrant mesodermal differentiation in the presumptive ectoderm. Furthermore, we find that XFDL156 and its mammalian homologs interact with the C-terminal regulatory region of p53, thereby inhibiting p53 target gene induction and mesodermal differentiation. Thus, XFDL156 actively restricts mesodermal differentiation in the presumptive ectoderm by controlling the spatiotemporal responsiveness to p53.	[Sasai, Noriaki; Yakura, Rieko; Kamiya, Daisuke; Nakazawa, Yoko; Sasai, Yoshiki] RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan	RIKEN	Sasai, N (corresponding author), RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan.	norisa@cdb.riken.jp; yoshikisasai@cdb.riken.jp		Sasai, Noriaki/0000-0003-0360-1138				Bell E, 2003, DEVELOPMENT, V130, P1381, DOI 10.1242/dev.00344; Bellefroid E, 1997, MECH DEVELOP, V63, P99, DOI 10.1016/S0925-4773(97)00034-8; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; COFFMAN CR, 1993, CELL, V73, P659, DOI 10.1016/0092-8674(93)90247-N; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; Eimon PM, 2002, DEVELOPMENT, V129, P3089; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; Germain S, 2000, GENE DEV, V14, P435; Grimm OH, 2002, NAT CELL BIOL, V4, P519, DOI 10.1038/ncb812; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; HOEVER M, 1994, ONCOGENE, V9, P109; KINOSHITA M, 1994, FEBS LETT, V352, P191, DOI 10.1016/0014-5793(94)00909-0; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Liu KJ, 2005, DEVELOPMENT, V132, P1511, DOI 10.1242/dev.01703; Looman C, 2002, MOL BIOL EVOL, V19, P2118, DOI 10.1093/oxfordjournals.molbev.a004037; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Marechal V, 1997, ONCOGENE, V14, P1427, DOI 10.1038/sj.onc.1200967; Matsuo-Takasaki M, 2005, DEVELOPMENT, V132, P3885, DOI 10.1242/dev.01959; Mir A, 2007, DEVELOPMENT, V134, P779, DOI 10.1242/dev.02768; Mizuseki K, 1998, DEVELOPMENT, V125, P579; Nakatani J, 2000, MECH DEVELOP, V91, P81, DOI 10.1016/S0925-4773(99)00274-9; Nakayama T, 2001, MECH DEVELOP, V100, P251, DOI 10.1016/S0925-4773(00)00533-5; Onai T, 2004, DEV CELL, V7, P95, DOI 10.1016/j.devcel.2004.06.004; Onai T, 2007, EMBO J, V26, P2350, DOI 10.1038/sj.emboj.7601684; Sasai N, 2004, NAT CELL BIOL, V6, P741, DOI 10.1038/ncb1158; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Smith J, 1997, CURR OPIN GENET DEV, V7, P474, DOI 10.1016/S0959-437X(97)80073-1; SMITH WC, 1995, CELL, V82, P37, DOI 10.1016/0092-8674(95)90050-0; Snir M, 2006, EMBO J, V25, P3664, DOI 10.1038/sj.emboj.7601238; Steinbach OC, 1997, NATURE, V389, P395, DOI 10.1038/38755; Stewart David, 2006, V322, P165; Sun BI, 1999, DEVELOPMENT, V126, P1467; Takebayashi-Suzuki K, 2003, DEVELOPMENT, V130, P3929, DOI 10.1242/dev.00615; Tosoni D, 2005, CELL, V123, P875, DOI 10.1016/j.cell.2005.10.021; Trindade M, 2003, DEVELOPMENT, V130, P4611, DOI 10.1242/dev.00489; TSAI RYL, 1999, ROAZ MOL CELL BIOL, V18, P6447; Wardle FC, 2006, SEMIN CELL DEV BIOL, V17, P99, DOI 10.1016/j.semcdb.2005.11.008; Watabe T, 1995, GENE DEV, V9, P3038, DOI 10.1101/gad.9.24.3038; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Watanabe M, 1999, DEVELOPMENT, V126, P5621; WOLKOWICZ R, 1995, P NATL ACAD SCI USA, V92, P6842, DOI 10.1073/pnas.92.15.6842; ZAMBETTI GP, 1992, GENE DEV, V6, P1143, DOI 10.1101/gad.6.7.1143; Zhang C, 2007, DIFFERENTIATION, V75, P536, DOI 10.1111/j.1432-0436.2007.00190.x; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974	52	36	36	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 30	2008	133	5					878	890		10.1016/j.cell.2008.03.035	http://dx.doi.org/10.1016/j.cell.2008.03.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	306UY	18510931	Bronze			2022-12-24	WOS:000256274500019
J	Yu, XK; Jin, L; Zhou, ZH				Yu, Xuekui; Jin, Lei; Zhou, Z. Hong			3.88 angstrom structure of cytoplasmic polyhedrosis virus by cryo-electron microscopy	NATURE			English	Article							PROTEIN-RNA INTERACTIONS; ELECTRON CRYOMICROSCOPY; SPHERICAL VIRUSES; FOURIER SYNTHESIS; ATOMIC-STRUCTURE; REOVIRUS CORE; GENOME; VISUALIZATION; CYPOVIRUS; REVEALS	Cytoplasmic polyhedrosis virus (CPV) is unique within the Reoviridae family in having a turreted single-layer capsid contained within polyhedrin inclusion bodies, yet being fully capable of cell entry and endogenous RNA transcription(1-4). Biochemical data have shown that the amino-terminal 79 residues of the CPV turret protein (TP) is sufficient to bring CPV or engineered proteins into the polyhedrin matrix for micro-encapsulation(5,6). Here we report the three-dimensional structure of CPV at 3.88 angstrom resolution using single-particle cryo-electron microscopy. Our map clearly shows the turns and deep grooves of alpha-helices, the strand separation in beta-sheets, and densities for loops and many bulky side chains; thus permitting atomic model-building effort from cryoelectron microscopy maps. We observed a helix-to-beta-hairpin conformational change between the two conformational states of the capsid shell protein in the region directly interacting with genomic RNA. We have also discovered a messenger RNA release hole coupled with the mRNA capping machinery unique to CPV. Furthermore, we have identified the polyhedrin-binding domain, a structure that has potential in nanobiotechnology applications.	[Yu, Xuekui; Jin, Lei; Zhou, Z. Hong] Univ Texas Houston, Sch Med, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Yu, Xuekui; Jin, Lei; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Yu, Xuekui; Jin, Lei; Zhou, Z. Hong] Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA 90095 USA	University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Zhou, ZH (corresponding author), Univ Texas Houston, Sch Med, Dept Pathol & Lab Med, Houston, TX 77030 USA.	Hong.Zhou@UCLA.edu	Zhou, Z Hong/HDN-0747-2022		NCRR NIH HHS [P41 RR002250-226489, P41 RR002250-217385, P41 RR002250-200043, P41 RR002250, P41 RR002250-190043] Funding Source: Medline; NIAID NIH HHS [R01 AI069015-01A1, R01 AI069015-03, R01 AI069015-02, R01 AI069015] Funding Source: Medline; NIGMS NIH HHS [R01 GM071940, R01 GM071940-03, R01 GM071940-01A2, R01 GM071940-04, R01 GM071940-02] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071940] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baker Matthew L., 2008, P89; Baker TS, 1996, J STRUCT BIOL, V116, P120, DOI 10.1006/jsbi.1996.0020; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Conway JF, 1997, NATURE, V386, P91, DOI 10.1038/386091a0; Coulibaly F, 2007, NATURE, V446, P97, DOI 10.1038/nature05628; CROWTHER RA, 1970, NATURE, V226, P421, DOI 10.1038/226421a0; CROWTHER RA, 1971, PHILOS T R SOC B, V261, P221, DOI 10.1098/rstb.1971.0054; DeLano WL, 2002, PYMOL USERS MANUAL; DI X, 1991, VIROLOGY, V180, P153; Diprose JM, 2001, EMBO J, V20, P7229, DOI 10.1093/emboj/20.24.7229; Gouet P, 1999, CELL, V97, P481, DOI 10.1016/S0092-8674(00)80758-8; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Hagiwara K, 2000, J GEN VIROL, V81, P1143, DOI 10.1099/0022-1317-81-4-1143; Hagiwara K, 2003, J GEN VIROL, V84, P2439, DOI 10.1099/vir.0.19216-0; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; Hill CL, 1999, NAT STRUCT BIOL, V6, P565, DOI 10.1038/9347; Ikeda K, 2006, PROTEOMICS, V6, P54, DOI 10.1002/pmic.200500022; Ikeda K, 2001, J VIROL, V75, P988, DOI 10.1128/JVI.75.2.988-995.2001; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Jiang W, 2008, NATURE, V451, P1130, DOI 10.1038/nature06665; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lawton JA, 1997, NAT STRUCT BIOL, V4, P118, DOI 10.1038/nsb0297-118; Liang YY, 2002, J STRUCT BIOL, V137, P292, DOI 10.1016/S1047-8477(02)00014-X; Liu HR, 2008, J STRUCT BIOL, V161, P64, DOI 10.1016/j.jsb.2007.09.016; Ludtke SJ, 2008, STRUCTURE, V16, P441, DOI 10.1016/j.str.2008.02.007; Mertens PPC, 2005, VIRUS TAXONOMY, P447; Nakagawa A, 2003, STRUCTURE, V11, P1227, DOI 10.1016/j.str.2003.08.012; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; Xia Q, 2003, J BIOL CHEM, V278, P1094, DOI 10.1074/jbc.M205964200; XU PT, 1993, VIROLOGY, V197, P726, DOI 10.1006/viro.1993.1648; Zhang H, 1999, J VIROL, V73, P1624, DOI 10.1128/JVI.73.2.1624-1629.1999; Zhang X, 2008, P NATL ACAD SCI USA, V105, P1867, DOI 10.1073/pnas.0711623105; Zhou ZH, 2003, ADV PROTEIN CHEM, V64, P93; Zhou ZH, 2003, STRUCTURE, V11, P651, DOI 10.1016/S0969-2126(03)00091-1	37	224	250	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2008	453	7193					415	U73		10.1038/nature06893	http://dx.doi.org/10.1038/nature06893			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18449192	Green Accepted			2022-12-24	WOS:000255868400057
J	Semenza, GL				Semenza, Gregg L.			A new weapon for attacking tumor blood vessels	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ANGIOGENESIS		Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA	Johns Hopkins University	Semenza, GL (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.							Alani RM, 2004, CANCER BIOL THER, V3, P498, DOI 10.4161/cbt.3.6.930; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187	5	29	34	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2008	358	19					2066	2067		10.1056/NEJMcibr0800272	http://dx.doi.org/10.1056/NEJMcibr0800272			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296WY	18463385				2022-12-24	WOS:000255577700014
J	Djupedal, I; Ekwall, K				Djupedal, Ingela; Ekwall, Karl			Molecular biology - The paradox of silent heterochromatin	SCIENCE			English	Editorial Material							TRANSCRIPTION; METHYLATION; GENES		[Djupedal, Ingela; Ekwall, Karl] Karolinska Inst, Novum, Univ Coll Sodertorn, Sweden Sch Life Sci,Dept Biosci & Med Nutr, S-14157 Huddinge, Sweden	Karolinska Institutet; Sodertorn University	Djupedal, I (corresponding author), Karolinska Inst, Novum, Univ Coll Sodertorn, Sweden Sch Life Sci,Dept Biosci & Med Nutr, S-14157 Huddinge, Sweden.	karl.ekwall@ki.se		Ekwall, Karl/0000-0002-3029-4041				ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Chen ZJ, 2007, BBA-GENE STRUCT EXPR, V1769, P295, DOI 10.1016/j.bbaexp.2007.04.007; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Lloyd VK, 2003, GENOME, V46, P1104, DOI 10.1139/G03-070; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Yasuhara JC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040016; Yasuhara JC, 2006, TRENDS GENET, V22, P330, DOI 10.1016/j.tig.2006.04.008	13	8	8	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2008	320	5876					624	625		10.1126/science.1158923	http://dx.doi.org/10.1126/science.1158923			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451292				2022-12-24	WOS:000255454300033
J	Samuel, DG				Samuel, David Gwynfor			The tale of an anorexic male medical student	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Cardiff Univ, Cardiff, Wales	Cardiff University	Samuel, DG (corresponding author), Cardiff Univ, Cardiff, Wales.	welshsledge@hotmail.com							0	1	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2008	336	7649					892	892		10.1136/bmj.39546.715347.94	http://dx.doi.org/10.1136/bmj.39546.715347.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	290QH	18420696	Green Published			2022-12-24	WOS:000255136800037
J	Psaty, BM; Lumley, T				Psaty, Bruce M.; Lumley, Thomas			Surrogate end points and FDA approval - A tale of 2 lipid-altering drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ESTER TRANSFER PROTEIN; CHOLESTEROL ABSORPTION INHIBITOR; PRIMARY HYPERCHOLESTEROLEMIA; MYOCARDIAL-INFARCTION; TORCETRAPIB; EZETIMIBE; EFFICACY; SAFETY; RISK; ROSIGLITAZONE		[Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98101 USA; [Lumley, Thomas] Univ Washington, Cardiovasc Hlth Res Unit, Dept Biostat, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative	Psaty, BM (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, 1730 Minor Ave,Ste 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu						Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; BERENSON A, 2008, NY TIMES        0115, pA1; Bots ML, 2007, LANCET, V370, P153, DOI 10.1016/S0140-6736(07)61088-5; Brousseau ME, 2004, NEW ENGL J MED, V350, P1505, DOI 10.1056/NEJMoa031766; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; Davidson MH, 2002, J AM COLL CARDIOL, V40, P2125, DOI 10.1016/S0735-1097(02)02610-4; Davidson MH, 2006, J AM COLL CARDIOL, V48, P1774, DOI 10.1016/j.jacc.2006.06.067; Dujovne CA, 2002, AM J CARDIOL, V90, P1092, DOI 10.1016/S0002-9149(02)02798-4; Gagne C, 2002, AM J CARDIOL, V90, P1084, DOI 10.1016/S0002-9149(02)02774-1; Greenland P, 2008, JAMA-J AM MED ASSOC, V299, P953, DOI 10.1001/jama.299.8.953; Hellings WE, 2008, JAMA-J AM MED ASSOC, V299, P547, DOI 10.1001/jama.299.5.547; Joffe HV, 2007, NEW ENGL J MED, V357, P1775; Knopp RH, 2003, EUR HEART J, V24, P729, DOI 10.1016/S0195-668X(02)00807-2; McKenney JM, 2006, J AM COLL CARDIOL, V48, P1782, DOI 10.1016/j.jacc.2006.06.066; *MERCK SCHER PLOUG, 2008, PROD NEWS MERCK SHER; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; Psaty BM, 1999, JAMA-J AM MED ASSOC, V282, P786, DOI 10.1001/jama.282.8.786; Psaty BM, 2004, J AM GERIATR SOC, V52, P1639, DOI 10.1111/j.1532-5415.2004.52455.x; *US FDA, 1990, GUID CLIN EV LIP ALT	20	33	33	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 26	2008	299	12					1474	1476		10.1001/jama.299.12.1474	http://dx.doi.org/10.1001/jama.299.12.1474			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	278MY	18364491				2022-12-24	WOS:000254292200023
J	Tanriverdi, F; Unluhizarci, K; Kocyigit, I; Tuna, IS; Karaca, Z; Durak, AC; Selcuklu, A; Casanueva, FF; Kelestimur, F				Tanriverdi, Fatih; Unluhizarci, Kursad; Kocyigit, Ismail; Tuna, Ibrahim S.; Karaca, Zuleyha; Durak, Ahmet C.; Selcuklu, Ahmet; Casanueva, Felipe F.; Kelestimur, Fahrettin			Brief communication: Pituitary volume and function in competing and retired male boxers	ANNALS OF INTERNAL MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; HYPOPITUITARISM; SPORT	Background: Pituitary consequences of chronic head trauma in boxing have not been investigated in detail. Objective: To investigate the pituitary function in retired or active amateur boxers. Design: Cross-sectional, observational study. Setting: Turkey. Participants: 61 actively competing (n = 44) or retired (n = 17) male boxers of the Turkish National Boxing Team. Measurements: Body composition variables, pituitary volume (in 38 of 61 boxers), and pituitary function. Results: 9 of 61 boxers (15%) had growth hormone (GH) deficiency and 5 of 61 boxers (8%) had adrenocorticotropic hormone deficiency. All boxers with GH deficiency except 1 were retired from boxing. Of 17 retired boxers, 8 (47%) had GH deficiency. Retired boxers with GH deficiency had significantly lower pituitary volume than retired boxers with normal GH. Limitation: Pituitary volume was measured in only 38 of 61 boxers, and the study had no comparison group. Conclusion: This study suggests that retired boxers have a high rate of pituitary dysfunction. Therefore, investigation of pituitary function in boxers, particularly retired ones, is recommended.	Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey; Inst Salud Carlos III, Santiago De Compostela, Spain	Erciyes University; Instituto de Salud Carlos III	Tanriverdi, F (corresponding author), Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey.	fatihtan@erciyes.edu.tr	Karaca, Züleyha/ABB-7891-2021; kelestimur, f/ABE-9873-2021; selcuklu, selcuklu/GON-9516-2022	Tuna, Ibrahim/0000-0003-4170-6483; KOCYIGIT, ISMAIL/0000-0002-6654-4727				Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; BURKE CW, 1992, CLIN ENDOCRINOL, V36, P133, DOI 10.1111/j.1365-2265.1992.tb00946.x; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Kelestimur Fahrettin, 2005, Pituitary, V8, P259, DOI 10.1007/s11102-006-6051-3; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Lamberts SWJ, 1998, LANCET, V352, P127; Melmed S, 2003, J CLIN INVEST, V112, P1603, DOI 10.1172/JCI200320401; Orme SM, 1996, CLIN ENDOCRINOL, V45, P135, DOI 10.1046/j.1365-2265.1996.d01-1562.x; Popovic V, 2000, LANCET, V356, P1137, DOI 10.1016/S0140-6736(00)02755-0; Regal M, 2001, CLIN ENDOCRINOL, V55, P735, DOI 10.1046/j.1365-2265.2001.01406.x; Takano K, 1999, AM J NEURORADIOL, V20, P312; Tanriverdi F, 2007, CLIN ENDOCRINOL, V66, P360, DOI 10.1111/j.1365-2265.2006.02737.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Zazryn TR, 2003, BRIT J SPORT MED, V37, P448, DOI 10.1136/bjsm.37.5.448; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52	17	71	71	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 3	2008	148	11					827	U35		10.7326/0003-4819-148-11-200806030-00005	http://dx.doi.org/10.7326/0003-4819-148-11-200806030-00005			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	308CG	18519929				2022-12-24	WOS:000256365300004
J	Andersson, AF; Banfield, JF				Andersson, Anders F.; Banfield, Jillian F.			Virus population dynamics and acquired virus resistance in natural microbial communities	SCIENCE			English	Article							DNA; RECOMBINATION; SEQUENCES; ELEMENTS; REPEATS; GENOMES; PHAGE; BACTERIOPHAGES; MECHANISMS; EVOLUTION	Viruses shape microbial community structure and function by altering the fitness of their hosts and by promoting genetic exchange. The complexity of most natural ecosystems has precluded detailed studies of virus- host interactions. We reconstructed virus and host bacterial and archaeal genome sequences from community genomic data from two natural acidophilic biofilms. Viruses were matched to their hosts by analyzing spacer sequences that occur among clustered regularly interspaced short palindromic repeats (CRISPRs) that are a hallmark of virus resistance. Virus population genomic analyses provided evidence that extensive recombination shuffles sequence motifs sufficiently to evade CRISPR spacers. Only the most recently acquired spacers match coexisting viruses, which suggests that community stability is achieved by rapid but compensatory shifts in host resistance levels and virus population structure.	[Andersson, Anders F.; Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Andersson, Anders F.; Banfield, Jillian F.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Banfield, JF (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	jbanfield@berkeley.edu	Andersson, Anders/J-9310-2019	Andersson, Anders/0000-0002-3627-6899; Banfield, Jill/0000-0001-8203-8771				Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Botstein D, 1980, Ann N Y Acad Sci, V354, P484, DOI 10.1111/j.1749-6632.1980.tb27987.x; BRATBAK G, 1990, APPL ENVIRON MICROB, V56, P1400, DOI 10.1128/AEM.56.5.1400-1405.1990; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Brussow H, 2001, MOL MICROBIOL, V39, P213, DOI 10.1046/j.1365-2958.2001.02228.x; Canchaya C, 2003, CURR OPIN MICROBIOL, V6, P417, DOI 10.1016/S1369-5274(03)00086-9; Chen YG, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-54; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Druschel GK, 2004, GEOCHEM T, V5, P13, DOI 10.1186/1467-4866-5-13; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Juhala RJ, 2000, J MOL BIOL, V299, P27, DOI 10.1006/jmbi.2000.3729; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Lo I, 2007, NATURE, V446, P537, DOI 10.1038/nature05624; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Nilsson AS, 2001, MOL PHYLOGENET EVOL, V21, P259, DOI 10.1006/mpev.2001.1020; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Peng X, 2004, MOL MICROBIOL, V54, P366, DOI 10.1111/j.1365-2958.2004.04287.x; Peng X, 2001, VIROLOGY, V291, P226, DOI 10.1006/viro.2001.1190; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Pride DT, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-8; Prust C, 2005, NAT BIOTECHNOL, V23, P195, DOI 10.1038/nbt1062; Rossler N, 2004, MOL MICROBIOL, V52, P413, DOI 10.1111/j.1365-2958.2003.03983.x; Snyder JC, 2007, P NATL ACAD SCI USA, V104, P19102, DOI 10.1073/pnas.0709445104; Tang SL, 2004, J BACTERIOL, V186, P2810, DOI 10.1128/JB.186.9.2810-2817.2004; Tetart F, 1998, J MOL BIOL, V282, P543, DOI 10.1006/jmbi.1998.2047; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Vestergaard G, 2008, J VIROL, V82, P371, DOI 10.1128/JVI.01410-07; Wiedenheft B, 2004, J VIROL, V78, P1954, DOI 10.1128/JVI.78.4.1954-1961.2004	35	357	378	2	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2008	320	5879					1047	1050		10.1126/science.1157358	http://dx.doi.org/10.1126/science.1157358			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303RY	18497291				2022-12-24	WOS:000256059800037
J	Cadarette, SM; Katz, JN; Brookhart, MA; Sturmer, T; Stedman, MR; Solomon, DH				Cadarette, Suzanne M.; Katz, Jeffrey N.; Brookhart, M. Alan; Sturmer, Til; Stedman, Margaret R.; Solomon, Daniel H.			Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture	ANNALS OF INTERNAL MEDICINE			English	Article							BONE-MINERAL DENSITY; ALENDRONATE 70 MG; PROPENSITY SCORE; POSTMENOPAUSAL OSTEOPOROSIS; HIP-FRACTURES; RISEDRONATE; WOMEN; RALOXIFENE; PERSISTENCE; BISPHOSPHONATES	Background: Little information is available on the comparative effectiveness of osteoporosis pharmacotherapies. Objective: To compare the relative effectiveness of osteoporosis treatments to reduce nonvertebral fracture risk among older adults. Design: Cohort study. Setting: Enrollees in 2 statewide pharmaceutical benefit programs for persons age 65 years or older. Patients: 43 135 new recipients of oral bisphosphonates, nasal calcitonin, and raloxifene who began treatment from 2000 to 2005. The mean age was 79 years (SD, 6.9), and 96% were women. Measurements: The primary outcome was nonvertebral fracture (hip, humerus, or radius or ulna) within 12 months of treatment initiation. Cox proportional hazard models stratified by state and adjusted for risk factors for fracture were used to compare fracture rates. Alendronate was the reference category in all analyses. Results: A total of 1051 nonvertebral fractures were observed within 12 months (2.62 fractures per 100 person-years). No large differences in fracture risk were found between risedronate (hazard ratio [HR], 1.01 [95% CI, 0.85 to 1.21]) or raloxifene (HR, 1.18 [CI, 0.96 to 1.46]) and alendronate. However, among those with a fracture history, raloxifene recipients experienced more nonvertebral fractures within 12 months (HR, 1.78 [CI, 1.20 to 2.63]) compared with alendronate recipients. Patients who received calcitonin experienced more nonvertebral fractures than those who received alendronate (HR, 1.40, [CI, 1.20 to 1.63]). Results were similar in sensitivity analyses that examined different lengths of follow-up (6 months and 24 months), were restricted to hip fracture as the outcome, and were completed in various subgroups. Limitation: Confounder adjustment was limited to health care utilization data, and the confidence bounds of some comparisons were too wide to rule out potential clinically important differences between agents. Conclusion: Differences in fracture risk between risedronate or raloxifene and alendronate were small. Nasal calcitonin recipients may have a higher risk for nonvertebral fractures compared with alendronate recipients. Future studies that can better adjust for possible confounding may further clarify these relationships.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; Boston Univ, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Boston University	Cadarette, SM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Suitte 3030, Boston, MA 02120 USA.		Stürmer, Til/AAB-5459-2022; Cadarette, Suzanne/A-2608-2014	Cadarette, Suzanne/0000-0002-8584-9649	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR047782, K24AR002123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023178, K25AG027400, R21AG027066] Funding Source: NIH RePORTER; NIAMS NIH HHS [K24 AR002123-08, P60 AR47782, K24 AR02123, K24 AR002123, P60 AR047782] Funding Source: Medline; NIA NIH HHS [R21 AG027066, K25 AG027400, R01 AG023178] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allen MR, 2006, BONE, V39, P1130, DOI 10.1016/j.bone.2006.05.007; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Black DM, 2006, VALUE HEALTH, V9, P54, DOI 10.1111/j.1524-4733.2006.00081.x; Bonnick S, 2006, J CLIN ENDOCR METAB, V91, P2631, DOI 10.1210/jc.2005-2602; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Cadarette SM, 2007, MED CARE, V45, P896, DOI 10.1097/MLR.0b013e318054689f; Chesnut CH, 2000, AM J MED, V109, P267, DOI 10.1016/S0002-9343(00)00490-3; Clowes JA, 2004, J CLIN ENDOCR METAB, V89, P1117, DOI 10.1210/jc.2003-030501; Cramer JA, 2007, OSTEOPOROSIS INT, V18, P1023, DOI 10.1007/s00198-006-0322-8; Cranney A, 2002, ENDOCR REV, V23, P570, DOI 10.1210/er.2001-9002; Delmas PD, 2007, J CLIN ENDOCR METAB, V92, P1296, DOI 10.1210/jc.2006-1526; Ensrud KE, 2008, J BONE MINER RES, V23, P112, DOI 10.1359/JBMR.070904; Fitt NS, 2001, CAN MED ASSOC J, V164, P777; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Imai K, 2008, J R STAT SOC A STAT, V171, P481, DOI 10.1111/j.1467-985X.2007.00527.x; Imbens GW, 2000, BIOMETRIKA, V87, P706, DOI 10.1093/biomet/87.3.706; Kanis JA, 2004, OSTEOPOROSIS INT, V15, P108, DOI 10.1007/s00198-003-1516-y; Lindsay R, 2007, BONE, V40, pS32, DOI 10.1016/j.bone.2007.03.004; Luckey M, 2004, MENOPAUSE, V11, P405, DOI 10.1097/01.GME.0000119981.77837.1F; MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; *NAT OST FDN, 2004, PHYS GUID PREV TREAT; PECK WA, 1993, AM J MED, V94, P646; RAY WA, 1992, J CLIN EPIDEMIOL, V45, P703, DOI 10.1016/0895-4356(92)90047-Q; Recker RR, 2007, BONE, V40, P843, DOI 10.1016/j.bone.2006.11.001; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Rosen CJ, 2005, J BONE MINER RES, V20, P141, DOI 10.1359/jbmr.2005.20.1.141; Sambrook PN, 2004, J INTERN MED, V255, P503, DOI 10.1111/j.1365-2796.2004.01317.x; Schneeweiss S, 2004, J GEN INTERN MED, V19, P444, DOI 10.1111/j.1525-1497.2004.30109.x; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Schneeweiss S, 2007, MED CARE, V45, pS131, DOI 10.1097/MLR.0b013e318070c08e; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Schousboe JT, 2006, J BONE MINER RES, V21, P1557, DOI 10.1359/JBMR.060711; Seeman E, 2007, BONE, V41, P308, DOI 10.1016/j.bone.2007.06.010; Silverman SL, 2007, OSTEOPOROSIS INT, V18, P25, DOI 10.1007/s00198-006-0274-z; Solomon DH, 2005, ARCH INTERN MED, V165, P2414, DOI 10.1001/archinte.165.20.2414; Sturmer T, 2006, J CLIN EPIDEMIOL, V59, P437, DOI 10.1016/j.jclinepi.2005.07.004; Sturmer T, 2005, AM J EPIDEMIOL, V162, P279, DOI 10.1093/aje/kwi192; Sturmer T, 2007, AM J EPIDEMIOL, V165, P1110, DOI 10.1093/aje/kwm074; Thiebaut ACM, 2007, ANN INTERN MED, V146, P65, DOI 10.7326/0003-4819-146-1-200701020-00012; Watts NB, 2005, J BONE MINER RES, V20, P2097, DOI 10.1359/JBMR.050814; Watts Nelson B, 2004, J Manag Care Pharm, V10, P142	42	71	72	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 6	2008	148	9					637	646		10.7326/0003-4819-148-9-200805060-00003	http://dx.doi.org/10.7326/0003-4819-148-9-200805060-00003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299BW	18458276	Green Accepted			2022-12-24	WOS:000255731800001
J	Mullighan, CG; Miller, CB; Radtke, I; Phillips, LA; Dalton, J; Ma, J; White, D; Hughes, TP; Le Beau, MM; Pui, CH; Relling, MV; Shurtleff, SA; Downing, JR				Mullighan, Charles G.; Miller, Christopher B.; Radtke, Ina; Phillips, Letha A.; Dalton, James; Ma, Jing; White, Deborah; Hughes, Timothy P.; Le Beau, Michelle M.; Pui, Ching-Hon; Relling, Mary V.; Shurtleff, Sheila A.; Downing, James R.			BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros	NATURE			English	Article							POLYMERASE-CHAIN-REACTION; CHRONIC MYELOID-LEUKEMIA; DNA-BINDING PROTEINS; GENE ENCODES; EXPRESSION; ISOFORMS; FAMILY; CELLS; PHENOTYPE; MUTATION	The Philadelphia chromosome, a chromosomal abnormality that encodes BCR - ABL1, is the defining lesion of chronic myelogenous leukaemia ( CML) and a subset of acute lymphoblastic leukaemia (ALL)(1-3). To define oncogenic lesions that cooperate with BCR ABL1 to induce ALL, we performed a genome- wide analysis of diagnostic leukaemia samples from 304 individuals with ALL, including 43 BCR - ABL1 B- progenitor ALLs and 23 CML cases. IKZF1 ( encoding the transcription factor Ikaros) was deleted in 83.7% of BCR - ABL1 ALL, but not in chronic- phase CML. Deletion of IKZF1 was also identified as an acquired lesion at the time of transformation of CML to ALL ( lymphoid blast crisis). The IKZF1 deletions resulted in haploin sufficiency, expression of a dominant- negative Ikaros isoform, or the complete loss of Ikaros expression. Sequencing of IKZF1 deletion breakpoints suggested that aberrant RAG- mediated recombination is responsible for the deletions. These findings suggest that genetic lesions resulting in the loss of Ikaros function are an important event in the development of BCR - ABL1 ALL.	[Mullighan, Charles G.; Miller, Christopher B.; Radtke, Ina; Phillips, Letha A.; Dalton, James; Shurtleff, Sheila A.; Downing, James R.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Pui, Ching-Hon] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA; [Relling, Mary V.] St Jude Childrens Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Ma, Jing] St Jude Childrens Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [White, Deborah; Hughes, Timothy P.] Inst Med & Vet Sci, Div Haematol, Adelaide, SA 5000, Australia; [Le Beau, Michelle M.] Univ Chicago, Hematol Oncol Sect, Chicago, IL 60637 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; Institute Medical & Veterinary Science Australia; University of Chicago	Downing, JR (corresponding author), St Jude Childrens Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA.	james.downing@stjude.org	Downing, James R./N-8102-2018; Relling, Mary/N-5032-2018; Mullighan, Charles/H-3253-2011; Hughes, Tim/AAO-9975-2021; Pui, Ching-Hon/N-8076-2018	Mullighan, Charles/0000-0002-1871-1850; Pui, Ching-Hon/0000-0003-0303-5658; White, Deborah/0000-0003-4844-333X; Hughes, Timothy/0000-0002-0910-3730				DALEY GQ, 1991, P NATL ACAD SCI USA, V88, P11335, DOI 10.1073/pnas.88.24.11335; Drexler HG., 2001, LEUKEMIA LYMPHOMA CE, P2, DOI [10.1016/B978-012221970-2/50002-4, DOI 10.1016/B978-012221970-2/50002-4]; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Gleissner B, 2002, BLOOD, V99, P1536, DOI 10.1182/blood.V99.5.1536; Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; HAHM KM, 1994, MOL CELL BIOL, V14, P7111, DOI 10.1128/MCB.14.11.7111; Kirstetter P, 2002, EUR J IMMUNOL, V32, P720, DOI 10.1002/1521-4141(200203)32:3<720::AID-IMMU720>3.0.CO;2-P; Klein F, 2006, ONCOGENE, V25, P1118, DOI 10.1038/sj.onc.1209133; Klug CA, 1998, P NATL ACAD SCI USA, V95, P657, DOI 10.1073/pnas.95.2.657; MANABE A, 1994, BLOOD, V83, P1731, DOI 10.1182/blood.V83.7.1731.bloodjournal8371731; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Melo JV, 1996, BLOOD, V88, P2375, DOI 10.1182/blood.V88.7.2375.bloodjournal8872375; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Molnar A, 1996, J IMMUNOL, V156, P585; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nakase K, 2000, CANCER RES, V60, P4062; Nishii K, 2000, INT J HEMATOL, V71, P372; Olivero S, 2000, BRIT J HAEMATOL, V110, P826, DOI 10.1046/j.1365-2141.2000.02297.x; Rebollo A, 2003, IMMUNOL CELL BIOL, V81, P171, DOI 10.1046/j.1440-1711.2003.01159.x; RIBEIRO RC, 1987, BLOOD, V70, P948; Sun L, 1999, CLIN CANCER RES, V5, P2112; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Sun L, 1999, P NATL ACAD SCI USA, V96, P680, DOI 10.1073/pnas.96.2.680; Sun L, 1999, J CLIN ONCOL, V17, P3753, DOI 10.1200/JCO.1999.17.12.3753; Takanashi M, 2002, BRIT J HAEMATOL, V117, P525, DOI 10.1046/j.1365-2141.2002.03487.x; Tonnelle Cecile, 2003, Hematol J, V4, P104, DOI 10.1038/sj.thj.6200235; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Williams RT, 2006, P NATL ACAD SCI USA, V103, P6688, DOI 10.1073/pnas.0602030103; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1	32	759	797	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2008	453	7191					110	+		10.1038/nature06866	http://dx.doi.org/10.1038/nature06866			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294ID	18408710				2022-12-24	WOS:000255398800049
J	Anthony, RM; Nimmerjahn, F; Ashline, DJ; Reinhold, VN; Paulson, JC; Ravetch, JV				Anthony, Robert M.; Nimmerjahn, Falk; Ashline, David J.; Reinhold, Vernon N.; Paulson, James C.; Ravetch, Jeffrey V.			Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG fc	SCIENCE			English	Article							IMMUNOGLOBULIN-G; AUTOIMMUNE-DISEASE; BINDING; RECEPTOR; GLYCOSYLATION; SPECIFICITY; SIALYLTRANSFERASE; OLIGOSACCHARIDES; SIALYLATION; PROTECTION	It is well established that high doses of monomeric immunoglobulin G ( IgG) purified from pooled human plasma [ intravenous immunoglobulin ( IVIG)] confer anti- inflammatory activity in a variety of autoimmune settings. However, exactly how those effects are mediated is not clear because of the heterogeneity of IVIG. Recent studies have demonstrated that the anti- inflammatory activity of IgG is completely dependent on sialylation of the N- linked glycan of the IgG Fc fragment. Here we determine the precise glycan requirements for this anti- inflammatory activity, allowing us to engineer an appropriate IgG1 Fc fragment, and thus generate a fully recombinant, sialylated IgG1 Fc with greatly enhanced potency. This therapeutic molecule precisely defines the biologically active component of IVIG and helps guide development of an IVIG replacement with improved activity and availability.	[Anthony, Robert M.; Nimmerjahn, Falk; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA; [Ashline, David J.; Reinhold, Vernon N.] Univ New Hampshire, Dept Biochem & Mol Biol, Glycom Ctr, Durham, NH 03824 USA; [Paulson, James C.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Paulson, James C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Nimmerjahn, Falk] Univ Erlangen Nurnberg, Lab Expt Immunol & Immunotherapy, D-91054 Erlangen, Germany	Rockefeller University; University System Of New Hampshire; University of New Hampshire; Scripps Research Institute; Scripps Research Institute; University of Erlangen Nuremberg	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10021 USA.	ravetch@rockefeller.edu	Ravetch, Jeffrey/Z-1596-2019; Nimmerjahn, Falk/J-4986-2013; Paulson, James/AAG-3565-2019	Ravetch, Jeffrey/0000-0003-2024-9041; Nimmerjahn, Falk/0000-0002-5418-316X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054045, R01GM060938] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM060938-09, R01 GM054045-11, R01 GM054045, R01 GM060938, GM60938] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Arnold JN, 2004, J IMMUNOL, V173, P6831, DOI 10.4049/jimmunol.173.11.6831; Bruhns P, 2003, IMMUNITY, V18, P573, DOI 10.1016/S1074-7613(03)00080-3; Dalziel M, 1999, GLYCOCONJUGATE J, V16, P801, DOI 10.1023/A:1007183915921; HANISCH FG, 1993, INFECT IMMUN, V61, P2108, DOI 10.1128/IAI.61.5.2108-2115.1993; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; JEFFERIS R, 1990, BIOCHEM J, V268, P529, DOI 10.1042/bj2680529; Kaneko Y, 2006, J EXP MED, V203, P789, DOI 10.1084/jem.20051900; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; KITAGAWA H, 1994, J BIOL CHEM, V269, P17872; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Lehmann F, 2006, CELL MOL LIFE SCI, V63, P1331, DOI 10.1007/s00018-005-5589-y; Mayer DCG, 2001, P NATL ACAD SCI USA, V98, P5222, DOI 10.1073/pnas.081075398; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2007, J EXP MED, V204, P11, DOI 10.1084/jem.20061788; ORLANDI PA, 1992, J CELL BIOL, V116, P901, DOI 10.1083/jcb.116.4.901; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; Scallon BJ, 2007, MOL IMMUNOL, V44, P1524, DOI 10.1016/j.molimm.2006.09.005; TAKAHASHI N, 1987, BIOCHEMISTRY-US, V26, P1137, DOI 10.1021/bi00378a023; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Wormald MR, 1997, BIOCHEMISTRY-US, V36, P1370, DOI 10.1021/bi9621472	23	604	689	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2008	320	5874					373	376		10.1126/science.1154315	http://dx.doi.org/10.1126/science.1154315			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZZ	18420934	Green Accepted			2022-12-24	WOS:000255026100043
J	Chan, CC; Chiu, HC				Chan, Chih-Chieh; Chiu, Hsien-Ching			Vestibular papillomatosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chan, Chih-Chieh; Chiu, Hsien-Ching] Natl Taiwan Univ Hosp, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital	Chan, CC (corresponding author), Natl Taiwan Univ Hosp, Taipei 100, Taiwan.	hcchiu1003@ntu.edu.tw		CHIU, HSIEN-CHING/0000-0002-1409-8470					0	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 3	2008	358	14					1495	1495		10.1056/NEJMicm076056	http://dx.doi.org/10.1056/NEJMicm076056			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	282CY	18385501				2022-12-24	WOS:000254546400011
J	Breaker, RR				Breaker, Ronald R.			Complex riboswitches	SCIENCE			English	Editorial Material							GENE-EXPRESSION; S-ADENOSYLMETHIONINE; STRUCTURAL BASIS; MESSENGER-RNA; BINDING; BACTERIA; LIGAND; SPEED		Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Breaker, RR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	ronald.breaker@yale.edu		Breaker, Ronald/0000-0002-2165-536X	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Bocobza S, 2007, GENE DEV, V21, P2874, DOI 10.1101/gad.443907; Breaker RR, 2006, COLD SPRING HARB MON, V43, P89; Breaker RR, 2003, RNA, V9, P949, DOI 10.1261/rna.5670703; Cheah MT, 2007, NATURE, V447, P497, DOI 10.1038/nature05769; Cochrane JC, 2007, CHEM BIOL, V14, P97, DOI 10.1016/j.chembiol.2006.12.005; Coppins RL, 2007, CURR OPIN MICROBIOL, V10, P176, DOI 10.1016/j.mib.2007.03.006; Croft MT, 2007, P NATL ACAD SCI USA, V104, P20770, DOI 10.1073/pnas.0705786105; Edwards TE, 2007, CURR OPIN STRUC BIOL, V17, P273, DOI 10.1016/j.sbi.2007.05.004; Fuchs RT, 2006, NAT STRUCT MOL BIOL, V13, P226, DOI 10.1038/nsmb1059; Gallivan JP, 2007, CURR OPIN CHEM BIOL, V11, P612, DOI 10.1016/j.cbpa.2007.10.004; Gilbert SD, 2008, NAT STRUCT MOL BIOL, V15, P177, DOI 10.1038/nsmb.1371; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Gutierrez-Preciado A, 2005, TRENDS GENET, V21, P432, DOI 10.1016/j.tig.2005.06.001; Kazanov MD, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-347; Klein DJ, 2006, SCIENCE, V313, P1752, DOI 10.1126/science.1129666; Kubodera T, 2003, FEBS LETT, V555, P516, DOI 10.1016/S0014-5793(03)01335-8; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829; Montange RK, 2006, NATURE, V441, P1172, DOI 10.1038/nature04819; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Osborne SE, 1997, CHEM REV, V97, P349, DOI 10.1021/cr960009c; Rieder R, 2007, CHEMBIOCHEM, V8, P896, DOI 10.1002/cbic.200700057; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Stoddard CD, 2006, ACS CHEM BIOL, V1, P751, DOI 10.1021/cb600458w; Sudarsan N, 2006, SCIENCE, V314, P300, DOI 10.1126/science.1130716; Thore S, 2006, SCIENCE, V312, P1208, DOI 10.1126/science.1128451; Vitreschak AG, 2004, TRENDS GENET, V20, P44, DOI 10.1016/j.tig.2003.11.008; Wachter A, 2007, PLANT CELL, V19, P3437, DOI 10.1105/tpc.107.053645; Weinberg Z, 2007, NUCLEIC ACIDS RES, V35, P4809, DOI 10.1093/nar/gkm487; Welz R, 2007, RNA, V13, P573, DOI 10.1261/rna.407707; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032	31	79	89	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 28	2008	319	5871					1795	1797		10.1126/science.1152621	http://dx.doi.org/10.1126/science.1152621			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279ZF	18369140				2022-12-24	WOS:000254394000037
J	Brabin, L; Roberts, SA; Stretch, R; Baxter, D; Chambers, G; Kitchener, H; McCann, R				Brabin, Loretta; Roberts, Stephen A.; Stretch, Rebecca; Baxter, David; Chambers, Gloria; Kitchener, Henry; McCann, Rosemary			Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							PARENTAL ATTITUDES; HPV VACCINATION; RUBELLA VACCINE; MEASLES; MUMPS	Objective To assess the feasibility and acceptability of delivering a human papillomavirus (HPV) vaccine to adolescent girls. Design Prospective cohort study. Setting 36 secondary schools in two primary care trusts in Greater Manchester, United Kingdom. Participants 2817 schoolgirls in year 8 (12 and 13 Year olds). Intervention Delivery of the bivalent vaccine at 0, 1, and 6 months over one school year. Main outcome measures Vaccine-uptake for doses 1 and 2 of a three dose schedule. Results Vaccine uptake was 70.6% (1989/2817) for the first dose and 68.5% (1930/2817) for the second close. Uptake was significantly tower in schools with a higher proportion of ethnic minority girls (P<0.001 for trend) or higher proportion of girls entitled to free school meals (P=0.029 for trend). The main reason for parents' refusal of vaccination was insufficient information about the vaccine and its long term safety. Maintaining the vaccine schedule was challenging as 16.3% (dose 1) and 23.6% (dose 2) of girls missed their vaccination day and had to be offered alternative appointments. No serious adverse events were reported. Conclusion Delivery of the first two doses of HPV vaccine to adolescent schoolgirls is encouraging, but the success of the vaccination programme depends on high coverage for the third dose.	[Brabin, Loretta; Stretch, Rebecca; Kitchener, Henry] Univ Manchester, St Marys Hosp, Acad Unit Obstet & Gynaecol, Manchester M13 0JH, Lancs, England; [Roberts, Stephen A.] Univ Manchester, Hlth Methodol Res Grp, Manchester M13 9PL, Lancs, England; [Baxter, David] Stockport Primary Care Trust, Dept Publ Hlth, Stockport, Lancs, England; [Chambers, Gloria] Bury Primary Care Trust, Dept Publ Hlth, Bury St Edmunds, Suffolk, England; [McCann, Rosemary] Greater Manchester Hlth Protect Unit, Eccles, Lancs, England	University of Manchester; University of Manchester	Brabin, L (corresponding author), Univ Manchester, St Marys Hosp, Acad Unit Obstet & Gynaecol, Manchester M13 0JH, Lancs, England.	loretta.brabin@manchester.ac.uk	Bujan, Miren Karmele/F-5542-2014	Brabin, Loretta/0000-0003-4478-6503; Roberts, Steve/0000-0002-7477-7731				Brabin L, 2006, VACCINE, V24, P3087, DOI 10.1016/j.vaccine.2006.01.048; *DEP HLTH, HPV VACC REC NHS IMM; Kohli M, 2007, BRIT J CANCER, V96, P143, DOI 10.1038/sj.bjc.6603501; Marlow LAV, 2007, VACCINE, V25, P1945, DOI 10.1016/j.vaccine.2007.01.059; Middleton E, 2003, BMJ-BRIT MED J, V326, P854, DOI 10.1136/bmj.326.7394.854; Mixer RE, 2007, J EPIDEMIOL COMMUN H, V61, P797, DOI 10.1136/jech.2005.045633; Raffle AE, 2007, BMJ-BRIT MED J, V335, P375, DOI 10.1136/bmj.39273.458322.BE; Rambout L, 2007, CAN MED ASSOC J, V177, P469, DOI 10.1503/cmaj.070948; VALLELY LA, 2008, VACCINE; Wallace LA, 2004, ARCH DIS CHILD, V89, P1041, DOI 10.1136/adc.2003.043687; Zimet GD, 2006, VACCINE, V24, P201, DOI 10.1016/j.vaccine.2006.06.017; 2008, CANADIAN NATL P 0219	12	155	155	0	16	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 10	2008	336	7652					1056	1058		10.1136/bmj.39541.534109.BE	http://dx.doi.org/10.1136/bmj.39541.534109.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	304IN	18436917	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000256103300029
J	Wood, AJJ				Wood, Alastair J. J.			Playing "Kick the FDA" - Risk-free to players but hazardous to public health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wood, Alastair J. J.] Symphony Capital, New York, NY USA; [Wood, Alastair J. J.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA	Cornell University	Wood, AJJ (corresponding author), Symphony Capital, New York, NY USA.							Food and Drug Administration Science Board, 2007, FDA SCI MISS RISK RE; MATHEWS AW, 2008, WALL STREET J   0320, pA4; 2005, SEATTLE TIMES   1021	3	8	8	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 24	2008	358	17					1774	1775		10.1056/NEJMp0802227	http://dx.doi.org/10.1056/NEJMp0802227			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PL	18434649				2022-12-24	WOS:000255209200002
J	Nordtveit, TI; Melve, KK; Albrechtsen, S; Skjaerven, R				Nordtveit, Tone Irene; Melve, Kari Klungsoyr; Albrechtsen, Susanne; Skjaerven, Rolv			Maternal and paternal contribution to intergenerational recurrence of breech delivery: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							GESTATIONAL-AGE; BIRTH-WEIGHT; RISK-FACTORS; TERM; MORTALITY; SURVIVAL; CHILDREN; DEFECTS; NORWAY	Objective To investigate intergenerational recurrence of breech delivery, with a hypothesis that both women and men delivered in breech presentation contribute to increased risk of breech delivery in their offspring. Design Population based cohort study for two generations. Setting Data from the medical birth registry of Norway, based on all births in Norway 1967-2004 (2.2 million births). Participants Generational data were provided through linkage by national identification numbers, forming 451393 mother-offspring units and 295 253 father-offspring units. We included units where both parents and offspring were singletons and offspring were first born, forming 232 704 mother-offspring units and 154 851 father-offspring units for our analyses. Main outcome measure Breech delivery in the second generation. Results Men and women who themselves were delivered in breech presentation had more than twice the risk of breech delivery in their own first pregnancies compared with men and women who had been cephalic presentations (odds ratios 2.2, 95% confidence interval 1.8 to 2.7, and 2.2, 1.9 to 2.5, for men and women, respectively). The strongest risks of recurrence were found for vaginally delivered offspring and were equally strong for men and women. Increased risk of recurrence of breech delivery in offspring was present only for parents delivered at term. Conclusion Intergenerational recurrence risk of breech delivery in offspring was equally high when transmitted through fathers and mothers. It seems reasonable to attribute the observed pattern of familial predisposition to term breech delivery to genetic inheritance, predominantly through the fetus.	[Nordtveit, Tone Irene; Melve, Kari Klungsoyr; Skjaerven, Rolv] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Epidemiol & Med Stat, N-5018 Bergen, Norway; [Melve, Kari Klungsoyr; Skjaerven, Rolv] Norwegian Inst Publ Hlth, Med Birth Registry, Bergen, Norway; [Albrechtsen, Susanne] Haukeland Hosp, Dept Obstet & Gynaecol, N-5021 Bergen, Norway	University of Bergen; Norwegian Institute of Public Health (NIPH); University of Bergen; Haukeland University Hospital	Nordtveit, TI (corresponding author), Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Epidemiol & Med Stat, Kalfarveien 31, N-5018 Bergen, Norway.	Tone.Nordtveit@isf.uib.no	Klungsøyr, Kari/ABC-6147-2020; Albrechtsen, Susanne/H-4680-2019	Klungsøyr, Kari/0000-0003-2482-1690; 				Albrechtsen S, 1998, OBSTET GYNECOL, V92, P775, DOI 10.1016/S0029-7844(98)00307-X; Albrechtsen S, 1998, ACTA OBSTET GYN SCAN, V77, P410, DOI 10.1034/j.1600-0412.1998.770409.x; Albrechtsen S, 1998, OBSTET GYNECOL, V92, P345, DOI 10.1016/S0029-7844(98)00176-8; BACKE B, 1993, BRIT J OBSTET GYNAEC, V100, P727, DOI 10.1111/j.1471-0528.1993.tb14263.x; BARTLETT D, 1994, DEV MED CHILD NEUROL, V36, P833; BENRAFAEL Z, 1991, J REPROD MED, V36, P723; BLOOMBERG L, 1994, HEALTH EDUC QUART, V21, P447, DOI 10.1177/109019819402100407; BRAUN FHT, 1975, J PEDIATR-US, V86, P419, DOI 10.1016/S0022-3476(75)80977-2; Cartledge LJ, 1942, J HERED, V33, P409, DOI 10.1093/oxfordjournals.jhered.a105106; CRUIKSHANK DP, 1986, CLIN OBSTET GYNECOL, V29, P255, DOI 10.1097/00003081-198606000-00008; Danielian PJ, 1996, BRIT MED J, V312, P1451, DOI 10.1136/bmj.312.7044.1451; DUNN LJ, 1965, OBSTET GYNECOL, V25, P170; Herbst A, 2005, ACTA OBSTET GYN SCAN, V84, P593, DOI 10.1111/j.0001-6349.2005.00852.x; Jaquet D, 2005, BJOG-INT J OBSTET GY, V112, P153, DOI 10.1111/j.1471-0528.2004.00313.x; Kramer MS, 2000, PAEDIATR PERINAT EP, V14, P194, DOI 10.1046/j.1365-3016.2000.00266.x; Lie RT, 2007, PAEDIATR PERINAT EP, V21, P13, DOI 10.1111/j.1365-3016.2007.00832.x; Lie RT, 2001, JAMA-J AM MED ASSOC, V285, P755, DOI 10.1001/jama.285.6.755; LUBCHENCO LO, 1963, PEDIATRICS, V32, P793; LUTERKORT M, 1984, OBSTET GYNECOL, V64, P55; MAGNUS P, 1993, ANN HUM BIOL, V20, P231, DOI 10.1080/03014469300002662; Rayl J, 1996, AM J OBSTET GYNECOL, V174, P28, DOI 10.1016/S0002-9378(96)70368-X; Skjaerven R, 1999, NEW ENGL J MED, V340, P1057, DOI 10.1056/NEJM199904083401401; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; *STAT NORW, 2000, NORW STAND ED GROUP; TOMPKINS P, 1946, AM J OBSTET GYNECOL, V51, P595, DOI 10.1016/S0002-9378(15)30116-2	25	18	19	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 19	2008	336	7649					872	876		10.1136/bmj.39505.436539.BE	http://dx.doi.org/10.1136/bmj.39505.436539.BE			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290QH	18369204	Green Published, Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000255136800033
J	Makita, T; Sucov, HM; Gariepy, CE; Yanagisawa, M; Ginty, DD				Makita, Takako; Sucov, Henry M.; Gariepy, Cheryl E.; Yanagisawa, Masashi; Ginty, David D.			Endothelins are vascular-derived axonal guidance cues for developing sympathetic neurons	NATURE			English	Article							CARDIAC NEURAL CREST; B-RECEPTOR; GENE; EXPRESSION; DISRUPTION; ANTAGONIST; PROFILE; CLONING; POTENT; ECE-1	During development, sympathetic neurons extend axons along a myriad of distinct trajectories, often consisting of arteries, to innervate one of a large variety of distinct final target tissues. Whether or not subsets of neurons within complex sympathetic ganglia are predetermined to innervate select end-organs is unknown. Here we demonstrate in mouse embryos that the endothelin family member Edn3 (ref. 1), acting through the endothelin receptor EdnrA (refs 2, 3), directs extension of axons of a subset of sympathetic neurons from the superior cervical ganglion to a preferred intermediate target, the external carotid artery, which serves as the gateway to select targets, including the salivary glands. These findings establish a previously unknown mechanism of axonal pathfinding involving vascular-derived endothelins, and have broad implications for endothelins as general mediators of axonal growth and guidance in the developing nervous system. Moreover, they suggest a model in which newborn sympathetic neurons distinguish and choose between distinct vascular trajectories to innervate their appropriate end organs.	[Makita, Takako; Ginty, David D.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Sucov, Henry M.] Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90033 USA; [Gariepy, Cheryl E.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Yanagisawa, Masashi] Univ Texas Dallas, SW Med Ctr, Dept Mol Genet, Howard Hughes Med Inst, Dallas, TX 75235 USA	Howard Hughes Medical Institute; Johns Hopkins University; University of Southern California; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	dginty@jhmi.edu	Gariepy, Cheryl/AAQ-3441-2021; Gariepy, Cheryl/C-6141-2012	Sucov, Henry/0000-0002-3792-3795	Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL078891, R01 HL078891-01A1, R01 HL078891-03, R01 HL078891-02] Funding Source: Medline; NINDS NIH HHS [R37 NS034814-11, R37 NS034814-13, R37 NS034814-11S1, R37 NS034814-12, R37 NS034814] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034814] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Choudhary B, 2006, DEV BIOL, V289, P420, DOI 10.1016/j.ydbio.2005.11.008; Clouthier DE, 1998, DEVELOPMENT, V125, P813; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; FIRTH JD, 1992, J CLIN INVEST, V90, P1023, DOI 10.1172/JCI115915; Gariepy CE, 1996, P NATL ACAD SCI USA, V93, P867, DOI 10.1073/pnas.93.2.867; GUTHRIE S, 1994, NEUROPROTOCOLS, V4, P116; Hiruma T, 2002, J ANAT, V201, P15, DOI 10.1046/j.1469-7580.2002.00071.x; IHARA M, 1992, J CARDIOVASC PHARM, V20, pS11, DOI 10.1097/00005344-199204002-00005; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; ISHIKAWA K, 1994, P NATL ACAD SCI USA, V91, P4892, DOI 10.1073/pnas.91.11.4892; Jiang XB, 2000, DEVELOPMENT, V127, P1607; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; SCHOTZINGER RJ, 1988, NATURE, V335, P637, DOI 10.1038/335637a0; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; XU D, 1994, CELL, V78, P473, DOI 10.1016/0092-8674(94)90425-1; Yanagisawa H, 1998, DEVELOPMENT, V125, P825; Yanagisawa H, 2000, J CLIN INVEST, V105, P1373, DOI 10.1172/JCI7447	19	137	140	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2008	452	7188					759	U8		10.1038/nature06859	http://dx.doi.org/10.1038/nature06859			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	285QY	18401410	Green Published, Green Accepted			2022-12-24	WOS:000254792500047
J	Sila, CA; Higashida, RT; Clagett, GP				Sila, Cathy A.; Higashida, Randall T.; Clagett, G. Patrick			Management of carotid stenosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; ARTERY STENOSIS; ENDARTERECTOMY; STROKE		[Sila, Cathy A.] Case Western Reserve Univ, Sch Med, Neurol Inst, Case Med Ctr, Cleveland, OH 44106 USA; [Higashida, Randall T.] Univ Calif San Francisco, Med Ctr, Div Intervent Neurovasc Radiol, San Francisco, CA 94143 USA; [Higashida, Randall T.] Univ Calif San Francisco, Med Ctr, Dept Radiol, San Francisco, CA 94143 USA; [Higashida, Randall T.] Univ Calif San Francisco, Med Ctr, Dept Neurol, San Francisco, CA 94143 USA; [Higashida, Randall T.] Univ Calif San Francisco, Med Ctr, Dept Neurol Surg, San Francisco, CA 94143 USA; [Higashida, Randall T.] Univ Calif San Francisco, Med Ctr, Dept Anesthesiol, San Francisco, CA 94143 USA; [Clagett, G. Patrick] Univ Texas SW Med Ctr Dallas, Dept Surg, Div Vasc & Endovasc Surg, Dallas, TX 75390 USA	Case Western Reserve University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sila, CA (corresponding author), Case Western Reserve Univ, Sch Med, Neurol Inst, Case Med Ctr, Cleveland, OH 44106 USA.							Abbott AL, 2007, INT J STROKE, V2, P27, DOI 10.1111/j.1747-4949.2007.00096.x; Adams RJ, 2003, CIRCULATION, V108, P1278, DOI 10.1161/01.CIR.0000090444.87006.CF; COHEN SN, 1993, J VASC SURG, V18, P1002, DOI 10.1016/0741-5214(93)90555-Z; Coward LJ, 2005, STROKE, V36, P905, DOI 10.1161/01.STR.0000158921.51037.64; *CTR MED MED SERV, MED COV PERC TRANSL; Feasby TE, 2007, ARCH NEUROL-CHICAGO, V64, P1496, DOI 10.1001/archneur.64.10.1496; Halliday A, 2004, LANCET, V363, P1491; HALLIDAY A, 2004, LANCET, V364, P416; Matsen SL, 2006, J VASC SURG, V44, P488, DOI 10.1016/j.jvs.2006.05.017; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; Wolff T, 2007, ANN INTERN MED, V147, P860, DOI 10.7326/0003-4819-147-12-200712180-00006; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127	12	13	15	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 10	2008	358	15					1617	1621						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	285NK	18403770				2022-12-24	WOS:000254783300013
J	Nickolas, TL; O'Rourke, MJ; Yang, J; Sise, ME; Canetta, PA; Barasch, N; Buchen, C; Khan, F; Mori, K; Gigllo, J; Devarajan, P; Barasch, J				Nickolas, Thomas L.; O'Rourke, Matthew J.; Yang, Jun; Sise, Meghan E.; Canetta, Pietro A.; Barasch, Nicholas; Buchen, Charles; Khan, Faris; Mori, Kiyoshi; Gigllo, James; Devarajan, Prasad; Barasch, Jonathan			Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE-RENAL-FAILURE; CRITICALLY-ILL PATIENTS; SERUM CREATININE; MORTALITY; NGAL; BIOMARKER; IRON; PROGNOSIS; MARKER; IL-18	Background: A single serum creatinine measurement cannot distinguish acute kidney injury from chronic kidney disease or prerenal azotemia. Objective: To test the sensitivity and specificity of a single measurement of urinary neutrophil gelatinase-associated lipocalin (NGAL) and other urinary proteins to detect acute kidney injury in a spectrum of patients. Design: Prospective cohort study. Setting: Emergency department of Columbia University Medical Center, New York, New York. Participants: 635 patients admitted to the hospital with acute kidney injury, prerenal azotemia, chronic kidney disease, or normal kidney function. Measurements: Diagnosis of acute kidney injury was based on the RIFLE (risk, injury, failure, loss, and end-stage) criteria and assigned by researchers who were blinded to experimental measurements. Urinary NGAL was measured by immunoblot, N-acetyl-beta-D-glucosaminidase (NAG) by enzyme measurement, alpha(1)-microglobulin and alpha(1)-acid glycoprotein by immunonephelometry, and serum creatinine by Jaffe kinetic reaction. Experimental measurements were not available to treating physicians. Results: Patients with acute kidney injury had a significantly elevated mean urinary NGAL level compared with the other kidney function groups (416 mu g/g creatinine [SD, 387]; P = 0.001). At a cutoff value of 130 mu g/g creatinine, sensitivity and specificity of NGAL for detecting acute injury were 0.900 (95% CI, 0.73 to 0.98) and 0.995 (CI, 0.990 to 1.00), respectively, and positive and negative likelihood ratios were 181.5 (CI, 58.33 to 564.71) and 0.10 (CI, 0.03 to 0.29); these values were superior to those for NAG, alpha(1)-microglobulin, alpha(1)-acid glycoprotein, fractional excretion of sodium, and serum creatinine. In multiple logistic regression, urinary NGAL level was highly predictive of clinical outcomes, including nephrology consultation, dialysis, and admission to the intensive care unit (odds ratio, 24.71 [CI, 7.69 to 79.42]). Limitations: All patients came from a single center. Few kidney biopsies were performed. Conclusion: A single measurement of urinary NGAL helps to distinguish acute injury from normal function, prerenal azotemia, and chronic kidney disease and predicts poor inpatient outcomes.			Nickolas, TL (corresponding author), Columbia Univ, PH 4 Stem,Room 124,622 W 168th St, New York, NY 10032 USA.	tln2001@columbia.edu	Canetta, Pietro/I-3823-2019; Mori, Kiyoshi/N-1267-2014	Canetta, Pietro/0000-0003-1130-5486; Mori, Kiyoshi/0000-0002-7285-8351; Devarajan, Prasad/0000-0002-7847-8552	NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073462, R01DK058872, P01DK055388] Funding Source: NIH RePORTER; NCRR NIH HHS [UL1 RR024156] Funding Source: Medline; NIDDK NIH HHS [R01 DK073462-03, R01 DK058872, P01 DK055388, R01 DK073462] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; Ahlstrom A, 2004, CLIN NEPHROL, V62, P344; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Bonventre JV, 2003, J AM SOC NEPHROL, V14, P2199, DOI 10.1097/01.ASN.0000079785.13922.F6; Brivet FG, 1996, CRIT CARE MED, V24, P192, DOI 10.1097/00003246-199602000-00003; BUNDGAARD JR, 1994, BIOCHEM BIOPH RES CO, V202, P1468, DOI 10.1006/bbrc.1994.2096; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; CHERTOW GM, 1995, ARCH INTERN MED, V155, P1505, DOI 10.1001/archinte.155.14.1505; de Vries B, 2004, TRANSPLANTATION, V78, P1116, DOI 10.1097/01.TP.0000138096.14126.CA; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fischer MJ, 2005, AM J KIDNEY DIS, V46, P1049, DOI 10.1053/j.ajkd.2005.09.006; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Gottlieb SS, 2002, J CARD FAIL, V8, P136, DOI 10.1054/jcaf.2002.125289; Han WK, 2008, KIDNEY INT, V73, P863, DOI 10.1038/sj.ki.5002715; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; Herget-Rosenthal S, 2004, KIDNEY INT, V66, P1115, DOI 10.1111/j.1523-1755.2004.00861.x; Herget-Rosenthal S, 2004, CLIN CHEM, V50, P552, DOI 10.1373/clinchem.2003.027763; KAUFMAN J, 1991, AM J KIDNEY DIS, V17, P191, DOI 10.1016/S0272-6386(12)81128-0; Lameire Norbert, 2004, Curr Opin Crit Care, V10, P468, DOI 10.1097/01.ccx.0000144939.24897.71; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liangos O, 2007, J AM SOC NEPHROL, V18, P904, DOI 10.1681/ASN.2006030221; Liano F, 1996, KIDNEY INT, V50, P811, DOI 10.1038/ki.1996.380; MAHER ER, 1989, Q J MED, V72, P857; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mishra J, 2006, PEDIATR NEPHROL, V21, P856, DOI 10.1007/s00467-006-0055-0; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Mori K, 2007, KIDNEY INT, V71, P967, DOI 10.1038/sj.ki.5002165; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; NGUYEN MT, 2006, J AM SOC NEPHROL, V17, pA49; NOVIS BK, 1994, ANESTH ANALG, V78, P143; PALLER MS, 1988, KIDNEY INT, V34, P474, DOI 10.1038/ki.1988.205; Parikh CR, 2006, KIDNEY INT, V70, P199, DOI 10.1038/sj.ki.5001527; Parikh CR, 2006, AM J TRANSPLANT, V6, P1639, DOI 10.1111/j.1600-6143.2006.01352.x; Parikh CR, 2005, J AM SOC NEPHROL, V16, P3046, DOI 10.1681/ASN.2005030236; Parikh CR, 2004, AM J KIDNEY DIS, V43, P405, DOI 10.1053/j.ajkd.2003.10.040; PASCUAL J, 1990, J AM GERIATR SOC, V38, P25, DOI 10.1111/j.1532-5415.1990.tb01592.x; Schmidt-Ott KM, 2007, J AM SOC NEPHROL, V18, P407, DOI 10.1681/ASN.2006080882; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Smith GL, 2003, J CARD FAIL, V9, P13, DOI 10.1054/jcaf.2003.3; Star RA, 1998, KIDNEY INT, V54, P1817, DOI 10.1046/j.1523-1755.1998.00210.x; Stone DH, 2005, SURGERY, V138, P368, DOI 10.1016/j.surg.2005.06.004; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Vera T, 2005, J AM SOC NEPHROL, V16, P950, DOI 10.1681/ASN.2004090736; Wagener G, 2006, ANESTHESIOLOGY, V105, P485, DOI 10.1097/00000542-200609000-00011; Xue JL, 2006, J AM SOC NEPHROL, V17, P1135, DOI 10.1681/ASN.2005060668; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4; ZANARDO G, 1994, J THORAC CARDIOV SUR, V107, P1489, DOI 10.1016/S0022-5223(94)70429-5; Zappitelli M, 2007, CRIT CARE, V11, DOI 10.1186/cc6089	52	505	536	0	41	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 3	2008	148	11					810	U21		10.7326/0003-4819-148-11-200806030-00003	http://dx.doi.org/10.7326/0003-4819-148-11-200806030-00003			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	308CG	18519927	Green Accepted			2022-12-24	WOS:000256365300002
J	Raj, A; Gomez, C; Silverman, JG				Raj, Anita; Gomez, Charlemagne; Silverman, Jay G.			Human rights - Driven to a fiery death - The tragedy of self-immolation in Afghanistan	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Raj, Anita] Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02215 USA; [Gomez, Charlemagne] Med Mondial, Cologne, Germany; [Silverman, Jay G.] Harvard Univ, Sch Publ Hlth, Dep Soc Human Dev & Hlth, Boston, MA 02115 USA	Boston University; Harvard University; Harvard T.H. Chan School of Public Health	Raj, A (corresponding author), Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02215 USA.							*CENTR INT AG, WORLD FACTB AFGH; *UN DEV PROGR, HUM DEV REP AFGH 200; *UNIFEM, AFGH UNIFEM FACT SHE	3	18	18	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 22	2008	358	21					2201	2203		10.1056/NEJMp0801340	http://dx.doi.org/10.1056/NEJMp0801340			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	303EK	18499564				2022-12-24	WOS:000256023600002
J	Chien, KR				Chien, Kenneth R.			Regenerative medicine and human models of human disease	NATURE			English	Editorial Material							SMOOTH-MUSCLE; CARDIOVASCULAR PROGENITORS; HEART; CELL; DIFFERENTIATION; CARDIOMYOCYTE		Massachusetts Gen Hosp, Cardiovasc Res Ctr, Simches Res Ctr, Boston, MA 02114 USA; Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University	Chien, KR (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Simches Res Ctr, 185 Cambridge St, Boston, MA 02114 USA.	kchien@partners.org						Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kaye DM, 2008, ANNU REV MED, V59, P13, DOI 10.1146/annurev.med.59.052407.103237; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Martin-Puig S, 2008, CELL STEM CELL, V2, P320, DOI 10.1016/j.stem.2008.03.010; Mather PJ, 2007, HEART FAIL REV, V12, P167, DOI 10.1007/s10741-007-9018-1; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Slepian MJ, 2008, NAT CLIN PRACT CARD, V5, P64, DOI 10.1038/ncpcardio1085; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	16	66	69	2	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2008	453	7193					302	305		10.1038/nature07037	http://dx.doi.org/10.1038/nature07037			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18480810				2022-12-24	WOS:000255868400036
J	Zethelius, B; Berglund, L; Sundstrom, J; Ingelsson, E; Basu, S; Larsson, A; Venge, P; Arnlov, J				Zethelius, Bjorn; Berglund, Lars; Sundstrom, Johan; Ingelsson, Erik; Basu, Samar; Larsson, Anders; Venge, Per; Arnlov, Johan			Use of multiple biomarkers to improve the prediction of death from cardiovascular causes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							C-REACTIVE PROTEIN; BRAIN NATRIURETIC PEPTIDE; SERUM CYSTATIN-C; RISK PREDICTION; MEDIATED INFLAMMATION; MYOCARDIAL-INFARCTION; GENERAL-POPULATION; INSULIN-RESISTANCE; SURVIVAL ANALYSIS; 70-YEAR-OLD MEN	Background: The incremental usefulness of adding multiple biomarkers from different disease pathways for predicting the risk of death from cardiovascular causes has not, to our knowledge, been evaluated among the elderly. Methods: We used data from the Uppsala Longitudinal Study of Adult Men (ULSAM), a community-based cohort of elderly men, to investigate whether a combination of biomarkers that reflect myocardial cell damage, left ventricular dysfunction, renal failure, and inflammation (troponin I, N-terminal pro-brain natriuretic peptide, cystatin C, and C-reactive protein, respectively) improved the risk stratification of a person beyond an assessment that was based on the established risk factors for cardiovascular disease (age, systolic blood pressure, use or nonuse of antihypertensive treatment, total cholesterol, high-density lipoprotein cholesterol, use or nonuse of lipid-lowering treatment, presence or absence of diabetes, smoking status, and body-mass index). Results: During follow-up (median, 10.0 years), 315 of the 1135 participants in our study (mean age, 71 years at baseline) died; 136 deaths were the result of cardiovascular disease. In Cox proportional-hazards models adjusted for established risk factors, all of the biomarkers significantly predicted the risk of death from cardiovascular causes. The C statistic increased significantly when the four biomarkers were incorporated into a model with established risk factors, both in the whole cohort (C statistic with biomarkers vs. without biomarkers, 0.766 vs. 0.664; P<0.001) and in the group of 661 participants who did not have cardiovascular disease at baseline (0.748 vs. 0.688, P=0.03). The improvement in risk assessment remained strong when it was estimated by other statistical measures of model discrimination, calibration, and global fit. Conclusions: Our data suggest that in elderly men with or without prevalent cardiovascular disease, the simultaneous addition of several biomarkers of cardiovascular and renal abnormalities substantially improves the risk stratification for death from cardiovascular causes beyond that of a model that is based only on established risk factors.	[Zethelius, Bjorn; Berglund, Lars; Ingelsson, Erik; Basu, Samar; Arnlov, Johan] Uppsala Univ, Dept Publ Hlth & Caring Sci Geriatr, SE-75185 Uppsala, Sweden; [Berglund, Lars] Uppsala Univ, Uppsala Clin Res Ctr, SE-75185 Uppsala, Sweden; [Sundstrom, Johan; Larsson, Anders; Venge, Per] Uppsala Univ, Dept Med Sci, SE-75185 Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	Arnlov, J (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci Geriatr, Uppsala Sci Pk, SE-75185 Uppsala, Sweden.	johan.arnlov@pubcare.uu.se	Sundstrom, Johan/R-2139-2019; Berglund, Lars/AAD-3856-2019; Berglund, Lars/AAA-3188-2019; Ärnlöv, Johan/AAF-2746-2019; Sundström, Johan/A-6286-2009	Sundstrom, Johan/0000-0003-2247-8454; Berglund, Lars/0000-0002-7437-9047; Ärnlöv, Johan/0000-0002-6933-4637; Sundström, Johan/0000-0003-2247-8454				Antolini L, 2004, COMMUN STAT-THEOR M, V33, P2117, DOI 10.1081/STA-200026579; Barbier CE, 2006, J AM COLL CARDIOL, V48, P765, DOI 10.1016/j.jacc.2006.05.041; Byberg L, 2000, DIABETOLOGIA, V43, P54, DOI 10.1007/s001250050007; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Emberson JR, 2007, J AM COLL CARDIOL, V49, P311; Groenning BA, 2004, HEART, V90, P297, DOI 10.1136/hrt.2003.026021; Gronnesby J K, 1996, Lifetime Data Anal, V2, P315, DOI 10.1007/BF00127305; Helmersson J, 2004, CIRCULATION, V109, P1729, DOI 10.1161/01.CIR.0000124718.99562.91; James SK, 2003, CIRCULATION, V108, P275, DOI 10.1161/01.CIR.0000079170.10579.DC; Kannel William B., 1995, Am J Geriatr Cardiol, V4, P10; Kannel William B, 2002, Am J Geriatr Cardiol, V11, P101, DOI 10.1111/j.1076-7460.2002.00995.x; Larsson A, 2005, SCAND J CLIN LAB INV, V65, P301, DOI 10.1080/00365510510013839; Lucia P, 2001, INT J CARDIOL, V77, P215, DOI 10.1016/S0167-5273(00)00429-0; Moller CS, 2006, J INTERN MED, V260, P22, DOI 10.1111/j.1365-2796.2006.01642.x; Olsen MH, 2007, EUR HEART J, V28, P1374, DOI 10.1093/eurheartj/ehl448; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P1433; Ridker PM, 2007, J AM COLL CARDIOL, V49, P2129, DOI 10.1016/j.jacc.2007.02.052; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249; Wasen E, 2004, J INTERN MED, V256, P70, DOI 10.1111/j.1365-2796.2004.01340.x; Wohlin M, 2007, CYTOKINE, V38, P130, DOI 10.1016/j.cyto.2007.05.014; Zethelius B, 2006, CIRCULATION, V113, P1071, DOI 10.1161/CIRCULATIONAHA.105.570762; Zethelius B, 2004, DIABETES CARE, V27, P1433, DOI 10.2337/diacare.27.6.1433	31	691	895	4	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2008	358	20					2107	2116		10.1056/NEJMoa0707064	http://dx.doi.org/10.1056/NEJMoa0707064			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300TY	18480203				2022-12-24	WOS:000255849300004
J	Vanhollebeke, B; De Muylder, G; Nielsen, MJ; Pays, A; Tebabi, P; Dieu, M; Raes, M; Moestrup, SK; Pays, E				Vanhollebeke, Benoit; De Muylder, Geraldine; Nielsen, Marianne J.; Pays, Annette; Tebabi, Patricia; Dieu, Marc; Raes, Martine; Moestrup, Soren K.; Pays, Etienne			A haptoglobin-hemoglobin receptor conveys innate immunity to Trypanosoma brucei in humans	SCIENCE			English	Article							HIGH-DENSITY-LIPOPROTEIN; HUMAN SERUM; LYTIC FACTOR; APOLIPOPROTEIN L-1; PROTEIN; IDENTIFICATION; ENDOCYTOSIS; BINDING	The protozoan parasite Trypanosoma brucei is lysed by apolipoprotein L-I, a component of human high- density lipoprotein ( HDL) particles that are also characterized by the presence of haptoglobin- related protein. We report that this process is mediated by a parasite glycoprotein receptor, which binds the haptoglobin- hemoglobin complex with high affinity for the uptake and incorporation of heme into intracellular hemoproteins. In mice, this receptor was required for optimal parasite growth and the resistance of parasites to the oxidative burst by host macrophages. In humans, the trypanosome receptor also recognized the complex between hemoglobin and haptoglobin- related protein, which explains its ability to capture trypanolytic HDLs. Thus, in humans the presence of haptoglobin- related protein has diverted the function of the trypanosome haptoglobin- hemoglobin receptor to elicit innate host immunity against the parasite.	[Vanhollebeke, Benoit; De Muylder, Geraldine; Pays, Annette; Tebabi, Patricia; Pays, Etienne] Univ Libre Bruxelles, Inst Mol Biol & Med, Mol Parasitol Lab, B-6041 Gosselies, Belgium; [Nielsen, Marianne J.; Moestrup, Soren K.] Aarhus Univ, Dept Med Biochem, DK-8000 Aarhus, Denmark; [Dieu, Marc; Raes, Martine] Univ Namur, Unit Cellular Biochem & Biol, B-5000 Namur, Belgium	Universite Libre de Bruxelles; Aarhus University; University of Namur	Pays, E (corresponding author), Univ Libre Bruxelles, Inst Mol Biol & Med, Mol Parasitol Lab, 12 Rue Profs Jeener & Brachet, B-6041 Gosselies, Belgium.	epays@ulb.ac.be	Moestrup, Søren Kragh/A-1403-2014; Moestrup, Søren Kragh/AAD-1735-2019	Moestrup, Søren Kragh/0000-0003-3862-2107; Vanhollebeke, Benoit/0000-0002-0353-365X; Dieu, Marc/0000-0002-3902-542X	Lundbeck Foundation [R7-2006-752] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden)		BERGER BJ, 1993, BIOCHEM PHARMACOL, V46, P149, DOI 10.1016/0006-2952(93)90359-5; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bridges DJ, 2008, PROTEOMICS, V8, P83, DOI 10.1002/pmic.200700607; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Drain J, 2001, J BIOL CHEM, V276, P30254, DOI 10.1074/jbc.M010198200; Duchateau PN, 1997, J BIOL CHEM, V272, P25576, DOI 10.1074/jbc.272.41.25576; HAGER KM, 1994, J CELL BIOL, V126, P155, DOI 10.1083/jcb.126.1.155; Koda Y, 1998, AM J HUM GENET, V62, P245, DOI 10.1086/301701; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Lepesheva GI, 2007, CHEM BIOL, V14, P1283, DOI 10.1016/j.chembiol.2007.10.011; Lugli EB, 2004, MOL BIOCHEM PARASIT, V138, P9, DOI 10.1016/j.molbiopara.2004.07.004; MAEDA N, 1985, J BIOL CHEM, V260, P6698; Nielsen MJ, 2006, BLOOD, V108, P2846, DOI 10.1182/blood-2006-05-022327; Nolan DP, 1999, CURR BIOL, V9, P1169, DOI 10.1016/S0960-9822(00)80018-4; Pays E, 2006, NAT REV MICROBIOL, V4, P477, DOI 10.1038/nrmicro1428; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; Raper J, 1999, INFECT IMMUN, V67, P1910; Raper J, 1996, J EXP MED, V183, P1023, DOI 10.1084/jem.183.3.1023; Shiflett AM, 2005, J BIOL CHEM, V280, P32578, DOI 10.1074/jbc.M503510200; Steverding D, 2006, MICROBES INFECT, V8, P2777, DOI 10.1016/j.micinf.2006.08.007; Tripodi KEJ, 2006, FEBS J, V273, P271, DOI 10.1111/j.1742-4658.2005.05049.x; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Vanhollebeke B, 2007, J EUKARYOT MICROBIOL, V54, P448, DOI 10.1111/j.1550-7408.2007.00285.x; Vanhollebeke B, 2007, P NATL ACAD SCI USA, V104, P4118, DOI 10.1073/pnas.0609902104; Widener J, 2007, PLOS PATHOG, V3, P1250, DOI 10.1371/journal.ppat.0030129; Xong HV, 1998, CELL, V95, P839, DOI 10.1016/S0092-8674(00)81706-7	26	187	189	3	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2008	320	5876					677	681		10.1126/science.1156296	http://dx.doi.org/10.1126/science.1156296			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451305				2022-12-24	WOS:000255454300050
J	Veldhoen, M; Hirota, K; Westendorf, AM; Buer, J; Dumoutier, L; Renauld, JC; Stockinger, B				Veldhoen, Marc; Hirota, Keiji; Westendorf, Astrid M.; Buer, Jan; Dumoutier, Laure; Renauld, Jean-Christophe; Stockinger, Brigitta			The aryl hydrocarbon receptor links T(H)17-cell-mediated autoimmunity to environmental toxins	NATURE			English	Article							NF-KAPPA-B; AH RECEPTOR; TH17 CELLS; MICE LACKING; DIFFERENTIATION; INTERLEUKIN-22; IL-22; ENCEPHALOMYELITIS; INFLAMMATION; HEPATOCYTES	The aryl hydrocarbon receptor ( AHR) is a ligand- dependent transcription factor best known for mediating the toxicity of dioxin(1). Environmental factors are believed to contribute to the increased prevalence of autoimmune diseases, many of which are due to the activity of T(H)17 T cells, a new helper T- cell subset characterized by the production of the cytokine IL- 17. Here we show that in the CD4(+) T- cell lineage of mice AHR expression is restricted to the T(H)17 cell subset and its ligation results in the production of the T(H)17 cytokine interleukin ( IL)- 22. AHR is also expressed in human T(H)17 cells. Activation of AHR by a high-affinity ligand during T(H)17 cell development markedly increases the proportion of T(H)17 T cells and their production of cytokines. CD4(+) T cells from AHR- deficient mice can develop T(H)17 cell responses, but when confronted with AHR ligand fail to produce IL- 22 and do not show enhanced T(H)17 cell development. AHR activation during induction of experimental autoimmune encephalomyelitis causes accelerated onset and increased pathology in wild- type mice, but not AHR- deficient mice. AHR ligands may therefore represent co- factors in the development of autoimmune diseases.	[Veldhoen, Marc; Hirota, Keiji; Stockinger, Brigitta] Natl Inst Med Res, MRC, Div Mol Immunol, London NW7 1AA, England; [Westendorf, Astrid M.; Buer, Jan] Univ Hosp Essen, Inst Med Microbiol, D-45122 Essen, Germany; [Westendorf, Astrid M.] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Dumoutier, Laure; Renauld, Jean-Christophe] Ludwig Inst Canc Res, Brussels Branch, B-1200 Brussels, Belgium; [Dumoutier, Laure; Renauld, Jean-Christophe] Catholic Univ Louvain, Expt Med Unit, B-1200 Brussels, Belgium	MRC National Institute for Medical Research; University of Duisburg Essen; Helmholtz Association; Helmholtz-Center for Infection Research; Ludwig Institute for Cancer Research; Universite Catholique Louvain	Stockinger, B (corresponding author), Natl Inst Med Res, MRC, Div Mol Immunol, Ridgeway,Mill Hill, London NW7 1AA, England.	bstocki@nimr.mrc.ac.uk	Westendorf, Astrid M./AAX-1937-2020; Veldhoen, Marc/AAJ-2759-2020; Veldhoen, Marc/AAM-5357-2021; Renauld, Jean-Christophe/B-7268-2012	Veldhoen, Marc/0000-0002-1478-9562; Hirota, Keiji/0000-0002-4737-0661; Renauld, Jean-Christophe/0000-0003-1736-2131; Dumoutier, Laure/0000-0002-6645-684X; Stockinger, Brigitta/0000-0001-8781-336X; Buer, Jan/0000-0002-7602-1698	Medical Research Council Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Cox AL, 2005, EUR J IMMUNOL, V35, P3332, DOI 10.1002/eji.200535075; DENISON MS, 1988, P NATL ACAD SCI USA, V85, P2528, DOI 10.1073/pnas.85.8.2528; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; Funatake CJ, 2005, J IMMUNOL, V175, P4184, DOI 10.4049/jimmunol.175.7.4184; Harper PA, 2006, BIOCHEM PHARMACOL, V72, P267, DOI 10.1016/j.bcp.2006.01.007; Hilliard B, 1999, J IMMUNOL, V163, P2937; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Katiyar SK, 2000, J INVEST DERMATOL, V114, P328, DOI 10.1046/j.1523-1747.2000.00876.x; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kerkvliet NI, 2002, INT IMMUNOPHARMACOL, V2, P277, DOI 10.1016/S1567-5769(01)00179-5; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Minamimura K, 2006, J IMMUNOL, V176, P4125, DOI 10.4049/jimmunol.176.7.4125; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Okey AB, 2007, TOXICOL SCI, V98, P5, DOI 10.1093/toxsci/kfm096; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Rannug A, 2006, BIOL CHEM, V387, P1149, DOI 10.1515/BC.2006.143; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Tian YN, 2002, CHEM-BIOL INTERACT, V141, P97, DOI 10.1016/S0009-2797(02)00068-6; Uyttenhove C, 2006, EUR J IMMUNOL, V36, P2868, DOI 10.1002/eji.200636662; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	30	1201	1264	2	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2008	453	7191					106	+		10.1038/nature06881	http://dx.doi.org/10.1038/nature06881			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294ID	18362914	Green Submitted			2022-12-24	WOS:000255398800048
J	Nordin, P; van der Linden, W				Nordin, Par; van der Linden, Willem			Volume of procedures and risk of recurrence after repair of groin hernia: national register study	BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; HOSPITAL VOLUME; FOLLOW-UP; MORTALITY; QUALITY; SURGEON; METAANALYSIS; CANCER; IMPACT	Objective To determine whether the association between volume and outcome found in major surgery also holds true for a minor operation. Design Review of outcomes after hernia surgery in Sweden. Setting Surgical units registered with the Swedish hernia register, which in 2004 covered about 95% of all hernia operations in Sweden. Participants 86 409 patients over 15 years, who underwent 96 601 unilateral or bilateral groin hernia repairs (94 077 inguinal and 2524 femoral) in 1996-2004 at the participating surgical units. Main outcome measure Re-operation for recurrence. Results There was a significantly higher rate of re-operation in surgeons who carried out 1-5 repairs a year than in surgeons who carried out more repairs. There was no association between outcome and further increases in volume. Although about half of surgeons in Sweden who repair hernias are low volume operators, they performed only 8.4% of all repairs. Conclusions Sweden's numerous low volume hernia surgeons perform such a small proportion of all operations that the impact of their inferior results on the nationwide re-operation rate is minimal. Volume indicates an approximate minimum value for the number of hernia repairs a surgeon should do each year but the outcome in surgeons who carry out more than that number disqualifies volume as an indicator of proficiency.	[Nordin, Par; van der Linden, Willem] Ostersund Hosp, Dept Surg, S-83183 Ostersund, Sweden		Nordin, P (corresponding author), Ostersund Hosp, Dept Surg, S-83183 Ostersund, Sweden.	par.nordin@jll.se	Nordin, Pär/Y-6278-2019	Nordin, Par/0000-0001-6117-5777				Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Bittner R, 2005, SURG ENDOSC, V19, P605, DOI 10.1007/s00464-004-9049-9; Carter D, 2003, BRIT MED J, V326, P832, DOI 10.1136/bmj.326.7394.832; COX DR, 1972, J R STAT SOC B, V34, P187; Devereaux PJ, 2005, BMJ-BRIT MED J, V330, P88, DOI 10.1136/bmj.330.7482.88; Dimick JB, 2005, WORLD J SURG, V29, P1217, DOI 10.1007/s00268-005-7989-4; Gouma DJ, 2000, ANN SURG, V232, P786, DOI 10.1097/00000658-200012000-00007; Haapaniemi S, 2002, EUR J SURG, V168, P22, DOI 10.1080/110241502317307535; HAAPANIEMI S, 2001, THESIS LINKOPING U L; Haapaniemi S, 2007, RECURRENT HERNIA PRE, P3; Holt PJE, 2007, EUR J VASC ENDOVASC, V34, P646, DOI 10.1016/j.ejvs.2007.07.021; Kald A, 1998, EUR J SURG, V164, P45; Khuri SF, 2005, WORLD J SURG, V29, P1222, DOI 10.1007/s00268-005-7987-6; Lunde A S, 1980, Vital Health Stat 2, P1; Martling A, 2002, BRIT J SURG, V89, P1008, DOI 10.1046/j.1365-2168.2002.02151.x; Nilsson E., 2000, HERNIA, V4, P286, DOI [10.1007/BF01201085, DOI 10.1007/BF01201085]; Nilsson E, 2002, HERNIA, P567; O'Neill L, 2000, NEUROLOGY, V55, P773, DOI 10.1212/WNL.55.6.773; Schmedt CG, 2005, SURG ENDOSC, V19, P188, DOI 10.1007/s00464-004-9126-0; Sheldon TA, 2004, QUAL SAF HEALTH CARE, V13, P325, DOI 10.1136/qshc.2004.012161; VANDERHOFF JW, 1983, SCI TECHNOLOGY POLYM, V1, P1	22	57	57	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 26	2008	336	7650					934	937		10.1136/bmj.39525.514572.25	http://dx.doi.org/10.1136/bmj.39525.514572.25			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296KC	18426843	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000255540900031
J	Benfey, PN; Mitchell-Olds, T				Benfey, Philip N.; Mitchell-Olds, Thomas			Perspective - From genotype to phenotype: Systems biology meets natural variation	SCIENCE			English	Editorial Material							GENETIC-VARIATION; NETWORK; EVOLUTIONARY; PROTEIN; EPISTASIS; DISEASE; TRAITS	The promise that came with genome sequencing was that we would soon know what genes do, particularly genes involved in human diseases and those of importance to agriculture. We now have the full genomic sequence of human, chimpanzee, mouse, chicken, dog, worm, fly, rice, and cress, as well as those for a wide variety of other species, and yet we still have a lot of trouble figuring out what genes do. Mapping genes to their function is called the "genotype-to-phenotype problem," where phenotype is whatever is changed in the organism when a gene's function is altered.	[Benfey, Philip N.; Mitchell-Olds, Thomas] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Benfey, Philip N.] Duke Univ, Inst Genome Sci & Policy, Ctr Syst Biol, Durham, NC 27708 USA	Duke University; Duke University	Benfey, PN (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	philip.benfey@duke.edu	Mitchell-Olds, Thomas/K-8121-2012	Mitchell-Olds, Thomas/0000-0003-3439-9921	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081883] Funding Source: NIH RePORTER; NIGMS NIH HHS [P50 GM081883-010003, P50 GM081883-01, P50 GM081883-02, P50 GM081883-020003, P50 GM081883] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Batada NN, 2006, PLOS COMPUT BIOL, V2, P748, DOI 10.1371/journal.pcbi.0020088; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Dworkin I, 2003, CURR BIOL, V13, P1888, DOI 10.1016/j.cub.2003.10.001; Friedman A, 2007, CELL, V128, P225, DOI 10.1016/j.cell.2007.01.007; Gjuvsland AB, 2007, GENETICS, V175, P411, DOI 10.1534/genetics.106.058859; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Jonsson H, 2005, BIOINFORMATICS, V21, pI232, DOI 10.1093/bioinformatics/bti1036; Kim PM, 2007, P NATL ACAD SCI USA, V104, P20274, DOI 10.1073/pnas.0710183104; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Kroymann J, 2005, NATURE, V435, P95, DOI 10.1038/nature03480; Kusterer B, 2007, GENETICS, V177, P1839, DOI 10.1534/genetics.107.077628; Makino T, 2006, MOL BIOL EVOL, V23, P784, DOI 10.1093/molbev/msj090; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; Sieberts SK, 2007, MAMM GENOME, V18, P389, DOI 10.1007/s00335-007-9040-6; SLONIM N, 2006, MOL SYST BIOL, V2; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Vitkup D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r39; Welch SM, 2005, AUST J AGR RES, V56, P919, DOI 10.1071/AR05155	19	136	143	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					495	497		10.1126/science.1153716	http://dx.doi.org/10.1126/science.1153716			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436781	Green Accepted			2022-12-24	WOS:000255249300040
J	Zhou, ZF; Zhu, GS; Hariri, AR; Enoch, MA; Scott, D; Sinha, R; Virkkunen, M; Mash, DC; Lipsky, RH; Hu, XZ; Hodgkinson, CA; Xu, K; Buzas, B; Yuan, QP; Shen, PH; Ferrell, RE; Manuck, SB; Brown, SM; Hauger, RL; Stohler, CS; Zubieta, JK; Goldman, D				Zhou, Zhifeng; Zhu, Guanshan; Hariri, Ahmad R.; Enoch, Mary-Anne; Scott, David; Sinha, Rajita; Virkkunen, Matti; Mash, Deborah C.; Lipsky, Robert H.; Hu, Xian-Zhang; Hodgkinson, Colin A.; Xu, Ke; Buzas, Beata; Yuan, Qiaoping; Shen, Pei-Hong; Ferrell, Robert E.; Manuck, Stephen B.; Brown, Sarah M.; Hauger, Richard L.; Stohler, Christian S.; Zubieta, Jon-Kar; Goldman, David			Genetic variation in human NPY expression affects stress response and emotion	NATURE			English	Article							NEUROPEPTIDE-Y DISTRIBUTION; HUMAN AMYGDALA; SEROTONIN TRANSPORTER; POLYMORPHISM; BRAIN; GENOTYPE; DISEASE; ANXIETY; PAIN; ASSOCIATION	Understanding inter- individual differences in stress response requires the explanation of genetic influences at multiple phenotypic levels, including complex behaviours and the metabolic responses of brain regions to emotional stimuli. Neuropeptide Y ( NPY) is anxiolytic(1,2) and its release is induced by stress(3). NPY is abundantly expressed in regions of the limbic system that are implicated in arousal and in the assignment of emotional valences to stimuli and memories(4-6). Here we show that haplotype- driven NPY expression predicts brain responses to emotional and stress challenges and also inversely correlates with trait anxiety. NPY haplotypes predicted levels of NPY messenger RNA in postmortem brain and lymphoblasts, and levels of plasma NPY. Lower haplotype- driven NPY expression predicted higher emotion- induced activation of the amygdala, as well as diminished resiliency as assessed by pain/ stress- induced activations of endogenous opioid neurotransmission in various brain regions. A single nucleotide polymorphism ( SNP rs16147) located in the promoter region alters NPY expression in vitro and seems to account for more than half of the variation in expression in vivo. These convergent findings are consistent with the function of NPY as an anxiolytic peptide and help to explain inter- individual variation in resiliency to stress, a risk factor for many diseases.	[Zhou, Zhifeng; Zhu, Guanshan; Enoch, Mary-Anne; Lipsky, Robert H.; Hu, Xian-Zhang; Hodgkinson, Colin A.; Xu, Ke; Buzas, Beata; Yuan, Qiaoping; Shen, Pei-Hong; Goldman, David] NIAAA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Hariri, Ahmad R.; Ferrell, Robert E.; Manuck, Stephen B.; Brown, Sarah M.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15261 USA; [Hariri, Ahmad R.; Ferrell, Robert E.; Manuck, Stephen B.; Brown, Sarah M.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15261 USA; [Hariri, Ahmad R.; Ferrell, Robert E.; Manuck, Stephen B.; Brown, Sarah M.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15261 USA; [Scott, David; Zubieta, Jon-Kar] Univ Michigan, Sch Med, Dept Psychiat, Ann Arbor, MI 48109 USA; [Scott, David; Zubieta, Jon-Kar] Univ Michigan, Sch Med, Dept Radiol, Ann Arbor, MI 48109 USA; [Sinha, Rajita] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA; [Virkkunen, Matti] Univ Helsinki, Dept Psychiat, Helsinki 00014, Finland; [Mash, Deborah C.] Univ Miami, Sch Med, Dept Neurol, Miami, FL 33124 USA; [Hauger, Richard L.] San Diego VA Healthcare Syst, Dept Psychiat, San Diego, CA 92161 USA; [Hauger, Richard L.] Univ Calif San Diego, San Diego, CA 92161 USA; [Stohler, Christian S.] Univ Maryland, Sch Dent, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Yale University; University of Helsinki; University of Miami; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University System of Maryland; University of Maryland Baltimore	Goldman, D (corresponding author), NIAAA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.	davidgoldman@mail.nih.gov	STOHLER, CHRISTIAN/AAQ-7539-2020; Majid, Salma/AAT-2616-2020; Hariri, Ahmad/D-5761-2011; Zubieta, Jon-Kar/AAB-5565-2022; Goldman, David/F-9772-2010	Majid, Salma/0000-0002-1724-5405; Goldman, David/0000-0002-1724-5405; Yuan, Qiaoping/0000-0002-5880-8702; Hodgkinson, Colin/0000-0002-5365-8119; Stohler, Christian S/0000-0003-0443-6146; Lipsky, Robert/0000-0001-7753-1473; Shen, Pei-Hong/0000-0002-8031-9374	Intramural NIH HHS [Z01 AA000301-09, Z99 AA999999] Funding Source: Medline; NHLBI NIH HHS [P01 HL040962, R01 HL065137] Funding Source: Medline; NIAAA NIH HHS [R01-AA13892, R01 AA013892] Funding Source: Medline; NIDA NIH HHS [R01 DA016423, P50-DA16556, PL1 DA024859-02, P50 DA016556, K02 DA017232, PL1 DA024859, K02-DA17232, R01 DA 016423] Funding Source: Medline; NIDCR NIH HHS [R01 DE015396, R01 DE 15396] Funding Source: Medline; NIMH NIH HHS [R01 MH074697, R01 MH074697-04A1, K01 MH072837] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065137, P01HL040962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074697, K01MH072837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013892, Z01AA000305, Z01AA000301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016423, PL1DA024859, P50DA016556, K02DA017232] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ADRIAN TE, 1983, NATURE, V306, P584, DOI 10.1038/306584a0; ALLEN R, 1991, CLIN EXP PHARMACOL P, V18, P825, DOI 10.1111/j.1440-1681.1991.tb01402.x; ALLEN YS, 1983, SCIENCE, V221, P877, DOI 10.1126/science.6136091; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Britton KT, 2001, PEPTIDES, V22, P607, DOI 10.1016/S0196-9781(01)00371-0; BROQUA P, 1995, BEHAV PHARMACOL, V6, P215; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Enoch Mary-Anne, 2006, J Psychopharmacol, V20, P19, DOI 10.1177/1359786806066041; Haas BW, 2007, BEHAV NEUROSCI, V121, P249, DOI 10.1037/0735-7044.121.2.249; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hariri AR, 2005, ARCH GEN PSYCHIAT, V62, P146, DOI 10.1001/archpsyc.62.2.146; HEILIG M, 1989, PSYCHOPHARMACOLOGY, V98, P524, DOI 10.1007/BF00441953; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; Horsell A, 1999, NEUROREPORT, V10, P3003, DOI 10.1097/00001756-199909290-00024; Karvonen MK, 1998, NAT MED, V4, P1434, DOI 10.1038/4027; Li Y, 2002, BRAIN RES, V940, P69, DOI 10.1016/S0006-8993(02)02594-5; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Moles A, 2004, SCIENCE, V304, P1983, DOI 10.1126/science.1095943; Niskanen L, 2000, EXP CLIN ENDOCR DIAB, V108, P235, DOI 10.1055/s-2000-7748; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Sen S, 2004, AM J MED GENET B, V127B, P85, DOI 10.1002/ajmg.b.20158; Sinha R, 2006, ARCH GEN PSYCHIAT, V63, P324, DOI 10.1001/archpsyc.63.3.324; Somerville LH, 2004, BIOL PSYCHIAT, V55, P897, DOI 10.1016/j.biopsych.2004.01.007; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; TATEMOTO K, 1982, NATURE, V296, P659, DOI 10.1038/296659a0; TEMPLETON AR, 1995, GENETICS, V140, P403; Tessitore A, 2002, J NEUROSCI, V22, P9099, DOI 10.1523/jneurosci.22-20-09099.2002; WATKINS LR, 1982, SCIENCE, V216, P1185, DOI 10.1126/science.6281891; Zhu GS, 2004, PSYCHOPHARMACOLOGY, V177, P178, DOI 10.1007/s00213-004-1938-z; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546; Zubieta JK, 2001, SCIENCE, V293, P311, DOI 10.1126/science.1060952	35	326	335	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2008	452	7190					997	U8		10.1038/nature06858	http://dx.doi.org/10.1038/nature06858			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291PF	18385673	Green Published, Green Accepted			2022-12-24	WOS:000255208600040
J	Larson, MH; Greenleaf, WJ; Landick, R; Block, SM				Larson, Matthew H.; Greenleaf, William J.; Landick, Robert; Block, Steven M.			Applied force reveals mechanistic and energetic details of transcription termination	CELL			English	Article							RNA-POLYMERASE MOLECULES; ESCHERICHIA-COLI RNA; SINGLE-MOLECULE; ELONGATION COMPLEX; STRUCTURAL BASIS; NUCLEIC-ACID; REGULATORY STRATEGY; NASCENT RNA; SEQUENCE; ATTENUATION	Transcription termination by bacterial RNA polymerase (RNAP) occurs at sequences coding for a GC-rich RNA hairpin followed by a U-rich tract. We used single-molecule techniques to investigate the mechanism by which three representative terminators (his, t500, and tR2) destabilize the elongation complex (EC). For his and tR2 terminators, loads exerted to bias translocation did not affect termination efficiency (TE). However, the force-dependent kinetics of release and the force-dependent TE of a mutant imply a forward translocation mechanism for the t500 terminator. Tension on isolated U-tracts induced transcript release in a manner consistent with RNA: DNA hybrid shearing. We deduce that different mechanisms, involving hypertranslocation or shearing, operate at terminators with different U-tracts. Tension applied to RNA at terminators suggests that closure of the final 2-3 hairpin bases destabilizes the hybrid and that competing RNA structures modulate TE. We propose a quantitative, energetic model that predicts the behavior for these terminators and mutant variants.	[Greenleaf, William J.; Block, Steven M.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Larson, Matthew H.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Block, Steven M.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Landick, Robert] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	Stanford University; Stanford University; Stanford University; University of Wisconsin System; University of Wisconsin Madison	Block, SM (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	sblock@stanford.edu	Larson, Matthew/C-8289-2014	Larson, Matthew/0000-0002-6778-2604	NIGMS NIH HHS [R01 GM057035-03, R37 GM038660, R01 GM057035-11, R01 GM038660, R37 GM057035, R01 GM057035, GM38660, GM057035] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038660, R29GM038660, R01GM057035, R01GM038660, R37GM057035] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Adelman K, 2002, P NATL ACAD SCI USA, V99, P13538, DOI 10.1073/pnas.212358999; CHENG SWC, 1991, SCIENCE, V254, P1205, DOI 10.1126/science.1835546; Dalal RV, 2006, MOL CELL, V23, P231, DOI 10.1016/j.molcel.2006.06.023; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Greenleaf WJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208102; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Herbert KM, 2006, CELL, V125, P1083, DOI 10.1016/j.cell.2006.04.032; Komissarova N, 2002, MOL CELL, V10, P1151, DOI 10.1016/S1097-2765(02)00738-4; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Korzheva N, 1998, COLD SPRING HARB SYM, V63, P337, DOI 10.1101/sqb.1998.63.337; Lang MJ, 2004, NAT METHODS, V1, P133, DOI 10.1038/NMETH714; Lesnik EA, 2001, NUCLEIC ACIDS RES, V29, P3583, DOI 10.1093/nar/29.17.3583; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; MACDONALD LE, 1993, NUCLEIC ACIDS RES, V8, P2295; MCDOWELL JC, 1994, SCIENCE, V266, P822, DOI 10.1126/science.7526463; Merino E, 2005, TRENDS GENET, V21, P260, DOI 10.1016/j.tig.2005.03.002; Neuman KC, 1999, BIOPHYS J, V77, P2856, DOI 10.1016/S0006-3495(99)77117-1; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Nudler E, 2002, GENES CELLS, V7, P755, DOI 10.1046/j.1365-2443.2002.00563.x; ODIJK T, 1995, MACROMOLECULES, V28, P7016, DOI 10.1021/ma00124a044; PLATT T, 1981, CELL, V24, P10, DOI 10.1016/0092-8674(81)90496-7; REYNOLDS R, 1992, J MOL BIOL, V224, P53, DOI 10.1016/0022-2836(92)90575-5; Santangelo TJ, 2004, MOL CELL, V14, P117, DOI 10.1016/S1097-2765(04)00154-6; Seol Y, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.118102; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Shundrovsky A, 2004, BIOPHYS J, V87, P3945, DOI 10.1529/biophysj.104.044081; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Toulokhonov I, 2003, MOL CELL, V12, P1125, DOI 10.1016/S1097-2765(03)00439-8; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; TUERK C, 1988, P NATL ACAD SCI USA, V85, P1364, DOI 10.1073/pnas.85.5.1364; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; WILSON KS, 1995, P NATL ACAD SCI USA, V92, P8793, DOI 10.1073/pnas.92.19.8793; Woodside MT, 2006, SCIENCE, V314, P1001, DOI 10.1126/science.1133601; Woodside MT, 2006, P NATL ACAD SCI USA, V103, P6190, DOI 10.1073/pnas.0511048103; YANOFSKY C, 1981, NATURE, V289, P751, DOI 10.1038/289751a0; Yanofsky C, 2000, J BACTERIOL, V182, P1, DOI 10.1128/JB.182.1.1-8.2000; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Yin H, 1999, P NATL ACAD SCI USA, V96, P13124, DOI 10.1073/pnas.96.23.13124; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	43	121	126	0	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 21	2008	132	6					971	982		10.1016/j.cell.2008.01.027	http://dx.doi.org/10.1016/j.cell.2008.01.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	278GR	18358810	Green Accepted, Bronze			2022-12-24	WOS:000254273600016
J	Collins, PJ; Haire, LF; Lin, YP; Liu, JF; Russell, RJ; Walker, PA; Skehel, JJ; Martin, SR; Hay, AJ; Gamblin, SJ				Collins, Patrick J.; Haire, Lesley F.; Lin, Yi Pu; Liu, Junfeng; Russell, Rupert J.; Walker, Philip A.; Skehel, John J.; Martin, Stephen R.; Hay, Alan J.; Gamblin, Steven J.			Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants	NATURE			English	Article							IN-VITRO; A H5N1; SIALIC-ACID; INHIBITORS; DESIGN; SENSITIVITY; VARIANTS; ALTER	The potential impact of pandemic influenza makes effective measures to limit the spread and morbidity of virus infection a public health priority. Antiviral drugs are seen as essential requirements for control of initial influenza outbreaks caused by a new virus, and in pre- pandemic plans there is a heavy reliance on drug stockpiles. The principal target for these drugs is a virus surface glycoprotein, neuraminidase, which facilitates the release of nascent virus and thus the spread of infection. Oseltamivir (Tamiflu) and zanamivir ( Relenza) are two currently used neuraminidase inhibitors that were developed using knowledge of the enzyme structure(1,2). It has been proposed that the closer such inhibitors resemble the natural substrate, the less likely they are to select drug- resistant mutant viruses that retain viability(3). However, there have been reports of drug- resistant mutant selection in vitro(4) and from infected humans(5,6). We report here the enzymatic properties and crystal structures of neuraminidase mutants from H5N1- infected patients that explain the molecular basis of resistance. Our results show that these mutants are resistant to oseltamivir but still strongly inhibited by zanamivir owing to an altered hydrophobic pocket in the active site of the enzyme required for oseltamivir binding. Together with recent reports of the viability and pathogenesis of H5N1 ( ref. 7) and H1N1 ( ref. 8) viruses with neuraminidases carrying these mutations, our results indicate that it would be prudent for pandemic stockpiles of oseltamivir to be augmented by additional antiviral drugs, including zanamivir.	[Collins, Patrick J.; Haire, Lesley F.; Lin, Yi Pu; Liu, Junfeng; Walker, Philip A.; Skehel, John J.; Martin, Stephen R.; Hay, Alan J.; Gamblin, Steven J.] Natl Inst Med Res, MRC, London NW7 1AA, England; [Russell, Rupert J.] Univ St Andrews, Interdisciplinary Ctr Human & Avian Influenza Res, Sch Biol, St Andrews KY16 9ST, Fife, Scotland	MRC National Institute for Medical Research; University of St Andrews	Gamblin, SJ (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	sgambli@nimr.mrc.ac.uk		liu, junfeng/0000-0001-5825-5397; Gamblin, Steve/0000-0001-5331-639X	Medical Research Council [MC_U117512711, MC_U117584222, MC_U117512723] Funding Source: Medline; MRC [MC_U117512723, MC_U117584222, MC_U117512711] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER AT, 1987, PROTEINS, V2, P111, DOI 10.1002/prot.340020205; BURMEISTER WP, 1993, STRUCTURE, V1, P19, DOI 10.1016/0969-2126(93)90005-2; Cheung CL, 2006, J INFECT DIS, V193, P1626, DOI 10.1086/504723; De Clercq E, 2007, NAT REV DRUG DISCOV, V6, P1001, DOI 10.1038/nrd2424; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gubareva LV, 2001, ANTIMICROB AGENTS CH, V45, P3403, DOI 10.1128/AAC.45.12.3403-3408.2001; Gubareva LV, 2001, J INFECT DIS, V183, P523, DOI 10.1086/318537; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Ives J, 2000, J CLIN VIROL, V18, P251; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Lackenby A, 2008, EURO SURVEILL, V13; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; McKimm-Breschkin JL, 2007, EMERG INFECT DIS, V13, P1354, DOI 10.3201/eid1309.070164; McKimm-Breschkin JL, 2000, ANTIVIR RES, V47, P1, DOI 10.1016/S0166-3542(00)00103-0; Murphy B.R, 1996, FIELDS VIROLOGY, P1397; Otwinowski Z., 1993, DATA COLLECTION PROC, P556; Rameix-Welti MA, 2006, ANTIMICROB AGENTS CH, V50, P3809, DOI 10.1128/AAC.00645-06; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Smith BJ, 2002, J MED CHEM, V45, P2207, DOI 10.1021/jm010528u; Tai CY, 1998, ANTIMICROB AGENTS CH, V42, P3234, DOI 10.1128/AAC.42.12.3234; VARGHESE JN, 1992, PROTEINS, V14, P327, DOI 10.1002/prot.340140302; Varghese JN, 1998, STRUCT FOLD DES, V6, P735, DOI 10.1016/S0969-2126(98)00075-6; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Wang MZ, 2002, ANTIMICROB AGENTS CH, V46, P3809, DOI 10.1128/AAC.46.12.3809-3816.2002; Yen HL, 2005, ANTIMICROB AGENTS CH, V49, P4075, DOI 10.1128/AAC.49.10.4075-4084.2005; Yen HL, 2007, J VIROL, V81, P12418, DOI 10.1128/JVI.01067-07	35	396	436	2	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2008	453	7199					1258	U61		10.1038/nature06956	http://dx.doi.org/10.1038/nature06956			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18480754	Bronze			2022-12-24	WOS:000257075800047
J	Hafting, T; Fyhn, M; Bonnevie, T; Moser, MB; Moser, EI				Hafting, Torkel; Fyhn, Marianne; Bonnevie, Tora; Moser, May-Britt; Moser, Edvard I.			Hippocampus-independent phase precession in entorhinal grid cells	NATURE			English	Article							CORTEX LAYER-II; THETA-RHYTHM; PLACE CELLS; SUBTHRESHOLD OSCILLATIONS; PYRAMIDAL CELLS; SPATIAL MAP; EXPERIENCE; DYNAMICS; NEURONS; MODEL	Theta- phase precession in hippocampal place cells(1) is one of the best- studied experimental models of temporal coding in the brain. Theta- phase precession is a change in spike timing in which the place cell fires at progressively earlier phases of the extracellular theta rhythm as the animal crosses the spatially restricted firing field of the neuron(1-5). Within individual theta cycles, this phase advance results in a compressed replication of the firing sequence of consecutively activated place cells along the animal's trajectory(2,6-8), at a timescale short enough to enable spike-time-dependent plasticity between neurons in different parts of the sequence. The neuronal circuitry required for phase precession has not yet been established. The fact that phase precession can be seen in hippocampal output stuctures such as the prefrontal cortex(9) suggests either that efferent structures inherit the precession from the hippocampus or that it is generated locally in those structures. Here we show that phase precession is expressed independently of the hippocampus in spatially modulated grid cells(10,11) in layer II of medial entorhinal cortex, one synapse upstream of the hippocampus. Phase precession is apparent in nearly all principal cells in layer II but only sparsely in layer III. The precession in layer II is not blocked by inactivation of the hippocampus, suggesting that the phase advance is generated in the grid cell network. The results point to possible mechanisms for grid formation and raise the possibility that hippocampal phase precession is inherited from entorhinal cortex.	[Hafting, Torkel; Fyhn, Marianne; Bonnevie, Tora; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, NO-7489 Trondheim, Norway; [Hafting, Torkel; Fyhn, Marianne; Bonnevie, Tora; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Ctr Biol Memory, NO-7489 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, NO-7489 Trondheim, Norway.	edvard.moser@ntnu.no		Hafting, Torkel/0000-0002-0928-3487				ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; Blair HT, 2007, J NEUROSCI, V27, P3211, DOI 10.1523/JNEUROSCI.4724-06.2007; Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Dickson CT, 1997, NEUROSCIENCE, V81, P937, DOI 10.1016/S0306-4522(97)00263-7; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Ekstrom AD, 2001, NEURON, V31, P631, DOI 10.1016/S0896-6273(01)00401-9; Erchova I, 2004, J PHYSIOL-LONDON, V560, P89, DOI 10.1113/jphysiol.2004.069930; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hamam BN, 2000, J COMP NEUROL, V418, P457; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Jones MW, 2005, HIPPOCAMPUS, V15, P867, DOI 10.1002/hipo.20119; KLINK R, 1993, J NEUROPHYSIOL, V70, P144, DOI 10.1152/jn.1993.70.1.144; Kloosterman F, 2003, J COMP NEUROL, V455, P156, DOI 10.1002/cne.10472; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 2001, NEUROSCIENTIST, V7, P490, DOI 10.1177/107385840100700605; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Schmitz D, 1998, NEUROSCIENCE, V85, P999, DOI 10.1016/S0306-4522(98)00113-4; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Yamaguchi Y, 2002, J NEUROPHYSIOL, V87, P2629, DOI 10.1152/jn.2002.87.6.2629; Zugaro MB, 2005, NAT NEUROSCI, V8, P67, DOI 10.1038/nn1369	30	293	294	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2008	453	7199					1248	U50		10.1038/nature06957	http://dx.doi.org/10.1038/nature06957			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18480753				2022-12-24	WOS:000257075800045
J	Muller, B; Sheen, J				Muller, Bruno; Sheen, Jen			Cytokinin and auxin interaction in root stem-cell specification during early embryogenesis	NATURE			English	Article							ARABIDOPSIS RESPONSE REGULATORS; TOBACCO BY-2 CELLS; SIGNAL-TRANSDUCTION; DNA-BINDING; GENE; THALIANA; FAMILY; SHOOT; SCARECROW; MERISTEM	Plant stem-cell pools, the source for all organs, are first established during embryogenesis. It has been known for decades that cytokinin and auxin interact to control organ regeneration in cultured tissue(1). Auxin has a critical role in root stem-cell specification in zygotic embryogenesis(2,3), but the early embryonic function of cytokinin is obscure(4-6). Here, we introduce a synthetic reporter to visualize universally cytokinin output in vivo. Notably, the first embryonic signal is detected in the hypophysis, the founder cell of the root stem-cell system. Its apical daughter cell, the precursor of the quiescent centre, maintains phosphorelay activity, whereas the basal daughter cell represses signalling output. Auxin activity levels, however, exhibit the inverse profile. Furthermore, we show that auxin antagonizes cytokinin output in the basal cell lineage by direct transcriptional activation of ARABIDOPSIS RESPONSE REGULATOR genes, ARR7 and ARR15, feedback repressors of cytokinin signalling. Loss of ARR7 and ARR15 function or ectopic cytokinin signalling in the basal cell during early embryogenesis results in a defective root stem-cell system. These results provide a molecular model of transient and antagonistic interaction between auxin and cytokinin critical for specifying the first root stem-cell niche.	[Muller, Bruno; Sheen, Jen] Harvard Univ, Sch Med, Dept Mol Biol, Massachusetts Gen Hosp,Dept Genet, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Sheen, J (corresponding author), Harvard Univ, Sch Med, Dept Mol Biol, Massachusetts Gen Hosp,Dept Genet, Boston, MA 02114 USA.	mueller@molbio.mgh.harvard.edu; sheen@molbio.mgh.harvard.edu	Mueller, Bruno/E-9888-2017	Mueller, Bruno/0000-0003-2664-7219	NIGMS NIH HHS [R01 GM070567-04, R01 GM070567, R01 GM060493-08, R01 GM060493] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060493, R01GM070567] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Aloni R, 2004, PLANTA, V220, P177, DOI 10.1007/s00425-004-1381-8; D'Agostino IB, 2000, PLANT PHYSIOL, V124, P1706, DOI 10.1104/pp.124.4.1706; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Gallie DR, 2002, NUCLEIC ACIDS RES, V30, P3401, DOI 10.1093/nar/gkf457; Guilfoyle T, 1998, PLANT PHYSIOL, V118, P341, DOI 10.1104/pp.118.2.341; Hass C, 2004, EMBO J, V23, P3290, DOI 10.1038/sj.emboj.7600337; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; Hosoda K, 2002, PLANT CELL, V14, P2015, DOI 10.1105/tpc.002733; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Imamura A, 2003, PLANT CELL PHYSIOL, V44, P122, DOI 10.1093/pcp/pcg014; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; Laureys F, 1998, FEBS LETT, V426, P29, DOI 10.1016/S0014-5793(98)00297-X; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Lohar DP, 2004, PLANT J, V38, P203, DOI 10.1111/j.1365-313X.2004.02038.x; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Muller B, 2007, SCIENCE, V318, P68, DOI 10.1126/science.1145461; Nishimura C, 2004, PLANT CELL, V16, P1365, DOI 10.1105/tpc.021477; Orchard CB, 2005, PLANT J, V44, P290, DOI 10.1111/j.1365-313X.2005.02524.x; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Rashotte AM, 2003, PLANT PHYSIOL, V132, P1998, DOI 10.1104/pp.103.021436; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Roslan HA, 2001, PLANT J, V28, P225, DOI 10.1046/j.1365-313X.2001.01146.x; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Sauer M, 2004, PLANT J, V40, P835, DOI 10.1111/j.1365-313X.2004.02248.x; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; Weijers D, 2005, CURR OPIN PLANT BIOL, V8, P32, DOI 10.1016/j.pbi.2004.11.001; Weijers D, 2001, DEVELOPMENT, V128, P4289; Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	36	465	490	6	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2008	453	7198					1094	U7		10.1038/nature06943	http://dx.doi.org/10.1038/nature06943			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18463635	Green Accepted			2022-12-24	WOS:000256839900055
J	Maris, JM; Mosse, YP; Bradfield, JP; Hou, CP; Monni, S; Scott, RH; Asgharzadeh, S; Attiyeh, EF; Diskin, SJ; Laudenslager, M; Winter, C; Cole, KA; Glessner, JT; Kim, C; Frackelton, EC; Casalunovo, T; Eckert, AW; Capasso, M; Rappaport, EF; McConville, C; London, WB; Seeger, RC; Rahman, N; Devoto, M; Grant, SFA; Li, HZ; Hakonarson, H				Maris, John M.; Mosse, Yael P.; Bradfield, Jonathan P.; Hou, Cuiping; Monni, Stefano; Scott, Richard H.; Asgharzadeh, Shahab; Attiyeh, Edward F.; Diskin, Sharon J.; Laudenslager, Marci; Winter, Cynthia; Cole, Kristina A.; Glessner, Joseph T.; Kim, Cecilia; Frackelton, Edward C.; Casalunovo, Tracy; Eckert, Andrew W.; Capasso, Mario; Rappaport, Eric F.; McConville, Carmel; London, Wendy B.; Seeger, Robert C.; Rahman, Nazneen; Devoto, Marcella; Grant, Struan F. A.; Li, Hongzhe; Hakonarson, Hakon			Chromosome 6p22 locus associated with clinically aggressive neuroblastoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PARENTAL OCCUPATIONAL EXPOSURES; HIGH-RISK NEUROBLASTOMA; GENE AMPLIFICATION; GENOME; PREDISPOSITION; EPIDEMIOLOGY; CHEMOTHERAPY	Background: Neuroblastoma is a malignant condition of the developing sympathetic nervous system that most commonly affects young children and is often lethal. Its cause is not known. Methods: We performed a genomewide association study by first genotyping blood DNA samples from 1032 patients with neuroblastoma and 2043 control subjects of European descent using the Illumina HumanHap550 BeadChip. Samples from three independent groups of patients with neuroblastoma (a total of 720 patients) and 2128 control subjects were then genotyped to replicate significant associations. Results: We observed a significant association between neuroblastoma and the common minor alleles of three consecutive single-nucleotide polymorphisms (SNPs) at chromosome band 6p22 and containing the predicted genes FLJ22536 and FLJ44180 (P=1.71 x 10(-9) to 7.01 x 10(-10); allelic odds ratio, 1.39 to 1.40). Homozygosity for the at-risk G allele of the most significantly associated SNP, rs6939340, resulted in an increased likelihood of the development of neuroblastoma (odds ratio, 1.97; 95% confidence interval, 1.58 to 2.45). Subsequent genotyping of the three 6p22 SNPs in three independent case series confirmed our observation of an association (P=9.33 x 10(-15) at rs6939340 for joint analysis). Patients with neuroblastoma who were homozygous for the risk alleles at 6p22 were more likely to have metastatic (stage 4) disease (P=0.02), amplification of the MYCN oncogene in the tumor cells (P=0.006), and disease relapse (P=0.01). Conclusions: A common genetic variation at chromosome band 6p22 is associated with susceptibility to neuroblastoma.	[Maris, John M.; Mosse, Yael P.; Hou, Cuiping; Attiyeh, Edward F.; Diskin, Sharon J.; Laudenslager, Marci; Winter, Cynthia; Cole, Kristina A.; Rappaport, Eric F.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Maris, John M.; Mosse, Yael P.; Hou, Cuiping; Attiyeh, Edward F.; Diskin, Sharon J.; Laudenslager, Marci; Winter, Cynthia; Cole, Kristina A.; Rappaport, Eric F.] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Bradfield, Jonathan P.; Glessner, Joseph T.; Kim, Cecilia; Frackelton, Edward C.; Casalunovo, Tracy; Eckert, Andrew W.; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Capasso, Mario; Devoto, Marcella; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Genet, Philadelphia, PA 19104 USA; [Maris, John M.; Mosse, Yael P.; Hou, Cuiping; Attiyeh, Edward F.; Diskin, Sharon J.; Laudenslager, Marci; Winter, Cynthia; Cole, Kristina A.; Rappaport, Eric F.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Maris, John M.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Monni, Stefano; Devoto, Marcella; Li, Hongzhe] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Capasso, Mario; Devoto, Marcella; Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Scott, Richard H.; Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Asgharzadeh, Shahab; Seeger, Robert C.] Childrens Hosp Los Angeles, Div Hematol Oncol, Los Angeles, CA 90027 USA; [Asgharzadeh, Shahab; Seeger, Robert C.] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Asgharzadeh, Shahab; Seeger, Robert C.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Capasso, Mario] Univ Naples Federico II, Ctr Ingn Genet Biotecnol Avanzate, Naples, Italy; [McConville, Carmel] Univ Birmingham, Div Reprod & Child Hlth, Birmingham, W Midlands, England; [McConville, Carmel] Univ Birmingham, CRUK Inst Canc Studies, Birmingham, W Midlands, England; [London, Wendy B.] Univ Florida, Dept Stat, Gainesville, FL 32611 USA; [London, Wendy B.] Childrens Oncol Grp, Gainesville, FL 32611 USA; [Devoto, Marcella] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of London; Institute of Cancer Research - UK; Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California; University of Naples Federico II; University of Birmingham; University of Birmingham; State University System of Florida; University of Florida; Children's Oncology Group (COG); Sapienza University Rome	Maris, JM (corresponding author), Childrens Hosp Philadelphia, Div Oncol, 907A,3516 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	maris@chop.edu; hakonarson@chop.edu	Cole, Kristina/M-3922-2015; Rappaport, Eric/GRO-4051-2022; Devoto, Marcella/AAP-7595-2021; Rahman, Nazneen/B-8890-2012; London, Wendy Beth/ABA-8948-2021; London, Wendy/ABD-4624-2021; Capasso, Mario/D-1617-2014; Rahman, Nazneen/D-2802-2013	London, Wendy Beth/0000-0003-3571-6538; Rahman, Nazneen/0000-0003-4376-0440; DEVOTO, MARCELLA/0000-0002-4431-5114; Glessner, Joseph/0000-0001-5131-2811; Capasso, Mario/0000-0003-3306-1259; Grant, Struan/0000-0003-2025-5302	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; Medical Research Council [G0000934] Funding Source: Medline; NCI NIH HHS [R01-CA78454, R01 CA124709, U10 CA098543-06, U10 CA098543, R01 CA124709-01A2, R01-CA60104, U10-CA98543, R01 CA060104] Funding Source: Medline; NIEHS NIH HHS [R01 ES009911, R01-ES009911] Funding Source: Medline; Wellcome Trust [068545/Z/02] Funding Source: Medline; MRC [G0000934] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [U10CA098543, R01CA124709, R01CA060104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009911] Funding Source: NIH RePORTER	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berthold F, 2005, LANCET ONCOL, V6, P649, DOI 10.1016/S1470-2045(05)70291-6; Brodeur G. M., 2006, PRINCIPLES PRACTICE, P933; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; De Roos AJ, 2001, AM J EPIDEMIOL, V154, P106, DOI 10.1093/aje/154.2.106; De Roos AJ, 2001, EPIDEMIOLOGY, V12, P508, DOI 10.1097/00001648-200109000-00008; George RE, 2005, J CLIN ONCOL, V23, P6466, DOI 10.1200/JCO.2005.05.582; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Longo L, 2007, HUM HERED, V63, P205, DOI 10.1159/000099997; LOOK AT, 1991, J CLIN ONCOL, V9, P581, DOI 10.1200/JCO.1991.9.4.581; Maris JM, 2005, PEDIAT ONCOL, P21; Maris JM, 2002, CANCER RES, V62, P6651; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Mathew P, 2001, NEOPLASIA, V3, P105, DOI 10.1038/sj.neo.7900146; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Olshan AF, 1999, CANCER CAUSE CONTROL, V10, P539, DOI 10.1023/A:1008998925889; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shimada H, 1999, CANCER, V86, P364, DOI 10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.3.CO;2-Z; Shojaei-Brosseau T, 2004, PEDIATR BLOOD CANCER, V42, P99, DOI 10.1002/pbc.10381; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Trochet D, 2004, AM J HUM GENET, V74, P761, DOI 10.1086/383253; Yang N, 2005, HUM GENET, V118, P382, DOI 10.1007/s00439-005-0012-1	26	211	219	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 12	2008	358	24					2585	2593		10.1056/NEJMoa0708698	http://dx.doi.org/10.1056/NEJMoa0708698			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	311IJ	18463370	Green Accepted			2022-12-24	WOS:000256593600006
J	Bouatia-Naji, N; Rocheleau, G; Van Lommel, L; Lemaire, K; Schuit, F; Cavalcanti-Proenca, C; Marchand, M; Hartikainen, AL; Sovio, U; De Graeve, F; Rung, J; Vaxillaire, M; Tichet, J; Marre, M; Balkau, B; Weill, J; Elliott, P; Jarvelin, MR; Meyre, D; Polychronakos, C; Dina, C; Sladek, R; Froguel, P				Bouatia-Naji, Nabila; Rocheleau, Ghislain; Van Lommel, Leentje; Lemaire, Katleen; Schuit, Frans; Cavalcanti-Proenca, Christine; Marchand, Marion; Hartikainen, Anna-Liisa; Sovio, Ulla; De Graeve, Franck; Rung, Johan; Vaxillaire, Martine; Tichet, Jean; Marre, Michel; Balkau, Beverley; Weill, Jacques; Elliott, Paul; Jarvelin, Marjo-Riitta; Meyre, David; Polychronakos, Constantin; Dina, Christian; Sladek, Robert; Froguel, Philippe			A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; REGULATORY PROTEIN; DIABETES-MELLITUS; MORTALITY RISK; POPULATION; DISEASE; LOCUS	Several studies have shown that healthy individuals with fasting plasma glucose ( FPG) levels at the high end of the normal range have an increased risk of mortality. To identify genetic determinants that contribute to interindividual variation in FPG, we tested 392,935 single- nucleotide polymorphisms ( SNPs) in 654 normoglycemic participants for association with FPG, and we replicated the most strongly associated SNP ( rs560887, P = 4 x 10(-7)) in 9353 participants. SNP rs560887 maps to intron 3 of the G6PC2 gene, which encodes glucose- 6- phosphatase catalytic subunit- related protein ( also known as IGRP), a protein selectively expressed in pancreatic islets. This SNP was associated with FPG ( linear regression coefficient beta = -0.06 millimoles per liter per A allele, combined P = 4 x 10(-23)) and with pancreatic beta cell function ( Homa-B model, combined P = 3 x 10(-13)) in three populations; however, it was not associated with type 2 diabetes risk. We speculate that G6PC2 regulates FPG by modulating the set point for glucose- stimulated insulin secretion in pancreatic beta cells.	[Bouatia-Naji, Nabila; Cavalcanti-Proenca, Christine; Marchand, Marion; De Graeve, Franck; Vaxillaire, Martine; Meyre, David; Dina, Christian; Froguel, Philippe] Univ Lille 2, CNRS, Inst Biol, Pasteur Inst Lille,UMR 8090, F-59019 Lille, France; [Rocheleau, Ghislain; Rung, Johan; Polychronakos, Constantin; Sladek, Robert] McGill Univ, Dept Human Genet, Fac Med, Montreal, PQ H3A 1A4, Canada; [Rocheleau, Ghislain; Rung, Johan; Polychronakos, Constantin; Sladek, Robert] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Van Lommel, Leentje; Lemaire, Katleen; Schuit, Frans] Katholieke Univ Leuven, Gene Express Unit, Dept Mol Cell Biol, B-3000 Louvain, Belgium; [Hartikainen, Anna-Liisa] Dept Obstet & Gynaecol, Oulu 90014, Finland; [Sovio, Ulla; Elliott, Paul; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Tichet, Jean] Inst Inter Reg Sante IRSA, F-37520 La Riche, France; [Marre, Michel] Hop Xavier Bichat, INSERM, U695, F-75722 Paris, France; [Balkau, Beverley] Univ Paris Sud, INSERM, U780, IFR69, F-94807 Villejuif, France; [Weill, Jacques] Jean Flandre Hosp, Pediat Endocrine Unit, F-59037 Lille, France; [Jarvelin, Marjo-Riitta] Oulu Univ, Dept Publ Hlth & Gen Practice, Oulu 90014, Finland; [Polychronakos, Constantin] McGill Univ, Dept Pediat, Fac Med, Montreal, PQ H3H 1P3, Canada; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London W12 0NN, England	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; McGill University; KU Leuven; Imperial College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universite de Lille - ISITE; CHU Lille; University of Oulu; McGill University; Imperial College London	Froguel, P (corresponding author), Univ Lille 2, CNRS, Inst Biol, Pasteur Inst Lille,UMR 8090, F-59019 Lille, France.	p.froguel@imperial.ac.uk	Dina, Christian R/D-3535-2015; Meyre, David/D-7315-2011; Sovio, Ulla/H-8532-2019; Bouatia-Naji, Nabila/AGF-1400-2022; FROGUEL, Philippe/O-6799-2017; Sladek, Robert/R-2391-2019; BOUATIA-NAJI, NABILA/D-5863-2013; Polychronakos, Constantin/B-8151-2008	Dina, Christian R/0000-0002-7722-7348; Meyre, David/0000-0003-4850-7444; Sovio, Ulla/0000-0002-0799-1105; Bouatia-Naji, Nabila/0000-0001-5424-2134; FROGUEL, Philippe/0000-0003-2972-0784; Sladek, Robert/0000-0002-2730-1204; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Rung, Johan/0000-0001-5875-8429; Marre, Michel/0000-0002-3071-1837; Polychronakos, Constantin/0000-0002-7624-6635	MRC [G0600331] Funding Source: UKRI; Medical Research Council [G0600331] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Balkau B, 1999, DIABETES CARE, V22, P696, DOI 10.2337/diacare.22.5.696; Cauchi S, 2006, DIABETES, V55, P3189, DOI 10.2337/db06-0692; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Cuesta-Munoz AL, 2004, DIABETES, V53, P2164, DOI 10.2337/diabetes.53.8.2164; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; Lawes CMM, 2004, DIABETES CARE, V27, P2836; Levitan EB, 2008, DIABETOLOGIA, V51, P267, DOI 10.1007/s00125-007-0882-y; Loos RJF, 2007, DIABETES, V56, P1943, DOI 10.2337/db07-0055; Martin CC, 2001, J BIOL CHEM, V276, P25197, DOI 10.1074/jbc.M101549200; Marz W, 2004, CIRCULATION, V109, P2844, DOI 10.1161/01.CIR.0000129306.44085.C4; Orho-Melander M, 2007, DIABETOLOGIA, V50, pS40; Panzer C, 2002, DIABETES, V51, P803, DOI 10.2337/diabetes.51.3.803; Pertea M, 2001, NUCLEIC ACIDS RES, V29, P1185, DOI 10.1093/nar/29.5.1185; Qiao Q, 2003, DIABETES CARE, V26, P688; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shieh JJ, 2004, FEBS LETT, V562, P160, DOI 10.1016/S0014-5793(04)00223-6; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Sparso T, 2008, DIABETOLOGIA, V51, P70, DOI 10.1007/s00125-007-0865-z; VANSCHAFTINGEN E, 1994, FASEB J, V8, P414, DOI 10.1096/fasebj.8.6.8168691; Wang Y, 2007, DIABETOLOGIA, V50, P774, DOI 10.1007/s00125-006-0564-1; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	23	186	192	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 23	2008	320	5879					1085	1088		10.1126/science.1156849	http://dx.doi.org/10.1126/science.1156849			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303RY	18451265	Green Accepted			2022-12-24	WOS:000256059800048
J	Ahn, TK; Avenson, TJ; Ballottari, M; Cheng, YC; Niyogi, KK; Bassi, R; Fleming, GR				Ahn, Tae Kyu; Avenson, Thomas J.; Ballottari, Matteo; Cheng, Yuan-Chung; Niyogi, Krishna K.; Bassi, Roberto; Fleming, Graham R.			Architecture of a charge-transfer state regulating light harvesting in a plant antenna protein	SCIENCE			English	Article							PHOTOSYSTEM-II; ENERGY-DISSIPATION; GREEN PLANTS; OXYGENIC PHOTOSYNTHESIS; TRANSIENT ABSORPTION; CATION FORMATION; COMPLEX; MECHANISM; PSBS; IDENTIFICATION	Energy- dependent quenching of excess absorbed light energy ( qE) is a vital mechanism for regulating photosynthetic light harvesting in higher plants. All of the physiological characteristics of qE have been positively correlated with charge transfer between coupled chlorophyll and zeaxanthin molecules in the light- harvesting antenna of photosystem II ( PSII). We found evidence for charge- transfer quenching in all three of the individual minor antenna complexes of PSII ( CP29, CP26, and CP24), and we conclude that charge- transfer quenching in CP29 involves a delocalized state of an excitonically coupled chlorophyll dimer. We propose that reversible conformational changes in CP29 can "tune" the electronic coupling between the chlorophylls in this dimer, thereby modulating the energy of the chlorophyll-zeaxanthin charge- transfer state and switching on and off the charge- transfer quenching during qE.	[Ballottari, Matteo; Bassi, Roberto] Univ Verona, Dept Sci & Technol, I-37134 Verona, Italy; [Ahn, Tae Kyu; Niyogi, Krishna K.; Fleming, Graham R.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Ahn, Tae Kyu; Avenson, Thomas J.; Cheng, Yuan-Chung; Fleming, Graham R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Ahn, Tae Kyu; Avenson, Thomas J.; Cheng, Yuan-Chung; Fleming, Graham R.] Univ Calif Berkeley, QB3 Inst, Berkeley, CA 94720 USA; [Avenson, Thomas J.; Niyogi, Krishna K.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of Verona; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Bassi, R (corresponding author), Univ Verona, Dept Sci & Technol, I-37134 Verona, Italy.	bassi@sci.univr.it; grfleming@lbl.gov	Cheng, Yuan-Chung/A-6566-2008; Ballottari, Matteo/N-1916-2019; Ahn, Tae Kyu/A-5838-2013	Cheng, Yuan-Chung/0000-0003-0125-4267; Ballottari, Matteo/0000-0001-8410-3397; Ahn, Tae Kyu/0000-0002-7474-6513; bassi, roberto/0000-0002-4140-8446				Amarie S, 2007, J PHYS CHEM B, V111, P3481, DOI 10.1021/jp066458q; Andersson J, 2003, PLANT J, V35, P350, DOI 10.1046/j.1365-313X.2003.01811.x; Andersson J, 2001, PLANT CELL, V13, P1193, DOI 10.1105/tpc.13.5.1193; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Bassi R, 1999, P NATL ACAD SCI USA, V96, P10056, DOI 10.1073/pnas.96.18.10056; Berera R, 2006, P NATL ACAD SCI USA, V103, P5343, DOI 10.1073/pnas.0508530103; BOEKEMA EJ, 1995, P NATL ACAD SCI USA, V92, P175, DOI 10.1073/pnas.92.1.175; Bonente G, 2008, J BIOL CHEM, V283, P8434, DOI 10.1074/jbc.M708291200; BRIANTAIS JM, 1979, BIOCHIM BIOPHYS ACTA, V548, P128, DOI 10.1016/0005-2728(79)90193-2; Cinque G, 2000, BIOPHYS J, V79, P1706, DOI 10.1016/S0006-3495(00)76423-X; Connelly JP, 1997, BIOCHEMISTRY-US, V36, P281, DOI 10.1021/bi962467l; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; Dreuw A, 2003, PHYS CHEM CHEM PHYS, V5, P3247, DOI 10.1039/b304944b; Hagfeldt A, 2000, ACCOUNTS CHEM RES, V33, P269, DOI 10.1021/ar980112j; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Moore TA, 2002, PHILOS T R SOC B, V357, P1481, DOI 10.1098/rstb.2002.1147; Morosinotto T, 2003, PHYSIOL PLANTARUM, V119, P347, DOI 10.1034/j.1399-3054.2003.00213.x; Rhee KH, 1997, NATURE, V389, P522, DOI 10.1038/39103; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Teardo E, 2007, BBA-BIOENERGETICS, V1767, P703, DOI 10.1016/j.bbabio.2006.12.002; van Amerongen H, 2001, J PHYS CHEM B, V105, P604, DOI 10.1021/jp0028406	27	437	444	14	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2008	320	5877					794	797		10.1126/science.1154800	http://dx.doi.org/10.1126/science.1154800			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18467588	Green Submitted			2022-12-24	WOS:000255644400041
J	Ishikawa, K; Takenaga, K; Akimoto, M; Koshikawa, N; Yamaguchi, A; Imanishi, H; Nakada, K; Honma, Y; Hayashi, J				Ishikawa, Kaori; Takenaga, Keizo; Akimoto, Miho; Koshikawa, Nobuko; Yamaguchi, Aya; Imanishi, Hirotake; Nakada, Kazuto; Honma, Yoshio; Hayashi, Jun-Ichi			ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis	SCIENCE			English	Article							LUNG-CARCINOMA CELLS; PREVENTION; MOUSE; TUMORIGENICITY; PARAGANGLIOMA; APOPTOSIS; BINDING; GENOME; CANCER; MTDNA	Mutations in mitochondrial DNA ( mtDNA) occur at high frequency in human tumors, but whether these mutations alter tumor cell behavior has been unclear. We used cytoplasmic hybrid ( cybrid) technology to replace the endogenous mtDNA in a mouse tumor cell line that was poorly metastatic with mtDNA from a cell line that was highly metastatic, and vice versa. Using assays of metastasis in mice, we found that the recipient tumor cells acquired the metastatic potential of the transferred mtDNA. The mtDNA conferring high metastatic potential contained G13997A and 13885insC mutations in the gene encoding NADH ( reduced form of nicotinamide adenine dinucleotide) dehydrogenase subunit 6 (ND6). These mutations produced a deficiency in respiratory complex I activity and were associated with overproduction of reactive oxygen species ( ROS). Pretreatment of the highly metastatic tumor cells with ROS scavengers suppressed their metastatic potential in mice. These results indicate that mtDNA mutations can contribute to tumor progression by enhancing the metastatic potential of tumor cells.	[Ishikawa, Kaori; Yamaguchi, Aya; Imanishi, Hirotake; Nakada, Kazuto; Hayashi, Jun-Ichi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Ishikawa, Kaori; Nakada, Kazuto] Univ Tsukuba, Tsukuba Adv Res Alliance Ctr, Tsukuba, Ibaraki 3058572, Japan; [Ishikawa, Kaori] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1028472, Japan; [Takenaga, Keizo; Koshikawa, Nobuko] Chiba Canc Ctr, Res Inst, Div Chemotherapy, Chuo Ku, Chiba 2608717, Japan; [Takenaga, Keizo; Akimoto, Miho; Honma, Yoshio] Shimane Univ, Fac Med, Izumo, Shimane 6938501, Japan	University of Tsukuba; University of Tsukuba; Japan Society for the Promotion of Science; Chiba Cancer Center; Shimane University	Hayashi, J (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	jih45@sakura.cc.tsukuba.ac.jp		ISHIKAWA, Kaori/0000-0001-9895-5996				ALLEN JA, 1980, NATURE, V287, P244, DOI 10.1038/287244a0; Augenlicht LH, 2001, NAT GENET, V28, P104, DOI 10.1038/88800; BACKER JM, 1980, SCIENCE, V209, P297, DOI 10.1126/science.6770466; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859; Czarnecka AM, 2006, J APPL GENET, V47, P67, DOI 10.1007/BF03194602; DeFlora S, 1996, INT J CANCER, V67, P842, DOI 10.1002/(SICI)1097-0215(19960917)67:6<842::AID-IJC14>3.0.CO;2-3; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; Gallardo ME, 2006, HUM MUTAT, V27, P575, DOI 10.1002/humu.20338; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; Koshikawa N, 2006, ONCOGENE, V25, P917, DOI 10.1038/sj.onc.1209128; Koshikawa N, 2003, ONCOGENE, V22, P6717, DOI 10.1038/sj.onc.1206765; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296; SHAY JW, 1987, MUTAT RES, V186, P149, DOI 10.1016/0165-1110(87)90028-5; Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012; Shitara H, 1998, GENETICS, V148, P851; Takasu M, 1999, CLIN EXP METASTAS, V17, P409, DOI 10.1023/A:1006632819086; Takenaga K, 1997, ONCOGENE, V14, P331, DOI 10.1038/sj.onc.1200820; Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482	26	1000	1044	2	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2008	320	5876					661	664		10.1126/science.1156906	http://dx.doi.org/10.1126/science.1156906			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18388260	Green Submitted			2022-12-24	WOS:000255454300045
J	Gerber, S; Comellas-Bigler, M; Goetz, BA; Locher, KP				Gerber, Sabina; Comellas-Bigler, Mireia; Goetz, Birke A.; Locher, Kaspar P.			Structural basis of trans-inhibition in a molybdate/tungstate ABC transporter	SCIENCE			English	Article							AMINO-ACID TRANSPORT; BINDING-PROTEIN; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MECHANISM; COMPLEX; CELLS; MODE; DEREPRESSION; SPECIFICITY	Transport across cellular membranes is an essential process that is catalyzed by diverse membrane transport proteins. The turnover rates of certain transporters are inhibited by their substrates in a process termed trans- inhibition, whose structural basis is poorly understood. We present the crystal structure of a molybdate/ tungstate ABC transporter ( ModBC) from Methanosarcina acetivorans in a trans- inhibited state. The regulatory domains of the nucleotide- binding subunits are in close contact and provide two oxyanion binding pockets at the shared interface. By specifically binding to these pockets, molybdate or tungstate prevent adenosine triphosphatase activity and lock the transporter in an inward- facing conformation, with the catalytic motifs of the nucleotide- binding domains separated. This allosteric effect prevents the transporter from switching between the inward- facing and the outward- facing states, thus interfering with the alternating access and release mechanism.	[Gerber, Sabina; Comellas-Bigler, Mireia; Goetz, Birke A.; Locher, Kaspar P.] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Locher, KP (corresponding author), ETH, Inst Mol Biol & Biophys, HPK D14-3, CH-8093 Zurich, Switzerland.	kaspar.locher@mol.biol.ethz.ch						Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; CHERVITZ SA, 1995, J BIOL CHEM, V270, P24043, DOI 10.1074/jbc.270.41.24043; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Dawson RJP, 2007, MOL MICROBIOL, V65, P250, DOI 10.1111/j.1365-2958.2007.05792.x; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Debernardi R, 1999, BRAIN RES, V850, P39, DOI 10.1016/S0006-8993(99)02022-3; Delarbre L, 2001, J MOL BIOL, V308, P1063, DOI 10.1006/jmbi.2001.4636; Deves R, 1998, PHYSIOL REV, V78, P487, DOI 10.1152/physrev.1998.78.2.487; Glaasker E, 1998, J BACTERIOL, V180, P5540, DOI 10.1128/JB.180.21.5540-5546.1998; Hall DR, 1999, EMBO J, V18, P1435, DOI 10.1093/emboj/18.6.1435; HEATON JH, 1977, J BIOL CHEM, V252, P2900; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; HUNTER DR, 1973, ARCH BIOCHEM BIOPHYS, V154, P387, DOI 10.1016/0003-9861(73)90071-4; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; KASHIWAGI K, 1995, J BIOL CHEM, V270, P25377, DOI 10.1074/jbc.270.43.25377; KELLEY DS, 1979, J BIOL CHEM, V254, P6691; Lee SJ, 2007, TRENDS MICROBIOL, V15, P389, DOI 10.1016/j.tim.2007.08.002; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; MARZLUF GA, 1973, ARCH BIOCHEM BIOPHYS, V156, P244, DOI 10.1016/0003-9861(73)90362-7; Mouncey NJ, 1996, MICROBIOL-SGM, V142, P1997, DOI 10.1099/13500872-142-8-1997; NELSON SO, 1984, EUR J BIOCHEM, V139, P29, DOI 10.1111/j.1432-1033.1984.tb07971.x; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; PALL ML, 1971, BIOCHEM BIOPH RES CO, V42, P940, DOI 10.1016/0006-291X(71)90521-3; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; REYES M, 1988, J BACTERIOL, V170, P4598, DOI 10.1128/jb.170.10.4598-4602.1988; Schuttelkopf AW, 2003, J MOL BIOL, V326, P761, DOI 10.1016/S0022-2836(02)01358-X; STEVENS BR, 1984, ANNU REV PHYSIOL, V46, P417; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Verheul A, 1997, J BACTERIOL, V179, P6979, DOI 10.1128/jb.179.22.6979-6985.1997; Wagner UG, 2000, STRUCTURE, V8, P1127, DOI 10.1016/S0969-2126(00)00525-6; WOODWARD JR, 1977, J BACTERIOL, V130, P714, DOI 10.1128/JB.130.2.714-723.1977	32	150	155	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2008	321	5886					246	250		10.1126/science.1156213	http://dx.doi.org/10.1126/science.1156213			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18511655				2022-12-24	WOS:000257512900039
J	Yang, L; Soonpaa, MH; Adler, ED; Roepke, TK; Kattman, SJ; Kennedy, M; Henckaerts, E; Bonham, K; Abbott, GW; Linden, RM; Field, LJ; Keller, GM				Yang, Lei; Soonpaa, Mark H.; Adler, Eric D.; Roepke, Torsten K.; Kattman, Steven J.; Kennedy, Marion; Henckaerts, Els; Bonham, Kristina; Abbott, Geoffrey W.; Linden, R. Michael; Field, Loren J.; Keller, Gordon M.			Human cardiovascular progenitor cells develop from a KDR plus embryonic-stem-cell-derived population	NATURE			English	Article							SMOOTH-MUSCLE; HEART; SPECIFICATION; DIFFERENTIATION; PROLIFERATION; CARDIOGENESIS; REQUIREMENT; EXPRESSION	The functional heart is comprised of distinct mesoderm-derived lineages including cardiomyocytes, endothelial cells and vascular smooth muscle cells. Studies in the mouse embryo and the mouse embryonic stem cell differentiation model have provided evidence indicating that these three lineages develop from a common Flk-1(+) (kinase insert domain protein receptor, also known as Kdr) cardiovascular progenitor that represents one of the earliest stages in mesoderm specification to the cardiovascular lineages(1). To determine whether a comparable progenitor is present during human cardiogenesis, we analysed the development of the cardiovascular lineages in human embryonic stem cell differentiation cultures. Here we show that after induction with combinations of activin A, bone morphogenetic protein 4 (BMP4), basic fibroblast growth factor (bFGF, also known as FGF2), vascular endothelial growth factor (VEGF, also known as VEGFA) and dickkopf homolog 1 (DKK1) in serum-free media, human embryonic-stem-cell-derived embryoid bodies generate a KDRlow/C-KIT (CD117)(neg) population that displays cardiac, endothelial and vascular smooth muscle potential in vitro and, after transplantation, in vivo. When plated in monolayer cultures, these KDR low/C-KIT neg cells differentiate to generate populations consisting of greater than 50% contracting cardiomyocytes. Populations derived from the KDRlow/C-KITneg fraction give rise to colonies that contain all three lineages when plated in methylcellulose cultures. Results from limiting dilution studies and cell-mixing experiments support the interpretation that these colonies are clones, indicating that they develop from a cardiovascular colonyforming cell. Together, these findings identify a human cardiovascular progenitor that defines one of the earliest stages of human cardiac development.	[Yang, Lei; Adler, Eric D.; Linden, R. Michael; Keller, Gordon M.] Mt Sinai Sch Med, Dept Gene & Cell Med, Black Family Stem Cell Inst, New York, NY 10029 USA; [Soonpaa, Mark H.; Field, Loren J.] Indiana Univ, Sch Med, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Roepke, Torsten K.; Abbott, Geoffrey W.] Cornell Univ, Greenberg Div Cardiol, Dept Med, Weill Med Coll, New York, NY 10021 USA; [Roepke, Torsten K.; Abbott, Geoffrey W.] Cornell Univ, Greenberg Div Cardiol, Dept Pharmacol, Weill Med Coll, New York, NY 10021 USA; [Kattman, Steven J.; Kennedy, Marion; Keller, Gordon M.] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada; [Henckaerts, Els; Linden, R. Michael] Kings Coll London, Dept Infect Dis, London SE1 9RT, England; [Bonham, Kristina] VistaGen Therapeut Inc, San Francisco, CA 94080 USA	Icahn School of Medicine at Mount Sinai; Indiana University System; Indiana University-Purdue University Indianapolis; Cornell University; Cornell University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of London; King's College London	Keller, GM (corresponding author), Mt Sinai Sch Med, Dept Gene & Cell Med, Black Family Stem Cell Inst, 1425 Madison Ave, New York, NY 10029 USA.	gkeller@uhnresearch.ca	Henckaerts, Els/S-2727-2018; Yang, Lei/D-7462-2015	Abbott, Geoffrey/0000-0003-4552-496X; Henckaerts, Els Jeanny V/0000-0002-4624-7856; Keller, Gordon/0000-0001-9309-9297	NHLBI NIH HHS [R01 HL079275, R01 HL083126-03, R01 HL083126] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083126, R01HL079275] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; BRADY G, 1993, METHOD ENZYMOL, V225, P611; Bruneau BG, 1999, DEV BIOL, V211, P100, DOI 10.1006/dbio.1999.9298; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Cai CL, 2005, DEVELOPMENT, V132, P2475, DOI 10.1242/dev.01832; CONLON FL, 1994, DEVELOPMENT, V120, P1919; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; KISPERT A, 1994, DEV BIOL, V161, P179, DOI 10.1006/dbio.1994.1019; KONARZEWSKA H, 1995, CIRCULATION, V92, P1179, DOI 10.1161/01.CIR.92.5.1179; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Leor J, 2007, HEART, V93, P1278, DOI 10.1136/hrt.2006.093161; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Lough J, 1996, DEV BIOL, V178, P198, DOI 10.1006/dbio.1996.0211; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Meyer D, 1997, DEVELOPMENT, V124, P3575; Meyer T, 2004, DRUG SAFETY, V27, P763, DOI 10.2165/00002018-200427110-00002; MIMA T, 1995, P NATL ACAD SCI USA, V92, P467, DOI 10.1073/pnas.92.2.467; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Rubart M, 2007, NAT BIOTECHNOL, V25, P993, DOI 10.1038/nbt0907-993; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; SHIBATA EF, 1989, AM J PHYSIOL, V257, pH1773, DOI 10.1152/ajpheart.1989.257.6.H1773; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028	30	1063	1154	1	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2008	453	7194					524	U6		10.1038/nature06894	http://dx.doi.org/10.1038/nature06894			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303EL	18432194				2022-12-24	WOS:000256023700043
J	Gonzales, R; Corbett, KK; Wirtz, V; Dreser, A				Gonzales, Ralph; Corbett, Kitty K.; Wirtz, Veronika; Dreser, Anahl			Making a difference - Drug resistant infections in poor countries - A shrinking window of opportunity	BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTIMICROBIAL RESISTANCE		[Gonzales, Ralph] Univ Calif San Francisco, Clin & Translat Sci Inst, Multidisciplinary Career Dev Program KL2, San Francisco, CA 94143 USA; [Corbett, Kitty K.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Wirtz, Veronika; Dreser, Anahl] Inst Nacl Salud Publ, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico	University of California System; University of California San Francisco; Simon Fraser University; Instituto Nacional de Salud Publica	Gonzales, R (corresponding author), Univ Calif San Francisco, Clin & Translat Sci Inst, Multidisciplinary Career Dev Program KL2, San Francisco, CA 94143 USA.	ralphg@medicine.ucsf.edu	Wirtz, Veornika/AAG-9712-2019	Wirtz, Veronika J./0000-0002-0863-8768; Dreser, Anahi/0000-0001-9019-2330				Avorn J, 2000, ANN INTERN MED, V133, P128, DOI 10.7326/0003-4819-133-2-200007180-00012; Bavestrello L, 2002, REV MED CHILE, V130, P1265; Byarugaba DK, 2004, INT J ANTIMICROB AG, V24, P105, DOI 10.1016/j.ijantimicag.2004.02.015; Hart CA, 1998, BRIT MED J, V317, P647, DOI 10.1136/bmj.317.7159.647; Okeke IN, 1999, EMERG INFECT DIS, V5, P18, DOI 10.3201/eid0501.990103; Planta MB, 2007, J AM BOARD FAM MED, V20, P533, DOI 10.3122/jabfm.2007.06.070019; SALVATIERRAGONZ.R, 1999, REV PANAM INFECT S1, V3; Shojania KG, 2005, HEALTH AFFAIR, V24, P138, DOI 10.1377/hlthaff.24.1.138; WIRTZ V, 2007, 12 NAT M RES LEON GU; World Health Organization, 2001, WHOCDSCSDRDRS20019, P9	10	5	5	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 26	2008	336	7650					948	+		10.1136/bmj.39534.553044.94	http://dx.doi.org/10.1136/bmj.39534.553044.94			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296KC	18397943	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000255540900036
J	Walsh, T; McClellan, JM; McCarthy, SE; Addington, AM; Pierce, SB; Cooper, GM; Nord, AS; Kusenda, M; Malhotra, D; Bhandari, A; Stray, SM; Rippey, CF; Roccanova, P; Makarov, V; Lakshmi, B; Findling, RL; Sikich, L; Stromberg, T; Merriman, B; Gogtay, N; Butler, P; Eckstrand, K; Noory, L; Gochman, P; Long, R; Chen, ZG; Davis, S; Baker, C; Eichler, EE; Meltzer, PS; Nelson, SF; Singleton, AB; Lee, MK; Rapoport, JL; King, MC; Sebat, J				Walsh, Tom; McClellan, Jon M.; McCarthy, Shane E.; Addington, Anjene M.; Pierce, Sarah B.; Cooper, Greg M.; Nord, Alex S.; Kusenda, Mary; Malhotra, Dheeraj; Bhandari, Abhishek; Stray, Sunday M.; Rippey, Caitlin F.; Roccanova, Patricia; Makarov, Vlad; Lakshmi, B.; Findling, Robert L.; Sikich, Linmarie; Stromberg, Thomas; Merriman, Barry; Gogtay, Nitin; Butler, Philip; Eckstrand, Kristen; Noory, Laila; Gochman, Peter; Long, Robert; Chen, Zugen; Davis, Sean; Baker, Carl; Eichler, Evan E.; Meltzer, Paul S.; Nelson, Stanley F.; Singleton, Andrew B.; Lee, Ming K.; Rapoport, Judith L.; King, Mary-Claire; Sebat, Jonathan			Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia	SCIENCE			English	Article							CHILDHOOD-ONSET SCHIZOPHRENIA; NEURONAL MIGRATION; COMMON DISEASE; NMDA RECEPTOR; SUSCEPTIBILITY; GLUTAMATE; NEUREGULIN; EXPRESSION; NEUROTRANSMITTERS; DIFFERENTIATION	Schizophrenia is a devastating neurodevelopmental disorder whose genetic influences remain elusive. We hypothesize that individually rare structural variants contribute to the illness. Microdeletions and microduplications >100 kilobases were identified by microarray comparative genomic hybridization of genomic DNA from 150 individuals with schizophrenia and 268 ancestry-matched controls. All variants were validated by high- resolution platforms. Novel deletions and duplications of genes were present in 5% of controls versus 15% of cases and 20% of young- onset cases, both highly significant differences. The association was independently replicated in patients with childhood- onset schizophrenia as compared with their parents. Mutations in cases disrupted genes disproportionately from signaling networks controlling neurodevelopment, including neuregulin and glutamate pathways. These results suggest that multiple, individually rare mutations altering genes in neurodevelopmental pathways contribute to schizophrenia.	[McClellan, Jon M.] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; [Walsh, Tom; Pierce, Sarah B.; Stray, Sunday M.; Lee, Ming K.; King, Mary-Claire] Univ Washington, Dept Med, Seattle, WA 98195 USA; [McCarthy, Shane E.; Kusenda, Mary; Malhotra, Dheeraj; Bhandari, Abhishek; Roccanova, Patricia; Makarov, Vlad; Lakshmi, B.; Sebat, Jonathan] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Addington, Anjene M.; Stromberg, Thomas; Gogtay, Nitin; Butler, Philip; Eckstrand, Kristen; Noory, Laila; Gochman, Peter; Long, Robert; Rapoport, Judith L.] NIMH, Child Psychiat Branch, NIH, Bethesda, MD 20892 USA; [Cooper, Greg M.; Nord, Alex S.; Rippey, Caitlin F.; Baker, Carl; Eichler, Evan E.; King, Mary-Claire] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Kusenda, Mary] SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; [Findling, Robert L.] Case Med Ctr, Dept Psychiat, Cleveland, OH 44106 USA; [Sikich, Linmarie] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA; [Merriman, Barry; Chen, Zugen; Nelson, Stanley F.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Davis, Sean; Meltzer, Paul S.] NCI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Singleton, Andrew B.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Cold Spring Harbor Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Washington; University of Washington Seattle; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Case Western Reserve University; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	McClellan, JM (corresponding author), Univ Washington, Dept Psychiat, Seattle, WA 98195 USA.	drjack@u.washington.edu	Gogtay, Nitin/A-3035-2008; Davis, Sean/AAD-1801-2021; Cooper, Gregory/D-6914-2011; Nelson, Stanley F/D-4771-2009; Singleton, Andrew B/C-3010-2009; Eckstrand, Kristen/AAV-4858-2020; Gogtay, Nitin/GRR-1980-2022	Davis, Sean/0000-0002-8991-6458; Cooper, Gregory/0000-0001-5509-9923; Nelson, Stanley F/0000-0002-2082-3114; Eckstrand, Kristen/0000-0002-6506-3649; Pierce, Sarah/0000-0001-6739-7135; Addington, Anjene/0000-0001-7770-299X; Nord, Alexander/0000-0003-4259-7514; Gochman, Peter/0000-0003-0791-3155; Sebat, Jonathan/0000-0002-9087-526X; Walsh, Tom/0000-0002-8875-0310; King, Mary-Claire/0000-0001-9426-1743	Howard Hughes Medical Institute Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; NCRR NIH HHS [RR000046, UL1 RR025014, M01 RR000046, RR025014] Funding Source: Medline; NICHD NIH HHS [HD043569, R01 HD043569] Funding Source: Medline; NIMH NIH HHS [MH061355, U01 MH061464, MH061464, U01 MH061528, MH061528] Funding Source: Medline; NINDS NIH HHS [U24 NS052108, NS052108] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC011091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000949] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Beart PM, 2007, BRIT J PHARMACOL, V150, P5, DOI 10.1038/sj.bjp.0706949; Benzel I, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-31; Bernard-Trifilo JA, 2005, J NEUROCHEM, V93, P834, DOI 10.1111/j.1471-4159.2005.03062.x; Buxbaum JD, 2008, MOL PSYCHIATR, V13, P162, DOI 10.1038/sj.mp.4001991; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Esper RM, 2006, BRAIN RES REV, V51, P161, DOI 10.1016/j.brainresrev.2005.11.006; Friedman JI, 2008, MOL PSYCHIATR, V13, P261, DOI 10.1038/sj.mp.4002049; Friedman JM, 2006, AM J HUM GENET, V79, P500, DOI 10.1086/507471; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; Ghiani CA, 2007, NEUROCHEM RES, V32, P363, DOI 10.1007/s11064-006-9213-9; Giehl KM, 2007, PROG EXP TUMOR RES, V39, P1, DOI 10.1159/000100041; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Heng JIT, 2007, EUR J NEUROSCI, V26, P537, DOI 10.1111/j.1460-9568.2007.05694.x; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Idol JR, 2008, J AUTISM DEV DISORD, V38, P668, DOI 10.1007/s10803-007-0435-8; Kamnasaran D, 2003, J MED GENET, V40, P325, DOI 10.1136/jmg.40.5.325; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Law AJ, 2007, HUM MOL GENET, V16, P129, DOI 10.1093/hmg/ddl449; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Liu H, 2002, P NATL ACAD SCI USA, V99, P16859, DOI 10.1073/pnas.232186099; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; MacIntyre D, 2003, MOL PSYCHIATR, V8, P275, DOI 10.1038/sj.mp.4001232; Makoff A, 1996, MOL BRAIN RES, V40, P165, DOI 10.1016/0169-328X(96)00110-6; Manent JB, 2007, NEUROSCIENTIST, V13, P268, DOI 10.1177/1073858406298918; McClellan JM, 2007, BRIT J PSYCHIAT, V190, P194, DOI 10.1192/bjp.bp.106.025585; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Nedergaard M, 2002, NAT REV NEUROSCI, V3, P748, DOI 10.1038/nrn916; Norton N, 2006, AM J MED GENET B, V141B, P96, DOI 10.1002/ajmg.b.30236; Rapoport J L, 2000, Curr Psychiatry Rep, V2, P410, DOI 10.1007/s11920-000-0024-4; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Sammut S, 2007, J NEUROCHEM, V103, P1145, DOI 10.1111/j.1471-4159.2007.04811.x; Seal JL, 2006, J MED GENET, V43, P887, DOI 10.1136/jmg.2006.043380; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Smith RE, 2001, AM J PSYCHIAT, V158, P1393, DOI 10.1176/appi.ajp.158.9.1393; Sporn A, 2004, MOL PSYCHIATR, V9, P225, DOI 10.1038/sj.mp.4001477; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Wang JQ, 2007, J NEUROCHEM, V100, P1, DOI 10.1111/j.1471-4159.2006.04208.x; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974	42	1307	1354	0	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2008	320	5875					539	543		10.1126/science.1155174	http://dx.doi.org/10.1126/science.1155174			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18369103				2022-12-24	WOS:000255249300053
J	Xing, YN; Li, Z; Chen, Y; Stock, JB; Jeffrey, PD; Shi, YG				Xing, Yongna; Li, Zhu; Chen, Yu; Stock, Jeffry B.; Jeffrey, Philip D.; Shi, Yigong			Structural mechanism of demethylation and inactivation of protein phosphatase 2A	CELL			English	Article							TERMINAL LEUCINE RESIDUE; PP2A CATALYTIC SUBUNIT; CARBOXYL METHYLATION; REGULATORY SUBUNITS; BOVINE BRAIN; A-SUBUNIT; ASSOCIATION; METHYLTRANSFERASE; METHYLESTERASE; ESTERIFICATION	Protein phosphatase 2A (PP2A) is an important serine/ threonine phosphatase that plays a role in many biological processes. Reversible carboxyl methylation of the PP2A catalytic subunit is an essential regulatory mechanism for its function. Demethylation and negative regulation of PP2A is mediated by a PP2A-specific methylesterase PME-1, which is conserved from yeast to humans. However, the underlying mechanism of PME-1 function remains enigmatic. Here we report the crystal structures of PME-1 by itself and in complex with a PP2A heterodimeric core enzyme. The structures reveal that PME-1 directly binds to the active site of PP2A and that this interaction results in the activation of PME-1 by rearranging the catalytic triad into an active conformation. Strikingly, these interactions also lead to inactivation of PP2A by evicting the manganese ions that are required for the phosphatase activity of PP2A. These observations identify a dual role of PME-1 that regulates PP2A activation, methylation, and holoenzyme assembly in cells.	[Xing, Yongna; Li, Zhu; Chen, Yu; Stock, Jeffry B.; Jeffrey, Philip D.; Shi, Yigong] Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Shi, YG (corresponding author), Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA.	ygshi@princeton.edu		Jeffrey, Philip/0000-0002-4351-5341; Li, Zhu/0000-0003-1536-9401; Shi, Yigong/0000-0003-2030-168X	NATIONAL CANCER INSTITUTE [R01CA123155, K01CA124856] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA123155, K01 CA124856] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arroyo JD, 2005, ONCOGENE, V24, P7746, DOI 10.1038/sj.onc.1209038; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; Chen Y, 2007, NAT STRUCT MOL BIOL, V14, P527, DOI 10.1038/nsmb1254; Cho US, 2007, PLOS BIOL, V5, P1810, DOI 10.1371/journal.pbio.0050202; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Chung HY, 1999, BIOCHEMISTRY-US, V38, P10371, DOI 10.1021/bi990902g; De Baere I, 1999, BIOCHEMISTRY-US, V38, P16539, DOI 10.1021/bi991646a; Fellner T, 2003, GENE DEV, V17, P2138, DOI 10.1101/gad.259903; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; HENDRICKSON WA, 1988, PROTEINS, V4, P77, DOI 10.1002/prot.340040202; Hombauer H, 2007, PLOS BIOL, V5, P1355, DOI 10.1371/journal.pbio.0050155; Ikehara T, 2007, BIOCHEM BIOPH RES CO, V354, P1052, DOI 10.1016/j.bbrc.2007.01.085; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kloeker S, 1997, BIOCHEM J, V327, P481, DOI 10.1042/bj3270481; Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; LEE J, 1993, J BIOL CHEM, V268, P19192; Lee J, 1996, P NATL ACAD SCI USA, V93, P6043, DOI 10.1073/pnas.93.12.6043; Lee JA, 2007, J BIOL CHEM, V282, P30974, DOI 10.1074/jbc.M704861200; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Longin S, 2004, BIOCHEM J, V380, P111, DOI 10.1042/BJ20031643; Longin S, 2008, EXP CELL RES, V314, P68, DOI 10.1016/j.yexcr.2007.07.030; Longin S, 2007, J BIOL CHEM, V282, P26971, DOI 10.1074/jbc.M704059200; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mumby M., 2001, SCI STKE, pe1; Ogris E, 1999, J BIOL CHEM, V274, P14382, DOI 10.1074/jbc.274.20.14382; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; RUEDIGER R, 1994, J VIROL, V68, P123, DOI 10.1128/JVI.68.1.123-129.1994; RUEDIGER R, 1992, MOL CELL BIOL, V12, P4872, DOI 10.1128/MCB.12.11.4872; Schonthal AH, 2001, CANCER LETT, V170, P1, DOI 10.1016/S0304-3835(01)00561-4; SHELDRICK G, 1991, PATTERSON INTERPRETA; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P1080, DOI 10.1093/jnen/63.10.1080; Sontag E, 2007, J NEUROSCI, V27, P2751, DOI 10.1523/JNEUROSCI.3316-06.2007; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; TUROWSKI P, 1995, J CELL BIOL, V129, P397, DOI 10.1083/jcb.129.2.397; Vafai SB, 2002, FEBS LETT, V518, P1, DOI 10.1016/S0014-5793(02)02702-3; Van Hoof C, 2004, CANCER CELL, V5, P105, DOI 10.1016/S1535-6108(04)00027-3; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; XIE HY, 1994, BIOCHEM BIOPH RES CO, V203, P1710, DOI 10.1006/bbrc.1994.2383; XIE HY, 1993, J BIOL CHEM, V268, P13364; XIE HY, 1994, J BIOL CHEM, V269, P1981; Xing Y, 2006, CELL, V127, P341, DOI 10.1016/j.cell.2006.09.025; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yu H, 2007, P NATL ACAD SCI USA, V104, P17245, DOI 10.1073/pnas.0708582104; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185	52	139	155	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 4	2008	133	1					154	163		10.1016/j.cell.2008.02.041	http://dx.doi.org/10.1016/j.cell.2008.02.041			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	283MW	18394995	Bronze			2022-12-24	WOS:000254641300016
J	Li, W; Howard, JD; Parrish, TB; Gottfried, JA				Li, Wen; Howard, James D.; Parrish, Todd B.; Gottfried, Jay A.			Aversive learning enhances perceptual and cortical discrimination of indiscriminable odor cues	SCIENCE			English	Article							HUMAN AUDITORY-CORTEX; PIRIFORM CORTEX; ORBITOFRONTAL CORTEX; OLFACTORY CORTEX; PLASTICITY; AMYGDALA; REPRESENTATIONS; ENANTIOMERS; MODULATION; MECHANISMS	Learning to associate sensory cues with threats is critical for minimizing aversive experience. The ecological benefit of associative learning relies on accurate perception of predictive cues, but how aversive learning enhances perceptual acuity of sensory signals, particularly in humans, is unclear. We combined multivariate functional magnetic resonance imaging with olfactory psychophysics to show that initially indistinguishable odor enantiomers ( mirror- image molecules) become discriminable after aversive conditioning, paralleling the spatial divergence of ensemble activity patterns in primary olfactory ( piriform) cortex. Our findings indicate that aversive learning induces piriform plasticity with corresponding gains in odor enantiomer discrimination, underscoring the capacity of fear conditioning to update perceptual representation of predictive cues, over and above its well- recognized role in the acquisition of conditioned responses. That completely indiscriminable sensations can be transformed into discriminable percepts further accentuates the potency of associative learning to enhance sensory cue perception and support adaptive behavior.	[Li, Wen; Howard, James D.; Parrish, Todd B.; Gottfried, Jay A.] Northwestern Univ, Feinberg Sch Med, Cognit Neurol & Alzheimers Dis Ctr, Chicago, IL 60611 USA; [Parrish, Todd B.] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA; [Gottfried, Jay A.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Gottfried, Jay A.] Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University	Li, W (corresponding author), Northwestern Univ, Feinberg Sch Med, Cognit Neurol & Alzheimers Dis Ctr, Chicago, IL 60611 USA.	wenli@northwestern.edu	Li, Wen/AAU-8505-2020	Parrish, Todd/0000-0002-1184-1572	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K08DC007653] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC007653, K08 DC007653-03, K08 DC007653] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Balleine BW, 2005, PHYSIOL BEHAV, V86, P717, DOI 10.1016/j.physbeh.2005.08.061; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Edeline JM, 1999, PROG NEUROBIOL, V57, P165, DOI 10.1016/S0301-0082(98)00042-2; Everitt B.J., 2000, AMYGDALA FUNCTIONAL, P353; Gottfried JA, 2006, NEURON, V49, P467, DOI 10.1016/j.neuron.2006.01.007; Haberly L. B., 1998, SYNAPTIC ORG BRAIN; Hall G, 2003, Q J EXP PSYCHOL-B, V56, P43, DOI 10.1080/02724990244000151; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Holland PC, 2004, CURR OPIN NEUROBIOL, V14, P148, DOI 10.1016/j.conb.2004.03.007; Illig KR, 2005, J COMP NEUROL, V488, P224, DOI 10.1002/cne.20595; Kadohisa M, 2006, P NATL ACAD SCI USA, V103, P15206, DOI 10.1073/pnas.0604313103; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; Laska M, 1999, CHEM SENSES, V24, P161, DOI 10.1093/chemse/24.2.161; Li W, 2006, NEURON, V52, P1097, DOI 10.1016/j.neuron.2006.10.026; Linster C, 2001, J NEUROSCI, V21, P9837, DOI 10.1523/JNEUROSCI.21-24-09837.2001; McLaren IPL, 2000, ANIM LEARN BEHAV, V28, P211, DOI 10.3758/BF03200258; Morris JS, 1998, P ROY SOC B-BIOL SCI, V265, P649, DOI 10.1098/rspb.1998.0343; Ohl FW, 2005, CURR OPIN NEUROBIOL, V15, P470, DOI 10.1016/j.conb.2005.07.002; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Polley DB, 2004, P NATL ACAD SCI USA, V101, P16351, DOI 10.1073/pnas.0407586101; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Weinberger NM, 2007, LEARN MEMORY, V14, P1, DOI 10.1101/lm.421807; Wilson D. A., 2006, LEARNING SMELL; Zelano C, 2005, NAT NEUROSCI, V8, P114, DOI 10.1038/nn1368; Zou ZH, 2005, P NATL ACAD SCI USA, V102, P7724, DOI 10.1073/pnas.0503027102	26	228	231	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 28	2008	319	5871					1842	1845		10.1126/science.1152837	http://dx.doi.org/10.1126/science.1152837			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279ZF	18369149	Green Accepted			2022-12-24	WOS:000254394000051
J	Sylantyev, S; Savtchenko, LP; Niu, YP; Ivanov, AI; Jensen, TP; Kullmann, DM; Xiao, MY; Rusakov, DA				Sylantyev, Sergiy; Savtchenko, Leonid P.; Niu, Yin-Ping; Ivanov, Anton I.; Jensen, Thomas P.; Kullmann, Dimitri M.; Xiao, Min-Yi; Rusakov, Dmitri A.			Electric fields due to synaptic currents sharpen excitatory transmission	SCIENCE			English	Article							CA1 PYRAMIDAL NEURONS; RAT HIPPOCAMPAL SLICES; MULTIVESICULAR RELEASE; PERFORANT PATH; TIME COURSE; SYNAPSES; GLUTAMATE; CLEFT; CELLS; EPSCS	The synaptic response waveform, which determines signal integration properties in the brain, depends on the spatiotemporal profile of neurotransmitter in the synaptic cleft. Here, we show that electrophoretic interactions between AMPA receptor- mediated excitatory currents and negatively charged glutamate molecules accelerate the clearance of glutamate from the synaptic cleft, speeding up synaptic responses. This phenomenon is reversed upon depolarization and diminished when intracleft electric fields are weakened through a decrease in the AMPA receptor density. In contrast, the kinetics of receptor- mediated currents evoked by direct application of glutamate are voltage- independent, as are synaptic currents mediated by the electrically neutral neurotransmitter GABA. Voltage- dependent temporal tuning of excitatory synaptic responses may thus contribute to signal integration in neural circuits.	[Sylantyev, Sergiy; Savtchenko, Leonid P.; Jensen, Thomas P.; Kullmann, Dimitri M.; Rusakov, Dmitri A.] UCL, Inst Neurol, London WC1N 3BG, England; [Savtchenko, Leonid P.] Dnepropetrovsk Natl Univ, Lab Biophys & Bioelect, Dnepropetrovsk, Ukraine; [Niu, Yin-Ping; Xiao, Min-Yi] Gothenburg Univ, Inst Neurosci & Physiol, Gothenburg, Sweden; [Ivanov, Anton I.] INSERM, INMED, U29, F-13258 Marseille, France	University of London; University College London; Ministry of Education & Science of Ukraine; Oles Honchar Dnipro National University; University of Gothenburg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Rusakov, DA (corresponding author), UCL, Inst Neurol, Queen Sq, London WC1N 3BG, England.	d.rusakov@ion.ucl.ac.uk	Kullmann, Dimitri M/A-3162-2009; Rusakov, Dmitri A/E-1987-2011; Rusakov, Dmitri/AAH-4529-2021	Kullmann, Dimitri M/0000-0001-6696-3545; Rusakov, Dmitri A/0000-0001-9539-9947; Rusakov, Dmitri/0000-0001-9539-9947; Jensen, Thomas/0000-0002-2560-6784; Ivanov, Anton/0000-0002-8650-6322; Sylantyev, Sergiy/0000-0002-1358-0601	Medical Research Council [G0400627(76527), G0400627, G0400627(71256), G0600368(77987), G0600368, G116/147] Funding Source: Medline; Wellcome Trust [071179] Funding Source: Medline; MRC [G0600368, G0400627, G116/147] Funding Source: UKRI; Medical Research Council [G0601943B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Andrasfalvy BK, 2001, J NEUROSCI, V21, P9151, DOI 10.1523/JNEUROSCI.21-23-09151.2001; Arnth-Jensen N, 2002, NAT NEUROSCI, V5, P325, DOI 10.1038/nn825; Cathala L, 2005, NAT NEUROSCI, V8, P1310, DOI 10.1038/nn1534; Christie JM, 2006, J NEUROSCI, V26, P210, DOI 10.1523/JNEUROSCI.4307-05.2006; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; ECCLES JC, 1958, PROC R SOC SER B-BIO, V148, P38, DOI 10.1098/rspb.1958.0003; Franks KM, 2002, BIOPHYS J, V83, P2333, DOI 10.1016/S0006-3495(02)75248-X; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; KNEISLER TB, 1995, HIPPOCAMPUS, V5, P151, DOI 10.1002/hipo.450050302; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P151, DOI 10.1113/jphysiol.1972.sp009839; MCBAIN C, 1992, J NEUROPHYSIOL, V68, P16, DOI 10.1152/jn.1992.68.1.16; Migliore M, 2003, J COMPUT NEUROSCI, V14, P185, DOI 10.1023/A:1021906818333; Nicholson DA, 2006, NEURON, V50, P431, DOI 10.1016/j.neuron.2006.03.022; Nielsen TA, 2004, NEURON, V42, P757, DOI 10.1016/j.neuron.2004.04.003; Raghavachari S, 2004, J NEUROPHYSIOL, V92, P2456, DOI 10.1152/jn.00258.2004; Raman IM, 1995, BIOPHYS J, V69, P1868, DOI 10.1016/S0006-3495(95)80057-3; Savtchenko LP, 2007, P NATL ACAD SCI USA, V104, P1823, DOI 10.1073/pnas.0606636104; Savtchenko LP, 2000, BIOPHYS J, V78, P1119, DOI 10.1016/S0006-3495(00)76670-7; Scimemi A, 2004, J NEUROSCI, V24, P4767, DOI 10.1523/JNEUROSCI.0364-04.2004; TAKEUCHI A, 1959, J NEUROPHYSIOL, V22, P395, DOI 10.1152/jn.1959.22.4.395; Veruki ML, 2003, J PHYSIOL-LONDON, V549, P759, DOI 10.1113/jphysiol.2003.039982; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3	27	57	57	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 28	2008	319	5871					1845	1849		10.1126/science.1154330	http://dx.doi.org/10.1126/science.1154330			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279ZF	18369150	Green Accepted			2022-12-24	WOS:000254394000052
J	Guelen, L; Pagie, L; Brasset, E; Meuleman, W; Faza, MB; Talhout, W; Eussen, BH; de Klein, A; Wessels, L; de Laat, W; van Steensel, B				Guelen, Lars; Pagie, Ludo; Brasset, Emilie; Meuleman, Wouter; Faza, Marius B.; Talhout, Wendy; Eussen, Bert H.; de Klein, Annelies; Wessels, Lodewyk; de Laat, Wouter; van Steensel, Bas			Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions	NATURE			English	Article							GENE-EXPRESSION; MEMBRANE PROTEIN; HUMAN GENOME; CELLS; ARCHITECTURE; LOCALIZATION; EMERIN; TRANSCRIPTION; MECHANISMS; PERIPHERY	The architecture of human chromosomes in interphase nuclei is still largely unknown. Microscopy studies have indicated that specific regions of chromosomes are located in close proximity to the nuclear lamina (NL)(1-3). This has led to the idea that certain genomic elements may be attached to the NL, which may contribute to the spatial organization of chromosomes inside the nucleus. However, sequences in the human genome that interact with the NL in vivo have not been identified. Here we construct a high-resolution map of the interaction sites of the entire genome with NL components in human fibroblasts. This map shows that genome - lamina interactions occur through more than 1,300 sharply defined large domains 0.1 - 10 megabases in size. These lamina-associated domains ( LADs) are typified by low gene- expression levels, indicating that LADs represent a repressive chromatin environment. The borders of LADs are demarcated by the insulator protein CTCF, by promoters that are oriented away from LADs, or by CpG islands, suggesting possible mechanisms of LAD confinement. Taken together, these results demonstrate that the human genome is divided into large, discrete domains that are units of chromosome organization within the nucleus.	[Guelen, Lars; Pagie, Ludo; Meuleman, Wouter; Faza, Marius B.; Talhout, Wendy; Wessels, Lodewyk; van Steensel, Bas] Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands; [Brasset, Emilie; de Laat, Wouter] Erasmus MC, Dept Cell Biol & Genet, NL-3000 CA Rotterdam, Netherlands; [Eussen, Bert H.; de Klein, Annelies] Erasmus MC, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; [Meuleman, Wouter; Wessels, Lodewyk] Delft Univ Technol, Fac Elect Engn Math & Comp Sci, NL-2628 CD Delft, Netherlands	Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Delft University of Technology	van Steensel, B (corresponding author), Netherlands Canc Inst, Div Mol Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	b.v.steensel@nki.nl	Brasset, Emilie/J-6684-2015	Meuleman, Wouter/0000-0002-1196-5401; Brasset, Emilie/0000-0003-2479-7969; de Laat, Wouter/0000-0002-6393-595X				Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Bengtsson L, 2004, CURR OPIN CELL BIOL, V16, P73, DOI 10.1016/j.ceb.2003.11.012; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bridger JM, 2000, CURR BIOL, V10, P149, DOI 10.1016/S0960-9822(00)00312-2; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gilchrist Susan, 2004, Chromosome Res, V12, P505; Goetze S, 2007, MOL CELL BIOL, V27, P4475, DOI 10.1128/MCB.00208-07; Imai S, 1997, MOL BIOL CELL, V8, P2407, DOI 10.1091/mbc.8.12.2407; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lenhard B, 2002, BIOINFORMATICS, V18, P1135, DOI 10.1093/bioinformatics/18.8.1135; Manilal S, 1996, HUM MOL GENET, V5, P801, DOI 10.1093/hmg/5.6.801; Masny PS, 2004, HUM MOL GENET, V13, P1857, DOI 10.1093/hmg/ddh205; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Murmann AE, 2005, EXP CELL RES, V311, P14, DOI 10.1016/j.yexcr.2005.07.020; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Parada LA, 2003, TRENDS CELL BIOL, V13, P393, DOI 10.1016/S0962-8924(03)00149-1; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Solovei I, 2002, EXP CELL RES, V276, P10, DOI 10.1006/excr.2002.5513; Taddei A, 2004, ANNU REV GENET, V38, P305, DOI 10.1146/annurev.genet.37.110801.142705; VANSTEENSEL B, 1995, J CELL SCI, V108, P3003; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wiblin AE, 2005, J CELL SCI, V118, P3861, DOI 10.1242/jcs.02500; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2	35	1278	1307	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2008	453	7197					948	U83		10.1038/nature06947	http://dx.doi.org/10.1038/nature06947			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311WV	18463634				2022-12-24	WOS:000256632000050
J	Fuller, PM; Lu, J; Saper, CB				Fuller, Patrick M.; Lu, Jun; Saper, Clifford B.			Differential rescue of light- and food-entrainable circadian rhythms	SCIENCE			English	Article							DORSOMEDIAL HYPOTHALAMIC NUCLEUS; CLOCK PROTEIN; BMAL1; OSCILLATORS; ENTRAINMENT; PACEMAKER; COMPONENT; LESIONS; SLEEP; BRAIN	When food is plentiful, circadian rhythms of animals are powerfully entrained by the light- dark cycle. However, if animals have access to food only during their normal sleep cycle, they will shift most of their circadian rhythms to match the food availability. We studied the basis for entrainment of circadian rhythms by food and light in mice with targeted disruption of the clock gene Bmal1, which lack circadian rhythmicity. Injection of a viral vector containing the Bmal1 gene into the suprachiasmatic nuclei of the hypothalamus restored light- entrainable, but not food- entrainable, circadian rhythms. In contrast, restoration of the Bmal1 gene only in the dorsomedial hypothalamic nucleus restored the ability of animals to entrain to food but not to light. These results demonstrate that the dorsomedial hypothalamus contains a Bmal1- based oscillator that can drive food entrainment of circadian rhythms.	[Fuller, Patrick M.; Lu, Jun; Saper, Clifford B.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol,Div Sleep Med, Boston, MA 02215 USA; [Fuller, Patrick M.; Lu, Jun; Saper, Clifford B.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Program Neurosci, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Saper, CB (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol,Div Sleep Med, Boston, MA 02215 USA.	csaper@bidmc.harvard.edu	Saper, Clifford/L-3815-2019		NHLBI NIH HHS [T32 HL007901, HL07901-08, P50 HL060292-08, HL60292, P50 HL060292] Funding Source: Medline; NINDS NIH HHS [NS33987, R01 NS051609, F32 NS057119, NS057119, NS051609, R01 NS033987, R01 NS033987-11] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060292, T32HL007901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS057119, R01NS051609, R01NS033987] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Bunger MK, 2005, GENESIS, V41, P122, DOI 10.1002/gene.20102; Chou TC, 2003, J NEUROSCI, V23, P10691; COOLEY JJ, 2008, J BIOL RHYTHM, V22, P479; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; FULLER CA, 1981, AM J PHYSIOL, V241, P5; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gooley JJ, 2006, NAT NEUROSCI, V9, P398, DOI 10.1038/nn1651; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; HIROSHIGE T, 1991, BRAIN RES BULL, V27, P441, DOI 10.1016/0361-9230(91)90139-B; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; KRIEGER DT, 1977, SCIENCE, V197, P398, DOI 10.1126/science.877566; LANDRY GJ, 2006, AM J PHYSIOL, V290, P6; Laposky A, 2005, SLEEP, V28, P395, DOI 10.1093/sleep/28.4.395; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430; Mieda M, 2006, P NATL ACAD SCI USA, V103, P12150, DOI 10.1073/pnas.0604189103; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Saper CB, 2005, TRENDS NEUROSCI, V28, P152, DOI 10.1016/j.tins.2004.12.009; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P346, DOI 10.1016/S0163-1047(79)90415-1; STEPHAN FK, 1989, PHYSIOL BEHAV, V46, P489, DOI 10.1016/0031-9384(89)90026-7; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Thompson RH, 1998, BRAIN RES REV, V27, P89, DOI 10.1016/S0165-0173(98)00010-1; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	25	187	191	3	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2008	320	5879					1074	1077		10.1126/science.1153277	http://dx.doi.org/10.1126/science.1153277			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303RY	18497298	Green Accepted			2022-12-24	WOS:000256059800045
J	Roussel, EG; Cambon-Bonavita, MA; Querellou, J; Cragg, BA; Webster, G; Prieur, D; Parkes, RJ				Roussel, Erwan G.; Cambon-Bonavita, Marie-Anne; Querellou, Joel; Cragg, Barry A.; Webster, Gordon; Prieur, Daniel; Parkes, R. John			Extending the sub-sea-floor biosphere	SCIENCE			English	Article							PACIFIC-OCEAN; SEDIMENTS; DEEP; TEMPERATURE; BASIN		[Cragg, Barry A.; Webster, Gordon; Parkes, R. John] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3YE, Wales; [Roussel, Erwan G.; Cambon-Bonavita, Marie-Anne; Querellou, Joel; Prieur, Daniel] Univ Bretagne Occidentale, IFREMER, Ctr Brest, Lab Microbiol Environn Extremes,UMR 6197, F-29280 Plouzane, France	Cardiff University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale	Parkes, RJ (corresponding author), Cardiff Univ, Sch Earth & Ocean Sci, Main Bldg,Park Pl, Cardiff CF10 3YE, Wales.	J.Parkes@earth.cf.ac.uk	QUERELLOU, JOEL/E-9747-2010; Parkes, Ronald/B-1731-2010; Roussel, Erwan G/B-9992-2009; Cragg, Barry/D-2690-2009; Webster, Gordon/A-1877-2008	Parkes, Ronald/0000-0001-9402-5943; Roussel, Erwan G/0000-0002-8735-5597; Webster, Gordon/0000-0002-9530-7835; Cambon-Bonavita, Marie-Anne/0000-0002-4076-0472				Kallmeyer J, 2004, APPL ENVIRON MICROB, V70, P1231, DOI 10.1128/AEM.70.2.1231-1233.2004; Parkes RJ, 2007, ORG GEOCHEM, V38, P845, DOI 10.1016/j.orggeochem.2006.12.011; PARKES RJ, 1994, NATURE, V371, P410, DOI 10.1038/371410a0; Tucholke B.E., 2004, PROC OCEAN DRILL SCI, V210, DOI [10.2973/odp.proc.ir.210.2004, DOI 10.2973/ODP.PROC.IR.210.2004]; Wellsbury P, 2002, FEMS MICROBIOL ECOL, V42, P59, DOI 10.1111/j.1574-6941.2002.tb00995.x; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	6	141	152	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 23	2008	320	5879					1046	1046		10.1126/science.1154545	http://dx.doi.org/10.1126/science.1154545			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303RY	18497290	Green Published			2022-12-24	WOS:000256059800036
J	Guler, AD; Ecker, JL; Lall, GS; Haq, S; Altimus, CM; Liao, HW; Barnard, AR; Cahill, H; Badea, TC; Zhao, HQ; Hankins, MW; Berson, DM; Lucas, RJ; Yau, KW; Hattar, S				Gueler, Ali D.; Ecker, Jennifer L.; Lall, Gurprit S.; Haq, Shafiqul; Altimus, Cara M.; Liao, Hsi-Wen; Barnard, Alun R.; Cahill, Hugh; Badea, Tudor C.; Zhao, Haiqing; Hankins, Mark W.; Berson, David M.; Lucas, Robert J.; Yau, King-Wai; Hattar, Samer			Melanopsin cells are the principal conduits for rod-cone input to non-image-forming vision	NATURE			English	Article							RETINAL GANGLION-CELLS; RESPONSES; PROJECTIONS; LIGHT	Rod and cone photoreceptors detect light and relay this information through a multisynaptic pathway to the brain by means of retinal ganglion cells (RGCs)(1). These retinal outputs support not only pattern vision but also non- image- forming ( NIF) functions, which include circadian photoentrainment and pupillary light reflex ( PLR). In mammals, NIF functions are mediated by rods, cones and the melanopsin- containing intrinsically photosensitive retinal ganglion cells (ipRGCs)(2,3). Rod - cone photoreceptors and ipRGCs are complementary in signalling light intensity for NIF functions(4-12). The ipRGCs, in addition to being directly photosensitive, also receive synaptic input from rod - cone networks(13,14). To determine how the ipRGCs relay rod - cone light information for both image- forming and non- image- forming functions, we genetically ablated ipRGCs in mice. Here we show that animals lacking ipRGCs retain pattern vision but have deficits in both PLR and circadian photoentrainment that are more extensive than those observed in melanopsin knockouts(8,10,11). The defects in PLR and photoentrainment resemble those observed in animals that lack phototransduction in all three photoreceptor classes(6). These results indicate that light signals for irradiance detection are dissociated from pattern vision at the retinal ganglion cell level, and animals that cannot detect light for NIF functions are still capable of image formation.	[Gueler, Ali D.; Ecker, Jennifer L.; Altimus, Cara M.; Zhao, Haiqing; Hattar, Samer] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Lall, Gurprit S.; Barnard, Alun R.; Lucas, Robert J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Haq, Shafiqul; Liao, Hsi-Wen; Cahill, Hugh; Yau, King-Wai] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Hankins, Mark W.] Univ Oxford, Oxford OX3 7BN, England; [Berson, David M.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Johns Hopkins University; University of Manchester; Johns Hopkins University; University of Oxford; Brown University	Hattar, S (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	robert.lucas@manchester.ac.uk; shattar@jhu.edu	Hattar, Samer/W-6927-2019; Badea, Tudor Constantin/B-1654-2018	Badea, Tudor Constantin/0000-0003-3086-6713; Lall, Gurprit/0000-0003-3725-4795; Guler, Ali Deniz/0000-0001-8218-850X; Lucas, Robert/0000-0002-1088-8029	NEI NIH HHS [R01 EY006837, R01 EY014596-01, R01 EY014596-03, R01 EY014596-06, R01 EY014596-04, R01 EY006837-21, R01 EY014596-02, R01 EY006837-20A1, R01 EY006837-18, R01 EY014596-05, R01 EY006837-16A1, R01 EY017137, R01 EY014596] Funding Source: Medline; NIDCD NIH HHS [R01 DC006904-04, R01 DC006904, R01 DC006904-02, R01 DC006904-03, R01 DC006904-01] Funding Source: Medline; NIGMS NIH HHS [R01 GM076430-01, R01 GM076430-04, R01 GM076430-02, R01 GM076430, R01 GM076430-05, R01 GM076430-03] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY006837, R01EY014596, R01EY017137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006904] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		[Anonymous], 1988, EYE BRAIN VISION; Barnard AR, 2006, CURR BIOL, V16, P389, DOI 10.1016/j.cub.2005.12.045; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; CZEISLER CA, 1995, NEW ENGL J MED, V332, P6, DOI 10.1056/NEJM199501053320102; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Hannibal J, 2004, CELL TISSUE RES, V316, P99, DOI 10.1007/s00441-004-0858-x; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Iwakabe H, 1997, NEUROPHARMACOLOGY, V36, P135, DOI 10.1016/S0028-3908(96)00167-0; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; MAXWELL F, 1987, MOL CELL BIOL, V7, P1576, DOI 10.1128/MCB.7.4.1576; Morin LP, 2003, J COMP NEUROL, V465, P401, DOI 10.1002/cne.10881; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Sollars PJ, 2003, VISUAL NEUROSCI, V20, P601, DOI 10.1017/S0952523803206027; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wee R, 2002, J NEUROSCI, V22, P10427; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751	26	577	591	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2008	453	7191					102	+		10.1038/nature06829	http://dx.doi.org/10.1038/nature06829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294ID	18432195	Green Accepted			2022-12-24	WOS:000255398800047
J	Lakatos, P; Karmos, G; Mehta, AD; Ulbert, I; Schroeder, CE				Lakatos, Peter; Karmos, George; Mehta, Ashesh D.; Ulbert, Istvan; Schroeder, Charles E.			Entrainment of neuronal oscillations as a mechanism of attentional selection	SCIENCE			English	Article							AUDITORY-CORTEX; EVOKED-POTENTIALS; VISUAL-CORTEX; SYNCHRONIZATION; MODULATION; FREQUENCY; SEARCH; BRAIN; POWER; V1	Whereas gamma- band neuronal oscillations clearly appear integral to visual attention, the role of lower- frequency oscillations is still being debated. Mounting evidence indicates that a key functional property of these oscillations is the rhythmic shifting of excitability in local neuronal ensembles. Here, we show that when attended stimuli are in a rhythmic stream, delta- band oscillations in the primary visual cortex entrain to the rhythm of the stream, resulting in increased response gain for task- relevant events and decreased reaction times. Because of hierarchical cross- frequency coupling, delta phase also determines momentary power in higher- frequency activity. These instrumental functions of low- frequency oscillations support a conceptual framework that integrates numerous earlier findings.	[Lakatos, Peter; Schroeder, Charles E.] Nathan S Kline Inst Psychiat Res, Cognit Neurosci & Schizophrenia Program, Orangeburg, NY 10962 USA; [Lakatos, Peter; Karmos, George; Ulbert, Istvan] Hungarian Acad Sci, Inst Psychol, H-1394 Budapest, Hungary; [Karmos, George; Ulbert, Istvan] Peter Pazmany Catholic Univ, Fac Informat Technol, H-1083 Budapest, Hungary; [Mehta, Ashesh D.] Long Isl Jewish Med Ctr, Comprehens Epilepsy Ctr, New Hyde Pk, NY 11040 USA; [Schroeder, Charles E.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA	Nathan Kline Institute for Psychiatric Research; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Northwell Health; Columbia University	Schroeder, CE (corresponding author), Nathan S Kline Inst Psychiat Res, Cognit Neurosci & Schizophrenia Program, Orangeburg, NY 10962 USA.	schrod@nki.rfmh.org	Ulbert, Istvan/F-2213-2010	Lakatos, Peter/0000-0003-0221-4021	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060358] Funding Source: NIH RePORTER; NIMH NIH HHS [MH060358] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Brosch M, 2005, J NEUROSCI, V25, P6797, DOI 10.1523/JNEUROSCI.1571-05.2005; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Ding J, 2006, CEREB CORTEX, V16, P1016, DOI 10.1093/cercor/bhj044; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fell J, 2003, BRAIN RES REV, V42, P265, DOI 10.1016/S0165-0173(03)00178-4; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2003, TRENDS NEUROSCI, V26, P123, DOI 10.1016/S0166-2236(03)00023-7; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; GALAMBOS R, 1981, P NATL ACAD SCI-BIOL, V78, P2643, DOI 10.1073/pnas.78.4.2643; Jack AI, 2006, NEURON, V51, P135, DOI 10.1016/j.neuron.2006.06.003; Kim YJ, 2007, NAT NEUROSCI, V10, P117, DOI 10.1038/nn1821; KLEIN R, 1988, NATURE, V334, P430, DOI 10.1038/334430a0; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Mehta SD, 2000, CEREB CORTEX, V10, P343, DOI 10.1093/cercor/10.4.343; Miniussi C, 1999, BRAIN, V122, P1507, DOI 10.1093/brain/122.8.1507; Morgan ST, 1996, P NATL ACAD SCI USA, V93, P4770, DOI 10.1073/pnas.93.10.4770; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; REGAN D, 1977, J OPT SOC AM, V67, P1475, DOI 10.1364/JOSA.67.001475; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]	27	1089	1102	3	156	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2008	320	5872					110	113		10.1126/science.1154735	http://dx.doi.org/10.1126/science.1154735			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283JR	18388295				2022-12-24	WOS:000254633000043
J	Eliades, SJ; Wang, XQ				Eliades, Steven J.; Wang, Xiaoqin			Neural substrates of vocalization feedback monitoring in primate auditory cortex	NATURE			English	Article							SPEECH PRODUCTION; RESPONSES; VOICE; SCHIZOPHRENIA; MODULATION; MARMOSETS; MONKEY; SIGN; FMRI	Vocal communication involves both speaking and hearing, often taking place concurrently. Vocal production, including human speech and animal vocalization, poses a number of unique challenges for the auditory system. It is important for the auditory system to monitor external sounds continuously from the acoustic environment during speaking despite the potential for sensory masking by self-generated sounds(1). It is also essential for the auditory system to monitor feedback of one's own voice. This self-monitoring may play a part in distinguishing between self-generated or externally generated(2,3) auditory inputs and in detecting errors in our vocal production(4). Previous work in humans(5-10) and other animals(11-13) has demonstrated that the auditory cortex is largely suppressed during speaking or vocalizing. Despite the importance of self-monitoring, the underlying neural mechanisms in the mammalian brain, in particular the role of vocalization-induced suppression, remain virtually unknown. Here we show that neurons in the auditory cortex of marmoset monkeys (Callithrix jacchus) are sensitive to auditory feedback during vocal production, and that changes in the feedback alter the coding properties of these neurons. Furthermore, we found that the previously described cortical suppression during vocalization actually increased the sensitivity of these neurons to vocal feedback. This heightened sensitivity to vocal feedback suggests that these neurons may have an important role in auditory self-monitoring.	[Eliades, Steven J.; Wang, Xiaoqin] Johns Hopkins Univ, Sch Med, Lab Auditory Neurophysiol, Dept Biomed Engn, Baltimore, MD 21205 USA	Johns Hopkins University	Eliades, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Lab Auditory Neurophysiol, Dept Biomed Engn, Baltimore, MD 21205 USA.	seliades@jhu.edu; xiaoqin.wang@jhu.edu		Eliades, Steven/0000-0002-6503-2252				Brumm H, 2004, J EXP BIOL, V207, P443, DOI 10.1242/jeb.00768; Burnett TA, 1998, J ACOUST SOC AM, V103, P3153, DOI 10.1121/1.423073; CREUTZFELDT O, 1989, EXP BRAIN RES, V77, P476, DOI 10.1007/BF00249601; Crone NE, 2001, NEUROLOGY, V57, P2045, DOI 10.1212/WNL.57.11.2045; Curio G, 2000, HUM BRAIN MAPP, V9, P183, DOI 10.1002/(SICI)1097-0193(200004)9:4<183::AID-HBM1>3.0.CO;2-Z; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Eliades SJ, 2005, CEREB CORTEX, V15, P1510, DOI 10.1093/cercor/bhi030; Eliades SJ, 2003, J NEUROPHYSIOL, V89, P2194, DOI 10.1152/jn.00627.2002; Ford JM, 2001, AM J PSYCHIAT, V158, P2069, DOI 10.1176/appi.ajp.158.12.2069; FRITH C. D., 1992, COGNITIVE NEUROPSYCH; Fu CHY, 2006, CEREB CORTEX, V16, P969, DOI 10.1093/cercor/bhj039; Hashimoto Y, 2003, HUM BRAIN MAPP, V20, P22, DOI 10.1002/hbm.10119; Heinks-Maldonado TH, 2005, PSYCHOPHYSIOLOGY, V42, P180, DOI 10.1111/j.1469-8986.2005.00272.x; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; Houde JF, 1998, SCIENCE, V279, P1213, DOI 10.1126/science.279.5354.1213; Houde JF, 2002, J COGNITIVE NEUROSCI, V14, P1125, DOI 10.1162/089892902760807140; Johns LC, 2001, PSYCHOL MED, V31, P705, DOI 10.1017/S0033291701003774; LANE H, 1971, J SPEECH HEAR RES, V14, P677, DOI 10.1044/jshr.1404.677; LEVELT WJM, 1983, COGNITION, V14, P41, DOI 10.1016/0010-0277(83)90026-4; Lu T, 2001, J NEUROPHYSIOL, V85, P2364, DOI 10.1152/jn.2001.85.6.2364; Miller CT, 2006, J COMP PHYSIOL A, V192, P27, DOI 10.1007/s00359-005-0043-z; MULLERPREUSS P, 1981, BRAIN RES, V215, P61, DOI 10.1016/0006-8993(81)90491-1; Paus T, 1996, EUR J NEUROSCI, V8, P2236, DOI 10.1111/j.1460-9568.1996.tb01187.x; Poulet JFA, 2002, NATURE, V418, P872, DOI 10.1038/nature00919; Snowdon CT, 1999, ETHOLOGY, V105, P893, DOI 10.1046/j.1439-0310.1999.00483.x; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; SUGA N, 1974, SCIENCE, V183, P1211, DOI 10.1126/science.183.4130.1211; TIMMONS BA, 1972, J SPEECH HEAR DISORD, V37, P476, DOI 10.1044/jshd.3704.476; VONBEKESY G, 1949, J ACOUST SOC AM, V21, P217; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	30	276	278	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2008	453	7198					1102	U8		10.1038/nature06910	http://dx.doi.org/10.1038/nature06910			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18454135				2022-12-24	WOS:000256839900057
J	Mazmanian, SK; Round, JL; Kasper, DL				Mazmanian, Sarkis K.; Round, June L.; Kasper, Dennis L.			A microbial symbiosis factor prevents intestinal inflammatory disease	NATURE			English	Article							REGULATORY T-CELLS; BOWEL-DISEASE; BACTERIA; SUPPRESS; COLITIS; GUT; FLORA; INTERLEUKIN-10; PATHOGENESIS; MICROFLORA	Humans are colonized by multitudes of commensal organisms representing members of five of the six kingdoms of life; however, our gastrointestinal tract provides residence to both beneficial and potentially pathogenic microorganisms. Imbalances in the composition of the bacterial microbiota, known as dysbiosis, are postulated to be a major factor in human disorders such as inflammatory bowel disease. We report here that the prominent human symbiont Bacteroides fragilis protects animals from experimental colitis induced by Helicobacter hepaticus, a commensal bacterium with pathogenic potential. This beneficial activity requires a single microbial molecule ( polysaccharide A, PSA). In animals harbouring B. fragilis not expressing PSA, H. hepaticus colonization leads to disease and pro- inflammatory cytokine production in colonic tissues. Purified PSA administered to animals is required to suppress pro- inflammatory interleukin- 17 production by intestinal immune cells and also inhibits in vitro reactions in cell cultures. Furthermore, PSA protects from inflammatory disease through a functional requirement for interleukin- 10- producing CD4(+) T cells. These results show that molecules of the bacterial microbiota can mediate the critical balance between health and disease. Harnessing the immunomodulatory capacity of symbiosis factors such as PSA might potentially provide therapeutics for human inflammatory disorders on the basis of entirely novel biological principles.	[Mazmanian, Sarkis K.; Round, June L.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Kasper, Dennis L.] Harvard Univ, Sch Med, Channing Lab, Brigham & Womens Hosp, Boston, MA 02115 USA; [Kasper, Dennis L.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	California Institute of Technology; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Mazmanian, SK (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	sarkis@caltech.edu; dennis_kasper@hms.harvard.edu	Mazmanian, Sarkis/ABD-7729-2021	Mazmanian, Sarkis/0000-0003-2713-1513	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039576] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI039576] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bell E B, 1992, Semin Immunol, V4, P43; Bregenholt S, 2000, EXP CLIN IMMUNOGENET, V17, P115, DOI 10.1159/000019131; Cahill RJ, 1997, INFECT IMMUN, V65, P3126, DOI 10.1128/IAI.65.8.3126-3131.1997; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Elson CO, 2000, GASTROENTEROLOGY, V119, P254, DOI 10.1053/gast.2000.9159; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Kullberg MC, 2003, P NATL ACAD SCI USA, V100, P15830, DOI 10.1073/pnas.2534546100; Kullberg MC, 2002, J EXP MED, V196, P505, DOI 10.1084/jem.20020556; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Liu CH, 2008, P NATL ACAD SCI USA, V105, P3951, DOI 10.1073/pnas.0709266105; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Mazmanian SK, 2006, NAT REV IMMUNOL, V6, P849, DOI 10.1038/nri1956; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; PARNER EG, 2007, NATURE IMMUNOL, V8, P1173; Powrie F, 2003, SCIENCE, V299, P1030, DOI 10.1126/science.1082031; Poxton IR, 1997, J MED MICROBIOL, V46, P85, DOI 10.1099/00222615-46-1-85; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Scheinin T, 2003, CLIN EXP IMMUNOL, V133, P38, DOI 10.1046/j.1365-2249.2003.02193.x; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; TAUROG JD, 1994, J EXP MED, V180, P2359, DOI 10.1084/jem.180.6.2359; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; TZIANABOS AO, 1992, J BIOL CHEM, V267, P18230; VIDELA S, 1994, GUT, V35, P1090, DOI 10.1136/gut.35.8.1090; Xavier R, 2005, GASTROENTEROLOGY, V128, P1122, DOI 10.1053/j.gastro.2005.02.053	38	1585	1695	55	551	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2008	453	7195					620	625		10.1038/nature07008	http://dx.doi.org/10.1038/nature07008			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305NN	18509436				2022-12-24	WOS:000256185200036
J	Tam, OH; Aravin, AA; Stein, P; Girard, A; Murchison, EP; Cheloufi, S; Hodges, E; Anger, M; Sachidanandam, R; Schultz, RM; Hannon, GJ				Tam, Oliver H.; Aravin, Alexei A.; Stein, Paula; Girard, Angelique; Murchison, Elizabeth P.; Cheloufi, Sihem; Hodges, Emily; Anger, Martin; Sachidanandam, Ravi; Schultz, Richard M.; Hannon, Gregory J.			Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes	NATURE			English	Article							PIWI; PROTEIN; MILI; BIOGENESIS; MICRORNAS; MECHANISM	Pseudogenes populate the mammalian genome as remnants of artefactual incorporation of coding messenger RNAs into transposon pathways(1). Here we show that a subset of pseudogenes generates endogenous small interfering RNAs (endo-siRNAs) in mouse oocytes. These endo-siRNAs are often processed from double-stranded RNAs formed by hybridization of spliced transcripts from protein-coding genes to antisense transcripts from homologous pseudogenes. An inverted repeat pseudogene can also generate abundant small RNAs directly. A second class of endosiRNAs may enforce repression of mobile genetic elements, acting together with Piwi-interacting RNAs. Loss of Dicer, a protein integral to small RNA production, increases expression of endosiRNA targets, demonstrating their regulatory activity. Our findings indicate a function for pseudogenes in regulating gene expression by means of the RNA interference pathway and may, in part, explain the evolutionary pressure to conserve argonautemediated catalysis in mammals.	[Tam, Oliver H.; Aravin, Alexei A.; Girard, Angelique; Murchison, Elizabeth P.; Cheloufi, Sihem; Hodges, Emily; Sachidanandam, Ravi; Hannon, Gregory J.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Tam, Oliver H.; Aravin, Alexei A.; Girard, Angelique; Murchison, Elizabeth P.; Cheloufi, Sihem; Hodges, Emily; Sachidanandam, Ravi; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Stein, Paula; Anger, Martin; Schultz, Richard M.] Univ Penn, Dept Biol, Lynch Labs 205, Philadelphia, PA 19104 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; University of Pennsylvania	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Anger, Martin/A-3152-2015; Anger, Martin/R-9917-2019; Hannon, Gregory/AAB-3568-2019; Stein, Paula/ABE-9388-2020; sachidanandam, ravi/Q-6916-2019	Anger, Martin/0000-0003-0128-1054; Anger, Martin/0000-0003-0128-1054; Stein, Paula/0000-0002-2040-4593; sachidanandam, ravi/0000-0001-9844-4459; Hodges, Emily/0000-0001-6513-610X; Cheloufi, Sihem/0000-0002-1726-4796; Tam, Oliver/0000-0002-1023-3655; Murchison, Elizabeth Proby/0000-0001-7462-8907	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P01 CA013106-34] Funding Source: Medline; NIGMS NIH HHS [R01 GM062534, R01 GM062534-07, R01 GM062534-08] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062534] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bettegowda A, 2007, FRONT BIOSCI-LANDMRK, V12, P3713, DOI 10.2741/2346; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; D'Errico Ilenia, 2004, Briefings in Functional Genomics & Proteomics, V3, P157, DOI 10.1093/bfgp/3.2.157; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Joshua-Tor L, 2006, COLD SPRING HARB SYM, V71, P67, DOI 10.1101/sqb.2006.71.048; Korneev SA, 1999, J NEUROSCI, V19, P7711; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee JSM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-189; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; MURCHISON EP, IN PRESS GENOME RES; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; SCHULTZ RM, 1983, DEV BIOL, V97, P264, DOI 10.1016/0012-1606(83)90085-4; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Stein P, 2005, DEV BIOL, V286, P464, DOI 10.1016/j.ydbio.2005.08.015; Stitzel ML, 2007, SCIENCE, V316, P407, DOI 10.1126/science.1138236; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Weil D, 1997, GENE, V187, P115, DOI 10.1016/S0378-1119(96)00733-0; ZHOU BS, 1992, CANCER RES, V52, P4280	29	782	832	2	82	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 22	2008	453	7194					534	U8		10.1038/nature06904	http://dx.doi.org/10.1038/nature06904			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303EL	18404147	Green Accepted			2022-12-24	WOS:000256023700045
J	Rajendran, L; Schneider, A; Schlechtingen, G; Weidlich, S; Ries, J; Braxmeier, T; Schwille, P; Schulz, JB; Schroeder, C; Simons, M; Jennings, G; Knolker, HJ; Simons, K				Rajendran, Lawrence; Schneider, Anja; Schlechtingen, Georg; Weidlich, Sebastian; Ries, Jonas; Braxmeier, Tobias; Schwille, Petra; Schulz, Joerg B.; Schroeder, Cornelia; Simons, Mikael; Jennings, Gary; Knoelker, Hans-Joachim; Simons, Kai			Efficient inhibition of the Alzheimer's disease beta-secretase by membrane targeting	SCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; BACE; NEURODEGENERATION; CHOLESTEROL; INVOLVEMENT; MODULATORS; PEPTIDE	beta-secretase plays a critical role in beta- amyloid formation and thus provides a therapeutic target for Alzheimer's disease. Inhibitor design has usually focused on active- site binding, neglecting the subcellular localization of active enzyme. We have addressed this issue by synthesizing a membrane- anchored version of a beta- secretase transition- state inhibitor by linking it to a sterol moiety. Thus, we targeted the inhibitor to active beta- secretase found in endosomes and also reduced the dimensionality of the inhibitor, increasing its local membrane concentration. This inhibitor reduced enzyme activity much more efficiently than did the free inhibitor in cultured cells and in vivo. In addition to effectively targeting beta- secretase, this strategy could also be used in designing potent drugs against other membrane protein targets.	[Rajendran, Lawrence; Simons, Kai] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Schneider, Anja; Simons, Mikael] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Schlechtingen, Georg; Braxmeier, Tobias; Jennings, Gary; Knoelker, Hans-Joachim] JADO Technol GmbH, D-01307 Dresden, Germany; [Schlechtingen, Georg; Weidlich, Sebastian; Braxmeier, Tobias; Schroeder, Cornelia; Knoelker, Hans-Joachim] Tech Univ Dresden, Dept Chem, D-01069 Dresden, Germany; [Ries, Jonas; Schwille, Petra] Biotec, Biotechnol Zentrum, D-01307 Dresden, Germany; [Schulz, Joerg B.] Ctr Neurol Med, D-37073 Gottingen, Germany	Max Planck Society; Max Planck Society; Technische Universitat Dresden; Technische Universitat Dresden	Simons, K (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	simons@mpi-cbg.de	Schneider, Anja/F-5293-2010; Schulz, Jorg B./D-9786-2012; Ries, Jonas/P-3027-2014	Schulz, Jorg B./0000-0002-8903-0593; Simons, Kai/0000-0002-9231-9996; Schneider, Anja/0000-0001-9540-8700; Simons, Mikael/0000-0001-5329-192X; Rajendran, Lawrence/0000-0002-6390-1821; Ries, Jonas/0000-0002-6640-9250				Adam G., 1968, STRUCTURAL CHEM MOL, P198; Annaert W, 2002, ANNU REV CELL DEV BI, V18, P25, DOI 10.1146/annurev.cellbio.18.020402.142302; Capell A, 2002, J BIOL CHEM, V277, P5637, DOI 10.1074/jbc.M109119200; Cordy JM, 2006, MOL MEMBR BIOL, V23, P111, DOI 10.1080/09687860500496417; Greeve I, 2004, J NEUROSCI, V24, P3899, DOI 10.1523/JNEUROSCI.0283-04.2004; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; He XY, 2007, J NEUROSCI, V27, P4052, DOI 10.1523/JNEUROSCI.3993-06.2007; Hills ID, 2007, CURR OPIN DRUG DISC, V10, P383; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; Kholodenko BN, 2000, TRENDS CELL BIOL, V10, P173, DOI 10.1016/S0962-8924(00)01741-4; Kinoshita A, 2003, J CELL SCI, V116, P3339, DOI 10.1242/jcs.00643; Kojro E, 2005, SUB CELL BIOCHEM, V38, P105; Koo EH, 2002, TRAFFIC, V3, P763, DOI 10.1034/j.1600-0854.2002.31101.x; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Resh MD, 2004, SUB CELL BIOCHEM, V37, P217; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; Schmidt B, 2006, CURR TOP MED CHEM, V6, P377, DOI 10.2174/156802606776287027; Simons M, 2001, NEUROLOGY, V57, P1089, DOI 10.1212/WNL.57.6.1089; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Tung JS, 2002, J MED CHEM, V45, P259, DOI 10.1021/jm0155695; Vassar R, 2002, ADV DRUG DELIVER REV, V54, P1589, DOI 10.1016/S0169-409X(02)00157-6; WANG R, 1991, J BIOL CHEM, V266, P16960	25	221	230	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					520	523		10.1126/science.1156609	http://dx.doi.org/10.1126/science.1156609			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436784				2022-12-24	WOS:000255249300048
J	Wheeler, DA; Srinivasan, M; Egholm, M; Shen, Y; Chen, L; McGuire, A; He, W; Chen, YJ; Makhijani, V; Roth, GT; Gomes, X; Tartaro, K; Niazi, F; Turcotte, CL; Irzyk, GP; Lupski, JR; Chinault, C; Song, XZ; Liu, Y; Yuan, Y; Nazareth, L; Qin, X; Muzny, DM; Margulies, M; Weinstock, GM; Gibbs, RA; Rothberg, JM				Wheeler, David A.; Srinivasan, Maithreyan; Egholm, Michael; Shen, Yufeng; Chen, Lei; McGuire, Amy; He, Wen; Chen, Yi-Ju; Makhijani, Vinod; Roth, G. Thomas; Gomes, Xavier; Tartaro, Karrie; Niazi, Faheem; Turcotte, Cynthia L.; Irzyk, Gerard P.; Lupski, James R.; Chinault, Craig; Song, Xing-zhi; Liu, Yue; Yuan, Ye; Nazareth, Lynne; Qin, Xiang; Muzny, Donna M.; Margulies, Marcel; Weinstock, George M.; Gibbs, Richard A.; Rothberg, Jonathan M.			The complete genome of an individual by massively parallel DNA sequencing	NATURE			English	Article							STRUCTURAL VARIATION; GENE	The association of genetic variation with disease and drug response, and improvements in nucleic acid technologies, have given great optimism for the impact of 'genomic medicine'. However, the formidable size of the diploid human genome(1), approximately 6 gigabases, has prevented the routine application of sequencing methods to deciphering complete individual human genomes. To realize the full potential of genomics for human health, this limitation must be overcome. Here we report the DNA sequence of a diploid genome of a single individual, James D. Watson, sequenced to 7.4- fold redundancy in two months using massively parallel sequencing in picolitre- size reaction vessels. This sequence was completed in two months at approximately one-hundredth of the cost of traditional capillary electrophoresis methods. Comparison of the sequence to the reference genome led to the identification of 3.3 million single nucleotide polymorphisms, of which 10,654 cause amino- acid substitution within the coding sequence. In addition, we accurately identified small-scale ( 2 - 40,000 base pair ( bp)) insertion and deletion polymorphism as well as copy number variation resulting in the large- scale gain and loss of chromosomal segments ranging from 26,000 to 1.5 million base pairs. Overall, these results agree well with recent results of sequencing of a single individual(2) by traditional methods. However, in addition to being faster and significantly less expensive, this sequencing technology avoids the arbitrary loss of genomic sequences inherent in random shotgun sequencing by bacterial cloning because it amplifies DNA in a cell- free system. As a result, we further demonstrate the acquisition of novel human sequence, including novel genes not previously identified by traditional genomic sequencing. This is the first genome sequenced by next- generation technologies. Therefore it is a pilot for the future challenges of 'personalized genome sequencing'.	[Wheeler, David A.; Chen, Lei; Song, Xing-zhi; Liu, Yue; Yuan, Ye; Nazareth, Lynne; Qin, Xiang; Muzny, Donna M.; Weinstock, George M.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [McGuire, Amy] Baylor Coll Med, Ctr Eth & Hlth Policy, Houston, TX 77030 USA; [Lupski, James R.; Chinault, Craig; Weinstock, George M.; Gibbs, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Texas Med Ctr, Houston, TX 77030 USA; [Srinivasan, Maithreyan; Egholm, Michael; He, Wen; Chen, Yi-Ju; Makhijani, Vinod; Roth, G. Thomas; Gomes, Xavier; Tartaro, Karrie; Niazi, Faheem; Turcotte, Cynthia L.; Irzyk, Gerard P.; Margulies, Marcel; Rothberg, Jonathan M.] Roche Diagnost, Bradford, CT 06405 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Roche Holding	Rothberg, JM (corresponding author), Roche Diagnost, 454 Life Sci,20 Commercial St, Bradford, CT 06405 USA.	agibbs@bcm.tmc.edu; jonathan.rothberg@gmail.com	Wheeler, David A/M-9740-2018; Weinstock, George M/C-6314-2013	Wheeler, David A/0000-0002-9056-6299; Weinstock, George M/0000-0002-2997-4592	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bennettt EA, 2004, GENETICS, V168, P933, DOI 10.1534/genetics.104.031757; BITTLES AH, 1994, NAT GENET, V8, P117, DOI 10.1038/ng1094-117; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Halligan DL, 2003, TRENDS GENET, V19, P57, DOI 10.1016/S0168-9525(02)00045-8; Havlak P, 2004, GENOME RES, V14, P721, DOI 10.1101/gr.2264004; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; LANDER E S, 1988, Genomics, V2, P231; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Lupski JR, 2007, NEW ENGL J MED, V356, P1169, DOI 10.1056/NEJMcibr067658; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McGuire AL, 2008, NAT REV GENET, V9, P152, DOI 10.1038/nrg2302; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; VOGEL F, 1986, HUMAN GENETICS PROBL, P487; Weber JL, 2002, AM J HUM GENET, V71, P854, DOI 10.1086/342727	21	1241	1353	14	239	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2008	452	7189					872	U5		10.1038/nature06884	http://dx.doi.org/10.1038/nature06884			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZY	18421352	hybrid			2022-12-24	WOS:000255026000048
J	Venteicher, AS; Meng, ZJ; Mason, PJ; Veenstra, TD; Artandi, SE				Venteicher, Andrew S.; Meng, Zhaojing; Mason, Philip J.; Veenstra, Timothy D.; Artandi, Steven E.			Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly	CELL			English	Article							DOMINANT DYSKERATOSIS-CONGENITA; CHROMATIN REMODELING COMPLEX; SMALL NUCLEOLAR RNPS; REVERSE-TRANSCRIPTASE; RNA COMPONENT; LENGTH; CELLS; PROTEINS; RIBONUCLEOPROTEINS; PURIFICATION	Telomerase is a multisubunit ribonucleoprotein (RNP) complex that adds telomere repeats to the ends of chromosomes. Three essential telomerase components have been identified thus far: the telomerase reverse transcriptase (TERT), the telomerase RNA component (TERC), and the TERC-binding protein dyskerin. Few other proteins are known to be required for human telomerase function, limiting our understanding of both telomerase regulation and mechanisms of telomerase action. Here, we identify the ATPases pontin and reptin as telomerase components through affinity purification of TERT from human cells. Pontin interacts directly with both TERT and dyskerin, and the amount of TERT bound to pontin and reptin peaks in S phase, evidence for cell-cycle-dependent regulation of TERT. Depletion of pontin and reptin markedly impairs telomerase RNP accumulation, indicating an essential role in telomerase assembly. These findings reveal an unanticipated requirement for additional enzymes in telomerase biogenesis and suggest alternative approaches for inhibiting telomerase in cancer.	[Venteicher, Andrew S.; Artandi, Steven E.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Venteicher, Andrew S.; Artandi, Steven E.] Stanford Univ, Sch Med, Program Biophys, Stanford, CA 94305 USA; [Artandi, Steven E.] Stanford Univ, Sch Med, Program Canc Biol, Stanford, CA 94305 USA; [Meng, Zhaojing; Veenstra, Timothy D.] NCI, Lab Proteom & Analyt Technol, Adv Technol Program, SAIC Frederick Inc, Frederick, MD 21702 USA; [Mason, Philip J.] Washington Univ, Sch Med, Dept Internal Med, Div Hematol, St Louis, MO 63110 USA	Stanford University; Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Washington University (WUSTL)	Artandi, SE (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	sartandi@stanford.edu	Venteicher, Andrew/AAN-5666-2021; Mason, Philip J/B-1087-2008	Venteicher, Andrew/0000-0003-0643-0493; 	NATIONAL CANCER INSTITUTE [R01CA111691, R01CA106995, R01CA125453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-12400, N01CO12400, R01 CA125453, R01 CA125453-02, CA125453, R01 CA111691, R01 CA111691-03, R01 CA106995, CA111691] Funding Source: Medline; NIGMS NIH HHS [T32 GM007365, GM07365] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Collins K, 2006, NAT REV MOL CELL BIO, V7, P484, DOI 10.1038/nrm1961; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Dragon F, 2000, MOL CELL BIOL, V20, P3037, DOI 10.1128/MCB.20.9.3037-3048.2000; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Fu D, 2006, GENE DEV, V20, P531, DOI 10.1101/gad.1390306; Fu D, 2007, MOL CELL, V28, P773, DOI 10.1016/j.molcel.2007.09.023; Gallant P, 2007, TRENDS CELL BIOL, V17, P187, DOI 10.1016/j.tcb.2007.02.005; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Jady BE, 2006, MOL BIOL CELL, V17, P944, DOI 10.1091/mbc.E05-09-0904; Jonsson ZO, 2004, MOL CELL, V16, P465, DOI 10.1016/j.molcel.2004.09.033; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Marrone A, 2005, CURR OPIN GENET DEV, V15, P249, DOI 10.1016/j.gde.2005.04.004; Matias PM, 2006, J BIOL CHEM, V281, P38918, DOI 10.1074/jbc.M605625200; Meier UT, 2005, CHROMOSOMA, V114, P1, DOI 10.1007/s00412-005-0333-9; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Newman DR, 2000, RNA, V6, P861, DOI 10.1017/S1355838200992446; Pogacic V, 2000, MOL CELL BIOL, V20, P9028, DOI 10.1128/MCB.20.23.9028-9040.2000; Prathapam R, 2005, NAT STRUCT MOL BIOL, V12, P252, DOI 10.1038/nsmb900; Rottbauer W, 2002, CELL, V111, P661, DOI 10.1016/S0092-8674(02)01112-1; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Schnapp G, 1998, NUCLEIC ACIDS RES, V26, P3311, DOI 10.1093/nar/26.13.3311; Seto AG, 1999, NATURE, V401, P177, DOI 10.1038/43694; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy TJ, 2006, BLOOD, V107, P2680, DOI 10.1182/blood-2005-07-2622; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Watkins NJ, 2004, MOL CELL, V16, P789, DOI 10.1016/j.molcel.2004.11.012; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Wenz C, 2001, EMBO J, V20, P3526, DOI 10.1093/emboj/20.13.3526; Witkin KL, 2004, GENE DEV, V18, P1107, DOI 10.1101/gad.1201704; Wu YL, 2006, J CELL SCI, V119, P2797, DOI 10.1242/jcs.03001; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Yong JS, 2004, TRENDS CELL BIOL, V14, P226, DOI 10.1016/j.tcb.2004.03.010	45	236	242	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 21	2008	132	6					945	957		10.1016/j.cell.2008.01.019	http://dx.doi.org/10.1016/j.cell.2008.01.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	278GR	18358808	Green Accepted, Bronze			2022-12-24	WOS:000254273600014
J	Shen, JX; Feng, AS; Xu, ZM; Yu, ZL; Arch, VS; Yu, XJ; Narins, PM				Shen, Jun-Xian; Feng, Albert S.; Xu, Zhi-Min; Yu, Zu-Lin; Arch, Victoria S.; Yu, Xin-Jian; Narins, Peter M.			Ultrasonic frogs show hyperacute phonotaxis to female courtship calls	NATURE			English	Article							COMMUNICATION; SIGNALS; VOCALIZATIONS	Sound communication plays a vital role in frog reproduction(1,2), in which vocal advertisement is generally the domain of males. Females are typically silent, but in a few anuran species they can produce a feeble reciprocal call(3) or rapping sounds(4) during courtship. Males of concave- eared torrent frogs ( Odorrana tormota) have demonstrated ultrasonic communication capacity(5). Although females of O. tormota have an unusually well- developed vocal production system(6), it is unclear whether or not they produce calls or are only passive partners in a communication system dominated by males. Here we show that before ovulation, gravid females of O. tormota emit calls that are distinct from males' advertisement calls, having higher fundamental frequencies and harmonics and shorter call duration. In the field and in a quiet, darkened indoor arena, these female calls evoke vocalizations and extraordinarily precise positive phonotaxis ( a localization error of <1 degrees), rivalling that of vertebrates with the highest localization acuity ( barn owls(7,8), dolphins, elephants and humans(9)). The localization accuracy of O. tormota is remarkable in light of their small head size ( interaural distance of <1 cm), and suggests an additional selective advantage of high- frequency hearing beyond the ability to avoid masking by low- frequency background noise(5).	[Shen, Jun-Xian; Xu, Zhi-Min; Yu, Zu-Lin] Chinese Acad Sci, State Key Lab Brain & Cognit Sci, Inst Biophys, Beijing 100101, Peoples R China; [Feng, Albert S.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Feng, Albert S.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Arch, Victoria S.; Narins, Peter M.] Univ Calif Los Angeles, Dept Ecol & Evolut Biol, Los Angeles, CA 90095 USA; [Narins, Peter M.] Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA; [Yu, Xin-Jian] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Shen, JX (corresponding author), Chinese Acad Sci, State Key Lab Brain & Cognit Sci, Inst Biophys, Beijing 100101, Peoples R China.	shenjx@sun5.ibp.ac.cn	YU, ZULIN/D-7979-2012					Bala ADS, 2003, NATURE, V424, P771, DOI 10.1038/nature01835; Cai HX, 2007, ZOOTAXA, P49; Capranica RR, 1965, RES MONOGRAPH, V33; Christensen-Dalsgaard J, 2005, SPR HDB AUD, V25, P67, DOI 10.1007/0-387-28863-5_4; Duellman W. E., 1986, BIOL AMPHIBIANS; Emerson SB, 1999, BRAIN BEHAV EVOLUT, V53, P187, DOI 10.1159/000006594; Feng AS, 2006, NATURE, V440, P333, DOI 10.1038/nature04416; Feng AS, 2002, NATURWISSENSCHAFTEN, V89, P352, DOI 10.1007/s00114-002-0335-x; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; GLAW F, 1994, FIELDGUIDE AMPHIBIAN; Kelley DB, 2004, CURR OPIN NEUROBIOL, V14, P751, DOI 10.1016/j.conb.2004.10.015; Kelley DB, 1999, DESIGN OF ANIMAL COMMUNICATION, P9; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P1, DOI 10.1007/BF00663105; MARQUEZ R, 1995, BEHAVIOUR, V132, P151, DOI 10.1163/156853995X00342; McClelland BE, 1996, J EXP BIOL, V199, P1907; Narins PM, 2004, J ACOUST SOC AM, V115, P910, DOI 10.1121/1.1636851; NARINS PM, 1986, BEHAV ECOL SOCIOBIOL, V19, P135, DOI 10.1007/BF00299948; Narins PM, 2007, HEARING SOUND COMMUN; Randall JE, 2001, ICHTHYOL RES, V48, P3, DOI 10.1007/s10228-001-8111-z; ROY D, 1995, CURR SCI INDIA, V69, P265; Roy D, 1997, CURR SCI INDIA, V72, P923; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; Suthers RA, 2006, J EXP BIOL, V209, P4984, DOI 10.1242/jeb.02594; Tobias ML, 1998, P NATL ACAD SCI USA, V95, P1870, DOI 10.1073/pnas.95.4.1870; [No title captured]	25	78	95	3	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2008	453	7197					914	U46		10.1038/nature06719	http://dx.doi.org/10.1038/nature06719			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311WV	18469804				2022-12-24	WOS:000256632000042
J	Metzger, RJ; Klein, OD; Martin, GR; Krasnow, MA				Metzger, Ross J.; Klein, Ophir D.; Martin, Gail R.; Krasnow, Mark A.			The branching programme of mouse lung development	NATURE			English	Article							3-DIMENSIONAL MODEL; MORPHOGENESIS; ARCHITECTURE; EPITHELIUM; MECHANISMS; EVOLUTION; PATTERNS; ORIGIN; GENES	Mammalian lungs are branched networks containing thousands to millions of airways arrayed in intricate patterns that are crucial for respiration. How such trees are generated during development, and how the developmental patterning information is encoded, have long fascinated biologists and mathematicians. However, models have been limited by a lack of information on the normal sequence and pattern of branching events. Here we present the complete three- dimensional branching pattern and lineage of the mouse bronchial tree, reconstructed from an analysis of hundreds of developmental intermediates. The branching process is remarkably stereotyped and elegant: the tree is generated by three geometrically simple local modes of branching used in three different orders throughout the lung. We propose that each mode of branching is controlled by a genetically encoded subroutine, a series of local patterning and morphogenesis operations, which are themselves controlled by a more global master routine. We show that this hierarchical and modular programme is genetically tractable, and it is ideally suited to encoding and evolving the complex networks of the lung and other branched organs.	[Metzger, Ross J.; Krasnow, Mark A.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Metzger, Ross J.; Krasnow, Mark A.] Stanford Univ, Sch Med, HHMI, Stanford, CA 94305 USA; [Metzger, Ross J.; Klein, Ophir D.; Martin, Gail R.] Univ Calif San Francisco, Sch Med, Dept Anat, San Francisco, CA 94158 USA; [Klein, Ophir D.; Martin, Gail R.] Univ Calif San Francisco, Sch Med, Program Dev Biol, San Francisco, CA 94158 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Metzger, RJ (corresponding author), Univ Calif San Francisco, Sch Med, Dept Anat, San Francisco, CA 94158 USA.	ross.metzger@ucsf.edu; krasnow@cmgm.stanford.edu		Klein, Ophir/0000-0002-6254-7082	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA078711-05, R01 CA078711-03, R01 CA078711-02, R01 CA078711, R01 CA078711-04] Funding Source: Medline; NHLBI NIH HHS [R01 HL075769, R01 HL075769-03, R01 HL075769-01, R01 HL075769-02, R01 HL075769-04] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078711] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075769] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AEBY C, 1880, BRONCHIALBAUM SAUGET; Al-Awqati Q, 1998, KIDNEY INT, V54, P1832, DOI 10.1046/j.1523-1755.1998.00196.x; ALESCIO T, 1960, Arch Ital Anat Embriol, V65, P323; Bejan A., 2000, SHAPE STRUCTURE ENG; BORGHESE E, 1950, J ANAT, V84, P287; Boyden EA, 1955, SEGMENTAL ANATOMY LU; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; EPPIG JT, 2005, MOUSE GENOME DATABAS; Flint JM, 1906, AM J ANAT, V6, P1; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; HEISS R, 1919, ARCH ANAT PHYSIOL, P1; HIRAI Y, 1989, DEVELOPMENT, V105, P263; His W., 1887, Archiv fuer Anatomie und Physiologie Anat Abth, P89; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; Hummel K. P., 1959, Journal of Heredity, V50, P9; Kitaoka H, 1999, J APPL PHYSIOL, V87, P2207, DOI 10.1152/jappl.1999.87.6.2207; Lu PF, 2006, J MAMMARY GLAND BIOL, V11, P213, DOI 10.1007/s10911-006-9027-z; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; MASSOUD EAS, 1993, PEDIATR PULM, V15, P89, DOI 10.1002/ppul.1950150205; Mauroy B, 2004, NATURE, V427, P633, DOI 10.1038/nature02287; MEINHARDT H, 1976, DIFFERENTIATION, V6, P117, DOI 10.1111/j.1432-0436.1976.tb01478.x; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Minowada G, 1999, DEVELOPMENT, V126, P4465; Miura T, 2008, CURR TOP DEV BIOL, V81, P291, DOI 10.1016/S0070-2153(07)81010-6; NELSON TR, 1988, IEEE T MED IMAGING, V7, P321, DOI 10.1109/42.14515; PRUSINKIEWICZ P, 1990, ALGORITHMIC BEAUTY P; Prusinkiewicz P, 2007, SCIENCE, V316, P1452, DOI 10.1126/science.1140429; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; SHUBIN NH, 1986, EVOL BIOL, V20, P319; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Tawhai MH, 2000, ANN BIOMED ENG, V28, P793, DOI 10.1114/1.1289457; Tebockhorst S, 2007, J APPL PHYSIOL, V102, P294, DOI 10.1152/japplphysiol.00665.2006; Thomson AA, 2006, DIFFERENTIATION, V74, P382, DOI 10.1111/j.1432-0436.2006.00101.x; Warburton D, 2005, PEDIATR RES, V57, p26R, DOI 10.1203/01.PDR.0000159570.01327.ED; Watanabe T, 2004, DEV BIOL, V271, P98, DOI 10.1016/j.ydbio.2004.03.025; Weibel E R., 1984, PATHWAY OXYGEN; Weibel E.R., 1963, MORPHOMETRY HUMAN LU, DOI DOI 10.1007/978-3-642-87553-3; WEIBEL ER, 1962, SCIENCE, V137, P577, DOI 10.1126/science.137.3530.577; WELLS LJ, 1954, AM J ANAT, V95, P163, DOI 10.1002/aja.1000950202; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122	42	513	519	2	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2008	453	7196					745	U1		10.1038/nature07005	http://dx.doi.org/10.1038/nature07005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308UK	18463632	Green Accepted			2022-12-24	WOS:000256415300035
J	Ghildiyal, M; Seitz, H; Horwich, MD; Li, CJ; Du, TT; Lee, S; Xu, J; Kittler, ELW; Zapp, ML; Weng, ZP; Zamore, PD				Ghildiyal, Megha; Seitz, Herve; Horwich, Michael D.; Li, Chengjian; Du, Tingting; Lee, Soohyun; Xu, Jia; Kittler, Ellen L. W.; Zapp, Maria L.; Weng, Zhiping; Zamore, Phillip D.			Endogenous siRNAs derived from transposons and mRNAs in Drosophila somatic cells	SCIENCE			English	Article							SMALL INTERFERING RNAS; ARGONAUTE PROTEINS; MELANOGASTER; COMPONENTS; GERMLINE; CLEAVAGE; PIWI	Small interfering RNAs ( siRNAs) direct RNA interference ( RNAi) in eukaryotes. In flies, somatic cells produce siRNAs from exogenous double- stranded RNA ( dsRNA) as a defense against viral infection. We identified endogenous siRNAs ( endo- siRNAs), 21 nucleotides in length, that correspond to transposons and heterochromatic sequences in the somatic cells of Drosophila melanogaster. We also detected endo- siRNAs complementary to messenger RNAs ( mRNAs); these siRNAs disproportionately mapped to the complementary regions of overlapping mRNAs predicted to form double- stranded RNA in vivo. Normal accumulation of somatic endo- siRNAs requires the siRNA- generating ribonuclease Dicer- 2 and the RNAi effector protein Argonaute2 ( Ago2). We propose that endo- siRNAs generated by the fly RNAi pathway silence selfish genetic elements in the soma, much as Piwi- interacting RNAs do in the germ line.	[Ghildiyal, Megha; Seitz, Herve; Horwich, Michael D.; Li, Chengjian; Du, Tingting; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Lee, Soohyun] Boston Univ, Program Bioinformat, Boston, MA 02215 USA; [Xu, Jia] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Kittler, Ellen L. W.; Zapp, Maria L.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Kittler, Ellen L. W.; Zapp, Maria L.] Univ Massachusetts, Sch Med, Ctr AIDS Res, Worcester, MA 01605 USA; [Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Boston University; Boston University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Zamore, PD (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	phillip.zamore@umassmed.edu	Ghildiyal, Megha/F-7980-2014; Seitz, Hervé/AAE-6487-2019; Zamore, Phillip D/A-8941-2013; Xu, Jia/F-7750-2012	Seitz, Hervé/0000-0001-8172-5393; Lee, Soohyun/0000-0002-3594-6213; Xu, Jia/0000-0003-3921-018X; Zamore, Phillip/0000-0002-4505-9618	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043208, P30AI042845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065236, R01GM062862, R01GM080625, R37GM062862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG030283] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHGRI NIH HHS [HG003367, R01 HG003367, R01 HG003367-03] Funding Source: Medline; NIAID NIH HHS [R01 AI043208-08, P30 AI042845-119008, R01 AI043208, P30 AI042845] Funding Source: Medline; NIA NIH HHS [F30 AG030283-03, F30AG030283, F30 AG030283-02, F30 AG030283-04] Funding Source: Medline; NIGMS NIH HHS [GM65236, R01 GM065236-07, GM62862, R01 GM065236-08, R01 GM080625-02, R01 GM080625-03, R37 GM062862, R01 GM062862-08, R01 GM062862, R01 GM062862-09, R01 GM065236, R37 GM062862-11, GM080625, R01 GM080625] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; CSINK AK, 1994, GENETICS, V138, P153; CZECH B, 2008, NATURE; Desset S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001526; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Haynes KA, 2006, CURR BIOL, V16, P2222, DOI 10.1016/j.cub.2006.09.035; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; KAWAMURA Y, 2008, NATURE; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; OKAMURA K, 2008, NATURE; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Pelisson A, 2007, J VIROL, V81, P1951, DOI 10.1128/JVI.01980-06; Rehwinkel J, 2006, MOL CELL BIOL, V26, P2965, DOI 10.1128/MCB.26.8.2965-2975.2006; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Sunkar R, 2005, NUCLEIC ACIDS RES, V33, P4443, DOI 10.1093/nar/gki758; Tchurikov NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000476; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	24	457	478	3	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 23	2008	320	5879					1077	1081		10.1126/science.1157396	http://dx.doi.org/10.1126/science.1157396			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303RY	18403677	Green Accepted			2022-12-24	WOS:000256059800046
J	Wang, L; Du, FH; Wang, XD				Wang, Lai; Du, Fenghe; Wang, Xiaodong			TNF-alpha induces two distinct caspase-8 activation pathways	CELL			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; INDUCED CELL-DEATH; INDUCED APOPTOSIS; KINASE RIP; DEPENDENT APOPTOSIS; STRUCTURAL BASIS; C-FLIP; PROTEIN; SMAC/DIABLO	The inflammatory response of mammalian cells to TNF-alpha can be switched to apoptosis either by cotreatment with a protein synthesis inhibitor, cycloheximide, or Smac mimetic, a small molecule mimic of Smac/Diablo protein. Cycloheximide promotes caspase-8 activation by eliminating endogenous caspase-8 inhibitor, c-FLIP, while Smac mimetic does so by triggering autodegradation of cIAP1 and cIAP2 (cIAP1/2), leading to the release of receptor interacting protein kinase (RIPK1) from the activated TNF receptor complex to form a caspase-8-activating complex consisting of RIPK1, FADD, and caspase-8. This process also requires the action of CYLD, a RIPK1 K63 deubiquitinating enzyme. RIPK1 is critical for caspase-8 activation-induced by Smac mimetic but dispensable for that triggered by cycloheximide. Moreover, Smac mimetic-induced caspase-8 activation is not blocked by endogenous c-FLIP. These findings revealed that TNF-alpha is able to induce apoptosis via two distinct caspase-8 activation pathways that are differentially regulated by cIAP1/2 and c-FLIP.	[Wang, Lai; Du, Fenghe; Wang, Xiaodong] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Wang, Lai; Du, Fenghe; Wang, Xiaodong] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wang, XD (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	xiaodong.wang@utsouthwestern.edu		Wang, Xiaodong/0000-0001-9885-356X	NCI NIH HHS [P01 CA 95471] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA095471] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; O'Donnell MA, 2007, CURR BIOL, V17, P418, DOI 10.1016/j.cub.2007.01.027; Panka DJ, 2001, J BIOL CHEM, V276, P6893, DOI 10.1074/jbc.C000569200; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wright A, 2007, DEV CELL, V13, P705, DOI 10.1016/j.devcel.2007.09.007; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Yang QH, 2004, J BIOL CHEM, V279, P16963, DOI 10.1074/jbc.M401253200; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Zheng LX, 2006, MOL CELL BIOL, V26, P3505, DOI 10.1128/MCB.26.9.3505-3513.2006; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	42	947	993	10	124	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 16	2008	133	4					693	703		10.1016/j.cell.2008.03.036	http://dx.doi.org/10.1016/j.cell.2008.03.036			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485876	Bronze			2022-12-24	WOS:000255903300023
J	Laughlin, ST; Baskin, JM; Amacher, SL; Bertozzi, CR				Laughlin, Scott T.; Baskin, Jeremy M.; Amacher, Sharon L.; Bertozzi, Carolyn R.			In vivo imaging of membrane-associated glycans in developing zebrafish	SCIENCE			English	Article							O-LINKED GLYCOSYLATION; LIVING ANIMALS; CELL; VISUALIZATION; MECHANISMS; PROTEINS; DISEASE	Glycans are attractive targets for molecular imaging but have been inaccessible because of their incompatibility with genetically encoded reporters. We demonstrated the noninvasive imaging of glycans in live developing zebrafish, using a chemical reporter strategy. Zebrafish embryos were treated with an unnatural sugar to metabolically label their cell- surface glycans with azides. Subsequently, the embryos were reacted with fluorophore conjugates by means of copper- free click chemistry, enabling the visualization of glycans in vivo at subcellular resolution during development. At 60 hours after fertilization, we observed an increase in de novo glycan biosynthesis in the jaw region, pectoral fins, and olfactory organs. Using a multicolor detection strategy, we performed a spatiotemporal analysis of glycan expression and trafficking and identified patterns that would be undetectable with conventional molecular imaging approaches.	[Laughlin, Scott T.; Baskin, Jeremy M.; Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Amacher, Sharon L.; Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Mol Foundry, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bertozzi, CR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	crb@berkeley.edu	Baskin, Jeremy/X-7077-2019	Baskin, Jeremy/0000-0003-2939-3138	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM058867, R01GM061952, R01GM058867] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R37 GM058867, R01 GM058867, R01 GM061952-06A2S1, GM061952, R01 GM061952, GM058867, R01 GM058867-11] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baskin JM, 2007, P NATL ACAD SCI USA, V104, P16793, DOI 10.1073/pnas.0707090104; Beatty KE, 2006, ANGEW CHEM INT EDIT, V45, P7364, DOI 10.1002/anie.200602114; CARLSSON SR, 1993, ARCH BIOCHEM BIOPHYS, V304, P65, DOI 10.1006/abbi.1993.1322; Chang PV, 2007, J AM CHEM SOC, V129, P8400, DOI 10.1021/ja070238o; Clement M, 2004, J CELL SCI, V117, P5059, DOI 10.1242/jcs.01350; DRIEVER W, 1993, IN VITRO CELL DEV-AN, V29, P749; Dube DH, 2006, P NATL ACAD SCI USA, V103, P4819, DOI 10.1073/pnas.0506855103; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hang HC, 2003, P NATL ACAD SCI USA, V100, P14846, DOI 10.1073/pnas.2335201100; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Laughlin ST, 2006, METHOD ENZYMOL, V415, P230, DOI 10.1016/S0076-6879(06)15015-6; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Prescher JA, 2004, NATURE, V430, P873, DOI 10.1038/nature02791; Sawa M, 2006, P NATL ACAD SCI USA, V103, P12371, DOI 10.1073/pnas.0605418103; Wopereis S, 2006, CLIN CHEM, V52, P574, DOI 10.1373/clinchem.2005.063040; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200	19	764	833	33	351	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2008	320	5876					664	667		10.1126/science.1155106	http://dx.doi.org/10.1126/science.1155106			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451302	Green Accepted			2022-12-24	WOS:000255454300046
J	Elmen, J; Lindow, M; Schutz, S; Lawrence, M; Petri, A; Obad, S; Lindholm, M; Hedtjarn, M; Hansen, HF; Berger, U; Gullans, S; Kearney, P; Sarnow, P; Straarup, EM; Kauppinen, S				Elmen, Joacim; Lindow, Morten; Schutz, Sylvia; Lawrence, Matthew; Petri, Andreas; Obad, Susanna; Lindholm, Marie; Hedtjarn, Maj; Hansen, Henrik Frydenlund; Berger, Urs; Gullans, Steven; Kearney, Phil; Sarnow, Peter; Straarup, Ellen Marie; Kauppinen, Sakari			LNA-mediated microRNA silencing in non-human primates	NATURE			English	Article							ANIMAL DEVELOPMENT; IN-VIVO; SPECIFICITY; MODULATION; EXPRESSION	microRNAs ( miRNAs) are small regulatory RNAs that are important in development and disease(1-3) and therefore represent a potential new class of targets for therapeutic intervention(4). Despite recent progress in silencing of miRNAs in rodents(5,6), the development of effective and safe approaches for sequence-specific antagonism of miRNAs in vivo remains a significant scientific and therapeutic challenge. Moreover, there are no reports of miRNA antagonism in primates. Here we show that the simple systemic delivery of a unconjugated, PBS- formulated locked- nucleic- acid- modified oligonucleotide ( LNA- antimiR) effectively antagonizes the liver- expressed miR- 122 in non- human primates. Acute administration by intravenous injections of 3 or 10 mg kg(-1) LNA- antimiR to African green monkeys resulted in uptake of the LNA- antimiR in the cytoplasm of primate hepatocytes and formation of stable heteroduplexes between the LNA-antimiR and miR- 122. This was accompanied by depletion of mature miR- 122 and dose- dependent lowering of plasma cholesterol. Efficient silencing of miR- 122 was achieved in primates by three doses of 10 mg kg(-1) LNA- antimiR, leading to a long- lasting and reversible decrease in total plasma cholesterol without any evidence for LNA- associated toxicities or histopathological changes in the study animals. Our findings demonstrate the utility of systemically administered LNA- antimiRs in exploring miRNA function in rodents and primates, and support the potential of these compounds as a new class of therapeutics for disease-associated miRNAs.	[Elmen, Joacim; Lindow, Morten; Petri, Andreas; Obad, Susanna; Lindholm, Marie; Hedtjarn, Maj; Kearney, Phil; Straarup, Ellen Marie; Kauppinen, Sakari] Santaris Pharma, DK-2970 Horsholm, Denmark; [Schutz, Sylvia; Sarnow, Peter] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Lawrence, Matthew; Gullans, Steven] RxGen Inc, Hamden, CT 06517 USA; [Berger, Urs] UB In situ, Natick, MA 01760 USA; [Kauppinen, Sakari] Univ Copenhagen, Dept Cellular & Mol Med, Wilhelm Johannsen Ctr Funct Genome Res, DK-2200 Copenhagen N, Denmark	Stanford University; University of Copenhagen	Kauppinen, S (corresponding author), Santaris Pharma, Boge Allee 3, DK-2970 Horsholm, Denmark.	sk@santaris.com	Lindholm, Marie W/B-8736-2015	Lindholm, Marie W/0000-0003-4309-3203; Kearney, Phil/0000-0001-7408-1067; Wikstrom Lindholm, Marie/0000-0002-0975-2394; Sarnow, Peter/0000-0002-2043-2770				Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569	25	1303	1429	0	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2008	452	7189					896	U10		10.1038/nature06783	http://dx.doi.org/10.1038/nature06783			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZY	18368051				2022-12-24	WOS:000255026000053
J	Erez, N; Gordon, G; Nest, M; Kurizki, G				Erez, Noam; Gordon, Goren; Nest, Mathias; Kurizki, Gershon			Thermodynamic control by frequent quantum measurements	NATURE			English	Article							DECAY; WORK; BATH	Heat flow between a large thermal `bath' and a smaller system brings them progressively closer to thermal equilibrium while increasing their entropy(1). Fluctuations involving a small fraction of a statistical ensemble of systems interacting with the bath result in deviations from this trend. In this respect, quantum and classical thermodynamics are in agreement(1-5). Here we predict a different trend in a purely quantum mechanical setting: disturbances of thermal equilibrium between two-level systems (TLSs) and a bath(6), caused by frequent, brief quantum non-demolition(7-10) measurements of the TLS energy states. By making the measurements increasingly frequent, we encounter first the anti-Zeno regime and then the Zeno regime (namely where the TLSs' relaxation respectively speeds up and slows down(11-15)). The corresponding entropy and temperature of both the system and the bath are then found to either decrease or increase depending only on the rate of observation, contrary to the standard thermodynamical rules that hold for memory-less ( Markov) baths(2,5). From a practical viewpoint, these anomalies may offer the possibility of very fast control of heat and entropy in quantum systems, allowing cooling and state purification over an interval much shorter than the time needed for thermal equilibration or for a feedback control loop.	[Erez, Noam; Gordon, Goren; Kurizki, Gershon] Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel; [Nest, Mathias] Univ Potsdam, D-14476 Potsdam, Germany	Weizmann Institute of Science; University of Potsdam	Kurizki, G (corresponding author), Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel.	gershon.kurizki@weizmann.ac.il	Nest, Mathias/C-1412-2010; Gordon, Goren/ABB-8100-2021	Gordon, Goren/0000-0002-8351-7034				ALICKI R, 1979, J PHYS A-MATH GEN, V12, pL103, DOI 10.1088/0305-4470/12/5/007; Allahverdyan AE, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.260404; Allahverdyan AE, 2000, PHYS REV LETT, V85, P1799, DOI 10.1103/PhysRevLett.85.1799; BARNETT SM, 1993, NATURE, V362, P113, DOI 10.1038/362113a0; Beck MH, 2000, PHYS REP, V324, P1, DOI 10.1016/S0370-1573(99)00047-2; Braginsky V. B., 1995, QUANTUM MEASUREMENT; Cohen-Tannoudji C., 1992, ATOM PHOTON INTERACT; Facchi P, 2001, PROG OPTICS, V42, P147, DOI 10.1016/S0079-6638(01)80017-2; Gelman D, 2003, CHEM PHYS LETT, V381, P129, DOI 10.1016/j.cplett.2003.09.119; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Kofman AG, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.130406; Kofman AG, 2000, NATURE, V405, P546, DOI 10.1038/35014537; LANE AM, 1983, PHYS LETT A, V99, P359, DOI 10.1016/0375-9601(83)90292-X; LINDBLAD G, 1974, COMMUN MATH PHYS, V39, P111, DOI 10.1007/BF01608390; MISRA B, 1977, J MATH PHYS, V18, P756, DOI 10.1063/1.523304; Nest M, 2003, J CHEM PHYS, V119, P24, DOI 10.1063/1.1576384; Schulman LS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.240405; Scully MO, 2003, SCIENCE, V299, P862, DOI 10.1126/science.1078955; Scully MO, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.220601; SPOHN H, 1978, J MATH PHYS, V19, P1227, DOI 10.1063/1.523789; Stelmachovic P, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.062106; Zurek WH, 2003, REV MOD PHYS, V75, P715, DOI 10.1103/RevModPhys.75.715; [No title captured]	24	156	158	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2008	452	7188					724	727		10.1038/nature06873	http://dx.doi.org/10.1038/nature06873			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	285QY	18401404	Green Submitted			2022-12-24	WOS:000254792500039
J	Hunt, DE; David, LA; Gevers, D; Preheim, SP; Alm, EJ; Polz, MF				Hunt, Dana E.; David, Lawrence A.; Gevers, Dirk; Preheim, Sarah P.; Alm, Eric J.; Polz, Martin F.			Resource partitioning and sympatric differentiation among closely related bacterioplankton	SCIENCE			English	Article							BACTERIAL DIVERSITY; FUNDAMENTAL UNITS; SEXUAL ISOLATION; COMMUNITY; SPECIATION; SYSTEMATICS; MECHANISMS; CHARACTER; MICROBES; GENOMICS	Identifying ecologically differentiated populations within complex microbial communities remains challenging, yet is critical for interpreting the evolution and ecology of microbes in the wild. Here we describe spatial and temporal resource partitioning among Vibrionaceae strains coexisting in coastal bacterioplankton. A quantitative model ( AdaptML) establishes the evolutionary history of ecological differentiation, thus revealing populations specific for seasons and life- styles ( combinations of free- living, particle, or zooplankton associations). These ecological population boundaries frequently occur at deep phylogenetic levels ( consistent with named species); however, recent and perhaps ongoing adaptive radiation is evident in Vibrio splendidus, which comprises numerous ecologically distinct populations at different levels of phylogenetic differentiation. Thus, environmental specialization may be an important correlate or even trigger of speciation among sympatric microbes.	[Hunt, Dana E.; Gevers, Dirk; Preheim, Sarah P.; Alm, Eric J.; Polz, Martin F.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [David, Lawrence A.] MIT, Computat & Syst Biol Initiat, Cambridge, MA 02139 USA; [Gevers, Dirk] Univ Ghent, Microbiol Lab, B-9000 Ghent, Belgium; [Gevers, Dirk] Univ Ghent, Bioinformat & Evolutionary Genom Grp, B-9000 Ghent, Belgium; [Alm, Eric J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Alm, Eric J.] MIT, Broad Inst, Cambridge, MA 02139 USA; [Alm, Eric J.] Harvard Univ, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Ghent University; Ghent University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Alm, EJ (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ejalm@mit.edu; mpolz@mit.edu	David, Lawrence/B-1044-2010; Hunt, Dana/A-2051-2012; Gevers, Dirk/C-1451-2009; Polz, Martin/ABE-7199-2020; Preheim, Sarah P/B-3432-2010	David, Lawrence/0000-0002-3570-4767; Hunt, Dana/0000-0002-8801-9624; Preheim, Sarah P/0000-0001-7365-2382; Polz, Martin/0000-0002-4975-2946; /0000-0001-9296-3733				Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Cohan FM, 2002, GENETICA, V116, P359, DOI 10.1023/A:1021232409545; Cohan FM, 2007, CURR BIOL, V17, pR373, DOI 10.1016/j.cub.2007.03.032; Daubin V, 2004, SCIENCE, V306; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Doolittle WF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-116; Ferris MJ, 2003, APPL ENVIRON MICROB, V69, P2893, DOI 10.1128/AEM.69.5.2893-2898.2003; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Giovannoni SJ, 2005, NATURE, V437, P343, DOI 10.1038/nature04158; Heidelberg JF, 2002, APPL ENVIRON MICROB, V68, P5498, DOI 10.1128/AEM.68.11.5498-5507.2002; Hunt DE, 2008, APPL ENVIRON MICROB, V74, P44, DOI 10.1128/AEM.01412-07; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kiorboe T, 2002, APPL ENVIRON MICROB, V68, P3996, DOI 10.1128/AEM.68.8.3996-4006.2002; Koeppel A, 2008, P NATL ACAD SCI USA, V105, P2504, DOI 10.1073/pnas.0712205105; MADDISON WP, 1991, EVOLUTION, V45, P1184, DOI [10.1111/j.1558-5646.1991.tb04385.x, 10.2307/2409726]; Majewski J, 2001, FEMS MICROBIOL LETT, V199, P161, DOI 10.1016/S0378-1097(01)00183-5; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Panagiotopoulos C, 2002, ORG GEOCHEM, V33, P985, DOI 10.1016/S0146-6380(02)00057-8; Pernthaler J, 2005, MICROBIOL MOL BIOL R, V69, P440, DOI 10.1128/MMBR.69.3.440-461.2005; Polz MF, 2006, PHILOS T R SOC B, V361, P2009, DOI 10.1098/rstb.2006.1928; POMEROY LR, 1984, B MAR SCI, V35, P426; Ramette A, 2007, P NATL ACAD SCI USA, V104, P2761, DOI 10.1073/pnas.0610671104; Retchless AC, 2007, SCIENCE, V317, P1093, DOI 10.1126/science.1144876; Ronquist F, 2004, TRENDS ECOL EVOL, V19, P475, DOI 10.1016/j.tree.2004.07.002; Thompson JR, 2006, BIOLOGY OF VIBRIOS, P190; Thompson JR, 2005, SCIENCE, V307, P1311, DOI 10.1126/science.1106028; Thompson JR, 2004, APPL ENVIRON MICROB, V70, P4103, DOI 10.1128/AEM.70.7.4103-4110.2004; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420	29	362	367	4	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2008	320	5879					1081	1085		10.1126/science.1157890	http://dx.doi.org/10.1126/science.1157890			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303RY	18497299				2022-12-24	WOS:000256059800047
J	Husnjak, K; Elsasser, S; Zhang, NX; Chen, X; Randles, L; Shi, Y; Hofmann, K; Walters, KJ; Finley, D; Dikic, I				Husnjak, Koraljka; Elsasser, Suzanne; Zhang, Naixia; Chen, Xiang; Randles, Leah; Shi, Yuan; Hofmann, Kay; Walters, Kylie J.; Finley, Daniel; Dikic, Ivan			Proteasome subunit Rpn13 is a novel ubiquitin receptor	NATURE			English	Article							DEUBIQUITINATING ENZYME; 26S PROTEASOME; POLYUBIQUITIN CHAINS; PROTEIN INTERACTOME; UBA DOMAINS; DEGRADATION; PROTEOLYSIS; RAD23; BINDS; UCH37	Proteasomal receptors that recognize ubiquitin chains attached to substrates are key mediators of selective protein degradation in eukaryotes. Here we report the identification of a new ubiquitin receptor, Rpn13/ARM1, a known component of the proteasome. Rpn13 binds ubiquitin through a conserved amino-terminal region termed the pleckstrin-like receptor for ubiquitin (Pru) domain, which binds K48-linked diubiquitin with an affinity of approximately 90 nM. Like proteasomal ubiquitin receptor Rpn10/S5a, Rpn13 also binds ubiquitin-like (UBL) domains of UBL- ubiquitin- associated (UBA) proteins. In yeast, a synthetic phenotype results when specific mutations of the ubiquitin binding sites of Rpn10 and Rpn13 are combined, indicating functional linkage between these ubiquitin receptors. Because Rpn13 is also the proteasomal receptor for Uch37, a deubiquitinating enzyme, our findings suggest a coupling of chain recognition and disassembly at the proteasome.	[Husnjak, Koraljka; Dikic, Ivan] Univ Frankfurt, Inst Biochem 2, D-60590 Frankfurt, Germany; [Husnjak, Koraljka; Dikic, Ivan] Mediterranean Inst Life Sci, Tumor Biol Program, Split 21000, Croatia; [Elsasser, Suzanne; Shi, Yuan; Finley, Daniel] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Zhang, Naixia; Chen, Xiang; Randles, Leah; Walters, Kylie J.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Hofmann, Kay] Miltenyi Biotec GmbH, D-50829 Cologne, Germany; [Dikic, Ivan] Univ Split, Sch Med, Dept Immunol, Split 21000, Croatia	Goethe University Frankfurt; Harvard University; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities; Miltenyi Biotec; University of Split	Dikic, I (corresponding author), Univ Frankfurt, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	walte048@umn.edu; daniel_finley@hms.harvard.edu; Ivan.Dikic@biochem2.de	Husnjak, Koraljka/C-3717-2015; Hofmann, Kay/D-6714-2011; Dikic, Ivan/O-4650-2015; Chen, Xiang/E-2840-2010	Husnjak, Koraljka/0000-0003-0573-6239; Hofmann, Kay/0000-0002-2289-9083; Dikic, Ivan/0000-0001-8156-9511; 	NATIONAL CANCER INSTITUTE [R01CA097004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043601, T32GM008700, R01GM043601] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA097004, R01 CA097004-05, R01 CA097004-06A1, CA097004] Funding Source: Medline; NIGMS NIH HHS [R37 GM043601, GM043601, T32 GM008700-09, R01 GM043601, GM008700, T32 GM008700, R37 GM043601-17] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Boutet SC, 2007, CELL, V130, P349, DOI 10.1016/j.cell.2007.05.044; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Guterman A, 2004, J BIOL CHEM, V279, P1729, DOI 10.1074/jbc.M307050200; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hiyama H, 1999, J BIOL CHEM, V274, P28019, DOI 10.1074/jbc.274.39.28019; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; JOHNSON ES, 1992, EMBO J, V11, P497, DOI 10.1002/j.1460-2075.1992.tb05080.x; Jorgensen JP, 2006, J MOL BIOL, V360, P1043, DOI 10.1016/j.jmb.2006.06.011; Kaplun L, 2005, MOL CELL BIOL, V25, P5355, DOI 10.1128/MCB.25.13.5355-5362.2005; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Madura K, 2004, TRENDS BIOCHEM SCI, V29, P637, DOI 10.1016/j.tibs.2004.10.008; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V293, P986, DOI 10.1016/S0006-291X(02)00340-6; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; Seong KM, 2007, FEBS LETT, V581, P2567, DOI 10.1016/j.febslet.2007.04.064; Sone T, 2004, J BIOL CHEM, V279, P28807, DOI 10.1074/jbc.M403165200; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Wang QH, 2003, BIOCHEMISTRY-US, V42, P13529, DOI 10.1021/bi035391j; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460	36	468	479	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 22	2008	453	7194					481	488		10.1038/nature06926	http://dx.doi.org/10.1038/nature06926			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303EL	18497817	Green Accepted			2022-12-24	WOS:000256023700034
J	Kitano, M; Nakaya, M; Nakamura, T; Nagata, S; Matsuda, M				Kitano, Masahiro; Nakaya, Michio; Nakamura, Takeshi; Nagata, Shigekazu; Matsuda, Michiyuki			Imaging of Rab5 activity identifies essential regulators for phagosome maturation	NATURE			English	Article							APOPTOTIC CELLS; PROTEINS; MACROPHAGES; ACTIVATION; DYNAMICS; FUSION; PHAGOCYTOSIS; RECRUITMENT; RHO	Efficient phagocytosis of apoptotic cells is crucial for tissue homeostasis and the immune response(1,2). Rab5 is known as a key regulator of the early endocytic pathway(3) and we have recently shown that Rab5 is also implicated in apoptotic cell engulfment(4); however, the precise spatio- temporal dynamics of Rab5 activity remain unknown. Here, using a newly developed fluorescence resonance energy transfer biosensor, we describe a change in Rab5 activity during the engulfment of apoptotic thymocytes. Rab5 activity on phagosome membranes began to increase on disassembly of the actin coat encapsulating phagosomes. Rab5 activation was either continuous or repetitive for up to 10 min, but it ended before the collapse of engulfed apoptotic cells. Expression of a dominant-negative mutant of Rab5 delayed this collapse of apoptotic thymocytes, showing a role for Rab5 in phagosome maturation. Disruption of microtubules with nocodazole inhibited Rab5 activation on the phagosome membrane without perturbing the engulfment of apoptotic cells. Furthermore, we found that Gapex-5 is the guanine nucleotide exchange factor essential for Rab5 activation during the engulfment of apoptotic cells. Gapex- 5 was bound to a microtubule- tip- associating protein, EB1, whose depletion inhibited Rab5 activation during phagocytosis. We therefore propose a mechanistic model in which the recruitment of Gapex- 5 to phagosomes through the microtubule network induces the transient Rab5 activation.	[Kitano, Masahiro; Nakamura, Takeshi; Matsuda, Michiyuki] Kyoto Univ, Grad Sch Biostudies, Lab Bioimaging & Cell Signaling, Sakyo Ku, Kyoto 6068501, Japan; [Nakaya, Michio; Nagata, Shigekazu] Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan; [Kitano, Masahiro] Osaka Univ, Microbial Dis Res Inst, Dept Signal Transduct, Suita, Osaka 5650871, Japan; [Nakaya, Michio; Nagata, Shigekazu] Japan Sci & Technol Corp, Solut Oriented Res Sci & Technol, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Kyoto University; Osaka University; Japan Science & Technology Agency (JST)	Nakamura, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Bioimaging & Cell Signaling, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	tnakamr@path1.med.kyoto-u.ac.jp	Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426; Matsuda, Michiyuki/0000-0002-5876-9969				Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; AlvarezDominguez C, 1996, J BIOL CHEM, V271, P13834, DOI 10.1074/jbc.271.23.13834; Diakonova M, 2002, MOL BIOL CELL, V13, P402, DOI 10.1091/mbc.01-05-0273; Duclos S, 2000, J CELL SCI, V113, P3531; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Imamura H, 1998, MOL BIOL CELL, V9, P2561, DOI 10.1091/mbc.9.9.2561; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakaya M, 2006, J BIOL CHEM, V281, P8836, DOI 10.1074/jbc.M510972200; Niedergang F, 2004, CURR OPIN CELL BIOL, V16, P422, DOI 10.1016/j.ceb.2004.06.006; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Takaya A, 2004, MOL BIOL CELL, V15, P2549, DOI 10.1091/mbc.E03-11-0857; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003; Yoshizaki H, 2007, MOL BIOL CELL, V18, P119, DOI 10.1091/mbc.E06-05-0467; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014	24	108	114	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2008	453	7192					241	U15		10.1038/nature06857	http://dx.doi.org/10.1038/nature06857			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297BP	18385674	Bronze			2022-12-24	WOS:000255592400044
J	Oprea, GE; Kroeber, S; McWhorter, ML; Rossoll, W; Mueller, S; Krawczak, M; Bassell, GJ; Beattie, CE; Wirth, B				Oprea, Gabriela E.; Kroeber, Sandra; McWhorter, Michelle L.; Rossoll, Wilfried; Mueller, Stefan; Krawczak, Michael; Bassell, Gary J.; Beattie, Christine E.; Wirth, Brunhilde			Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy	SCIENCE			English	Article							DISEASE GENE-PRODUCT; MESSENGER-RNA; SMN PROTEIN; DELETIONS; IDENTIFICATION; SEVERITY	Homozygous deletion of the survival motor neuron 1 gene ( SMN1) causes spinal muscular atrophy ( SMA), the most frequent genetic cause of early childhood lethality. In rare instances, however, individuals are asymptomatic despite carrying the same SMN1 mutations as their affected siblings, thereby suggesting the influence of modifier genes. We discovered that unaffected SMN1- deleted females exhibit significantly higher expression of plastin 3 ( PLS3) than their SMA- affected counterparts. We demonstrated that PLS3 is important for axonogenesis through increasing the F- actin level. Overexpression of PLS3 rescued the axon length and outgrowth defects associated with SMN down- regulation in motor neurons of SMA mouse embryos and in zebrafish. Our study suggests that defects in axonogenesis are the major cause of SMA, thereby opening new therapeutic options for SMA and similar neuromuscular diseases.	[Oprea, Gabriela E.; Kroeber, Sandra; Wirth, Brunhilde] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Oprea, Gabriela E.; Kroeber, Sandra; Wirth, Brunhilde] Univ Cologne, Inst Genet, D-50931 Cologne, Germany; [Oprea, Gabriela E.; Mueller, Stefan; Wirth, Brunhilde] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [McWhorter, Michelle L.; Beattie, Christine E.] Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA; [McWhorter, Michelle L.; Beattie, Christine E.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Rossoll, Wilfried; Bassell, Gary J.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; [Krawczak, Michael] Univ Kiel, Inst Med Informat & Stat, D-24105 Kiel, Germany	University of Cologne; University of Cologne; University of Cologne; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Emory University; University of Kiel	Wirth, B (corresponding author), Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany.	brunhilde.wirth@uk-koeln.de	Krawczak, Michael/A-8964-2010; Oprea, Gabriela Elena/AAM-5356-2020; Wirth, Brunhilde/H-3192-2019	Krawczak, Michael/0000-0003-2603-1502; Oprea, Gabriela Elena/0000-0001-5467-5247; McWhorter, Michelle/0000-0001-6931-4946; Rossoll, Wilfried/0000-0002-9622-541X; Wirth, Brunhilde/0000-0003-4051-5191	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD001799, R01HD055835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077, R01NS050414] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD055835, P30 HD001799, HD055835, P30 HD024064] Funding Source: Medline; NINDS NIH HHS [R01 NS050414, R01NS50414, P30 NS055077] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Carrel TL, 2006, J NEUROSCI, V26, P11014, DOI 10.1523/JNEUROSCI.1637-06.2006; COBBEN JM, 1995, AM J HUM GENET, V57, P805; Delanote V, 2005, ACTA PHARMACOL SIN, V26, P769, DOI 10.1111/j.1745-7254.2005.00145.x; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; HAHNEN E, 1995, HUM MOL GENET, V4, P1927, DOI 10.1093/hmg/4.10.1927; Jablonka S, 2007, J CELL BIOL, V179, P139, DOI 10.1083/jcb.200703187; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lin CS, 1999, DNA CELL BIOL, V18, P27, DOI 10.1089/104454999315592; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Munsat T, 1996, NEUROMUSCULAR DISORD, V6, P125, DOI 10.1016/0960-8966(95)00032-1; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Prior TW, 2004, AM J MED GENET A, V130A, P307, DOI 10.1002/ajmg.a.30251; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; RUDNIKSCHONEBORN S, 1994, AM J MED GENET, V51, P70, DOI 10.1002/ajmg.1320510115; Wang CH, 1996, HUM MOL GENET, V5, P359, DOI 10.1093/hmg/5.3.359; ZERRES K, 1995, ARCH NEUROL-CHICAGO, V52, P518, DOI 10.1001/archneur.1995.00540290108025	21	363	384	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2008	320	5875					524	527		10.1126/science.1155085	http://dx.doi.org/10.1126/science.1155085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18440926	Green Accepted			2022-12-24	WOS:000255249300049
J	Sheppard, SK; McCarthy, ND; Falush, D; Maiden, MCJ				Sheppard, Samuel K.; McCarthy, Noel D.; Falush, Daniel; Maiden, Martin C. J.			Convergence of Campylobacter species: Implications for bacterial evolution	SCIENCE			English	Article							MULTILOCUS GENOTYPE DATA; JEJUNI; SPECIATION; COLI; INFERENCE; MICROEVOLUTION; RECOMBINATION; HYBRIDIZATION; HISTORY	The nature of species boundaries in bacteria remains controversial. In particular, the mechanisms of bacterial speciation and maintenance in the face of frequent genetic exchange are poorly understood. Here, we report patterns of genetic exchange that show two closely related zoonotic pathogenic species, Campylobacter jejuni and Campylobacter coli, are converging as a consequence of recent changes in gene flow. Population expansion into a novel ecological niche generated by human activity is the most probable explanation for the increase in genetic exchange between these species. Bacterial speciation can therefore occur by mechanisms analogous to those seen in metazoans, where genetic diversification and incipient speciation caused by ecological factors have been reported in several genera.	[Sheppard, Samuel K.; McCarthy, Noel D.; Falush, Daniel; Maiden, Martin C. J.] Univ Oxford, Dept Zool, Oxford OX1 3SY, England; [Sheppard, Samuel K.; McCarthy, Noel D.; Falush, Daniel; Maiden, Martin C. J.] Univ Oxford, Dept Stat, Oxford OX1 3SY, England	University of Oxford; University of Oxford	Falush, D (corresponding author), Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Lee Rd, Cork, Ireland.	d.falush@ucc.ie; martin.maiden@zoo.ox.ac.uk	Maiden, Martin C J/C-5055-2014; Maiden, Martin/N-6805-2019; McCarthy, Noel D/K-3314-2012	Maiden, Martin C J/0000-0001-6321-5138; Maiden, Martin/0000-0001-6321-5138; McCarthy, Noel/0000-0003-1113-1017; Sheppard, Samuel/0000-0001-6901-3203	Wellcome Trust [047072] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Bull SA, 2006, APPL ENVIRON MICROB, V72, P645, DOI 10.1128/AEM.72.1.645-652.2006; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Coker AO, 2002, EMERG INFECT DIS, V8, P237, DOI 10.3201/eid0803.010233; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dingle KE, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P43; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dingle KE, 2005, J CLIN MICROBIOL, V43, P340, DOI 10.1128/JCM.43.1.340-347.2005; Eggleston AK, 1997, CURR BIOL, V7, pR745, DOI 10.1016/S0960-9822(06)00394-0; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2006, PHILOS T R SOC B, V361, P2045, DOI 10.1098/rstb.2006.1925; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Gupta S, 2001, TRENDS MICROBIOL, V9, P181, DOI 10.1016/S0966-842X(01)01986-2; Hanage WP, 2006, PHILOS T R SOC B, V361, P2039, DOI 10.1098/rstb.2006.1926; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Lawrence JG, 2002, THEOR POPUL BIOL, V61, P449, DOI 10.1006/tpbi.2002.1587; Lo I, 2007, NATURE, V446, P537, DOI 10.1038/nature05624; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; McCarthy ND, 2007, EMERG INFECT DIS, V13, P267, DOI 10.3201/eid1302.060620; Meinersmann RJ, 2003, GENOME LETT, V2, P48, DOI DOI 10.1166/gl.2003.000; Narra HP, 2006, CURR BIOL, V16, pR705, DOI 10.1016/j.cub.2006.08.024; Ochman H, 1994, EXS, V69, P479; Pritchard JK, 2000, GENETICS, V155, P945; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; ROSEF O, 1983, APPL ENVIRON MICROB, V46, P855, DOI 10.1128/AEM.46.4.855-859.1983; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Samuel MC, 2004, CLIN INFECT DIS, V38, pS165, DOI 10.1086/381583; Waldenstrom J, 2002, APPL ENVIRON MICROB, V68, P5911, DOI 10.1128/AEM.68.12.5911-5917.2002; Zhu PX, 2001, P NATL ACAD SCI USA, V98, P5234, DOI 10.1073/pnas.061386098	31	179	181	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2008	320	5873					237	239		10.1126/science.1155532	http://dx.doi.org/10.1126/science.1155532			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286HJ	18403712				2022-12-24	WOS:000254836700045
J	Stepanova, AN; Robertson-Hoyt, J; Yun, J; Benavente, LM; Xie, DY; DoleZal, K; Schlereth, A; Jurgens, G; Alonso, JM				Stepanova, Anna N.; Robertson-Hoyt, Joyce; Yun, Jeonga; Benavente, Larissa M.; Xie, De-Yu; Dolezal, Karel; Schlereth, Alexandra; Juergens, Gerd; Alonso, Jose M.			TAA1-mediated auxin biosynthesis is essential for hormone crosstalk and plant development	CELL			English	Article							YUCCA FLAVIN MONOOXYGENASES; ARABIDOPSIS-THALIANA; RESPONSE PATHWAY; ETHYLENE; TRANSPORT; ENCODES; GENE; TRYPTOPHAN; GRADIENTS; MUTATION	Plants have evolved a tremendous ability to respond to environmental changes by adapting their growth and development. The interaction between hormonal and developmental signals is a critical mechanism in the generation of this enormous plasticity. A good example is the response to the hormone ethylene that depends on tissue type, developmental stage, and environmental conditions. By characterizing the Arabidopsis wei8 mutant, we have found that a small family of genes mediates tissue-specific responses to ethylene. Biochemical studies revealed that WEI8 encodes a long-anticipated tryptophan aminotransferase, TAA1, in the essential, yet genetically uncharacterized, indole-3-pyruvic acid (IPA) branch of the auxin biosynthetic pathway. Analysis of TAA1 and its paralogues revealed a link between local auxin production, tissue-specific ethylene effects, and organ development. Thus, the IPA route of auxin production is key to generating robust auxin gradients in response to environmental and developmental cues.	[Stepanova, Anna N.; Robertson-Hoyt, Joyce; Yun, Jeonga; Benavente, Larissa M.; Alonso, Jose M.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Xie, De-Yu] N Carolina State Univ, Dept Plant Biol, Raleigh, NC 27695 USA; [Dolezal, Karel] Palacky Univ, Lab Growth Regulators, CZ-78371 Olomouc, Czech Republic; [Dolezal, Karel] Inst Expt Bot ASCR, CZ-78371 Olomouc, Czech Republic; [Schlereth, Alexandra; Juergens, Gerd] Univ Tubingen, D-72076 Tubingen, Germany	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Eberhard Karls University of Tubingen	Alonso, JM (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	jmalonso@unity.ncsu.edu	Alonso, Jose M/K-6826-2014; Doležal, Karel/H-2436-2014	Alonso, Jose M/0000-0001-7087-1571; Doležal, Karel/0000-0003-4938-0350; XIE, DE-YU/0000-0002-3054-1188; STEPANOVA, ANNA/0000-0003-1018-4758				ABEL S, 1995, J BIOL CHEM, V270, P19093, DOI 10.1074/jbc.270.32.19093; Barlier I, 2000, P NATL ACAD SCI USA, V97, P14819, DOI 10.1073/pnas.260502697; Bartel B, 1997, ANNU REV PLANT PHYS, V48, P49; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bennett M, 2005, PHYSIOL PLANTARUM, V123, P109, DOI 10.1111/j.1399-3054.2005.00483.x; BOERJAN W, 1995, PLANT CELL, V7, P1405, DOI 10.1105/tpc.7.9.1405; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Cheng YF, 2007, PLANT CELL, V19, P2430, DOI 10.1105/tpc.107.053009; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cohen JD, 2003, TRENDS PLANT SCI, V8, P197, DOI 10.1016/S1360-1385(03)00058-X; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; EDLUND A, 1995, PLANT PHYSIOL, V108, P1043, DOI 10.1104/pp.108.3.1043; FERREIRA GC, 1993, PROTEIN SCI, V2, P1959, DOI 10.1002/pro.5560021117; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Gray WM, 1998, P NATL ACAD SCI USA, V95, P7197, DOI 10.1073/pnas.95.12.7197; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Hamann T, 1999, DEVELOPMENT, V126, P1387; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Jiang K, 2005, ANNU REV CELL DEV BI, V21, P485, DOI 10.1146/annurev.cellbio.21.122303.114753; KANG BG, 1967, SCIENCE, V156, P958, DOI 10.1126/science.156.3777.958; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Lauber MH, 1997, J CELL BIOL, V139, P1485, DOI 10.1083/jcb.139.6.1485; Li H, 2004, DEV CELL, V7, P193, DOI 10.1016/j.devcel.2004.07.002; Liepman AH, 2004, CRIT REV PLANT SCI, V23, P73, DOI 10.1080/07352680490273419; Ljung K, 2005, PLANT CELL, V17, P1090, DOI 10.1105/tpc.104.029272; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Muday GK, 2001, J PLANT GROWTH REGUL, V20, P226, DOI 10.1007/s003440010027; Nawy T, 2005, PLANT CELL, V17, P1908, DOI 10.1105/tpc.105.031724; Nemhauser JL, 2000, DEVELOPMENT, V127, P3877; Ortega-Martinez O, 2007, SCIENCE, V317, P507, DOI 10.1126/science.1143409; Pedraza RO, 2004, FEMS MICROBIOL LETT, V233, P15, DOI 10.1016/j.femsle.2004.01.047; Ruzicka K, 2007, PLANT CELL, V19, P2197, DOI 10.1105/tpc.107.052126; Sohlberg JJ, 2006, PLANT J, V47, P112, DOI 10.1111/j.1365-313X.2006.02775.x; Stepanova AN, 2005, PHYSIOL PLANTARUM, V123, P195, DOI 10.1111/j.1399-3054.2005.00447.x; Stepanova AN, 2005, PLANT CELL, V17, P2230, DOI 10.1105/tpc.105.033365; Stepanova AN, 2007, PLANT CELL, V19, P2169, DOI 10.1105/tpc.107.052068; Swarup R, 2002, PLANT MOL BIOL, V49, P411; Swarup R, 2007, PLANT CELL, V19, P2186, DOI 10.1105/tpc.107.052100; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; Till BJ, 2004, NUCLEIC ACIDS RES, V32, P2632, DOI 10.1093/nar/gkh599; Vieten A, 2007, TRENDS PLANT SCI, V12, P160, DOI 10.1016/j.tplants.2007.03.006; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Weijers D, 2006, DEV CELL, V10, P265, DOI 10.1016/j.devcel.2005.12.001; Weijers D, 2005, PLANT CELL, V17, P2517, DOI 10.1105/tpc.105.034637; Xu J, 2006, SCIENCE, V311, P385, DOI 10.1126/science.1121790; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402	48	758	809	12	202	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 4	2008	133	1					177	191		10.1016/j.cell.2008.01.047	http://dx.doi.org/10.1016/j.cell.2008.01.047			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	283MW	18394997	Bronze			2022-12-24	WOS:000254641300018
J	Tao, Y; Ferrer, JL; Ljung, K; Pojer, F; Hong, FX; Long, JA; Li, L; Moreno, JE; Bowman, ME; Ivans, LJ; Cheng, YF; Lim, J; Zhao, YD; Ballare, CL; Sandberg, G; Noel, JP; Chory, J				Tao, Yi; Ferrer, Jean-Luc; Ljung, Karin; Pojer, Florence; Hong, Fangxin; Long, Jeff A.; Li, Lin; Moreno, Javier E.; Bowman, Marianne E.; Ivans, Lauren J.; Cheng, Youfa; Lim, Jason; Zhao, Yunde; Ballare, Carlos L.; Sandberg, Goeran; Noel, Joseph P.; Chory, Joanne			Rapid synthesis of auxin via a new tryptophan-dependent pathway is required for shade avoidance in plants	CELL			English	Article							AMINO-ACID AMINOTRANSFERASES; ENTEROBACTER-CLOACAE; INDOLE-3-ACETIC-ACID BIOSYNTHESIS; INDOLEPYRUVATE DECARBOXYLASE; INDOLE-3-PYRUVIC ACID; ARABIDOPSIS-THALIANA; REACTION SPECIFICITY; INDOLEACETIC-ACID; LIGHT QUALITY; PHYTOCHROME-B	Plants grown at high densities perceive a decrease in the red to far-red (R:FR) ratio of incoming light, resulting from absorption of red light by canopy leaves and reflection of far-red light from neighboring plants. These changes in light quality trigger a series of responses known collectively as the shade avoidance syndrome. During shade avoidance, stems elongate at the expense of leaf and storage organ expansion, branching is inhibited, and flowering is accelerated. We identified several loci in Arabidopsis, mutations in which lead to plants defective in multiple shade avoidance responses. Here we describe TAA1, an aminotransferase, and show that TAA1 catalyzes the formation of indole-3-pyruvic acid (IPA) from L-tryptophan (L-Trp), the first step in a previously proposed, but uncharacterized, auxin biosynthetic pathway. This pathway is rapidly deployed to synthesize auxin at the high levels required to initiate the multiple changes in body plan associated with shade avoidance.	[Tao, Yi; Pojer, Florence; Hong, Fangxin; Bowman, Marianne E.; Lim, Jason; Noel, Joseph P.; Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Tao, Yi; Hong, Fangxin; Long, Jeff A.; Li, Lin; Ivans, Lauren J.; Lim, Jason; Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Ferrer, Jean-Luc] UJF, CNRS, CEA, Inst Biol Struct,Lab Cristallog & Cristallogenese, F-38027 Grenoble, France; [Ferrer, Jean-Luc; Pojer, Florence; Bowman, Marianne E.; Noel, Joseph P.] Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Proteom, La Jolla, CA 92037 USA; [Ljung, Karin] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, SE-90183 Umea, Sweden; [Hong, Fangxin] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Moreno, Javier E.; Ballare, Carlos L.] Consejo Nacl Invest Cient & Tecn, Inst Invest Fisiol & Ecol Vinculadas Agr, Buenos Aires, DF, Argentina; [Moreno, Javier E.; Ballare, Carlos L.] Univ Buenos Aires, Buenos Aires, DF, Argentina; [Ivans, Lauren J.; Cheng, Youfa; Zhao, Yunde] Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA; [Sandberg, Goeran] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, SE-90187 Umea, Sweden	Howard Hughes Medical Institute; Salk Institute; Salk Institute; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Salk Institute; Swedish University of Agricultural Sciences; Umea University; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of California System; University of California San Diego; Umea University	Chory, J (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.	chory@salk.edu	Cheng, Youfa/E-4187-2012; Tao, Yi/B-7718-2012; Zhao, Yunde/AAC-5360-2019; Ljung, Karin/AAE-8691-2019; Noel, Joseph P/A-9459-2009; Ballare, Carlos L/F-5141-2011	Ljung, Karin/0000-0003-2901-189X; Ballare, Carlos L/0000-0001-9129-4531; Tao, Yi/0000-0002-7460-7927; Moreno, Javier/0000-0001-9763-5325; Li, Lin/0000-0003-4840-5245	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM052413, GM52413, R01 GM052413-13] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052413] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aitken SM, 2005, ARCH BIOCHEM BIOPHYS, V433, P166, DOI 10.1016/j.abb.2004.08.024; Aloni R, 2003, PLANTA, V216, P841, DOI 10.1007/s00425-002-0937-8; BACA BE, 1994, SOIL BIOL BIOCHEM, V26, P57, DOI 10.1016/0038-0717(94)90195-3; BADENOCHJONES J, 1982, BIOMED MASS SPECTROM, V9, P429, DOI 10.1002/bms.1200091005; Ballare CL, 1999, TRENDS PLANT SCI, V4, P97, DOI 10.1016/S1360-1385(99)01383-7; Ballare CL, 1997, PLANT CELL ENVIRON, V20, P820, DOI 10.1046/j.1365-3040.1997.d01-112.x; Cerdan PD, 2003, NATURE, V423, P881, DOI 10.1038/nature01636; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Devlin PF, 2003, PLANT PHYSIOL, V133, P1617, DOI 10.1104/pp.103.034397; DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712; Franklin KA, 2005, ANN BOT-LONDON, V96, P169, DOI 10.1093/aob/mci165; Gray WM, 1998, P NATL ACAD SCI USA, V95, P7197, DOI 10.1073/pnas.95.12.7197; HALLIDAY KJ, 1994, PLANT PHYSIOL, V104, P1311, DOI 10.1104/pp.104.4.1311; Hisamatsu T, 2005, PLANT PHYSIOL, V138, P1106, DOI 10.1104/pp.104.059055; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Izaguirre MM, 2006, P NATL ACAD SCI USA, V103, P7170, DOI 10.1073/pnas.0509805103; JEFFERSON RA, 1987, EMBO J, V6, P3901; JONES AM, 1991, PLANT PHYSIOL, V97, P352, DOI 10.1104/pp.97.1.352; KANESHIRO T, 1983, CURR MICROBIOL, V8, P301, DOI 10.1007/BF01577732; Kanyuka K, 2003, PLANT J, V35, P57, DOI 10.1046/j.1365-313X.2003.01779.x; Kim BC, 1998, PLANT J, V15, P61, DOI 10.1046/j.1365-313X.1998.00179.x; KOGA J, 1994, BBA-PROTEIN STRUCT M, V1209, P241, DOI 10.1016/0167-4838(94)90191-0; KOGA J, 1992, J BIOL CHEM, V267, P15823; KOGA J, 1991, MOL GEN GENET, V226, P10, DOI 10.1007/BF00273581; Kuettner EB, 2002, ARCH BIOCHEM BIOPHYS, V402, P192, DOI 10.1016/S0003-9861(02)00088-7; Kuettner EB, 2002, J BIOL CHEM, V277, P46402, DOI 10.1074/jbc.M208669200; Kurepin LV, 2007, J EXP BOT, V58, P2145, DOI 10.1093/jxb/erm068; Ljung K, 2005, PLANT CELL, V17, P1090, DOI 10.1105/tpc.104.029272; Luccioni LG, 2002, PLANT PHYSIOL, V128, P173, DOI 10.1104/pp.010668; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; MATHERON ME, 1973, PLANT PHYSIOL, V52, P63, DOI 10.1104/pp.52.1.63; Morelli G, 2000, PLANT PHYSIOL, V122, P621, DOI 10.1104/pp.122.3.621; Morelli G, 2002, TRENDS PLANT SCI, V7, P399, DOI 10.1016/S1360-1385(02)02314-2; Neff MM, 1999, P NATL ACAD SCI USA, V96, P15316, DOI 10.1073/pnas.96.26.15316; Peng J, 1997, PLANT PHYSIOL, V113, P1051, DOI 10.1104/pp.113.4.1051; Pierik R, 2004, PLANT PHYSIOL, V136, P2928, DOI 10.1104/pp.104.045120; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Salter MG, 2003, NATURE, V426, P680, DOI 10.1038/nature02174; Sessa G, 2005, GENE DEV, V19, P2811, DOI 10.1101/gad.364005; SNUSTAD DP, 1992, PLANT CELL, V4, P549, DOI 10.1105/tpc.4.5.549; Sorin C, 2005, PLANT CELL, V17, P1343, DOI 10.1105/tpc.105.031625; SotoUrzua L, 1996, CAN J MICROBIOL, V42, P294, DOI 10.1139/m96-043; Steindler C, 1999, DEVELOPMENT, V126, P4235; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Tam YY, 1998, J CHROMATOGR A, V800, P101, DOI 10.1016/S0021-9673(97)01051-0; Tanaka SI, 2002, PLANT CELL PHYSIOL, V43, P1171, DOI 10.1093/pcp/pcf133; TRUELSEN TA, 1972, PHYSIOL PLANTARUM, V26, P289, DOI 10.1111/j.1399-3054.1972.tb01110.x; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402	52	720	766	13	231	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 4	2008	133	1					164	176		10.1016/j.cell.2008.01.049	http://dx.doi.org/10.1016/j.cell.2008.01.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	283MW	18394996	Bronze, Green Accepted			2022-12-24	WOS:000254641300017
J	Nagalakshmi, U; Wang, Z; Waern, K; Shou, C; Raha, D; Gerstein, M; Snyder, M				Nagalakshmi, Ugrappa; Wang, Zhong; Waern, Karl; Shou, Chong; Raha, Debasish; Gerstein, Mark; Snyder, Michael			The transcriptional landscape of the yeast genome defined by RNA sequencing	SCIENCE			English	Article							GENE	The identification of untranslated regions, introns, and coding regions within an organism remains challenging. We developed a quantitative sequencing- based method called RNA- Seq for mapping transcribed regions, in which complementary DNA fragments are subjected to high- throughput sequencing and mapped to the genome. We applied RNA- Seq to generate a high- resolution transcriptome map of the yeast genome and demonstrated that most ( 74.5%) of the nonrepetitive sequence of the yeast genome is transcribed. We confirmed many known and predicted introns and demonstrated that others are not actively used. Alternative initiation codons and upstream open reading frames also were identified for many yeast genes. We also found unexpected 3'- end heterogeneity and the presence of many overlapping genes. These results indicate that the yeast transcriptome is more complex than previously appreciated.	[Nagalakshmi, Ugrappa; Wang, Zhong; Waern, Karl; Raha, Debasish; Snyder, Michael] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Shou, Chong; Gerstein, Mark; Snyder, Michael] Yale Univ, Program Comp Sci & Computat Biol, New Haven, CT 06520 USA; [Gerstein, Mark; Snyder, Michael] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Snyder, M (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	michael.snyder@yale.edu	Wang, Zhong/E-7897-2011; Wang, Zhong/J-3244-2019; Albers, Pieter/I-2563-2017	Wang, Zhong/0000-0002-6307-0458; Snyder, Michael/0000-0003-0784-7987	NATIONAL CANCER INSTITUTE [R01CA077808] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002357] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA077808, R01 CA077808-12] Funding Source: Medline; NHGRI NIH HHS [P50 HG002357, P50 HG002357-10] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ADAMS MD, 1995, NATURE, V377, P3; ALBRIGHT CF, 1990, J BIOL CHEM, V265, P7042; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Gerstein MB, 2007, GENOME RES, V17, P669, DOI 10.1101/gr.6339607; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Juneau K, 2007, P NATL ACAD SCI USA, V104, P1522, DOI 10.1073/pnas.0610354104; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Perocchi F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm683; Ruiz-Echevarria MJ, 2000, CELL, V101, P741, DOI 10.1016/S0092-8674(00)80886-7; Snyder M, 2003, SCIENCE, V300, P258, DOI 10.1126/science.1084354	16	1699	1781	11	391	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2008	320	5881					1344	1349		10.1126/science.1158441	http://dx.doi.org/10.1126/science.1158441			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309DO	18451266	Green Accepted			2022-12-24	WOS:000256441100046
J	Cavey, M; Rauzi, M; Lenne, PF; Lecuit, T				Cavey, Matthieu; Rauzi, Matteo; Lenne, Pierre-Francois; Lecuit, Thomas			A two-tiered mechanism for stabilization and immobilization of E-cadherin	NATURE			English	Article							SINGLE-PARTICLE TRACKING; CELL-CELL ADHESION; ADHERENS JUNCTIONS; EPITHELIAL-CELLS; ALPHA-CATENIN; DROSOPHILA EMBRYO; ACTIN; POLARITY; ENDOCYTOSIS; MEMBRANE	Epithelial tissues maintain a robust architecture which is important for their barrier function, but they are also remodelled through the reorganization of cell - cell contacts. Tissue stability requires intercellular adhesion mediated by E- cadherin, in particular its trans- association in homophilic complexes supported by actin filaments through beta- and alpha- catenin. How alpha- catenin dynamic interactions between E- cadherin/ beta- catenin and cortical actin control both stability and remodelling of adhesion is unclear. Here we focus on Drosophila homophilic E- cadherin complexes rather than total E- cadherin, including diffusing 'free' E- cadherin, because these complexes are a better proxy for adhesion. We find that E- cadherin complexes partition in very stable microdomains ( that is, bona fide adhesive foci which are more stable than remodelling contacts). Furthermore, we find that stability and mobility of these microdomains depend on two actin populations: small, stable actin patches concentrate at homophilic E- cadherin clusters, whereas a rapidly turning over, contractile network constrains their lateral movement by a tethering mechanism. alpha- Catenin controls epithelial architecture mainly through regulation of the mobility of homophilic clusters and it is largely dispensable for their stability. Uncoupling stability and mobility of E- cadherin complexes suggests that stable epithelia may remodel through the regulated mobility of very stable adhesive foci.	[Cavey, Matthieu; Rauzi, Matteo; Lecuit, Thomas] Univ Aix Marseille 2, CNRS, Inst Biol Dev Marseille Luminy, UMR 6216, F-13288 Marseille 09, France; [Rauzi, Matteo; Lenne, Pierre-Francois] Univ Aix Marseille 3, CNRS, Inst Fresnel, UMR 6133, F-13397 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Lecuit, T (corresponding author), Univ Aix Marseille 2, CNRS, Inst Biol Dev Marseille Luminy, UMR 6216, Campus Luminy Case 907, F-13288 Marseille 09, France.	lenne@fresnel.fr; lecuit@ibdm.univ-mrs.fr	Ladoux, Benoit/A-9879-2013	Lenne, Pierre-Francois/0000-0003-1066-7506; Rauzi, Matteo/0000-0002-6313-0668				Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Adams CL, 1998, CURR OPIN CELL BIOL, V10, P572, DOI 10.1016/S0955-0674(98)80031-8; Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Bogdan S, 2005, NAT CELL BIOL, V7, P977, DOI 10.1038/ncb1305; CAVEY M, 2008, IMAGING CELLULAR MOL; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; Cliffe A, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-37; Cox RT, 1996, J CELL BIOL, V134, P133, DOI 10.1083/jcb.134.1.133; Dutta D, 2002, GENESIS, V34, P146, DOI 10.1002/gene.10113; Gates J, 2005, CELL, V123, P769, DOI 10.1016/j.cell.2005.11.009; Harris TJC, 2005, J CELL BIOL, V170, P813, DOI 10.1083/jcb.200505127; Izumi G, 2004, J CELL BIOL, V166, P237, DOI 10.1083/jcb.200401078; Kametani Y, 2007, NAT CELL BIOL, V9, P92, DOI 10.1038/ncb1520; KARTENBECK J, 1991, J CELL BIOL, V113, P881, DOI 10.1083/jcb.113.4.881; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Kofron M, 1997, DEVELOPMENT, V124, P1553; Konig K, 2000, J MICROSC-OXFORD, V200, P83, DOI 10.1046/j.1365-2818.2000.00738.x; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Leckband D, 2006, ANNU REV BIOMED ENG, V8, P259, DOI 10.1146/annurev.bioeng.8.061505.095753; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Oda H, 1998, DEV BIOL, V203, P435, DOI 10.1006/dbio.1998.9047; Oda H, 2001, J CELL SCI, V114, P493; Pilot F, 2006, NATURE, V442, P580, DOI 10.1038/nature04935; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Sako Y, 1998, J CELL BIOL, V140, P1227, DOI 10.1083/jcb.140.5.1227; Saxton MJ, 1997, BIOPHYS J, V72, P1744, DOI 10.1016/S0006-3495(97)78820-9; Somogyi K, 2004, DEV CELL, V7, P85, DOI 10.1016/j.devcel.2004.05.020; TEPASS U, 1994, DEV BIOL, V161, P563, DOI 10.1006/dbio.1994.1054; Thiery JP, 2003, CURR OPIN GENET DEV, V13, P365, DOI 10.1016/S0959-437X(03)00088-1; Torres M, 1997, P NATL ACAD SCI USA, V94, P901, DOI 10.1073/pnas.94.3.901; Troyanovsky RB, 2006, MOL BIOL CELL, V17, P3484, DOI 10.1091/mbc.E06-03-0190; TSUJI A, 1986, BIOCHEMISTRY-US, V25, P6133, DOI 10.1021/bi00368a045; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020	42	303	308	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2008	453	7196					751	U2		10.1038/nature06953	http://dx.doi.org/10.1038/nature06953			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308UK	18480755				2022-12-24	WOS:000256415300036
J	McGinty, RK; Kim, J; Chatterjee, C; Roeder, RG; Muir, TW				McGinty, Robert K.; Kim, Jaehoon; Chatterjee, Champak; Roeder, Robert G.; Muir, Tom W.			Chemically ubiquitylated histone H2B stimulates hDot1L-mediated intranucleosomal methylation	NATURE			English	Article							H3 METHYLATION; UBIQUITINATION; CYSTEINE; DOT1P; YEAST; CORE; MONOUBIQUITINATION; LIGATION; PROTEINS; DOMAIN	Numerous post- translational modifications of histones have been described in organisms ranging from yeast to humans(1). Growing evidence for dynamic regulation of these modifications, position- and modification- specific protein interactions, and biochemical crosstalk between modifications has strengthened the 'histone code' hypothesis, in which histone modifications are integral to choreographing the expression of the genome(1,2). One such modification, ubiquitylation of histone H2B ( uH2B) on lysine 120 ( K120) in humans(3), and lysine 123 in yeast(4), has been correlated with enhanced methylation of lysine 79 ( K79) of histone H3 ( refs 5 - 8), by K79- specific methyltransferase Dot1 ( KMT4)(9-11). However, the specific function of uH2B in this crosstalk pathway is not understood. Here we demonstrate, using chemically ubiquitylated H2B, a direct stimulation of hDot1L- mediated intranucleosomal methylation of H3 K79. Two traceless orthogonal expressed protein ligation ( EPL) reactions were used to ubiquitylate H2B site- specifically. This strategy, using a photolytic ligation auxiliary and a desulphurization reaction, should be generally applicable to the chemical ubiquitylation of other proteins. Reconstitution of our uH2B into chemically defined nucleosomes, followed by biochemical analysis, revealed that uH2B directly activates methylation of H3 K79 by hDot1L. This effect is mediated through the catalytic domain of hDot1L, most likely through allosteric mechanisms. Furthermore, asymmetric incorporation of uH2B into dinucleosomes showed that the enhancement of methylation was limited to nucleosomes bearing uH2B. This work demonstrates a direct biochemical crosstalk between two modifications on separate histone proteins within a nucleosome.	[McGinty, Robert K.; Chatterjee, Champak; Muir, Tom W.] Rockefeller Univ, Lab Synth Prot Chem, New York, NY 10065 USA; [Kim, Jaehoon; Roeder, Robert G.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA	Rockefeller University; Rockefeller University	Muir, TW (corresponding author), Rockefeller Univ, Lab Synth Prot Chem, New York, NY 10065 USA.	muirt@rockefeller.edu	Muir, Tom/AHD-0860-2022; Chatterjee, Champak/R-7214-2017; Kim, Jaehoon/G-2711-2011	Muir, Tom/0000-0001-9635-0344; Kim, Jaehoon/0000-0003-4035-0438	NCI NIH HHS [R01 CA129325] Funding Source: Medline; NIGMS NIH HHS [R01 GM086868, T32 GM007739, GM07739] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739, R01GM086868] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Chatterjee C, 2007, ANGEW CHEM INT EDIT, V46, P2814, DOI 10.1002/anie.200605155; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; Henry KW, 2002, NAT STRUCT BIOL, V9, P565, DOI 10.1038/nsb0802-565; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Muralidharan V, 2006, NAT METHODS, V3, P429, DOI 10.1038/NMETH886; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Owen-Hughes T, 1999, METH MOL B, V119, P319; Pentelute BL, 2007, ORG LETT, V9, P687, DOI 10.1021/ol0630144; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Sawada K, 2004, J BIOL CHEM, V279, P43296, DOI 10.1074/jbc.M405902200; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Smith AB, 2002, ORG LETT, V4, P4041, DOI 10.1021/ol026736d; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; WANG SS, 1977, J ORG CHEM, V42, P1286, DOI 10.1021/jo00428a004; WEST MHP, 1980, NUCLEIC ACIDS RES, V8, P4671, DOI 10.1093/nar/8.20.4671; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Yan LZ, 2001, J AM CHEM SOC, V123, P526, DOI 10.1021/ja003265m; Zheng CY, 2003, J BIOL CHEM, V278, P24217, DOI 10.1074/jbc.M302817200; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	37	398	407	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2008	453	7196					812	U12		10.1038/nature06906	http://dx.doi.org/10.1038/nature06906			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308UK	18449190	Green Accepted, Green Published			2022-12-24	WOS:000256415300050
J	Loose, M; Fischer-Friedrich, E; Ries, J; Kruse, K; Schwille, P				Loose, Martin; Fischer-Friedrich, Elisabeth; Ries, Jonas; Kruse, Karsten; Schwille, Petra			Spatial regulators for bacterial cell division self-organize into surface waves in vitro	SCIENCE			English	Article							ESCHERICHIA-COLI; MIN-PROTEINS; PATTERN-FORMATION; POLE OSCILLATION; RAPID POLE; RING; LOCALIZATION; INHIBITOR; MEMBRANE; SEPTUM	In the bacterium Escherichia coli, the Min proteins oscillate between the cell poles to select the cell center as division site. This dynamic pattern has been proposed to arise by self- organization of these proteins, and several models have suggested a reaction- diffusion type mechanism. Here, we found that the Min proteins spontaneously formed planar surface waves on a flat membrane in vitro. The formation and maintenance of these patterns, which extended for hundreds of micrometers, required adenosine 5 '- triphosphate (ATP), and they persisted for hours. We present a reaction- diffusion model of the MinD and MinE dynamics that accounts for our experimental observations and also captures the in vivo oscillations.	[Kruse, Karsten] Univ Saarland, D-66041 Saarbrucken, Germany; [Loose, Martin; Ries, Jonas; Schwille, Petra] Tech Univ Dresden, Biotechnol Zentrum, D-01307 Dresden, Germany; [Loose, Martin; Schwille, Petra] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Fischer-Friedrich, Elisabeth] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany	Saarland University; Technische Universitat Dresden; Max Planck Society; Max Planck Society	Kruse, K (corresponding author), Univ Saarland, Postfach 151150, D-66041 Saarbrucken, Germany.	k.kruse@physik.uni-saarland.de; petra.schwille@biotec.tu-dresden.de	Ries, Jonas/Q-5157-2019; Schwille, Petra/A-4983-2010; Kruse, Karsten/GOG-8298-2022; Fischer-Friedrich, Elisabeth/B-2697-2017; Ries, Jonas/P-3027-2014	Kruse, Karsten/0000-0001-8665-2349; Fischer-Friedrich, Elisabeth/0000-0002-2433-916X; Ries, Jonas/0000-0002-6640-9250; Loose, Martin/0000-0001-7309-9724				BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; Fischer-Friedrich E, 2007, PHYS BIOL, V4, P38, DOI 10.1088/1478-3975/4/1/005; Hale CA, 2001, EMBO J, V20, P1563, DOI 10.1093/emboj/20.7.1563; Hu ZL, 2003, MOL MICROBIOL, V47, P345, DOI 10.1046/j.1365-2958.2003.03321.x; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Huang KC, 2003, P NATL ACAD SCI USA, V100, P12724, DOI 10.1073/pnas.2135445100; Karsenti E, 2008, NAT REV MOL CELL BIO, V9, P255, DOI 10.1038/nrm2357; Kruse K, 2007, MOL MICROBIOL, V63, P1279, DOI 10.1111/j.1365-2958.2007.05607.x; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Meacci G, 2006, PHYS BIOL, V3, P255, DOI 10.1088/1478-3975/3/4/003; Meacci G, 2005, PHYS BIOL, V2, P89, DOI 10.1088/1478-3975/2/2/002; Meinhardt H, 2001, P NATL ACAD SCI USA, V98, P14202, DOI 10.1073/pnas.251216598; Nicolis G., 1977, SELF ORG NONEQUILIBR; Raskin DM, 1997, CELL, V91, P685, DOI 10.1016/S0092-8674(00)80455-9; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; TURING AM, 1990, B MATH BIOL, V52, P153, DOI 10.1007/BF02459572	20	373	378	5	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2008	320	5877					789	792		10.1126/science.1154413	http://dx.doi.org/10.1126/science.1154413			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18467587				2022-12-24	WOS:000255644400039
J	Carlile, TM; Amon, A				Carlile, Thomas M.; Amon, Angelika			Meiosis I is established through division-specific translational control of a cyclin	CELL			English	Article							B-TYPE CYCLINS; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; CHROMOSOME SEGREGATION; CDC14 PHOSPHATASE; PROTEIN-KINASE; YEAST MEIOSIS; ANAPHASE; MITOSIS; CDC28	In budding yeast, key meiotic events such as DNA replication, recombination, and the meiotic divisions are controlled by Clb cyclin-dependent kinases (Clb-CDKs). Using a novel synchronization procedure, we have characterized the activity of these Clb-CDKs and observed a surprising diversity in their regulation during the meiotic divisions. Clb1-CDK activity is restricted to meiosis I, and Clb3-CDK activity to meiosis II, through 5'UTR-mediated translational control of its transcript. The analysis of cells inappropriately producing Clb3-CDKs during meiosis I furthermore defines Clb3 as an inhibitor of the meiosis I chromosome segregation program. Our results demonstrate an essential role for Clb-CDK regulation in establishing the meiotic chromosome segregation pattern.	[Carlile, Thomas M.; Amon, Angelika] MIT, Ctr Canc Res, Cambridge, MA 02139 USA; [Carlile, Thomas M.; Amon, Angelika] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, Ctr Canc Res, E17-233,40 Ames St, Cambridge, MA 02139 USA.	angelika@mit.edu		Amon, Angelika/0000-0001-9837-0314; Carlile, Thomas/0000-0002-7699-9354	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062207] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM062207-07, R01 GM062207, GM62207] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Buonomo SBC, 2003, DEV CELL, V4, P727, DOI 10.1016/S1534-5807(03)00129-1; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; COLLART MA, 1993, CURRENT PROTOCOLS MO, V2; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; CROSS FR, 1991, CELL, V65, P875, DOI 10.1016/0092-8674(91)90394-E; DAHMANN C, 1995, GENETICS, V140, P957; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Dirick L, 1998, SCIENCE, V281, P1854, DOI 10.1126/science.281.5384.1854; Henderson KA, 2006, CELL, V125, P1321, DOI 10.1016/j.cell.2006.04.039; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hochwagen A, 2005, MOL CELL BIOL, V25, P4767, DOI 10.1128/MCB.25.11.4767-4781.2005; Ishiguro K, 2007, J CELL SCI, V120, P367, DOI 10.1242/jcs.03324; Katis VL, 2004, CURR BIOL, V14, P2183, DOI 10.1016/j.cub.2004.12.020; Kiburz BM, 2008, MOL BIOL CELL, V19, P1199, DOI 10.1091/mbc.E07-06-0584; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; Marston AL, 2003, DEV CELL, V4, P711, DOI 10.1016/S1534-5807(03)00130-8; MCCARROLL RM, 1994, GENETICS, V138, P47; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Monje-Casas F, 2007, CELL, V128, P477, DOI 10.1016/j.cell.2006.12.040; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Picard D, 1999, NUCL RECEPTORS PRACT, P261; Salah SM, 2000, CHROMOSOMA, V109, P27, DOI 10.1007/s004120050409; Shonn MA, 2002, GENE DEV, V16, P1659, DOI 10.1101/gad.975802; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; Stuart D, 1998, GENE DEV, V12, P2698, DOI 10.1101/gad.12.17.2698; Sudo T, 2001, EMBO J, V20, P6499, DOI 10.1093/emboj/20.22.6499; Vardy L, 2007, DEV CELL, V12, P157, DOI 10.1016/j.devcel.2006.10.017; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; XU L, 1995, MOL CELL BIOL, V12, P6572; Zachariae W, 1996, MOL BIOL CELL, V7, P791, DOI 10.1091/mbc.7.5.791	39	137	138	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 18	2008	133	2					280	291		10.1016/j.cell.2008.02.032	http://dx.doi.org/10.1016/j.cell.2008.02.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	289JY	18423199	Green Accepted, Bronze			2022-12-24	WOS:000255052000017
J	Dekker, J				Dekker, Job			Gene regulation in the third dimension	SCIENCE			English	Editorial Material							CHROMOSOME CONFORMATION CAPTURE; BETA-GLOBIN LOCUS; X-INACTIVATION; ORGANIZATION; EXPRESSION; TRANSCRIPTION; MOUSE		Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Dekker, J (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, 364 Plantat St, Worcester, MA 01605 USA.	Job.Dekker@umassmed.edu			NHGRI NIH HHS [R01 HG003143, R01 HG003143-04, HG003143] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; Engel JD, 2000, CELL, V100, P499, DOI 10.1016/S0092-8674(00)80686-8; Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023; Grass JA, 2006, MOL CELL BIOL, V26, P7056, DOI 10.1128/MCB.01033-06; Jing HI, 2008, MOL CELL, V29, P232, DOI 10.1016/j.molcel.2007.11.020; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Simonis M, 2007, NAT METHODS, V4, P895, DOI 10.1038/NMETH1114; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vernimmen D, 2007, EMBO J, V26, P2041, DOI 10.1038/sj.emboj.7601654; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; Wold B, 2008, NAT METHODS, V5, P19, DOI 10.1038/NMETH1157; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891; Zhou GL, 2006, MOL CELL BIOL, V26, P5096, DOI 10.1128/MCB.02454-05	25	178	185	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 28	2008	319	5871					1793	1794		10.1126/science.1152850	http://dx.doi.org/10.1126/science.1152850			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279ZF	18369139	Green Accepted, Green Submitted			2022-12-24	WOS:000254394000036
J	Kim, IJ; Zhang, YF; Yamagata, M; Meister, M; Sanes, JR				Kim, In-Jung; Zhang, Yifeng; Yamagata, Masahito; Meister, Markus; Sanes, Joshua R.			Molecular identification of a retinal cell type that responds to upward motion	NATURE			English	Article							GANGLION-CELLS; ADHESION MOLECULES; SELECTIVE UNITS; MOUSE; MORPHOLOGIES; PARALLEL; RECEPTOR	The retina contains complex circuits of neurons that extract salient information from visual inputs. Signals from photoreceptors are processed by retinal interneurons, integrated by retinal ganglion cells ( RGCs) and sent to the brain by RGC axons. Distinct types of RGC respond to different visual features, such as increases or decreases in light intensity ( ON and OFF cells, respectively), colour or moving objects(1-5). Thus, RGCs comprise a set of parallel pathways from the eye to the brain. The identification of molecular markers for RGC subsets will facilitate attempts to correlate their structure with their function, assess their synaptic inputs and targets, and study their diversification. Here we show, by means of a transgenic marking method, that junctional adhesion molecule B ( JAM- B) marks a previously unrecognized class of OFF RGCs in mice. These cells have asymmetric dendritic arbors aligned in a dorsal- to- ventral direction across the retina. Their receptive fields are also asymmetric and respond selectively to stimuli moving in a soma- to- dendrite direction; because the lens reverses the image of the world on the retina, these cells detect upward motion in the visual field. Thus, JAM- B identifies a unique population of RGCs in which structure corresponds remarkably to function.	[Kim, In-Jung; Zhang, Yifeng; Yamagata, Masahito; Meister, Markus; Sanes, Joshua R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Kim, In-Jung; Zhang, Yifeng; Yamagata, Masahito; Meister, Markus; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Meister, M (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	meister@fas.harvard.edu; sanesj@mcb.harvard.edu	Yamagata, Masahito/H-6695-2016	Yamagata, Masahito/0000-0001-8193-2931; Meister, Markus/0000-0003-2136-6506				AMTHOR FR, 1989, J COMP NEUROL, V280, P72, DOI 10.1002/cne.902800107; Badea TC, 2004, J COMP NEUROL, V480, P331, DOI 10.1002/cne.20304; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; BARNSTABLE CJ, 1984, NEUROSCIENCE, V11, P847, DOI 10.1016/0306-4522(84)90195-7; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Braz JM, 2002, P NATL ACAD SCI USA, V99, P15148, DOI 10.1073/pnas.222546999; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Coombs J, 2006, NEUROSCIENCE, V140, P123, DOI 10.1016/j.neuroscience.2006.02.079; CRONER LJ, 1995, VISION RES, V35, P7, DOI 10.1016/0042-6989(94)E0066-T; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; DRAGER UC, 1975, J NEUROPHYSIOL, V38, P690, DOI 10.1152/jn.1975.38.3.690; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fox MA, 2007, J COMP NEUROL, V503, P280, DOI 10.1002/cne.21381; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; Giolli RA, 2006, PROG BRAIN RES, V151, P407, DOI 10.1016/S0079-6123(05)51013-6; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Jakobs TC, 2003, J COMP NEUROL, V465, P361, DOI 10.1002/cne.10845; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lin B, 2000, EUR J NEUROSCI, V12, P4155, DOI 10.1111/j.1460-9568.2000.01311.x; Ling CY, 1998, VISUAL NEUROSCI, V15, P559; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; Nelson R, 2003, VISUAL NEUROSCIENCES, P260; OYSTER CW, 1967, SCIENCE, V155, P841, DOI 10.1126/science.155.3764.841; Rice DS, 2000, J COMP NEUROL, V424, P327, DOI 10.1002/1096-9861(20000821)424:2<327::AID-CNE10>3.0.CO;2-6; RODIECK RW, 1991, VISUAL NEUROSCI, V6, P95, DOI 10.1017/S095252380001049X; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; Taylor WR, 2003, TRENDS NEUROSCI, V26, P379, DOI 10.1016/S0166-2236(03)00167-X; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469	37	292	297	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2008	452	7186					478	U11		10.1038/nature06739	http://dx.doi.org/10.1038/nature06739			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279FU	18368118				2022-12-24	WOS:000254341300033
J	Lupien, M; Eeckhoute, J; Meyer, CA; Wang, QB; Zhang, Y; Li, W; Carroll, JS; Liu, XS; Brown, M				Lupien, Mathieu; Eeckhoute, Jerome; Meyer, Clifford A.; Wang, Qianben; Zhang, Yong; Li, Wei; Carroll, Jason S.; Liu, X. Shirley; Brown, Myles			FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription	CELL			English	Article							ESTROGEN-RECEPTOR-ALPHA; CELL-CYCLE PROGRESSION; BREAST-CANCER; GENE-EXPRESSION; BINDING-SITES; HUMAN GENOME; CHROMATIN SIGNATURES; COMPACTED CHROMATIN; ANDROGEN RECEPTOR; LOCATION ANALYSIS	Complex organisms require tissue-specific transcriptional programs, yet little is known about how these are established. The transcription factor FoxA1 is thought to contribute to gene regulation through its ability to act as a pioneer factor binding to nucleosomal DNA. Through genome-wide positional analyses, we demonstrate that FoxA1 cell type-specific functions rely primarily on differential recruitment to chromatin predominantly at distant enhancers rather than proximal promoters. This differential recruitment leads to cell type-specific changes in chromatin structure and functional collaboration with lineage-specific transcription factors. Despite the ability of FoxA1 to bind nucleosomes, its differential binding to chromatin sites is dependent on the distribution of histone H3 lysine 4 dimethylation. Together, our results suggest that methylation of histone H3 lysine 4 is part of the epigenetic signature that defines lineage-specific FoxA1 recruitment sites in chromatin. FoxA1 translates this epigenetic signature into changes in chromatin structure thereby establishing lineage-specific transcriptional enhancers and programs.	[Lupien, Mathieu; Eeckhoute, Jerome; Wang, Qianben; Carroll, Jason S.; Brown, Myles] Dana Farber Canc Inst, Dept Med Oncol, Div Mol & Cellular Oncol, Boston, MA 02115 USA; [Lupien, Mathieu; Eeckhoute, Jerome; Wang, Qianben; Carroll, Jason S.; Brown, Myles] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Lupien, Mathieu; Eeckhoute, Jerome; Wang, Qianben; Carroll, Jason S.; Brown, Myles] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Meyer, Clifford A.; Zhang, Yong; Li, Wei; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Meyer, Clifford A.; Zhang, Yong; Li, Wei; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Brown, M (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Div Mol & Cellular Oncol, Boston, MA 02115 USA.	myles_brown@dfci.harvard.edu	Zhang, Yong/B-4838-2011; Brown, Myles/AAX-5332-2021; Wang, Qianben/E-4267-2011; Brown, Myles/B-6906-2008; Li, Wei/A-8544-2009; Eeckhoute, Jerome/AAN-8219-2021	Zhang, Yong/0000-0001-6316-2734; Brown, Myles/0000-0002-8213-1658; Eeckhoute, Jerome/0000-0002-7222-9264; Carroll, Jason/0000-0003-3643-0080; Lupien, Mathieu/0000-0003-0929-9478; Li, Wei/0000-0001-9931-5990	NCI NIH HHS [P01 CA080111-090002, P01 CA080111-060002, P01 CA080111-080002, P01 CA080111-100002, P01 CA080111-070002, P01 CA080111, P50 CA089393-080012, P01 CA080111-010002, P50 CA089393, P01 CA8011105, P50 CA089393-060012, P50 CA089393-070012] Funding Source: Medline; NHGRI NIH HHS [R01 HG004069, 1R01 HG004069-02, R01 HG004069-02] Funding Source: Medline; NIDDK NIH HHS [R56 DK074967-01, R01 DK074967-01A1, R01 DK074967, R56 DK074967, R01DK074967] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA089393, P01CA080111] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074967, R56DK074967] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Badve S, 2007, CLIN CANCER RES, V13, P4415, DOI 10.1158/1078-0432.CCR-07-0122; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Bossard P, 2000, DEVELOPMENT, V127, P4915; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cheng ASL, 2006, MOL CELL, V21, P393, DOI 10.1016/j.molcel.2005.12.016; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Eeckhoute J, 2006, GENE DEV, V20, P2513, DOI 10.1101/gad.1446006; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Gao N, 2003, MOL ENDOCRINOL, V17, P1484, DOI 10.1210/me.2003-0020; Geles KG, 2006, P NATL ACAD SCI USA, V103, P2594, DOI 10.1073/pnas.0510764103; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Hatzis P, 2002, MOL CELL, V10, P1467, DOI 10.1016/S1097-2765(02)00786-4; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Keeton EK, 2005, MOL ENDOCRINOL, V19, P1543, DOI 10.1210/me.2004-0395; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lacroix M, 2004, MOL CELL ENDOCRINOL, V219, P1, DOI 10.1016/j.mce.2004.02.021; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Lin L, 2002, CANCER RES, V62, P5273; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Lupien M, 2007, MOL ENDOCRINOL, V21, P797, DOI 10.1210/me.2006-0074; Marr MT, 2006, GENE DEV, V20, P1458, DOI 10.1101/gad.1418806; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mirosevich J, 2006, PROSTATE, V66, P1013, DOI 10.1002/pros.20299; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Schrem H, 2002, PHARMACOL REV, V54, P129, DOI 10.1124/pr.54.1.129; Schwartz B, 2007, ONCOGENE, V26, P4049, DOI 10.1038/sj.onc.1210193; Sekiya T, 2007, MOL CELL, V28, P291, DOI 10.1016/j.molcel.2007.10.002; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Son CG, 2005, GENOME RES, V15, P443, DOI 10.1101/gr.3124505; Spear BT, 2006, CELL MOL LIFE SCI, V63, P2922, DOI 10.1007/s00018-006-6258-5; Stossi F, 2006, J BIOL CHEM, V281, P16272, DOI 10.1074/jbc.M513405200; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439	53	704	732	3	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 21	2008	132	6					958	970		10.1016/j.cell.2008.01.018	http://dx.doi.org/10.1016/j.cell.2008.01.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	278GR	18358809	Green Accepted, Bronze			2022-12-24	WOS:000254273600015
J	Tarassov, K; Messier, V; Landry, CR; Radinovic, S; Molina, MMS; Shames, I; Malitskaya, Y; Vogel, J; Bussey, H; Michnick, SW				Tarassov, Kirill; Messier, Vincent; Landry, Christian R.; Radinovic, Stevo; Molina, Mercedes M. Serna; Shames, Igor; Malitskaya, Yelena; Vogel, Jackie; Bussey, Howard; Michnick, Stephen W.			An in vivo map of the yeast protein interactome	SCIENCE			English	Article							FRAGMENT COMPLEMENTATION ASSAYS; LARGE-SCALE IDENTIFICATION; SACCHAROMYCES-CEREVISIAE; PHYSICAL INTERACTOME; CELL-CYCLE; MEMBRANE; COMPLEXES; ENDOSOME; RETROMER; ARCHITECTURE	Protein interactions regulate the systems-level behavior of cells; thus, deciphering the structure and dynamics of protein interaction networks in their cellular context is a central goal in biology. We have performed a genome-wide in vivo screen for protein-protein interactions in Saccharomyces cerevisiae by means of a protein-fragment complementation assay (PCA). We identified 2770 interactions among 1124 endogenously expressed proteins. Comparison with previous studies confirmed known interactions, but most were not known, revealing a previously unexplored subspace of the yeast protein interactome. The PCA detected structural and topological relationships between proteins, providing an 8-nanometer-resolution map of dynamically interacting complexes in vivo and extended networks that provide insights into fundamental cellular processes, including cell polarization and autophagy, pathways that are evolutionarily conserved and central to both development and human health.	[Tarassov, Kirill; Messier, Vincent; Landry, Christian R.; Radinovic, Stevo; Molina, Mercedes M. Serna; Shames, Igor; Malitskaya, Yelena; Michnick, Stephen W.] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada; [Landry, Christian R.; Michnick, Stephen W.] Univ Montreal, Ctr Robert Cedergren, Montreal, PQ H3C 3J7, Canada; [Vogel, Jackie; Bussey, Howard] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	Universite de Montreal; Universite de Montreal; McGill University	Michnick, SW (corresponding author), Univ Montreal, Dept Biochim, Casier Postal 6128,Succursale Centrville, Montreal, PQ H3C 3J7, Canada.	stephen.michnick@umontreal.ca	Landry, Christian R/F-3890-2011	Landry, Christian/0000-0003-3028-6866				Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Cid VJ, 2002, MICROBIOL-SGM, V148, P2647, DOI 10.1099/00221287-148-9-2647; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Damelin M, 2002, BIOPHYS J, V83, P3626, DOI 10.1016/S0006-3495(02)75363-0; Deloche O, 2002, MOL BIOL CELL, V13, P4296, DOI 10.1091/mbc.02-07-0105; Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Kim H, 2006, P NATL ACAD SCI USA, V103, P11142, DOI 10.1073/pnas.0604075103; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; McCusker D, 2007, NAT CELL BIOL, V9, P506, DOI 10.1038/ncb1568; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Miller JP, 2005, P NATL ACAD SCI USA, V102, P12123, DOI 10.1073/pnas.0505482102; MONOD J, 1968, P 11 NOB S SOD LID C; Nickell S, 2006, NAT REV MOL CELL BIO, V7, P225, DOI 10.1038/nrm1861; Nothwehr SF, 2000, J CELL BIOL, V151, P297, DOI 10.1083/jcb.151.2.297; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Pelletier JN, 1999, NAT BIOTECHNOL, V17, P683, DOI 10.1038/10897; Pena-Castillo L, 2007, GENETICS, V176, P7, DOI 10.1534/genetics.107.074468; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Pu SY, 2007, PROTEOMICS, V7, P944, DOI 10.1002/pmic.200600636; Reddy JV, 2001, MOL BIOL CELL, V12, P3242, DOI 10.1091/mbc.12.10.3242; Remy I, 1999, P NATL ACAD SCI USA, V96, P5394, DOI 10.1073/pnas.96.10.5394; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Stefan E, 2007, P NATL ACAD SCI USA, V104, P16916, DOI 10.1073/pnas.0704257104; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Yen WL, 2007, MOL BIOL CELL, V18, P581, DOI 10.1091/mbc.E06-07-0612; Zamyatnin AA, 2006, PLANT J, V46, P145, DOI 10.1111/j.1365-313X.2006.02674.x	36	560	571	0	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 13	2008	320	5882					1465	1470		10.1126/science.1153878	http://dx.doi.org/10.1126/science.1153878			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	312MV	18467557				2022-12-24	WOS:000256676400037
J	Charmantier, A; McCleery, RH; Cole, LR; Perrins, C; Kruuk, LEB; Sheldon, BC				Charmantier, Anne; McCleery, Robin H.; Cole, Lionel R.; Perrins, Chris; Kruuk, Loeske E. B.; Sheldon, Ben C.			Adaptive phenotypic plasticity in response to climate change in a wild bird population	SCIENCE			English	Article							PARUS-MAJOR; LONG-TERM; SELECTION; REPRODUCTION; TEMPERATURE; PHENOLOGY	Rapid climate change has been implicated as a cause of evolution in poorly adapted populations. However, phenotypic plasticity provides the potential for organisms to respond rapidly and effectively to environmental change. Using a 47- year population study of the great tit ( Parus major) in the United Kingdom, we show that individual adjustment of behavior in response to the environment has enabled the population to track a rapidly changing environment very closely. Individuals were markedly invariant in their response to environmental variation, suggesting that the current response may be fixed in this population. Phenotypic plasticity can thus play a central role in tracking environmental change; understanding the limits of plasticity is an important goal for future research.	[Charmantier, Anne; McCleery, Robin H.; Cole, Lionel R.; Perrins, Chris; Sheldon, Ben C.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [Charmantier, Anne] CNRS, Ctr Ecol Fonct & Evolut, Unite Mixte Rech, F-34293 Montpellier 5, France; [Kruuk, Loeske E. B.] Univ Edinburgh, Inst Evolut Biol, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland	University of Oxford; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of Edinburgh	Sheldon, BC (corresponding author), Univ Oxford, Dept Zool, Edward Grey Inst, S Parks Rd, Oxford OX1 3PS, England.	ben.sheldon@zoo.ox.ac.uk	Kruuk, Loeske/AAB-8714-2019; Kruuk, Loeske E. B./J-3295-2012; Sheldon, Ben C/A-8056-2010; Vazquez-Dominguez, Guillermo GVD/L-7818-2014	Kruuk, Loeske/0000-0001-8588-1123; Kruuk, Loeske E. B./0000-0001-8588-1123; Sheldon, Ben C/0000-0002-5240-7828; 	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Balanya J, 2006, SCIENCE, V313, P1773, DOI 10.1126/science.1131002; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; Brommer JE, 2005, EVOLUTION, V59, P1362; Cresswell W, 2003, J ANIM ECOL, V72, P356, DOI 10.1046/j.1365-2656.2003.00701.x; Crick HQP, 1997, NATURE, V388, P526, DOI 10.1038/41453; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; McCleery RH, 2004, AM NAT, V164, pE62, DOI 10.1086/422660; Moller AP, 2004, ADV ECOL RES, V35, P111, DOI 10.1016/S0065-2504(04)35006-3; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Nussey DH, 2005, SCIENCE, V310, P304, DOI 10.1126/science.1117004; Nussey DH, 2005, J ANIM ECOL, V74, P387, DOI 10.1111/j.1365-2656.2005.00941.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Przybylo R, 2000, J ANIM ECOL, V69, P395, DOI 10.1046/j.1365-2656.2000.00401.x; Reale D, 2003, P ROY SOC B-BIOL SCI, V270, P591, DOI 10.1098/rspb.2002.2224; Reed TE, 2006, P R SOC B, V273, P2713, DOI 10.1098/rspb.2006.3631; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; VANNOORDWIJK AJ, 1995, J ANIM ECOL, V64, P451, DOI 10.2307/5648; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Visser ME, 2003, P ROY SOC B-BIOL SCI, V270, P367, DOI 10.1098/rspb.2002.2244; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Visser ME, 2004, ADV ECOL RES, V35, P89, DOI 10.1016/S0065-2504(04)35005-1; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P289, DOI 10.1098/rspb.2000.1363	25	871	883	12	751	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2008	320	5877					800	803		10.1126/science.1157174	http://dx.doi.org/10.1126/science.1157174			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18467590				2022-12-24	WOS:000255644400043
J	Gilbert, MTP; Jenkins, DL; Gotherstrom, A; Naveran, N; Sanchez, JJ; Hofreiter, M; Thomsen, PF; Binladen, J; Higham, TFG; Yohe, RM; Parr, R; Cummings, LS; Willerslev, E				Gilbert, M. Thomas P.; Jenkins, Dennis L.; Gotherstrom, Anders; Naveran, Nuria; Sanchez, Juan J.; Hofreiter, Michael; Thomsen, Philip Francis; Binladen, Jonas; Higham, Thomas F. G.; Yohe, Robert M., II; Parr, Robert; Cummings, Linda Scott; Willerslev, Eske			DNA from pre-Clovis human coprolites in Oregon, North America	SCIENCE			English	Article							ANCIENT DNA; COLONIZATION; CALIBRATION; CHRONOLOGY	The timing of the first human migration into the Americas and its relation to the appearance of the Clovis technological complex in North America at about 11,000 to 10,800 radiocarbon years before the present ( C-14 years B. P.) remains contentious. We establish that humans were present at Paisley 5 Mile Point Caves, in south- central Oregon, by 12,300 C-14 years B. P., through the recovery of human mitochondrial DNA ( mtDNA) from coprolites, directly dated by accelerator mass spectrometry. The mtDNA corresponds to Native American founding haplogroups A2 and B2. The dates of the coprolites are > 1000 C-14 years earlier than currently accepted dates for the Clovis complex.	[Gilbert, M. Thomas P.; Thomsen, Philip Francis; Binladen, Jonas; Willerslev, Eske] Univ Copenhagen, Ctr Ancient Genet, DK-2100 Copenhagen, Denmark; [Jenkins, Dennis L.] Univ Oregon, Museum Nat & Cultural Hist, Eugene, OR 97403 USA; [Gotherstrom, Anders] Uppsala Univ, Dept Evolut Biol, S-74236 Uppsala, Sweden; [Naveran, Nuria] Univ Santiago de Compostela, Inst Med Legal, Fac Med, Santiago De Compostela, Spain; [Sanchez, Juan J.] Natl Inst Toxicol & Forens Sci, Tenerife 38320, Spain; [Hofreiter, Michael] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; [Higham, Thomas F. G.] Univ Oxford, Archaeol & Hist Art Res Lab, Oxford OX1 3QY, England; [Yohe, Robert M., II; Parr, Robert] Calif State Univ, Dept Sociol Anthropol, Bakersfield, CA 93311 USA; [Cummings, Linda Scott] Palaeo Res Inst, Golden, CO 80401 USA	University of Copenhagen; University of Oregon; Uppsala University; Universidade de Santiago de Compostela; Max Planck Society; University of Oxford; California State University System; California State University Bakersfield	Willerslev, E (corresponding author), Univ Copenhagen, Ctr Ancient Genet, Universitetspk 15, DK-2100 Copenhagen, Denmark.	ewillerslev@bi.ku.dk	Willerslev, Eske/A-9619-2011; Willerslev, Eske/AAA-5686-2019; Gilbert, Marcus TP/A-8936-2013; Thomsen, Philip Francis/AAE-9354-2019; Higham, Tom/Y-2707-2019; Hofreiter, Michael/A-3996-2017	Willerslev, Eske/0000-0002-7081-6748; Gilbert, Marcus TP/0000-0002-5805-7195; Thomsen, Philip Francis/0000-0002-9867-4366; Higham, Tom/0000-0002-5949-598X; Hofreiter, Michael/0000-0003-0441-4705; Gotherstrom, Anders/0000-0001-8579-1304	NERC [NRCF010002] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Adovasio J. M., 2004, ENTERING AM NE ASIA; ALLISON IS, 1982, STUDIES GEOLOGY, V11; Dillehay T. D., 1997, ARCHAEOLOGICAL CONTE, VII; Dixon EJ, 2001, QUATERNARY SCI REV, V20, P277; Eshleman JA, 2003, EVOL ANTHROPOL, V12, P7, DOI 10.1002/evan.10048; Falk T, 2004, SCIENCE, V305, P590; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Haile J, 2007, MOL BIOL EVOL, V24, P982, DOI 10.1093/molbev/msm016; Hamilton MJ, 2007, P NATL ACAD SCI USA, V104, P15625, DOI 10.1073/pnas.0704215104; Hansen AJ, 2006, GENETICS, V173, P1175, DOI 10.1534/genetics.106.057349; Jenkins D. L., 2007, PALEOINDIAN PALEOARC; Licciardi JM, 2001, J QUATERNARY SCI, V16, P545, DOI 10.1002/jqs.619; Orr P.C., 1968, PREHISTORY SANTA ROS; Ramsey CB, 2001, RADIOCARBON, V43, P355; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; ROOSEVELT AC, 2002, MEMOIRS CALIFORNIA A, V27, pCH7; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813	18	214	220	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2008	320	5877					786	789		10.1126/science.1154116	http://dx.doi.org/10.1126/science.1154116			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18388261				2022-12-24	WOS:000255644400038
J	Osawa, M; Anderson, DE; Erickson, HP				Osawa, Masaki; Anderson, David E.; Erickson, Harold P.			Reconstitution of contractile FtsZ rings in liposomes	SCIENCE			English	Article							CELL-DIVISION PROTEIN; ASSEMBLY DYNAMICS; TUBULIN; HOMOLOG	FtsZ is a tubulin homolog and the major cytoskeletal protein in bacterial cell division. It assembles into the Z ring, which contains FtsZ and a dozen other division proteins, and constricts to divide the cell. We have constructed a membrane- targeted FtsZ ( FtsZ- mts) by splicing an amphipathic helix to its C terminus. When mixed with lipid vesicles, FtsZ- mts was incorporated into the interior of some tubular vesicles. There it formed multiple Z rings that could move laterally in both directions along the length of the liposome and coalesce into brighter Z rings. Brighter Z rings produced visible constrictions in the liposome, suggesting that FtsZ itself can assemble the Z ring and generate a force. No other proteins were needed for assembly and force generation.	[Osawa, Masaki; Anderson, David E.; Erickson, Harold P.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University	Erickson, HP (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	h.erickson@cellbio.duke.edu		Anderson, David/0000-0001-9334-6438	NIGMS NIH HHS [R01 GM066014, R01 GM066014-01, GM66014] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066014] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; Andrews SS, 2007, BIOPHYS J, V93, P1872, DOI 10.1529/biophysj.106.102343; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; DAI K, 1991, J BACTERIOL, V173, P3500, DOI 10.1128/jb.173.11.3500-3506.1991; Erickson HP, 2007, BIOESSAYS, V29, P668, DOI 10.1002/bies.20601; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; Erickson HP, 1997, TRENDS CELL BIOL, V7, P362, DOI 10.1016/S0962-8924(97)01108-2; Feucht A, 2001, MOL MICROBIOL, V40, P115, DOI 10.1046/j.1365-2958.2001.02356.x; Lara B, 2005, MOL MICROBIOL, V55, P699, DOI 10.1111/j.1365-2958.2004.04432.x; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Peters PC, 2007, MOL MICROBIOL, V64, P487, DOI 10.1111/j.1365-2958.2007.05673.x; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; Redick SD, 2005, J BACTERIOL, V187, P2727, DOI 10.1128/JB.187.8.2727-2736.2005; Romberg L, 2001, J BIOL CHEM, V276, P11743, DOI 10.1074/jbc.M009033200; Thanedar S, 2004, CURR BIOL, V14, P1167, DOI 10.1016/j.cub.2004.06.048	15	390	399	7	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2008	320	5877					792	794		10.1126/science.1154520	http://dx.doi.org/10.1126/science.1154520			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18420899	Green Accepted			2022-12-24	WOS:000255644400040
J	Prahlad, V; Cornelius, T; Morimoto, RI				Prahlad, Veena; Cornelius, Tyler; Morimoto, Richard I.			Regulation of the cellular heat shock response in Caenorhabditis elegans by thermosensory neurons	SCIENCE			English	Article							PROTEIN; STRESS; FAMILY; HSP70	Temperature pervasively affects all cellular processes. In response to a rapid increase in temperature, all cells undergo a heat shock response, an ancient and highly conserved program of stress- inducible gene expression, to reestablish cellular homeostasis. In isolated cells, the heat shock response is initiated by the presence of misfolded proteins and therefore thought to be cell- autonomous. In contrast, we show that within the metazoan Caenorhabditis elegans, the heat shock response of somatic cells is not cell- autonomous but rather depends on the thermosensory neuron, AFD, which senses ambient temperature and regulates temperature- dependent behavior. We propose a model whereby this loss of cell autonomy serves to integrate behavioral, metabolic, and stress- related responses to establish an organismal response to environmental change.	[Prahlad, Veena; Cornelius, Tyler; Morimoto, Richard I.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Rice Inst Biomed Res, Evanston, IL 60208 USA	Northwestern University	Morimoto, RI (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Rice Inst Biomed Res, Evanston, IL 60208 USA.	r-morimoto@northwestern.edu	Longo, Kenneth A/A-5631-2010	Prahlad, Veena/0000-0002-0413-6074	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038109, R01GM038109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026647] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Clark DA, 2007, J NEUROSCI, V27, P6083, DOI 10.1523/JNEUROSCI.1032-07.2007; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; FAWCETT TW, 1994, J BIOL CHEM, V269, P32272; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Garcia SM, 2007, GENE DEV, V21, P3006, DOI 10.1101/gad.1575307; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; Hajdu-Cronin YM, 2004, GENETICS, V168, P1937, DOI 10.1534/genetics.104.028423; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hu P.J., 2007, DAUER, DOI [10.1895/wormbook.1.144.1, DOI 10.1895/WORMBOOK.1.144.1]; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; Mori I, 1999, ANNU REV GENET, V33, P399, DOI 10.1146/annurev.genet.33.1.399; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; SNUTCH TP, 1988, GENE, V64, P241, DOI 10.1016/0378-1119(88)90339-3; Sokolchik I, 2005, J NEUROSCI, V25, P1015, DOI 10.1523/JNEUROSCI.3107-04.2005; STRINGHAM EG, 1993, J EXP ZOOL, V266, P227, DOI 10.1002/jez.1402660309	18	235	260	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2008	320	5877					811	814		10.1126/science.1156093	http://dx.doi.org/10.1126/science.1156093			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18467592	Green Accepted			2022-12-24	WOS:000255644400046
J	Coelho, D; Suormala, T; Stucki, M; Lerner-Ellis, JP; Rosenblatt, DS; Newbold, RF; Baumgartner, MR; Fowler, B				Coelho, David; Suormala, Terttu; Stucki, Martin; Lerner-Ellis, Jordan P.; Rosenblatt, David S.; Newbold, Robert F.; Baumgartner, Matthias R.; Fowler, Brian			Gene identification for the cblD defect of vitamin B-12 metabolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							METHYLMALONIC ACIDURIA; COBALAMIN METABOLISM; MEGALOBLASTIC-ANEMIA; ABC TRANSPORTER; ADENOSYLCOBALAMIN; COMPLEMENTATION; DEFICIENCY; GENOME; CELLS; DNA	Background: Vitamin B-12 (cobalamin) is an essential cofactor in several metabolic pathways. Intracellular conversion of cobalamin to its two coenzymes, adenosylcobalamin in mitochondria and methylcobalamin in the cytoplasm, is necessary for the homeostasis of methylmalonic acid and homocysteine. Nine defects of intracellular cobalamin metabolism have been defined by means of somatic complementation analysis. One of these defects, the cblD defect, can cause isolated methylmalonic aciduria, isolated homocystinuria, or both. Affected persons present with multisystem clinical abnormalities, including developmental, hematologic, neurologic, and metabolic findings. The gene responsible for the cblD defect has not been identified. Methods: We studied seven patients with the cblD defect, and skin fibroblasts from each were investigated in cell culture. Microcell-mediated chromosome transfer and refined genetic mapping were used to localize the responsible gene. This gene was transfected into cblD fibroblasts to test for the rescue of adenosylcobalamin and methylcobalamin synthesis. Results: The cblD gene was localized to human chromosome 2q23.2, and a candidate gene, designated MMADHC (methylmalonic aciduria, cblD type, and homocystinuria), was identified in this region. Transfection of wild-type MMADHC rescued the cellular phenotype, and the functional importance of mutant alleles was shown by means of transfection with mutant constructs. The predicted MMADHC protein has sequence homology with a bacterial ATP-binding cassette transporter and contains a putative cobalamin binding motif and a putative mitochondrial targeting sequence. Conclusions: Mutations in a gene we designated MMADHC are responsible for the cblD defect in vitamin B-12 metabolism. Various mutations are associated with each of the three biochemical phenotypes of the disorder.	[Coelho, David; Suormala, Terttu; Lerner-Ellis, Jordan P.; Fowler, Brian] Univ Childrens Hosp Basel, Metab Unit, CH-4005 Basel, Switzerland; [Stucki, Martin; Baumgartner, Matthias R.] Univ Zurich, Childrens Hosp, Div Metab & Mol Pediat, Zurich, Switzerland; [Stucki, Martin] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Lerner-Ellis, Jordan P.; Rosenblatt, David S.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Lerner-Ellis, Jordan P.; Rosenblatt, David S.] McGill Univ, Ctr Hlth, Div Med Genet, Montreal, PQ, Canada; [Newbold, Robert F.] Brunel Univ, Brunel Inst Canc Genet & Pharmacogenom, Uxbridge UB8 3PH, Middx, England	University of Basel; University Children's Hospital Zurich; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); McGill University; McGill University; Brunel University	Fowler, B (corresponding author), Univ Childrens Hosp Basel, Metab Unit, Roemergasse 8, CH-4005 Basel, Switzerland.	brian.fowler@ukbb.ch	Coelho, David/AAE-9547-2020; Baumgartner, Matthias R/Q-2855-2017; Coelho, David/F-6680-2011; Lerner-Ellis, Jordan/J-5559-2016	Baumgartner, Matthias R/0000-0002-9270-0826; Coelho, David/0000-0001-7010-5789; 				Baumgartner MR, 2001, J CLIN INVEST, V107, P495, DOI 10.1172/JCI11948; CARMEL R, 1982, BLOOD, V59, P306; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; COOPER BA, 1990, AM J HEMATOL, V34, P115, DOI 10.1002/ajh.2830340207; Cosma MP, 2004, HUM MUTAT, V23, P576, DOI 10.1002/humu.20040; CUTHBERT AP, 1995, CYTOGENET CELL GENET, V71, P68, DOI 10.1159/000134066; Davidson AL, 2002, SCIENCE, V296, P1038, DOI 10.1126/science.1072484; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; FENTON WA, 1978, ARCH BIOCHEM BIOPHYS, V189, P441, DOI 10.1016/0003-9861(78)90232-1; GEBHARD W, 1983, J MOL BIOL, V170, P255, DOI 10.1016/S0022-2836(83)80147-8; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; GOODMAN SI, 1970, BIOCHEM MED METAB B, V4, P500, DOI 10.1016/0006-2944(70)90080-3; Hunt JD, 1996, ANAL BIOCHEM, V238, P107, DOI 10.1006/abio.1996.0263; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lerner-Ellis JP, 2006, NAT GENET, V38, P957, DOI 10.1038/ng0806-957a; LITZKAS P, 1984, MOL CELL BIOL, V4, P2549, DOI 10.1128/MCB.4.11.2549; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; MAHONEY MJ, 1975, P NATL ACAD SCI USA, V72, P2799, DOI 10.1073/pnas.72.7.2799; Rosenblatt D. S., 2001, METABOLIC MOL BASES, V8th, P3897; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; Suormala T, 2004, J BIOL CHEM, V279, P42742, DOI 10.1074/jbc.M407733200; Tanner SM, 2003, NAT GENET, V33, P426, DOI 10.1038/ng1098; Walker JA, 2004, GENOMICS, V83, P518, DOI 10.1016/j.ygeno.2003.09.003; Watkins D, 2000, J MED GENET, V37, P510, DOI 10.1136/jmg.37.7.510; WILLARD HF, 1978, AM J HUM GENET, V30, P1; Zhang J, 1997, EMBO J, V16, P826, DOI 10.1093/emboj/16.4.826	26	113	119	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 3	2008	358	14					1454	1464		10.1056/NEJMoa072200	http://dx.doi.org/10.1056/NEJMoa072200			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	282CY	18385497	Green Published, Green Accepted			2022-12-24	WOS:000254546400006
J	Weinstein, JN				Weinstein, John N.			Biochemistry - A postgenomic visual icon	SCIENCE			English	Editorial Material							CANCER-CELL LINES; MOLECULAR PHARMACOLOGY; EXPRESSION PATTERNS; MICROARRAYS; GENES		Univ Texas Houston, MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Weinstein, JN (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jweinste@mdanderson.org		Weinstein, John/0000-0001-9401-6908				Biron DG, 2006, INSECT MOL BIOL, V15, P731, DOI 10.1111/j.1365-2583.2006.00671.x; Bobe J, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-39; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; Doxey AC, 2007, MOL BIOL EVOL, V24, P1045, DOI 10.1093/molbev/msm024; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Kluger Y, 2003, GENOME RES, V13, P703, DOI 10.1101/gr.648603; Le Priol Y, 2006, J IMMUNOL, V177, P5145, DOI 10.4049/jimmunol.177.8.5145; Myers TG, 1997, ELECTROPHORESIS, V18, P467; Nesbit J, 2007, SCIENCE, V317, P1857, DOI 10.1126/science.317.5846.1857; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Wang XY, 2006, ARCH MICROBIOL, V186, P151, DOI 10.1007/s00203-006-0129-1; Weinstein JN, 2003, CR BIOL, V326, P909, DOI 10.1016/j.crvi.2003.08.005; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343	17	48	50	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2008	319	5871					1772	1773		10.1126/science.1151888	http://dx.doi.org/10.1126/science.1151888			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279ZF	18369130				2022-12-24	WOS:000254394000028
J	Krojer, T; Sawa, J; Schafer, E; Saibil, HR; Ehrmann, M; Clausen, T				Krojer, Tobias; Sawa, Justyna; Schaefer, Eva; Saibil, Helen R.; Ehrmann, Michael; Clausen, Tim			Structural basis for the regulated protease and chaperone function of DegP	NATURE			English	Article							OUTER-MEMBRANE BIOGENESIS; ENVELOPE STRESS-RESPONSE; ESCHERICHIA-COLI; PDZ DOMAINS; PERIPLASMIC PROTEIN; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; RESOLUTION; SYSTEM; PORIN	All organisms have to monitor the folding state of cellular proteins precisely. The heat- shock protein DegP is a protein quality control factor in the bacterial envelope that is involved in eliminating misfolded proteins and in the biogenesis of outer- membrane proteins. Here we describe the molecular mechanisms underlying the regulated protease and chaperone function of DegP from Escherichia coli. We show that binding of misfolded proteins transforms hexameric DegP into large, catalytically active 12- meric and 24- meric multimers. A structural analysis of these particles revealed that DegP represents a protein packaging device whose central compartment is adaptable to the size and concentration of substrate. Moreover, the inner cavity serves antagonistic functions. Whereas the encapsulation of folded protomers of outer- membrane proteins is protective and might allow safe transit through the periplasm, misfolded proteins are eliminated in the molecular reaction chamber. Oligomer reassembly and concomitant activation on substrate binding may also be critical in regulating other HtrA proteases implicated in protein- folding diseases.	[Krojer, Tobias; Sawa, Justyna; Clausen, Tim] Inst Mol Pathol, Res Inst Mol Pathol, A-1030 Vienna, Austria; [Schaefer, Eva; Saibil, Helen R.] Univ London Birkbeck Coll, Dept Crystallog, London WC1E 7HX, England; [Schaefer, Eva; Saibil, Helen R.] Univ London Birkbeck Coll, Inst Struct Mol Biol, London WC1E 7HX, England; [Ehrmann, Michael] Univ Duisburg Essen, Ctr Med Biotechnol, FB Biol & Geog, D-45117 Essen, Germany	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of London; Birkbeck University London; University of London; Birkbeck University London; University of Duisburg Essen	Clausen, T (corresponding author), Inst Mol Pathol, Res Inst Mol Pathol, Dr Bohrgasse 7, A-1030 Vienna, Austria.	clausen@imp.univie.ac.at	Ehrmann, Michael/A-7307-2012; Krojer, Tobias/ABE-3829-2021	Ehrmann, Michael/0000-0002-1927-260X; Krojer, Tobias/0000-0003-0661-0814; Clausen, Tim/0000-0003-1582-6924	BBSRC [BB/F010281/1, BB/C516179/1, BB/C516144/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C516144/1, BB/F010281/1, BBS/B/03955, BB/C516179/1] Funding Source: Medline; Wellcome Trust [070776, 079605] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; BANYARD SH, 1978, NATURE, V271, P282, DOI 10.1038/271282a0; Basle A, 2006, J MOL BIOL, V362, P933, DOI 10.1016/j.jmb.2006.08.002; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CastilloKeller M, 2003, J BACTERIOL, V185, P148, DOI 10.1128/JB.185.1.148-154.2003; Chen R, 1996, MOL MICROBIOL, V19, P1287, DOI 10.1111/j.1365-2958.1996.tb02473.x; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; DECOCK H, 1990, J BIOL CHEM, V265, P4646; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DUBOCHET J, 1983, J BACTERIOL, V155, P381, DOI 10.1128/JB.155.1.381-390.1983; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Guisbert E, 2007, J BACTERIOL, V189, P1963, DOI 10.1128/JB.01243-06; Harris BZ, 2001, J CELL SCI, V114, P3219; Hasselblatt H, 2007, GENE DEV, V21, P2659, DOI 10.1101/gad.445307; Iwanczyk J, 2007, J BACTERIOL, V189, P3176, DOI 10.1128/JB.01788-06; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KLOSE M, 1993, J BIOL CHEM, V268, P25664; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; LEDUC M, 1985, J BACTERIOL, V161, P627, DOI 10.1128/JB.161.2.627-635.1985; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Macario AJL, 2005, NEW ENGL J MED, V353, P1489, DOI 10.1056/NEJMra050111; MATSUYAMA S, 1984, J BACTERIOL, V158, P1041, DOI 10.1128/JB.158.3.1041-1047.1984; Meltzer M, 2008, ANGEW CHEM INT EDIT, V47, P1332, DOI 10.1002/anie.200703273; Misra R, 2000, J BACTERIOL, V182, P4882, DOI 10.1128/JB.182.17.4882-4888.2000; MISRA R, 1991, J BIOL CHEM, V266, P13592; Mortier E, 2005, EMBO J, V24, P2556, DOI 10.1038/sj.emboj.7600722; NAKAE T, 1979, J BIOL CHEM, V254, P1457; Pan L, 2007, EMBO J, V26, P4576, DOI 10.1038/sj.emboj.7601860; PARK SH, 1988, SCIENCE, V239, P1033, DOI 10.1126/science.3278378; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Purdy GE, 2007, J BACTERIOL, V189, P5566, DOI 10.1128/JB.00483-07; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Rizzitello AE, 2001, J BACTERIOL, V183, P6794, DOI 10.1128/JB.183.23.6794-6800.2001; Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; SCHWEIZER M, 1978, EUR J BIOCHEM, V82, P211, DOI 10.1111/j.1432-1033.1978.tb12013.x; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; SEN K, 1991, J BACTERIOL, V173, P926, DOI 10.1128/jb.173.2.926-928.1991; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P111, DOI 10.1016/0304-3991(87)90078-7; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; WINKLER FK, 1977, NATURE, V265, P509, DOI 10.1038/265509a0; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Yan J, 2005, EMBO J, V24, P3985, DOI 10.1038/sj.emboj.7600858; Zimmermann P, 2002, MOL CELL, V9, P1215, DOI 10.1016/S1097-2765(02)00549-X	55	285	294	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 12	2008	453	7197					885	U31		10.1038/nature07004	http://dx.doi.org/10.1038/nature07004			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311WV	18496527				2022-12-24	WOS:000256632000035
J	Holmes, E; Loo, RL; Stamler, J; Bictash, M; Yap, IKS; Chan, Q; Ebbels, T; De Iorio, M; Brown, IJ; Veselkov, KA; Daviglus, ML; Kesteloot, H; Ueshima, H; Zhao, LC; Nicholson, JK; Elliott, P				Holmes, Elaine; Loo, Ruey Leng; Stamler, Jeremiah; Bictash, Magda; Yap, Ivan K. S.; Chan, Queenie; Ebbels, Tim; De Iorio, Maria; Brown, Ian J.; Veselkov, Kirill A.; Daviglus, Martha L.; Kesteloot, Hugo; Ueshima, Hirotsugu; Zhao, Liancheng; Nicholson, Jeremy K.; Elliott, Paul			Human metabolic phenotype diversity and its association with diet and blood pressure	NATURE			English	Article							COMPLEX BIOLOGICAL MIXTURES; H-1-NMR; SPECTROSCOPY	Metabolic phenotypes are the products of interactions among a variety of factors-dietary, other lifestyle/environmental, gut microbial and genetic(1-3). We use a large-scale exploratory analytical approach to investigate metabolic phenotype variation across and within four human populations, based on H-1 NMR spectroscopy. Metabolites discriminating across populations are then linked to data for individuals on blood pressure, a major risk factor for coronary heart disease and stroke (leading causes of mortality worldwide(4)). We analyse spectra from two 24-hour urine specimens for each of 4,630 participants from the INTERMAP epidemiological study(5), involving 17 population samples aged 40-59 in China, Japan, UK and USA. We show that urinary metabolite excretion patterns for East Asian and western population samples, with contrasting diets, diet-related major risk factors, and coronary heart disease/stroke rates, are significantly differentiated (P < 10(-16)), as are Chinese/Japanese metabolic phenotypes, and subgroups with differences in dietary vegetable/animal protein and blood pressure(6). Among discriminatory metabolites, we quantify four and show association (P < 0.05 to P < 0.0001) of mean 24-hour urinary formate excretion with blood pressure in multiple regression analyses for individuals. Mean 24-hour urinary excretion of alanine (direct) and hippurate (inverse), reflecting diet and gut microbial activities(2,7), are also associated with blood pressure of individuals. Metabolic phenotyping applied to high-quality epidemiological data offers the potential to develop an area of aetiopathogenetic knowledge involving discovery of novel biomarkers related to cardiovascular disease risk.	[Holmes, Elaine; Loo, Ruey Leng; Bictash, Magda; Yap, Ivan K. S.; Ebbels, Tim; Veselkov, Kirill A.; Nicholson, Jeremy K.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Surg Oncol Reprod Biol & Anaesthet SORA, London SW7 2AZ, England; [Loo, Ruey Leng; Bictash, Magda; Yap, Ivan K. S.; Chan, Queenie; De Iorio, Maria; Brown, Ian J.; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Stamler, Jeremiah; Daviglus, Martha L.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Kesteloot, Hugo] Akad Ziekenhuis St Rafael, Dept Publ Hlth, Div Epidemiol, B-3000 Louvain, Belgium; [Ueshima, Hirotsugu] Shiga Univ Med Sci, Dept Hlth Sci, Shiga 5202192, Japan; [Zhao, Liancheng] Chinese Acad Med Sci, Dept Epidemiol, Fu Wai Hosp, Beijing 100037, Peoples R China; [Zhao, Liancheng] Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100037, Peoples R China	Imperial College London; Imperial College London; Northwestern University; Feinberg School of Medicine; KU Leuven; Shiga University of Medical Science; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College	Nicholson, JK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Surg Oncol Reprod Biol & Anaesthet SORA, S Kensington Campus, London SW7 2AZ, England.	j.nicholson@imperial.ac.uk; p.elliott@imperial.ac.uk	Yap, Ivan Kok Seng/ABD-4843-2020; Ebbels, Tim/ABB-2627-2021; Holmes, Elaine/A-2189-2015; Holmes, Elaine/ABE-6606-2020; Chan, Queenie/C-5017-2011; Nicholson, Jeremy K/B-3395-2012	Yap, Ivan Kok Seng/0000-0002-7523-5352; Ebbels, Tim/0000-0002-3372-8423; Holmes, Elaine/0000-0002-0556-8389; Chan, Queenie/0000-0001-9278-230X; Nicholson, Jeremy K/0000-0002-8123-8349; De Iorio, Maria/0000-0003-3109-0478; Loo, Ruey Leng/0000-0001-5307-5709; Elliott, Paul/0000-0002-7511-5684; Veselkov, Kirill/0000-0002-1164-0359	NHLBI NIH HHS [R01 HL50490, R01 HL084228, R01 HL050490] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050490, R01HL084228] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CHEN SH, 1971, SCIENCE, V173, P148, DOI 10.1126/science.173.3992.148; Cloarec O, 2005, ANAL CHEM, V77, P1282, DOI 10.1021/ac048630x; CONLAY LA, 1990, PHARMACOL TOXICOL, V66, P415, DOI 10.1111/j.1600-0773.1990.tb00771.x; Crockford DJ, 2005, ANAL CHEM, V77, P4556, DOI 10.1021/ac0503456; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Dumas ME, 2006, ANAL CHEM, V78, P2199, DOI 10.1021/ac0517085; ELLIOTT P, 1988, BRIT MED J, V297, P319; Elliott P, 2006, ARCH INTERN MED, V166, P79, DOI 10.1001/archinte.166.1.79; ELLIOTT P, 2005, CORONARY HEART DIS E, P751; Elliott P, 2008, HYPERTENSION, V51, P669, DOI 10.1161/HYPERTENSIONAHA.107.103747; Elliott P, 2007, CIRCULATION, V116, P1563, DOI 10.1161/CIRCULATIONAHA.106.675579; Fekkes D, 2000, J CHROMATOGR B, V744, P183, DOI 10.1016/S0378-4347(00)00234-6; Grandits GA, 1997, AM J CLIN NUTR, V65, P211; Gregory JF, 2000, AM J CLIN NUTR, V72, P1535; Holmes E, 2007, ANAL CHEM, V79, P2629, DOI 10.1021/ac062305n; Hotelling H, 1931, ANN MATH STAT, V2, P360, DOI 10.1214/aoms/1177732979; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P2064, DOI 10.1073/pnas.0308434100; Lenz EM, 2007, J PROTEOME RES, V6, P443, DOI 10.1021/pr0605217; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Lin SH, 2001, QJM-MON J ASSOC PHYS, V94, P133, DOI 10.1093/qjmed/94.3.133; Martens H, 2000, FOOD QUAL PREFER, V11, P5, DOI 10.1016/S0950-3293(99)00039-7; Mulder TP, 2005, AM J CLIN NUTR, V81, p256S, DOI 10.1093/ajcn/81.1.256S; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Stamler J, 2003, J HUM HYPERTENS, V17, P591, DOI 10.1038/sj.jhh.1001603; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; WOLD S, 1978, TECHNOMETRICS, V20, P397, DOI 10.2307/1267639	30	796	828	12	284	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2008	453	7193					396	U50		10.1038/nature06882	http://dx.doi.org/10.1038/nature06882			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18425110	Green Accepted			2022-12-24	WOS:000255868400053
J	Peng, RD; Chang, HH; Bell, ML; McDermott, A; Zeger, SL; Samet, JM; Dominici, F				Peng, Roger D.; Chang, Howard H.; Bell, Michelle L.; McDermott, Aidan; Zeger, Scott L.; Samet, Jonathan M.; Dominici, Francesca			Coarse particulate matter air pollution and hospital admissions for cardiovascular and respiratory diseases among medicare patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEART-RATE-VARIABILITY; DAILY MORTALITY; FINE PARTICLES; COACHELLA VALLEY; US CITIES; ADULTS; SIZE; LUNG	Context Health risks of fine particulate matter of 2.5 mu m or less in aerodynamic diameter ( PM2.5) have been studied extensively over the last decade. Evidence concerning the health risks of the coarse fraction of greater than 2.5 mu m and 10 mu m or less in aerodynamic diameter ( PM10-2.5) is limited. Objective To estimate risk of hospital admissions for cardiovascular and respiratory diseases associated with PM10-2.5 exposure, controlling for PM2.5. Design, Setting, and Participants Using a database assembled for 108 US counties with daily cardiovascular and respiratory disease admission rates, temperature and dew- point temperature, and PM10-2.5 and PM2.5 concentrations were calculated with monitoring data as an exposure surrogate from January 1, 1999, through December 31, 2005. Admission rates were constructed from the Medicare National Claims History Files, for a study population of approximately 12 million Medicare enrollees living on average 9 miles ( 14.4 km) from collocated pairs of PM10 and PM2.5 monitors. Main Outcome Measures Daily counts of county- wide emergency hospital admissions for primary diagnoses of cardiovascular or respiratory disease. Results There were 3.7 million cardiovascular disease and 1.4 million respiratory disease admissions. A 10-mu g/m(3) increase in PM10-2.5 was associated with a 0.36% ( 95% posterior interval [ PI], 0.05% to 0.68%) increase in cardiovascular disease admissions on the same day. However, when adjusted for PM2.5, the association was no longer statistically significant ( 0.25%; 95% PI, - 0.11% to 0.60%). A 10-mu g/m(3) increase in PM10-2.5 was associated with a nonstatistically significant unadjusted 0.33% ( 95% PI, - 0.21% to 0.86%) increase in respiratory disease admissions and with a 0.26% ( 95% PI, - 0.32% to 0.84%) increase in respiratory disease admissions when adjusted for PM2.5. The unadjusted associations of PM2.5 with cardiovascular and respiratory disease admissions were 0.71% ( 95% PI, 0.45%- 0.96%) for same- day exposure and 0.44% ( 95% PI, 0.06% to 0.82%) for exposure 2 days before hospital admission. Conclusion After adjustment for PM2.5, there were no statistically significant associations between coarse particulates and hospital admissions for cardiovascular and respiratory diseases.	[Peng, Roger D.; Chang, Howard H.; McDermott, Aidan; Zeger, Scott L.; Dominici, Francesca] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Samet, Jonathan M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Bell, Michelle L.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yale University	Dominici, F (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, 615 N Wolfe St, Baltimore, MD 21205 USA.	fdominic@jhsph.edu	Bell, Michelle/Y-4608-2018	Bell, Michelle/0000-0002-3965-1359; Zeger, Scott/0000-0001-8907-1603	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012054, P30ES003819] Funding Source: NIH RePORTER; NIEHS NIH HHS [P30 ES003819, R01 ES012054, ES012054-03, R01 ES012054-03, P30 ES003819-22, P30 ES 03819] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bell ML, 2007, ENVIRON HEALTH PERSP, V115, P989, DOI 10.1289/ehp.9621; Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372; *BOARD TRUST FED H, 2007, ANN REP BOARDS TRUST; Brunekreef B, 2005, EUR RESPIR J, V26, P309, DOI 10.1183/09031936.05.00001805; Burnett RT, 1997, ENVIRON HEALTH PERSP, V105, P614, DOI 10.2307/3433607; Carroll RJ, 2006, MEASUREMENT ERROR NO; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Dominici F, 2000, J ROY STAT SOC A STA, V163, P263, DOI 10.1111/1467-985X.00170; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Dominici F, 2005, J TOXICOL ENV HEAL A, V68, P1071, DOI 10.1080/15287390590935932; DUMOUCHEL WH, 1983, J AM STAT ASSOC, V78, P293, DOI 10.2307/2288631; Everson PJ, 2000, J ROY STAT SOC B, V62, P399, DOI 10.1111/1467-9868.00239; Gelman A., 2003, BAYESIAN DATA ANAL; Happo MS, 2007, INHAL TOXICOL, V19, P227, DOI 10.1080/08958370601067897; Health Effects Institute, 2003, REV AN NAT MORB MORT; Host S, 2008, OCCUP ENVIRON MED, V65, P544, DOI 10.1136/oem.2007.036194; Kan HD, 2007, ENVIRON INT, V33, P376, DOI 10.1016/j.envint.2006.12.001; LINDLEY DV, 1972, J ROY STAT SOC B, V34, P1; Lipsett MJ, 2006, ENVIRON HEALTH PERSP, V114, P1215, DOI 10.1289/ehp.8856; *NAT RES COUNC, 2004, RES PRIOR AIRB PART, V4; Nel A, 2005, SCIENCE, V308, P804, DOI 10.1126/science.1108752; Ostro BD, 2000, J EXPO ANAL ENV EPID, V10, P412, DOI 10.1038/sj.jea.7500094; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; SAMET JM, 2000, NATL MORBIDITY MO 1; SAMET JM, 2000, NATL MORBIDITY MO 2; Schwartz J, 1996, J AIR WASTE MANAGE, V46, P927, DOI 10.1080/10473289.1996.10467528; Schwartz J, 2000, EPIDEMIOLOGY, V11, P320, DOI 10.1097/00001648-200005000-00016; Schwartz J, 1999, ENVIRON HEALTH PERSP, V107, P339, DOI 10.2307/3434536; Schwartz J, 2000, EPIDEMIOLOGY, V11, P6, DOI 10.1097/00001648-200001000-00004; *US EPA, 2005, REV NAT AMB AIR QUAL; US-EPA, 2004, AIR QUAL CRIT PART M; VANDERPOOL R, 2004, MULTISITE EVALUATION; Venkataraman C, 1999, INHAL TOXICOL, V11, P151, DOI 10.1080/089583799197221; WHITBY KT, 1978, ATMOS ENVIRON, V12, P135, DOI 10.1016/0004-6981(78)90196-8; WILLEKE K, 1975, JAPCA J AIR WASTE MA, V25, P529, DOI 10.1080/00022470.1975.10470110; Wilson WE, 1997, J AIR WASTE MANAGE, V47, P1238, DOI 10.1080/10473289.1997.10464074; Yeatts K, 2007, ENVIRON HEALTH PERSP, V115, P709, DOI 10.1289/ehp.9499; Zanobetti A, 2000, Biostatistics, V1, P279, DOI 10.1093/biostatistics/1.3.279; 2006, FED REG, V17, P2620	40	289	296	1	49	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2008	299	18					2172	2179		10.1001/jama.299.18.2172	http://dx.doi.org/10.1001/jama.299.18.2172			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299XX	18477784	Bronze, Green Accepted			2022-12-24	WOS:000255790000024
J	Nogues-Bravo, D; Araujo, MB; Romdal, T; Rahbek, C				Nogues-Bravo, D.; Araujo, M. B.; Romdal, T.; Rahbek, C.			Scale effects and human impact on the elevational species richness gradients	NATURE			English	Article							LATITUDINAL GRADIENTS; SPATIAL SCALE; DIVERSITY; PATTERNS; AREA; BIODIVERSITY	Despite two centuries of effort in characterizing environmental gradients of species richness in search of universal patterns, surprisingly few of these patterns have been widely acknowledged(1-3). Species richness along altitudinal gradients was previously assumed to increase universally from cool highlands to warm lowlands, mirroring the latitudinal increase in species richness from cool to warm latitudes(1,4,5). However, since the more recent general acceptance of altitudinal gradients as model templates for testing hypotheses behind large- scale patterns of diversity(5-9), these gradients have been used in support of all the main diversity hypotheses, although little consensus has been achieved. Here we show that when resampling a data set comprising 400,000 records for 3,046 Pyrenean floristic species at different scales of analysis ( achieved by varying grain size and the extent of the gradients sampled), the derived species richness pattern changed progressively from hump- shaped to a monotonic pattern as the scale of extent diminished. Scale effects alone gave rise to as many conflicting patterns of species richness as had previously been reported in the literature, and scale effects lent significantly different statistical support to competing diversity hypotheses. Effects of scale on current studies may be affected by human activities, because montane ecosystems and human activities are intimately connected(10). This interdependence has led to a global reduction in natural lowland habitats, hampering our ability to detect universal patterns and impeding the search for universal diversity gradients to discover the mechanisms determining the distribution of biological diversity on Earth.	[Nogues-Bravo, D.; Araujo, M. B.] CSIC, Museo Nacl Ciencias Nat, Dept Biodivers & Evolutionary Biol, E-28006 Madrid, Spain; [Nogues-Bravo, D.; Araujo, M. B.; Romdal, T.; Rahbek, C.] Univ Copenhagen, Inst Biol, Ctr Macroecol, DK-2100 Copenhagen O, Denmark; [Nogues-Bravo, D.] CSIC, Pyrenean Inst Ecol, E-50080 Zaragoza, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of Copenhagen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE)	Nogues-Bravo, D (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Biodivers & Evolutionary Biol, C Jose Gutierrez Abascal 2, E-28006 Madrid, Spain.	davidnogues@mncn.csic.es	Rahbek, Carsten/L-1129-2013; Rahbek, Carsten/D-9372-2013; Araújo, Miguel B/B-6117-2008	Rahbek, Carsten/0000-0003-4585-0300; Araújo, Miguel B/0000-0002-5107-7265; Nogues-Bravo, David/0000-0002-4060-0153				Bhattarai KR, 2004, J BIOGEOGR, V31, P389, DOI 10.1046/j.0305-0270.2003.01013.x; Brehm G, 2007, GLOBAL ECOL BIOGEOGR, V16, P205, DOI 10.1111/j.1466-8238.2006.00281.x; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; *CLARK LABS, 2004, IDR KIL VERS 14 02 G; Colwell RK, 2004, AM NAT, V163, pE1, DOI 10.1086/382056; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Dunn RR, 2007, GLOBAL ECOL BIOGEOGR, V16, P305, DOI 10.1111/j.1466-8238.2006.00284.x; Heaney LR, 2001, GLOBAL ECOL BIOGEOGR, V10, P15, DOI 10.1046/j.1466-822x.2001.00227.x; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; MacArthur R.H., 1972, pvii; Mace GM, 2000, NATURE, V405, P393, DOI 10.1038/35013247; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-8238.2006.00263.x; McCain CM, 2007, ECOLOGY, V88, P76, DOI 10.1890/0012-9658(2007)88[76:AAMED]2.0.CO;2; McCoy ED, 2002, OIKOS, V99, P189, DOI 10.1034/j.1600-0706.2002.990120.x; McNeill J. R., 1992, MOUNTAINS MEDITERRAN; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Rahbek C, 1997, AM NAT, V149, P875, DOI 10.1086/286028; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Romdal TS, 2007, ECOGRAPHY, V30, P440, DOI [10.1111/j.2007.0906-7590.04954.x, 10.1111/j.0906-7590.2007.04954.x]; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Sanders NJ, 2002, ECOGRAPHY, V25, P25, DOI 10.1034/j.1600-0587.2002.250104.x; Sanders NJ, 2003, GLOBAL ECOL BIOGEOGR, V12, P93, DOI 10.1046/j.1466-822X.2003.00324.x; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032	28	364	400	9	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2008	453	7192					216	U8		10.1038/nature06812	http://dx.doi.org/10.1038/nature06812			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297BP	18464741	Bronze			2022-12-24	WOS:000255592400038
J	Gullerova, M; Proudfoot, NJ				Gullerova, Monika; Proudfoot, Nick J.			Cohesin complex promotes transcriptional termination between convergent genes in S. pombe	CELL			English	Article							CELL-CYCLE CONTROL; RNA-POLYMERASE-II; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; SMC PROTEINS; HETEROCHROMATIN; INTERFERENCE; CHROMOSOMES; SITES	Transcription analyses reported in these studies reveal that convergent genes in S. pombe generate overlapping transcripts in the G1 phase of the cell cycle. We show that this double-strand (ds) RNA induces localized RNAi (Dicer and RITS) dependent transient heterochromatin structures including histone H3 lysine 9 trimethylation marks and Swi6 association. Consequently cohesin is recruited to these chromosomal positions through interaction with Swi6. In G2, localized cohesin is further concentrated into the intergenic regions of the convergent genes tested. This results in a block to further dsRNA formation by promoting gene-proximal transcription termination between the convergent genes. Cohesin release at mitosis leads to a new G1 phase with repeated dsRNA formation, transient heterochromatin, and cohesin recruitment. Our results uncover a hitherto unanticipated role for cohesin and further suggest a widespread role for the selective formation of dsRNA, heterochromatin, and subsequent cohesin recruitment in regulated transcriptional termination.	[Gullerova, Monika; Proudfoot, Nick J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Proudfoot, NJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	nicholas.proudfoot@path.ox.ac.uk		Gullerova, Monika/0000-0002-4512-2779; Proudfoot, Nicholas/0000-0001-8646-3222	MRC [G9826944] Funding Source: UKRI; Medical Research Council [G9826944] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aranda A, 1999, MOL CELL BIOL, V19, P1251; Bahler J, 2005, ANNU REV GENET, V39, P69, DOI 10.1146/annurev.genet.39.110304.095808; Bernard P, 2008, EMBO J, V27, P111, DOI 10.1038/sj.emboj.7601955; Birse CE, 1997, EMBO J, V16, P3633, DOI 10.1093/emboj/16.12.3633; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Chen SX, 1996, NUCLEIC ACIDS RES, V24, P2885, DOI 10.1093/nar/24.15.2885; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Greger IH, 2000, P NATL ACAD SCI USA, V97, P8415, DOI 10.1073/pnas.140217697; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hansen K, 1998, EMBO J, V17, P3066, DOI 10.1093/emboj/17.11.3066; HEGEMANN JH, 1993, BIOESSAYS, V15, P451, DOI 10.1002/bies.950150704; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Martin AM, 2004, GENETICS, V167, P1123, DOI 10.1534/genetics.104.026674; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; PROUDFOOD N, 2002, CELL, V131, P649; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	31	152	158	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 21	2008	132	6					983	995		10.1016/j.cell.2008.02.040	http://dx.doi.org/10.1016/j.cell.2008.02.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	278GR	18358811	Bronze			2022-12-24	WOS:000254273600017
J	Chen, ZC; Yang, HJ; Pavletich, NP				Chen, Zhucheng; Yang, Haijuan; Pavletich, Nikola P.			Mechanism of homologous recombination from the RecA-ssDNA/dsDNA structures	NATURE			English	Article							DOUBLE-STRAND BREAKS; AMINO-ACID-RESIDUES; DNA-BINDING SITE; SUBUNIT INTERFACE; CRYSTAL-STRUCTURE; PROTEIN; FILAMENTS; REPAIR; RAD51; COMPLEXES	The RecA family of ATPases mediates homologous recombination, a reaction essential for maintaining genomic integrity and for generating genetic diversity. RecA, ATP and single-stranded DNA (ssDNA) form a helical filament that binds to double-stranded DNA (dsDNA), searches for homology, and then catalyses the exchange of the complementary strand, producing a new heteroduplex. Here we have solved the crystal structures of the Escherichia coli RecA-ssDNA and RecA-heteroduplex filaments. They show that ssDNA and ATP bind to RecA-RecA interfaces cooperatively, explaining the ATP dependency of DNA binding. The ATP c-phosphate is sensed across the RecA-RecA interface by two lysine residues that also stimulate ATP hydrolysis, providing a mechanism for DNA release. The DNA is underwound and stretched globally, but locally it adopts a B-DNA-like conformation that restricts the homology search to Watson - Crick- type base pairing. The complementary strand interacts primarily through base pairing, making heteroduplex formation strictly dependent on complementarity. The underwound, stretched filament conformation probably evolved to destabilize the donor duplex, freeing the complementary strand for homology sampling.	[Chen, Zhucheng; Yang, Haijuan; Pavletich, Nikola P.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA; [Pavletich, Nikola P.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; [Chen, Zhucheng] Cornell Univ, Weill Med Coll, Dept Biochem & Struct Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Cornell University	Pavletich, NP (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10021 USA.	pavletin@mskcc.org	Zhang, Qiuyu/E-3326-2010; Chen, Zhucheng/E-3327-2010		Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bell CE, 2005, MOL MICROBIOL, V58, P358, DOI 10.1111/j.1365-2958.2005.04876.x; BENEDICT RC, 1988, J BIOL CHEM, V263, P15513; Bianco P R, 1998, Front Biosci, V3, pD570; Campbell MJ, 1999, J MOL BIOL, V286, P417, DOI 10.1006/jmbi.1998.2456; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; Cox JM, 2006, J BIOL CHEM, V281, P12968, DOI 10.1074/jbc.M513736200; COX MM, 2007, TOP CURR GEN, V17, P53; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; Daumke O, 2004, NATURE, V429, P197, DOI 10.1038/nature02505; De Zutter JK, 2001, STRUCTURE, V9, P47, DOI 10.1016/S0969-2126(00)00552-9; DICAPUA E, 1990, J MOL BIOL, V214, P557, DOI 10.1016/0022-2836(90)90198-U; DUTREIX M, 1992, MOL GEN GENET, V232, P489, DOI 10.1007/BF00266254; FLORY J, 1984, P NATL ACAD SCI-BIOL, V81, P7026, DOI 10.1073/pnas.81.22.7026; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Hortnagel K, 1999, J MOL BIOL, V286, P1097, DOI 10.1006/jmbi.1998.2515; Ishimori K, 1996, J MOL BIOL, V264, P696, DOI 10.1006/jmbi.1996.0670; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; Kelley JA, 1997, J BIOL CHEM, V272, P25778, DOI 10.1074/jbc.272.41.25778; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Kurumizaka H, 1999, ARCH BIOCHEM BIOPHYS, V365, P83, DOI 10.1006/abbi.1999.1166; LARMINAT F, 1992, J BACTERIOL, V174, P6264, DOI 10.1128/JB.174.19.6264-6269.1992; Leger JF, 1998, P NATL ACAD SCI USA, V95, P12295, DOI 10.1073/pnas.95.21.12295; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; MALKOV VV, 1995, J BIOL CHEM, V270, P30230; Mazin AV, 1998, EMBO J, V17, P1161, DOI 10.1093/emboj/17.4.1161; McGrew DA, 2003, CRIT REV BIOCHEM MOL, V38, P385, DOI 10.1080/10409230390242489; MIKAWA T, 1995, J MOL BIOL, V250, P471, DOI 10.1006/jmbi.1995.0391; MORIMATSU K, 1995, ADV BIOPHYS, V31, P23, DOI 10.1016/0065-227X(95)99381-X; Morimatsu K, 2002, P NATL ACAD SCI USA, V99, P11688, DOI 10.1073/pnas.142404499; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; NGUYEN TT, 1993, J BIOL CHEM, V268, P3107; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RADDING CM, 1981, CELL, V25, P3, DOI 10.1016/0092-8674(81)90224-5; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Seitz EM, 1998, GENE DEV, V12, P1248, DOI 10.1101/gad.12.9.1248; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Skiba MC, 1999, BIOCHEMISTRY-US, V38, P11933, DOI 10.1021/bi991118z; SKIBA MC, 1994, J BIOL CHEM, V269, P3823; STASIAK A, 1988, J MOL BIOL, V202, P659, DOI 10.1016/0022-2836(88)90293-8; STASIAK A, 1982, NATURE, V299, P185, DOI 10.1038/299185a0; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; VanLoock MS, 2003, STRUCTURE, V11, P187, DOI 10.1016/S0969-2126(03)00003-0; Wang Y, 1996, BIOCHEMISTRY-US, V35, P3563, DOI 10.1021/bi952438v; Wu Y, 2004, MOL CELL, V15, P423, DOI 10.1016/j.molcel.2004.07.014; Yu X, 2004, CURR PROTEIN PEPT SC, V5, P73, DOI 10.2174/1389203043486883; Yu X, 2001, P NATL ACAD SCI USA, V98, P8419, DOI 10.1073/pnas.111005398	50	493	504	1	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2008	453	7194					489	U3		10.1038/nature06971	http://dx.doi.org/10.1038/nature06971			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303EL	18497818				2022-12-24	WOS:000256023700035
J	Dinneny, JR; Long, TA; Wang, JY; Jung, JW; Mace, D; Pointer, S; Barron, C; Brady, SM; Schiefelbein, J; Benfey, PN				Dinneny, Jose R.; Long, Terri A.; Wang, Jean Y.; Jung, Jee W.; Mace, Daniel; Pointer, Solomon; Barron, Christa; Brady, Siobhan M.; Schiefelbein, John; Benfey, Philip N.			Cell identity mediates the response of Arabidopsis roots to abiotic stress	SCIENCE			English	Article							TRANSCRIPTION FACTOR EXPRESSION; GENE-EXPRESSION; HAIR DEVELOPMENT; LOW-TEMPERATURE; SALT STRESS; THALIANA; DROUGHT; GROWTH; PLANTS; IRON	Little is known about the way developmental cues affect how cells interpret their environment. We characterized the transcriptional response to high salinity of different cell layers and developmental stages of the Arabidopsis root and found that transcriptional responses are highly constrained by developmental parameters. These transcriptional changes lead to the differential regulation of specific biological functions in subsets of cell layers, several of which correspond to observable physiological changes. We showed that known stress pathways primarily control semiubiquitous responses and used mutants that disrupt epidermal patterning to reveal cell-layer-specific and inter-cell-layer effects. By performing a similar analysis using iron deprivation, we identified common cell-type-specific stress responses and revealed the crucial role the environment plays in defining the transcriptional outcome of cell-fate decisions.	[Dinneny, Jose R.; Long, Terri A.; Wang, Jean Y.; Jung, Jee W.; Pointer, Solomon; Brady, Siobhan M.; Benfey, Philip N.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Mace, Daniel; Benfey, Philip N.] Duke Univ, Inst Genome Sci, Durham, NC 27708 USA; [Mace, Daniel; Benfey, Philip N.] Duke Univ, Policy Ctr Syst Biol, Durham, NC 27708 USA; [Barron, Christa; Schiefelbein, John] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	Duke University; Duke University; Duke University; University of Michigan System; University of Michigan	Benfey, PN (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	philip.benfey@duke.edu	Long, Terri/AAA-1984-2020; Dinneny, Jose/J-8312-2012; Brady, Siobhan/AAY-1729-2021	Dinneny, Jose/0000-0002-3998-724X; Long, Terri/0000-0001-7846-0195; Brady, Siobhan/0000-0001-9424-8055				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bao YQ, 2001, PLANT J, V28, P145, DOI 10.1046/j.1365-313X.2001.01142.x; Birnbaum K, 2005, NAT METHODS, V2, P615, DOI 10.1038/nmeth0805-615; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Burn JE, 2002, PLANT J, V32, P949, DOI 10.1046/j.1365-313X.2002.01483.x; Burssens S, 2000, PLANTA, V211, P632, DOI 10.1007/s004250000334; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gonzalez-Guzman M, 2002, PLANT CELL, V14, P1833, DOI 10.1105/tpc.002477; Halperin SJ, 2003, J EXP BOT, V54, P1269, DOI 10.1093/jxb/erg134; Jones MA, 2006, PLANT J, V45, P83, DOI 10.1111/j.1365-313X.2005.02609.x; Kiegle E, 2000, PLANT J, V23, P267, DOI 10.1046/j.1365-313x.2000.00786.x; Kim SA, 2007, FEBS LETT, V581, P2273, DOI 10.1016/j.febslet.2007.04.043; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Kwak SH, 2005, SCIENCE, V307, P1111, DOI 10.1126/science.1105373; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Ma SS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r49; Mace DL, 2006, BIOINFORMATICS, V22, pE323, DOI 10.1093/bioinformatics/btl228; MARCOTTE WR, 1989, PLANT CELL, V1, P969, DOI 10.2307/3868997; Muller M, 2004, PLANT PHYSIOL, V134, P409, DOI 10.1104/pp.103.029066; MUNDY J, 1990, P NATL ACAD SCI USA, V87, P1406, DOI 10.1073/pnas.87.4.1406; Nambara E, 1998, PLANT CELL PHYSIOL, V39, P853, DOI 10.1093/oxfordjournals.pcp.a029444; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Pagant S, 2002, PLANT CELL, V14, P2001, DOI 10.1105/tpc.002873; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Schellmann S, 2002, EMBO J, V21, P5036, DOI 10.1093/emboj/cdf524; SCHERES B, 2002, ARABIDOPSIS BOOK, P1, DOI DOI 10.1199/TAB.0101; Schindelman G, 2001, GENE DEV, V15, P1115, DOI 10.1101/gad.879101; Wang HY, 2007, PLANTA, V226, P897, DOI 10.1007/s00425-007-0535-x; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251	34	522	537	5	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2008	320	5878					942	945		10.1126/science.1153795	http://dx.doi.org/10.1126/science.1153795			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18436742				2022-12-24	WOS:000255868300045
J	Diaz, J; Ingall, E; Benitez-Nelson, C; Paterson, D; de Jonge, MD; McNulty, I; Brandes, JA				Diaz, Julia; Ingall, Ellery; Benitez-Nelson, Claudia; Paterson, David; de Jonge, Martin D.; McNulty, Ian; Brandes, Jay A.			Marine polyphosphate: A key player in geologic phosphorus sequestration	SCIENCE			English	Article							SEDIMENTS; FLUXES; WATERS; CARBON	The in situ or authigenic formation of calcium phosphate minerals in marine sediments is a major sink for the vital nutrient phosphorus. However, because typical sediment chemistry is not kinetically conducive to the precipitation of these minerals, the mechanism behind their formation has remained a fundamental mystery. Here, we present evidence from high- sensitivity x- ray and electrodialysis techniques to describe a mechanism by which abundant diatom- derived polyphosphates play a critical role in the formation of calcium phosphate minerals in marine sediments. This mechanism can explain the puzzlingly dispersed distribution of calcium phosphate minerals observed in marine sediments worldwide.	[Diaz, Julia; Ingall, Ellery] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Benitez-Nelson, Claudia] Univ S Carolina, Marine Sci Program, Columbia, SC 29208 USA; [Benitez-Nelson, Claudia] Univ S Carolina, Dept Geol Sci, Columbia, SC 29208 USA; [Paterson, David; de Jonge, Martin D.; McNulty, Ian] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Brandes, Jay A.] Skidaway Inst Oceanog, Savannah, GA 31411 USA	University System of Georgia; Georgia Institute of Technology; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; United States Department of Energy (DOE); Argonne National Laboratory; University System of Georgia; University of Georgia; Skidaway Institute of Oceanography	Ingall, E (corresponding author), Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA.	ingall@eas.gatech.edu	de Jonge, Martin D/C-3400-2011; Ingall, Ellery/A-5447-2008	de Jonge, Martin D/0000-0001-7731-6175; Ingall, Ellery/0000-0003-1954-0317; Benitez-Nelson, Claudia/0000-0002-1004-5048				AIGEO TJ, 2007, PALAEOGEOGR PALAEOCL, V256, P130; Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Benitez-Nelson CR, 2000, EARTH-SCI REV, V51, P109, DOI 10.1016/S0012-8252(00)00018-0; Bidle KD, 1999, NATURE, V397, P508, DOI 10.1038/17351; Brandes JA, 2007, MAR CHEM, V103, P250, DOI 10.1016/j.marchem.2006.09.004; Brown MRW, 2004, P NATL ACAD SCI USA, V101, P16085, DOI 10.1073/pnas.0406909101; Clark LL, 1998, NATURE, V393, P426, DOI 10.1038/30881; Clark LL, 1999, AM J SCI, V299, P724, DOI 10.2475/ajs.299.7-9.724; KARL DM, 2002, BIOGEOCHEMISTRY MARI, pCH6; Katz ME, 2004, ANNU REV ECOL EVOL S, V35, P523, DOI 10.1146/annurev.ecolsys.35.112202.130137; Kolowith LC, 2001, LIMNOL OCEANOGR, V46, P309, DOI 10.4319/lo.2001.46.2.0309; Lawerence BA, 1998, ARCH MICROBIOL, V169, P195, DOI 10.1007/s002030050560; Louanchi F, 2001, DEEP-SEA RES PT I, V48, P1581, DOI 10.1016/S0967-0637(00)00086-8; Mateo P, 2006, J PHYCOL, V42, P61, DOI 10.1111/j.1529-8817.2006.00180.x; MIYATA K, 1986, MAR BIOL, V93, P291, DOI 10.1007/BF00508266; Paytan A, 2007, CHEM REV, V107, P563, DOI 10.1021/cr0503613; PERRY MJ, 1976, LIMNOL OCEANOGR, V21, P88, DOI 10.4319/lo.1976.21.1.0088; RUTTENBERG KC, 1993, GEOCHIM COSMOCHIM AC, V57, P991, DOI 10.1016/0016-7037(93)90035-U; Sannigrahi P, 2005, GEOCHEM T, V6, P52, DOI [10.1063/1.1946447, 10.1186/1467-4866-6-52]; Sannigrahi P, 2006, GEOCHIM COSMOCHIM AC, V70, P5868, DOI 10.1016/j.gca.2006.08.037; Schulz HN, 2005, SCIENCE, V307, P416, DOI 10.1126/science.1103096; SOLORZAN.L, 1968, LIMNOL OCEANOGR, V13, P515, DOI 10.4319/lo.1968.13.3.0515; VanCappellen P, 1996, SCIENCE, V271, P493, DOI 10.1126/science.271.5248.493; VANCAPPELLEN P, 1991, GEOCHIM COSMOCHIM AC, V55, P1219; Vetter TA, 2007, SEP PURIF TECHNOL, V56, P383, DOI 10.1016/j.seppur.2007.04.012	25	187	193	6	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2008	320	5876					652	655		10.1126/science.1151751	http://dx.doi.org/10.1126/science.1151751			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451299				2022-12-24	WOS:000255454300042
J	Wicher, D; Schafer, R; Bauernfeind, R; Stensmyr, MC; Heller, R; Heinemann, SH; Hansson, BS				Wicher, Dieter; Schaefer, Ronny; Bauernfeind, Rene; Stensmyr, Marcus C.; Heller, Regine; Heinemann, Stefan H.; Hansson, Bill S.			Drosophila odorant receptors are both ligand-gated and cyclic-nucleotide-activated cation channels	NATURE			English	Article							NEUROSECRETORY INSECT NEURONS; OLFACTORY RECEPTOR; MOLECULAR-BASIS; FUNCTIONAL EXPRESSION; IN-VIVO; CAMP; TRANSDUCTION; MELANOGASTER; PROTEINS; ANTENNA	From worm to man, many odorant signals are perceived by the binding of volatile ligands to odorant receptors(1) that belong to the G- protein- coupled receptor ( GPCR) family(2). They couple to heterotrimeric G- proteins, most of which induce cAMP production(3). This second messenger then activates cyclic- nucleotide-gated ion channels to depolarize the olfactory receptor neuron, thus providing a signal for further neuronal processing. Recent findings, however, have challenged this concept of odorant signal transduction in insects, because their odorant receptors, which lack any sequence similarity to other GPCRs(4), are composed of conventional odorant receptors ( for example, Or22a), dimerized with a ubiquitously expressed chaperone protein(5), such as Or83b in Drosophila(6). Or83b has a structure akin to GPCRs, but has an inverted orientation in the plasma membrane(4,7). However, G proteins are expressed in insect olfactory receptor neurons(8), and olfactory perception is modified by mutations affecting the cAMP transduction pathway(9). Here we show that application of odorants to mammalian cells co- expressing Or22a and Or83b results in non- selective cation currents activated by means of an ionotropic and a metabotropic pathway, and a subsequent increase in the intracellular Ca2+ concentration. Expression of Or83b alone leads to functional ion channels not directly responding to odorants, but being directly activated by intracellular cAMP or cGMP. Insect odorant receptors thus form ligand- gated channels as well as complexes of odorant- sensing units and cyclic- nucleotide- activated non- selective cation channels. Thereby, they provide rapid and transient as well as sensitive and prolonged odorant signalling.	[Wicher, Dieter; Schaefer, Ronny; Bauernfeind, Rene; Stensmyr, Marcus C.; Hansson, Bill S.] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, D-07745 Jena, Germany; [Heller, Regine] Univ Jena, Inst Mol Cell Biol, Ctr Mol Biomed, D-07743 Jena, Germany; [Heinemann, Stefan H.] Univ Jena, Dept Biophys, Ctr Mol Biomed, D-07745 Jena, Germany	Max Planck Society; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Wicher, D (corresponding author), Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Hans Knoll St 8, D-07745 Jena, Germany.	dwicher@ice.mpg.de	Hansson, Bill S/G-2774-2013; Heller, Regine/AAC-9353-2019	Hansson, Bill S/0000-0002-4811-1223; Heinemann, Stefan H./0000-0002-4144-0251; Stensmyr, Marcus/0000-0003-4009-9212				Barry PH, 2003, J GEN PHYSIOL, V122, P247, DOI 10.1085/jgp.200308910; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Bugaj V, 2005, J BIOL CHEM, V280, P16790, DOI 10.1074/jbc.M500192200; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hill, 2001, ION CHANNELS EXCITAB, P441; Katada S, 2003, BIOCHEM BIOPH RES CO, V305, P964, DOI 10.1016/S0006-291X(03)00863-5; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; Martin F, 2001, J COMP PHYSIOL A, V187, P359, DOI 10.1007/s003590100208; Messutat S, 2001, CELL CALCIUM, V30, P199, DOI 10.1054/ceca.2001.0227; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Pelz D, 2006, J NEUROBIOL, V66, P1544, DOI 10.1002/neu.20333; Ronnett GV, 2002, ANNU REV PHYSIOL, V64, P189, DOI 10.1146/annurev.physiol.64.082701.102219; Rutzler M, 2006, J COMP NEUROL, V499, P533, DOI 10.1002/cne.21083; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; Wicher D, 2006, J NEUROPHYSIOL, V95, P2314, DOI 10.1152/jn.01007.2005; Wicher D, 2006, J BIOL CHEM, V281, P3227, DOI 10.1074/jbc.M511741200; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906	28	612	661	8	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2008	452	7190					1007	U10		10.1038/nature06861	http://dx.doi.org/10.1038/nature06861			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291PF	18408711				2022-12-24	WOS:000255208600042
J	Clyne, JD; Miesenbock, G				Clyne, J. Dylan; Miesenboeck, Gero			Sex-specific control and tuning of the pattern generator for courtship song in Drosophila	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; REMOTE-CONTROL; REPRODUCTIVE-BEHAVIOR; NEURAL CIRCUITRY; FRUITLESS GENE; NEURONS; MELANOGASTER; EXPRESSION; MOSAICS; PROTEIN	The differentially spliced transcription factors encoded by the fruitless (fru) gene are key determinants of sexual behavior in Drosophila. They are expressed in a minority of neurons with limited dimorphisms and regulate neural processes that remain largely unknown. Here, we use light-activated ion channels to stimulate fru-expressing neurons in the thoracic-abdominal ganglia, enabling direct functional comparisons of homologous circuitry between sexes. Optical stimulation of males or females initiates the unilateral wing vibrations that normally generate the male courtship song. The pattern-generating circuit operates differently in the two sexes, producing wing movement and sound in both but authentic songs only in males and in females expressing male fru product. A song-like motor program is thus present in females but lies dormant because the neural commands required for song initiation are absent. Supplying such commands artificially reveals fru-specific differences in the internal dynamics of the song generator and sets the stage for exploring their physiological basis.	[Clyne, J. Dylan; Miesenboeck, Gero] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Miesenboeck, Gero] Univ Oxford, Dept Physiol Anat & AGenet, Oxford OX1 3PT, England	Yale University; University of Oxford	Miesenbock, G (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	gero.miesenboeck@dpag.ox.ac.uk		Miesenboeck, Gero/0000-0003-2940-3228	Medical Research Council [G0701225, G0700888] Funding Source: Medline; MRC [G0700888, G0701225] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Appleton EV, 1922, PHILOS MAG, V43, P177, DOI 10.1080/14786442208633861; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; BASTOCK M, 1956, EVOLUTION, V10, P421, DOI 10.2307/2407002; BASTOCK M., 1955, BEHAVIOR, V8, P85, DOI 10.1163/156853955X00184; BENNETCL.HC, 1967, NATURE, V215, P669, DOI 10.1038/215669a0; Billeter JC, 2004, J COMP NEUROL, V475, P270, DOI 10.1002/cne.20177; BORST A, 1990, BIOSCIENCE, V40, P292, DOI 10.2307/1311266; BRAND AH, 1994, DROSOPHILA MELANOGAS, P635; Broughton SJ, 2004, CURR BIOL, V14, pR290, DOI 10.1016/j.cub.2004.03.037; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; COGGSHALL JC, 1973, Z NATURFORSCH C, VC 28, P783; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; EWING AW, 1968, BEHAVIOUR, V31, P288, DOI 10.1163/156853968X00298; FASANO L, 1991, CELL, V64, P63, DOI 10.1016/0092-8674(91)90209-H; HALL JC, 1977, BEHAV GENET, V7, P291, DOI 10.1007/BF01066800; HALL JC, 1979, GENETICS, V92, P437; Hedwig B, 2000, J NEUROPHYSIOL, V83, P712, DOI 10.1152/jn.2000.83.2.712; Hirsch M., 1974, DIFFERENTIAL EQUATIO; HOTTA Y, 1976, P NATL ACAD SCI USA, V73, P4154, DOI 10.1073/pnas.73.11.4154; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; KIEHN O, 1991, TRENDS NEUROSCI, V14, P68, DOI 10.1016/0166-2236(91)90023-N; Kimchi T, 2007, NATURE, V448, P1009, DOI 10.1038/nature06089; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Miesenbock G, 2005, ANNU REV NEUROSCI, V28, P533, DOI 10.1146/annurev.neuro.28.051804.101610; Rideout EJ, 2007, CURR BIOL, V17, P1473, DOI 10.1016/j.cub.2007.07.047; RODER L, 1992, DEVELOPMENT, V115, P1017; Roeder KD, 1935, BIOL BULL-US, V69, P203, DOI 10.2307/1537420; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; SHOREY HH, 1962, SCIENCE, V137, P677, DOI 10.1126/science.137.3531.677; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Sturtevant A. H., 1915, Journal of Animal Behavior Boston, V5, DOI 10.1037/h0074109; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; Tauber E, 2003, BEHAV PROCESS, V64, P197, DOI 10.1016/S0376-6357(03)00135-9; TAYLOR BJ, 1994, DEV GENET, V15, P275, DOI 10.1002/dvg.1020150309; van der Pol B, 1926, PHILOS MAG, V2, P978; van der Pol B, 1934, P IRE, V22, P1051, DOI 10.1109/JRPROC.1934.226781; VONSCHILCHER F, 1976, ANIM BEHAV, V24, P622, DOI 10.1016/S0003-3472(76)80076-0; VONSCHILCHER F, 1979, J COMP PHYSIOL A, P85; WHEELER DA, 1988, BEHAV GENET, V18, P675, DOI 10.1007/BF01066850; WIERSMA CAG, 1964, COMP BIOCHEM PHYSIOL, V12, P509, DOI 10.1016/0010-406X(64)90153-7; Zemelman BV, 2003, P NATL ACAD SCI USA, V100, P1352, DOI 10.1073/pnas.242738899; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8	50	205	206	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2008	133	2					354	363		10.1016/j.cell.2008.01.050	http://dx.doi.org/10.1016/j.cell.2008.01.050			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	289JY	18423205	Bronze			2022-12-24	WOS:000255052000023
J	Sharma, S; Chakraborty, K; Mueller, BK; Astola, N; Tang, YC; Lamb, DC; Hayer-Hartl, M; Hartl, FU				Sharma, Shruti; Chakraborty, Kausik; Mueller, Barbara K.; Astola, Nagore; Tang, Yun-Chi; Lamb, Don C.; Hayer-Hartl, Manajit; Hartl, F. Ulrich			Monitoring protein conformation along the pathway of chaperonin-assisted folding	CELL			English	Article							MOLECULAR CHAPERONES; GROEL; ATP; INTERMEDIATE; MECHANISM; RELEASE; BINDING; CYTOSOL; STATES; CHAIN	The GroEL/GroES chaperonin system mediates protein folding in the bacterial cytosol. Newly synthesized proteins reach GroEL via transfer from upstream chaperones such as DnaK/DnaJ (Hsp70). Here we employed single molecule and ensemble FRET to monitor the conformational transitions of a model substrate as it proceeds along this chaperone pathway. We find that DnaK/DnaJ stabilizes the protein in collapsed states that fold exceedingly slowly. Transfer to GroEL results in unfolding, with a fraction of molecules reaching locally highly expanded conformations. ATP-induced domain movements in GroEL cause transient further unfolding and rapid mobilization of protein segments with moderate hydrophobicity, allowing partial compaction on the GroEL surface. The more hydrophobic regions are released upon subsequent protein encapsulation in the central GroEL cavity by GroES, completing compaction and allowing rapid folding. Segmental chain release and compaction may be important in avoiding misfolding by proteins that fail to fold efficiently through spontaneous hydrophobic collapse.	[Mueller, Barbara K.; Lamb, Don C.] Univ Munich, Dept Chem & Biochem, D-81377 Munich, Germany; [Mueller, Barbara K.; Lamb, Don C.] Univ Munich, Ctr Nanosci, D-81377 Munich, Germany; [Sharma, Shruti; Chakraborty, Kausik; Astola, Nagore; Tang, Yun-Chi; Hayer-Hartl, Manajit; Hartl, F. Ulrich] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; [Lamb, Don C.] Univ Illinois, Dept Phys, Urbana, IL 61801 USA	University of Munich; University of Munich; Max Planck Society; University of Illinois System; University of Illinois Urbana-Champaign	Lamb, DC (corresponding author), Univ Munich, Dept Chem & Biochem, Butenandtstr 11,Haus E, D-81377 Munich, Germany.	don.lamb@cup.uni-muenchen.de; mhartl@biochem.mpg.de; uhartl@biochem.mpg.de	Hayer-Hartl, Manajit/V-8078-2017; Lamb, Don C/G-9501-2014; Chakraborty, Kausik/AAL-5748-2021; Hartl, F. Ulrich/Y-8206-2019; Chakraborty, Kausik/B-2247-2009; Tang, Yun-Chi/GRE-8205-2022	Hayer-Hartl, Manajit/0000-0001-8213-6742; Lamb, Don C/0000-0002-0232-1903; tang, yun qi/0000-0001-9385-2787; chakraborty, kausik/0000-0001-6000-8379				ABRAHAM DJ, 1987, PROTEINS, V2, P130, DOI 10.1002/prot.340020207; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Chang HC, 2005, J MOL BIOL, V353, P397, DOI 10.1016/j.jmb.2005.08.052; Chen JW, 2001, NAT STRUCT BIOL, V8, P721, DOI 10.1038/90443; Coban O, 2006, BIOPHYS J, V90, P4605, DOI 10.1529/biophysj.105.078840; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Elad N, 2007, MOL CELL, V26, P415, DOI 10.1016/j.molcel.2007.04.004; Farr GW, 1997, CELL, V89, P927, DOI 10.1016/S0092-8674(00)80278-0; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; Fenton WA, 2003, Q REV BIOPHYS, V36, P229, DOI 10.1017/S0033583503003883; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hayer-Hartl MK, 1999, BIOL CHEM, V380, P531, DOI 10.1515/BC.1999.068; HAYERHARTL MK, 1994, EMBO J, V13, P3192, DOI 10.1002/j.1460-2075.1994.tb06618.x; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; Horst R, 2005, P NATL ACAD SCI USA, V102, P12748, DOI 10.1073/pnas.0505642102; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Lin Z, 2004, MOL CELL, V16, P23, DOI 10.1016/j.molcel.2004.09.003; MARTIN J, 1993, NATURE, V366, P228, DOI 10.1038/366228a0; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Merchant KA, 2007, P NATL ACAD SCI USA, V104, P1528, DOI 10.1073/pnas.0607097104; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; Radford SE, 2000, TRENDS BIOCHEM SCI, V25, P611, DOI 10.1016/S0968-0004(00)01707-2; ROBINSON CV, 1994, NATURE, V372, P646, DOI 10.1038/372646a0; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Saibil HR, 2002, TRENDS BIOCHEM SCI, V27, P627, DOI 10.1016/S0968-0004(02)02211-9; Schuler B, 2005, P NATL ACAD SCI USA, V102, P2754, DOI 10.1073/pnas.0408164102; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Shtilerman M, 1999, SCIENCE, V284, P822, DOI 10.1126/science.284.5415.822; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Tezuka-Kawakami T, 2006, BIOPHYS J, V91, pL42, DOI 10.1529/biophysj.106.088344; Walter S, 1996, P NATL ACAD SCI USA, V93, P9425, DOI 10.1073/pnas.93.18.9425; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Zahn R, 1996, J MOL BIOL, V261, P43, DOI 10.1006/jmbi.1996.0440	38	134	136	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 4	2008	133	1					142	153		10.1016/j.cell.2008.01.048	http://dx.doi.org/10.1016/j.cell.2008.01.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	283MW	18394994	Bronze			2022-12-24	WOS:000254641300015
J	Capito, RM; Azevedo, HS; Velichko, YS; Mata, A; Stupp, SI				Capito, Ramille M.; Azevedo, Helena S.; Velichko, Yuri S.; Mata, Alvaro; Stupp, Samuel I.			Self-assembly of large and small molecules into hierarchically ordered sacs and membranes	SCIENCE			English	Article							POLYION COMPLEX FIBER; GELLAN; CHITOSAN; FILMS	We report here the self- assembly of macroscopic sacs and membranes at the interface between two aqueous solutions, one containing a megadalton polymer and the other, small self- assembling molecules bearing opposite charge. The resulting structures have a highly ordered architecture in which nanofiber bundles align and reorient by nearly 90 degrees as the membrane grows. The formation of a diffusion barrier upon contact between the two liquids prevents their chaotic mixing. We hypothesize that growth of the membrane is then driven by a dynamic synergy between osmotic pressure of ions and static self- assembly. These robust, self- sealing macroscopic structures offer opportunities in many areas, including the formation of privileged environments for cells, immune barriers, new biological assays, and self- assembly of ordered thick membranes for diverse applications.	[Capito, Ramille M.; Azevedo, Helena S.; Mata, Alvaro; Stupp, Samuel I.] Northwestern Univ, Inst Bionanotechnol Med, Chicago, IL 60611 USA; [Azevedo, Helena S.] Univ Minho, Dept Polymer Engn, 3Bs Res Grp, Braga, Portugal; [Velichko, Yuri S.; Stupp, Samuel I.] Northwestern Univ, Dept Mat Sci & Engn, Chicago, IL 60208 USA; [Stupp, Samuel I.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Stupp, Samuel I.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA	Northwestern University; Universidade do Minho; Northwestern University; Northwestern University; Northwestern University	Stupp, SI (corresponding author), Northwestern Univ, Inst Bionanotechnol Med, Chicago, IL 60611 USA.	s-stupp@northwestern.edu	Mata, Alvaro/D-6028-2015; Stupp, Samuel/B-6737-2009; Velichko, Yuri/D-8596-2011; Stupp, Samuel/AGV-1942-2022; Shah, Ramille/E-3737-2010; Azevedo, Helena/A-8298-2011	Mata, Alvaro/0000-0002-6739-9111; Azevedo, Helena/0000-0002-5470-1844; Velichko, Yury S/0000-0002-2287-5727	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS054287] Funding Source: NIH RePORTER; NIBIB NIH HHS [5-R01-EB003806] Funding Source: Medline; NIDCR NIH HHS [5-R01-DE015920] Funding Source: Medline; NINDS NIH HHS [5-P50-NS054287] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049; Behanna HA, 2005, J AM CHEM SOC, V127, P1193, DOI 10.1021/ja044863u; Blodgett KB, 1935, J AM CHEM SOC, V57, P1007, DOI 10.1021/ja01309a011; Bowden N, 1997, SCIENCE, V276, P233, DOI 10.1126/science.276.5310.233; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Deserno M, 2001, NATO SCI SER II MATH, V46, P27; Deserno M, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.011401; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; Hsu L, 2008, J AM CHEM SOC, V130, P3892, DOI 10.1021/ja076553s; Ohkawa K, 2004, MACROMOL MATER ENG, V289, P33, DOI 10.1002/mame.200300188; Pirondini L, 2002, P NATL ACAD SCI USA, V99, P4911, DOI 10.1073/pnas.072612199; Rajangam K, 2006, NANO LETT, V6, P2086, DOI 10.1021/nl0613555; RINGSDORF H, 1988, ANGEW CHEM INT EDIT, V27, P113, DOI 10.1002/anie.198801131; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Storrie H, 2007, BIOMATERIALS, V28, P4608, DOI 10.1016/j.biomaterials.2007.06.026; WEN S, 1991, BIOMATERIALS, V12, P374, DOI 10.1016/0142-9612(91)90005-U; WHITESIDES GM, 1990, LANGMUIR, V6, P87, DOI 10.1021/la00091a013; Yamamoto H, 2001, J APPL POLYM SCI, V79, P437, DOI 10.1002/1097-4628(20010118)79:3<437::AID-APP60>3.0.CO;2-Q; Yamamoto H, 2000, MACROMOL CHEM PHYSIC, V201, P84, DOI 10.1002/(SICI)1521-3935(20000101)201:1<84::AID-MACP84>3.0.CO;2-Y; ZASADZINSKI JA, 1994, SCIENCE, V263, P1726, DOI 10.1126/science.8134836	20	486	493	12	501	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2008	319	5871					1812	1816		10.1126/science.1154586	http://dx.doi.org/10.1126/science.1154586			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279ZF	18369143				2022-12-24	WOS:000254394000043
J	Conrad, KL; Tseng, KY; Uejima, JL; Reimers, JM; Heng, LJ; Shaham, Y; Marinelli, M; Wolf, ME				Conrad, Kelly L.; Tseng, Kuei Y.; Uejima, Jamie L.; Reimers, Jeremy M.; Heng, Li-Jun; Shaham, Yavin; Marinelli, Michela; Wolf, Marina E.			Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving	NATURE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; NUCLEUS-ACCUMBENS; SURFACE EXPRESSION; SYNAPTIC PLASTICITY; BEHAVIORAL SENSITIZATION; DOPAMINE-RECEPTORS; SEEKING BEHAVIOR; NMDA RECEPTORS; RAT; ADDICTION	Relapse to cocaine use after prolonged abstinence is an important clinical problem. This relapse is often induced by exposure to cues associated with cocaine use. To account for the persistent propensity for relapse, it has been suggested(1) that cue- induced cocaine craving increases over the first several weeks of abstinence and remains high for extended periods. We and others identified an analogous phenomenon in rats that was termed 'incubation of cocaine craving': time- dependent increases in cue- induced cocaine- seeking over the first months after withdrawal from self- administered cocaine(2-4). Cocaine- seeking requires the activation of glutamate projections that excite receptors for alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid ( AMPA) in the nucleus accumbens(5-7). Here we show that the number of synaptic AMPA receptors in the accumbens is increased after prolonged withdrawal from cocaine self-administration by the addition of new AMPA receptors lacking glutamate receptor 2 ( GluR2). Furthermore, we show that these new receptors mediate the incubation of cocaine craving. Our results indicate that GluR2- lacking AMPA receptors could be a new target for drug development for the treatment of cocaine addiction. We propose that after prolonged withdrawal from cocaine, increased numbers of synaptic AMPA receptors combined with the higher conductance of GluR2- lacking AMPA receptors(8,9) causes increased reactivity of accumbens neurons to cocaine- related cues, leading to an intensification of drug craving and relapse.	[Conrad, Kelly L.; Reimers, Jeremy M.; Wolf, Marina E.] Rosalind Franklin Univ Med & Sci, Dept Neurosci, N Chicago, IL 60064 USA; [Tseng, Kuei Y.; Heng, Li-Jun; Marinelli, Michela] Rosalind Franklin Univ Med & Sci, Dept Mol & Cellular Pharmacol, N Chicago, IL 60064 USA; [Uejima, Jamie L.; Shaham, Yavin] NIDA, Behav Neurosci Branch, IRP, NIH, Baltimore, MD 21224 USA	Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Wolf, ME (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Neurosci, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	marina.wolf@rosalindfranklin.edu	Marinelli, Michela/P-7645-2018; shaham, yavin/G-1306-2014	Marinelli, Michela/0000-0002-1903-1937; 	Intramural NIH HHS [Z01 DA000434-08] Funding Source: Medline; NIDA NIH HHS [R01 DA015835, K02 DA000453, R01 DA009621, DA00453, DA015835, R37 DA015835, DA020654, DA09621, R01 DA020654] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000434, R37DA015835, R01DA020654, R01DA015835, R01DA009621] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Archibald K, 1998, NEUROPHARMACOLOGY, V37, P1345, DOI 10.1016/S0028-3908(98)00135-X; Balland B, 2006, J PHYSIOL-LONDON, V574, P245, DOI 10.1113/jphysiol.2006.108738; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bernard V, 1997, J NEUROSCI, V17, P819; Beveridge TJR, 2006, EUR J NEUROSCI, V23, P3109, DOI 10.1111/j.1460-9568.2006.04788.x; Bossert JM, 2007, J NEUROSCI, V27, P12655, DOI 10.1523/JNEUROSCI.3926-07.2007; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Boudreau AC, 2007, J NEUROSCI, V27, P10621, DOI 10.1523/JNEUROSCI.2163-07.2007; Broutman G, 2001, J NEUROSCI, V21, P27, DOI 10.1523/JNEUROSCI.21-01-00027.2001; Clayton DA, 2002, J BIOL CHEM, V277, P14367, DOI 10.1074/jbc.C200074200; Cornish JL, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-15-j0006.2000; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Di Ciano P, 2001, J NEUROSCI, V21, P9471, DOI 10.1523/JNEUROSCI.21-23-09471.2001; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; GAWIN FH, 1986, ARCH GEN PSYCHIAT, V43, P107; Gerges NZ, 2004, J NEUROSCI, V24, P4758, DOI 10.1523/JNEUROSCI.0594-04.2004; Goto Y, 2005, NEURON, V47, P255, DOI 10.1016/j.neuron.2005.06.017; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; GROSSHANS DR, 2002, SCI STKE, V137, pPL8; Hall RA, 1997, J BIOL CHEM, V272, P4135, DOI 10.1074/jbc.272.7.4135; Hall RA, 1997, NEUROSCIENCE, V78, P361, DOI 10.1016/S0306-4522(96)00525-8; Hall RA, 1997, J NEUROCHEM, V68, P625; Hollander JA, 2007, J NEUROSCI, V27, P3535, DOI 10.1523/JNEUROSCI.3667-06.2007; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Lu L, 2004, NEUROPHARMACOLOGY, V47, P214, DOI 10.1016/j.neuropharm.2004.06.027; Lu L, 2007, BIOL PSYCHIAT, V61, P591, DOI 10.1016/j.biopsych.2006.04.011; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Mead AN, 2007, NEUROPSYCHOPHARMACOL, V32, P343, DOI 10.1038/sj.npp.1301045; Meredith GE, 1999, ANN NY ACAD SCI, V877, P140, DOI 10.1111/j.1749-6632.1999.tb09266.x; Neisewander JL, 2000, J NEUROSCI, V20, P798, DOI 10.1523/JNEUROSCI.20-02-00798.2000; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Pierce RC, 1996, J NEUROSCI, V16, P1550; Robinson R, 2004, HIGH EDUC, V47, P1, DOI 10.1023/B:HIGH.0000009803.70418.9c; Sans N, 2003, J NEUROSCI, V23, P9367; Stefani A, 1998, DEV NEUROSCI-BASEL, V20, P242, DOI 10.1159/000017318; Suto N, 2004, NEUROPSYCHOPHARMACOL, V29, P2149, DOI 10.1038/sj.npp.1300533; Sutton MA, 2003, NATURE, V421, P70, DOI 10.1038/nature01249; Takazawa A, 1996, BRAIN RES, V706, P173, DOI 10.1016/0006-8993(95)01334-2; Tseng KY, 2007, SYNAPSE, V61, P843, DOI 10.1002/syn.20432; Tseng KY, 2004, J NEUROSCI, V24, P5131, DOI 10.1523/JNEUROSCI.1021-04.2004; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0	50	638	648	3	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2008	454	7200					118	U9		10.1038/nature06995	http://dx.doi.org/10.1038/nature06995			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18500330	Green Accepted			2022-12-24	WOS:000257308300049
J	Gallagher, FA; Kettunen, MI; Day, SE; Hu, DE; Ardenkjaer-Larsen, JH; in't Zandt, R; Jensen, PR; Karlsson, M; Golman, K; Lerche, MH; Brindle, KM				Gallagher, Ferdia A.; Kettunen, Mikko I.; Day, Sam E.; Hu, De-En; Ardenkjaer-Larsen, Jan Henrik; in't Zandt, Rene; Jensen, Pernille R.; Karlsson, Magnus; Golman, Klaes; Lerche, Mathilde H.; Brindle, Kevin M.			Magnetic resonance imaging of pH in vivo using hyperpolarized C-13-labelled bicarbonate	NATURE			English	Article							EXTRACELLULAR PH; CONTRAST AGENT; TUMOR PH; C-13; NMR; SPECTROSCOPY; INVIVO; BRAIN; MRS	As alterations in tissue pH underlie many pathological processes, the capability to image tissue pH in the clinic could offer new ways of detecting disease and response to treatment(1). Dynamic nuclear polarization is an emerging technique for substantially increasing the sensitivity of magnetic resonance imaging experiments(2,3). Here we show that tissue pH can be imaged in vivo from the ratio of the signal intensities of hyperpolarized bicarbonate ((HCO3-)-C-13) and (CO2)-C-13 following intravenous injection of hyperpolarized (HCO3-)-C-13. The technique was demonstrated in a mouse tumour model, which showed that the average tumour interstitial pH was significantly lower than the surrounding tissue. Given that bicarbonate is an endogenous molecule that can be infused in relatively high concentrations into patients(4), we propose that this technique could be used clinically to image pathological processes that are associated with alterations in tissue pH, such as cancer, ischaemia and inflammation.	[Gallagher, Ferdia A.; Kettunen, Mikko I.; Day, Sam E.; Hu, De-En; Brindle, Kevin M.] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Gallagher, Ferdia A.; Kettunen, Mikko I.; Day, Sam E.; Hu, De-En; Brindle, Kevin M.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Gallagher, Ferdia A.] Univ Cambridge, Addenbrookes Hosp, Dept Radiol, Cambridge CB2 2QQ, England; [Ardenkjaer-Larsen, Jan Henrik] GE Healthcare, Grove Ctr GC 18, Amersham HP7 9LL, England; [in't Zandt, Rene; Jensen, Pernille R.; Karlsson, Magnus; Golman, Klaes; Lerche, Mathilde H.] Imagnia AB, SE-20041 Malmo, Sweden	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; General Electric	Brindle, KM (corresponding author), Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England.	kmb@mole.bio.cam.ac.uk	Ardenkjær-Larsen, Jan Henrik/B-5765-2017; Kettunen, Mikko I/K-2299-2012; Karlsson, Magnus/AAZ-1768-2021; Jensen, Pernille Rose/AAX-5696-2020; Jensen, Pernille Rose/GQQ-6261-2022; Jensen, Pernille Rose/J-8648-2016; Lerche, Mathilde Hauge/J-5487-2017	Ardenkjær-Larsen, Jan Henrik/0000-0001-6167-6926; Kettunen, Mikko I/0000-0002-2004-660X; Jensen, Pernille Rose/0000-0003-4359-848X; Jensen, Pernille Rose/0000-0003-4359-848X; Jensen, Pernille Rose/0000-0003-4359-848X; Lerche, Mathilde Hauge/0000-0002-5899-2781; Gallagher, Ferdia Aidan/0000-0003-4784-5230; in 't Zandt, Rene/0000-0002-3610-9513; Karlsson, Magnus/0000-0001-7738-1700	Cancer Research UK [C197/A3514] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Adrogue HJ, 1998, NEW ENGL J MED, V338, P26, DOI 10.1056/NEJM199801013380106; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; BEAUREGARD DA, 1998, P 6 ANN M ISMRM SYDN, P653; BRINDLE KM, 1988, PROG NUCL MAG RES SP, V20, P257, DOI 10.1016/0079-6565(88)80003-7; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; Gillies RJ, 2004, IEEE ENG MED BIOL, V23, P57, DOI 10.1109/MEMB.2004.1360409; GILLIES RJ, 1994, AM J PHYSIOL, V267, pC195, DOI 10.1152/ajpcell.1994.267.1.C195; Golman K, 2006, CANCER RES, V66, P10855, DOI 10.1158/0008-5472.CAN-06-2564; Golman K, 2006, ACAD RADIOL, V13, P932, DOI 10.1016/j.acra.2006.06.001; GRINSTEIN S, 1991, CLIN BIOCHEM, V24, P241, DOI 10.1016/0009-9120(91)80014-T; HOFFMAN DW, 1987, BIOCHEM BIOPH RES CO, V143, P67, DOI 10.1016/0006-291X(87)90630-9; Hohn-Berlage M, 1989, NMR Biomed, V2, P240, DOI 10.1002/nbm.1940020512; MAREN TH, 1977, AM J PHYSIOL, V232, pF291, DOI 10.1152/ajprenal.1977.232.4.F291; Mason RP, 1999, CURR MED CHEM, V6, P481; MCCOY CL, 1995, BRIT J CANCER, V72, P905, DOI 10.1038/bjc.1995.431; MELDRUM N. IT., 1933, JOUR PHYSIOL, V80, P113; Merritt ME, 2007, P NATL ACAD SCI USA, V104, P19773, DOI 10.1073/pnas.0706235104; Raghunand N, 1999, BRIT J CANCER, V80, P1005, DOI 10.1038/sj.bjc.6690455; Raghunand N, 2002, ACAD RADIOL, V9, pS481, DOI 10.1016/S1076-6332(03)80270-2; Raghunand N, 2001, NEOPLASIA, V3, P227, DOI 10.1038/sj.neo.7900151; ROTTENBERG DA, 1985, ANN NEUROL, V17, P70, DOI 10.1002/ana.410170116; SIWETACH P, 2007, CANC METASTASIS REV, V26, P299; STABENAU EK, 1993, J EXP BIOL, V180, P311; STUBBS M, 1992, NMR BIOMED, V5, P351, DOI 10.1002/nbm.1940050606; van Sluis R, 1999, MAGN RESON MED, V41, P743, DOI 10.1002/(SICI)1522-2594(199904)41:4<743::AID-MRM13>3.0.CO;2-Z; Vermathen P, 2000, MAGN RESON MED, V43, P665, DOI 10.1002/(SICI)1522-2594(200005)43:5<665::AID-MRM8>3.0.CO;2-3; Ward KM, 2000, MAGN RESON MED, V44, P799, DOI 10.1002/1522-2594(200011)44:5<799::AID-MRM18>3.0.CO;2-S; WHITE A, 1968, PRINCIPLES BIOCH; Zhao M, 2001, NAT MED, V7, P1241, DOI 10.1038/nm1101-1241; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907	30	639	657	3	215	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2008	453	7197					940	U73		10.1038/nature07017	http://dx.doi.org/10.1038/nature07017			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311WV	18509335				2022-12-24	WOS:000256632000048
J	Sattar, N; McConnachie, A; Shaper, AG; Blauw, GJ; Buckley, BM; de Craen, AJ; Ford, I; Forouhi, NG; Freeman, DJ; Jukema, JW; Lennon, L; Macfarlane, PW; Murphy, MB; Packard, CJ; Stott, DJ; Westendorp, RG; Whincup, PH; Shepherd, J; Wannamethee, SG				Sattar, Naveed; McConnachie, Alex; Shaper, A. Gerald; Blauw, Gerard J.; Buckley, Brendan M.; de Craen, Anton J.; Ford, Ian; Forouhi, Nita G.; Freeman, Dilys J.; Jukema, J. Wouter; Lennon, Lucy; Macfarlane, Peter W.; Murphy, Michael B.; Packard, Chris J.; Stott, David J.; Westendorp, Rudi G.; Whincup, Peter H.; Shepherd, James; Wannamethee, S. Goya			Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies	LANCET			English	Article							CORONARY-HEART-DISEASE; RISK SCORE; FOLLOW-UP; OLDER; PRAVASTATIN; MORTALITY; STROKE; INDIVIDUALS; DEFINITION; PEOPLE	Background Clinical use of criteria for metabolic syndrome to simultaneously predict risk of cardiovascular disease and diabetes remains uncertain. We investigated to what extent metabolic syndrome and its individual components were related to risk for these two diseases in elderly populations. Methods We related metabolic syndrome (defined on the basis of criteria from the Third Report of the National Cholesterol Education Program) and its five individual components to the risk of events of incident cardiovascular disease and type 2 diabetes in 4812 non-diabetic individuals aged 70-82 years from the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). We corroborated these data in a second prospective study (the British Regional Heart Study [BRHS]) of 2737 non-diabetic men aged 60-79 years. Findings In PROSPER, 772 cases of incident cardiovascular disease and 287 of diabetes occurred over 3.2 years. Metabolic syndrome was not associated with increased risk of cardiovascular disease in those without baseline disease (hazard ratio 1 . 07 [95% CI 0 . 86-1.32]) but was associated with increased risk of diabetes (4.41 [3.33-5.84]) as was each of its components, particularly fasting glucose (18.4 [13.9-24.5]). Results were similar in participants with existing cardiovascular disease. In BRHS, 440 cases of incident cardiovascular disease and 105 of diabetes occurred over 7 years. Metabolic syndrome was modestly associated with incident cardiovascular disease (relative risk 1.27 [1 . 04-1.56]) despite strong association with diabetes (7.47 [4.90-11.46]). In both studies, body-mass index or waist circumference, triglyceride, and glucose cutoff points were not associated with risk of cardiovascular disease, but all five components were associated with risk of new-onset diabetes. Interpretation Metabolic syndrome and its components are associated with type 2 diabetes but have weak or no association with vascular risk in elderly populations, suggesting that attempts to define criteria that simultaneously predict risk for both cardiovascular disease and diabetes are unhelpful. Clinical focus should remain on establishing optimum risk algorithms for each disease. Funding Diabetes UK and British Heart Foundation.	[Sattar, Naveed; Freeman, Dilys J.; Macfarlane, Peter W.; Packard, Chris J.; Stott, David J.; Shepherd, James] Univ Glasgow, Fac Med, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland; [McConnachie, Alex; Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8TA, Lanark, Scotland; [Forouhi, Nita G.] Addenbrookes Hosp, MRC Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Buckley, Brendan M.; Murphy, Michael B.] Cork Univ Hosp, Dept Pharmacol & Therapeut, Cork, Ireland; [Blauw, Gerard J.; de Craen, Anton J.; Westendorp, Rudi G.] Leiden Univ, Med Ctr, Sect Gerontol & Geriatr, Leiden, Netherlands; [Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Shaper, A. Gerald; Lennon, Lucy; Wannamethee, S. Goya] UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London WC1E 6BT, England; [Whincup, Peter H.] Univ London St Georges Hosp, Div Community Hlth Sci, London, England	University of Glasgow; University of Glasgow; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University College Cork; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of London; University College London; UCL Medical School; St Georges University London	Sattar, N (corresponding author), Univ Glasgow, Fac Med, BHF Glasgow Cardiovasc Res Ctr, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.	nsattar@clinmed.gla.ac.uk	Murphy, Michael B/A-1310-2011; Ford, Ian/ABE-6145-2020; Lennon, Lucy/ABB-9433-2020; Blauw, Gerard/GWD-1079-2022; Blauw, Gerard/AAW-7904-2021; Jukema, J. Wouter/ABD-6503-2021; Lennon, Lucy/AFT-1973-2022	Lennon, Lucy/0000-0002-1738-1351; Jukema, J. Wouter/0000-0002-3246-8359; Forouhi, Nita/0000-0002-5041-248X; Wannamethee, Sasiwarang/0000-0001-9484-9977; Murphy, Michael/0000-0001-6722-7080; Whincup, Peter/0000-0002-5589-4107	British Heart Foundation Funding Source: Medline; Medical Research Council [MC_U106179471] Funding Source: Medline	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Boshuizen HC, 1998, BMJ-BRIT MED J, V316, P1780, DOI 10.1136/bmj.316.7147.1780; Chien KL, 2007, ATHEROSCLEROSIS, V194, P214, DOI 10.1016/j.atherosclerosis.2006.07.033; Deedwania P, 2006, LANCET, V368, P919, DOI 10.1016/S0140-6736(06)69292-1; Emberson JR, 2002, ANN CLIN BIOCHEM, V39, P493, DOI 10.1258/000456302320314511; Espinola-Klein C, 2007, AM J CARDIOL, V99, P1623, DOI 10.1016/j.amjcard.2007.01.049; Ferrannini E, 2007, J CLIN ENDOCR METAB, V92, P396, DOI 10.1210/jc.2006-0944; Gale EAM, 2005, DIABETOLOGIA, V48, P1679, DOI 10.1007/s00125-005-1873-5; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Jeppesen J, 2007, J AM COLL CARDIOL, V49, P2112, DOI 10.1016/j.jacc.2007.01.088; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Lawlor DA, 2006, DIABETOLOGIA, V49, P41, DOI 10.1007/s00125-005-0040-3; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; McNeill AM, 2006, J AM GERIATR SOC, V54, P1317, DOI 10.1111/j.1532-5415.2006.00862.x; Packard CJ, 2005, CIRCULATION, V112, P3058, DOI 10.1161/CIRCULATIONAHA.104.526848; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Rose G, 1982, CARDIOVASCULAR SURVE; Sattar N, 2003, CIRCULATION, V108, P414, DOI 10.1161/01.CIR.0000080897.52664.94; Sattar N, 2006, CURR OPIN LIPIDOL, V17, P404, DOI 10.1097/01.mol.0000236366.48593.07; Schulze MB, 2007, DIABETES CARE, V30, P510, DOI 10.2337/dc06-2089; SHAPER AG, 1981, BRIT MED J, V283, P179, DOI 10.1136/bmj.283.6285.179; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Shepherd J, 1999, AM J CARDIOL, V84, P1192, DOI 10.1016/S0002-9149(99)00533-0; Stern MP, 2004, DIABETES CARE, V27, P2676, DOI 10.2337/diacare.27.11.2676; Takahashi K, 2007, INTERNAL MED, V46, P643, DOI 10.2169/internalmedicine.46.6094; Walker M, 2000, J PUBLIC HEALTH MED, V22, P479, DOI 10.1093/pubmed/22.4.479; Wang JJ, 2007, EUR HEART J, V28, P857, DOI 10.1093/eurheartj/ehl524; Wannamethee SG, 2007, AM J CLIN NUTR, V86, P1339, DOI 10.1093/ajcn/86.5.1339; Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644; Wannamethee SG, 2002, CIRCULATION, V105, P1785, DOI 10.1161/01.CIR.0000016346.14762.71; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528	32	351	361	1	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2008	371	9628					1927	1935		10.1016/S0140-6736(08)60602-9	http://dx.doi.org/10.1016/S0140-6736(08)60602-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	310OI	18501419				2022-12-24	WOS:000256538500029
J	Yang, HG; Sun, CH; Qiao, SZ; Zou, J; Liu, G; Smith, SC; Cheng, HM; Lu, GQ				Yang, Hua Gui; Sun, Cheng Hua; Qiao, Shi Zhang; Zou, Jin; Liu, Gang; Smith, Sean Campbell; Cheng, Hui Ming; Lu, Gao Qing			Anatase TiO2 single crystals with a large percentage of reactive facets	NATURE			English	Article							TOTAL-ENERGY CALCULATIONS; WAVE BASIS-SET; HYDROTHERMAL CONDITIONS; TITANIUM-DIOXIDE; SURFACE; OXIDE; NANOSTRUCTURES; NANOPARTICLES; NANOCRYSTALS; EFFICIENCY	Owing to their scientific and technological importance, inorganic single crystals with highly reactive surfaces have long been studied(1-13). Unfortunately, surfaces with high reactivity usually diminish rapidly during the crystal growth process as a result of the minimization of surface energy. A typical example is titanium dioxide ( TiO2), which has promising energy and environmental applications(14-17). Most available anatase TiO2 crystals are dominated by the thermodynamically stable {101} facets ( more than 94 per cent, according to the Wulff construction(10)), rather than the much more reactive {001} facets(8-13,18-20). Here we demonstrate that for fluorine- terminated surfaces this relative stability is reversed: {001} is energetically preferable to {101}. We explored this effect systematically for a range of non- metallic adsorbate atoms by first- principle quantum chemical calculations. On the basis of theoretical predictions, we have synthesized uniform anatase TiO2 single crystals with a high percentage ( 47 per cent) of {001} facets using hydrofluoric acid as a morphology controlling agent. Moreover, the fluorated surface of anatase single crystals can easily be cleaned using heat treatment to render a fluorine-	[Yang, Hua Gui; Sun, Cheng Hua; Qiao, Shi Zhang; Liu, Gang; Smith, Sean Campbell; Lu, Gao Qing] Univ Queensland, ARC Ctr Excellence Funct Nanomat, Sch Engn, Brisbane, Qld 4072, Australia; [Yang, Hua Gui; Sun, Cheng Hua; Qiao, Shi Zhang; Liu, Gang; Smith, Sean Campbell; Lu, Gao Qing] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Ctr Computat Mol Sci, Brisbane, Qld 4072, Australia; [Zou, Jin] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia; [Zou, Jin] Univ Queensland, Sch Engn, Brisbane, Qld 4072, Australia; [Liu, Gang; Cheng, Hui Ming] Chinese Acad Sci, Met Res Inst, Shenyang Natl Lab Mat sci, Shenyang 110016, Peoples R China	University of Queensland; University of Queensland; University of Queensland; University of Queensland; Chinese Academy of Sciences; Institute of Metal Research, CAS	Lu, GQ (corresponding author), Univ Queensland, ARC Ctr Excellence Funct Nanomat, Sch Engn, Brisbane, Qld 4072, Australia.	s.qiao@uq.edu.au; maxlu@uq.edu.au	Liu, Gang/J-9729-2012; Qiao, Shizhang/A-6057-2010; Sun, Chenghua/U-2054-2017; Cheng, Hui-Ming/B-8682-2012; Sun, Chenghua/C-5734-2009; Smith, Sean/GYJ-6782-2022; Smith, Sean C/H-5003-2015; Lu, Gaoqing/A-2859-2008; Yang, Hug Gui/N-7612-2018; Zou, Jin/B-3183-2009	Liu, Gang/0000-0002-6946-7552; Qiao, Shizhang/0000-0002-4568-8422; Sun, Chenghua/0000-0001-7654-669X; Smith, Sean C/0000-0002-5679-8205; Lu, Gaoqing/0000-0002-5223-1674; Yang, Hug Gui/0000-0003-0436-8622; Zou, Jin/0000-0001-9435-8043; Lu, Gaoqing (Max)/0000-0002-1456-6983; Cheng, Hui-Ming/0000-0002-5387-4241				Barbe CJ, 1997, J AM CERAM SOC, V80, P3157, DOI 10.1111/j.1151-2916.1997.tb03245.x; Barnard AS, 2005, NANO LETT, V5, P1261, DOI 10.1021/nl050355m; Barnard AS, 2004, J CHEM PHYS, V121, P4276, DOI 10.1063/1.1775770; BERGER H, 1993, J CRYST GROWTH, V130, P108, DOI 10.1016/0022-0248(93)90842-K; Bikondoa O, 2006, NAT MATER, V5, P189, DOI 10.1038/nmat1592; Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535; Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0; Dulub O, 2007, SCIENCE, V317, P1052, DOI 10.1126/science.1144787; FUJISHIMA A, 1972, NATURE, V238, P38; Gong XQ, 2005, J PHYS CHEM B, V109, P19560, DOI 10.1021/jp055311g; Gong XQ, 2006, NAT MATER, V5, P665, DOI 10.1038/nmat1695; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; Herman GS, 2000, PHYS REV LETT, V84, P3354, DOI 10.1103/PhysRevLett.84.3354; HUBER KP, 1979, MOL SPECTRA MOL STRU, V4, P642; IZUMI F, 1978, B CHEM SOC JPN, V51, P1771, DOI 10.1246/bcsj.51.1771; Jun YW, 2003, J AM CHEM SOC, V125, P15981, DOI 10.1021/ja0369515; Kavan L, 1996, J AM CHEM SOC, V118, P6716, DOI 10.1021/ja954172l; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Lazzeri M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.266105; Lazzeri M, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.155409; Lou XW, 2003, J AM CHEM SOC, V125, P2697, DOI 10.1021/ja029086h; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Penn RL, 1999, GEOCHIM COSMOCHIM AC, V63, P1549, DOI 10.1016/S0016-7037(99)00037-X; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Thomas AG, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.035110; Tian N, 2007, SCIENCE, V316, P732, DOI 10.1126/science.1140484; Vittadini A, 1998, PHYS REV LETT, V81, P2954, DOI 10.1103/PhysRevLett.81.2954; Vittadini A, 2007, THEOR CHEM ACC, V117, P663, DOI 10.1007/s00214-006-0191-4; Yang HG, 2005, J AM CHEM SOC, V127, P270, DOI 10.1021/ja045253x; Yang HG, 2004, ANGEW CHEM INT EDIT, V43, P5206, DOI 10.1002/anie.200460767; Yang HG, 2004, J PHYS CHEM B, V108, P3492, DOI 10.1021/jp0377782; Yu JC, 2002, CHEM MATER, V14, P3808, DOI 10.1021/cm020027c; Zaban A, 2000, J PHYS CHEM B, V104, P4130, DOI 10.1021/jp993198m; ZMBOV KF, 1967, J PHYS CHEM-US, V71, P2893, DOI 10.1021/j100868a021	37	3501	3601	124	3524	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2008	453	7195					638	U4		10.1038/nature06964	http://dx.doi.org/10.1038/nature06964			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305NN	18509440	Green Published			2022-12-24	WOS:000256185200040
J	Zhou, L; Lopes, JE; Chong, MMW; Ivanov, II; Min, R; Victora, GD; Shen, YL; Du, JG; Rubtsov, YP; Rudensky, AY; Ziegler, SF; Littman, DR				Zhou, Liang; Lopes, Jared E.; Chong, Mark M. W.; Ivanov, Ivaylo I.; Min, Roy; Victora, Gabriel D.; Shen, Yuelei; Du, Jianguang; Rubtsov, Yuri P.; Rudensky, Alexander Y.; Ziegler, Steven F.; Littman, Dan R.			TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing ROR gamma t function	NATURE			English	Article							AUTOIMMUNE INFLAMMATION; GENERATION; CYTOKINE; IL-21; INTERLEUKIN-17; TRANSCRIPTION; ACTIVATION; REPRESSOR; RESPONSES; PATHWAYS	T helper cells that produce IL- 17 (T(H)17 cells) promote autoimmunity in mice and have been implicated in the pathogenesis of human inflammatory diseases. At mucosal surfaces, T(H)17 cells are thought to protect the host from infection, whereas regulatory T ( T-reg) cells control immune responses and inflammation triggered by the resident microflora(1-5). Differentiation of both cell types requires transforming growth factor-beta (TGF-beta), but depends on distinct transcription factors: ROR gamma t ( encoded by Rorc(gamma t)) for T(H)17 cells and Foxp3 for T-reg cells(6-8). How TGF-beta regulates the differentiation of T cells with opposing activities has been perplexing. Here we demonstrate that, together with pro- inflammatory cytokines, TGF-beta orchestrates T(H)17 cell differentiation in a concentration-dependent manner. At low concentrations, TGF-b synergizes with interleukin ( IL)- 6 and IL- 21 ( refs 9 - 11) to promote IL- 23 receptor (Il23r) expression, favouring T(H)17 cell differentiation. High concentrations of TGF-beta repress IL23r expression and favour Foxp3(+) T-reg cells. ROR gamma t and Foxp3 are co- expressed in naive CD4(+) T cells exposed to TGF-beta and in a subset of T cells in the small intestinal lamina propria of the mouse. In vitro, TGF-beta-induced Foxp3 inhibits ROR gamma t function, at least in part through their interaction. Accordingly, lamina propria T cells that co-express both transcription factors produce less IL- 17 ( also known as IL-17a) than those that express ROR gamma t alone. IL- 6, IL- 21 and IL- 23 relieve Foxp3- mediated inhibition of ROR gamma t, thereby promoting TH17 cell differentiation. Therefore, the decision of antigen- stimulated cells to differentiate into either T(H)17 or T-reg cells depends on the cytokine- regulated balance of ROR gamma t and Foxp3.	[Zhou, Liang; Chong, Mark M. W.; Ivanov, Ivaylo I.; Min, Roy; Victora, Gabriel D.; Shen, Yuelei; Littman, Dan R.] NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Min, Roy; Littman, Dan R.] NYU, Sch Med, Dept Microbiol, Howard Hughes Med Inst, New York, NY 10016 USA; [Min, Roy; Littman, Dan R.] NYU, Sch Med, Dept Pathol, Howard Hughes Med Inst, New York, NY 10016 USA; [Lopes, Jared E.; Du, Jianguang; Ziegler, Steven F.] Benaroya Res Inst, Program Immunol, Seattle, WA 98101 USA; [Lopes, Jared E.; Du, Jianguang; Ziegler, Steven F.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA USA; [Rubtsov, Yuri P.; Rudensky, Alexander Y.] Univ Washington, Dept Immunol, Howard Hughes Med Inst, Seattle, WA 98195 USA	New York University; Howard Hughes Medical Institute; New York University; Howard Hughes Medical Institute; New York University; Benaroya Research Institute; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Littman, DR (corresponding author), NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10016 USA.	littman@saturn.med.nyu.edu	Rubtsov, Yury P/A-8227-2014; Chong, Mark/H-6684-2016; Victora, Gabriel/C-5946-2011	Rubtsov, Yury P/0000-0001-9175-3013; Chong, Mark/0000-0002-3701-7397; Victora, Gabriel/0000-0001-8807-348X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048779] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI048779-05, R01 AI048779, AI48779] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Allan SE, 2005, J CLIN INVEST, V115, P3276, DOI 10.1172/JCI24685; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; DU J, IN PRESS J IMMUNOL; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Witowski J, 2004, CELL MOL LIFE SCI, V61, P567, DOI 10.1007/s00018-003-3228-z; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	30	1417	1577	4	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 8	2008	453	7192					236	U14		10.1038/nature06878	http://dx.doi.org/10.1038/nature06878			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297BP	18368049	Green Accepted, Bronze			2022-12-24	WOS:000255592400043
J	Leitch, AR; Leitch, IJ				Leitch, A. R.; Leitch, I. J.			Perspective - Genomic plasticity and the diversity of polyploid plants	SCIENCE			English	Editorial Material							ALLOPOLYPLOID NICOTIANA; GENE-EXPRESSION; BRASSICA-NAPUS; MECHANISMS; EVOLUTION; PRODUCTS	Polyploidy, a change whereby the entire chromosome set is multiplied, arises through mitotic or meiotic misdivisions and frequently involves unreduced gametes and interspecific hybridization. The success of newly formed angiosperm polyploids is partly attributable to their highly plastic genome structure, as manifested by tolerance to changing chromosome numbers ( aneuploidy and polyploidy), genome size, ( retro) transposable element mobility, insertions, deletions, and epigenome restructuring. The ability to withstand large- scale changes, frequently within one or a few generations, is associated with a restructuring of the transcriptome, metabolome, and proteome and can result in an altered phenotype and ecology. Thus, polyploid- induced changes can generate individuals that are able to exploit new niches or to outcompete progenitor species. This process has been a major driving force behind the divergence of the angiosperms and their biodiversity.	[Leitch, A. R.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Leitch, I. J.] Royal Bot Gardens, Jodrell Lab, Richmond TW9 3AB, Surrey, England	University of London; Queen Mary University London; Royal Botanic Gardens, Kew	Leitch, AR (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.	a.r.leitch@qmul.ac.uk; i.leitch@kew.edu	Leitch, Andrew R/J-6385-2014; Leitch, Ilia J/X-5449-2019; Leitch, Ilia J/D-6052-2011	Leitch, Andrew R/0000-0001-8574-302X; Leitch, Ilia J/0000-0002-3837-8186; Leitch, Ilia J/0000-0002-3837-8186	Natural Environment Research Council [NE/C511964/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Abbott RJ, 2004, BIOL J LINN SOC, V82, P467, DOI 10.1111/j.1095-8312.2004.00333.x; Adams KL, 2005, TRENDS GENET, V21, P539, DOI 10.1016/j.tig.2005.07.009; Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Ainouche ML, 2004, BIOL J LINN SOC, V82, P475, DOI 10.1111/j.1095-8312.2004.00334.x; Albertin W, 2006, GENETICS, V173, P1101, DOI 10.1534/genetics.106.057554; Albertin W, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-56; BEADLE NCW, 1962, ECOLOGY, V43, P281, DOI 10.2307/1931983; Brochmann C, 2004, BIOL J LINN SOC, V82, P521, DOI 10.1111/j.1095-8312.2004.00337.x; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Clarkson JJ, 2005, NEW PHYTOL, V168, P241, DOI 10.1111/j.1469-8137.2005.01480.x; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Husband BC, 2004, BIOL J LINN SOC, V82, P537, DOI 10.1111/j.1095-8312.2004.00339.x; JAUCH A, 1992, P NATL ACAD SCI USA, V89, P8611, DOI 10.1073/pnas.89.18.8611; Leitch IJ, 2004, BIOL J LINN SOC, V82, P651, DOI 10.1111/j.1095-8312.2004.00349.x; Lim KY, 2007, NEW PHYTOL, V175, P756, DOI 10.1111/j.1469-8137.2007.02121.x; Lim KY, 2006, AM J BOT, V93, P875, DOI 10.3732/ajb.93.6.875; Lou Y, 2003, P NATL ACAD SCI USA, V100, P14581, DOI 10.1073/pnas.2135348100; Ma JX, 2004, GENOME RES, V14, P860, DOI 10.1101/gr.1466204; Pearse IS, 2006, PLANT J, V47, P196, DOI 10.1111/j.1365-313X.2006.02776.x; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Soltis DE, 2004, NEW PHYTOL, V161, P173, DOI 10.1046/j.1469-8137.2003.00948.x; Thomas BC, 2006, GENOME RES, V16, P934, DOI 10.1101/gr.4708406; Yang FT, 2004, CHROMOSOME RES, V12, P65, DOI 10.1023/B:CHRO.0000009298.02689.8a	27	594	614	6	217	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2008	320	5875					481	483		10.1126/science.1153585	http://dx.doi.org/10.1126/science.1153585			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436776				2022-12-24	WOS:000255249300035
J	Fowlkes, CC; Luengo Hendriks, CL; Keranen, SVE; Weber, GH; Rubel, O; Huang, MY; Chatoor, S; DePace, AH; Simirenko, L; Henriquez, C; Beaton, A; Weiszmann, R; Celniker, S; Hamann, B; Knowles, DW; Biggin, MD; Eisen, MB; Malik, J				Fowlkes, Charless C.; Luengo Hendriks, Cris L.; Keraenen, Soile V. E.; Weber, Gunther H.; Ruebel, Oliver; Huang, Min-Yu; Chatoor, Sohail; DePace, Angela H.; Simirenko, Lisa; Henriquez, Clara; Beaton, Amy; Weiszmann, Richard; Celniker, Susan; Hamann, Bernd; Knowles, David W.; Biggin, Mark D.; Eisen, Michael B.; Malik, Jitendra			A quantitative spatiotemporal atlas of gene expression in the Drosophila blastoderm	CELL			English	Article							TRANSCRIPTIONAL REGULATION; 3-DIMENSIONAL MORPHOLOGY; POSITIONAL INFORMATION; EGG SIZE; EMBRYOGENESIS; MELANOGASTER; PATTERNS; EMBRYO; SPECIFICATION; EVOLUTION	To fully understand animal transcription networks, it is essential to accurately measure the spatial and temporal expression patterns of transcription factors and their targets. We describe a registration technique that takes image-based data from hundreds of Drosophila blastoderm embryos, each costained for a reference gene and one of a set of genes of interest, and builds a model VirtualEmbryo. This model captures in a common framework the average expression patterns for many genes in spite of significant variation in morphology and expression between individual embryos. We establish the method's accuracy by showing that relationships between a pair of genes' expression inferred from the model are nearly identical to those measured in embryos costained for the pair. We present a VirtualEmbryo containing data for 95 genes at six time cohorts. We show that known gene-regulatory interactions can be automatically recovered from this data set and predict hundreds of new interactions.	[Fowlkes, Charless C.; Luengo Hendriks, Cris L.; Keraenen, Soile V. E.; Weber, Gunther H.; Ruebel, Oliver; Huang, Min-Yu; Chatoor, Sohail; DePace, Angela H.; Simirenko, Lisa; Henriquez, Clara; Celniker, Susan; Hamann, Bernd; Knowles, David W.; Biggin, Mark D.; Eisen, Michael B.; Malik, Jitendra] Univ Calif Irvine, Berkeley Drosophila Transcript Network Project, Irvine, CA 92697 USA; [Fowlkes, Charless C.] Univ Calif Irvine, Dept Comp Sci, Irvine, CA 92697 USA; [Luengo Hendriks, Cris L.; Chatoor, Sohail; Celniker, Susan; Knowles, David W.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Keraenen, Soile V. E.; DePace, Angela H.; Simirenko, Lisa; Henriquez, Clara; Beaton, Amy; Weiszmann, Richard; Biggin, Mark D.; Eisen, Michael B.] Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; [Weber, Gunther H.; Ruebel, Oliver; Huang, Min-Yu; Hamann, Bernd] Univ Calif Davis, Inst Data Anal & Visualizat IDAV, Davis, CA 95616 USA; [Ruebel, Oliver; Huang, Min-Yu; Chatoor, Sohail; Hamann, Bernd] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA; [Malik, Jitendra] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Berkeley	Eisen, MB (corresponding author), Univ Calif Irvine, Berkeley Drosophila Transcript Network Project, Irvine, CA 92697 USA.	mbeisen@lbl.gov; malik@cs.berkeley.edu	Luengo Hendriks, Cris L./B-1097-2008; Weber, Gunther/AAA-9678-2019	Luengo Hendriks, Cris L./0000-0002-8279-1760; Weber, Gunther/0000-0002-1794-1398; Fowlkes, Charless/0000-0002-2990-1780; Eisen, Michael/0000-0002-7528-738X	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070444] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG002779, R01 HG002779-05, R01 HG002779-06] Funding Source: Medline; NIGMS NIH HHS [GM704403, R01 GM070444] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnosti DN, 1996, DEVELOPMENT, V122, P205; Azevedo RBR, 1996, EVOLUTION, V50, P2338, DOI [10.2307/2410702, 10.1111/j.1558-5646.1996.tb03621.x]; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Clyde DE, 2003, NATURE, V426, P849, DOI 10.1038/nature02189; Duchon J, 1977, CONSTRUCTIVE THEORY, P85, DOI DOI 10.1007/BFB0086566; EDGAR BA, 1986, CELL, V44, P365, DOI 10.1016/0092-8674(86)90771-3; ELDON ED, 1991, DEVELOPMENT, V111, P367; FOWLKES CC, 2006, UCBEECS2006142; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Janssens H, 2006, NAT GENET, V38, P1159, DOI 10.1038/ng1886; Keranen SVE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r124; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; Laney JD, 1996, DEVELOPMENT, V122, P2303; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; Luengo Hendriks CL, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r123; Mjolsness E, 2007, J BIOINF COMPUT BIOL, V5, P467, DOI 10.1142/S0219720007002874; Myasnikova E, 2001, BIOINFORMATICS, V17, P3, DOI 10.1093/bioinformatics/17.1.3; Oliveri P, 2004, CURR OPIN GENET DEV, V14, P351, DOI 10.1016/j.gde.2004.06.004; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; RUBEL O, 2006, DATA VISUALIZATION 2; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; Spirov AV, 2002, REAL-TIME IMAGING, V8, P507, DOI 10.1006/rtim.2002.0292; Struffi P, 2004, DEVELOPMENT, V131, P2419, DOI 10.1242/dev.01075; Tassy O, 2006, CURR BIOL, V16, P345, DOI 10.1016/j.cub.2005.12.044; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; TURNER FR, 1976, DEV BIOL, V50, P95, DOI 10.1016/0012-1606(76)90070-1; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Wahba G., 1990, SPLINE MODELS OBSERV; Warren DC, 1924, GENETICS, V9, P41; Weber GH, 2009, IEEE ACM T COMPUT BI, V6, P296, DOI 10.1109/TCBB.2007.70249; Yuh CH, 2001, DEVELOPMENT, V128, P617; ZALOKAR M, 1976, J MICROSC BIOL CELL, V25, P97	35	185	188	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2008	133	2					364	374		10.1016/j.cell.2008.01.053	http://dx.doi.org/10.1016/j.cell.2008.01.053			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	289JY	18423206	Bronze, Green Submitted			2022-12-24	WOS:000255052000024
J	Sancak, Y; Peterson, TR; Shaul, YD; Lindquist, RA; Thoreen, CC; Bar-Peled, L; Sabatini, DM				Sancak, Yasemin; Peterson, Timothy R.; Shaul, Yoav D.; Lindquist, Robert A.; Thoreen, Carson C.; Bar-Peled, Liron; Sabatini, David M.			The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; MAMMALIAN TARGET; PROTEIN COMPLEXES; S6 KINASE; RAPAMYCIN; PATHWAY; TOR; ACTIVATION; RHEB; MICROAUTOPHAGY	The multiprotein mTORC1 protein kinase complex is the central component of a pathway that promotes growth in response to insulin, energy levels, and amino acids and is deregulated in common cancers. We find that the Rag proteins - a family of four related small guanosine triphosphatases (GTPases)-interact with mTORC1 in an amino acid-sensitive manner and are necessary for the activation of the mTORC1 pathway by amino acids. A Rag mutant that is constitutively bound to guanosine triphosphate interacted strongly with mTORC1, and its expression within cells made the mTORC1 pathway resistant to amino acid deprivation. Conversely, expression of a guanosine diphosphate-bound Rag mutant prevented stimulation of mTORC1 by amino acids. The Rag proteins do not directly stimulate the kinase activity of mTORC1, but, like amino acids, promote the intracellular localization of mTOR to a compartment that also contains its activator Rheb.	[Sancak, Yasemin; Peterson, Timothy R.; Shaul, Yoav D.; Lindquist, Robert A.; Thoreen, Carson C.; Bar-Peled, Liron; Sabatini, David M.] MIT, Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Sancak, Yasemin; Peterson, Timothy R.; Shaul, Yoav D.; Lindquist, Robert A.; Thoreen, Carson C.; Bar-Peled, Liron; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Sancak, Yasemin; Peterson, Timothy R.; Shaul, Yoav D.; Lindquist, Robert A.; Thoreen, Carson C.; Sabatini, David M.] MIT, Canc Res Ctr, Cambridge, MA 02139 USA; [Sabatini, David M.] Broad Inst, Cambridge Ctr 7, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Sabatini, DM (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	Shaul, Yoav/AAY-7011-2020	/0000-0002-1446-7256; Lindquist, Robert/0000-0003-4746-0605	NATIONAL CANCER INSTITUTE [R01CA103866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389, R01AI047389] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA103866-05, R01 CA103866] Funding Source: Medline; NIAID NIH HHS [R01 AI047389, R01 AI047389-09, AI47389] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Chen EJ, 2003, J CELL BIOL, V161, P333, DOI 10.1083/jcb.200210141; Christie GR, 2002, J BIOL CHEM, V277, P9952, DOI 10.1074/jbc.M107694200; Drenan RM, 2004, J BIOL CHEM, V279, P772, DOI 10.1074/jbc.M305912200; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hirose E, 1998, J CELL SCI, V111, P11; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kunz JB, 2004, J BIOL CHEM, V279, P9987, DOI 10.1074/jbc.M307905200; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; MASANORI BY, 1992, MOL CELL BIOL, V12, P2958, DOI 10.1128/MCB.12.7.2958; Mavrakis M, 2007, AUTOPHAGY, V3, P151, DOI 10.4161/auto.3632; Nakashima N, 1999, GENETICS, V152, P853; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; PRICE DJ, 1989, J BIOL CHEM, V264, P13825; Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; SCHURMANN A, 1995, J BIOL CHEM, V270, P28982, DOI 10.1074/jbc.270.48.28982; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609	27	1838	1895	7	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2008	320	5882					1496	1501		10.1126/science.1157535	http://dx.doi.org/10.1126/science.1157535			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	312MV	18497260	Green Accepted			2022-12-24	WOS:000256676400045
J	Hanikenne, M; Talke, IN; Haydon, MJ; Lanz, C; Nolte, A; Motte, P; Kroymann, J; Weigel, D; Kramer, U				Hanikenne, Marc; Talke, Ina N.; Haydon, Michael J.; Lanz, Christa; Nolte, Andrea; Motte, Patrick; Kroymann, Juergen; Weigel, Detlef; Kraemer, Ute			Evolution of metal hyperaccumulation required cis-regulatory changes and triplication of HMA4	NATURE			English	Article							ARABIDOPSIS-THALIANA; ZINC TOLERANCE; GENETIC-BASIS; COPY NUMBER; HOMEOSTASIS; PLANT; TRANSPORTER; EXPRESSION; SELECTION; CADMIUM	Little is known about the types of mutations underlying the evolution of species-specific traits. The metal hyperaccumulator Arabidopsis halleri has the rare ability to colonize heavy-metal-polluted soils, and, as an extremophile sister species of Arabidopsis thaliana, it is a powerful model for research on adaptation(1-3). A. halleri naturally accumulates and tolerates leaf concentrations as high as 2.2% zinc and 0.28% cadmium in dry biomass(4). On the basis of transcriptomics studies, metal hyperaccumulation in A. halleri has been associated with more than 30 candidate genes that are expressed at higher levels in A. halleri than in A. thaliana(4-6). Some of these genes have been genetically mapped to broad chromosomal segments of between 4 and 24 cM co-segregating with Zn and Cd hypertolerance(7-9). However, the in planta loss-of-function approaches required to demonstrate the contribution of a given candidate gene to metal hyperaccumulation or hypertolerance have not been pursued to date. Using RNA interference to downregulate HMA4 (HEAVY METAL ATPASE 4) expression, we show here that Zn hyperaccumulation and full hypertolerance to Cd and Zn in A. halleri depend on the metal pump HMA4. Contrary to a postulated global trans regulatory factor governing high expression of numerous metal hyperaccumulation genes, we demonstrate that enhanced expression of HMA4 in A. halleri is attributable to a combination of modified cis-regulatory sequences and copy number expansion, in comparison to A. thaliana. Transfer of an A. halleri HMA4 gene to A. thaliana recapitulates Zn partitioning into xylem vessels and the constitutive transcriptional upregulation of Zn deficiency response genes characteristic of Zn hyperaccumulators. Our results demonstrate the importance of cis-regulatory mutations and gene copy number expansion in the evolution of a complex naturally selected extreme trait(10). The elucidation of a natural strategy for metal hyperaccumulation enables the rational design of technologies for the clean-up of metal-contaminated soils and for bio-fortification.	[Hanikenne, Marc; Talke, Ina N.; Haydon, Michael J.; Nolte, Andrea; Kraemer, Ute] Max Planck Inst Mol Plant Physiol, D-14476 Potsdam, Germany; [Lanz, Christa; Weigel, Detlef] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; [Motte, Patrick] Univ Liege, Dept Life Sci, B-4000 Liege, Belgium; [Motte, Patrick] Univ Liege, Ctr Assistance Technol Microscopy, Dept Chem, B-4000 Liege, Belgium; [Kroymann, Juergen] Max Planck Inst Chem Ecol, D-07745 Jena, Germany	Max Planck Society; Max Planck Society; University of Liege; University of Liege; Max Planck Society	Kramer, U (corresponding author), Heidelberg Univ, BIOQUANT Ctr, Heidelberg Inst Plant Sci, D-69120 Heidelberg, Germany.	ute.kraemer@bioquant.uni-heidelberg.de	Weigel, Detlef/AAR-3312-2021; Kroymann, Juergen/AAY-8562-2021; Haydon, Michael/B-9326-2014; Kroymann, Juergen/B-4317-2013; Hanikenne, Marc/Y-4642-2019; Kraemer, Ute/C-5025-2008; Weigel, Detlef/C-1418-2008; Weigel, Detlef/GSJ-0799-2022	Kroymann, Juergen/0000-0002-4573-6498; Haydon, Michael/0000-0003-2486-9387; Hanikenne, Marc/0000-0002-8964-9601; Kraemer, Ute/0000-0001-7870-4508; Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Talke, Ina/0000-0002-8319-1951				Arrivault S, 2006, PLANT J, V46, P861, DOI 10.1111/j.1365-313X.2006.02746.x; Axelsen KB, 2001, PLANT PHYSIOL, V126, P696, DOI 10.1104/pp.126.2.696; Baker AJM, 2000, PHYTOREMEDIATION OF CONTAMINATED SOIL AND WATER, P85; Becher M, 2004, PLANT J, V37, P251, DOI 10.1046/j.1365-313X.2003.01959.x; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Benderoth M, 2006, P NATL ACAD SCI USA, V103, P9118, DOI 10.1073/pnas.0601738103; Bert V, 2003, PLANT SOIL, V249, P9, DOI 10.1023/A:1022580325301; Bray N, 2003, GENOME RES, V13, P97, DOI 10.1101/gr.789803; Chateau S, 2000, J EXP BOT, V51, P1961, DOI 10.1093/jexbot/51.353.1961; Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Clemens S, 2002, TRENDS PLANT SCI, V7, P309, DOI 10.1016/S1360-1385(02)02295-1; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Courbot M, 2007, PLANT PHYSIOL, V144, P1052, DOI 10.1104/pp.106.095133; Couronne O, 2003, GENOME RES, V13, P73, DOI 10.1101/gr.762503; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Drager DB, 2004, PLANT J, V39, P425, DOI 10.1111/j.1365-313X.2004.02143.x; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Hussain D, 2004, PLANT CELL, V16, P1327, DOI 10.1105/tpc.020487; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Kramer U, 1996, NATURE, V379, P635, DOI 10.1038/379635a0; Kupper H, 2000, PLANTA, V212, P75, DOI 10.1007/s004250000366; Lasat MM, 2000, J EXP BOT, V51, P71, DOI 10.1093/jexbot/51.342.71; Macnair MR, 1999, P ROY SOC B-BIOL SCI, V266, P2175, DOI 10.1098/rspb.1999.0905; Mitchell-Olds T, 2001, TRENDS ECOL EVOL, V16, P693, DOI 10.1016/S0169-5347(01)02291-1; Sinclair SA, 2007, NEW PHYTOL, V174, P39, DOI 10.1111/j.1469-8137.2007.02030.x; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; Sugino RP, 2006, TRENDS GENET, V22, P642, DOI 10.1016/j.tig.2006.09.014; Talke IN, 2006, PLANT PHYSIOL, V142, P148, DOI 10.1104/pp.105.076232; VANCANNEYT G, 1990, MOL GEN GENET, V220, P245, DOI 10.1007/BF00260489; Walther D, 2001, GENOME RES, V11, P875, DOI 10.1101/gr.177901; Weber M, 2004, PLANT J, V37, P269, DOI 10.1046/j.1365-313X.2003.01960.x; Weigel D, 2005, PLANT PHYSIOL, V138, P567, DOI 10.1104/pp.104.900157; Willems G, 2007, GENETICS, V176, P659, DOI 10.1534/genetics.106.064485; Windsor AJ, 2006, PLANT PHYSIOL, V140, P1169, DOI 10.1104/pp.105.073981; Zhong SB, 2004, P NATL ACAD SCI USA, V101, P11719, DOI 10.1073/pnas.0404397101	38	560	586	8	318	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2008	453	7193					391	U44		10.1038/nature06877	http://dx.doi.org/10.1038/nature06877			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18425111				2022-12-24	WOS:000255868400052
J	Aronov, D; Andalman, AS; Fee, MS				Aronov, Dmitriy; Andalman, Aaron S.; Fee, Michale S.			A specialized forebrain circuit for vocal babbling in the juvenile songbird	SCIENCE			English	Article							EARLY MOTOR-ACTIVITY; MALE ZEBRA FINCHES; AXONAL CONNECTIONS; HUMAN INFANTS; NUCLEUS; BIRDSONG; LESIONS; BRAIN; MECHANISMS; BEHAVIOR	Young animals engage in variable exploratory behaviors essential for the development of neural circuitry and adult motor control, yet the neural basis of these behaviors is largely unknown. Juvenile songbirds produce subsong- a succession of primitive vocalizations akin to human babbling. We found that subsong production in zebra finches does not require HVC ( high vocal center), a key premotor area for singing in adult birds, but does require LMAN ( lateral magnocellular nucleus of the nidopallium), a forebrain nucleus involved in learning but not in adult singing. During babbling, neurons in LMAN exhibited premotor correlations to vocal output on a fast time scale. Thus, juvenile singing is driven by a circuit distinct from that which produces the adult behavior- a separation possibly general to other developing motor systems.	[Aronov, Dmitriy; Andalman, Aaron S.; Fee, Michale S.] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Fee, MS (corresponding author), MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, E25-618, Cambridge, MA 02139 USA.	fee@mit.edu	Andalman, Aaron S/C-7694-2011	Fee, Michale/0000-0001-7539-1745	NIMH NIH HHS [MH067105] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067105] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AKUTAGAWA E, 1994, P NATL ACAD SCI USA, V91, P12413, DOI 10.1073/pnas.91.26.12413; ALVAREZBUYLLA A, 1992, J NEUROBIOL, V23, P396, DOI 10.1002/neu.480230406; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; BOTTJER SW, 1989, J COMP NEUROL, V279, P312, DOI 10.1002/cne.902790211; Chi ZY, 2001, NEURON, V32, P899, DOI 10.1016/S0896-6273(01)00524-4; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Doya K, 1996, ADV NEURAL INFORMATI, P101; EDELMAN GM, 1987, NEURAL DARWIMISM THE; Elowson AM, 1998, TRENDS COGN SCI, V2, P31, DOI 10.1016/S1364-6613(97)01115-7; Eyre JA, 2000, BRAIN, V123, P51, DOI 10.1093/brain/123.1.51; Fagen RM, 1981, ANIMAL PLAY BEHAV; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; Forssberg H, 1999, CURR OPIN NEUROBIOL, V9, P676, DOI 10.1016/S0959-4388(99)00037-9; Fujii N, 2003, SCIENCE, V301, P1246, DOI 10.1126/science.1086872; Hadders-Algra M, 2000, DEV MED CHILD NEUROL, V42, P566, DOI 10.1017/S0012162200001067; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; HERRMANN K, 1991, J NEUROSCI, V11, P2063; Imada T, 2006, NEUROREPORT, V17, P957, DOI 10.1097/01.wnr.0000223387.51704.89; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Kittelberger JM, 1999, J NEUROSCI, V19, P9385; Knornschild M, 2006, NATURWISSENSCHAFTEN, V93, P451, DOI 10.1007/s00114-006-0127-9; Leonardo A, 2005, J NEUROSCI, V25, P652, DOI 10.1523/JNEUROSCI.3036-04.2005; MARLER P, 1970, AM SCI, V58, P669; Marler P, 1997, J NEUROBIOL, V33, P501; Milh M, 2007, CEREB CORTEX, V17, P1582, DOI 10.1093/cercor/bhl069; MOONEY R, 1994, J NEUROSCI, V14, P6532; MOONEY R, 1992, J NEUROSCI, V12, P2464; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Petersson P, 2003, NATURE, V424, P72, DOI 10.1038/nature01719; Prechtl HFR, 1997, LANCET, V349, P1361, DOI 10.1016/S0140-6736(96)10182-3; REISS D, 1993, J COMP PSYCHOL, V107, P301, DOI 10.1037/0735-7036.107.3.301; Robinson SR, 2000, BEHAV NEUROSCI, V114, P328, DOI 10.1037//0735-7044.114.2.328; SCHARFF C, 1991, J NEUROSCI, V11, P2896; SIMPSON HB, 1990, J NEUROSCI, V10, P1541; SPORNS O, 1993, CHILD DEV, V64, P960, DOI 10.2307/1131321; Stark LL, 1999, J NEUROSCI, V19, P9107, DOI 10.1523/JNEUROSCI.19-20-09107.1999; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Thompson JA, 2007, DEV NEUROBIOL, V67, P205, DOI 10.1002/dneu.20287; Troyer TW, 2001, CURR OPIN NEUROBIOL, V11, P721, DOI 10.1016/S0959-4388(01)00275-6; Wallace PS, 2003, NEUROPSYCHOLOGIA, V41, P1912, DOI 10.1016/S0028-3932(03)00128-3; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	44	234	237	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2008	320	5876					630	634		10.1126/science.1155140	http://dx.doi.org/10.1126/science.1155140			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451295				2022-12-24	WOS:000255454300036
J	Howitz, KT; Sinclair, DA				Howitz, Konrad T.; Sinclair, David A.			Xenohormesis: Sensing the chemical cues of other species	CELL			English	Article							RESVERATROL; FLAVONOIDS; ACTIVATORS; SIRTUINS; MOLECULE	Many plant molecules interact with and modulate key regulators of mammalian physiology in ways that are beneficial to health, but why? We propose that heterotrophs (animals and fungi) are able to sense chemical cues synthesized by plants and other autotrophs in response to stress. These cues provide advance warning about deteriorating environmental conditions, allowing the heterotrophs to prepare for adversity while conditions are still favorable.	[Howitz, Konrad T.] BIOMOL Int LP, Plymouth Meeting, PA 19462 USA; [Sinclair, David A.] Harvard Univ, Sch Med, Dept Pathol, Paul F Glenn Labs, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Howitz, KT (corresponding author), BIOMOL Int LP, 5120 Butler Pike, Plymouth Meeting, PA 19462 USA.	howitzkt@biomol.com; david_sinclair@hms.harvard.edu		Sinclair, David/0000-0002-9936-436X	NIA NIH HHS [P01 AG027916-020003, R01 AG019719, R01 AG028730-01A1, P01 AG027916, R01 AG028730] Funding Source: Medline; NIGMS NIH HHS [R01 GM068072-01, R01 GM068072] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028730, P01AG027916, R01AG019719] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Corson TW, 2007, CELL, V130, P769, DOI 10.1016/j.cell.2007.08.021; Dore S, 2005, NEUROSIGNALS, V14, P61, DOI 10.1159/000085386; GANGE AC, 1989, OECOLOGIA, V81, P38, DOI 10.1007/BF00377007; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Halliwell B, 2005, AM J CLIN NUTR, V81, p268S, DOI 10.1093/ajcn/81.1.268S; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Khan N, 2006, CANCER RES, V66, P2500, DOI 10.1158/0008-5472.CAN-05-3636; Kushiro T, 2003, NATURE, V422, P122, DOI 10.1038/422122a; Mattson MP, 2006, TRENDS NEUROSCI, V29, P632, DOI 10.1016/j.tins.2006.09.001; Nandi A, 2003, PLANT CELL, V15, P2383, DOI 10.1105/tpc.015529; Oren A, 2007, FEMS MICROBIOL LETT, V269, P1, DOI 10.1111/j.1574-6968.2007.00650.x; Schultz JC, 2002, INTEGR COMP BIOL, V42, P454, DOI 10.1093/icb/42.3.454; Soleas GJ, 1997, CLIN BIOCHEM, V30, P91, DOI 10.1016/S0009-9120(96)00155-5; STAFFORD HA, 1991, PLANT PHYSIOL, V96, P680, DOI 10.1104/pp.96.3.680; Varady KA, 2007, AM J CLIN NUTR, V86, P7, DOI 10.1093/ajcn/86.1.7; Westphal CH, 2007, TRENDS BIOCHEM SCI, V32, P555, DOI 10.1016/j.tibs.2007.09.008; Woo HH, 2005, BIOTECHNOL LETT, V27, P365, DOI 10.1007/s10529-005-1521-7; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yu CW, 2002, PHARM RES-DORDR, V19, P1907, DOI 10.1023/A:1021414129280	21	195	209	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2008	133	3					387	391		10.1016/j.cell.2008.04.019	http://dx.doi.org/10.1016/j.cell.2008.04.019			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455976	Green Accepted, Bronze			2022-12-24	WOS:000255503900006
J	Paerl, HW; Huisman, J				Paerl, Hans W.; Huisman, Jef			Climate - Blooms like it hot	SCIENCE			English	Editorial Material							PHYTOPLANKTON COMMUNITIES; CYANOBACTERIUM		[Paerl, Hans W.] Univ N Carolina, Inst Marine Sci, Morehead City, NC 28557 USA; [Huisman, Jef] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1018 WS Amsterdam, Netherlands	University of North Carolina; University of North Carolina Chapel Hill; University of Amsterdam	Paerl, HW (corresponding author), Univ N Carolina, Inst Marine Sci, Morehead City, NC 28557 USA.	hpaerl@email.unc.edu; jef.huisman@science.uva.nl	Huisman, Jef/A-1089-2013	Huisman, Jef/0000-0001-9598-3211				Carmichael WW, 2001, HUM ECOL RISK ASSESS, V7, P1393, DOI 10.1080/20018091095087; Elliott JA, 2006, HYDROBIOLOGIA, V559, P401, DOI 10.1007/s10750-005-1233-y; Guo L, 2007, SCIENCE, V317, P1166, DOI 10.1126/science.317.5842.1166; Honjo M, 2006, J PLANKTON RES, V28, P407, DOI 10.1093/plankt/fbi128; Huisman J., 2005, HARMFUL CYANOBACTERI; Ibelings BW, 2003, ECOL APPL, V13, P1456, DOI 10.1890/01-5345; Johnk KD, 2008, GLOBAL CHANGE BIOL, V14, P495, DOI 10.1111/j.1365-2486.2007.01510.x; KAHRU M, 1993, MAR ECOL PROG SER, V101, P1, DOI 10.3354/meps101001; Kardinaal WEA, 2007, AQUAT MICROB ECOL, V48, P1, DOI 10.3354/ame048001; Moisander PH, 2002, MICROB ECOL, V43, P432, DOI 10.1007/s00248-001-1044-2; Paerl HW, 2006, ECOL STU AN, V189, P95, DOI 10.1007/978-3-540-32210-8_8; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Suikkanen S, 2007, ESTUAR COAST SHELF S, V71, P580, DOI 10.1016/j.ecss.2006.09.004; Tonk L, 2007, AQUAT MICROB ECOL, V46, P117, DOI 10.3354/ame046117; Wiedner C, 2007, OECOLOGIA, V152, P473, DOI 10.1007/s00442-007-0683-5	16	1733	1845	48	938	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2008	320	5872					57	58		10.1126/science.1155398	http://dx.doi.org/10.1126/science.1155398			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283JR	18388279	Green Submitted			2022-12-24	WOS:000254633000024
J	Wang, XT; Arai, S; Song, XY; Reichart, D; Du, K; Pascual, G; Tempst, P; Rosenfeld, MG; Glass, CK; Kurokawa, R				Wang, Xiangting; Arai, Shigeki; Song, Xiaoyuan; Reichart, Donna; Du, Kun; Pascual, Gabriel; Tempst, Paul; Rosenfeld, Michael G.; Glass, Christopher K.; Kurokawa, Riki			Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription	NATURE			English	Article							PRO-ONCOPROTEIN TLS/FUS; NONCODING RNAS; GENE-EXPRESSION; COACTIVATOR; GENOME; TLS; IDENTIFICATION; CHROMATIN; COMPLEX; MICE	With the recent recognition of non- coding RNAs ( ncRNAs) flanking many genes(1-5), a central issue is to obtain a full understanding of their potential roles in regulated gene transcription programmes, possibly through different mechanisms(6-12). Here we show that an RNA- binding protein, TLS ( for translocated in liposarcoma), serves as a key transcriptional regulatory sensor of DNA damage signals that, on the basis of its allosteric modulation by RNA, specifically binds to and inhibits CREB- binding protein ( CBP) and p300 histone acetyltransferase activities on a repressed gene target, cyclin D1 ( CCND1) in human cell lines. Recruitment of TLS to the CCND1 promoter to cause gene- specific repression is directed by single- stranded, low- copy- number ncRNA transcripts tethered to the 5' regulatory regions of CCND1 that are induced in response to DNA damage signals. Our data suggest that signal-induced ncRNAs localized to regulatory regions of transcription units can act cooperatively as selective ligands, recruiting and modulating the activities of distinct classes of RNA- binding co-regulators in response to specific signals, providing an unexpected ncRNA/RNA-binding protein-based strategy to integrate transcriptional programmes.	[Arai, Shigeki; Du, Kun; Kurokawa, Riki] Saitama Med Univ, Res Ctr Genom Med, Div Gene Struct & Funct, Hidaka, Saitama 3501241, Japan; [Wang, Xiangting; Song, Xiaoyuan; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Wang, Xiangting] Univ Calif San Diego, Sch Med, Mol Pathol Grad Program, La Jolla, CA 92093 USA; [Reichart, Donna; Pascual, Gabriel; Glass, Christopher K.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Pascual, Gabriel; Rosenfeld, Michael G.; Glass, Christopher K.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Tempst, Paul] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Saitama Medical University; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Memorial Sloan Kettering Cancer Center	Kurokawa, R (corresponding author), Saitama Med Univ, Res Ctr Genom Med, Div Gene Struct & Funct, 1397-1 Yamane, Hidaka, Saitama 3501241, Japan.	mgr@ucsd.edu; ckg@ucsd.edu; rkurokaw@saitama-med.ac.jp	Glass, Christopher/AAI-3933-2021; , songxy/P-1094-2014; xiangting, wang/P-1010-2014	Glass, Christopher/0000-0003-4344-3592; , songxy/0000-0002-9011-5033; xiangting, wang/0000-0003-2106-3425; Tempst, Paul/0000-0002-6680-3987	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P30 CA008748, CA097134, CA52599, P30 CA08748, R01 CA052599, R01 CA052599-19] Funding Source: Medline; NHLBI NIH HHS [R01 HL059694-10, R01 HL059694, HL59694] Funding Source: Medline; NIDDK NIH HHS [R01 DK039949, DK074868, DK39949, R01 DK091183, R37 DK039949, R37 DK039949-26] Funding Source: Medline; NINDS NIH HHS [R01 NS034934, NS34934, R01 NS034934-20A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA052599, R01CA097134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039949, P01DK074868, R01DK091183, R01DK039949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; Baechtold H, 1999, J BIOL CHEM, V274, P34337, DOI 10.1074/jbc.274.48.34337; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bertrand P, 1999, ONCOGENE, V18, P4515, DOI 10.1038/sj.onc.1203048; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Hicks GG, 2000, NAT GENET, V24, P175, DOI 10.1038/72842; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Kuroda M, 2000, EMBO J, V19, P453, DOI 10.1093/emboj/19.3.453; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; Lerga A, 2001, J BIOL CHEM, V276, P6807, DOI 10.1074/jbc.M008304200; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Miyakawa Y, 2001, BIOCHEM BIOPH RES CO, V284, P71, DOI 10.1006/bbrc.2001.4950; Murata T, 2001, HUM MOL GENET, V10, P1071, DOI 10.1093/hmg/10.10.1071; O'Neill MJ, 2005, HUM MOL GENET, V14, pR113, DOI 10.1093/hmg/ddi108; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Ron D, 1997, CURR TOP MICROBIOL, V220, P131; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Sanchez-Elsner T, 2006, SCIENCE, V311, P1118, DOI 10.1126/science.1117705; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Uranishi H, 2001, J BIOL CHEM, V276, P13395, DOI 10.1074/jbc.M011176200; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0; Yang L, 1998, J BIOL CHEM, V273, P27761, DOI 10.1074/jbc.273.43.27761	29	772	841	1	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2008	454	7200					126	U11		10.1038/nature06992	http://dx.doi.org/10.1038/nature06992			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18509338	Green Accepted			2022-12-24	WOS:000257308300051
J	Chahrour, M; Jung, SY; Shaw, C; Zhou, XB; Wong, STC; Qin, J; Zoghbi, HY				Chahrour, Maria; Jung, Sung Yun; Shaw, Chad; Zhou, Xiaobo; Wong, Stephen T. C.; Qin, Jun; Zoghbi, Huda Y.			MeCP2, a key contributor to neurological disease, activates and represses transcription	SCIENCE			English	Article							RETT-SYNDROME; METHYLTRANSFERASE DEFICIENCY; HISTONE DEACETYLASE; BDNF TRANSCRIPTION; MENTAL-RETARDATION; GENE; EXPRESSION; PHOSPHORYLATION; DISORDERS; BRAIN	Mutations in the gene encoding the transcriptional repressor methyl- CpG binding protein 2 ( MeCP2) cause the neurodevelopmental disorder Rett syndrome. Loss of function as well as increased dosage of the MECP2 gene cause a host of neuropsychiatric disorders. To explore the molecular mechanism( s) underlying these disorders, we examined gene expression patterns in the hypothalamus of mice that either lack or overexpress MeCP2. In both models, MeCP2 dysfunction induced changes in the expression levels of thousands of genes, but unexpectedly the majority of genes (similar to 85%) appeared to be activated by MeCP2. We selected six genes and confirmed that MeCP2 binds to their promoters. Furthermore, we showed that MeCP2 associates with the transcriptional activator CREB1 at the promoter of an activated target but not a repressed target. These studies suggest that MeCP2 regulates the expression of a wide range of genes in the hypothalamus and that it can function as both an activator and a repressor of transcription.	[Chahrour, Maria; Shaw, Chad; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Jung, Sung Yun; Qin, Jun] Baylor Coll Med, Ctr Mol Discovery, Dept Biochem, Houston, TX 77030 USA; [Jung, Sung Yun; Qin, Jun] Baylor Coll Med, Ctr Mol Discovery, Dept Mol Biol, Houston, TX 77030 USA; [Zhou, Xiaobo; Wong, Stephen T. C.] Methodist Hosp, Res Inst, Ctr Bioinformat, Houston, TX 77030 USA; [Zhou, Xiaobo; Wong, Stephen T. C.] Weill Cornell Coll Med, Houston, TX 77030 USA; [Qin, Jun] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Cell & Mol Biol Program, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Texas Childrens Hosp, Howard Hughes Med Inst, Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	hzoghbi@bcm.edu		Zoghbi, Huda/0000-0002-0700-3349; Shaw, Chad/0000-0001-7267-5398; Chahrour, Maria/0000-0002-3174-1480	Howard Hughes Medical Institute Funding Source: Medline; NICHD NIH HHS [HD024064, P30 HD024064, P30 HD024064-19] Funding Source: Medline; NINDS NIH HHS [R01 NS057819, R01 NS057819-02, NS057819] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057819] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Araujo HC, 2005, AM J MED GENET A, V133A, P122, DOI 10.1002/ajmg.a.30226; Axelrod FB, 2006, PEDIATRICS, V118, P309, DOI 10.1542/peds.2005-3032; Bhalla K, 2004, J HUM GENET, V49, P308, DOI 10.1007/s10038-004-0145-4; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Martin CL, 2007, AM J MED GENET B, V144B, P869, DOI 10.1002/ajmg.b.30530; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Moretti P, 2006, CURR OPIN GENET DEV, V16, P276, DOI 10.1016/j.gde.2006.04.009; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Srinivasan K, 2005, METHODS, V37, P345, DOI 10.1016/j.ymeth.2005.09.007; Sykut-Cegielska J, 2004, ACTA BIOCHIM POL, V51, P875; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Verbruggen KT, 2007, EUR J PEDIATR, V166, P921, DOI 10.1007/s00431-006-0340-8; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	22	1272	1317	4	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 30	2008	320	5880					1224	1229		10.1126/science.1153252	http://dx.doi.org/10.1126/science.1153252			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306FF	18511691	Green Accepted			2022-12-24	WOS:000256233000041
J	Murakami, M; Kouyama, T				Murakami, Midori; Kouyama, Tsutomu			Crystal structure of squid rhodopsin	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; OUTER SEGMENT MEMBRANES; PHOTORECEPTOR MICROVILLI; CEPHALOPOD RHODOPSIN; POLARIZED-LIGHT; ACTIVATION; VERTEBRATE; SYSTEM; PHOTOISOMERIZATION; CRYSTALLOGRAPHY	Invertebrate phototransduction uses an inositol-1,4,5-trisphosphate signalling cascade in which photoactivated rhodopsin stimulates a G(q)-type G protein, that is, a class of G protein that stimulates membrane-bound phospholipase C beta. The same cascade is used by many G-protein-coupled receptors, indicating that invertebrate rhodopsin is a prototypical member. Here we report the crystal structure of squid (Todarodes pacificus) rhodopsin at 2.5 angstrom resolution. Among seven transmembrane alpha-helices, helices V and VI extend into the cytoplasmic medium and, together with two cytoplasmic helices, they form a rigid protrusion from the membrane surface. This peculiar structure, which is not seen in bovine rhodopsin, seems to be crucial for the recognition of G(q)-type G proteins. The retinal Schiff base forms a hydrogen bond to Asn 87 or Tyr 111; it is far from the putative counterion Glu 180. In the crystal, a tight association is formed between the amino-terminal polypeptides of neighbouring monomers; this intermembrane dimerization may be responsible for the organization of hexagonally packed microvillar membranes in the photoreceptor rhabdom.	[Murakami, Midori; Kouyama, Tsutomu] Nagoya Univ, Dept Phys, Grad Sch Sci, Nagoya, Aichi 4648602, Japan; [Kouyama, Tsutomu] RIKEN Harima Inst, SPring 8, Sayo, Hyogo 6795148, Japan	Nagoya University; Japan Synchrotron Radiation Research Institute; RIKEN	Kouyama, T (corresponding author), Nagoya Univ, Dept Phys, Grad Sch Sci, Nagoya, Aichi 4648602, Japan.	kouyama@bio.phys.nagoya-u.ac.jp	murakami, midori/AAL-1023-2021					Ashida A, 2004, ZOOL SCI, V21, P245, DOI 10.2108/zsj.21.245; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Davies A, 2001, J MOL BIOL, V314, P455, DOI 10.1006/jmbi.2001.5167; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DOI T, 1990, P NATL ACAD SCI USA, V87, P4991, DOI 10.1073/pnas.87.13.4991; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; HARANISHIMURA I, 1993, FEBS LETT, V317, P5, DOI 10.1016/0014-5793(93)81480-N; Horn F, 1998, NUCLEIC ACIDS RES, V26, P275, DOI 10.1093/nar/26.1.275; HUBBARD R, 1958, J GEN PHYSIOL, V41, P501, DOI 10.1085/jgp.41.3.501; JANDER R, 1963, Z VERGL PHYSIOL, V46, P383, DOI 10.1007/BF00340466; KITO Y, 1982, METHOD ENZYMOL, V81, P167; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Matsui Y, 2002, J MOL BIOL, V324, P469, DOI 10.1016/S0022-2836(02)01110-5; McRee D.E., 1999, PRACTICAL PROTEIN CR, V2nd ed., P91; Morizumi T, 2005, BIOCHEMISTRY-US, V44, P9936, DOI 10.1021/bi0504512; Murakami M, 2007, ACTA CRYSTALLOGR F, V63, P475, DOI 10.1107/S1744309107017423; NAITO T, 1981, VISION RES, V21, P935, DOI 10.1016/0042-6989(81)90195-4; Nakagawa M, 1999, P NATL ACAD SCI USA, V96, P6189, DOI 10.1073/pnas.96.11.6189; Okada T, 1998, PHOTOCHEM PHOTOBIOL, V67, P495, DOI 10.1111/j.1751-1097.1998.tb09445.x; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Ota T, 2006, BIOCHEMISTRY-US, V45, P2845, DOI 10.1021/bi051937l; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; SAIBIL H, 1987, J CELL BIOL, V105, P19, DOI 10.1083/jcb.105.1.19; SAIBIL HR, 1982, J MOL BIOL, V158, P435, DOI 10.1016/0022-2836(82)90208-X; Saidel WM, 2005, COMP BIOCHEM PHYS A, V142, P340, DOI 10.1016/j.cbpa.2005.08.003; Shichida Y, 1998, CELL MOL LIFE SCI, V54, P1299, DOI 10.1007/s000180050256; Steller I, 1997, J APPL CRYSTALLOGR, V30, P1036, DOI 10.1107/S0021889897008777; SUZUKI T, 1976, BIOCHIM BIOPHYS ACTA, V428, P321, DOI 10.1016/0304-4165(76)90040-4; Terakita A, 1998, FEBS LETT, V439, P110, DOI 10.1016/S0014-5793(98)01340-4; Urizar E, 2005, J BIOL CHEM, V280, P17135, DOI 10.1074/jbc.M414678200; VENIENBRYAN C, 1995, FEBS LETT, V359, P45, DOI 10.1016/0014-5793(94)01449-B; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; YARFITZ S, 1994, J BIOL CHEM, V269, P14329	40	392	406	5	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 15	2008	453	7193					363	U33		10.1038/nature06925	http://dx.doi.org/10.1038/nature06925			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18480818				2022-12-24	WOS:000255868400045
J	Abbondanzieri, EA; Bokinsky, G; Rausch, JW; Zhang, JX; Le Grice, SFJ; Zhuang, XW				Abbondanzieri, Elio A.; Bokinsky, Gregory; Rausch, Jason W.; Zhang, Jennifer X.; Le Grice, Stuart F. J.; Zhuang, Xiaowei			Dynamic binding orientations direct activity of HIV reverse transcriptase	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DEPENDENT DNA-POLYMERASE; RNASE-H-FUNCTION; ANGSTROM RESOLUTION; PRIMED INITIATION; CRYSTAL-STRUCTURE; ENERGY-TRANSFER; RNA/DNA HYBRID; MECHANISM; COMPLEX	The reverse transcriptase of human immunodeficiency virus ( HIV) catalyses a series of reactions to convert the single- stranded RNA genome of HIV into double- stranded DNA for host- cell integration. This task requires the reverse transcriptase to discriminate a variety of nucleic- acid substrates such that active sites of the enzyme are correctly positioned to support one of three catalytic functions: RNA- directed DNA synthesis, DNA- directed DNA synthesis and DNA- directed RNA hydrolysis. However, the mechanism by which substrates regulate reverse transcriptase activities remains unclear. Here we report distinct orientational dynamics of reverse transcriptase observed on different substrates with a single- molecule assay. The enzyme adopted opposite binding orientations on duplexes containing DNA or RNA primers, directing its DNA synthesis or RNA hydrolysis activity, respectively. On duplexes containing the unique polypurine RNA primers for plus- strand DNA synthesis, the enzyme can rapidly switch between the two orientations. The switching kinetics were regulated by cognate nucleotides and non- nucleoside reverse transcriptase inhibitors, a major class of anti- HIV drugs. These results indicate that the activities of reverse transcriptase are determined by its binding orientation on substrates.	[Abbondanzieri, Elio A.; Bokinsky, Gregory; Zhang, Jennifer X.; Zhuang, Xiaowei] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Rausch, Jason W.; Le Grice, Stuart F. J.] NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA	Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zhuang, XW (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu			NATIONAL CANCER INSTITUTE [ZIABC010493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068518] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; Intramural NIH HHS [Z01 BC010493-05] Funding Source: Medline; NIGMS NIH HHS [R01 GM068518-05, GM 068518, R01 GM068518] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIYAR A, 1992, J VIROL, V66, P2464, DOI 10.1128/JVI.66.4.2464-2472.1992; ARNOLD E, 1992, NATURE, V357, P85, DOI 10.1038/357085a0; BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0; CHAMPOUX JJ, 1993, REVERSE TRANSCRIPTAS, P103; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; El Safadi Y, 2007, APPL MICROBIOL BIOT, V75, P723, DOI 10.1007/s00253-007-0919-7; FINSTON WI, 1984, J VIROL, V51, P26, DOI 10.1128/JVI.51.1.26-33.1984; Goff S, 2001, FIELDS VIROLOGY, P1871; GOPALAKRISHNAN V, 1992, P NATL ACAD SCI USA, V89, P10763, DOI 10.1073/pnas.89.22.10763; Grobler JA, 2007, J BIOL CHEM, V282, P8005, DOI 10.1074/jbc.M608274200; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; HANSEN J, 1988, EMBO J, V7, P239, DOI 10.1002/j.1460-2075.1988.tb02805.x; HOSTOMSKY Z, 1992, J VIROL, V66, P3179, DOI 10.1128/JVI.66.5.3179-3182.1992; HSIEH JC, 1993, J BIOL CHEM, V268, P24607; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; HUBER HE, 1990, J BIOL CHEM, V265, P10565; Julias JG, 2002, P NATL ACAD SCI USA, V99, P9515, DOI 10.1073/pnas.142123199; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; KATI WM, 1992, J BIOL CHEM, V267, P25988; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; LEIS JP, 1973, P NATL ACAD SCI USA, V70, P466, DOI 10.1073/pnas.70.2.466; METZGER W, 1993, P NATL ACAD SCI USA, V90, P5909, DOI 10.1073/pnas.90.13.5909; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; OMER CA, 1984, J VIROL, V50, P465, DOI 10.1128/JVI.50.2.465-470.1984; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Rausch JW, 2000, J BIOL CHEM, V275, P16015, DOI 10.1074/jbc.M909808199; Rausch JW, 2004, INT J BIOCHEM CELL B, V36, P1752, DOI 10.1016/j.biocel.2004.02.016; Rothwell PJ, 2003, P NATL ACAD SCI USA, V100, P1655, DOI 10.1073/pnas.0434003100; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; SCHATZ O, 1989, FEBS LETT, V257, P311, DOI 10.1016/0014-5793(89)81559-5; Schultz SJ, 2000, J BIOL CHEM, V275, P32299, DOI 10.1074/jbc.M000021200; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; Stone MD, 2007, NATURE, V446, P458, DOI 10.1038/nature05600; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; TANESE N, 1991, J VIROL, V65, P4387, DOI 10.1128/JVI.65.8.4387-4397.1991; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; Venezia CF, 2006, BIOCHEMISTRY-US, V45, P2779, DOI 10.1021/bi051915z; Wisniewski M, 2000, P NATL ACAD SCI USA, V97, P11978, DOI 10.1073/pnas.210392297	41	143	147	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2008	453	7192					184	U2		10.1038/nature06941	http://dx.doi.org/10.1038/nature06941			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297BP	18464735	Green Accepted, Bronze			2022-12-24	WOS:000255592400031
J	Vartanian, JP; Guetard, D; Henry, M; Wain-Hobson, S				Vartanian, Jean-Pierre; Guetard, Denise; Henry, Michel; Wain-Hobson, Simon			Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions	SCIENCE			English	Article							CYTIDINE DEAMINASE; SOMATIC HYPERMUTATION; ANTIRETROVIRAL FACTOR; HIV-1 DNA; PROTEINS; FAMILY; VIF; EXPRESSION; EVOLUTION; VIRUS	Cytidine deaminases of the APOBEC3 family all have specificity for single-stranded DNA, which may become exposed during replication or transcription of double-stranded DNA. Three human APOBEC3A (hA3A), hA3B, and hA3H genes are expressed in keratinocytes and skin, leading us to determine whether genetic editing of human papillomavirus (HPV) DNA occurred. In a study of HPV1a plantar warts and HPV16 precancerous cervical biopsies, hyperedited HPV1a and HPV16 genomes were found. Strictly analogous results were obtained from transfection experiments with HPV plasmid DNA and the three nuclear localized enzymes: hA3A, hA3C, and hA3H. Thus, stochastic or transient overexpression of APOBEC3 genes may expose the genome to a broad spectrum of mutations that could influence the development of tumors.	[Vartanian, Jean-Pierre; Guetard, Denise; Henry, Michel; Wain-Hobson, Simon] Inst Pasteur, Mol Retrovirol Unit, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Wain-Hobson, S (corresponding author), Inst Pasteur, Mol Retrovirol Unit, 28 Rue Dr Roux, F-75724 Paris 15, France.	simon@pasteur.fr		Vartanian, Jean-Pierre/0000-0001-8079-8814				Arbyn M, 2007, J CLIN VIROL, V38, P189, DOI 10.1016/j.jcv.2006.12.009; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Goodman Myron F, 2007, Adv Immunol, V94, P127, DOI 10.1016/S0065-2776(06)94005-X; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Madsen P, 1999, J INVEST DERMATOL, V113, P162, DOI 10.1046/j.1523-1747.1999.00682.x; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; OhAinle M, 2006, J VIROL, V80, P3853, DOI 10.1128/JVI.80.8.3853-3862.2006; Okazaki Il-mi, 2007, Adv Immunol, V94, P245, DOI 10.1016/S0065-2776(06)94008-5; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stunkel W, 1999, J VIROL, V73, P1918; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Suspene R, 2005, J GEN VIROL, V86, P125, DOI 10.1099/vir.0.80426-0; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Trivedi NR, 2006, J INVEST DERMATOL, V126, P1071, DOI 10.1038/sj.jid.5700213; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	27	237	247	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 11	2008	320	5873					230	233		10.1126/science.1153201	http://dx.doi.org/10.1126/science.1153201			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286HJ	18403710				2022-12-24	WOS:000254836700043
J	Yu, IM; Zhang, W; Holdaway, HA; Li, L; Kostyuchenko, VA; Chipman, PR; Kuhn, RJ; Rossmann, MG; Chen, J				Yu, I-Mei; Zhang, Wei; Holdaway, Heather A.; Li, Long; Kostyuchenko, Victor A.; Chipman, Paul R.; Kuhn, Richard J.; Rossmann, Michael G.; Chen, Jue			Structure of the immature dengue virus at low pH primes proteolytic maturation	SCIENCE			English	Article							BORNE ENCEPHALITIS-VIRUS; WEST-NILE-VIRUS; ENVELOPE GLYCOPROTEIN; MEMBRANE-FUSION; HETERODIMERIC ASSOCIATION; INFLUENZA HEMAGGLUTININ; CRYSTAL-STRUCTURE; CELL-SURFACE; FLAVIVIRUS; PROTEIN	Intracellular cleavage of immature flaviviruses is a critical step in assembly that generates the membrane fusion potential of the E glycoprotein. With cryo- electron microscopy we show that the immature dengue particles undergo a reversible conformational change at low pH that renders them accessible to furin cleavage. At a pH of 6.0, the E proteins are arranged in a herringbone pattern with the pr peptides docked onto the fusion loops, a configuration similar to that of the mature virion. After cleavage, the dissociation of pr is pH- dependent, suggesting that in the acidic environment of the trans- Golgi network pr is retained on the virion to prevent membrane fusion. These results suggest a mechanism by which flaviviruses are processed and stabilized in the host cell secretory pathway.	[Yu, I-Mei; Zhang, Wei; Holdaway, Heather A.; Li, Long; Kostyuchenko, Victor A.; Chipman, Paul R.; Kuhn, Richard J.; Rossmann, Michael G.; Chen, Jue] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Chen, J (corresponding author), Purdue Univ, Dept Biol Sci, 915 W State St, W Lafayette, IN 47907 USA.	chenjue@purdue.edu	Kuhn, Richard/AAR-2722-2021; Li, Long/F-8892-2010	Kuhn, Richard/0000-0003-4148-1026; Chipman, Paul/0000-0003-3652-4087	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI055672, U54AI057153] Funding Source: NIH RePORTER; NIAID NIH HHS [AI055672, 1-U54-AI-057153] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995; CIAMPOR F, 1992, VIROLOGY, V188, P14, DOI 10.1016/0042-6822(92)90730-D; DECURTIS I, 1988, P NATL ACAD SCI USA, V85, P8052, DOI 10.1073/pnas.85.21.8052; GUIRAKHOO F, 1991, J GEN VIROL, V72, P1323, DOI 10.1099/0022-1317-72-6-1323; HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013; Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; RANDOLPH VB, 1990, VIROLOGY, V174, P450, DOI 10.1016/0042-6822(90)90099-D; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; SARIOLA M, 1995, J CELL SCI, V108, P2465; SCHLESINGER S, 2001, FIELDS VIROLOGY, P895; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997; Stiasny K, 1996, J VIROL, V70, P8142, DOI 10.1128/JVI.70.11.8142-8147.1996; SUGRUE RJ, 1990, EMBO J, V9, P3469, DOI 10.1002/j.1460-2075.1990.tb07555.x; WAHLBERG JM, 1989, J VIROL, V63, P4991, DOI 10.1128/JVI.63.12.4991-4997.1989; WENGLER G, 1989, J VIROL, V63, P2521, DOI 10.1128/JVI.63.6.2521-2526.1989; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019; Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270; Zhang Y, 2007, J VIROL, V81, P6141, DOI 10.1128/JVI.00037-07	28	440	456	3	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 28	2008	319	5871					1834	1837		10.1126/science.1153264	http://dx.doi.org/10.1126/science.1153264			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279ZF	18369148				2022-12-24	WOS:000254394000049
J	Gladyshev, EA; Meselson, M; Arkhipova, IR				Gladyshev, Eugene A.; Meselson, Matthew; Arkhipova, Irina R.			Massive horizontal gene transfer in bdelloid rotifers	SCIENCE			English	Article							EUKARYOTES; TELOMERES; EVOLUTION; GENOMES	Horizontal gene transfer in metazoans has been documented in only a few species and is usually associated with endosymbiosis or parasitism. By contrast, in bdelloid rotifers we found many genes that appear to have originated in bacteria, fungi, and plants, concentrated in telomeric regions along with diverse mobile genetic elements. Bdelloid proximal gene- rich regions, however, appeared to lack foreign genes, thereby resembling those of model metazoan organisms. Some of the foreign genes were defective, whereas others were intact and transcribed; some of the latter contained functional spliceosomal introns. One such gene, apparently of bacterial origin, was overexpressed in Escherichia coli and yielded an active enzyme. The capture and functional assimilation of exogenous genes may represent an important force in bdelloid evolution.	[Gladyshev, Eugene A.; Meselson, Matthew; Arkhipova, Irina R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Meselson, Matthew; Arkhipova, Irina R.] Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA	Harvard University; Marine Biological Laboratory - Woods Hole	Meselson, M (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	msm@wjh.harvard.edu; iarkhipova@mbl.edu	Puigbò, Pere/A-2214-2008	Arkhipova, Irina/0000-0002-4805-1339; Gladyshev, Eugene/0000-0002-4074-4966	NIGMS NIH HHS [R01 GM072708, GM072708] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072708] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; Arkhipova IR, 2005, P NATL ACAD SCI USA, V102, P11781, DOI 10.1073/pnas.0505333102; Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; Bergthorsson U, 2003, NATURE, V424, P197, DOI 10.1038/nature01743; Boucher Y, 2003, ANNU REV GENET, V37, P283, DOI 10.1146/annurev.genet.37.050503.084247; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Doolittle WE, 1998, TRENDS GENET, V14, P307; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Gladyshev E, 2008, P NATL ACAD SCI USA, V105, P5139, DOI 10.1073/pnas.0800966105; Gladyshev EA, 2007, GENE, V390, P136, DOI 10.1016/j.gene.2006.09.025; Gladyshev EA, 2007, P NATL ACAD SCI USA, V104, P9352, DOI 10.1073/pnas.0702741104; Haviv-Chesner A, 2007, NUCLEIC ACIDS RES, V35, P5192, DOI 10.1093/nar/gkm521; HUR JH, 2006, THESIS HARVARD U; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Katz LA, 2002, INT J SYST EVOL MICR, V52, P1893, DOI 10.1099/00207713-52-5-1893; KIDWELL MG, 1993, ANNU REV GENET, V27, P235, DOI 10.1146/annurev.ge.27.120193.001315; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; Lapinski J, 2003, FEBS LETT, V553, P387, DOI 10.1016/S0014-5793(03)01062-7; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Normark BB, 2003, BIOL J LINN SOC, V79, P69, DOI 10.1046/j.1095-8312.2003.00182.x; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Pouchkina-Stantcheva NN, 2005, MOL BIOL EVOL, V22, P1482, DOI 10.1093/molbev/msi139; Suga K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000671; Syvanen M., 2002, HORIZONTAL GENE TRAN; Welch DBM, 2008, P NATL ACAD SCI USA, V105, P5145, DOI 10.1073/pnas.0800972105; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211	28	306	322	3	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2008	320	5880					1210	1213		10.1126/science.1156407	http://dx.doi.org/10.1126/science.1156407			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306FF	18511688	Green Submitted			2022-12-24	WOS:000256233000037
J	Neves, SR; Tsokas, P; Sarkar, A; Grace, EA; Rangamani, P; Taubenfeld, SM; Alberini, CM; Schaff, JC; Blitzer, RD; Moraru, II; Iyengar, R				Neves, Susana R.; Tsokas, Panayiotis; Sarkar, Anamika; Grace, Elizabeth A.; Rangamani, Padmini; Taubenfeld, Stephen M.; Alberini, Cristina M.; Schaff, James C.; Blitzer, Robert D.; Moraru, Ion I.; Iyengar, Ravi			Cell shape and negative links in regulatory motifs together control spatial information flow in signaling networks	CELL			English	Article							DEPENDENT PROTEIN-KINASE; CYCLIC-AMP; QUANTITATIVE AUTORADIOGRAPHY; FLUORESCENT INDICATOR; SYNAPTIC PLASTICITY; MORPHOGEN GRADIENT; PTP-SL; CAMP; ACTIVATION; PHOSPHATASE	The role of cell size and shape in controlling local intracellular signaling reactions, and how this spatial information originates and is propagated, is not well understood. We have used partial differential equations to model the flow of spatial information from the beta-adrenergic receptor to MAPK1,2 through the cAMP/PKA/B-Raf/MAPK1,2 network in neurons using real geometries. The numerical simulations indicated that cell shape controls the dynamics of local biochemical activity of signal-modulated negative regulators, such as phosphodiesterases and protein phosphatases within regulatory loops to determine the size of microdomains of activated signaling components. The model prediction that negative regulators control the flow of spatial information to downstream components was verified experimentally in rat hippocampal slices. These results suggest a mechanism by which cellular geometry, the presence of regulatory loops with negative regulators, and key reaction rates all together control spatial information transfer and microdomain characteristics within cells.	[Neves, Susana R.; Tsokas, Panayiotis; Sarkar, Anamika; Grace, Elizabeth A.; Rangamani, Padmini; Blitzer, Robert D.; Iyengar, Ravi] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Taubenfeld, Stephen M.; Alberini, Cristina M.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Schaff, James C.; Moraru, Ion I.] Univ Connecticut, Ctr Hlth, Ctr Cell Anal & Modeling, Farmington, CT 06030 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Connecticut	Iyengar, R (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, 1 Gustave L Levy Pl,Box 1215, New York, NY 10029 USA.	ravi.iyengar@mssm.edu		Moraru, Ion/0000-0002-3746-9676; tsokas, panayiotis/0000-0002-1679-8980; Neves-Zaph, Susana/0000-0002-3388-0054	NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072853, F31GM065065, R01GM054508, P50GM071558] Funding Source: NIH RePORTER; NEI NIH HHS [PN2 EY016586, PN2EY016586, PN2 EY016586-05S1] Funding Source: Medline; NIDDK NIH HHS [R01 DK038761, R01 DK038761-21, DK 38761] Funding Source: Medline; NIGMS NIH HHS [R01 GM072853-04, P50 GM071558, P50 GM071558-01A2, R01 GM054508, R01 GM072853, F31 GM065065, F31 GM065065-05, GM-65065, GM072853] Funding Source: Medline; PHS HHS [PSDGM071558] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; BANKER G, 1998, CULTURING NERVE CELL; Berg, 2018, RANDOM WALKS BIOL; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bird R. B., 2007, TRANSPORT PHENOMENA, DOI DOI 10.1002/AIC.690070245; Blanco-Aparicio C, 1999, J CELL BIOL, V147, P1129, DOI 10.1083/jcb.147.6.1129; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Brown GC, 1999, FEBS LETT, V457, P452, DOI 10.1016/S0014-5793(99)01058-3; BRUNTON LL, 1981, ADV CYCL NUCL RES<D>, V14, P391; BUXTON ILO, 1983, J BIOL CHEM, V258, P233; Cancela JM, 2002, EMBO J, V21, P909, DOI 10.1093/emboj/21.5.909; CORBIN JD, 1977, J BIOL CHEM, V252, P3854; Craske ML, 2005, J CELL BIOL, V170, P1147, DOI 10.1083/jcb.200503118; DUNCAN GE, 1991, BRAIN RES, V561, P84, DOI 10.1016/0006-8993(91)90752-H; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; FULTON AB, 1982, CELL, V30, P345, DOI 10.1016/0092-8674(82)90231-8; Goentoro LA, 2006, DEV CELL, V11, P263, DOI 10.1016/j.devcel.2006.07.004; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Katsuki H, 1997, J NEUROPHYSIOL, V77, P3013, DOI 10.1152/jn.1997.77.6.3013; KEELY SL, 1979, MOL PHARMACOL, V15, P235; LEVENSPIEL O, 1995, CHEM REACTION ENG; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Loew LM, 2001, TRENDS BIOTECHNOL, V19, P401, DOI 10.1016/S0167-7799(01)01740-1; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; MALETICSAVATIC M, 1995, J NEUROSCI, V15, P3840; Marsault R, 1997, EMBO J, V16, P1575, DOI 10.1093/emboj/16.7.1575; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Meyers J, 2006, CURR BIOL, V16, P1685, DOI 10.1016/j.cub.2006.07.056; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Morozov A, 2003, NEURON, V39, P309, DOI 10.1016/S0896-6273(03)00404-5; Nagai Y, 2000, NAT BIOTECHNOL, V18, P313, DOI 10.1038/73767; NEVES SR, 2006, THESIS MOUNT SINAI S; Nika K, 2004, BIOCHEM J, V378, P335, DOI 10.1042/BJ20031244; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Onsum MD, 2006, PHYS BIOL, V3, P190, DOI 10.1088/1478-3975/3/3/004; ORDWAY GA, 1988, J PHARMACOL EXP THER, V247, P379; POST SR, 1995, BIOCHEM J, V311, P75, DOI 10.1042/bj3110075; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; RAINBOW TC, 1984, P NATL ACAD SCI-BIOL, V81, P1585, DOI 10.1073/pnas.81.5.1585; Remy S, 2007, P NATL ACAD SCI USA, V104, P17192, DOI 10.1073/pnas.0707919104; Schneider IC, 2005, BIOPHYS J, V89, P1420, DOI 10.1529/biophysj.105.061218; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Slepchenko BM, 2003, TRENDS CELL BIOL, V13, P570, DOI 10.1016/j.tcb.2003.09.002; Slepchenko BM, 2002, ANNU REV BIOPH BIOM, V31, P423, DOI 10.1146/annurev.biophys.31.101101.140930; Ting AY, 2001, P NATL ACAD SCI USA, V98, P15003, DOI 10.1073/pnas.211564598; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zaccolo M, 2000, NAT CELL BIOL, V2, P25, DOI 10.1038/71345	53	205	206	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 16	2008	133	4					666	680		10.1016/j.cell.2008.04.025	http://dx.doi.org/10.1016/j.cell.2008.04.025			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485874	Green Accepted, Bronze			2022-12-24	WOS:000255903300021
J	Phares, CR; Lynfield, R; Farley, MM; Mohle-Boetani, J; Harrison, LH; Petit, S; Craig, AS; Schaffner, W; Zansky, SM; Gershman, K; Stefonek, KR; Albanese, BA; Zell, ER; Schuchat, A; Schrag, SJ				Phares, Christina R.; Lynfield, Ruth; Farley, Monica M.; Mohle-Boetani, Janet; Harrison, Lee H.; Petit, Susan; Craig, Allen S.; Schaffner, William; Zansky, Shelley M.; Gershman, Ken; Stefonek, Karen R.; Albanese, Bernadette A.; Zell, Elizabeth R.; Schuchat, Anne; Schrag, Stephanie J.			Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TOXOID CONJUGATE VACCINE; RISK-FACTORS; IMMUNE-RESPONSE; PREGNANT-WOMEN; INFECTIONS; IMMUNOGENICITY; SURVEILLANCE; PREVENTION; ADULTS; STRATEGIES	Context Group B streptococcus is a leading infectious cause of morbidity in newborns and causes substantial disease in elderly individuals. Guidelines for prevention of perinatal disease through intrapartum chemoprophylaxis were revised in 2002. Candidate vaccines are under development. Objective To describe disease trends among populations that might benefit from vaccination and among newborns during a period of evolving prevention strategies. Design and Setting Analysis of active, population- based surveillance in 10 states participating in the Active Bacterial Core surveillance/ Emerging Infections Program Network. Main Outcome Measures Age- and race- specific incidence of invasive group B streptococcal disease. Results There were 14 573 cases of invasive group B streptococcal disease during 1999- 2005, including 1348 deaths. The incidence of invasive group B streptococcal disease among infants from birth through 6 days decreased from 0.47 per 1000 live births in 1999- 2001 to 0.34 per 1000 live births in 2003- 2005 ( P <. 001), a relative reduction of 27% ( 95% confidence interval [ CI], 16%- 37%). Incidence remained stable among infants aged 7 through 89 days ( mean, 0.34 per 1000 live births) and pregnant women ( mean, 0.12 per 1000 live births). Among persons aged 15 through 64 years, disease incidence increased from 3.4 per 100 000 population in 1999 to 5.0 per 100 000 in 2005 ( chi(2)(1) for trend, 57; P <. 001), a relative increase of 48% ( 95% CI, 32%-65%). Among adults 65 years or older, incidence increased from 21.5 per 100 000 to 26.0 per 100 000 ( chi(2)(1) for trend, 15; P <. 001), a relative increase of 20% ( 95% CI, 8%-35%). All 4882 isolates tested were susceptible to penicillin, ampicillin, and vancomycin, but 32% and 15% were resistant to erythromycin and clindamycin, respectively. Serotypes Ia, Ib, II, III, and V accounted for 96% of neonatal cases and 88% of adult cases. Conclusions Among infants from birth through 6 days, the incidence of group B streptococcal disease was lower in 2003- 2005 relative to 1999-2001. This reduction coincided with the release of revised disease prevention guidelines in 2002. However, the disease burden in adults is substantial and increased significantly during the study period.	[Phares, Christina R.] Ctr Dis Control & Prevent, Epidem Intelligence Serv Program, Off Workforce & Career Dev, Div Bacterial Dis,Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Phares, Christina R.; Schuchat, Anne; Schrag, Stephanie J.] Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Zell, Elizabeth R.] Ctr Dis Control & Prevent, Biostat & Informat Management Branch, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Lynfield, Ruth] Minnesota Dept Hlth, St Paul, MN USA; [Farley, Monica M.] Emory Univ, Sch Med, Atlanta, GA USA; [Farley, Monica M.] Vet Affairs Med Ctr, Georgia Emerging Infect Program, Atlanta, GA 30033 USA; [Mohle-Boetani, Janet] Calif Dept Hlth Serv, Infect Dis Branch, Richmond, CA USA; [Harrison, Lee H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Petit, Susan] Connecticut Dept Publ Hlth, Emerging Infect Program, Hartford, CT USA; [Craig, Allen S.] Tennessee Dept Hlth, Nashville, TN USA; [Schaffner, William] Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37212 USA; [Zansky, Shelley M.] New York State Dept Hlth, Albany, NY USA; [Gershman, Ken] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Stefonek, Karen R.] Oregon Publ Hlth Serv, Portland, OR USA; [Albanese, Bernadette A.] New Mexico Dept Hlth, Emerging Infect Program, Santa Fe, NM USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Minnesota Department of Health (MHD); Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; California Department of Health Care Services; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Tennessee Department Health; Vanderbilt University; State University of New York (SUNY) System; Colorado Department of Public Health & Environment; New Mexico Department of Health	Phares, CR (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv Program, Off Workforce & Career Dev, Div Bacterial Dis,Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd NE,Mailstop E-03, Atlanta, GA 30333 USA.	cphares@cdc.gov	Mohle-Boetani, Janet/AAH-4221-2019					*AM COLL OBST GYN, 1996, PREV EARL ONS GROUP; Baker CJ, 2007, VACCINE, V25, P55, DOI 10.1016/j.vaccine.2006.07.018; Baker CJ, 1999, J INFECT DIS, V179, P142, DOI 10.1086/314574; Baker CJ, 2004, J INFECT DIS, V189, P1103, DOI 10.1086/382193; Baker CJ, 2003, VACCINE, V21, P3468, DOI 10.1016/S0264-410X(03)00353-0; Baker CJ, 2003, J INFECT DIS, V188, P66, DOI 10.1086/375536; Baker CJ, 2000, J INFECT DIS, V182, P1129, DOI 10.1086/315839; Blumberg HM, 1996, J INFECT DIS, V173, P365, DOI 10.1093/infdis/173.2.365; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P1205; *CDCP, 1996, MMWR-MORBID MORTAL W, V45, P679; Centers for Diseases Control and Prevention, 2006, ACT BACT COR SURV AB; Centre for Disease Control and Prevention [Internet], ACT BACT COR SURV SU; Davies HD, 2001, PEDIATR INFECT DIS J, V20, P879, DOI 10.1097/00006454-200109000-00011; DILLON HC, 1982, J INFECT DIS, V145, P794, DOI 10.1093/infdis/145.6.794; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; Eisenberg E, 2005, PEDIATR INFECT DIS J, V24, P520, DOI 10.1097/01.inf.0000164765.12808.26; FARLEY MM, 1993, NEW ENGL J MED, V328, P1807, DOI 10.1056/NEJM199306243282503; Farley MM, 2001, CLIN INFECT DIS, V33, P556, DOI 10.1086/322696; Halsey NA, 1997, PEDIATRICS, V99, P489, DOI 10.1542/peds.99.3.489; Harrison LH, 1998, J INFECT DIS, V177, P998, DOI 10.1086/515260; HEARD SR, 1993, J CLIN PATHOL, V46, P145, DOI 10.1136/jcp.46.2.145; JACKSON LA, 1995, ANN INTERN MED, V123, P415, DOI 10.7326/0003-4819-123-6-199509150-00003; JORDAN H, 2006, 44 ANN M INF DIS SOC, P169; Kann Laura, 1996, Morbidity and Mortality Weekly Report, V45, P1; Kaspar DL, 1996, J CLIN INVEST, V98, P2308, DOI 10.1172/JCI119042; Lin FYC, 2003, J INFECT DIS, V188, P267, DOI 10.1086/376457; Locksmith GJ, 1999, AM J OBSTET GYNECOL, V180, P416, DOI 10.1016/S0002-9378(99)70225-5; *NCCLS, 2002, NCCLS PERF STAND ANT; Newton ER, 1996, OBSTET GYNECOL, V88, P577, DOI 10.1016/0029-7844(96)00264-5; Palazzi DL, 2004, J INFECT DIS, V190, P558, DOI 10.1086/422010; Paoletti LC, 2001, INFECT IMMUN, V69, P6696, DOI 10.1128/IAI.69.11.6696-6701.2001; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Reingold A., 2007, Morbidity and Mortality Weekly Report, V56, P701; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; Schrag SJ, 2000, NEW ENGL J MED, V342, P15, DOI 10.1056/NEJM200001063420103; Schrag SJ, 2002, NEW ENGL J MED, V347, P233, DOI 10.1056/NEJMoa020205; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497; SCHUCHAT A, 1990, J INFECT DIS, V162, P672, DOI 10.1093/infdis/162.3.672; SCHUCHAT A, 1994, EPIDEMIOL REV, V16, P374, DOI 10.1093/oxfordjournals.epirev.a036159; Schuchat A, 2001, EMERG INFECT DIS, V7, P92, DOI 10.3201/eid0701.010114; SCHWARTZ B, 1991, JAMA-J AM MED ASSOC, V266, P1112, DOI 10.1001/jama.266.8.1112; Slotved HC, 2003, J CLIN MICROBIOL, V41, P4445, DOI 10.1128/JCM.41.9.4445-4447.2003; Sukhnanand S, 2005, J CLIN MICROBIOL, V43, P1177, DOI 10.1128/JCM.43.3.1177-1186.2005; Tyrrell GJ, 2000, J INFECT DIS, V182, P168, DOI 10.1086/315699; Zaleznik DF, 2000, CLIN INFECT DIS, V30, P276, DOI 10.1086/313665	45	601	636	2	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2008	299	17					2056	2065		10.1001/jama.299.17.2056	http://dx.doi.org/10.1001/jama.299.17.2056			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296NI	18460666	Bronze			2022-12-24	WOS:000255552700022
J	Sato, K; Pellegrino, M; Nakagawa, T; Nakagawa, T; Vosshall, LB; Touhara, K				Sato, Koji; Pellegrino, Maurizio; Nakagawa, Takao; Nakagawa, Tatsuro; Vosshall, Leslie B.; Touhara, Kazushige			Insect olfactory receptors are heteromeric ligand-gated ion channels	NATURE			English	Article							DROSOPHILA-ANTENNA; ODORANT RECEPTOR; MEMBRANE TOPOLOGY; TRANSDUCTION; NEURONS; SYSTEM; MODEL	In insects, each olfactory sensory neuron expresses between one and three ligand- binding members of the olfactory receptor ( OR) gene family, along with the highly conserved and broadly expressed Or83b co-receptor(1-9). The functional insect OR consists of a heteromeric complex of unknown stoichiometry but comprising at least one variable odorant- binding subunit and one constant Or83b family subunit(10-16). Insect ORs lack homology to G- protein-coupled chemosensory receptors in vertebrates(17) and possess a distinct seven- transmembrane topology with the amino terminus located intracellularly(10,18). Here we provide evidence that heteromeric insect ORs comprise a new class of ligand- activated nonselective cation channels. Heterologous cells expressing silkmoth, fruitfly or mosquito heteromeric OR complexes showed extracellular Ca2+ influx and cation- non- selective ion conductance on stimulation with odorant. Odour- evoked OR currents are independent of known G- protein- coupled second messenger pathways. The fast response kinetics and OR- subunit- dependent K+ ion selectivity of the insect OR complex support the hypothesis that the complex between OR and Or83b itself confers channel activity. Direct evidence for odorant- gated channels was obtained by outside- out patch- clamp recording of Xenopus oocyte and HEK293T cell membranes expressing insect OR complexes. The ligand- gated ion channel formed by an insect OR complex seems to be the basis for a unique strategy that insects have acquired to respond to the olfactory environment.	[Sato, Koji; Nakagawa, Takao; Nakagawa, Tatsuro; Touhara, Kazushige] Univ Tokyo, Dept Integrated Biosci, Chiba 2778562, Japan; [Pellegrino, Maurizio; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA	University of Tokyo; Rockefeller University	Touhara, K (corresponding author), Univ Tokyo, Dept Integrated Biosci, Chiba 2778562, Japan.	touhara@k.u-tokyo.ac.jp		Vosshall, Leslie/0000-0002-6060-8099; xing zhi, zuo teng/0000-0001-6198-6406				Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Elmore T, 2003, J NEUROSCI, V23, P9906; FIRESTEIN S, 1990, J PHYSIOL-LONDON, V430, P135, DOI 10.1113/jphysiol.1990.sp018286; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Halaszovich CR, 2000, J BIOL CHEM, V275, P37423, DOI 10.1074/jbc.M007010200; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Kaissling KE, 1996, CHEM SENSES, V21, P257, DOI 10.1093/chemse/21.2.257; Kanzaki M, 1999, SCIENCE, V285, P882, DOI 10.1126/science.285.5429.882; Katada S, 2003, BIOCHEM BIOPH RES CO, V305, P964, DOI 10.1016/S0006-291X(03)00863-5; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; LACAMPAGNE A, 1994, BBA-BIOMEMBRANES, V1191, P205, DOI 10.1016/0005-2736(94)90250-X; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Murakami M, 2000, J GEN PHYSIOL, V115, P455, DOI 10.1085/jgp.115.4.455; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Sato K, 2000, J EXP BIOL, V203, P253; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906; Zagotta WN, 2006, NATURE, V440, P427, DOI 10.1038/440427a	31	721	781	7	225	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2008	452	7190					1002	U9		10.1038/nature06850	http://dx.doi.org/10.1038/nature06850			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291PF	18408712				2022-12-24	WOS:000255208600041
J	Mukherjee, K; Sharma, M; Urlaub, H; Bourenkov, GP; Jahn, R; Sudhof, TC; Wahl, MC				Mukherjee, Konark; Sharma, Manu; Urlaub, Henning; Bourenkov, Gleb P.; Jahn, Reinhard; Suedhof, Thomas C.; Wahl, Markus C.			CASK functions as a Mg2+-independent neurexin kinase	CELL			English	Article							DEPENDENT PROTEIN-KINASE; SYNAPTIC VESICLE EXOCYTOSIS; BASOLATERAL MEMBRANE; ACTIVATION SEGMENT; NUCLEOTIDE-BINDING; ADHESION MOLECULE; CATALYTIC DOMAIN; EPITHELIAL-CELLS; CASK/LIN-2; COMPLEX	CASK is a unique MAGUK protein that contains an N-terminal CaM-kinase domain besides the typical MAGUK domains. The CASK CaM-kinase domain is presumed to be a catalytically inactive pseudokinase because it lacks the canonical DFG motif required for Mg2+ binding that is thought to be indispensable for kinase activity. Here we show, however, that CASK functions as an active protein kinase even without Mg2+ binding. High-resolution crystal structures reveal that the CASK CaM-kinase domain adopts a constitutively active conformation that binds ATP and catalyzes phosphotransfer without Mg2+. The CASK CaM-kinase domain phosphorylates itself and at least one physiological interactor, the synaptic protein neurexin-1, to which CASK is recruited via its PDZ domain. Thus, our data indicate that CASK combines the scaffolding activity of MAGUKs with an unusual kinase activity that phosphorylates substrates recuited by the scaffolding activity. Moreover, our study suggests that other pseudokinases (10% of the kinome) could also be catalytically active.	[Mukherjee, Konark; Sharma, Manu; Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Nuerosci, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Mukherjee, Konark; Jahn, Reinhard] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; [Urlaub, Henning] Max Planck Inst Biophys Chem, Res Grp Bioanalyt Mass Spectrometry, D-37077 Gottingen, Germany; [Wahl, Markus C.] Max Planck Inst Biophys Chem, Res Grp Xray Crystallog, D-37077 Gottingen, Germany; [Wahl, Markus C.] Univ Gottingen, Dept Med, D-37077 Gottingen, Germany	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Max Planck Society; Max Planck Society; Max Planck Society; University of Gottingen	Mukherjee, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Nuerosci, Howard Hughes Med Inst, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	konark.mukherjee@utsouthwestern..edu; thomas.sudhof@utsouthwestern.edu; mwahl@gwdg.de	Wahl, Markus C./D-6365-2017; Bourenkov, Gleb P/C-7794-2017	Wahl, Markus C./0000-0002-2811-5307; Bourenkov, Gleb P/0000-0002-2617-5920; Jahn, Reinhard/0000-0003-1542-3498	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH052804] Funding Source: NIH RePORTER; NIMH NIH HHS [R37 MH052804, R37 MH052804-08, R37 MH52804-08] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abel ES, 2001, J BIOL CHEM, V276, P10320, DOI 10.1074/jbc.M006589200; Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Biederer T, 2001, J BIOL CHEM, V276, P47869, DOI 10.1074/jbc.M105287200; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bilwes AM, 2001, NAT STRUCT BIOL, V8, P353, DOI 10.1038/86243; Borg JP, 1998, J BIOL CHEM, V273, P31633, DOI 10.1074/jbc.273.48.31633; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Dimitratos SD, 1998, GENOMICS, V51, P308, DOI 10.1006/geno.1998.5404; Fallon L, 2002, J BIOL CHEM, V277, P486, DOI 10.1074/jbc.M109806200; Froyen G, 2007, HUM MUTAT, V28, P1034, DOI 10.1002/humu.20564; Goldberg J, 1996, CELL, V84, P875, DOI 10.1016/S0092-8674(00)81066-1; Gotoh H, 1999, BRAIN RES, V828, P163, DOI 10.1016/S0006-8993(99)01298-6; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HANLEY RM, 1988, BIOCHEM BIOPH RES CO, V152, P122, DOI 10.1016/S0006-291X(88)80688-0; Hata Y, 1996, J NEUROSCI, V16, P2488; Hodge JJL, 2006, NEURON, V51, P327, DOI 10.1016/j.neuron.2006.06.020; Hoskins R, 1996, DEVELOPMENT, V122, P97; Hsueh YP, 2000, NATURE, V404, P298, DOI 10.1038/35005118; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Itano N, 1996, BIOCHEM J, V315, P925, DOI 10.1042/bj3150925; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jauch R, 2006, EMBO J, V25, P4020, DOI 10.1038/sj.emboj.7601285; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; KWIATKOWSKI AP, 1987, BIOCHEMISTRY-US, V26, P7636, DOI 10.1021/bi00398a016; Leonoudakis D, 2004, J BIOL CHEM, V279, P19051, DOI 10.1074/jbc.M400284200; Lopes C, 2001, BIOCHEM BIOPH RES CO, V284, P1004, DOI 10.1006/bbrc.2001.5050; Lu CS, 2003, NEURON, V40, P1185, DOI 10.1016/S0896-6273(03)00786-4; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marble DD, 2005, J NEUROSCI, V25, P4898, DOI 10.1523/JNEUROSCI.4566-04.2005; Martin JR, 1996, EMBO J, V15, P1865, DOI 10.1002/j.1460-2075.1996.tb00537.x; Martinez-Estrada OM, 2001, J BIOL CHEM, V276, P9291, DOI 10.1074/jbc.M006991200; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Nix SL, 2000, J BIOL CHEM, V275, P41192, DOI 10.1074/jbc.M002078200; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Olsen O, 2006, CURR OPIN CELL BIOL, V18, P223, DOI 10.1016/j.ceb.2006.02.010; Schuh K, 2003, J BIOL CHEM, V278, P9778, DOI 10.1074/jbc.M212507200; Stewart RC, 1998, BIOCHEMISTRY-US, V37, P12269, DOI 10.1021/bi980970n; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tabuchi K, 2002, J NEUROSCI, V22, P4264, DOI 10.1523/JNEUROSCI.22-11-04264.2002; TAYLOR JS, 1991, P NATL ACAD SCI USA, V88, P6810, DOI 10.1073/pnas.88.15.6810; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; Tereshko V, 2001, NAT STRUCT BIOL, V8, P899, DOI 10.1038/nsb1001-899; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Waas WF, 2004, BBA-PROTEINS PROTEOM, V1697, P81, DOI 10.1016/j.bbapap.2003.11.015; Warmuth M, 2007, CURR OPIN ONCOL, V19, P55, DOI 10.1097/CCO.0b013e328011a25f; Zordan MA, 2005, J NEUROPHYSIOL, V94, P1074, DOI 10.1152/jn.00954.2004	53	193	200	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 18	2008	133	2					328	339		10.1016/j.cell.2008.02.036	http://dx.doi.org/10.1016/j.cell.2008.02.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	289JY	18423203	Green Accepted, Bronze			2022-12-24	WOS:000255052000021
J	Kremen, C; Cameron, A; Moilanen, A; Phillips, SJ; Thomas, CD; Beentje, H; Dransfield, J; Fisher, BL; Glaw, F; Good, TC; Harper, GJ; Hijmans, RJ; Lees, DC; Louis, E; Nussbaum, RA; Raxworthy, CJ; Razafimpahanana, A; Schatz, GE; Vences, M; Vieites, DR; Wright, PC; Zjhra, ML				Kremen, C.; Cameron, A.; Moilanen, A.; Phillips, S. J.; Thomas, C. D.; Beentje, H.; Dransfield, J.; Fisher, B. L.; Glaw, F.; Good, T. C.; Harper, G. J.; Hijmans, R. J.; Lees, D. C.; Louis, E., Jr.; Nussbaum, R. A.; Raxworthy, C. J.; Razafimpahanana, A.; Schatz, G. E.; Vences, M.; Vieites, D. R.; Wright, P. C.; Zjhra, M. L.			Aligning conservation priorities across taxa in Madagascar with high-resolution planning tools	SCIENCE			English	Article							SOUTH-AFRICA; STRATEGIES; DISTRIBUTIONS; DIVERSITY; ENDEMISM; RARE	Globally, priority areas for biodiversity are relatively well known, yet few detailed plans exist to direct conservation action within them, despite urgent need. Madagascar, like other globally recognized biodiversity hot spots, has complex spatial patterns of endemism that differ among taxonomic groups, creating challenges for the selection of within-country priorities. We show, in an analysis of wide taxonomic and geographic breadth and high spatial resolution, that multitaxonomic rather than single-taxon approaches are critical for identifying areas likely to promote the persistence of most species. Our conservation prioritization, facilitated by newly available techniques, identifies optimal expansion sites for the Madagascar government's current goal of tripling the land area under protection. Our findings further suggest that high-resolution multitaxonomic approaches to prioritization may be necessary to ensure protection for biodiversity in other global hot spots.	[Kremen, C.; Cameron, A.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Kremen, C.; Cameron, A.; Razafimpahanana, A.] Wildlife Conservat Soc, Reseau Biodivers Madagascar, Antananarivo, Madagascar; [Moilanen, A.] Univ Helsinki, Metapopulat Res Grp, Dept Biol & Environm Sci, FI-00014 Helsinki, Finland; [Phillips, S. J.] AT&T Labs Res, Florham Pk, NJ 07932 USA; [Thomas, C. D.] Univ York, Dept Biol, Area 18, York YO10 5YW, N Yorkshire, England; [Beentje, H.; Dransfield, J.] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England; [Fisher, B. L.] Calif Acad Sci, Dept Entomol, San Francisco, CA 94103 USA; [Glaw, F.] Zool Staatssammlung, D-81247 Munich, Germany; [Good, T. C.; Zjhra, M. L.] Georgia So Univ, Dept Biol, Statesboro, GA 30460 USA; [Harper, G. J.] Conservat Int, Ctr Appl Biodivers Sci, Arlington, VA 22202 USA; [Hijmans, R. J.] Int Rice Res Inst, Los Banos, Philippines; [Lees, D. C.] Nat Hist Museum, Dept Entomol, London SW7 5BD, England; [Louis, E., Jr.] Henry Doorly Zoo, Ctr Conservat & Res, Omaha, NE 68107 USA; [Nussbaum, R. A.] Univ Michigan, Zool Museum, Ann Arbor, MI 48109 USA; [Raxworthy, C. J.] Amer Museum Nat Hist, New York, NY 10024 USA; [Schatz, G. E.] Missouri Bot Garden, St Louis, MO 63166 USA; [Vences, M.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, D-38106 Braunschweig, Germany; [Vieites, D. R.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Vieites, D. R.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Wright, P. C.] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA	University of California System; University of California Berkeley; University of Helsinki; AT&T; University of York - UK; Royal Botanic Gardens, Kew; California Academy of Sciences; University System of Georgia; Georgia Southern University; Conservation International; CGIAR; International Rice Research Institute (IRRI); Natural History Museum London; University of Michigan System; University of Michigan; American Museum of Natural History (AMNH); Missouri Botanical Gardens; Braunschweig University of Technology; University of California System; University of California Berkeley; University of California System; University of California Berkeley; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kremen, C (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, 137 Mulford Hall, Berkeley, CA 94720 USA.	ckremen@nature.berkeley.edu	Cameron, Alison/D-3911-2009; Vences, Miguel/E-5573-2010; Moilanen, Atte/A-5005-2011; Lees, David/AAD-7382-2021; Vieites, David/B-4481-2009; Hijmans, Robert/N-3299-2016; Fisher, Brian L./S-9374-2019; Thomas, Chris D/A-1894-2012; Thomas, Chris D/A-1460-2014	Cameron, Alison/0000-0001-8236-7954; Vieites, David/0000-0001-5551-7419; Thomas, Chris D/0000-0003-2822-1334; Thomas, Chris D/0000-0003-2822-1334; Vences, Miguel/0000-0003-0747-0817; Fisher, Brian/0000-0002-4653-3270; Hijmans, Robert/0000-0001-5872-2872				Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Cowling R. M., 1999, Diversity and Distributions, V5, P51, DOI 10.1046/j.1472-4642.1999.00038.x; Cowling RM, 2003, BIOL CONSERV, V112, P191, DOI 10.1016/S0006-3207(02)00425-1; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Knight AT, 2006, CONSERV BIOL, V20, P739, DOI 10.1111/j.1523-1739.2006.00452.x; Kohler J, 2005, BIOSCIENCE, V55, P693, DOI 10.1641/0006-3568(2005)055[0693:NAAGCA]2.0.CO;2; Kremen Claire, 2003, P517; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mittermeier R, 2005, HOTSPOTS REVISITED E; Moilanen A, 2005, P ROY SOC B-BIOL SCI, V272, P1885, DOI 10.1098/rspb.2005.3164; Moilanen A, 2007, BIOL CONSERV, V134, P571, DOI 10.1016/j.biocon.2006.09.008; Moritz C, 2001, P ROY SOC B-BIOL SCI, V268, P1875, DOI 10.1098/rspb.2001.1713; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Raherilalao MJ, 2005, REV ECOL-TERRE VIE, V60, P355; Raxworthy CJ, 1996, COLLOQ SEMI, P369; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; SCHATZ GE, 2000, MEMOIRES SOC BIOGEOG, P1; SCHATZ GE, 2000, DIVERSITE ENDEMISME, P11; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Turner WR, 2006, CONSERV BIOL, V20, P527, DOI 10.1111/j.1523-1739.2006.00333.x; van Jaarsveld AS, 1998, SCIENCE, V279, P2106, DOI 10.1126/science.279.5359.2106	24	403	411	5	198	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 11	2008	320	5873					222	226		10.1126/science.1155193	http://dx.doi.org/10.1126/science.1155193			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286HJ	18403708				2022-12-24	WOS:000254836700041
J	Mikkelsen, TS; Hanna, J; Zhang, XL; Ku, MC; Wernig, M; Schorderet, P; Bernstein, BE; Jaenisch, R; Lander, ES; Meissner, A				Mikkelsen, Tarjei S.; Hanna, Jacob; Zhang, Xiaolan; Ku, Manching; Wernig, Marius; Schorderet, Patrick; Bernstein, Bradley E.; Jaenisch, Rudolf; Lander, Eric S.; Meissner, Alexander			Dissecting direct reprogramming through integrative genomic analysis	NATURE			English	Article							PLURIPOTENT STEM-CELLS; GENERATION; FIBROBLASTS; MOUSE; MYC; EXPRESSION; MICE	Somatic cells can be reprogrammed to a pluripotent state through the ectopic expression of defined transcription factors. Understanding the mechanism and kinetics of this transformation may shed light on the nature of developmental potency and suggest strategies with improved efficiency or safety. Here we report an integrative genomic analysis of reprogramming of mouse fibroblasts and B lymphocytes. Lineage- committed cells show a complex response to the ectopic expression involving induction of genes downstream of individual reprogramming factors. Fully reprogrammed cells show gene expression and epigenetic states that are highly similar to embryonic stem cells. In contrast, stable partially reprogrammed cell lines show reactivation of a distinctive subset of stem- cell- related genes, incomplete repression of lineage- specifying transcription factors, and DNA hypermethylation at pluripotency- related loci. These observations suggest that some cells may become trapped in partially reprogrammed states owing to incomplete repression of transcription factors, and that DNA de- methylation is an inefficient step in the transition to pluripotency. We demonstrate that RNA inhibition of transcription factors can facilitate reprogramming, and that treatment with DNA methyltransferase inhibitors can improve the overall efficiency of the reprogramming process.	[Mikkelsen, Tarjei S.; Zhang, Xiaolan; Bernstein, Bradley E.; Lander, Eric S.; Meissner, Alexander] MIT, Broad Inst, Cambridge, MA 02142 USA; [Mikkelsen, Tarjei S.; Zhang, Xiaolan; Bernstein, Bradley E.; Lander, Eric S.; Meissner, Alexander] Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; [Mikkelsen, Tarjei S.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Jaenisch, Rudolf; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Hanna, Jacob; Wernig, Marius; Schorderet, Patrick; Jaenisch, Rudolf; Lander, Eric S.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Ku, Manching; Bernstein, Bradley E.] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Ku, Manching; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Bernstein, Bradley E.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA; [Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University	Meissner, A (corresponding author), MIT, Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	alex@broad.mit.edu	Mikkelsen, Tarjei S/A-1306-2007; jia, xu/A-8386-2016; Hanna, Jacob/K-1339-2012	Mikkelsen, Tarjei S/0000-0002-8133-3135; Hanna, Jacob/0000-0003-2042-9974	NHGRI NIH HHS [U54 HG003067-04, U54 HG003067] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Gregory MA, 2005, CELL CYCLE, V4, P249; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Imamura M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-34; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Lei H, 1996, DEVELOPMENT, V122, P3195; Lim LS, 2007, MOL BIOL CELL, V18, P1348, DOI 10.1091/mbc.E06-07-0624; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; MEISSNER A, IN PRESS NATURE; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Rideout WM, 2000, NAT GENET, V24, P109, DOI 10.1038/72753; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	33	1089	1184	0	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2008	454	7200					49	U1		10.1038/nature07056	http://dx.doi.org/10.1038/nature07056			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18509334	Green Accepted			2022-12-24	WOS:000257308300033
J	Velliste, M; Perel, S; Spalding, MC; Whitford, AS; Schwartz, AB				Velliste, Meel; Perel, Sagi; Spalding, M. Chance; Whitford, Andrew S.; Schwartz, Andrew B.			Cortical control of a prosthetic arm for self-feeding	NATURE			English	Article							POPULATION REPRESENTATION; DRAWING MOVEMENTS; COMPUTER; NEURONS; RESTORATION; INTERFACES; DIRECTION; SIGNALS	Arm movement is well represented in populations of neurons recorded from the motor cortex(1-7). Cortical activity patterns have been used in the new field of brain-machine interfaces(8-11) to show how cursors on computer displays can be moved in two- and three-dimensional space(12-22). Although the ability to move a cursor can be useful in its own right, this technology could be applied to restore arm and hand function for amputees and paralysed persons. However, the use of cortical signals to control a multi-jointed prosthetic device for direct real-time interaction with the physical environment ('embodiment') has not been demonstrated. Here we describe a system that permits embodied prosthetic control; we show how monkeys (Macaca mulatta) use their motor cortical activity to control a mechanized arm replica in a self-feeding task. In addition to the three dimensions of movement, the subjects' cortical signals also proportionally controlled a gripper on the end of the arm. Owing to the physical interaction between the monkey, the robotic arm and objects in the workspace, this new task presented a higher level of difficulty than previous virtual (cursor-control) experiments. Apart from an example of simple one-dimensional control(23), previous experiments have lacked physical interaction even in cases where a robotic arm(16,19,24) or hand(20) was included in the control loop, because the subjects did not use it to interact with physical objects - an interaction that cannot be fully simulated. This demonstration of multi-degree-of-freedom embodied prosthetic control paves the way towards the development of dexterous prosthetic devices that could ultimately achieve arm and hand function at a near-natural level.	[Velliste, Meel; Schwartz, Andrew B.] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15213 USA; [Perel, Sagi; Spalding, M. Chance; Whitford, Andrew S.; Schwartz, Andrew B.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA; [Perel, Sagi; Spalding, M. Chance; Whitford, Andrew S.; Schwartz, Andrew B.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Perel, Sagi; Spalding, M. Chance; Whitford, Andrew S.; Schwartz, Andrew B.] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; [Schwartz, Andrew B.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Schwartz, Andrew B.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA; [Schwartz, Andrew B.] Carnegie Mellon Univ, Inst Robot, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Schwartz, AB (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurobiol, E1440 BST,Lothrop St, Pittsburgh, PA 15213 USA.	abs21@pitt.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050256] Funding Source: NIH RePORTER; NINDS NIH HHS [NS050256] Funding Source: Medline; PHS HHS [N01-2-2346] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Brockwell AE, 2004, J NEUROPHYSIOL, V91, P1899, DOI 10.1152/jn.00438.2003; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Georgopoulos A. P., 1984, DYNAMIC ASPECTS NEOC, P501; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2928; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Kennedy PR, 2000, IEEE T REHABIL ENG, V8, P198, DOI 10.1109/86.847815; Kennedy PR, 1998, NEUROREPORT, V9, P1707, DOI 10.1097/00001756-199806010-00007; Lebedev MA, 2005, J NEUROSCI, V25, P4681, DOI 10.1523/JNEUROSCI.4088-04.2005; Leuthardt EC, 2006, NEUROSURGERY, V59, P1, DOI 10.1227/01.NEU.0000221506.06947.AC; Moran DW, 1999, J NEUROPHYSIOL, V82, P2693, DOI 10.1152/jn.1999.82.5.2693; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Sanchez JC, 2005, IEEE T NEUR SYS REH, V13, P213, DOI 10.1109/TNSRE.2005.847382; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Schwartz AB, 1999, J NEUROPHYSIOL, V82, P2705, DOI 10.1152/jn.1999.82.5.2705; Schwartz AB, 2004, ANNU REV NEUROSCI, V27, P487, DOI 10.1146/annurev.neuro.27.070203.144233; Schwartz AB, 2001, CURR OPIN NEUROBIOL, V11, P701, DOI 10.1016/S0959-4388(01)00272-0; SCHWARTZ AB, 1994, SCIENCE, V265, P540, DOI 10.1126/science.8036499; Schwartz AB, 2006, NEURON, V52, P205, DOI 10.1016/j.neuron.2006.09.019; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; SOECHTING JF, 1984, EXP BRAIN RES, V54, P121; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Tillery SIH, 2003, P ANN INT IEEE EMBS, V25, P2043, DOI 10.1109/IEMBS.2003.1280137; Wahnoun R, 2006, J NEURAL ENG, V3, P162, DOI 10.1088/1741-2560/3/2/010; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Yu BM, 2007, J NEUROPHYSIOL, V97, P3763, DOI 10.1152/jn.00482.2006	30	1053	1105	10	416	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2008	453	7198					1098	1101		10.1038/nature06996	http://dx.doi.org/10.1038/nature06996			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18509337	Green Published			2022-12-24	WOS:000256839900056
J	Czech, B; Malone, CD; Zhou, R; Stark, A; Schlingeheyde, C; Dus, M; Perrimon, N; Kellis, M; Wohlschlegel, JA; Sachidanandam, R; Hannon, GJ; Brennecke, J				Czech, Benjamin; Malone, Colin D.; Zhou, Rui; Stark, Alexander; Schlingeheyde, Catherine; Dus, Monica; Perrimon, Norbert; Kellis, Manolis; Wohlschlegel, James A.; Sachidanandam, Ravi; Hannon, Gregory J.; Brennecke, Julius			An endogenous small interfering RNA pathway in Drosophila	NATURE			English	Article							C-ELEGANS; MICRORNA MATURATION; ARGONAUTE PROTEINS; DISTINCT ROLES; BIOGENESIS; INITIATION; GERMLINE; ELEMENTS; REVEALS; VIRUSES	Drosophila endogenous small RNAs are categorized according to their mechanisms of biogenesis and the Argonaute protein to which they bind. MicroRNAs are a class of ubiquitously expressed RNAs of 22 nucleotides in length, which arise from structured precursors through the action of Drosha - Pasha and Dicer- 1-Loquacious complexes(1-7). These join Argonaute-1 to regulate gene expression(8,9). A second endogenous small RNA class, the Piwi-interacting RNAs, bind Piwi proteins and suppress transposons(10,11). Piwi- interacting RNAs are restricted to the gonad, and at least a subset of these arises by Piwi- catalysed cleavage of single-stranded RNAs(12,13). Here we show that Drosophila generates a third small RNA class, endogenous small interfering RNAs, in both gonadal and somatic tissues. Production of these RNAs requires Dicer- 2, but a subset depends preferentially on Loquacious(1,4,5) rather than the canonical Dicer- 2 partner, R2D2 ( ref. 14). Endogenous small interfering RNAs arise both from convergent transcription units and from structured genomic loci in a tissue- specific fashion. They predominantly join Argonaute- 2 and have the capacity, as a class, to target both protein- coding genes and mobile elements. These observations expand the repertoire of small RNAs in Drosophila, adding a class that blurs distinctions based on known biogenesis mechanisms and functional roles.	[Czech, Benjamin; Malone, Colin D.; Schlingeheyde, Catherine; Dus, Monica; Sachidanandam, Ravi; Hannon, Gregory J.; Brennecke, Julius] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Zhou, Rui; Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Howard Hughes Med Inst, Boston, MA 02115 USA; [Stark, Alexander; Kellis, Manolis] MIT, Broad Inst, Cambridge, MA 02141 USA; [Stark, Alexander; Kellis, Manolis] Harvard Univ, Broad Inst, Cambridge, MA 02141 USA; [Stark, Alexander] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Wohlschlegel, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu; brenneck@cshl.edu	sachidanandam, ravi/Q-6916-2019; Czech, Benjamin/AAJ-8592-2020; Brennecke, Julius/C-1626-2015; Hannon, Gregory/AAB-3568-2019; Stark, Alexander/D-1473-2012; Kellis, Manolis/ABE-7385-2020; Brennecke, Julius/T-5883-2019	sachidanandam, ravi/0000-0001-9844-4459; Czech, Benjamin/0000-0001-8471-0007; Brennecke, Julius/0000-0002-5141-0814; Stark, Alexander/0000-0003-2611-0841; Kellis, Manolis/0000-0001-7113-9630; Brennecke, Julius/0000-0002-5141-0814; Perrimon, Norbert/0000-0001-7542-472X	NHGRI NIH HHS [U54 HG004570-01, U54 HG004555-01, U01 HG004264-02, U54 HG004570, U54 HG004555, U01 HG004264] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004570, U54HG004555, U01HG004264] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Forsyth D, 1907, Q J MED, V1, P287; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Rehwinkel J, 2006, MOL CELL BIOL, V26, P2965, DOI 10.1128/MCB.26.8.2965-2975.2006; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Stark A, 2007, GENOME RES, V17, P1865, DOI 10.1101/gr.6593807; TAM OH, 2008, NATURE          0410; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; WATANABE T, 2008, NATURE          0410; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033	32	504	527	5	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2008	453	7196					798	U7		10.1038/nature07007	http://dx.doi.org/10.1038/nature07007			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308UK	18463631	Green Accepted			2022-12-24	WOS:000256415300047
J	Mani, SA; Guo, W; Liao, MJ; Eaton, EN; Ayyanan, A; Zhou, AY; Brooks, M; Reinhard, F; Zhang, CC; Shipitsin, M; Campbell, LL; Polyak, K; Brisken, C; Yang, J; Weinberg, RA				Mani, Sendurai A.; Guo, Wenjun; Liao, Mai-Jing; Eaton, Elinor Ng.; Ayyanan, Ayyakkannu; Zhou, Alicia Y.; Brooks, Mary; Reinhard, Ferenc; Zhang, Cheng Cheng; Shipitsin, Michail; Campbell, Lauren L.; Polyak, Kornelia; Brisken, Cathrin; Yang, Jing; Weinberg, Robert A.			The epithelial-mesenchymal transition generates cells with properties of stem cells	CELL			English	Article							BREAST-CANCER CELLS; TRANSCRIPTION FACTOR SNAIL; TUMOR PROGRESSION; E-CADHERIN; MAMMARY-GLAND; METASTASIS; EXPRESSION; TWIST; IDENTIFICATION; TRANSFORMATION	The epithelial-mesenchymal transition (EMT) is a key developmental program that is often activated during cancer invasion and metastasis. We here report that the induction of an EMT in immortalized human mammary epithelial cells (HMLEs) results in the acquisition of mesenchymal traits and in the expression of stem-cell markers. Furthermore, we show that those cells have an increased ability to form mammospheres, a property associated with mammary epithelial stem cells. Independent of this, stem cell-like cells isolated from HMLE cultures form mammospheres and express markers similar to those of HMLEs that have undergone an EMT. Moreover, stem-like cells isolated either from mouse or human mammary glands or mammary carcinomas express EMT markers. Finally, transformed human mammary epithelial cells that have undergone an EMT form mammospheres, soft agar colonies, and tumors more efficiently. These findings illustrate a direct link between the EMT and the gain of epithelial stem cell properties.	[Mani, Sendurai A.; Guo, Wenjun; Liao, Mai-Jing; Eaton, Elinor Ng.; Zhou, Alicia Y.; Brooks, Mary; Reinhard, Ferenc; Zhang, Cheng Cheng; Weinberg, Robert A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Zhou, Alicia Y.; Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Mani, Sendurai A.] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77054 USA; [Ayyanan, Ayyakkannu; Brisken, Cathrin] Swiss Inst Expt Canc Res, NCCR Mol Oncol, Ecole Polytech Fed Lausanne, CH-1066 Epalinges, Switzerland; [Shipitsin, Michail; Campbell, Lauren L.; Polyak, Kornelia] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Shipitsin, Michail; Polyak, Kornelia] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Campbell, Lauren L.; Polyak, Kornelia] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Yang, Jing] Univ Calif San Diego, Sch Med, Dept Pediat & Pharmacol, La Jolla, CA 92093 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Texas System; UTMD Anderson Cancer Center; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of California System; University of California San Diego	Mani, SA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	smani@mdanderson.org; weinberg@wi.mit.edu	Mani, Sendurai A./A-7244-2009; Zhang, Cheng/GRS-8698-2022; Sayan, A. Emre/H-7330-2012	Mani, Sendurai A./0000-0002-5918-4276; Sayan, A. Emre/0000-0002-5291-1485; Zhou, Alicia/0000-0003-0388-8909; Brisken, Cathrin/0000-0002-6857-3230	NATIONAL CANCER INSTITUTE [P50CA089393, R01CA078461, R01CA116235, R01CA094074, P01CA080111] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA089393-080014, P01 CA080111, R01-CA078461, P50 CA089393-070014, R01 CA078461, P50 CA089393-060014, R01 CA094074, R01 CA078461-09, R01 CA116235, P50 CA089393, R01 CA116235-03, R01 CA116235-01A1, P0-CA080111, CA89393, CA94074, R01 CA116235-02, P01 CA080111-09] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Briegel KJ, 2006, IUBMB LIFE, V58, P123, DOI 10.1080/15216540600686870; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; CIFONE MA, 1980, P NATL ACAD SCI-BIOL, V77, P1039, DOI 10.1073/pnas.77.2.1039; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Davies JA, 1996, ACTA ANAT, V156, P187; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hartwell KA, 2006, P NATL ACAD SCI USA, V103, P18969, DOI 10.1073/pnas.0608636103; Hay ED, 1995, ACTA ANAT, V154, P8; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; LIAO MJ, 2007, IN PRESS CANC RES; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perez-Pomares JM, 2002, ANAT RECORD, V268, P343, DOI 10.1002/ar.10165; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Savagner P, 2005, J CELL PHYSIOL, V202, P858, DOI 10.1002/jcp.20188; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Weaver VM, 1999, J MAMMARY GLAND BIOL, V4, P193, DOI 10.1023/A:1018781325716; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2006, CANCER RES, V66, P4549, DOI 10.1158/0008-5472.CAN-05-3850	42	6362	6686	15	1013	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 16	2008	133	4					704	715		10.1016/j.cell.2008.03.027	http://dx.doi.org/10.1016/j.cell.2008.03.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485877	Green Accepted, Bronze			2022-12-24	WOS:000255903300024
J	Allesina, S; Alonso, D; Pascual, M				Allesina, Stefano; Alonso, David; Pascual, Mercedes			A general model for food web structure	SCIENCE			English	Article							BODY-SIZE; ECOLOGICAL NETWORKS	A central problem in ecology is determining the processes that shape the complex networks known as food webs formed by species and their feeding relationships. The topology of these networks is a major determinant of ecosystems' dynamics and is ultimately responsible for their responses to human impacts. Several simple models have been proposed for the intricate food webs observed in nature. We show that the three main models proposed so far fail to fully replicate the empirical data, and we develop a likelihood- based approach for the direct comparison of alternative models based on the full structure of the network. Results drive a new model that is able to generate all the empirical data sets and to do so with the highest likelihood.	[Allesina, Stefano; Alonso, David; Pascual, Mercedes] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Allesina, Stefano] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Alonso, David] Univ Groningen, Ctr Ecol & Evolutionary Studies, Community & Conservat Ecol Grp, NL-9750 AA Haren, Netherlands; [Pascual, Mercedes] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Michigan System; University of Michigan; National Center for Ecological Analysis & Synthesis; University of Groningen; The Santa Fe Institute	Allesina, S (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Nat Sci Bldg,830 North Univ, Ann Arbor, MI 48109 USA.	allesina@nceas.ucsb.edu	Allesina, Stefano/A-2255-2009; Alonso, David/A-5406-2008	Alonso, David/0000-0002-8888-1644; Allesina, Stefano/0000-0003-0313-8374				Bersier LF, 2006, SFI S SCI C, P91; Brose U, 2006, ECOL LETT, V9, P1228, DOI 10.1111/j.1461-0248.2006.00978.x; Caldarelli G, 1998, J THEOR BIOL, V193, P345, DOI 10.1006/jtbi.1998.0706; Cattin MF, 2004, NATURE, V427, P835, DOI 10.1038/nature02327; COHEN JE, 1977, P NATL ACAD SCI USA, V74, P4533, DOI 10.1073/pnas.74.10.4533; COHEN JE, 1985, PROC R SOC SER B-BIO, V224, P421, DOI 10.1098/rspb.1985.0042; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; DUNNE JA, 2006, ECOLOGICAL NETWORKS, pCH2; Jonsson T, 2005, ADV ECOL RES, V36, P1, DOI 10.1016/S0065-2504(05)36001-6; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Layman CA, 2005, ECOLOGY, V86, P2530, DOI 10.1890/04-1098; Levin SA, 1998, ECOSYSTEMS, V1, P431, DOI 10.1007/s100219900037; Martinez ND, 2006, SFI S SCI C, P87; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; Montoya JM, 2003, ECOL LETT, V6, P587, DOI 10.1046/j.1461-0248.2003.00469.x; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Neubert MG, 2000, OECOLOGIA, V123, P241, DOI 10.1007/s004420051011; PIMM SL, 1991, NATURE, V350, P669, DOI 10.1038/350669a0; PIMM SL, 1982, FOOD WEBS; Rossberg AG, 2006, J THEOR BIOL, V241, P552, DOI 10.1016/j.jtbi.2005.12.021; Rossberg AG, 2005, ECOL COMPLEX, V2, P312, DOI 10.1016/j.ecocom.2005.04.007; Santamaria L, 2007, PLOS BIOL, V5, P354, DOI 10.1371/journal.pbio.0050031; Schindler DE, 1997, SCIENCE, V277, P248, DOI 10.1126/science.277.5323.248; Stouffer DB, 2006, P NATL ACAD SCI USA, V103, P19015, DOI 10.1073/pnas.0603844103; Vazquez DP, 2005, OIKOS, V108, P421, DOI 10.1111/j.0030-1299.2005.13619.x; Williams RJ, 2004, EUR PHYS J B, V38, P297, DOI 10.1140/epjb/e2004-00122-1; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005	28	182	186	1	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2008	320	5876					658	661		10.1126/science.1156269	http://dx.doi.org/10.1126/science.1156269			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451301				2022-12-24	WOS:000255454300044
J	Clauset, A; Moore, C; Newman, MEJ				Clauset, Aaron; Moore, Cristopher; Newman, M. E. J.			Hierarchical structure and the prediction of missing links in networks	NATURE			English	Article							FOOD-WEB STRUCTURE; METABOLIC NETWORKS; COMPLEX NETWORKS; COMMUNITY STRUCTURE; SOCIAL NETWORKS; ORGANIZATION; MODULARITY	Networks have in recent years emerged as an invaluable tool for describing and quantifying complex systems in many branches of science(1-3). Recent studies suggest that networks often exhibit hierarchical organization, in which vertices divide into groups that further subdivide into groups of groups, and so forth over multiple scales. In many cases the groups are found to correspond to known functional units, such as ecological niches in food webs, modules in biochemical networks ( protein interaction networks, metabolic networks or genetic regulatory networks) or communities in social networks(4-7). Here we present a general technique for inferring hierarchical structure from network data and show that the existence of hierarchy can simultaneously explain and quantitatively reproduce many commonly observed topological properties of networks, such as right- skewed degree distributions, high clustering coefficients and short path lengths. We further show that knowledge of hierarchical structure can be used to predict missing connections in partly known networks with high accuracy, and for more general network structures than competing techniques(8). Taken together, our results suggest that hierarchy is a central organizing principle of complex networks, capable of offering insight into many network phenomena.	[Clauset, Aaron; Moore, Cristopher] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA; [Moore, Cristopher] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA; [Clauset, Aaron; Moore, Cristopher; Newman, M. E. J.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Newman, M. E. J.] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Newman, M. E. J.] Univ Michigan, Ctr Study Complex Syst, Ann Arbor, MI 48109 USA	University of New Mexico; University of New Mexico; The Santa Fe Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Clauset, A (corresponding author), Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA.	aaronc@santafe.edu		CLAUSET, AARON/0000-0002-3529-8746; Moore, Cristopher/0000-0002-2062-1942				Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], 2002, CONNECTIONS; Bryant D., 2003, BIOCONSENSUS, P163; Casella G, 2001, STAT INFERENCE, V2nd; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; COSENTINOLAGOMA.M, 2001, P NATL ACAD SCI USA, V104, P5516; DAWAH HA, 1995, J ANIM ECOL, V64, P708, DOI 10.2307/5850; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Huss M, 2007, IET SYST BIOL, V1, P280, DOI 10.1049/iet-syb:20060077; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kleinberg J, 2002, ADV NEUR IN, V14, P431; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; Lakhina A, 2003, IEEE INFOCOM SER, P332; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Martinez ND, 1999, ECOLOGY, V80, P1044, DOI 10.1890/0012-9658(1999)080[1044:EOSEOC]2.0.CO;2; Newman M., 1999, MONTE CARLO METHODS; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Sprinzak E, 2003, J MOL BIOL, V327, P919, DOI 10.1016/S0022-2836(03)00239-0; Szilagyi A, 2005, PHYS BIOL, V2, pS1, DOI 10.1088/1478-3975/2/2/S01; Wasserman S., 1994, SOCIAL NETWORK ANAL; Watts DJ, 2002, SCIENCE, V296, P1302, DOI 10.1126/science.1070120	30	1266	1376	18	367	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2008	453	7191					98	101		10.1038/nature06830	http://dx.doi.org/10.1038/nature06830			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294ID	18451861	Green Published, Green Submitted			2022-12-24	WOS:000255398800046
J	Maya-Vetencourt, JF; Sale, A; Viegi, A; Baroncelli, L; De Pasquale, R; O'Leary, OF; Castren, E; Maffei, L				Maya-Vetencourt, Jose Fernando; Sale, Alessandro; Viegi, Alessandro; Baroncelli, Laura; De Pasquale, Roberto; O'Leary, Olivia F.; Castren, Eero; Maffei, Lamberto			The antidepressant fluoxetine restores plasticity in the adult visual cortex	SCIENCE			English	Article							OCULAR DOMINANCE PLASTICITY; CRITICAL-PERIOD; EVOKED-POTENTIALS; RAT HIPPOCAMPUS; MOUSE MODEL; INHIBITION; BRAIN; BDNF; NEUROGENESIS; DEPRESSION	We investigated whether fluoxetine, a widely prescribed medication for treatment of depression, restores neuronal plasticity in the adult visual system of the rat. We found that chronic administration of fluoxetine reinstates ocular dominance plasticity in adulthood and promotes the recovery of visual functions in adult amblyopic animals, as tested electrophysiologically and behaviorally. These effects were accompanied by reduced intracortical inhibition and increased expression of brain- derived neurotrophic factor in the visual cortex. Cortical administration of diazepam prevented the effects induced by fluoxetine, indicating that the reduction of intracortical inhibition promotes visual cortical plasticity in the adult. Our results suggest a potential clinical application for fluoxetine in amblyopia as well as new mechanisms for the therapeutic effects of antidepressants and for the pathophysiology of mood disorders.	[Maya-Vetencourt, Jose Fernando; Sale, Alessandro; Viegi, Alessandro; Baroncelli, Laura; De Pasquale, Roberto; Maffei, Lamberto] Scuola Normale Super Pisa, I-56100 Pisa, Italy; [Maffei, Lamberto] CNR, Inst Neurosci, I-56100 Pisa, Italy; [Castren, Eero] Univ Helsinki, Ctr Neurosci, FIN-00014 Helsinki, Finland	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Helsinki	Maya-Vetencourt, JF (corresponding author), Scuola Normale Super Pisa, Piazza Cavalieri, I-56100 Pisa, Italy.	jf.maya@in.cnr.it	Baroncelli, Laura/K-5823-2016; Castrén, Eero/A-4618-2010; Sale, Alessandro/K-7760-2016; Maya-Vetencourt, Jose Fernando/Q-6539-2019; DE PASQUALE, ROBERTO/AAE-2941-2019; O'Leary, Olivia/E-7964-2013	Baroncelli, Laura/0000-0001-6739-2860; Maya-Vetencourt, Jose Fernando/0000-0003-3808-8944; De Pasquale, Roberto/0000-0003-3383-7715; Castren, Eero/0000-0002-1402-2791; O'Leary, Olivia/0000-0002-9171-2032; Sale, Alessandro/0000-0001-7608-4456				ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; Castren E, 2005, NAT REV NEUROSCI, V6, P241, DOI 10.1038/nrn1629; Castren E, 2004, CURR OPIN PHARMACOL, V4, P58, DOI 10.1016/j.coph.2003.10.004; D'Sa C, 2002, BIPOLAR DISORD, V4, P183, DOI 10.1034/j.1399-5618.2002.01203.x; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Guire ES, 1999, J NEUROPHYSIOL, V81, P121, DOI 10.1152/jn.1999.81.1.121; Hajszan T, 2005, EUR J NEUROSCI, V21, P1299, DOI 10.1111/j.1460-9568.2005.03968.x; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Holmes JM, 2006, LANCET, V367, P1343, DOI 10.1016/S0140-6736(06)68581-4; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; Koponen E, 2005, CELL MOL NEUROBIOL, V25, P973, DOI 10.1007/s10571-005-8468-z; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Nestler EJ, 1998, BIOL PSYCHIAT, V44, P526, DOI 10.1016/S0006-3223(98)00095-X; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Normann C, 2007, BIOL PSYCHIAT, V62, P373, DOI 10.1016/j.biopsych.2006.10.006; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; REYNOLDS JN, 1988, BRAIN RES, V456, P286, DOI 10.1016/0006-8993(88)90230-2; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002	27	595	600	2	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2008	320	5874					385	388		10.1126/science.1150516	http://dx.doi.org/10.1126/science.1150516			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZZ	18420937				2022-12-24	WOS:000255026100047
J	Padua, D; Zhang, XHF; Wang, QQ; Nadal, C; Gerald, WL; Gomis, RR; Massague, J				Padua, David; Zhang, Xiang H. -F.; Wang, Qiongqing; Nadal, Cristina; Gerald, William L.; Gomis, Roger R.; Massague, Joan			TGF beta primes breast tumors for lung metastasis seeding through angiopoietin-like 4	CELL			English	Article							GROWTH-FACTOR-BETA; ENDOTHELIAL-CELL ADHESION; GENE-EXPRESSION SIGNATURE; CANCER METASTASIS; EXTRACELLULAR-MATRIX; C-MYC; RECEPTOR; SMAD; BONE; ANGIOGENESIS	Cells released from primary tumors seed metastases to specific organs by a nonrandom process, implying the involvement of biologically selective mechanisms. Based on clinical, functional, and molecular evidence, we show that the cytokine TGF beta in the breast tumor microenvironment primes cancer cells for metastasis to the lungs. Central to this process is the induction of angiopoietin-like 4 (ANGPTL4) by TGFb via the Smad signaling pathway. TGFb induction of Angptl4 in cancer cells that are about to enter the circulation enhances their subsequent retention in the lungs, but not in the bone. Tumor cell-derived Angptl4 disrupts vascular endothelial cell-cell junctions, increases the permeability of lung capillaries, and facilitates the trans-endothelial passage of tumor cells. These results suggest a mechanism for metastasis whereby a cytokine in the primary tumor microenvironment induces the expression of another cytokine in departing tumor cells, empowering these cells to disrupt lung capillary walls and seed pulmonary metastases.	[Padua, David; Zhang, Xiang H. -F.; Wang, Qiongqing; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Gerald, William L.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Massague, Joan] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; [Gomis, Roger R.] Inst Res Biomed, Oncol Programme, Barcelona 08028, Spain; [Nadal, Cristina] Hosp Clin IDIBAPS, Inst Malalties Hemato Oncol, Barcelona 08036, Spain	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	j-massague@mskcc.org	Gomis, Roger R/E-9788-2016	Gomis, Roger R/0000-0001-6473-2858; Massague, Joan/0000-0001-9324-8408; Zhang, Xiang/0000-0002-5674-8670; Padua, David/0000-0003-2549-9939	NATIONAL CANCER INSTITUTE [P01CA094060, P30CA008748, R37CA034610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R37 CA034610, P01 CA094060-01A10002, R37 CA034610-25, P30 CA008748, P01 CA094060] Funding Source: Medline; NIGMS NIH HHS [GM07739, T32 GM007739] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Buck MB, 2004, CLIN CANCER RES, V10, P491, DOI 10.1158/1078-0432.CCR-0320-03; Camenisch G, 2002, J BIOL CHEM, V277, P17281, DOI 10.1074/jbc.M109768200; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; DALAL BI, 1993, AM J PATHOL, V143, P381; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dumont N, 2003, CANCER CELL, V3, P531, DOI 10.1016/S1535-6108(03)00135-1; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Forrester E, 2005, CANCER RES, V65, P2296, DOI 10.1158/0008-5472.CAN-04-3272; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hermann LM, 2005, CLIN IMMUNOL, V115, P93, DOI 10.1016/j.clim.2004.12.002; Ito Y, 2003, CANCER RES, V63, P6651; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kielhorn E, 2002, CANCER, V94, P205, DOI 10.1002/cncr.10193; Kim I, 2000, BIOCHEM J, V346, P603, DOI 10.1042/0264-6021:3460603; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Lynch CC, 2005, CANCER CELL, V7, P485, DOI 10.1016/j.ccr.2005.04.013; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; OGHISO Y, 1979, JPN J EXP MED, V49, P223; Oike Y, 2004, INT J HEMATOL, V80, P21, DOI 10.1532/ijh97.04034; Paget S., 1889, LANCET, V1, P571, DOI DOI 10.1016/S0140-6736(00)49915-0; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Siegel PM, 2003, P NATL ACAD SCI USA, V100, P8430, DOI 10.1073/pnas.0932636100; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; WeisGarcia F, 1996, EMBO J, V15, P276, DOI 10.1002/j.1460-2075.1996.tb00358.x; WELCH DR, 1990, P NATL ACAD SCI USA, V87, P7678, DOI 10.1073/pnas.87.19.7678	54	704	735	1	65	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 4	2008	133	1					66	77		10.1016/j.cell.2008.01.046	http://dx.doi.org/10.1016/j.cell.2008.01.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	283MW	18394990	Green Accepted, Bronze			2022-12-24	WOS:000254641300009
J	Hobert, O				Hobert, Oliver			Gene regulation by transcription factors and microRNAs	SCIENCE			English	Editorial Material							PROTEIN-SYNTHESIS; REPRESSION; EXPRESSION; FEEDBACK		Columbia Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Hobert, O (corresponding author), Columbia Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	or38@columbia.edu		Hobert, Oliver/0000-0002-7634-2854	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Alon U., 2006, INTRO SYSTEMS BIOL D; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Buck MJ, 2006, NAT GENET, V38, P1446, DOI 10.1038/ng1917; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Davidson E. H., 2001, DEV EVOLUTION; Gray S, 1996, CURR OPIN CELL BIOL, V8, P358; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hobert O, 2004, TRENDS BIOCHEM SCI, V29, P462, DOI 10.1016/j.tibs.2004.07.001; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Lee EJ, 2008, RNA, V14, P35, DOI 10.1261/rna.804508; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; PTASHNE M, 2002, GENES SIGNALS; Robins H, 2005, P NATL ACAD SCI USA, V102, P4006, DOI 10.1073/pnas.0500775102; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140	26	672	713	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2008	319	5871					1785	1786		10.1126/science.1151651	http://dx.doi.org/10.1126/science.1151651			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279ZF	18369135				2022-12-24	WOS:000254394000032
J	Wilhelm, BT; Marguerat, S; Watt, S; Schubert, F; Wood, V; Goodhead, I; Penkett, CJ; Rogers, J; Bahler, J				Wilhelm, Brian T.; Marguerat, Samuel; Watt, Stephen; Schubert, Falk; Wood, Valerie; Goodhead, Ian; Penkett, Christopher J.; Rogers, Jane; Bahler, Jurg			Dynamic repertoire of a eukaryotic transcriptome surveyed at single-nucleotide resolution	NATURE			English	Article							GENOME-WIDE TRANSCRIPTION; GENE-EXPRESSION; FISSION YEAST; MEIOSIS; IDENTIFICATION; PROGRAM; NETWORK; TER1; MAP	Recent data from several organisms indicate that the transcribed portions of genomes are larger and more complex than expected, and that many functional properties of transcripts are based not on coding sequences but on regulatory sequences in untranslated regions or non- coding RNAs1-9. Alternative start and polyadenylation sites and regulation of intron splicing add additional dimensions to the rich transcriptional output(10,11). This transcriptional complexity has been sampled mainly using hybridization- based methods under one or few experimental conditions. Here we applied direct high- throughput sequencing of complementary DNAs ( RNA- Seq), supplemented with data from high- density tiling arrays, to globally sample transcripts of the fission yeast Schizosaccharomyces pombe, independently from available gene annotations. We interrogated transcriptomes under multiple conditions, including rapid proliferation, meiotic differentiation and environmental stress, as well as in RNA processing mutants to reveal the dynamic plasticity of the transcriptional landscape as a function of environmental, developmental and genetic factors. High- throughput sequencing proved to be a powerful and quantitative method to sample transcriptomes deeply at maximal resolution. In contrast to hybridization, sequencing showed little, if any, background noise and was sensitive enough to detect widespread transcription in >90% of the genome, including traces of RNAs that were not robustly transcribed or rapidly degraded. The combined sequencing and strand- specific array data provide rich condition- specific information on novel, mostly non- coding transcripts, untranslated regions and gene structures, thus improving the existing genome annotation. Sequence reads spanning exon-exon or exon - intron junctions give unique insight into a surprising variability in splicing efficiency across introns, genes and conditions. Splicing efficiency was largely coordinated with transcript levels, and increased transcription led to increased splicing in test genes. Hundreds of introns showed such regulated splicing during cellular proliferation or differentiation.	[Wilhelm, Brian T.; Marguerat, Samuel; Watt, Stephen; Schubert, Falk; Wood, Valerie; Goodhead, Ian; Penkett, Christopher J.; Rogers, Jane; Bahler, Jurg] Wellcome Trust Sanger Inst, Canc Res UK Fiss Yeast Funct Genom Grp, Cambridge CB10 1HH, England	Wellcome Trust Sanger Institute	Bahler, J (corresponding author), UCL, Dept Genet Evolut & Environm, Mortimer St, London WC1E 6BT, England.	jurg@sanger.ac.uk	Goodhead, Ian/ABC-9200-2020; Wood, Valerie/Y-7759-2018; Marguerat, Samuel/AAY-3792-2020; Bahler, Jurg/B-4572-2009	Wood, Valerie/0000-0001-6330-7526; Marguerat, Samuel/0000-0002-2402-3165; Bahler, Jurg/0000-0003-4036-1532; Goodhead, Ian/0000-0002-3110-9442	Cancer Research UK [A6517, C9546/A6517] Funding Source: Medline; Wellcome Trust [077118] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Averbeck N, 2005, MOL CELL, V18, P491, DOI 10.1016/j.molcel.2005.04.007; Bernstein BE, 2004, METHOD ENZYMOL, V376, P349; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bickel KS, 2006, MOL CELL, V22, P309, DOI 10.1016/j.molcel.2006.04.010; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Borgne A, 2002, MOL BIOL CELL, V13, P2080, DOI 10.1091/mbc.01-10-0507; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Huber W, 2006, BIOINFORMATICS, V22, P1963, DOI 10.1093/bioinformatics/btl289; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Lackner DH, 2007, MOL CELL, V26, P145, DOI 10.1016/j.molcel.2007.03.002; Leonardi J, 2008, NAT STRUCT MOL BIOL, V15, P26, DOI 10.1038/nsmb1343; Li L, 2006, NAT GENET, V38, P124, DOI 10.1038/ng1704; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; Malapeira J, 2005, MOL CELL BIOL, V25, P6330, DOI 10.1128/MCB.25.15.6330-6337.2005; Mata J, 2003, GENOME RES, V13, P2686, DOI 10.1101/gr.1420903; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r217; Munoz MJ, 2002, MOL GENET GENOMICS, V267, P792, DOI 10.1007/s00438-002-0710-5; POTASHKIN J, 1989, EMBO J, V8, P551, DOI 10.1002/j.1460-2075.1989.tb03409.x; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Watt S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001428; Webb CJ, 2008, NAT STRUCT MOL BIOL, V15, P34, DOI 10.1038/nsmb1354; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305	31	741	792	3	192	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 26	2008	453	7199					1239	U39		10.1038/nature07002	http://dx.doi.org/10.1038/nature07002			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18488015				2022-12-24	WOS:000257075800043
J	Gonzalez-Jose, R; Escapa, I; Neves, WA; Cuneo, R; Pucciarelli, HM				Gonzalez-Jose, Rolando; Escapa, Ignacio; Neves, Walter A.; Cuneo, Ruben; Pucciarelli, Hector M.			Cladistic analysis of continuous modularized traits provides phylogenetic signals in Homo evolution	NATURE			English	Article							INTEGRATION; CHARACTERS	Evolutionary novelties in the skeleton are usually expressed as changes in the timing of growth of features intrinsically integrated at different hierarchical levels of development(1). As a consequence, most of the shape- traits observed across species do vary quantitatively rather than qualitatively(2), in a multivariate space(3) and in a modularized way(4,5). Because most phylogenetic analyses normally use discrete, hypothetically independent characters(6), previous attempts have disregarded the phylogenetic signals potentially enclosed in the shape of morphological structures. When analysing low taxonomic levels, where most variation is quantitative in nature, solving basic requirements like the choice of characters and the capacity of using continuous, integrated traits is of crucial importance in recovering wider phylogenetic information. This is particularly relevant when analysing extinct lineages, where available data are limited to fossilized structures. Here we show that when continuous, multivariant and modularized characters are treated as such, cladistic analysis successfully solves relationships among main Homo taxa. Our attempt is based on a combination of cladistics, evolutionary- development- derived selection of characters, and geometric morphometrics methods. In contrast with previous cladistic analyses of hominid phylogeny, our method accounts for the quantitative nature of the traits, and respects their morphological integration patterns. Because complex phenotypes are observable across different taxonomic groups and are potentially informative about phylogenetic relationships, future analyses should point strongly to the incorporation of these types of trait.	[Gonzalez-Jose, Rolando] Consejo Nacl Invest Cient & Tecn, Unidad Invest Divers Sistemat & Evoluc, Ctr Nacl Patagonico, Consejo Nacl Invest Cient & Tecn, Puerto Madryn, Argentina; [Escapa, Ignacio; Cuneo, Ruben] Consejo Nacl Invest Cient & Tecn, Museo Paleontol Egidio Feruglio, Consejo Nacl Invest Cient & Tecn, Trelew, Argentina; [Neves, Walter A.] Univ Sao Paulo, Lab Estud Evolut Humanos, Dept Genet & Biol Evolut, Inst Biociencias, BR-05422970 Sao Paulo, Brazil; [Pucciarelli, Hector M.] Natl Univ La Plata, Consejo Nacl Invest Cient & Tecn, CONICET, Dept Cientifico Antropol Museo La Plata, RA-1900 La Plata, Argentina	Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade de Sao Paulo; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata	Gonzalez-Jose, R (corresponding author), Consejo Nacl Invest Cient & Tecn, Unidad Invest Divers Sistemat & Evoluc, Ctr Nacl Patagonico, Consejo Nacl Invest Cient & Tecn, Blvd Brown 2825,U9120ACF, Puerto Madryn, Argentina.	rolando@cenpat.edu.ar	E., Ignacio/AAA-3569-2021; Rohlf, F J/A-8710-2008; Neves, Walter A/Q-8316-2016	Neves, Walter A/0000-0001-9124-3937; Gonzalez-Jose, Rolando/0000-0002-8128-9381; Escapa, Ignacio/0000-0002-7042-7750				Ackermann RR, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P302; Arsuaga JL, 1997, J HUM EVOL, V33, P219, DOI 10.1006/jhev.1997.0133; CHEVERUD JM, 1995, AM NAT, V145, P63, DOI 10.1086/285728; Collard Mark, 2007, P1575, DOI 10.1007/978-3-540-33761-4_51; Curnoe D, 2003, HOMO, V53, P225, DOI 10.1078/0018-442X-00048; FARRIS JS, 1970, SYST ZOOL, V19, P172, DOI 10.2307/2412452; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; FELSENSTEIN J, 2007, PHYLIP PHYLOGENY INF; Goloboff P. A., 2008, TREE ANAL USING NEW; GOLOBOFF PA, IN PRESS CLADISTICS; Goloboff PA, 2006, CLADISTICS, V22, P589, DOI 10.1111/j.1096-0031.2006.00122.x; Humphries Christopher John, 2002, VVolume 64, P8; Lalueza-Fox C, 2005, MOL BIOL EVOL, V22, P1077, DOI 10.1093/molbev/msi094; Lieberman DE, 2002, P NATL ACAD SCI USA, V99, P1134, DOI 10.1073/pnas.022440799; MacLeod Norman, 2002, VVolume 64, P1; Olson E. C., 1958, MORPHOLOGICAL INTEGR; Pigliucci M., 2004, PHENOTYPIC INTEGRATI; Polly P. David, 2004, Palaeontologia Electronica, V7, P1; Polly PD, 2003, J MAMMAL, V84, P369, DOI 10.1644/1545-1542(2003)084<0369:PTTOGD>2.0.CO;2; Rae TC, 1998, CLADISTICS, V14, P221, DOI 10.1111/j.1096-0031.1998.tb00335.x; Rightmire G. Philip, 2007, P1695, DOI 10.1007/978-3-540-33761-4_55; Rozzi FVR, 2004, NATURE, V428, P936, DOI 10.1038/nature02428; SKELTON RR, 1992, J HUM EVOL, V23, P309, DOI 10.1016/0047-2484(92)90070-P; Spoor F, 2007, NATURE, V448, P688, DOI 10.1038/nature05986; Strait DS, 2004, J HUM EVOL, V47, P399, DOI 10.1016/j.jhevol.2004.08.008; Strait DS, 2001, AM J PHYS ANTHROPOL, V114, P273, DOI 10.1002/ajpa.1041; STRAIT DS, 2007, HDB PALEOANTHROPOLOG, P1782; Stringer CB, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P524; Vekua A, 2002, SCIENCE, V297, P85, DOI 10.1126/science.1072953; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5	31	72	79	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2008	453	7196					775	U4		10.1038/nature06891	http://dx.doi.org/10.1038/nature06891			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308UK	18454137				2022-12-24	WOS:000256415300042
J	Hughes, WOH; Oldroyd, BP; Beekman, M; Ratnieks, FLW				Hughes, William O. H.; Oldroyd, Benjamin P.; Beekman, Madeleine; Ratnieks, Francis L. W.			Ancestral monogamy shows kin selection is key to the evolution of eusociality	SCIENCE			English	Article							SPHECID WASP; MOLE-RAT; RELATEDNESS; ORIGIN; BEES; MICROSTIGMUS; SOCIALITY; ALTRUISM; INSECTS	Close relatedness has long been considered crucial to the evolution of eusociality. However, it has recently been suggested that close relatedness may be a consequence, rather than a cause, of eusociality. We tested this idea with a comparative analysis of female mating frequencies in 267 species of eusocial bees, wasps, and ants. We found that mating with a single male, which maximizes relatedness, is ancestral for all eight independent eusocial lineages that we investigated. Mating with multiple males is always derived. Furthermore, we found that high polyandry (> 2 effective mates) occurs only in lineages whose workers have lost reproductive totipotency. These results provide the first evidence that monogamy was critical in the evolution of eusociality, strongly supporting the prediction of inclusive fitness theory.	[Hughes, William O. H.] Univ Leeds, Inst Integrat & Comparat Biol, Leeds LS2 9JT, W Yorkshire, England; [Oldroyd, Benjamin P.; Beekman, Madeleine] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Ratnieks, Francis L. W.] Univ Sussex, Dept Biol & Environm Sci, Brighton BN1 9QG, E Sussex, England	University of Leeds; University of Sydney; University of Sussex	Hughes, WOH (corresponding author), Univ Leeds, Inst Integrat & Comparat Biol, Leeds LS2 9JT, W Yorkshire, England.	w.o.h.hughes@leeds.ac.uk	Beekman, Madeleine/A-3983-2011; Oldroyd, Benjamin/A-4800-2008; Hughes, William OH/A-6957-2014; Beekman, Madeleine/AAF-8574-2019	Beekman, Madeleine/0000-0002-9040-3756; Oldroyd, Benjamin/0000-0001-6831-3677; Hughes, William OH/0000-0003-0951-9768; Beekman, Madeleine/0000-0002-9040-3756				Beekman M, 2006, BEHAV ECOL, V17, P622, DOI 10.1093/beheco/ark006; Boomsma JJ, 2007, CURR BIOL, V17, pR673, DOI 10.1016/j.cub.2007.06.033; Brady SG, 2006, P ROY SOC B-BIOL SCI, V273, P1643, DOI 10.1098/rspb.2006.3496; Burland TM, 2002, P ROY SOC B-BIOL SCI, V269, P1025, DOI 10.1098/rspb.2002.1978; Chapman TW, 2000, P NATL ACAD SCI USA, V97, P1648, DOI 10.1073/pnas.020510097; CRESPI BJ, 1995, BEHAV ECOL, V6, P109, DOI 10.1093/beheco/6.1.109; Crozier RH, 2008, AUST J ENTOMOL, V47, P2, DOI 10.1111/j.1440-6055.2007.00621.x; Duffy JE, 2002, GENES BEHAV EVOLUTIO, V217, P254; Field J, 2000, NATURE, V404, P869, DOI 10.1038/35009097; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Helantera H, 2007, OIKOS, V116, P217, DOI 10.1111/j.0030-1299.2007.15411.x; Hines HM, 2007, P NATL ACAD SCI USA, V104, P3295, DOI 10.1073/pnas.0610140104; HUGHES WOH, 2008, J EVOLUTION BIOL, DOI DOI 10.1111/J.14202008.01532.X; KIRKENDALL LR, 1997, EVOLUTION SOCIAL BEH; MATTHEWS RW, 1968, SCIENCE, V160, P787, DOI 10.1126/science.160.3829.787; Queller DC, 1998, BIOSCIENCE, V48, P165, DOI 10.2307/1313262; REEVE HK, 1990, P NATL ACAD SCI USA, V87, P2496, DOI 10.1073/pnas.87.7.2496; ROSS KG, 1989, ANIM BEHAV, V38, P613, DOI 10.1016/S0003-3472(89)80006-5; Schwarz MP, 2003, SYST BIOL, V52, P1, DOI 10.1080/10635150390132632; Strassmann J, 2001, INSECT SOC, V48, P1, DOI 10.1007/PL00001737; Sumner S, 2004, NATURE, V428, P35, DOI 10.1038/428035a; Sumner S, 2007, CURR BIOL, V17, P140, DOI 10.1016/j.cub.2006.11.064; Tarpy DR, 2004, INSECT SOC, V51, P203, DOI 10.1007/s00040-004-0734-4; Thompson GJ, 2004, MOL PHYLOGENET EVOL, V33, P452, DOI 10.1016/j.ympev.2004.06.016; Wilson E.O., 1975, P1; Wilson EO, 2008, BIOSCIENCE, V58, P17, DOI 10.1641/B580106; Wilson EO, 2005, SOC RES, V72, P159; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102	28	447	456	2	567	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2008	320	5880					1213	1216		10.1126/science.1156108	http://dx.doi.org/10.1126/science.1156108			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306FF	18511689				2022-12-24	WOS:000256233000038
J	Anderson, JS; Reisz, RR; Scott, D; Frobisch, NB; Sumida, SS				Anderson, Jason S.; Reisz, Robert R.; Scott, Diane; Frobisch, Nadia B.; Sumida, Stuart S.			A stem batrachian from the Early Permian of Texas and the origin of frogs and salamanders	NATURE			English	Article							PHYLOGENY; ANCESTRY	The origin of extant amphibians (Lissamphibia: frogs, salamanders and caecilians) is one of the most controversial questions in vertebrate evolution, owing to large morphological and temporal gaps in the fossil record(1-3). Current discussions focus on three competing hypotheses: a monophyletic origin within either Temnospondyli(4-7) or Lepospondyli(8-10), or a polyphyletic origin with frogs and salamanders arising among temnospondyls and caecilians among the lepospondyls(11-16). Recent molecular analyses are also controversial, with estimations for the batrachian (frog salamander) divergence significantly older than the palaeontological evidence supports(17,18). Here we report the discovery of an amphibamid temnospondyl from the Early Permian of Texas that bridges the gap between other Palaeozoic amphibians and the earliest known salientians(19,20) and caudatans(21) from the Mesozoic. The presence of a mosaic of salientian and caudatan characters in this small fossil makes it a key taxon close to the batrachian (frog and salamander) divergence. Phylogenetic analysis suggests that the batrachian divergence occurred in the Middle Permian, rather than the late Carboniferous as recently estimated using molecular clocks(18,22), but the divergence with caecilians corresponds to the deep split between temnospondyls and lepospondyls, which is congruent with themolecular estimates.	[Anderson, Jason S.] Univ Calgary, Dept Comparat Biol & Expt Med, Fac Vet Med, Calgary, AB T2N 4N1, Canada; [Reisz, Robert R.; Scott, Diane] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Frobisch, Nadia B.] McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada; [Sumida, Stuart S.] Calif State Univ San Bernardino, Dept Biol, San Bernardino, CA 92407 USA	University of Calgary; University of Toronto; University Toronto Mississauga; McGill University; California State University System; California State University San Bernardino	Anderson, JS (corresponding author), Univ Calgary, Dept Comparat Biol & Expt Med, Fac Vet Med, 3330 Hosp Dr, Calgary, AB T2N 4N1, Canada.	janders@ucalgary.ca						Anderson Jason S., 2007, P182; Anderson JS, 2008, J VERTEBR PALEONTOL, V28, P61, DOI 10.1671/0272-4634(2008)28[61:GCANGA]2.0.CO;2; Anderson JS, 2001, SYST BIOL, V50, P170; [Anonymous], 2004, RECENT ADV ORIGIN EA; Bolt J.R., 1991, P194; Carroll R, 2004, NEUES JAHRB GEOL P-A, V232, P157; CARROLL RL, 1975, ZOOL J LINN SOC-LOND, V57, P229, DOI 10.1111/j.1096-3642.1975.tb00817.x; Carroll RL, 2007, ZOOL J LINN SOC-LOND, V150, P1, DOI 10.1111/j.1096-3642.2007.00246.x; Carroll Robert L., 2000, Amphibian Biology, V4, P1402; Duellman WE., 1994, BIOL AMPHIBIANS; Frobisch NB, 2007, EVOL DEV, V9, P69; Gao KQ, 2003, NATURE, V422, P424, DOI 10.1038/nature01491; Ivachnenko M, 1978, PALEONTOL J, V1978, P362; Laurin M, 1998, ANN SCI NAT ZOOL, V19, P1, DOI 10.1016/S0003-4339(98)80132-9; Laurin Michel, 1997, P9, DOI 10.1016/B978-012676460-4/50003-2; Lee MSY, 2006, MOL PHYLOGENET EVOL, V40, P635, DOI 10.1016/j.ympev.2006.03.013; Milner Andrew R., 1993, Herpetological Monographs, V7, P8, DOI 10.2307/1466948; MILNER AR, 1988, PHYLOGENY CLASSIFICA, V1, P59; Piveteau J., 1937, ANN PALEONTOL, V26, P135; RAGE JC, 1989, Z PALAEONTOGRAPHIC A, V206, P1; Ruta M, 2003, BIOL REV, V78, P251, DOI 10.1017/S1464793102006103; Ruta M, 2007, J SYST PALAEONTOL, V5, P69, DOI 10.1017/S1477201906002008; San Mauro D, 2005, AM NAT, V165, P590, DOI 10.1086/429523; San Mauro D, 2004, MOL PHYLOGENET EVOL, V33, P413, DOI 10.1016/j.ympev.2004.05.014; Shubin Neil H., 2003, Amphibian Biology, V5, P1782; Trueb L, 1991, ORIGINS HIGHER GROUP, P174; Trueb Linda, 1993, P255; Vallin G, 2004, J VERTEBR PALEONTOL, V24, P56, DOI 10.1671/5.1; Wang Y, 2004, CHINESE SCI BULL, V49, P858, DOI 10.1360/03wd0115; Zhang P, 2005, SYST BIOL, V54, P391, DOI 10.1080/10635150590945278	30	155	161	2	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2008	453	7194					515	518		10.1038/nature06865	http://dx.doi.org/10.1038/nature06865			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303EL	18497824				2022-12-24	WOS:000256023700041
J	Holvoet, P; Lee, DH; Steffes, M; Gross, M; Jacobs, DR				Holvoet, Paul; Lee, Duk-Hee; Steffes, Michael; Gross, Myron; Jacobs, David R., Jr.			Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEART-DISEASE; RISK-FACTORS; LDL; PLASMA; HEALTH; MEN; ATHEROSCLEROSIS; COMPLICATIONS; ADIPOGENESIS; MORTALITY	Context Experimental data support the hypothesis that oxidized low-density lipoprotein (LDL) is associated with the metabolic syndrome. However, this hypothesis has not been tested in humans. Objective To establish the relation of oxidized LDL with metabolic syndrome in the general community. Design, Setting, and Participants The Coronary Artery Risk Development in Young Adults (CARDIA) study is a population-based, prospective, observational study. We studied 1889 participants who were between the ages of 18 and 30 years at the time of recruitment in 1985 and 1986 and living in 1 of 4 US metropolitan areas (41% African American; 56% women) and were seen both at year 15 (2000-2001, ages 33-45 years) and year 20 examinations (2005-2006). Main Outcome Measure The longitudinal association of oxidized LDL and incident metabolic syndrome. Oxidized LDL was measured with a monoclonal antibody-based enzyme-linked immunosorbent assay. The metabolic syndrome was defined according to the Adult Treatment Panel III of the National Cholesterol Education Program. Results Incident metabolic syndrome was diagnosed at the year 20 follow-up in 12.9% (243 of 1889) of participants who did not have metabolic syndrome at the 15-year follow-up. The odds ratios (ORs) for incident metabolic syndrome after 5 years' follow-up and adjusted for age, sex, race, study center, cigarette smoking, body mass index, physical activity, and LDL cholesterol levels by quintiles of oxidized LDL were 2.1 (95% confidence interval [CI], 1.1-3.8) for the second quintile (55.4-69.1 U/L); 2.4 (95% CI, 1.3-4.3) for the third quintile (69.2-81.2 U/L); 2.8 (95% CI, 1.5-5.1) for the fourth quintile (81.3-97.3 U/L); and 3.5 (95% CI, 1.9-6.6) for the fifth quintile (>= 97.4U/L). The adjusted ORs for incidence of dichotomous components of metabolic syndrome in the highest vs the lowest quintile of oxidized LDL were 2.1 (95% CI, 1.2-3.6) for abdominal obesity, 2.4 (95% CI, 1.5-3.8) for high fasting glucose, and 2.1 (95% CI, 1.1-4.0) for high triglycerides. Low-density lipoprotein cholesterol was not associated with incident metabolic syndrome or with any of its components in the fully adjusted model containing oxidized LDL. Conclusion Higher concentration of oxidized LDL was associated with increased incidence of metabolic syndrome overall, as well as its components of abdominal obesity, hyperglycemia, and hypertriglyceridemia.	[Lee, Duk-Hee; Jacobs, David R., Jr.] Univ Minnesota, Div Epidemiol & Community Hlth, Sch Publ Hlth, Minneapolis, MN 55454 USA; [Steffes, Michael; Gross, Myron] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55454 USA; [Holvoet, Paul] Katholieke Univ Leuven, Atherosclerosis & Metab Unit, Louvain, Belgium; [Lee, Duk-Hee] Kyungpook Natl Univ, Dept Prevent Med, Sch Med, Taegu, South Korea; [Jacobs, David R., Jr.] Univ Oslo, Dept Nutr, Oslo, Norway	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; KU Leuven; Kyungpook National University; University of Oslo	Jacobs, DR (corresponding author), Univ Minnesota, Div Epidemiol & Community Hlth, Sch Publ Hlth, 1300 S 2nd St,Ste 300, Minneapolis, MN 55454 USA.	jacob004@umn.edu	HOLVOET, PAUL/T-8434-2017	HOLVOET, PAUL/0000-0001-9201-0772; Jacobs, David/0000-0002-7232-0543	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048050, N01HC048048, N01HC048047, N01HC048049] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL048048, R01HL048050, R01HL048048, R01HL053560, R01HL048049] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL053560, N01-HC-48050, N01HC95095, 1R01-HL53560, N01-HC-48049, N01HC48050, N01-HC-48048, N01HC48048, N01-HC-48047, N01HC48049, N01HC48047, R01 HL053560-05] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AVOGARO P, 1988, ARTERIOSCLEROSIS, V8, P79, DOI 10.1161/01.ATV.8.1.79; Chen NG, 2000, ATHEROSCLEROSIS, V152, P203, DOI 10.1016/S0021-9150(99)00460-8; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z; Cutter G R, 1991, Control Clin Trials, V12, p1S, DOI 10.1016/0197-2456(91)90002-4; Ehara S, 2001, CIRCULATION, V103, P1955, DOI 10.1161/01.cir.103.15.1955; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Holvoet P, 2006, CLIN CHEM, V52, P760, DOI 10.1373/clinchem.2005.064337; Holvoet P, 1998, CIRCULATION, V98, P1487, DOI 10.1161/01.CIR.98.15.1487; Holvoet P, 2004, DIABETES, V53, P1068, DOI 10.2337/diabetes.53.4.1068; Holvoet P, 2003, ARTERIOSCL THROM VAS, V23, P1444, DOI 10.1161/01.ATV.0000080379.05071.22; Holvoet P, 2001, ARTERIOSCL THROM VAS, V21, P844, DOI 10.1161/01.ATV.21.5.844; Holvoet P, 1998, ARTERIOSCL THROM VAS, V18, P100, DOI 10.1161/01.ATV.18.1.100; Holvoet P, 2007, ATHEROSCLEROSIS, V194, P245, DOI 10.1016/j.atherosclerosis.2006.08.002; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Isomaa B, 2001, DIABETOLOGIA, V44, P1148, DOI 10.1007/s001250100615; Jacobs David R Jr, 1989, J Cardiopulm Rehabil, V9, P448, DOI 10.1097/00008483-198911000-00003; Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907; Lamarche B, 1998, CORONARY ARTERY DIS, V9, P473, DOI 10.1097/00019501-199809080-00002; Lapointe A, 2007, ATHEROSCLEROSIS, V191, P362, DOI 10.1016/j.atherosclerosis.2006.03.036; Lindblad U, 2001, AM J EPIDEMIOL, V153, P481, DOI 10.1093/aje/153.5.481; Macy EM, 1997, CLIN CHEM, V43, P52; Maddux BA, 2001, DIABETES, V50, P404, DOI 10.2337/diabetes.50.2.404; Masella R, 2006, FEBS LETT, V580, P2421, DOI 10.1016/j.febslet.2006.03.068; Maziere C, 2004, ATHEROSCLEROSIS, V175, P23, DOI 10.1016/j.atherosclerosis.2004.02.006; National cholesterol education program National heart lung and blood institute National institutes of health, 2002, 3 REP NAT CHOL ED PR; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Shepherd J, 2001, CURR OPIN LIPIDOL, V12, P601, DOI 10.1097/00041433-200112000-00002; Shoji T, 2000, ATHEROSCLEROSIS, V148, P171, DOI 10.1016/S0021-9150(99)00218-X; Sigurdardottir V, 2002, J INTERN MED, V252, P440, DOI 10.1046/j.1365-2796.2002.01054.x; Trevisan M, 1998, AM J EPIDEMIOL, V148, P958; Tsimikas S, 2003, J AM COLL CARDIOL, V41, P360, DOI 10.1016/S0735-1097(02)02769-9; VANBERKEL TJC, 1991, J BIOL CHEM, V266, P2282; Verreth W, 2004, CIRCULATION, V110, P3259, DOI 10.1161/01.CIR.0000147614.85888.7A; Weinbrenner T, 2006, AM J CLIN NUTR, V83, P30; Yamagishi S, 2007, INT J CARDIOL, V118, P270, DOI 10.1016/j.ijcard.2006.06.058	38	239	265	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2008	299	19					2287	2293		10.1001/jama.299.19.2287	http://dx.doi.org/10.1001/jama.299.19.2287			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302QN	18492970	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000255984500023
J	Boeger, H; Griesenbeck, J; Kornberg, RD				Boeger, Hinrich; Griesenbeck, Joachim; Kornberg, Roger D.			Nucleosome retention and the stochastic nature of promoter chromatin remodeling for transcription	CELL			English	Article							PHO5 PROMOTER; HISTONE ACETYLATION; DNA TRANSLOCATION; PH05 PROMOTER; IN-VIVO; YEAST; SWI/SNF; ACTIVATION; COMPLEX; REPLICATION	The rate-limiting step of transcriptional activation in eukaryotes, and thus the critical point for gene regulation, is unknown. Combining biochemical analyses of the chromatin transition at the transcriptionally induced PHO5 promoter in yeast with modeling based on a small number of simple assumptions, we demonstrate that random removal and reformation of promoter nucleosomes can account for stochastic and kinetic properties of PHO5 expression. Our analysis suggests that the disassembly of promoter nucleosomes is rate limiting for PHO5 expression, and supports a model for the underlying mechanism of promoter chromatin remodeling, which appears to conserve a single nucleosome on the promoter at all times.	[Boeger, Hinrich] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Griesenbeck, Joachim] Univ Regensburg, Lehrstuhl Biochem III, D-93080 Regensburg, Germany; [Kornberg, Roger D.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	University of California System; University of California Santa Cruz; University of Regensburg; Stanford University	Boeger, H (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	boeger@biology.ucsc.edu		Griesenbeck, Joachim/0000-0002-7817-6095	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036659, R01GM078111, R37GM036659] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM078111-02, R01 GM036659, GM078111-01, R01 GM078111, GM36659, R37 GM036659] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Barbaric S, 2003, MOL CELL BIOL, V23, P3468, DOI 10.1128/MCB.23.10.3468-3476.2003; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boeger H, 2004, MOL CELL, V14, P667, DOI 10.1016/j.molcel.2004.05.013; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Chandy M, 2006, EUKARYOT CELL, V5, P1738, DOI 10.1128/EC.00165-06; Corona DFV, 2002, EMBO REP, V3, P242, DOI 10.1093/embo-reports/kvf056; Cote J, 1998, P NATL ACAD SCI USA, V95, P4947, DOI 10.1073/pnas.95.9.4947; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Feller W., 1957, INTRO PROBABILITY TH, VI; Ferreira H, 2007, J MOL BIOL, V374, P563, DOI 10.1016/j.jmb.2007.09.059; Flaus A, 2003, MOL CELL BIOL, V23, P7767, DOI 10.1128/MCB.23.21.7767-7779.2003; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gregory PD, 1998, MOL CELL, V1, P495, DOI 10.1016/S1097-2765(00)80050-7; Griesenbeck J, 2004, METHOD ENZYMOL, V375, P170; Griesenbeck J, 2003, MOL CELL BIOL, V23, P9275, DOI 10.1128/MCB.23.24.9275-9282.2003; Grimmett G. R., 2001, PROBABILITY RANDOM P; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Jaskelioff M, 2000, MOL CELL BIOL, V20, P3058, DOI 10.1128/MCB.20.9.3058-3068.2000; Jessen WJ, 2006, NAT STRUCT MOL BIOL, V13, P256, DOI 10.1038/nsmb1062; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Kaffman A, 1998, GENE DEV, V12, P2673, DOI 10.1101/gad.12.17.2673; KAFFMAN A, 1994, SCIENCE, V263, P1153, DOI 10.1126/science.8108735; Kassabov SR, 2003, MOL CELL, V11, P391, DOI 10.1016/S1097-2765(03)00039-X; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; Lorch Y, 2006, P NATL ACAD SCI USA, V103, P3090, DOI 10.1073/pnas.0511050103; McAndrew PC, 1998, MOL CELL BIOL, V18, P5818, DOI 10.1128/MCB.18.10.5818; Nourani A, 2004, EMBO J, V23, P2597, DOI 10.1038/sj.emboj.7600230; PARANJAPE SM, 1994, ANNU REV BIOCHEM, V63, P265, DOI 10.1146/annurev.biochem.63.1.265; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Pollard KJ, 1998, BIOESSAYS, V20, P771, DOI 10.1002/(SICI)1521-1878(199809)20:9<771::AID-BIES10>3.0.CO;2-V; PRUNELL A, 1977, COLD SPRING HARB SYM, V42, P103, DOI 10.1101/SQB.1978.042.01.011; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Saha A, 2005, NAT STRUCT MOL BIOL, V12, P747, DOI 10.1038/nsmb973; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; Svaren J, 1997, TRENDS BIOCHEM SCI, V22, P93, DOI 10.1016/S0968-0004(97)01001-3; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Thomas MR, 2005, P NATL ACAD SCI USA, V102, P9565, DOI 10.1073/pnas.0501122102; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; VENTER U, 1994, EMBO J, V13, P4848, DOI 10.1002/j.1460-2075.1994.tb06811.x; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Wykoff DD, 2007, MOL CELL, V27, P1005, DOI 10.1016/j.molcel.2007.07.022; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025	54	131	133	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 16	2008	133	4					716	726		10.1016/j.cell.2008.02.051	http://dx.doi.org/10.1016/j.cell.2008.02.051			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485878	Bronze, Green Accepted			2022-12-24	WOS:000255903300025
J	Pesaran, B; Nelson, MJ; Andersen, RA				Pesaran, Bijan; Nelson, Matthew J.; Andersen, Richard A.			Free choice activates a decision circuit between frontal and parietal cortex	NATURE			English	Article							NEURONAL-ACTIVITY; PREMOTOR; SYNCHRONIZATION; REPRESENTATION; PERFORMANCE; POTENTIALS; COHERENCE; ATTENTION; SELECTION; DIRECTION	We often face alternatives that we are free to choose between. Planning movements to select an alternative involves several areas in frontal and parietal cortex(1-11) that are anatomically connected into long-range circuits(12). These areas must coordinate their activity to select a common movement goal, but how neural circuits make decisions remains poorly understood. Here we simultaneously record from the dorsal premotor area (PMd) in frontal cortex and the parietal reach region (PRR) in parietal cortex to investigate neural circuit mechanisms for decision making. We find that correlations in spike and local field potential (LFP) activity between these areas are greater when monkeys are freely making choices than when they are following instructions. We propose that a decision circuit featuring a sub-population of cells in frontal and parietal cortex may exchange information to coordinate activity between these areas. Cells participating in this decision circuit may influence movement choices by providing a common bias to the selection of movement goals.	[Pesaran, Bijan] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Nelson, Matthew J.; Andersen, Richard A.] CALTECH, Computat & Neural Syst Program, Pasadena, CA 91125 USA; [Pesaran, Bijan; Andersen, Richard A.] CALTECH, Div Biol, Pasadena, CA 91125 USA	New York University; California Institute of Technology; California Institute of Technology	Pesaran, B (corresponding author), NYU, Ctr Neural Sci, 550 1St Ave, New York, NY 10003 USA.	bijan@nyu.edu	Nelson, Matthew/K-6635-2018	Nelson, Matthew/0000-0002-2325-4578; Pesaran, Bijan/0000-0003-4116-0038	NEI NIH HHS [R01 EY007492, R01 EY007492-19] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007492] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; BRESSLER SL, 1993, NATURE, V366, P153, DOI 10.1038/366153a0; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Cisek P, 2006, J NEUROSCI, V26, P9761, DOI 10.1523/JNEUROSCI.5605-05.2006; Daw ND, 2006, CURR OPIN NEUROBIOL, V16, P199, DOI 10.1016/j.conb.2006.03.006; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Gail A, 2006, J NEUROSCI, V26, P9376, DOI 10.1523/JNEUROSCI.1570-06.2006; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; GOLDBERG G, 1985, BEHAV BRAIN SCI, V8, P567, DOI 10.1017/S0140525X00045167; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; Johnson PB, 1996, CEREB CORTEX, V6, P102, DOI 10.1093/cercor/6.2.102; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; KREPS DM, 1990, MICROECONOMIC THEORY, pCH2; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3968, DOI 10.1152/jn.1996.76.6.3968; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Pesaran B, 2006, NEURON, V51, P125, DOI 10.1016/j.neuron.2006.05.025; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Quiroga RQ, 2006, J NEUROSCI, V26, P3615, DOI 10.1523/JNEUROSCI.3468-05.2006; Rickert J, 2005, J NEUROSCI, V25, P8815, DOI 10.1523/JNEUROSCI.0816-05.2005; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; ROMO R, 1987, EXP BRAIN RES, V67, P656; Scherberger H, 2005, NEURON, V46, P347, DOI 10.1016/j.neuron.2005.03.004; Scherberger H, 2007, J NEUROSCI, V27, P2001, DOI 10.1523/JNEUROSCI.4274-06.2007; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852	30	310	314	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 15	2008	453	7193					406	U61		10.1038/nature06849	http://dx.doi.org/10.1038/nature06849			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18418380	Green Accepted			2022-12-24	WOS:000255868400055
J	Lister, R; O'Malley, RC; Tonti-Filippini, J; Gregory, BD; Berry, CC; Millar, AH; Ecker, JR				Lister, Ryan; O'Malley, Ronan C.; Tonti-Filippini, Julian; Gregory, Brian D.; Berry, Charles C.; Millar, A. Harvey; Ecker, Joseph R.			Highly integrated single-base resolution maps of the epigenome in Arabidopsis	CELL			English	Article							DIRECTED DNA METHYLATION; CYTOSINE METHYLTRANSFERASE; EPIGENETIC INHERITANCE; CG METHYLATION; DE-NOVO; GENOME; THALIANA; GLYCOSYLASE/LYASE; MAINTENANCE; ARGONAUTE4	Deciphering the multiple layers of epigenetic regulation that control transcription is critical to understanding how plants develop and respond to their environment. Using sequencing-by-synthesis technology we directly sequenced the cytosine methylome (methylC-seq), transcriptome (mRNA-seq), and small RNA transcriptome (smRNA-seq) to generate highly integrated epigenome maps for wild-type Arabidopsis thaliana and mutants defective in DNA methyltransferase or demethylase activity. At singlebase resolution we discovered extensive, previously undetected DNA methylation, identified the context and level of methylation at each site, and observed local sequence effects upon methylation state. Deep sequencing of smRNAs revealed a direct relationship between the location of smRNAs and DNA methylation, perturbation of smRNA biogenesis upon loss of CpG DNA methylation, and a tendency for smRNAs to direct strand-specific DNA methylation in regions of RNA-DNA homology. Finally, strandspecific mRNA-seq revealed altered transcript abundance of hundreds of genes, transposons, and unannotated intergenic transcripts upon modification of the DNA methylation state.	[Lister, Ryan; O'Malley, Ronan C.; Gregory, Brian D.; Ecker, Joseph R.] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Lister, Ryan; O'Malley, Ronan C.; Gregory, Brian D.; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Berry, Charles C.] Univ Calif San Diego, Dept Family Prevent Med, La Jolla, CA 92093 USA; [Millar, A. Harvey] Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, Crawley, WA 6009, Australia	Salk Institute; Salk Institute; University of California System; University of California San Diego; University of Western Australia	Ecker, JR (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ecker@salk.edu	Gregory, Brian D/G-2890-2010; jia, xu/A-8386-2016; Lister, Ryan/B-5168-2012; Tonti-Filippini, Julian S/L-8020-2018; Ecker, Joseph R/B-9144-2008; Millar, A. Harvey/A-5452-2008	Lister, Ryan/0000-0001-6637-7239; Tonti-Filippini, Julian S/0000-0003-3464-0770; Ecker, Joseph R/0000-0001-5799-5895; Millar, A. Harvey/0000-0001-9679-1473; omalley, ronan/0000-0002-4907-0339	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003523] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG003523, R01 HG003523-01, R01 HG003523-03, R01 HG003523-02] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Aufsatz W, 2004, PLANT MOL BIOL, V54, P793, DOI 10.1007/s11103-004-0179-1; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Chan SWL, 2006, PLOS GENET, V2, P791, DOI 10.1371/journal.pgen.0020083; FINNEGAN EJ, 1993, NUCLEIC ACIDS RES, V21, P2383, DOI 10.1093/nar/21.10.2383; Fojtova M, 2001, PLANT SCI, V160, P585, DOI 10.1016/S0168-9452(00)00411-8; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Kankel MW, 2003, GENETICS, V163, P1109; Kato M, 2003, CURR BIOL, V13, P421, DOI 10.1016/S0960-9822(03)00106-4; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Matzke M, 2007, CURR OPIN PLANT BIOL, V10, P512, DOI 10.1016/j.pbi.2007.06.007; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Tompa R, 2002, CURR BIOL, V12, P65, DOI 10.1016/S0960-9822(01)00622-4; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Yu ZH, 2000, GENETICS, V156, P2019; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	33	1692	1765	7	266	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 2	2008	133	3					523	536		10.1016/j.cell.2008.03.029	http://dx.doi.org/10.1016/j.cell.2008.03.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18423832	Green Accepted, Bronze			2022-12-24	WOS:000255503900022
J	Tang, HB; Bowers, JE; Wang, XY; Ming, R; Alam, M; Paterson, AH				Tang, Haibao; Bowers, John E.; Wang, Xiyin; Ming, Ray; Alam, Maqsudul; Paterson, Andrew H.			Perspective - Synteny and collinearity in plant genomes	SCIENCE			English	Editorial Material							DUPLICATION; EVOLUTION; SEQUENCE; SORGHUM; GENE; SACCHAROMYCES; RECOMBINATION; CONSERVATION; ARABIDOPSIS; EVENTS	Correlated gene arrangements among taxa provide a valuable framework for inference of shared ancestry of genes and for the utilization of findings from model organisms to study less- well- understood systems. In angiosperms, comparisons of gene arrangements are complicated by recurring polyploidy and extensive genome rearrangement. New genome sequences and improved analytical approaches are clarifying angiosperm evolution and revealing patterns of differential gene loss after genome duplication and differential gene retention associated with evolution of some morphological complexity. Because of variability in DNA substitution rates among taxa and genes, deviation from collinearity might be a more reliable phylogenetic character.	[Tang, Haibao; Bowers, John E.; Wang, Xiyin; Paterson, Andrew H.] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; [Ming, Ray] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Alam, Maqsudul] Univ Hawaii, Adv Studies Genom Proteom & Bioinformat Unit, Honolulu, HI 96822 USA	University System of Georgia; University of Georgia; University of Illinois System; University of Illinois Urbana-Champaign; University of Hawaii System	Paterson, AH (corresponding author), Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA.	paterson@uga.edu	Bowers, John/B-9245-2009; Bowers, John/AAD-7601-2019; Tang, Haibao/A-6715-2011	Bowers, John/0000-0001-8984-9796; Tang, Haibao/0000-0002-3460-8570; Bowers, John/0000-0001-5693-2796				BENNETT MD, 1991, PHILOS T R SOC B, V334, P309, DOI 10.1098/rstb.1991.0120; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Bowers JE, 2005, P NATL ACAD SCI USA, V102, P13206, DOI 10.1073/pnas.0502365102; Bowers JE, 2003, GENETICS, V165, P367; Coghlan A, 2005, TRENDS GENET, V21, P673, DOI 10.1016/j.tig.2005.09.009; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; Ferguson-Smith MA, 2007, NAT REV GENET, V8, P950, DOI 10.1038/nrg2199; Freeling M, 2006, GENOME RES, V16, P805, DOI 10.1101/gr.3681406; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; MING R, IN PRESS NATURE; Mower JP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-135; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Nam J, 2003, MOL BIOL EVOL, V20, P1435, DOI 10.1093/molbev/msg152; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Paterson AH, 2006, TRENDS GENET, V22, P597, DOI 10.1016/j.tig.2006.09.003; Rokas A, 2000, TRENDS ECOL EVOL, V15, P454, DOI 10.1016/S0169-5347(00)01967-4; Soltis D, 2005, PHYLOGENY EVOLUTION; Spangler R, 1999, SYST BOT, V24, P267, DOI 10.2307/2419552; Swigonova Z, 2004, GENOME RES, V14, P1916, DOI 10.1101/gr.2332504; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Van de Peer Y, 2004, NAT REV GENET, V5, P752, DOI 10.1038/nrg1449; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Yogeeswaran K, 2005, GENOME RES, V15, P505, DOI 10.1101/gr.3436305	26	682	714	13	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2008	320	5875					486	488		10.1126/science.1153917	http://dx.doi.org/10.1126/science.1153917			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436778				2022-12-24	WOS:000255249300037
J	Steffen, KK; MacKay, VL; Kerr, EO; Tsuchiya, M; Hu, D; Fox, LA; Dang, N; Johnston, ED; Oakes, JA; Tchao, BN; Pak, DN; Fields, S; Kennedy, BK; Kaeberlein, M				Steffen, Kristan K.; MacKay, Vivian L.; Kerr, Emily O.; Tsuchiya, Mitsuhiro; Hu, Di; Fox, Lindsay A.; Dang, Nick; Johnston, Elijah D.; Oakes, Jonathan A.; Tchao, Bie N.; Pak, Diana N.; Fields, Stanley; Kennedy, Brian K.; Kaeberlein, Matt			Yeast life span extension by depletion of 60S ribosomal subunits is mediated by Gcn4	CELL			English	Article							OPEN READING FRAMES; TOR-SIGNALING PATHWAY; GENE-EXPRESSION; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-CHARACTERIZATION; TRANSLATIONAL REGULATION; CALORIE RESTRICTION; PROTEIN-SYNTHESIS; STRESS-RESPONSE	In nearly every organism studied, reduced caloric intake extends life span. In yeast, span extension from dietary restriction is thought to be mediated by the highly conserved, nutrient-responsive target of rapamycin (TOR), protein kinase A (PKA), and Sch9 kinases. These kinases coordinately regulate various cellular processes including stress responses, protein turnover, cell growth, and ribosome biogenesis. Here we show that a specific reduction of 60S ribosomal subunit levels slows aging in yeast. Deletion of genes encoding 60S subunit proteins or processing factors or treatment with a small molecule, which all inhibit 60S subunit biogenesis, are each sufficient to significantly increase replicative life span. One mechanism by which reduced 60S subunit levels leads to life span extension is through induction of Gcn4, a nutrient-responsive transcription factor. Genetic epistasis analyses suggest that dietary restriction, reduced 60S subunit abundance, and Gcn4 activation extend yeast life span by similar mechanisms.	[Steffen, Kristan K.; MacKay, Vivian L.; Kerr, Emily O.; Tsuchiya, Mitsuhiro; Hu, Di; Fox, Lindsay A.; Dang, Nick; Johnston, Elijah D.; Oakes, Jonathan A.; Tchao, Bie N.; Pak, Diana N.; Kennedy, Brian K.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Fields, Stanley] Univ Washington, Dept Genom Sci & Med, Seattle, WA 98195 USA; [Fields, Stanley] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Kaeberlein, Matt] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kennedy, BK (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	bkenn@u.washington.edu; kaeber@u.washington.edu	Pak, Diana/GWZ-8091-2022	Kennedy, Brian/0000-0002-5754-1874; Kaeberlein, Matt/0000-0002-1311-3421	Howard Hughes Medical Institute Funding Source: Medline; NIA NIH HHS [R01 AG025549-03, P50 AG005136, R01 AG025549, P30 AG013280, R01 AG024287, P50 AG005136-25] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P50AG005136, R01AG024287, P30AG013280, R01AG025549] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baldock C, 1998, BIOCHEM PHARMACOL, V55, P1541; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Carey J. R., 2003, LONGEVITY BIOL DEMOG, DOI [10.1515/9780691224084, DOI 10.1515/9780691224084]; Chen D, 2007, AGING CELL, V6, P525, DOI 10.1111/j.1474-9726.2007.00305.x; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Chiocchetti A, 2007, EXP GERONTOL, V42, P275, DOI 10.1016/j.exger.2006.11.002; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Dilova I, 2002, CURR BIOL, V12, P389, DOI 10.1016/S0960-9822(02)00677-2; Fabrizio P, 2004, FEBS LETT, V557, P136, DOI 10.1016/S0014-5793(03)01462-5; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; FOIANI M, 1991, MOL CELL BIOL, V11, P3203, DOI 10.1128/MCB.11.6.3203; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6; Henderson ST, 2006, J GERONTOL A-BIOL, V61, P444, DOI 10.1093/gerona/61.5.444; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hung NJ, 2006, MOL CELL BIOL, V26, P3718, DOI 10.1128/MCB.26.10.3718-3727.2006; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Jia MH, 2000, PHYSIOL GENOMICS, V3, P83, DOI 10.1152/physiolgenomics.2000.3.2.83; Jiang JC, 2000, FASEB J, V14, P2135; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2005, MECH AGEING DEV, V126, P491, DOI 10.1016/j.mad.2004.10.007; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2006, HDB MODELS HUMAN AGI, P109; Kaeberlein M, 2007, AGING CELL, V6, P731, DOI 10.1111/j.1474-9726.2007.00341.x; Kaeberlein M, 2006, SCIENCE, V312, DOI 10.1126/science.1124608; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Keeling KM, 2004, RNA, V10, P691, DOI 10.1261/rna.5147804; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Kubota H, 2003, J BIOL CHEM, V278, P20457, DOI 10.1074/jbc.C300133200; Lebreton A, 2006, J CELL BIOL, V173, P349, DOI 10.1083/jcb.200510080; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; LUCCHINI G, 1984, MOL CELL BIOL, V4, P1326, DOI 10.1128/MCB.4.7.1326; MacKay VL, 2004, MOL CELL PROTEOMICS, V3, P478, DOI 10.1074/mcp.M300129-MCP200; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Martin-Marcos P, 2007, MOL CELL BIOL, V27, P5968, DOI 10.1128/MCB.00019-07; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Miyoshi K, 2002, J BIOL CHEM, V277, P18334, DOI 10.1074/jbc.M201667200; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; Mueller PP, 1998, J BIOL CHEM, V273, P32870, DOI 10.1074/jbc.273.49.32870; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Patil CK, 2004, PLOS BIOL, V2, P1208, DOI 10.1371/journal.pbio.0020246; Pertschy B, 2004, MOL CELL BIOL, V24, P6476, DOI 10.1128/MCB.24.14.6476-6487.2004; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Powers T, 2007, CELL METAB, V6, P1, DOI 10.1016/j.cmet.2007.06.009; Salas-Marco J, 2005, J MOL BIOL, V348, P801, DOI 10.1016/j.jmb.2005.03.025; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; TSAY YF, 1988, GENE DEV, V2, P664, DOI 10.1101/gad.2.6.664; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Valenzuela L, 2001, J BACTERIOL, V183, P2331, DOI 10.1128/JB.183.7.2331-2334.2001; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Vilela C, 2003, MOL MICROBIOL, V49, P859, DOI 10.1046/j.1365-2958.2003.03622.x; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; WARNER JR, 1985, MOL CELL BIOL, V5, P1512, DOI 10.1128/MCB.5.6.1512; WEINDRUCH R, 1988, J GERONTOL, V43, pB40, DOI 10.1093/geronj/43.2.B40; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang RJ, 2000, MOL CELL BIOL, V20, P2706, DOI 10.1128/MCB.20.8.2706-2717.2000; Zhang ZH, 2005, CURR GENET, V48, P77, DOI 10.1007/s00294-005-0001-x; Zhao Y, 2003, MOL CELL BIOL, V23, P699, DOI 10.1128/MCB.23.2.699-707.2003	70	336	339	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2008	133	2					292	302		10.1016/j.cell.2008.02.037	http://dx.doi.org/10.1016/j.cell.2008.02.037			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	289JY	18423200	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000255052000018
J	Li, L; Lok, SM; Yu, IM; Zhang, Y; Kuhn, RJ; Chen, J; Rossmann, MG				Li, Long; Lok, Shee-Mei; Yu, I-Mei; Zhang, Ying; Kuhn, Richard J.; Chen, Jue; Rossmann, Michael G.			The flavivirus precursor membrane-envelope protein complex: Structure and maturation	SCIENCE			English	Article							BORNE ENCEPHALITIS-VIRUS; WEST-NILE-VIRUS; DENGUE VIRUS; CRYSTAL-STRUCTURE; E-GLYCOPROTEIN; PRM PROTEIN; PARTICLES; EPITOPES; FUSION; FURIN	Many viruses go through a maturation step in the final stages of assembly before being transmitted to another host. The maturation process of flaviviruses is directed by the proteolytic cleavage of the precursor membrane protein (prM), turning inert virus into infectious particles. We have determined the 2.2 angstrom resolution crystal structure of a recombinant protein in which the dengue virus prM is linked to the envelope glycoprotein E. The structure represents the prM- E heterodimer and fits well into the cryo- electron microscopy density of immature virus at neutral pH. The pr peptide beta-barrel structure covers the fusion loop in E, preventing fusion with host cell membranes. The structure provides a basis for identifying the stages of its pH- directed conformational metamorphosis during maturation, ending with release of pr when budding from the host.	[Li, Long; Lok, Shee-Mei; Yu, I-Mei; Zhang, Ying; Kuhn, Richard J.; Chen, Jue; Rossmann, Michael G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	mr@purdue.edu	Li, Long/F-8892-2010; Lok, Shee-mei/I-7050-2012; Kuhn, Richard/AAR-2722-2021	Kuhn, Richard/0000-0003-4148-1026; Lok, Shee-Mei/0000-0003-4631-8041	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI055672, U54AI057153] Funding Source: NIH RePORTER; NIAID NIH HHS [1-U54-AI-057153, AI055672] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		GUIRAKHOO F, 1992, VIROLOGY, V191, P921, DOI 10.1016/0042-6822(92)90267-S; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lin YJ, 2005, J VIROL, V79, P8535, DOI 10.1128/JVI.79.13.8535-8544.2005; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997; Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019; Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270; Zhang Y, 2007, J VIROL, V81, P6141, DOI 10.1128/JVI.00037-07	17	367	388	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2008	319	5871					1830	1834		10.1126/science.1153263	http://dx.doi.org/10.1126/science.1153263			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279ZF	18369147				2022-12-24	WOS:000254394000048
J	Yang, SH; Cheng, PH; Banta, H; Piotrowska-Nitsche, K; Yang, JJ; Cheng, ECH; Snyder, B; Larkin, K; Liu, J; Orkin, J; Fang, ZH; Smith, Y; Bachevalier, J; Zola, SM; Li, SH; Li, XJ; Chan, AWS				Yang, Shang-Hsun; Cheng, Pei-Hsun; Banta, Heather; Piotrowska-Nitsche, Karolina; Yang, Jin-Jing; Cheng, Eric C. H.; Snyder, Brooke; Larkin, Katherine; Liu, Jun; Orkin, Jack; Fang, Zhi-Hui; Smith, Yoland; Bachevalier, Jocelyne; Zola, Stuart M.; Li, Shi-Hua; Li, Xiao-Jiang; Chan, Anthony W. S.			Towards a transgenic model of Huntington's disease in a non-human primate	NATURE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; GENE; MICE	Non- human primates are valuable for modelling human disorders and for developing therapeutic strategies; however, little work has been reported in establishing transgenic non- human primate models of human diseases. Huntington's disease ( HD) is an autosomal dominant neurodegenerative disorder characterized by motor impairment, cognitive deterioration and psychiatric disturbances followed by death within 10 - 15 years of the onset of the symptoms(1-4). HD is caused by the expansion of cytosine-adenine-guanine ( CAG, translated into glutamine) trinucleotide repeats in the first exon of the human huntingtin ( HTT) gene(5). Mutant HTT with expanded polyglutamine ( polyQ) is widely expressed in the brain and peripheral tissues(2,6), but causes selective neurodegeneration that is most prominent in the striatum and cortex of the brain. Although rodent models of HD have been developed, these models do not satisfactorily parallel the brain changes and behavioural features observed in HD patients. Because of the close physiological(7), neurological and genetic similarities(8,9) between humans and higher primates, monkeys can serve as very useful models for understanding human physiology and diseases(10,11). Here we report our progress in developing a transgenic model of HD in a rhesus macaque that expresses polyglutamine- expanded HTT. Hallmark features of HD, including nuclear inclusions and neuropil aggregates, were observed in the brains of the HD transgenic monkeys. Additionally, the transgenic monkeys showed important clinical features of HD, including dystonia and chorea. A transgenic HD monkey model may open the way to understanding the underlying biology of HD better, and to the development of potential therapies. Moreover, our data suggest that it will be feasible to generate valuable non-human primate models of HD and possibly other human genetic diseases.	[Yang, Shang-Hsun; Cheng, Pei-Hsun; Banta, Heather; Piotrowska-Nitsche, Karolina; Yang, Jin-Jing; Cheng, Eric C. H.; Snyder, Brooke; Larkin, Katherine; Liu, Jun; Orkin, Jack; Smith, Yoland; Bachevalier, Jocelyne; Zola, Stuart M.; Chan, Anthony W. S.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Yang, Shang-Hsun; Cheng, Pei-Hsun; Piotrowska-Nitsche, Karolina; Yang, Jin-Jing; Cheng, Eric C. H.; Snyder, Brooke; Liu, Jun; Fang, Zhi-Hui; Li, Shi-Hua; Li, Xiao-Jiang; Chan, Anthony W. S.] Emory Univ, Dept Human Genet, Atlanta, GA 30329 USA; [Yang, Shang-Hsun; Li, Xiao-Jiang; Chan, Anthony W. S.] Emory Univ, Genet & Mol Biol Program, Atlanta, GA 30329 USA; [Liu, Jun; Smith, Yoland; Zola, Stuart M.; Li, Xiao-Jiang; Chan, Anthony W. S.] Emory Univ, Neurosci Program, Atlanta, GA 30329 USA; [Smith, Yoland] Emory Univ, Dept Neurol, Atlanta, GA 30329 USA; [Bachevalier, Jocelyne] Emory Univ, Dept Psychol, Atlanta, GA 30329 USA; [Bachevalier, Jocelyne; Zola, Stuart M.] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30329 USA; [Piotrowska-Nitsche, Karolina] Polish Acad Sci, Dept Expt Embryol, Inst Genet & Anim Breeding, PL-05552 Wolka Kosowska, Poland; [Zola, Stuart M.] Vet Affairs Med Ctr, Atlanta, GA 30033 USA	Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Chan, AWS (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA.	achan@genetics.emory.edu	Yang, Shang-Hsun/AAV-3763-2020	Yang, Shang-Hsun/0000-0002-1601-3653	NIA NIH HHS [R01 AG019206-07, R01 AG019206] Funding Source: Medline; NIH HHS [R24 OD010930] Funding Source: Medline; NINDS NIH HHS [R01 NS036232, R01 NS041669, R01 NS041669-07, R01 NS036232-09] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036232, R01NS041669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019206] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010930] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bates GP, 1998, BIOCHEM SOC T, V26, P471, DOI 10.1042/bst0260471; Chan AWS, 2001, SCIENCE, V291, P309, DOI 10.1126/science.291.5502.309; CHAN AWS, 2002, TRANSGENIC ANIMAL TE; Cummings CJ, 2000, ANNU REV GENOM HUM G, V1, P281, DOI 10.1146/annurev.genom.1.1.281; Davies S, 2001, J CLIN PATHOL-MOL PA, V54, P409, DOI 10.1136/mp.54.6.409; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Lane MA, 2000, EXP GERONTOL, V35, P533, DOI 10.1016/S0531-5565(00)00102-9; Li H, 2001, J NEUROSCI, V21, P8473, DOI 10.1523/JNEUROSCI.21-21-08473.2001; Li H, 1999, HUM MOL GENET, V8, P1227, DOI 10.1093/hmg/8.7.1227; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; McConkey EH, 2000, SCIENCE, V289, P1295; Myers R.H. M.K., 1998, HUNTINGTONS DIS GENE, P301; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; Yang SH, 2007, GENESIS, V45, P177, DOI 10.1002/dvg.20289; Yu ZX, 2003, J NEUROSCI, V23, P2193; Zhou H, 2003, J CELL BIOL, V163, P109, DOI 10.1083/jcb.200306038	21	341	367	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2008	453	7197					921	U56		10.1038/nature06975	http://dx.doi.org/10.1038/nature06975			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311WV	18488016	Green Accepted			2022-12-24	WOS:000256632000044
J	Potts, M; Halperin, DT; Kirby, D; Swidler, A; Marseille, E; Klausner, JD; Hearst, N; Wamai, RG; Kahn, JG; Walsh, J				Potts, Malcolm; Halperin, Daniel T.; Kirby, Douglas; Swidler, Ann; Marseille, Elliot; Klausner, Jeffrey D.; Hearst, Norman; Wamai, Richard G.; Kahn, James G.; Walsh, Julia			Public health - Reassessing HIV prevention	SCIENCE			English	Editorial Material							MALE CIRCUMCISION; BEHAVIOR-CHANGE; INFECTION; REDUCTION; COUNTRIES		[Halperin, Daniel T.; Wamai, Richard G.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Potts, Malcolm; Walsh, Julia] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Kirby, Douglas] ETR Assoc, Scotts Valley, CA 95066 USA; [Swidler, Ann] Univ Calif Berkeley, Dept Sociol, Berkeley, CA 94720 USA; [Marseille, Elliot; Kahn, James G.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Klausner, Jeffrey D.] San Francisco Dept Publ Hlth, San Francisco, CA 94103 USA; [Hearst, Norman] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; San Francisco Department of Public Health; University of California System; University of California San Francisco	Halperin, DT (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	daniel_halperin@harvard.edu			NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA015612, R01 DA015612-08] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Carter MW, 2007, AIDS BEHAV, V11, P822, DOI 10.1007/s10461-006-9203-6; Cassell MM, 2007, LANCET INFECT DIS, V7, P491, DOI 10.1016/S1473-3099(07)70114-7; Cohen J, 2008, SCIENCE, V319, P888, DOI 10.1126/science.319.5865.888; Corbett EL, 2007, AIDS, V21, P483, DOI 10.1097/QAD.0b013e3280115402; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; EPSTEIN H, 2007, INVISIBLE CURE AFRIC; Gray RH, 2007, LANCET, V370, P200, DOI 10.1016/S0140-6736(07)61058-7; Green EC, 2006, AIDS BEHAV, V10, P335, DOI 10.1007/s10461-006-9073-y; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Halperin DT, 2007, S AFR J HIV MED, P19; Halperin DT, 2004, LANCET, V364, P1913, DOI 10.1016/S0140-6736(04)17487-4; Hearst N, 2004, STUD FAMILY PLANN, V35, P39, DOI 10.1111/j.1728-4465.2004.00004.x; Klausner Jeffrey D, 2008, Futur HIV Ther, V2, P1, DOI 10.2217/17469600.2.1.1; Maman S, 2003, AIDS BEHAV, V7, P373, DOI 10.1023/B:AIBE.0000004729.89102.d4; Mishra V, 2007, AIDS, V21, pS17, DOI 10.1097/01.aids.0000300532.51860.2a; *SDAC, 2006, EXP THINK TANK M HIV; Shelton JD, 2007, LANCET, V370, P1809, DOI 10.1016/S0140-6736(07)61755-3; Shelton JD, 2006, LANCET, V367, P1120, DOI 10.1016/S0140-6736(06)68436-5; Shelton JD, 2004, BMJ-BRIT MED J, V328, P891, DOI 10.1136/bmj.328.7444.891; Spiegel PB, 2007, LANCET, V369, P2187, DOI 10.1016/S0140-6736(07)61015-0; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; *UNAIDS, 2007, UNAIDS PUBL; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; 2007, ECONOMIST       0628, P95	26	159	160	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2008	320	5877					749	750		10.1126/science.1153843	http://dx.doi.org/10.1126/science.1153843			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VB	18467575	Green Accepted			2022-12-24	WOS:000255644400023
J	Kurant, E; Axelrod, S; Leaman, D; Gaul, U				Kurant, Estee; Axelrod, Sofia; Leaman, Dan; Gaul, Ulrike			Six-microns-under acts upstream of draper in the glial phagocytosis of apoptotic neurons	CELL			English	Article							PROGRAMMED CELL-DEATH; CAENORHABDITIS-ELEGANS; HOMOLOGOUS RECOMBINATION; DROSOPHILA METAMORPHOSIS; ENGULFMENT RECEPTOR; SCAVENGER RECEPTOR; CORPSE ENGULFMENT; NERVOUS-SYSTEM; C-ELEGANS; CLEARANCE	The removal of apoptotic cells by phagocytic neighbors is essential for metazoan development but remains poorly characterized. Here we report the discovery of a Drosophila phagocytosis receptor, Six-microns-under (SIMU), which is expressed in highly phagocytic cell types during development and required for efficient apoptotic cell clearance by glia in the nervous system and by macrophages elsewhere. SIMU is part of a conserved family of proteins that includes CED-1 and Draper (DRPR). Phenotypic analysis reveals that simu acts upstream of drpr in the same pathway and affects the recognition and engulfment of apoptotic cells, while drpr affects their subsequent degradation. SIMU strongly binds to apoptotic cells, presumably through its EMILIN-like domain, but requires no membrane anchoring, suggesting that it can function as a bridging molecule. Our study introduces an important factor in tissue-resident apoptotic clearance and underscores the prominent role of glia as "semiprofessional'' phagocytes in the nervous system.	[Kurant, Estee; Axelrod, Sofia; Leaman, Dan; Gaul, Ulrike] Rockefeller Univ, Lab Dev Neurogenet, New York, NY 10065 USA	Rockefeller University	Gaul, U (corresponding author), Rockefeller Univ, Lab Dev Neurogenet, 1230 York Ave, New York, NY 10065 USA.	gaul@mail.rockefeller.edu	Kurant, Estee/ADQ-6246-2022	Kurant, Estee/0000-0003-4795-4074; Axelrod, Sofia/0000-0003-4024-8521	NEI NIH HHS [R01 EY011560-10, R01 EY011560, EY011560] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011560, R55EY011560] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Adachi H, 1997, J BIOL CHEM, V272, P31217, DOI 10.1074/jbc.272.50.31217; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Callebaut I, 2003, BIOCHEM BIOPH RES CO, V300, P619, DOI 10.1016/S0006-291X(02)02904-2; Finn JT, 2000, J NEUROSCI, V20, P1333; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Grimsley C, 2003, TRENDS CELL BIOL, V13, P648, DOI 10.1016/j.tcb.2003.10.004; Hamon Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000120; Hanayama R, 2005, P NATL ACAD SCI USA, V102, P16886, DOI 10.1073/pnas.0508599102; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; ITO K, 1995, ROUX ARCH DEV BIOL, V204, P284, DOI 10.1007/BF02179499; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kurucz E, 2007, CURR BIOL, V17, P649, DOI 10.1016/j.cub.2007.02.041; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Li W, 2007, CELL, V129, P1215, DOI 10.1016/j.cell.2007.03.054; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; Mergliano J, 2003, DEVELOPMENT, V130, P5779, DOI 10.1242/dev.00824; Nakanishi Y, 2004, BIOL PHARM BULL, V27, P13, DOI 10.1248/bpb.27.13; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Parnaik R, 2000, CURR BIOL, V10, P857, DOI 10.1016/S0960-9822(00)00598-4; Platt N, 1998, CHEM BIOL, V5, pR193, DOI 10.1016/S1074-5521(98)90156-9; Platt N, 2001, J CLIN INVEST, V108, P649, DOI 10.1172/JCI200113903; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Rogulja-Ortmann A, 2007, DEVELOPMENT, V134, P105, DOI 10.1242/dev.02707; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Schwabe T, 2005, CELL, V123, P133, DOI 10.1016/j.cell.2005.08.037; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Silva E, 2007, IMMUNITY, V27, P585, DOI 10.1016/j.immuni.2007.08.016; SONNENFELD MJ, 1995, J COMP NEUROL, V359, P644, DOI 10.1002/cne.903590410; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; TRUMAN JW, 1992, J NEUROBIOL, V23, P1295, DOI 10.1002/neu.480230917; van den Eijnde SM, 1998, APOPTOSIS, V3, P9, DOI 10.1023/A:1009650917818; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Wood W, 2000, DEVELOPMENT, V127, P5245; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	46	121	124	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 2	2008	133	3					498	509		10.1016/j.cell.2008.02.052	http://dx.doi.org/10.1016/j.cell.2008.02.052			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455990	Green Accepted, Bronze			2022-12-24	WOS:000255503900020
J	Wang, H; Feng, Z; Shu, Y; Yu, H; Zhou, L; Zu, RQ; Huai, Y; Dong, J; Bao, CJ; Wen, LY; Wang, H; Yang, P; Zhao, W; Dong, LB; Zhou, MH; Liao, QH; Yang, HT; Wang, M; Lu, XJ; Shi, ZY; Wang, W; Gu, L; Zhu, FC; Li, Q; Yin, WD; Yang, WZ; Li, DX; Uyeki, TM; Wang, Y				Wang, Hua; Feng, Zijian; Shu, Yuelong; Yu, Hongjie; Zhou, Lei; Zu, Rongqiang; Huai, Yang; Dong, Jie; Bao, Changjun; Wen, Leying; Wang, Hong; Yang, Peng; Zhao, Wei; Dong, Libo; Zhou, Minghao; Liao, Qiaohong; Yang, Haitao; Wang, Min; Lu, Xiaojun; Shi, Zhiyang; Wang, Wei; Gu, Ling; Zhu, Fengcai; Li, Qun; Yin, Weidong; Yang, Weizhong; Li, Dexin; Uyeki, Timothy M.; Wang, Yu			Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China	LANCET			English	Article							HEALTH-CARE WORKERS; RECEPTOR SPECIFICITY; ANTI-H5 ANTIBODY; INFECTION; HEMAGGLUTININ; DISEASE; EPIDEMIOLOGY; RISK	Bankground in December, 2007, family cluster of two individuals infected with highly pathogenic avian influenza A (H5N1) virus was identified in Jiangsu Province, China. Field and laboratory investigations were implemented immediately by public-health authorities. Methods Epidemiological, clinical, and virological data were collected and analysed. Respiratory specimens from the patients were tested by reverse transcriptase (RT) PCR and by viral culture for the presence of H5N1 virus. Contacts of cases were monitored for symptoms of illness for 10 days. Any contacts who became ill had respiratory specimens collected for H5N1 testing by RT PCR. Sera were obtained from contacts for H5N1 serological testing by microneutralisation and horse red-blood-cell haemagglutinin inhibition assays. Findings The 24-year-old index case died, and the second case, his 52-year-old father, survived after receiving early antiviral treatment and post-vaccination plasma from a participant in an H5N1 vaccine trial. The index case's only plausible exposure to H5N1 virus was a poultry market visit 6 days before the onset of illness. The second case had substantial unprotected close exposure to his ill son. 91 contacts with close exposure to one or both cases without adequate protective equipment provided consent for serological investigation. Of these individuals, 78 (86%) received oseltamivir chemoprophylaxis and two had mild illness. Both ill contacts tested negative for H5N1 by RT PCR. All 91 close contacts tested negative for H5N1 antibodies. HSN1 viruses isolated from the two cases were genetically identical except for one non-synonymous nucleotide substitution. Interpretation Limited, non-sustained person-to-person transmission of H5N1 virus probably occurred in this family cluster. Funding Chinese Ministry of Science and Technology; US National Institute of Allergy and infectious Diseases, National Institutes of Health; China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases.	[Feng, Zijian; Yu, Hongjie; Zhou, Lei; Huai, Yang; Yang, Peng; Liao, Qiaohong; Li, Qun; Yang, Weizhong; Wang, Yu] Chinese Ctr Dis Control & Prevent, Off Dis Control & Emergency Response, Beijing 100050, Peoples R China; [Wang, Hua; Zu, Rongqiang; Bao, Changjun; Zhou, Minghao; Yang, Haitao; Shi, Zhiyang; Gu, Ling; Zhu, Fengcai] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Peoples R China; [Shu, Yuelong; Dong, Jie; Wen, Leying; Dong, Libo; Wang, Min; Wang, Wei; Li, Dexin] China CDC, State Key Lab Infect Dis Prevent & Control, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Wang, Hong] Jiangsu Prov Peoples Hosp, Nanjing, Peoples R China; [Zhao, Wei] Nanjing Secondary Peoples Hosp, Nanjing, Peoples R China; [Lu, Xiaojun] Nanjing Ctr Dis Control & Prevent, Nanjing, Peoples R China; [Yin, Weidong] Sinovac Biotech Co, Beijing, Peoples R China; [Uyeki, Timothy M.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Chinese Center for Disease Control & Prevention; Jiangsu Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Centers for Disease Control & Prevention - USA	Wang, Y (corresponding author), Chinese Ctr Dis Control & Prevent, Off Dis Control & Emergency Response, 27 Nanwei Rd, Beijing 100050, Peoples R China.	wangyu@chinacdc.cn	zhou, minghao/GZA-7244-2022; Yu, Hongjie/GZK-5351-2022		NIAID NIH HHS [U19 AI51915] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051915] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; [Anonymous], WHO CAS DEF HUM INF; Apisarnthanarak A, 2005, CLIN INFECT DIS, V40, pE16, DOI 10.1086/427034; Auewarakul P, 2007, J VIROL, V81, P9950, DOI 10.1128/JVI.00468-07; Bridges CB, 2000, J INFECT DIS, V181, P344, DOI 10.1086/315213; Chassagne P, 1996, AM J MED, V100, P65, DOI 10.1016/S0002-9343(96)90013-3; Chiu CH, 2004, CLIN MICROBIOL REV, V17, P311, DOI 10.1128/CMR.17.2.311-322.2004; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Katz JM, 1999, J INFECT DIS, V180, P1763, DOI 10.1086/315137; Liem NT, 2005, EMERG INFECT DIS, V11, P210, DOI 10.3201/eid1102.041075; Mounts AW, 1999, J INFECT DIS, V180, P505, DOI 10.1086/314903; Olsen SJ, 2005, EMERG INFECT DIS, V11, P1799; Oner AF, 2006, NEW ENGL J MED, V355, P2179, DOI 10.1056/NEJMoa060601; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Pitzer VE, 2007, EMERG INFECT DIS, V13, P1074, DOI 10.3201/eid1307.061538; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Schultsz C, 2005, EMERG INFECT DIS, V11, P1158; Scientific Panel on Biological Hazards, 2006, EUR FOOD SAFETY AUTH, V74, P1; Sedyaningsih ER, 2007, J INFECT DIS, V196, P522, DOI 10.1086/519692; Songserm T, 2006, EMERG INFECT DIS, V12, P1744, DOI 10.3201/eid1211.060542; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Stephenson I, 2003, J MED VIROL, V70, P391, DOI 10.1002/jmv.10408; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Webster RG, 2004, LANCET, V363, P234, DOI 10.1016/S0140-6736(03)15329-9; WHO, CLIN MAN HUM INF AV; WHO, AV INFL SIT IND UPD; *WHO, REC LAB PROC DET AV; WHO, WHO GUID INV HUM CAS; World Health Organization, COLL PRES SHIPP SPEC; World Health Organization, CUM NUMB CONF HUM CA; World Health Organization (WHO), WHO MAN AN INFL DIAG; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yu HJ, 2007, EMERG INFECT DIS, V13, P1061, DOI 10.3201/eid1307.061557; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zhou BP, 2007, NEW ENGL J MED, V357, P1450, DOI 10.1056/NEJMc070359; 2006, WKLY EPIDEMIOL REC, V81, P183	39	216	249	4	57	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2008	371	9622					1427	1434		10.1016/S0140-6736(08)60493-6	http://dx.doi.org/10.1016/S0140-6736(08)60493-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294XW	18400288				2022-12-24	WOS:000255440600023
J	Kim, JW; Chu, JL; Shen, XH; Wang, JL; Orkin, SH				Kim, Jonghwan; Chu, Jianlin; Shen, Xiaohua; Wang, Jianlong; Orkin, Stuart H.			An extended transcriptional network for pluripotency of embryonic stem cells	CELL			English	Article							DEVELOPMENTAL REGULATORS; MAMMALIAN-CELLS; SELF-RENEWAL; C-MYC; GENOME; MOUSE; NANOG; FIBROBLASTS; EXPRESSION; SALL4	Much attention has focused on a small set of transcription factors that maintain human or mouse embryonic stem (ES) cells in a pluripotent state. To gain a more complete understanding of the regulatory network that maintains this state, we identified target promoters of nine transcription factors, including somatic cell reprogramming factors (Oct4, Sox2, Klf4, and c-Myc) and others (Nanog, Dax1, Rex1, Zpf281, and Nac1), on a global scale in mouse ES cells. We found that target genes fall into two classes: promoters bound by few factors tend to be inactive or repressed, whereas promoters bound by more than four factors are largely active in the pluripotent state and become repressed upon differentiation. Furthermore, we propose a transcriptional hierarchy for reprogramming factors and broadly distinguish targets of c-Myc versus other factors. Our data provide a resource for exploration of the complex network maintaining pluripotency.	[Kim, Jonghwan; Chu, Jianlin; Shen, Xiaohua; Wang, Jianlong; Orkin, Stuart H.] Dept Pediat Oncol, Boston, MA 02115 USA; [Orkin, Stuart H.] Childrens Hosp, Boston, MA 02115 USA; [Orkin, Stuart H.] Dana Farber Canc Inst, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Kim, Jonghwan; Chu, Jianlin; Shen, Xiaohua; Wang, Jianlong; Orkin, Stuart H.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kim, Jonghwan; Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Dept Pediat Oncol, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu	Wang, Jianlong/AAG-9425-2020; Kim, Jonghwan/AAR-2815-2021; Wang, Jianlong/GQR-1191-2022	Wang, Jianlong/0000-0002-1317-6457; Kim, Jonghwan/0000-0002-9919-9843	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Ernst M, 1996, J BIOL CHEM, V271, P30136, DOI 10.1074/jbc.271.47.30136; Euskirchen GM, 2007, GENOME RES, V17, P898, DOI 10.1101/gr.5583007; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Kim JW, 2005, NAT METHODS, V2, P47, DOI 10.1038/NMETH726; Kuhn RM, 2007, NUCLEIC ACIDS RES, V35, pD668, DOI 10.1093/nar/gkl928; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MacIsaac KD, 2006, BIOINFORMATICS, V22, P423, DOI 10.1093/bioinformatics/bti815; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mao DYL, 2003, CURR BIOL, V13, P882, DOI 10.1016/S0960-9822(03)00297-5; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Messina DN, 2004, GENOME RES, V14, P2041, DOI 10.1101/gr.2584104; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Niakan KK, 2006, MOL GENET METAB, V88, P261, DOI 10.1016/j.ymgme.2005.12.010; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Orkin SH, 2005, CELL, V122, P828, DOI 10.1016/j.cell.2005.09.002; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pirity MK, 2005, MOL CELL BIOL, V25, P7193, DOI 10.1128/MCB.25.16.7193-7202.2005; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Roh TY, 2004, NAT BIOTECHNOL, V22, P1013, DOI 10.1038/nbt990; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Walhout AJM, 2006, GENOME RES, V16, P1445, DOI 10.1101/gr.5321506; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; YOSHIDA K, 1994, MECH DEVELOP, V45, P163, DOI 10.1016/0925-4773(94)90030-2; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	59	1001	1029	0	81	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 21	2008	132	6					1049	1061		10.1016/j.cell.2008.02.039	http://dx.doi.org/10.1016/j.cell.2008.02.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	278GR	18358816	Bronze, Green Accepted			2022-12-24	WOS:000254273600022
J	Graves, AR; Curran, PK; Smith, CL; Mindell, JA				Graves, Austin R.; Curran, Patricia K.; Smith, Carolyn L.; Mindell, Joseph A.			The Cl(-)/H(+) antiporter ClC-7 is the primary chloride permeation pathway in lysosomes	NATURE			English	Article							OSTEOPETROSIS TYPE-II; FUNCTIONAL RECONSTITUTION; TORPEDO-CALIFORNICA; PROTON PUMP; CHANNEL; PROTEINS; MUTATION; DISEASE; LEADS	Lysosomes are the stomachs of the cell - terminal organelles on the endocytic pathway where internalized macromolecules are degraded. Containing a wide range of hydrolytic enzymes, lysosomes depend on maintaining acidic luminal pH values for efficient function. Although acidification is mediated by a V- type proton ATPase, a parallel anion pathway is essential to allow bulk proton transport(1,2). The molecular identity of this anion transporter remains unknown. Recent results of knockout experiments raise the possibility that ClC- 7, a member of the CLC family of anion channels and transporters, is a contributor to this pathway in an osteoclast lysosome- like compartment, with loss of ClC- 7 function causing osteopetrosis(3). Several mammalian members of the CLC family have been characterized in detail; some ( including ClC- 0, ClC- 1 and ClC- 2) function as Cl(-) -conducting ion channels(4), whereas others act as Cl(-)/H(+) antiporters ( ClC- 4 and ClC-5) (5,6). However, previous attempts at heterologous expression of ClC- 7 have failed to yield evidence of functional protein, so it is unclear whether ClC- 7 has an important function in lysosomal biology, and also whether this protein functions as a Cl(-) channel, a Cl(-)/H(+) antiporter, or as something else entirely. Here we directly demonstrate an anion transport pathway in lysosomes that has the defining characteristics of a CLC Cl(-)/H(+) antiporter and show that this transporter is the predominant route for Cl(-) through the lysosomal membrane. Furthermore, knockdown of ClC- 7 expression by short interfering RNA can essentially ablate this lysosomal Cl(-)/H(+) antiport activity and can strongly diminish the ability of lysosomes to acidify in vivo, demonstrating that ClC- 7 is a Cl(-)/H(+) antiporter, that it constitutes the major Cl(-) permeability of lysosomes, and that it is important in lysosomal acidification.	[Graves, Austin R.; Curran, Patricia K.; Mindell, Joseph A.] Natl Inst Neurol Disorders & Stroke, Membrane Transport Biophys Unit, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA; [Smith, Carolyn L.] Natl Inst Neurol Disorders & Stroke, Light Microscopy Facil, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Mindell, JA (corresponding author), Natl Inst Neurol Disorders & Stroke, Membrane Transport Biophys Unit, Porter Neurosci Res Ctr, NIH, 35 Convent Dr,Bldg 35,MSC 3701, Bethesda, MD 20892 USA.	mindellj@ninds.nih.gov	Mindell, Joseph/P-4461-2017	Mindell, Joseph/0000-0002-6952-8247; Graves, Austin/0000-0003-1087-3684	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003015, Z01NS003015] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; DELLANTONE P, 1979, BIOCHEM BIOPH RES CO, V86, P180, DOI 10.1016/0006-291X(79)90398-X; GARTY H, 1983, J BIOL CHEM, V258, P3094; GOLDBERG AFX, 1991, J MEMBRANE BIOL, V124, P199, DOI 10.1007/BF01994354; Gottlieb RA, 2000, METHOD ENZYMOL, V322, P213; Graham JM., 2000, CURRENT PROTOCOLS CE; Henriksen K, 2004, AM J PATHOL, V164, P1537, DOI 10.1016/S0002-9440(10)63712-1; ILLSLEY NP, 1987, BIOCHEMISTRY-US, V26, P1215, DOI 10.1021/bi00379a002; Jentsch TJ, 2007, J PHYSIOL-LONDON, V578, P633, DOI 10.1113/jphysiol.2006.124719; Jentsch TJ, 1999, PFLUG ARCH EUR J PHY, V437, P783, DOI 10.1007/s004240050847; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kornak U, 2006, J CLIN ENDOCR METAB, V91, P995, DOI 10.1210/jc.2005-2017; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Letizia C, 2004, CALCIFIED TISSUE INT, V74, P42, DOI 10.1007/s00223-002-1087-5; Maduke M, 1999, J GEN PHYSIOL, V114, P713, DOI 10.1085/jgp.114.5.713; OHKUMA S, 1982, P NATL ACAD SCI-BIOL, V79, P2758, DOI 10.1073/pnas.79.9.2758; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Rychkov GY, 1998, J GEN PHYSIOL, V111, P653, DOI 10.1085/jgp.111.5.653; Schaller S, 2004, J BONE MINER RES, V19, P1144, DOI 10.1359/JBMR.040302; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; WHITE MM, 1979, J BIOL CHEM, V254, P161	22	253	267	7	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2008	453	7196					788	792		10.1038/nature06907	http://dx.doi.org/10.1038/nature06907			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308UK	18449189				2022-12-24	WOS:000256415300045
J	Akin, O; Mullins, RD				Akin, Orkun; Mullins, R. Dyche			Capping protein increases the rate of actin-based motility by promoting filament nucleation by the Arp2/3 complex	CELL			English	Article							CELL MOTILITY; LISTERIA-MONOCYTOGENES; WASP/SCAR PROTEINS; ENA/VASP PROTEINS; ATP HYDROLYSIS; FREE SYSTEM; BARBED END; IN-VITRO; N-WASP; POLYMERIZATION	Capping protein (CP) is an integral component of Arp2/3-nucleated actin networks that drive amoeboid motility. Increasing the concentration of capping protein, which caps barbed ends of actin filaments and prevents elongation, increases the rate of actin-based motility in vivo and in vitro. We studied the synergy between CP and Arp2/3 using an in vitro actin-based motility system reconstituted from purified proteins. We find that capping protein increases the rate of motility by promoting more frequent filament nucleation by the Arp2/3 complex and not by increasing the rate of filament elongation as previously suggested. One consequence of this coupling between capping and nucleation is that, while the rate of motility depends strongly on the concentration of CP and Arp2/3, the net rate of actin assembly is insensitive to changes in either factor. By reorganizing their architecture, dendritic actin networks harness the same assembly kinetics to drive different rates of motility.	[Akin, Orkun; Mullins, R. Dyche] Univ Calif San Francisco, Sch Med, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Mullins, RD (corresponding author), Univ Calif San Francisco, Sch Med, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	dyche@mullinslab.ucsf.edu		Akin, Orkun/0000-0003-1719-4887	NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061010] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [PN2 EY016546, PN2 EY016546-04] Funding Source: Medline; NIGMS NIH HHS [R01 GM061010-09, R01 GM061010, R01GM61010] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Applewhite DA, 2007, MOL BIOL CELL, V18, P2579, DOI 10.1091/mbc.e06-11-0990; Baum B, 2005, CURR BIOL, V15, pR305, DOI 10.1016/j.cub.2005.04.004; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bernheim-Groswasser A, 2002, NATURE, V417, P308, DOI 10.1038/417308a; Cameron LA, 1999, P NATL ACAD SCI USA, V96, P4908, DOI 10.1073/pnas.96.9.4908; Cameron LA, 2004, MOL BIOL CELL, V15, P2312, DOI 10.1091/mbc.E03-12-0913; Carlier MF, 1997, J MOL BIOL, V269, P459, DOI 10.1006/jmbi.1997.1062; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; COOPER JA, 1985, BIOCHEMISTRY-US, V24, P793, DOI 10.1021/bi00324a039; DABIRI GA, 1990, P NATL ACAD SCI USA, V87, P6068, DOI 10.1073/pnas.87.16.6068; Dayel MJ, 2004, PLOS BIOL, V2, P476, DOI 10.1371/journal.pbio.0020091; Dayel MJ, 2001, P NATL ACAD SCI USA, V98, P14871, DOI 10.1073/pnas.261419298; Eddy RJ, 1997, J CELL BIOL, V139, P1243, DOI 10.1083/jcb.139.5.1243; Goley ED, 2004, MOL CELL, V16, P269, DOI 10.1016/j.molcel.2004.09.018; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Haviv L, 2006, P NATL ACAD SCI USA, V103, P4906, DOI 10.1073/pnas.0508269103; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; HUG C, 1995, CELL, V81, P591, DOI 10.1016/0092-8674(95)90080-2; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; KELLEHER JF, 1995, J CELL BIOL, V131, P385, DOI 10.1083/jcb.131.2.385; Kelly AE, 2006, J BIOL CHEM, V281, P10589, DOI 10.1074/jbc.M507470200; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Machesky LM, 1997, BIOCHEM J, V328, P105; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Martin AC, 2006, NAT CELL BIOL, V8, P826, DOI 10.1038/ncb1443; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Miyoshi T, 2006, J CELL BIOL, V175, P947, DOI 10.1083/jcb.200604176; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Mullins RD, 1999, CURR BIOL, V9, P405, DOI 10.1016/S0960-9822(99)80187-0; Plastino J, 2004, CURR BIOL, V14, P1766, DOI 10.1016/j.cub.2004.09.054; Samarin S, 2003, J CELL BIOL, V163, P131, DOI 10.1083/jcb.200303191; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; Stevens JM, 2006, NAT REV MICROBIOL, V4, P91, DOI 10.1038/nrmicro1320; van der Gucht J, 2005, P NATL ACAD SCI USA, V102, P7847, DOI 10.1073/pnas.0502121102; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Wiesner S, 2003, J CELL BIOL, V160, P387, DOI 10.1083/jcb.200207148; Yarar D, 1999, CURR BIOL, V9, P555, DOI 10.1016/S0960-9822(99)80243-7	44	175	179	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 30	2008	133	5					841	851		10.1016/j.cell.2008.04.011	http://dx.doi.org/10.1016/j.cell.2008.04.011			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	306UY	18510928	Green Accepted, Bronze			2022-12-24	WOS:000256274500016
J	Tsaousis, AD; Kunji, ERS; Goldberg, AV; Lucocq, JM; Hirt, RP; Embley, TM				Tsaousis, Anastasios D.; Kunji, Edmund R. S.; Goldberg, Alina V.; Lucocq, John M.; Hirt, Robert P.; Embley, T. Martin			A novel route for ATP acquisition by the remnant mitochondria of Encephalitozoon cuniculi	NATURE			English	Article							RICKETTSIA-PROWAZEKII; ATP/ADP TRANSLOCASES; MICROSPORIDIA; TRANSPORT; PROTEINS; EVOLUTION; PROTOZOA; ARABIDOPSIS; CHLAMYDIAE; BIOLOGY	Mitochondria use transport proteins of the eukaryotic mitochondrial carrier family (MCF) to mediate the exchange of diverse substrates, including ATP, with the host cell cytosol. According to classical endosymbiosis theory, insertion of a host-nuclear-encoded MCF transporter into the protomitochondrion was the key step that allowed the host cell to harvest ATP from the enslaved endosymbiont(1). Notably the genome of the microsporidian Encephalitozoon cuniculi has lost all of its genes for MCF proteins(2). This raises the question of how the recently discovered microsporidian remnant mitochondrion, called a mitosome, acquires ATP to support protein import and other predicted ATP-dependent activities(2-4). The E. cuniculi genome does contain four genes for an unrelated type of nucleotide transporter used by plastids and bacterial intracellular parasites, such as Rickettsia and Chlamydia, to import ATP from the cytosol of their eukaryotic host cells(5-7). The inference is that E. cuniculi also uses these proteins to steal ATP from its eukaryotic host to sustain its lifestyle as an obligate intracellular parasite. Here we show that, consistent with this hypothesis, all four E. cuniculi transporters can transport ATP, and three of them are expressed on the surface of the parasite when it is living inside host cells. The fourth transporter co-locates with mitochondrial Hsp70 to the E. cuniculi mitosome. Thus, uniquely among eukaryotes, the traditional relationship between mitochondrion and host has been subverted in E. cuniculi, by reductive evolution and analogous gene replacement. Instead of the mitosome providing the parasite cytosol with ATP, the parasite cytosol now seems to provide ATP for the organelle.	[Tsaousis, Anastasios D.; Goldberg, Alina V.; Hirt, Robert P.; Embley, T. Martin] Univ Newcastle, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Tsaousis, Anastasios D.] Univ Newcastle, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Kunji, Edmund R. S.] MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England; [Lucocq, John M.] Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland	Newcastle University - UK; Newcastle University - UK; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Dundee	Hirt, RP (corresponding author), Univ Newcastle, Inst Cell & Mol Biosci, Catherine Cookson Bldg,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	r.p.hirt@ncl.ac.uk; ek@mrc-dunn.cam.ac.uk	Hirt, Robert/R-5429-2017; Kunji, Edmund/AAH-2362-2020	Hirt, Robert/0000-0002-3760-9958; Kunji, Edmund/0000-0002-0610-4500; lucocq, john/0000-0002-5191-0093; Embley, Thomas Martin/0000-0002-1484-340X; Tsaousis, Anastasios/0000-0002-5424-1905	MRC [MC_U105663139] Funding Source: UKRI; Medical Research Council [MC_U105663139] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Audia JP, 2006, J BACTERIOL, V188, P6261, DOI 10.1128/JB.00371-06; de Koning HP, 2005, FEMS MICROBIOL REV, V29, P987, DOI 10.1016/j.femsre.2005.03.004; Didier ES, 2006, CURR OPIN INFECT DIS, V19, P485, DOI 10.1097/01.qco.0000244055.46382.23; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Farthing MJG, 2006, NAT CLIN PRACT GASTR, V3, P436, DOI 10.1038/ncpgasthep0557; Goldberg AV, 2008, NATURE, V452, P624, DOI 10.1038/nature06606; Haferkamp I, 2004, NATURE, V432, P622, DOI 10.1038/nature03131; Haferkamp I, 2006, MOL MICROBIOL, V60, P1534, DOI 10.1111/j.1365-2958.2006.05193.x; Hollister WS, 1996, J EUKARYOT MICROBIOL, V43, pS104, DOI 10.1111/j.1550-7408.1996.tb05026.x; JOHN P, 1975, NATURE, V254, P495, DOI 10.1038/254495a0; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; Kunji ERS, 2004, FEBS LETT, V564, P239, DOI 10.1016/S0014-5793(04)00242-X; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mohlmann T, 1998, EUR J BIOCHEM, V252, P353, DOI 10.1046/j.1432-1327.1998.2520353.x; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Richards TA, 2003, PROTIST, V154, P17, DOI 10.1078/143446103764928468; Schmitz-Esser S, 2004, J BACTERIOL, V186, P683, DOI 10.1128/JB.186.3.683-691.2004; Taupin V, 2006, PARASITOL RES, V99, P708, DOI 10.1007/s00436-006-0231-y; Trentmann O, 2000, EUR J BIOCHEM, V267, P4098, DOI 10.1046/j.1432-1033.2000.01468.x; Vavra J, 2005, FOLIA PARASIT, V52, P193, DOI 10.14411/fp.2005.024; Vossbrinck CR, 2005, FOLIA PARASIT, V52, P131, DOI 10.14411/fp.2005.017; WEIDNER E, 1999, MICROSPORIDIA MICROS; Williams BAP, 2002, NATURE, V418, P865, DOI 10.1038/nature00949; Winkler HH, 1999, TRENDS BIOCHEM SCI, V24, P64, DOI 10.1016/S0968-0004(98)01334-6; Zheng L, 2007, PLOS BIOL, V5, P1530, DOI 10.1371/journal.pbio.0050170	26	175	195	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2008	453	7194					553	U11		10.1038/nature06903	http://dx.doi.org/10.1038/nature06903			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303EL	18449191				2022-12-24	WOS:000256023700049
J	Condon, MA; Scheffer, SJ; Lewis, ML; Swensen, SM				Condon, Marty A.; Scheffer, Sonja J.; Lewis, Matthew L.; Swensen, Susan M.			Hidden neotropical diversity: Greater than the sum of its parts	SCIENCE			English	Article							BLEPHARONEURA DIPTERA; HERBIVOROUS INSECTS; SPECIES RICHNESS; FRUIT-FLIES; TEPHRITIDAE; DIVERSIFICATION; CUCURBITACEAE; SPECIATION; RADIATION; PATTERNS	The diversity of tropical herbivorous insects has been explained as a direct function of plant species diversity. Testing that explanation, we reared 2857 flies from flowers and seeds of 24 species of plants from 34 neotropical sites. Samples yielded 52 morphologically similar species of flies and documented highly conserved patterns of specificity to host taxa and host parts. Widespread species of plants can support 13 species of flies. Within single populations of plants, we typically found one or more fly species specific to female flowers and multiple specialists on male flowers. We suggest that neotropical herbivorous insect diversity is not simply a function of plant taxonomic and architectural diversity, but also reflects the geographic distribution of hosts and the age and area of the neotropics.	[Condon, Marty A.] Cornell Coll, Dept Biol, Mt Vernon, IA 52314 USA; [Condon, Marty A.; Scheffer, Sonja J.] Smithsonian Inst, Natl Museum Amer Hist, Dept Entomol, Washington, DC 20560 USA; [Scheffer, Sonja J.; Lewis, Matthew L.] USDA ARS, Syst Entomol Lab, Beltsville, MD 20705 USA; [Scheffer, Sonja J.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Swensen, Susan M.] Ithaca Coll, Dept Biol, Ithaca, NY 14850 USA	Cornell University; Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of Agriculture (USDA); University System of Maryland; University of Maryland College Park	Condon, MA (corresponding author), Cornell Coll, Dept Biol, Mt Vernon, IA 52314 USA.	mcondon@cornellcollege.edu						Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Condon MA, 1997, BIOL J LINN SOC, V60, P443, DOI 10.1006/bijl.1996.0106; CONDON MA, 1988, AM J BOT, V75, P875, DOI 10.2307/2444007; Condon M, 2008, BIOL J LINN SOC, V93, P779, DOI 10.1111/j.1095-8312.2007.00943.x; CORNELL HV, 1985, ECOLOGY, V66, P1247, DOI 10.2307/1939178; CRACRAFT J, 1988, EVOLUTION, V42, P603, DOI 10.1111/j.1558-5646.1988.tb04164.x; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Godfray HCJ, 1999, PHILOS T R SOC B, V354, P1811, DOI 10.1098/rstb.1999.0523; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hubbell Stephen P., 2001, V32, pi; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Joy JB, 2007, EVOLUTION, V61, P784, DOI 10.1111/j.1558-5646.2007.00069.x; MAY RM, 1990, PHILOS T R SOC B, V330, P293, DOI 10.1098/rstb.1990.0200; McPeek MA, 2007, AM NAT, V169, pE97, DOI 10.1086/512135; Mendelson TC, 2005, NATURE, V433, P375, DOI 10.1038/433375a; Norton DA, 2007, SCIENCE, V315, P1666, DOI 10.1126/science.1137249; Novotny V, 2005, J TROP ECOL, V21, P67, DOI 10.1017/S0266467404002044; Novotny V, 2007, NATURE, V448, P692, DOI 10.1038/nature06021; Novotny V, 2006, SCIENCE, V313, P1115, DOI 10.1126/science.1129237; SOUTHWOOD TRE, 1961, J ANIM ECOL, V30, P1, DOI 10.2307/2109; Stireman JO, 2005, EVOLUTION, V59, P2573, DOI 10.1554/05-222.1; THOMAS CD, 1990, NATURE, V347, P237, DOI 10.1038/347237a0; Thompson J. N., 2005, INTERSPEC INTERACT; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240	27	53	56	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2008	320	5878					928	931		10.1126/science.1155832	http://dx.doi.org/10.1126/science.1155832			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18487192				2022-12-24	WOS:000255868300041
J	Mercer, J; Helenius, A				Mercer, Jason; Helenius, Ari			Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells	SCIENCE			English	Article							PLASMA-MEMBRANE; ENTRY; PHOSPHATIDYLSERINE; ENDOCYTOSIS; INHIBITION; PATHWAYS; KINASE; DEATH	Viruses employ many different strategies to enter host cells. Vaccinia virus, a prototype poxvirus, enters cells in a pH- dependent fashion. Live cell imaging showed that fluorescent virus particles associated with and moved along filopodia to the cell body, where they were internalized after inducing the extrusion of large transient membrane blebs. p21- activated kinase 1 ( PAK1) was activated by the virus, and the endocytic process had the general characteristics of macropinocytosis. The induction of blebs, the endocytic event, and infection were all critically dependent on the presence of exposed phosphatidylserine in the viral membrane, which suggests that vaccinia virus uses apoptotic mimicry to enter cells.	[Mercer, Jason; Helenius, Ari] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Mercer, Jason; Helenius, Ari] ETH Honggerberg, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Helenius, A (corresponding author), ETH, Inst Biochem, Schafmattstr 18, CH-8093 Zurich, Switzerland.	ari.helenius@bc.biol.ethz.ch		Mercer, Jason/0000-0003-1466-9541				Albert ML, 2004, NAT REV IMMUNOL, V4, P223, DOI 10.1038/nri11308; Carter GC, 2005, J GEN VIROL, V86, P1279, DOI 10.1099/vir.0.80831-0; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; FISHKIND DJ, 1991, J CELL BIOL, V114, P967, DOI 10.1083/jcb.114.5.967; Harrison SC, 2004, P NATL ACAD SCI USA, V101, P11178, DOI 10.1073/pnas.0403600101; Hayasaka D, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-22; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; ICHIHASHI Y, 1983, VIROLOGY, V130, P306, DOI 10.1016/0042-6822(83)90085-5; ICHIHASHI Y, 1984, J VIROL, V50, P929, DOI 10.1128/JVI.50.3.929-938.1984; Knipe D. M., 2007, FIELDS VIROLOGY, V5; Lehmann MJ, 2005, J CELL BIOL, V170, P317, DOI 10.1083/jcb.200503059; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mills JC, 1998, J CELL BIOL, V140, P627, DOI 10.1083/jcb.140.3.627; OIE M, 1985, VIROLOGY, V142, P299, DOI 10.1016/0042-6822(85)90338-1; Parrini MC, 2005, BIOCHEM SOC T, V33, P646, DOI 10.1042/BST0330646; Platt N, 1998, TRENDS CELL BIOL, V8, P365, DOI 10.1016/S0962-8924(98)01329-4; Sieczkarski SB, 2002, J GEN VIROL, V83, P1535, DOI 10.1099/0022-1317-83-7-1535; Townsley AC, 2006, J VIROL, V80, P8899, DOI 10.1128/JVI.01053-06; Valderrama F, 2006, SCIENCE, V311, P377, DOI 10.1126/science.1122411; Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731; ZWARTOUW HT, 1964, J GEN MICROBIOL, V34, P115, DOI 10.1099/00221287-34-1-115	25	556	583	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2008	320	5875					531	535		10.1126/science.1155164	http://dx.doi.org/10.1126/science.1155164			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436786				2022-12-24	WOS:000255249300051
J	Zhang, XY				Zhang, Xiaoyu			Perspective - The epigenetic landscape of plants	SCIENCE			English	Editorial Material							GENOME-WIDE ANALYSIS; DNA-METHYLATION; TRANSPOSABLE ELEMENTS; CG METHYLATION; RNA-POLYMERASE; GENE; HISTONE; MICRORNAS; METHYLTRANSFERASES; PARAMUTATION	In plants, DNA methylation, histone modifications, and RNA interference play critically important roles in regulating chromatin structure, thereby profoundly affecting transcription and other molecular events. Recent advances in microarray and high- throughput sequencing technologies have enabled genome- wide studies of these pathways in great detail. The vast amounts of "epigenomic" data generated so far have provided new insights into the mechanisms and functions of these pathways and have broadened our understanding of the structure and organization of plant chromatin as a whole.	[Zhang, Xiaoyu] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Zhang, XY (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	xiaoyu@plantbio.uga.edu	Zhang, xiaoyu/GXA-3206-2022					Alleman M, 2006, NATURE, V442, P295, DOI 10.1038/nature04884; Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; BENDER J, 1995, CELL, V83, P725, DOI 10.1016/0092-8674(95)90185-X; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Chan SWL, 2006, PLOS BIOL, V4, P1923, DOI 10.1371/journal.pbio.0040363; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Devos KM, 2005, P NATL ACAD SCI USA, V102, P19243, DOI 10.1073/pnas.0509473102; Ding Y, 2007, PLANT CELL, V19, P9, DOI 10.1105/tpc.106.048124; Dorweiler JE, 2000, PLANT CELL, V12, P2101, DOI 10.1105/tpc.12.11.2101; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Gehring M, 2007, BBA-GENE STRUCT EXPR, V1769, P276, DOI 10.1016/j.bbaexp.2007.01.009; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Li XY, 2008, PLANT CELL, V20, P259, DOI 10.1105/tpc.107.056879; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; MARTIENSSEN R, 1994, GENETICS, V136, P1157; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Matzke M, 2007, CURR OPIN PLANT BIOL, V10, P512, DOI 10.1016/j.pbi.2007.06.007; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Pfluger J, 2007, CURR OPIN PLANT BIOL, V10, P645, DOI 10.1016/j.pbi.2007.07.013; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinders J, 2008, GENOME RES, V18, P469, DOI 10.1101/gr.7073008; Saze H, 2007, EMBO J, V26, P3641, DOI 10.1038/sj.emboj.7601788; Shi JH, 2006, GENETICS, V173, P1571, DOI 10.1534/genetics.106.056853; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Stokes TL, 2002, GENE DEV, V16, P171, DOI 10.1101/gad.952102; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; Vaillant I, 2007, CURR OPIN PLANT BIOL, V10, P528, DOI 10.1016/j.pbi.2007.06.008; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006; Woodhouse MR, 2006, PLOS BIOL, V4, P1678, DOI 10.1371/journal.pbio.0040339; Zhang X, 2006, COLD SPRING HARB SYM, V71, P439, DOI 10.1101/sqb.2006.71.047; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhang XY, 2007, P NATL ACAD SCI USA, V104, P4536, DOI 10.1073/pnas.0611456104; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, DEVELOPMENT, V134, P3959, DOI 10.1242/dev.001131; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	53	161	168	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2008	320	5875					489	492		10.1126/science.1153996	http://dx.doi.org/10.1126/science.1153996			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436779				2022-12-24	WOS:000255249300038
J	Kurz, WA; Dymond, CC; Stinson, G; Rampley, GJ; Neilson, ET; Carroll, AL; Ebata, T; Safranyik, L				Kurz, W. A.; Dymond, C. C.; Stinson, G.; Rampley, G. J.; Neilson, E. T.; Carroll, A. L.; Ebata, T.; Safranyik, L.			Mountain pine beetle and forest carbon feedback to climate change	NATURE			English	Article							DISTURBANCE; OUTBREAK; ECOSYSTEM	The mountain pine beetle ( Dendroctonus ponderosae Hopkins, Coleoptera: Curculionidae, Scolytinae) is a native insect of the pine forests of western North America, and its populations periodically erupt into large- scale outbreaks(1-3). During outbreaks, the resulting widespread tree mortality reduces forest carbon uptake and increases future emissions from the decay of killed trees. The impacts of insects on forest carbon dynamics, however, are generally ignored in large- scale modelling analyses. The current outbreak in British Columbia, Canada, is an order of magnitude larger in area and severity than all previous recorded outbreaks(4). Here we estimate that the cumulative impact of the beetle outbreak in the affected region during 2000 - 2020 will be 270 megatonnes ( Mt) carbon ( or 36 g carbon m(-2) yr(-1) on average over 374,000 km 2 of forest). This impact converted the forest from a small net carbon sink to a large net carbon source both during and immediately after the outbreak. In the worst year, the impacts resulting from the beetle outbreak in British Columbia were equivalent to similar to 75% of the average annual direct forest fire emissions from all of Canada during 1959 - 1999. The resulting reduction in net primary production was of similar magnitude to increases observed during the 1980s and 1990s as a result of global change(5). Climate change has contributed to the unprecedented extent and severity of this outbreak(6). Insect outbreaks such as this represent an important mechanism by which climate change may undermine the ability of northern forests to take up and store atmospheric carbon, and such impacts should be accounted for in large- scale modelling analyses.	[Kurz, W. A.; Dymond, C. C.; Stinson, G.; Rampley, G. J.; Neilson, E. T.; Carroll, A. L.; Safranyik, L.] Nat Resources Canada, Canadian Forest Serv, Pacific Forestry Ctr, Victoria, BC V8Z 1M5, Canada; [Ebata, T.] British Columbia Minist Forests & Range, Victoria, BC V8W 9C2, Canada	Natural Resources Canada; Canadian Forest Service	Kurz, WA (corresponding author), Nat Resources Canada, Canadian Forest Serv, Pacific Forestry Ctr, Victoria, BC V8Z 1M5, Canada.	wkurz@nrcan.gc.ca	Dymond, Caren/P-6981-2019; Lukeš, Petr/B-1771-2010	Dymond, Caren/0000-0003-4542-0773; Kurz, Werner/0000-0003-4576-7849				Amiro BD, 2001, CAN J FOREST RES, V31, P512, DOI 10.1139/cjfr-31-3-512; Amman G.D., 1983, GTRINT145 USDA FOR S; Ayres MP, 2000, SCI TOTAL ENVIRON, V262, P263, DOI 10.1016/S0048-9697(00)00528-3; Berg EE, 2006, FOREST ECOL MANAG, V227, P219, DOI 10.1016/j.foreco.2006.02.038; Berryman A. A., 1988, DYNAMICS FOREST INSE; Bond-Lamberty B, 2007, NATURE, V450, P89, DOI 10.1038/nature06272; Canadell Josep G., 2007, P1; Carroll AL, 2004, PACIF FOR C, V399, P223; Environment Canada, 2007, NAT INV REP 1990 200; Hamann A, 2006, ECOLOGY, V87, P2773, DOI 10.1890/0012-9658(2006)87[2773:PEOCCO]2.0.CO;2; Kull S., 2006, OPERATIONAL SCALE CA; Kurz W.A., 1995, BIOTIC FEEDBACKS GLO, P119; Kurz WA, 1999, ECOL APPL, V9, P526, DOI 10.1890/1051-0761(1999)009[0526:AYRAOC]2.0.CO;2; KURZ WA, 1992, NORX326 FOR CAN NW R; Kurz WA, 2008, PHILOS T R SOC B, V363, P2261, DOI 10.1098/rstb.2007.2198; Logan J.A., 2001, AM ENTOMOL, V47, P160; MATTSON WJ, 1975, SCIENCE, V190, P515, DOI 10.1126/science.190.4214.515; McGuire AD, 2001, GLOBAL BIOGEOCHEM CY, V15, P183, DOI 10.1029/2000GB001298; Myneni RB, 2001, P NATL ACAD SCI USA, V98, P14784, DOI 10.1073/pnas.261555198; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Parkins JR, 2007, GLOBAL ENVIRON CHANG, V17, P460, DOI 10.1016/j.gloenvcha.2007.01.003; Safranyik L, 1974, MANAGEMENT LODGEPOLE; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Taylor Steve W., 2006, P67; Taylor SW, 2004, PACIF FOR C, V399, P41; Volney WJA, 2000, AGR ECOSYST ENVIRON, V82, P283, DOI 10.1016/S0167-8809(00)00232-2; WALTON A, 2007, PROVINCIAL LEVEL PRO; Westfall J., 2007, 2006 SUMMARY FOREST; Williams DW, 2002, AGR FOREST ENTOMOL, V4, P87, DOI 10.1046/j.1461-9563.2002.00124.x; WULDER MA, 2001, FOREST ECOL MANAG, V221, P27	30	1258	1298	17	816	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2008	452	7190					987	990		10.1038/nature06777	http://dx.doi.org/10.1038/nature06777			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291PF	18432244				2022-12-24	WOS:000255208600038
J	Ming, R; Hou, SB; Feng, Y; Yu, QY; Dionne-Laporte, A; Saw, JH; Senin, P; Wang, W; Ly, BV; Lewis, KLT; Salzberg, SL; Feng, L; Jones, MR; Skelton, RL; Murray, JE; Chen, CX; Qian, WB; Shen, JG; Du, P; Eustice, M; Tong, E; Tang, HB; Lyons, E; Paull, RE; Michael, TP; Wall, K; Rice, DW; Albert, H; Wang, ML; Zhu, YJ; Schatz, M; Nagarajan, N; Acob, RA; Guan, PZ; Blas, A; Wai, CM; Ackerman, CM; Ren, Y; Liu, C; Wang, JM; Wang, JP; Na, JK; Shakirov, EV; Haas, B; Thimmapuram, J; Nelson, D; Wang, XY; Bowers, JE; Gschwend, AR; Delcher, AL; Singh, R; Suzuki, JY; Tripathi, S; Neupane, K; Wei, HR; Irikura, B; Paidi, M; Jiang, N; Zhang, WL; Presting, G; Windsor, A; Navajas-Perez, R; Torres, MJ; Feltus, FA; Porter, B; Li, YJ; Burroughs, AM; Luo, MC; Liu, L; Christopher, DA; Mount, SM; Moore, PH; Sugimura, T; Jiang, JM; Schuler, MA; Friedman, V; Mitchell-Olds, T; Shippen, DE; dePamphilis, CW; Palmer, JD; Freeling, M; Paterson, AH; Gonsalves, D; Wang, L; Alam, M				Ming, Ray; Hou, Shaobin; Feng, Yun; Yu, Qingyi; Dionne-Laporte, Alexandre; Saw, Jimmy H.; Senin, Pavel; Wang, Wei; Ly, Benjamin V.; Lewis, Kanako L. T.; Salzberg, Steven L.; Feng, Lu; Jones, Meghan R.; Skelton, Rachel L.; Murray, Jan E.; Chen, Cuixia; Qian, Wubin; Shen, Junguo; Du, Peng; Eustice, Moriah; Tong, Eric; Tang, Haibao; Lyons, Eric; Paull, Robert E.; Michael, Todd P.; Wall, Kerr; Rice, Danny W.; Albert, Henrik; Wang, Ming-Li; Zhu, Yun J.; Schatz, Michael; Nagarajan, Niranjan; Acob, Ricelle A.; Guan, Peizhu; Blas, Andrea; Wai, Ching Man; Ackerman, Christine M.; Ren, Yan; Liu, Chao; Wang, Jianmei; Wang, Jianping; Na, Jong-Kuk; Shakirov, Eugene V.; Haas, Brian; Thimmapuram, Jyothi; Nelson, David; Wang, Xiyin; Bowers, John E.; Gschwend, Andrea R.; Delcher, Arthur L.; Singh, Ratnesh; Suzuki, Jon Y.; Tripathi, Savarni; Neupane, Kabi; Wei, Hairong; Irikura, Beth; Paidi, Maya; Jiang, Ning; Zhang, Wenli; Presting, Gernot; Windsor, Aaron; Navajas-Perez, Rafael; Torres, Manuel J.; Feltus, F. Alex; Porter, Brad; Li, Yingjun; Burroughs, A. Max; Luo, Ming-Cheng; Liu, Lei; Christopher, David A.; Mount, Stephen M.; Moore, Paul H.; Sugimura, Tak; Jiang, Jiming; Schuler, Mary A.; Friedman, Vikki; Mitchell-Olds, Thomas; Shippen, Dorothy E.; dePamphilis, Claude W.; Palmer, Jeffrey D.; Freeling, Michael; Paterson, Andrew H.; Gonsalves, Dennis; Wang, Lei; Alam, Maqsudul			The draft genome of the transgenic tropical fruit tree papaya (Carica papaya Linnaeus)	NATURE			English	Article							ARABIDOPSIS-THALIANA; RINGSPOT VIRUS; Y-CHROMOSOME; GENE; SEQUENCE; PROTEIN; DNA; EVOLUTION; FAMILIES; PLANTS	Papaya, a fruit crop cultivated in tropical and subtropical regions, is known for its nutritional benefits and medicinal applications. Here we report a 33 draft genome sequence of 'SunUp' papaya, the first commercial virus- resistant transgenic fruit tree(1) to be sequenced. The papaya genome is three times the size of the Arabidopsis genome, but contains fewer genes, including significantly fewer disease- resistance gene analogues. Comparison of the five sequenced genomes suggests a minimal angiosperm gene set of 13,311. A lack of recent genome duplication, atypical of other angiosperm genomes sequenced so far(2-5), may account for the smaller papaya gene number in most functional groups. Nonetheless, striking amplifications in gene number within particular functional groups suggest roles in the evolution of tree- like habit, deposition and remobilization of starch reserves, attraction of seed dispersal agents, and adaptation to tropical daylengths. Transgenesis at three locations is closely associated with chloroplast insertions into the nuclear genome, and with topoisomerase I recognition sites. Papaya offers numerous advantages as a system for fruit- tree functional genomics, and this draft genome sequence provides the foundation for revealing the basis of Carica's distinguishing morpho- physiological, medicinal and nutritional properties.	[Hou, Shaobin; Dionne-Laporte, Alexandre; Saw, Jimmy H.; Senin, Pavel; Ly, Benjamin V.; Lewis, Kanako L. T.; Alam, Maqsudul] Univ Hawaii, Dept Microbiol, Honolulu, HI 96822 USA; [Ming, Ray; Yu, Qingyi; Jones, Meghan R.; Skelton, Rachel L.; Murray, Jan E.; Eustice, Moriah; Tong, Eric; Wang, Ming-Li; Zhu, Yun J.; Acob, Ricelle A.; Guan, Peizhu; Blas, Andrea; Wai, Ching Man; Ackerman, Christine M.; Singh, Ratnesh; Paidi, Maya] Hawaii Agr Res Ctr, Aiea, HI 96701 USA; [Ming, Ray; Murray, Jan E.; Chen, Cuixia; Wang, Jianping; Na, Jong-Kuk; Gschwend, Andrea R.; Li, Yingjun] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Feng, Yun; Wang, Wei; Feng, Lu; Qian, Wubin; Ren, Yan; Liu, Chao; Wang, Jianmei; Wang, Lei] Nankai Univ, TEDA Sch Biol Sci & Biotechnol, Tianjin Econ Technol Dev Area, Tianjin 300457, Peoples R China; [Feng, Yun; Feng, Lu; Shen, Junguo; Du, Peng; Wang, Lei] Tianjin Res Ctr Funct Genom & Biochip, Tianjin Econ Technol Dev Area, Tianjin 300457, Peoples R China; [Wang, Wei; Feng, Lu; Wang, Lei] Nankai Univ, Coll Life Sci, Minist Educ, Key Lab Mol Microbiol & Technol, Tianjin 300071, Peoples R China; [Salzberg, Steven L.; Schatz, Michael; Nagarajan, Niranjan; Delcher, Arthur L.; Burroughs, A. Max; Mount, Stephen M.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Eustice, Moriah; Acob, Ricelle A.; Guan, Peizhu; Blas, Andrea; Singh, Ratnesh; Paidi, Maya; Presting, Gernot; Porter, Brad; Christopher, David A.] Univ Hawaii, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA; [Tang, Haibao; Wang, Xiyin; Bowers, John E.; Navajas-Perez, Rafael; Torres, Manuel J.; Feltus, F. Alex; Paterson, Andrew H.] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; [Lyons, Eric; Freeling, Michael] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Paull, Robert E.; Wai, Ching Man; Irikura, Beth] Univ Hawaii, Dept Trop Plant & Soil Sci, Honolulu, HI 96822 USA; [Michael, Todd P.] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA; [Michael, Todd P.] Rutgers State Univ, Dept Plant Biol & Pathol, Piscataway, NJ 08854 USA; [Wall, Kerr; dePamphilis, Claude W.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Rice, Danny W.; Palmer, Jeffrey D.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Albert, Henrik; Suzuki, Jon Y.; Tripathi, Savarni; Moore, Paul H.; Gonsalves, Dennis] ARS, USDA, Pacific Basin Agr Res Ctr, Hilo, HI 96720 USA; [Shakirov, Eugene V.; Shippen, Dorothy E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Haas, Brian] Inst Genom Res, Rockville, MD 20850 USA; [Thimmapuram, Jyothi; Liu, Lei] Univ Illinois, WM Keck Ctr Comparat & Funct Genom, Urbana, IL 61801 USA; [Nelson, David] Univ Tennessee, Dept Mol Sci, Memphis, TN 38163 USA; [Neupane, Kabi] Univ Hawaii, Leeward Community Coll, Pearl City, HI 96782 USA; [Wei, Hairong] Wicell Res Inst, Madison, WI 53707 USA; [Jiang, Ning] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Zhang, Wenli; Jiang, Jiming] Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; [Windsor, Aaron; Mitchell-Olds, Thomas] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Luo, Ming-Cheng] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Mount, Stephen M.] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA; [Sugimura, Tak] Maui High Performance Comp Ctr, Kihei, HI 96753 USA; [Schuler, Mary A.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Schuler, Mary A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Schuler, Mary A.] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Friedman, Vikki] Appl Biosyst Inc, Foster City, CA 94404 USA	University of Hawaii System; University of Illinois System; University of Illinois Urbana-Champaign; Nankai University; Nankai University; University System of Maryland; University of Maryland College Park; University of Hawaii System; University System of Georgia; University of Georgia; University of California System; University of California Berkeley; University of Hawaii System; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Indiana University System; Indiana University Bloomington; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; J. Craig Venter Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Tennessee System; University of Tennessee Health Science Center; University of Hawaii System; WiCell Research Institute; Michigan State University; University of Wisconsin System; University of Wisconsin Madison; Duke University; University of California System; University of California Davis; University System of Maryland; University of Maryland College Park; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Thermo Fisher Scientific; Applied Biosystems	Alam, M (corresponding author), Univ Hawaii, Dept Microbiol, Honolulu, HI 96822 USA.	wanglei@nankai.edu.cn; alam@hawaii.edu	feng, lu/M-5113-2015; Mitchell-Olds, Thomas/K-8121-2012; Jiang, Jiming/V-6060-2019; Palmer, Jeffrey/P-6747-2014; Jiang, Jiming/A-9614-2009; Bowers, John/AAD-7601-2019; Singh, Ratnesh/A-9739-2011; wei, hairong/GNM-7061-2022; Schatz, Michael/L-2690-2019; Wang, Lei/C-5176-2009; Salzberg, Steven/Q-6514-2019; Luo, Ming-Cheng/C-5600-2011; Singh, Ratnesh/I-1392-2015; Tang, Haibao/A-6715-2011; Saw, Jimmy/J-1360-2019; Bowers, John/B-9245-2009; Tripathi, Savarni/A-6910-2009; Saw, Jimmy HW/A-9972-2009; Liu, Chao/O-7322-2018; Shakirov, Eugene V/A-1363-2012; Salzberg, Steven L/F-6162-2011; Jiang, Ning/G-6546-2012; dePamphilis, Claude W/P-6652-2016; Yu, Qingyi/E-8899-2019; Wang, Jianmei/HHZ-0585-2022; Navajas-Pérez, Rafael/F-7122-2012	Mitchell-Olds, Thomas/0000-0003-3439-9921; Jiang, Jiming/0000-0002-6435-6140; Palmer, Jeffrey/0000-0002-4626-2220; Jiang, Jiming/0000-0002-6435-6140; wei, hairong/0000-0002-3551-4998; Schatz, Michael/0000-0002-4118-4446; Wang, Lei/0000-0003-4427-0881; Salzberg, Steven/0000-0002-8859-7432; Luo, Ming-Cheng/0000-0002-9744-5887; Singh, Ratnesh/0000-0001-5647-3390; Tang, Haibao/0000-0002-3460-8570; Saw, Jimmy/0000-0001-8353-3854; Bowers, John/0000-0001-8984-9796; Tripathi, Savarni/0000-0002-1814-2117; Saw, Jimmy HW/0000-0001-8353-3854; Liu, Chao/0000-0003-1303-1175; Shakirov, Eugene V/0000-0003-2689-7410; Salzberg, Steven L/0000-0002-8859-7432; Yu, Qingyi/0000-0001-5393-5764; Navajas-Pérez, Rafael/0000-0002-6147-3640; Burroughs, A. Max/0000-0002-2229-8771; Nelson, David/0000-0003-0583-5421; Michael, Todd/0000-0001-6272-2875; Feltus, Frank/0000-0002-2123-6114; Nagarajan, Niranjan/0000-0003-0850-5604; Lyons, Eric/0000-0002-3348-8845; Bowers, John/0000-0001-5693-2796; Wang, Wei/0000-0002-6660-8540; Senin, Pavel/0000-0001-5517-7768; Mount, Steve/0000-0003-2748-8205; Rice, Danny/0000-0002-1123-4617; Gschwend, Andrea/0000-0002-6208-2457	NIGMS NIH HHS [R01 GM083873-05, R01 GM083873] Funding Source: Medline; NLM NIH HHS [R01 LM006845-08, R01 LM006845] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083873] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Attwood TK, 2003, NUCLEIC ACIDS RES, V31, P400, DOI 10.1093/nar/gkg030; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Bru C, 2005, NUCLEIC ACIDS RES, V33, pD212, DOI 10.1093/nar/gki034; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Ehlting J, 2005, PLANT J, V42, P618, DOI 10.1111/j.1365-313X.2005.02403.x; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FITCH MMM, 1992, BIO-TECHNOL, V10, P1466, DOI 10.1038/nbt1192-1466; Fry SC, 2004, NEW PHYTOL, V161, P641, DOI 10.1111/j.1469-8137.2004.00980.x; Gonsalves D, 1998, ANNU REV PHYTOPATHOL, V36, P415, DOI 10.1146/annurev.phyto.36.1.415; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Hanada K, 2007, GENOME RES, V17, P632, DOI 10.1101/gr.5836207; Huang XQ, 1997, GENOMICS, V46, P37, DOI 10.1006/geno.1997.4984; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Inada DC, 2003, GENOME RES, V13, P2030, DOI 10.1101/gr.1280703; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Korf I, 2001, Bioinformatics, V17 Suppl 1, pS140; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LANDER E S, 1988, Genomics, V2, P231; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Li L, 2006, NAT GENET, V38, P124, DOI 10.1038/ng1704; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu ZY, 2004, NATURE, V427, P348, DOI 10.1038/nature02228; Lyons E, 2008, PLANT J, V53, P661, DOI 10.1111/j.1365-313X.2007.03326.x; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Meyers BC, 2002, PLANT J, V32, P77, DOI 10.1046/j.1365-313X.2002.01404.x; PAULL RE, 1983, PLANT PHYSIOL, V72, P382, DOI 10.1104/pp.72.2.382; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Richardt S, 2007, PLANT PHYSIOL, V143, P1452, DOI 10.1104/pp.107.095760; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Sawasaki T, 1998, GENE, V218, P27, DOI 10.1016/S0378-1119(98)00388-6; Schranz ME, 2006, PLANT CELL, V18, P1152, DOI 10.1105/tpc.106.041111; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Storey W. B., 1969, Miscellaneous Papers. Landbouwhogeschool Wageningen, P389; Thomas BC, 2007, P NATL ACAD SCI USA, V104, P3348, DOI 10.1073/pnas.0611574104; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Wall PK, 2008, NUCLEIC ACIDS RES, V36, pD970, DOI 10.1093/nar/gkm972; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Yu QY, 2008, PLANT J, V53, P124, DOI 10.1111/j.1365-313X.2007.03329.x; Yu QY, 2007, MOL GENET GENOMICS, V278, P177, DOI 10.1007/s00438-007-0243-z; Zhou LL, 2001, J AM SOC HORTIC SCI, V126, P351, DOI 10.21273/JASHS.126.3.351; Zhou T, 2004, MOL GENET GENOMICS, V271, P402, DOI 10.1007/s00438-004-0990-z	51	721	843	5	209	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2008	452	7190					991	U7		10.1038/nature06856	http://dx.doi.org/10.1038/nature06856			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291PF	18432245	hybrid, Green Accepted, Green Published			2022-12-24	WOS:000255208600039
J	Kalka, MB; Smith, AR; Kalko, EKV				Kalka, Margareta B.; Smith, Adam R.; Kalko, Elisabeth K. V.			Bats limit arthropods and herbivory in a tropical forest	SCIENCE			English	Article							TREES		[Kalka, Margareta B.; Smith, Adam R.; Kalko, Elisabeth K. V.] Smithsonian Trop Res Inst, Balboa 03092, Panama; [Kalko, Elisabeth K. V.] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany	Smithsonian Institution; Smithsonian Tropical Research Institute; Ulm University	Kalka, MB (corresponding author), Smithsonian Trop Res Inst, Apdo 0843, Balboa 03092, Panama.	mbkalka@gmail.com	Smith, Adam/GPS-8322-2022					Cleveland CJ, 2006, FRONT ECOL ENVIRON, V4, P238, DOI 10.1890/1540-9295(2006)004[0238:EVOTPC]2.0.CO;2; Fine PVA, 2004, SCIENCE, V305, P663, DOI 10.1126/science.1098982; Greenberg R, 2000, ECOLOGY, V81, P1750, DOI 10.1890/0012-9658(2000)081[1750:TIOAIO]2.0.CO;2; HOLMES RT, 1979, SCIENCE, V206, P462, DOI 10.1126/science.206.4417.462; Kalka M, 2006, J TROP ECOL, V22, P1, DOI 10.1017/S0266467405002920; Van Bael SA, 2003, P NATL ACAD SCI USA, V100, P8304, DOI 10.1073/pnas.1431621100	6	194	207	2	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2008	320	5872					71	71		10.1126/science.1153352	http://dx.doi.org/10.1126/science.1153352			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283JR	18388286				2022-12-24	WOS:000254633000031
J	Hung, RJ; Mckay, JD; Gaborieau, V; Boffetta, P; Hashibe, M; Zaridze, D; Mukeria, A; Szeszenia-Dabrowska, N; Lissowska, J; Rudnai, P; Fabianova, E; Mates, D; Bencko, V; Foretova, L; Janout, V; Chen, C; Goodman, G; Field, JK; Liloglou, T; Xinarianos, G; Cassidy, A; McLaughlin, J; Liu, G; Narod, S; Krokan, HE; Skorpen, F; Elvestad, MB; Hveem, K; Vatten, L; Linseisen, J; Clavel-Chapelon, F; Vineis, P; Bueno-De-Mesquita, HB; Lund, E; Martinez, C; Bingham, S; Rasmuson, T; Hainaut, P; Riboli, E; Ahrens, W; Benhamou, S; Lagiou, P; Trichopoulos, D; Holcatova, I; Merletti, F; Kjaerheim, K; Agudo, A; Macfarlane, G; Talamini, R; Simonato, L; Lowry, R; Conway, DI; Znaor, A; Healy, C; Zelenika, D; Boland, A; Delepine, M; Foglio, M; Lechner, D; Matsuda, F; Blanche, H; Gut, I; Heath, S; Lathrop, M; Brennan, P				Hung, Rayjean J.; Mckay, James D.; Gaborieau, Valerie; Boffetta, Paolo; Hashibe, Mia; Zaridze, David; Mukeria, Anush; Szeszenia-Dabrowska, Neonilia; Lissowska, Jolanta; Rudnai, Peter; Fabianova, Eleonora; Mates, Dana; Bencko, Vladimir; Foretova, Lenka; Janout, Vladimir; Chen, Chu; Goodman, Gary; Field, John K.; Liloglou, Triantafillos; Xinarianos, George; Cassidy, Adrian; McLaughlin, John; Liu, Geoffrey; Narod, Steven; Krokan, Hans E.; Skorpen, Frank; Elvestad, Maiken Bratt; Hveem, Kristian; Vatten, Lars; Linseisen, Jakob; Clavel-Chapelon, Francoise; Vineis, Paolo; Bueno-de-Mesquita, H. Bas; Lund, Eiliv; Martinez, Carmen; Bingham, Sheila; Rasmuson, Torgny; Hainaut, Pierre; Riboli, Elio; Ahrens, Wolfgang; Benhamou, Simone; Lagiou, Pagona; Trichopoulos, Dimitrios; Holcatova, Ivana; Merletti, Franco; Kjaerheim, Kristina; Agudo, Antonio; Macfarlane, Gary; Talamini, Renato; Simonato, Lorenzo; Lowry, Ray; Conway, David I.; Znaor, Ariana; Healy, Claire; Zelenika, Diana; Boland, Anne; Delepine, Marc; Foglio, Mario; Lechner, Doris; Matsuda, Fumihiko; Blanche, Helene; Gut, Ivo; Heath, Simon; Lathrop, Mark; Brennan, Paul			A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25	NATURE			English	Article							FAGERSTROM TOLERANCE QUESTIONNAIRE; GENOME-WIDE ASSOCIATION; HAPLOTYPE MAP; DEPENDENCE; EXPRESSION; SMOKERS; CELLS; SNPS	Lung cancer is the most common cause of cancer death worldwide, with over one million cases annually(1). To identify genetic factors that modify disease risk, we conducted a genome- wide association study by analysing 317,139 single- nucleotide polymorphisms in 1,989 lung cancer cases and 2,625 controls from six central European countries. We identified a locus in chromosome region 15q25 that was strongly associated with lung cancer ( P= 9 x 10(-10)). This locus was replicated in five separate lung cancer studies comprising an additional 2,513 lung cancer cases and 4,752 controls ( P = 5 x 10(-20) overall), and it was found to account for 14%( attributable risk) of lung cancer cases. Statistically similar risks were observed irrespective of smoking status or propensity to smoke tobacco. The association region contains several genes, including three that encode nicotinic acetylcholine receptor subunits ( CHRNA5, CHRNA3 and CHRNB4). Such subunits are expressed in neurons and other tissues, in particular alveolar epithelial cells, pulmonary neuroendocrine cells and lung cancer cell lines(2,3), and they bind to N'- nitrosonornicotine and potential lung carcinogens(4). A non- synonymous variant of CHRNA5 that induces an amino acid substitution ( D398N) at a highly conserved site in the second intracellular loop of the protein is among the markers with the strongest disease associations. Our results provide compelling evidence of a locus at 15q25 predisposing to lung cancer, and reinforce interest in nicotinic acetylcholine receptors as potential disease candidates and chemopreventative targets(5).	[Hung, Rayjean J.; Mckay, James D.; Gaborieau, Valerie; Boffetta, Paolo; Hashibe, Mia; Hainaut, Pierre; Brennan, Paul] IARC, F-69008 Lyon, France; [Hung, Rayjean J.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Zaridze, David; Mukeria, Anush] Canc Res Ctr, Inst Carcinogenesis, Moscow 115478, Russia; [Szeszenia-Dabrowska, Neonilia] Inst Occupat Med, Dept Epidemiol, PL-90950 Lodz, Poland; [Lissowska, Jolanta] M Sklodowska Curie Mem Canc Ctr & Inst Oncol, PL-02781 Warsaw, Poland; [Rudnai, Peter] Natl Inst Environm Hlth, H-1097 Budapest, Hungary; [Fabianova, Eleonora] Specialized Inst Hyg & Epidemiol, Banska Bystrica 97556, Slovakia; [Mates, Dana] Inst Publ Hlth, Bucharest 050463, Romania; [Bencko, Vladimir] Charles Univ Prague, Fac Med 1, Inst Hyg & Epidemiol, Prague 12800 2, Czech Republic; [Foretova, Lenka] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno 65653, Czech Republic; [Janout, Vladimir] Palacky Univ, Olomouc 77515, Czech Republic; [Chen, Chu; Goodman, Gary] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Field, John K.; Liloglou, Triantafillos; Xinarianos, George; Cassidy, Adrian] Univ Liverpool, Canc Res Ctr, Roy Castle Lung Canc Res Programme, Liverpool L3 9TA, Merseyside, England; [McLaughlin, John] Canc Care Ontario, Toronto, ON M5G 2L7, Canada; [McLaughlin, John] Samuel Lunenfeld Res Inst, Toronto, ON M5G 2L7, Canada; [Liu, Geoffrey] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Narod, Steven] Womens Coll Res Inst, Toronto, ON M5G 1N8, Canada; [Krokan, Hans E.; Skorpen, Frank; Elvestad, Maiken Bratt; Hveem, Kristian; Vatten, Lars] Norwegian Univ Sci & Technol, N-7489 Trondheim, Norway; [Linseisen, Jakob] German Canc Res Ctr, Div Canc Epidemiol, D-69120 Heidelberg, Germany; [Clavel-Chapelon, Francoise] Inst Gustave Roussy, INSERM, ER120, F-94805 Villejuif, France; [Vineis, Paolo; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Vineis, Paolo] ISI, I-10133 Turin, Italy; [Bueno-de-Mesquita, H. Bas] Natl Inst Publ Hlth & Environm, Ctr Nutr & Hlth, NL-3710 BA Bilthoven, Netherlands; [Lund, Eiliv] Univ Tromso, Inst Community Med, N-9037 Tromso, Norway; [Martinez, Carmen] Andalusian Sch Publ Hlth & Ciber Epidemiol & Salu, Granada 18011, Spain; [Bingham, Sheila] Univ Cambridge, MRC Ctr Nutr & Canc, Dept Publ Hlth & Primary Care, Cambridge CB2 0XY, England; [Bingham, Sheila] MRC Dunn Human Nutr Unit, Cambridge CB2 0XY, England; [Rasmuson, Torgny] Umea Univ, Dept Radiat Sci, S-90187 Umea, Sweden; [Ahrens, Wolfgang] Bremen Inst Prevent Res & Social Med, D-28359 Bremen, Germany; [Benhamou, Simone] Fdn Jean Dausset CEPH, INSERM, U794, F-75010 Paris, France; [Benhamou, Simone] Inst Gustave Roussy, CNRS, FRE2939, F-94805 Villejuif, France; [Lagiou, Pagona; Trichopoulos, Dimitrios] Univ Athens, Sch Med, Dept Hyg & Epidemiol, Athens 11527, Greece; [Lagiou, Pagona; Trichopoulos, Dimitrios] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Holcatova, Ivana] Inst Hyg & Epidemiol, Prague 12800 2, Czech Republic; [Merletti, Franco] Univ Turin, I-10126 Turin, Italy; [Kjaerheim, Kristina] Canc Registry Norway, N-0310 Oslo, Norway; [Agudo, Antonio] Inst Catala Oncol, Barcelona 08907, Spain; [Macfarlane, Gary] Univ Aberdeen, Sch Med, Aberdeen AB25 2ZD, Scotland; [Talamini, Renato] Aviano Canc Ctr, I-33081 Aviano, Italy; [Simonato, Lorenzo] Univ Padua, Dept Environm Med & Publ Hlth, I-35131 Padua, Italy; [Lowry, Ray] Univ Newcastle, Sch Dent, Newcastle Upon Tyne NE2 4BW, Tyne & Wear, England; [Conway, David I.] Univ Glasgow, Sch Dent, Glasgow G2 3JZ, Lanark, Scotland; [Znaor, Ariana] Natl Inst Publ Hlth, Croatian Natl Canc Registry, Zagreb 10000, Croatia; [Healy, Claire] Univ Dublin Trinity Coll, Sch Dent Sci, Dublin 2, Ireland; [Zelenika, Diana; Boland, Anne; Delepine, Marc; Foglio, Mario; Lechner, Doris; Matsuda, Fumihiko; Gut, Ivo; Lathrop, Mark] Commiss Energie Atom, Ctr Natl Genotype, Inst Genom, F-91000 Evry, France; [Blanche, Helene; Heath, Simon; Lathrop, Mark] Ctr Etud Polymorphisme Humain, Fdn Jean Dausset, F-75010 Paris, France	World Health Organization; International Agency for Research on Cancer (IARC); University of California System; University of California Berkeley; Nofer Institute of Occupational Medicine; Maria Sklodowska-Curie National Research Institute of Oncology; Charles University Prague; Masaryk Memorial Cancer Institute; Palacky University Olomouc; Fred Hutchinson Cancer Center; University of Liverpool; Cancer Care Ontario; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; Womens College Hospital; Norwegian University of Science & Technology (NTNU); Helmholtz Association; German Cancer Research Center (DKFZ); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Imperial College London; Netherlands National Institute for Public Health & the Environment; UiT The Arctic University of Tromso; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Escuela Andaluza de Salud Publica; University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Umea University; Leibniz Institute for Prevention Research & Epidemiology (BIPS); Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; Athens Medical School; National & Kapodistrian University of Athens; Harvard University; Harvard T.H. Chan School of Public Health; University of Turin; University of Oslo; Catalan Institute of Oncology; University of Aberdeen; University of Padua; Newcastle University - UK; University of Glasgow; Trinity College Dublin; CEA; UDICE-French Research Universities; Universite Paris Saclay; Foundation Jean Dausset-CEPH	Brennan, P (corresponding author), IARC, F-69008 Lyon, France.	brennan@iarc.fr	Hung, Rayjean J/A-7439-2013; Janout, Vladimir/M-5133-2014; Vatten, Lars/AFK-2073-2022; Xinarianos, George/B-7534-2012; Benhamou, Simone/K-6554-2015; Matsuda, Fumihiko/B-9893-2009; Znaor, A/H-6718-2019; Agudo, Antonio/J-1805-2016; Boffetta, Paolo/AAI-7767-2021; Lissowska, Jolanta/AAH-3252-2020; Szeszenia-Dabrowska, Neonila/F-7190-2010; Gut, Ivo/ABF-3188-2020; Narod, Steven A/AAA-6112-2022; Bencko, Vladimir/H-8598-2017; Healy, Claire M/AGL-9755-2022; Linseisen, Jakob/B-5353-2014; Field, John K./AAD-5674-2020; Hveem, Kristian/AFV-4683-2022; Liu, Geoffrey/N-4421-2016; Benhamou, Simone/ABD-2590-2020; Zaridze, David/K-5605-2013; Holcatova, Ivana/C-8327-2017; Heath, Simon C/J-4138-2012; Vatten, Lars/AAF-9380-2022; Clavel-Chapelon, Francoise/G-6733-2014; Foglio, mary A./B-9149-2012; McLaughlin, John R/E-4577-2013; Macfarlane, Gary J/I-9521-2014; Hainaut, Pierre/B-6018-2012; Ahrens, Wolfgang/A-2740-2012	Agudo, Antonio/0000-0001-9900-5677; Boffetta, Paolo/0000-0002-3811-2791; Lissowska, Jolanta/0000-0003-2695-5799; Gut, Ivo/0000-0001-7219-632X; Bencko, Vladimir/0000-0003-1935-2228; Healy, Claire M/0000-0003-0583-6360; Linseisen, Jakob/0000-0002-9386-382X; Field, John K./0000-0003-3951-6365; Holcatova, Ivana/0000-0002-1366-0337; Heath, Simon C/0000-0002-9550-0897; Foglio, mary A./0000-0001-7715-4452; Macfarlane, Gary J/0000-0003-2322-3314; Hainaut, Pierre/0000-0002-1303-1610; SIMONATO, LORENZO/0000-0002-9914-1000; Hung, Rayjean/0000-0002-4486-7496; Ahrens, Wolfgang/0000-0003-3777-570X; Xinarianos, George/0000-0001-9185-5554; Riboli, Elio/0000-0001-6795-6080; mates, dana/0000-0002-6219-9807; BENHAMOU, Simone/0000-0001-5853-8047; Foretova, Lenka/0000-0003-0494-2620; Kjaerheim, Kristina/0000-0003-0691-3735; Skorpen, Frank/0000-0001-7093-8000; Conway, David/0000-0001-7762-4063; Liu, Geoffrey/0000-0002-2603-7296; Healy, Claire M/0000-0001-7940-4611; Lund, Eiliv/0000-0002-8071-8711	NATIONAL CANCER INSTITUTE [R01CA092039] Funding Source: NIH RePORTER; MRC [G9900432] Funding Source: UKRI; Medical Research Council [G9900432] Funding Source: Medline; NCI NIH HHS [R01 CA092039] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; BERRETINI W, 2008, MOL PSYCHIAT    0429; Chabrol H, 2005, ADDICT BEHAV, V30, P1474, DOI 10.1016/j.addbeh.2005.02.001; Coleman MP, 2003, ANN ONCOL, V14, pV128, DOI 10.1093/annonc/mdg756; Dasgupta P, 2006, CELL CYCLE, V5, P2324, DOI 10.4161/cc.5.20.3366; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; FAGERSTROM KO, 1989, J BEHAV MED, V12, P159, DOI 10.1007/BF00846549; Falush D, 2003, GENETICS, V164, P1567; Ferlay J., 2004, GLOBOCAN 2002 IARC C; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; *INT AG RES CANC, 2007, IARC HDB CANC PREV, V11, P15; International Agency for Research on Cancer, 2004, IARC MONOGRAPHS EVAL, V83, P33; Lam DCL, 2007, CANCER RES, V67, P4638, DOI 10.1158/0008-5472.CAN-06-4628; Matakidou A, 2005, BRIT J CANCER, V93, P825, DOI 10.1038/sj.bjc.6602769; Minna JD, 2003, J CLIN INVEST, V111, P31, DOI 10.1172/JCI200317492; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Russo P, 2006, CURR MED CHEM, V13, P3493, DOI 10.2174/092986706779026192; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Schuller HM, 2007, LIFE SCI, V80, P2274, DOI 10.1016/j.lfs.2007.03.006; Tritto T, 2002, PHARMACOGENETICS, V12, P197, DOI 10.1097/00008571-200204000-00004; Wang Y, 2001, MOL PHARMACOL, V60, P1201, DOI 10.1124/mol.60.6.1201; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147	23	967	1011	0	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 3	2008	452	7187					633	637		10.1038/nature06885	http://dx.doi.org/10.1038/nature06885			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282KR	18385738	Green Submitted, Green Published			2022-12-24	WOS:000254567200046
J	Ito, K; Bernardi, R; Morotti, A; Matsuoka, S; Saglio, G; Ikeda, Y; Rosenblatt, J; Avigan, DE; Teruya-Feldstein, J; Pandolfi, PP				Ito, Keisuke; Bernardi, Rosa; Morotti, Alessandro; Matsuoka, Sahoko; Saglio, Giuseppe; Ikeda, Yasuo; Rosenblatt, Jacalyn; Avigan, David E.; Teruya-Feldstein, Julie; Pandolfi, Pier Paolo			PML targeting eradicates quiescent leukaemia-initiating cells	NATURE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; ACUTE PROMYELOCYTIC LEUKEMIA; HEMATOPOIETIC STEM-CELLS; IMATINIB MESYLATE; RETINOIC ACID; MYELOID-LEUKEMIA; ARSENIC TRIOXIDE; CANCER; DISCONTINUATION; REMISSION	The existence of a small population of 'cancer-initiating cells' responsible for tumour maintenance has been firmly demonstrated in leukaemia. This concept is currently being tested in solid tumours. Leukaemia-initiating cells, particularly those that are in a quiescent state, are thought to be resistant to chemotherapy and targeted therapies, resulting in disease relapse. Chronic myeloid leukaemia is a paradigmatic haematopoietic stem cell disease in which the leukaemia-initiating-cell pool is not eradicated by current therapy, leading to disease relapse on drug discontinuation. Here we define the critical role of the promyelocytic leukaemia protein (PML) tumour suppressor in haematopoietic stem cell maintenance, and present a new therapeutic approach for targeting quiescent leukaemia-initiating cells and possibly cancer-initiating cells by pharmacological inhibition of PML.	[Ito, Keisuke; Bernardi, Rosa; Morotti, Alessandro; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Canc Genet Program, Beth Israel Deaconess Canc Ctr,Dept Med, Boston, MA 02215 USA; [Ito, Keisuke; Bernardi, Rosa; Morotti, Alessandro; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Canc Genet Program, Beth Israel Deaconess Canc Ctr,Dept Pathol, Boston, MA 02215 USA; [Rosenblatt, Jacalyn; Avigan, David E.] Harvard Univ, Sch Med, Div Hematol & Oncol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Ito, Keisuke; Bernardi, Rosa; Morotti, Alessandro; Pandolfi, Pier Paolo] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Ito, Keisuke; Bernardi, Rosa; Morotti, Alessandro; Teruya-Feldstein, Julie; Pandolfi, Pier Paolo] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Matsuoka, Sahoko; Ikeda, Yasuo] Keio Univ, Sch Med, Div Hematol, Dept Internal Med,Shinjuku Ku, Tokyo 1608582, Japan; [Saglio, Giuseppe] Univ Turin, Div Hematol & Internal Med, Dept Clin & Biol Sci, I-10043 Turin, Italy	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Keio University; University of Turin	Pandolfi, PP (corresponding author), Harvard Univ, Sch Med, Canc Genet Program, Beth Israel Deaconess Canc Ctr,Dept Med, New Res Bldg,330 Brookline Ave, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Morotti, Alessandro/J-7590-2018; bernardi, rosa/B-1650-2013	Morotti, Alessandro/0000-0002-8407-2903; bernardi, rosa/0000-0002-3607-6336; Saglio, Giuseppe/0000-0002-1046-3514	NATIONAL CANCER INSTITUTE [R00CA139009, R37CA071692, K99CA139009] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA071692-12, R00 CA139009, K99 CA139009, R37 CA071692] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Aronson S M, 1994, R I Med, V77, P233; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Bhatia R, 2003, BLOOD, V101, P4701, DOI 10.1182/blood-2002-09-2780; BRUCE WR, 1963, NATURE, V199, P79, DOI 10.1038/199079a0; Cortes J, 2004, BLOOD, V104, P2204, DOI 10.1182/blood-2004-04-1335; CROSS NCP, 1993, BRIT J HAEMATOL, V84, P67, DOI 10.1111/j.1365-2141.1993.tb03026.x; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; DEKLEIN A, 1982, NATURE, V300, P765, DOI 10.1038/300765a0; Di Cristofano A, 2001, J EXP MED, V194, P275, DOI 10.1084/jem.194.3.275; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Ghanima W, 2004, EUR J HAEMATOL, V72, P441, DOI 10.1111/j.1600-0609.2004.00257.x; Gurrieri C, 2004, BLOOD, V103, P2358, DOI 10.1182/blood-2003-07-2200; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Higashi T, 2004, AM J HEMATOL, V76, P275, DOI 10.1002/ajh.20096; Holtz M, 2007, CANCER RES, V67, P1113, DOI 10.1158/0008-5472.CAN-06-2014; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Huntly BJP, 2005, NAT REV CANCER, V5, P311, DOI 10.1038/nrc1592; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Jorgensen HG, 2005, EXP HEMATOL, V33, P1140, DOI 10.1016/j.exphem.2005.05.020; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; KLAASSEN CD, 1996, PHARMACOL BASIS THER, P1649; Lallemand-Breitenbach V, 1999, J EXP MED, V189, P1043, DOI 10.1084/jem.189.7.1043; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Mathews V, 2006, BLOOD, V107, P2627, DOI 10.1182/blood-2005-08-3532; Mauro MJ, 2004, LEUKEMIA RES, V28, pS71, DOI 10.1016/j.leukres.2003.10.017; Merante S, 2005, HAEMATOLOGICA, V90, P979; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Rego EM, 2000, P NATL ACAD SCI USA, V97, P10173, DOI 10.1073/pnas.180290497; Rego EM, 2001, J EXP MED, V193, P521, DOI 10.1084/jem.193.4.521; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rousselot P, 2007, BLOOD, V109, P58, DOI 10.1182/blood-2006-03-011239; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Scadden DT, 2004, NAT IMMUNOL, V5, P701, DOI 10.1038/ni0704-701; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wang ZG, 1998, SCIENCE, V279, P1547; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747	45	437	465	3	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2008	453	7198					1072	U4		10.1038/nature07016	http://dx.doi.org/10.1038/nature07016			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18469801	Green Accepted			2022-12-24	WOS:000256839900050
J	Tagkopoulos, I; Liu, YC; Tavazoie, S				Tagkopoulos, Ilias; Liu, Yir-Chung; Tavazoie, Saeed			Predictive behavior within microbial genetic networks	SCIENCE			English	Article							ESCHERICHIA-COLI; REGULATORY ROLE; EVOLUTION; ADAPTATION; OSCILLATORS; ROBUSTNESS; MICROARRAY; ORGANISMS; DYNAMICS; GENOME	The homeostatic framework has dominated our understanding of cellular physiology. We question whether homeostasis alone adequately explains microbial responses to environmental stimuli, and explore the capacity of intracellular networks for predictive behavior in a fashion similar to metazoan nervous systems. We show that in silico biochemical networks, evolving randomly under precisely defined complex habitats, capture the dynamical, multidimensional structure of diverse environments by forming internal representations that allow prediction of environmental change. We provide evidence for such anticipatory behavior by revealing striking correlations of Escherichia coli transcriptional responses to temperature and oxygen perturbations- precisely mirroring the covariation of these parameters upon transitions between the outside world and the mammalian gastrointestinal tract. We further show that these internal correlations reflect a true associative learning paradigm, because they show rapid decoupling upon exposure to novel environments.	[Tagkopoulos, Ilias; Liu, Yir-Chung; Tavazoie, Saeed] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Tagkopoulos, Ilias] Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA; [Liu, Yir-Chung; Tavazoie, Saeed] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Tavazoie, S (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	tavazoie@genomics.princeton.edu	Tagkopoulos, Ilias/B-3468-2009	Tagkopoulos, Ilias/0000-0003-1104-7616	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003787] Funding Source: NIH RePORTER; NIGMS NIH HHS [P50 GM071508, P50 GM071508-01, P50 GM071508-06] Funding Source: Medline; NIH HHS [DP1 OD003787] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Berman-Frank I, 2001, SCIENCE, V294, P1534, DOI 10.1126/science.1064082; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Cannon W.B., 1932, WISDOM BODY; Cheung KJ, 2003, GENOME RES, V13, P206, DOI 10.1101/gr.401003; Courcelle J, 2001, GENETICS, V158, P41; Dunne C, 2001, INFLAMM BOWEL DIS, V7, P136, DOI 10.1097/00054725-200105000-00010; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Francois P, 2004, P NATL ACAD SCI USA, V101, P580, DOI 10.1073/pnas.0304532101; Francois P, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100192; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Neidhardt F.C., 1996, ESCHERICHIA SALMONEL; Rodrigo G, 2007, CENT EUR J BIOL, V2, P233, DOI 10.2478/s11535-007-0016-z; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Soyer OS, 2006, J THEOR BIOL, V241, P223, DOI 10.1016/j.jtbi.2005.11.024; Wagner A, 2005, P NATL ACAD SCI USA, V102, P11775, DOI 10.1073/pnas.0501094102; Yura T, 1999, CURR OPIN MICROBIOL, V2, P153, DOI 10.1016/S1369-5274(99)80027-7	25	276	282	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2008	320	5881					1313	1317		10.1126/science.1154456	http://dx.doi.org/10.1126/science.1154456			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309DO	18467556	Green Accepted			2022-12-24	WOS:000256441100037
J	Li, LB; Yu, ZM; Teng, XY; Bonini, NM				Li, Ling-Bo; Yu, Zhenming; Teng, Xiuyin; Bonini, Nancy M.			RNA toxicity is a component of ataxin-3 degeneration in Drosophila	NATURE			English	Article							POLYGLUTAMINE-INDUCED DISEASE; MYOTONIC-DYSTROPHY TYPE-1; SCA1 TRANSGENIC MICE; MUSCLEBLIND PROTEINS; BINDING PROTEIN; NUCLEAR FOCI; NEURODEGENERATION; REPEATS; AGGREGATION; INCLUSIONS	Polyglutamine (polyQ) diseases are a class of dominantly inherited neurodegenerative disorders caused by the expansion of a CAG repeat encoding glutamine within the coding region of the respective genes(1). The molecular and cellular pathways underlying polyQ-induced neurodegeneration are the focus of much research, and it is widely considered that toxic activities of the protein, resulting from the abnormally long polyQ tract, cause pathogenesis(2,3). Here we provide evidence for a pathogenic role of the CAG repeat RNA in polyQ toxicity using Drosophila. In a Drosophila screen for modifiers of polyQ degeneration induced by the spinocerebellar ataxia type 3 (SCA3) protein ataxin-3, we isolated an upregulation allele of muscleblind (mbl), a gene implicated in the RNA toxicity of CUG expansion diseases(4-6). Further analysis indicated that there may be a toxic role of the RNA in polyQ-induced degeneration. We tested the role of the RNA by altering the CAG repeat sequence to an interrupted CAACAG repeat within the polyQ-encoding region; this dramatically mitigated toxicity. In addition, expression of an untranslated CAG repeat of pathogenic length conferred neuronal degeneration. These studies reveal a role for the RNA in polyQ toxicity, highlighting common components in RNA-based and polyQ-protein-based trinucleotide repeat expansion diseases.	[Li, Ling-Bo; Yu, Zhenming; Teng, Xiuyin; Bonini, Nancy M.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Yu, Zhenming; Teng, Xiuyin; Bonini, Nancy M.] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania	Bonini, NM (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	nbonini@sas.upenn.edu		Bonini, Nancy/0000-0003-0226-5291	Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [R01 NS043578-04, R01 NS043578-02, R01 NS043578-03, R01 NS043578-01A1, R01 NS043578, R01 NS043578-05] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043578] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Artero R, 1998, DEV BIOL, V195, P131, DOI 10.1006/dbio.1997.8833; Begemann G, 1997, DEVELOPMENT, V124, P4321; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Garcia-Casado Z, 2002, GENESIS, V34, P111, DOI 10.1002/gene.10147; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Goti D, 2004, J NEUROSCI, V24, P10266, DOI 10.1523/JNEUROSCI.2734-04.2004; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Ho TH, 2005, J CELL SCI, V118, P2923, DOI 10.1242/jcs.02404; Jiang H, 2004, HUM MOL GENET, V13, P3079, DOI 10.1093/hmg/ddh327; Jin P, 2003, NEURON, V39, P739, DOI 10.1016/S0896-6273(03)00533-6; Jung J, 2007, SCIENCE, V315, P1857, DOI 10.1126/science.1139517; Kanadia RN, 2006, P NATL ACAD SCI USA, V103, P11748, DOI 10.1073/pnas.0604970103; Kino Y, 2004, HUM MOL GENET, V13, P495, DOI 10.1093/hmg/ddh056; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; McLeod CJ, 2005, HUM MOL GENET, V14, P1041, DOI 10.1093/hmg/ddi096; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Ranum LPW, 2004, TRENDS GENET, V20, P506, DOI 10.1016/j.tig.2004.08.004; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Tapscott SJ, 2001, SCIENCE, V293, P816, DOI 10.1126/science.1063517; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Wheeler TM, 2007, CURR OPIN NEUROL, V20, P572, DOI 10.1097/WCO.0b013e3282ef6064	30	234	238	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2008	453	7198					1107	U9		10.1038/nature06909	http://dx.doi.org/10.1038/nature06909			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18449188	Green Accepted			2022-12-24	WOS:000256839900058
J	Sidi, S; Sanda, T; Kennedy, RD; Hagen, AT; Jette, CA; Hoffmans, R; Pascual, J; Imamura, S; Kishi, S; Amatruda, JF; Kanki, JP; Green, DR; D'Andrea, AA; Look, AT				Sidi, Samuel; Sanda, Takaomi; Kennedy, Richard D.; Hagen, Andreas T.; Jette, Cicely A.; Hoffmans, Raymond; Pascual, Jennifer; Imamura, Shintaro; Kishi, Shuji; Amatruda, James F.; Kanki, John P.; Green, Douglas R.; D'Andrea, Alan A.; Look, A. Thomas			Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3	CELL			English	Article							CYTOCHROME-C RELEASE; CELL-DEATH; TRANSGENIC ZEBRAFISH; MITOTIC CATASTROPHE; CHECKPOINT KINASES; GENOTOXIC STRESS; GLIOMA-CELLS; S-PHASE; RADIATION; ACTIVATION	Evasion of DNA damage-induced cell death, via mutation of the p53 tumor suppressor or overexpression of prosurvival Bcl-2 family proteins, is a key step toward malignant transformation and therapeutic resistance. We report that depletion or acute inhibition of checkpoint kinase 1 (Chk1) is sufficient to restore gamma-radiation-induced apoptosis in p53 mutant zebrafish embryos. Surprisingly, caspase-3 is not activated prior to DNA fragmentation, in contrast to classical intrinsic or extrinsic apoptosis. Rather, an alternative apoptotic program is engaged that cell autonomously requires atm (ataxia telangiectasia mutated), atr (ATM and Rad3-related) and caspase-2, and is not affected by p53 loss or overexpression of bcl-2/xl. Similarly, Chk1 inhibitor-treated human tumor cells hyperactivate ATM, ATR, and caspase-2 after gamma-radiation and trigger a caspase-2-dependent apoptotic program that bypasses p53 deficiency and excess Bcl-2. The evolutionarily conserved "Chk1-suppressed'' pathway defines a novel apoptotic process, whose responsiveness to Chk1 inhibitors and insensitivity to p53 and BCL2 alterations have important implications for cancer therapy.	[Sidi, Samuel; Sanda, Takaomi; Hagen, Andreas T.; Jette, Cicely A.; Hoffmans, Raymond; Pascual, Jennifer; Kanki, John P.; Look, A. Thomas] Harvard Univ, Sch Med, Dept Pediat Oncol, Boston, MA 02115 USA; [Kennedy, Richard D.; D'Andrea, Alan A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol,Div Genom Stabil & DNA Repair, Boston, MA 02115 USA; [Look, A. Thomas] Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat,Div Hematol Oncol, Boston, MA 02115 USA; [Imamura, Shintaro; Kishi, Shuji] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02114 USA; [Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Pediat Mol Biol & Internal Med, Dallas, TX 75390 USA; [Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Schepens Eye Research Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; St Jude Children's Research Hospital	Look, AT (corresponding author), Harvard Univ, Sch Med, Dept Pediat Oncol, Boston, MA 02115 USA.	thomas_look@dfci.harvard.edu	Green, Douglas R/N-8083-2018; Kennedy, Richard/J-3489-2012	Green, Douglas R/0000-0002-7332-1417; Kennedy, Richard/0000-0003-4737-6163	NHLBI NIH HHS [HL-88664, R01 HL088664, R01 HL088664-02] Funding Source: Medline; NIAID NIH HHS [R01 AI047891, AI47891] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047891] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Afshar G, 2006, CANCER RES, V66, P4223, DOI 10.1158/0008-5472.CAN-05-1283; Arienti KL, 2005, J MED CHEM, V48, P1873, DOI 10.1021/jm0495935; BAPTISTEOKOH N, 2008, CELL CYCLE      0219, V7; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Bernassola F, 2005, ONCOGENE, V24, P6982, DOI 10.1038/sj.onc.1208843; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Castedo M, 2004, ONCOGENE, V23, P4353, DOI 10.1038/sj.onc.1207573; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Cuadrado M, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-7; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Eimon PM, 2006, CELL DEATH DIFFER, V13, P1619, DOI 10.1038/sj.cdd.4402015; Fogarty P, 1997, CURR BIOL, V7, P418, DOI 10.1016/S0960-9822(06)00189-8; Frenkel J, 1999, ONCOGENE, V18, P2901, DOI 10.1038/sj.onc.1202518; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Gong JG, 1999, NATURE, V399, P806; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hong WY, 2004, CANCER RES, V64, P7256, DOI 10.1158/0008-5472.CAN-04-0931; Hsu K, 2004, BLOOD, V104, P1291, DOI 10.1182/blood-2003-09-3105; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kawabe T, 2004, MOL CANCER THER, V3, P513; Kohn EA, 2003, CANCER RES, V63, P31; Kolesnick R, 2003, ONCOGENE, V22, P5897, DOI 10.1038/sj.onc.1206702; Kratz E, 2006, CELL DEATH DIFFER, V13, P1631, DOI 10.1038/sj.cdd.4402016; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Langenau DM, 2005, BLOOD, V105, P3278, DOI 10.1182/blood-2004-08-3073; Langenau DM, 2003, SCIENCE, V299, P887, DOI 10.1126/science.1080280; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Liu QH, 2000, GENE DEV, V14, P1448; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mendelsohn AR, 2002, P NATL ACAD SCI USA, V99, P6871, DOI 10.1073/pnas.072290599; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Pyati UJ, 2007, SEMIN CANCER BIOL, V17, P154, DOI 10.1016/j.semcancer.2006.11.007; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Rentzsch F, 2003, GENE, V323, P19, DOI 10.1016/j.gene.2003.10.002; Rodriguez R, 2006, MOL BIOL CELL, V17, P402, DOI 10.1091/mbc.E05-07-0594; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Shin S, 2005, EMBO J, V24, P3532, DOI 10.1038/sj.emboj.7600827; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tse AN, 2007, CLIN CANCER RES, V13, P1955, DOI 10.1158/1078-0432.CCR-06-2793; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; Urist M, 2004, GENE DEV, V18, P3041, DOI 10.1101/gad.1221004; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wichmann A, 2006, P NATL ACAD SCI USA, V103, P9952, DOI 10.1073/pnas.0510528103; Xiao Z, 2005, ONCOGENE, V24, P1403, DOI 10.1038/sj.onc.1208309; Yount GL, 2001, ONCOGENE, V20, P2826, DOI 10.1038/sj.onc.1204393; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zhivotovsky B, 2005, BIOCHEM BIOPH RES CO, V331, P859, DOI 10.1016/j.bbrc.2005.03.191; Zhivotovsky B, 1999, CELL DEATH DIFFER, V6, P644, DOI 10.1038/sj.cdd.4400536; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296	60	258	265	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 30	2008	133	5					864	877		10.1016/j.cell.2008.03.037	http://dx.doi.org/10.1016/j.cell.2008.03.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	306UY	18510930	Bronze, Green Accepted			2022-12-24	WOS:000256274500018
J	Ying, QL; Wray, J; Nichols, J; Batlle-Morera, L; Doble, B; Woodgett, J; Cohen, P; Smith, A				Ying, Qi-Long; Wray, Jason; Nichols, Jennifer; Batlle-Morera, Laura; Doble, Bradley; Woodgett, James; Cohen, Philip; Smith, Austin			The ground state of embryonic stem cell self-renewal	NATURE			English	Article							PLURIPOTENCY; ACTIVATION; DIFFERENTIATION; TERATOCARCINOMA; MAINTENANCE; EXPRESSION; MECHANISM; SURVIVAL; RECEPTOR; GENE	In the three decades since pluripotent mouse embryonic stem (ES) cells were first described(1,2) they have been derived and maintained by using various empirical combinations of feeder cells, conditioned media, cytokines, growth factors, hormones, fetal calf serum, and serum extracts(1-7). Consequently ES-cell self-renewal is generally considered to be dependent on multifactorial stimulation of dedicated transcriptional circuitries, pre-eminent among which is the activation of STAT3 by cytokines (ref. 8). Here we show, however, that extrinsic stimuli are dispensable for the derivation, propagation and pluripotency of ES cells. Self-renewal is enabled by the elimination of differentiation-inducing signalling from mitogen-activated protein kinase. Additional inhibition of glycogen synthase kinase 3 consolidates biosynthetic capacity and suppresses residual differentiation. Complete bypass of cytokine signalling is confirmed by isolating ES cells genetically devoid of STAT3. These findings reveal that ES cells have an innate programme for self-replication that does not require extrinsic instruction. This property may account for their latent tumorigenicity. The delineation of minimal requirements for self-renewal now provides a defined platform for the precise description and dissection of the pluripotent state.	[Ying, Qi-Long] Univ So Calif, Ctr Stem Cell & Regenerat Med, Dept Cell & Neurobiol, Keck Sch Med, Los Angeles, CA 90033 USA; [Wray, Jason; Nichols, Jennifer; Batlle-Morera, Laura; Smith, Austin] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Doble, Bradley] McMaster Univ, Mcmaster Stem Cell & Canc Res Inst, Hamilton, ON L8N 3Z5, Canada; [Woodgett, James] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Cohen, Philip] Univ Dundee, Div Signal Transduct Therapy, Dundee DD1 5EH, Scotland; [Cohen, Philip] Univ Dundee, MRC Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland	University of Southern California; University of Cambridge; McMaster University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Dundee; University of Dundee	Ying, QL (corresponding author), Univ So Calif, Ctr Stem Cell & Regenerat Med, Dept Cell & Neurobiol, Keck Sch Med, 1501 San Pablo St,ZNI 529, Los Angeles, CA 90033 USA.	qying@keck.usc.edu; ags39@cscr.cam.ac.uk	Doble, Bradley/V-7848-2019; Woodgett, Jim/F-1087-2010; Doble, Brad/L-7551-2016	Doble, Bradley/0000-0002-0260-2983; Woodgett, Jim/0000-0003-3731-5797; Doble, Brad/0000-0002-0260-2983; Nichols, Jennifer/0000-0002-8650-1388; BATLLE MORERA, LAURA/0000-0002-6924-9002; Smith, Austin/0000-0002-3029-4682	Biotechnology and Biological Sciences Research Council [G15381/2] Funding Source: Medline; CIHR [12858, 12043] Funding Source: Medline; Medical Research Council [G9806702, MC_U127084348] Funding Source: Medline; Medical Research Council [G0300723B] Funding Source: researchfish; MRC [G9806702, MC_U127084348] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CIHR(Canadian Institutes of Health Research (CIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Buehr M, 2003, PHILOS T R SOC B, V358, P1397, DOI 10.1098/rstb.2003.1327; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niemann C, 2002, DEVELOPMENT, V129, P95; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; Ogawa K, 2004, GENES CELLS, V9, P471, DOI 10.1111/j.1356-9597.2004.00736.x; Rathjen J, 1999, J CELL SCI, V112, P601; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Wilder PJ, 1997, DEV BIOL, V192, P614, DOI 10.1006/dbio.1997.8777; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; YOSHIDA K, 1994, MECH DEVELOP, V45, P163, DOI 10.1016/0925-4773(94)90030-2; Zhen Y, 2007, ONCOGENE, V26, P6372, DOI 10.1038/sj.onc.1210473	36	2405	2514	5	338	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2008	453	7194					519	U5		10.1038/nature06968	http://dx.doi.org/10.1038/nature06968			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303EL	18497825	Green Accepted			2022-12-24	WOS:000256023700042
J	Baerenfaller, K; Grossmann, J; Grobei, MA; Hull, R; Hirsch-Hoffmann, M; Yalovsky, S; Zimmermann, P; Grossniklaus, U; Gruissem, W; Baginsky, S				Baerenfaller, Katja; Grossmann, Jonas; Grobei, Monica A.; Hull, Roger; Hirsch-Hoffmann, Matthias; Yalovsky, Shaul; Zimmermann, Philip; Grossniklaus, Ueli; Gruissem, Wilhelm; Baginsky, Sacha			Genome-scale proteomics reveals Arabidopsis thaliana gene models and proteome dynamics	SCIENCE			English	Article							PREDICTION; ANNOTATION; ABUNDANCE; PRIDE	We have assembled a proteome map for Arabidopsis thaliana from high-density, organ-specific proteome catalogs that we generated for different organs, developmental stages, and undifferentiated cultured cells. We matched 86,456 unique peptides to 13,029 proteins and provide expression evidence for 57 gene models that are not represented in the TAIR7 protein database. Analysis of the proteome identified organ-specific biomarkers and allowed us to compile an organ-specific set of proteotypic peptides for 4105 proteins to facilitate targeted quantitative proteomics surveys. Quantitative information for the identified proteins was used to establish correlations between transcript and protein accumulation in different plant organs. The Arabidopsis proteome map provides information about genome activity and proteome assembly and is available as a resource for plant systems biology.	[Baerenfaller, Katja; Grossmann, Jonas; Hirsch-Hoffmann, Matthias; Zimmermann, Philip; Gruissem, Wilhelm; Baginsky, Sacha] ETH, Swiss Fed Inst Technol, Inst Plant Sci, CH-8092 Zurich, Switzerland; [Baerenfaller, Katja; Grossmann, Jonas; Grobei, Monica A.; Grossniklaus, Ueli; Gruissem, Wilhelm; Baginsky, Sacha] Univ Zurich, Ctr Model Organism Proteomes, CH-8057 Zurich, Switzerland; [Grossmann, Jonas; Gruissem, Wilhelm] Funct Genom Ctr Zurich, CH-8057 Zurich, Switzerland; [Grobei, Monica A.; Grossniklaus, Ueli] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Hull, Roger] Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England; [Yalovsky, Shaul] Tel Aviv Univ, Dept Plant Sci, IL-69978 Tel Aviv, Israel	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich; University of Manchester; Tel Aviv University	Baerenfaller, K (corresponding author), ETH, Swiss Fed Inst Technol, Inst Plant Sci, Universitatstr 2, CH-8092 Zurich, Switzerland.	kbaerenfaller@ethz.ch; wgruissem@ethz.ch; sbaginsky@ethz.ch	Baerenfaller, Katja/D-8799-2017; Grossniklaus, Ueli/A-2736-2012; Baerenfaller, Katja/Z-5765-2019; Gruissem, Wilhelm/H-1752-2013; Hull, Roger/B-4080-2013; Grossniklaus, Ueli/E-9995-2016; Zimmermann, Philip/J-4488-2012	Baerenfaller, Katja/0000-0002-1904-9440; Grossniklaus, Ueli/0000-0002-0522-8974; Gruissem, Wilhelm/0000-0002-1872-2998; Hirsch-Hoffmann, Matthias/0000-0002-4802-754X; Grossmann, Jonas/0000-0002-6899-9020; Baginsky, Sacha/0000-0002-5440-3898				Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; Baginsky S, 2005, J PROTEOME RES, V4, P637, DOI 10.1021/pr049764u; Berardini TZ, 2004, PLANT PHYSIOL, V135, P745, DOI 10.1104/pp.104.040071; Brunner E, 2007, NAT BIOTECHNOL, V25, P576, DOI 10.1038/nbt1300; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; Cox J, 2007, CELL, V130, P395, DOI 10.1016/j.cell.2007.07.032; Desiere F, 2006, NUCLEIC ACIDS RES, V34, pD655, DOI [10.1093/nar/gkj040, 10.1007/978-1-60761-444-9_19]; Eriksson J, 2007, NAT BIOTECHNOL, V25, P651, DOI 10.1038/nbt1315; Foissac S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-25; Gallardo K, 2007, MOL CELL PROTEOMICS, V6, P2165, DOI 10.1074/mcp.M700171-MCP200; Jones P, 2008, NUCLEIC ACIDS RES, V36, pD878, DOI 10.1093/nar/gkm1021; Jones P, 2006, NUCLEIC ACIDS RES, V34, pD659, DOI 10.1093/nar/gkj138; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; King NL, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r106; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; Korf I, 2001, Bioinformatics, V17 Suppl 1, pS140; Kuster B, 2005, NAT REV MOL CELL BIO, V6, P577, DOI 10.1038/nrm1683; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275; Nesvizhskii AI, 2007, METHOD MOL BIOL, V367, P87, DOI DOI 10.1385/1-59745-275-0:87; Roos FF, 2007, BIOINFORMATICS, V23, P3016, DOI 10.1093/bioinformatics/btm417; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Tanner S, 2007, GENOME RES, V17, P231, DOI 10.1101/gr.5646507; Taylor CF, 2007, NAT BIOTECHNOL, V25, P887, DOI 10.1038/nbt1329; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	27	396	404	3	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2008	320	5878					938	941		10.1126/science.1157956	http://dx.doi.org/10.1126/science.1157956			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18436743				2022-12-24	WOS:000255868300044
J	Bromberg, KD; Ma'ayan, A; Neves, SR; Iyengar, R				Bromberg, Kenneth D.; Ma'ayan, Avi; Neves, Susana R.; Iyengar, Ravi			Design logic of a cannabinoid receptor signaling network that triggers neurite outgrowth	SCIENCE			English	Article							BRCA1; DATABASE; ACTIVATION; CANCER; PROTEINS; UPDATE; ROLES; CNS	Cannabinoid receptor 1 (CB1R) regulates neuronal differentiation. To understand the logic underlying decision-making in the signaling network controlling CB1R-induced neurite outgrowth, we profiled the activation of several hundred transcription factors after cell stimulation. We assembled an in silico signaling network by connecting CB1R to 23 activated transcription factors. Statistical analyses of this network predicted a role for the breast cancer 1 protein BRCA1 in neuronal differentiation and a new pathway from CB1R through phosphoinositol 3-kinase to the transcription factor paired box 6 (PAX6). Both predictions were experimentally confirmed. Results of transcription factor activation experiments that used pharmacological inhibitors of kinases revealed a network organization of partial OR gates regulating kinases stacked above AND gates that control transcription factors, which together allow for distributed decision-making in CB1R-induced neurite outgrowth.	[Bromberg, Kenneth D.; Ma'ayan, Avi; Neves, Susana R.; Iyengar, Ravi] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Iyengar, R (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	ravi.iyengar@mssm.edu	Ma'ayan, Avi/AAG-3131-2019	Ma'ayan, Avi/0000-0002-6904-1017	NCI NIH HHS [T32 CA088796, R24 CA095823, 5R24 CA095823-04, T32 CA88796] Funding Source: Medline; NCRR NIH HHS [1 S10 RR0 9145-01] Funding Source: Medline; NIGMS NIH HHS [R01 GM054508-21, P50 GM071558-01A2, R01 GM054508, P50 GM071558-030007, R01 GM072853, P50 GM071558, GM54508, P50 GM071558-02, R01 GM072853-04, P50 GM071558-01A20007, GM072853, P50 GM071558-020007] Funding Source: Medline; PHS HHS [P50-071558] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA088796, R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054508, R01GM072853, P50GM071558] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Berger SI, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-372; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Centonze D, 2007, TRENDS PHARMACOL SCI, V28, P180, DOI 10.1016/j.tips.2007.02.004; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Clagett-Dame M, 2006, J NEUROBIOL, V66, P739, DOI 10.1002/neu.20241; Dubrovska A, 2005, ONCOGENE, V24, P2289, DOI 10.1038/sj.onc.1208443; Eccles D, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.028084; Eccles D M, 2003, J Med Genet, V40, pe24, DOI 10.1136/jmg.40.3.e24; Gao B, 2001, FEBS LETT, V488, P179, DOI 10.1016/S0014-5793(00)02430-3; Garcia-Campmany L, 2007, DEVELOPMENT, V134, P65, DOI 10.1242/dev.02702; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Gowen LC, 1996, NAT GENET, V12, P191, DOI 10.1038/ng0296-191; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Gutkind J. S., 2000, SCI STKE, pre1, DOI DOI 10.1126/STKE.2000.40.RE1; Harkany T, 2007, TRENDS PHARMACOL SCI, V28, P83, DOI 10.1016/j.tips.2006.12.004; He JCJ, 2005, J BIOL CHEM, V280, P33426, DOI 10.1074/jbc.M502812200; Houvras Y, 2000, J BIOL CHEM, V275, P36230, DOI 10.1074/jbc.M002539200; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jordan JD, 2005, J BIOL CHEM, V280, P11413, DOI 10.1074/jbc.M411521200; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; Miralem T, 2003, MOL CELL BIOL, V23, P579, DOI 10.1128/MCB.23.2.579-593.2003; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xenarios I, 2001, NUCLEIC ACIDS RES, V29, P239, DOI 10.1093/nar/29.1.239; Yan Q, 2007, J BIOL CHEM, V282, P13954, DOI 10.1074/jbc.M611476200; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	37	107	109	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2008	320	5878					903	909		10.1126/science.1152662	http://dx.doi.org/10.1126/science.1152662			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18487186	Green Accepted			2022-12-24	WOS:000255868300035
J	Kuhara, A; Okumura, M; Kimata, T; Tanizawa, Y; Takano, R; Kimura, KD; Inada, H; Matsumoto, K; Mori, I				Kuhara, Atsushi; Okumura, Masatoshi; Kimata, Tsubasa; Tanizawa, Yoshinori; Takano, Ryo; Kimura, Koutarou D.; Inada, Hitoshi; Matsumoto, Kunihiro; Mori, Ikue			Temperature sensing by an olfactory neuron in a circuit controlling behavior of C-elegans	SCIENCE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; NERVOUS-SYSTEM; G-PROTEINS; CHEMOSENSATION; THERMOTAXIS; PATHWAY; GENES	Temperature is an unavoidable environmental cue that affects the metabolism and behavior of any creature on Earth, yet how animals perceive temperature is poorly understood. The nematode Caenorhabditis elegans "memorizes" temperatures, and this stored information modifies its subsequent migration along a temperature gradient. We show that the olfactory neuron designated AWC senses temperature. Calcium imaging revealed that AWC responds to temperature changes and that response thresholds differ depending on the temperature to which the animal was previously exposed. In the mutant with impaired heterotrimeric guanine nucleotide- binding protein ( G protein)- mediated signaling, AWC was hyperresponsive to temperature, whereas the AIY interneuron ( which is postsynaptic to AWC) was hyporesponsive to temperature. Thus, temperature sensation exhibits a robust influence on a neural circuit controlling a memory- regulated behavior.	[Kuhara, Atsushi; Okumura, Masatoshi; Kimata, Tsubasa; Tanizawa, Yoshinori; Takano, Ryo; Kimura, Koutarou D.; Inada, Hitoshi; Mori, Ikue] Nagoya Univ, Grad Sch Sci, Grp Mol Neurobiol, Nagoya, Aichi 4648602, Japan; [Matsumoto, Kunihiro] Nagoya Univ, Grad Sch Sci, Grp Signal Transduct, Nagoya, Aichi 4648602, Japan; [Mori, Ikue] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648602, Japan; [Mori, Ikue] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Nagoya University; Nagoya University; Nagoya University; Japan Science & Technology Agency (JST)	Mori, I (corresponding author), Nagoya Univ, Grad Sch Sci, Grp Mol Neurobiol, Nagoya, Aichi 4648602, Japan.	m46920a@nucc.cc.nagoya-u.ac.jp	Kimura, Koutarou D./T-9645-2019; Okumura, Masatoshi/AAT-2157-2020; Inada, Hitoshi/GQH-1084-2022; Kuhara, Atsushi/S-5855-2018; Inada, Hitoshi/T-2773-2019	Kimura, Koutarou D./0000-0002-3359-1578; Okumura, Masatoshi/0000-0002-0563-9909; Inada, Hitoshi/0000-0002-6121-3830; Kuhara, Atsushi/0000-0003-2994-8658; Inada, Hitoshi/0000-0002-6121-3830; Tanizawa, Yoshinori/0000-0002-5014-2483				BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Biron D, 2006, NAT NEUROSCI, V9, P1499, DOI 10.1038/nn1796; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Clark DA, 2006, J NEUROSCI, V26, P7444, DOI 10.1523/JNEUROSCI.1137-06.2006; Fukuto HS, 2004, NEURON, V42, P581, DOI 10.1016/S0896-6273(04)00252-1; Hajdu-Cronin YM, 1999, GENE DEV, V13, P1780, DOI 10.1101/gad.13.14.1780; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; Ito H, 2006, J NEUROSCI METH, V154, P45, DOI 10.1016/j.jneumeth.2005.11.011; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Kimura KD, 2004, CURR BIOL, V14, P1291, DOI 10.1016/j.cub.2004.06.060; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Mohri A, 2005, GENETICS, V169, P1437, DOI 10.1534/genetics.104.036111; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Tanizawa Y, 2006, GENE DEV, V20, P3296, DOI 10.1101/gad.1497806; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zwaal RR, 1997, GENETICS, V145, P715	22	128	144	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2008	320	5877					803	807		10.1126/science.1148922	http://dx.doi.org/10.1126/science.1148922			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18403676				2022-12-24	WOS:000255644400044
J	Hochstim, C; Deneen, B; Lukaszewicz, A; Zhou, Q; Anderson, DJ				Hochstim, Christian; Deneen, Benjamin; Lukaszewicz, Agnes; Zhou, Qiao; Anderson, David J.			Identification of positionally distinct astrocyte subtypes whose identities are specified by a homeodomain code	CELL			English	Article							PROGENITOR-CELL IDENTITY; REELIN SIGNALING PATHWAY; DEVELOPING SPINAL-CORD; VENTRAL NEURAL-TUBE; RAT OPTIC-NERVE; TRANSCRIPTION FACTOR; MOTOR-NEURON; OLIGODENDROCYTE DIFFERENTIATION; PREGANGLIONIC NEURONS; IN-VITRO	Astrocytes constitute the most abundant cell type in the central nervous system (CNS) and play diverse functional roles, but the ontogenetic origins of this phenotypic diversity are poorly understood. We have investigated whether positional identity, a fundamental organizing principle governing the generation of neuronal subtype diversity, is also relevant to astrocyte diversification. We identified three positionally distinct subtypes of white-matter astrocytes (WMA) in the spinal cord, which can be distinguished by the combinatorial expression of Reelin and Slit1. These astrocyte subtypes derive from progenitor domains expressing the homeodomain transcription factors Pax6 and Nkx6.1, respectively. Loss- and gain-of-function experiments indicate that the positional identity of these astrocyte subtypes is controlled by Pax6 and Nkx6.1 in a combinatorial manner. Thus, positional identity is an organizing principle underlying astrocyte, as well as neuronal, subtype diversification and is controlled by a homeodomain transcriptional code whose elements are reutilized following the specification of neuronal identity earlier in development.	[Hochstim, Christian; Deneen, Benjamin; Lukaszewicz, Agnes; Anderson, David J.] CALTECH, Howard Hughes Med Inst, Div Biol 216 76, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Anderson, DJ (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol 216 76, Pasadena, CA 91125 USA.	wuwei@caltech.edu		Deneen, Benjmain/0000-0002-6335-1081; Zhou, Qiao/0000-0002-0099-3909	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023476] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [R01 NS023476, R01 NS023476-22, 1R01-NS23476] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAILEY MS, 1993, J COMP NEUROL, V328, P501, DOI 10.1002/cne.903280405; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Burrill JD, 1997, DEVELOPMENT, V124, P4493; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; D'Ambrosio R, 1998, J NEUROSCI, V18, P4425; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Fu H, 2003, J COMP NEUROL, V456, P237, DOI 10.1002/cne.10481; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gauthier BR, 2007, BIOCHEM J, V403, P593, DOI 10.1042/BJ20070053; Goulding M, 2000, CURR BIOL, V10, pR565, DOI 10.1016/S0960-9822(00)00615-1; Holmes GP, 1998, MECH DEVELOP, V79, P57, DOI 10.1016/S0925-4773(98)00174-9; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kubasak MD, 2004, J COMP NEUROL, V468, P165, DOI 10.1002/cne.10946; Lemke G, 2001, ANNU REV NEUROSCI, V24, P87, DOI 10.1146/annurev.neuro.24.1.87; LIUZZI FJ, 1987, BRAIN RES, V403, P385, DOI 10.1016/0006-8993(87)90081-3; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; McMahon AP, 2000, GENE DEV, V14, P2261, DOI 10.1101/gad.840800; MILLER RH, 1984, J NEUROSCI, V4, P585; MILLER RH, 1994, PERSPECT DEV NEUROBI, V2, P225; MORI S, 1969, J COMP NEUROL, V137, P197, DOI 10.1002/cne.901370206; Mukouyama Y, 2006, P NATL ACAD SCI USA, V103, P1551, DOI 10.1073/pnas.0510658103; Muroyama Y, 2005, NATURE, V438, P360, DOI 10.1038/nature04139; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Ogawa Y, 2005, DEV NEUROSCI-BASEL, V27, P364, DOI 10.1159/000088452; Osumi N, 1997, DEVELOPMENT, V124, P2961; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Powell EM, 1997, CELL TISSUE RES, V290, P385, DOI 10.1007/s004410050945; Pringle NP, 2003, DEVELOPMENT, V130, P93, DOI 10.1242/dev.00184; Qi YC, 2001, DEVELOPMENT, V128, P2723; RAFF MC, 1984, DEV BIOL, V106, P53, DOI 10.1016/0012-1606(84)90060-5; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Sharif A, 2004, NEUROSCIENCE, V126, P263, DOI 10.1016/j.neuroscience.2004.02.039; Shibata T, 1997, J NEUROSCI, V17, P9212; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Sugimori M, 2007, DEVELOPMENT, V134, P1617, DOI 10.1242/dev.001255; Takahashi M, 2002, DEVELOPMENT, V129, P1327; Taylor DG, 2005, BIOCHEMISTRY-US, V44, P11269, DOI 10.1021/bi050821m; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; VAUGHN JE, 1967, J COMP NEUROL, V131, P143, DOI 10.1002/cne.901310206; Yip YP, 2007, J COMP NEUROL, V502, P635, DOI 10.1002/cne.21318; Yip YP, 2004, J COMP NEUROL, V475, P564, DOI 10.1002/cne.20212; Yip YP, 2004, J COMP NEUROL, V470, P210, DOI 10.1002/cne.20001; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	55	237	242	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2008	133	3					510	522		10.1016/j.cell.2008.02.046	http://dx.doi.org/10.1016/j.cell.2008.02.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455991	Green Accepted, Bronze			2022-12-24	WOS:000255503900021
J	Sun, HH; Gong, S; Carmody, RJ; Hilliard, A; Li, L; Sun, J; Kong, L; Xu, LY; Hilliard, B; Hu, SM; Shen, H; Yang, XL; Chen, YHH				Sun, Honghong; Gong, Shunyou; Carmody, Ruaidhri J.; Hilliard, Anja; Li, Li; Sun, Jing; Kong, Li; Xu, Lingyun; Hilliard, Brendan; Hu, Shimin; Shen, Hao; Yang, Xiaolu; Chen, Youhai H.			TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis	CELL			English	Article							NF-KAPPA-B; CELL-CYCLE PROGRESSION; DEATH DOMAIN PROTEIN; AUTOIMMUNE INFLAMMATION; T-LYMPHOCYTES; FAS LIGAND; ACTIVATION; CASPASE-8; APOPTOSIS; PATHWAY	Immune homeostasis is essential for the normal functioning of the immune system, and its breakdown leads to fatal inflammatory diseases. We report here the identification of a member of the tumor necrosis factor-alpha-induced protein-8 (TNFAIP8) family, designated TIPE2, that is required for maintaining immune homeostasis. TIPE2 is preferentially expressed in lymphoid tissues, and its deletion in mice leads to multiorgan inflammation, splenomegaly, and premature death. TIPE2-deficient animals are hypersensitive to septic shock, and TIPE2-deficient cells are hyper-responsive to Toll-like receptor (TLR) and T cell receptor (TCR) activation. Importantly, TIPE2 binds to caspase-8 and inhibits activating protein-1 and nuclear factor-kappa B activation while promoting Fas-induced apoptosis. Inhibiting caspase-8 significantly blocks the hyper-responsiveness of TIPE2-deficient cells. These results establish that TIPE2 is an essential negative regulator of TLR and TCR function, and its selective expression in the immune system prevents hyperresponsiveness and maintains immune homeostasis.	[Sun, Honghong; Gong, Shunyou; Carmody, Ruaidhri J.; Hilliard, Anja; Li, Li; Sun, Jing; Kong, Li; Hilliard, Brendan; Chen, Youhai H.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Hu, Shimin; Yang, Xiaolu] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; [Shen, Hao] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Chen, YHH (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	yhc@mail.med.upenn.edu	Hu, Shimin/H-3427-2019; shen, hao/HGF-0551-2022; Carmody, Ruaidhri/H-5396-2019; Gong, Shunyou/ABE-1345-2021; Chen, Youhai/AAJ-4031-2021	Hu, Shimin/0000-0001-7110-3814; Hilliard, Brendan/0000-0002-4689-6821; Gong, Shunyou/0000-0002-7883-4879	NIAID NIH HHS [R01 AI050059, R01 AI055934, R56 AI050059, AI50059, R01 AI050059-05, R01 AI055934-04, R01 AI050059-04, AI069289, R01 AI136945, R01 AI069289, R01 AI050059-03, R01 AI055934-05] Funding Source: Medline; NIDDK NIH HHS [R01 DK070691, R01 DK070691-02, DK070691] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI050059, R01AI055934, R01AI069289, R01AI050059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070691] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bidere N, 2006, CURR BIOL, V16, P1666, DOI 10.1016/j.cub.2006.06.062; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Carmody RJ, 2002, J NEUROIMMUNOL, V133, P95, DOI 10.1016/S0165-5728(02)00366-1; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Chaudhary PM, 2000, ONCOGENE, V19, P4451, DOI 10.1038/sj.onc.1203812; Chaudhary PM, 1999, J BIOL CHEM, V274, P19211, DOI 10.1074/jbc.274.27.19211; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Dudley E, 1999, EUR J IMMUNOL, V29, P878, DOI 10.1002/(SICI)1521-4141(199903)29:03<878::AID-IMMU878>3.0.CO;2-9; Hu WH, 2000, J BIOL CHEM, V275, P10838, DOI 10.1074/jbc.275.15.10838; Hua ZC, 2003, IMMUNITY, V18, P513, DOI 10.1016/S1074-7613(03)00083-9; Hueber AO, 2000, J BIOL CHEM, V275, P10453, DOI 10.1074/jbc.275.14.10453; KABELITZ D, 1993, IMMUNOL TODAY, V14, P338, DOI 10.1016/0167-5699(93)90231-9; Kumar D, 2004, ONCOGENE, V23, P612, DOI 10.1038/sj.onc.1207123; Kumar D, 2000, J BIOL CHEM, V275, P2973, DOI 10.1074/jbc.275.4.2973; Lemmers B, 2007, J BIOL CHEM, V282, P7416, DOI 10.1074/jbc.M606721200; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; Ochsenbein AF, 1999, P NATL ACAD SCI USA, V96, P9293, DOI 10.1073/pnas.96.16.9293; Patel S, 1997, ORAL ONCOL, V33, P197, DOI 10.1016/S0964-1955(96)00065-6; Rivera-Walsh I, 2000, J BIOL CHEM, V275, P25222, DOI 10.1074/jbc.M000444200; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Salmena L, 2005, J EXP MED, V202, P727, DOI 10.1084/jem.20050683; Song KM, 2000, J EXP MED, V191, P1095, DOI 10.1084/jem.191.7.1095; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Van Parijs L, 1998, SCIENCE, V280, P243; Wahl SM, 2006, IMMUNOL REV, V213, P213, DOI 10.1111/j.1600-065X.2006.00437.x; Yoshinaga-Hirabayashi T, 2001, MARC MALPIG SYMP SER, V7, P51; Zhang CB, 2006, MOL THER, V13, P947, DOI 10.1016/j.ymthe.2005.11.020	29	274	328	0	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2008	133	3					415	426		10.1016/j.cell.2008.03.026	http://dx.doi.org/10.1016/j.cell.2008.03.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455983	Green Accepted, Bronze			2022-12-24	WOS:000255503900013
J	Lammermann, T; Bader, BL; Monkley, SJ; Worbs, T; Wedlich-Soldner, R; Hirsch, K; Keller, M; Forster, R; Critchley, DR; Fassler, R; Sixt, M				Laemmermann, Tim; Bader, Bernhard L.; Monkley, Susan J.; Worbs, Tim; Wedlich-Soeldner, Roland; Hirsch, Karin; Keller, Markus; Foerster, Reinhold; Critchley, David R.; Faessler, Reinhard; Sixt, Michael			Rapid leukocyte migration by integrin-independent flowing and squeezing	NATURE			English	Article							DENDRITIC CELLS; BLOOD-VESSELS; ADHESION; MOUSE; BETA-1-INTEGRIN; MOTILITY; COLLAGEN; FORCE; LINKS; TALIN	All metazoan cells carry transmembrane receptors of the integrin family, which couple the contractile force of the actomyosin cytoskeleton to the extracellular environment. In agreement with this principle, rapidly migrating leukocytes use integrin- mediated adhesion when moving over two- dimensional surfaces. As migration on two- dimensional substrates naturally overemphasizes the role of adhesion, the contribution of integrins during three- dimensional movement of leukocytes within tissues has remained controversial. We studied the interplay between adhesive, contractile and protrusive forces during interstitial leukocyte chemotaxis in vivo and in vitro. We ablated all integrin heterodimers from murine leukocytes, and show here that functional integrins do not contribute to migration in three- dimensional environments. Instead, these cells migrate by the sole force of actin- network expansion, which promotes protrusive flowing of the leading edge. Myosin II- dependent contraction is only required on passage through narrow gaps, where a squeezing contraction of the trailing edge propels the rigid nucleus.	[Laemmermann, Tim; Hirsch, Karin; Faessler, Reinhard; Sixt, Michael] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Wedlich-Soeldner, Roland] Max Planck Inst Biochem, Jr Res Grp Cellular Dynam & Cell Patterning, D-82152 Martinsried, Germany; [Bader, Bernhard L.; Keller, Markus] Tech Univ Munich, Dept Med Nutr, D-85350 Freising Weihenstephan, Germany; [Monkley, Susan J.; Critchley, David R.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Worbs, Tim; Foerster, Reinhold] Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany	Max Planck Society; Max Planck Society; Technical University of Munich; University of Leicester; Hannover Medical School	Sixt, M (corresponding author), Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany.	sixt@biochem.mpg.de	Keller, Markus/A-2823-2009; Förster, Reinhold/D-6770-2011; Lämmermann, Tim/AAD-7453-2022; Sixt, Michael/F-3925-2010	Forster, Reinhold/0000-0001-6190-7923; Worbs, Tim/0000-0001-9945-3103; Sixt, Michael/0000-0002-6620-9179; Monkley, Susan/0000-0001-9174-6278	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; BERG DJ, 1995, J EXP MED, V182, P99, DOI 10.1084/jem.182.1.99; Bottino D, 2002, J CELL SCI, V115, P367; Bungartz G, 2006, BLOOD, V108, P1857, DOI 10.1182/blood-2005-10-007658; Calderwood DA, 2003, NAT CELL BIOL, V5, P694, DOI 10.1038/ncb0803-694; Croft DR, 2005, J CELL BIOL, V168, P245, DOI 10.1083/jcb.200409049; DEBRUYN PPH, 1946, ANAT REC, V95, P177, DOI 10.1002/ar.1090950209; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Hu SH, 2005, BIOCHEM BIOPH RES CO, V329, P423, DOI 10.1016/j.bbrc.2005.02.026; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lammermann T, 2008, IMMUNOL REV, V221, P26, DOI 10.1111/j.1600-065X.2008.00592.x; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Morin NA, 2008, J EXP MED, V205, P195, DOI 10.1084/jem.20071543; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Paluch E, 2006, TRENDS CELL BIOL, V16, P5, DOI 10.1016/j.tcb.2005.11.003; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Pittet MJ, 2008, IMMUNOL REV, V221, P107, DOI 10.1111/j.1600-065X.2008.00584.x; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076; Sixt M, 2006, CURR OPIN CELL BIOL, V18, P482, DOI 10.1016/j.ceb.2006.08.007; Stoitzner P, 2002, J INVEST DERMATOL, V118, P117, DOI 10.1046/j.0022-202x.2001.01631.x; Vanni S, 2003, BIOPHYS J, V84, P2715, DOI 10.1016/S0006-3495(03)75077-2; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; WILSON RW, 1993, J IMMUNOL, V151, P1571; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706	45	962	977	3	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2008	453	7191					51	+		10.1038/nature06887	http://dx.doi.org/10.1038/nature06887			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294ID	18451854	Green Published			2022-12-24	WOS:000255398800037
J	Bieber, T				Bieber, Thomas			Mechanisms of disease: Atopic dermatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							FC-EPSILON-RI; EPIDERMAL LANGERHANS CELLS; SINGLE NUCLEOTIDE POLYMORPHISMS; PLASMACYTOID DENDRITIC CELLS; CORNEUM CHYMOTRYPTIC ENZYME; HIGH-AFFINITY RECEPTOR; OF-FUNCTION MUTATIONS; SKIN BARRIER FUNCTION; PATCH TEST REACTIONS; T-CELLS		Univ Bonn, Med Ctr, Dept Dermatol & Allergy, D-53105 Bonn, Germany	University of Bonn	Bieber, T (corresponding author), Univ Bonn, Med Ctr, Dept Dermatol & Allergy, Sigmund Freud Str 25, D-53105 Bonn, Germany.	thomas.bieber@ukb.uni-bonn.de						Ahmad-Nejad P, 2004, J ALLERGY CLIN IMMUN, V113, P565, DOI 10.1016/j.jaci.2003.12.583; Aichberger KJ, 2005, J IMMUNOL, V175, P1286, DOI 10.4049/jimmunol.175.2.1286; Akdis CA, 2006, J ALLERGY CLIN IMMUN, V118, P724; Akdis CA, 2006, J ALLERGY CLIN IMMUN, V118, P152, DOI 10.1016/j.jaci.2006.03.045; Berth-Jones J, 2003, BRIT MED J, V326, P1367, DOI 10.1136/bmj.326.7403.1367; BIEBER T, 1992, J EXP MED, V175, P1285, DOI 10.1084/jem.175.5.1285; Bieber T, 2007, IMMUNOBIOLOGY, V212, P499, DOI 10.1016/j.imbio.2007.03.001; Bowcock AM, 2004, HUM MOL GENET, V13, pR43, DOI 10.1093/hmg/ddh094; Braff MH, 2006, CURR TOP MICROBIOL, V306, P91; BRATTON DL, 1995, J CLIN INVEST, V95, P211, DOI 10.1172/JCI117642; BRUYNZEELKOOMEN C, 1986, ARCH DERMATOL RES, V278, P199, DOI 10.1007/BF00412924; Bunikowski R, 1999, J ALLERGY CLIN IMMUN, V103, P119, DOI 10.1016/S0091-6749(99)70535-X; Cao W, 2007, CURR OPIN IMMUNOL, V19, P24, DOI 10.1016/j.coi.2006.11.004; Cardona ID, 2006, J ALLERGY CLIN IMMUN, V117, P688, DOI 10.1016/j.jaci.2005.11.037; Cardona ID, 2006, AM J CLIN DERMATOL, V7, P273, DOI 10.2165/00128071-200607050-00001; CHAN SC, 1993, J IMMUNOL, V151, P3345; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; Cookson WOCM, 2001, NAT GENET, V27, P372, DOI 10.1038/86867; Cork MJ, 2006, J ALLERGY CLIN IMMUN, V118, P3, DOI 10.1016/j.jaci.2006.04.042; Denburg JA, 2006, EUR RESPIR J, V27, P441, DOI 10.1183/09031936.06.00000706; Diepgen TL, 2002, PEDIAT ALLERG IMM-UK, V13, P278, DOI 10.1034/j.1399-3038.2002.01047.x; Flohr C, 2004, J ALLERGY CLIN IMMUN, V114, P150, DOI 10.1016/j.jaci.2004.04.027; Gilliet M, 2003, J EXP MED, V197, P1059, DOI 10.1084/jem.20030240; Gombert M, 2005, J IMMUNOL, V174, P8219, DOI 10.4049/jimmunol.174.12.8219; Gombert M, 2005, J IMMUNOL, V174, P5082, DOI 10.4049/jimmunol.174.8.5082; GREWE M, 1995, J INVEST DERMATOL, V105, P407, DOI 10.1111/1523-1747.ep12321078; Haagerup A, 2004, ACTA DERM-VENEREOL, V84, P346, DOI 10.1080/00015550410034426; Hallstrand TS, 2004, BLOOD, V104, P3086, DOI 10.1182/blood-2004-05-1775; Hansson L, 2002, J INVEST DERMATOL, V118, P444, DOI 10.1046/j.0022-202x.2001.01684.x; Hoffjan S, 2005, J MOL MED, V83, P682, DOI 10.1007/s00109-005-0672-2; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; Homey B, 2006, J ALLERGY CLIN IMMUN, V118, P178, DOI 10.1016/j.jaci.2006.03.047; Howell MD, 2006, J ALLERGY CLIN IMMUN, V117, P836, DOI 10.1016/j.jaci.2005.12.1345; Howell MD, 2006, IMMUNITY, V24, P341, DOI 10.1016/j.immuni.2006.02.006; Howell MD, 2007, J ALLERGY CLIN IMMUN, V120, P150, DOI 10.1016/j.jaci.2007.04.031; Hudson TJ, 2006, NAT GENET, V38, P399, DOI 10.1038/ng0406-399; Illi S, 2004, J ALLERGY CLIN IMMUN, V113, P925, DOI 10.1016/j.jaci.2004.01.778; Ingordo V, 2002, J EUR ACAD DERMATOL, V16, P450, DOI 10.1046/j.1468-3083.2002.00525.x; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Kerschenlohr K, 2004, CURR ALLERGY ASTHM R, V4, P285, DOI 10.1007/s11882-004-0072-7; Kerschenlohr K, 2003, J ALLERGY CLIN IMMUN, V111, P869, DOI 10.1067/mai.2003.1347; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Lange J, 2005, PEDIAT ALLERG IMM-UK, V16, P456, DOI 10.1111/j.1399-3038.2005.00277.x; LARSEN FVS, 1985, ACTA DERM-VENEREOL, P159; Lee YA, 2000, NAT GENET, V26, P470, DOI 10.1038/82625; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Marenholz I, 2006, J ALLERGY CLIN IMMUN, V118, P866, DOI 10.1016/j.jaci.2006.07.026; McGirt LY, 2006, J ALLERGY CLIN IMMUN, V118, P202, DOI 10.1016/j.jaci.2006.04.033; MIHM MC, 1976, J INVEST DERMATOL, V67, P305, DOI 10.1111/1523-1747.ep12514346; Mittermann I, 2004, CURR OPIN ALLERGY CL, V4, P367, DOI 10.1097/00130832-200410000-00007; Morales J, 1999, P NATL ACAD SCI USA, V96, P14470, DOI 10.1073/pnas.96.25.14470; Morar N, 2006, J ALLERGY CLIN IMMUN, V118, P24, DOI 10.1016/j.jaci.2006.03.037; Mothes N, 2005, J ALLERGY CLIN IMMUN, V116, P706, DOI 10.1016/j.jaci.2005.06.025; Neis MM, 2006, J ALLERGY CLIN IMMUN, V118, P930, DOI 10.1016/j.jaci.2006.07.015; Nomura L, 2003, J ALLERGY CLIN IMMUN, V112, P1195, DOI 10.1016/j.jaci.2003.08.049; Nomura T, 2007, J ALLERGY CLIN IMMUN, V119, P434, DOI 10.1016/j.jaci.2006.12.646; Novak N, 2003, J ALLERGY CLIN IMMUN, V112, P252, DOI 10.1067/mai.2003.1595; Novak N, 2005, J AM ACAD DERMATOL, V53, pS171, DOI 10.1016/j.jaad.2005.04.060; Novak N, 2005, J ALLERGY CLIN IMMUN, V115, P828, DOI 10.1016/j.jaci.2005.01.030; Novak N, 2004, J ALLERGY CLIN IMMUN, V113, P949, DOI 10.1016/j.jaci.2004.02.005; Novak N, 2002, J INVEST DERMATOL, V119, P870, DOI 10.1046/j.1523-1747.2002.00191.x; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Ou LS, 2004, J ALLERGY CLIN IMMUN, V113, P756, DOI 10.1016/j.jaci.2004.01.772; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Palmer LJ, 2005, LANCET, V366, P1223, DOI 10.1016/S0140-6736(05)67485-5; Paus R, 2006, J CLIN INVEST, V116, P1174, DOI 10.1172/JCI28553; Peng WM, 2007, J INVEST DERMATOL, V127, P1261, DOI 10.1038/sj.jid.5700657; Proksch E, 2003, CLIN DERMATOL, V21, P134, DOI 10.1016/S0738-081X(02)00370-X; Proksch E, 2006, J DERMATOL SCI, V43, P159, DOI 10.1016/j.jdermsci.2006.06.003; Reich K, 2001, J IMMUNOL, V167, P6321, DOI 10.4049/jimmunol.167.11.6321; Rieg S, 2005, J IMMUNOL, V174, P8003, DOI 10.4049/jimmunol.174.12.8003; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Schmid-Grendelmeier P, 2005, J ALLERGY CLIN IMMUN, V115, P1068, DOI 10.1016/j.jaci.2005.01.065; Schmid-Wendtner MH, 2006, SKIN PHARMACOL PHYS, V19, P296, DOI 10.1159/000094670; SCOTT IR, 1986, DEV BIOL, V115, P84, DOI 10.1016/0012-1606(86)90230-7; Seguchi T, 1996, ARCH DERMATOL RES, V288, P442, DOI 10.1007/s004030050080; Shreffler WG, 2006, J IMMUNOL, V177, P3677, DOI 10.4049/jimmunol.177.6.3677; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Soderhall C, 2007, PLOS BIOL, V5, P1952, DOI 10.1371/journal.pbio.0050242; Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Taha RA, 1998, J ALLERGY CLIN IMMUN, V102, P245, DOI 10.1016/S0091-6749(98)70093-4; Traidl-Hoffmann C, 2005, J EXP MED, V201, P627, DOI 10.1084/jem.20041065; Trautmann A, 2000, J CLIN INVEST, V106, P25, DOI 10.1172/JCI9199; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Vasilopoulos Y, 2004, J INVEST DERMATOL, V123, P62, DOI 10.1111/j.0022-202X.2004.22708.x; Verhagen J, 2006, J ALLERGY CLIN IMMUN, V117, P176, DOI 10.1016/j.jaci.2005.10.040; von Bubnoff D, 2004, ALLERGY, V59, P933, DOI 10.1111/j.1398-9995.2004.00546.x; WANG B, 1992, J EXP MED, V175, P1353, DOI 10.1084/jem.175.5.1353; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P922; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P724; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P214, DOI 10.1016/j.jaci.2006.05.004; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P277, DOI 10.1016/j.jaci.2006.04.034; Williams H, 2006, J ALLERGY CLIN IMMUN, V118, P209, DOI 10.1016/j.jaci.2006.04.043; Wollenberg A, 2002, J INVEST DERMATOL, V119, P1096, DOI 10.1046/j.1523-1747.2002.19515.x; Wollenberg A, 1996, J INVEST DERMATOL, V106, P446, DOI 10.1111/1523-1747.ep12343596; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547; Zutavern A, 2005, CLIN EXP ALLERGY, V35, P1301, DOI 10.1111/j.1365-2222.2005.02350.x	101	1401	1487	10	208	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 3	2008	358	14					1483	1494		10.1056/NEJMra074081	http://dx.doi.org/10.1056/NEJMra074081			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	282CY	18385500				2022-12-24	WOS:000254546400009
J	Montoya, D; Zavala, MA; Rodriguez, MA; Purves, DW				Montoya, Daniel; Zavala, Miguel A.; Rodriguez, Miguel A.; Purves, Drew W.			Animal versus wind dispersal and the robustness of tree species to deforestation	SCIENCE			English	Article							LONG-DISTANCE DISPERSAL; SEED DISPERSAL; HABITAT; CORRIDORS; NETWORKS	Studies suggest that populations of different species do not decline equally after habitat loss. However, empirical tests have been confined to fine spatiotemporal scales and have rarely included plants. Using data from 89,365 forest survey plots covering peninsular Spain, we explored, for each of 34 common tree species, the relationship between probability of occurrence and the local cover of remaining forest. Twenty-four species showed a significant negative response to forest loss, so that decreased forest cover had a negative effect on tree diversity, but the responses of individual species were highly variable. Animal-dispersed species were less vulnerable to forest loss, with six showing positive responses to decreased forest cover. The results imply that plant-animal interactions help prevent the collapse of forest communities that suffer habitat destruction.	[Montoya, Daniel; Zavala, Miguel A.; Rodriguez, Miguel A.] Univ Alcala de Henares, Dept Ecol, Alcala De Henares 28871, Spain; [Zavala, Miguel A.] Inst Nacl Invest & Tecnol Agr & Alimentaria, Ctr Invest Forestal, Madrid 28040, Spain; [Purves, Drew W.] Microsoft Res Cambridge, Cambridge CB3 0FB, England	Universidad de Alcala; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Microsoft	Montoya, D (corresponding author), Univ Alcala de Henares, Dept Ecol, Alcala De Henares 28871, Spain.	daniel.montoya@alu.uah.es	Montoya, Daniel/L-2266-2019; Rodriguez, Miguel A/A-3409-2011; Zavala, Miguel A./H-3603-2015	Montoya, Daniel/0000-0002-5521-5282; Rodriguez, Miguel A/0000-0002-4082-2995; Zavala, Miguel A./0000-0003-1456-0132				Bascompte J, 2001, ECOL LETT, V4, P417, DOI 10.1046/j.1461-0248.2001.00242.x; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Chetkiewicz CLB, 2006, ANNU REV ECOL EVOL S, V37, P317, DOI 10.1146/annurev.ecolsys.37.091305.110050; Conradt L, 2001, OIKOS, V95, P416, DOI 10.1034/j.1600-0706.2001.950306.x; Damschen EI, 2006, SCIENCE, V313, P1284, DOI 10.1126/science.1130098; Fahrig L, 2001, BIOL CONSERV, V100, P65, DOI 10.1016/S0006-3207(00)00208-1; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Ferraz G, 2007, SCIENCE, V315, P238, DOI 10.1126/science.1133097; Gomez JM, 2003, ECOGRAPHY, V26, P573, DOI 10.1034/j.1600-0587.2003.03586.x; HANSKI I, 1994, ECOLOGY, V75, P747, DOI 10.2307/1941732; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hanski I, 1999, METAPOPULATION ECOLO; Higgins SI, 2003, ECOLOGY, V84, P1945, DOI 10.1890/01-0616; Johst K, 2002, OIKOS, V98, P263, DOI 10.1034/j.1600-0706.2002.980208.x; Jordano P, 2007, P NATL ACAD SCI USA, V104, P3278, DOI 10.1073/pnas.0606793104; MANZANEQUE FG, 2005, BOSQUES IBERICOS INT; McEuen AB, 2004, ECOLOGY, V85, P507, DOI 10.1890/03-4006; *MIN AGR PESC AL, 1995, SEG INV FOR NAC; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Purves DW, 2007, ECOL MONOGR, V77, P77, DOI 10.1890/05-1923; Purves DW, 2005, J ECOL, V93, P658, DOI 10.1111/j.1365-2745.2005.00988.x; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Rees M, 2001, SCIENCE, V293, P650, DOI 10.1126/science.1062586; Restrepo C, 1999, ECOLOGY, V80, P668, DOI 10.1890/0012-9658(1999)080[0668:AETGAF]2.0.CO;2; Sanchez-Gomez D, 2006, NEW PHYTOL, V170, P795, DOI 10.1111/j.1469-8137.2006.01711.x; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Sole R. V., 2007, SELF ORG COMPLEX ECO	27	104	109	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2008	320	5882					1502	1504		10.1126/science.1158404	http://dx.doi.org/10.1126/science.1158404			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	312MV	18535208	Green Submitted			2022-12-24	WOS:000256676400046
J	Peri, F; Nusslein-Volhard, C				Peri, Francesca; Nuesslein-Volhard, Christiane			Live imaging of neuronal degradation by microglia reveals a role for v0-ATPase a1 in phagosomal fusion in vivo	CELL			English	Article							APOPTOTIC CELLS; V-ATPASES; P53-DEPENDENT APOPTOSIS; CAENORHABDITIS-ELEGANS; EARLY MACROPHAGES; DEVELOPING BRAIN; LYSOSOME FUSION; ZEBRAFISH; PHAGOCYTOSIS; ACIDIFICATION	A significant proportion of neurons in the brain undergo programmed cell death. In order to prevent the diffusion of damaging degradation products, dying neurons are quickly digested by microglia. Despite the importance of microglia in several neuronal pathologies, the mechanism underlying their degradation of neurons remains elusive. Here, we exploit a microglial population in the zebrafish to study this process in intact living brains. In vivo imaging reveals that digestion of neurons occurs in compartments arising from the progressive fusion of vesicles. We demonstrate that this fusion is mediated by the v0-ATPase a1 subunit. By applying live pH indicators, we show that the a1 subunit mediates fusion between phagosomes and lysosomes during phagocytosis, a function that is independent of its proton pump activity. As a real-time description of microglial phagocytosis in vivo, this work advances our understanding of microglial-mediated neuronal degeneration, a hallmark of many neuronal diseases.	[Peri, Francesca; Nuesslein-Volhard, Christiane] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany	Max Planck Society	Peri, F (corresponding author), EMBL Heidlberg, Meyerhofstr 1, D-69117 Heidelberg, Germany.	peri@embl.de		Peri, Francesca/0000-0001-7068-4952				Barron KD, 1995, J NEUROL SCI, V134, P57, DOI 10.1016/0022-510X(95)00209-K; Bayer MJ, 2003, J CELL BIOL, V162, P211, DOI 10.1083/jcb.200212004; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Blott EJ, 2001, J CELL SCI, V114, P2405; BOUVIER G, 1994, J LEUKOCYTE BIOL, V55, P729, DOI 10.1002/jlb.55.6.729; Bowman EJ, 2004, J BIOL CHEM, V279, P33131, DOI 10.1074/jbc.M404638200; Campbell WA, 2006, J NEUROCHEM, V96, P1423, DOI 10.1111/j.1471-4159.2006.03648.x; de Saint-Vis B, 1998, IMMUNITY, V9, P325, DOI 10.1016/S1074-7613(00)80615-9; Desjardins M, 2003, CURR OPIN CELL BIOL, V15, P498, DOI 10.1016/S0955-0674(03)00083-8; Duhon D, 2002, J MUSCLE RES CELL M, V23, P803, DOI 10.1023/A:1024435913949; GEISOW MJ, 1981, J CELL BIOL, V89, P645, DOI 10.1083/jcb.89.3.645; GRINSTEIN S, 1992, J EXP BIOL, V172, P179; Harris E, 2002, J CELL SCI, V115, P3703, DOI 10.1242/jcs.00050; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; Kawasaki-Nishi S, 2003, FEBS LETT, V545, P76, DOI 10.1016/S0014-5793(03)00396-X; Kettenmann H, 2007, NATURE, V446, P987, DOI 10.1038/nature05713; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; Kurant E, 2008, CELL, V133, P498, DOI 10.1016/j.cell.2008.02.052; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072; Liu TX, 2003, DEV CELL, V5, P903, DOI 10.1016/S1534-5807(03)00339-3; MCNEIL PL, 1983, J CELL BIOL, V97, P692, DOI 10.1083/jcb.97.3.692; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Muller O, 2002, EMBO J, V21, P259, DOI 10.1093/emboj/21.3.259; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nijhawan D, 2000, ANNU REV NEUROSCI, V23, P73, DOI 10.1146/annurev.neuro.23.1.73; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Ober EA, 1999, DEV BIOL, V215, P167, DOI 10.1006/dbio.1999.9455; Parnaik R, 2000, CURR BIOL, V10, P857, DOI 10.1016/S0960-9822(00)00598-4; Perzov N, 2002, J EXP BIOL, V205, P1209; Platt N, 1998, TRENDS CELL BIOL, V8, P365, DOI 10.1016/S0962-8924(98)01329-4; Pujol N, 2001, J BIOL CHEM, V276, P11913, DOI 10.1074/jbc.M009451200; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Schneider VA, 2006, NEURON, V50, P683, DOI 10.1016/j.neuron.2006.04.024; Streit W. J., 1995, SCI AM, V273, P58; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE	42	394	403	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 30	2008	133	5					916	927		10.1016/j.cell.2008.04.037	http://dx.doi.org/10.1016/j.cell.2008.04.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	306UY	18510934	Green Accepted, Bronze			2022-12-24	WOS:000256274500022
J	Tullet, JMA; Hertweck, M; An, JH; Baker, J; Hwang, JY; Liu, S; Oliveira, RP; Baumeister, R; Blackwell, TK				Tullet, Jennifer M. A.; Hertweck, Maren; An, Jae Hyung; Baker, Joseph; Hwang, Ji Yun; Liu, Shu; Oliveira, Riva P.; Baumeister, Ralf; Blackwell, T. Keith			Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans	CELL			English	Article							RESTRICTION-INDUCED LONGEVITY; EXTENDS LIFE-SPAN; CAENORHABDITIS-ELEGANS; OXIDATIVE STRESS; DIETARY RESTRICTION; DAF-16; GENE; RESISTANCE; PROTEINS; MUTATION	Insulin/IGF-1-like signaling (IIS) is central to growth and metabolism and has a conserved role in aging. In C. elegans, reductions in IIS increase stress resistance and longevity, effects that require the IIS-inhibited FOXO protein DAF-16. The C. elegans transcription factor SKN-1 also defends against oxidative stress by mobilizing the conserved phase 2 detoxification response. Here we show that IIS not only opposes DAF-16 but also directly inhibits SKN-1 in parallel. The IIS kinases AKT-1, -2, and SGK-1 phosphorylate SKN-1, and reduced IIS leads to constitutive SKN-1 nuclear accumulation in the intestine and SKN-1 target gene activation. SKN-1 contributes to the increased stress tolerance and longevity resulting from reduced IIS and delays aging when expressed transgenically. Furthermore, SKN-1 that is constitutively active increases life span independently of DAF-16. Our findings indicate that the transcription network regulated by SKN-1 promotes longevity and is an important direct target of IIS.	[Tullet, Jennifer M. A.; An, Jae Hyung; Baker, Joseph; Oliveira, Riva P.; Blackwell, T. Keith] Harvard Univ, Sch Med, Harvard Stem Cell Inst,Dept Pathol, Joslin Diabet Ctr,Sect Dev & Stem Cell Biol, Boston, MA 02215 USA; [Hertweck, Maren; Liu, Shu; Baumeister, Ralf] Univ Freiburg, ZBMZ, Ctr Biochem & Mol Cell Res, Fac Med,Bioinformat & Mol Genet Fac Biol, D-79104 Freiburg, Germany; [An, Jae Hyung; Hwang, Ji Yun] Yonsei Univ, Prot Network Res Ctr, Seoul 120749, South Korea; [Baumeister, Ralf] Univ Freiburg, Ctr Syst Biol ZBSA, D-79104 Freiburg, Germany	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Freiburg; Yonsei University; University of Freiburg	Blackwell, TK (corresponding author), Harvard Univ, Sch Med, Harvard Stem Cell Inst,Dept Pathol, Joslin Diabet Ctr,Sect Dev & Stem Cell Biol, 1 Joslin Pl, Boston, MA 02215 USA.	keith.blackwell@joslin.harvard.edu	Oliveira, Riva/J-8408-2013; Tullet, Jennifer/C-1779-2008	Oliveira, Riva/0000-0002-4917-7646; de Paula Oliveira, Riva/0000-0002-6092-6142; Tullet, Jennifer/0000-0002-2037-526X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062891, F32GM070088] Funding Source: NIH RePORTER; NIDDK NIH HHS [T32 DK07260] Funding Source: Medline; NIGMS NIH HHS [R01 GM062891-05, R01 GM062891-07, R01 GM062891-08, R01 GM062891-06, 5 F32 GM070088-02, 2 R01 GM062891, R01 GM062891] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; An JH, 2005, P NATL ACAD SCI USA, V102, P16275, DOI 10.1073/pnas.0508105102; Antebi A, 2007, PLOS GENET, V3, P1565, DOI 10.1371/journal.pgen.0030129; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Cahill CM, 2001, J BIOL CHEM, V276, P13402, DOI 10.1074/jbc.M010042200; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FRIEDMAN DB, 1988, GENETICS, V118, P75; Gems D, 1998, GENETICS, V150, P129; Goldstein BJ, 2005, DIABETES, V54, P311, DOI 10.2337/diabetes.54.2.311; Gottesmann B., 1994, HALLESCHES JB GEOWIS, V16, P23; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Hayes JD, 2001, CANCER LETT, V174, P103, DOI 10.1016/S0304-3835(01)00695-4; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Houthoofd K, 2003, EXP GERONTOL, V38, P947, DOI 10.1016/S0531-5565(03)00161-X; Houthoofd K, 2002, EXP GERONTOL, V37, P1371, DOI 10.1016/S0531-5565(02)00173-0; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Kell A, 2007, FREE RADICAL BIO MED, V43, P1560, DOI 10.1016/j.freeradbiomed.2007.08.025; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lithgow GJ, 2002, MECH AGEING DEV, V123, P765, DOI 10.1016/S0047-6374(01)00422-5; McMahon M, 2001, CANCER RES, V61, P3299; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190	42	619	648	2	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 21	2008	132	6					1025	1038		10.1016/j.cell.2008.01.030	http://dx.doi.org/10.1016/j.cell.2008.01.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	278GR	18358814	Green Accepted, Bronze			2022-12-24	WOS:000254273600020
J	Guiso, L; Monte, F; Sapienza, P; Zingales, L				Guiso, Luigi; Monte, Ferdinando; Sapienza, Paola; Zingales, Luigi			Diversity - Culture, gender, and math	SCIENCE			English	Editorial Material							SEX-DIFFERENCES		[Sapienza, Paola] Northwestern Univ, JL Kellogg Grad Sch Management, Evanston, IL 60208 USA; [Zingales, Luigi] Univ Chicago, Grad Sch Business, Chicago, IL 60637 USA; [Guiso, Luigi] European Univ Inst, I-50133 Florence, Italy; [Monte, Ferdinando] Univ Chicago, Dept Econ, Chicago, IL 60637 USA	Northwestern University; University of Chicago; European University Institute; University of Chicago	Sapienza, P (corresponding author), Northwestern Univ, JL Kellogg Grad Sch Management, Evanston, IL 60208 USA.	Paola-Sapienza@northwestern.edu	Sapienza, Paola/CSU-7580-2022; Zingales, Luigi/AAY-8081-2020; Monte, Ferdinando/V-3968-2019; Sapienza, Paola/P-4917-2016	Sapienza, Paola/0000-0002-3663-422X; Zingales, Luigi/0000-0002-6804-1883; Sapienza, Paola/0000-0002-3663-422X				Baron-Cohen S., 2003, ESSENTIAL DIFFERENCE; BENBOW C P, 1980, Science (Washington D C), V210, P1262, DOI 10.1126/science.7434028; Cavalli-Sforza LL, 1996, HIST GEOGRAPHY HUMAN; Goldin C, 2006, J ECON PERSPECT, V20, P133, DOI 10.1257/jep.20.4.133; Halpern D. F., 2005, GENDER DIFFERENCES M, P48; Hausmann R., 2006, GLOBAL GENDER GAP RE; HEDGES LV, 1995, SCIENCE, V269, P41, DOI 10.1126/science.7604277; Inglehart R., 2000, WORLD VALUES SURVEYS; Kimura Doreen, 1999, SEX COGNITION; Ontario Student Assistance Program, 2020, PROGRAM INT STUDENT; Spelke ES, 2005, AM PSYCHOL, V60, P950, DOI 10.1037/0003-066X.60.9.950; SPOLAORE E, 2006, 5630 CEPR; 2005, EDGE            0510	13	453	458	2	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 30	2008	320	5880					1164	1165		10.1126/science.1154094	http://dx.doi.org/10.1126/science.1154094			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306FF	18511674				2022-12-24	WOS:000256233000020
J	Hsu, M; Anen, C; Quartz, SR				Hsu, Ming; Anen, Cedric; Quartz, Steven R.			The right and the good: Distributive justice and neural encoding of equity and efficiency	SCIENCE			English	Article							INEQUALITY AVERSION; MAXIMIN PREFERENCES; REWARD; RESPONSES; TRUST; BRAIN; RISK; GAME	Distributive justice concerns how individuals and societies distribute benefits and burdens in a just or moral manner. We combined distribution choices with functional magnetic resonance imaging to investigate the central problem of distributive justice: the trade- off between equity and efficiency. We found that the putamen responds to efficiency, whereas the insula encodes inequity, and the caudate/ septal subgenual region encodes a unified measure of efficiency and inequity ( utility). Notably, individual differences in inequity aversion correlate with activity in inequity and utility regions. Against utilitarianism, our results support the deontological intuition that a sense of fairness is fundamental to distributive justice but, as suggested by moral sentimentalists, is rooted in emotional processing. More generally, emotional responses related to norm violations may underlie individual differences in equity considerations and adherence to ethical rules.	[Anen, Cedric; Quartz, Steven R.] CALTECH, Social Cognit Neurosci Lab, Div Humanities & Social Sci 228 77, Pasadena, CA 91125 USA; [Hsu, Ming] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Hsu, Ming] Univ Illinois, Dept Econ, Urbana, IL 61801 USA	California Institute of Technology; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Quartz, SR (corresponding author), CALTECH, Social Cognit Neurosci Lab, Div Humanities & Social Sci 228 77, Pasadena, CA 91125 USA.	steve@hss.caltech.edu	sarinopoulos, isidoros/B-5453-2010					AMIEL Y, 1999, THINIKING INQUALITY; [Anonymous], 1984, COLLECTIVE CHOICE SO; Aristotle, 1980, NICOMACHEAN ETHICS; ATKINSON AB, 1970, J ECON THEORY, V2, P244, DOI 10.1016/0022-0531(70)90039-6; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Engelmann D, 2004, AM ECON REV, V94, P857, DOI 10.1257/0002828042002741; Fehr E, 2006, AM ECON REV, V96, P1912, DOI 10.1257/aer.96.5.1912; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Harsanyi J.C., 1976, ESSAYS ETHICS SOCIAL; Hume D., 1978, TREATISE HUMAN NATUR, V2nd; Kahneman D, 1997, Q J ECON, V112, P375, DOI 10.1162/003355397555235; Kohlberg L, 1981, PHILOS MORAL DEV MOR, V1; Krueger F, 2007, P NATL ACAD SCI USA, V104, P20084, DOI 10.1073/pnas.0710103104; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Loeber R, 2000, J AM ACAD CHILD PSY, V39, P1468, DOI 10.1097/00004583-200012000-00007; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Montague PR, 2007, NEURON, V56, P14, DOI 10.1016/j.neuron.2007.09.020; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Rawls J., 1972, SOCIAL JUSTICE LIBER; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Smith Adam., 1812, THEORY MORAL SENTIME	27	221	235	5	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 23	2008	320	5879					1092	1095		10.1126/science.1153651	http://dx.doi.org/10.1126/science.1153651			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303RY	18467558				2022-12-24	WOS:000256059800050
J	Kiers, ET; Leakey, RRB; Izac, AM; Heinemann, JA; Rosenthal, E; Nathan, D; Jiggins, J				Kiers, E. Toby; Leakey, Roger R. B.; Izac, Anne-Marie; Heinemann, Jack A.; Rosenthal, Erika; Nathan, Dev; Jiggins, Janice			Ecology - Agriculture at a crossroads	SCIENCE			English	Editorial Material							AFRICA; IMPACT; WORLD		[Kiers, E. Toby] Free Univ Amsterdam, Inst Ecol Sci, Fac Earth & Life Sci, NL-1081 HV Amsterdam, Netherlands; [Leakey, Roger R. B.] James Cook Univ N Queensland, Sch Marine & Trop Biol, Cairns, Qld, Australia; [Izac, Anne-Marie] IFAD, Alliance CGIAR Ctr, Rome, Italy; [Heinemann, Jack A.] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand; [Rosenthal, Erika] Ctr Int Environm Law, Washington, DC USA; [Nathan, Dev] Inst Human Dev, New Delhi, India; [Jiggins, Janice] Wageningen Univ Res, Wageningen, Netherlands	Vrije Universiteit Amsterdam; James Cook University; CGIAR; University of Canterbury; Wageningen University & Research	Kiers, ET (corresponding author), Free Univ Amsterdam, Inst Ecol Sci, Fac Earth & Life Sci, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	ekiers@falw.vu.nl	Toby, Kiers/H-4819-2017	Toby, Kiers/0000-0002-0597-1653				Alston J, 2002, 113 IFPRI; [Anonymous], 2007, WATER FOOD WATER LIF; [Anonymous], 2007, IPCC 4 ASS REP CLIM; [Anonymous], 2006, FOOD SECURITY HUNGER; Delmer DP, 2005, P NATL ACAD SCI USA, V102, P15739, DOI 10.1073/pnas.0505895102; Dingkuhn M, 2006, AGR WATER MANAGE, V80, P241, DOI 10.1016/j.agwat.2005.07.016; Evans LT, 2005, J AGR SCI, V143, P7, DOI 10.1017/S0021859604004460; Evenson RE, 2003, SCIENCE, V300, P758, DOI 10.1126/science.1078710; *FAO, 2004, MILK DAIR PROD POST; FAO, 2007, STAT FOOD AGR 2007 P; *FAO, 2007, FOOD OUTL 2007 GLOB; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; JANE TS, 1994, ZIMBABWES AGR REVOLU; Lilja N, 2008, EXP AGR, V44, P3, DOI 10.1017/S0014479707005972; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING GL; Morrison Jamie, 2007, WTO RULES AGR COMPAT; Nederlof E. S., 2007, International Journal of Agricultural Sustainability, V5, P247; Pardey P., 2007, SCI TECHNOLOGY SKILL; Pardey P. G., 2006, Agricultural research: a growing global divide?; Pray CE, 2007, J DEV STUD, V43, P192, DOI 10.1080/00220380601055676; Sanchez PA, 2002, SCIENCE, V295, P2019, DOI 10.1126/science.1065256; Stokstad E, 2008, SCIENCE, V319, P1474, DOI 10.1126/science.319.5869.1474; *SUST DEV DEP FAO, 2007, SUST RUR DEV PROGR C; *SUST RIC PROD FOO, 2003, P 20 SESS INT RIC CO; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; UNEP (United Nations Environment Programme), 2007, GLOB ENV OUTL GEO 4, DOI 10.1227/01.NEU.0000108643.94730.21; Van Mele P, 2008, AGR FOREST ENTOMOL, V10, P13, DOI 10.1111/j.1461-9563.2007.00350.x; 2008, NAT BIOTECHNOL, V26, P247; 2008, NATURE, V451, P223; 2008, INT ASSESSMENT AGR S	32	79	84	1	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2008	320	5874					320	321		10.1126/science.1158390	http://dx.doi.org/10.1126/science.1158390			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZZ	18420917				2022-12-24	WOS:000255026100024
J	Cauchemez, S; Valleron, AJ; Boelle, PY; Flahault, A; Ferguson, NM				Cauchemez, Simon; Valleron, Alain-Jacques; Boelle, Pierre-Yves; Flahault, Antoine; Ferguson, Neil M.			Estimating the impact of school closure on influenza transmission from Sentinel data	NATURE			English	Article							PANDEMIC INFLUENZA; NONPHARMACEUTICAL INTERVENTIONS; COMMUNICABLE DISEASES; US CITIES; SURVEILLANCE; STRATEGIES; HOUSEHOLD	The threat posed by the highly pathogenic H5N1 influenza virus requires public health authorities to prepare for a human pandemic. Although pre-pandemic vaccines and antiviral drugs might significantly reduce illness rates(1,2), their stockpiling is too expensive to be practical for many countries. Consequently, alternative control strategies, based on non-pharmaceutical interventions, are a potentially attractive policy option. School closure is the measure most often considered. The high social and economic costs of closing schools for months make it an expensive and therefore controversial policy, and the current absence of quantitative data on the role of schools during influenza epidemics means there is little consensus on the probable effectiveness of school closure in reducing the impact of a pandemic. Here, from the joint analysis of surveillance data and holiday timing in France, we quantify the role of schools in influenza epidemics and predict the effect of school closure during a pandemic. We show that holidays lead to a 20 - 29% reduction in the rate at which influenza is transmitted to children, but that they have no detectable effect on the contact patterns of adults. Holidays prevent 16 - 18% of seasonal influenza cases (18 - 21% in children). By extrapolation, we find that prolonged school closure during a pandemic might reduce the cumulative number of cases by 13 - 17% (18 - 23% in children) and peak attack rates by up to 39 - 45% (47 - 52% in children). The impact of school closure would be reduced if it proved difficult to maintain low contact rates among children for a prolonged period.	[Cauchemez, Simon; Ferguson, Neil M.] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London W2 1PG, England; [Valleron, Alain-Jacques; Boelle, Pierre-Yves; Flahault, Antoine] Univ Paris 06, UMR S707, F-75012 Paris, France; [Valleron, Alain-Jacques; Boelle, Pierre-Yves; Flahault, Antoine] INSERM, UMR S 707, F-75012 Paris, France; [Valleron, Alain-Jacques; Boelle, Pierre-Yves] Hop St Antoine, AP HP, F-75012 Paris, France; [Flahault, Antoine] French Sch Publ Hlth EHESP, F-75004 Paris, France	Imperial College London; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Cauchemez, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, Norfolk Pl, London W2 1PG, England.	s.cauchemez@imperial.ac.uk	Ferguson, Neil/B-8578-2008	Ferguson, Neil/0000-0002-1154-8093; Boelle, Pierre-Yves/0000-0002-5367-8232	Medical Research Council [G0600719B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Bell D, 2006, EMERG INFECT DIS, V12, P88; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Denoeud L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000464; Doucet A., 2001, SEQUENTIAL MONTE CAR; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Finkenstadt BF, 2005, STAT MED, V24, P3447, DOI 10.1002/sim.2196; Flahault A, 2006, STAT METHODS MED RES, V15, P413, DOI 10.1177/0962280206071639; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Gilks WR, 1996, MARKOV CHAIN MONTE C; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; GLEZEN WP, 1991, AM J EPIDEMIOL, V133, P296, DOI 10.1093/oxfordjournals.aje.a115874; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; Heymann A, 2004, PEDIATR INFECT DIS J, V23, P675, DOI 10.1097/01.inf.0000128778.54105.06; LIU JS, 2001, MONTE CARLO STRATEGI; LONGINI IM, 1988, AM J EPIDEMIOL, V128, P845, DOI 10.1093/oxfordjournals.aje.a115038; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; MONTO AS, 1993, EPIDEMIOL INFECT, V110, P145, DOI 10.1017/S0950268800050779; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; VALLERON AJ, 1986, AM J PUBLIC HEALTH, V76, P1289, DOI 10.2105/AJPH.76.11.1289; VALLERON AJ, 2003, INT C OPT CONTR INFL, V5; Xia YC, 2005, J R STAT SOC C-APPL, V54, P659, DOI 10.1111/j.1467-9876.2005.05383.x	22	452	462	4	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2008	452	7188					750	U6		10.1038/nature06732	http://dx.doi.org/10.1038/nature06732			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	285QY	18401408				2022-12-24	WOS:000254792500045
J	Dawlaty, MM; Malureanu, L; Jeganathan, KB; Kao, E; Sustmann, C; Tahk, S; Shuai, K; Grosschedl, R; van Deursen, JM				Dawlaty, Meelad M.; Malureanu, Liviu; Jeganathan, Karthik B.; Kao, Esther; Sustmann, Claudio; Tahk, Samuel; Shuai, Ke; Grosschedl, Rudolf; van Deursen, Jan M.			Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase II alpha	CELL			English	Article							NUCLEAR-PORE COMPLEX; CHROMATID SEGREGATION; GENE-EXPRESSION; PROTEIN EXPORT; E3 LIGASE; RAN-GTP; IN-VIVO; NUCLEOPORIN; RANGAP1; PIASY	RanBP2 is a nucleoporin with SUMO E3 ligase activity that functions in both nucleocytoplasmic transport and mitosis. However, the biological relevance of RanBP2 and the in vivo targets of its E3 ligase activity are unknown. Here we show that animals with low amounts of RanBP2 develop severe aneuploidy in the absence of overt transport defects. The main chromosome segregation defect in cells from these mice is anaphase-bridge formation. Topoisomerase II alpha (Topo II alpha), which decatenates sister centromeres prior to anaphase onset to prevent bridges, fails to accumulate at inner centromeres when RanBP2 levels are low. We find that RanBP2 sumoylates Topo II alpha in mitosis and that this modification is required for its proper localization to inner centromeres. Furthermore, mice with low amounts of RanBP2 are highly sensitive to tumor formation. Together, these data identify RanBP2 as a chromosomal instability gene that regulates Topo II alpha by sumoylation and suppresses tumorigenesis.	[Dawlaty, Meelad M.; van Deursen, Jan M.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Malureanu, Liviu; Jeganathan, Karthik B.; Kao, Esther; van Deursen, Jan M.] Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; [Sustmann, Claudio; Grosschedl, Rudolf] Max Planck Inst Immunobiol, Dept Cellular & Mol Immunol, D-79108 Freiburg, Germany; [Tahk, Samuel] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Shuai, Ke] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA	Mayo Clinic; Mayo Clinic; Max Planck Society; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	van Deursen, JM (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	vandeursen.jan@mayo.edu		Jeganathan, KARTHIK/0000-0001-5587-1266	NCI NIH HHS [R01 CA077262, R01 CA077262-11, R01-CA077262] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA077262] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arnaoutov A, 2005, NAT CELL BIOL, V7, P626, DOI 10.1038/ncb1263; Aslanukov A, 2006, PLOS GENET, V2, P1653, DOI 10.1371/journal.pgen.0020177; Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Azuma Y, 2005, EMBO J, V24, P2172, DOI 10.1038/sj.emboj.7600700; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bernad R, 2004, MOL CELL BIOL, V24, P2373, DOI 10.1128/MCB.24.6.2373-2384.2004; Bhat MA, 1996, CELL, V87, P1103, DOI 10.1016/S0092-8674(00)81804-8; CLARKE DJ, 1993, J CELL SCI, V105, P563; Dawlaty MM, 2006, METHODS, V39, P370, DOI 10.1016/j.ymeth.2006.06.009; Diaz-Martinez LA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000053; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Hutten S, 2006, MOL CELL BIOL, V26, P6772, DOI 10.1128/MCB.00342-06; Jeganathan KB, 2005, NATURE, V438, P1036, DOI 10.1038/nature04221; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mao Y, 2000, J BIOL CHEM, V275, P26066, DOI 10.1074/jbc.M001831200; Matunis MJ, 2005, NAT STRUCT MOL BIOL, V12, P565, DOI 10.1038/nsmb0705-565; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Michor F, 2005, SEMIN CANCER BIOL, V15, P43, DOI 10.1016/j.semcancer.2004.09.007; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Pichler A, 2004, NAT STRUCT MOL BIOL, V11, P984, DOI 10.1038/nsmb834; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Roth W, 2004, J IMMUNOL, V173, P6189, DOI 10.4049/jimmunol.173.10.6189; Salina D, 2003, J CELL BIOL, V162, P991, DOI 10.1083/jcb.200304080; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Takahashi Y, 2006, GENETICS, V172, P783, DOI 10.1534/genetics.105.047167; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Wong KA, 2004, MOL CELL BIOL, V24, P5577, DOI 10.1128/MCB.24.12.5577-5586.2004; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002	33	244	253	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 4	2008	133	1					103	115		10.1016/j.cell.2008.01.045	http://dx.doi.org/10.1016/j.cell.2008.01.045			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	283MW	18394993	Green Accepted, Bronze			2022-12-24	WOS:000254641300012
J	Losonczy, A; Makara, JK; Magee, JC				Losonczy, Attila; Makara, Judit K.; Magee, Jeffrey C.			Compartmentalized dendritic plasticity and input feature storage in neurons	NATURE			English	Article							CA1 PYRAMIDAL NEURONS; ACTION-POTENTIALS; EXCITABILITY; HIPPOCAMPUS; PATTERNS; SPIKES; MEMORY; CELLS; KV4.2; RAT	Although information storage in the central nervous system is thought to be primarily mediated by various forms of synaptic plasticity, other mechanisms, such as modifications in membrane excitability, are available. Local dendritic spikes are nonlinear voltage events that are initiated within dendritic branches by spatially clustered and temporally synchronous synaptic input. That local spikes selectively respond only to appropriately correlated input allows them to function as input feature detectors and potentially as powerful information storage mechanisms. However, it is currently unknown whether any effective form of local dendritic spike plasticity exists. Here we show that the coupling between local dendritic spikes and the soma of rat hippocampal CA1 pyramidal neurons can be modified in a branch- specific manner through an N- methyl- D- aspartate receptor ( NMDAR)- dependent regulation of dendritic Kv4.2 potassium channels. These data suggest that compartmentalized changes in branch excitability could store multiple complex features of synaptic input, such as their spatio- temporal correlation. We propose that this 'branch strength potentiation' represents a previously unknown form of information storage that is distinct from that produced by changes in synaptic efficacy both at the mechanistic level and in the type of information stored.	[Losonczy, Attila; Makara, Judit K.; Magee, Jeffrey C.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Losonczy, A (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	losonczya@janelia.hhmi.org; makaraj@janelia.hhmi.org						Ariav G, 2003, J NEUROSCI, V23, P7750; BANNISTER NJ, 1995, J COMP NEUROL, V360, P150, DOI 10.1002/cne.903600111; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Gasparini S, 2007, J PHYSIOL-LONDON, V580, P787, DOI 10.1113/jphysiol.2006.121343; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Guo WN, 2005, CIRC RES, V97, P1342, DOI 10.1161/01.RES.0000196559.63223.aa; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hasselmo ME, 2006, J MOL NEUROSCI, V30, P133, DOI 10.1385/JMN:30:1:133; Hoffman DA, 1999, J NEUROPHYSIOL, V81, P408, DOI 10.1152/jn.1999.81.1.408; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Magee JC, 2005, CURR OPIN NEUROBIOL, V15, P334, DOI 10.1016/j.conb.2005.05.013; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	30	410	414	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2008	452	7186					436	U3		10.1038/nature06725	http://dx.doi.org/10.1038/nature06725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279FU	18368112				2022-12-24	WOS:000254341300024
J	Jouvenet, N; Bieniasz, PD; Simon, SM				Jouvenet, Nolwenn; Bieniasz, Paul D.; Simon, Sanford M.			Imaging the biogenesis of individual HIV-1 virions in live cells	NATURE			English	Article							PLASMA-MEMBRANE; FLUORESCENT PROTEINS; LIVING CELLS; VIRUS; MICROSCOPY; RELEASE; VISUALIZATION; REPLICATION; MACROPHAGES; CLATHRIN	Observations of individual virions in live cells have led to the characterization of their attachment, entry and intracellular transport(1). However, the assembly of individual virions has never been observed in real time. Insights into this process have come primarily from biochemical analyses of populations of virions or from microscopic studies of fixed infected cells. Thus, some assembly properties, such as kinetics and location, are either unknown or controversial(2-5). Here we describe quantitatively the genesis of individual virions in real time, from initiation of assembly to budding and release. We studied fluorescently tagged derivatives of Gag, the major structural component of HIV-1-which is sufficient to drive the assembly of virus- like particles(6) - with the use of fluorescence resonance energy transfer, fluorescence recovery after photobleaching and total- internal- reflection fluorescent microscopy in living cells. Virions appeared individually at the plasma membrane, their assembly rate accelerated as Gag protein accumulated in cells, and typically 5 - 6 min was required to complete the assembly of a single virion. These approaches allow a previously unobserved view of the genesis of individual virions and the determination of parameters of viral assembly that are inaccessible with conventional techniques.	[Jouvenet, Nolwenn; Bieniasz, Paul D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10065 USA; [Jouvenet, Nolwenn; Bieniasz, Paul D.] Rockefeller Univ, Lab Retrovirol, New York, NY 10065 USA; [Simon, Sanford M.] Rockefeller Univ, Lab Cellular Biophys, New York, NY 10065 USA	Rockefeller University; Rockefeller University; Rockefeller University	Bieniasz, PD (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10065 USA.	pbienias@adarc.org; simon@rockefeller.edu	jouvenet, nolwenn/K-2067-2019	jouvenet, nolwenn/0000-0001-6103-6048; Simon, Sanford/0000-0002-8615-4224	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM072015, R01GM087977] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI089844] Funding Source: Medline; NIGMS NIH HHS [P20 GM072015-04S1, P20 GM072015-01, P20 GM072015-02, P20 GM072015, R01 GM087977, P20 GM072015-02S1, P20 GM072015-04, P20 GM072015-03] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Brandenburg B, 2007, NAT REV MICROBIOL, V5, P197, DOI 10.1038/nrmicro1615; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Derdowski A, 2004, J VIROL, V78, P1230, DOI 10.1128/JVI.78.3.1230-1242.2004; Finzi A, 2007, J VIROL, V81, P7476, DOI 10.1128/JVI.00308-07; Gottlinger HG, 2001, AIDS, V15, pS13; Hubner W, 2007, J VIROL, V81, P12596, DOI 10.1128/JVI.01088-07; Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154; Jaiswal JK, 2007, NAT CHEM BIOL, V3, P92, DOI 10.1038/nchembio855; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Keyel PA, 2004, J BIOL CHEM, V279, P13190, DOI 10.1074/jbc.M312717200; Larson DR, 2005, P NATL ACAD SCI USA, V102, P15453, DOI 10.1073/pnas.0504812102; Larson DR, 2003, J CELL BIOL, V162, P1233, DOI 10.1083/jcb.200303200; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Perez-Caballero D, 2004, J VIROL, V78, P9560, DOI 10.1128/JVI.78.17.9560-9563.2004; Pornillos O, 2002, TRENDS CELL BIOL, V12, P569, DOI 10.1016/S0962-8924(02)02402-9; Rappoport JZ, 2003, TRAFFIC, V4, P460, DOI 10.1034/j.1600-0854.2003.00100.x; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; SIMON S, 1994, P NATL ACAD SCI USA, V91, P1128, DOI 10.1073/pnas.91.3.1128; Tramier M, 2006, MICROSC RES TECHNIQ, V69, P933, DOI 10.1002/jemt.20370; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036	27	247	250	3	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 10	2008	454	7201					236	240		10.1038/nature06998	http://dx.doi.org/10.1038/nature06998			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18500329	Green Accepted			2022-12-24	WOS:000257466900048
J	Gonzalez, MC; Hidalgo, CA; Barabasi, AL				Gonzalez, Marta C.; Hidalgo, Cesar A.; Barabasi, Albert-Laszlo			Understanding individual human mobility patterns	NATURE			English	Article							FLIGHT SEARCH PATTERNS; SCALING LAWS	Despite their importance for urban planning(1), traffic forecasting(2) and the spread of biological(3-5) and mobile viruses(6), our understanding of the basic laws governing human motion remains limited owing to the lack of tools to monitor the time- resolved location of individuals. Here we study the trajectory of 100,000 anonymized mobile phone users whose position is tracked for a six- month period. We find that, in contrast with the random trajectories predicted by the prevailing Levy flight and random walk models(7), human trajectories show a high degree of temporal and spatial regularity, each individual being characterized by a time-independent characteristic travel distance and a significant probability to return to a few highly frequented locations. After correcting for differences in travel distances and the inherent anisotropy of each trajectory, the individual travel patterns collapse into a single spatial probability distribution, indicating that, despite the diversity of their travel history, humans follow simple reproducible patterns. This inherent similarity in travel patterns could impact all phenomena driven by human mobility, from epidemic prevention to emergency response, urban planning and agent- based modelling.	[Gonzalez, Marta C.; Hidalgo, Cesar A.; Barabasi, Albert-Laszlo] Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA; [Gonzalez, Marta C.; Hidalgo, Cesar A.; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Phys Biol & Comp Sci, Boston, MA 02115 USA; [Hidalgo, Cesar A.; Barabasi, Albert-Laszlo] Univ Notre Dame, Ctr Complex Network Res, Notre Dame, IN 46556 USA; [Hidalgo, Cesar A.; Barabasi, Albert-Laszlo] Univ Notre Dame, Dept Phys & Comp Sci, Notre Dame, IN 46556 USA; [Barabasi, Albert-Laszlo] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA	Northeastern University; Northeastern University; University of Notre Dame; University of Notre Dame; Harvard University; Dana-Farber Cancer Institute	Barabasi, AL (corresponding author), Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA.	alb@neu.edu	Hidalgo, Cesar A./B-5155-2009; Gonzalez, Marta C./E-9456-2011; Barabasi, Albert-Laszlo/S-6474-2017	Hidalgo, Cesar A./0000-0002-6977-9492; Gonzalez, Marta C./0000-0002-8482-0318; /0000-0002-6031-5982; Barabasi, Albert/0000-0002-4028-3522				Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Caldarelli G., 2007, SCALE FREE NETWORKS; Cecconi F, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.088102; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Condamin S, 2007, NATURE, V450, P77, DOI 10.1038/nature06201; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; EAGLE N, IN PRESS BEHAV ECOL; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Gonzalez MC, 2007, NAT PHYS, V3, P224, DOI 10.1038/nphys581; Gonzalez MC, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.088702; Havlin S, 2002, ADV PHYS, V51, P187, DOI 10.1080/00018730110116353; Hidalgo CA, 2008, PHYSICA A, V387, P3017, DOI 10.1016/j.physa.2008.01.073; Horner MW., 2001, J TRANSP GEOGR, V9, P255, DOI DOI 10.1016/S0966-6923(01)00019-9; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Kitamura R, 2000, TRANSPORTATION, V27, P25, DOI 10.1023/A:1005259324588; Klafter J, 1996, PHYS TODAY, V49, P33, DOI 10.1063/1.881487; Kleinberg J, 2007, NATURE, V449, P287, DOI 10.1038/449287a; MANTEGNA RN, 1994, PHYS REV LETT, V73, P2946, DOI 10.1103/PhysRevLett.73.2946; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; RAMOSFERNANDEZ G, 2004, BEHAV ECOL SOCIOBIOL, V273, P1743; Redner S, 2001, GUIDE 1 PASSAGE PROC; Schlich R, 2003, TRANSPORTATION, V30, P13, DOI 10.1023/A:1021230507071; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sohn T, 2006, LECT NOTES COMPUT SC, V4206, P212; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Yook SH, 2002, P NATL ACAD SCI USA, V99, P13382, DOI 10.1073/pnas.172501399	30	3606	3779	46	1051	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2008	453	7196					779	782		10.1038/nature06958	http://dx.doi.org/10.1038/nature06958			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308UK	18528393				2022-12-24	WOS:000256415300043
J	Okamura, K; Chung, WJ; Ruby, JG; Guo, HL; Bartel, DP; Lai, EC				Okamura, Katsutomo; Chung, Wei-Jen; Ruby, J. Graham; Guo, Huili; Bartel, David P.; Lai, Eric C.			The Drosophila hairpin RNA pathway generates endogenous short interfering RNAs	NATURE			English	Article							DOUBLE-STRANDED-RNA; PASSENGER-STRAND; DISTINCT ROLES; MICRORNAS; EXPRESSION; GERMLINE; CLEAVAGE; COMPLEXES; DICER-1; PLANTS	In contrast to microRNAs and Piwi- associated RNAs, short interfering RNAs ( siRNAs) are seemingly dispensable for host- directed gene regulation in Drosophila. This notion is based on the fact that mutants lacking the core siRNA- generating enzyme Dicer- 2 or the predominant siRNA effector Argonaute 2 are viable, fertile and of relatively normal morphology(1,2). Moreover, endogenous Drosophila siRNAs have not yet been identified. Here we report that siRNAs derived from long hairpin RNA genes ( hpRNAs) programme Slicer complexes that can repress endogenous target transcripts. The Drosophila hpRNA pathway is a hybrid mechanism that combines canonical RNA interference factors ( Dicer- 2, Hen1 ( known as CG12367) and Argonaute 2) with a canonical microRNA factor ( Loquacious) to generate similar to 21- nucleotide siRNAs. These novel regulatory RNAs reveal unexpected complexity in the sorting of small RNAs, and open a window onto the biological usage of endogenous RNA interference in Drosophila.	[Okamura, Katsutomo; Chung, Wei-Jen; Lai, Eric C.] Sloan Kettering Inst, Dept Dev Biol, Rockefeller Res Labs 521, New York, NY 10065 USA; [Ruby, J. Graham; Guo, Huili; Bartel, David P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Ruby, J. Graham; Guo, Huili; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Ruby, J. Graham; Guo, Huili; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Lai, EC (corresponding author), Sloan Kettering Inst, Dept Dev Biol, Rockefeller Res Labs 521, 1275 York Ave,Box 252, New York, NY 10065 USA.	laie@mskcc.org	Lai, Eric C/A-3412-2008; Lai, Eric/AAO-1143-2021	Lai, Eric/0000-0002-8432-5851; Guo, Huili/0000-0002-2294-5684	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM067031-01, R01 GM083300, R01 GM067031, GM067031, GM083300, R01 GM083300-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067031, R01GM083300] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Forsyth D, 1907, Q J MED, V1, P287; GHILDIYAL M, 2008, SCIENCE; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Harris PV, 1996, MOL CELL BIOL, V16, P5764; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Liu X, 2007, RNA, V13, P2324, DOI 10.1261/rna.723707; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Park JK, 2007, CURR BIOL, V17, P533, DOI 10.1016/j.cub.2007.01.060; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wilson RJ, 2008, NUCLEIC ACIDS RES, V36, pD588, DOI 10.1093/nar/gkm930	28	287	302	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2008	453	7196					803	U8		10.1038/nature07015	http://dx.doi.org/10.1038/nature07015			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308UK	18463630	Green Accepted			2022-12-24	WOS:000256415300048
J	Prakash, M; Quere, D; Bush, JWM				Prakash, Manu; Quere, David; Bush, John W. M.			Surface tension transport of prey by feeding shorebirds: The capillary ratchet	SCIENCE			English	Article							SIZE DIMORPHISM; BEHAVIOR; BILL; PHALAROPES; MORPHOLOGY; VIBRATION; STABILITY; PARALLEL; MOTION; DROPS	The variability of bird beak morphology reflects diverse foraging strategies. One such feeding mechanism in shorebirds involves surface tension-induced transport of prey in millimetric droplets: By repeatedly opening and closing its beak in a tweezering motion, the bird moves the drop from the tip of its beak to its mouth in a stepwise ratcheting fashion. We have analyzed the subtle physical mechanism responsible for drop transport and demonstrated experimentally that the beak geometry and the dynamics of tweezering may be tuned to optimize transport efficiency. We also highlight the critical dependence of the capillary ratchet on the beak's wetting properties, thus making clear the vulnerability of capillary feeders to surface pollutants.	[Prakash, Manu] MIT, Ctr Bits & Atoms, Cambridge, MA 02139 USA; [Quere, David] ESPCI, CNRS, UMR 7636, F-75005 Paris, France; [Bush, John W. M.] MIT, Dept Math, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Sorbonne Universite; Universite Paris Cite; Massachusetts Institute of Technology (MIT)	Prakash, M (corresponding author), MIT, Ctr Bits & Atoms, 20 Ames St, Cambridge, MA 02139 USA.			Prakash, Manu/0000-0002-8046-8388				Barbosa A, 1999, AUK, V116, P712; Bouasse H., 1924, CAPILLARITE PHENOMEN; BROCHARD F, 1989, LANGMUIR, V5, P432, DOI 10.1021/la00086a025; CHEN TY, 1992, J COLLOID INTERF SCI, V151, P49, DOI 10.1016/0021-9797(92)90237-G; Concus P, 1998, PHYS FLUIDS, V10, P39, DOI 10.1063/1.869547; Daniel S, 2005, LANGMUIR, V21, P4240, DOI 10.1021/la046886s; Daniel S, 2002, LANGMUIR, V18, P3404, DOI 10.1021/la025505c; DEGENNES PG, 1985, REV MOD PHYS, V57, P827, DOI 10.1103/RevModPhys.57.827; DETTRE R, 1964, ADV CHEM SERIES, V43; DUSSAN EB, 1983, J FLUID MECH, V137, P1, DOI 10.1017/S002211208300227X; Elner RW, 2005, MAR BIOL, V146, P1223, DOI 10.1007/s00227-004-1521-5; EPPLEY ZA, 1989, NATURE, V340, P513, DOI 10.1038/340513a0; Estrella SM, 2007, AUK, V124, P1244, DOI 10.1642/0004-8038(2007)124[1244:SPFAOS]2.0.CO;2; Estrella SM, 2007, J EXP BIOL, V210, P3757, DOI 10.1242/jeb.007690; Gennes P.-G.d., 2003, CAPILLARITY WETTING, V2004 ed.; HAUKSBEE F., 1710, PHILOS T, V27, P395, DOI DOI 10.1098/RSTL.1710.0036; Humphries S, 2007, PLOS BIOL, V5, P1647, DOI 10.1371/journal.pbio.0050204; KAMATH YK, 1978, J APPL POLYM SCI, V22, P2295, DOI 10.1002/app.1978.070220821; LOWRY BJ, 1995, P R SOC-MATH PHYS SC, V449, P411, DOI 10.1098/rspa.1995.0051; Nebel S, 2005, ANIM BIOL, V55, P235, DOI 10.1163/1570756054472818; Obst BS, 1996, NATURE, V384, P121, DOI 10.1038/384121a0; Prakash M, 2007, SCIENCE, V315, P832, DOI 10.1126/science.1136907; Rubega MA, 1996, J MORPHOL, V228, P45, DOI 10.1002/(SICI)1097-4687(199604)228:1<45::AID-JMOR4>3.0.CO;2-O; RUBEGA MA, 1993, AUK, V110, P169; Rubega MA, 1997, IBIS, V139, P488, DOI 10.1111/j.1474-919X.1997.tb04663.x; RUBEGA MA, 1993, THESIS U CALIFORNIA; Stephenson R, 1997, ENVIRON CONSERV, V24, P121, DOI 10.1017/S0376892997000180; Szekely T, 2004, P NATL ACAD SCI USA, V101, P12224, DOI 10.1073/pnas.0404503101; ZWEERS G, 1991, ACTA BIOTHEOR, V39, P15, DOI 10.1007/BF00046405	29	323	335	35	385	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2008	320	5878					931	934		10.1126/science.1156023	http://dx.doi.org/10.1126/science.1156023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18487193				2022-12-24	WOS:000255868300042
J	Mili, S; Moissoglu, K; Macara, IG				Mili, Stavroula; Moissoglu, Konstadinos; Macara, Ian G.			Genome-wide screen reveals APC-associated RNAs enriched in cell protrusions	NATURE			English	Article							ADENOMATOUS POLYPOSIS-COLI; ACTIN MESSENGER-RNA; DROSOPHILA OOCYTES; F-ACTIN; LOCALIZATION; MIGRATION; MICROTUBULES; OSKAR; TRANSPORT; MEMBRANE	RNA localization is important for the establishment and maintenance of polarity in multiple cell types. Localized RNAs are usually transported along microtubules or actin filaments(1) and become anchored at their destination to some underlying subcellular structure. Retention commonly involves actin or actin- associated proteins(2-7), although cytokeratin filaments and dynein anchor certain RNAs8,9. RNA localization is important for diverse processes ranging from cell fate determination to synaptic plasticity; however, so far there have been few comprehensive studies of localized RNAs in mammalian cells. Here we have addressed this issue, focusing on migrating fibroblasts that polarize to form a leading edge and a tail in a process that involves asymmetric distribution of RNAs10-12. We used a fractionation scheme(13) combined with microarrays to identify, on a genome- wide scale, RNAs that localize in protruding pseudopodia of mouse fibroblasts in response to migratory stimuli. We find that a diverse group of RNAs accumulates in such pseudopodial protrusions. Through their 39 untranslated regions these transcripts are anchored in granules concentrated at the plus ends of detyrosinated microtubules. RNAs in the granules associate with the adenomatous polyposis coli ( APC) tumour suppressor and the fragile X mental retardation protein ( FMRP). APC is required for the accumulation of transcripts in protrusions. Our results suggest a new type of RNA anchoring mechanism as well as a new, unanticipated function for APC in localizing RNAs.	[Mili, Stavroula; Macara, Ian G.] Univ Virginia, Hlth Sci Ctr, Dept Microbiol, Ctr Cell Signaling, Charlottesville, VA 22908 USA; [Moissoglu, Konstadinos] Univ Virginia, Hlth Sci Ctr, Cardiovasc Res Ctr, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Macara, IG (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Microbiol, Ctr Cell Signaling, Charlottesville, VA 22908 USA.	sm2ju@virginia.edu; igm9c@virginia.edu	Mili, Stavroula/AAI-7076-2021	Mili, Stavroula/0000-0002-9161-8660; Moissoglu, Konstadinos/0000-0001-7211-4320	NIGMS NIH HHS [R01 GM070902-05, R01 GM070902] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070902] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Alarcon VB, 2001, J CELL SCI, V114, P1731; Babu K, 2004, GENE DEV, V18, P138, DOI 10.1101/gad.282604; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Beach DL, 1999, CURR BIOL, V9, P569, DOI 10.1016/S0960-9822(99)80260-7; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Blower MD, 2007, J CELL BIOL, V179, P1365, DOI 10.1083/jcb.200705163; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Condeelis J, 2005, BIOL CELL, V97, P97; Delanoue R, 2005, CELL, V122, P97, DOI 10.1016/j.cell.2005.04.033; ERDELYI M, 1995, NATURE, V377, P524, DOI 10.1038/377524a0; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Forrest KM, 2003, CURR BIOL, V13, P1159, DOI 10.1016/S0960-9822(03)00451-2; Galjart N, 2005, NAT REV MOL CELL BIO, V6, P487, DOI 10.1038/nrm1664; Infante AS, 2000, J CELL SCI, V113, P3907; Jambhekar A, 2007, RNA, V13, P625, DOI 10.1261/rna.262607; Jankovics F, 2002, CURR BIOL, V12, P2060, DOI 10.1016/S0960-9822(02)01256-3; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Kita K, 2006, MOL BIOL CELL, V17, P2331, DOI 10.1091/mbc.E05-06-0498; Kroboth K, 2007, MOL BIOL CELL, V18, P910, DOI 10.1091/mbc.E06-03-0179; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Liu G, 2002, MOL BIOL CELL, V13, P579, DOI 10.1091/mbc.01-03-0140; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Mingle LA, 2005, J CELL SCI, V118, P2425, DOI 10.1242/jcs.02371; Moissoglu K, 2006, BIOL CELL, V98, P547, DOI 10.1042/BC20060025; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160	30	210	213	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2008	453	7191					115	+		10.1038/nature06888	http://dx.doi.org/10.1038/nature06888			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294ID	18451862	Green Accepted			2022-12-24	WOS:000255398800050
J	Richards, S; Gibbs, RA; Weinstock, GM; Brown, SJ; Denell, R; Beeman, RW; Gibbs, R; Bucher, G; Friedrich, M; Grimmelikhuijzen, CJP; Klingler, M; Lorenzen, MD; Roth, S; Schroder, R; Tautz, D; Zdobnov, EM; Muzny, D; Attaway, T; Bell, S; Buhay, CJ; Chandrabose, MN; Chavez, D; Clerk-Blankenburg, KP; Cree, A; Dao, M; Davis, C; Chacko, J; Dinh, H; Dugan-Rocha, S; Fowler, G; Garner, TT; Garnes, J; Gnirke, A; Hawes, A; Hernandez, J; Hines, S; Holder, M; Hume, J; Jhangiani, SN; Joshi, V; Khan, ZM; Jackson, L; Kovar, C; Kowis, A; Lee, S; Lewis, LR; Margolis, J; Morgan, M; Nazareth, LV; Nguyen, N; Okwuonu, G; Parker, D; Ruiz, SJ; Santibanez, J; Savard, J; Scherer, SE; Schneider, B; Sodergren, E; Vattahil, S; Villasana, D; White, CS; Wright, R; Park, Y; Lord, J; Oppert, B; Brown, S; Wang, LJ; Savard, J; Liu, Y; Worley, K; Elsik, CG; Reese, JT; Elhaik, E; Landan, G; Graur, D; Arensburger, P; Atkinson, P; Beidler, J; Demuth, JP; Drury, DW; Du, YZ; Fujiwara, H; Maselli, V; Osanai, M; Robertson, HM; Tu, Z; Wang, JJ; Wang, SZ; Song, H; Zhang, L; Sodergren, E; Werner, D; Stanke, M; Morgenstern, B; Solovyev, V; Kosarev, P; Brown, G; Chen, HC; Ermolaeva, O; Hlavina, W; Kapustin, Y; Kiryutin, B; Kitts, P; Maglott, D; Pruitt, K; Sapojnikov, V; Souvorov, A; Mackey, AJ; Waterhouse, RM; Wyder, S; Zdobnov, EM; Kriventseva, EV; Kadowaki, T; Bork, P; Aranda, M; Bao, RY; Beermann, A; Berns, N; Bolognesi, R; Bonneton, F; Bopp, D; Butts, T; Chaumot, A; Denell, RE; Ferrier, DEK; Gordon, CM; Jindra, M; Klingler, M; Lan, Q; Lattorff, HMG; Laudet, V; von Levetsow, C; Liu, ZY; Lutz, R; Lynch, JA; da Fonseca, RN; Posnien, N; Reuter, R; Roth, S; Schinko, JB; Schmitt, C; Schoppmeier, M; Shippy, TD; Simonnet, F; Marques-Souza, H; Tomoyasu, Y; Trauner, J; Van der Zee, M; Vervoort, M; Wittkopp, N; Wimmer, EA; Yang, XY; Jones, AK; Sattelle, DB; Ebert, PR; Nelson, D; Scott, JG; Muthukrishnan, S; Kramer, KJ; Arakane, Y; Zhu, QS; Hogenkamp, D; Dixit, R; Jiang, HB; Zou, Z; Marshall, J; Elpidina, E; Vinokurov, K; Oppert, C; Evans, J; Lu, ZQ; Zhao, PC; Sumathipala, N; Altincicek, B; Vilcinskas, A; Williams, M; Hultmark, D; Hetru, C; Hauser, F; Cazzamali, G; Williamson, M; Li, B; Tanaka, Y; Predel, R; Neupert, S; Schachtner, J; Verleyen, P; Raible, F; Walden, KKO; Robertson, HM; Angeli, S; Foret, S; Schuetz, S; Maleszka, R; Miller, SC; Grossmann, D				Richards, Stephen; Gibbs, Richard A.; Weinstock, George M.; Brown, Susan J.; Denell, Robin; Beeman, Richard W.; Gibbs, Richard; Bucher, Gregor; Friedrich, Markus; Grimmelikhuijzen, Cornelis J. P.; Klingler, Martin; Lorenzen, Marce D.; Roth, Siegfried; Schroeder, Reinhard; Tautz, Diethard; Zdobnov, Evgeny M.; Muzny, Donna; Attaway, Tony; Bell, Stephanie; Buhay, Christian J.; Chandrabose, Mimi N.; Chavez, Dean; Clerk-Blankenburg, Kerstin P.; Cree, Andrew; Dao, Marvin; Davis, Clay; Chacko, Joseph; Dinh, Huyen; Dugan-Rocha, Shannon; Fowler, Gerald; Garner, Toni T.; Garnes, Jeffrey; Gnirke, Andreas; Hawes, Alica; Hernandez, Judith; Hines, Sandra; Holder, Michael; Hume, Jennifer; Jhangiani, Shalini N.; Joshi, Vandita; Khan, Ziad Mohid; Jackson, LaRonda; Kovar, Christie; Kowis, Andrea; Lee, Sandra; Lewis, Lora R.; Margolis, Jon; Morgan, Margaret; Nazareth, Lynne V.; Nguyen, Ngoc; Okwuonu, Geoffrey; Parker, David; Ruiz, San-Juana; Santibanez, Jireh; Savard, Joel; Scherer, Steven E.; Schneider, Brian; Sodergren, Erica; Vattahil, Selina; Villasana, Donna; White, Courtney S.; Wright, Rita; Park, Yoonseong; Lord, Jeff; Oppert, Brenda; Brown, Susan; Wang, Liangjiang; Savard, Joel; Liu, Yue; Worley, Kim; Elsik, Christine G.; Reese, Justin T.; Elhaik, Eran; Landan, Giddy; Graur, Dan; Arensburger, Peter; Atkinson, Peter; Beidler, Jim; Demuth, Jeffery P.; Drury, Douglas W.; Du, Yu-Zhou; Fujiwara, Haruhiko; Maselli, Vincenza; Osanai, Mizuko; Robertson, Hugh M.; Tu, Zhijian; Wang, Jian-Jun; Wang, Suzhi; Song, Henry; Zhang, Lan; Sodergren, Erica; Werner, Doreen; Stanke, Mario; Morgenstern, Burkhard; Solovyev, Victor; Kosarev, Peter; Brown, Garth; Chen, Hsiu-Chuan; Ermolaeva, Olga; Hlavina, Wratko; Kapustin, Yuri; Kiryutin, Boris; Kitts, Paul; Maglott, Donna; Pruitt, Kim; Sapojnikov, Victor; Souvorov, Alexandre; Mackey, Aaron J.; Waterhouse, Robert M.; Wyder, Stefan; Zdobnov, Evgeny M.; Kriventseva, Evgenia V.; Kadowaki, Tatsuhiko; Bork, Peer; Aranda, Manuel; Bao, Riyue; Beermann, Anke; Berns, Nicola; Bolognesi, Renata; Bonneton, Francois; Bopp, Daniel; Butts, Thomas; Chaumot, Arnaud; Denell, Robin E.; Ferrier, David E. K.; Gordon, Cassondra M.; Jindra, Marek; Klingler, Martin; Lan, Que; Lattorff, H. Michael G.; Laudet, Vincent; von Levetsow, Cornelia; Liu, Zhenyi; Lutz, Rebekka; Lynch, Jeremy A.; da Fonseca, Rodrigo Nunes; Posnien, Nico; Reuter, Rolf; Roth, Siegfried; Schinko, Johannes B.; Schmitt, Christian; Schoppmeier, Michael; Shippy, Teresa D.; Simonnet, Franck; Marques-Souza, Henrique; Tomoyasu, Yoshinori; Trauner, Jochen; Van der Zee, Maurijn; Vervoort, Michel; Wittkopp, Nadine; Wimmer, Ernst A.; Yang, Xiaoyun; Jones, Andrew K.; Sattelle, David B.; Ebert, Paul R.; Nelson, David; Scott, Jeffrey G.; Muthukrishnan, Subbaratnam; Kramer, Karl J.; Arakane, Yasuyuki; Zhu, Qingsong; Hogenkamp, David; Dixit, Radhika; Jiang, Haobo; Zou, Zhen; Marshall, Jeremy; Elpidina, Elena; Vinokurov, Konstantin; Oppert, Cris; Evans, Jay; Lu, Zhiqiang; Zhao, Picheng; Sumathipala, Niranji; Altincicek, Boran; Vilcinskas, Andreas; Williams, Michael; Hultmark, Dan; Hetru, Charles; Hauser, Frank; Cazzamali, Giuseppe; Williamson, Michael; Li, Bin; Tanaka, Yoshiaki; Predel, Reinhard; Neupert, Susanne; Schachtner, Joachim; Verleyen, Peter; Raible, Florian; Walden, Kimberly K. O.; Robertson, Hugh M.; Angeli, Sergio; Foret, Sylvain; Schuetz, Stefan; Maleszka, Ryszard; Miller, Sherry C.; Grossmann, Daniela		Tribolium Genome Sequencing Consortium	The genome of the model beetle and pest Tribolium castaneum	NATURE			English	Article							SHORT-GERM INSECT; RED FLOUR BEETLE; DROSOPHILA-MELANOGASTER; GENE SUPERFAMILY; APIS-MELLIFERA; MESSENGER-RNA; BOMBYX-MORI; HONEY-BEE; PROTEIN; SEGMENTATION	Tribolium castaneum is a member of the most species-rich eukaryotic order, a powerful model organism for the study of generalized insect development, and an important pest of stored agricultural products. We describe its genome sequence here. This omnivorous beetle has evolved the ability to interact with a diverse chemical environment, as shown by large expansions in odorant and gustatory receptors, as well as P450 and other detoxification enzymes. Development in Tribolium is more representative of other insects than is Drosophila, a fact reflected in gene content and function. For example, Tribolium has retained more ancestral genes involved in cell - cell communication than Drosophila, some being expressed in the growth zone crucial for axial elongation in short- germ development. Systemic RNA interference in T. castaneum functions differently from that in Caenorhabditis elegans, but nevertheless offers similar power for the elucidation of gene function and identification of targets for selective insect control.	[Richards, Stephen; Gibbs, Richard A.; Weinstock, George M.; Gibbs, Richard; Bucher, Gregor; Muzny, Donna; Attaway, Tony; Bell, Stephanie; Buhay, Christian J.; Chandrabose, Mimi N.; Chavez, Dean; Clerk-Blankenburg, Kerstin P.; Cree, Andrew; Dao, Marvin; Davis, Clay; Chacko, Joseph; Dinh, Huyen; Dugan-Rocha, Shannon; Fowler, Gerald; Garner, Toni T.; Hawes, Alica; Hernandez, Judith; Hines, Sandra; Holder, Michael; Hume, Jennifer; Jhangiani, Shalini N.; Joshi, Vandita; Khan, Ziad Mohid; Jackson, LaRonda; Kovar, Christie; Kowis, Andrea; Lee, Sandra; Lewis, Lora R.; Morgan, Margaret; Nazareth, Lynne V.; Nguyen, Ngoc; Okwuonu, Geoffrey; Parker, David; Ruiz, San-Juana; Santibanez, Jireh; Scherer, Steven E.; Schneider, Brian; Sodergren, Erica; Vattahil, Selina; Villasana, Donna; White, Courtney S.; Wright, Rita; Liu, Yue; Worley, Kim; Song, Henry; Zhang, Lan; Sodergren, Erica] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Richards, Stephen; Gibbs, Richard A.; Weinstock, George M.; Gibbs, Richard; Bucher, Gregor; Muzny, Donna; Attaway, Tony; Bell, Stephanie; Buhay, Christian J.; Chandrabose, Mimi N.; Chavez, Dean; Clerk-Blankenburg, Kerstin P.; Cree, Andrew; Dao, Marvin; Davis, Clay; Chacko, Joseph; Dinh, Huyen; Dugan-Rocha, Shannon; Fowler, Gerald; Garner, Toni T.; Hawes, Alica; Hernandez, Judith; Hines, Sandra; Holder, Michael; Hume, Jennifer; Jhangiani, Shalini N.; Joshi, Vandita; Khan, Ziad Mohid; Jackson, LaRonda; Kovar, Christie; Kowis, Andrea; Lee, Sandra; Lewis, Lora R.; Morgan, Margaret; Nazareth, Lynne V.; Nguyen, Ngoc; Okwuonu, Geoffrey; Parker, David; Ruiz, San-Juana; Santibanez, Jireh; Scherer, Steven E.; Schneider, Brian; Sodergren, Erica; Vattahil, Selina; Villasana, Donna; White, Courtney S.; Wright, Rita; Liu, Yue; Worley, Kim; Song, Henry; Zhang, Lan; Sodergren, Erica] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Brown, Susan J.; Denell, Robin; Lorenzen, Marce D.; Brown, Susan; Wang, Liangjiang; Wang, Suzhi; Bolognesi, Renata; Denell, Robin E.; Gordon, Cassondra M.; Shippy, Teresa D.; Tomoyasu, Yoshinori; Marshall, Jeremy; Miller, Sherry C.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Beeman, Richard W.; Lorenzen, Marce D.; Lord, Jeff; Oppert, Brenda; Kramer, Karl J.; Arakane, Yasuyuki; Oppert, Cris] ARS, Grain Mkt & Prod Res Ctr, USDA, Manhattan, KS 66502 USA; [Posnien, Nico; Schinko, Johannes B.; Simonnet, Franck; Wimmer, Ernst A.; Schuetz, Stefan; Grossmann, Daniela] Univ Gottingen, Johann Friedrich Blumenbach Inst, Dept Dev Biol, D-37077 Gottingen, Germany; [Friedrich, Markus; Bao, Riyue; Yang, Xiaoyun] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Grimmelikhuijzen, Cornelis J. P.; Hauser, Frank; Cazzamali, Giuseppe; Williamson, Michael] Univ Copenhagen, Ctr Funct & Comparat Insect Genom, DK-2100 Copenhagen, Denmark; [Hauser, Frank; Cazzamali, Giuseppe; Williamson, Michael] Univ Copenhagen, Dept Cell Biol & Comparat Zool, Inst Biol, DK-2100 Copenhagen, Denmark; [Klingler, Martin; Klingler, Martin; Schmitt, Christian; Schoppmeier, Michael; Trauner, Jochen] Friedrich Alexander Univ Erlangen, Dept Dev Biol, Inst Biol, D-91058 Erlangen, Germany; [Roth, Siegfried; von Levetsow, Cornelia; Lynch, Jeremy A.; da Fonseca, Rodrigo Nunes; Roth, Siegfried] Univ Cologne, Inst Dev Biol, D-50674 Cologne, Germany; [Schroeder, Reinhard; Beermann, Anke; Berns, Nicola; Lutz, Rebekka; Reuter, Rolf; Wittkopp, Nadine] Univ Tubingen, Interfac Inst Cell Biol, D-72076 Tubingen, Germany; [Tautz, Diethard; Savard, Joel; Savard, Joel; Aranda, Manuel; Marques-Souza, Henrique; Van der Zee, Maurijn] Univ Cologne, Dept Genet, D-50674 Cologne, Germany; [Zdobnov, Evgeny M.; Wyder, Stefan; Zdobnov, Evgeny M.; Kriventseva, Evgenia V.] Univ Geneva, Med Sch, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Zdobnov, Evgeny M.; Zdobnov, Evgeny M.] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Zdobnov, Evgeny M.; Waterhouse, Robert M.; Zdobnov, Evgeny M.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; Childrens Hosp Oakland, Res Inst, BACPAC Resources, Oakland, CA 94609 USA; [Garnes, Jeffrey] MIT, Broad Inst, Cambridge, MA 02142 USA; [Garnes, Jeffrey] Harvard Univ, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Gnirke, Andreas; Margolis, Jon] AgraQuest Inc, Davis, CA 95616 USA; [Park, Yoonseong; Li, Bin] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Elsik, Christine G.; Reese, Justin T.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Elhaik, Eran; Landan, Giddy; Graur, Dan] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Arensburger, Peter; Atkinson, Peter] Univ Calif, Dept Entomol, Riverside, CA 92521 USA; [Beidler, Jim; Tu, Zhijian] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Demuth, Jeffery P.] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Drury, Douglas W.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Du, Yu-Zhou; Wang, Jian-Jun] Yangzhou Univ, Dept Plant Protect, Yangzhou 225009, Peoples R China; [Fujiwara, Haruhiko; Osanai, Mizuko] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan; [Maselli, Vincenza] European Sch Mol Med, I-80131 Naples, Italy; Telethon Inst Genet & Med, I-80131 Naples, Italy; [Robertson, Hugh M.; Walden, Kimberly K. O.; Robertson, Hugh M.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Werner, Doreen; Stanke, Mario; Morgenstern, Burkhard] Univ Gottingen, Dept Bioinformat, Inst Microbiol & Genet, D-37077 Gottingen, Germany; [Solovyev, Victor] Univ London, Dept Comp Sci, Surrey TW20 0EX, England; [Kosarev, Peter] Softberry Inc, Mt Kisco, NY 10549 USA; [Brown, Garth; Chen, Hsiu-Chuan; Ermolaeva, Olga; Hlavina, Wratko; Kapustin, Yuri; Kiryutin, Boris; Kitts, Paul; Maglott, Donna; Pruitt, Kim; Sapojnikov, Victor; Souvorov, Alexandre] Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [Mackey, Aaron J.] GlaxoSmithKline, Collegeville, PA 19426 USA; [Kriventseva, Evgenia V.] Univ Geneva, Dept Struct Biol & Bioinformat, Sch Med, CH-1211 Geneva, Switzerland; [Kadowaki, Tatsuhiko] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Bork, Peer; Raible, Florian] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Bork, Peer] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Bonneton, Francois; Laudet, Vincent] Univ Lyon 1, Inst Genom Fonctionnelle Lyon, Equipe Zool Mol, ENS Lyon,CNRS,UMR 5242,INRA,IFR128, F-69364 Lyon 07, France; [Bopp, Daniel] Univ Zurich, Zool Inst, CH-8057 Zurich, Switzerland; [Butts, Thomas; Ferrier, David E. K.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Chaumot, Arnaud] Irstea, Lab Ecotoxicol, F-69336 Lyon 09, France; [Jindra, Marek] Inst Entomol ASCR, Ceske Budejovice 37005, Czech Republic; [Lan, Que] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Lattorff, H. Michael G.] Univ Halle Wittenberg, Inst Biol, D-06099 Halle, Saale, Germany; [Liu, Zhenyi] Washington Univ, Dept Mol Biol & Pharmacol, Sch Med, St Louis, MO 63110 USA; [Vervoort, Michel] Univ Paris 07, Ctr Genet Mol, CNRS UPR 2167, F-91198 Gif Sur Yvette, France; [Jones, Andrew K.; Sattelle, David B.] Univ Oxford, MRC Funct Genet Unit, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; [Ebert, Paul R.] Univ Queensland, Sch Integrat Biol, St Lucia, Qld 4072, Australia; [Ebert, Paul R.] Univ Queensland, Sch Mol & Microbial Sci, St Lucia, Qld 4072, Australia; [Nelson, David] Univ Tennessee, Dept Mol Sci, Memphis, TN 38163 USA; [Nelson, David] Univ Tennessee, Ct Excellence Genom & Bioinformat, Memphis, TN 38163 USA; [Scott, Jeffrey G.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Muthukrishnan, Subbaratnam; Kramer, Karl J.; Arakane, Yasuyuki; Zhu, Qingsong; Hogenkamp, David; Dixit, Radhika] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA; [Jiang, Haobo; Zou, Zhen; Lu, Zhiqiang; Zhao, Picheng; Sumathipala, Niranji] Oklahoma State Univ, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA; [Elpidina, Elena; Vinokurov, Konstantin] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119992, Russia; [Evans, Jay] ARS, USDA, Bee Res Lab, Beltsville, MD 20705 USA; [Altincicek, Boran; Vilcinskas, Andreas] Univ Giessen, Inst Phytopathol & Appl Zool, Interdisciplinary Res Ctr, D-35392 Giessen, Germany; [Williams, Michael; Hultmark, Dan] Umea Univ, Umea Ctr Mol Pathogenesis, SE-90187 Umea, Sweden; [Hetru, Charles] CNRS, Inst Biol Molec Cell, F-67084 Strasbourg, France; [Tanaka, Yoshiaki] Natl Inst Agrobiol Sci, Div Insect Sci, Tsukuba, Ibaraki 3058634, Japan; [Predel, Reinhard; Neupert, Susanne] Univ Jena, Inst Gen Zool, D-07743 Jena, Germany; [Schachtner, Joachim] Univ Marburg, Dept Anim Physiol, D-35032 Marburg, Germany; [Verleyen, Peter] Univ Louvain, Dept Anim Physiol & Neurobiol, BE-3000 Louvain, Belgium; [Angeli, Sergio] Inst Forest Zool & Forest Conservat, D-37077 Gottingen, Germany; [Foret, Sylvain; Maleszka, Ryszard] Australian Natl Univ, Visual Sci & ARC Ctr Mol Genet Dev, Res Sch Biol Sci, Canberra, ACT 0200, Australia	Baylor College of Medicine; Baylor College of Medicine; Kansas State University; United States Department of Agriculture (USDA); University of Gottingen; Wayne State University; University of Copenhagen; University of Copenhagen; University of Erlangen Nuremberg; University of Cologne; Eberhard Karls University of Tubingen; University of Cologne; University of Geneva; Swiss Institute of Bioinformatics; Imperial College London; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Kansas State University; Texas A&M University System; Texas A&M University College Station; University of Houston System; University of Houston; University of California System; University of California Riverside; Virginia Polytechnic Institute & State University; University of Texas System; University of Texas Arlington; Indiana University System; Indiana University Bloomington; Yangzhou University; University of Tokyo; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Illinois System; University of Illinois Urbana-Champaign; University of Gottingen; University of London; Royal Holloway University London; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); GlaxoSmithKline; University of Geneva; Nagoya University; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); University of Zurich; University of Oxford; INRAE; Czech Academy of Sciences; University of Wisconsin System; University of Wisconsin Madison; Martin Luther University Halle Wittenberg; Washington University (WUSTL); UDICE-French Research Universities; Universite Paris Cite; University of Oxford; University of Queensland; University of Queensland; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Cornell University; Kansas State University; Oklahoma State University System; Oklahoma State University - Stillwater; Lomonosov Moscow State University; United States Department of Agriculture (USDA); Justus Liebig University Giessen; Umea University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; National Institute of Agrobiological Sciences - Japan; Friedrich Schiller University of Jena; Philipps University Marburg; Australian National University	Richards, S (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, 1 Baylor Plaza, Houston, TX 77030 USA.		Schachtner, Joachim/D-5522-2009; Waterhouse, Robert M/A-1858-2010; Hultmark, Dan/C-5058-2013; Maleszka, Ryszard/A-6078-2008; Zdobnov, Evgeny/AAB-2745-2022; Weinstock, George M/C-6314-2013; Liu, Zhenyi/H-5673-2011; Landan, Giddy/C-1086-2019; Predel, Reinhard/O-5243-2015; Nguyen, Ngoc/HHZ-0886-2022; Raible, Florian/G-6019-2011; Tomoyasu, Yoshinori/D-3061-2017; Posnien, Nico/D-1639-2012; Nunes-da-Fonseca, Rodrigo/ABI-1404-2022; Altincicek, Boran/C-1191-2009; Solovyev, Victor/C-4614-2013; zou, zhen/C-6134-2016; Vervoort, Michel/S-1448-2019; Hauser, Frank/M-2952-2014; Marshall, Jeremy/D-1436-2013; Evans, Jay D/C-8408-2012; Lattorff, Michael/F-6287-2010; Elpidina, Elena/D-5646-2012; Maselli, Vincenza/H-4672-2014; Fonseca, Rodrigo/B-2981-2009; FORET, Sylvain/B-9207-2012; Marques-Souza, Henrique/X-5865-2019; Angeli, Sergio/A-7720-2008; Bucher, Gregor/B-9004-2015; da Fonseca, Rodrigo Nunes/S-3964-2018; Foret, Sylvain/C-7661-2011; Zdobnov, Evgeny M/K-1133-2012; Wimmer, Ernst A./I-3333-2019; Tautz, Diethard/H-8436-2014; Elsik, Christine G/C-4120-2017; Aranda Lastra, Manuel/D-9530-2011; Bopp, Daniel/L-3517-2018; Klingler, Martin/J-8383-2013; Ferrier, David E.K./D-7595-2013; Elhaik, Eran/H-6838-2019; Bao, Riyue/G-8765-2014; ZHAO, PICHENG/G-3737-2014; Vinokurov, Konstantin S/F-9521-2011; Roth, Siegfried/E-8241-2010; Stanke, Mario/P-7876-2019; Jindra, Marek/H-2082-2014; Z., Q./I-4446-2013; Schachtner, Joachim/AAG-1101-2020; Bork, Peer/F-1813-2013; Morgenstern, Burkhard/A-7486-2008; Tautz, Diethard/D-4304-2011; Park, Yoonseong/J-5861-2013	Waterhouse, Robert M/0000-0003-4199-9052; Hultmark, Dan/0000-0002-6506-5855; Maleszka, Ryszard/0000-0003-1855-555X; Zdobnov, Evgeny/0000-0002-5178-1498; Weinstock, George M/0000-0002-2997-4592; Landan, Giddy/0000-0002-2502-8750; Tomoyasu, Yoshinori/0000-0001-9824-3454; Posnien, Nico/0000-0003-0700-5595; Nunes-da-Fonseca, Rodrigo/0000-0001-9576-2849; Altincicek, Boran/0000-0003-2019-452X; Solovyev, Victor/0000-0001-8885-493X; zou, zhen/0000-0003-3550-7656; Hauser, Frank/0000-0001-5563-2345; Evans, Jay D/0000-0002-0036-4651; Lattorff, Michael/0000-0002-8603-6332; Elpidina, Elena/0000-0002-4988-4842; Maselli, Vincenza/0000-0002-9877-3751; Fonseca, Rodrigo/0000-0003-3063-7806; Angeli, Sergio/0000-0002-8463-7476; Bucher, Gregor/0000-0002-4615-6401; da Fonseca, Rodrigo Nunes/0000-0001-9576-2849; Wimmer, Ernst A./0000-0002-2480-2804; Tautz, Diethard/0000-0002-0460-5344; Elsik, Christine G/0000-0002-4248-7713; Aranda Lastra, Manuel/0000-0001-6673-016X; Bopp, Daniel/0000-0002-0740-9672; Klingler, Martin/0000-0001-8859-1965; Ferrier, David E.K./0000-0003-3247-6233; Elhaik, Eran/0000-0003-4795-1084; Bao, Riyue/0000-0002-6105-1704; Roth, Siegfried/0000-0001-5772-3558; Stanke, Mario/0000-0001-8696-0384; Jindra, Marek/0000-0002-2196-9924; Schachtner, Joachim/0000-0001-7268-0699; Bork, Peer/0000-0002-2627-833X; Morgenstern, Burkhard/0000-0002-7431-2862; Shippy, Teresa/0000-0003-2305-7432; Jones, Andrew/0000-0002-7835-0890; Park, Yoonseong/0000-0003-1191-7335; Schroder, Reinhard/0000-0002-3483-1916; Grimmelikhuijzen, Cornelis Johannes Pieter/0000-0001-6486-2046; Worley, Kim/0000-0002-0282-1000; Wyder, Stefan/0000-0002-3412-0292; Walden, Kimberly/0000-0002-5799-8639; Nelson, David/0000-0003-0583-5421; Pruitt, Kim/0000-0001-7950-1374; Butts, Thomas/0000-0002-1781-5287; Ebert, Paul/0000-0002-4435-0737; Lorenzen, Marce/0000-0003-2318-1388; chaumot, arnaud/0000-0001-9132-3419; Bonneton, Francois/0000-0002-6500-1931; Marques-Souza, Henrique/0000-0002-5008-8413; Brown, Susan/0000-0002-7984-0445; Jiang, Haobo/0000-0003-1357-1315	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058634] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/B/12067/2, BBS/B/12067] Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; NICHD NIH HHS [R01 HD029594-16, R01 HD029594] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bankir L, 2001, CARDIOVASC RES, V51, P372, DOI 10.1016/S0008-6363(01)00328-5; Beermann A, 2001, DEVELOPMENT, V128, P287; BEERMANN A, IN PRESS DEV GENES E; BOLOGNESI R, IN PRESS DEV GENES E; BROWN SJ, 1990, INSECT BIOCHEM, V20, P185, DOI 10.1016/0020-1790(90)90011-I; Bucher G, 2004, DEVELOPMENT, V131, P1729, DOI 10.1242/dev.01073; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; Cerny AC, 2005, DEVELOPMENT, V132, P5353, DOI 10.1242/dev.02154; Choe CP, 2006, P NATL ACAD SCI USA, V103, P6560, DOI 10.1073/pnas.0510440103; Ciccarelli FD, 2005, GENOME RES, V15, P343, DOI 10.1101/gr.3266405; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Demuth JP, 2007, MOL ECOL NOTES, V7, P1189, DOI 10.1111/j.1471-8286.2007.01826.x; Draper BW, 1996, CELL, V87, P205, DOI 10.1016/S0092-8674(00)81339-2; ENGSONTIA P, IN PRESS INSECT BIOC; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; FONSECA RN, IN PRESS DEV CELL; Fujiwara H, 2005, CHROMOSOME RES, V13, P455, DOI 10.1007/s10577-005-0990-9; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Jackowska M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-24; Jones AK, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-327; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Lorenzen MD, 2007, INSECT MOL BIOL, V16, P265, DOI 10.1111/j.1365-2583.2007.00727.x; Lorenzen MD, 2005, GENETICS, V170, P741, DOI 10.1534/genetics.104.032227; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; Osanai M, 2006, GENE, V376, P281, DOI 10.1016/j.gene.2006.04.022; Raymond-Delpech Valerie, 2005, Invertebrate Neuroscience, V5, P119; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2006, GENOME RES, V16, P1345, DOI 10.1101/gr.5085606; Savard J, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-7; Savard J, 2006, GENOME RES, V16, P1334, DOI 10.1101/gr.5204306; Savard J, 2006, CELL, V126, P559, DOI 10.1016/j.cell.2006.05.053; Schroder R, 2003, NATURE, V422, P621, DOI 10.1038/nature01536; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sokoloff A, 1972, BIOL TRIBOLIUM SPECI, V1; SOKOLOFF A, 1974, BIOL TRIBOLIUM SPECI, V1; SOKOLOFF A, 1977, BIOL TRIBOLIUM SPECI, V1; TAUTZ D, 1994, DEVELOPMENT, P193; Tautz D, 2004, DEV CELL, V7, P301, DOI 10.1016/j.devcel.2004.08.008; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; TOMOYASU Y, IN PRESS GENOME BIOL; Ugarkovic D, 1996, MOL BIOL EVOL, V13, P1059, DOI 10.1093/oxfordjournals.molbev.a025668; van der Zee M, 2006, P NATL ACAD SCI USA, V103, P16307, DOI 10.1073/pnas.0605154103; Vinokurov KS, 2006, COMP BIOCHEM PHYS B, V145, P126, DOI 10.1016/j.cbpb.2006.05.005; WANG S, IN PRESS GENOME BIOL; Wong MD, 2005, ANNU REV GENET, V39, P173, DOI 10.1146/annurev.genet.39.073003.105855; Wyder S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r242; XIONG Y, 1988, MOL CELL BIOL, V8, P114, DOI 10.1128/MCB.8.1.114	51	988	1047	12	311	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2008	452	7190					949	955		10.1038/nature06784	http://dx.doi.org/10.1038/nature06784			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291PF	18362917	hybrid, Green Published, Green Accepted			2022-12-24	WOS:000255208600030
J	Hillenmeyer, ME; Fung, E; Wildenhain, J; Pierce, SE; Hoon, S; Lee, W; Proctor, M; St Onge, RP; Tyers, M; Koller, D; Altman, RB; Davis, RW; Nislow, C; Giaever, G				Hillenmeyer, Maureen E.; Fung, Eula; Wildenhain, Jan; Pierce, Sarah E.; Hoon, Shawn; Lee, William; Proctor, Michael; St Onge, Robert P.; Tyers, Mike; Koller, Daphne; Altman, Russ B.; Davis, Ronald W.; Nislow, Corey; Giaever, Guri			The chemical genomic portrait of yeast: Uncovering a phenotype for all genes	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; SMALL MOLECULES; MULTIDRUG-RESISTANCE; BIOACTIVE COMPOUNDS; METABOLIC NETWORK; MEMBRANE; ROBUSTNESS; PROTEINS; DRUGS	Genetics aims to understand the relation between genotype and phenotype. However, because complete deletion of most yeast genes (similar to 80%) has no obvious phenotypic consequence in rich medium, it is difficult to study their functions. To uncover phenotypes for this nonessential fraction of the genome, we performed 1144 chemical genomic assays on the yeast whole- genome heterozygous and homozygous deletion collections and quantified the growth fitness of each deletion strain in the presence of chemical or environmental stress conditions. We found that 97% of gene deletions exhibited a measurable growth phenotype, suggesting that nearly all genes are essential for optimal growth in at least one condition.	[Hillenmeyer, Maureen E.; Fung, Eula; Pierce, Sarah E.; Hoon, Shawn; Lee, William; Proctor, Michael; St Onge, Robert P.] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Hillenmeyer, Maureen E.; Altman, Russ B.; Davis, Ronald W.] Stanford Univ, Program Biomed Informat, Palo Alto, CA 94304 USA; [Wildenhain, Jan; Tyers, Mike] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Pierce, Sarah E.; Hoon, Shawn; Lee, William; Altman, Russ B.; Davis, Ronald W.] Stanford Univ, Dept Genet, Palo Alto, CA 94304 USA; [Tyers, Mike; Nislow, Corey; Giaever, Guri] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Koller, Daphne] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Nislow, Corey; Giaever, Guri] Univ Toronto, Donelley Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Giaever, Guri] Univ Toronto, Dept Pharmaceut Sci, Toronto, ON M5S 3M2, Canada	Stanford University; Stanford University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Stanford University; University of Toronto; Stanford University; University of Toronto; University of Toronto	Giaever, G (corresponding author), Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA.	guri.giaever@utoronto.ca	Giaever, Guri/D-3930-2009; Tyers, Michael/ABE-3194-2021; Wildenhain, Jan/Q-6596-2019; Wildenhain, Jan/E-5597-2011; Hoon, Shawn/Q-2472-2016	Wildenhain, Jan/0000-0002-5461-3828; Wildenhain, Jan/0000-0002-5461-3828; Hoon, Shawn/0000-0002-3892-3332	NIGMS NIH HHS [U01 GM061374-09, U01 GM061374] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061374] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bagshaw RD, 2005, MOL CELL PROTEOMICS, V4, P133, DOI 10.1074/mcp.M400128-MCP200; Blower P. E., 2002, Pharmacogenomics Journal, V2, P259, DOI 10.1038/sj.tpj.6500116; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Chua G, 2004, CURR OPIN MICROBIOL, V7, P638, DOI 10.1016/j.mib.2004.10.009; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; DUDLEY AM, 2005, MOL SYSTEMS BIOL, V1; Egner R, 1996, FEBS LETT, V378, P177, DOI 10.1016/0014-5793(95)01450-0; Ferte J, 2000, EUR J BIOCHEM, V267, P277, DOI 10.1046/j.1432-1327.2000.01046.x; Fry RC, 2005, ANNU REV MICROBIOL, V59, P357, DOI 10.1146/annurev.micro.59.031805.133658; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gong YP, 2003, J BIOL CHEM, V278, P50234, DOI 10.1074/jbc.M306606200; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Jungwirth H, 2006, FEBS LETT, V580, P1131, DOI 10.1016/j.febslet.2005.12.050; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Liang XJ, 2006, CANCER RES, V66, P2346, DOI 10.1158/0008-5472.CAN-05-3436; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Schrader M, 2004, HISTOCHEM CELL BIOL, V122, P383, DOI 10.1007/s00418-004-0673-1; Schreiber SL, 2005, NAT CHEM BIOL, V1, P64, DOI 10.1038/nchembio0705-64; Sharom JR, 2004, CURR OPIN CHEM BIOL, V8, P81, DOI 10.1016/j.cbpa.2003.12.007; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	28	710	728	1	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2008	320	5874					362	365		10.1126/science.1150021	http://dx.doi.org/10.1126/science.1150021			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZZ	18420932	Green Accepted			2022-12-24	WOS:000255026100040
J	Russell, CA; Jones, TC; Barr, IG; Cox, NJ; Garten, RJ; Gregory, V; Gust, ID; Hampson, AW; Hay, AJ; Hurt, AC; de Jong, JC; Kelso, A; Klimov, AI; Kageyama, T; Komadina, N; Lapedes, AS; Lin, YP; Mosterin, A; Obuchi, M; Odagiri, T; Osterhaus, ADME; Rimmelzwaan, GF; Shaw, MW; Skepner, E; Stohr, K; Tashiro, M; Fouchier, RAM; Smith, DJ				Russell, Colin A.; Jones, Terry C.; Barr, Ian G.; Cox, Nancy J.; Garten, Rebecca J.; Gregory, Vicky; Gust, Ian D.; Hampson, Alan W.; Hay, Alan J.; Hurt, Aeron C.; de Jong, Jan C.; Kelso, Anne; Klimov, Alexander I.; Kageyama, Tsutomu; Komadina, Naomi; Lapedes, Alan S.; Lin, Yi P.; Mosterin, Ana; Obuchi, Masatsugu; Odagiri, Takato; Osterhaus, Albert D. M. E.; Rimmelzwaan, Guus F.; Shaw, Michael W.; Skepner, Eugene; Stohr, Klaus; Tashiro, Masato; Fouchier, Ron A. M.; Smith, Derek J.			The global circulation of seasonal influenza A (H3N2) viruses	SCIENCE			English	Article							SURVEILLANCE; EPIDEMICS; EVOLUTION; REASSORTMENT; HIERARCHIES; INFECTIONS; REVEALS; BRAZIL	Antigenic and genetic analysis of the hemagglutinin of similar to 13,000 human influenza A ( H3N2) viruses from six continents during 2002- 2007 revealed that there was continuous circulation in east and Southeast Asia ( E- SE Asia) via a region- wide network of temporally overlapping epidemics and that epidemics in the temperate regions were seeded from this network each year. Seed strains generally first reached Oceania, North America, and Europe, and later South America. This evidence suggests that once A ( H3N2) viruses leave E- SE Asia, they are unlikely to contribute to long- term viral evolution. If the trends observed during this period are an accurate representation of overall patterns of spread, then the antigenic characteristics of A ( H3N2) viruses outside E- SE Asia may be forecast each year based on surveillance within E- SE Asia, with consequent improvements to vaccine strain selection.	[Russell, Colin A.; Jones, Terry C.; Mosterin, Ana; Skepner, Eugene; Smith, Derek J.] Univ Cambridge, Dept Zool, Cambridge, England; [Jones, Terry C.; Osterhaus, Albert D. M. E.; Rimmelzwaan, Guus F.; Fouchier, Ron A. M.; Smith, Derek J.] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Jones, Terry C.] Univ Pompeu Fabra, Barcelona, Spain; [Barr, Ian G.; Gust, Ian D.; Hampson, Alan W.; Hurt, Aeron C.; Kelso, Anne; Komadina, Naomi] WHO, Collaborating Ctr Reference & Res Influenza, Melbourne, Vic, Australia; [Cox, Nancy J.; Garten, Rebecca J.; Klimov, Alexander I.; Shaw, Michael W.] Ctr Dis Control & Prevent, WHO Collaborating Ctr Influenza, Atlanta, GA USA; [Obuchi, Masatsugu; Odagiri, Takato; Tashiro, Masato] Natl Inst Med Res, WHO Collaborating Ctr Influenza, London NW7 1AA, England; [Gregory, Vicky; Lin, Yi P.] Natl Inst Infect Dis, WHO Collaborating Ctr Influenza, Tokyo, Japan; [Lapedes, Alan S.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA; [Stohr, Klaus] Novartis Vaccines & Diagnost, Cambridge, MA USA	University of Cambridge; Erasmus University Rotterdam; Erasmus MC; Pompeu Fabra University; World Health Organization; Centers for Disease Control & Prevention - USA; MRC National Institute for Medical Research; National Institute of Infectious Diseases (NIID); United States Department of Energy (DOE); Los Alamos National Laboratory; Novartis	Smith, DJ (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	dsmith@zoo.cam.ac.uk	Russell, Colin/ABE-7106-2020; Fouchier, Ron A/A-1911-2014; Russell, Colin/B-2226-2008; Smith, Derek/Z-3075-2019	Fouchier, Ron A/0000-0001-8095-2869; Smith, Derek/0000-0002-2393-1890; Kelso, Anne/0000-0002-3166-3267; Osterhaus, Albert/0000-0002-6074-1172; Barr, Ian/0000-0002-7351-418X; Russell, Colin/0000-0002-2113-162X; Hurt, Aeron/0000-0003-1826-4314	Medical Research Council [MC_U117512723] Funding Source: Medline; NIH HHS [DP1-OD000490-01] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000490] Funding Source: NIH RePORTER; MRC [MC_U117512723] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Chew FT, 1998, EPIDEMIOL INFECT, V121, P121, DOI 10.1017/S0950268898008905; *COMM AC RESP DIS, 1948, AM J HYG, V47, P290; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; COX NJ, 1994, EUR J EPIDEMIOL, V10, P467, DOI 10.1007/BF01719678; DAVIDWEST TS, 1974, B WORLD HEALTH ORGAN, V51, P103; DEARRUDA E, 1991, J INFECT DIS, V164, P252, DOI 10.1093/infdis/164.2.252; DORAISINGHAM S, 1988, B WORLD HEALTH ORGAN, V66, P57; Dosseh A, 2000, AM J TROP MED HYG, V62, P639, DOI 10.4269/ajtmh.2000.62.639; DUDGEON JA, 1946, LANCET, V248, P627; Fitzner K. A., 1999, Hong Kong Medical Journal, V5, P87; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; GLEZEN WP, 1989, VIRAL INFECTIONS HUM, P419; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Grenfell BT, 1998, ECOL LETT, V1, P63; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Monto AS, 2004, INT CONGR SER, V1263, P3, DOI 10.1016/j.ics.2004.02.049; Nelson MI, 2007, PLOS PATHOG, V3, P1220, DOI 10.1371/journal.ppat.0030131; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Nguyen-Van-Tam JS, 1998, TXB INFLUENZA, P181; Shih SR, 2005, J CLIN MICROBIOL, V43, P1651, DOI 10.1128/JCM.43.4.1651-1661.2005; Shortridge KF, 1997, CHINESE MED J-PEKING, V110, P637; Simmerman JM, 2004, VACCINE, V23, P182, DOI 10.1016/j.vaccine.2004.05.025; Simonsen L, 2007, MOL BIOL EVOL, V24, P1811, DOI 10.1093/molbev/msm103; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Stohr K, 2002, LANCET INFECT DIS, V2, P517, DOI 10.1016/S1473-3099(02)00366-3; Taylor RM, 1949, AM J PUBLIC HEALTH N, V39, P171, DOI 10.2105/AJPH.39.2.171; THACKER SB, 1986, EPIDEMIOL REV, V8, P129, DOI 10.1093/oxfordjournals.epirev.a036291; Viboud C, 2004, EMERG INFECT DIS, V10, P32, DOI 10.3201/eid1001.020705; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Wong CM, 2006, PLOS MED, V3, P485, DOI 10.1371/journal.pmed.0030121	33	512	542	1	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2008	320	5874					340	346		10.1126/science.1154137	http://dx.doi.org/10.1126/science.1154137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZZ	18420927				2022-12-24	WOS:000255026100034
J	Ober, C; Tan, Z; Sun, Y; Possick, JD; Pan, L; Nicolae, R; Radford, S; Parry, RR; Heinzmann, A; Deichmann, KA; Lester, LA; Gern, JE; Lemanske, RF; Nicolae, DL; Elias, JA; Chupp, GL				Ober, Carole; Tan, Zheng; Sun, Ying; Possick, Jennifer D.; Pan, Lin; Nicolae, Raluca; Radford, Sadie; Parry, Rodney R.; Heinzmann, Andrea; Deichmann, Klaus A.; Lester, Lucille A.; Gern, James E.; Lemanske, Robert F., Jr.; Nicolae, Dan L.; Elias, Jack A.; Chupp, Geoffrey L.			Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FOUNDER POPULATION; QUANTITATIVE TRAITS; COMPLEX PEDIGREES; CHITINASE; SUSCEPTIBILITY; PROTEIN; MARKER; CELLS	Background: The chitinase-like protein YKL-40 is involved in inflammation and tissue remodeling. We recently showed that serum YKL-40 levels were elevated in patients with asthma and were correlated with severity, thickening of the subepithelial basement membrane, and pulmonary function. We hypothesized that single-nucleotide polymorphisms (SNPs) that affect YKL-40 levels also influence asthma status and lung function. Methods: We carried out a genomewide association study of serum YKL-40 levels in a founder population of European descent, the Hutterites, and then tested for an association between an implicated SNP and asthma and lung function. One associated variant was genotyped in a birth cohort at high risk for asthma, in which YKL-40 levels were measured from birth through 5 years of age, and in two populations of unrelated case patients of European descent with asthma and controls. Results: A promoter SNP (-131C-->G) in CHI3L1, the chitinase 3-like 1 gene encoding YKL-40, was associated with elevated serum YKL-40 levels (P=1.1 x 10(-13)), asthma (P=0.047), bronchial hyperresponsiveness (P=0.002), and measures of pulmonary function (P=0.046 to 0.002) in the Hutterites. The same SNP could be used to predict the presence of asthma in the two case-control populations (combined P=1.2 x 10(-5)) and serum YKL-40 levels at birth (in cord-blood specimens) through 5 years of age in the birth cohort (P=8.9 x 10(-3) to 2.5 x 10(-4)). Conclusions CHI3L1 is a susceptibility gene for asthma, bronchial hyperresponsiveness, and reduced lung function, and elevated circulating YKL-40 levels are a biomarker for asthma and decline in lung function.	[Ober, Carole; Tan, Zheng; Sun, Ying; Pan, Lin; Nicolae, Raluca; Radford, Sadie; Lester, Lucille A.; Nicolae, Dan L.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Gern, James E.; Lemanske, Robert F., Jr.] Univ Wisconsin, Madison, WI USA; [Possick, Jennifer D.; Elias, Jack A.; Chupp, Geoffrey L.] Yale Univ, Sch Med, New Haven, CT USA; [Parry, Rodney R.] Univ S Dakota, Sch Med, Sioux Falls, SD USA; [Heinzmann, Andrea; Deichmann, Klaus A.] Univ Freiburg, Freiburg, Germany	University of Chicago; University of Wisconsin System; University of Wisconsin Madison; Yale University; University of South Dakota; University of Freiburg	Ober, C (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St, Chicago, IL 60637 USA.	c-ober@genetics.uchicago.edu	Possick, Jennifer/AFG-1039-2022	Nicolae, Dan/0000-0002-0918-4630; Ober, Carole/0000-0003-4626-9809	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000055] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066533, R01HL072414, R01HL085197, P50HL056399, U01HL049596, P01HL056389, R01HL061879, P50HL056389, P01HL070831] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000055, M01 RR00055] Funding Source: Medline; NHLBI NIH HHS [R01 HL085197, P01 HL056389, HL72414, HL56389, P01 HL070831, HL70831, U01 HL049596, HL61879, R01 HL066533, HL81638, R01 HL085197-02, R01 HL072414, P50 HL056399, HL66533, HL56399, P50 HL056389, HL85197] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abney M, 2002, AM J HUM GENET, V70, P920, DOI 10.1086/339705; Abney M, 2001, AM J HUM GENET, V68, P1302, DOI 10.1086/320112; Bourgain C, 2004, GENETICS, V168, P2349, DOI 10.1534/genetics.104.031617; Bourgain C, 2003, AM J HUM GENET, V73, P612, DOI 10.1086/378208; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; JOHANSEN JS, 1993, BRIT J RHEUMATOL, V32, P949; JOHANSEN JS, 1992, J BONE MINER RES, V7, P501; Johansen JS, 2006, DAN MED BULL, V53, P172; Kelleher TB, 2005, J HEPATOL, V43, P78, DOI 10.1016/j.jhep.2005.02.025; Kruit A, 2007, RESP MED, V101, P1563, DOI 10.1016/j.rmed.2006.12.006; Lemanske RF, 2002, PEDIAT ALLERG IMM-UK, V13, P38, DOI 10.1034/j.1399-3038.13.s.15.8.x; Lester LA, 2001, J ALLERGY CLIN IMMUN, V108, P357, DOI 10.1067/mai.2001.117796; McPeek MS, 2004, BIOMETRICS, V60, P359; Ober C, 2000, AM J HUM GENET, V67, P1154, DOI 10.1016/S0002-9297(07)62946-2; Ober C, 2001, AM J HUM GENET, V69, P1068, DOI 10.1086/324025; Pan L, 2007, GENET EPIDEMIOL, V31, P338, DOI 10.1002/gepi.20214; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Zhao XZ, 2007, AM J HUM GENET, V80, P12, DOI 10.1086/510438; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	21	380	396	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 17	2008	358	16					1682	1691		10.1056/NEJMoa0708801	http://dx.doi.org/10.1056/NEJMoa0708801			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288DO	18403759	Green Accepted			2022-12-24	WOS:000254966600006
J	Tye, KM; Stuber, GD; de Ridder, B; Bonci, A; Janak, PH				Tye, Kay M.; Stuber, Garret D.; de Ridder, Bram; Bonci, Antonello; Janak, Patricia H.			Rapid strengthening of thalamo-amygdala synapses mediates cue-reward learning	NATURE			English	Article							LONG-TERM POTENTIATION; LATERAL AMYGDALA; PREFRONTAL CORTEX; VENTRAL STRIATUM; FEAR; PLASTICITY; NEURONS; STIMULI; RAT; PROJECTIONS	What neural changes underlie individual differences in goal-directed learning? The lateral amygdala ( LA) is important for assigning emotional and motivational significance to discrete environmental cues(1-4), including those that signal rewarding events(5-8). Recognizing that a cue predicts a reward enhances an animal's ability to acquire that reward; however, the cellular and synaptic mechanisms that underlie cue - reward learning are unclear. Here we show that marked changes in both cue- induced neuronal firing and input- specific synaptic strength occur with the successful acquisition of a cue - reward association within a single training session. We performed both in vivo and ex vivo electrophysiological recordings in the LA of rats trained to self- administer sucrose. We observed that reward- learning success increased in proportion to the number of amygdala neurons that responded phasically to a reward- predictive cue. Furthermore, cue - reward learning induced an AMPA (alpha-amino- 3- hydroxy- 5- methyl-isoxazole propionic acid)- receptor- mediated increase in the strength of thalamic, but not cortical, synapses in the LA that was apparent immediately after the first training session. The level of learning attained by individual subjects was highly correlated with the degree of synaptic strength enhancement. Importantly, intra-LA NMDA ( N- methyl- D- aspartate)- receptor blockade impaired reward- learning performance and attenuated the associated increase in synaptic strength. These findings provide evidence of a connection between LA synaptic plasticity and cue - reward learning, potentially representing a key mechanism underlying goal-directed behaviour.	[Tye, Kay M.; Stuber, Garret D.; de Ridder, Bram; Bonci, Antonello; Janak, Patricia H.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA; [Stuber, Garret D.; Bonci, Antonello; Janak, Patricia H.] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; [Bonci, Antonello; Janak, Patricia H.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Bonci, Antonello; Janak, Patricia H.] Univ Calif San Francisco, Wheeler Ctr Neurobiol Addict, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Janak, PH (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA.	pjanak@gallo.ucsf.edu	Tye, Kay/J-6158-2013; Stuber, Garret/E-1160-2011	Tye, Kay/0000-0002-2435-0182; Stuber, Garret/0000-0003-1730-4855; Janak, Patricia/0000-0002-3333-9049	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015096] Funding Source: NIH RePORTER; NIDA NIH HHS [R01DA115096, R01 DA015096, R01 DA015096-06] Funding Source: Medline; NIDDK NIH HHS [DP2 DK102256] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AZUMA S, 1984, EXP BRAIN RES, V56, P12; Baldwin AE, 2000, BEHAV NEUROSCI, V114, P84, DOI 10.1037/0735-7044.114.1.84; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; BURNS LH, 1994, BEHAV NEURAL BIOL, V61, P242, DOI 10.1016/S0163-1047(05)80007-X; CADOR M, 1989, NEUROSCIENCE, V30, P77, DOI 10.1016/0306-4522(89)90354-0; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; DAVIS M, 1992, P255; Doron NN, 1999, J COMP NEUROL, V412, P383; HESS G, 1987, NEUROSCI LETT, V77, P187, DOI 10.1016/0304-3940(87)90584-2; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; McGaugh JL, 2002, TRENDS NEUROSCI, V25, P456, DOI 10.1016/S0166-2236(02)02211-7; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Nakashima M, 2000, NEUROSCI RES, V36, P297, DOI 10.1016/S0168-0102(99)00129-7; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Samson RD, 2006, NEUROSCIENCE, V141, P1599, DOI 10.1016/j.neuroscience.2006.04.077; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Shin RM, 2006, NEURON, V52, P883, DOI 10.1016/j.neuron.2006.10.010; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Tye KM, 2007, J NEUROSCI, V27, P3937, DOI 10.1523/JNEUROSCI.5281-06.2007; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; UWANO T, 1995, NEUROSCIENCE, V68, P339, DOI 10.1016/0306-4522(95)00125-3	30	155	155	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2008	453	7199					1253	U56		10.1038/nature06963	http://dx.doi.org/10.1038/nature06963			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18469802	Green Accepted			2022-12-24	WOS:000257075800046
J	Stipanovich, A; Valjent, E; Matamales, M; Nishi, A; Ahn, JH; Maroteaux, M; Bertran-Gonzalez, J; Brami-Cherrier, K; Enslen, H; Corbille, AG; Filhol, O; Nairn, AC; Greengard, P; Herve, D; Girault, JA				Stipanovich, Alexandre; Valjent, Emmanuel; Matamales, Miriam; Nishi, Akinori; Ahn, Jung-Hyuck; Maroteaux, Matthieu; Bertran-Gonzalez, Jesus; Brami-Cherrier, Karen; Enslen, Herve; Corbille, Anne-Gaelle; Filhol, Odile; Nairn, Angus C.; Greengard, Paul; Herve, Denis; Girault, Jean-Antoine			A phosphatase cascade by which rewarding stimuli control nucleosomal response	NATURE			English	Article							HISTONE H3 PHOSPHORYLATION; INNERVATED BRAIN-REGIONS; NUCLEAR EXPORT; DOPAMINERGIC NEUROTRANSMISSION; REGULATED PHOSPHOPROTEIN; PROTEIN PHOSPHATASE-1; GENE-EXPRESSION; DRUG-ADDICTION; KINASE; DARPP-32	Dopamine orchestrates motor behaviour and reward- driven learning. Perturbations of dopamine signalling have been implicated in several neurological and psychiatric disorders, and in drug addiction. The actions of dopamine are mediated in part by the regulation of gene expression in the striatum, through mechanisms that are not fully understood. Here we show that drugs of abuse, as well as food reinforcement learning, promote the nuclear accumulation of 32- kDa dopamine- regulated and cyclic- AMP- regulated phosphoprotein ( DARPP- 32). This accumulation is mediated through a signalling cascade involving dopamine D1 receptors, cAMP- dependent activation of protein phosphatase- 2A, dephosphorylation of DARPP- 32 at Ser 97 and inhibition of its nuclear export. The nuclear accumulation of DARPP- 32, a potent inhibitor of protein phosphatase- 1, increases the phosphorylation of histone H3, an important component of nucleosomal response. Mutation of Ser 97 profoundly alters behavioural effects of drugs of abuse and decreases motivation for food, underlining the functional importance of this signalling cascade.	[Stipanovich, Alexandre; Valjent, Emmanuel; Matamales, Miriam; Maroteaux, Matthieu; Bertran-Gonzalez, Jesus; Brami-Cherrier, Karen; Enslen, Herve; Corbille, Anne-Gaelle; Herve, Denis; Girault, Jean-Antoine] INSERM, UMR S 839, F-75005 Paris, France; [Stipanovich, Alexandre; Valjent, Emmanuel; Matamales, Miriam; Maroteaux, Matthieu; Bertran-Gonzalez, Jesus; Brami-Cherrier, Karen; Enslen, Herve; Corbille, Anne-Gaelle; Herve, Denis; Girault, Jean-Antoine] Univ Paris 06, F-75005 Paris, France; [Stipanovich, Alexandre; Valjent, Emmanuel; Matamales, Miriam; Maroteaux, Matthieu; Bertran-Gonzalez, Jesus; Brami-Cherrier, Karen; Enslen, Herve; Corbille, Anne-Gaelle; Herve, Denis; Girault, Jean-Antoine] Inst Fer Moulin, F-75005 Paris, France; [Nishi, Akinori] Kurume Univ, Sch Med, Dept Pharmacol, Fukuoka 8300011, Japan; [Nishi, Akinori; Ahn, Jung-Hyuck; Nairn, Angus C.; Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; [Filhol, Odile] CEA, INSERM, U873, F-38054 Grenoble, France; [Nairn, Angus C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Kurume University; Rockefeller University; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); Yale University	Girault, JA (corresponding author), INSERM, UMR S 839, F-75005 Paris, France.	girault@fer-a-moulin.inserm.fr	Girault, Jean-Antoine/F-7518-2013; Filhol-Cochet, Odile/I-3962-2016; Bertran-Gonzalez, J/L-1410-2017; Enslen, Hervé/M-3400-2017; Enslen, Hervé/AAH-4492-2021; HERVE, Denis/E-2929-2017; Matamales, Miriam/J-5189-2014; brami-cherrier, karen/I-9263-2014	Girault, Jean-Antoine/0000-0002-7900-1705; Bertran-Gonzalez, J/0000-0002-3794-1782; Enslen, Hervé/0000-0001-9741-5293; Enslen, Hervé/0000-0001-9741-5293; HERVE, Denis/0000-0003-1376-1522; Matamales, Miriam/0000-0001-9978-0091; brami-cherrier, karen/0000-0002-3009-3821; Ahn, Jung-Hyuck/0000-0001-9589-3881; Nairn, Angus/0000-0002-7075-0195; Valjent, Emmanuel/0000-0002-1034-606X; Filhol, Odile/0000-0003-1964-7958; Greengard, Paul/0000-0002-4437-0893	NIDA NIH HHS [P01 DA010044-11, P01 DA010044-090002, P01 DA010044-14S1, P01 DA010044-050002, P01 DA010044-14, P01 DA010044-120005, P01 DA010044-030002, P01 DA010044-110005, P01 DA010044-080002, P01 DA010044-04, P01 DA010044-13, P01 DA010044, P01 DA010044-10, P01 DA010044-140005, P01 DA010044-060002, P01 DA010044-130005, P01 DA010044-139002, P01 DA010044-05, DA10044, P01 DA010044-08, P01 DA010044-129002, P01 DA010044-09, P01 DA010044-100002, P01 DA010044-020002, P01 DA010044-07, P01 DA010044-040002, P01 DA010044-070002, P01 DA010044-06, P01 DA010044-12, P01 DA010044-149002] Funding Source: Medline; NIMH NIH HHS [P50 MH074866-040001, P50 MH074866-010001, P50 MH074866, P50 MH074866-050001, P50 MH074866-020001, P50 MH074866-029001, P50 MH074866-049001, P50 MH074866-030001, P50 MH074866-019001, MH74866, P50 MH074866-039001, P50 MH074866-059001] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; BODE AM, 2005, SCI STKE, V281, P1; Brami-Cherrier K, 2005, J NEUROSCI, V25, P11444, DOI 10.1523/JNEUROSCI.1711-05.2005; Di Chiara G, 1999, EUR J PHARMACOL, V375, P13, DOI 10.1016/S0014-2999(99)00372-6; DRAGO J, 1994, P NATL ACAD SCI USA, V91, P12564, DOI 10.1073/pnas.91.26.12564; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fienberg AA, 1998, SCIENCE, V281, P838, DOI 10.1126/science.281.5378.838; GIRAULT JA, 1989, J BIOL CHEM, V264, P21748; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Levenson JM, 2006, CELL MOL LIFE SCI, V63, P1009, DOI 10.1007/s00018-006-6026-6; Murnion ME, 2001, J BIOL CHEM, V276, P26656, DOI 10.1074/jbc.M102288200; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Nishi A, 2000, P NATL ACAD SCI USA, V97, P12840, DOI 10.1073/pnas.220410397; Nishi A, 1999, J NEUROCHEM, V72, P2015, DOI 10.1046/j.1471-4159.1999.0722015.x; NISHI K, 1994, J BIOL CHEM, V269, P6320; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; OUIMET CC, 1984, J NEUROSCI, V4, P111; OUIMET CC, 1990, J NEUROCYTOL, V19, P39, DOI 10.1007/BF01188438; Panasyuk G, 2006, J BIOL CHEM, V281, P31188, DOI 10.1074/jbc.M602618200; Pontieri FE, 1995, P NATL ACAD SCI USA, V92, P12304, DOI 10.1073/pnas.92.26.12304; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Rastogi S, 2006, J BIOL CHEM, V281, P2951, DOI 10.1074/jbc.M508669200; Reynolds JNJ, 2002, NEURAL NETWORKS, V15, P507, DOI 10.1016/S0893-6080(02)00045-X; Salvador LM, 2001, J BIOL CHEM, V276, P40146, DOI 10.1074/jbc.M106710200; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Stedman DR, 2004, FEBS LETT, V566, P275, DOI 10.1016/j.febslet.2004.04.042; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Svenningsson P, 2003, SCIENCE, V302, P1412, DOI 10.1126/science.1089681; Usui H, 1998, FEBS LETT, V430, P312, DOI 10.1016/S0014-5793(98)00684-X; Valjent E, 2000, J NEUROSCI, V20, P8701; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Vanderschuren LJMJ, 1999, J NEUROSCI, V19, P9579, DOI 10.1523/jneurosci.19-21-09579.1999; WALAAS SI, 1983, NATURE, V301, P69; Zhang Y, 2006, J NEUROSCI, V26, P2645, DOI 10.1523/JNEUROSCI.3923-05.2006	44	172	177	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 12	2008	453	7197					879	U23		10.1038/nature06994	http://dx.doi.org/10.1038/nature06994			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311WV	18496528	Green Accepted, Green Published			2022-12-24	WOS:000256632000034
J	Kawamura, Y; Saito, K; Kin, T; Ono, Y; Asai, K; Sunohara, T; Okada, TN; Siomi, MC; Siomi, H				Kawamura, Yoshinori; Saito, Kuniaki; Kin, Taishin; Ono, Yukiteru; Asai, Kiyoshi; Sunohara, Takafumi; Okada, Tomoko N.; Siomi, Mikiko C.; Siomi, Haruhiko			Drosophila endogenous small RNAs bind to Argonaute 2 in somatic cells	NATURE			English	Article							PIWI-INTERACTING RNAS; DISTINCT ROLES; INTERFERENCE; GERMLINE; PATHWAYS; PROTEINS; HETEROCHROMATIN; ELEMENTS; SIRNAS; GENOME	RNA silencing is a conserved mechanism in which small RNAs trigger various forms of sequence- specific gene silencing by guiding Argonaute complexes to target RNAs by means of base pairing(1,2). RNA silencing is thought to have evolved as a form of nucleic- acid- based immunity to inactivate viruses and transposable elements. Although the activity of transposable elements in animals has been thought largely to be restricted to the germ line, recent studies have shown that they may also actively transpose in somatic cells, creating somatic mosaicism in animals(3). In the Drosophila germ line, Piwi- interacting RNAs arise from repetitive intergenic elements including retrotransposons by a Dicer-independent pathway and function through the Piwi subfamily of Argonautes to ensure silencing of retrotransposons(4-9). Here we show that, in cultured Drosophila S2 cells, Argonaute 2 ( AGO2), an AGO subfamily member of Argonautes, associates with endogenous small RNAs of 20 - 22 nucleotides in length, which we have collectively named endogenous short interfering RNAs ( esiRNAs). esiRNAs can be divided into two groups: one that mainly corresponds to a subset of retrotransposons, and the other that arises from stem - loop structures. esiRNAs are produced in a Dicer- 2-dependent manner from distinctive genomic loci, are modified at their 39 ends and can direct AGO2 to cleave target RNAs. Mutations in Dicer- 2 caused an increase in retrotransposon transcripts. Together, our findings indicate that different types of small RNAs and Argonautes are used to repress retrotransposons in germline and somatic cells in Drosophila.	[Kawamura, Yoshinori; Saito, Kuniaki; Sunohara, Takafumi; Okada, Tomoko N.; Siomi, Mikiko C.; Siomi, Haruhiko] Univ Tokushima, Inst Genome Res, Tokushima 7708503, Japan; [Saito, Kuniaki; Okada, Tomoko N.; Siomi, Mikiko C.; Siomi, Haruhiko] Keio Univ, Sch Med, Dept Mol Biol, Shinjuku Ku, Tokyo 1608582, Japan; [Kin, Taishin; Asai, Kiyoshi] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Tokyo 1350664, Japan; [Ono, Yukiteru] Informat & Math Sci Lab Inc, Tokyo 1120012, Japan; [Asai, Kiyoshi] Univ Tokyo, Grad Sch Frontier Sci, Chiba 2778561, Japan; [Siomi, Mikiko C.] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Tokushima University; Keio University; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; Japan Science & Technology Agency (JST)	Siomi, MC (corresponding author), Univ Tokushima, Inst Genome Res, Tokushima 7708503, Japan.	siomim@sc.itc.keio.ac.jp; awa403@sc.itc.keio.ac.jp	Asai, Kiyoshi/AAT-8344-2020; Saito, Kuniaki/A-6967-2015; Siomi, Haruhiko/A-7020-2015	Asai, Kiyoshi/0000-0003-0909-4982; Saito, Kuniaki/0000-0001-8233-9283; Siomi, Haruhiko/0000-0001-8690-3822				Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; CELNIKER SE, 2002, GENOME BIOL, V0003; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Crosby MA, 2007, NUCLEIC ACIDS RES, V35, pD486, DOI 10.1093/nar/gkl827; Deshpande G, 2005, GENE DEV, V19, P1680, DOI 10.1101/gad.1316805; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Kim VN, 2006, GENE DEV, V20, P1993, DOI 10.1101/gad.1456106; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Muotri AR, 2007, HUM MOL GENET, V16, pR159, DOI 10.1093/hmg/ddm196; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nishida KM, 2007, RNA, V13, P1911, DOI 10.1261/rna.744307; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263	29	331	349	3	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2008	453	7196					793	U5		10.1038/nature06938	http://dx.doi.org/10.1038/nature06938			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308UK	18463636				2022-12-24	WOS:000256415300046
J	Whitham, TG; DiFazio, SP; Schweitzer, JA; Shuster, SM; Allan, GJ; Bailey, JK; Woolbright, SA				Whitham, Thomas G.; DiFazio, Stephen P.; Schweitzer, Jennifer A.; Shuster, Stephen M.; Allan, Gery J.; Bailey, Joseph K.; Woolbright, Scott A.			Perspective - Extending genomics to natural communities and ecosystems	SCIENCE			English	Editorial Material							POPULUS-FREMONTII; COTTONWOOD; ANGUSTIFOLIA; CONSEQUENCES; HERITABILITY; RESISTANCE; INSIGHTS; GENETICS; TRAIT	An important step in the integration of ecology and genomics is the progression from molecular studies of relatively simple model systems to complex field systems. The recent availability of sequenced genomes from key plants is leading to a new understanding of the molecular drivers of community composition and ecosystem processes. As genome sequences accumulate for species that form intimate associations in nature, a detailed view may emerge as to how these associations cause changes among species at the nucleotide level. This advance could dramatically alter views about the structure and evolution of communities and ecosystems.	[Whitham, Thomas G.; Shuster, Stephen M.; Allan, Gery J.; Woolbright, Scott A.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Whitham, Thomas G.; Shuster, Stephen M.; Allan, Gery J.; Woolbright, Scott A.] No Arizona Univ, Merriam Powell Ctr Environm Res, Flagstaff, AZ 86011 USA; [DiFazio, Stephen P.] W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA; [Schweitzer, Jennifer A.; Bailey, Joseph K.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA	Northern Arizona University; Northern Arizona University; West Virginia University; University of Tennessee System; University of Tennessee Knoxville	Whitham, TG (corresponding author), No Arizona Univ, Dept Biol Sci, Box 5640, Flagstaff, AZ 86011 USA.	Thomas.Whitham@nau.edu	Woolbright, Scott/B-4354-2012	Woolbright, Scott/0000-0002-7886-1009; DiFazio, Stephen/0000-0003-4077-1590				Antonovics J., 1992, Plant resistance to herbivores and pathogens: ecology, evolution, and genetics., P426; Bailey JK, 2006, ECOL LETT, V9, P78, DOI 10.1111/j.1461-0248.2005.00844.x; Bangert RK, 2008, HEREDITY, V100, P121, DOI 10.1038/sj.hdy.6800914; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Freeman JS, 2008, NEW PHYTOL, V178, P846, DOI 10.1111/j.1469-8137.2008.02417.x; Hanley SJ, 2007, TREE GENET GENOMES, V3, P35, DOI 10.1007/s11295-006-0049-x; Harding SA, 2005, TREE PHYSIOL, V25, P1475, DOI 10.1093/treephys/25.12.1475; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; MORAN NA, 1988, EVOLUTION, V42, P717, DOI 10.1111/j.1558-5646.1988.tb02490.x; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Rae AM, 2007, NEW PHYTOL, V175, P59, DOI 10.1111/j.1469-8137.2007.02091.x; Rehill B, 2005, BIOCHEM SYST ECOL, V33, P125, DOI 10.1016/j.bse.2004.06.004; Schweitzer JA, 2004, ECOL LETT, V7, P127, DOI 10.1111/j.1461-0248.2003.00562.x; Schweitzer JA, 2008, ECOLOGY, V89, P773, DOI 10.1890/07-0337.1; Shuster SM, 2006, EVOLUTION, V60, P991, DOI 10.1111/j.0014-3820.2006.tb01177.x; Thompson J. N., 2005, INTERSPEC INTERACT; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Wade MJ, 2007, NAT REV GENET, V8, P185, DOI 10.1038/nrg2031; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Woolbright SA, 2008, HEREDITY, V100, P59, DOI 10.1038/sj.hdy.6801063; Yin T, 2008, GENOME RES, V18, P422, DOI 10.1101/gr.7076308	24	152	154	0	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2008	320	5875					492	495		10.1126/science.1153918	http://dx.doi.org/10.1126/science.1153918			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436780				2022-12-24	WOS:000255249300039
J	Lund, JM; Hsing, L; Pham, TT; Rudensky, AY				Lund, Jennifer M.; Hsing, Lianne; Pham, Thuy T.; Rudensky, Alexander Y.			Coordination of early protective immunity to viral infection by regulatory T cells	SCIENCE			English	Article							TRANSCRIPTION FACTOR FOXP3; SIMPLEX-VIRUS TYPE-2; DENDRITIC CELLS; PERSISTENCE; RESPONSES; DISEASE; MICE	Suppression of immune responses by regulatory T cells ( Tregs) is thought to limit late stages of pathogen- specific immunity as a means of minimizing associated tissue damage. We examined a role for Tregs during mucosal herpes simplex virus infection in mice, and observed an accelerated fatal infection with increased viral loads in the mucosa and central nervous system after ablation of Tregs. Although augmented interferon production was detected in the draining lymph nodes ( dLNs) in Treg- deprived mice, it was profoundly reduced at the infection site. This was associated with a delay in the arrival of natural killer cells, dendritic cells, and T cells to the site of infection and a sharp increase in proinflammatory chemokine levels in the dLNs. Our results suggest that Tregs facilitate early protective responses to local viral infection by allowing a timely entry of immune cells into infected tissue.	[Lund, Jennifer M.; Hsing, Lianne; Pham, Thuy T.; Rudensky, Alexander Y.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Lund, Jennifer M.; Hsing, Lianne; Pham, Thuy T.; Rudensky, Alexander Y.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Rudensky, AY (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	aruden@u.washington.edu		Lund, Jennifer/0000-0003-3284-979X	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Harandi AM, 2003, J VIROL, V77, P953, DOI 10.1128/JVI.77.2.953-962.2003; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lund JM, 2006, J IMMUNOL, V177, P7510, DOI 10.4049/jimmunol.177.11.7510; MILLIGAN GN, 1995, VIROLOGY, V212, P481, DOI 10.1006/viro.1995.1506; Parr MB, 1999, VIROLOGY, V258, P282, DOI 10.1006/viro.1999.9739; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Suvas S, 2004, J IMMUNOL, V172, P4123, DOI 10.4049/jimmunol.172.7.4123; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	17	338	352	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2008	320	5880					1220	1224		10.1126/science.1155209	http://dx.doi.org/10.1126/science.1155209			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306FF	18436744	Green Accepted			2022-12-24	WOS:000256233000040
J	Rambaut, A; Pybus, OG; Nelson, MI; Viboud, C; Taubenberger, JK; Holmes, EC				Rambaut, Andrew; Pybus, Oliver G.; Nelson, Martha I.; Viboud, Cecile; Taubenberger, Jeffery K.; Holmes, Edward C.			The genomic and epidemiological dynamics of human influenza A virus	NATURE			English	Article							PHYLOGENETIC ANALYSIS; MEMBRANE ASSOCIATION; GENETIC EVOLUTION; MATRIX PROTEIN; M(2) PROTEIN; H3N2 VIRUSES; HEMAGGLUTININ; REASSORTMENT; H1N1; GLYCOPROTEINS	The evolutionary interaction between influenza A virus and the human immune system, manifest as 'antigenic drift' of the viral haemagglutinin, is one of the best described patterns in molecular evolution. However, little is known about the genome- scale evolutionary dynamics of this pathogen. Similarly, how genomic processes relate to global influenza epidemiology, in which the A/ H3N2 and A/ H1N1 subtypes co- circulate, is poorly understood. Here through an analysis of 1,302 complete viral genomes sampled from temperate populations in both hemispheres, we show that the genomic evolution of influenza A virus is characterized by a complex interplay between frequent reassortment and periodic selective sweeps. The A/ H3N2 and A/ H1N1 subtypes exhibit different evolutionary dynamics, with diverse lineages circulating in A/ H1N1, indicative of weaker antigenic drift. These results suggest a sink - source model of viral ecology in which new lineages are seeded from a persistent influenza reservoir, which we hypothesize to be located in the tropics, to sink populations in temperate regions.	[Rambaut, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland; [Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Nelson, Martha I.; Holmes, Edward C.] Penn State Univ, Ctr Infect Dis Dynam, Dept Biol, Mueller Lab, University Pk, PA 16802 USA; [Viboud, Cecile; Holmes, Edward C.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Taubenberger, Jeffery K.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA	University of Edinburgh; University of Oxford; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Rambaut, A (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland.	a.rambaut@ed.ac.uk; ech15@psu.edu	Taubenberger, Jeffery/AAQ-1407-2021; Pybus, Oliver G/B-2640-2012; Holmes, Edward/GVR-9499-2022; Rambaut, Andrew/B-2481-2009; Holmes, Edward/Y-2789-2019	Pybus, Oliver G/0000-0002-8797-2667; Rambaut, Andrew/0000-0003-4337-3707; Holmes, Edward/0000-0001-9596-3552; Rambaut FRSE, Professor Andrew/0000-0002-1278-598X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000996] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AI000996-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ali A, 2000, J VIROL, V74, P8709, DOI 10.1128/JVI.74.18.8709-8719.2000; Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Barman S, 2001, VIRUS RES, V77, P61, DOI 10.1016/S0168-1702(01)00266-0; Berkhoff EGM, 2005, J VIROL, V79, P11239, DOI 10.1128/JVI.79.17.11239-11246.2005; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Carrington CVF, 2005, J VIROL, V79, P14680, DOI 10.1128/JVI.79.23.14680-14687.2005; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Enami M, 1996, J VIROL, V70, P6653, DOI 10.1128/JVI.70.10.6653-6657.1996; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; FITCH WM, 1991, P NATL ACAD SCI USA, V88, P4270, DOI 10.1073/pnas.88.10.4270; Gerhard W, 2006, EMERG INFECT DIS, V12, P569, DOI 10.3201/eid1204.051020; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Gregory V, 2002, VIROLOGY, V300, P1, DOI 10.1006/viro.2002.1513; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Kaji M, 2003, RESPIROLOGY, V8, P231, DOI 10.1046/j.1440-1843.2003.00457.x; Kingman J, 1982, STOCHASTIC PROCESS A, V13, P235, DOI [10.1016/0304-4149(82)90011-4, DOI 10.1016/0304-4149(82)90011-4]; Krug RM, 2003, VIROLOGY, V309, P181, DOI 10.1016/S0042-6822(03)00119-3; Lavenu A, 2006, EPIDEMIOL INFECT, V134, P514, DOI 10.1017/S0950268805005686; Lemey P, 2006, AIDS REV, V8, P125; Lindstrom SE, 1998, J VIROL, V72, P8021, DOI 10.1128/JVI.72.10.8021-8031.1998; Lindstrom SE, 2004, VIROLOGY, V328, P101, DOI 10.1016/j.virol.2004.06.009; LUDWIG S, 1991, VIROLOGY, V183, P566, DOI 10.1016/0042-6822(91)90985-K; Macken CA, 2006, J GEN VIROL, V87, P2803, DOI 10.1099/vir.0.81454-0; Mitnaul LJ, 2000, J VIROL, V74, P6015, DOI 10.1128/JVI.74.13.6015-6020.2000; Nelson MI, 2007, PLOS PATHOG, V3, P1220, DOI 10.1371/journal.ppat.0030131; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; OHUCHI M, 1994, J VIROL, V68, P920, DOI 10.1128/JVI.68.2.920-926.1994; Rambaut A, 2000, BIOINFORMATICS, V16, P395, DOI 10.1093/bioinformatics/16.4.395; Reid AH, 2004, NAT REV MICROBIOL, V2, P909, DOI 10.1038/nrmicro1027; SCHOLTISSEK C, 1978, VIROLOGY, V89, P613, DOI 10.1016/0042-6822(78)90203-9; Schweiger B, 2006, VACCINE, V24, P6683, DOI 10.1016/j.vaccine.2006.05.105; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Shortridge KF, 1997, CHINESE MED J-PEKING, V110, P637; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; SONOGUCHI T, 1985, J INFECT DIS, V151, P81, DOI 10.1093/infdis/151.1.81; TAKEUCHI K, 1994, J VIROL, V68, P911, DOI 10.1128/JVI.68.2.911-919.1994; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; *WHO, 2003, INFL; Wolf YI, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-34; WRIGHT PF, 1980, AM J EPIDEMIOL, V112, P814, DOI 10.1093/oxfordjournals.aje.a113053; YOUNG JF, 1979, P NATL ACAD SCI USA, V76, P6547, DOI 10.1073/pnas.76.12.6547	49	674	708	1	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2008	453	7195					615	U2		10.1038/nature06945	http://dx.doi.org/10.1038/nature06945			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305NN	18418375	Bronze, Green Accepted			2022-12-24	WOS:000256185200035
J	Peacock, WF; De Marco, T; Fonarow, GC; Diercks, D; Wynne, J; Apple, FS; Wu, AHB				Peacock, W. Frank; De Marco, Teresa; Fonarow, Gregg C.; Diercks, Deborah; Wynne, Janet; Apple, Fred S.; Wu, Alan H. B.		ADHERE Investigators	Cardiac troponin and outcome in acute heart failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYOCARDIAL-INFARCTION; NATRIURETIC PEPTIDE; RISK STRATIFICATION; MORTALITY; DYSFUNCTION	Background: Cardiac troponin provides diagnostic and prognostic information in acute coronary syndromes, but its role in acute decompensated heart failure is unclear. The purpose of our study was to describe the association between elevated cardiac troponin levels and adverse events in hospitalized patients with acute decompensated heart failure. Methods: We analyzed hospitalizations for acute decompensated heart failure between October 2001 and January 2004 that were recorded in the Acute Decompensated Heart Failure National Registry (ADHERE). Entry criteria included a troponin level that was obtained at the time of hospitalization in patients with a serum creatinine level of less than 2.0 mg per deciliter (177 micromol per liter). A positive troponin test was defined as a cardiac troponin I level of 1.0 mu g per liter or higher or a cardiac troponin T level of 0.1 mu g per liter or higher. Results: Troponin was measured at the time of admission in 84,872 of 105,388 patients (80.5%) who were hospitalized for acute decompensated heart failure. Of these patients, 67,924 had a creatinine level of less than 2.0 mg per deciliter. Cardiac troponin I was measured in 61,379 patients, and cardiac troponin T in 7880 patients (both proteins were measured in 1335 patients). Overall, 4240 patients (6.2%) were positive for troponin. Patients who were positive for troponin had lower systolic blood pressure on admission, a lower ejection fraction, and higher in-hospital mortality (8.0% vs. 2.7%, P<0.001) than those who were negative for troponin. The adjusted odds ratio for death in the group of patients with a positive troponin test was 2.55 (95% confidence interval, 2.24 to 2.89; P<0.001 by the Wald test). Conclusions: In patients with acute decompensated heart failure, a positive cardiac troponin test is associated with higher in-hospital mortality, independently of other predictive variables. (ClinicalTrials.gov number, NCT00366639.).	[Peacock, W. Frank] Cleveland Clin Fdn, Dept Emergency Med, Cleveland, OH 44195 USA; [De Marco, Teresa] Univ Calif San Francisco, Div Cardiol, San Francisco, CA 94143 USA; [Wu, Alan H. B.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Fonarow, Gregg C.] Univ Calif Los Angeles, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA USA; [Diercks, Deborah] Univ Calif Davis, Dept Emergency Med, Sacramento, CA 95817 USA; [Wynne, Janet] Scios, Dept Stat, Mountain View, CA USA; [Apple, Fred S.] Hennepin Cty Med Ctr, Dept Lab Med & Pathol, Minneapolis, MN 55415 USA; [Apple, Fred S.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA	Cleveland Clinic Foundation; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California System; University of California Davis; Scios; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities	Peacock, WF (corresponding author), Cleveland Clin Fdn, Dept Emergency Med E19, 9500 Euclid Ave, Cleveland, OH 44195 USA.	peacocw@ccf.org	Fonarow, Gregg C/D-5988-2014	Fonarow, Gregg C/0000-0002-3192-8093				Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Angheloiu GO, 2004, RESUSCITATION, V63, P195, DOI 10.1016/j.resuscitation.2004.05.018; Apple FS, 2002, AM HEART J, V144, P981, DOI 10.1067/mhj.2002.124048; Burkhardt J, 2005, ACAD EMERG MED, V12, P869, DOI 10.1197/j.aem.2005.03.534; Del Carlo CH, 1999, AM HEART J, V138, P646, DOI 10.1016/S0002-8703(99)70178-X; Diercks DB, 2006, AM J EMERG MED, V24, P319, DOI 10.1016/j.ajem.2005.11.014; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; Fonarow Gregg C, 2003, Rev Cardiovasc Med, V4 Suppl 4, pS20; Gattis WA, 2004, AM J CARDIOL, V93, P1436, DOI 10.1016/j.amjcard.2004.02.051; Goto T, 2003, HEART, V89, P1303, DOI 10.1136/heart.89.11.1303; Horwich TB, 2003, CIRCULATION, V108, P833, DOI 10.1161/01.CIR.0000084543.79097.34; Ishii J, 2002, AM J CARDIOL, V89, P691, DOI 10.1016/S0002-9149(01)02341-4; Lowbeer C, 2004, SCAND J CLIN LAB INV, V64, P667, DOI 10.1080/00365510410003002; Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999; Mueller C, 2004, NEW ENGL J MED, V350, P647, DOI 10.1056/NEJMoa031681; Peacock W Frank, 2003, Congest Heart Fail, V9, P303, DOI 10.1111/j.1527-5299.2003.02036.x; Perna ER, 2004, MED SCI MONITOR, V10, pCR90; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Wu AHB, 1999, CLIN CHIM ACTA, V284, P161, DOI 10.1016/S0009-8981(99)00078-9; Xue CC, 2003, CHINESE MED J-PEKING, V116, P469; You JJ, 2007, AM HEART J, V153, P462, DOI 10.1016/j.ahj.2007.01.027	21	487	667	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2008	358	20					2117	2126		10.1056/NEJMoa0706824	http://dx.doi.org/10.1056/NEJMoa0706824			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300TY	18480204	Bronze			2022-12-24	WOS:000255849300005
J	Spalding, KL; Arner, E; Westermark, PO; Bernard, S; Buchholz, BA; Bergmann, O; Blomqvist, L; Hoffstedt, J; Naslund, E; Britton, T; Concha, H; Hassan, M; Ryden, M; Frisen, J; Arner, P				Spalding, Kirsty L.; Arner, Erik; Westermark, Pal O.; Bernard, Samuel; Buchholz, Bruce A.; Bergmann, Olaf; Blomqvist, Lennart; Hoffstedt, Johan; Naslund, Erik; Britton, Tom; Concha, Hernan; Hassan, Moustapha; Ryden, Mikael; Frisen, Jonas; Arner, Peter			Dynamics of fat cell turnover in humans	NATURE			English	Article							ADIPOSE-TISSUE CELLULARITY; MECHANISMS LINKING OBESITY; NUCLEAR TESTS; ADIPOCYTES; DISEASE; NUMBER; SIZE; C-14; AGE	Obesity is increasing in an epidemic manner in most countries and constitutes a public health problem by enhancing the risk for cardiovascular disease and metabolic disorders such as type 2 diabetes(1,2). Owing to the increase in obesity, life expectancy may start to decrease in developed countries for the first time in recent history(3). The factors determining fat mass in adult humans are not fully understood, but increased lipid storage in already developed fat cells ( adipocytes) is thought to be most important(4,5). Here we show that adipocyte number is a major determinant for the fat mass in adults. However, the number of fat cells stays constant in adulthood in lean and obese individuals, even after marked weight loss, indicating that the number of adipocytes is set during childhood and adolescence. To establish the dynamics within the stable population of adipocytes in adults, we have measured adipocyte turnover by analysing the integration of C-14 derived from nuclear bomb tests in genomic DNA(6). Approximately 10% of fat cells are renewed annually at all adult ages and levels of body mass index. Neither adipocyte death nor generation rate is altered in early onset obesity, suggesting a tight regulation of fat cell number in this condition during adulthood. The high turnover of adipocytes establishes a new therapeutic target for pharmacological intervention in obesity.	[Spalding, Kirsty L.; Arner, Erik; Bergmann, Olaf; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Westermark, Pal O.] Humboldt Univ, ITB, D-10115 Berlin, Germany; [Westermark, Pal O.] Charite, D-10115 Berlin, Germany; [Bernard, Samuel] Fdn Res & Technol, Inst Appl & Computat Math, Iraklion 71110, Greece; [Buchholz, Bruce A.] Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94551 USA; [Blomqvist, Lennart; Hoffstedt, Johan; Concha, Hernan; Hassan, Moustapha; Ryden, Mikael; Arner, Peter] Karolinska Univ Hosp, Dept Med, SE-14186 Stockholm, Sweden; [Naslund, Erik] Karolinska Inst, Div Surg, Dept Clin Sci, Danderyd Hosp, SE-18288 Stockholm, Sweden; [Britton, Tom] Stockholm Univ, Dept Math, S-10691 Stockholm, Sweden	Karolinska Institutet; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Karolinska Institutet; Karolinska University Hospital; Danderyds Hospital; Karolinska Institutet; Stockholm University	Spalding, KL (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	kirsty.spalding@ki.se; jonas.frisen@ki.se; peter.arner@ki.se	Arner, Erik/A-1895-2010; Spalding, Kirsty/CAF-4248-2022; Bergmann, Olaf/A-5706-2009; Bernard, Samuel/A-5623-2009; Buchholz, Bruce A/G-1356-2011; spalding, kirsty/I-6046-2017; Hassan, Moustapha/H-9260-2015	Arner, Erik/0000-0003-1225-4908; Spalding, Kirsty/0000-0002-5189-7028; Bergmann, Olaf/0000-0003-1065-4107; Bernard, Samuel/0000-0002-8442-9968; Buchholz, Bruce A/0000-0002-9531-551X; Hassan, Moustapha/0000-0003-1927-5859; Arner, Peter/0000-0002-6208-6220; Westermark, Pal/0000-0002-6637-2566	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013461] Funding Source: NIH RePORTER; NCRR NIH HHS [RR13461, P41 RR013461] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ALTMAN DG, 1991, PRACTICAL STAT MED R, P164; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; BJORNTORP P, 1974, METABOLISM, V23, P1091, DOI 10.1016/0026-0495(74)90076-6; BJORNTORP P, 1975, AM J CLIN NUTR, V28, P445; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; DEVRIES H, 1958, SCIENCE, V128, P1550, DOI 10.1126/science.128.3338.1550; Freedman DS, 2001, PEDIATRICS, V108, P712, DOI 10.1542/peds.108.3.712; HAGER A, 1978, AM J CLIN NUTR, V31, P68; HARKNESS DD, 1972, NATURE, V240, P302, DOI 10.1038/240302a0; HIRSCH J, 1976, CLIN ENDOCRINOL META, V5, P299, DOI 10.1016/S0300-595X(76)80023-0; Joulia-Ekaza D, 2006, EXP CELL RES, V312, P3458, DOI 10.1016/j.yexcr.2006.07.010; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; KNITTLE JL, 1979, J CLIN INVEST, V63, P239, DOI 10.1172/JCI109295; KRAL JG, 1977, EUR J CLIN INVEST, V7, P413, DOI 10.1111/j.1365-2362.1977.tb01628.x; Levin I, 2004, RADIOCARBON, V46, P1261, DOI 10.1017/S0033822200033130; LIBBY WF, 1964, SCIENCE, V146, P1171; Lofgren P, 2005, J CLIN ENDOCR METAB, V90, P6207, DOI 10.1210/jc.2005-0596; MILLER WH, 1984, J LIPID RES, V25, P336; NYDAL R, 1965, NATURE, V206, P1029, DOI 10.1038/2061029a0; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; PETRUSCHKE T, 1993, J CLIN ENDOCR METAB, V76, P742, DOI 10.1210/jc.76.3.742; PRINS JB, 1994, BIOCHEM BIOPH RES CO, V201, P500, DOI 10.1006/bbrc.1994.1730; Prins JB, 1997, CLIN SCI, V92, P3, DOI 10.1042/cs0920003; Raff MC, 1996, CELL, V86, P173, DOI 10.1016/S0092-8674(00)80087-2; Rodriguez AM, 2005, BIOCHIMIE, V87, P125, DOI 10.1016/j.biochi.2004.11.007; Sims E A, 1968, Trans Assoc Am Physicians, V81, P153; Spalding KL, 2005, NATURE, V437, P333, DOI 10.1038/437333a; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487	30	1496	1545	8	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2008	453	7196					783	787		10.1038/nature06902	http://dx.doi.org/10.1038/nature06902			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308UK	18454136				2022-12-24	WOS:000256415300044
J	Watanabe, T; Totoki, Y; Toyoda, A; Kaneda, M; Kuramochi-Miyagawa, S; Obata, Y; Chiba, H; Kohara, Y; Kono, T; Nakano, T; Surani, MA; Sakaki, Y; Sasaki, H				Watanabe, Toshiaki; Totoki, Yasushi; Toyoda, Atsushi; Kaneda, Masahiro; Kuramochi-Miyagawa, Satomi; Obata, Yayoi; Chiba, Hatsune; Kohara, Yuji; Kono, Tomohiro; Nakano, Toru; Surani, M. Azim; Sakaki, Yoshiyuki; Sasaki, Hiroyuki			Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes	NATURE			English	Article							SMALL RNAS; C-ELEGANS; MICRORNAS; GENE; ANTISENSE; GERMLINE; GENOME; TESTES; PIWI; RETROTRANSPOSON	RNA interference (RNAi) is a mechanism by which doublestranded RNAs (dsRNAs) suppress specific transcripts in a sequence-dependent manner. dsRNAs are processed by Dicer to 21-24-nucleotide small interfering RNAs (siRNAs) and then incorporated into the argonaute (Ago) proteins(1-4). Gene regulation by endogenous siRNAs has been observed only in organisms possessing RNA- dependent RNA polymerase (RdRP)(5-10). In mammals, where no RdRP activity has been found, biogenesis and function of endogenous siRNAs remain largely unknown. Here we show, using mouse oocytes, that endogenous siRNAs are derived from naturally occurring dsRNAs and have roles in the regulation of gene expression. By means of deep sequencing, we identify a large number of both similar to 25-27-nucleotide Piwi-interacting RNAs (piRNAs) and similar to 21-nucleotide siRNAs corresponding to messenger RNAs or retrotransposons in growing oocytes. piRNAs are bound to Mili and have a role in the regulation of retrotransposons. siRNAs are exclusively mapped to retrotransposons or other genomic regions that produce transcripts capable of forming dsRNA structures. Inverted repeat structures, bidirectional transcription and antisense transcripts from various loci are sources of the dsRNAs. Some precursor transcripts of siRNAs are derived from expressed pseudogenes, indicating that one role of pseudogenes is to adjust the level of the founding source mRNA through RNAi. Loss of Dicer or Ago2 results in decreased levels of siRNAs and increased levels of retrotransposon and protein-coding transcripts complementary to the siRNAs. Thus, the RNAi pathway regulates both protein-coding transcripts and retrotransposons in mouse oocytes. Our results reveal a role for endogenous siRNAs in mammalian oocytes and show that organisms lacking RdRP activity can produce functional endogenous siRNAs from naturally occurring dsRNAs.	[Watanabe, Toshiaki; Chiba, Hatsune; Sasaki, Hiroyuki] Res Org Informat & Syst, Div Human Genet, Dept Integrated Genet, Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Watanabe, Toshiaki; Chiba, Hatsune; Kohara, Yuji; Sasaki, Hiroyuki] Grad Univ Adv Studies, SOKENDAI, Dept Genet, Sch Life Sci, Mishima, Shizuoka 4118540, Japan; [Totoki, Yasushi; Sakaki, Yoshiyuki] RIKEN, Genome Sci Ctr, Genome Annotat & Comparat Anal Team, Computat & Expt Syst Biol Grp, Yokohama, Kanagawa 2300045, Japan; [Toyoda, Atsushi; Sakaki, Yoshiyuki] RIKEN, Genome Sci Ctr, Sequence Technol Team, Yokohama, Kanagawa 2300045, Japan; [Kaneda, Masahiro] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc Dev B, Cambridge CB2 1QN, England; [Kaneda, Masahiro] Natl Agr & Food Res Org, Reprod Biol & Technol Res Team, Natl Inst Livestock & Grassland Sci, Tsukuba, Ibaraki 3050901, Japan; [Kuramochi-Miyagawa, Satomi; Nakano, Toru] Osaka Univ, Dept Pathol, Grad Sch Med & Frontier Biosci, Suita, Osaka 5650871, Japan; [Obata, Yayoi; Kono, Tomohiro; Surani, M. Azim] Tokyo Univ Agr, Dept Biosci, Tokyo 1568502, Japan; [Kohara, Yuji] Res Org Informat & Syst, Genome Biol Lab, Ctr Genet Resources Informat, Natl Inst Genet, Mishima, Shizuoka 4118540, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; RIKEN; RIKEN; University of Cambridge; National Agriculture & Food Research Organization - Japan; Osaka University; Tokyo University of Agriculture; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Watanabe, T (corresponding author), Res Org Informat & Syst, Div Human Genet, Dept Integrated Genet, Natl Inst Genet, Mishima, Shizuoka 4118540, Japan.	toshwata@lab.nig.ac.jp; hisasaki@lab.nig.ac.jp	Kaneda, Masahiro/E-3117-2010	Kaneda, Masahiro/0000-0003-0660-7156; Surani, Azim/0000-0002-8640-4318	Grants-in-Aid for Scientific Research [19061001] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ambros V, 2007, DEVELOPMENT, V134, P1635, DOI 10.1242/dev.002006; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Gray TA, 2006, P NATL ACAD SCI USA, V103, P12039, DOI 10.1073/pnas.0602216103; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Hirotsune S, 2003, NATURE, V423, P91, DOI 10.1038/nature01535; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lavorgna G, 2004, TRENDS BIOCHEM SCI, V29, P88, DOI 10.1016/j.tibs.2003.12.002; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033	29	817	889	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2008	453	7194					539	U9		10.1038/nature06908	http://dx.doi.org/10.1038/nature06908			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303EL	18404146				2022-12-24	WOS:000256023700046
J	O'Neill, JS; Maywood, ES; Chesham, JE; Takahashi, JS; Hastings, MH				O'Neill, John S.; Maywood, Elizabeth S.; Chesham, Johanna E.; Takahashi, Joseph S.; Hastings, Michael H.			cAMP-dependent signaling as a core component of the mammalian circadian pacemaker	SCIENCE			English	Article							CLOCK FUNCTION; FEEDBACK LOOP; CYCLIC-AMP; NEURONS; OSCILLATION; PHASE; CELLS; EPAC	The mammalian circadian clockwork is modeled as transcriptional and posttranslational feedback loops, whereby circadian genes are periodically suppressed by their protein products. We show that adenosine 3 ', 5 '-monophosphate (cAMP) signaling constitutes an additional, bona fide component of the oscillatory network. cAMP signaling is rhythmic and sustains the transcriptional loop of the suprachiasmatic nucleus, determining canonical pacemaker properties of amplitude, phase, and period. This role is general and is evident in peripheral mammalian tissues and cell lines, which reveals an unanticipated point of circadian regulation in mammals qualitatively different from the existing transcriptional feedback model. We propose that daily activation of cAMP signaling, driven by the transcriptional oscillator, in turn sustains progression of transcriptional rhythms. In this way, clock output constitutes an input to subsequent cycles.	[O'Neill, John S.; Maywood, Elizabeth S.; Chesham, Johanna E.; Hastings, Michael H.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Takahashi, Joseph S.] Northwestern Univ, Howard Hughes Med Inst, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	MRC Laboratory Molecular Biology; Howard Hughes Medical Institute; Northwestern University	Hastings, MH (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	mha@mrc-lmb.cam.ac.uk	Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; O'Neill, John Stuart/0000-0003-2204-6096; Hastings, Michael Harvey/0000-0001-8576-6651	MRC [MC_U105170643] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council Funding Source: Medline; Howard Hughes Medical Institute Funding Source: Medline; Medical Research Council [MC_U105170643, U.1051.02.004(78799)] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Aton SJ, 2006, P NATL ACAD SCI USA, V103, P19188, DOI 10.1073/pnas.0607466103; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Dodd AN, 2007, SCIENCE, V318, P1789, DOI 10.1126/science.1146757; ESKIN A, 1983, SCIENCE, V220, P82, DOI 10.1126/science.6298939; Fan YZ, 2007, CURR BIOL, V17, P1091, DOI 10.1016/j.cub.2007.05.048; Harrisingh MC, 2007, J NEUROSCI, V27, P12489, DOI 10.1523/JNEUROSCI.3680-07.2007; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Huang CC, 2006, MOL PHARMACOL, V69, P846, DOI 10.1124/mol.105.018093; Lakin-Thomas PL, 2006, J BIOL RHYTHM, V21, P83, DOI 10.1177/0748730405286102; LIPPE C, 1991, COMP BIOCHEM PHYS C, V99, P209, DOI 10.1016/0742-8413(91)90101-X; Lundkvist GB, 2005, J NEUROSCI, V25, P7682, DOI 10.1523/JNEUROSCI.2211-05.2005; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; NIKAIDO SS, 1989, NEURON, V3, P609, DOI 10.1016/0896-6273(89)90271-7; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; PROSSER RA, 1989, J NEUROSCI, V9, P1073; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rosenbaum T, 2004, NEURON, V42, P193, DOI 10.1016/S0896-6273(04)00199-0; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Shi GX, 2006, MOL CELL BIOL, V26, P9136, DOI 10.1128/MCB.00332-06; TAKAHASHI JS, 1982, SCIENCE, V217, P1104, DOI 10.1126/science.6287576; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453	25	303	311	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2008	320	5878					949	953		10.1126/science.1152506	http://dx.doi.org/10.1126/science.1152506			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18487196	Green Accepted			2022-12-24	WOS:000255868300047
J	An, SG; Kumar, R; Sheets, ED; Benkovic, SJ				An, Songon; Kumar, Ravindra; Sheets, Erin D.; Benkovic, Stephen J.			Reversible compartmentalization of de novo purine biosynthetic complexes in living cells	SCIENCE			English	Article							FOLATE-REQUIRING ENZYMES; HUMAN-FIBROBLASTS; AMIDOPHOSPHORIBOSYLTRANSFERASE; METABOLISM; GROWTH; DENOVO; PHOSPHORIBOSYLPYROPHOSPHATE; PURIFICATION; PYRIMIDINE; NUCLEOTIDE	Purines are synthesized de novo in 10 chemical steps that are catalyzed by six enzymes in eukaryotes. Studies in vitro have provided little evidence of anticipated protein- protein interactions that would enable substrate channeling and regulation of the metabolic flux. We applied fluorescence microscopy to HeLa cells and discovered that all six enzymes colocalize to form clusters in the cellular cytoplasm. The association and dissociation of these enzyme clusters can be regulated dynamically, by either changing the purine levels of or adding exogenous agents to the culture media. Collectively, the data provide strong evidence for the formation of a multi- enzyme complex, the "purinosome," to carry out de novo purine biosynthesis in cells.	[An, Songon; Kumar, Ravindra; Sheets, Erin D.; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	An, SG (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	sua13@psu.edu; eds11@psu.edu; sjb1@psu.edu	An, Songon/A-6714-2009	Sheets, Erin/0000-0002-5980-3225; An, Songon/0000-0003-2189-7374	NATIONAL INSTITUTE ON AGING [R21AG030949] Funding Source: NIH RePORTER; NIA NIH HHS [R21 AG030949-01, R21 AG030949] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BECKER MA, 1987, J BIOL CHEM, V262, P14531; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; CAPERELLI CA, 1980, J BIOL CHEM, V255, P1885; Constantine CZ, 2006, BIOCHEMISTRY-US, V45, P8193, DOI 10.1021/bi060465n; Gooljarsingh LT, 2001, P NATL ACAD SCI USA, V98, P6565, DOI 10.1073/pnas.121182998; Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102; IWAHANA H, 1995, BBA-GENE STRUCT EXPR, V1261, P369, DOI 10.1016/0167-4781(95)00036-G; Kondo M, 2000, J BIOCHEM, V128, P57, DOI 10.1093/oxfordjournals.jbchem.a022730; Li SX, 2007, J MOL BIOL, V366, P1603, DOI 10.1016/j.jmb.2006.12.027; PAGLIARO L, 1988, J CELL BIOL, V107, P981, DOI 10.1083/jcb.107.3.981; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; RUDOLPH J, 1995, BIOCHEMISTRY-US, V34, P2241, DOI 10.1021/bi00007a019; SMITH GK, 1980, BIOCHEMISTRY-US, V19, P4313, DOI 10.1021/bi00559a026; Stasolla C, 2003, J PLANT PHYSIOL, V160, P1271, DOI 10.1078/0176-1617-01169; THOMPSON LF, 1978, P NATL ACAD SCI USA, V75, P3722, DOI 10.1073/pnas.75.8.3722; WASSERMAN GF, 1984, BIOCHEMISTRY-US, V23, P6704, DOI 10.1021/bi00321a065; Yamaoka T, 1997, J BIOL CHEM, V272, P17719, DOI 10.1074/jbc.272.28.17719; Yamaoka T, 2001, J BIOL CHEM, V276, P21285, DOI 10.1074/jbc.M011103200; Zrenner R, 2006, ANNU REV PLANT BIOL, V57, P805, DOI 10.1146/annurev.arplant.57.032905.105421	19	340	348	5	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2008	320	5872					103	106		10.1126/science.1152241	http://dx.doi.org/10.1126/science.1152241			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283JR	18388293				2022-12-24	WOS:000254633000041
J	Harris, TD; Buzby, PR; Babcock, H; Beer, E; Bowers, J; Braslavsky, I; Causey, M; Colonell, J; Dimeo, J; Efcavitch, JW; Giladi, E; Gill, J; Healy, J; Jarosz, M; Lapen, D; Moulton, K; Quake, SR; Steinmann, K; Thayer, E; Tyurina, A; Ward, R; Weiss, H; Xie, Z				Harris, Timothy D.; Buzby, Phillip R.; Babcock, Hazen; Beer, Eric; Bowers, Jayson; Braslavsky, Ido; Causey, Marie; Colonell, Jennifer; DiMeo, James; Efcavitch, J. William; Giladi, Eldar; Gill, Jaime; Healy, John; Jarosz, Mirna; Lapen, Dan; Moulton, Keith; Quake, Stephen R.; Steinmann, Kathleen; Thayer, Edward; Tyurina, Anastasia; Ward, Rebecca; Weiss, Howard; Xie, Zheng			Single-molecule DNA sequencing of a viral genome	SCIENCE			English	Article							POLYMERASE	The full promise of human genomics will be realized only when the genomes of thousands of individuals can be sequenced for comparative analysis. A reference sequence enables the use of short read length. We report an amplification- free method for determining the nucleotide sequence of more than 280,000 individual DNA molecules simultaneously. A DNA polymerase adds labeled nucleotides to surface- immobilized primer-template duplexes in stepwise fashion, and the asynchronous growth of individual DNA molecules was monitored by fluorescence imaging. Read lengths of > 25 bases and equivalent phred software program quality scores approaching 30 were achieved. We used this method to sequence the M13 virus to an average depth of > 150x and with 100% coverage; thus, we resequenced the M13 genome with high-sensitivity mutation detection. This demonstrates a strategy for high- throughput low- cost resequencing.	[Harris, Timothy D.; Buzby, Phillip R.; Babcock, Hazen; Beer, Eric; Bowers, Jayson; Causey, Marie; Colonell, Jennifer; DiMeo, James; Efcavitch, J. William; Giladi, Eldar; Gill, Jaime; Healy, John; Jarosz, Mirna; Lapen, Dan; Moulton, Keith; Steinmann, Kathleen; Thayer, Edward; Tyurina, Anastasia; Ward, Rebecca; Weiss, Howard; Xie, Zheng] Helicos Biosci Corp, Cambridge, MA 02139 USA; [Braslavsky, Ido] Ohio Univ, Dept Phys & Astron, Athens, OH 45701 USA; [Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Quake, Stephen R.] Howard Hughes Med Inst, Stanford, CA 94305 USA	University System of Ohio; Ohio University; Stanford University; Howard Hughes Medical Institute	Harris, TD (corresponding author), Helicos Biosci Corp, 1 Kendall Sq, Cambridge, MA 02139 USA.	tharris@helicosbio.com	Braslavsky, Ido/O-1859-2013	Braslavsky, Ido/0000-0001-8985-8211; Babcock, Hazen/0000-0003-4835-3692	Howard Hughes Medical Institute Funding Source: Medline; NHGRI NIH HHS [R01 HG004144-01] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004144] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BARNES WM, 1992, GENE, V112, P29, DOI 10.1016/0378-1119(92)90299-5; Braslavsky I, 2003, P NATL ACAD SCI USA, V100, P3960, DOI 10.1073/pnas.0230489100; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Greenleaf WJ, 2006, SCIENCE, V313, P801, DOI 10.1126/science.1130105; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; JETT JH, 1989, J BIOMOL STRUCT DYN, V7, P301, DOI 10.1080/07391102.1989.10507773; Ju JY, 2006, P NATL ACAD SCI USA, V103, P19635, DOI 10.1073/pnas.0609513103; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; STADEN R, 1979, NUCLEIC ACIDS RES, V6, P2601, DOI 10.1093/nar/6.7.2601; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	14	467	869	3	219	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2008	320	5872					106	109		10.1126/science.1150427	http://dx.doi.org/10.1126/science.1150427			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283JR	18388294				2022-12-24	WOS:000254633000042
J	Chang, HH; Hemberg, M; Barahona, M; Ingber, DE; Huang, S				Chang, Hannah H.; Hemberg, Martin; Barahona, Mauricio; Ingber, Donald E.; Huang, Sui			Transcriptome-wide noise controls lineage choice in mammalian progenitor cells	NATURE			English	Article							EUKARYOTIC GENE-EXPRESSION; SINGLE-CELL; STEM-CELLS; DYNAMICS; HEMATOPOIESIS; STOCHASTICITY	Phenotypic cell-to-cell variability within clonal populations may be a manifestation of 'gene expression noise'(1-6), or it may reflect stable phenotypic variants(7). Such 'non-genetic cell individuality'(7) can arise from the slow fluctuations of protein levels(8) in mammalian cells. These fluctuations produce persistent cell individuality, thereby rendering a clonal population heterogeneous. However, it remains unknown whether this heterogeneity may account for the stochasticity of cell fate decisions in stem cells. Here we show that in clonal populations of mouse haematopoietic progenitor cells, spontaneous 'outlier' cells with either extremely high or low expression levels of the stem cell marker Sca-1 (also known as Ly6a; ref. 9) reconstitute the parental distribution of Sca-1 but do so only after more than one week. This slow relaxation is described by a gaussian mixture model that incorporates noise- driven transitions between discrete subpopulations, suggesting hidden multi-stability within one cell type. Despite clonality, the Sca-1 outliers had distinct transcriptomes. Although their unique gene expression profiles eventually reverted to that of the median cells, revealing an attractor state, they lasted long enough to confer a greatly different proclivity for choosing either the erythroid or the myeloid lineage. Preference in lineage choice was associated with increased expression of lineage-specific transcription factors, such as a > 200-fold increase in Gata1 (ref. 10) among the erythroid-prone cells, or a > 15-fold increased PU.1 (Sfpi1) (ref. 11) expression among myeloid-prone cells. Thus, clonal heterogeneity of gene expression level is not due to independent noise in the expression of individual genes, but reflects metastable states of a slowly fluctuating transcriptome that is distinct in individual cells and may govern the reversible, stochastic priming of multipotent progenitor cells in cell fate decision.	[Chang, Hannah H.; Ingber, Donald E.; Huang, Sui] Childrens Hosp, Vasc Biol Programme, Dept Pathol & Surg, Boston, MA 02115 USA; [Chang, Hannah H.; Ingber, Donald E.; Huang, Sui] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Chang, Hannah H.] Harvard Univ, Sch Med, Program Biophys, Boston, MA 02115 USA; [Chang, Hannah H.] Harvard Univ, Sch Med, MD PhD Programme, Boston, MA 02115 USA; [Hemberg, Martin; Barahona, Mauricio] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London SW7 2AZ, England; [Hemberg, Martin; Barahona, Mauricio] Univ London Imperial Coll Sci Technol & Med, Inst Math Sci, London SW7 2AZ, England; [Ingber, Donald E.] Harvard Inst Biol Inspired Engn, Cambridge, MA 02139 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Imperial College London; Imperial College London; Harvard University	Huang, S (corresponding author), Univ Calgary, Inst Biocomplex & Informat, Calgary, AB T2N 1N4, Canada.	sui.huang@ucalgary.ca	Barahona, Mauricio/M-9747-2019; Ingber, Donald E/AAC-5894-2019; Barahona, Mauricio/C-3638-2008	Barahona, Mauricio/0000-0002-1089-5675; Barahona, Mauricio/0000-0002-1089-5675	NCI NIH HHS [P01 CA045548-210002, R21 CA123284, P01 CA045548] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA045548, R21CA123284] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Cantor AB, 2002, MOL CELL BIOL, V22, P4268, DOI 10.1128/MCB.22.12.4268-4279.2002; Chang HH, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-11; Eichler GS, 2003, BIOINFORMATICS, V19, P2321, DOI 10.1093/bioinformatics/btg307; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Koschmieder S, 2005, INT J HEMATOL, V81, P368, DOI 10.1532/IJH97.05051; Kurchan J, 1996, J PHYS A-MATH GEN, V29, P1929, DOI 10.1088/0305-4470/29/9/009; Orkin SH, 2002, NAT IMMUNOL, V3, P323, DOI 10.1038/ni0402-323; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; TSAI S, 1994, GENE DEV, V8, P2831, DOI 10.1101/gad.8.23.2831; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; VANDERIJN M, 1989, P NATL ACAD SCI USA, V86, P4634; WANG R, 1992, DEVELOPMENT, V114, P303; Zenger VE, 1998, CYTOMETRY, V33, P138, DOI 10.1002/(SICI)1097-0320(19981001)33:2<138::AID-CYTO8>3.0.CO;2-F	25	783	792	3	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 22	2008	453	7194					544	U10		10.1038/nature06965	http://dx.doi.org/10.1038/nature06965			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303EL	18497826	Green Accepted			2022-12-24	WOS:000256023700047
J	Mariani, FV; Ahn, CP; Martin, GR				Mariani, Francesca V.; Ahn, Christina P.; Martin, Gail R.			Genetic evidence that FGFs have an instructive role in limb proximal-distal patterning	NATURE			English	Article							APICAL ECTODERMAL RIDGE; VERTEBRATE LIMB; CHICK LIMB; FEEDBACK LOOP; MOUSE EMBRYOS; BUD; OUTGROWTH; GROWTH; AXIS; DIFFERENTIATION	Half a century ago, the apical ectodermal ridge (AER) at the distal tip of the tetrapod limb bud was shown to produce signals necessary for development along the proximal-distal (P-D) axis, but how these signals influence limb patterning is still much debated(1,2). Fibroblast growth factor (FGF) gene family members are key AER-derived signals(3,4), with Fgf4, Fgf8, Fgf9 and Fgf17 expressed specifically in the mouse AER(5). Here we demonstrate that mouse limbs lacking Fgf4, Fgf9 and Fgf17 have normal skeletal pattern, indicating that Fgf8 is sufficient among AER-FGFs to sustain normal limb formation. Inactivation of Fgf8 alone causes a mild skeletal phenotype(6,7); however, when we also removed different combinations of the other AER-FGF genes, we obtained unexpected skeletal phenotypes of increasing severity, reflecting the contribution that each FGF can make to the total AER-FGF signal. Analysis of the compound mutant limb buds revealed that, in addition to sustaining cell survival, AER-FGFs regulate P-D-patterning gene expression during early limb bud development, providing genetic evidence that AER-FGFs function to specify a distal domain and challenging the long-standing hypothesis that AER-FGF signalling is permissive rather than instructive for limb patterning. We discuss how a two-signal model for P-D patterning can be integrated with the concept of early specification to explain the genetic data presented here.	[Mariani, Francesca V.; Ahn, Christina P.; Martin, Gail R.] Univ Calif San Francisco, Dept Anat, Sch Med, San Francisco, CA 94158 USA; [Mariani, Francesca V.; Ahn, Christina P.; Martin, Gail R.] Univ Calif San Francisco, Program Dev Biol, Sch Med, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Martin, GR (corresponding author), Univ Calif San Francisco, Dept Anat, Sch Med, San Francisco, CA 94158 USA.	gail.r.martin@ucsf.edu		Mariani, Francesca/0000-0003-1619-8763	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD008696, R01HD034380] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD034380-07, F32 HD008696, F32 HD008696-02, R01 HD034380-05, F32 HD008696-03, R01 HD34380, R01 HD034380-08, R01 HD034380-09, F32 HD008696-01, R01 HD034380, R01 HD034380-06] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Barna M, 2007, DEV CELL, V12, P931, DOI 10.1016/j.devcel.2007.04.016; Boulet AM, 2004, DEV BIOL, V273, P361, DOI 10.1016/j.ydbio.2004.06.012; Colvin JS, 2001, DEVELOPMENT, V128, P2095; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Dudley AT, 2002, NATURE, V418, P539, DOI 10.1038/nature00945; FALLON JF, 1994, SCIENCE, V264, P104, DOI 10.1126/science.7908145; Grieshammer U, 2005, DEVELOPMENT, V132, P3847, DOI 10.1242/dev.01944; Hung IH, 2007, DEV BIOL, V307, P300, DOI 10.1016/j.ydbio.2007.04.048; Kawakami Y, 2003, NAT CELL BIOL, V5, P513, DOI 10.1038/ncb989; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Lu PF, 2006, DEVELOPMENT, V133, P33, DOI 10.1242/dev.02172; MADEN M, 1980, J EMBRYOL EXP MORPH, V56, P201; Mariani FV, 2003, NATURE, V423, P319, DOI 10.1038/nature01655; Mercader N, 2000, DEVELOPMENT, V127, P3961; Mercader N, 1999, NATURE, V402, P425, DOI 10.1038/46580; Moon AM, 2000, NAT GENET, V26, P455, DOI 10.1038/82601; Moon AM, 2000, DEVELOPMENT, V127, P989; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; Pajni-Underwood S, 2007, DEVELOPMENT, V134, P2359, DOI 10.1242/dev.001677; Sato K, 2007, DEVELOPMENT, V134, P1397, DOI 10.1242/dev.02822; STOCUM DL, 1984, DIFFERENTIATION, V27, P13, DOI 10.1111/j.1432-0436.1984.tb01403.x; SUMMERBELL D, 1973, NATURE, V244, P492, DOI 10.1038/244492a0; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Tabin C, 2007, GENE DEV, V21, P1433, DOI 10.1101/gad.1547407; WOLPERT L, 1979, J EMBRYOL EXP MORPH, V50, P175; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Xu JS, 2000, DEVELOPMENT, V127, P1833; Zucker RM, 1999, METHODS, V18, P473, DOI 10.1006/meth.1999.0815	31	244	248	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 15	2008	453	7193					401	U56		10.1038/nature06876	http://dx.doi.org/10.1038/nature06876			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18449196	Green Accepted			2022-12-24	WOS:000255868400054
J	Hume, AJ; Finkel, JS; Kamil, JP; Coen, DM; Culbertson, MR; Kalejta, RF				Hume, Adam J.; Finkel, Jonathan S.; Kamil, Jeremy P.; Coen, Donald M.; Culbertson, Michael R.; Kalejta, Robert F.			Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function	SCIENCE			English	Article							HUMAN CYTOMEGALOVIRUS REPLICATION; CELL-CYCLE; UL97; MECHANISMS; INHIBITORS; COMPLEX; FAMILY; TARGET; POTENT; PP65	As obligate intracellular parasites, viruses expertly modify cellular processes to facilitate their replication and spread, often by encoding genes that mimic the functions of cellular proteins while lacking regulatory features that modify their activity. We show that the human cytomegalovirus UL97 protein has activities similar to cellular cyclin- cyclin- dependent kinase ( CDK) complexes. UL97 phosphorylated and inactivated the retinoblastoma tumor suppressor, stimulated cell cycle progression in mammalian cells, and rescued proliferation of Saccharomyces cerevisiae lacking CDK activity. UL97 is not inhibited by the CDK inhibitor p21 and lacks amino acid residues conserved in the CDKs that permit the attenuation of kinase activity. Thus, UL97 represents a functional ortholog of cellular CDKs that is immune from normal CDK control mechanisms.	[Hume, Adam J.; Kalejta, Robert F.] Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA; [Hume, Adam J.; Kalejta, Robert F.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Finkel, Jonathan S.; Culbertson, Michael R.] Univ Wisconsin, Lab Genet Biol, Madison, WI 53706 USA; [Finkel, Jonathan S.; Culbertson, Michael R.] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; [Kamil, Jeremy P.; Coen, Donald M.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School	Kalejta, RF (corresponding author), Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA.	rfkalejta@wisc.edu	Kamil, Jeremy P./Q-9688-2018; Finkel, Jonathan/ADD-4684-2022; Hume, Adam/ABA-7439-2020	Kamil, Jeremy P./0000-0001-8422-7656; Finkel, Jonathan/0000-0002-4244-5337; Hume, Adam/0000-0001-8454-3472	NCI NIH HHS [T32 CA009135-31, T32 CA009135] Funding Source: Medline; NIAID NIH HHS [AI26077, R56 AI064703, T32 AI07245, R56 AI026077, R56-AI064703] Funding Source: Medline; NIGMS NIH HHS [T32 GM007215, T32 GM077078-01, GM65172] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026077, T32AI007245, R56AI026077, R56AI064703, U01AI026077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215, F31GM077078, R01GM065172] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 2001, BBA-REV CANCER, V1471, pM123, DOI 10.1016/S0304-419X(01)00019-1; Biron KK, 2002, ANTIMICROB AGENTS CH, V46, P2365, DOI 10.1128/AAC.46.8.2365-2372.2002; HARPER JW, 1993, CELL, V75, P805; Helt AM, 2003, CARCINOGENESIS, V24, P159, DOI 10.1093/carcin/24.2.159; JAULT FM, 1995, J VIROL, V69, P6697, DOI 10.1128/JVI.69.11.6697-6704.1995; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Kalejta RF, 2003, MOL CELL BIOL, V23, P1885, DOI 10.1128/MCB.23.6.1885-1895.2003; Kamil JP, 2007, J VIROL, V81, P10659, DOI 10.1128/JVI.00497-07; Lolli G, 2005, CELL CYCLE, V4, P572, DOI 10.4161/cc.4.4.1607; Marschall M, 2001, J GEN VIROL, V82, P1439, DOI 10.1099/0022-1317-82-6-1439; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Prichard MN, 1999, J VIROL, V73, P5663, DOI 10.1128/JVI.73.7.5663-5670.1999; Prichard MN, 2005, J VIROL, V79, P15494, DOI 10.1128/JVI.79.24.15494-15502.2005; Romaker D, 2006, J MED CHEM, V49, P7044, DOI 10.1021/jm060696s; SULLIVAN V, 1992, NATURE, V359, P85, DOI 10.1038/359085a0; Verschuren EW, 2004, J GEN VIROL, V85, P1347, DOI 10.1099/vir.0.79812-0; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Welburn JPI, 2007, J BIOL CHEM, V282, P3173, DOI 10.1074/jbc.M609151200; WITTENBERG C, 1990, CELL, V62, P225, DOI 10.1016/0092-8674(90)90361-H	20	176	181	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2008	320	5877					797	799		10.1126/science.1152095	http://dx.doi.org/10.1126/science.1152095			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18467589				2022-12-24	WOS:000255644400042
J	Muneepeerakul, R; Bertuzzo, E; Lynch, HJ; Fagan, WF; Rinaldo, A; Rodriguez-Iturbe, I				Muneepeerakul, Rachata; Bertuzzo, Enrico; Lynch, Heather J.; Fagan, William F.; Rinaldo, Andrea; Rodriguez-Iturbe, Ignacio			Neutral metacommunity models predict fish diversity patterns in Mississippi-Missouri basin	NATURE			English	Article							RELATIVE SPECIES ABUNDANCE; BIODIVERSITY; COMMUNITIES; ECOLOGY	River networks, seen as ecological corridors featuring connected and hierarchical dendritic landscapes for animals and plants, present unique challenges and opportunities for testing biogeographical theories and macroecological laws(1). Although local and basin- scale differences in riverine fish diversity have been analysed as functions of energy availability and habitat heterogeneity(2), scale- dependent environmental conditions(3) and river discharge(4,5), a model that predicts a comprehensive set of system-wide diversity patterns has been hard to find. Here we show that fish diversity patterns throughout the Mississippi - Missouri River System are well described by a neutral metacommunity model coupled with an appropriate habitat capacity distribution and dispersal kernel. River network structure acts as an effective template for characterizing spatial attributes of fish biodiversity. We show that estimates of average dispersal behaviour and habitat capacities, objectively calculated from average runoff production, yield reliable predictions of large- scale spatial biodiversity patterns in riverine systems. The success of the neutral theory in two- dimensional forest ecosystems(6-8) and here in dendritic riverine ecosystems suggests the possible application of neutral metacommunity models in a diverse suite of ecosystems. This framework offers direct linkage from large- scale forcing, such as global climate change, to biodiversity patterns.	[Muneepeerakul, Rachata; Bertuzzo, Enrico; Rodriguez-Iturbe, Ignacio] Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA; [Bertuzzo, Enrico; Rinaldo, Andrea] Ecole Polytech Fed Lausanne, Fac ENAC, Lab Ecohydrol, CH-1015 Lausanne, Switzerland; [Lynch, Heather J.; Fagan, William F.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Rinaldo, Andrea] Univ Padua, Dipartimento Ingn Idraul Marittima Ambientale & G, I-35131 Padua, Italy; [Rinaldo, Andrea] Univ Padua, Ctr Int Idrol Dino Tonini, I-35131 Padua, Italy	Princeton University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University System of Maryland; University of Maryland College Park; University of Padua; University of Padua	Muneepeerakul, R (corresponding author), Princeton Univ, Dept Civil & Environm Engn, E Quad, Princeton, NJ 08544 USA.	rmuneepe@princeton.edu; irodrigu@princeton.edu	Bertuzzo, Enrico/U-7129-2017; Lynch, Heather J/E-7371-2012	Bertuzzo, Enrico/0000-0001-5872-0666; 				Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; Angermeier PL, 1998, ECOLOGY, V79, P911, DOI 10.1890/0012-9658(1998)079[0911:LVRIOL]2.0.CO;2; Bertuzzo E, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005533; Campos D, 2006, THEOR POPUL BIOL, V69, P88, DOI 10.1016/j.tpb.2005.09.001; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Dingman S., 2002, PHYS HYDROLOGY; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; Economo EP, 2008, ECOL LETT, V11, P52, DOI 10.1111/j.1461-0248.2007.01126.x; Etienne RS, 2005, ECOL LETT, V8, P493, DOI 10.1111/j.1461-0248.2005.00745.x; Fernandes CC, 2004, SCIENCE, V305, P1960, DOI 10.1126/science.1101240; Gebert W. A., 1987, AVERAGE ANN RUNOFF U; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Guegan JF, 1998, NATURE, V391, P382, DOI 10.1038/34899; Holt RD, 2006, TRENDS ECOL EVOL, V21, P531, DOI 10.1016/j.tree.2006.08.003; Hubbell Stephen P., 2001, V32, pi; Levin SA, 2003, ANNU REV ECOL EVOL S, V34, P575, DOI 10.1146/annurev.ecolsys.34.011802.132428; Master L.L., 1998, RIVERS LIFE CRITICAL; Matthews W. J., 1998, PATTERNS FRESHWATER; McGill BJ, 2003, NATURE, V422, P881, DOI 10.1038/nature01583; Muneepeerakul R, 2007, J THEOR BIOL, V245, P351, DOI 10.1016/j.jtbi.2006.10.005; *NATURESERVE, 2004, DISTR NAT US FISH WA; Oberdorff T, 1995, ECOGRAPHY, V18, P345, DOI 10.1111/j.1600-0587.1995.tb00137.x; Purves Drew W., 2005, P107, DOI 10.1017/CBO9780511541971.006; SEABER PR, 1994, 2294 US GEOL SURV; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; Volkov I, 2007, NATURE, V450, P45, DOI 10.1038/nature06197; Walker SC, 2007, OIKOS, V116, P143, DOI 10.1111/j.2006.0030-1299.15300.x; Xenopoulos MA, 2006, ECOLOGY, V87, P1907, DOI 10.1890/0012-9658(2006)87[1907:GWTFUS]2.0.CO;2; [No title captured]	30	266	272	2	160	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 8	2008	453	7192					220	U9		10.1038/nature06813	http://dx.doi.org/10.1038/nature06813			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297BP	18464742	Bronze			2022-12-24	WOS:000255592400039
J	Erickson, JR; Joiner, MLA; Guan, X; Kutschke, W; Yang, JY; Oddis, CV; Bartlett, RK; Lowe, JS; O'Donnell, SE; Aykin-Burns, N; Zimmerman, MC; Zimmerman, K; Ham, AJL; Weiss, RM; Spitz, DR; Shea, MA; Colbran, RJ; Mohler, PJ; Anderson, ME				Erickson, Jeffrey R.; Joiner, Mei-ling A.; Guan, Xiaoqun; Kutschke, William; Yang, Jinying; Oddis, Carmine V.; Bartlett, Ryan K.; Lowe, John S.; O'Donnell, Susan E.; Aykin-Burns, Nukhet; Zimmerman, Matthew C.; Zimmerman, Kathy; Ham, Amy-Joan L.; Weiss, Robert M.; Spitz, Douglas R.; Shea, Madeline A.; Colbran, Roger J.; Mohler, Peter J.; Anderson, Mark E.			A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation	CELL			English	Article							CALMODULIN KINASE-II; DEPENDENT PROTEIN-KINASE; LEFT-VENTRICULAR DYSFUNCTION; HEART-FAILURE; MYOCARDIAL-INFARCTION; SULFOXIDE REDUCTASE; INHIBITION PROTECTS; AUTONOMOUS ENZYME; BINDING DOMAIN; ANGIOTENSIN-II	Calcium/calmodulin (Ca2+/CaM)-dependent protein kinase II (CaMKII) couples increases in cellular Ca2+ to fundamental responses in excitable cells. CaMKII was identified over 20 years ago by activation dependence on Ca2+/CaM, but recent evidence shows that CaMKII activity is also enhanced by pro-oxidant conditions. Here we show that oxidation of paired regulatory domain methionine residues sustains CaMKII activity in the absence of Ca2+/CaM. CaMKII is activated by angiotensin II (AngII)-induced oxidation, leading to apoptosis in cardiomyocytes both in vitro and in vivo. CaMKII oxidation is reversed by methionine sulfoxide reductase A (MsrA), and MsrA(-/-) mice show exaggerated CaMKII oxidation and myocardial apoptosis, impaired cardiac function, and increased mortality after myocardial infarction. Our data demonstrate a dynamic mechanism for CaMKII activation by oxidation and highlight the critical importance of oxidation-dependent CaMKII activation to AngII and ischemic myocardial apoptosis.	[Erickson, Jeffrey R.; Joiner, Mei-ling A.; Guan, Xiaoqun; Kutschke, William; Yang, Jinying; Lowe, John S.; Weiss, Robert M.; Mohler, Peter J.; Anderson, Mark E.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [O'Donnell, Susan E.; Shea, Madeline A.] Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA; [Mohler, Peter J.; Anderson, Mark E.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Aykin-Burns, Nukhet; Zimmerman, Matthew C.; Spitz, Douglas R.] Univ Iowa, Free Rad & Radiat Biol Program, Dept Radiat Oncol, Iowa City, IA 52242 USA; [Oddis, Carmine V.] Vanderbilt Univ, Dept Internal Med, Nashville, TN 37232 USA; [Bartlett, Ryan K.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Ham, Amy-Joan L.; Colbran, Roger J.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Ham, Amy-Joan L.] Vanderbilt Univ, Mass Spectrometry Res Ctr, Nashville, TN 37232 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Anderson, ME (corresponding author), Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA.	mark-e-anderson@uiowa.edu	Shea, Madeline A/F-5798-2010; Colbran, Roger/AAU-7708-2021	Colbran, Roger/0000-0001-7401-8244; Zimmerman, Matthew/0000-0001-5658-9051; Spitz, Douglas/0000-0002-1254-8765; Shea, Madeline/0000-0003-0814-7069; Joiner, Mei-ling/0000-0002-7775-7349	NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR017369] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084583, R01HL079031, R01HL070250, R01HL062494, R01HL083422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063232] Funding Source: NIH RePORTER; NCRR NIH HHS [RR017369, K26 RR017369] Funding Source: Medline; NHLBI NIH HHS [R01 HL 62494, R01 HL062494, R01 HL 079031, R01 HL070250-06A1, R01 HL070250, R01 HL084583, R01 HL083422, R01 HL079031-02, R01 HL062494-09, R01 HL079031, R01 HL 70250] Funding Source: Medline; NIGMS NIH HHS [R01 GM057001, R01 GM57001] Funding Source: Medline; NIMH NIH HHS [R01 MH063232-08, R01 MH063232] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012; Bers DM, 2005, NAT MED, V11, P379, DOI 10.1038/nm0405-379; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; Cross JV, 2004, BIOCHEM J, V381, P675, DOI 10.1042/BJ20040591; Doerries C, 2007, CIRC RES, V100, P894, DOI 10.1161/01.RES.0000261657.76299.ff; Engers R, 2006, FEBS J, V273, P4754, DOI 10.1111/j.1742-4658.2006.05476.x; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; Hare JM, 2001, CIRC RES, V89, P198, DOI 10.1161/res.89.3.198; Hjalmarson A, 1999, LANCET, V353, P2001; Hoshi T, 2001, J PHYSIOL-LONDON, V531, P1, DOI 10.1111/j.1469-7793.2001.0001j.x; Howe CJ, 2004, J BIOL CHEM, V279, P44573, DOI 10.1074/jbc.M404175200; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Khoo MSC, 2006, CIRCULATION, V114, P1352, DOI 10.1161/CIRCULATIONAHA.106.644583; Kinugawa S, 2000, CIRC RES, V87, P392; Kryukov GV, 2002, P NATL ACAD SCI USA, V99, P4245, DOI 10.1073/pnas.072603099; LOU LL, 1986, P NATL ACAD SCI USA, V83, P9497, DOI 10.1073/pnas.83.24.9497; Lyle AN, 2006, PHYSIOLOGY, V21, P269, DOI 10.1152/physiol.00004.2006; Maack C, 2003, CIRCULATION, V108, P1567, DOI 10.1161/01.CIR.0000091084.46500.BB; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; Mohler PJ, 2007, CIRCULATION, V115, P432, DOI 10.1161/CIRCULATIONAHA.106.656512; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Munzel T, 2001, CIRCULATION, V104, P1571, DOI 10.1161/hc3801.095585; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; PATTON BL, 1990, J BIOL CHEM, V265, P11204; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; SAITOH T, 1985, J CELL BIOL, V100, P835, DOI 10.1083/jcb.100.3.835; Santarelli LC, 2006, J PHYSIOL-LONDON, V571, P329, DOI 10.1113/jphysiol.2005.101089; SCHULMAN H, 1978, P NATL ACAD SCI USA, V75, P5432, DOI 10.1073/pnas.75.11.5432; SHARMA RV, 1995, NEUROSCIENCE, V66, P433, DOI 10.1016/0306-4522(94)00560-R; Tojo A, 2002, HYPERTENSION, V40, P834, DOI 10.1161/01.HYP.0000039506.43589.D5; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Weiss RM, 2006, CIRCULATION, V114, P2065, DOI 10.1161/CIRCULATIONAHA.106.634139; Weissbach H, 2002, ARCH BIOCHEM BIOPHYS, V397, P172, DOI 10.1006/abbi.2001.2664; Wu YJ, 2002, CIRCULATION, V106, P1288, DOI 10.1161/01.CIR.0000027583.73268.E7; Yang YB, 2006, AM J PHYSIOL-HEART C, V291, pH3065, DOI 10.1152/ajpheart.00353.2006; ZANGERLE L, 1992, J NEUROCHEM, V59, P181, DOI 10.1111/j.1471-4159.1992.tb08889.x; Zhabotinsky AM, 2000, BIOPHYS J, V79, P2211, DOI 10.1016/S0006-3495(00)76469-1; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhu WZ, 2007, J BIOL CHEM, V282, P10833, DOI 10.1074/jbc.M611507200; Zhu WZ, 2003, J CLIN INVEST, V111, P617, DOI 10.1172/JCI200316326; Zimmerman MC, 2004, CIRC RES, V95, P532, DOI 10.1161/01.RES.0000139957.22530.b9	47	806	840	2	80	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 2	2008	133	3					462	474		10.1016/j.cell.2008.02.048	http://dx.doi.org/10.1016/j.cell.2008.02.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455987	Green Accepted, Bronze			2022-12-24	WOS:000255503900017
J	Rius, J; Guma, M; Schachtrup, C; Akassoglou, K; Zinkernagel, AS; Nizet, V; Johnson, RS; Haddad, GG; Karin, M				Rius, Jordi; Guma, Monica; Schachtrup, Christian; Akassoglou, Katerina; Zinkernagel, Annelies S.; Nizet, Victor; Johnson, Randall S.; Haddad, Gabriel G.; Karin, Michael			NF-kappa B links innate immunity to the hypoxic response through transcriptional regulation of HIF-1 alpha	NATURE			English	Article							IKK-BETA; CUTTING EDGE; CELLS; EXPRESSION; OXYGEN; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; CARCINOGENESIS; INFLAMMATION; INHIBITION; PREVENTION	The hypoxic response is an ancient stress response triggered by low ambient oxygen ( O(2)) ( ref. 1) and controlled by hypoxia-inducible transcription factor- 1 ( HIF- 1), whose a subunit is rapidly degraded under normoxia but stabilized when O(2)- dependent prolyl hydroxylases ( PHDs) that target its O(2)- dependent degradation domain are inhibited(2-4). Thus, the amount of HIF-1 alpha, which controls genes involved in energy metabolism and angiogenesis, is regulated post- translationally. Another ancient stress response is the innate immune response, regulated by several transcription factors, among which NF-kappa B plays a central role(5,6). NF-kappa B activation is controlled by I kappa B kinases ( IKK), mainly IKK-beta, needed for phosphorylation- induced degradation of I kappa B inhibitors in response to infection and inflammation(7). IKK-beta is modestly activated in hypoxic cell cultures when PHDs that attenuate its activation are inhibited(8). However, defining the relationship between NF-kappa B and HIF-1 alpha has proven elusive. Using in vitro systems, it was reported that HIF-1 alpha activates NF- kappa B(9), that NF-kappa B controls HIF-1 alpha transcription(10) and that HIF-1 alpha activation may be concurrent with inhibition of NF-kappa B(11). Here we show, with the use of mice lacking IKK-beta in different cell types, that NF-kappa B is a critical transcriptional activator of HIF-1 alpha and that basal NF-kappa B activity is required for HIF-1 alpha protein accumulation under hypoxia in cultured cells and in the liver and brain of hypoxic animals. IKK-beta deficiency results in defective induction of HIF-1 alpha target genes including vascular endothelial growth factor. IKK-beta is also essential for HIF-1 alpha accumulation in macrophages experiencing a bacterial infection. Hence, IKK-beta is an important physiological contributor to the hypoxic response, linking it to innate immunity and inflammation.	[Rius, Jordi; Guma, Monica; Karin, Michael] Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; [Rius, Jordi; Guma, Monica; Schachtrup, Christian; Akassoglou, Katerina; Karin, Michael] Univ Calif San Diego, Dept Pharmacol, Sch Med, La Jolla, CA 92093 USA; [Rius, Jordi; Guma, Monica; Karin, Michael] Univ Calif San Diego, Dept Pathol, Sch Med, La Jolla, CA 92093 USA; [Zinkernagel, Annelies S.; Nizet, Victor; Haddad, Gabriel G.] Univ Calif San Diego, Dept Pediat, Sch Med, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Johnson, Randall S.] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Karin, M (corresponding author), Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Nizet, Victor/AAF-3190-2019; Johnson, Randall/AAM-1189-2021; Zinkernagel, Annelies S/F-1780-2017	Johnson, Randall/0000-0002-4084-6639; Zinkernagel, Annelies S/0000-0003-4700-1118; Nizet, Victor/0000-0003-3847-0422; Akassoglou, Katerina/0000-0002-2632-1465; guma, monica/0000-0003-1951-9411	NCI NIH HHS [R01 CA118165] Funding Source: Medline; NCRR NIH HHS [P41 RR004050-208577, P41 RR004050] Funding Source: Medline; NIAID NIH HHS [R01 AI043477, R01 AI043477-12] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA118165] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Elson DA, 2000, CANCER RES, V60, P6189; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; HACKER H, 2006, SCI STKE, V357, pRE13, DOI DOI 10.1126/STKE.3572006RE13; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jain S, 1998, MECH DEVELOP, V73, P117, DOI 10.1016/S0925-4773(98)00038-0; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Leach RM, 1998, BRIT MED J, V317, P1370, DOI 10.1136/bmj.317.7169.1370; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Makino Y, 2003, J IMMUNOL, V171, P6534, DOI 10.4049/jimmunol.171.12.6534; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Paul SAM, 2004, J CELL PHYSIOL, V200, P20, DOI 10.1002/jcp.10479; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; Riboldi E, 2005, J IMMUNOL, V175, P2788, DOI 10.4049/jimmunol.175.5.2788; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Schoch HJ, 2002, BRAIN, V125, P2549, DOI 10.1093/brain/awf257; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304	30	1085	1142	3	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2008	453	7196					807	U9		10.1038/nature06905	http://dx.doi.org/10.1038/nature06905			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308UK	18432192	Green Accepted, Bronze			2022-12-24	WOS:000256415300049
J	Jin, LY; Williamson, A; Banerjee, S; Philipp, I; Rape, M				Jin, Lingyan; Williamson, Adam; Banerjee, Sudeep; Philipp, Isabelle; Rape, Michael			Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex	CELL			English	Article							CONJUGATING ENZYMES; POLYUBIQUITIN CHAIN; FUNCTIONAL-ANALYSIS; DESTRUCTION BOX; PROTEINS; DOMAIN; PROCESSIVITY; DEGRADATION; PROTEOMICS; SUBSTRATE	The anaphase-promoting complex (APC/C) orchestrates progression through mitosis by decorating cell-cycle regulators with ubiquitin chains. To nucleate chains, the APC/C links ubiquitin to a lysine in substrates, but to elongate chains it modifies lysine residues in attached ubiquitin moieties. The mechanism enabling the APC/C, and ubiquitin ligases in general, to switch from lysine residues in substrates to specific ones in ubiquitin remains poorly understood. Here, we determine the topology and the mechanism of assembly for the ubiquitin chains mediating functions of the human APC/C. We find that the APC/C triggers substrate degradation by assembling K11-linked ubiquitin chains, the efficient formation of which depends on a surface of ubiquitin, the TEK-box. Strikingly, homologous TEK-boxes are found in APC/C substrates, where they facilitate chain nucleation. We propose that recognition of similar motifs in substrates and ubiquitin enables the APC/C to assemble ubiquitin chains with the specificity and efficiency required for tight cell-cycle control.	[Jin, Lingyan; Williamson, Adam; Banerjee, Sudeep; Philipp, Isabelle; Rape, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Rape, M (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 16 Barker Hall, Berkeley, CA 94720 USA.	mrape@berkeley.edu		Rape, Michael/0000-0003-4849-6343	NIGMS NIH HHS [R01 GM083064, R01 GM083064-01] Funding Source: Medline; NIH HHS [DP2 OD003088-01, DP2 OD003088] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083064] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003088] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022; Carroll CW, 2002, NAT CELL BIOL, V4, P880, DOI 10.1038/ncb871; Dube P, 2005, MOL CELL, V20, P867, DOI 10.1016/j.molcel.2005.11.008; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Lin YQ, 2002, J BIOL CHEM, V277, P21913, DOI 10.1074/jbc.M109398200; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; Tolbert BS, 2005, BIOCHEMISTRY-US, V44, P16385, DOI 10.1021/bi0514459; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wirth KG, 2004, GENE DEV, V18, P88, DOI 10.1101/gad.285404; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	31	378	416	0	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 16	2008	133	4					653	665		10.1016/j.cell.2008.04.012	http://dx.doi.org/10.1016/j.cell.2008.04.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485873	Bronze, Green Accepted			2022-12-24	WOS:000255903300020
J	Zhang, Z; Lotti, F; Dittmar, K; Younis, I; Wan, L; Kasim, M; Dreyfuss, G				Zhang, Zhenxi; Lotti, Francesco; Dittmar, Kimberly; Younis, Ihab; Wan, Lili; Kasim, Mumtaz; Dreyfuss, Gideon			SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing	CELL			English	Article							SPINAL MUSCULAR-ATROPHY; DISEASE GENE-PRODUCT; MOTOR-NEURON COMPLEX; MESSENGER-RNA; ASSEMBLY MACHINE; IN-VIVO; PROTEIN; SURVIVAL; COMPONENT; MOUSE	The survival of motor neurons (SMN) protein is essential for the biogenesis of small nuclear RNA (snRNA)-ribonucleoproteins (snRNPs), the major components of the pre-mRNA splicing machinery. Though it is ubiquitously expressed, SMN deficiency causes the motor neuron degenerative disease spinal muscular atrophy (SMA). We show here that SMN deficiency, similar to that which occurs in severe SMA, has unexpected cell type-specific effects on the repertoire of snRNAs and mRNAs. It alters the stoichiometry of snRNAs and causes widespread pre-mRNA splicing defects in numerous transcripts of diverse genes, preferentially those containing a large number of introns, in SMN-deficient mouse tissues. These findings reveal a key role for the SMN complex in RNA metabolism and in splicing regulation and indicate that SMA is a general splicing disease that is not restricted to motor neurons.	[Zhang, Zhenxi; Lotti, Francesco; Dittmar, Kimberly; Younis, Ihab; Wan, Lili; Kasim, Mumtaz; Dreyfuss, Gideon] Univ Penn, Sch Med, Dept Biochem & Biophys, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania	Dreyfuss, G (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.	gdreyfuss@hhmi.upenn.edu	Dreyfuss, Gideon/D-1218-2013; Younis, Ihab/M-1849-2019; Lotti, Francesco/AAC-3186-2019	Dreyfuss, Gideon/0000-0001-8129-8774; Younis, Ihab/0000-0003-3329-5979; 	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Baccon J, 2002, J BIOL CHEM, V277, P31957, DOI 10.1074/jbc.M203478200; Balabanian S, 2007, NEUROL RES, V29, P413, DOI 10.1179/016164107X159243; Battle DJ, 2006, COLD SPRING HARB SYM, V71, P313, DOI 10.1101/sqb.2006.71.001; Battle DJ, 2006, MOL CELL, V23, P273, DOI 10.1016/j.molcel.2006.05.036; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Carissimi C, 2006, J BIOL CHEM, V281, P8126, DOI 10.1074/jbc.M512243200; Charroux B, 2000, J CELL BIOL, V148, P1177, DOI 10.1083/jcb.148.6.1177; Charroux B, 1999, J CELL BIOL, V147, P1181, DOI 10.1083/jcb.147.6.1181; Cifuentes-Diaz Carmen, 2002, Semin Pediatr Neurol, V9, P145, DOI 10.1053/spen.2002.33801; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Feng WQ, 2005, HUM MOL GENET, V14, P1605, DOI 10.1093/hmg/ddi168; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Gabanella F, 2005, HUM MOL GENET, V14, P3629, DOI 10.1093/hmg/ddi390; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Gubitz AK, 2002, J BIOL CHEM, V277, P5631, DOI 10.1074/jbc.M109448200; Hou VC, 2002, EMBO J, V21, P6195, DOI 10.1093/emboj/cdf625; Iannaccone Susan T, 2004, Curr Neurol Neurosci Rep, V4, P74, DOI 10.1007/s11910-004-0016-6; Jablonka S, 2004, J NEUROBIOL, V58, P272, DOI 10.1002/neu.10313; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Klinck R, 2008, CANCER RES, V68, P657, DOI 10.1158/0008-5472.CAN-07-2580; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Massenet S, 2002, MOL CELL BIOL, V22, P6533, DOI 10.1128/MCB.22.18.6533-6541.2002; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; Narayanan U, 2002, HUM MOL GENET, V11, P1785, DOI 10.1093/hmg/11.15.1785; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Olaso R, 2006, PHYSIOL GENOMICS, V24, P97, DOI 10.1152/physiolgenomics.00134.2005; Pagliardini S, 2000, HUM MOL GENET, V9, P47, DOI 10.1093/hmg/9.1.47; Paradis C, 2007, RNA, V13, P1287, DOI 10.1261/rna.403607; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Pellizzoni L, 2001, J CELL BIOL, V152, P75, DOI 10.1083/jcb.152.1.75; Pellizzoni L, 2002, J BIOL CHEM, V277, P7540, DOI 10.1074/jbc.M110141200; Pellizzoni L, 2001, CURR BIOL, V11, P1079, DOI 10.1016/S0960-9822(01)00316-5; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pleiss JA, 2007, PLOS BIOL, V5, P745, DOI 10.1371/journal.pbio.0050090; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; SAUTERER RA, 1988, EXP CELL RES, V176, P344, DOI 10.1016/0014-4827(88)90336-9; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Talbot K, 2001, SEMIN NEUROL, V21, P189, DOI 10.1055/s-2001-15264; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; WANG J, 1995, RNA, V1, P335; Wang J, 2001, J BIOL CHEM, V276, P9599, DOI 10.1074/jbc.M009162200; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Whitehead SE, 2002, J BIOL CHEM, V277, P48087, DOI 10.1074/jbc.M204551200; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Yong JS, 2004, TRENDS CELL BIOL, V14, P226, DOI 10.1016/j.tcb.2004.03.010; Zhang HLL, 2003, J NEUROSCI, V23, P6627; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9; ZIEVE GW, 1988, J MOL BIOL, V199, P259, DOI 10.1016/0022-2836(88)90312-9	62	463	473	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 16	2008	133	4					585	600		10.1016/j.cell.2008.03.031	http://dx.doi.org/10.1016/j.cell.2008.03.031			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485868	Green Accepted, Bronze			2022-12-24	WOS:000255903300015
J	Organ, CL; Schweitzer, MH; Zheng, WX; Freimark, LM; Cantley, LC; Asara, JM				Organ, Chris L.; Schweitzer, Mary H.; Zheng, Wenxia; Freimark, Lisa M.; Cantley, Lewis C.; Asara, John M.			Molecular phylogenetics of mastodon and Tyrannosaurus rex	SCIENCE			English	Article							SEQUENCES		[Freimark, Lisa M.; Cantley, Lewis C.; Asara, John M.] Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Cantley, Lewis C.; Asara, John M.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Organ, Chris L.] Harvard Univ, Cambridge, MA 02138 USA; [Organ, Chris L.] Museum Comparat Zool, Cambridge, MA 02138 USA; [Schweitzer, Mary H.; Zheng, Wenxia] N Carolina State Univ, Raleigh, NC 27695 USA; [Schweitzer, Mary H.] N Carolina Museum Nat Sci, Raleigh, NC 27601 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; University of North Carolina; North Carolina State University	Asara, JM (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	jasara@bidmc.harvard.edu	schweitzer, mary h/A-6756-2010; Cantley, Lewis C/D-1800-2014; Schweitzer, Mary/V-8143-2019	schweitzer, mary h/0000-0002-0427-3829; Cantley, Lewis C/0000-0002-1298-7653; 	NIGMS NIH HHS [F32 GM075490] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM075490] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asara JM, 2008, SCIENCE, V319, DOI 10.1126/science.1147364; Asara JM, 2007, SCIENCE, V317, P1324, DOI 10.1126/science.317.5843.1324; Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; Benton MJ, 2004, DINOSAURIA, 2ND EDITION, P7; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P21; Rohland N, 2007, PLOS BIOL, V5, P1663, DOI 10.1371/journal.pbio.0050207; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Springer MS, 2007, SYST BIOL, V56, P673, DOI 10.1080/10635150701491149; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Thomas MG, 2000, P ROY SOC B-BIOL SCI, V267, P2493, DOI 10.1098/rspb.2000.1310; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330	11	39	41	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					499	499		10.1126/science.1154284	http://dx.doi.org/10.1126/science.1154284			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436782				2022-12-24	WOS:000255249300041
J	Imai, Y; Kuba, K; Neely, GG; Yaghubian-Malhami, R; Perkmann, T; van Loo, G; Ermolaeva, M; Veldhuizen, R; Leung, YHC; Wang, HL; Liu, HL; Sun, Y; Pasparakis, M; Kopf, M; Mech, C; Bavari, S; Peiris, JSM; Slutsky, AS; Akira, S; Hultqvist, M; Holmdahl, R; Nicholls, J; Jiang, CY; Binder, CJ; Penninger, JM				Imai, Yumiko; Kuba, Keiji; Neely, G. Greg; Yaghubian-Malhami, Rubina; Perkmann, Thomas; van Loo, Geert; Ermolaeva, Maria; Veldhuizen, Ruud; Leung, Y. H. Connie; Wang, Hongliang; Liu, Haolin; Sun, Yang; Pasparakis, Manolis; Kopf, Manfred; Mech, Christin; Bavari, Sina; Peiris, J. S. Malik; Slutsky, Arthur S.; Akira, Shizuo; Hultqvist, Malin; Holmdahl, Rikard; Nicholls, John; Jiang, Chengyu; Binder, Christoph J.; Penninger, Josef M.			Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury	CELL			English	Article							RESPIRATORY-DISTRESS-SYNDROME; LOW-DENSITY-LIPOPROTEIN; 1918 PANDEMIC VIRUS; FACTOR-KAPPA-B; OXIDIZED PHOSPHOLIPIDS; TRANSCRIPTION FACTORS; PULMONARY SURFACTANT; APOLIPOPROTEIN-E; APOPTOTIC CELLS; SYNCYTIAL VIRUS	Multiple lung pathogens such as chemical agents, H5N1 avian flu, or SARS cause high lethality due to acute respiratory distress syndrome. Here we report that Toll-like receptor 4 (TLR4) mutant mice display natural resistance to acid-induced acute lung injury (ALI). We show that TLR4-TRIF-TRAF6 signaling is a key disease pathway that controls the severity of ALI. The oxidized phospholipid (OxPL) OxPAPC was identified to induce lung injury and cytokine production by lung macrophages via TLR4-TRIF. We observed OxPL production in the lungs of humans and animals infected with SARS, Anthrax, or H5N1. Pulmonary challenge with an inactivated H5N1 avian influenza virus rapidly induces ALI and OxPL formation in mice. Loss of TLR4 or TRIF expression protects mice from H5N1-induced ALI. Moreover, deletion of ncf1, which controls ROS production, improves the severity of H5N1-mediated ALI. Our data identify oxidative stress and innate immunity as key lung injury pathways that control the severity of ALI.	[Kuba, Keiji] Tokyo Med & Dent Univ, Med Res Inst, Chiyoda Ku, Tokyo 1010062, Japan; [Perkmann, Thomas; Binder, Christoph J.] Med Univ Vienna, Inst Med & Chem Lab Diagnost, A-1090 Vienna, Austria; [Perkmann, Thomas; Binder, Christoph J.] Austrian Acad Sci, CeMM, Res Ctr Mol Med, A-1090 Vienna, Austria; [van Loo, Geert; Ermolaeva, Maria; Pasparakis, Manolis] European Mol Biol Lab, Mouse Biol Unit, I-00016 Monterotondo, Italy; [Ermolaeva, Maria; Pasparakis, Manolis] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Veldhuizen, Ruud] Univ Western Ontario, Lawson Hlth Res Inst, Dept Med, London, ON N6A 4V2, Canada; [Veldhuizen, Ruud] Univ Western Ontario, Lawson Hlth Res Inst, Dept Physiol & Pharmacol, London, ON N6A 4V2, Canada; [Nicholls, John] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Leung, Y. H. Connie; Peiris, J. S. Malik] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Wang, Hongliang; Liu, Haolin; Sun, Yang; Jiang, Chengyu] Peking Union Med Coll, Natl Key Lab Med Mol Biol, Sch Basic Med, Beijing 100005, Peoples R China; [Wang, Hongliang; Liu, Haolin; Sun, Yang; Jiang, Chengyu] Chinese Acad Med Sci, Beijing 100005, Peoples R China; [Kopf, Manfred] Swiss Fed Inst Technol, CH-8952 Zurich, Switzerland; [Mech, Christin; Bavari, Sina] USA, Med Res Inst Infect Dis, Frederick, MD 21701 USA; [Slutsky, Arthur S.] Univ Toronto, Interdepartmental Div Crit Care Med, Toronto, ON M5B 1W8, Canada; [Slutsky, Arthur S.] Univ Toronto, Dept Crit Care, St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Akira, Shizuo] Osaka Univ, Dept Host Def, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Hultqvist, Malin; Holmdahl, Rikard] BMC, Med Inflammat Res, Lund, Sweden; [Hultqvist, Malin; Holmdahl, Rikard] Karolinska Inst, Med Inflammat Res, MBB, Stockholm, Sweden; [Imai, Yumiko; Kuba, Keiji; Neely, G. Greg; Yaghubian-Malhami, Rubina; Penninger, Josef M.] Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria	Tokyo Medical & Dental University (TMDU); Medical University of Vienna; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; European Molecular Biology Laboratory (EMBL); University of Cologne; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Hong Kong; University of Hong Kong; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Osaka University; Karolinska Institutet; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Imai, Y (corresponding author), Akita Univ, Sch Med, Global COE Program, Akita 0108543, Japan.	imai@med.akita-u.ac.jp; josef.penninger@imba.oeaw.ac.at	Penninger, Josef M/I-6860-2013; Leung, Connie/C-4600-2009; Holmdahl, Rikard/AAI-7682-2020; neely, graham/A-6511-2011; Bavari, Sina/L-3642-2019; Wang, Hongliang/J-1941-2012; Kopf, Manfred/B-6907-2009; Neely, Greg/AAB-4642-2020; van Loo, Geert/C-1505-2009; Pasparakis, Manolis/H-9292-2017; Imai, Yumiko/GXW-1144-2022; Slutsky, Arthur/M-3325-2019; Akira, Shizuo/C-3134-2009; Pasparakis, Manolis/N-4350-2019; , van Loo Geert/AAD-1220-2019; , 孙阳/B-2495-2016; Perkmann, Thomas/F-3074-2012; Veldhuizen, Ruud/G-3352-2011; Nicholls, John Malcolm/C-4375-2009; Peiris, Joseph Sriyal Malik/C-4380-2009	Penninger, Josef M/0000-0002-8194-3777; Bavari, Sina/0000-0001-8424-5635; Wang, Hongliang/0000-0002-3304-2683; Kopf, Manfred/0000-0002-0628-7140; Neely, Greg/0000-0002-1957-9732; Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; , van Loo Geert/0000-0002-8427-4775; , 孙阳/0000-0002-1463-689X; Veldhuizen, Ruud/0000-0002-8802-1580; Leung, Connie YH/0000-0003-1102-4684; Binder, Christoph J./0000-0001-8313-7050; Nicholls, John Malcolm/0000-0001-7217-7444; Perkmann, Thomas/0000-0002-7976-0285; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bailey TC, 2004, J APPL PHYSIOL, V96, P1674, DOI 10.1152/japplphysiol.01143.2003; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118; Binder CJ, 2002, NAT MED, V8, P1218, DOI 10.1038/nm1102-1218; Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023; Capote KR, 2003, J BIOL CHEM, V278, P20461, DOI 10.1074/jbc.M212697200; Chang MK, 2004, J EXP MED, V200, P1359, DOI 10.1084/jem.20031763; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Friedman P, 2002, J BIOL CHEM, V277, P7010, DOI 10.1074/jbc.M108860200; Furnkranz A, 2005, ARTERIOSCL THROM VAS, V25, P633, DOI 10.1161/01.ATV.0000153106.03644.a0; Guarner J, 2003, AM J PATHOL, V163, P701, DOI 10.1016/S0002-9440(10)63697-8; Haeberle HA, 2002, J INFECT DIS, V186, P1199, DOI 10.1086/344644; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoshino K, 1999, J IMMUNOL, V162, P3749; Huang CK, 2000, J LEUKOCYTE BIOL, V67, P210, DOI 10.1002/jlb.67.2.210; HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182; Hultqvist M, 2004, P NATL ACAD SCI USA, V101, P12646, DOI 10.1073/pnas.0403831101; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; JACOBS DM, 1977, J IMMUNOL, V118, P21; Kash JC, 2004, J VIROL, V78, P9499, DOI 10.1128/JVI.78.17.9499-9511.2004; Knapp S, 2007, J IMMUNOL, V178, P993, DOI 10.4049/jimmunol.178.2.993; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lew TWK, 2003, JAMA-J AM MED ASSOC, V290, P374, DOI 10.1001/jama.290.3.374; Martin TR, 1999, CHEST, V116, p2S, DOI 10.1378/chest.116.suppl_1.2S; McKinney LC, 2003, VIRUS RES, V97, P117, DOI 10.1016/j.virusres.2003.08.007; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Miller YI, 2005, ARTERIOSCL THROM VAS, V25, P1213, DOI 10.1161/01.ATV.0000159891.73193.31; Miller YI, 2003, CURR OPIN LIPIDOL, V14, P437, DOI 10.1097/00041433-200310000-00004; Miller YI, 2003, J BIOL CHEM, V278, P1561, DOI 10.1074/jbc.M209634200; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; Nagase T, 2000, NAT IMMUNOL, V1, P42, DOI 10.1038/76897; Nonas S, 2006, AM J RESP CRIT CARE, V173, P1130, DOI 10.1164/rccm.200511-1737OC; Palinski W, 1996, J CLIN INVEST, V98, P800, DOI 10.1172/JCI118853; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Powers KA, 2006, J EXP MED, V203, P1951, DOI 10.1084/jem.20060943; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Veldhuizen R, 1998, BBA-MOL BASIS DIS, V1408, P90, DOI 10.1016/S0925-4439(98)00061-1; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; *WHO, 2008, SARS; World Health Organization, 2005, AV INFL ASS PAND THR; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	51	980	1055	7	195	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 18	2008	133	2					235	249		10.1016/j.cell.2008.02.043	http://dx.doi.org/10.1016/j.cell.2008.02.043			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	289JY	18423196	Bronze, Green Published			2022-12-24	WOS:000255052000014
J	Isalan, M; Lemerle, C; Michalodimitrakis, K; Horn, C; Beltrao, P; Raineri, E; Garriga-Canut, M; Serrano, L				Isalan, Mark; Lemerle, Caroline; Michalodimitrakis, Konstantinos; Horn, Carsten; Beltrao, Pedro; Raineri, Emanuele; Garriga-Canut, Mireia; Serrano, Luis			Evolvability and hierarchy in rewired bacterial gene networks	NATURE			English	Article							ESCHERICHIA-COLI; REGULATORY NETWORK; TRANSCRIPTIONAL REGULATION; OPERON ORGANIZATION; BIOFILM FORMATION; GROWTH; EXPRESSION; TOLERANCE; RPOS; PHENOTYPES	Sequencing DNA from several organisms has revealed that duplication and drift of existing genes have primarily moulded the contents of a given genome. Though the effect of knocking out or overexpressing a particular gene has been studied in many organisms, no study has systematically explored the effect of adding new links in a biological network. To explore network evolvability, we constructed 598 recombinations of promoters ( including regulatory regions) with different transcription or sigma-factor genes in Escherichia coli, added over a wild- type genetic background. Here we show that similar to 95% of new networks are tolerated by the bacteria, that very few alter growth, and that expression level correlates with factor position in the wild- type network hierarchy. Most importantly, we find that certain networks consistently survive over the wild type under various selection pressures. Therefore new links in the network are rarely a barrier for evolution and can even confer a fitness advantage.	[Isalan, Mark; Michalodimitrakis, Konstantinos; Raineri, Emanuele; Garriga-Canut, Mireia; Serrano, Luis] UPF, CRG, EMBL, CRG Syst Biol, Barcelona 08003, Spain; [Lemerle, Caroline; Horn, Carsten; Beltrao, Pedro] European Mol Biol Lab, D-69117 Heidelberg, Germany	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Isalan, M (corresponding author), UPF, CRG, EMBL, CRG Syst Biol, Barcelona 08003, Spain.	isalan@crg.es	Serrano, Luis/B-3355-2013; Beltrao, Pedro/B-3342-2010; Raineri, Emanuele/AAX-7874-2020	Serrano, Luis/0000-0002-5276-1392; Beltrao, Pedro/0000-0002-2724-7703; Isalan, Mark/0000-0002-4652-0365	Wellcome Trust [066543] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Babu MM, 2006, J MOL BIOL, V358, P614, DOI 10.1016/j.jmb.2006.02.019; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Cheville AM, 1996, APPL ENVIRON MICROB, V62, P1822, DOI 10.1128/AEM.62.5.1822-1824.1996; COSMA CL, 1995, MOL MICROBIOL, V18, P491, DOI 10.1111/j.1365-2958.1995.mmi_18030491.x; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; DELANEY JM, 1992, J BACTERIOL, V174, P1240, DOI 10.1128/jb.174.4.1240-1247.1992; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fong SS, 2005, GENOME RES, V15, P1365, DOI 10.1101/gr.3832305; Foster JW, 1999, NOVART FDN SYMP, V221, P55; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; HOLM S, 1979, SCAND J STAT, V6, P65; Hooper SD, 2003, MOL BIOL EVOL, V20, P945, DOI 10.1093/molbev/msg101; Isalan M, 2005, PLOS BIOL, V3, P488, DOI 10.1371/journal.pbio.0030064; Isalan M, 2005, NAT METHODS, V2, P113, DOI 10.1038/NMETH732; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; LANGE R, 1994, MOL MICROBIOL, V13, P733, DOI 10.1111/j.1365-2958.1994.tb00466.x; Loewen PC, 1998, CAN J MICROBIOL, V44, P707, DOI 10.1139/cjm-44-8-707; Lozada-Chavez I, 2006, NUCLEIC ACIDS RES, V34, P3434, DOI 10.1093/nar/gkl423; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; MADAN BM, 2003, NUCLEIC ACIDS RES, V31, P1234, DOI DOI 10.1093/NAR/GKG210; Mangan MW, 2006, MOL MICROBIOL, V59, P1831, DOI 10.1111/j.1365-2958.2006.05062.x; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; Perez-Rueda E, 2000, NUCLEIC ACIDS RES, V28, P1838, DOI 10.1093/nar/28.8.1838; Poelwijk FJ, 2006, PLOS COMPUT BIOL, V2, P467, DOI 10.1371/journal.pcbi.0020058; Pratt LA, 1996, MOL MICROBIOL, V20, P911, DOI 10.1111/j.1365-2958.1996.tb02532.x; Prigent-Combaret C, 2001, J BACTERIOL, V183, P7213, DOI 10.1128/JB.183.24.7213-7223.2001; Pruss BM, 1996, J BACTERIOL, V178, P668; Romling U, 1998, J BACTERIOL, V180, P722; Salgado H, 2001, NUCLEIC ACIDS RES, V29, P72, DOI 10.1093/nar/29.1.72; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Slonczewski JL, 1999, NOVART FDN SYMP, V221, P75; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Teichmann SA, 1998, P NATL ACAD SCI USA, V95, P14658, DOI 10.1073/pnas.95.25.14658; Vidal O, 1998, J BACTERIOL, V180, P2442, DOI 10.1128/JB.180.9.2442-2449.1998; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895	45	225	234	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2008	452	7189					840	U2		10.1038/nature06847	http://dx.doi.org/10.1038/nature06847			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZY	18421347	Green Accepted			2022-12-24	WOS:000255026000041
J	Reyes-Lamothe, R; Possoz, C; Danilova, O; Sherratt, DJ				Reyes-Lamothe, Rodrigo; Possoz, Christophe; Danilova, Olessia; Sherratt, David J.			Independent positioning and action of Escherichia coli replisomes in live cells	CELL			English	Article							CHROMOSOME SEGREGATION; DNA-REPLICATION; FLUORESCENT PROTEIN; BACILLUS-SUBTILIS; TEMPORAL ORGANIZATION; FACTORY MODEL; LOCALIZATION; MOVEMENT; HALVES; ARMS	A prevalent view of DNA replication has been that it is carried out in fixed "replication factories.'' By tracking the progression of sister replication forks with respect to genetic loci in live Escherichia coli, we show that at initiation replisomes assemble at replication origins irrespective of where the origins are positioned within the cell. Sister replisomes separate and move to opposite cell halves shortly after initiation, migrating outwards as replication proceeds and both returning to midcell as replication termination approaches. DNA polymerase is maintained at stalled replication forks, and over short intervals of time replisomes are more dynamic than genetic loci. The data are inconsistent with models in which replisomes associated with sister forks act within a fixed replication factory. We conclude that independent replication forks follow the path of the compacted chromosomal DNA, with no structure other than DNA anchoring the replisome to any particular cellular region.	[Reyes-Lamothe, Rodrigo; Possoz, Christophe; Danilova, Olessia; Sherratt, David J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Sherratt, DJ (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	sherratt@bioch.ox.ac.uk			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adachi S, 2005, MOL GENET GENOMICS, V274, P264, DOI 10.1007/s00438-005-0023-6; Bates D, 2005, CELL, V121, P899, DOI 10.1016/j.cell.2005.04.013; Berkmen MB, 2006, MOL MICROBIOL, V62, P57, DOI 10.1111/j.1365-2958.2006.05356.x; Breier AM, 2005, P NATL ACAD SCI USA, V102, P3942, DOI 10.1073/pnas.0500812102; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Danilova O, 2007, MOL MICROBIOL, V65, P1485, DOI 10.1111/j.1365-2958.2007.05881.x; den Blaauwen T, 2006, MOL MICROBIOL, V62, P695, DOI 10.1111/j.1365-2958.2006.05417.x; Deng S, 2005, MOL MICROBIOL, V57, P1511, DOI 10.1111/j.1365-2958.2005.04796.x; DINGMAN CW, 1974, J THEOR BIOL, V43, P187, DOI 10.1016/S0022-5193(74)80052-4; Elmore S, 2005, J STRUCT BIOL, V151, P275, DOI 10.1016/j.jsb.2005.06.004; Fekete RA, 2005, MOL MICROBIOL, V55, P175, DOI 10.1111/j.1365-2958.2004.04392.x; Fiebig A, 2006, MOL MICROBIOL, V60, P1164, DOI 10.1111/j.1365-2958.2006.05175.x; Hearst JE, 1998, TRENDS GENET, V14, P244, DOI 10.1016/S0168-9525(98)01481-4; Hiraga S, 2000, GENES CELLS, V5, P327, DOI 10.1046/j.1365-2443.2000.00334.x; HOZAK P, 1993, CELL, V73, P361, DOI 10.1016/0092-8674(93)90235-I; JACOB F, 1963, COLD SPRING HARB SYM, V28, P329, DOI 10.1101/SQB.1963.028.01.048; Jensen RB, 2001, EMBO J, V20, P4952, DOI 10.1093/emboj/20.17.4952; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Kongsuwan K, 2002, FEMS MICROBIOL LETT, V216, P255, DOI 10.1111/j.1574-6968.2002.tb11444.x; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Lemon KP, 1998, SCIENCE, V282, P1516, DOI 10.1126/science.282.5393.1516; Lemon KP, 2000, MOL CELL, V6, P1321, DOI 10.1016/S1097-2765(00)00130-1; Maisnier-Patin S, 2001, MOL MICROBIOL, V42, P1371, DOI 10.1046/j.1365-2958.2001.02718.x; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Meile JC, 2006, PROTEOMICS, V6, P2135, DOI 10.1002/pmic.200500512; Migocki MD, 2004, MOL MICROBIOL, V54, P452, DOI 10.1111/j.1365-2958.2004.04267.x; Molina F, 2004, MOL MICROBIOL, V52, P1597, DOI 10.1111/j.1365-2958.2004.04097.x; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Nielsen HJ, 2006, MOL MICROBIOL, V62, P331, DOI 10.1111/j.1365-2958.2006.05346.x; Nielsen HJ, 2006, MOL MICROBIOL, V61, P383, DOI 10.1111/j.1365-2958.2006.05245.x; O'Donnell M, 2006, J BIOL CHEM, V281, P10653, DOI 10.1074/jbc.R500028200; Possoz C, 2006, EMBO J, V25, P2596, DOI 10.1038/sj.emboj.7601155; Postow L, 2004, GENE DEV, V18, P1766, DOI 10.1101/gad.1207504; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Sawitzke J, 2001, MOL MICROBIOL, V40, P786, DOI 10.1046/j.1365-2958.2001.02350.x; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sunako Y, 2001, MOL MICROBIOL, V42, P1233, DOI 10.1046/j.1365-2958.2001.02680.x; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Wang XD, 2005, GENE DEV, V19, P2367, DOI 10.1101/gad.345305; Wang XD, 2006, GENE DEV, V20, P1727, DOI 10.1101/gad.388406; Withers HL, 1998, J BACTERIOL, V180, P1624, DOI 10.1128/JB.180.7.1624-1631.1998; Woldringh CL, 2006, J STRUCT BIOL, V156, P273, DOI 10.1016/j.jsb.2006.04.013; Zimmerman SB, 2006, J STRUCT BIOL, V156, P255, DOI 10.1016/j.jsb.2006.03.022	43	199	199	3	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 4	2008	133	1					90	102		10.1016/j.cell.2008.01.044	http://dx.doi.org/10.1016/j.cell.2008.01.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	283MW	18394992	Green Published, hybrid			2022-12-24	WOS:000254641300011
J	Ley, RE; Hamady, M; Lozupone, C; Turnbaugh, PJ; Ramey, RR; Bircher, JS; Schlegel, ML; Tucker, TA; Schrenzel, MD; Knight, R; Gordon, JI				Ley, Ruth E.; Hamady, Micah; Lozupone, Catherine; Turnbaugh, Peter J.; Ramey, Rob Roy; Bircher, J. Stephen; Schlegel, Michael L.; Tucker, Tammy A.; Schrenzel, Mark D.; Knight, Rob; Gordon, Jeffrey I.			Evolution of mammals and their gut microbes	SCIENCE			English	Article							PHYLOGENETIC ANALYSIS; MOLECULAR ANALYSIS; FECAL MICROBIOTA; DIVERSITY; ECOLOGY; SEQUENCES; UNIFRAC; OBESITY; FLORA	Mammals are metagenomic in that they are composed of not only their own gene complements but also those of all of their associated microbes. To understand the coevolution of the mammals and their indigenous microbial communities, we conducted a network- based analysis of bacterial 16S ribosomal RNA gene sequences from the fecal microbiota of humans and 59 other mammalian species living in two zoos and in the wild. The results indicate that host diet and phylogeny both influence bacterial diversity, which increases from carnivory to omnivory to herbivory; that bacterial communities codiversified with their hosts; and that the gut microbiota of humans living a modern life- style is typical of omnivorous primates.	[Ley, Ruth E.; Lozupone, Catherine; Turnbaugh, Peter J.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci, St Louis, MO 63108 USA; [Hamady, Micah] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Lozupone, Catherine; Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Ramey, Rob Roy] Wildlife Sci Int Inc, Nederland, CO 80466 USA; [Bircher, J. Stephen] St Louis Zoo, St Louis, MO 63110 USA; [Schlegel, Michael L.; Tucker, Tammy A.; Schrenzel, Mark D.] Zool Soc San Diego, San Diego, CA 92112 USA	Washington University (WUSTL); University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Zoological Society of San Diego	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci, St Louis, MO 63108 USA.	jgordon@wustl.edu	Vazquez-Dominguez, Guillermo GVD/L-7818-2014; Knight, Rob/D-1299-2010; Ley, Ruth E/M-8542-2014; Lozupone, Catherine/AAD-9317-2020	Ley, Ruth E/0000-0002-9087-1672; Turnbaugh, Peter/0000-0002-0888-2875; Knight, Rob/0000-0002-0975-9019	NIDDK NIH HHS [R01 DK070977, DK70977, R01 DK070977-04, DK78669, R01 DK030292-24, DK30292, P01 DK078669, R01 DK030292, P01 DK078669-02] Funding Source: Medline; NIGMS NIH HHS [T32 GM142607, T32 GM008759, T32 GM065103, T32GM065103, T32 GM065103-07] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030292, P01DK078669, R01DK030292, R01DK070977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759, T32GM065103] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnason U, 2002, P NATL ACAD SCI USA, V99, P8151, DOI 10.1073/pnas.102164299; Brooks SPJ, 2003, CAN J MICROBIOL, V49, P589, DOI 10.1139/W03-075; Cerling TE, 1998, PHILOS T R SOC B, V353, P159, DOI 10.1098/rstb.1998.0198; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Frey JC, 2006, APPL ENVIRON MICROB, V72, P3788, DOI 10.1128/AEM.72.5.3788-3792.2006; Hayashi H, 2003, MICROBIOL IMMUNOL, V47, P557, DOI 10.1111/j.1348-0421.2003.tb03418.x; Hayashi H, 2002, MICROBIOL IMMUNOL, V46, P819, DOI 10.1111/j.1348-0421.2002.tb02769.x; Hayashi H, 2002, MICROBIOL IMMUNOL, V46, P535, DOI 10.1111/j.1348-0421.2002.tb02731.x; Huang Y, 2001, SCIENCE, V293, P1647, DOI 10.1126/science.1060143; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Koch P.L., 1994, STABLE ISOTOPES ECOL; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lister AM, 2004, PHILOS T R SOC B, V359, P221, DOI 10.1098/rstb.2003.1436; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; MacFadden BJ, 2005, TRENDS ECOL EVOL, V20, P355, DOI 10.1016/j.tree.2005.05.003; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019; Ozutsumi Y, 2005, BIOSCI BIOTECH BIOCH, V69, P1793, DOI 10.1271/bbb.69.1793; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Russell JB, 2001, SCIENCE, V292, P1119, DOI 10.1126/science.1058830; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stevens C. E., 2004, COMP PHYSL VERTEBRAT; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	30	2293	2431	38	1110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2008	320	5883					1647	1651		10.1126/science.1155725	http://dx.doi.org/10.1126/science.1155725			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18497261	Green Accepted			2022-12-24	WOS:000256886700051
J	Rajagopal, A; Rao, AU; Amigo, J; Tian, M; Upadhyay, SK; Hall, C; Uhm, S; Mathew, MK; Fleming, MD; Paw, BH; Krause, M; Hamza, I				Rajagopal, Abbhirami; Rao, Anita U.; Amigo, Julio; Tian, Meng; Upadhyay, Sanjeev K.; Hall, Caitlin; Uhm, Suji; Mathew, M. K.; Fleming, Mark D.; Paw, Barry H.; Krause, Michael; Hamza, Iqbal			Haem homeostasis is regulated by the conserved and concerted functions of HRG-1 proteins	NATURE			English	Article							TRANSPORTER; ZEBRAFISH; BIOSYNTHESIS; DISORDERS; SENSOR	Haems are metalloporphyrins that serve as prosthetic groups for various biological processes including respiration, gas sensing, xenobiotic detoxification, cell differentiation, circadian clock control, metabolic reprogramming and microRNA processing(1-4). With a few exceptions, haem is synthesized by a multistep biosynthetic pathway comprising defined intermediates that are highly conserved throughout evolution(5). Despite our extensive knowledge of haem biosynthesis and degradation, the cellular pathways and molecules that mediate intracellular haem trafficking are unknown. The experimental setback in identifying haem trafficking pathways has been the inability to dissociate the highly regulated cellular synthesis and degradation of haem from intracellular trafficking events(6). Caenorhabditis elegans and related helminths are natural haem auxotrophs that acquire environmental haem for incorporation into haemoproteins, which have vertebrate orthologues(7). Here we show, by exploiting this auxotrophy to identify HRG-1 proteins in C. elegans, that these proteins are essential for haem homeostasis and normal development in worms and vertebrates. Depletion of hrg-1, or its paralogue hrg-4, in worms results in the disruption of organismal haem sensing and an abnormal response to haem analogues. HRG-1 and HRG-4 are previously unknown transmembrane proteins, which reside in distinct intracellular compartments. Transient knockdown of hrg-1 in zebrafish leads to hydrocephalus, yolk tube malformations and, most strikingly, profound defects in erythropoiesis-phenotypes that are fully rescued by worm HRG-1. Human and worm proteins localize together, and bind and transport haem, thus establishing an evolutionarily conserved function for HRG-1. These findings reveal conserved pathways for cellular haem trafficking in animals that define the model for eukaryotic haem transport. Thus, uncovering the mechanisms of haem transport in C. elegans may provide insights into human disorders of haem metabolism and reveal new drug targets for developing anthelminthics to combat worm infestations.	[Rajagopal, Abbhirami; Rao, Anita U.; Uhm, Suji; Hamza, Iqbal] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Rajagopal, Abbhirami; Rao, Anita U.; Hall, Caitlin; Uhm, Suji; Hamza, Iqbal] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Amigo, Julio; Paw, Barry H.] Harvard Univ, Sch Med, Div Hematol, Dept Med,Brigham & Womens Hosp, Boston, MA 02115 USA; [Tian, Meng; Fleming, Mark D.] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Upadhyay, Sanjeev K.; Mathew, M. K.] Univ Agr Sci Bangalore, Natl Ctr Biol Sci, Tata Inst Fundamental Res, Bangalore 560065, Karnataka, India; [Krause, Michael] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Agricultural Sciences Bangalore; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hamza, I (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.	hamza@umd.edu		amigo, julio/0000-0002-6481-8034; Krause, Michael/0000-0001-6127-3940; Fleming, Mark/0000-0003-0948-4024; Paw, Barry/0000-0002-0492-1419; Hamza, Iqbal/0000-0003-0045-0610	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036134, R01DK074797] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; NIDDK NIH HHS [R01 DK074797-01, R01 DK074797] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Dailey HA, 2002, BIOCHEM SOC T, V30, P590, DOI 10.1042/bst0300590; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Goldman BS, 1998, P NATL ACAD SCI USA, V95, P5003, DOI 10.1073/pnas.95.9.5003; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hamza I, 2006, ACS CHEM BIOL, V1, P627, DOI 10.1021/cb600442b; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Lin HF, 2005, BLOOD, V106, P3803, DOI 10.1182/blood-2005-01-0179; Mao XQ, 2007, J BIOL CHEM, V282, P6992, DOI 10.1074/jbc.M610552200; McGhee JD, 2007, DEV BIOL, V302, P627, DOI 10.1016/j.ydbio.2006.10.024; MEDLOCK AE, 2007, TETRAPYRROLES, P116; NASS R, 2007, CURRENT PROTOCOLS TO; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Rees EM, 2004, CURR OPIN MICROBIOL, V7, P175, DOI 10.1016/j.mib.2004.02.004; Schmidt PM, 2005, EUR J PHARMACOL, V513, P67, DOI 10.1016/j.ejphar.2005.02.046; Shafizadeh E, 2004, CURR OPIN HEMATOL, V11, P255, DOI 10.1097/01.moh.0000138686.15806.71; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179	23	223	238	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2008	453	7198					1127	1131		10.1038/nature06934	http://dx.doi.org/10.1038/nature06934			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18418376	Green Accepted			2022-12-24	WOS:000256839900062
J	Guo, Y; Walther, TC; Rao, M; Stuurman, N; Goshima, G; Terayama, K; Wong, JS; Vale, RD; Walter, P; Farese, RV				Guo, Yi; Walther, Tobias C.; Rao, Meghana; Stuurman, Nico; Goshima, Gohta; Terayama, Koji; Wong, Jinny S.; Vale, Ronald D.; Walter, Peter; Farese, Robert V., Jr.			Functional genomic screen reveals genes involved in lipid-droplet formation and utilization	NATURE			English	Article							DROSOPHILA; PROTEINS; ROLES; PHOSPHORYLATION; ENDOCYTOSIS; PERILIPIN; RECEPTOR; RNA	Eukaryotic cells store neutral lipids in cytoplasmic lipid droplets(1,2) enclosed in a monolayer of phospholipids and associated proteins(3,4). These dynamic organelles(5) serve as the principal reservoirs for storing cellular energy and for the building blocks for membrane lipids. Excessive lipid accumulation in cells is a central feature of obesity, diabetes and atherosclerosis, yet remarkably little is known about lipid- droplet cell biology. Here we show, by means of a genome- wide RNA interference ( RNAi) screen in Drosophila S2 cells that about 1.5% of all genes function in lipid- droplet formation and regulation. The phenotypes of the gene knockdowns sorted into five distinct phenotypic classes. Genes encoding enzymes of phospholipid biosynthesis proved to be determinants of lipid- droplet size and number, suggesting that the phospholipid composition of the monolayer profoundly affects droplet morphology and lipid utilization. A subset of the Arf1 - COPI vesicular transport proteins also regulated droplet morphology and lipid utilization, thereby identifying a previously unrecognized function for this machinery. These phenotypes are conserved in mammalian cells, suggesting that insights from these studies are likely to be central to our understanding of human diseases involving excessive lipid storage.	[Guo, Yi; Walther, Tobias C.; Walter, Peter; Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Stuurman, Nico; Goshima, Gohta; Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Guo, Yi; Rao, Meghana; Terayama, Koji; Wong, Jinny S.; Farese, Robert V., Jr.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Walther, Tobias C.] Max Planck Inst Biochem, D-12852 Martinsried, Germany; [Vale, Ronald D.; Walter, Peter] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; Max Planck Society; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Farese, RV (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	twalther@biochem.mpg.de; bfarese@gladstone.ucsf.edu	Stuurman, Nico/AAV-4894-2021; Lai, Michael M. C./I-7001-2012	Stuurman, Nico/0000-0002-6179-8613; Terayama, Koji/0000-0002-0740-9074; Walther, Tobias/0000-0003-1442-1327	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK078254] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [R21 DK078254-01, R21 DK078254] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Brown DA, 2001, CURR BIOL, V11, pR446, DOI 10.1016/S0960-9822(01)00257-3; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Hafez IM, 2001, ADV DRUG DELIVER REV, V47, P139, DOI 10.1016/S0169-409X(01)00103-X; Hojjati MR, 2006, J LIPID RES, V47, P673, DOI 10.1194/jlr.D500040-JLR200; Kent C, 2005, BBA-MOL CELL BIOL L, V1733, P53, DOI 10.1016/j.bbalip.2004.12.008; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Miura S, 2002, J BIOL CHEM, V277, P32253, DOI 10.1074/jbc.M204410200; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Morrison DK, 2000, J CELL BIOL, V150, pF57, DOI 10.1083/jcb.150.2.F57; Nakamura N, 2005, BIOCHEM BIOPH RES CO, V335, P117, DOI 10.1016/j.bbrc.2005.07.050; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199; Ulvila J, 2006, J BIOL CHEM, V281, P14370, DOI 10.1074/jbc.M513868200; Verghese PB, 2007, MOL CELL BIOCHEM, V302, P241, DOI 10.1007/s11010-007-9447-0; Weber U, 2003, DEV CELL, V5, P559, DOI 10.1016/S1534-5807(03)00273-9	30	532	541	5	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2008	453	7195					657	661		10.1038/nature06928	http://dx.doi.org/10.1038/nature06928			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305NN	18408709	Green Accepted			2022-12-24	WOS:000256185200045
J	Keren, K; Pincus, Z; Allen, GM; Barnhart, EL; Marriott, G; Mogilner, A; Theriot, JA				Keren, Kinneret; Pincus, Zachary; Allen, Greg M.; Barnhart, Erin L.; Marriott, Gerard; Mogilner, Alex; Theriot, Julie A.			Mechanism of shape determination in motile cells	NATURE			English	Article							FISH KERATOCYTES; RETROGRADE FLOW; LEADING-EDGE; ACTIN; DYNAMICS; LAMELLIPODIA; CYTOSKELETON; LOCOMOTION; FRAGMENTS; MIGRATION	The shape of motile cells is determined by many dynamic processes spanning several orders of magnitude in space and time, from local polymerization of actin monomers at subsecond timescales to global, cell-scale geometry that may persist for hours. Understanding the mechanism of shape determination in cells has proved to be extremely challenging due to the numerous components involved and the complexity of their interactions. Here we harness the natural phenotypic variability in a large population of motile epithelial keratocytes from fish (Hypsophrys nicaraguensis) to reveal mechanisms of shape determination. We find that the cells inhabit a low-dimensional, highly correlated spectrum of possible functional states. We further show that a model of actin network treadmilling in an inextensible membrane bag can quantitatively recapitulate this spectrum and predict both cell shape and speed. Our model provides a simple biochemical and biophysical basis for the observed morphology and behaviour of motile cells.	[Keren, Kinneret; Pincus, Zachary; Allen, Greg M.; Barnhart, Erin L.; Theriot, Julie A.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Theriot, Julie A.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Keren, Kinneret] Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; [Pincus, Zachary] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Marriott, Gerard] Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA; [Mogilner, Alex] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Mogilner, Alex] Univ Calif Davis, Dept Math, Davis, CA 95616 USA	Stanford University; Stanford University; Technion Israel Institute of Technology; Yale University; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis; University of California System; University of California Davis	Theriot, JA (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.	theriot@stanford.edu	Mogilner, Alex/A-3135-2008; Theriot, Julie/HHN-2034-2022	Pincus, Zachary/0000-0001-9785-5977; Theriot, Julie/0000-0002-2334-2535; Keren, Kinneret/0000-0002-2962-6977; Marriott, Gerard/0000-0003-3197-4839	NIGMS NIH HHS [U54 GM064346, U54 GM064346-099040, U54 GM64346] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson KI, 2000, CURR BIOL, V10, P253, DOI 10.1016/S0960-9822(00)00357-2; Bakal C, 2007, SCIENCE, V316, P1753, DOI 10.1126/science.1140324; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; COOTES TF, 1995, COMPUT VIS IMAGE UND, V61, P38, DOI 10.1006/cviu.1995.1004; EUTENEUER U, 1984, NATURE, V310, P58, DOI 10.1038/310058a0; Footer MJ, 2007, P NATL ACAD SCI USA, V104, P2181, DOI 10.1073/pnas.0607052104; GANDER W, 1994, BIT, V34, P558, DOI 10.1007/BF01934268; Goodrich HB, 1924, BIOL BULL-US, V46, P252, DOI 10.2307/1536726; Grimm HP, 2003, EUR BIOPHYS J BIOPHY, V32, P563, DOI 10.1007/s00249-003-0300-4; Jurado C, 2005, MOL BIOL CELL, V16, P507, DOI 10.1091/mbc.E04-10-0860; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Kozlov MM, 2007, BIOPHYS J, V93, P3811, DOI 10.1529/biophysj.107.110411; KUCIK DF, 1990, J CELL BIOL, V111, P1617, DOI 10.1083/jcb.111.4.1617; Lacayo CI, 2007, PLOS BIOL, V5, P2035, DOI 10.1371/journal.pbio.0050233; LEE J, 1993, NATURE, V362, P167, DOI 10.1038/362167a0; Lee J, 1997, J CELL SCI, V110, P2833; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Parekh SH, 2005, NAT CELL BIOL, V7, P1219, DOI 10.1038/ncb1336; Petchprayoon C, 2005, BIOCONJUGATE CHEM, V16, P1382, DOI 10.1021/bc050006j; Pincus Z, 2007, J MICROSC-OXFORD, V227, P140, DOI 10.1111/j.1365-2818.2007.01799.x; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Prass M, 2006, J CELL BIOL, V174, P767, DOI 10.1083/jcb.200601159; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SANGER JW, 1980, J EXP ZOOL, V213, P227, DOI 10.1002/jez.1402130210; SCHAUS TE, IN PRESS BIOPHYS J; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Tanaka J, 2003, P NATL ACAD SCI USA, V100, P13851, DOI 10.1073/pnas.2233339100; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Vallotton P, 2005, MOL BIOL CELL, V16, P1223, DOI 10.1091/mbc.E04-07-0615; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Wilson CA, 2006, IEEE T IMAGE PROCESS, V15, P1939, DOI 10.1109/TIP.2006.873434; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416	36	511	516	2	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 22	2008	453	7194					475	U1		10.1038/nature06952	http://dx.doi.org/10.1038/nature06952			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303EL	18497816	Green Accepted, Bronze			2022-12-24	WOS:000256023700033
J	Ciferri, C; Pasqualato, S; Screpanti, E; Varetti, G; Santaguida, S; Dos Reis, G; Maiolica, A; Polka, J; De Luca, JG; De Wulf, P; Salek, M; Rappsilber, J; Moores, CA; Salmon, ED; Musacchio, A				Ciferri, Claudio; Pasqualato, Sebastiano; Screpanti, Emanuela; Varetti, Gianluca; Santaguida, Stefano; Dos Reis, Gabriel; Maiolica, Alessio; Polka, Jessica; De Luca, Jennifer G.; De Wulf, Peter; Salek, Mogjiborahman; Rappsilber, Juri; Moores, Carolyn A.; Salmon, Edward D.; Musacchio, Andrea			Implications for kinetochore-microtubule attachment from the structure of an engineered Ndc80 complex	CELL			English	Article							MOLECULAR ARCHITECTURE; CENTROMERIC NUCLEOSOME; OUTER PLATE; CENP-A; CHECKPOINT; COMPONENTS; NETWORK; PROTEIN; SPACE	Kinetochores are proteinaceous assemblies that mediate the interaction of chromosomes with the mitotic spindle. The 180 kDa Ndc80 complex is a direct point of contact between kinetochores and microtubules. Its four subunits contain coiled coils and form an elongated rod structure with functional globular domains at either end. We crystallized an engineered "bonsai'' Ndc80 complex containing a shortened rod domain but retaining the globular domains required for kinetochore localization and microtubule binding. The structure reveals a microtubule-binding interface containing a pair of tightly interacting calponin-homology (CH) domains with a previously unknown arrangement. The interaction with microtubules is cooperative and predominantly electrostatic. It involves positive charges in the CH domains and in the N-terminal tail of the Ndc80 subunit and negative charges in tubulin C-terminal tails and is regulated by the Aurora B kinase. We discuss our results with reference to current models of kinetochore-microtubule attachment and centromere organization.	[Ciferri, Claudio; Pasqualato, Sebastiano; Screpanti, Emanuela; Varetti, Gianluca; Santaguida, Stefano; Dos Reis, Gabriel; Maiolica, Alessio; De Wulf, Peter; Musacchio, Andrea] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; [Polka, Jessica; Salmon, Edward D.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [De Luca, Jennifer G.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Salek, Mogjiborahman] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Rappsilber, Juri] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Moores, Carolyn A.] Univ London Birkbeck Coll, Sch Crystallog, London WC1E 7HX, England; [Musacchio, Andrea] Italian Inst Technol Fdn, Res Unit, I-20139 Milan, Italy	IRCCS European Institute of Oncology (IEO); University of North Carolina; University of North Carolina Chapel Hill; Colorado State University; University of Oxford; University of Edinburgh; University of London; Birkbeck University London; Istituto Italiano di Tecnologia - IIT	Musacchio, A (corresponding author), European Inst Oncol, Dept Expt Oncol, Via Adamello 16, I-20139 Milan, Italy.	andrea.musacchio@ifom-ieo-campus.it	Rappsilber, Juri/ABF-3328-2020; Santaguida, Stefano/ABH-5433-2020; Pasqualato, Sebastiano/G-1032-2011; Rappsilber, Juri/B-7265-2015; santaguida, stefano/G-2716-2010; Moores, Carolyn/A-4942-2010; Moores, Carolyn A/R-2497-2019	Santaguida, Stefano/0000-0002-1501-6190; Rappsilber, Juri/0000-0001-5999-1310; Moores, Carolyn A/0000-0001-5686-6290; Salek, Mogjiborahman/0000-0002-6664-4752; Polka, Jessica/0000-0001-6610-9293; Pasqualato, Sebastiano/0000-0002-9038-7768; De Wulf, Peter/0000-0001-9772-5881; Musacchio, Andrea/0000-0003-2362-8784	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; NCI NIH HHS [K01 CA125051] Funding Source: Medline; NIGMS NIH HHS [R37 GM024364] Funding Source: Medline; Telethon [GGP06044] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K01CA125051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024364] Funding Source: NIH RePORTER	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Telethon(Fondazione Telethon); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bharadwaj R, 2004, J BIOL CHEM, V279, P13076, DOI 10.1074/jbc.M310224200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cassimeris L, 2001, INT REV CYTOL, V210, P163; CASTRESANA J, 1995, FEBS LETT, V374, P149, DOI 10.1016/0014-5793(95)01098-Y; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Ciferri C, 2007, FEBS LETT, V581, P2862, DOI 10.1016/j.febslet.2007.05.012; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Cowtan K, 2000, ACTA CRYSTALLOGR D, V56, P1612, DOI 10.1107/S0907444900013263; COWTAN K, 2006, J CELL BIOL, V111, P1069; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Dong YM, 2007, NAT CELL BIOL, V9, P516, DOI 10.1038/ncb1576; Dougherty GW, 2005, CELL MOTIL CYTOSKEL, V62, P141, DOI 10.1002/cm.20093; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Furuyama S, 2007, P NATL ACAD SCI USA, V104, P14706, DOI 10.1073/pnas.0706985104; Gillett ES, 2004, J CELL BIOL, V164, P535, DOI 10.1083/jcb.200308100; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; Hori T, 2003, J CELL SCI, V116, P3347, DOI 10.1242/jcs.00645; Joglekar AP, 2006, NAT CELL BIOL, V8, P581, DOI 10.1038/ncb1414; Kline-Smith SL, 2005, CURR OPIN CELL BIOL, V17, P35, DOI 10.1016/j.ceb.2004.12.009; Korenbaum E, 2002, J CELL SCI, V115, P3543, DOI 10.1242/jcs.00003; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Maiolica A, 2007, MOL CELL PROTEOMICS, V6, P2200, DOI 10.1074/mcp.M700274-MCP200; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025; Serber Z, 2007, CELL, V128, P441, DOI 10.1016/j.cell.2007.01.018; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Tanaka TU, 2005, NAT REV MOL CELL BIO, V6, P929, DOI 10.1038/nrm1764; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Waterman-Storer CM, 1998, BIOPHYS J, V75, P2059, DOI 10.1016/S0006-3495(98)77648-9; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Wei RR, 2006, STRUCTURE, V14, P1003, DOI 10.1016/j.str.2006.04.007; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102	53	383	388	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2008	133	3					427	439		10.1016/j.cell.2008.03.020	http://dx.doi.org/10.1016/j.cell.2008.03.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455984	Green Submitted, Bronze, Green Accepted			2022-12-24	WOS:000255503900014
J	Wang, PYT; Caspi, L; Lam, CKL; Chari, M; Li, XS; Light, PE; Gutierrez-Juarez, R; Ang, M; Schwartz, GJ; Lam, TKT				Wang, Penny Y. T.; Caspi, Liora; Lam, Carol K. L.; Chari, Madhu; Li, Xiaosong; Light, Peter E.; Gutierrez-Juarez, Roger; Ang, Michelle; Schwartz, Gary J.; Lam, Tony K. T.			Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production	NATURE			English	Article							D-ASPARTATE RECEPTORS; FOOD-INTAKE; OBESITY; ENERGY; MECHANISMS; HOMEOSTASIS; NUCLEUS; BALANCE; SIGNALS; WEIGHT	Energy and glucose homeostasis are regulated by food intake and liver glucose production, respectively. The upper intestine has a critical role in nutrient digestion and absorption. However, studies indicate that upper intestinal lipids inhibit food intake as well in rodents and humans by the activation of an intestine - brain axis(1-4). In parallel, a brain - liver axis has recently been proposed to detect blood lipids to inhibit glucose production in rodents(5). Thus, we tested the hypothesis that upper intestinal lipids activate an intestine - brain - liver neural axis to regulate glucose homeostasis. Here we demonstrate that direct administration of lipids into the upper intestine increased upper intestinal long- chain fatty acyl-coenzyme A ( LCFA- CoA) levels and suppressed glucose production. Co- infusion of the acyl- CoA synthase inhibitor triacsin C or the anaesthetic tetracaine with duodenal lipids abolished the inhibition of glucose production, indicating that upper intestinal LCFA- CoAs regulate glucose production in the preabsorptive state. Subdiaphragmatic vagotomy or gut vagal deafferentation interrupts the neural connection between the gut and the brain, and blocks the ability of upper intestinal lipids to inhibit glucose production. Direct administration of the N- methyl- D- aspartate ion channel blocker MK- 801 into the fourth ventricle or the nucleus of the solitary tract where gut sensory fibres terminate abolished the upper- intestinal- lipid- induced inhibition of glucose production. Finally, hepatic vagotomy negated the inhibitory effects of upper intestinal lipids on glucose production. These findings indicate that upper intestinal lipids activate an intestine - brain - liver neural axis to inhibit glucose production, and thereby reveal a previously unappreciated pathway that regulates glucose homeostasis.	[Wang, Penny Y. T.; Caspi, Liora; Lam, Carol K. L.; Chari, Madhu; Ang, Michelle; Lam, Tony K. T.] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Toronto, ON M5G 1L7, Canada; [Lam, Carol K. L.; Chari, Madhu; Lam, Tony K. T.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Lam, Tony K. T.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Li, Xiaosong; Gutierrez-Juarez, Roger; Schwartz, Gary J.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Li, Xiaosong; Gutierrez-Juarez, Roger; Schwartz, Gary J.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Light, Peter E.] Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2H7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Alberta	Lam, TKT (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Res Inst, Toronto, ON M5G 1L7, Canada.	tony.lam@uhnres.utoronto.ca		Lam, Carol/0000-0002-9736-3347	NIDDK NIH HHS [DK47208, DK45024] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047208, R01DK045024, R29DK045024] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aicher SA, 1999, NEUROSCIENCE, V91, P119, DOI 10.1016/S0306-4522(98)00530-2; Badman MK, 2005, SCIENCE, V307, P1909, DOI 10.1126/science.1109951; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Berthoud HR, 2001, BRAIN RES, V915, P143, DOI 10.1016/S0006-8993(01)02826-8; Caspi L, 2007, CELL METAB, V6, P99, DOI 10.1016/j.cmet.2007.07.005; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Covasa M, 2004, AM J PHYSIOL-REG I, V287, pR1462, DOI 10.1152/ajpregu.00471.2004; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Cummings David E., 2004, Journal of Clinical Endocrinology & Metabolism, V89, P2608, DOI 10.1210/jc.2004-0433; GREENBERG D, 1995, AM J PHYSIOL-REG I, V269, pR432, DOI 10.1152/ajpregu.1995.269.2.R432; GREENBERG D, 1990, AM J PHYSIOL, V259, pR110, DOI 10.1152/ajpregu.1990.259.1.R110; Lam TKT, 2005, SCIENCE, V309, P943, DOI 10.1126/science.1112085; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Lam TKT, 2007, NAT MED, V13, P171, DOI 10.1038/nm1540; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Matzinger D, 2000, GUT, V46, P688, DOI 10.1136/gut.46.5.689; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Monnikes H, 1997, AM J PHYSIOL-REG I, V273, pR2059, DOI 10.1152/ajpregu.1997.273.6.R2059; MORAN TP, 1994, HUM-COMPUT INTERACT, V9, P1, DOI 10.1207/s15327051hci0901_1; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Pocai A, 2006, J CLIN INVEST, V116, P1081, DOI 10.1172/JCI26640; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Sclafani A, 2003, PHYSIOL BEHAV, V78, P285, DOI 10.1016/S0031-9384(02)00968-X; Treece BR, 1998, BRAIN RES, V810, P34, DOI 10.1016/S0006-8993(98)00867-1; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414	30	211	221	5	62	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 24	2008	452	7190					1012	1016		10.1038/nature06852	http://dx.doi.org/10.1038/nature06852			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291PF	18401341				2022-12-24	WOS:000255208600043
J	Kutik, S; Stojanovski, D; Becker, L; Becker, T; Meinecke, M; Kruger, V; Prinz, C; Meisinger, C; Guiard, B; Wagner, R; Pfanner, N; Wiedemann, N				Kutik, Stephan; Stojanovski, Diana; Becker, Lars; Becker, Thomas; Meinecke, Michael; Krueger, Vivien; Prinz, Claudia; Meisinger, Chris; Guiard, Bernard; Wagner, Richard; Pfanner, Nikolaus; Wiedemann, Nils			Dissecting membrane insertion of mitochondrial beta-barrel proteins	CELL			English	Article							OUTER-MEMBRANE; ESSENTIAL COMPONENT; ASSEMBLY MACHINERY; TOM COMPLEX; IMPORT; BIOGENESIS; TRANSLOCASE; DOMAIN; MUTATIONS; CHANNEL	Communication of mitochondria with the rest of the cell requires beta-barrel proteins of the outer membrane. All beta-barrel proteins are synthesized as precursors in the cytosol and imported into mitochondria by the general translocase TOM and the sorting machinery SAM. The SAM complex contains two proteins essential for cell viability, the channel-forming Sam50 and Sam35. We have identified the sorting signal of mitochondrial beta-barrel proteins that is universal in all eukaryotic kingdoms. The beta-signal initiates precursor insertion into a hydrophilic, proteinaceous membrane environment by forming a ternary complex with Sam35 and Sam50. Sam35 recognizes the beta-signal, inducing a major conductance increase of the Sam50 channel. Subsequent precursor release from SAM is coupled to integration into the lipid phase. We propose that a two-stage mechanism of signal-driven insertion into a membrane protein complex and subsequent integration into the lipid phase may represent a general mechanism for biogenesis of beta-barrel proteins.	[Kutik, Stephan; Stojanovski, Diana; Becker, Thomas; Krueger, Vivien; Prinz, Claudia; Meisinger, Chris; Pfanner, Nikolaus; Wiedemann, Nils] Univ Freiburg, Inst Biochem & Mol Biol, Zentrum Biochem & Mol Zellforsch, D-79014 Freiburg, Germany; [Kutik, Stephan] Univ Freiburg, Fak Biol, D-79014 Freiburg, Germany; [Becker, Lars; Meinecke, Michael; Krueger, Vivien; Wagner, Richard] Univ Osnabruck, FB Biol Chem, D-49034 Osnabruck, Germany; [Guiard, Bernard] CNRS, Ctr Genet Mol, F-91190 Gif Sur Yvette, France	University of Freiburg; University of Freiburg; University Osnabruck; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Pfanner, N (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, Zentrum Biochem & Mol Zellforsch, D-79014 Freiburg, Germany.	nikolaus.pfanner@biochemie.uni-freiburg.de	Pfanner, Nikolaus/AAV-7878-2021; Meinecke, Michael/C-4833-2013; Becker, Thomas/AAS-9404-2020; Meisinger, Chris/J-1110-2014	Meinecke, Michael/0000-0003-1414-6951; Meisinger, Chris/0000-0002-8326-3548; Wiedemann, Nils/0000-0001-8305-6728; Stojanovski, Diana/0000-0002-0199-3222				Becker L, 2005, J MOL BIOL, V353, P1011, DOI 10.1016/j.jmb.2005.09.019; Bos MP, 2007, EMBO REP, V8, P1149, DOI 10.1038/sj.embor.7401092; Chan NC, 2008, MOL BIOL CELL, V19, P126, DOI 10.1091/mbc.E07-08-0796; Court DA, 1996, FEBS LETT, V390, P73, DOI 10.1016/0014-5793(96)00629-1; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Habib SJ, 2007, J CELL BIOL, V176, P77, DOI 10.1083/jcb.200602050; Habib SJ, 2005, J BIOL CHEM, V280, P6434, DOI 10.1074/jbc.M411510200; Hoppins SC, 2004, J BIOL CHEM, V279, P12396, DOI 10.1074/jbc.M313037200; Humphries AD, 2005, J BIOL CHEM, V280, P11535, DOI 10.1074/jbc.M413816200; Ishikawa D, 2004, J CELL BIOL, V166, P621, DOI 10.1083/jcb.200405138; Johnson AE, 2004, NAT STRUCT MOL BIOL, V11, P113, DOI 10.1038/nsmb0204-113; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Kovermann P, 2002, MOL CELL, V9, P363, DOI 10.1016/S1097-2765(02)00446-X; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Milenkovic D, 2004, J BIOL CHEM, V279, P22781, DOI 10.1074/jbc.C400120200; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Rapaport D, 1999, J CELL BIOL, V146, P321, DOI 10.1083/jcb.146.2.321; Rapaport D, 2001, MOL BIOL CELL, V12, P1189, DOI 10.1091/mbc.12.5.1189; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Ryan MT, 2004, CURR BIOL, V14, pR207, DOI 10.1016/j.cub.2004.02.024; Sanchez-Pulido L, 2003, TRENDS BIOCHEM SCI, V28, P523, DOI 10.1016/j.tibs.2003.08.003; Schleiff E, 2005, EMBO REP, V6, P1023, DOI 10.1038/sj.embor.7400563; Sherman EL, 2006, J BIOL CHEM, V281, P22554, DOI 10.1074/jbc.M601630200; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Taylor RD, 2003, J BIOL CHEM, V278, P765, DOI 10.1074/jbc.M208083200; Tommassen J, 2007, SCIENCE, V317, P903, DOI 10.1126/science.1146518; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; Waizenegger T, 2004, EMBO REP, V5, P704, DOI 10.1038/sj.embor.7400183; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753	33	229	254	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 21	2008	132	6					1011	1024		10.1016/j.cell.2008.01.028	http://dx.doi.org/10.1016/j.cell.2008.01.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	278GR	18358813	Bronze			2022-12-24	WOS:000254273600019
J	Sandoval, H; Thiagarajan, P; Dasgupta, SK; Schumacher, A; Prchal, JT; Chen, M; Wang, J				Sandoval, Hector; Thiagarajan, Perumal; Dasgupta, Swapan K.; Schumacher, Armin; Prchal, Josef T.; Chen, Min; Wang, Jin			Essential role for Nix in autophagic maturation of erythroid cells	NATURE			English	Article							IN-VITRO; MICE; APOPTOSIS; SURVIVAL; RETICULOCYTES; ERYTHROBLASTS; MITOCHONDRIA; PHOSPHATIDYLSERINE; ERYTHROPOIESIS; INHIBITOR	Erythroid cells undergo enucleation and the removal of organelles during terminal differentiation(1-3). Although autophagy has been suggested to mediate the elimination of organelles for erythroid maturation(2-6), the molecular mechanisms underlying this process remain undefined. Here we report a role for a Bcl- 2 family member, Nix ( also called Bnip3L)(7-9), in the regulation of erythroid maturation through mitochondrial autophagy. Nix(-/-) mice developed anaemia with reduced mature erythrocytes and compensatory expansion of erythroid precursors. Erythrocytes in the peripheral blood of Nix(-/-) mice exhibited mitochondrial retention and reduced lifespan in vivo. Although the clearance of ribosomes proceeded normally in the absence of Nix, the entry of mitochondria into autophagosomes for clearance was defective. Deficiency in Nix inhibited the loss of mitochondrial membrane potential (Delta Psi(m)), and treatment with uncoupling chemicals or a BH3 mimetic induced the loss of Delta Psi(m) and restored the sequestration of mitochondria into autophagosomes in Nix(-/-) erythroid cells. These results suggest that Nix- dependent loss of Delta Psi(m) is important for targeting the mitochondria into autophagosomes for clearance during erythroid maturation, and interference with this function impairs erythroid maturation and results in anaemia. Our study may also provide insights into molecular mechanisms underlying mitochondrial quality control involving mitochondrial autophagy.	[Sandoval, Hector; Chen, Min; Wang, Jin] Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA; [Thiagarajan, Perumal; Dasgupta, Swapan K.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Schumacher, Armin] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Prchal, Josef T.] Univ Utah, Sch Med, Div Hematol, Salt Lake City, UT 84132 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Utah System of Higher Education; University of Utah	Chen, M (corresponding author), Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA.	minc@bcm.tmc.edu; jinwang@bcm.tmc.edu		Wang, Jin/0000-0002-3116-0838; Sandoval, Hector/0000-0002-9186-7384; Thiagarajan, Perumal/0000-0003-2186-7036; Chen, Min/0000-0002-0093-9056; Wang, Jin/0000-0002-7882-1699	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074949, R01AI056210, F31AI058932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087710] Funding Source: NIH RePORTER; NIAID NIH HHS [F31 AI058932, R01 AI056210, R01 AI074949, R01 AI074949-01, R01 AI056210-05] Funding Source: Medline; NIGMS NIH HHS [R01 GM087710] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aerbajinai W, 2003, BLOOD, V102, P712, DOI 10.1182/blood-2002-11-3324; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Diwan A, 2007, P NATL ACAD SCI USA, V104, P6794, DOI 10.1073/pnas.0610666104; Fader CM, 2006, AUTOPHAGY, V2, P122, DOI 10.4161/auto.2.2.2350; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; HEYNEN MJ, 1982, CELL TISSUE RES, V224, P397, DOI 10.1007/BF00216882; HOFFMANNFEZER G, 1993, ANN HEMATOL, V67, P81, DOI 10.1007/BF01788131; Holm TM, 2002, BLOOD, V99, P1817, DOI 10.1182/blood.V99.5.1817; Imazu T, 1999, ONCOGENE, V18, P4523, DOI 10.1038/sj.onc.1202722; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; KENT G, 1966, AM J PATHOL, V48, P831; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Koury MJ, 2005, BLOOD, V105, P2168, DOI 10.1182/blood-2004-02-0616; KOURY ST, 1989, J CELL BIOL, V109, P3005, DOI 10.1083/jcb.109.6.3005; Levin J, 1999, BLOOD, V94, P3037, DOI 10.1182/blood.V94.9.3037.421k42_3037_3047; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Mok H, 2004, DEVELOPMENT, V131, P4871, DOI 10.1242/dev.01342; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Raha S, 2001, AM J MED GENET, V106, P62, DOI 10.1002/ajmg.1398; Sivilotti Marco L A, 2004, Toxicol Rev, V23, P169; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Takano-Ohmuro H, 2000, EUR J CELL BIOL, V79, P759, DOI 10.1078/0171-9335-00096; Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Vannucchi AM, 2001, BLOOD, V97, P3040, DOI 10.1182/blood.V97.10.3040; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964	32	829	868	3	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2008	454	7201					232	U66		10.1038/nature07006	http://dx.doi.org/10.1038/nature07006			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18454133	Green Accepted			2022-12-24	WOS:000257466900047
J	Brodersen, P; Sakvarelidze-Achard, L; Bruun-Rasmussen, M; Dunoyer, P; Yamamoto, YY; Sieburth, L; Voinnet, O				Brodersen, Peter; Sakvarelidze-Achard, Lali; Bruun-Rasmussen, Marianne; Dunoyer, Patrice; Yamamoto, Yoshiharu Y.; Sieburth, Leslie; Voinnet, Olivier			Widespread translational inhibition by plant miRNAs and siRNAs	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; SILENCING PATHWAYS; DECAPPING COMPLEX; SMALL RNAS; MICRORNAS; GENE; ARGONAUTE1; STRESS; SPECIALIZATION; IDENTIFICATION	High complementarity between plant microRNAs ( miRNAs) and their messenger RNA targets is thought to cause silencing, prevalently by endonucleolytic cleavage. We have isolated Arabidopsis mutants defective in miRNA action. Their analysis provides evidence that plant miRNA- guided silencing has a widespread translational inhibitory component that is genetically separable from endonucleolytic cleavage. We further show that the same is true of silencing mediated by small interfering RNA ( siRNA) populations. Translational repression is effected in part by the ARGONAUTE proteins AGO1 and AGO10. It also requires the activity of the microtubule- severing enzyme katanin, implicating cytoskeleton dynamics in miRNA action, as recently suggested from animal studies. Also as in animals, the decapping component VARICOSE ( VCS)/ Ge- 1 is required for translational repression by miRNAs, which suggests that the underlying mechanisms in the two kingdoms are related.	[Brodersen, Peter; Sakvarelidze-Achard, Lali; Bruun-Rasmussen, Marianne; Dunoyer, Patrice; Voinnet, Olivier] CNRS, Inst Biol Mol Plantes, Unite Propre Rech 2357, F-67084 Strasbourg, France; [Yamamoto, Yoshiharu Y.] Nagoya Univ, Ctr Gene Res, Chikusa Ku, Aichi 4648602, Japan; [Sieburth, Leslie] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Nagoya University; Utah System of Higher Education; University of Utah	Voinnet, O (corresponding author), CNRS, Inst Biol Mol Plantes, Unite Propre Rech 2357, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	olivier.voinnet@ibmp-ulp.u-strasbg.fr	Yamamoto, Yoshiharu Y./B-6574-2011	Yamamoto, Yoshiharu Y./0000-0002-9667-0572; Voinnet, Olivier/0000-0001-6982-9544				Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bouquin T, 2003, J CELL SCI, V116, P791, DOI 10.1242/jcs.00274; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Dugas DV, 2008, PLANT MOL BIOL, V67, P403, DOI 10.1007/s11103-008-9329-1; Dunoyer P, 2007, NAT GENET, V39, P848, DOI 10.1038/ng2081; Eulalio A, 2007, GENE DEV, V21, P2558, DOI 10.1101/gad.443107; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Goeres DC, 2007, PLANT CELL, V19, P1549, DOI 10.1105/tpc.106.047621; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jones J, 2006, PROF ENG, V19, P19; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lo C, 2005, FEBS LETT, V579, P1498, DOI 10.1016/j.febslet.2005.01.062; Lynn K, 1999, DEVELOPMENT, V126, P469; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Moussian B, 1998, EMBO J, V17, P1799, DOI 10.1093/emboj/17.6.1799; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Parry DH, 2007, CURR BIOL, V17, P2013, DOI 10.1016/j.cub.2007.10.058; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rao MK, 2006, GENE DEV, V20, P147, DOI 10.1101/gad1367806; Rodriguez AJ, 2005, RNA, V11, P646, DOI 10.1261/rna.7198205; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Stoppin-Mellet V, 2006, PLANT J, V46, P1009, DOI 10.1111/j.1365-313X.2006.02761.x; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Wang HP, 2008, MOL BIOL CELL, V19, P105, DOI 10.1091/mbc.E07-06-0583; Wang JF, 2004, NUCLEIC ACIDS RES, V32, P1688, DOI 10.1093/nar/gkh332; Webb M, 2002, DEVELOPMENT, V129, P123; Xu J, 2006, PLANT CELL, V18, P3386, DOI 10.1105/tpc.106.047605; Yamasaki H, 2007, J BIOL CHEM, V282, P16369, DOI 10.1074/jbc.M700138200; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383	44	1063	1148	7	213	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 30	2008	320	5880					1185	1190		10.1126/science.1159151	http://dx.doi.org/10.1126/science.1159151			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306FF	18483398				2022-12-24	WOS:000256233000030
J	Reece, SE; Drew, DR; Gardner, A				Reece, Sarah E.; Drew, Damien R.; Gardner, Andy			Sex ratio adjustment and kin discrimination in malaria parasites	NATURE			English	Article							LOCAL MATE COMPETITION; PLASMODIUM-FALCIPARUM; POPULATION-STRUCTURE; TOXOPLASMA-GONDII; BLOOD PARASITES; PREMATURE REJECTION; FERTILITY INSURANCE; EVOLUTION; VIRULENCE; TRANSMISSION	Malaria parasites and related Apicomplexans are the causative agents of the some of the most serious infectious diseases of humans, companion animals, livestock and wildlife. These parasites must undergo sexual reproduction to transmit from vertebrate hosts to vectors, and their sex ratios are consistently female- biased. Sex allocation theory, a cornerstone of evolutionary biology, is remarkably successful at explaining female- biased sex ratios in multicellular taxa, but has proved controversial when applied to malaria parasites. Here we show that, as predicted by theory, sex ratio is an important fitness- determining trait and Plasmodium chabaudi parasites adjust their sex allocation in response to the presence of unrelated conspecifics. This suggests that P. chabaudi parasites use kin discrimination to evaluate the genetic diversity of their infections, and they adjust their behaviour in response to environmental cues. Malaria parasites provide a novel way to test evolutionary theory, and support the generality and power of a darwinian approach.	[Reece, Sarah E.; Gardner, Andy] Univ Edinburgh, Inst Evolut Biol, Ashworth Labs, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland; [Reece, Sarah E.; Drew, Damien R.] Univ Edinburgh, Inst Immunol & Infect Res, Ashworth Labs, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland; [Drew, Damien R.] Walter & Eliza Hall Inst Med Res, Ctr Biotechnol, Bundoora, Vic 3086, Australia	University of Edinburgh; University of Edinburgh; Walter & Eliza Hall Institute	Reece, SE (corresponding author), Univ Edinburgh, Inst Evolut Biol, Ashworth Labs, Sch Biol Sci, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	sarah.reece@ed.ac.uk	Reece, Sarah E/C-9447-2009; Reece, Sarah/AAA-6426-2020; Gardner, Andy/K-5353-2013	Reece, Sarah E/0000-0001-6716-6732; Reece, Sarah/0000-0001-6716-6732; Gardner, Andy/0000-0002-1304-3734	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Al-Olayan EM, 2002, INT J PARASITOL, V32, P1133, DOI 10.1016/S0020-7519(02)00087-5; CHARNOV E L, 1982; Conway DJ, 1999, P NATL ACAD SCI USA, V96, P4506, DOI 10.1073/pnas.96.8.4506; CROZIER RH, 1986, EVOLUTION, V40, P1100, DOI 10.1111/j.1558-5646.1986.tb00578.x; Drew DR, 2007, MOL BIOCHEM PARASIT, V156, P199, DOI 10.1016/j.molbiopara.2007.08.004; DYE C, 1993, J THEOR BIOL, V161, P131, DOI 10.1006/jtbi.1993.1045; Ferguson DJP, 2003, TRENDS PARASITOL, V19, P157, DOI 10.1016/S1471-4922(03)00032-1; Ferguson DJP, 2002, TRENDS PARASITOL, V18, P355, DOI 10.1016/S1471-4922(02)02330-9; Fisher R.A., 1930, GENETICAL THEORY NAT; FRANK S. A., 2002, EVOLUTION, V56, P2561; FRANK SA, 1990, ANNU REV ECOL SYST, V21, P13, DOI 10.1146/annurev.es.21.110190.000305; FRANK SA, 1992, P ROY SOC B-BIOL SCI, V250, P195, DOI 10.1098/rspb.1992.0149; FRANK SA, 1994, P ROY SOC B-BIOL SCI, V258, P153, DOI 10.1098/rspb.1994.0156; Gardner A, 2003, J THEOR BIOL, V223, P515, DOI 10.1016/S0022-5193(03)00142-5; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Hardy I.C.W, 2002, SEX RATIOS CONCEPTS; HERRE EA, 1993, SCIENCE, V259, P1442, DOI 10.1126/science.259.5100.1442; JANSE CJ, 1985, PARASITOLOGY, V91, P19, DOI 10.1017/S0031182000056481; Khan SM, 2005, CELL, V121, P675, DOI 10.1016/j.cell.2005.03.027; Mackinnon MJ, 1999, EVOLUTION, V53, P689, DOI [10.2307/2640710, 10.1111/j.1558-5646.1999.tb05364.x]; Mehdiabadi NJ, 2006, NATURE, V442, P881, DOI 10.1038/442881a; Nee S, 2002, P ROY SOC B-BIOL SCI, V269, P755, DOI 10.1098/rspb.2001.1938; Nesse RM, 1995, WHY WE GET SICK NEW; Osgood SM, 2002, J PARASITOL, V88, P494, DOI 10.1645/0022-3395(2002)088[0494:GSROAM]2.0.CO;2; Paul REL, 2003, ECOL LETT, V6, P866, DOI 10.1046/j.1461-0248.2003.00509.x; Paul REL, 2000, SCIENCE, V287, P128, DOI 10.1126/science.287.5450.128; PAUL REL, 1995, SCIENCE, V269, P1709, DOI 10.1126/science.7569897; Paul REL, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P153; Pickering J, 2000, EVOL ECOL RES, V2, P171; Razakandrainibe FG, 2005, P NATL ACAD SCI USA, V102, P17388, DOI 10.1073/pnas.0508871102; Read AF, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P314, DOI 10.1017/CBO9780511542053.016; READ AF, 1992, PARASITOLOGY, V104, P387, DOI 10.1017/S0031182000063630; READ AF, 1995, P ROY SOC B-BIOL SCI, V260, P359, DOI 10.1098/rspb.1995.0105; Reece SE, 2000, TRENDS ECOL EVOL, V15, P259, DOI 10.1016/S0169-5347(00)01893-0; Reece SE, 2005, P ROY SOC B-BIOL SCI, V272, P511, DOI 10.1098/rspb.2004.2972; Robert V, 2003, PARASITOLOGY, V127, P1, DOI 10.1017/S0031182003003299; Robert V, 1996, T ROY SOC TROP MED H, V90, P621, DOI 10.1016/S0035-9203(96)90408-3; Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169; Rousset F, 2007, EVOLUTION, V61, P2320, DOI 10.1111/j.1558-5646.2007.00191.x; Schall JJ, 2000, PARASITOLOGY, V121, P575, DOI 10.1017/S0031182000006818; SHUTLER D, 1995, P NATL ACAD SCI USA, V92, P6748, DOI 10.1073/pnas.92.15.6748; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; Walliker David, 1998, P235; WERREN JH, 1980, SCIENCE, V208, P1157, DOI 10.1126/science.208.4448.1157; West SA, 2005, EVOLUTION, V59, P1211; West SA, 2000, P ROY SOC B-BIOL SCI, V267, P257, DOI 10.1098/rspb.2000.0995; West SA, 2003, TRENDS PARASITOL, V19, P155, DOI 10.1016/S1471-4922(03)00033-3; West SA, 2002, J PARASITOL, V88, P258, DOI 10.1645/0022-3395(2002)088[0258:FIATSR]2.0.CO;2; West SA, 2001, TRENDS PARASITOL, V17, P525, DOI 10.1016/S1471-4922(01)02058-X; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461	50	159	164	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2008	453	7195					609	U1		10.1038/nature06954	http://dx.doi.org/10.1038/nature06954			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305NN	18509435	Green Accepted			2022-12-24	WOS:000256185200034
J	Li, GW; Zhang, P; Wang, JP; Gregg, EW; Yang, WY; Gong, QH; Li, H; Li, HL; Jiang, YY; An, YL; Shuai, Y; Zhang, B; Zhang, JL; Thompson, TJ; Gerzoff, RB; Roglic, G; Hu, YH; Bennett, PH				Li, Guangwei; Zhang, Ping; Wang, Jinping; Gregg, Edward W.; Yang, Wenying; Gong, Qiuhong; Li, Hui; Li, Hongliang; Jiang, Yayun; An, Yali; Shuai, Ying; Zhang, Bo; Zhang, Jingling; Thompson, Theodore J.; Gerzoff, Robert B.; Roglic, Gojka; Hu, Yinghua; Bennett, Peter H.			The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study	LANCET			English	Article							IMPAIRED GLUCOSE-TOLERANCE; MORTALITY; RISK; REDUCTION; EXERCISE; PROGRAM; PEOPLE; NIDDM; IGT	Background Intensive lifestyle interventions can reduce the incidence of type 2 diabetes in people with impaired glucose tolerance, but how long these benefits extend beyond the period of active intervention, and whether such interventions reduce the risk of cardiovascular disease (CVD) and mortality, is unclear. We aimed to assess whether intensive lifestyle interventions have a long-term effect on the risk of diabetes, diabetes-related macrovascular and microvascular complications, and mortality. Methods In 1986, 577 adults with impaired glucose tolerance from 33 clinics in China were randomly assigned to either the control group or to one of three lifestyle intervention groups (diet, exercise, or diet plus exercise). Active intervention took place over 6 years until 1992. In 2006, study participants were followed-up to assess the long-term effect of the interventions. The primary outcomes were diabetes incidence, CVD incidence and mortality, and all-cause mortality. Findings Compared with control participants, those in the combined lifestyle intervention groups had a 51% lower incidence of diabetes (hazard rate ratio [HRR] 0 . 49; 95% CI 0 . 33-0-73) during the active intervention period and a 43% lower incidence (0 . 57; 0 . 41-0 . 81) over the 20 year period, controlled for age and clustering by clinic. The average annual incidence of diabetes was 7% for intervention participants versus 11% in control participants, with 20-year cumulative incidence of 80% in the intervention groups and 93% in the control group. Participants in the intervention group spent an average of 3.6 fewer years with diabetes than those in the control group. There was no significant difference between the intervention and control groups in the rate of first CVD events (HRR 0 . 98; 95% CI 0 . 71-1.37), CVD mortality (0 . 83; 0.48-1.40), and all-cause mortality (0 - 96; 0 . 65-1.41), but our study had limited statistical power to detect differences for these outcomes. Interpretation Group-based lifestyle interventions over 6 years can prevent or delay diabetes for up to 14 years after the active intervention. However, whether lifestyle intervention also leads to reduced CVD and mortality remains unclear. Funding Centers for Disease Control and Prevention, WHO, the China-Japan Friendship Hospital, and Da Qing First Hospital.	[Zhang, Ping; Gregg, Edward W.; Thompson, Theodore J.; Gerzoff, Robert B.] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Diabet Translat, Atlanta, GA 30341 USA; [Li, Guangwei; Yang, Wenying; Gong, Qiuhong; Li, Hongliang; An, Yali; Shuai, Ying; Zhang, Bo] China Japan Friendship Hosp, Dept Endocrinol, Beijing 100029, Peoples R China; [Wang, Jinping; Li, Hui; Jiang, Yayun; Zhang, Jingling; Hu, Yinghua] Da Qing First Hosp, Dept Cardiol, Da Qing, Peoples R China; [Roglic, Gojka] WHO, Dept Chron Dis & Hlth Promot, CH-1211 Geneva, Switzerland; [Bennett, Peter H.] NIDDKD, Phoenix Epidemiol & Clin Res Branch, NIH, Phoenix, AZ USA	Centers for Disease Control & Prevention - USA; China-Japan Friendship Hospital; World Health Organization; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Zhang, P (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Diabet Translat, Atlanta, GA 30341 USA.	guangwei_li@medmail.com.cn; pzhang@cdc.gov	Bennett, Peter/AAH-9605-2021; Northe, Hilda/I-1916-2012; wang, jinping/AAE-4392-2020; Li, Hongliang/AAV-1697-2020	Northe, Hilda/0000-0002-8873-5014; Roglic, Gojka/0000-0003-0872-0689; Gregg, Edward/0000-0003-2381-6822	PHS HHS [U58/CCU424123-01-02] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Chiasson Jean-Louis, 2006, Endocr Pract, V12 Suppl 1, P25; Chiasson JL, 2003, JAMA-J AM MED ASSOC, V290, P486, DOI 10.1001/jama.290.4.486; EFRON B, 1988, J AM STAT ASSOC, V83, P414, DOI 10.2307/2288857; Gelman A., 2007, DATA ANAL USING REGR; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Holloszy JO, 2005, J APPL PHYSIOL, V99, P338, DOI 10.1152/japplphysiol.00123.2005; *INT DIAB FED, 2006, DIAB ATL; Knowler WC, 1997, DIABETOLOGIA, V40, P680, DOI 10.1007/s001250050734; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kosaka K, 2005, DIABETES RES CLIN PR, V67, P152, DOI 10.1016/j.diabres.2004.06.010; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130; Rubin RR, 2002, CONTROL CLIN TRIALS, V23, P157; SAAD MF, 1988, NEW ENGL J MED, V319, P1500, DOI 10.1056/NEJM198812083192302; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; *WHO, 1985, TECHN REP SER GHO, V727; Wu YF, 2006, BMJ-BRIT MED J, V333, P362, DOI 10.1136/bmj.333.7564.362; Wu ZS, 2001, CIRCULATION, V103, P462	24	1034	1161	4	162	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 24	2008	371	9626					1783	1789		10.1016/S0140-6736(08)60766-7	http://dx.doi.org/10.1016/S0140-6736(08)60766-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	304IO	18502303				2022-12-24	WOS:000256103400033
J	Schreiner, P; Chen, X; Husnjak, K; Randles, L; Zhang, NX; Elsasser, S; Finley, D; Dikic, I; Walters, KJ; Groll, M				Schreiner, Patrick; Chen, Xiang; Husnjak, Koraljka; Randles, Leah; Zhang, Naixia; Elsasser, Suzanne; Finley, Daniel; Dikic, Ivan; Walters, Kylie J.; Groll, Michael			Ubiquitin docking at the proteasome through a novel pleckstrin-homology domain interaction	NATURE			English	Article							DEUBIQUITINATING ENZYME; STRUCTURAL BASIS; MULTIUBIQUITIN CHAIN; PROTEIN INTERACTOME; EAP45-GLUE DOMAIN; RECOGNITION; DEGRADATION; COMPLEX; BINDING; SUBUNIT	Targeted protein degradation is largely performed by the ubiquitin-proteasome pathway, in which substrate proteins are marked by covalently attached ubiquitin chains that mediate recognition by the proteasome. It is currently unclear how the proteasome recognizes its substrates, as the only established ubiquitin receptor intrinsic to the proteasome is Rpn10/S5a (ref. 1), which is not essential for ubiquitin- mediated protein degradation in budding yeast(2). In the accompanying manuscript we report that Rpn13 (refs 3-7), a component of the nine-subunit proteasome base, functions as a ubiquitin receptor(8), complementing its known role in docking de-ubiquitinating enzyme Uch37/UCHL5 (refs 4-6) to the proteasome. Here we merge crystallography and NMRdata to describe the ubiquitin-binding mechanism of Rpn13. We determine the structure of Rpn13 alone and complexed with ubiquitin. The co-complex reveals a novel ubiquitin-binding mode in which loops rather than secondary structural elements are used to capture ubiquitin. Further support for the role of Rpn13 as a proteasomal ubiquitin receptor is demonstrated by its ability to bind ubiquitin and proteasome subunit Rpn2/S1 simultaneously. Finally, we provide a model structure of Rpn13 complexed to diubiquitin, which provides insights into how Rpn13 as a ubiquitin receptor is coupled to substrate deubiquitination by Uch37.	[Schreiner, Patrick; Groll, Michael] Tech Univ Munich, Ctr Integrated Prot Sci, Dept Chem, Lehrstuhl Biochem, D-85747 Garching, Germany; [Chen, Xiang; Randles, Leah; Zhang, Naixia; Walters, Kylie J.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Husnjak, Koraljka; Dikic, Ivan] Univ Frankfurt, Inst Biochem 2, D-60590 Frankfurt, Germany; [Husnjak, Koraljka; Dikic, Ivan] Mediterranean Inst Life Sci, Tumor Biol Program, Split 21000, Croatia; [Elsasser, Suzanne; Finley, Daniel] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Dikic, Ivan] Univ Split, Sch Med, Dept Immunol, Split 21000, Croatia; [Groll, Michael] Charite Univ Med Berlin CCM, Inst Biochem, D-10117 Berlin, Germany	Technical University of Munich; University of Minnesota System; University of Minnesota Twin Cities; Goethe University Frankfurt; Harvard University; Harvard Medical School; University of Split; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Groll, M (corresponding author), Tech Univ Munich, Ctr Integrated Prot Sci, Dept Chem, Lehrstuhl Biochem, Lichtenbergstr 4, D-85747 Garching, Germany.	ivan.dikic@biochem2.de; walte048@umn.edu; michael.groll@ch.tum.de	Dikic, Ivan/O-4650-2015; Groll, Michael/F-5572-2015; Groll, Michael/C-1174-2010; Husnjak, Koraljka/C-3717-2015; Chen, Xiang/E-2840-2010	Dikic, Ivan/0000-0001-8156-9511; Husnjak, Koraljka/0000-0003-0573-6239; Schreiner, Patrick/0000-0002-3141-9133	NCI NIH HHS [R01 CA097004-05, R01 CA097004, CA097004, R01 CA097004-06A1] Funding Source: Medline; NIGMS NIH HHS [R37 GM043601-17, T32 GM008700-09, R37 GM043601, R01 GM043601, T32 GM008700, GM43601, GM008700] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA097004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043601, T32GM008700, R37GM043601] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alam SL, 2006, NAT STRUCT MOL BIOL, V13, P1029, DOI 10.1038/nsmb1160; BORNAR MG, 2007, EMBO REP, V8, P247; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; Fu HY, 1998, J BIOL CHEM, V273, P1970, DOI 10.1074/jbc.273.4.1970; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P1031, DOI 10.1038/nsmb1163; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jorgensen JP, 2006, J MOL BIOL, V360, P1043, DOI 10.1016/j.jmb.2006.06.011; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Lam YA, 1997, J BIOL CHEM, V272, P28438, DOI 10.1074/jbc.272.45.28438; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Swanson KA, 2003, EMBO J, V22, P4597, DOI 10.1093/emboj/cdg471; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	28	249	256	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 22	2008	453	7194					548	552		10.1038/nature06924	http://dx.doi.org/10.1038/nature06924			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303EL	18497827	Green Accepted			2022-12-24	WOS:000256023700048
